Citrus Sinensis ID: 038671
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 707 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VZG8 | 1045 | Probable LRR receptor-lik | yes | no | 0.991 | 0.670 | 0.484 | 0.0 | |
| Q9LP24 | 1120 | Probable leucine-rich rep | no | no | 0.963 | 0.608 | 0.491 | 0.0 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.984 | 0.632 | 0.368 | 1e-124 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.981 | 0.555 | 0.366 | 1e-121 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.988 | 0.558 | 0.357 | 1e-119 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.985 | 0.632 | 0.345 | 1e-114 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.980 | 0.616 | 0.359 | 1e-113 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.987 | 0.614 | 0.333 | 1e-108 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.971 | 0.602 | 0.326 | 1e-106 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.968 | 0.683 | 0.346 | 1e-105 |
| >sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3 | Back alignment and function desciption |
|---|
Score = 697 bits (1798), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/735 (48%), Positives = 500/735 (68%), Gaps = 34/735 (4%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
N+ LA L+LY N +GSIP E+G ++S+ DLE+S NKL G +P S G LT + +L L D
Sbjct: 308 NIKTLAVLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRD 367
Query: 61 NALSGAIPKEYGNLVKLTLL------------------------TLENNQLRGPIP-NLR 95
N LSG IP N +LT+L TL++N GP+P +LR
Sbjct: 368 NQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLR 427
Query: 96 NLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS 155
+ SL+RVR N +G+ISE+FG++P L FIDLS+N F+G++S++W + KL S+
Sbjct: 428 DCKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSN 487
Query: 156 NNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG 215
N+ITG++P EI + +QL LDLSSN I GE+P + ++ + KL LN N+L G++ +
Sbjct: 488 NSITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIR 547
Query: 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275
LT LE LDLSSNR S+ IP +L NL +L+Y+NLS N + IP L KL L LDLS+
Sbjct: 548 LLTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSY 607
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA 335
N L E+ SQ ++Q+LE+L+LSHNNLSG IP F+++ L+++D+S+N L G IP++ A
Sbjct: 608 NQLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAA 667
Query: 336 FRDAPMEALQGNKGLCGDI---KGFPSCKASKSHK-QASRKIWVVIVFPLLGSFALLISL 391
FR+AP +A +GNK LCG + +G C + S K R + + I+ P++G+ +L
Sbjct: 668 FRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVC 727
Query: 392 IGLFFMFRRSSSQTQQSSPGNAPG-FLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQG 450
G+F FR+ + Q ++ + + G LS+ SF+GK+ Y+EII+ T +FD ++ IG GG G
Sbjct: 728 AGIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHG 787
Query: 451 SVYKAELPSGEIVAVKKFHSPLPSEMA---SQQEFLNEVKTLTGIRHRNIVKFYGFCSHA 507
VYKA+LP+ I+AVKK + S ++ ++QEFLNE++ LT IRHRN+VK +GFCSH
Sbjct: 788 KVYKAKLPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHR 846
Query: 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDI 567
R++F+VYEY+E GSL +L ND AK L W KR+NV+KGV ALSYMH+D P IVHRDI
Sbjct: 847 RNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDI 906
Query: 568 SSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSF 627
SS N+LL + EA +SDFGTAK LKPDSSNW+ +AGTYGYVAPELAY MKVTEKCDVYSF
Sbjct: 907 SSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSF 966
Query: 628 GVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISC 687
GVL LEVIKG+HP D +S++SSS + ++L + D RLP P+ ++++++ I++VA+ C
Sbjct: 967 GVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLC 1026
Query: 688 LDESPESRPTIQKVS 702
L P++RPT+ +S
Sbjct: 1027 LHSDPQARPTMLSIS 1041
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 661 bits (1706), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/718 (49%), Positives = 474/718 (66%), Gaps = 37/718 (5%)
Query: 17 GSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVK 76
G IP E+G ++S+ +L+LS NKL GS+P S GN T++ L L N LSGAIP N
Sbjct: 404 GVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSH 463
Query: 77 LTLLTLENN------------------------QLRGPIP-NLRNLTSLVRVRLNQNHLT 111
LT L L+ N L GPIP +LR+ SL+R R N T
Sbjct: 464 LTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFT 523
Query: 112 GNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQ 171
G+I E+FGI+P+L FID SHN F+GEISS+W + PKLG L S+NNITG++P EI + +Q
Sbjct: 524 GDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQ 583
Query: 172 LKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLS 231
L LDLS+N++ GE+P +G L++L +L LN NQL G++ L LT LE LDLSSN S
Sbjct: 584 LVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFS 643
Query: 232 NSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQS 291
+ IP++ + +KLH +NLS N+F IP L KL L++LDLSHN L E+PSQ+ ++QS
Sbjct: 644 SEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQS 702
Query: 292 LEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLC 351
L+KL+LSHNNLSG IP+ FE + L+ +DIS N+L G +P++ FR A +AL+ N GLC
Sbjct: 703 LDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLC 762
Query: 352 GDI---KGFPSCKASKSHKQASRKIWVVIVFPLLGSFALLISLIGLF-FMFRRSSSQTQQ 407
+I + P + K K + +W+++ P+LG +L F + R+ Q +
Sbjct: 763 SNIPKQRLKPCRELKKPKKNGNLVVWILV--PILGVLVILSICANTFTYCIRKRKLQNGR 820
Query: 408 SSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKK 467
++ +S+ S +GK Y++II TN+FD H IG GG VY+A L I+AVK+
Sbjct: 821 NTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANL-QDTIIAVKR 879
Query: 468 FHSPLPSEMAS---QQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAM 524
H + E++ +QEFLNEVK LT IRHRN+VK +GFCSH RH+F++YEY+E GSL
Sbjct: 880 LHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNK 939
Query: 525 ILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSD 584
+L+ND AK L WTKR+NV+KGV ALSYMH+D PIVHRDISS N+LLD + A +SD
Sbjct: 940 LLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISD 999
Query: 585 FGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFI 644
FGTAK LK DSSNW+ +AGTYGYVAPE AYTMKVTEKCDVYSFGVL LE+I GKHP D +
Sbjct: 1000 FGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLV 1059
Query: 645 SSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVS 702
SS+SSS ++L + D R+ P ++KL+ ++E+A+ CL +PESRPT+ +S
Sbjct: 1060 SSLSSSPGE-ALSLRSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSIS 1116
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 445 bits (1144), Expect = e-124, Method: Compositional matrix adjust.
Identities = 275/747 (36%), Positives = 395/747 (52%), Gaps = 51/747 (6%)
Query: 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNAL 63
NL L+L+ N G IP E+G L L L+LS N+L G+IP L L + L LFDN L
Sbjct: 332 NLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQL 391
Query: 64 SGAIPKEYGNLVKLTLLTLENNQLRGPIP-------------------------NLRNLT 98
G IP G ++L + N L GPIP +L+
Sbjct: 392 EGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCK 451
Query: 99 SLVRVRLNQNHLTGNIS-ESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNN 157
SL ++ L N LTG++ E F + NL ++L N+ G IS+D G+ L L ++NN
Sbjct: 452 SLTKLMLGDNQLTGSLPIELFNLQ-NLTALELHQNWLSGNISADLGKLKNLERLRLANNN 510
Query: 158 ITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSL 217
TG +P EI + +++ ++SSN + G +P +LG ++ +L L+ N+ G ++ ELG L
Sbjct: 511 FTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQL 570
Query: 218 TQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLS-ELDLSHN 276
LE L LS NRL+ IP S G+L +L L L N + IPVEL KL L L++SHN
Sbjct: 571 VYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHN 630
Query: 277 FLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAF 336
L +P + N+Q LE L L+ N LSG IP+ L L +IS N L G++P++ F
Sbjct: 631 NLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVF 690
Query: 337 RDAPMEALQGNKGLCGDIKGFPSCKASKSHKQ---------ASRKIWVVIVFPLLGSFAL 387
+ GN GLC + C+ H + R+ + I ++GS
Sbjct: 691 QRMDSSNFAGNHGLCNSQRS--HCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGS-VF 747
Query: 388 LISLIGLFFMFRRSSSQTQQSSPGNAPGFLSVLSFEGK-IVYEEIIRVTNDFDDEHCIGK 446
LI+ +GL + +R P + F K Y+ ++ T +F ++ +G+
Sbjct: 748 LITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGR 807
Query: 447 GGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH 506
G G+VYKAE+ GE++AVKK +S +S F E+ TL IRHRNIVK YGFC H
Sbjct: 808 GACGTVYKAEMSGGEVIAVKKLNSR-GEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYH 866
Query: 507 ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRD 566
+ ++YEY+ GSL L L W R + G + L Y+H+DC P IVHRD
Sbjct: 867 QNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRD 926
Query: 567 ISSKNVLLDLENEAHVSDFGTAKFLKPD-SSNWAELAGTYGYVAPELAYTMKVTEKCDVY 625
I S N+LLD +AHV DFG AK + S + + +AG+YGY+APE AYTMKVTEKCD+Y
Sbjct: 927 IKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIY 986
Query: 626 SFGVLALEVIKGKHP-------RDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLI 678
SFGV+ LE+I GK P D ++ + S N+ I EM D RL T ++
Sbjct: 987 SFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNM-IPTIEMFDARLDTNDKRTVHEMS 1045
Query: 679 SIMEVAISCLDESPESRPTIQKVSQLL 705
++++A+ C SP SRPT+++V ++
Sbjct: 1046 LVLKIALFCTSNSPASRPTMREVVAMI 1072
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 434 bits (1117), Expect = e-121, Method: Compositional matrix adjust.
Identities = 288/785 (36%), Positives = 417/785 (53%), Gaps = 91/785 (11%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
N ++L + ++ N F G IP IGRLK L+ L L N+L G +P SLGN Q+ L L D
Sbjct: 454 NCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLAD 513
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNI----- 114
N LSG+IP +G L L L L NN L+G +P+ L +L +L R+ L+ N L G I
Sbjct: 514 NQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCG 573
Query: 115 SESF------------------GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSN 156
S S+ G NL + L N G+I G+ +L LD SSN
Sbjct: 574 SSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSN 633
Query: 157 NITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGS 216
+TG++P +++ +L +DL++N + G +P LGKLS L +L L+SNQ L EL +
Sbjct: 634 ALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFN 693
Query: 217 LTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHN 276
T+L L L N L+ SIP+ +GNL L+ LNL NQF +P + KL L EL LS N
Sbjct: 694 CTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRN 753
Query: 277 FLGEEMPSQICNMQSLE-KLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA 335
L E+P +I +Q L+ L+LS+NN +G IPS L L +D+S+N+L G +P S
Sbjct: 754 SLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVG 813
Query: 336 ----------------------FRDAPMEALQGNKGLCGDIKGFPSCKASKSHKQ----A 369
F P ++ GN GLCG C +S+ + +
Sbjct: 814 DMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCG--SPLSRCNRVRSNNKQQGLS 871
Query: 370 SRKIWVVIVFPLLGSFALLISLIGLFFMFRR---------SSSQTQQSSPGNA---PGFL 417
+R + ++ L + L+I +I LFF R S++ T SS A P F
Sbjct: 872 ARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFR 931
Query: 418 SVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMA 477
+ S + I +E+I+ T++ +E IG GG G VYKAEL +GE VAVKK ++
Sbjct: 932 NGAS-KSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKIL--WKDDLM 988
Query: 478 SQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH--SFIVYEYLEMGSLAMILSNDAAA--- 532
S + F EVKTL IRHR++VK G+CS + ++YEY++ GS+ L D
Sbjct: 989 SNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEK 1048
Query: 533 --KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590
K L W R+ + G+ + Y+H+DC PPIVHRDI S NVLLD EAH+ DFG AK
Sbjct: 1049 KKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKV 1108
Query: 591 L------KPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFI 644
L DS+ W A +YGY+APE AY++K TEK DVYS G++ +E++ GK P D +
Sbjct: 1109 LTENCDTNTDSNTW--FACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSV 1166
Query: 645 -----SSISSSSSNLEI---ALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRP 696
+ ++LE+ A ++++DP+L +D ++E+A+ C SP+ RP
Sbjct: 1167 FGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERP 1226
Query: 697 TIQKV 701
+ ++
Sbjct: 1227 SSRQA 1231
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 429 bits (1103), Expect = e-119, Method: Compositional matrix adjust.
Identities = 280/784 (35%), Positives = 413/784 (52%), Gaps = 85/784 (10%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
N + L + Y N SG IPS IGRLK L+ L L N+L G+IP SLGN Q+T + L D
Sbjct: 455 NCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLAD 514
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIP----NLRNL------------------- 97
N LSG+IP +G L L L + NN L+G +P NL+NL
Sbjct: 515 NQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCG 574
Query: 98 -------------------------TSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHN 132
T+L R+RL +N TG I +FG L+ +D+S N
Sbjct: 575 SSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRN 634
Query: 133 YFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGK 192
G I + G C KL +D ++N ++G +P + L L LSSN VG +P+++
Sbjct: 635 SLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFS 694
Query: 193 LSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNN 252
L++++ L L+ N L G + E+G+L L L+L N+LS +P ++G L KL L LS N
Sbjct: 695 LTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRN 754
Query: 253 QFIKKIPVELEKLIHL-SELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFE 311
+IPVE+ +L L S LDLS+N +PS I + LE L+LSHN L G +P
Sbjct: 755 ALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIG 814
Query: 312 ELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIKGFPSCKASKSHKQASR 371
++ L Y+++SYN L G + F +A GN GLCG + SK+ + S
Sbjct: 815 DMKSLGYLNLSYNNLEGKL--KKQFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSP 872
Query: 372 KIWVVI-VFPLLGSFALLISLIGLFF-----MFRR----SSSQTQQSSPGNAPGFLSVLS 421
K V+I L + AL++ +I LFF +F++ +S+ + SS AP F S
Sbjct: 873 KTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLF-SNGG 931
Query: 422 FEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQE 481
+ I +++I+ T+ ++E IG GG G VYKAEL +GE +AVKK ++ S +
Sbjct: 932 AKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKIL--WKDDLMSNKS 989
Query: 482 FLNEVKTLTGIRHRNIVKFYGFCSHARH--SFIVYEYLEMGSLAMIL---SNDAAAKDLG 536
F EVKTL IRHR++VK G+CS + ++YEY+ GS+ L N + LG
Sbjct: 990 FNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLG 1049
Query: 537 WTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596
W R+ + G+ + Y+H DC PPIVHRDI S NVLLD EAH+ DFG AK L +
Sbjct: 1050 WETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYD 1109
Query: 597 NWAE----LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD---------- 642
E AG+YGY+APE AY++K TEK DVYS G++ +E++ GK P +
Sbjct: 1110 TNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMV 1169
Query: 643 -FISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
++ ++ + E A +++D L + ++ ++E+A+ C P+ RP+ ++
Sbjct: 1170 RWVETVLDTPPGSE-AREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQA 1228
Query: 702 SQLL 705
S+ L
Sbjct: 1229 SEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 412 bits (1060), Expect = e-114, Method: Compositional matrix adjust.
Identities = 276/800 (34%), Positives = 409/800 (51%), Gaps = 103/800 (12%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+L +L FLYLY N +G+IP EIG L +++ S N L G IP LGN+ + L LF+
Sbjct: 287 DLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFE 346
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFG 119
N L+G IP E L L+ L L N L GPIP + L L ++L QN L+G I G
Sbjct: 347 NQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLG 406
Query: 120 IHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS 179
+ +L +D+S N+ G I S + L+ +NN++G++P I L L L+
Sbjct: 407 WYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLAR 466
Query: 180 NHIVGEMPSKL------------------------GKLSSLIKLILNSNQLCGQLSLELG 215
N++VG PS L G S+L +L L N G+L E+G
Sbjct: 467 NNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIG 526
Query: 216 SLTQLERLDLSSNRL------------------------SNSIPKSLGNLVKLHYLNLSN 251
L+QL L++SSN+L S ++P +G+L +L L LSN
Sbjct: 527 MLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSN 586
Query: 252 NQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLE-KLNLSHNNL-------- 302
N IPV L L L+EL + N +P ++ ++ L+ LNLS+N L
Sbjct: 587 NNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPEL 646
Query: 303 ----------------SGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQG 346
SG IPS F L L + SYN L G IP R+ M + G
Sbjct: 647 SNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIG 703
Query: 347 NKGLCG-------DIKGF-PSCKASKSHKQASRKIWVVIVFPLLGSFALLISLIGLFFMF 398
N+GLCG + F PS K S KI + + G +LI+LI ++
Sbjct: 704 NEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALI--VYLM 761
Query: 399 RRSSSQTQQSSPGNAPGFLSV-LSFEGK--IVYEEIIRVTNDFDDEHCIGKGGQGSVYKA 455
RR S+ P +S+ + F K +++++ T++FD+ +G+G G+VYKA
Sbjct: 762 RRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKA 821
Query: 456 ELPSGEIVAVKKFHSPLPSEMASQQE--FLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513
LP+G +AVKK S + + F E+ TL IRHRNIVK +GFC+H + ++
Sbjct: 822 VLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLL 881
Query: 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVL 573
YEY+ GSL IL + + +L W+KR + G L+Y+H+DC P I HRDI S N+L
Sbjct: 882 YEYMPKGSLGEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNIL 939
Query: 574 LDLENEAHVSDFGTAKFLK-PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLAL 632
LD + EAHV DFG AK + P S + + +AG+YGY+APE AYTMKVTEK D+YS+GV+ L
Sbjct: 940 LDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLL 999
Query: 633 EVIKGKHP-------RDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAI 685
E++ GK P D ++ + S ++ + +LD RL + +++++++A+
Sbjct: 1000 ELLTGKAPVQPIDQGGDVVNWVRSYIRRDALS-SGVLDARLTLEDERIVSHMLTVLKIAL 1058
Query: 686 SCLDESPESRPTIQKVSQLL 705
C SP +RP++++V +L
Sbjct: 1059 LCTSVSPVARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 411 bits (1056), Expect = e-113, Method: Compositional matrix adjust.
Identities = 274/763 (35%), Positives = 402/763 (52%), Gaps = 70/763 (9%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
+S L LYL+ N +G IP+E+ +L++L+ L+LS N L G IP NLT + L LF N
Sbjct: 348 ISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHN 407
Query: 62 ALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN---------LRNL--------------- 97
+LSG IP+ G L ++ NQL G IP L NL
Sbjct: 408 SLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLR 467
Query: 98 -TSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSN 156
SL+++R+ N LTG NL+ I+L N F G + + G C KL L ++N
Sbjct: 468 CKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAAN 527
Query: 157 NITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGS 216
+ ++P EI S L ++SSN + G +PS++ L +L L+ N G L ELGS
Sbjct: 528 QFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGS 587
Query: 217 LTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLS-ELDLSH 275
L QLE L LS NR S +IP ++GNL L L + N F IP +L L L ++LS+
Sbjct: 588 LHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSY 647
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA 335
N E+P +I N+ L L+L++N+LSG IP+ FE L L + SYN L G +P++
Sbjct: 648 NDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQI 707
Query: 336 FRDAPMEALQGNKGLCGDIKGFPSCKASKSH-------KQASRKIWVVIVFPLLGSFALL 388
F++ + + GNKGLCG SC S S K S + +I+ +
Sbjct: 708 FQNMTLTSFLGNKGLCGG--HLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGIS 765
Query: 389 ISLIGLFFMFRRSSSQTQQSSPGNAPGFL--SVLSF--EGKIVYEEIIRVTNDFDDEHCI 444
+ LI + F R+ + + F S + F + + ++I+ T F D + +
Sbjct: 766 LLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIV 825
Query: 445 GKGGQGSVYKAELPSGEIVAVKKFH----SPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
G+G G+VYKA +PSG+ +AVKK + + F E+ TL IRHRNIV+
Sbjct: 826 GRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRL 885
Query: 501 YGFCSH--ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC 558
Y FC H + + ++YEY+ GSL +L + + + W R + G + L+Y+H+DC
Sbjct: 886 YSFCYHQGSNSNLLLYEYMSRGSLGELL-HGGKSHSMDWPTRFAIALGAAEGLAYLHHDC 944
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK-PDSSNWAELAGTYGYVAPELAYTMK 617
P I+HRDI S N+L+D EAHV DFG AK + P S + + +AG+YGY+APE AYTMK
Sbjct: 945 KPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMK 1004
Query: 618 VTEKCDVYSFGVLALEVIKGKHP--------------RDFISSISSSSSNLEIALNEMLD 663
VTEKCD+YSFGV+ LE++ GK P R+ I S +S E+LD
Sbjct: 1005 VTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDHSLTS--------EILD 1056
Query: 664 PRLPTPSHNV-QDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
P L +V + +I++ ++A+ C SP RPT+++V +L
Sbjct: 1057 PYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 392 bits (1008), Expect = e-108, Method: Compositional matrix adjust.
Identities = 266/798 (33%), Positives = 402/798 (50%), Gaps = 100/798 (12%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
N S L L+LY+N SG++P E+G+L++L + L N L G IP +G + + + L
Sbjct: 273 NCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSM 332
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFG 119
N SG IPK +GNL L L L +N + G IP+ L N T LV+ +++ N ++G I G
Sbjct: 333 NYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIG 392
Query: 120 IHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS 179
+ L N G I + C L LD S N +TGS+PA + L L L S
Sbjct: 393 LLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLIS 452
Query: 180 NHIVGEMPSKLGKLSSLIKLILNSNQLCGQ------------------------------ 209
N I G +P ++G +SL++L L +N++ G+
Sbjct: 453 NAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEIS 512
Query: 210 ------------------LSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSN 251
L L L SLT+L+ LD+SSN L+ IP SLG+L+ L+ L LS
Sbjct: 513 NCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSK 572
Query: 252 NQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLE-KLNLSHNNLSGFIPSCF 310
N F +IP L +L LDLS N + +P ++ ++Q L+ LNLS N+L GFIP
Sbjct: 573 NSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERI 632
Query: 311 EELHGLSYIDISYNELHGS-----------------------IPNSTAFRDAPMEALQGN 347
L+ LS +DIS+N L G +P+S FR ++GN
Sbjct: 633 SALNRLSVLDISHNMLSGDLSALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGN 692
Query: 348 KGLCGDIKGFPSCKASKSHKQASRKI----WVVIVFPLLGSFALLISLIGLFFMFRRSS- 402
GLC KGF SC S S + +++ + I LL S +++++G+ + R
Sbjct: 693 NGLCS--KGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQM 750
Query: 403 -SQTQQSSPGNAPGFLSVLSFEG-KIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSG 460
S G F+ E +++ + + IGKG G VYKAE+P+
Sbjct: 751 IRDDNDSETGENLWTWQFTPFQKLNFTVEHVLKC---LVEGNVIGKGCSGIVYKAEMPNR 807
Query: 461 EIVAVKK-FHSPLPS------EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513
E++AVKK + +P+ + F EVKTL IRH+NIV+F G C + ++
Sbjct: 808 EVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLM 867
Query: 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVL 573
Y+Y+ GSL +L + LGW R +I G L+Y+H+DC PPIVHRDI + N+L
Sbjct: 868 YDYMSNGSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNIL 927
Query: 574 LDLENEAHVSDFGTAKFLKPDSSNWAE----LAGTYGYVAPELAYTMKVTEKCDVYSFGV 629
+ + E ++ DFG AK + D ++A +AG+YGY+APE Y+MK+TEK DVYS+GV
Sbjct: 928 IGPDFEPYIGDFGLAKLV--DDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGV 985
Query: 630 LALEVIKGKHPRD--FISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISC 687
+ LEV+ GK P D + +I +++D L + ++++ + VA+ C
Sbjct: 986 VVLEVLTGKQPIDPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEVEEMMQTLGVALLC 1045
Query: 688 LDESPESRPTIQKVSQLL 705
++ PE RPT++ V+ +L
Sbjct: 1046 INPIPEDRPTMKDVAAML 1063
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 386 bits (992), Expect = e-106, Method: Compositional matrix adjust.
Identities = 265/812 (32%), Positives = 407/812 (50%), Gaps = 125/812 (15%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
N S L L+LY NS SGSIP EIG+L L L L N L G IP +GN + + + L
Sbjct: 272 NCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSL 331
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFG 119
N LSG+IP G L L + +N+ G IP + N +SLV+++L++N ++G I G
Sbjct: 332 NLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELG 391
Query: 120 IHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPA--------------- 164
L N G I C L LD S N++TG++P+
Sbjct: 392 TLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLIS 451
Query: 165 ---------EIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG 215
EI + S L L L N I GE+PS +G L + L +SN+L G++ E+G
Sbjct: 452 NSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIG 511
Query: 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSE----- 270
S ++L+ +DLS+N L S+P + +L L L++S NQF KIP L +L+ L++
Sbjct: 512 SCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSK 571
Query: 271 -------------------LDLSHNFLGEEMPSQICNMQSLE-KLNLSHNNLSGFIPSCF 310
LDL N L E+PS++ ++++LE LNLS N L+G IPS
Sbjct: 572 NLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKI 631
Query: 311 EELHGLSYID-----------------------ISYNELHGSIPNSTAFRDAPMEALQGN 347
L+ LS +D ISYN G +P++ FR + L+GN
Sbjct: 632 ASLNKLSILDLSHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGN 691
Query: 348 KGLCGDIKGFPSC--------------KASKSHK---QASRKIWVVIVFPLLGSFALLIS 390
K LC + SC AS++ K + I + +V +LG+ A++ +
Sbjct: 692 KKLCSSTQD--SCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRA 749
Query: 391 LIGLFFMFRRSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQG 450
RR+ + S G + + ++IIR + + IGKG G
Sbjct: 750 --------RRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRC---LVEPNVIGKGCSG 798
Query: 451 SVYKAELPSGEIVAVKKFHSPLPSEMASQQ------EFLNEVKTLTGIRHRNIVKFYGFC 504
VY+A++ +GE++AVKK + + ++ F EVKTL IRH+NIV+F G C
Sbjct: 799 VVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCC 858
Query: 505 SHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVH 564
+ ++Y+Y+ GSL +L ++ L W R ++ G L+Y+H+DC PPIVH
Sbjct: 859 WNRNTRLLMYDYMPNGSLGSLL-HERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVH 917
Query: 565 RDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE--LAGTYGYVAPELAYTMKVTEKC 622
RDI + N+L+ L+ E +++DFG AK + +AG+YGY+APE Y+MK+TEK
Sbjct: 918 RDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKS 977
Query: 623 DVYSFGVLALEVIKGKHPRD--------FISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674
DVYS+GV+ LEV+ GK P D + + + +LE+ LD L + +
Sbjct: 978 DVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLEV-----LDSTLRSRTEAEA 1032
Query: 675 DKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
D+++ ++ A+ C++ SP+ RPT++ V+ +LK
Sbjct: 1033 DEMMQVLGTALLCVNSSPDERPTMKDVAAMLK 1064
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 382 bits (981), Expect = e-105, Method: Compositional matrix adjust.
Identities = 249/719 (34%), Positives = 382/719 (53%), Gaps = 34/719 (4%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
L L L+L N+F+G+I E+G + SL ++LS N G IP S L +T L LF N
Sbjct: 262 LQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRN 321
Query: 62 ALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGI 120
L GAIP+ G + +L +L L N G IP L LV + L+ N LTG + +
Sbjct: 322 KLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCS 381
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
L + N+ +G I G+C L + N + GS+P E+ +L ++L N
Sbjct: 382 GNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDN 441
Query: 181 HIVGEMPSKLGKLSS-LIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLG 239
++ GE+P G +S L ++ L++NQL G L +G+L+ +++L L N+ S SIP +G
Sbjct: 442 YLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIG 501
Query: 240 NLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSH 299
L +L L+ S+N F +I E+ + L+ +DLS N L ++P+++ M+ L LNLS
Sbjct: 502 RLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSR 561
Query: 300 NNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIKGFPS 359
N+L G IP + L+ +D SYN L G +P++ F + GN LCG G
Sbjct: 562 NHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPCG 621
Query: 360 CKASKSHKQ---ASRKIWVVIVFPLLGSFALLISLIGLFFMFRRSSSQTQQSSPGNAPGF 416
+SH + A+ K+ +V+ ++++I RS ++ F
Sbjct: 622 KGTHQSHVKPLSATTKLLLVLGLLFCSMVFAIVAIIK-----ARSLRNASEAKAWRLTAF 676
Query: 417 LSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEM 476
L F V + + +++ IGKGG G VYK +P G++VAVK+ + +
Sbjct: 677 -QRLDFTCDDVLDSL-------KEDNIIGKGGAGIVYKGTMPKGDLVAVKRLAT-MSHGS 727
Query: 477 ASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLG 536
+ F E++TL IRHR+IV+ GFCS+ + +VYEY+ GSL +L L
Sbjct: 728 SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGH-LH 786
Query: 537 WTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596
W R + L Y+H+DC P IVHRD+ S N+LLD EAHV+DFG AKFL+ +
Sbjct: 787 WNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGT 846
Query: 597 N--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-------RDFISSI 647
+ + +AG+YGY+APE AYT+KV EK DVYSFGV+ LE+I GK P D + +
Sbjct: 847 SECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVDIVQWV 906
Query: 648 SSSSSNLEIALNEMLDPRLPT-PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
S + + + + +++D RL + P H V + VA+ C++E RPT+++V Q+L
Sbjct: 907 RSMTDSNKDCVLKVIDLRLSSVPVHEVTH----VFYVALLCVEEQAVERPTMREVVQIL 961
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 707 | ||||||
| 225456159 | 1038 | PREDICTED: probable LRR receptor-like se | 0.994 | 0.677 | 0.565 | 0.0 | |
| 147767326 | 1032 | hypothetical protein VITISV_008862 [Viti | 0.994 | 0.681 | 0.571 | 0.0 | |
| 359491509 | 1032 | PREDICTED: probable LRR receptor-like se | 0.994 | 0.681 | 0.570 | 0.0 | |
| 147772402 | 996 | hypothetical protein VITISV_022117 [Viti | 0.994 | 0.705 | 0.565 | 0.0 | |
| 359491512 | 1078 | PREDICTED: probable LRR receptor-like se | 0.994 | 0.652 | 0.561 | 0.0 | |
| 225456161 | 1037 | PREDICTED: probable LRR receptor-like se | 0.992 | 0.676 | 0.554 | 0.0 | |
| 255545702 | 1008 | receptor protein kinase, putative [Ricin | 0.995 | 0.698 | 0.538 | 0.0 | |
| 297813345 | 1019 | hypothetical protein ARALYDRAFT_489780 [ | 0.991 | 0.687 | 0.489 | 0.0 | |
| 297846638 | 1123 | hypothetical protein ARALYDRAFT_473694 [ | 0.985 | 0.620 | 0.501 | 0.0 | |
| 297846644 | 782 | hypothetical protein ARALYDRAFT_891228 [ | 0.985 | 0.891 | 0.5 | 0.0 |
| >gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 800 bits (2066), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/734 (56%), Positives = 519/734 (70%), Gaps = 31/734 (4%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+LS L L+LY N SG IP EIG LKSL DLELS N+L GSIP SLGNLT + L L D
Sbjct: 303 DLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRD 362
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQL------------------------RGPIP-NLR 95
N LSG IP+E G L KL +L ++ NQL GPIP +L+
Sbjct: 363 NQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQAGSLVRFAVSDNHLSGPIPKSLK 422
Query: 96 NLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS 155
N +L R N LTGNISE G PNL FIDLS+N F+GE+S +WGRCP+L L+ +
Sbjct: 423 NCRNLTRALFQGNRLTGNISEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAG 482
Query: 156 NNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG 215
NNITGS+P + S+ L +LDLSSNH+VGE+P K+G L+SL+ LILN NQL G + ELG
Sbjct: 483 NNITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELG 542
Query: 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275
SL+ LE LDLS+NRL+ SIP+ LG+ + LHYLNLSNN+ IPV++ KL HLS+LDLSH
Sbjct: 543 SLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSH 602
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA 335
N L +P QI +QSLE L+LSHNNL GFIP FE++ LSY+DISYN+L G IP+S A
Sbjct: 603 NLLAGGIPPQIQGLQSLEMLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNA 662
Query: 336 FRDAPMEALQGNKGLCGDIKGFPSCK----ASKSHKQASRKIWVVIVFPLLGSFALLISL 391
FR+A +E L+GNK LCG++KG CK + + S K+ +I+FPLLG+ LL +
Sbjct: 663 FRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLFAF 722
Query: 392 IGLFFMFRRSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGS 451
IG+F + R + S+ +F+G+ +YEEII+ T DFD +CIGKGG GS
Sbjct: 723 IGIFLIAERRERTPEIEEGDVQNDLFSISNFDGRTMYEEIIKATKDFDPMYCIGKGGHGS 782
Query: 452 VYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511
VYKAELPS IVAVKK H P +EMA+Q++FLNE++ LT I+HRNIVK GFCSH RH F
Sbjct: 783 VYKAELPSSNIVAVKKLH-PSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKF 841
Query: 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKN 571
+VYEYLE GSLA ILS + A K LGW R+N+IKGV AL+YMH+DC PPIVHRD+SS N
Sbjct: 842 LVYEYLERGSLATILSREEAKK-LGWATRVNIIKGVAHALAYMHHDCSPPIVHRDVSSNN 900
Query: 572 VLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLA 631
+LLD + EAH+SDFGTAK LK DSSN + LAGT+GY+APELAYTMKVTEK DV+SFGV+A
Sbjct: 901 ILLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIA 960
Query: 632 LEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDES 691
LEVIKG+HP D I S+S S IAL +MLDPRLP + + ++I+I++ AI CL +
Sbjct: 961 LEVIKGRHPGDQILSLSVSPEKDNIALEDMLDPRLPPLTPQDEGEVIAILKQAIECLKAN 1020
Query: 692 PESRPTIQKVSQLL 705
P+SRPT+Q VSQ+L
Sbjct: 1021 PQSRPTMQTVSQML 1034
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 796 bits (2057), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/731 (57%), Positives = 530/731 (72%), Gaps = 28/731 (3%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+LS L L L++N SG IP E+G L+SL DLE+S N+L GSIP SLGNL + L L D
Sbjct: 300 DLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPTSLGNLINLEILYLRD 359
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRG------------------------PIP-NLR 95
N LS +IP E G L KL L ++ NQL G PIP +L+
Sbjct: 360 NKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLK 419
Query: 96 NLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS 155
N SL R RL +N LTGNISE+FG+ PNL I+LS+N FYGE+S +WGRC KL LD +
Sbjct: 420 NCPSLARARLQRNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAG 479
Query: 156 NNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG 215
NNITGS+PA+ S+QL VL+LSSNH+VGE+P KLG +SSL KLILN N+L G + ELG
Sbjct: 480 NNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELG 539
Query: 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275
SL L LDLS NRL+ SIP+ LGN + L+YLNLSNN+ IPV++ KL HLS LDLSH
Sbjct: 540 SLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSH 599
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA 335
N L E+PSQI +QSLEKLNLSHNNLSG IP FE++HGL +DISYN+L GSIPNS A
Sbjct: 600 NLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEA 659
Query: 336 FRDAPMEALQGNKGLCGDIKGFPSCKASKSHKQASRKIWVVIVFPLLGSFALLISLIGLF 395
F++ +E LQGNKGLCG +KG C+ ++S + + K +I+F LLG+ +L + IG+
Sbjct: 660 FQNVTIEVLQGNKGLCGSVKGLQPCE-NRSATKGTHKAVFIIIFSLLGALLILSAFIGIS 718
Query: 396 FMFR-RSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYK 454
+ + R +++ +++ S+ +F+G+ YE II T DFD +CIG+GG GSVYK
Sbjct: 719 LISQGRRNAKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYK 778
Query: 455 AELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514
AELPSG IVAVKK H +MA Q++F+NE++ LT I+HRNIVK GFCSH+RHSF+VY
Sbjct: 779 AELPSGNIVAVKKLHR-FDIDMAHQKDFMNEIRALTEIKHRNIVKLLGFCSHSRHSFLVY 837
Query: 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL 574
EYLE GSL ILS + AK++GW R+N+IKGV ALSY+H+DC PPIVHRDISS NVLL
Sbjct: 838 EYLERGSLGTILSKELQAKEVGWGTRVNIIKGVAHALSYLHHDCVPPIVHRDISSNNVLL 897
Query: 575 DLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 634
D + EAHVSDFGTAKFLK DSSNW+ LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV
Sbjct: 898 DSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 957
Query: 635 IKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPES 694
++G+HP D ISS+S+S + L ++LDPRLP P+ + +++S++++A +CL+ SP+S
Sbjct: 958 MRGRHPGDLISSLSASPGKDNVVLKDVLDPRLPPPTLRDEAEVMSVIQLATACLNGSPQS 1017
Query: 695 RPTIQKVSQLL 705
RPT+Q VSQ+L
Sbjct: 1018 RPTMQMVSQML 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 791 bits (2043), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/731 (57%), Positives = 526/731 (71%), Gaps = 28/731 (3%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+LS L L L++N SG IP E+G L+SL DLE+S N+L GSIP LGNL + L L D
Sbjct: 300 DLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPTLLGNLINLEILYLRD 359
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRG------------------------PIP-NLR 95
N LS +IP E G L KL L ++ NQL G PIP +L+
Sbjct: 360 NKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLK 419
Query: 96 NLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS 155
N SL R RL N LTGNISE+FG+ PNL I+LS+N FYGE+S +WGRC KL LD +
Sbjct: 420 NCPSLARARLQGNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAG 479
Query: 156 NNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG 215
NNITGS+PA+ S+QL VL+LSSNH+VGE+P KLG +SSL KLILN N+L G + ELG
Sbjct: 480 NNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELG 539
Query: 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275
SL L LDLS NRL+ SIP+ LGN + L+YLNLSNN+ IPV++ KL HLS LDLSH
Sbjct: 540 SLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSH 599
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA 335
N L E+PSQI +QSLEKLNLSHNNLSG IP FE++HGL +DISYN+L GSIPNS A
Sbjct: 600 NLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEA 659
Query: 336 FRDAPMEALQGNKGLCGDIKGFPSCKASKSHKQASRKIWVVIVFPLLGSFALLISLIGLF 395
F++ +E LQGNKGLCG +KG C+ ++S + + K +I+F LLG+ +L + IG+
Sbjct: 660 FQNVTIEVLQGNKGLCGSVKGLQPCE-NRSATKGTHKAVFIIIFSLLGALLILSAFIGIS 718
Query: 396 FMFR-RSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYK 454
+ + R +++ +++ S+ +F+G+ YE II T DFD +CIG+GG GSVYK
Sbjct: 719 LISQGRRNAKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYK 778
Query: 455 AELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514
AELPSG IVAVKK H +MA Q++F+NE++ LT I+HRNIVK GFCSH+RHSF+VY
Sbjct: 779 AELPSGNIVAVKKLHR-FDIDMAHQKDFVNEIRALTEIKHRNIVKLLGFCSHSRHSFLVY 837
Query: 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL 574
EYLE GSL ILS + AK++GW R+N+IKGV ALSY+H+DC PPIVHRDISS NVLL
Sbjct: 838 EYLERGSLGTILSKELQAKEVGWGTRVNIIKGVSHALSYLHHDCVPPIVHRDISSNNVLL 897
Query: 575 DLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 634
D + EAHVSDFGTAKFLK DSSNW+ LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV
Sbjct: 898 DSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 957
Query: 635 IKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPES 694
++G+HP D ISS+S S + L ++LDPRLP P+ + ++ S++++A +CL+ SP+S
Sbjct: 958 MRGRHPGDLISSLSDSPGKDNVVLKDVLDPRLPPPTFRDEAEVTSVIQLATACLNGSPQS 1017
Query: 695 RPTIQKVSQLL 705
RPT+Q VSQ+L
Sbjct: 1018 RPTMQMVSQML 1028
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2039), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/734 (56%), Positives = 516/734 (70%), Gaps = 31/734 (4%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+LS L L+LY N SG IP EIG LKSL DLELS N+L GSIP SLGNLT + L L D
Sbjct: 261 DLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLETLFLRD 320
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQL------------------------RGPIP-NLR 95
N LSG IP+E G L KL +L ++ NQL GPIP +L+
Sbjct: 321 NQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLK 380
Query: 96 NLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS 155
N +L R N LTGNISE G PNL +I++S+N F+GE+S +WGR P+L L+ +
Sbjct: 381 NCKNLTRALFGGNQLTGNISEVVGDCPNLEYINVSYNSFHGELSHNWGRYPRLQRLEMAW 440
Query: 156 NNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG 215
NNITGS+P + S+ L +LDLSSNH+ GE+P K+G ++SL KLILN NQL G + ELG
Sbjct: 441 NNITGSIPEDFGISTDLTLLDLSSNHLFGEIPKKMGSVTSLWKLILNDNQLSGNIPPELG 500
Query: 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275
SL L LDLS+NRL+ SIP+ LG+ + L+YLNLSNN+ IPV++ KL HLS+LDLSH
Sbjct: 501 SLADLGYLDLSANRLNGSIPEHLGDCLGLNYLNLSNNKLSHGIPVQMGKLGHLSQLDLSH 560
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA 335
N L ++P QI +QSLE LNLSHNNLSGFIP FEE+ GLS +DISYN+L G IPNS A
Sbjct: 561 NLLTGDIPPQIEGLQSLENLNLSHNNLSGFIPKAFEEMLGLSDVDISYNQLQGPIPNSKA 620
Query: 336 FRDAPMEALQGNKGLCGDIKGFPSCKASKSHKQ----ASRKIWVVIVFPLLGSFALLISL 391
FRDA +EAL+GNKGLCG++K CK Q S K+ +I+FPLLG+ LL +
Sbjct: 621 FRDATIEALKGNKGLCGNVKRLRPCKYGSGVDQQPVKKSHKVVFIIIFPLLGALVLLFAF 680
Query: 392 IGLFFMFRRSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGS 451
IG+F + R + S+ +F+G+ +YEEII+ T DFD +CIGKGG GS
Sbjct: 681 IGIFLIAARRERTPEIKEGEVQNDLFSISTFDGRTMYEEIIKATKDFDPMYCIGKGGHGS 740
Query: 452 VYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511
VYKAELPS IVAVKK H P +EMA+Q++FLNE++ LT I+HRNIVK GFCSH RH F
Sbjct: 741 VYKAELPSSNIVAVKKLH-PSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKF 799
Query: 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKN 571
+VYEYLE GSLA ILS + A K LGW R+N+IKGV AL+YMH+DC PPIVHRDISS N
Sbjct: 800 LVYEYLERGSLATILSREEAKK-LGWATRVNIIKGVAHALAYMHHDCSPPIVHRDISSNN 858
Query: 572 VLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLA 631
+LLD + EAH+SDFGTAK LK DSSN + LAGT+GY+APELAYTMKVTEK DV+SFGV+A
Sbjct: 859 ILLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIA 918
Query: 632 LEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDES 691
LEVIKG+HP D I S+S S IAL +MLDPRLP + + ++I+I++ A CL +
Sbjct: 919 LEVIKGRHPGDQILSLSVSPEKDNIALEDMLDPRLPPLTPQDEGEVIAIIKQATECLKAN 978
Query: 692 PESRPTIQKVSQLL 705
P+SRPT+Q VSQ+L
Sbjct: 979 PQSRPTMQTVSQML 992
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 783 bits (2023), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/734 (56%), Positives = 513/734 (69%), Gaps = 31/734 (4%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+LS L L+LY N SG IP EIG LKSL DLELS N+L GSIP SLGNLT + L L D
Sbjct: 310 DLSGLTLLHLYANQLSGPIPPEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRD 369
Query: 61 NALSGAIPKEYGNLVKLTLL------------------------TLENNQLRGPIP-NLR 95
N LSG PKE G L KL +L T+ +N L GPIP +++
Sbjct: 370 NHLSGYFPKEIGKLHKLVVLEIDTNRLSGSLPEGICQGGSLVRFTVSDNLLSGPIPKSMK 429
Query: 96 NLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS 155
N +L R N LTGNISE G PNL +IDLS+N F+GE+S +WGRCP+L L+ +
Sbjct: 430 NCRNLTRALFGGNQLTGNISEVVGDCPNLEYIDLSYNRFHGELSHNWGRCPQLQRLEMAG 489
Query: 156 NNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG 215
N+ITGS+P + S+ L +LDLSSNH+VGE+P K+G L+SL++L LN NQL G + ELG
Sbjct: 490 NDITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSLLELKLNDNQLSGSIPPELG 549
Query: 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275
SL L LDLS+NRL+ SI ++LG + LHYLNLSNN+ +IP ++ KL HLS+LDLSH
Sbjct: 550 SLFSLAHLDLSANRLNGSITENLGACLNLHYLNLSNNKLSNRIPAQMGKLSHLSQLDLSH 609
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA 335
N L E+P QI ++SLE LNLSHNNLSGFIP FEE+ GLS IDISYN+L G IPNS A
Sbjct: 610 NLLSGEIPPQIEGLESLENLNLSHNNLSGFIPKAFEEMRGLSDIDISYNQLQGPIPNSKA 669
Query: 336 FRDAPMEALQGNKGLCGDIKGFPSCK----ASKSHKQASRKIWVVIVFPLLGSFALLISL 391
FRDA +E L+GNK LCG++KG CK A + + KI +IVFPLLG+ LL +
Sbjct: 670 FRDATIELLKGNKDLCGNVKGLQPCKNDSGAGQQPVKKGHKIVFIIVFPLLGALVLLFAF 729
Query: 392 IGLFFMFRRSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGS 451
IG+F + R+ + S+ +F+G+ +YEEII+ T DFD +CIGKGG GS
Sbjct: 730 IGIFLIAERTKRTPEIEEGDVQNDLFSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGS 789
Query: 452 VYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511
VYKAEL SG IVAVKK ++ +MA+Q++F NEV+ LT I+HRNIVK GFCSH RHSF
Sbjct: 790 VYKAELSSGNIVAVKKLYAS-DIDMANQRDFFNEVRALTEIKHRNIVKLLGFCSHPRHSF 848
Query: 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKN 571
+VYEYLE GSLA +LS + A K LGW R+N+IKGV ALSYMH+DC PPIVHRDISS N
Sbjct: 849 LVYEYLERGSLAAMLSREEAKK-LGWATRINIIKGVAHALSYMHHDCSPPIVHRDISSNN 907
Query: 572 VLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLA 631
+LLD + E H+SDFGTAK LK DSSN + LAGT+GYVAPE AYTMKVTEK DVYSFGV+
Sbjct: 908 ILLDSQYEPHISDFGTAKLLKLDSSNQSALAGTFGYVAPEHAYTMKVTEKTDVYSFGVIT 967
Query: 632 LEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDES 691
LEVIKG+HP D I S+S S I L +MLDPRLP + + ++ISI+ +A +CL +
Sbjct: 968 LEVIKGRHPGDQILSLSVSPEKENIVLEDMLDPRLPPLTAQDEGEVISIINLATACLSVN 1027
Query: 692 PESRPTIQKVSQLL 705
PESRPT++ +SQ+L
Sbjct: 1028 PESRPTMKIISQML 1041
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 783 bits (2021), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/734 (55%), Positives = 519/734 (70%), Gaps = 32/734 (4%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+LS L L+LY N SG IP EIG LKSL DLELS N+L GSIP SLGNLT + L L D
Sbjct: 303 DLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRD 362
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQL------------------------RGPIP-NLR 95
N LSG P+E G L KL +L ++ NQL GPIP +L+
Sbjct: 363 NRLSGYFPQEIGKLHKLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLK 422
Query: 96 NLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS 155
N +L R N LTGN+SE G PNL FIDLS+N F+GE+S +WGRCP+L L+ +
Sbjct: 423 NCRNLTRALFQGNRLTGNVSEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAG 482
Query: 156 NNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG 215
NNITGS+P + S+ L +LDLSSNH+VGE+P K+G L+SL+ LILN NQL G + ELG
Sbjct: 483 NNITGSIPEDFGISTNLILLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELG 542
Query: 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275
SL+ LE LDLS+NRL+ SIP+ LG+ + LHYLNLSNN+ IPV++ KL HLS+LDLSH
Sbjct: 543 SLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSH 602
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA 335
N L +P+QI ++SLE L+LSHNNL GFIP FE++ LSY+DISYN+L G IP+S A
Sbjct: 603 NLLTGGIPAQIQGLESLEMLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNA 662
Query: 336 FRDAPMEALQGNKGLCGDIKGFPSCK----ASKSHKQASRKIWVVIVFPLLGSFALLISL 391
FR+A +E L+GNK LCG++KG CK + + S K+ +I+FPLLG+ LL +
Sbjct: 663 FRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLSAF 722
Query: 392 IGLFFMFRRSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGS 451
IG+F + R + LS+ +F+G+ +YEEII+ T DFD +CIGKGG GS
Sbjct: 723 IGIFLIAERRERTPEIEEGDVQNNLLSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGS 782
Query: 452 VYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511
VYKAELPSG IVAVKK H P +MA+Q++FLN+V+ +T I+HRNIV+ GFCS+ RHSF
Sbjct: 783 VYKAELPSGNIVAVKKLH-PSDMDMANQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRHSF 841
Query: 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKN 571
+VYEYLE GSLA ILS + A K LGW R+ +IKGV ALSYMH+DC PPIVHRDISS N
Sbjct: 842 LVYEYLERGSLATILSREEAKK-LGWATRVKIIKGVAHALSYMHHDCSPPIVHRDISSNN 900
Query: 572 VLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLA 631
+LLD + EAH+S+ GTAK LK DSSN ++LAGT GYVAPE AYTMKVTEK DVYSFGV+A
Sbjct: 901 ILLDSQYEAHISNLGTAKLLKVDSSNQSKLAGTVGYVAPEHAYTMKVTEKTDVYSFGVIA 960
Query: 632 LEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDES 691
LEVIKG+HP D I SIS S I L +MLDPRLP + + ++++I+++A +CL+ +
Sbjct: 961 LEVIKGRHPGDQILSISVSPEK-NIVLKDMLDPRLPPLTPQDEGEVVAIIKLATACLNAN 1019
Query: 692 PESRPTIQKVSQLL 705
P+SRPT++ +SQ+L
Sbjct: 1020 PQSRPTMEIISQML 1033
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545702|ref|XP_002513911.1| receptor protein kinase, putative [Ricinus communis] gi|223546997|gb|EEF48494.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 745 bits (1923), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/734 (53%), Positives = 527/734 (71%), Gaps = 30/734 (4%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
L++L L+LY N SG+IP E+G L SLS+LELS NKL GSIP SLGNL+++ L L +N
Sbjct: 275 LTSLTILHLYQNQLSGTIPKELGNLNSLSNLELSENKLTGSIPASLGNLSRLELLFLKNN 334
Query: 62 ALSGAIPKEYGNLVK------------------------LTLLTLENNQLRGPIP-NLRN 96
LSG IP++ NL K L ++ +N+L GPIP ++R+
Sbjct: 335 QLSGPIPEQIANLSKLSLLQLQSNQLTGYLPQNICQSKVLQNFSVNDNRLEGPIPKSMRD 394
Query: 97 LTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSN 156
SLVR+ L N GNISE FG++P L F+D+ +N F+GEISS WG CP LGTL S N
Sbjct: 395 CKSLVRLHLEGNQFIGNISEDFGVYPYLQFVDIRYNKFHGEISSKWGMCPHLGTLLISGN 454
Query: 157 NITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGS 216
NI+G +P EI ++++L+ LD SSN +VG +P +LGKL+SL+++ L NQL + E GS
Sbjct: 455 NISGIIPPEIGNAARLQGLDFSSNQLVGRIPKELGKLTSLVRVNLEDNQLSDGVPSEFGS 514
Query: 217 LTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHN 276
LT LE LDLS+NR + SIP ++GNLVKL+YLNLSNNQF ++IP++L KL+HLS+LDLS N
Sbjct: 515 LTDLESLDLSANRFNQSIPGNIGNLVKLNYLNLSNNQFSQEIPIQLGKLVHLSKLDLSQN 574
Query: 277 FLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAF 336
FL E+PS++ MQSLE LNLS NNLSGFIP +E+HGLS IDISYN+L G +P++ AF
Sbjct: 575 FLIGEIPSELSGMQSLEVLNLSRNNLSGFIPGDLKEMHGLSSIDISYNKLEGPVPDNKAF 634
Query: 337 RDAPMEALQGNKGLCGDIKGFPSCKASKSHKQAS----RKIWVVIVFPLLGSFALLISLI 392
+++ +EA QGNKGLCG ++G CK S + + +S +++++VI PL G+F +L L
Sbjct: 635 QNSSIEAFQGNKGLCGHVQGLQPCKPSSTEQGSSIKFHKRLFLVISLPLFGAFLILSFLG 694
Query: 393 GLFFMFRRSSSQTQ-QSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGS 451
LFF +RS + + S + L + SF+GK +++EII T+ F+D +CIGKGG GS
Sbjct: 695 VLFFQSKRSKEALEAEKSSQESEEILLITSFDGKSMHDEIIEATDSFNDIYCIGKGGCGS 754
Query: 452 VYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511
VYKA+L SG VAVKK H + Q+EF +E++ LT I+HRNIVKFYGFCS++ +SF
Sbjct: 755 VYKAKLSSGSTVAVKKLHQSHDAWKPYQKEFWSEIRALTEIKHRNIVKFYGFCSYSAYSF 814
Query: 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKN 571
+VYE +E GSLA IL ++ AAK+L W KR N+IKGV +ALSYMH+DC PPIVHRDISSKN
Sbjct: 815 LVYECIEKGSLATILRDNEAAKELEWFKRANIIKGVANALSYMHHDCSPPIVHRDISSKN 874
Query: 572 VLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLA 631
+LLD ENEA VSDFG A+ L DSS+ LAGT+GY+APELAY++ VTEKCDVYSFGVLA
Sbjct: 875 ILLDSENEARVSDFGIARILNLDSSHRTALAGTFGYMAPELAYSIVVTEKCDVYSFGVLA 934
Query: 632 LEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDES 691
LEVI GKHP + ISSISSSSS ++ L ++D RLP PS VQ +L++I+ +A +CL+ +
Sbjct: 935 LEVINGKHPGEIISSISSSSSTRKMLLENIVDLRLPFPSPEVQVELVNILNLAFTCLNSN 994
Query: 692 PESRPTIQKVSQLL 705
P+ RPT++ + +L
Sbjct: 995 PQVRPTMEMICHML 1008
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297813345|ref|XP_002874556.1| hypothetical protein ARALYDRAFT_489780 [Arabidopsis lyrata subsp. lyrata] gi|297320393|gb|EFH50815.1| hypothetical protein ARALYDRAFT_489780 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1810), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/732 (48%), Positives = 498/732 (68%), Gaps = 31/732 (4%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
N+ LA L+LY N SGSIP E+G ++++ DLE+S NKL G +P S G LT + +L L D
Sbjct: 285 NIKTLAILHLYLNQLSGSIPPELGDMEAMIDLEISENKLTGPVPDSFGKLTVLEWLFLRD 344
Query: 61 NALSGAIPKEYGNLVKLTLL------------------------TLENNQLRGPIP-NLR 95
N LSG IP N +LT+L TL++N GP+P +LR
Sbjct: 345 NQLSGPIPPGIANSTELTVLQLDTNNFTGFLPDTICRSGKLENLTLDDNHFEGPVPKSLR 404
Query: 96 NLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS 155
N SLVRVR NH +G+IS++FG++P L FIDLS+N F+G++S++W + KL S+
Sbjct: 405 NCKSLVRVRFKGNHFSGDISDAFGVYPTLNFIDLSNNNFHGQLSANWEQSTKLVAFILSN 464
Query: 156 NNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG 215
N+I+G++P EI + +QL LDLS N I GE+P + ++ + KL LN NQL G++ +
Sbjct: 465 NSISGAIPPEIWNMTQLNQLDLSFNRITGELPESISNINRISKLQLNGNQLSGKIPSGIR 524
Query: 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275
LT LE LDLSSN+ IP +L NL +L+Y+NLS N + IP L KL L LDLS+
Sbjct: 525 LLTNLEYLDLSSNQFGFEIPATLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSY 584
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA 335
N L E+ SQ ++Q+LE+L+LSHNNLSG IP+ F+++ L++ID+S+N L G IP++ A
Sbjct: 585 NQLDGEISSQFGSLQNLERLDLSHNNLSGQIPTSFKDMLALTHIDVSHNNLQGPIPDNAA 644
Query: 336 FRDAPMEALQGNKGLCGDIKGFPSCKASKSHK-QASRKIWVVIVFPLLGSFALLISLIGL 394
FR+A AL+GN LCGD K C + S K R + + I+ P++G+ +L G+
Sbjct: 645 FRNASPNALEGNNDLCGDNKALKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGI 704
Query: 395 FFMFRRSSSQTQQSSPGNAPG-FLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVY 453
F FR+ + Q +++S + G LS+ SF+GK+ Y+EII+ T +FD ++ IG GG G VY
Sbjct: 705 FICFRKRTKQIEENSDSESGGETLSIFSFDGKVRYQEIIKATGEFDSKYLIGTGGHGKVY 764
Query: 454 KAELPSGEIVAVKKFHSPLPSEM---ASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510
KA+LP+ I+AVKK + S + +++QEFLNE++ LT IRHRN+VK +GFCSH R++
Sbjct: 765 KAKLPNA-IMAVKKLNETTDSSITNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNT 823
Query: 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSK 570
F+VYEY+E GSL +L ND AK L W KR+NV+KGV DALSYMH+D P IVHRDISS
Sbjct: 824 FLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVADALSYMHHDRSPAIVHRDISSG 883
Query: 571 NVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 630
N+LL + EA +SDFGTAK LKPDSSNW+ +AGTYGYVAPELAY MKVTEKCDVYSFGVL
Sbjct: 884 NILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVL 943
Query: 631 ALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDE 690
LEVIKG+HP D +S++SSS + ++L + D RLP P+ ++++++ I++VA+ CL
Sbjct: 944 TLEVIKGEHPGDLVSTLSSSPPDTSLSLKTISDHRLPEPTPEIKEEVLEILKVALMCLHS 1003
Query: 691 SPESRPTIQKVS 702
P++RPT+ +S
Sbjct: 1004 DPQARPTMLSIS 1015
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297846638|ref|XP_002891200.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] gi|297337042|gb|EFH67459.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1800), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 368/734 (50%), Positives = 493/734 (67%), Gaps = 37/734 (5%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
NL NL LYL++N +G IP E+G ++S+ DL LS N L GSIP S GN T++ L L D
Sbjct: 391 NLKNLTVLYLHHNYLTGVIPPELGNMESMIDLALSQNNLTGSIPSSFGNFTKLESLYLRD 450
Query: 61 NALSGAIPKEYGNLVKLTLL------------------------TLENNQLRGPIP-NLR 95
N LSG IP+ N +LT L +L+ N L G IP +LR
Sbjct: 451 NHLSGTIPRGVANSSELTELLLDINNFTGFLPENICKGGKLQNFSLDYNHLEGHIPKSLR 510
Query: 96 NLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS 155
+ SL+R + N GNISE+FG++P+L FIDLSHN F GEISS+W + PKLG L S+
Sbjct: 511 DCKSLIRAKFVGNKFIGNISEAFGVYPDLDFIDLSHNKFNGEISSNWQKSPKLGALIMSN 570
Query: 156 NNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG 215
NNITG++P EI + QL LDLS+N++ GE+P +G L+ L KL+LN N+L G++ L
Sbjct: 571 NNITGAIPPEIWNMKQLGELDLSTNNLTGELPEAIGNLTGLSKLLLNGNKLSGRVPTGLS 630
Query: 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275
LT LE LDLSSNR S+ IP++ + +KLH +NLS N F +IP L KL L+ LDLSH
Sbjct: 631 FLTNLESLDLSSNRFSSQIPQTFDSFLKLHEMNLSKNNFDGRIP-GLTKLTQLTHLDLSH 689
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA 335
N L E+PSQ+ ++QSL+KLNLSHNNLSGFIP+ FE + L++IDIS N+L G +P++ A
Sbjct: 690 NQLDGEIPSQLSSLQSLDKLNLSHNNLSGFIPTTFESMKALTFIDISNNKLEGPLPDNPA 749
Query: 336 FRDAPMEALQGNKGLCGDI--KGFPSCKA-SKSHKQASRKIWVVIVFPLLGSFALLISLI 392
F++A +AL+GN+GLC +I + SC+ K K + +W+++ P+LG+ +L
Sbjct: 750 FQNATSDALEGNRGLCSNIPKQRLKSCRGFQKPKKNGNLLVWILV--PILGALVILSICA 807
Query: 393 GLF-FMFRRSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGS 451
G F + R+ +++ +S+ S +GK Y++II TN+FD + IG GG
Sbjct: 808 GAFTYYIRKRKPHNGRNTDSETGENMSIFSVDGKFKYQDIIESTNEFDQRYLIGSGGYSK 867
Query: 452 VYKAELPSGEIVAVKKFHSPLPSEMAS---QQEFLNEVKTLTGIRHRNIVKFYGFCSHAR 508
VYKA LP IVAVK+ H + E++ +QEFLNEV+ LT IRHRN+VK +GFCSH R
Sbjct: 868 VYKANLPDA-IVAVKRLHDTIDEEISKPVVKQEFLNEVRALTEIRHRNVVKLFGFCSHRR 926
Query: 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDIS 568
H+F++YEY+E GSL +L+N+ AK L WTKR+N++KGV ALSYMH+D PIVHRDIS
Sbjct: 927 HTFLIYEYMEKGSLNKLLANEEEAKRLTWTKRINIVKGVAHALSYMHHDRSTPIVHRDIS 986
Query: 569 SKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFG 628
S N+LLD + A +SDFGTAK LK DSSNW+ +AGTYGYVAPE AYTMKVTEKCDVYSFG
Sbjct: 987 SGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFG 1046
Query: 629 VLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCL 688
VL LEVI GKHP D ++S+SSS ++L + D R+ P ++KLI ++EVA+SCL
Sbjct: 1047 VLILEVIMGKHPGDLVASLSSSPGE-TLSLRSISDERILEPRGQNREKLIKMVEVALSCL 1105
Query: 689 DESPESRPTIQKVS 702
P+SRPT+ +S
Sbjct: 1106 QADPQSRPTMLSIS 1119
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297846644|ref|XP_002891203.1| hypothetical protein ARALYDRAFT_891228 [Arabidopsis lyrata subsp. lyrata] gi|297337045|gb|EFH67462.1| hypothetical protein ARALYDRAFT_891228 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 697 bits (1798), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/738 (50%), Positives = 493/738 (66%), Gaps = 41/738 (5%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
NL NL LYL+ N +G IP E+G ++S+ DLELS N L GSIP S GN T++ L L D
Sbjct: 46 NLKNLTVLYLHQNYITGVIPPELGNMESMIDLELSQNNLTGSIPSSFGNFTKLESLYLRD 105
Query: 61 NALSGAIPKEYGNLVKLTLL------------------------TLENNQLRGPIP-NLR 95
N LSG IP+ N +LT L +L+ N L G IP +LR
Sbjct: 106 NHLSGTIPRGVANSSELTELLLDINNFTGFLPENICKGGKLQNFSLDYNHLEGHIPKSLR 165
Query: 96 NLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS 155
+ SL+R + N GNISE+FG++P+L FIDLSHN F GEISS+W + PKLG L S+
Sbjct: 166 DCKSLIRAKFVGNKFIGNISEAFGVYPDLDFIDLSHNKFNGEISSNWQKSPKLGALIMSN 225
Query: 156 NNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG 215
NNITG++P EI + QL LDLS+N++ GE+P +G L+ L KL+LN N+L G++ L
Sbjct: 226 NNITGAIPPEIWNMKQLGELDLSTNNLTGELPEAIGNLTGLSKLLLNGNKLSGRVPTGLS 285
Query: 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275
LT LE LDLSSNR S+ IP++ + +KLH +NLS N F +IP L KL L+ LDLSH
Sbjct: 286 FLTNLESLDLSSNRFSSQIPQTFDSFLKLHEMNLSKNNFDGRIP-GLTKLTQLTHLDLSH 344
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA 335
N L E+PSQ+ ++QSL+KLNLSHNNLSGFIP+ FE + L++IDIS N+L G +P++ A
Sbjct: 345 NQLDGEIPSQLSSLQSLDKLNLSHNNLSGFIPTTFESMKALTFIDISNNKLEGPLPDNPA 404
Query: 336 FRDAPMEALQGNKGLCGDI--KGFPSCKASKSHKQASRK-----IWVVIVFPLLGSFALL 388
F++A +AL+GN+GLC +I + SC + Q +K +W+++ P+LG+ +L
Sbjct: 405 FQNATSDALEGNRGLCSNIPKQRLKSCPITSGGFQKPKKNGNLLVWILV--PILGALVIL 462
Query: 389 ISLIGLF-FMFRRSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKG 447
G F + R+ +++ +S+ S +GK Y++II TN+FD + IG G
Sbjct: 463 SICAGAFTYYIRKRKPHNGRNTDSETGENMSIFSVDGKFKYQDIIESTNEFDQRYLIGSG 522
Query: 448 GQGSVYKAELPSGEIVAVKKFHSPLPSEMAS---QQEFLNEVKTLTGIRHRNIVKFYGFC 504
G VYKA LP IVAVK+ H + E++ +QEFLNEV+ LT IRHRN+VK +GFC
Sbjct: 523 GYSKVYKANLPDA-IVAVKRLHDTIDEEISKPVVKQEFLNEVRALTEIRHRNVVKLFGFC 581
Query: 505 SHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVH 564
SH RH+F++YEY+E GSL +L+N+ AK L WTKR+N++KGV ALSYMH+D PIVH
Sbjct: 582 SHRRHTFLIYEYMEKGSLNKLLANEEEAKRLTWTKRINIVKGVAHALSYMHHDRSTPIVH 641
Query: 565 RDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDV 624
RDISS N+LLD + A +SDFGTAK LK DSSNW+ +AGTYGYVAPE AYTMKVTEKCDV
Sbjct: 642 RDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDV 701
Query: 625 YSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVA 684
YSFGVL LEVI GKHP D ++S+SSS ++L + D R+ P ++KLI ++EVA
Sbjct: 702 YSFGVLILEVIMGKHPGDLVASLSSSPGE-TLSLRSISDERILEPRGQNREKLIKMVEVA 760
Query: 685 ISCLDESPESRPTIQKVS 702
+SCL P+SRPT+ +S
Sbjct: 761 LSCLQADPQSRPTMLSIS 778
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 707 | ||||||
| TAIR|locus:2138268 | 1045 | AT4G08850 [Arabidopsis thalian | 0.987 | 0.667 | 0.452 | 2.4e-163 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.985 | 0.622 | 0.453 | 3.7e-158 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.985 | 0.633 | 0.356 | 2.1e-107 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.984 | 0.631 | 0.365 | 5.8e-105 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.898 | 0.564 | 0.366 | 8.4e-97 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.961 | 0.543 | 0.344 | 2.2e-96 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.981 | 0.608 | 0.335 | 7.6e-96 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.968 | 0.683 | 0.335 | 2.3e-94 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.983 | 0.612 | 0.333 | 6.1e-94 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.978 | 0.692 | 0.327 | 7.8e-94 |
| TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1590 (564.8 bits), Expect = 2.4e-163, P = 2.4e-163
Identities = 322/712 (45%), Positives = 454/712 (63%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
+ ++ L + N +G +P G+L +L L L N+L G IP + N T++T L L N
Sbjct: 333 MESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTN 392
Query: 62 ALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFGI 120
+G +P KL LTL++N GP+P +LR+ SL+RVR N +G+ISE+FG+
Sbjct: 393 NFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGV 452
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
+P L FIDLS+N F+G++S++W + KL S+N+ITG++P EI + +QL LDLSSN
Sbjct: 453 YPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSN 512
Query: 181 HIVGEMPXXXXXXXXXXXXXXXXXXXCGQLSLELGSLTQXXXXXXXXXXXXXXIPKSLGN 240
I GE+P G++ + LT IP +L N
Sbjct: 513 RITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNN 572
Query: 241 LVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHN 300
L +L+Y+NLS N + IP L KL L LDLS+N L E+ SQ ++Q+LE+L+LSHN
Sbjct: 573 LPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHN 632
Query: 301 NLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDI---KGF 357
NLSG IP F+++ L+++D+S+N L G IP++ AFR+AP +A +GNK LCG + +G
Sbjct: 633 NLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGL 692
Query: 358 PSCK---ASKSHKQASRKIWVVIVFPLLGSFALLISLIGLFFMFRRXXXXXXXXXPGNAP 414
C + KSHK R + + I+ P++G+ +L G+F FR+ +
Sbjct: 693 KPCSITSSKKSHKD--RNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESG 750
Query: 415 G-FLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLP 473
G LS+ SF+GK+ Y+EII+ T +FD ++ IG GG G VYKA+LP+ I+AVKK +
Sbjct: 751 GETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTD 809
Query: 474 SEMAS---QQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDA 530
S +++ +QEFLNE++ LT IRHRN+VK +GFCSH R++F+VYEY+E GSL +L ND
Sbjct: 810 SSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDD 869
Query: 531 AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590
AK L W KR+NV+KGV ALSYMH+D P IVHRDISS N+LL + EA +SDFGTAK
Sbjct: 870 EAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKL 929
Query: 591 LKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFXXXXXXX 650
LKPDSSNW+ +AGTYGYVAPELAY MKVTEKCDVYSFGVL LEVIKG+HP D
Sbjct: 930 LKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSS 989
Query: 651 XXNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVS 702
+ ++L + D RLP P+ ++++++ I++VA+ CL P++RPT+ +S
Sbjct: 990 PPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSIS 1041
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1541 (547.5 bits), Expect = 3.7e-158, P = 3.7e-158
Identities = 322/710 (45%), Positives = 437/710 (61%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
N+ ++ L L N +GS+P G L L L N L G+IP + N + +T L L
Sbjct: 412 NMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDT 471
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFG 119
N +G P+ KL ++L+ N L GPIP +LR+ SL+R R N TG+I E+FG
Sbjct: 472 NNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFG 531
Query: 120 IHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS 179
I+P+L FID SHN F+GEISS+W + PKLG L S+NNITG++P EI + +QL LDLS+
Sbjct: 532 IYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLST 591
Query: 180 NHIVGEMPXXXXXXXXXXXXXXXXXXXCGQLSLELGSLTQXXXXXXXXXXXXXXIPKSLG 239
N++ GE+P G++ L LT IP++
Sbjct: 592 NNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFD 651
Query: 240 NLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSH 299
+ +KLH +NLS N+F IP L KL L++LDLSHN L E+PSQ+ ++QSL+KL+LSH
Sbjct: 652 SFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSH 710
Query: 300 NNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDI--KGF 357
NNLSG IP+ FE + L+ +DIS N+L G +P++ FR A +AL+ N GLC +I +
Sbjct: 711 NNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRL 770
Query: 358 PSCKA-SKSHKQASRKIWVVIVFPLLGSFALLISLIGLF-FMFRRXXXXXXXXXPGNAPG 415
C+ K K + +W+++ P+LG +L F + R+
Sbjct: 771 KPCRELKKPKKNGNLVVWILV--PILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGE 828
Query: 416 FLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSE 475
+S+ S +GK Y++II TN+FD H IG GG VY+A L I+AVK+ H + E
Sbjct: 829 NMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEE 887
Query: 476 MAS---QQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAA 532
++ +QEFLNEVK LT IRHRN+VK +GFCSH RH+F++YEY+E GSL +L+ND A
Sbjct: 888 ISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEA 947
Query: 533 KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592
K L WTKR+NV+KGV ALSYMH+D PIVHRDISS N+LLD + A +SDFGTAK LK
Sbjct: 948 KRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLK 1007
Query: 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFXXXXXXXXX 652
DSSNW+ +AGTYGYVAPE AYTMKVTEKCDVYSFGVL LE+I GKHP D
Sbjct: 1008 TDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSPG 1067
Query: 653 NLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVS 702
++L + D R+ P ++KL+ ++E+A+ CL +PESRPT+ +S
Sbjct: 1068 EA-LSLRSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSIS 1116
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1062 (378.9 bits), Expect = 2.1e-107, P = 2.1e-107
Identities = 259/726 (35%), Positives = 374/726 (51%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
L+ L L L N +G+IP E+ L L DL+L N+L G IP +G + + L + N
Sbjct: 354 LTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSAN 413
Query: 62 ALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNIS-ESFG 119
+LSG IP + L LL+L +N+L G IP +L+ SL ++ L N LTG++ E F
Sbjct: 414 SLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFN 473
Query: 120 IHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS 179
+ NL ++L N+ G IS+D G+ L L ++NN TG +P EI + +++ ++SS
Sbjct: 474 LQ-NLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISS 532
Query: 180 NHIVGEMPXXXXXXXXXXXXXXXXXXXCGQLSLELGSLTQXXXXXXXXXXXXXXIPKSLG 239
N + G +P G ++ ELG L IP S G
Sbjct: 533 NQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFG 592
Query: 240 NLVKLHYLNLSNNQFIKKIPVELEKLIHLS-ELDLSHNFLGEEMPSQICNMQSLEKLNLS 298
+L +L L L N + IPVEL KL L L++SHN L +P + N+Q LE L L+
Sbjct: 593 DLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLN 652
Query: 299 HNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIKGFP 358
N LSG IP+ L L +IS N L G++P++ F+ GN GLC +
Sbjct: 653 DNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSH- 711
Query: 359 SCKASKSHKQASRKIWVV----------IVFPLLGSFALLISLIGLFFMFRRXXXXXXXX 408
C+ H S+ W++ I ++GS LI+ +GL + +R
Sbjct: 712 -CQPLVPHSD-SKLNWLINGSQRQKILTITCIVIGS-VFLITFLGLCWTIKRREPAFVAL 768
Query: 409 XPGNAPGFLSVLSFEGK-IVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKK 467
P + F K Y+ ++ T +F ++ +G+G G+VYKAE+ GE++AVKK
Sbjct: 769 EDQTKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKK 828
Query: 468 FHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS 527
+S +S F E+ TL IRHRNIVK YGFC H + ++YEY+ GSL L
Sbjct: 829 LNSR-GEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQ 887
Query: 528 NDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587
L W R + G + L Y+H+DC P IVHRDI S N+LLD +AHV DFG
Sbjct: 888 RGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGL 947
Query: 588 AKFLKPD-SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP------ 640
AK + S + + +AG+YGY+APE AYTMKVTEKCD+YSFGV+ LE+I GK P
Sbjct: 948 AKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQ 1007
Query: 641 -RDFXXXXXXXXXNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQ 699
D N+ I EM D RL T ++ ++++A+ C SP SRPT++
Sbjct: 1008 GGDLVNWVRRSIRNM-IPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMR 1066
Query: 700 KVSQLL 705
+V ++
Sbjct: 1067 EVVAMI 1072
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1039 (370.8 bits), Expect = 5.8e-105, P = 5.8e-105
Identities = 266/727 (36%), Positives = 381/727 (52%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
L NL+ L L N+ +G IP L+ L L+L N L G+IP LG + + L + DN
Sbjct: 360 LKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDN 419
Query: 62 ALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGI 120
LSG IP + +L L N L G IP + +LV++RL +N+L G +
Sbjct: 420 HLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCK 479
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
N+ I+L N F G I + G C L L + N TG +P EI SQL L++SSN
Sbjct: 480 QVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSN 539
Query: 181 HIVGEMPXXXXXXXXXXXXXXXXXXXCGQLSLELGSLTQXXXXXXXXXXXXXXIPKSLGN 240
+ GE+P G L E+GSL Q IP +LGN
Sbjct: 540 KLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGN 599
Query: 241 LVKLHYLNLSNNQFIKKIPVELEKLIHLS-ELDLSHNFLGEEMPSQICNMQSLEKLNLSH 299
L +L L + N F IP EL L L L+LS+N L E+P ++ N+ LE L L++
Sbjct: 600 LSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNN 659
Query: 300 NNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCG------- 352
NNLSG IPS F L L + SYN L G IP R+ M + GN+GLCG
Sbjct: 660 NNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCI 716
Query: 353 DIKGF-PSCKASKSHKQASRKIWVVIVFPLLGSFAL-LISLIGLFFMFRRXXXXXXXXXP 410
+ F PS K S KI + I ++G +L LI+LI ++ RR
Sbjct: 717 QTQPFAPSQSTGKPGGMRSSKI-IAITAAVIGGVSLMLIALI--VYLMRRPVRTVASSAQ 773
Query: 411 GNAPGFLSV-LSFEGK--IVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKK 467
P +S+ + F K +++++ T++FD+ +G+G G+VYKA LP+G +AVKK
Sbjct: 774 DGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKK 833
Query: 468 FHSPLPSEMASQQE--FLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMI 525
S + + F E+ TL IRHRNIVK +GFC+H + ++YEY+ GSL I
Sbjct: 834 LASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEI 893
Query: 526 LSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585
L + + +L W+KR + G L+Y+H+DC P I HRDI S N+LLD + EAHV DF
Sbjct: 894 LHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 951
Query: 586 GTAKFLK-PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK---HPR 641
G AK + P S + + +AG+YGY+APE AYTMKVTEK D+YS+GV+ LE++ GK P
Sbjct: 952 GLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPI 1011
Query: 642 DFXXXXXXXXXNL--EIALNE-MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTI 698
D + AL+ +LD RL + +++++++A+ C SP +RP++
Sbjct: 1012 DQGGDVVNWVRSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSM 1071
Query: 699 QKVSQLL 705
++V +L
Sbjct: 1072 RQVVLML 1078
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 962 (343.7 bits), Expect = 8.4e-97, P = 8.4e-97
Identities = 242/660 (36%), Positives = 343/660 (51%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
L NLA L L NS +G IP L S+ L+L N L G IP LG + + + +N
Sbjct: 372 LRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSEN 431
Query: 62 ALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFGI 120
LSG IP L LL L +N++ G IP + SL+++R+ N LTG
Sbjct: 432 QLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCK 491
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
NL+ I+L N F G + + G C KL L ++N + ++P EI S L ++SSN
Sbjct: 492 LVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSN 551
Query: 181 HIVGEMPXXXXXXXXXXXXXXXXXXXCGQLSLELGSLTQXXXXXXXXXXXXXXIPKSLGN 240
+ G +P G L ELGSL Q IP ++GN
Sbjct: 552 SLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGN 611
Query: 241 LVKLHYLNLSNNQFIKKIPVELEKLIHLS-ELDLSHNFLGEEMPSQICNMQSLEKLNLSH 299
L L L + N F IP +L L L ++LS+N E+P +I N+ L L+L++
Sbjct: 612 LTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNN 671
Query: 300 NNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIKGFPS 359
N+LSG IP+ FE L L + SYN L G +P++ F++ + + GNKGLCG S
Sbjct: 672 NHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGG--HLRS 729
Query: 360 CKASKS---H----KQAS--RKIWVVIVFPLLGSFALLISLIGLFFMFRRXXXXXXXXXP 410
C S S H K S R ++IV ++G +LL+ I + F+ R
Sbjct: 730 CDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFL-RNPVEPTAPYVH 788
Query: 411 GNAPGFL-SVLSFEGK--IVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKK 467
P F S + F K ++I+ T F D + +G+G G+VYKA +PSG+ +AVKK
Sbjct: 789 DKEPFFQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKK 848
Query: 468 FHSPLP----SEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH--ARHSFIVYEYLEMGS 521
S + + F E+ TL IRHRNIV+ Y FC H + + ++YEY+ GS
Sbjct: 849 LESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGS 908
Query: 522 LAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH 581
L +L + + + W R + G + L+Y+H+DC P I+HRDI S N+L+D EAH
Sbjct: 909 LGELL-HGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAH 967
Query: 582 VSDFGTAKFLK-PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
V DFG AK + P S + + +AG+YGY+APE AYTMKVTEKCD+YSFGV+ LE++ GK P
Sbjct: 968 VGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAP 1027
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 958 (342.3 bits), Expect = 2.2e-96, P = 2.2e-96
Identities = 245/712 (34%), Positives = 360/712 (50%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
N + + L +N SGSIPS G L +L + N L G++P SL NL +T +
Sbjct: 503 NCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSS 562
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFG 119
N +G+I G+ L+ EN G IP L T+L R+RL +N TG I +FG
Sbjct: 563 NKFNGSISPLCGSSSYLSFDVTENG-FEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFG 621
Query: 120 IHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS 179
L+ +D+S N G I + G C KL +D ++N ++G +P + L L LSS
Sbjct: 622 KISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSS 681
Query: 180 NHIVGEMPXXXXXXXXXXXXXXXXXXXCGQLSLELGSLTQXXXXXXXXXXXXXXIPKSLG 239
N VG +P G + E+G+L +P ++G
Sbjct: 682 NKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIG 741
Query: 240 NLVKLHYLNLSNNQFIKKIPVELEKLIHL-SELDLSHNFLGEEMPSQICNMQSLEKLNLS 298
L KL L LS N +IPVE+ +L L S LDLS+N +PS I + LE L+LS
Sbjct: 742 KLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLS 801
Query: 299 HNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIKGFP 358
HN L G +P ++ L Y+++SYN L G + F +A GN GLCG
Sbjct: 802 HNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCGSPLSHC 859
Query: 359 SCKASKSHKQASRKIWVVI-VFPLLGSFALLISLIGLFF-----MFRRXXXXXXXXXPGN 412
+ SK+ + S K V+I L + AL++ +I LFF +F++ +
Sbjct: 860 NRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNS 919
Query: 413 APGFLSVLSFEGK---IVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFH 469
+ + S G I +++I+ T+ ++E IG GG G VYKAEL +GE +AVKK
Sbjct: 920 SSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKIL 979
Query: 470 SPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH--SFIVYEYLEMGSL-AMIL 526
++ S + F EVKTL IRHR++VK G+CS + ++YEY+ GS+ +
Sbjct: 980 --WKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLH 1037
Query: 527 SNDAAAKD--LGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSD 584
+N+ K LGW R+ + G+ + Y+H DC PPIVHRDI S NVLLD EAH+ D
Sbjct: 1038 ANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGD 1097
Query: 585 FGTAKFLKPDSSNWAE----LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
FG AK L + E AG+YGY+APE AY++K TEK DVYS G++ +E++ GK P
Sbjct: 1098 FGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMP 1157
Query: 641 RDFXXXXXXXXXNLEIALNEMLDPRLPTPSHNVQDKLI-SIMEVAISCLDES 691
+ ++ + +LD P P ++KLI S ++ + C +E+
Sbjct: 1158 TE---AMFDEETDMVRWVETVLDT--P-PGSEAREKLIDSELKSLLPCEEEA 1203
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 953 (340.5 bits), Expect = 7.6e-96, P = 7.6e-96
Identities = 245/731 (33%), Positives = 377/731 (51%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
LS L + +N FSGSIP+ I SL L+L N++ G IP LG LT++T + N
Sbjct: 345 LSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSN 404
Query: 62 ALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN----LRNLTSLVRVRLNQNHLTGNISES 117
L G+IP + L L L N L G IP+ LRNLT L+ + N L+G I +
Sbjct: 405 QLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLI---SNSLSGFIPQE 461
Query: 118 FGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDL 177
G +L + L N GEI S G K+ LDFSSN + G +P EI S+L+++DL
Sbjct: 462 IGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDL 521
Query: 178 SSNHIVGEMPXXXXXXXXXXXXXXXXXXXCGQLSLELGSLTQXXXXXXXXXXXXXXIPKS 237
S+N + G +P G++ LG L IP S
Sbjct: 522 SNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTS 581
Query: 238 LGNLVKLHYLNLSNNQFIKKIPVELEKLIHLS-ELDLSHNFLGEEMPSQICNMQSLEKLN 296
LG L L+L +N+ +IP EL + +L L+LS N L ++PS+I ++ L L+
Sbjct: 582 LGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILD 641
Query: 297 LSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIKG 356
LSHN L G + + L ++ISYN G +P++ FR + L+GNK LC +
Sbjct: 642 LSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQD 700
Query: 357 --FPSCKASKS---HKQASRKIWVVIVFPLLGSFALLISLIGLFFMFR--RXXXXXXXXX 409
F + + ASR + + LL + +++ ++G + R R
Sbjct: 701 SCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSE 760
Query: 410 PGNAPGFLSVLSFEGKIVY--EEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKK 467
G + F+ K+ + ++IIR + + IGKG G VY+A++ +GE++AVKK
Sbjct: 761 LGETYKW-QFTPFQ-KLNFSVDQIIRC---LVEPNVIGKGCSGVVYRADVDNGEVIAVKK 815
Query: 468 FHSPLPS----EMAS--QQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGS 521
+ + E + F EVKTL IRH+NIV+F G C + ++Y+Y+ GS
Sbjct: 816 LWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGS 875
Query: 522 LAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH 581
L +L ++ L W R ++ G L+Y+H+DC PPIVHRDI + N+L+ L+ E +
Sbjct: 876 LGSLL-HERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPY 934
Query: 582 VSDFGTAKFL-KPDSSNWAE-LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 639
++DFG AK + + D + +AG+YGY+APE Y+MK+TEK DVYS+GV+ LEV+ GK
Sbjct: 935 IADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQ 994
Query: 640 PRDFXXXXXXXXXNLEIALN----EMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESR 695
P D + + N E+LD L + + D+++ ++ A+ C++ SP+ R
Sbjct: 995 PIDPTVPEGIHLVDW-VRQNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDER 1053
Query: 696 PTIQKVSQLLK 706
PT++ V+ +LK
Sbjct: 1054 PTMKDVAAMLK 1064
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 939 (335.6 bits), Expect = 2.3e-94, P = 2.3e-94
Identities = 241/719 (33%), Positives = 361/719 (50%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
L L L+L N+F+G+I E+G + SL ++LS N G IP S L +T L LF N
Sbjct: 262 LQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLLNLFRN 321
Query: 62 ALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGI 120
L GAIP+ G + +L +L L N G IP L LV + L+ N LTG + +
Sbjct: 322 KLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLPPNMCS 381
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
L + N+ +G I G+C L + N + GS+P E+ +L ++L N
Sbjct: 382 GNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQVELQDN 441
Query: 181 HIVGEMPXXXXXXXXXXXXXXXXXXXC-GQLSLELGSLTQXXXXXXXXXXXXXXIPKSLG 239
++ GE+P G L +G+L+ IP +G
Sbjct: 442 YLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIG 501
Query: 240 NLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSH 299
L +L L+ S+N F +I E+ + L+ +DLS N L ++P+++ M+ L LNLS
Sbjct: 502 RLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNYLNLSR 561
Query: 300 NNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIKGFPS 359
N+L G IP + L+ +D SYN L G +P++ F + GN LCG G P
Sbjct: 562 NHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLG-PC 620
Query: 360 CKAS-KSH-KQASRKIWVVIVFPLLGSFALLISLIGLFFMFRRXXXXXXXXXPGNAPGFL 417
K + +SH K S +++V LL F ++ I + + R F
Sbjct: 621 GKGTHQSHVKPLSATTKLLLVLGLL--FCSMVFAI-VAIIKARSLRNASEAKAWRLTAFQ 677
Query: 418 SVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMA 477
L F ++++ + +++ IGKGG G VYK +P G++VAVK+ + + +
Sbjct: 678 R-LDF----TCDDVL---DSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRL-ATMSHGSS 728
Query: 478 SQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGW 537
F E++TL IRHR+IV+ GFCS+ + +VYEY+ GSL +L L W
Sbjct: 729 HDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGH-LHW 787
Query: 538 TKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN 597
R + L Y+H+DC P IVHRD+ S N+LLD EAHV+DFG AKFL+ ++
Sbjct: 788 NTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTS 847
Query: 598 --WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-RDFXXXX------- 647
+ +AG+YGY+APE AYT+KV EK DVYSFGV+ LE+I GK P +F
Sbjct: 848 ECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVDIVQWVR 907
Query: 648 XXXXXNLEIALNEMLDPRLPT-PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
N + L +++D RL + P H V + VA+ C++E RPT+++V Q+L
Sbjct: 908 SMTDSNKDCVL-KVIDLRLSSVPVHEVTH----VFYVALLCVEEQAVERPTMREVVQIL 961
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 935 (334.2 bits), Expect = 6.1e-94, P = 6.1e-94
Identities = 243/729 (33%), Positives = 367/729 (50%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
NLSNL L L +N+ +GSIPS + L ++ N++ G IP +G L ++ +
Sbjct: 345 NLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQ 404
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIP----NLRNLTSLVRVRLNQNHLTGNISE 116
N L G IP E L L L N L G +P LRNLT L+ + N ++G I
Sbjct: 405 NKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLI---SNAISGVIPL 461
Query: 117 SFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLD 176
G +L + L +N GEI G L LD S NN++G +P EI + QL++L+
Sbjct: 462 EIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLN 521
Query: 177 LSSNHIVGEMPXXXXXXXXXXXXXXXXXXXCGQLSLELGSLTQXXXXXXXXXXXXXXIPK 236
LS+N + G +P G++ LG L IP
Sbjct: 522 LSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPS 581
Query: 237 SLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLS-ELDLSHNFLGEEMPSQICNMQSLEKL 295
SLG+ L L+LS+N IP EL + L L+LS N L +P +I + L L
Sbjct: 582 SLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVL 641
Query: 296 NLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIK 355
++SHN LSG + S L L ++IS+N G +P+S FR ++GN GLC K
Sbjct: 642 DISHNMLSGDL-SALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCS--K 698
Query: 356 GFPSCKASKSHKQASRK-IW---VVIVFPLLGSFALLISLIGLFFMFR--RXXXXXXXXX 409
GF SC S S + +++ + + I LL S +++++G+ + R +
Sbjct: 699 GFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSE 758
Query: 410 PGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFH 469
G F+ K+ + + V + + IGKG G VYKAE+P+ E++AVKK
Sbjct: 759 TGENLWTWQFTPFQ-KLNFT-VEHVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAVKKLW 816
Query: 470 S---PLPSEMAS----QQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL 522
P +E + F EVKTL IRH+NIV+F G C + ++Y+Y+ GSL
Sbjct: 817 PVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSL 876
Query: 523 AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV 582
+L + LGW R +I G L+Y+H+DC PPIVHRDI + N+L+ + E ++
Sbjct: 877 GSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYI 936
Query: 583 SDFGTAKFLKPDSSNWAE----LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 638
DFG AK + D ++A +AG+YGY+APE Y+MK+TEK DVYS+GV+ LEV+ GK
Sbjct: 937 GDFGLAKLV--DDGDFARSSNTIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGK 994
Query: 639 HPRDFXXXXXXXXXNL--EIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRP 696
P D + +I +++D L + ++++ + VA+ C++ PE RP
Sbjct: 995 QPIDPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRP 1054
Query: 697 TIQKVSQLL 705
T++ V+ +L
Sbjct: 1055 TMKDVAAML 1063
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 934 (333.8 bits), Expect = 7.8e-94, P = 7.8e-94
Identities = 236/720 (32%), Positives = 366/720 (50%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
L + + L+NNSFSG +P +G + +L + S NKL G IP +L NL + L LF+N
Sbjct: 259 LKTVEQIELFNNSFSGELPESMGNMTTLKRFDASMNKLTGKIPDNL-NLLNLESLNLFEN 317
Query: 62 ALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTS-LVRVRLNQNHLTGNISESFGI 120
L G +P+ L+ L L NN+L G +P+ S L V L+ N +G I +
Sbjct: 318 MLEGPLPESITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCG 377
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
L ++ L N F GEIS++ G+C L + S+N ++G +P +L +L+LS N
Sbjct: 378 EGKLEYLILIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDN 437
Query: 181 HIVGEMPXXXXXXXXXXXXXXXXXXXCGQLSLELGSLTQXXXXXXXXXXXXXXIPKSLGN 240
G +P G + E+GSL IP+SL
Sbjct: 438 SFTGSIPKTIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESLVK 497
Query: 241 LVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHN 300
L +L L+LS NQ +IP EL +L+EL+L++N L E+P ++ + L L+LS N
Sbjct: 498 LKQLSRLDLSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSN 557
Query: 301 NLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIKGFPSC 360
SG IP + L L+ +++SYN L G IP A + + + GN GLC D+ G C
Sbjct: 558 QFSGEIPLELQNLK-LNVLNLSYNHLSGKIPPLYANKIYAHDFI-GNPGLCVDLDGL--C 613
Query: 361 KASKSHKQASRKIWVVIVFPLLGSFALLISLIGLFFMFRRXXXXXXXXXPGNAPGFLSVL 420
+ K +W+++ LL ++ ++ R+ +
Sbjct: 614 RKITRSKNIGY-VWILLTIFLLAGLVFVVGIVMFIAKCRKLRALKSSTLAAS-----KWR 667
Query: 421 SFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLP------- 473
SF K+ + E + + D+++ IG G G VYK EL GE+VAVKK + +
Sbjct: 668 SFH-KLHFSEH-EIADCLDEKNVIGFGSSGKVYKVELRGGEVVAVKKLNKSVKGGDDEYS 725
Query: 474 SEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDA-AA 532
S+ ++ F EV+TL IRH++IV+ + CS +VYEY+ GSLA +L D
Sbjct: 726 SDSLNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKGG 785
Query: 533 KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592
LGW +R+ + + LSY+H+DC PPIVHRD+ S N+LLD + A V+DFG AK +
Sbjct: 786 VVLGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQ 845
Query: 593 PDSSNWAE----LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFXXXXX 648
S E +AG+ GY+APE YT++V EK D+YSFGV+ LE++ GK P D
Sbjct: 846 MSGSKTPEAMSGIAGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSELGDK 905
Query: 649 XXXXNLEIALNEM-LDPRL-PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ AL++ L+P + P ++++ ++ + + C P +RP+++KV +L+
Sbjct: 906 DMAKWVCTALDKCGLEPVIDPKLDLKFKEEISKVIHIGLLCTSPLPLNRPSMRKVVIMLQ 965
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 707 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-99 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-55 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-52 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-41 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-36 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-34 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-26 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-22 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-20 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-19 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-17 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-12 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-11 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-10 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 9e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-09 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-09 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-08 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 7e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 5e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-04 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.002 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 0.002 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 327 bits (841), Expect = 1e-99
Identities = 226/723 (31%), Positives = 357/723 (49%), Gaps = 48/723 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
NL NL +L+LY N SG IP I L+ L L+LS N L G IP + L + L LF
Sbjct: 258 NLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFS 317
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFG 119
N +G IP +L +L +L L +N+ G IP NL +L + L+ N+LTG I E
Sbjct: 318 NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLC 377
Query: 120 IHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS 179
NL + L N GEI G C L + N+ +G +P+E + LD+S+
Sbjct: 378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISN 437
Query: 180 NHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLG 239
N++ G + S+ + SL L L N+ G L GS +LE LDLS N+ S ++P+ LG
Sbjct: 438 NNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLG 496
Query: 240 NLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSH 299
+L +L L LS N+ +IP EL L LDLSHN L ++P+ M L +L+LS
Sbjct: 497 SLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQ 556
Query: 300 NNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIK--GF 357
N LSG IP + L ++IS+N LHGS+P++ AF A+ GN LCG G
Sbjct: 557 NQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGL 616
Query: 358 PSCKASKSHKQASRKIWVVIVFPLLGSFALLISLIGLFFMFRRSSSQTQQSSPGNAPGFL 417
P CK + W + LG+F L+++L+ F+F R + + N G
Sbjct: 617 PPCK-----RVRKTPSWWFYITCTLGAF-LVLALVAFGFVFIRGRNNLELKRVENEDGTW 670
Query: 418 SVLSFEGK----IVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEI----VAVKKFH 469
+ F+ K I +I+ +E+ I +G +G+ YK + + + +
Sbjct: 671 ELQFFDSKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVN 727
Query: 470 SPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSND 529
S +PS +E+ + ++H NIVK G C + +++++EY+E +L+ +L N
Sbjct: 728 S-IPS---------SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN- 776
Query: 530 AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589
L W +R + G+ AL ++H C P +V ++S + +++D ++E H+
Sbjct: 777 -----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830
Query: 590 FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISS 649
L D+ + A YVAPE T +TEK D+Y FG++ +E++ GK P D +
Sbjct: 831 LLCTDTKCFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG 886
Query: 650 SSSNL------EIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
S + L+ +DP + Q++++ +M +A+ C P +RP V +
Sbjct: 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
Query: 704 LLK 706
L+
Sbjct: 947 TLE 949
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 2e-55
Identities = 121/333 (36%), Positives = 172/333 (51%), Gaps = 2/333 (0%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
NL++L FL L +N G IP E+G++KSL + L N L G IP+ +G LT + L L
Sbjct: 186 NLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVY 245
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFG 119
N L+G IP GNL L L L N+L GPIP + +L L+ + L+ N L+G I E
Sbjct: 246 NNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305
Query: 120 IHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS 179
NL + L N F G+I P+L L SN +G +P + + L VLDLS+
Sbjct: 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST 365
Query: 180 NHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLG 239
N++ GE+P L +L KLIL SN L G++ LG+ L R+ L N S +P
Sbjct: 366 NNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFT 425
Query: 240 NLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSH 299
L +++L++SNN +I + L L L+ N +P + LE L+LS
Sbjct: 426 KLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENLDLSR 484
Query: 300 NNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332
N SG +P L L + +S N+L G IP+
Sbjct: 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPD 517
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 8e-52
Identities = 126/329 (38%), Positives = 177/329 (53%), Gaps = 3/329 (0%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA 62
S+L +L L NN+F+GSIP G + +L L+LS N L G IP+ +G+ + + L L N
Sbjct: 118 SSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175
Query: 63 LSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFGIH 121
L G IP NL L LTL +NQL G IP L + SL + L N+L+G I G
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGL 235
Query: 122 PNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNH 181
+L +DL +N G I S G L L N ++G +P I +L LDLS N
Sbjct: 236 TSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNS 295
Query: 182 IVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNL 241
+ GE+P + +L +L L L SN G++ + L SL +L+ L L SN+ S IPK+LG
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355
Query: 242 VKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNN 301
L L+LS N +IP L +L +L L N L E+P + +SL ++ L N+
Sbjct: 356 NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS 415
Query: 302 LSGFIPSCFEELHGLSYIDISYNELHGSI 330
SG +PS F +L + ++DIS N L G I
Sbjct: 416 FSGELPSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 181 bits (460), Expect = 1e-47
Identities = 114/320 (35%), Positives = 164/320 (51%), Gaps = 8/320 (2%)
Query: 14 SFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGN 73
SF SI + L + + S +C + N +++ + L +SG I
Sbjct: 36 SFKSSINDPLKYLSNWN----SSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFR 91
Query: 74 LVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSH 131
L + + L NNQL GPIP+ +SL + L+ N+ TG+I G PNL +DLS+
Sbjct: 92 LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSN 149
Query: 132 NYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLG 191
N GEI +D G L LD N + G +P + + + L+ L L+SN +VG++P +LG
Sbjct: 150 NMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELG 209
Query: 192 KLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSN 251
++ SL + L N L G++ E+G LT L LDL N L+ IP SLGNL L YL L
Sbjct: 210 QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQ 269
Query: 252 NQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFE 311
N+ IP + L L LDLS N L E+P + +Q+LE L+L NN +G IP
Sbjct: 270 NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT 329
Query: 312 ELHGLSYIDISYNELHGSIP 331
L L + + N+ G IP
Sbjct: 330 SLPRLQVLQLWSNKFSGEIP 349
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 2e-45
Identities = 71/275 (25%), Positives = 123/275 (44%), Gaps = 34/275 (12%)
Query: 438 FDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
++ +G+G G VY A + +G++VA+K ++ L E+K L ++H N
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIK--KKKIKKDRERILREIKILKKLKHPN 58
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN------VIKGVVDA 550
IV+ Y ++V EY E G L +L R++ ++ ++ A
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR---------GRLSEDEARFYLRQILSA 109
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAP 610
L Y+H+ IVHRD+ +N+LLD + ++DFG A+ L P GT Y+AP
Sbjct: 110 LEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLT-TFVGTPEYMAP 165
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670
E+ + D++S GV+ E++ GK P F L ++ P+ P P
Sbjct: 166 EVLLGKGYGKAVDIWSLGVILYELLTGKPP--F-----PGDDQLLELFKKIGKPKPPFPP 218
Query: 671 H--NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
++ + ++ L + PE R T ++ Q
Sbjct: 219 PEWDISPEAKDLIR---KLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 81/275 (29%), Positives = 123/275 (44%), Gaps = 25/275 (9%)
Query: 438 FDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
++ +G G G+VYKA +G+IVAVK Q E++ L + H N
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPN 59
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
IV+ H ++V EY E G L LS L + + ++ L Y+H+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHS 116
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE-LAYT 615
+ I+HRD+ +N+LLD ++DFG AK L SS+ GT Y+APE L
Sbjct: 117 N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173
Query: 616 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675
K DV+S GV+ E++ GK P F S + +++ L P +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP--F-------SGENILDQLQLIRRILGPPLEFDEP 224
Query: 676 KLISIMEVAIS----CLDESPESRPTIQKVSQLLK 706
K S E A CL++ P RPT + ++L+
Sbjct: 225 KWSSGSEEAKDLIKKCLNKDPSKRPTAE---EILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-43
Identities = 65/193 (33%), Positives = 105/193 (54%), Gaps = 10/193 (5%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G+GG G+VY A +G+ VA+K + +E L E++ L + H NIVK YG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
H ++V EY E GSL +L + L + + ++ +++ L Y+H++ I
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLHSN---GI 113
Query: 563 VHRDISSKNVLLDLEN-EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE-LAYTMKVTE 620
+HRD+ +N+LLD +N + ++DFG +K L D S + GT Y+APE L +E
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 621 KCDVYSFGVLALE 633
K D++S GV+ E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-41
Identities = 83/277 (29%), Positives = 132/277 (47%), Gaps = 34/277 (12%)
Query: 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
F+ IGKGG G VYKA +G+ VA+K +++ +NE++ L +H
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHP 57
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN------VIKGVVD 549
NIVK+YG +IV E+ GSL +L + + + V K ++
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS--------TNQTLTESQIAYVCKELLK 109
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVA 609
L Y+H++ I+HRDI + N+LL + E + DFG + L D+ + GT ++A
Sbjct: 110 GLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMA 165
Query: 610 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669
PE+ K D++S G+ A+E+ +GK P + + + +IA N P L P
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL---FKIATNGP--PGLRNP 220
Query: 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
D+ ++ CL ++PE RPT QLLK
Sbjct: 221 -EKWSDEFKDFLK---KCLQKNPEKRPT---AEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 6e-41
Identities = 101/306 (33%), Positives = 155/306 (50%), Gaps = 2/306 (0%)
Query: 29 LSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKE-YGNLVKLTLLTLENNQL 87
+ ++LSG + G I ++ L I + L +N LSG IP + + L L L NN
Sbjct: 71 VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130
Query: 88 RGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPK 147
G IP ++ +L + L+ N L+G I G +L +DL N G+I +
Sbjct: 131 TGSIPR-GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTS 189
Query: 148 LGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLC 207
L L +SN + G +P E+ LK + L N++ GE+P ++G L+SL L L N L
Sbjct: 190 LEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLT 249
Query: 208 GQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIH 267
G + LG+L L+ L L N+LS IP S+ +L KL L+LS+N +IP + +L +
Sbjct: 250 GPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQN 309
Query: 268 LSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELH 327
L L L N ++P + ++ L+ L L N SG IP + + L+ +D+S N L
Sbjct: 310 LEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT 369
Query: 328 GSIPNS 333
G IP
Sbjct: 370 GEIPEG 375
|
Length = 968 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 72/276 (26%), Positives = 127/276 (46%), Gaps = 36/276 (13%)
Query: 442 HCIGKGGQGSVYKAELP-SGEIVAVKK--FHSPLPSEMASQQEFLNEVKTLTGIRHRNIV 498
+G+G GSVY A +GE++AVK E+ + E++ L+ ++H NIV
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA---LEREIRILSSLQHPNIV 62
Query: 499 KFYGFCSHARHSF--IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG----VVDALS 552
++YG + I EY+ GSL+ +L + VI+ +++ L+
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLA 115
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE--LAGTYGYVAP 610
Y+H++ IVHRDI N+L+D + ++DFG AK L + + GT ++AP
Sbjct: 116 YLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670
E+ + D++S G +E+ GK P S + + + L + P +P
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPP---WSELGNPMAALYKIGSSGEPPEIPE-- 227
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
++ ++ + CL P+ RPT +LL+
Sbjct: 228 -HLSEEAKDFLR---KCLRRDPKKRPT---ADELLQ 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 72/272 (26%), Positives = 109/272 (40%), Gaps = 46/272 (16%)
Query: 444 IGKGGQGSVYKAEL-----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIV 498
+G+G G VYK L + VAVK E ++EFL E + + H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKLSHPNIV 64
Query: 499 KFYGFCSHARHSFIVYEYLEMGSL-AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHND 557
+ G C+ +IV EY+ G L + + L + + + + Y+ +
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK---LTLKDLLQMALQIAKGMEYLESK 121
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV-----APEL 612
F VHRD++++N L+ +SDFG ++ + D G + APE
Sbjct: 122 NF---VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY---YRKRGGGKLPIKWMAPES 175
Query: 613 AYTMKVTEKCDVYSFGVLALEVI-------KGKHPRDFISSISSSSSNLEIALNEMLDPR 665
K T K DV+SFGVL E+ G + + + R
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED-------------GYR 222
Query: 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPT 697
LP P N D+L +M + C PE RPT
Sbjct: 223 LPRP-ENCPDELYELM---LQCWAYDPEDRPT 250
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 3e-36
Identities = 77/269 (28%), Positives = 117/269 (43%), Gaps = 24/269 (8%)
Query: 444 IGKGGQGSVYKAEL-----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIV 498
+G+G G VYK L VAVK + +EFL E + + + H NIV
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNIV 64
Query: 499 KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC 558
K G C+ IV EY+ G L L K+L + ++ + + Y+ +
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKELSLSDLLSFALQIARGMEYLESK- 122
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA-GTYGYVAPELAYTMK 617
+HRD++++N L+ +SDFG ++ L D + ++APE K
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 618 VTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDK 676
T K DV+SFGVL E+ G+ P + SN E+ RLP P N +
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGM-------SNAEVLEYLKKGYRLPKP-PNCPPE 232
Query: 677 LISIMEVAISCLDESPESRPTIQKVSQLL 705
L +M C E PE RPT ++ ++L
Sbjct: 233 LYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 76/269 (28%), Positives = 117/269 (43%), Gaps = 25/269 (9%)
Query: 444 IGKGGQGSVYKAEL-----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIV 498
+G+G G VYK +L VAVK + +EFL E + + + H N+V
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNVV 64
Query: 499 KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC 558
K G C+ +IV EY+E G L L L + ++ + + Y+ +
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA-GTYGYVAPELAYTMK 617
+HRD++++N L+ +SDFG ++ L D ++APE K
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 618 VTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDK 676
T K DV+SFGVL E+ G+ P + SN E+ RLP P N +
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGM-------SNEEVLEYLKNGYRLPQP-PNCPPE 231
Query: 677 LISIMEVAISCLDESPESRPTIQKVSQLL 705
L +M C E PE RPT ++ ++L
Sbjct: 232 LYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-35
Identities = 80/274 (29%), Positives = 125/274 (45%), Gaps = 24/274 (8%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+D + +G+G G VYK P+G+I A+KK H E Q L E+KTL
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ--LLRELKTLRSCES 58
Query: 495 RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRM--NVIKGVVDAL 551
+VK YG F S IV EY++ GSLA D K + + + + ++ L
Sbjct: 59 PYVVKCYGAFYKEGEIS-IVLEYMDGGSLA-----DLLKKVGKIPEPVLAYIARQILKGL 112
Query: 552 SYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE 611
Y+H I+HRDI N+L++ + E ++DFG +K L+ GT Y++PE
Sbjct: 113 DYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170
Query: 612 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671
+ D++S G+ LE GK P F+ S L A+ + P L P+
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFP--FLPPGQPSFFELMQAICDGPPPSL--PAE 226
Query: 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
+ + +CL + P+ RP+ ++LL
Sbjct: 227 EFSPEFRDFIS---ACLQKDPKKRPS---AAELL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 72/290 (24%), Positives = 120/290 (41%), Gaps = 57/290 (19%)
Query: 444 IGKGGQGSVYKAELPSGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
+G+G G VYK +L + VAVK E +++FL E + + + H N+V+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNVVR 60
Query: 500 FYGFCSHARHSFIVYEYLEMGSL------AMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
G C+ ++V EY+E G L + + L ++ + + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN-----------WAELA 602
+ + VHRD++++N L+ + +SDFG ++ + D W
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW---- 173
Query: 603 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEM 661
+APE T K DV+SFGVL E+ G P ++ E+
Sbjct: 174 -----MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP------------GLSNEEV 216
Query: 662 LDP-----RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
L+ RLP P + D+L +M SC PE RPT ++ + L+
Sbjct: 217 LEYLRKGYRLPKPEY-CPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 9e-31
Identities = 74/284 (26%), Positives = 128/284 (45%), Gaps = 50/284 (17%)
Query: 438 FDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQE--FLNEVKTLTGIRH 494
+ + IG+G G VYKA + +G+ VA+KK + Q + +NE+ + +H
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR------LRKQNKELIINEILIMKDCKH 74
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN------VIKGVV 548
NIV +Y ++V EY++ GSL I++ + RMN V + V+
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN--------FVRMNEPQIAYVCREVL 126
Query: 549 DALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV 608
L Y+H+ ++HRDI S N+LL + ++DFG A L + S + GT ++
Sbjct: 127 QGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWM 183
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPR-DF-----ISSISSSSSNLEIALNEML 662
APE+ K D++S G++ +E+ +G+ P + I++
Sbjct: 184 APEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGI---------- 233
Query: 663 DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
P L P + + CL + PE RP+ + +LL+
Sbjct: 234 -PPLKNP-EKWSPEFKDFLN---KCLVKDPEKRPSAE---ELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-30
Identities = 73/266 (27%), Positives = 124/266 (46%), Gaps = 24/266 (9%)
Query: 443 CIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFY 501
IG+G G VYK L +G+ VA+K+ S + + + + E+ L ++H NIVK+
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQI-SLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
G + +I+ EY E GSL I+ + + V+ L+Y+H
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQ---G 119
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEK 621
++HRDI + N+L + ++DFG A L S + A + GT ++APE+ +
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTA 179
Query: 622 CDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP-SHNVQDKLISI 680
D++S G +E++ G P ++ ++ I ++ P LP S ++D L
Sbjct: 180 SDIWSLGCTVIELLTGNPP---YYDLNPMAALFRIVQDDH--PPLPEGISPELKDFL--- 231
Query: 681 MEVAISCLDESPESRPTIQKVSQLLK 706
+ C + P RPT + QLLK
Sbjct: 232 ----MQCFQKDPNLRPTAK---QLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 74/274 (27%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
IGKG G VYK L VAVK S LP ++ +++FL E + L H NIVK G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL--KRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDA---LSYMHNDCFP 560
C + +IV E + GSL L +++ +DA + Y+ +
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNR-----LTVKKLLQMSLDAAAGMEYLESKN-- 113
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT----YGYVAPELAYTM 616
+HRD++++N L+ N +SDFG ++ + + + G + APE
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 617 KVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPSHNV 673
+ T + DV+S+G+L E G P SN + E ++ R+P P
Sbjct: 171 RYTSESDVWSYGILLWETFSLGDTP-------YPGMSNQQT--RERIESGYRMPAPQL-C 220
Query: 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLKI 707
+++ +M C PE+RP+ ++ L+I
Sbjct: 221 PEEIYRLML---QCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 82/279 (29%), Positives = 130/279 (46%), Gaps = 42/279 (15%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVK--KFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
IG G G VY A L +GE++AVK + ++ + +E +E+K L ++H N+VK+
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQ---DNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVI----KGVVDALSYMHN 556
YG H +I EY G+L +L + G +VI +++ L+Y+H+
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELL-------EHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE----LAGTYGYVAPEL 612
IVHRDI N+ LD + DFG A LK +++ E LAGT Y+APE+
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 613 AYTMKVTEK---CDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIA--LNEMLDPRLP 667
K D++S G + LE+ GK P S + +I + P +P
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP------WSELDNEFQIMFHVGAGHKPPIP 228
Query: 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ + ++ CL+ P+ RPT S+LL+
Sbjct: 229 DSL-QLSPEGKDFLD---RCLESDPKKRPT---ASELLQ 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 79/276 (28%), Positives = 122/276 (44%), Gaps = 29/276 (10%)
Query: 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
++ IGKG G VY G++ +K+ SE +++ LNEVK L + H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE-KEREDALNEVKILKKLNHP 59
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD---ALS 552
NI+K+Y IV EY + G L+ + ++ V AL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKP--FPEEQILDWFVQLCLALK 117
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA----GTYGYV 608
Y+H+ I+HRDI +N+ L + DFG +K L S+ +LA GT Y+
Sbjct: 118 YLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL----SSTVDLAKTVVGTPYYL 170
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668
+PEL K D++S G + E+ KHP F + LE+AL + P
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLKHP--F-----EGENLLELALKILKGQYPPI 223
Query: 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704
PS +L +++ S L + PE RP+I ++ Q
Sbjct: 224 PSQ-YSSELRNLVS---SLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (285), Expect = 2e-27
Identities = 72/267 (26%), Positives = 125/267 (46%), Gaps = 17/267 (6%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH-RNIVKFYG 502
+G+G G VY A ++VA+K L S+ + FL E++ L + H NIVK Y
Sbjct: 8 LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
F ++V EY++ GSL +L L ++ + ++ ++ AL Y+H+ I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---I 122
Query: 563 VHRDISSKNVLLDLE-NEAHVSDFGTAKFLKPDSSN------WAELAGTYGYVAPELAYT 615
+HRDI +N+LLD + + DFG AK L S + GT GY+APE+
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 616 M---KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672
+ + D++S G+ E++ G P + + S++S L+I L S +
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 673 VQDKLIS-IMEVAISCLDESPESRPTI 698
+ + ++ L + P++R +
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSS 269
|
Length = 384 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 79/266 (29%), Positives = 124/266 (46%), Gaps = 26/266 (9%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
+G G G V+ + VA+K SE +F+ E K + + H N+V+ YG
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIV 563
C+ R FIV EY+ G L L W +++ V +A+ Y+ ++ F +
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNGF---I 122
Query: 564 HRDISSKNVLLDLENEAHVSDFGTAKFLKPD---SSNWAELAGTYGYVAPELAYTMKVTE 620
HRD++++N L+ +N VSDFG A+++ D SS + + PE+ + +
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFSS 180
Query: 621 KCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679
K DV+SFGVL EV +GK P + SN E+ + RL P ++ +
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYE-------RFSNSEVVESVSAGYRLYRP-KLAPTEVYT 232
Query: 680 IMEVAISCLDESPESRPTIQKVSQLL 705
IM SC E PE RP +K+ L
Sbjct: 233 IMY---SCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 70/210 (33%), Positives = 111/210 (52%), Gaps = 19/210 (9%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQE------FLNEVKTLTGIRHRN 496
IG G GSVY SGE++AVK+ P S + ++ E+ L ++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
IV++ G A H I EY+ GS+A +L+N A ++ T N ++ ++ L+Y+HN
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYLHN 124
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA------ELAGTYGYVAP 610
I+HRDI N+L+D + +SDFG +K L+ +S + L G+ ++AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
E+ T K D++S G L +E++ GKHP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 73/261 (27%), Positives = 122/261 (46%), Gaps = 31/261 (11%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
+G G G V+ VAVK P M S + FL E + + +RH +V+ Y
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLK---PGTM-SPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIV 563
CS +IV EY+ GSL L + K L + +++ + + ++Y+ + + +
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRNY---I 125
Query: 564 HRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG------YVAPELAYTMK 617
HRD++++N+L+ ++DFG A+ ++ D E G + APE A +
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDD-----EYTAREGAKFPIKWTAPEAANYGR 180
Query: 618 VTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDK 676
T K DV+SFG+L E++ G+ P +N E+ R+P P N ++
Sbjct: 181 FTIKSDVWSFGILLTEIVTYGRVP-------YPGMTNREVLEQVERGYRMPRP-PNCPEE 232
Query: 677 LISIMEVAISCLDESPESRPT 697
L +M + C D+ PE RPT
Sbjct: 233 LYDLM---LQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 69/231 (29%), Positives = 111/231 (48%), Gaps = 28/231 (12%)
Query: 478 SQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGW 537
S+ EF+ E K + + H +V+ YG C+ R +IV EY+ G L L K
Sbjct: 42 SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE--HGKRFQP 99
Query: 538 TKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN 597
++ + + K V + ++Y+ + F +HRD++++N L+D + VSDFG ++++ D
Sbjct: 100 SQLLEMCKDVCEGMAYLESKQF---IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD--- 153
Query: 598 WAELAGTYG------YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSS 650
E + G + PE+ K + K DV++FGVL EV GK P +
Sbjct: 154 --EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF------ 205
Query: 651 SSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
+N E RL P H +K+ +IM SC E E RPT Q++
Sbjct: 206 -NNSETVEKVSQGLRLYRP-HLASEKVYAIM---YSCWHEKAEERPTFQQL 251
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 76/273 (27%), Positives = 120/273 (43%), Gaps = 28/273 (10%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IG G VY A LP+ E VA+K+ L S E EV+ ++ H N+VK+Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRID--LEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
++V YL GSL I+ + L V+K V+ L Y+H++
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQ 123
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE----LAGTYGYVAPELAYTMK- 617
+HRDI + N+LL + ++DFG + L + GT ++APE+ +
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183
Query: 618 VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD--PRLPTPSHNVQD 675
K D++SFG+ A+E+ G P S +++ + + + P L T
Sbjct: 184 YDFKADIWSFGITAIELATGAAP-------YSKYPPMKVLMLTLQNDPPSLET---GADY 233
Query: 676 KLIS--IMEVAISCLDESPESRPTIQKVSQLLK 706
K S ++ CL + P RPT +LLK
Sbjct: 234 KKYSKSFRKMISLCLQKDPSKRPT---AEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 78/278 (28%), Positives = 128/278 (46%), Gaps = 37/278 (13%)
Query: 443 CIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQ--QEFLNEVKTLTGIRHRNIVK 499
IGKG G+V K G+I+ K+ M + Q+ ++EV L ++H NIV+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDY---GNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 500 FYG-FCSHARHS-FIVYEYLEMGSLAMILS-----NDAAAKDLGWTKRMNVIKGVVDALS 552
+Y + + +IV EY E G LA ++ ++ W ++ ++ AL
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLLLALY 119
Query: 553 YMHN--DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAP 610
HN D ++HRD+ N+ LD N + DFG AK L DSS GT Y++P
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSP 179
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIA--LNEMLDPRLPT 668
E M EK D++S G L E+ P F ++ + L++A + E R+P
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPP--F-----TARNQLQLASKIKEGKFRRIP- 231
Query: 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ +L +++ S L+ P+ RP+ +LL+
Sbjct: 232 --YRYSSELNEVIK---SMLNVDPDKRPS---TEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 78/270 (28%), Positives = 129/270 (47%), Gaps = 34/270 (12%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
+G G G V+ + + VA+K + SE ++F+ E K + + H +V+ YG
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 504 CSHARHSFIVYEYLEMGSLAMILSNDAA--AKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
C+ + +IV E++E G L L +KD+ +++ + V + + Y+ + F
Sbjct: 68 CTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM----LLSMCQDVCEGMEYLERNSF-- 121
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD---SSNWAELAGTYGYVAPELAYTMKV 618
+HRD++++N L+ VSDFG +++ D SS+ A+ + PE+ K
Sbjct: 122 -IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP--VKWSPPEVFNFSKY 178
Query: 619 TEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKL 677
+ K DV+SFGVL EV +GK P + SN E+ RL P KL
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFE-------KKSNYEVVEMISRGFRLYRP------KL 225
Query: 678 IS--IMEVAISCLDESPESRPTIQKVSQLL 705
S + EV SC E PE RPT ++ + +
Sbjct: 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 69/262 (26%), Positives = 123/262 (46%), Gaps = 19/262 (7%)
Query: 437 DFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
+F E +G G G V++ + VA+K S ++ QQ+F EV+ L +RH++
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS---DDLLKQQDFQKEVQALKRLRHKH 63
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
++ + CS +I+ E +E GSL L + L +++ V + ++Y+
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTM 616
+HRD++++N+L+ + V+DFG A+ +K D ++ Y + APE A
Sbjct: 123 Q---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHG 179
Query: 617 KVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675
+ K DV+SFG+L E+ G+ P +N E+ R+P P+ Q
Sbjct: 180 TFSTKSDVWSFGILLYEMFTYGQVPYP-------GMNNHEVYDQITAGYRMPCPAKCPQ- 231
Query: 676 KLISIMEVAISCLDESPESRPT 697
I ++ + C PE RP+
Sbjct: 232 ---EIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 32/275 (11%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+ IGKG G V + G+ VAVK L + + Q FL E +T +RH
Sbjct: 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKC----LKDDSTAAQAFLAEASVMTTLRHP 60
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
N+V+ G +IV EY+ GSL L + A + +++ V + + Y+
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLE 119
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY--GYVAPELA 613
F VHRD++++NVL+ + A VSDFG AK ++ + +G + APE
Sbjct: 120 EKNF---VHRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL 171
Query: 614 YTMKVTEKCDVYSFGVLALEVI---KGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670
K + K DV+SFG+L E+ + +PR + + + ++ P
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH-----VEKGYRMEAPEGCPP 226
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
+ +V C + P RPT +++ + L
Sbjct: 227 E--------VYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 70/266 (26%), Positives = 112/266 (42%), Gaps = 14/266 (5%)
Query: 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+D + +G G G V K P+G+I+AVK L A Q++ L E+ L
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNS 58
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
IV FYG + I EY++ GSL IL ++ V V+ L+Y+
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAV--AVLKGLTYL 116
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
H I+HRD+ N+L++ + + DFG + L + GT Y+APE
Sbjct: 117 HEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQ 172
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674
+ K D++S G+ +E+ G+ P + L + PRL PS
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRL--PSGKFS 230
Query: 675 DKLISIMEVAISCLDESPESRPTIQK 700
+ + CL + P RP+ ++
Sbjct: 231 PDFQDFVNL---CLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 78/273 (28%), Positives = 126/273 (46%), Gaps = 37/273 (13%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH---RNIVK 499
IG+G G+VY+ +P+G +VA+K + P + S + EV L+ +R NI K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS--DIQREVALLSQLRQSQPPNITK 66
Query: 500 FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVI-KGVVDALSYMHNDC 558
+YG +I+ EY E GS+ ++ A+ K ++VI + V+ AL Y+H
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAE-----KYISVIIREVLVALKYIHKV- 120
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL-----A 613
++HRDI + N+L+ + DFG A L +SS + GT ++APE+
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKY 178
Query: 614 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673
Y K D++S G+ E+ G P S+++ ML P+ P
Sbjct: 179 YDTKA----DIWSLGITIYEMATGNPPY----------SDVDAFRAMMLIPKSKPPRLED 224
Query: 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ E +CLDE P+ R + +LLK
Sbjct: 225 NGYSKLLREFVAACLDEEPKERLS---AEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 77/265 (29%), Positives = 134/265 (50%), Gaps = 26/265 (9%)
Query: 438 FDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
F D IG G G+VY A ++ + E+VA+KK Q+ + EV+ L +RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 497 IVKFYGFCSHARHS-FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
+++ G C H+ ++V EY +GS + IL + K L + + G + L+Y+H
Sbjct: 77 TIEYKG-CYLREHTAWLVMEYC-LGSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT 615
+ +HRDI + N+LL ++DFG+A + P +S GT ++APE+
Sbjct: 133 SHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEVILA 185
Query: 616 M---KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672
M + K DV+S G+ +E+ + K P + ++++ S+ IA N+ P L + +
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQND--SPTLSSNDWS 240
Query: 673 VQDKLISIMEVAISCLDESPESRPT 697
D + ++ SCL + P+ RP+
Sbjct: 241 --DYFRNFVD---SCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 80/279 (28%), Positives = 129/279 (46%), Gaps = 37/279 (13%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
FD +G+G GSVYKA +G++VA+K +P E QE + E+ L
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKV----VPVE-EDLQEIIKEISILKQCDS 57
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
IVK+YG +IV EY GS++ I+ K L + ++ + L Y+
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
H++ +HRDI + N+LL+ E +A ++DFG + L + + GT ++APE+
Sbjct: 116 HSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674
+ K D++S G+ A+E+ +GK P S I + I P P P+ +
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPY---SDIHPMRAIFMI-------PNKPPPTLSDP 222
Query: 675 DK-------LISIMEVAISCLDESPESRPTIQKVSQLLK 706
+K + CL + PE RP+ QLL+
Sbjct: 223 EKWSPEFNDFVK------KCLVKDPEERPS---AIQLLQ 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 79/274 (28%), Positives = 118/274 (43%), Gaps = 34/274 (12%)
Query: 444 IGKGGQGSVYKA--ELPSG-EI-VAVKKFHSPLPSEMASQ-QEFLNEVKTLTGIRHRNIV 498
+G G GSV K + SG E+ VAVK +A+ +EFL E + + H IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLK---QEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 499 KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC 558
+ G C +V E +G L L + V ++Y+ +
Sbjct: 60 RLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVS---DLKELAHQVAMGMAYLESKH 115
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW-AELAGTY--GYVAPELAYT 615
F VHRD++++NVLL ++A +SDFG ++ L S + A AG + + APE
Sbjct: 116 F---VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 616 MKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPSHN 672
K + K DV+S+GV E G P + E+ ML+ RLP P
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-------KGAEVI--AMLESGERLPRPE-E 222
Query: 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
++ SIM SC PE RPT ++ +
Sbjct: 223 CPQEIYSIML---SCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 72/280 (25%), Positives = 126/280 (45%), Gaps = 41/280 (14%)
Query: 441 EHCIGKGGQGSVYKA--ELPSGE--IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
E IG G G V + +LP + VA+K + + + +FL E + H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ--RLDFLTEASIMGQFDHPN 66
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMIL-SNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
I++ G + +R I+ EY+E GSL L ND + + +++G+ + Y+
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLS 123
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG--YVAPE-L 612
+ VHRD++++N+L++ VSDFG ++ L+ + + G + APE +
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 613 AYTMKVTEKCDVYSFGVLALEVIK-GKHP------RDFISSISSSSSNLEIALNEMLDPR 665
AY K T DV+SFG++ EV+ G+ P +D I ++ R
Sbjct: 181 AYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-------------GYR 226
Query: 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
LP P D ++ ++ + C + RPT ++ L
Sbjct: 227 LPPP----MDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 72/260 (27%), Positives = 123/260 (47%), Gaps = 25/260 (9%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
+G G G V++ + VAVK L ++FL E + + +RH +++ Y
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKT----LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIV 563
C+ +IV E ++ GSL L A + L + +++ V ++Y+ + +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAG-RALKLPQLIDMAAQVASGMAYLEAQNY---I 125
Query: 564 HRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAG-TYGYVAPELAYTMKVTEKC 622
HRD++++NVL+ N V+DFG A+ +K D E A + APE A + + K
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 623 DVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPSHNVQDKLIS 679
DV+SFG+L E++ G+ P +N E+ + +D R+P P +L
Sbjct: 186 DVWSFGILLTEIVTYGRMP-------YPGMTNAEVL--QQVDQGYRMPCPP-GCPKELYD 235
Query: 680 IMEVAISCLDESPESRPTIQ 699
IM + C E P+ RPT +
Sbjct: 236 IM---LDCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 8e-22
Identities = 75/278 (26%), Positives = 119/278 (42%), Gaps = 45/278 (16%)
Query: 437 DFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
D++ IG G G VYKA ++ +GE+VA+K + Q E+ L RH
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQ---QEISMLKECRHP 60
Query: 496 NIVKFYGFCSHARHS--FIVYEYLEMGSLAMI-------LSNDAAAKDLGWTKRMNVIKG 546
NIV ++G S+ R +IV EY GSL I LS A V +
Sbjct: 61 NIVAYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIA---------YVCRE 109
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG 606
+ L+Y+H +HRDI N+LL + + ++DFG + L + GT
Sbjct: 110 TLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPY 166
Query: 607 YVAPELA---YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD 663
++APE+A KCD+++ G+ A+E+ + + P +L L
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM----------FDLHPMRALFLI 216
Query: 664 PRLPTPSHNVQDK----LISIMEVAISCLDESPESRPT 697
+ P ++DK + + CL + P+ RPT
Sbjct: 217 SKSNFPPPKLKDKEKWSPVFHDFIK-KCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 81/285 (28%), Positives = 122/285 (42%), Gaps = 51/285 (17%)
Query: 444 IGKGGQGSVYKAELP-----SGEIVAVKKF-HSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
+G+G G V +GE VAVK HS E + +F E++ L + H NI
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS---GEEQHRSDFEREIEILRTLDHENI 68
Query: 498 VKFYGFC--SHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKR--MNVIKGVVDALSY 553
VK+ G C R ++ EYL GSL L +L + KG+ D L
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM-DYLGS 127
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV----- 608
+HRD++++N+L++ E+ +SDFG AK L D Y YV
Sbjct: 128 QR------YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKD--------YYYVKEPGE 173
Query: 609 ------APELAYTMKVTEKCDVYSFGVLALEVI----KGKHP-RDFISSISSSSSNLEIA 657
APE T K + DV+SFGV E+ + P +F+ I + + +
Sbjct: 174 SPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233
Query: 658 -LNEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQ 699
L E+L RLP P D++ +M+ C + P+ RP+
Sbjct: 234 RLLELLKEGERLPRPPS-CPDEVYDLMK---LCWEAEPQDRPSFA 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 76/282 (26%), Positives = 126/282 (44%), Gaps = 43/282 (15%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQ--EFLNEVKTLTGI 492
F CIGKG G VYKA + + ++VA+K + E A + + E++ L+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV----IDLEEAEDEIEDIQQEIQFLSQC 56
Query: 493 RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN------VIKG 546
R I K+YG +I+ EY GS DL +++ +++
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCL----------DLLKPGKLDETYIAFILRE 106
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG 606
V+ L Y+H + +HRDI + N+LL E + ++DFG + L S GT
Sbjct: 107 VLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF 163
Query: 607 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666
++APE+ EK D++S G+ A+E+ KG+ P + + L L P+
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------VL--FLIPKN 213
Query: 667 PTPSHNVQDKLIS--IMEVAISCLDESPESRPTIQKVSQLLK 706
PS ++ S + CL++ P+ RP+ +LLK
Sbjct: 214 NPPS--LEGNKFSKPFKDFVSLCLNKDPKERPS---AKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-21
Identities = 71/281 (25%), Positives = 126/281 (44%), Gaps = 43/281 (15%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVK--KFHSPLPSEMAS-QQEFLNEVKTLTGIRHRNIVK 499
+G G S Y+A ++ +G ++AVK + SE + E++ + + H +I++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 500 FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
G H + E++ GS++ +LS A K+ +N + ++ LSY+H +
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN-- 122
Query: 560 PPIVHRDISSKNVLLDLENE-AHVSDFGTAKFLKPDSSNWAE----LAGTYGYVAPELAY 614
I+HRD+ N+L+D + ++DFG A L + E L GT ++APE+
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHPRD---------FISSISSSSSNLEIALNEMLDPR 665
+ CDV+S G + +E+ K P + I I+S+++ I
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSI--------- 232
Query: 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
P H + +V + CL+ PE RP +LLK
Sbjct: 233 ---PEHLSPG----LRDVTLRCLELQPEDRP---PSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 3e-21
Identities = 73/265 (27%), Positives = 119/265 (44%), Gaps = 25/265 (9%)
Query: 437 DFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
DF+ + IGKG G V+K + + V K ++E ++E + L +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAA---AKDLGWTKRMNVIKGVVDALSY 553
I+++Y IV EY E G L +L +D W + ++ G L++
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAH 116
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE-LAGTYGYVAPEL 612
+H+ I+HRDI S N+ LD + + D G AK L ++N+A + GT Y++PEL
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPEL 172
Query: 613 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIAL-NEMLDPRLPTPSH 671
EK DV++ GV+ E GKHP D +N + AL +++ P S
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD---------ANNQGALILKIIRGVFPPVSQ 223
Query: 672 NVQDKLISIMEVAISCLDESPESRP 696
+L +++ CL + RP
Sbjct: 224 MYSQQLAQLID---QCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 75/264 (28%), Positives = 131/264 (49%), Gaps = 24/264 (9%)
Query: 438 FDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
F D IG G G+VY A ++ + E+VA+KK Q+ + EV+ L +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
+++ G +++V EY +GS + +L + K L + V G + L+Y+H+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTM 616
++HRD+ + N+LL + DFG+A + P + GT ++APE+ M
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAM 186
Query: 617 KVTE---KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673
+ K DV+S G+ +E+ + K P + ++++ S+ IA NE P L S +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE--SPAL--QSGHW 239
Query: 674 QDKLISIMEVAISCLDESPESRPT 697
+ + ++ SCL + P+ RPT
Sbjct: 240 SEYFRNFVD---SCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 4e-21
Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 39/278 (14%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLN---EVKTLTGIRHRNIVKF 500
+GKG G+VY G+++AVK+ + +A+++E+ EV L ++H NIV++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
G C I E++ GS++ IL+ + + K K ++D ++Y+HN+C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC-- 122
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG-----------YVA 609
+VHRDI NV+L + DFG A+ L W L GT+ ++A
Sbjct: 123 -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA-----WVGLHGTHSNMLKSMHGTPYWMA 176
Query: 610 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669
PE+ K D++S G E+ GK P ++S+ ++ I + L PRLP
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPP---LASMDRLAAMFYIGAHRGLMPRLPDS 233
Query: 670 -SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
S D SCL RP+ QLL+
Sbjct: 234 FSAAAID-------FVTSCLTRDQHERPS---ALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 4e-21
Identities = 56/198 (28%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IG+G G+VY A ++ +G+ VA+K+ + + ++ +NE+ + +H NIV +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNL---QQQPKKELIINEILVMRENKHPNIVNYLD 83
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
++V EYL GSL +++ D G + V + + AL ++H++ +
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEG--QIAAVCRECLQALEFLHSN---QV 136
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKC 622
+HRDI S N+LL ++ ++DFG + P+ S + + GT ++APE+ K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 623 DVYSFGVLALEVIKGKHP 640
D++S G++A+E+++G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 6e-21
Identities = 78/268 (29%), Positives = 136/268 (50%), Gaps = 24/268 (8%)
Query: 438 FDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
F D IG G G+VY A ++ + E+VA+KK Q+ + EVK L I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
+++ G +++V EY +GS + +L + K L + + G + L+Y+H+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTM 616
++HRDI + N+LL + ++DFG+A P +S GT ++APE+ M
Sbjct: 144 H---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAM 196
Query: 617 KVTE---KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673
+ K DV+S G+ +E+ + K P + ++++ S+ IA NE P L S+
Sbjct: 197 DEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE--SPTL--QSNEW 249
Query: 674 QDKLISIMEVAISCLDESPESRPTIQKV 701
D + ++ SCL + P+ RPT +++
Sbjct: 250 SDYFRNFVD---SCLQKIPQDRPTSEEL 274
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 8e-21
Identities = 75/265 (28%), Positives = 128/265 (48%), Gaps = 26/265 (9%)
Query: 438 FDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
F H IG G G+VY A + E+VAVKK Q+ + EVK L ++H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 497 IVKFYGFCSHARHS-FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
+++ G C H+ ++V EY +GS + +L + K L + + G + L+Y+H
Sbjct: 83 TIEYKG-CYLKEHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLH 138
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT 615
+ ++HRDI + N+LL + ++DFG+A P +S GT ++APE+
Sbjct: 139 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAPEVILA 191
Query: 616 MKVTE---KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672
M + K DV+S G+ +E+ + K P + ++++ S+ IA N+ +P+
Sbjct: 192 MDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQND-------SPTLQ 241
Query: 673 VQDKLISIMEVAISCLDESPESRPT 697
+ S CL + P+ RP
Sbjct: 242 SNEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 8e-21
Identities = 76/266 (28%), Positives = 122/266 (45%), Gaps = 24/266 (9%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
+G G G V+ VAVK P M S + FL E + + +RH +V+ Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLK---PGTM-SPESFLEEAQIMKKLRHDKLVQLYAV 69
Query: 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIV 563
S +IV EY+ GSL L D + L +++ V ++Y+ + +
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMNY---I 124
Query: 564 HRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY--GYVAPELAYTMKVTEK 621
HRD+ S N+L+ ++DFG A+ ++ D+ A + + APE A + T K
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 622 CDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISI 680
DV+SFG+L E++ KG+ P +N E+ R+P P QD IS+
Sbjct: 184 SDVWSFGILLTELVTKGRVP-------YPGMNNREVLEQVERGYRMPCP----QDCPISL 232
Query: 681 MEVAISCLDESPESRPTIQKVSQLLK 706
E+ + C + PE RPT + + L+
Sbjct: 233 HELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 92.9 bits (230), Expect = 1e-20
Identities = 74/268 (27%), Positives = 139/268 (51%), Gaps = 24/268 (8%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IG+G G+VY A ++ +G+ VA+++ + + ++ +NE+ + ++ NIV +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNL---QQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
++V EYL GSL +++ D G + V + + AL ++H++ +
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEG--QIAAVCRECLQALEFLHSN---QV 137
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKC 622
+HRDI S N+LL ++ ++DFG + P+ S + + GT ++APE+ K
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 623 DVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIME 682
D++S G++A+E+I+G+ P +++ + L IA N P L P +KL +I
Sbjct: 198 DIWSLGIMAIEMIEGEPP--YLNENPLRALYL-IATNGT--PELQNP-----EKLSAIFR 247
Query: 683 VAIS-CLDESPESRPTIQKV--SQLLKI 707
++ CLD E R + +++ Q LKI
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLKI 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 45/282 (15%)
Query: 437 DFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQ--EFL-NEVKTLTGI 492
D+ IG+G G V A + +G VAVKK ++ QQ E L NEV +
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM------DLRKQQRRELLFNEVVIMRDY 73
Query: 493 RHRNIVKFYGFCSH--ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN------VI 544
+H NIV+ Y S+ ++V E+LE G+L I+++ RMN V
Sbjct: 74 QHPNIVEMYS--SYLVGDELWVVMEFLEGGALTDIVTH----------TRMNEEQIATVC 121
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT 604
V+ ALS++H ++HRDI S ++LL + +SDFG + + L GT
Sbjct: 122 LAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGT 178
Query: 605 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP 664
++APE+ + + D++S G++ +E++ G+ P F + + + L P
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY-FNEPPLQAMKRIR----DNLPP 233
Query: 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+L H V +L S ++ L P R T +LL
Sbjct: 234 KLKNL-HKVSPRLRSFLD---RMLVRDPAQRATAA---ELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 83/290 (28%), Positives = 130/290 (44%), Gaps = 48/290 (16%)
Query: 438 FDDEHCI-----GKGGQGSVYKAELP-----SGEIVAVKKFHSPLPSEMASQQEFLNEVK 487
F++ H GKG GSV +GE+VAVKK S ++F E++
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQ---HSTAEHLRDFEREIE 57
Query: 488 TLTGIRHRNIVKFYGFC-SHARHSF-IVYEYLEMGSLAMILSNDAAAKDLGWTKRM---- 541
L ++H NIVK+ G C S R + +V EYL GSL L D +++
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLD---HRKLLLYA 114
Query: 542 -NVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE 600
+ KG + Y+ + + VHRD++++N+L++ EN + DFG K L D +
Sbjct: 115 SQICKG----MEYLGSKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV 167
Query: 601 L----AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI----KGKHP-RDFISSISSSS 651
+ + Y APE K + DV+SFGV+ E+ K P +F+ + +
Sbjct: 168 REPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDK 226
Query: 652 SNLEIA--LNEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPT 697
I L E+L RLP P ++ +IM+ C + P RP+
Sbjct: 227 QGQMIVYHLIELLKNNGRLPAPP-GCPAEIYAIMK---ECWNNDPSQRPS 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 92.5 bits (229), Expect = 1e-20
Identities = 55/198 (27%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IG+G G+V+ A ++ +G+ VA+K+ + + ++ +NE+ + +++ NIV F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINL---QKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
F+V EYL GSL +++ + + V + + AL ++H + +
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDE----AQIAAVCRECLQALEFLHAN---QV 136
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKC 622
+HRDI S NVLL ++ ++DFG + P+ S + + GT ++APE+ K
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 623 DVYSFGVLALEVIKGKHP 640
D++S G++A+E+++G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 28/227 (12%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-R 493
+DF IG+G +V A E + + A+K + + E + LT +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
H I+K Y + + V EY G L + + D T+ ++ AL Y
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTR--FYAAEILLALEY 117
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA----------- 602
+H+ I+HRD+ +N+LLD + ++DFGTAK L P+SS +
Sbjct: 118 LHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 603 ---------GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
GT YV+PEL + D+++ G + +++ GK P
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 69/262 (26%), Positives = 112/262 (42%), Gaps = 27/262 (10%)
Query: 444 IGKGGQGSVYKAE-LPSGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIV 498
+G G G+VYK +P GE VA+K + + +E L+E + + H ++V
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE--TSPKANKEILDEAYVMASVDHPHVV 72
Query: 499 KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC 558
+ G C ++ I + + +G L + N +G +N + +SY+
Sbjct: 73 RLLGICLSSQVQLIT-QLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEK- 128
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY--GYVAPELAYTM 616
+VHRD++++NVL+ ++DFG AK L D + G ++A E
Sbjct: 129 --RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHR 186
Query: 617 KVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675
T K DV+S+GV E++ G P + I + LE RLP P
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-VEIPDLLEKGE------RLPQP----PI 235
Query: 676 KLISIMEVAISCLDESPESRPT 697
I + V + C ESRPT
Sbjct: 236 CTIDVYMVLVKCWMIDAESRPT 257
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 75/280 (26%), Positives = 132/280 (47%), Gaps = 40/280 (14%)
Query: 441 EHCIGKGGQGSVYKA--ELPSGEIVAVK-KFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
+ IG G G V++ ++P + VAV K P +E +Q+FL+E + H NI
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNI 68
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHND 557
++ G + + + I+ EY+E G+L L + + + + +++G+ + Y+ +
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDM 126
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG---------YV 608
+ VHRD++++N+L++ E VSDFG ++ L+ D GTY +
Sbjct: 127 NY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE------GTYTTSGGKIPIRWT 177
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEI--ALNEMLDPR 665
APE K T DV+SFG++ EV+ G+ P SN E+ A+N+ R
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGERP-------YWDMSNHEVMKAINDGF--R 228
Query: 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
LP P D ++ ++ + C + RP + LL
Sbjct: 229 LPAP----MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 29/219 (13%)
Query: 444 IGKGGQGSVYKAELPSG------EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
+G+G G V+ E E+VAVK ++ ++++F E + LT +H NI
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASND--ARKDFEREAELLTNFQHENI 70
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMIL-----------SNDAAAKDLGWTKRMNVIKG 546
VKFYG C+ +V+EY+E G L L S D+ +L ++ + +
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT-- 604
+ + Y+ + F VHRD++++N L+ + + DFG ++ + ++++ + G
Sbjct: 131 IASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSRDVY--TTDYYRVGGHTM 185
Query: 605 --YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHP 640
++ PE K T + DV+SFGV+ E+ GK P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-20
Identities = 74/264 (28%), Positives = 120/264 (45%), Gaps = 21/264 (7%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
+G G G V+ + VAVK P M S Q FL E + ++H +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLK---PGTM-SVQAFLEEANLMKTLQHDKLVRLYAV 69
Query: 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIV 563
+ +I+ EY+ GSL L +D K + K ++ + + ++Y+ + +
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGK-VLLPKLIDFSAQIAEGMAYIERKNY---I 125
Query: 564 HRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAG-TYGYVAPELAYTMKVTEKC 622
HRD+ + NVL+ ++DFG A+ ++ + E A + APE T K
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 623 DVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIM 681
DV+SFG+L E++ GK P S+S++ AL R+P N D+L IM
Sbjct: 186 DVWSFGILLYEIVTYGKIPYP-----GMSNSDVMSALQRGY--RMPRM-ENCPDELYDIM 237
Query: 682 EVAISCLDESPESRPTIQKVSQLL 705
+ +C E E RPT + +L
Sbjct: 238 K---TCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 9e-20
Identities = 72/266 (27%), Positives = 120/266 (45%), Gaps = 30/266 (11%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTGIRHRNIVK 499
IG+G G V A E SG VAVK ++ QQ NEV + +H+N+V+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM------DLRKQQRRELLFNEVVIMRDYQHQNVVE 82
Query: 500 FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
Y +++ E+L+ G+L I+S L + V + V+ AL Y+H+
Sbjct: 83 MYKSYLVGEELWVLMEFLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ-- 136
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVT 619
++HRDI S ++LL L+ +SDFG + D L GT ++APE+
Sbjct: 137 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYG 195
Query: 620 EKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP--SHNVQDKL 677
+ D++S G++ +E++ G+ P S + A+ + D P +H + L
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRLRDSPPPKLKNAHKISPVL 247
Query: 678 ISIMEVAISCLDESPESRPTIQKVSQ 703
+E L P+ R T Q++
Sbjct: 248 RDFLE---RMLTREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 1e-19
Identities = 55/198 (27%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IG+G G+VY A ++ +G+ VA+K+ + + ++ +NE+ + ++ NIV +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNL---QQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
++V EYL GSL +++ D G + V + + AL ++H++ +
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEG--QIAAVCRECLQALDFLHSN---QV 136
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKC 622
+HRDI S N+LL ++ ++DFG + P+ S + + GT ++APE+ K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 623 DVYSFGVLALEVIKGKHP 640
D++S G++A+E+++G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 68/267 (25%), Positives = 113/267 (42%), Gaps = 29/267 (10%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+GKG GSVYK + L + A+K+ S+ +++ +NE++ L + H NI+ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKE 66
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAK-----DLGWTKRMNVIKGVVDALSYMHND 557
IV EY G L+ +S + W + +++G L +H
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----LQALHEQ 122
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA-GTYGYVAPELAYTM 616
I+HRD+ S N+LL + + D G +K LK N A+ GT Y+APE+
Sbjct: 123 ---KILHRDLKSANILLVANDLVKIGDLGISKVLK---KNMAKTQIGTPHYMAPEVWKGR 176
Query: 617 KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDK 676
+ K D++S G L E+ P + + S +L + P +P
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFE-----ARSMQDLRYKVQRGKYPPIP---PIYSQD 228
Query: 677 LISIMEVAISCLDESPESRPTIQKVSQ 703
L + + S L P+ RP K+
Sbjct: 229 LQNFIR---SMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 77/276 (27%), Positives = 130/276 (47%), Gaps = 44/276 (15%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSP------LPSEMASQQEFLN-EVKTLTGIRHR 495
IGKG G VY A + +GE++AVK+ P S + L E++TL + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAA-AKDLGWTKRMNVIKGVVDALSYM 554
NIV++ GF + + I EY+ GS+ L + L V++G L+Y+
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG----LAYL 124
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA--GTYGYVAPEL 612
H+ I+HRD+ + N+L+D + +SDFG +K N ++ G+ ++APE+
Sbjct: 125 HSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 613 --AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM-----LDPR 665
+Y+ + K D++S G + LE+ G+ P S+ E A+ M
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW----------SDEE-AIAAMFKLGNKRSA 230
Query: 666 LPTPSHNVQDKLISIMEVAISCLDE----SPESRPT 697
P P D +++ VA+ L+ +P++RPT
Sbjct: 231 PPIPP----DVSMNLSPVALDFLNACFTINPDNRPT 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 71/266 (26%), Positives = 119/266 (44%), Gaps = 42/266 (15%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
IG G G V+ VA+K SE ++F+ E + + + H +V+ YG
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 504 CSHARHSFIVYEYLEMGSLAMILSNDA---AAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
C+ +V+E++E G L+ L + + L + + V + ++Y+ +
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSNV- 121
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT---YGYVAPELAYTMK 617
+HRD++++N L+ VSDFG +F+ D + GT + +PE+ K
Sbjct: 122 --IHRDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 618 VTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEI-----ALNEMLDPRLPTPSH 671
+ K DV+SFGVL EV +GK P + + SN E+ A + PRL +
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYE-------NRSNSEVVETINAGFRLYKPRLASQ-- 228
Query: 672 NVQDKLISIMEVAISCLDESPESRPT 697
S+ E+ C E PE RP+
Sbjct: 229 -------SVYELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 74/274 (27%), Positives = 119/274 (43%), Gaps = 37/274 (13%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
+G+G GSV K L + ++ K + P+ Q++ L E++ + IVK+YG
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDL-QKQILRELEINKSCKSPYIVKYYGA 67
Query: 504 CSHARHS--FIVYEYLEMGSLAMIL------SNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
S I EY E GSL I K LG + + V+ LSY+H
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSYLH 122
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE---- 611
+ I+HRDI N+LL + + + DFG + L +S GT Y+APE
Sbjct: 123 SR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFTGTSFYMAPERIQG 177
Query: 612 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIA--LNEMLDPRLP-T 668
Y++ DV+S G+ LEV + + P F +E+ + M +P L
Sbjct: 178 KPYSI----TSDVWSLGLTLLEVAQNRFP--FPPEGEPPLGPIELLSYIVNMPNPELKDE 231
Query: 669 PSHNVQ--DKLISIMEVAISCLDESPESRPTIQK 700
P + ++ ++ ++ CL++ P RPT
Sbjct: 232 PGNGIKWSEEFKDFIKQ---CLEKDPTRRPTPWD 262
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 444 IGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF-Y 501
IGKG G V + + ++ A+K + E S + LNE + L + H +V Y
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILS-----NDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
F + ++V + L G L LS ++ K I +V AL Y+H+
Sbjct: 68 SFQDE-ENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFW--------ICEIVLALEYLHS 118
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTM 616
I+HRDI N+LLD + H++DF A + PD+ +GT GY+APE+
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-TSTSGTPGYMAPEVLCRQ 174
Query: 617 KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS 650
+ D +S GV A E ++GK P S
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD 208
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 75/287 (26%), Positives = 140/287 (48%), Gaps = 45/287 (15%)
Query: 444 IGKGGQGSVYKAEL----PSGE--IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
+G+G G V+ AE P+ + +VAVK P +A++++F E + LT ++H +I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHI 69
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSL----------AMILSND---AAAKDLGWTKRMNVI 544
VKFYG C +V+EY++ G L AMIL + A +LG ++ +++
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAG- 603
+ + Y+ + F VHRD++++N L+ + DFG ++ + S+++ + G
Sbjct: 130 SQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGGH 184
Query: 604 ---TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALN 659
++ PE K T + DV+SFGV+ E+ GK P +S++ I
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP---WFQLSNTEVIECITQG 241
Query: 660 EMLD-PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
+L+ PR+ P + ++ + C P+ R I+++ ++L
Sbjct: 242 RVLERPRV-CPKE--------VYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 4e-19
Identities = 72/279 (25%), Positives = 117/279 (41%), Gaps = 48/279 (17%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLN----EVKTLTGIRHRNIV 498
+G G GSVY+ L G+ AVK+ L + + QE + E+ L+ ++H NIV
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKE--VSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 499 KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC 558
++ G + +I E + GSLA +L + + + ++ L Y+H+
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE---PVIRLYTRQILLGLEYLHDR- 121
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL-----A 613
VHRDI N+L+D ++DFG AK + + S G+ ++APE+
Sbjct: 122 --NTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 614 YTMKVTEKCDVYSFGVLALEVIKGKHPRD------FISSISSSSSNLEIALNEMLDPRLP 667
Y + D++S G LE+ GK P + I S I
Sbjct: 179 YGLAA----DIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPI----------- 223
Query: 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
P H + I++ CL P RPT ++LL+
Sbjct: 224 -PDHLSDEAKDFILK----CLQRDPSLRPT---AAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 8e-19
Identities = 65/195 (33%), Positives = 93/195 (47%), Gaps = 14/195 (7%)
Query: 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
IGKG G V + G VAVK + A+ Q FL E +T +RH N+V+
Sbjct: 11 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQL 64
Query: 501 YGFCSHARHS-FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
G + +IV EY+ GSL L + + LG + V +A+ Y+ + F
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNF 123
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVT 619
VHRD++++NVL+ +N A VSDFG K SS + APE K +
Sbjct: 124 ---VHRDLAARNVLVSEDNVAKVSDFG---LTKEASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 620 EKCDVYSFGVLALEV 634
K DV+SFG+L E+
Sbjct: 178 TKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 9e-19
Identities = 71/264 (26%), Positives = 123/264 (46%), Gaps = 32/264 (12%)
Query: 459 SGEIVAVKKFHSPLPSEMASQQE--FLNEVKTLTGIRHRNIVKFYGFCSHA--RHSFIVY 514
+GE+VAVK L E Q + E+ L + H NIVK+ G CS + ++
Sbjct: 32 TGEMVAVKT----LKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87
Query: 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL 574
EY+ +GSL L L + + + + + ++Y+H+ + +HRD++++NVLL
Sbjct: 88 EYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQHY---IHRDLAARNVLL 140
Query: 575 DLENEAHVSDFGTAKFLKPDSSNWAELA----GTYGYVAPELAYTMKVTEKCDVYSFGVL 630
D + + DFG AK + P+ + + + A E K + DV+SFGV
Sbjct: 141 DNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVT 199
Query: 631 ALEVI-----KGKHPRDFISSISSSSSNL-EIALNEMLD--PRLPTPSHNVQDKLISIME 682
E++ K P+ F I + + L E+L+ RLP P N ++ +M+
Sbjct: 200 LYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPK-NCPQEVYILMK 258
Query: 683 VAISCLDESPESRPTIQKVSQLLK 706
+C + + RPT + + +LK
Sbjct: 259 ---NCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 9e-19
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
N ++ +G+G G V K +GEIVA+KKF E ++ L EVK L +RH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDED-VKKTALREVKVLRQLRH 59
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
NIV ++V+EY+E L ++ +A+ L + I ++ A++Y
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 555 H-NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK-PDSSNWAELAGTYGYVAPEL 612
H ++ I+HRDI +N+L+ + DFG A+ L+ +S + T Y APEL
Sbjct: 117 HSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172
Query: 613 -----AYTMKVTEKCDVYSFGVLALEVIKG 637
Y V DV++ G + E++ G
Sbjct: 173 LVGDTNYGKPV----DVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 9/197 (4%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IG+G G VYKA + +GEIVA+KK SE + L E+K L + H NI+K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA-LREIKLLKELNHPNIIKLLD 65
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
H ++V+E+++ +I + L + + + ++ L++ H+ I
Sbjct: 66 VFRHKGDLYLVFEFMDTDLYKLI---KDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKV-TEK 621
+HRD+ +N+L++ E ++DFG A+ + T Y APEL K +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 622 CDVYSFGVLALEVIKGK 638
D++S G + E++ +
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 26/268 (9%)
Query: 444 IGKGGQGSVYKAELPS-GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IG+G G V+ L + VAVK LP ++ + +FL E + L H NIV+ G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIG 60
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
C+ + +IV E ++ G L + L + + +++ + Y+ +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT----YGYVAPELAYTMKV 618
+HRD++++N L+ +N +SDFG ++ + + +A G + APE +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 619 TEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKL 677
+ + DV+SFG+L E G P +S+ + +E + RLP P D +
Sbjct: 174 SSESDVWSFGILLWEAFSLGAVPYANLSN-QQTREAIEQGV------RLPCPE-LCPDAV 225
Query: 678 ISIMEVAISCLDESPESRPTIQKVSQLL 705
+ME C + P RP+ V Q L
Sbjct: 226 YRLME---RCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 75/286 (26%), Positives = 133/286 (46%), Gaps = 42/286 (14%)
Query: 444 IGKGGQGSVYKAE----LPSGE--IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
+G+G G V+ AE LP + +VAVK S ++Q+F E + LT ++H++I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTVLQHQHI 69
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSL----------AMIL--SNDAAAKDLGWTKRMNVIK 545
V+FYG C+ R +V+EY+ G L A IL D A L + + +
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 546 GVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAG-- 603
+ + Y+ + F VHRD++++N L+ + DFG ++ + S+++ + G
Sbjct: 130 QIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGRT 184
Query: 604 --TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNE 660
++ PE K T + D++SFGV+ E+ GK P +S ++ + E
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS--NTEAIECITQGRE 242
Query: 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ PR P ++ +IM+ C P+ R I+ + L+
Sbjct: 243 LERPRTCPP------EVYAIMQ---GCWQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 76/285 (26%), Positives = 132/285 (46%), Gaps = 43/285 (15%)
Query: 441 EHCIGKGGQGSVYKAEL-PSGE---IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
E IG G G V + L G+ VA+K S + +++FL+E + H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEK--QRRDFLSEASIMGQFDHPN 66
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILS-NDAAAKDLGWTKRMNVIKGVVDALSYMH 555
I+ G + +R I+ E++E G+L L ND + + +++G+ + Y+
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLS 123
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG-----YVAP 610
+ VHRD++++N+L++ VSDFG ++FL+ D+S+ + G + AP
Sbjct: 124 EMNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIK-GKHP------RDFISSISSSSSNLEIALNEMLD 663
E K T DV+S+G++ EV+ G+ P +D I++I D
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-------------D 227
Query: 664 PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTI-QKVSQLLKI 707
RLP P D ++ ++ + C + +RP Q VS L K+
Sbjct: 228 YRLPPP----MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 71/266 (26%), Positives = 119/266 (44%), Gaps = 24/266 (9%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
+G+G G V+ VA+K P M S + FL E + + +RH +V+ Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLK---PGTM-SPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIV 563
S +IV EY+ GSL L + K L + +++ + ++Y+ + V
Sbjct: 70 VSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 124
Query: 564 HRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY--GYVAPELAYTMKVTEK 621
HRD+ + N+L+ V+DFG A+ ++ D+ A + + APE A + T K
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 622 CDVYSFGVLALEV-IKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISI 680
DV+SFG+L E+ KG+ P N E+ R+P P + S+
Sbjct: 184 SDVWSFGILLTELTTKGRVP-------YPGMVNREVLDQVERGYRMPCPPECPE----SL 232
Query: 681 MEVAISCLDESPESRPTIQKVSQLLK 706
++ C + PE RPT + + L+
Sbjct: 233 HDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 29/207 (14%)
Query: 444 IGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTGIRHRNIVK 499
IG+G G V A + SG++VAVKK ++ QQ NEV + +H N+V+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM------DLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 500 FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN------VIKGVVDALSY 553
Y ++V E+LE G+L I+++ RMN V V+ ALS
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTH----------TRMNEEQIAAVCLAVLKALSV 131
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELA 613
+H ++HRDI S ++LL + +SDFG + + L GT ++APEL
Sbjct: 132 LHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI 188
Query: 614 YTMKVTEKCDVYSFGVLALEVIKGKHP 640
+ + D++S G++ +E++ G+ P
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-18
Identities = 74/275 (26%), Positives = 118/275 (42%), Gaps = 38/275 (13%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
+GKG G V+K L VAVK LP E+ + +FL+E + L H NIVK G
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQEL--KIKFLSEARILKQYDHPNIVKLIGV 60
Query: 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIV 563
C+ + +IV E + G L KD TK++ +K +DA + M +
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQL--VKFALDAAAGMAYLESKNCI 115
Query: 564 HRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG----------YVAPELA 613
HRD++++N L+ N +SDFG ++ E G Y + APE
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---------QEDDGIYSSSGLKQIPIKWTAPEAL 166
Query: 614 YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672
+ + + DV+S+G+L E G P +++ + +E R+ P
Sbjct: 167 NYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-QQAREQVEKGY------RMSCPQKC 219
Query: 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLKI 707
D + +V C D PE+RP ++ + L
Sbjct: 220 PDD----VYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 17/201 (8%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTGIRHRNIVK 499
IG+G G V A E +G+ VAVKK ++ QQ NEV + H N+V
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM------DLRKQQRRELLFNEVVIMRDYHHENVVD 83
Query: 500 FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
Y ++V E+LE G+L I+++ ++ T ++V++ ALSY+HN
Sbjct: 84 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLR----ALSYLHNQ-- 137
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVT 619
++HRDI S ++LL + +SDFG + + L GT ++APE+ +
Sbjct: 138 -GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYG 196
Query: 620 EKCDVYSFGVLALEVIKGKHP 640
+ D++S G++ +E+I G+ P
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 441 EHCIGKGGQGSVYKAELPS-GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
+H +G G G VY+ VAVK L + +EFL E + I+H N+V+
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKT----LKEDTMEVEEFLKEAAVMKEIKHPNLVQ 66
Query: 500 FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
G C+ +I+ E++ G+L L + +++ + + + A+ Y+ F
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT---YGYVAPE-LAYT 615
+HRD++++N L+ + V+DFG ++ + D+ + AG + APE LAY
Sbjct: 126 ---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYN 180
Query: 616 MKVTEKCDVYSFGVLALEV 634
K + K DV++FGVL E+
Sbjct: 181 -KFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 71/267 (26%), Positives = 126/267 (47%), Gaps = 32/267 (11%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
IG+G G+V + E +G+ VAVK + + Q FL E +T + H+N+V+ G
Sbjct: 14 IGEGEFGAVLQGEY-TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 504 CSHARHSFIVYEYLEMGSLAMIL-SNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
H +IV E + G+L L + A + + ++ V + + Y+ + +
Sbjct: 68 ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL--DVAEGMEYLESK---KL 121
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKC 622
VHRD++++N+L+ + A VSDFG A+ + + ++L + APE K + K
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLP--VKWTAPEALKHKKFSSKS 178
Query: 623 DVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPSHNVQDKLIS 679
DV+S+GVL EV G+ P + S+ +E ++P P +
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKM-SLKEVKECVEKGYR--MEPPEGCPADVY-------V 228
Query: 680 IMEVAISCLDESPESRPTIQKVSQLLK 706
+M SC + P+ RP+ K+ + L+
Sbjct: 229 LMT---SCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 31/268 (11%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G G GSV K + +P+G ++A K H S + +++ L E++ + R IV FYG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV--RKQILRELQIMHECRSPYIVSFYG 70
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRM---NVIKGVVDALSYMHNDCF 559
+ + + E+++ GSL D K G + VV+ L+Y++N
Sbjct: 71 AFLNENNICMCMEFMDCGSL------DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV-- 122
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVT 619
I+HRDI N+L++ + + DFG + L ++ GT Y++PE K T
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFVGTSTYMSPERIQGGKYT 180
Query: 620 EKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD-------PRLPTPSHN 672
K DV+S G+ +E+ GK P F S+I + + + ++L PRLP
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAF-SNIDDDGQDDPMGILDLLQQIVQEPPPRLP----- 234
Query: 673 VQDKLISIMEVAIS-CLDESPESRPTIQ 699
+ + CL + P RPT Q
Sbjct: 235 -SSDFPEDLRDFVDACLLKDPTERPTPQ 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 61/203 (30%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK-FY 501
+GKG G V + +G++ A+K + + L E L+ I H IVK Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
F + ++V EY G L LS + +V AL Y+H+
Sbjct: 61 AFQTE-EKLYLVLEYAPGGELFSHLSK-EGRFSEERARFY--AAEIVLALEYLHSL---G 113
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL----AYTMK 617
I++RD+ +N+LLD + ++DFG AK L + S GT Y+APE+ Y
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 618 VTEKCDVYSFGVLALEVIKGKHP 640
V D +S GVL E++ GK P
Sbjct: 174 V----DWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 71/275 (25%), Positives = 117/275 (42%), Gaps = 15/275 (5%)
Query: 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR 493
+F E IGKG VYKA L G +VA+KK + ++Q+ L E+ L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRM-NVIKGVVDALS 552
H N++K+ IV E + G L+ ++ + K L + + + AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL 612
+MH+ I+HRDI NV + + D G +F ++ L GT Y++PE
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 613 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL-PTPSH 671
+ K D++S G L E+ + P NL ++ P P+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP------FYGDKMNLYSLCKKIEKCDYPPLPAD 231
Query: 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ ++L ++ C++ PE RP I V Q+ K
Sbjct: 232 HYSEELRDLVSR---CINPDPEKRPDISYVLQVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 72/274 (26%), Positives = 129/274 (47%), Gaps = 36/274 (13%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTGIRHRNIVKF 500
+G G G VYKA+ + A K ++ S++E F+ E+ L+ +H NIV
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKI-----IQIESEEELEDFMVEIDILSECKHPNIVGL 67
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
Y + +I+ E+ + G+L I+ + L + V + +++AL+++H+
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIM--LELERGLTEPQIRYVCRQMLEALNFLHSH--- 122
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY--TMKV 618
++HRD+ + N+LL L+ + ++DFG + K GT ++APE+ T K
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD 182
Query: 619 TE---KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH---N 672
K D++S G+ +E+ + + P ++ L+I +E P L PS +
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPPH---HELNPMRVLLKILKSE--PPTLDQPSKWSSS 237
Query: 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
D L SCL + P+ RPT ++LLK
Sbjct: 238 FNDFL-------KSCLVKDPDDRPT---AAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 66/259 (25%), Positives = 116/259 (44%), Gaps = 21/259 (8%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IGKG G V+K + + ++VA+K L ++ E+ L+ + K+YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
+I+ EYL GS +L A + ++K ++ L Y+H++
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KK 122
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKC 622
+HRDI + NVLL + + ++DFG A L GT ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKA 182
Query: 623 DVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIME 682
D++S G+ A+E+ KG+ P +S++ L P+ P+ + E
Sbjct: 183 DIWSLGITAIELAKGEPP----------NSDMHPMRVLFLIPKNNPPTL-TGEFSKPFKE 231
Query: 683 VAISCLDESPESRPTIQKV 701
+CL++ P RPT +++
Sbjct: 232 FIDACLNKDPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 52/197 (26%), Positives = 91/197 (46%), Gaps = 10/197 (5%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IG+G G V+KA + +GE VA+KK + L E+K L +H +VK
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLD 66
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
H +V EY+ L+ +L ++ K ++ ++ ++YMH + I
Sbjct: 67 VFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSY--MRMLLKGVAYMHAN---GI 120
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN-WAELAGTYGYVAPELAY-TMKVTE 620
+HRD+ N+L+ + ++DFG A+ + ++ T Y APEL Y K
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 621 KCDVYSFGVLALEVIKG 637
D+++ G + E++ G
Sbjct: 181 GVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 68/280 (24%), Positives = 118/280 (42%), Gaps = 37/280 (13%)
Query: 444 IGKGGQGSVYKAELPSGE------IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
+G+G G V+ A+ E +V VK + Q EF E+ + H+N+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNV 70
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMIL------SNDAAAKDLGWTKRMNVIKGVVDAL 551
V+ G C A +++ EY ++G L L L +++ + + +
Sbjct: 71 VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130
Query: 552 SYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG---YV 608
++ N F VHRD++++N L+ + E VS +K +S + +L ++
Sbjct: 131 DHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRWL 185
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEML--DPR 665
APE + K DV+SFGVL EV +G+ P S+ E+ LN +
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF-------YGLSDEEV-LNRLQAGKLE 237
Query: 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
LP P +L +M C +P+ RP+ ++ L
Sbjct: 238 LPVPE-GCPSRLYKLMT---RCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 67/269 (24%), Positives = 111/269 (41%), Gaps = 39/269 (14%)
Query: 444 IGKGGQGSVYKAEL--PSGEI--VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
+G G G V + E G++ VAVK S S++ +FL E + + H N+++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLIR 60
Query: 500 FYGFCSHARHSF-IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC 558
YG H +V E +GSL L DA + + + + + Y+ +
Sbjct: 61 LYGVV--LTHPLMMVTELAPLGSLLDRLRKDALGH-FLISTLCDYAVQIANGMRYLESKR 117
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW---AELAGTYGYVAPELAYT 615
F +HRD++++N+LL +++ + DFG + L + ++ L + + APE T
Sbjct: 118 F---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 616 MKVTEKCDVYSFGVLALEVIK-GKHP------RDFISSISSSSSNLEIALNEMLDPRLPT 668
+ DV+ FGV E+ G+ P + I E RL
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI---DKEGE---------RLER 222
Query: 669 PSHNVQDKLISIMEVAISCLDESPESRPT 697
P QD I V + C +P RPT
Sbjct: 223 PEACPQD----IYNVMLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 9e-17
Identities = 73/281 (25%), Positives = 129/281 (45%), Gaps = 35/281 (12%)
Query: 441 EHCIGKGGQGSVYKAEL--PSGEIVAVKK--FHSP-----LPSEMASQQEFLNEVKTLT- 490
EH +G G G VYK ++A+K+ H+P S + ++EV +
Sbjct: 6 EH-LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 491 GIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRM-NVIKGVVD 549
+RH NIV++Y +IV + +E L ++ K +R+ N+ +V
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVA 609
AL Y+H + IVHRD++ N++L +++ ++DFG AK K S + GT Y
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVVGTILYSC 181
Query: 610 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIA---LNEMLDPRL 666
PE+ EK DV++FG + ++ + S++ L +A + + +P
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT-------LQPPFYSTNMLSLATKIVEAVYEP-- 232
Query: 667 PTPSHNVQDKLIS--IMEVAISCLDESPESRPTIQKVSQLL 705
+ + + S + +V SCL E+RP I +VS ++
Sbjct: 233 ------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 9e-17
Identities = 87/257 (33%), Positives = 127/257 (49%), Gaps = 10/257 (3%)
Query: 73 NLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHN 132
NL+ L L L N+LR I L LT+L + L+ N++T + NL +DLS N
Sbjct: 91 NLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDN 150
Query: 133 YFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGK 192
+ S P L LD S N+++ +P + + S L LDLS N I ++P ++
Sbjct: 151 K-IESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI-SDLPPEIEL 207
Query: 193 LSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNN 252
LS+L +L L++N + +L L +L L L+LS+N+L + +P+S+GNL L L+LSNN
Sbjct: 208 LSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNN 265
Query: 253 QFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEE 312
Q I I L L +L ELDLS N L +P + LE L L +
Sbjct: 266 Q-ISSIS-SLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTL---KALELKL 320
Query: 313 LHGLSYIDISYNELHGS 329
L +I N S
Sbjct: 321 NSILLNNNILSNGETSS 337
|
Length = 394 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 75/299 (25%), Positives = 121/299 (40%), Gaps = 59/299 (19%)
Query: 435 TNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR 493
T F+ IG+G G VYKA +G++VA+K E ++E N ++ +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE-YNILRKYS--N 61
Query: 494 HRNIVKFYGFCSHARHS------FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN----- 542
H NI FYG ++V E GS+ D KR+
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT-----DLVKGLRKKGKRLKEEWIA 116
Query: 543 -VIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAEL 601
+++ + L+Y+H + ++HRDI +N+LL E + DFG + L
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 602 AGTYGYVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGK------HPRDFISSISSS 650
GT ++APE+ + + + DV+S G+ A+E+ GK HP + I +
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233
Query: 651 SSNLEIALNEMLDPRLPTP---SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
P L +P S D IS CL ++ E RP + +LL+
Sbjct: 234 PP-----------PTLKSPENWSKKFND-FIS------ECLIKNYEQRPF---MEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 24/266 (9%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
+G+G G V+ VA+K P M + FL E + + +RH +V Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLK---PGTM-MPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIV 563
S +IV E++ GSL L + K L + +++ + D ++Y+ + +
Sbjct: 70 VSE-EPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERMNY---I 124
Query: 564 HRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY--GYVAPELAYTMKVTEK 621
HRD+ + N+L+ ++DFG A+ ++ D+ A + + APE A + T K
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 622 CDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISI 680
DV+SFG+L E++ KG+ P N E+ R+P P Q S+
Sbjct: 184 SDVWSFGILLTELVTKGRVP-------YPGMVNREVLEQVERGYRMPCP----QGCPESL 232
Query: 681 MEVAISCLDESPESRPTIQKVSQLLK 706
E+ C + P+ RPT + + L+
Sbjct: 233 HELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 64/206 (31%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 444 IGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G GG G V ++ A+K E Q+ +E + L H IVK Y
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLG----WTKRMNVIKGVVDALSYMHNDC 558
++ +++ EY G L IL +D G +T R I VV A Y+HN
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTIL------RDRGLFDEYTARF-YIACVVLAFEYLHNR- 112
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL----AY 614
I++RD+ +N+LLD + DFG AK LK W GT YVAPE+ Y
Sbjct: 113 --GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILNKGY 169
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHP 640
V D +S G+L E++ G+ P
Sbjct: 170 DFSV----DYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 21/259 (8%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IGKG G VYK + + E+VA+K L ++ E+ L+ I ++YG
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
+I+ EYL GS +L L T +++ ++ L Y+H++
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSE---RK 122
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKC 622
+HRDI + NVLL + + ++DFG A L GT ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKA 182
Query: 623 DVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIME 682
D++S G+ A+E+ KG+ P +S+L L P+ P+ Q E
Sbjct: 183 DIWSLGITAIELAKGEPP----------NSDLHPMRVLFLIPKNSPPTLEGQYSK-PFKE 231
Query: 683 VAISCLDESPESRPTIQKV 701
+CL++ P RPT +++
Sbjct: 232 FVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 74/294 (25%), Positives = 129/294 (43%), Gaps = 56/294 (19%)
Query: 444 IGKGGQGSVYKAEL--PSGE-------IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+G+G G VYK EL P+ I +K+ P QQEF E + ++ ++H
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-----KVQQEFRQEAELMSDLQH 67
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
NIV G C+ + + +++EYL G L L ++ D+G +K +D ++
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 555 ---------------HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599
H+ VHRD++++N L+ +SDFG ++ + S+++
Sbjct: 128 HIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY--SADYY 180
Query: 600 ELAGT----YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNL 654
+ ++ PE K T + D++SFGV+ E+ G P SN
Sbjct: 181 RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPY-------YGFSNQ 233
Query: 655 EIALNEMLDPR--LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
E+ EM+ R LP P + ++ ++M I C +E P RP + + L+
Sbjct: 234 EVI--EMIRSRQLLPCPE-DCPARVYALM---IECWNEIPARRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 443 CIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFY 501
+G+G G VYKA + +GEIVA+KK E L E+ L ++H NIVK
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA-LREISLLKELKHPNIVKLL 64
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
R ++V+EY +M L L K + + ++ L+Y H+
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSI--MYQLLRGLAYCHSHR--- 118
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKF----LKPDSSN----WAELAGTYGYVAPEL- 612
I+HRD+ +N+L++ + ++DFG A+ L+ + W Y APE+
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW--------YRAPEIL 170
Query: 613 ----AYTMKVTEKCDVYSFGVLALEVIKGK 638
Y+ V D++S G + E+I GK
Sbjct: 171 LGSKHYSTAV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 3e-16
Identities = 71/259 (27%), Positives = 117/259 (45%), Gaps = 21/259 (8%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IGKG G V+K + + ++VA+K L ++ E+ L+ + K+YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
+I+ EYL GS +L L T+ +++ ++ L Y+H++
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSE---KK 122
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKC 622
+HRDI + NVLL E ++DFG A L GT ++APE+ K
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKA 182
Query: 623 DVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIME 682
D++S G+ A+E+ KG+ P S + I N +P PT N L +E
Sbjct: 183 DIWSLGITAIELAKGEPPH---SELHPMKVLFLIPKN---NP--PTLEGNYSKPLKEFVE 234
Query: 683 VAISCLDESPESRPTIQKV 701
+CL++ P RPT +++
Sbjct: 235 ---ACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 68/265 (25%), Positives = 118/265 (44%), Gaps = 22/265 (8%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
+G G G V+ VA+K L S + FL E + ++H +V+ Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKS----LKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIV 563
+ +I+ EY+E GSL L K L K +++ + + ++++ + +
Sbjct: 70 VTQ-EPIYIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKNY---I 124
Query: 564 HRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAG-TYGYVAPELAYTMKVTEKC 622
HRD+ + N+L+ ++DFG A+ ++ + E A + APE T K
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 623 DVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIM 681
DV+SFG+L E++ G+ P +N E+ N R+P P N ++L +M
Sbjct: 185 DVWSFGILLTEIVTYGRIP-------YPGMTNPEVIQNLERGYRMPRPD-NCPEELYELM 236
Query: 682 EVAISCLDESPESRPTIQKVSQLLK 706
C E PE RPT + + +L+
Sbjct: 237 ---RLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 4e-16
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 19/221 (8%)
Query: 483 LNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRM- 541
LNE+ L+ ++H NI+ +Y I EY G+L + K + + M
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ---KGQLFEEEMV 103
Query: 542 -NVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE 600
+ +V A+SY+H I+HRDI + N+ L + DFG +K L + S
Sbjct: 104 LWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160
Query: 601 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660
+ GT Y++PEL +K K D+++ G + E++ K R F +++ L + +
Sbjct: 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK--RTF-----DATNPLNLVVKI 213
Query: 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
+ P S + LIS++ S L + PE RPT +V
Sbjct: 214 VQGNYTPVVSVYSSE-LISLVH---SLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 5e-16
Identities = 62/223 (27%), Positives = 105/223 (47%), Gaps = 58/223 (26%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQE-----FLNEVKTLTGIRHRNI 497
IG+G G VYKA +GE+VA+KK M +++E + E+K L +RH NI
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI------RMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 498 VKFYGFC-SHARHS-FIVYEYLEMGSLAMILSN------DAAAKDLGWTKRMNVIKGVVD 549
V+ S + S ++V+EY++ L +L + ++ K + K++ ++G
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIK--CYMKQL--LEG--- 112
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN---------WAE 600
L Y+H++ I+HRDI N+L++ + ++DFG A+ +S W
Sbjct: 113 -LQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW-- 166
Query: 601 LAGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 638
Y PEL Y +V D++S G + E+ GK
Sbjct: 167 ------YRPPELLLGATRYGPEV----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 58/206 (28%), Positives = 92/206 (44%), Gaps = 15/206 (7%)
Query: 444 IGKGGQGSVYKAELPS-GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
I KG G V+ A+ S G+I A+K + L E L+ + +VK Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
++ ++V EYL G LA +L N + D + I +V AL Y+H++ I
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLEN-VGSLDEDVAR--IYIAEIVLALEYLHSN---GI 114
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKF--------LKPDSSNWAELAGTYGYVAPELAY 614
+HRD+ N+L+D ++DFG +K L D + GT Y+APE+
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHP 640
++ D +S G + E + G P
Sbjct: 175 GQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 71/288 (24%), Positives = 123/288 (42%), Gaps = 37/288 (12%)
Query: 432 IRVTNDFD---DEHCIGKGGQGSVYKAELPSGEI-VAVKKFHSPLPSEMASQQEFLNEVK 487
+ ++D + +GKG G VY A S ++ +A+K+ + Q E+
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPE---RDSRYVQPLHEEIA 57
Query: 488 TLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGV 547
+ ++HRNIV++ G S I E + GSL+ +L + + K +
Sbjct: 58 LHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI 117
Query: 548 VDALSYMHNDCFPPIVHRDISSKNVLLD-LENEAHVSDFGTAKFLKPDSSNWAELAGTYG 606
++ L Y+H++ IVHRDI NVL++ +SDFGT+K L + GT
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQ 174
Query: 607 YVAPELAYTMKVTEK--------CDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIAL 658
Y+APE V +K D++S G +E+ GK P FI ++ ++ +
Sbjct: 175 YMAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPP--FIELGEPQAAMFKVGM 226
Query: 659 NEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
++ P +P I + C + P+ R + LL+
Sbjct: 227 FKI-HPEIPESLSAEAKNFI------LRCFEPDPDKRAS---AHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 79/276 (28%), Positives = 139/276 (50%), Gaps = 40/276 (14%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G G G VYKA+ +G + A K + E+ ++++ E++ L H IVK G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPYIVKLLG 76
Query: 503 FCSHARHSFIVYEYLEMGSL-AMILSNDAAAKDLGWTKRMNVI-KGVVDALSYMHNDCFP 560
+I+ E+ G++ A++L D + ++ VI + +++AL Y+H+
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE----PQIQVICRQMLEALQYLHSM--- 129
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFG-TAKFLKP----DSSNWAELAGTYGYVAPELAY- 614
I+HRD+ + NVLL L+ + ++DFG +AK +K DS GT ++APE+
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS-----FIGTPYWMAPEVVMC 184
Query: 615 -TMKVTE---KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670
TMK T K D++S G+ +E+ + + P ++ + L+IA +E P L PS
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---LKIAKSE--PPTLSQPS 239
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ + + LD+ PE+RP+ +QLL+
Sbjct: 240 KWSME----FRDFLKTALDKHPETRPS---AAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 72/282 (25%), Positives = 128/282 (45%), Gaps = 44/282 (15%)
Query: 441 EHCIGKGGQGSVY--KAELPSG-EI-VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
E IG G G V + +LP EI VA+K + + +++FL+E + H N
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPN 66
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
I+ G + ++ IV EY+E GSL A + +D + + +++G+ + Y+
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLS 123
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG-----YVAP 610
+ + VHRD++++N+L++ VSDFG ++ L+ D A G + AP
Sbjct: 124 DMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE--AAYTTRGGKIPIRWTAP 178
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIK-GKHP------RDFISSISSSSSNLEIALNEMLD 663
E K T DV+S+G++ EV+ G+ P +D I +I
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY------------ 226
Query: 664 PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
RLP P D ++ ++ + C + RP +++ +L
Sbjct: 227 -RLPAP----MDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 67/284 (23%), Positives = 130/284 (45%), Gaps = 40/284 (14%)
Query: 444 IGKGGQGSVYKAEL----PSGE--IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
+G+G G V+ AE P + +VAVK + ++++F E + LT ++H +I
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHI 69
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSL----------AMILSNDAAAKDLGWTKRMNVIKGV 547
VKFYG C +V+EY++ G L A++++ +L ++ +++ + +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 548 VDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAG---- 603
+ Y+ + F VHRD++++N L+ + DFG ++ + S+++ + G
Sbjct: 130 AAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVY--STDYYRVGGHTML 184
Query: 604 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEML 662
++ PE K T + DV+S GV+ E+ GK P SN E+
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPW-------YQLSNNEVIECITQ 237
Query: 663 DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
L P ++ + ++ + C P R I+++ LL+
Sbjct: 238 GRVLQRPRTCPKE----VYDLMLGCWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 24/210 (11%)
Query: 443 CIGKGGQGSVYKA-ELPSGEIVAVKKFH-SPLPSEMASQQEFL-NEVKTLTGIRHRNIVK 499
+G+G G VY ++ +G +AVK+ P E + L E++ L ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 500 FYGFCSHARHSFIVYEYLEMGSLA------MILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
+YG I EY+ GS+ L+ K +T++ +++ + Y
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK---YTRQ------ILEGVEY 119
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP---DSSNWAELAGTYGYVAP 610
+H++ IVHRDI N+L D + DFG +K L+ + + GT +++P
Sbjct: 120 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
E+ K DV+S G +E++ K P
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 74/259 (28%), Positives = 120/259 (46%), Gaps = 26/259 (10%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G G G+VYKA L + I+AVK PL + Q++ ++E++ L I+ FYG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVI--PLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 503 -FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
F R S I E+++ GSL + LG R+ V VV L+Y+ +
Sbjct: 67 AFFVENRIS-ICTEFMDGGSLDVYRK--IPEHVLG---RIAV--AVVKGLTYLWS---LK 115
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEK 621
I+HRD+ N+L++ + + DFG + L +S GT Y+APE +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISGEQYGIH 173
Query: 622 CDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD---PRLPTPSHNVQDKLI 678
DV+S G+ +E+ G+ P I S L++ L ++D P LP +K +
Sbjct: 174 SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDEDPPVLPV--GQFSEKFV 230
Query: 679 SIMEVAISCLDESPESRPT 697
+ C+ + P+ RP
Sbjct: 231 HFI---TQCMRKQPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 71/278 (25%), Positives = 123/278 (44%), Gaps = 34/278 (12%)
Query: 448 GQGSVYKAEL--------PSGEIVAVKKFHSPLPSEMASQQEFL-NEVKTLTGIRHRNIV 498
G+G K EL +GE VAVK P + L E++ L + H NIV
Sbjct: 13 GEGHFGKVELCRYDPEGDNTGEQVAVKSLK---PESGGNHIADLKKEIEILRNLYHENIV 69
Query: 499 KFYGFCSHARHSFI--VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
K+ G C+ + I + E+L GSL L + +L +++ + + Y+ +
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDYLGS 127
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA---ELAGTYGYVAPELA 613
+ VHRD++++NVL++ E++ + DFG K ++ D + +L + APE
Sbjct: 128 RQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 614 YTMKVTEKCDVYSFGVLALEVI-----KGKHPRDFISSISSSSSNLEIA-LNEMLD--PR 665
K DV+SFGV E++ + F+ I + + + L +L+ R
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244
Query: 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
LP P N +++ +M C + P R T Q + +
Sbjct: 245 LPRPP-NCPEEVYQLMR---KCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 44/282 (15%)
Query: 444 IGKGGQGSVYKAEL----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
IGKG G VY L AVK + +++ ++FL E + H N++
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 500 FYGFCSHARHS-FIVYEYLEMGSLAMIL---SNDAAAKDL-GWTKRMNVIKGVVDALSYM 554
G C + S +V Y++ G L + +++ KDL G+ + V KG + Y+
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG--LQVAKG----MEYL 114
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK------FLKPDSSNWAELAGTYGYV 608
+ F VHRD++++N +LD V+DFG A+ + + A+L ++
Sbjct: 115 ASKKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP--VKWM 169
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667
A E T K T K DV+SFGVL E++ +G P + S +I + + RL
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-------FDITVYLLQGRRLL 222
Query: 668 TPSHNVQDKLISIMEVAISCLDESPESRPT----IQKVSQLL 705
P + D L +M +SC PE RPT + ++ Q+
Sbjct: 223 QPEY-CPDPLYEVM---LSCWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-14
Identities = 57/195 (29%), Positives = 87/195 (44%), Gaps = 25/195 (12%)
Query: 459 SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFY--GFCSHARHSFIVYEY 516
+G VA+K + P E + F E + H NIV G F V+EY
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEY 60
Query: 517 LEMGSLAMILSNDAA--AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL 574
+ +L +L+ D A A + G ++ V+DAL+ HN IVHRD+ +N+++
Sbjct: 61 VPGRTLREVLAADGALPAGETG-----RLMLQVLDALACAHNQ---GIVHRDLKPQNIMV 112
Query: 575 ---DLENEAHVSDFGTAKFLKPDSSNWA--------ELAGTYGYVAPELAYTMKVTEKCD 623
+ A V DFG L P + E+ GT Y APE VT D
Sbjct: 113 SQTGVRPHAKVLDFGIGTLL-PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 624 VYSFGVLALEVIKGK 638
+Y++G++ LE + G+
Sbjct: 172 LYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 68/273 (24%), Positives = 116/273 (42%), Gaps = 15/273 (5%)
Query: 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+F E IG+G VY+A L G VA+KK + ++ + + E+ L + H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRM-NVIKGVVDALSYM 554
N++K+Y IV E + G L+ ++ + K L K + + AL +M
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
H+ ++HRDI NV + + D G +F ++ L GT Y++PE +
Sbjct: 123 HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT-PSHNV 673
K D++S G L E+ + P NL ++ P PS +
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSP------FYGDKMNLYSLCKKIEQCDYPPLPSDHY 233
Query: 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
++L ++ + C++ PE RP I V + K
Sbjct: 234 SEELRQLVNM---CINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 14/207 (6%)
Query: 437 DFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
D + +G G G V+ + S A+K P + +Q NE + L + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG--VVDALSY 553
I++ + R +++ EY+ G L L N ++ + +V AL Y
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-----FSNSTGLFYASEIVCALEY 116
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELA 613
+H+ IV+RD+ +N+LLD E ++DFG AK L+ W L GT Y+APE+
Sbjct: 117 LHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWT-LCGTPEYLAPEVI 170
Query: 614 YTMKVTEKCDVYSFGVLALEVIKGKHP 640
+ + D ++ G+L E++ G P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 18/198 (9%)
Query: 444 IGKGGQGSVYKA---ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
+G G G+V K S + VAVK + ++ A + E L E + + + IV+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKND-NNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
G C A +V E E+G L L + + T+ ++ V + Y+ F
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEETNF- 116
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG-----YVAPELAYT 615
VHRD++++NVLL ++ A +SDFG +K L D + + A T+G + APE
Sbjct: 117 --VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMNY 172
Query: 616 MKVTEKCDVYSFGVLALE 633
K + K DV+SFGVL E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 65/265 (24%), Positives = 118/265 (44%), Gaps = 22/265 (8%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
+G G G V+ A VAVK P M S + FL E + ++H +VK +
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMK---PGSM-SVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIV 563
+ +I+ E++ GSL L +D +K K ++ + + ++++ + +
Sbjct: 70 VTK-EPIYIITEFMAKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQRNY---I 124
Query: 564 HRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAG-TYGYVAPELAYTMKVTEKC 622
HRD+ + N+L+ ++DFG A+ ++ + E A + APE T K
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 184
Query: 623 DVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIM 681
DV+SFG+L +E++ G+ P SN E+ R+P P + ++ +
Sbjct: 185 DVWSFGILLMEIVTYGRIP-------YPGMSNPEVIRALERGYRMPRPENCPEE----LY 233
Query: 682 EVAISCLDESPESRPTIQKVSQLLK 706
+ + C PE RPT + + +L
Sbjct: 234 NIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHS-------PLPSEMASQQEFLN 484
R +F+ + IG+G G VY+A + SGEIVA+KK P+ S L
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--------LR 55
Query: 485 EVKTLTGIRHRNIVKFYGFC--SHARHSFIVYEYLEMGSLAMILSN------DAAAKDLG 536
E+ L +RH NIV+ H F+V EY E LA +L N ++ K L
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCL- 113
Query: 537 WTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596
+ ++ L Y+H + I+HRD+ N+LL + ++DFG A+ +
Sbjct: 114 -------MLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163
Query: 597 NWAELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGK 638
T Y APEL T D+++ G + E++ K
Sbjct: 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 75/283 (26%), Positives = 123/283 (43%), Gaps = 39/283 (13%)
Query: 444 IGKGGQGSVYKAELP------SGEI-VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
+G G G VY+ SG I VAVK + ++EFL E ++ H N
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG--ATDQEKKEFLKEAHLMSNFNHPN 60
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKD----LGWTKRMNVIKGVVDALS 552
IVK G C +I+ E +E G L L + + L + +++ V
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 553 YMHNDCFPPIVHRDISSKNVLL-----DLENEAHVSDFGTAKFLKPDSSNWAELAG---- 603
Y+ F +HRD++++N L+ D + + DFG A+ + S++ G
Sbjct: 121 YLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY--KSDYYRKEGEGLL 175
Query: 604 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEML 662
++APE K T + DV+SFGVL E++ G+ P + +N E+ +
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP-------YPALNNQEVLQHVTA 228
Query: 663 DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
RL P N DK+ +M +C + P RPT ++ ++L
Sbjct: 229 GGRLQKPE-NCPDKIYQLMT---NCWAQDPSERPTFDRIQEIL 267
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-14
Identities = 79/291 (27%), Positives = 129/291 (44%), Gaps = 46/291 (15%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF-Y 501
IGKG G V A + +GE VA+KK + ++ L E+K L +RH +IV+ +
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 502 GFCSHARHSF----IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHND 557
+R F +V+E +E +I +ND DL + ++ AL Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELMESDLHQVIKAND----DLTPEHHQFFLYQLLRALKYIHT- 121
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAK--FLK-PDSSNWAELAGTYGYVAPEL-- 612
+ HRD+ KN+L + + + + DFG A+ F P + W + T Y APEL
Sbjct: 122 --ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 613 AYTMKVTEKCDVYSFGVLALEVIKGK---------HPRDFISSISSSSSNLEIA------ 657
++ K T D++S G + EV+ GK H D I+ + + S I+
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239
Query: 658 ----LNEMLDPRLPTPSHNVQDKLISIMEVAISCLDE----SPESRPTIQK 700
L+ M + P P K + +A+ L+ P+ RPT ++
Sbjct: 240 ARRYLSSM-RKKQPVP---FSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 9e-14
Identities = 53/205 (25%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKF----HSPLPSEMASQQEFLNEVKTLTGIRHRNIV 498
IG+G G V+K +G+IVA+KKF P+ ++A L E++ L ++H N+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA-----LREIRMLKQLKHPNLV 63
Query: 499 KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH-ND 557
R +V+EY + L + + + + +I + A+++ H ++
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL----- 612
C +HRD+ +N+L+ + + + DFG A+ L ++ + T Y APEL
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 613 AYTMKVTEKCDVYSFGVLALEVIKG 637
Y V DV++ G + E++ G
Sbjct: 177 QYGPPV----DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 77/277 (27%), Positives = 122/277 (44%), Gaps = 53/277 (19%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+GKG GSVYK P+G +A+K+ L + + + + E+ L IV FYG
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAA--KDLGWTKRMN--VIKGVVDALSYMHNDC 558
++ EY++ GSL + + A +R+ V+KG+ L HN
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL-KFLKEEHN-- 123
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA----GTYGYVAPE--- 611
I+HRD+ NVL++ + + DFG + L A LA G Y+APE
Sbjct: 124 ---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV------ASLAKTNIGCQSYMAPERIK 174
Query: 612 -------LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD- 663
YT+ + DV+S G+ LE+ G++P + +N+ L+ ++D
Sbjct: 175 SGGPNQNPTYTV----QSDVWSLGLSILEMALGRYPYP-----PETYANIFAQLSAIVDG 225
Query: 664 --PRLPTP-SHNVQDKLISIMEVAISCLDESPESRPT 697
P LP+ S + QD CL++ P RPT
Sbjct: 226 DPPTLPSGYSDDAQD-------FVAKCLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-13
Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 12/157 (7%)
Query: 247 LNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFI 306
L L N IP ++ KL HL ++LS N + +P + ++ SLE L+LS+N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 307 PSCFEELHGLSYIDISYNELHGSIPNSTA---FRDAPMEALQGNKGLCGDIKGFPSCKAS 363
P +L L ++++ N L G +P + A N GLCG I G +C
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN-FTDNAGLCG-IPGLRAC--- 537
Query: 364 KSHKQASRKIWVVIVFPLLGSFALLISLIGLFFMFRR 400
H KI + S A L +I ++R
Sbjct: 538 GPHLSVGAKIGIA----FGVSVAFLFLVICAMCWWKR 570
|
Length = 623 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 2e-13
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFH----SPLPSEMASQQEFLNEVKTLTGIRHRNIV 498
+G+G G VY ++ +G +A K+ SP S+ S E E++ L ++H IV
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC--EIQLLKNLQHERIV 67
Query: 499 KFYG-FCSHARHSFIVY-EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
++YG A + ++ EY+ GS+ L A + T++ + +++ +SY+H+
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE-SVTRKYT--RQILEGMSYLHS 124
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP---DSSNWAELAGTYGYVAPELA 613
+ IVHRDI N+L D + DFG +K L+ + + GT +++PE+
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 614 YTMKVTEKCDVYSFGVLALEVIKGKHP 640
K DV+S G +E++ K P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 72/273 (26%), Positives = 113/273 (41%), Gaps = 41/273 (15%)
Query: 443 CIGKGGQGSVYKA--ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
CIG+G G VY+ P E +AV + + +++FL E + H +IVK
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIK---GVVDALSYMHND 557
G + +IV E +G L L + ++I + AL+Y+ +
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQ-----VNKYSLDLASLILYSYQLSTALAYLESK 126
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY--GYVAPELAYT 615
F VHRDI+++NVL+ + + DFG +++L+ D S + G ++APE
Sbjct: 127 RF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINF 182
Query: 616 MKVTEKCDVYSFGVLALEVIK-GKHP------RDFISSISSSSSNLEIALNEMLDPRLPT 668
+ T DV+ FGV E++ G P D I I + RLP
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-------------RLPM 229
Query: 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
P N L S+M C P RP ++
Sbjct: 230 PP-NCPPTLYSLMT---KCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 31/211 (14%)
Query: 444 IGKGGQGSVYKAELPSGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
IG+G G +Y A+ S I + P+ + AS+ EV L ++H NIV
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK----KEVILLAKMKHPNIVT 63
Query: 500 FYGFCSHARHSFIVYEYLEMGSL--------AMILSNDAAAKDLGWTKRMNVIKGVVDAL 551
F+ FIV EY + G L ++ S D + L W ++++ L
Sbjct: 64 FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED---QILSWFVQISL------GL 114
Query: 552 SYMHNDCFPPIVHRDISSKNVLLDLENE-AHVSDFGTAKFLKPDSSNWAEL-AGTYGYVA 609
++H+ I+HRDI S+N+ L A + DFG A+ L DS A GT Y++
Sbjct: 115 KHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLS 170
Query: 610 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
PE+ K D++S G + E+ KHP
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 51/192 (26%), Positives = 77/192 (40%), Gaps = 35/192 (18%)
Query: 463 VAVKKFHSPLPSE-MASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGS 521
VAVK P ++++FL EVK L+ + NI + G C+ ++ EY+E G
Sbjct: 49 VAVKV---LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105
Query: 522 LAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM-------------HNDCFPPIVHRDIS 568
L L A N L YM N VHRD++
Sbjct: 106 LNQFLQKHVAETS---GLACNSKSLSFSTLLYMATQIASGMRYLESLN-----FVHRDLA 157
Query: 569 SKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAP------ELAYTMKVTEKC 622
++N L+ ++DFG ++ L SS++ + G P E K T K
Sbjct: 158 TRNCLVGKNYTIKIADFGMSRNLY--SSDYYRVQGR--APLPIRWMAWESVLLGKFTTKS 213
Query: 623 DVYSFGVLALEV 634
DV++FGV E+
Sbjct: 214 DVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 73/280 (26%), Positives = 108/280 (38%), Gaps = 52/280 (18%)
Query: 444 IGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQ---EFLNEVKTLTGIRH 494
+G G G VY+ VAVK LP E S+Q +FL E ++ H
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKT----LP-ESCSEQDESDFLMEALIMSKFNH 68
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL---------SNDAAAKDLGWTKRMNVIK 545
+NIV+ G FI+ E + G L L + KDL + +
Sbjct: 69 QNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL-----LFCAR 123
Query: 546 GVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE---AHVSDFGTAKFLKPDSSNWAELA 602
V Y+ + F +HRDI+++N LL + A ++DFG A+ + +++
Sbjct: 124 DVAKGCKYLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYRKG 178
Query: 603 GT----YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIA 657
G ++ PE T K DV+SFGVL E+ G P +N E+
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP-------YPGRTNQEVM 231
Query: 658 LNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPT 697
RL P + IM C +PE RP
Sbjct: 232 EFVTGGGRLDPPK-GCPGPVYRIMT---DCWQHTPEDRPN 267
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 70/276 (25%), Positives = 117/276 (42%), Gaps = 21/276 (7%)
Query: 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+F E IG+G VY+A L + VA+KK + ++Q+ + E+ L + H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVV---DALS 552
N++K+ IV E + G L+ ++ K L V K V A+
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL--IPERTVWKYFVQLCSAVE 120
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL 612
+MH+ ++HRDI NV + + D G +F ++ L GT Y++PE
Sbjct: 121 HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 613 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPS 670
+ K D++S G L E+ + P NL +L + ++ P P+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP------FYGDKMNL-FSLCQKIEQCDYPPLPT 230
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ +KL E+ C+ P+ RP I V Q+ K
Sbjct: 231 EHYSEKL---RELVSMCIYPDPDQRPDIGYVHQIAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 57/210 (27%), Positives = 87/210 (41%), Gaps = 34/210 (16%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR-----NI 497
I KG GSVY A+ +G+ A+K S+M ++ + N VK I +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKK---SDMIAKNQVTN-VKAERAIMMIQGESPYV 59
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLG-----WTKRMNVIKGVVDALS 552
K Y + ++V EYL G A ++ K LG W K I VV +
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAK--QYIAEVVLGVE 111
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK--FLKPDSSNWAELAGTYGYVAP 610
+H I+HRDI +N+L+D ++DFG ++ GT Y+AP
Sbjct: 112 DLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAP 162
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
E + + D +S G + E + G P
Sbjct: 163 ETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 70/305 (22%), Positives = 120/305 (39%), Gaps = 33/305 (10%)
Query: 405 TQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIV 463
SS ++ S + E+ RV IG G G+VYK P+G +
Sbjct: 50 PSSSSSSSSSSSASGSAPSAAKSLSELERVNR-------IGSGAGGTVYKVIHRPTGRLY 102
Query: 464 AVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLA 523
A+K + E +++ E++ L + H N+VK + H ++ E+++ GSL
Sbjct: 103 ALKVIYGN--HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE 160
Query: 524 MILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVS 583
D +V + ++ ++Y+H IVHRDI N+L++ ++
Sbjct: 161 GTHIADEQF-------LADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIA 210
Query: 584 DFGTAKFLKPDSSNWAELAGTYGYVAPE-----LAYTMKVTEKCDVYSFGVLALEVIKGK 638
DFG ++ L GT Y++PE L + D++S GV LE G+
Sbjct: 211 DFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
Query: 639 HPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTI 698
P F ++L A+ M P P + + CL P R +
Sbjct: 271 FP--FGVGRQGDWASLMCAIC-MSQP--PEAPATASREFRHFISC---CLQREPAKRWSA 322
Query: 699 QKVSQ 703
++ Q
Sbjct: 323 MQLLQ 327
|
Length = 353 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 6e-13
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 443 CIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPS-EMASQQEFLNEVKTLTGI-RHRNIVK 499
+G G GSVY A +GE+VA+KK S E L EVK+L + H NIVK
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LREVKSLRKLNEHPNIVK 62
Query: 500 FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
+ V+EY+E ++ K + ++I ++ L+++H F
Sbjct: 63 LKEVFRENDELYFVFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHGF 120
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFL--KPD-----SSNWAELAGTYGYVAPEL 612
HRD+ +N+L+ ++DFG A+ + +P S+ W Y APE+
Sbjct: 121 ---FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRW--------YRAPEI 169
Query: 613 -----AYTMKVTEKCDVYSFGVLALEVIKGK 638
+Y+ V D+++ G + E+ +
Sbjct: 170 LLRSTSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 6e-13
Identities = 63/220 (28%), Positives = 97/220 (44%), Gaps = 38/220 (17%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+DF+ +G G G V SG+ A+K ++ + LNE + L IRH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL------SNDA----AAKDLGWTKRMNVI 544
+V YG + ++V EY+ G L L AA+
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ----------- 109
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT 604
VV AL Y+H+ IV+RD+ +N+LLD + ++DFG AK +K + + L GT
Sbjct: 110 --VVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT-LCGT 161
Query: 605 YGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
Y+APE+ Y V D ++ G+L E++ G P
Sbjct: 162 PEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 7e-13
Identities = 35/85 (41%), Positives = 51/85 (60%)
Query: 8 LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAI 67
L L N G IP++I +L+ L + LSGN + G+IP SLG++T + L L N+ +G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 68 PKEYGNLVKLTLLTLENNQLRGPIP 92
P+ G L L +L L N L G +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 67/254 (26%), Positives = 114/254 (44%), Gaps = 34/254 (13%)
Query: 463 VAVKKFHSPLPSEMASQQEFL-NEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYLEMG 520
VAVK P+ +S++E L +E+K ++ + H NIV G C+ ++ EY G
Sbjct: 68 VAVKMLK---PTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYG 124
Query: 521 SLAMILSNDAAA----KDL-GWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD 575
L L + +DL ++ + V KG M +HRD++++NVLL
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQ--VAKG-------MAFLASKNCIHRDLAARNVLLT 175
Query: 576 LENEAHVSDFGTAKFLKPDSSNWAELAGTY---GYVAPELAYTMKVTEKCDVYSFGVLAL 632
+ DFG A+ + D SN+ ++APE + T + DV+S+G+L
Sbjct: 176 HGKIVKICDFGLARDIMND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLW 234
Query: 633 EVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDES 691
E+ G +P + S ++ R+ P H + + IM+ +C D
Sbjct: 235 EIFSLGSNPYPGMPVDSKFYKLIKEGY------RMAQPEHAPAE-IYDIMK---TCWDAD 284
Query: 692 PESRPTIQKVSQLL 705
P RPT +++ QL+
Sbjct: 285 PLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 68/288 (23%), Positives = 117/288 (40%), Gaps = 50/288 (17%)
Query: 444 IGKGGQGSVYK---AELPSGEI---VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
+G+G G VY+ + GE VA+K + + M + EFLNE + ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFNCHHV 71
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMIL----SNDAAAKDLG---WTKRMNVIKGVVDA 550
V+ G S + + +V E + G L L LG K + + + D
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK------FLKPDSS-----NWA 599
++Y+ F VHRD++++N ++ + + DFG + + + W
Sbjct: 132 MAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW- 187
Query: 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIAL 658
+APE T K DV+SFGV+ E+ + P +S+ E L
Sbjct: 188 --------MAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EEVL 231
Query: 659 NEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
++D N DKL+ +M + C +P+ RPT ++ LK
Sbjct: 232 KFVIDGGHLDLPENCPDKLLELMRM---CWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 73/279 (26%), Positives = 118/279 (42%), Gaps = 33/279 (11%)
Query: 435 TNDFDDEHCIGKGGQGSVYK-AELPSGEIVAVKKFH--SPLPSEMASQQEFLNEVKTLTG 491
T+ ++ IGKG G VYK G + AVK S + E+ ++ L +
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPN--- 77
Query: 492 IRHRNIVKFYGFCSHARHS-----FIVYEYLEMGSLAMILSND-AAAKDLGWTKRMNVIK 545
H N+VKFYG A ++V E GS+ ++ + L ++
Sbjct: 78 --HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 546 GVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY 605
G + L ++HN+ I+HRD+ N+LL E + DFG + L GT
Sbjct: 136 GALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 192
Query: 606 GYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660
++APE+ Y +CDV+S G+ A+E+ G P + + + +I
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP---LFDMHPVKTLFKI---- 245
Query: 661 MLDPRLPTPSHNVQDKLISIMEVAIS-CLDESPESRPTI 698
PR P P+ +K IS CL + E+RP++
Sbjct: 246 ---PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV 281
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 8e-13
Identities = 66/285 (23%), Positives = 119/285 (41%), Gaps = 33/285 (11%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G+G G V K + +G+IVA+KKF +M + E++ L +RH N+V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQLRHENLVNLIE 67
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
+ ++V+E+++ L + + L ++ + ++ + + H+ I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSH---NI 121
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY-TMKVTEK 621
+HRDI +N+L+ + DFG A+ L + + T Y APEL K
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRA 181
Query: 622 CDVYSFGVLALEVIKGKHPR-------DFISSISSSSSNLEIALNEMLDP-------RLP 667
D+++ G L E++ G+ P D + I NL E+ RLP
Sbjct: 182 VDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240
Query: 668 TPSH--NVQDKLISIMEVAI----SCLDESPESRPTIQKVSQLLK 706
++ + + + + CL P+ RP+ SQLL
Sbjct: 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS---SSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 67/226 (29%), Positives = 96/226 (42%), Gaps = 37/226 (16%)
Query: 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI 492
D D IG+G G+V K PSG I+AVK+ S + Q+ L ++ + +
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRST--VDEKEQKRLLMDLDVV--M 57
Query: 493 RHRN---IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNV---IKG 546
R + IVKFYG +I E M +S D K + + + I G
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICMEL-------MDISLDKFYKYVYEVLKSVIPEEILG 110
Query: 547 -----VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAEL 601
V AL+Y+ + I+HRD+ N+LLD + DFG + L DS
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRD 167
Query: 602 AGTYGYVAPEL-------AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
AG Y+APE Y + + DV+S G+ EV GK P
Sbjct: 168 AGCRPYMAPERIDPSARDGYDV----RSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 13/209 (6%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+D++ +G G G VYKA L +GE+ AVK + + Q+ + VK H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK---H 65
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
NIV ++G +I EY GSL I +L + V + + L+Y+
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGLAYL 122
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
H+ +HRDI N+LL + ++DFG A + + GT ++APE+A
Sbjct: 123 HSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAA 179
Query: 615 TMK---VTEKCDVYSFGVLALEVIKGKHP 640
K + CD+++ G+ A+E+ + + P
Sbjct: 180 VEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 55/197 (27%), Positives = 86/197 (43%), Gaps = 10/197 (5%)
Query: 448 GQGSVYKAEL----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
G+GS +A L S + A+K+ LP ++ ++ E L ++H NIV F
Sbjct: 9 GEGSFGRALLVQHVNSDQKYAMKEIR--LPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIV 563
H +IV EY + G L M K + + + ++H ++
Sbjct: 67 FEADGHLYIVMEYCDGGDL-MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVL 122
Query: 564 HRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCD 623
HRDI SKN+ L + + DFG+A+ L + GT YV PE+ M K D
Sbjct: 123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSD 182
Query: 624 VYSFGVLALEVIKGKHP 640
++S G + E+ KHP
Sbjct: 183 IWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 26/274 (9%)
Query: 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
DF+ IG G G VYKA + +GE+ A+K + A Q+ E+ + +H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHS 66
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
NIV ++G +I E+ GSL I L ++ V + + L Y+H
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLH 123
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT 615
+ +HRDI N+LL ++DFG + + + GT ++APE+A
Sbjct: 124 SK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 616 MK---VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672
+ + CD+++ G+ A+E+ + + P + + AL M P
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--------ALFLMTKSNFQPP--K 230
Query: 673 VQDKLI---SIMEVAISCLDESPESRPTIQKVSQ 703
++DK+ S L ++P+ RPT +K+ Q
Sbjct: 231 LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 68/272 (25%), Positives = 109/272 (40%), Gaps = 37/272 (13%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
DF +G+GG G V+ A+ +GEIVA+K+ L ++ + L E LT +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 495 RNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
+VK Y F + ++ EY+ G +L+N + M + VDAL
Sbjct: 61 EWLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE 119
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA----GTYGYVA 609
+ +HRD+ +N L+D ++DFG S A G+ Y+A
Sbjct: 120 LG------YIHRDLKPENFLIDASGHIKLTDFGL-------SKGIVTYANSVVGSPDYMA 166
Query: 610 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN-----EMLD- 663
PE+ D +S G + E + G P S S+ N E N E L
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP------FSGSTPN-ETWENLKYWKETLQR 219
Query: 664 PRLPTPSHNVQDKLISIMEVAISCLDESPESR 695
P P N+ D+ ++ +++ P R
Sbjct: 220 PVYDDPRFNLSDEAWDLIT---KLIND-PSRR 247
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 74/284 (26%), Positives = 121/284 (42%), Gaps = 38/284 (13%)
Query: 438 FDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
F+ +G G G VYK + +G++ A+K E +QE +N +K + HRN
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE-INMLKKYS--HHRN 64
Query: 497 IVKFYGFCSHAR------HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDA 550
I +YG ++V E+ GS+ ++ N L + + ++
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRG 123
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAP 610
LS++H ++HRDI +NVLL E + DFG + L GT ++AP
Sbjct: 124 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180
Query: 611 ELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPR 665
E+ + + K D++S G+ A+E+ +G P ++ L PR
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL----------CDMHPMRALFLIPR 230
Query: 666 LPTP---SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
P P S K S +E SCL ++ RPT + QL+K
Sbjct: 231 NPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPTTE---QLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 38/103 (36%), Positives = 58/103 (56%), Gaps = 1/103 (0%)
Query: 175 LDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSI 234
L L + + G +P+ + KL L + L+ N + G + LGS+T LE LDLS N + SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 235 PKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDLSHN 276
P+SLG L L LNL+ N ++P L +L+H + + + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 67/287 (23%), Positives = 111/287 (38%), Gaps = 47/287 (16%)
Query: 444 IGKGGQGSVYKAELPSGEIVA---VKKFH-SPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
IG G G V E G A VK+ S P E Q FL EV+ + H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE---QLLFLQEVQPYRELNHPNVLQ 59
Query: 500 FYGFCSHARHSFIVYEYLEMGSLAMILSND----AAAKDLGWTKRM--NVIKGVVDALSY 553
G C + +V E+ +G L L ++ A +RM V G++ +
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL----W 115
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA------KFLKPDSSNWAELAGTYGY 607
+H F +H D++ +N L + + D+G A + + L +
Sbjct: 116 LHQADF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----W 168
Query: 608 VAPELA-------YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALN 659
+APEL T+K +++S GV E+ P S+ ++
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP-------YPDLSDEQVLKQ 221
Query: 660 EMLDPRLPTPSHNVQDKLIS-IMEVAISCLDESPESRPTIQKVSQLL 705
+ + + P + K EV C PE+RPT ++V +LL
Sbjct: 222 VVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 74/287 (25%), Positives = 125/287 (43%), Gaps = 44/287 (15%)
Query: 438 FDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
F+ +G G G VYK + +G++ A+K E + E +N +K + HRN
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE-INMLKKYS--HHRN 74
Query: 497 IVKFYGF------CSHARHSFIVYEYLEMGSLAMILSN---DAAAKDLGWTKRMNVIKGV 547
I +YG H ++V E+ GS+ ++ N +A +D W + + +
Sbjct: 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED--WIAY--ICREI 130
Query: 548 VDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGY 607
+ L+++H ++HRDI +NVLL E + DFG + L GT +
Sbjct: 131 LRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYW 187
Query: 608 VAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML 662
+APE+ + + + D++S G+ A+E+ +G P ++ L
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL----------CDMHPMRALFL 237
Query: 663 DPRLPTP---SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
PR P P S K I +E CL ++ SRP+ + QLLK
Sbjct: 238 IPRNPPPKLKSKKWSKKFIDFIE---GCLVKNYLSRPSTE---QLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 75/293 (25%), Positives = 123/293 (41%), Gaps = 46/293 (15%)
Query: 444 IGKGGQGSVYKAE------LPSGEIVAVKKFHSPLPSEMASQQEF---LNEVKTLTGIRH 494
+G+G G V KA VAVK + E AS E L+E L + H
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVK-----MLKENASSSELRDLLSEFNLLKQVNH 62
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL--SNDAAAKDLGWTKRMNVIK------- 545
+++K YG CS ++ EY + GSL L S LG N
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 546 --GVVDALSYMHNDCFP-------PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596
+ D +S+ +VHRD++++NVL+ + +SDFG ++ + + S
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 597 NWAELAG--TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSN 653
G ++A E + T + DV+SFGVL E++ G +P I +
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI-----APER 237
Query: 654 LEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
L L R+ P N +++ ++M ++C + P+ RPT +S+ L+
Sbjct: 238 LFNLLKT--GYRMERPE-NCSEEMYNLM---LTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 9/205 (4%)
Query: 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
N F+ +G+G G V K + EIVA+KKF +E ++ L E+K L ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEV-KETTLRELKMLRTLKQ 59
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
NIV+ ++V+EY+E L ++ K + I ++ A+ +
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP---EKVRSYIYQLIKAIHWC 116
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS-SNWAELAGTYGYVAPELA 613
H + IVHRDI +N+L+ + + DFG A+ L S +N+ E T Y +PEL
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173
Query: 614 YTMKVTEKCDVYSFGVLALEVIKGK 638
+ D++S G + E+ G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 16/177 (9%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEV---KTLTGIRHRNIVK 499
IG+G G+VYKA +L +G VA+KK PL SE L E+ K L H NIV+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPL-SEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 500 FYGFC-----SHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
C +V+E+++ LA LS L ++++ ++ + ++
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSK-CPKPGLPPETIKDLMRQLLRGVDFL 123
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE 611
H+ IVHRD+ +N+L+ + + ++DFG A+ + + + T Y APE
Sbjct: 124 HSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPE 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 64/267 (23%), Positives = 117/267 (43%), Gaps = 27/267 (10%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQ--EFLNEVKTLTGIRHRNIVKF 500
+G G G+VYK +P GE V + L + EF++E + + H ++V+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
G C +V + + G L + ++G +N + + Y+
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY--GYVAPELAYTMKV 618
+VHRD++++NVL+ N ++DFG A+ L+ D + G ++A E + K
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188
Query: 619 TEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPSHNVQD 675
T + DV+S+GV E++ G P D I + + ++L+ RLP P
Sbjct: 189 THQSDVWSYGVTIWELMTFGGKPYDGIPTRE---------IPDLLEKGERLPQPPICT-- 237
Query: 676 KLISIMEVAISCLDESPESRPTIQKVS 702
I + V + C +SRP ++++
Sbjct: 238 --IDVYMVMVKCWMIDADSRPKFKELA 262
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFH----SPLPSEMASQQEFLNEVKTLTGIRHRNIV 498
+G+G G VY + +G +AVK+ SP S+ + E E++ L + H IV
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALEC--EIQLLKNLLHERIV 67
Query: 499 KFYGFC--SHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
++YG R I E++ GS+ L + A + T++ + +++ +SY+H+
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-NVTRKYT--RQILEGVSYLHS 124
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP---DSSNWAELAGTYGYVAPELA 613
+ IVHRDI N+L D + DFG +K L+ + + GT +++PE+
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 614 YTMKVTEKCDVYSFGVLALEVIKGKHP 640
K D++S G +E++ K P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 69/277 (24%), Positives = 117/277 (42%), Gaps = 33/277 (11%)
Query: 437 DFDDEHCIGKGGQGSVYKA-ELPSGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTG 491
+F +G G G+VYK +P GE VA+K+ + + +E L+E +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 65
Query: 492 IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKD-LGWTKRMNVIKGVVDA 550
+ + ++ + G C + I + + G L L KD +G +N +
Sbjct: 66 VDNPHVCRLLGICLTSTVQLIT-QLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKG 121
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY--GYV 608
++Y+ +VHRD++++NVL+ ++DFG AK L D + G ++
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFI--SSISSSSSNLEIALNEMLDPR 665
A E T + DV+S+GV E++ G P D I S ISS E R
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE---------R 229
Query: 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVS 702
LP P I + + + C +SRP +++
Sbjct: 230 LPQPPICT----IDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-11
Identities = 32/91 (35%), Positives = 50/91 (54%)
Query: 127 IDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEM 186
+ L + G I +D + L +++ S N+I G++P + + L+VLDLS N G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 187 PSKLGKLSSLIKLILNSNQLCGQLSLELGSL 217
P LG+L+SL L LN N L G++ LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 12/207 (5%)
Query: 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+DF+ +G G G V K + PSG I+A K H L + A + + + E++ L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIH--LEIKPAIRNQIIRELQVLHECNS 62
Query: 495 RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
IV FYG F S S I E+++ GSL +L AK + V V+ L+Y
Sbjct: 63 PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAY 118
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELA 613
+ I+HRD+ N+L++ E + DFG + L +N GT Y++PE
Sbjct: 119 LREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERL 174
Query: 614 YTMKVTEKCDVYSFGVLALEVIKGKHP 640
+ + D++S G+ +E+ G++P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 437 DFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
DF+ +G G G V K PSG I+A K H L + A + + + E+K L
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIH--LEIKPAIRNQIIRELKVLHECNSP 59
Query: 496 NIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
IV FYG F S S I E+++ GSL +L A + + V+ L+Y+
Sbjct: 60 YIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYL 115
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
I+HRD+ N+L++ E + DFG + L +N GT Y++PE
Sbjct: 116 REK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQ 171
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHP 640
T + D++S G+ +E+ G++P
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 54/206 (26%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVK--KFHS-----PLPSEMASQQEFLNEVKTLTGIRHR 495
I +G G VY+A + +GEIVA+K K P+ S L E+ L ++H
Sbjct: 13 IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS--------LREINILLKLQHP 64
Query: 496 NIV--KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
NIV K S+ ++V EY+E L ++ K ++ ++ +++
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVK--CLMLQLLSGVAH 121
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELA 613
+H++ I+HRD+ + N+LL+ + DFG A+ + +L T Y APEL
Sbjct: 122 LHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELL 178
Query: 614 Y-TMKVTEKCDVYSFGVLALEVIKGK 638
+ + D++S G + E++ K
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 72/287 (25%), Positives = 126/287 (43%), Gaps = 42/287 (14%)
Query: 427 VYEEIIRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNE 485
++ + +TN + D +G G G V A + +G+ VA+KK P + + +++ + E
Sbjct: 1 IFGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RE 59
Query: 486 VKTLTGIRHRNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVI 544
+K L +RH NI+ F S + V E L L +L++ K ++
Sbjct: 60 LKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQIL 118
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT 604
+G L Y+H+ +VHRD+ N+L++ + + DFG A+ P + + T
Sbjct: 119 RG----LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS---T 168
Query: 605 YGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK-------H--------------PRD 642
Y APE+ T K + D++S G + E+++GK H P D
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD 228
Query: 643 FISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLD 689
I++I S ++ L + L R P P +K + AI L+
Sbjct: 229 VINTICSENT-LRFV--QSLPKREPVP---FSEKFKNADPSAIDLLE 269
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 436 NDFDDEHCIGKGGQGSVYK-AELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+DF+ +G G G V+K + PSG I+A K H L + A + + + E++ L
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIH--LEIKPAIRNQIIRELQVLHECNS 62
Query: 495 RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTK-RMNVIKGVVDALS 552
IV FYG F S S I E+++ GSL +L + K + VIKG L+
Sbjct: 63 PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LT 117
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL 612
Y+ I+HRD+ N+L++ E + DFG + L +N GT Y++PE
Sbjct: 118 YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 173
Query: 613 AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
+ + D++S G+ +E+ G++P
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 20/233 (8%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKF-HSPLPSEMASQQEFLN-EVKTLTGIRHRNIVKF 500
+G+G G VY + +G +AVK+ P E + + L E++ L +RH IV++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 501 YGFC---SHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHND 557
YG C + I EY+ GS+ L A + T+R + ++ +SY+H++
Sbjct: 70 YG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTE-NVTRRYT--RQILQGVSYLHSN 125
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP---DSSNWAELAGTYGYVAPELAY 614
IVHRDI N+L D + DFG +K ++ + + GT +++PE+
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667
K DV+S +E++ K P + + ++ +IA + P LP
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEKPP---WAEYEAMAAIFKIA-TQPTKPMLP 231
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 69/288 (23%), Positives = 119/288 (41%), Gaps = 57/288 (19%)
Query: 442 HCIGKGGQGSVYKAEL-----PSGEI-VAVKKFHSPLPSEMASQQE---FLNEVKTLTGI 492
+G+G G V KAE P+ VAVK + A++++ ++E++ + I
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-----KDDATEKDLSDLVSEMEMMKMI 72
Query: 493 -RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS-----NDAAAKDLGWTKRMNVIKG 546
+H+NI+ G C+ ++V EY G+L L + A+ D + +
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132
Query: 547 VVDALSY-----MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAEL 601
+ + +Y M +HRD++++NVL+ ++ ++DFG A+ D +
Sbjct: 133 DLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYY 188
Query: 602 AGT------YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNL 654
T ++APE + T + DV+SFGVL E+ G P
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP------------ 236
Query: 655 EIALNEMLD-----PRLPTPSHNVQDKLISIMEVAISCLDESPESRPT 697
I + E+ R+ P N +L +M C E P RPT
Sbjct: 237 GIPVEELFKLLKEGYRMEKP-QNCTQELYHLM---RDCWHEVPSQRPT 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 65/235 (27%), Positives = 99/235 (42%), Gaps = 36/235 (15%)
Query: 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI 492
V + + IG+G G V A P+G VA+KK SP + Q+ L E+K L
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRT-LREIKILRRF 60
Query: 493 RHRNIVKFY------GFCSHARHSFIVYEYLEMGSLAMI----LSNDAAAKDLGWTKRMN 542
+H NI+ F S +IV E +E +I LSND L R
Sbjct: 61 KHENIIGILDIIRPPSFESF-NDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILR-- 117
Query: 543 VIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN---WA 599
L Y+H+ ++HRD+ N+LL+ + + DFG A+ P+ +
Sbjct: 118 -------GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167
Query: 600 ELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIK------GKHPRDFISSI 647
E T Y APE+ K T+ D++S G + E++ GK ++ I
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 66/271 (24%), Positives = 123/271 (45%), Gaps = 30/271 (11%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
+G G G VYKA+ ++A K E ++++ E+ L H NIVK
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIV 563
+ + +I+ E+ G++ ++ + L + V K ++AL+Y+H + I+
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 564 HRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTE--- 620
HRD+ + N+L L+ + ++DFG + GT ++APE+ +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 621 --KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH---NVQD 675
K DV+S G+ +E+ + + P ++ + L+IA +E P L PS +D
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHELNPMRVL---LKIAKSE--PPTLAQPSRWSSEFKD 240
Query: 676 KLISIMEVAISCLDESPESRPTIQKVSQLLK 706
L CL+++ ++R T +QLL+
Sbjct: 241 FL-------KKCLEKNVDARWT---TTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 442 HCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
+G G GSV A + +GE VA+KK P SE+ +++ + E+ L ++H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGL 79
Query: 501 YG-FCS----HARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
F S F YL M + L L K ++ ++ L Y+H
Sbjct: 80 LDVFTSAVSGDEFQDF----YLVMPYMQTDLQKIMGHP-LSEDKVQYLVYQMLCGLKYIH 134
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAG---TYGYVAPEL 612
+ I+HRD+ N+ ++ + E + DFG A+ AE+ G T Y APE+
Sbjct: 135 S---AGIIHRDLKPGNLAVNEDCELKILDFGLAR------HADAEMTGYVVTRWYRAPEV 185
Query: 613 AYT-MKVTEKCDVYSFGVLALEVIKGK 638
M + D++S G + E++ GK
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 76/319 (23%), Positives = 110/319 (34%), Gaps = 81/319 (25%)
Query: 19 IPSEIGRLKSLSDLELSGNKL------CGSIPHSLGNLTQITFLTLFDNALSGAIPKEYG 72
+ S + SL +L LS N+ S+ L + L L DNAL
Sbjct: 43 LASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLE 102
Query: 73 NLVK---LTLLTLENNQL---------RGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
+L++ L L L NN L +G L LV L +N L G E+
Sbjct: 103 SLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLV---LGRNRLEGASCEALA- 158
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEII----HSSQLKVLD 176
L N L L+ ++N I + + + L+VLD
Sbjct: 159 ------KALRAN-------------RDLKELNLANNGIGDAGIRALAEGLKANCNLEVLD 199
Query: 177 LSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSI-- 234
L++N + E ++ L L+ SL LE L+L N L+++
Sbjct: 200 LNNNGLTDE----------------GASALAETLA----SLKSLEVLNLGDNNLTDAGAA 239
Query: 235 ---PKSLGNLVKLHYLNLSNNQ-----FIKKIPVELEKLIHLSELDLSHNFLGEEM---- 282
L + L L+LS N V EK L ELDL N GEE
Sbjct: 240 ALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLL-ELDLRGNKFGEEGAQLL 298
Query: 283 -PSQICNMQSLEKLNLSHN 300
S + LE L + +
Sbjct: 299 AESLLEPGNELESLWVKDD 317
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 65/264 (24%), Positives = 118/264 (44%), Gaps = 27/264 (10%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTGIRHRNIVK 499
+G+G G V+ ++V +K+ +P E ++ E NE + L + H NI++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQ----IPVEQMTKDERLAAQNECQVLKLLSHPNIIE 63
Query: 500 FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
+Y + IV EY G+LA + L ++ ++ AL ++H
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDTILHFFVQILLALHHVHTKL- 121
Query: 560 PPIVHRDISSKNVLLDL-ENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKV 618
I+HRD+ ++N+LLD + + DFG +K L S + + GT Y++PEL
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCEGKPY 178
Query: 619 TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL-EIALNEMLDPRLPTPSHNVQDKL 677
+K D+++ G + E+ K R F ++NL + L M P D
Sbjct: 179 NQKSDIWALGCVLYELASLK--RAF------EAANLPALVLKIMSGTFAPISDRYSPD-- 228
Query: 678 ISIMEVAISCLDESPESRPTIQKV 701
+ ++ +S L+ P RP + ++
Sbjct: 229 --LRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-11
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 30/214 (14%)
Query: 444 IGKGGQGSVYKAELPS-GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IGKGG G VY A P VA+KK L ++ FL E K + H IV Y
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSN----DAAAKDLGWTKR----MNVIKGVVDALSYM 554
CS + Y+E +L +L + ++ +K+L +++ + + Y+
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAEL------------- 601
H+ ++HRD+ N+LL L E + D+G A F K + + ++
Sbjct: 130 HSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 602 -----AGTYGYVAPELAYTMKVTEKCDVYSFGVL 630
GT Y+APE + +E D+Y+ GV+
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220
|
Length = 932 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 50/206 (24%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLN-----EVKTLTGIRHRNI 497
+G+G VYKA +G IVA+KK E ++ +N E+K L ++H NI
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIK---LGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSND----AAAKDLGWTKRMNVIKGVVDALSY 553
+ H + +V+E++E L ++ + A + ++G L Y
Sbjct: 65 IGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT--LRG----LEY 117
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELA 613
+H+ + I+HRD+ N+L+ + ++DFG A+ + T Y APEL
Sbjct: 118 LHS-NW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELL 174
Query: 614 Y-TMKVTEKCDVYSFGVLALEVIKGK 638
+ D++S G + E++
Sbjct: 175 FGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 63/281 (22%), Positives = 123/281 (43%), Gaps = 36/281 (12%)
Query: 444 IGKGGQGSVYKA---ELPSGEI---VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
+G+G G VY+ ++ GE VAVK + + + + EFLNE + G ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 71
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMIL------SNDAAAKDLGWTKRMNVIKG-VVDA 550
V+ G S + + +V E + G L L + + + + M + + D
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT----YG 606
++Y++ F VHRD++++N ++ + + DFG + + +++ G
Sbjct: 132 MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVR 186
Query: 607 YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPR 665
++APE T D++SFGV+ E+ + P +S+ E L ++D
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVLKFVMDGG 238
Query: 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
N +++ +M + C +P+ RPT ++ LLK
Sbjct: 239 YLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 57/230 (24%), Positives = 104/230 (45%), Gaps = 40/230 (17%)
Query: 427 VYEEIIRVTNDFDDEHCIGKGGQGSV-YKAELPSGEIVAVKKFHSPLPSEMASQQEFLNE 485
V + I V + + D +G G G+V + +G VA+KK + P SE+ +++ + E
Sbjct: 6 VNKTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RE 64
Query: 486 VKTLTGIRHRNIV-------------KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAA 532
++ L ++H N++ +F+ F YL M + L
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPDLSLDRFHDF------------YLVMPFMGTDLGKLMKH 112
Query: 533 KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592
+ L + ++ ++ L Y+H I+HRD+ N+ ++ + E + DFG A+ +
Sbjct: 113 EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--Q 167
Query: 593 PDSSNWAELAG---TYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 638
DS E+ G T Y APE+ M T+ D++S G + E++ GK
Sbjct: 168 TDS----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 37/201 (18%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEF----LNEVK 487
R + FD IG+G G VYKA + +GE+VA+KK L +E ++ F + E+K
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR--LDNE---KEGFPITAIREIK 58
Query: 488 TLTGIRHRNIVKFY----------GFCSHARHSFIVYEYLE---MGSL--AMILSNDAAA 532
L + HRNIV F ++V+EY++ MG L ++ ++
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 533 KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592
K +K +++ L+Y H F +HRDI N+LL+ + + ++DFG A+
Sbjct: 119 KSF--------MKQLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 593 PDSSN-WAELAGTYGYVAPEL 612
+ S + T Y PEL
Sbjct: 168 SEESRPYTNKVITLWYRPPEL 188
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-11
Identities = 38/95 (40%), Positives = 49/95 (51%), Gaps = 1/95 (1%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
L +L + L NS G+IP +G + SL L+LS N GSIP SLG LT + L L N
Sbjct: 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500
Query: 62 ALSGAIPKEYGN-LVKLTLLTLENNQLRGPIPNLR 95
+LSG +P G L+ +N IP LR
Sbjct: 501 SLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLR 535
|
Length = 623 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 54/187 (28%), Positives = 90/187 (48%), Gaps = 30/187 (16%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQE-F----LNEVKTLTGIRHRNI 497
IG+G G V+KA + +IVA+KK M +++E F L E+K L ++H N+
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV------LMENEKEGFPITALREIKILQLLKHENV 73
Query: 498 VKFYGFC-------SHARHSF-IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD 549
V C + + SF +V+E+ E LA +LSN L K++ +K +++
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV--MKMLLN 130
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL----KPDSSNWAELAGTY 605
L Y+H I+HRD+ + N+L+ + ++DFG A+ + + T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 606 GYVAPEL 612
Y PEL
Sbjct: 188 WYRPPEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 7e-11
Identities = 38/111 (34%), Positives = 58/111 (52%), Gaps = 3/111 (2%)
Query: 151 LDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQL 210
L + + G +P +I L+ ++LS N I G +P LG ++SL L L+ N G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 211 SLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLH--YLNLSNNQFIKKIP 259
LG LT L L+L+ N LS +P +LG + LH N ++N + IP
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRL-LHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 7e-11
Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 49/220 (22%)
Query: 444 IGKGGQGSVYKAEL----PSGEIVAVKKFHSPLPSEMASQ--QEFLNEVKTLTGIRHRNI 497
+ K G+GS KA L G+ +K+ + S+M+ + +E EV L+ ++H NI
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINI---SKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD-------- 549
V++ + +IV +Y E G L K++N +GV+
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDL---------------YKKINAQRGVLFPEDQILDW 106
Query: 550 ------ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA- 602
AL ++H+ I+HRDI S+N+ L + + DFG A+ L ++ ELA
Sbjct: 107 FVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELAR 159
Query: 603 ---GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 639
GT Y++PE+ K D+++ G + E+ KH
Sbjct: 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKH 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 39/272 (14%)
Query: 444 IGKGGQGSVYKA-ELPSGE----IVAVKKFH---SPLPSEMASQQEFLNEVKTLTGIRHR 495
+G G G+VYK +P GE VA+K SP + +E L+E + G+
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP-----KANKEILDEAYVMAGVGSP 69
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKD-LGWTKRMNVIKGVVDALSYM 554
+ + G C + +V + + G L L KD +G +N + +SY+
Sbjct: 70 YVCRLLGICLTSTVQ-LVTQLMPYGCL---LDYVRENKDRIGSQDLLNWCVQIAKGMSYL 125
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY--GYVAPEL 612
+VHRD++++NVL+ N ++DFG A+ L D + + G ++A E
Sbjct: 126 EE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 613 AYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP--RLPTP 669
+ T + DV+S+GV E++ G P D I + + ++L+ RLP P
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---------IPDLLEKGERLPQP 233
Query: 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
D + + + C E RP +++
Sbjct: 234 PICTID----VYMIMVKCWMIDSECRPRFREL 261
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 57/204 (27%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 444 IGKGGQGSVYKA--ELPSGEI-VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
+G G G V K ++ +I VA+K + +E + + E + E + + + + IV+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
G C A +V E G L LS ++ + + ++ V + Y+ F
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEGKNF- 116
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW-AELAGTY--GYVAPELAYTMK 617
VHRD++++NVLL ++ A +SDFG +K L D S + A AG + + APE K
Sbjct: 117 --VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 618 VTEKCDVYSFGVLALEVIK-GKHP 640
+ + DV+S+G+ E G+ P
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 26/229 (11%)
Query: 428 YEEIIR-------VTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQ 480
YE+I+R D+D IG+G G V S + V K S S
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87
Query: 481 EFLNEVKTLTGIRHRN-IVKFYGFCSHARHSFIVYEYLEMGSLAMILSN-DAAAKDLGWT 538
F E + + + +V+ + ++ ++V EY+ G L ++SN D K W
Sbjct: 88 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK---WA 144
Query: 539 KRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW 598
K VV AL +H+ ++HRD+ N+LLD ++DFGT +K D +
Sbjct: 145 KFYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGM 197
Query: 599 AEL---AGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHP 640
GT Y++PE+ + +CD +S GV E++ G P
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 60/264 (22%), Positives = 113/264 (42%), Gaps = 36/264 (13%)
Query: 462 IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGS 521
+VAVK + + ++ +FL E+K ++ +++ NI++ G C ++ EY+E G
Sbjct: 46 LVAVKMLRADVTK--TARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 522 LAMILSND------AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD 575
L LS A ++ N++ V S M VHRD++++N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 576 LENEAHVSDFGTAKFLKPDSSNWAELAG----TYGYVAPELAYTMKVTEKCDVYSFGVLA 631
++DFG ++ L S ++ + G ++A E K T DV++FGV
Sbjct: 164 NHYTIKIADFGMSRNLY--SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 632 LEVIK--GKHPRDFISS---ISSS-----SSNLEIALNEMLDPRLPTPSHNVQDKLISIM 681
E+ + P +S I ++ + +I L++ P P+P +
Sbjct: 222 WEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQT--PLCPSP----------VF 269
Query: 682 EVAISCLDESPESRPTIQKVSQLL 705
++ + C + RPT K+ L
Sbjct: 270 KLMMRCWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 54/199 (27%), Positives = 85/199 (42%), Gaps = 8/199 (4%)
Query: 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLT-GIRHRNIVKFY 501
+GKG G V+ AEL + + A+K + + + E + L+ H + Y
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
+ F V EYL G L M DL + ++ L ++H+
Sbjct: 63 CTFQTKENLFFVMEYLNGGDL-MFHIQSCHKFDL--PRATFYAAEIICGLQFLHSK---G 116
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEK 621
IV+RD+ N+LLD + ++DFG K + GT Y+APE+ K
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTS 176
Query: 622 CDVYSFGVLALEVIKGKHP 640
D +SFGVL E++ G+ P
Sbjct: 177 VDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 12/201 (5%)
Query: 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF-Y 501
+GKGG G V ++ +G++ A KK + +Q LNE K L + R IV Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTK-RMNVIKG-VVDALSYMHNDCF 559
F + ++ + G L + N G+ + R ++ L ++H
Sbjct: 61 AFETKDDLCLVM-TLMNGGDLKYHIYNVGEP---GFPEARAIFYAAQIICGLEHLHQR-- 114
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVT 619
IV+RD+ +NVLLD +SD G A L AGT GY+APE+
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYD 172
Query: 620 EKCDVYSFGVLALEVIKGKHP 640
D ++ G E+I G+ P
Sbjct: 173 FSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 72/293 (24%), Positives = 124/293 (42%), Gaps = 53/293 (18%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGEI---VAVKKFHSPLPSEMASQ---QEFLNEVKTL 489
ND + IG+G G V KA + + A+K+ E AS+ ++F E++ L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASKDDHRDFAGELEVL 61
Query: 490 TGI-RHRNIVKFYGFCSHARHSFIVYEYLEMGSL------AMILSNDAA-------AKDL 535
+ H NI+ G C H + ++ EY G+L + +L D A A L
Sbjct: 62 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 536 GWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595
+ ++ V + Y+ F +HRD++++N+L+ A ++DFG ++
Sbjct: 122 SSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR------ 172
Query: 596 SNWAELAGTYG-----YVAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSIS 648
+ T G ++A E L Y++ T DV+S+GVL E++ G P
Sbjct: 173 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTP-------Y 224
Query: 649 SSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
+ E+ RL P N D++ +M C E P RP+ ++
Sbjct: 225 CGMTCAELYEKLPQGYRLEKPL-NCDDEVYDLMR---QCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 32/212 (15%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSP-----LPSEMASQQEFLNEVKTLTGIRHRNI 497
IG G G+VYKA + SG VA+K LP + L K L H NI
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALL---KRLEAFDHPNI 64
Query: 498 VKFYGFCSHARHS-----FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALS 552
V+ C+ +R +V+E+++ L L L ++++ + L
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDK-VPPPGLPAETIKDLMRQFLRGLD 122
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF------LKPDSSNWAELAGTYG 606
++H +C IVHRD+ +N+L+ + ++DFG A+ L P + T
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP-------VVVTLW 172
Query: 607 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 638
Y APE+ D++S G + E+ + K
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 444 IGKGGQGSVYKA-ELPSGEI----VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIV 498
+G G G+V+K +P G+ VA+K S + QE + + + + H IV
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 499 KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC 558
+ G C A +V + +GSL + + L + +N + + Y+
Sbjct: 73 RLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTM 616
+VHR+++++N+LL ++ ++DFG A L PD ++E ++A E
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 617 KVTEKCDVYSFGVLALEVIK-GKHP 640
+ T + DV+S+GV E++ G P
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEP 211
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR-----NI 497
+G+G G V K +P+G I+AVK+ + + S Q+ L ++ I R
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLD----ISMRSVDCPYT 62
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIK----GVVDALSY 553
V FYG +I E ++ SL D G T +++ +V AL Y
Sbjct: 63 VTFYGALFREGDVWICMEVMDT-SLDKFYKK---VYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL- 612
+H+ ++HRD+ NVL++ + + DFG + +L DS AG Y+APE
Sbjct: 119 LHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPERI 175
Query: 613 -------AYTMKVTEKCDVYSFGVLALEVIKGKHPRD 642
Y + K DV+S G+ +E+ G+ P D
Sbjct: 176 NPELNQKGYDV----KSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 65/270 (24%), Positives = 117/270 (43%), Gaps = 38/270 (14%)
Query: 444 IGKGGQGSVYKAELPS-GEIVAVKKF---HSPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
+GKG G V + G+ +KK ++ A++QE + L+ ++H NIV
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQE----AQLLSQLKHPNIVA 63
Query: 500 FYGFCSHARHS--------FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDAL 551
+ R S +IV + E G L L + K L + + + AL
Sbjct: 64 Y-------RESWEGEDGLLYIVMGFCEGGDLYHKL-KEQKGKLLPENQVVEWFVQIAMAL 115
Query: 552 SYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE 611
Y+H I+HRD+ ++NV L N V D G A+ L+ + L GT Y++PE
Sbjct: 116 QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172
Query: 612 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671
L K DV++ G E+ KH + ++ ++ + +++ +LP
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKH--------AFNAKDMNSLVYRIIEGKLPPMPK 224
Query: 672 NVQDKLISIMEVAISCLDESPESRPTIQKV 701
+ +L ++ + L + PE RP+++ +
Sbjct: 225 DYSPELGELIA---TMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (153), Expect = 2e-10
Identities = 58/233 (24%), Positives = 89/233 (38%), Gaps = 60/233 (25%)
Query: 438 FDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
++ IG G G V A +G VA+KK + + +++ L E+K L +RH N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-ILREIKLLRHLRHEN 60
Query: 497 IVKFYG-FCSHARHSF----IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD-- 549
I+ + F IV E +E DL VIK
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET--------------DLH-----KVIKSPQPLT 101
Query: 550 -------------ALSYMH--NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594
L Y+H N ++HRD+ N+L++ + + DFG A+ + PD
Sbjct: 102 DDHIQYFLYQILRGLKYLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156
Query: 595 SSNWAELAG---TYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKH 639
L T Y APEL YT + D++S G + E++ K
Sbjct: 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 57/230 (24%), Positives = 103/230 (44%), Gaps = 40/230 (17%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELP---SGE---IVAVKKFHSPLPSEMASQQEFLNEVKTL 489
N+ + IG+G G V++A P E +VAVK ++M Q +F E +
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALM 62
Query: 490 TGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL-------------SNDAAAK--- 533
H NIVK G C+ + +++EY+ G L L S +A K
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 534 ---DLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG---- 586
L T+++ + K V ++Y+ F VHRD++++N L+ ++DFG
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 587 --TAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 634
+A + K ++ + ++ PE + + T + DV+++GV+ E+
Sbjct: 180 IYSADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 72/290 (24%), Positives = 125/290 (43%), Gaps = 47/290 (16%)
Query: 437 DFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLT 490
D E IG+G G V +A + + I +K+F S ++F E++ L
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE-----NDHRDFAGELEVLC 57
Query: 491 GI-RHRNIVKFYGFCSHARHSFIVYEYLEMGSL------AMILSNDAA-AKDLGWTKRMN 542
+ H NI+ G C + + +I EY G+L + +L D A AK+ G +
Sbjct: 58 KLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117
Query: 543 ---VIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599
+++ D + M +HRD++++NVL+ + ++DFG ++
Sbjct: 118 SQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR------GEEV 171
Query: 600 ELAGTYG-----YVAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSS 652
+ T G ++A E L Y++ T K DV+SFGVL E++ G P + +
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTT-KSDVWSFGVLLWEIVSLGGTP-----YCGMTCA 225
Query: 653 NLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVS 702
L L + R+ P N D++ +M C + P RP ++S
Sbjct: 226 ELYEKLPQGY--RMEKPR-NCDDEVYELMR---QCWRDRPYERPPFAQIS 269
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 62/216 (28%), Positives = 92/216 (42%), Gaps = 32/216 (14%)
Query: 437 DFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
DF+ +G G G V A+ +GE A+K +M Q E L + H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 496 NIVKFY-GFCSHARHSFIVYEYLEMGSL------AMILSNDAA----AKDLGWTKRMNVI 544
IV F R + + E++ G L A ND A A+
Sbjct: 79 FIVNMMCSFQDENR-VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE----------- 126
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT 604
+V A Y+H+ I++RD+ +N+LLD + V+DFG AK + PD + L GT
Sbjct: 127 --LVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRT--FTLCGT 178
Query: 605 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
Y+APE+ + + D ++ GVL E I G P
Sbjct: 179 PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 24/213 (11%)
Query: 438 FDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
F +GKGG G V ++ +G++ A KK + + LNE + L + R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAK-------DLGWTKRMNVIKG--V 547
+V ++A YE + L + L N K + G+ + V +
Sbjct: 62 VVSL----AYA------YETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEI 111
Query: 548 VDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGY 607
L +H + IV+RD+ +N+LLD +SD G A + P+ GT GY
Sbjct: 112 CCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGY 167
Query: 608 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
+APE+ + T D ++ G L E+I G+ P
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 55/201 (27%), Positives = 89/201 (44%), Gaps = 13/201 (6%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF-Y 501
+GKG G V E SG+ A+K + L E + L RH + Y
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG--VVDALSYMHNDCF 559
F + R F++ EY+ G L LS + +++ G +V AL Y+H+
Sbjct: 63 SFQTKDRLCFVM-EYVNGGELFFHLSRERV-----FSEDRTRFYGAEIVSALDYLHSG-- 114
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVT 619
IV+RD+ +N++LD + ++DFG K D++ GT Y+APE+
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 620 EKCDVYSFGVLALEVIKGKHP 640
D + GV+ E++ G+ P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 73/297 (24%), Positives = 124/297 (41%), Gaps = 41/297 (13%)
Query: 426 IVYEEIIRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLN 484
I+++ ++ ++ IGKG G V+K +G AVK + + E+ N
Sbjct: 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEY-N 66
Query: 485 EVKTLTGIRHRNIVKFYGF-----CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTK 539
+K L+ H N+VKFYG + ++V E GS+ D L +
Sbjct: 67 ILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVT-----DLVKGFLKRGE 119
Query: 540 RMN------VIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593
RM ++ + L ++H + +HRD+ N+LL E + DFG + L
Sbjct: 120 RMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 176
Query: 594 DSSNWAELAGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIS 648
GT ++APE+ +CDV+S G+ A+E+ G P ++ +
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP---LADLH 233
Query: 649 SSSSNLEIALNEMLDPRLPTPSHNVQDKLIS--IMEVAISCLDESPESRPTIQKVSQ 703
+ +I PR P P+ + Q +L S + CL + E RPT+ + Q
Sbjct: 234 PMRALFKI-------PRNPPPTLH-QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 59/200 (29%), Positives = 89/200 (44%), Gaps = 10/200 (5%)
Query: 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+GKG G V AEL GE AVK + + E K + + N +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDV-VLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 503 FCSH--ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
+C+ H F V E+L G L M D DL + +V L ++H+
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDL-MFHIQDKGRFDL--YRATFYAAEIVCGLQFLHSK--- 115
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTE 620
I++RD+ NV+LD + ++DFG K + + GT Y+APE+ +K T
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175
Query: 621 KCDVYSFGVLALEVIKGKHP 640
D +SFGVL E++ G+ P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 34/223 (15%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+DF+ IG+G G V ++ E + K + ++ E L +T R
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMK--------ILNKWEMLKRAETACFREER 52
Query: 496 NIVK----------FYGFCSHARHSFIVYEYLEMGSLAMILSN--DAAAKDLGWTKRMNV 543
N++ Y F + ++V +Y G L +LS D +D+ R +
Sbjct: 53 NVLVNGDCQWITTLHYAF-QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA---RFYI 108
Query: 544 IKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA- 602
+ V+ A+ +H + VHRDI NVLLD+ ++DFG+ + D + + +A
Sbjct: 109 AEMVL-AIHSIHQLHY---VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV 164
Query: 603 GTYGYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHP 640
GT Y++PE+ M K +CD +S GV E++ G+ P
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 10/148 (6%)
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK-FLKPDSSNWAELAGTYGYV 608
AL+Y+H I++RD+ NVLLD E ++D+G K L+P + + GT Y+
Sbjct: 108 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTPNYI 163
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE-MLDPRLP 667
APE+ D ++ GVL E++ G+ P D + S + N E L + +L+ ++
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 223
Query: 668 TPSHNVQDKLISIMEVAISCLDESPESR 695
P ++ K S+++ S L++ P+ R
Sbjct: 224 IP-RSLSVKAASVLK---SFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 44/141 (31%), Positives = 63/141 (44%), Gaps = 10/141 (7%)
Query: 503 FCSHA--RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG-VVDALSYMHNDCF 559
FC+ H F V EYL G L M + D R ++ L ++H
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDL-MFHIQSSGRFDE---ARARFYAAEIICGLQFLHKK-- 115
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVT 619
I++RD+ NVLLD + ++DFG K + GT Y+APE+ K
Sbjct: 116 -GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN 174
Query: 620 EKCDVYSFGVLALEVIKGKHP 640
E D +SFGVL E++ G+ P
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 52/195 (26%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IG+G G VYKA +GE+VA+KK +E + E+ L + H NIVK
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA-IREISLLKELNHPNIVKLLD 66
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
++V+E+L + ++ + L K + + ++ L++ H+ +
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK--SYLFQLLQGLAFCHSH---RV 121
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAK-FLKPDSSNWAELAGTYGYVAPELAYTMKV-TE 620
+HRD+ +N+L++ E ++DFG A+ F P + E+ T Y APE+ K +
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYST 180
Query: 621 KCDVYSFGVLALEVI 635
D++S G + E++
Sbjct: 181 AVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 54/200 (27%), Positives = 86/200 (43%), Gaps = 10/200 (5%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF-Y 501
+GKG G V E +G A+K + L E + L RH + Y
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG-VVDALSYMHNDCFP 560
F +H R F++ EY G L LS + + R +V AL Y+H++
Sbjct: 63 SFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLHSE--K 115
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTE 620
+V+RD+ +N++LD + ++DFG K D + GT Y+APE+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175
Query: 621 KCDVYSFGVLALEVIKGKHP 640
D + GV+ E++ G+ P
Sbjct: 176 AVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 59/212 (27%), Positives = 90/212 (42%), Gaps = 17/212 (8%)
Query: 437 DFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
D++ IG+G G V S V K S S F E + + +
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 497 IVK--FYGFCSHARHSFIVYEYLEMGSLAMILSN-DAAAKDLGWTKRMNVIKGVVDALSY 553
V FY F R+ ++V EY+ G L ++SN D K W + VV AL
Sbjct: 104 WVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA--EVVLALDA 157
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA-GTYGYVAPEL 612
+H+ F +HRD+ N+LLD ++DFGT + + + A GT Y++PE+
Sbjct: 158 IHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 214
Query: 613 AYTMK----VTEKCDVYSFGVLALEVIKGKHP 640
+ +CD +S GV E++ G P
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFH-----SPLPSEMASQQEFLNEVKTLTGIRHRNI 497
IG+G G VYKA + + E +A+KK +PS + L E ++H NI
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKE------MQHGNI 63
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHND 557
V+ + ++V+EYL++ + S+ AK+ K + ++ ++Y H+
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIK--TYLYQILRGIAYCHSH 121
Query: 558 CFPPIVHRDISSKNVLLDLE-NEAHVSDFGTAK-FLKPDSSNWAELAGTYGYVAPEL--- 612
++HRD+ +N+L+D N ++DFG A+ F P + E+ T Y APE+
Sbjct: 122 ---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLG 177
Query: 613 --AYTMKVTEKCDVYSFGVLALEVIKGK 638
Y+ V D++S G + E++ K
Sbjct: 178 SRHYSTPV----DIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 61/232 (26%), Positives = 99/232 (42%), Gaps = 45/232 (19%)
Query: 438 FDDEHCIGKGGQGSVYKA---ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
++ E CIG+G G VYKA G+ A+KKF Q E+ L ++H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 495 RNIVKFYG-FCSHARHS-FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVV---- 548
N+V F HA S +++++Y E +I K KR+++ +V
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQII-------KFHRQAKRVSIPPSMVKSLL 114
Query: 549 ----DALSYMHNDCFPPIVHRDISSKNVLLDLENEAH----VSDFGTAKFLKPDSSNWAE 600
+ + Y+H++ ++HRD+ N+L+ E + D G A+ A+
Sbjct: 115 WQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 601 LAG---TYGYVAPELA-----YTMKVTEKCDVYSFG-----VLALEVI-KGK 638
L T Y APEL YT + D+++ G +L LE I KG+
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLEPIFKGR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 25/219 (11%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQE--FLNEVKTLTGI 492
DFD + +G+G G V E +G+I A+K S + +Q+ F E + + I
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKK---SVLLAQETVSFFEEERDILSI 57
Query: 493 RHRN-IVKF-YGFCSHARHSFIVYEYLEMGSLAMILS--NDAAAKDLGWTKRMNVIKGVV 548
+ I + Y F + ++V EY G L +L+ D +D+ + +V
Sbjct: 58 SNSPWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYLAELV 112
Query: 549 DALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAEL-AGTYGY 607
A+ +H + VHRDI +NVL+D ++DFG+A L + ++L GT Y
Sbjct: 113 LAIHSVHQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
Query: 608 VAPELAYTMKVTEK------CDVYSFGVLALEVIKGKHP 640
+APE+ TM K CD +S GV+A E+I G+ P
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 24/217 (11%)
Query: 437 DFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTGIR 493
DF+ IG+G G V +L + + V K + EM + E F E L
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW--EMLKRAETACFREERDVLVNGD 59
Query: 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSN--DAAAKDLG--WTKRMNVIKGVVD 549
++ I + + ++V +Y G L +LS D +D+ + M + +D
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVI---AID 116
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA-GTYGYV 608
++ +H VHRDI N+L+D+ ++DFG+ L D + + +A GT Y+
Sbjct: 117 SVHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 170
Query: 609 APELAYTM-----KVTEKCDVYSFGVLALEVIKGKHP 640
+PE+ M K +CD +S GV E++ G+ P
Sbjct: 171 SPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 63/310 (20%), Positives = 113/310 (36%), Gaps = 72/310 (23%)
Query: 443 CIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFL---NEVKTLTGIRHRNIVK 499
C + K + P+ +VAVKK + + S+++ E+ T ++H NI+
Sbjct: 9 CFEDLMIVHLAKHK-PTNTLVAVKKINL----DSCSKEDLKLLQQEIITSRQLQHPNILP 63
Query: 500 FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
+ ++V + GS +L + L ++K V++AL Y+H+ F
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKGF 122
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAK------------FLKPDSS----NWAELAG 603
+HR + + ++LL + + +S + P SS W
Sbjct: 123 ---IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL---- 175
Query: 604 TYGYVAPELAYT--MKVTEKCDVYSFGVLA-------------------LEVIKG--KHP 640
+PE+ EK D+YS G+ A LE ++G
Sbjct: 176 -----SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCL 230
Query: 641 RDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS-----IMEVAISCLDESPESR 695
D S+ ++ + + P + + S +E+ CL PESR
Sbjct: 231 LD-KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVEL---CLQRDPESR 286
Query: 696 PTIQKVSQLL 705
P+ SQLL
Sbjct: 287 PSA---SQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTG 491
+DF+ IG+G G V ++ +G++ A+K + EM + E F E L
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNK---WEMLKRAETACFREERDVLVN 57
Query: 492 IRHRNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSN--DAAAKDLGWTKRMNVIKGV- 547
R I Y F + ++V +Y G L +LS D +D+ R + + V
Sbjct: 58 GDRRWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA---RFYLAEMVL 113
Query: 548 -VDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA-GTY 605
+D++ + VHRDI NVLLD ++DFG+ L D + + +A GT
Sbjct: 114 AIDSVHQLG------YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTP 167
Query: 606 GYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHP 640
Y++PE+ M + +CD +S GV E++ G+ P
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 13/201 (6%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF-Y 501
+GKG G V E +G A+K + + E + L RH + Y
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG--VVDALSYMHNDCF 559
F +H R F V EY G L LS + +T+ G +V AL Y+H+
Sbjct: 63 AFQTHDRLCF-VMEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSR-- 114
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVT 619
+V+RDI +N++LD + ++DFG K D + GT Y+APE+
Sbjct: 115 -DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 620 EKCDVYSFGVLALEVIKGKHP 640
D + GV+ E++ G+ P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 56/223 (25%), Positives = 97/223 (43%), Gaps = 24/223 (10%)
Query: 423 EGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEI--VAVKKFHSPLPSEMASQQ 480
+ K+ YE DF+ +G G G V A + + VA+K+F +
Sbjct: 24 KNKMKYE-------DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76
Query: 481 EFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS-NDAAAKDLG--W 537
+E K L I H V YG + ++V E++ G L N D+G +
Sbjct: 77 HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY 136
Query: 538 TKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN 597
++ +I + +L+ IV+RD+ +N+LLD + ++DFG AK + +
Sbjct: 137 AAQIVLIFEYLQSLN---------IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT 187
Query: 598 WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
L GT Y+APE+ + + D ++ G+ E++ G P
Sbjct: 188 ---LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 7/200 (3%)
Query: 444 IGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF-Y 501
+GKGG G V ++ +G++ A KK + + + + E + L + R IV Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSN-DAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
F + +V + G L + N D + ++ L ++H
Sbjct: 61 AFQTKTDLC-LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTE 620
I++RD+ +NVLLD + +SD G A LK S AGT G++APEL +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176
Query: 621 KCDVYSFGVLALEVIKGKHP 640
D ++ GV E+I + P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G G GSV A + +G VAVKK P S + +++ + E++ L ++H N++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 503 FCSHARHSFIVYE--YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
+ AR S + YL + L+N + L +I ++ L Y+H+
Sbjct: 84 VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 139
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVT 619
I+HRD+ N+ ++ + E + DFG A+ + + + T Y APE+ M
Sbjct: 140 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYN 196
Query: 620 EKCDVYSFGVLALEVIKGK 638
+ D++S G + E++ G+
Sbjct: 197 QTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 58/221 (26%), Positives = 101/221 (45%), Gaps = 56/221 (25%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQE-----FLNEVKTLTGIRHRNI 497
IG+G G VYKA + +GEIVA+KK + ++ E + E+ L + H NI
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI------RLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN----------VIKG- 546
V+ ++V+E+L++ DL K M+ +IK
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDL--------------DL--KKYMDSSPLTGLDPPLIKSY 104
Query: 547 ---VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK-FLKPDSSNWAELA 602
++ ++Y H+ ++HRD+ +N+L+D E ++DFG A+ F P + E+
Sbjct: 105 LYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV 161
Query: 603 GTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 638
T Y APE+ Y+ V D++S G + E++ +
Sbjct: 162 -TLWYRAPEILLGSRQYSTPV----DIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 65/281 (23%), Positives = 113/281 (40%), Gaps = 44/281 (15%)
Query: 441 EHCIGKGGQGSVYKA--ELPSGE--IVAVKKFHSPLPSEMASQQE-FLNEVKTLTGIRHR 495
E +G G G + + +LPS VA+ + Q+ FL E TL H
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRA---GCSDKQRRGFLAEALTLGQFDHS 66
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
NIV+ G + IV EY+ G+L L L + M ++ G+ + Y+
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLS 124
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYG--YVAPE 611
+ VH+ +++ VL++ + +S F L+ D S + ++G + APE
Sbjct: 125 EMGY---VHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYTTMSGKSPVLWAAPE 178
Query: 612 LAYTMKVTEKCDVYSFGVLALEVIK-GKHP------RDFISSISSSSSNLEIALNEMLDP 664
+ DV+SFG++ EV+ G+ P +D I ++
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF------------- 225
Query: 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
RLP P + + L +M + C + RP ++ +L
Sbjct: 226 RLPAPRN-CPNLLHQLM---LDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 31/212 (14%)
Query: 146 PKLGTLDFSSNN------ITGSMPAEIIHSSQLKVLDLSSNHIVGEMP---SKLGKLSSL 196
P L L S N S+ + L+ LDLS N + + L + SSL
Sbjct: 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSL 110
Query: 197 IKLILNSNQLCGQ-LSLELGSLTQ----LERLDLSSNRLSNSIPKSLGNLV----KLHYL 247
+L LN+N L + L L L LE+L L NRL + ++L + L L
Sbjct: 111 QELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKEL 170
Query: 248 NLSNNQF----IKKIPVELEKLIHLSELDLSHNFLGEEMPSQIC----NMQSLEKLNLSH 299
NL+NN I+ + L+ +L LDL++N L +E S + +++SLE LNL
Sbjct: 171 NLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGD 230
Query: 300 NNLSG-----FIPSCFEELHGLSYIDISYNEL 326
NNL+ + L + +S N++
Sbjct: 231 NNLTDAGAAALASALLSPNISLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 74/301 (24%), Positives = 122/301 (40%), Gaps = 65/301 (21%)
Query: 444 IGKGGQGSVYKAELPSGE--------IVAVK--------KFHSPLPSEMASQQEFLNEVK 487
+G+G G V +AE + VAVK K + L SEM E+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM--------ELM 71
Query: 488 TLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS-------------NDAAAKD 534
L G +H+NI+ G C+ +++ EY G+L L +
Sbjct: 72 KLIG-KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 535 LGWTKRMNVIKGVVDALSYMHND-CFPPIVHRDISSKNVLLDLENEAHVSDFGTAK---- 589
L + ++ V + Y+ + C +HRD++++NVL+ +N ++DFG A+
Sbjct: 131 LSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHD 186
Query: 590 --FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISS 646
+ K S+ + ++APE + T + DV+SFG+L E+ G P I
Sbjct: 187 IDYYKKTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-- 240
Query: 647 ISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
L L E R+ PS N +L +M C P RPT +++ + L
Sbjct: 241 ---PVEELFKLLRE--GHRMDKPS-NCTHELYMLMR---ECWHAVPTQRPTFKQLVEALD 291
Query: 707 I 707
Sbjct: 292 K 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 21/214 (9%)
Query: 437 DFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
DFD IG+G G V S + V K S S F E + + + H N
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHAN 101
Query: 497 ---IVK-FYGFCSHARHSFIVYEYLEMGSLAMILSN-DAAAKDLGWTKRMNVIKGVVDAL 551
IV+ Y F ++ ++V EY+ G L ++SN D K W + VV AL
Sbjct: 102 SEWIVQLHYAF-QDDKYLYMVMEYMPGGDLVNLMSNYDIPEK---WARFY--TAEVVLAL 155
Query: 552 SYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA-GTYGYVAP 610
+H+ F +HRD+ N+LLD ++DFGT + + + A GT Y++P
Sbjct: 156 DAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISP 212
Query: 611 ELAYTMKVT----EKCDVYSFGVLALEVIKGKHP 640
E+ + +CD +S GV E++ G P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 61/282 (21%), Positives = 122/282 (43%), Gaps = 38/282 (13%)
Query: 444 IGKGGQGSVYKAELPSGEI-------VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
+G+G G VY+ + G + VA+K + + M + EFLNE + +
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 70
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMIL------SNDAAAKDLGWTKRMNVIKG-VVD 549
+V+ G S + + ++ E + G L L + + K+M + G + D
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT----Y 605
++Y++ + F VHRD++++N ++ + + DFG + + +++ G
Sbjct: 131 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 185
Query: 606 GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP 664
+++PE T DV+SFGV+ E+ + P +S+ E L +++
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQVLRFVMEG 237
Query: 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
L N D L +M + C +P+ RP+ ++ +K
Sbjct: 238 GLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 51/215 (23%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 438 FDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
F +GKGG G V ++ +G++ A K+ + + LNE + L + +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILS--NDAAAK-------DLGWTKRMNVIKG- 546
+V + Y Y +L ++L+ N K + G+ + +
Sbjct: 62 VVN------------LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 547 -VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY 605
++ L +H + V+RD+ +N+LLD +SD G A + P+ + GT
Sbjct: 110 EILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTV 165
Query: 606 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
GY+APE+ + T D + G L E+I+G+ P
Sbjct: 166 GYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 71/300 (23%), Positives = 127/300 (42%), Gaps = 42/300 (14%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAEL---PSGE---IVAVKKFHSPLPSEMASQQEFL 483
EI T F +E +G+ G VYK L GE VA+K +E ++EF
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK--AEGPLREEFK 56
Query: 484 NEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNV 543
+E + ++H NIV G + + +++ Y L L + D+G T
Sbjct: 57 HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 544 IKGVVDALSYMHNDC----------FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593
+K ++ ++H +VH+D++++NVL+ + +SD G F +
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL--FREV 174
Query: 594 DSSNWAELAGT----YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSIS 648
++++ +L G +++PE K + D++S+GV+ EV G P
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-------Y 227
Query: 649 SSSSNLEIALNEMLDPR--LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
SN ++ EM+ R LP P D + + + C +E P RP + + L+
Sbjct: 228 CGYSNQDVI--EMIRNRQVLPCPD----DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 31/95 (32%), Positives = 46/95 (48%), Gaps = 1/95 (1%)
Query: 29 LSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLR 88
+ L L L G IP+ + L + + L N++ G IP G++ L +L L N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 89 GPIP-NLRNLTSLVRVRLNQNHLTGNISESFGIHP 122
G IP +L LTSL + LN N L+G + + G
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 52/198 (26%), Positives = 92/198 (46%), Gaps = 10/198 (5%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G G GSV A + + VAVKK P S + +++ + E++ L ++H N++
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGLLD 81
Query: 503 FCSHARHSFIVYE-YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
+ A E YL + L+N + L +I ++ L Y+H+
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS---AG 138
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTE 620
I+HRD+ NV ++ + E + DFG A+ + + + T Y APE+ M +
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY---VATRWYRAPEIMLNWMHYNQ 195
Query: 621 KCDVYSFGVLALEVIKGK 638
D++S G + E++KGK
Sbjct: 196 TVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 55/243 (22%), Positives = 99/243 (40%), Gaps = 44/243 (18%)
Query: 474 SEMASQQEFLNEVKTLTGIRHRNIVKF--------YGFCSHARHSFIVYEYLEMGSLAMI 525
S A Q E NE+ L + H NI+K + ++ F +Y ++ +
Sbjct: 204 SRAAIQLE--NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF--- 258
Query: 526 LSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585
D + L R ++K ++ A+ Y+H+ ++HRDI +N+ L+ + + + DF
Sbjct: 259 ---DWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDF 311
Query: 586 GTA-KFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-------- 636
GTA F K + GT +PE+ E D++S G++ L+++
Sbjct: 312 GTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371
Query: 637 -GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESR 695
G P + I S S + D P P + D + S + +D + S
Sbjct: 372 GGGKPGKQLLKIIDSLS--------VCDEEFPDPPCKLFDYIDS------AEIDHAGHSV 417
Query: 696 PTI 698
P +
Sbjct: 418 PPL 420
|
Length = 501 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 18/204 (8%)
Query: 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQE----FLNEVKTL-TGIRHRNI 497
+GKG G V AEL + E+ AVK L ++ Q + + E + L +H +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKV----LKKDVILQDDDVECTMTEKRVLALAGKHPFL 58
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG-VVDALSYMHN 556
+ + F V EY+ G L + + R +V L ++H
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE----PRARFYAAEIVLGLQFLHE 114
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTM 616
I++RD+ NVLLD E ++DFG K + GT Y+APE+
Sbjct: 115 R---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 617 KVTEKCDVYSFGVLALEVIKGKHP 640
D ++ GVL E++ G+ P
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 48/199 (24%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G+G +VYK +GEIVA+K+ H L +E + + E+ + ++H NIV+ +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIH--LDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 503 FCSHARHSFIVYEYLEMGSLA--MILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
+V+EY++ L M A D K + ++ +++ H +
Sbjct: 66 VIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVK--SFTYQLLKGIAFCHEN--- 119
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKV-T 619
++HRD+ +N+L++ E ++DFG A+ + ++ T Y AP++ + +
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYS 179
Query: 620 EKCDVYSFGVLALEVIKGK 638
D++S G + E+I G+
Sbjct: 180 TSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 45/289 (15%)
Query: 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQ--EFLNEVKTLTGIRHRNIV 498
E GK +G +Y + ++VA+K L QQ EF E + + H NIV
Sbjct: 15 ECAFGKIYKGHLYLPGMDHAQLVAIKT----LKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 499 KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN-VIKGVVD-------- 549
G + + +++EYL G L L + D+G + + +K +D
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 550 -----ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT 604
+ Y+ + F VH+D++++N+L+ + +SD G ++ + S+++ +
Sbjct: 131 IQIAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIY--SADYYRVQPK 185
Query: 605 ----YGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALN 659
++ PE K + D++SFGV+ E+ G P SN E+
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP-------YYGFSNQEVI-- 236
Query: 660 EMLDPR--LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
EM+ R LP + ++ S+M C E P RP + + L+
Sbjct: 237 EMVRKRQLLPCS-EDCPPRMYSLM---TECWQEGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 74/283 (26%), Positives = 111/283 (39%), Gaps = 37/283 (13%)
Query: 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
ND ++ IG G G VYK +G ++AVK+ E + L ++ + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--ENKRILMDLDVVL-KSH 71
Query: 495 R--NIVKFYGFCSHARHSFIVYEYLEM--GSLAMILSNDAAAKDLGWTKRMNVIKGVVDA 550
IVK YG+ FI E + L + LG +M V +V A
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG---KMTV--AIVKA 126
Query: 551 LSYM---HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGY 607
L Y+ H ++HRD+ N+LLD + DFG + L DS AG Y
Sbjct: 127 LHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLV-DSKAKTRSAGCAAY 180
Query: 608 VAPELAYTMKVTEK----CDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD 663
+APE K DV+S G+ +E+ G+ P + + L L E +
Sbjct: 181 MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK---NCKTEFEVLTKILQE--E 235
Query: 664 PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
P P+ S ++ CL + RP K +LL+
Sbjct: 236 PPSLPPNEGFSPDFCSFVD---LCLTKDHRKRP---KYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 48/225 (21%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFH-SPLPSEMASQQEF----------LNEVKTLTG 491
+G+G G V KA +G+IVA+KK + +++ ++ L E+K +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 492 IRHRNIVKFYG-FCSHARHSFI--VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVV 548
I+H NI+ + FI V + + L ++ + ++ ++ ++
Sbjct: 77 IKHENIMGLVDVYVEG---DFINLVMDIMA-SDLKKVVDRKIRLTE---SQVKCILLQIL 129
Query: 549 DALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK-----FLKPDSSNWAELAG 603
+ L+ +H + +HRD+S N+ ++ + ++DFG A+ S +
Sbjct: 130 NGLNVLHK-WY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 604 ---------TYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGK 638
T Y APEL K D++S G + E++ GK
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 64/262 (24%), Positives = 108/262 (41%), Gaps = 47/262 (17%)
Query: 464 AVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLA 523
A +K S L SEM E+ + G +H+NI+ G C+ +++ EY G+L
Sbjct: 59 ATEKDLSDLVSEM--------EMMKMIG-KHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 524 MILS-------------NDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSK 570
L + + + ++ V + Y+ + +HRD++++
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR 166
Query: 571 NVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG------YVAPELAYTMKVTEKCDV 624
NVL+ N ++DFG A+ D +N T ++APE + T + DV
Sbjct: 167 NVLVTENNVMKIADFGLAR----DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222
Query: 625 YSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEV 683
+SFGVL E+ G P I L L E R+ P+ N ++L +M
Sbjct: 223 WSFGVLMWEIFTLGGSPYPGI-----PVEELFKLLKE--GHRMDKPA-NCTNELYMMMR- 273
Query: 684 AISCLDESPESRPTIQKVSQLL 705
C P RPT +++ + L
Sbjct: 274 --DCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 69/284 (24%), Positives = 123/284 (43%), Gaps = 41/284 (14%)
Query: 444 IGKGGQGSVYKAELPSG---EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
IG G G V E+ SG V VK+ + + Q +FL E + ++H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVS--ASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAK----DLGWTKRMNVIKGVVDALSYMHN 556
G C+ +V E+ +G L L + A+ D +RM + L ++H
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHLHK 118
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK-------FLKPDSSNWAELAGTYGYVA 609
+ F +H D++ +N LL + + D+G + ++ PD W L ++A
Sbjct: 119 NNF---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL-WVPLR----WIA 170
Query: 610 PELA-------YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEM 661
PEL + T++ +V+S GV E+ + G P +S + + ++
Sbjct: 171 PELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL 230
Query: 662 LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
PRL P + D+ +M+ C + PE RP+ ++V LL
Sbjct: 231 PKPRLKLP---LSDRWYEVMQ---FCWLQ-PEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 59/265 (22%), Positives = 105/265 (39%), Gaps = 27/265 (10%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503
I + Q S+YK + + V ++ F NE+K L I NI+K YGF
Sbjct: 28 IKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86
Query: 504 ----CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
++ EY G L +L + KDL + ++++ L ++
Sbjct: 87 IIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN 143
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK-PDSSNWAELAGTYGYVAPELAYTM-- 616
P +++++S + L+ + + G K L P N + Y + ++ +
Sbjct: 144 KP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFS 197
Query: 617 KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDK 676
+ T K D+YS GV+ E+ GK P F + + +L I N L +LP
Sbjct: 198 EYTIKDDIYSLGVVLWEIFTGKIP--FENLTTKEIYDLIINKNNSL--KLPLDCPLE--- 250
Query: 677 LISIMEVAISCLDESPESRPTIQKV 701
I + +C RP I+++
Sbjct: 251 ---IKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 12/201 (5%)
Query: 444 IGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+GKGG G V ++ +G++ A KK + + LNE + L + R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 503 FCSHARHSF-IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG--VVDALSYMHNDCF 559
+ + + +V + G L + N + G+ ++ + + L + +
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYN---MGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVT 619
IV+RD+ +N+LLD +SD G A + P+ GT GY+APE+ K T
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVINNEKYT 179
Query: 620 EKCDVYSFGVLALEVIKGKHP 640
D + G L E+I+G+ P
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 5e-08
Identities = 22/60 (36%), Positives = 31/60 (51%)
Query: 267 HLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326
+L LDLS+N L + +L+ L+LS NNL+ P F L L +D+S N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 36/156 (23%), Positives = 68/156 (43%), Gaps = 18/156 (11%)
Query: 543 VIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA 602
+ K +++ L Y+H I+HRD+ ++N+ ++ ++ + D G A+F + + LA
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLA 217
Query: 603 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML 662
GT APE+ K K D++S G++ E++ +P S+ +
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML--AYPSTIFEDPPSTPEEYVKS----- 270
Query: 663 DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTI 698
H+ K+IS ++V P SR
Sbjct: 271 -------CHSHLLKIISTLKVHPEEFPRDPGSRLVR 299
|
Length = 357 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 29/278 (10%)
Query: 444 IGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
+GKG GSV +A+L S + VAVK + + S + +EFL E + H N++K
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIK 65
Query: 500 FYGFCSHARHS------FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
G +R ++ +++ G L L ++ +++ ++D S
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT----YGYVA 609
M +HRD++++N +L+ V+DFG +K K S ++ ++A
Sbjct: 126 MEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK--KIYSGDYYRQGCASKLPVKWLA 183
Query: 610 PELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668
E T DV++FGV E++ +G+ P + N EI + RL
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV-------ENSEIYNYLIKGNRLKQ 236
Query: 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
P ++D + E+ C P+ RP+ Q + L+
Sbjct: 237 PPDCLED----VYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 9/208 (4%)
Query: 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF-Y 501
+GKGG G V ++ +G++ A KK + + ++ L E + L + IV Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
F S H +V + G L + N + L + ++ + + ++H+
Sbjct: 61 AFESKT-HLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MD 115
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEK 621
IV+RD+ +NVLLD + +SD G A L D + AGT GY+APE+ +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 622 CDVYSFGVLALEVIKGKHP-RDFISSIS 648
D ++ G E++ G+ P +D ++
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFKDHKEKVA 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 6e-08
Identities = 71/285 (24%), Positives = 118/285 (41%), Gaps = 44/285 (15%)
Query: 444 IGKGGQGSVYKAEL---PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
IG G G V +E+ V VK+ + S+ Q EFL + ++H NI++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSK--EQNEFLQQGDPYRILQHPNILQC 60
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAK---DLGWTKRMNVIKGVVDALSYMHND 557
G C A +V+EY E+G L LS + + L +RM + +++MH
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC--EIAAGVTHMHKH 118
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTA------KFLKPDSSNWAELAGTYGYVAPE 611
F +H D++ +N L + V D+G +++ + L ++APE
Sbjct: 119 NF---LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR----WLAPE 171
Query: 612 LA-------YTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEML- 662
L T + T+ +V++ GV E+ + P S S+ E+ LN ++
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP-------YSHLSDREV-LNHVIK 223
Query: 663 --DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
+L P EV C SPE R T ++V +LL
Sbjct: 224 DQQVKLFKP-QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 57/258 (22%), Positives = 114/258 (44%), Gaps = 25/258 (9%)
Query: 462 IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGS 521
+VAVK + ++ +FL E+K ++ ++ NI++ C + ++ EY+E G
Sbjct: 48 LVAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 522 LAMILSN--------DAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVL 573
L LS A + ++ + + + + Y+ + F VHRD++++N L
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRNCL 162
Query: 574 LDLENEAHVSDFGTAKFLKPDSSNWAELAG----TYGYVAPELAYTMKVTEKCDVYSFGV 629
+ ++DFG ++ L S ++ + G +++ E K T DV++FGV
Sbjct: 163 VGKNYTIKIADFGMSRNLY--SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220
Query: 630 LALEVIK--GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISC 687
E++ + P +S + E ++ LP P+ D L +M +SC
Sbjct: 221 TLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPAL-CPDSLYKLM---LSC 276
Query: 688 LDESPESRPTIQKVSQLL 705
+ + RP+ Q++ L
Sbjct: 277 WRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 39/148 (26%), Positives = 72/148 (48%), Gaps = 15/148 (10%)
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY---GYVAPELAYTMKVT 619
VHRD++++NVLL + DFG A+ + D SN+ T+ ++APE + T
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHD-SNYVSKGSTFLPVKWMAPESIFDNLYT 317
Query: 620 EKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLI 678
DV+S+G+L E+ G P + S+ + ++ R+ P H Q+
Sbjct: 318 TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGY------RMAKPDHATQE--- 368
Query: 679 SIMEVAISCLDESPESRPTIQKVSQLLK 706
+ ++ + C + PE RP+ +S +++
Sbjct: 369 -VYDIMVKCWNSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 57/206 (27%), Positives = 84/206 (40%), Gaps = 21/206 (10%)
Query: 444 IGKGGQGSVYKAEL-PSGEIVAVKKF-------HSPLPSEMASQQEFLNEVKTLTGIRHR 495
+G+G G V AE +GE+ A+K + S M ++ F T RH
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFE----TANSERHP 62
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG-VVDALSYM 554
+V + H V EY G L M + D + R VV L Y+
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-----EPRAVFYAACVVLGLQYL 117
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
H + IV+RD+ N+LLD E ++DFG K + GT ++APE+
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHP 640
T D + GVL E++ G+ P
Sbjct: 175 ETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 66/277 (23%), Positives = 115/277 (41%), Gaps = 28/277 (10%)
Query: 444 IGKGGQGSVYKAELPSGEI---VAVKKFHSPL--PSEMASQQEFLNEVKTLTGIRHRNIV 498
+G+G GSV + +L + VAVK + SEM ++FL+E + H N++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM---EDFLSEAVCMKEFDHPNVM 63
Query: 499 KFYGFC--SHARHSF----IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALS 552
+ G C + + ++ +++ G L L + ++K + D S
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG-TAKFLKPDSSNWAELAGT-YGYVAP 610
M +HRD++++N +L+ V+DFG + K D +A ++A
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 611 ELAYTMKVTEKCDVYSFGVLALEV-IKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669
E T K DV+SFGV E+ +G+ P + N EI RL P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV-------ENSEIYDYLRQGNRLKQP 236
Query: 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
D L + + SC +P+ RP+ + + L+
Sbjct: 237 P----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 61/250 (24%), Positives = 104/250 (41%), Gaps = 43/250 (17%)
Query: 474 SEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL----------A 523
S++ S+ E + + +H+NI+ G C+ +++ EY G+L
Sbjct: 62 SDLVSEMEMMKMIG-----KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPG 116
Query: 524 MILSNDAAA---KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEA 580
M S D + L + ++ V + Y+ + +HRD++++NVL+ +N
Sbjct: 117 MDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVM 173
Query: 581 HVSDFGTAKFLKPDSSNWAELAGTYG------YVAPELAYTMKVTEKCDVYSFGVLALEV 634
++DFG A+ D N T ++APE + T + DV+SFGVL E+
Sbjct: 174 KIADFGLAR----DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
Query: 635 IK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPE 693
G P I L L E R+ P+ N +L IM C P
Sbjct: 230 FTLGGSPYPGI-----PVEELFKLLKE--GHRMDKPA-NCTHELYMIMR---ECWHAVPS 278
Query: 694 SRPTIQKVSQ 703
RPT +++ +
Sbjct: 279 QRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 28/209 (13%)
Query: 444 IGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+GKGG G V ++ +G++ A KK + + LNE + L + R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS--- 64
Query: 503 FCSHARHSFIVYEYLEMGSLAMILS--NDAAAK-------DLGWTKRMNVIKG--VVDAL 551
+ Y Y +L ++L+ N K + G+ + V + L
Sbjct: 65 ---------LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGL 115
Query: 552 SYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE 611
+H + IV+RD+ +N+LLD +SD G A + P+ GT GY+APE
Sbjct: 116 EDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRVGTVGYMAPE 171
Query: 612 LAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
+ + T D + G L E+I+GK P
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 9e-08
Identities = 73/290 (25%), Positives = 124/290 (42%), Gaps = 55/290 (18%)
Query: 444 IGKGGQGSVYKAEL--PSGEI--VAVK--KFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
+G+G GSV + +L G VAVK K SE+ +EFL+E + H N+
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEI---EEFLSEAACMKDFDHPNV 63
Query: 498 VKFYGFC--SHARHSF----IVYEYLEMGSL-AMILSNDAAAKDLGWTKRMNVIKGVVD- 549
+K G C + + ++ +++ G L + +L + + ++K +VD
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT-LLKFMVDI 122
Query: 550 --ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY-- 605
+ Y+ N F +HRD++++N +L + V+DFG +K + +G Y
Sbjct: 123 ALGMEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSKKI---------YSGDYYR 170
Query: 606 ---------GYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLE 655
++A E T K DV++FGV E+ +G+ P + N E
Sbjct: 171 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV-------ENHE 223
Query: 656 IALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
I RL P D+L +M SC P+ RPT K+ ++L
Sbjct: 224 IYDYLRHGNRLKQPED-CLDELYDLM---YSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 9e-08
Identities = 53/205 (25%), Positives = 87/205 (42%), Gaps = 20/205 (9%)
Query: 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFY 501
+GKG G V A L SG + AVK + + + + E + L+ R H + + Y
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG------VVDALSYMH 555
F V E++ G L + ++R + + + AL ++H
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQK---------SRRFDEARARFYAAEITSALMFLH 113
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT 615
+ I++RD+ NVLLD E ++DFG K + + GT Y+APE+
Sbjct: 114 DK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE 170
Query: 616 MKVTEKCDVYSFGVLALEVIKGKHP 640
M D ++ GVL E++ G P
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 3/91 (3%)
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVA 609
AL ++H+ I++RD+ +N+LLD E ++DFG +K GT Y+A
Sbjct: 110 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 166
Query: 610 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
PE+ T+ D +SFGVL E++ G P
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 443 CIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFY 501
IG+G G V A + E VA+KK + + + +++ L E+K L + H N++
Sbjct: 12 PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIK 70
Query: 502 GFCS-HARHSF----IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
R +F IVYE ++ +I S+ + D +++G L Y+H+
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRG----LKYIHS 126
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL---- 612
++HRD+ N+LL+ + + DFG A+ E T Y APEL
Sbjct: 127 ---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNC 183
Query: 613 -AYTMKVTEKCDVYSFGVLALEVIKGK 638
YT + DV+S G + E++ K
Sbjct: 184 SEYTTAI----DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 9e-08
Identities = 44/146 (30%), Positives = 68/146 (46%), Gaps = 21/146 (14%)
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVT 619
++HRDI S N+LL + DFG +K S+ GT YVAPE+ +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 620 EKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML----DPRLPTPSHNVQD 675
+K D++S GVL E++ K P D N+E +++ L DP P+ S +Q
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD--------GENMEEVMHKTLAGRYDPLPPSISPEMQ- 274
Query: 676 KLISIMEVAISCLDESPESRPTIQKV 701
E+ + L P+ RP+ K+
Sbjct: 275 ------EIVTALLSSDPKRRPSSSKL 294
|
Length = 496 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 36/116 (31%), Positives = 55/116 (47%), Gaps = 31/116 (26%)
Query: 80 LTLENNQLRGPIPN----LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFY 135
L L+N LRG IPN LR+L S+ L+ N + GNI S G +L +DLS+N
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSI---NLSGNSIRGNIPPSLGSITSLEVLDLSYN--- 476
Query: 136 GEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLG 191
+ GS+P + + L++L+L+ N + G +P+ LG
Sbjct: 477 ---------------------SFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 19/150 (12%)
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW-----AELAGTYGYVAPELAYTMK 617
+HRD++++NVLL A + DFG A+ + D SN+ A L ++APE +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMND-SNYVVKGNARLP--VKWMAPESIFDCV 290
Query: 618 VTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDK 676
T + DV+S+G+L E+ GK P I ++S + +M P P +
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPYPGI-LVNSKFYKMVKRGYQMSRPDFAPP------E 343
Query: 677 LISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ SIM+ C + P RPT ++SQL++
Sbjct: 344 IYSIMK---MCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 5/107 (4%)
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK-FLKPDSSNWAELAGTYGYV 608
AL+++H I++RD+ NVLLD E ++D+G K ++P + + GT Y+
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT-STFCGTPNYI 163
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE 655
APE+ D ++ GVL E++ G+ P D + + N E
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTE 210
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 42/153 (27%), Positives = 68/153 (44%), Gaps = 27/153 (17%)
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAK--FLKPDSSNWAELAGTYGYVAPELAYTMKVTE 620
+HRD++++N+LL N + DFG A+ + PD + ++APE + T
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254
Query: 621 KCDVYSFGVLALEVIK-GKHP-------RDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672
+ DV+SFGVL E+ G P +F + + M P TP
Sbjct: 255 QSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT--------RMRAPEYATPE-- 304
Query: 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
+ SIM + C +PE RPT ++ ++L
Sbjct: 305 ----IYSIM---LDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 65/282 (23%), Positives = 115/282 (40%), Gaps = 45/282 (15%)
Query: 444 IGKGGQGSVYKAELPSG--EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKF 500
IG+G G V KA + + A K S+ ++F E++ L + H NI+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINL 61
Query: 501 YGFCSHARHSFIVYEYLEMGSL------AMILSNDAA-AKDLGWTKRMN---VIKGVVDA 550
G C H + ++ EY G+L + +L D A A ++ ++ D
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG---- 606
M +HRD++++N+L+ A ++DFG ++ + T G
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR------GQEVYVKKTMGRLPV 175
Query: 607 -YVAPE-LAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNE--- 660
++A E L Y++ T DV+S+GVL E++ G P + + L L +
Sbjct: 176 RWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTP-----YCGMTCAELYEKLPQGYR 229
Query: 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVS 702
+ P N D++ +M C E P RP+ ++
Sbjct: 230 LEKPL------NCDDEVYDLMR---QCWREKPYERPSFAQIL 262
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 444 IGKGGQGSVY---KAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN---- 496
IG+GG G VY KA+ +G++ A+K + LNE L+ + +
Sbjct: 2 IGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG-VVDALSYMH 555
+ Y F + + SFI+ + + G L LS + M ++ L +MH
Sbjct: 60 VCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSE----AEMRFYAAEIILGLEHMH 114
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA---KFLKPDSSNWAELAGTYGYVAPE- 611
N +V+RD+ N+LLD +SD G A KP +S GT+GY+APE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEV 166
Query: 612 LAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
L + D +S G + ++++G P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 39/153 (25%), Positives = 64/153 (41%), Gaps = 27/153 (17%)
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAK--FLKPDSSNWAELAGTYGYVAPELAYTMKVTE 620
+HRD++++N+LL N + DFG A+ + PD ++APE + T
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255
Query: 621 KCDVYSFGVLALEVIK-GKHP-------RDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672
+ DV+SFGVL E+ G P +F + + M P TP
Sbjct: 256 QSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT--------RMRAPENATP--- 304
Query: 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
I + ++C P+ RPT + ++L
Sbjct: 305 ------EIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 63/223 (28%), Positives = 97/223 (43%), Gaps = 26/223 (11%)
Query: 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSP-LPSEMASQQEFLNEVKTLTGIR 493
DF+ I G G+VY + + A+KK + L QQ F+ E LT
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAE 59
Query: 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAK-DLGWTKRMNVIKGVVDALS 552
+ +V + RH +V EY+E G A +L N A D+ RM + V+ AL
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA---RMYFAETVL-ALE 115
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF-LKPDSSNWAE----------- 600
Y+HN IVHRD+ N+L+ ++DFG +K L ++N E
Sbjct: 116 YLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 601 ---LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
+ GT Y+APE+ + D ++ G++ E + G P
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 29/210 (13%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFY 501
+GKG G V+KA + + E+VA+KK + +Q+ F E+ L + H NIVK
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIVKLL 73
Query: 502 GF--CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
+ + ++V+EY+E A+I +N +D+ KR ++ ++ AL Y+H+
Sbjct: 74 NVIKAENDKDIYLVFEYMETDLHAVIRAN--ILEDV--HKRY-IMYQLLKALKYIHSG-- 126
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVA------PEL- 612
++HRD+ N+LL+ + ++DFG A+ L N T YVA PE+
Sbjct: 127 -NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD-YVATRWYRAPEIL 184
Query: 613 ----AYTMKVTEKCDVYSFGVLALEVIKGK 638
YT V D++S G + E++ GK
Sbjct: 185 LGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 27/81 (33%), Positives = 42/81 (51%)
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEK 621
I++RD+ NV+LD E ++DFG K D GT Y+APE+ +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 181
Query: 622 CDVYSFGVLALEVIKGKHPRD 642
D ++FGVL E++ G+ P +
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 47/218 (21%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFH-----SPLPSEMASQQEFLNEVKTLTGIRHRNI 497
IG+G G+V+KA + EIVA+K+ +PS L E+ L ++H+NI
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA------LREICLLKELKHKNI 61
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDA------- 550
V+ Y + +V+EY + +DL K + G +D
Sbjct: 62 VRLYDVLHSDKKLTLVFEYCD--------------QDL--KKYFDSCNGDIDPEIVKSFM 105
Query: 551 ------LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK-FLKPDSSNWAELAG 603
L++ H+ ++HRD+ +N+L++ E ++DFG A+ F P AE+
Sbjct: 106 FQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV- 161
Query: 604 TYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHP 640
T Y P++ + K+ + D++S G + E+ P
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK-FLKPDSSNWAELAGTYGYV 608
AL+++H I++RD+ NVLLD + ++D+G K L P + + GT Y+
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT-STFCGTPNYI 163
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS 645
APE+ + D ++ GVL E++ G+ P D I+
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 444 IGKGGQGSVY---KAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN---- 496
IG+GG G VY KA+ +G++ A+K + LNE L+ + +
Sbjct: 2 IGRGGFGEVYGCRKAD--TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG-VVDALSYMH 555
+ Y F + + FI+ + + G L LS + K M ++ L +MH
Sbjct: 60 VCMTYAFHTPDKLCFIL-DLMNGGDLHYHLSQHGVFSE----KEMRFYATEIILGLEHMH 114
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA---KFLKPDSSNWAELAGTYGYVAPE- 611
N +V+RD+ N+LLD +SD G A KP +S GT+GY+APE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEV 166
Query: 612 LAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
L D +S G + ++++G P
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 41/201 (20%)
Query: 462 IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGS 521
+VAVK P ++ A + +FL EVK L+ ++ NI++ G C ++ EY+E G
Sbjct: 48 LVAVKILR-PDANKNA-RNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 522 LAMILS-----------NDAAAKD-----LGWTKRMNVIKGVVDALSYMHNDCFPPIVHR 565
L LS NDA + ++ ++V + + Y+ + F VHR
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF---VHR 162
Query: 566 DISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY-----------GYVAPELAY 614
D++++N L+ ++DFG ++ L AG Y ++A E
Sbjct: 163 DLATRNCLVGENLTIKIADFGMSRNL---------YAGDYYRIQGRAVLPIRWMAWECIL 213
Query: 615 TMKVTEKCDVYSFGVLALEVI 635
K T DV++FGV E++
Sbjct: 214 MGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 27/81 (33%), Positives = 42/81 (51%)
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEK 621
I++RD+ NV+LD E ++DFG K D GT Y+APE+ +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKS 181
Query: 622 CDVYSFGVLALEVIKGKHPRD 642
D +++GVL E++ G+ P D
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 62/264 (23%), Positives = 113/264 (42%), Gaps = 41/264 (15%)
Query: 463 VAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYLEMGS 521
VAVK S + S + ++E++ + I +H+NI+ G C+ +++ EY G+
Sbjct: 53 VAVKMLKSDATEKDLS--DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 522 LAMILS-------------NDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDIS 568
L L + L + ++ V + Y+ + +HRD++
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLA 167
Query: 569 SKNVLLDLENEAHVSDFGTAK------FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKC 622
++NVL+ +N ++DFG A+ + K ++ + ++APE + T +
Sbjct: 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQS 223
Query: 623 DVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIM 681
DV+SFGVL E+ G P + L L E R+ PS N ++L +M
Sbjct: 224 DVWSFGVLLWEIFTLGGSPYPGV-----PVEELFKLLKE--GHRMDKPS-NCTNELYMMM 275
Query: 682 EVAISCLDESPESRPTIQKVSQLL 705
C P RPT +++ + L
Sbjct: 276 R---DCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 46/203 (22%), Positives = 94/203 (46%), Gaps = 22/203 (10%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IG G QG V A + G VAVKK P ++ +++ + E+ L + H+NI+
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLN 87
Query: 503 FCSHAR------HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
+ + ++V E ++ +L ++ + + + + ++ ++ + ++H+
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHERMSY-----LLYQMLCGIKHLHS 141
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW--AELAGTYGYVAPELAY 614
I+HRD+ N+++ + + DFG A+ +N+ T Y APE+
Sbjct: 142 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPEVIL 195
Query: 615 TMKVTEKCDVYSFGVLALEVIKG 637
M E D++S G + E++KG
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQE----FLNEVKTLT-GIRHRNI 497
+GKG G V AEL + E+ A+K L ++ Q + + E + L +H +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKV----LKKDVILQDDDVDCTMTEKRILALAAKHPFL 58
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHND 557
+ F V EY+ G L + ++ + V AL ++H
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRH 115
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMK 617
+++RD+ N+LLD E ++DFG K + GT Y+APE+ ++
Sbjct: 116 ---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE 172
Query: 618 VTEKCDVYSFGVLALEVIKGKHP 640
D ++ GVL E++ G+ P
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 48/196 (24%), Positives = 87/196 (44%), Gaps = 10/196 (5%)
Query: 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G+G +VYK + +G++VA+K L E + + E L G++H NIV +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIR--LQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
+V+EY+ + D L + ++ LSY+H I
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKC 622
+HRD+ +N+L+ E ++DFG A+ S ++ T Y P++ C
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTC 184
Query: 623 -DVYSFGVLALEVIKG 637
D++ G + +E+I+G
Sbjct: 185 LDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 52/229 (22%), Positives = 93/229 (40%), Gaps = 26/229 (11%)
Query: 480 QEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTK 539
+ F ++ + H+++V YG C S +V EY++ GSL L + ++ W
Sbjct: 44 ESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW-- 101
Query: 540 RMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS--- 596
++ V K + AL ++ + + H ++ +KNVLL E + + K P S
Sbjct: 102 KLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158
Query: 597 ---NWAELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSS 652
L +V PE + ++ D +SFG E+ G D S S
Sbjct: 159 LPKEI--LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGG---DKPLSALDSQK 213
Query: 653 NLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
L+ + +LP P K + + C+D P+ RP+ + +
Sbjct: 214 KLQFYEDRH---QLPAP------KWTELANLINQCMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 13/201 (6%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF-Y 501
+GKG G V E +G+ A+K + L E + L RH + Y
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG--VVDALSYMHNDCF 559
F +H R F V EY G L LS + +++ G +V AL Y+H+
Sbjct: 63 SFQTHDRLCF-VMEYANGGELFFHLSRERV-----FSEDRARFYGAEIVSALGYLHSC-- 114
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVT 619
+V+RD+ +N++LD + ++DFG K D + GT Y+APE+
Sbjct: 115 -DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 620 EKCDVYSFGVLALEVIKGKHP 640
D + GV+ E++ G+ P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 3/96 (3%)
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG 606
+ L ++H+ I++RD+ NV+LD E ++DFG K GT
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD 166
Query: 607 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 642
Y+APE+ + D ++FGVL E++ G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 6/101 (5%)
Query: 543 VIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA-EL 601
I +V AL ++H I++RDI +N+LLD E ++DFG +K + A
Sbjct: 110 YIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSF 166
Query: 602 AGTYGYVAPELAYTMKV--TEKCDVYSFGVLALEVIKGKHP 640
GT Y+APE+ + D +S GVL E++ G P
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 65/270 (24%), Positives = 106/270 (39%), Gaps = 43/270 (15%)
Query: 444 IGKGGQGSVY-----KA----------ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKT 488
+GKG G+VY KA E+P GE+ + + +++ S+
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSK--------- 58
Query: 489 LTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSN-DAAAKDLGWTKRMNVIKGV 547
+ H IVKF+ I+ EY E L L K L + +
Sbjct: 59 ---LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 548 VDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGY 607
+ + YMH I+HRD+ +KN+ L N + DFG ++ L GT Y
Sbjct: 116 LLGVHYMHQR---RILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYY 171
Query: 608 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667
++PE K D++S G + E+ H + + ++ + + E P LP
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEMCCLAH-----AFEGQNFLSVVLRIVEGPTPSLP 226
Query: 668 TPSHNVQDKLISIMEVAISCLDESPESRPT 697
+L SIM+ S L++ P RP+
Sbjct: 227 ---ETYSRQLNSIMQ---SMLNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 9e-07
Identities = 22/58 (37%), Positives = 27/58 (46%)
Query: 219 QLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHN 276
L+ LDLS+NRL+ + L L L+LS N P L L LDLS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 9e-07
Identities = 58/247 (23%), Positives = 96/247 (38%), Gaps = 59/247 (23%)
Query: 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G G G V A +G VA+KK P S + +++ + E++ L + H N++
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGLLD 81
Query: 503 -FC--SHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRM-----NVIKGVV----DA 550
F S VY L L DL + + I+ +V
Sbjct: 82 VFTPASSLEDFQDVY-------LVTHL----MGADLNNIVKCQKLSDDHIQFLVYQILRG 130
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAG---TYGY 607
L Y+H+ I+HRD+ N+ ++ + E + DFG A+ E+ G T Y
Sbjct: 131 LKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR------HTDDEMTGYVATRWY 181
Query: 608 VAPELAYT-MKVTEKCDVYSFGVLALEVIKGK-------H--------------PRDFIS 645
APE+ M + D++S G + E++ GK H + +
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241
Query: 646 SISSSSS 652
ISS S+
Sbjct: 242 KISSESA 248
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 65/293 (22%), Positives = 117/293 (39%), Gaps = 43/293 (14%)
Query: 443 CIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK-- 499
IG G G V A + SG+ VA+KK + L E+K L +H NI+
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 500 --FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHND 557
+ + ++V + +E +I S+ ++ +++G L Y+H+
Sbjct: 71 DILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRG----LKYIHSA 126
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL--KPD--SSNWAELAGTYGYVAPELA 613
++HRD+ N+L++ + E + DFG A+ L P E T Y APEL
Sbjct: 127 N---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELL 183
Query: 614 YTM-KVTEKCDVYSFGVLALEVI------KGKH---------------PRDFISSISSSS 651
++ + T D++S G + E++ GK+ + ++ I S
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243
Query: 652 SNLEIALNEMLDPRLPTPSHNV-QDKLISIMEVAISCLDESPESRPTIQKVSQ 703
I + L + P P + +++ L PE R T+++ Q
Sbjct: 244 VRKYI---QNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 35/115 (30%), Positives = 55/115 (47%), Gaps = 12/115 (10%)
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL-----KPDSSNWA 599
+ +++AL+Y+H I+HRD+ ++N+ LD A + DFG A L P W
Sbjct: 192 RRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGW- 247
Query: 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL 654
+GT +PEL K D++S G++ E+ F + SSSS L
Sbjct: 248 --SGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL-FGKQVKSSSSQL 299
|
Length = 392 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 33/96 (34%), Positives = 50/96 (52%), Gaps = 5/96 (5%)
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK-FLKPDSSNWAELAGTY 605
++ AL ++H IV+RDI +N+LLD E ++DFG +K FL + GT
Sbjct: 114 IILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170
Query: 606 GYVAPELAYTMKVTEKC-DVYSFGVLALEVIKGKHP 640
Y+APE+ K D +S G+L E++ G P
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 49/206 (23%), Positives = 92/206 (44%), Gaps = 25/206 (12%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQE-----FLNEVKTLTGIRHRNI 497
IG+G G VYK +G+IVA+KK + S++E + E+ L ++H NI
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI------RLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHND 557
V ++++E+L M L L + + + + + ++ + + H+
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL----- 612
++HRD+ +N+L+D + ++DFG A+ + T Y APE+
Sbjct: 121 ---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 613 AYTMKVTEKCDVYSFGVLALEVIKGK 638
Y+ V D++S G + E+ K
Sbjct: 178 RYSTPV----DIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 53/233 (22%), Positives = 99/233 (42%), Gaps = 49/233 (21%)
Query: 439 DDEHCIGKGGQGS---VYKA-ELPSGEIVAVKKFHSPLPSEMASQQEF-----LNEVKTL 489
D +GK G+G+ VYKA ++ +G +VA+KK M ++++ L E+K L
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI------LMHNEKDGFPITALREIKIL 61
Query: 490 TGIRHRNIVK----FYGFCSHARHS----FIVYEYLEMGSLAMILSNDAAAKDLGWTKRM 541
++H N+V ++ ++V Y++ L+ +L N + K
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIK-- 118
Query: 542 NVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA--------KFLKP 593
+ +++ ++Y+H + I+HRDI + N+L+D + ++DFG A
Sbjct: 119 CYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 594 DSSNWAELAG---TYGYVAPELA-----YTMKVTEKCDVYSFGVLALEVIKGK 638
+ T Y PEL YT V D++ G + E+ +
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G+G +V+K + +VA+K+ L E + + EV L ++H NIV +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIK----GVVDALSYMHNDC 558
R +V+EYL+ L L N G M+ +K ++ LSY H
Sbjct: 71 IIHTERCLTLVFEYLD-SDLKQYLDN------CGNLMSMHNVKIFMFQLLRGLSYCHKR- 122
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE-LAYTMK 617
I+HRD+ +N+L++ + E ++DFG A+ + ++ T Y P+ L + +
Sbjct: 123 --KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 618 VTEKCDVYSFGVLALEVIKGK 638
+ D++ G + E+ G+
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 26/79 (32%), Positives = 40/79 (50%)
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEK 621
+++RD+ +N+LLD + + DFG K D GT Y+APEL T+
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA 173
Query: 622 CDVYSFGVLALEVIKGKHP 640
D ++ GVL E++ G P
Sbjct: 174 VDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 60/266 (22%), Positives = 94/266 (35%), Gaps = 63/266 (23%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+DF+ IG+G G V+ + +G++ A+K + E L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 495 RNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNV---------I 544
IVK +Y F H ++V EY+ G L + R +V I
Sbjct: 61 PWIVKLYYSF-QDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYI 107
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK--------------- 589
+V AL +H F +HRDI N+L+D + ++DFG K
Sbjct: 108 AELVLALDSVHKLGF---IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDS 164
Query: 590 ----FLKPDSSNWAEL----------AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 635
F + GT Y+APE+ +CD +S GV+ E++
Sbjct: 165 HNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
Query: 636 KGKHPRDFISSISSSSSNLEIALNEM 661
G P F S + E +
Sbjct: 225 YGFPP--F-----YSDTLQETYNKII 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 65/243 (26%), Positives = 93/243 (38%), Gaps = 46/243 (18%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+DF+ IG+G G V + +G I A+K E E L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 495 RNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKD-LGWTKRMNVIKGVVDALS 552
+VK FY F R+ +++ E+L G + +L KD L I V A+
Sbjct: 61 AWVVKMFYSF-QDKRNLYLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAID 115
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK--------------PDS--- 595
+H F +HRDI N+LLD + +SDFG LK P S
Sbjct: 116 AIHQLGF---IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 596 --------------SNWAELA----GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG 637
N +LA GT Y+APE+ + CD +S GV+ E++ G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 638 KHP 640
P
Sbjct: 233 YPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 27/217 (12%)
Query: 438 FDDEHC-IGKGGQGSVYKAELPSG---EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR 493
F+ E C +G+G G VYKA+ G A+K+ S A + E+ L ++
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR-----EIALLRELK 56
Query: 494 HRNIVKFYG-FCSHA-RHSFIVYEYLEMGSLAMI---LSNDAAAKDLGWTKRM--NVIKG 546
H N++ F SHA R +++++Y E +I ++ A K + + M +++
Sbjct: 57 HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 116
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLE----NEAHVSDFGTAKFLKPDSSNWAEL- 601
++D + Y+H + ++HRD+ N+L+ E ++D G A+ A+L
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 602 --AGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVI 635
T+ Y APEL + T+ D+++ G + E++
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 23/154 (14%)
Query: 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
+ N +K Y + + ++ +Y++ G L +L + L + +I+ +V+AL+
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALND 124
Query: 554 MHNDCFPPIVHRDISSKNVLLD-LENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL 612
+H I+H DI +NVL D ++ ++ D+G K + S GT Y +PE
Sbjct: 125 LHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC----YDGTLDYFSPE- 176
Query: 613 AYTMKVT-EKCDVYSF-----GVLALEVIKGKHP 640
K+ D SF GVL E++ GKHP
Sbjct: 177 ----KIKGHNYD-VSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 38/146 (26%), Positives = 62/146 (42%), Gaps = 13/146 (8%)
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAK--FLKPDSSNWAELAGTYGYVAPELAYTMKVTE 620
+HRD++++N+LL N + DFG A+ + PD + ++APE + T
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 621 KCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679
+ DV+SFGVL E+ G P + L+ M P TP
Sbjct: 261 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-TRMRAPDYTTP---------E 310
Query: 680 IMEVAISCLDESPESRPTIQKVSQLL 705
+ + + C P RPT ++ + L
Sbjct: 311 MYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 49/223 (21%), Positives = 88/223 (39%), Gaps = 30/223 (13%)
Query: 441 EHCIGKGGQGSVYKAELPSGEIV---AVKKFHSPLPSEMASQQEFLNEV---------KT 488
+ IG GG G VY+ + S + AV K + + + N + K
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76
Query: 489 LTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRM--NVIKG 546
+ I H I K+YG C + + Y ++ + L + + + + K++ N++K
Sbjct: 77 IHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKD 134
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL---------KPDSSN 597
++ L Y+H I H DI +N+++D N ++ D+G A + +
Sbjct: 135 MLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKD 191
Query: 598 WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
GT Y + VT + D+ S G L+ K P
Sbjct: 192 LHR--GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 12/198 (6%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G+G +VYK +G++VA+K + +E + E L G++H NIV +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVIS--MKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 503 FCSHARHSF-IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
H + + V+EY+ LA + L + ++ L+Y+H
Sbjct: 71 II-HTKETLTFVFEYMHT-DLAQYMIQHPGG--LHPYNVRLFMFQLLRGLAYIHGQ---H 123
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE-LAYTMKVTE 620
I+HRD+ +N+L+ E ++DFG A+ S ++ T Y P+ L +
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183
Query: 621 KCDVYSFGVLALEVIKGK 638
D++ G + +E+++G+
Sbjct: 184 ALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 54/212 (25%), Positives = 91/212 (42%), Gaps = 34/212 (16%)
Query: 444 IGKGGQGSVYKAELP-SGEIVAVKK----FHSPLPSEMASQQEFLNEVKTLTGIRHRNIV 498
IG G G V+ P G+ VA+KK F + + S + E+K L +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-----LVSCKRVFRELKMLCFFKHDNVL 62
Query: 499 KFY-----GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
++V E ++ +I+S + D +++G L Y
Sbjct: 63 SALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG----LKY 118
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW--AELAGTYGYVAPE 611
+H+ I+HRDI N+L++ + DFG A+ +PD S E+ Y Y APE
Sbjct: 119 LHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPE 174
Query: 612 LA-----YTMKVTEKCDVYSFGVLALEVIKGK 638
+ YT V D++S G + E++ +
Sbjct: 175 ILMGSRHYTSAV----DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 53/217 (24%), Positives = 103/217 (47%), Gaps = 27/217 (12%)
Query: 438 FDDEHC-IGKGGQGSVYKAELPSGEI---VAVKKFHSPLPSEMASQQEFLNEVKTLTGIR 493
F+ E C +G+G G VYKA+ G+ A+K+ S A + E+ L ++
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR-----EIALLRELK 56
Query: 494 HRNIVKFYG-FCSHA-RHSFIVYEYLEMGSLAMI---LSNDAAAKDLGWTKRM--NVIKG 546
H N++ F SH+ R +++++Y E +I ++ A K + + M +++
Sbjct: 57 HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLE----NEAHVSDFGTAKFLKPDSSNWAEL- 601
++D + Y+H + ++HRD+ N+L+ E ++D G A+ A+L
Sbjct: 117 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 602 --AGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVI 635
T+ Y APEL + T+ D+++ G + E++
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 29/211 (13%)
Query: 444 IGKGGQGSVYKAE------------LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG 491
IGKG G VY+ L EIVA K+ + + L+E + G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 492 IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNV-IKGVVDA 550
++ + F + ++V +Y+ G L L + + R I +V A
Sbjct: 61 LK-------FSFQT-DSDLYLVTDYMSGGELFWHLQKEGRFSE----DRAKFYIAELVLA 108
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAP 610
L ++H IV+RD+ +N+LLD + DFG +K D+ GT Y+AP
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAP 165
Query: 611 ELAYTMK-VTEKCDVYSFGVLALEVIKGKHP 640
E+ K T+ D +S GVL E+ G P
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 49/199 (24%), Positives = 80/199 (40%), Gaps = 8/199 (4%)
Query: 444 IGKGGQGSVYKAELPS-GEIVAVKKFHSPLPSEMASQQEFLNEVKTL-TGIRHRNIVKFY 501
IGKG G V A+ S G AVK + Q + E L ++H +V +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
A + V +Y+ G L L + + + V A+ Y+H+
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE---PRARFYAAEVASAIGYLHS---LN 116
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEK 621
I++RD+ +N+LLD + ++DFG K + GT Y+APE+
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT 176
Query: 622 CDVYSFGVLALEVIKGKHP 640
D + G + E++ G P
Sbjct: 177 VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 57/221 (25%), Positives = 101/221 (45%), Gaps = 31/221 (14%)
Query: 438 FDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
+ D +G G G V+ A + + VAVKK + ++ S + L E+K + + H N
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI---VLTDPQSVKHALREIKIIRRLDHDN 63
Query: 497 IVKFY--------------GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN 542
IVK Y G + +IV EY+E LA +L +++
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQ 122
Query: 543 VIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEA-HVSDFGTAKFLKPDSSNWAEL 601
+++G L Y+H+ ++HRD+ NV ++ E+ + DFG A+ + P S+ L
Sbjct: 123 LLRG----LKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYL 175
Query: 602 A---GTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 638
+ T Y +P L + T+ D+++ G + E++ GK
Sbjct: 176 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 31/229 (13%)
Query: 482 FLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRM 541
F ++ + H ++ +G C + +V E++E G L + L + + W ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120
Query: 542 NVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK---PDSSNW 598
V + + ALSY+ + +VH ++ +KN+LL A GT+ F+K P S
Sbjct: 121 TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAE----GTSPFIKLSDPGVSFT 173
Query: 599 A----ELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEV-IKGKHPRDFISSISSSSS 652
A E ++APE + ++ D +SFG LE+ G+ P + S
Sbjct: 174 ALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK-----ERTPS 228
Query: 653 NLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
E + RLP PS LIS CL P RP+ + +
Sbjct: 229 EKERFYEKKH--RLPEPSCKELATLIS------QCLTYEPTQRPSFRTI 269
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 48/201 (23%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G+G +VYK + +VA+K+ L E + + EV L ++H NIV +
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIK----GVVDALSYMHNDC 558
+ +V+EYL+ L L D G + M+ +K ++ L+Y H
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYLD------DCGNSINMHNVKLFLFQLLRGLNYCHRR- 123
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE-LAYTMK 617
++HRD+ +N+L++ E ++DFG A+ + ++ T Y P+ L +
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTD 181
Query: 618 VTEKCDVYSFGVLALEVIKGK 638
+ + D++ G + E+ G+
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 27/153 (17%)
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY---GYVAPELAYTMKVT 619
VHRD++++NVL+ + DFG A+ + D SN+ T+ ++APE + T
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRD-SNYISKGSTFLPLKWMAPESIFNNLYT 319
Query: 620 EKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEML------DPRLPTPSHN 672
DV+SFG+L E+ G P E+ +NE R+ P+H
Sbjct: 320 TLSDVWSFGILLWEIFTLGGTPYP------------ELPMNEQFYNAIKRGYRMAKPAH- 366
Query: 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
D++ IM+ C +E E RP ++ L+
Sbjct: 367 ASDEIYEIMQ---KCWEEKFEIRPDFSQLVHLV 396
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 54/245 (22%), Positives = 105/245 (42%), Gaps = 25/245 (10%)
Query: 444 IGKGGQGSV---YKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
IG G QG V Y A L VA+KK P ++ +++ + E+ + + H+NI+
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88
Query: 501 YGFCSHARH------SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
+ + +IV E ++ +L ++ + + + + ++ ++ + ++
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 142
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
H+ I+HRD+ N+++ + + DFG A+ + Y Y APE+
Sbjct: 143 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVIL 198
Query: 615 TMKVTEKCDVYSFGVLALEVIKGK--HP-RDFISSISSSSSNLEIALNEMLDPRLPTPSH 671
M E D++S G + E+IKG P D I + L E + PT
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 258
Query: 672 NVQDK 676
V+++
Sbjct: 259 YVENR 263
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 37/163 (22%), Positives = 74/163 (45%), Gaps = 24/163 (14%)
Query: 485 EVKTLTGIRHRNIVKFYGFCSHARHSFIV--------YEYLEMGSLAMILSNDAAAKDLG 536
E L I H +I++ G ++ + + ++ Y YL AA +++
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYL------------AAKRNIA 180
Query: 537 WTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF-LKPDS 595
+ + + V+ A+ Y+H + I+HRDI ++N+ ++ + + DFG A F + ++
Sbjct: 181 ICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237
Query: 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 638
+ + AGT APEL D++S G++ E+
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 23/48 (47%), Positives = 33/48 (68%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLG 48
++++L L L NSF+GSIP +G+L SL L L+GN L G +P +LG
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 61/243 (25%), Positives = 103/243 (42%), Gaps = 43/243 (17%)
Query: 482 FLNEVKTLTGIRHRNIVKFYGFCSHARHS-FIVYEYLEMGSLAMILSN---DAAAKDLGW 537
L E L G+ H+NI+ C F++Y Y+ G+L + L A
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114
Query: 538 TKRMNVIKG--VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP-- 593
+ + V + +SY+H ++H+DI+++N ++D E + ++D ++ L P
Sbjct: 115 STQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171
Query: 594 -----DSSN----WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDF 643
D+ N W +A E + + DV+SFGVL E++ G+ P
Sbjct: 172 YHCLGDNENRPVKW---------MALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222
Query: 644 ISSISSSSSNLEIALNEMLDP-RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVS 702
I E+A + D RL P N D+L ++M C PE RP+ ++
Sbjct: 223 IDP-------FEMA-AYLKDGYRLAQPI-NCPDELFAVMAC---CWALDPEERPSFSQLV 270
Query: 703 QLL 705
Q L
Sbjct: 271 QCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 53/245 (21%), Positives = 108/245 (44%), Gaps = 25/245 (10%)
Query: 444 IGKGGQGSV---YKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
IG G QG V Y A L VA+KK P ++ +++ + E+ + + H+NI+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 81
Query: 501 YGFCSHAR------HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
+ + ++V E ++ +L ++ + + + + ++ ++ + ++
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 135
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
H+ I+HRD+ N+++ + + DFG A+ S T Y APE+
Sbjct: 136 HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 615 TMKVTEKCDVYSFGVLALEVIKGK--HP-RDFISSISSSSSNLEIALNEMLDPRLPTPSH 671
M E D++S G + E+++ K P RD+I + L E + PT +
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 672 NVQDK 676
V+++
Sbjct: 252 YVENR 256
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 64/258 (24%), Positives = 101/258 (39%), Gaps = 36/258 (13%)
Query: 449 QGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR 508
S P E+ V K L S+ F ++ + H+++VK YG C
Sbjct: 18 VQSDLDIVGPGQEVSVVLKV---LGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDE 74
Query: 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDIS 568
+ +V EY++ G L + L + L W +++V K + AL Y+ + +VH ++
Sbjct: 75 NI-MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLEDK---KLVHGNVC 128
Query: 569 SKNVLL---DLENE----AHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY--TMKVT 619
KN+L+ L +SD G + E ++APE +T
Sbjct: 129 GKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE----ERVERIPWIAPECIRNGQASLT 184
Query: 620 EKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLI 678
D +SFG LE+ G+ P +S++SSS E RLP P LI
Sbjct: 185 IAADKWSFGTTLLEICSNGEEP---LSTLSSS----EKERFYQDQHRLPMPDCAELANLI 237
Query: 679 SIMEVAISCLDESPESRP 696
+ C P RP
Sbjct: 238 N------QCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 42/150 (28%), Positives = 72/150 (48%), Gaps = 19/150 (12%)
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW-----AELAGTYGYVAPELAYTMK 617
+HRD++++N+LL + DFG A+ ++ D SN+ A L ++APE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRND-SNYVVKGNARLP--VKWMAPESIFNCV 292
Query: 618 VTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDK 676
T + DV+S+G+L E+ G P + + S + ML P +
Sbjct: 293 YTFESDVWSYGILLWEIFSLGSSPYPGM-PVDSKFYKMIKEGYRMLSPECAPS------E 345
Query: 677 LISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ IM+ SC D P RPT +++ QL++
Sbjct: 346 MYDIMK---SCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 47/201 (23%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 444 IGKGGQGSVYKAELPSGE-IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G+G +V+K E +VA+K+ L E + + EV L ++H NIV +
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIK----GVVDALSYMHNDC 558
+ +V+EYL+ L + D G M+ +K ++ L+Y H
Sbjct: 72 IVHTDKSLTLVFEYLDK-DLKQYMD------DCGNIMSMHNVKIFLYQILRGLAYCHRR- 123
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE-LAYTMK 617
++HRD+ +N+L++ E ++DFG A+ + ++ T Y P+ L + +
Sbjct: 124 --KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSE 181
Query: 618 VTEKCDVYSFGVLALEVIKGK 638
+ + D++ G + E+ G+
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 46/171 (26%), Positives = 81/171 (47%), Gaps = 32/171 (18%)
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW---AELAG 603
+V AL +H+ ++HRD+ S N+ L + DFG +K DS + + G
Sbjct: 178 IVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS-DSVSLDVASSFCG 233
Query: 604 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVI------KGKHPRDFISSISSSSSNLEIA 657
T Y+APEL + ++K D++S GV+ E++ KG R+ + +
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV---------- 283
Query: 658 LNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV--SQLLK 706
L DP P P V + ++++ +S ++P RPT Q++ ++ LK
Sbjct: 284 LYGKYDP-FPCP---VSSGMKALLDPLLS---KNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-06
Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 8/199 (4%)
Query: 444 IGKGGQGSVYKAELPSGEIV-AVKKFHSPLPSEMASQQEFLNEVKTL-TGIRHRNIVKFY 501
IGKG G V A + E AVK + ++ ++E L ++H +V +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
A + V +Y+ G L L + L R + + AL Y+H+
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCF--LEPRARFYAAE-IASALGYLHS---LN 116
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEK 621
IV+RD+ +N+LLD + ++DFG K + + GT Y+APE+ +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRT 176
Query: 622 CDVYSFGVLALEVIKGKHP 640
D + G + E++ G P
Sbjct: 177 VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK-FLKPDSSNWAELAGTY 605
+V AL ++H I++RDI +N+LLD ++DFG +K F + + GT
Sbjct: 114 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 606 GYVAPELAYTMKV--TEKCDVYSFGVLALEVIKGKHP 640
Y+AP++ + D +S GVL E++ G P
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 444 IGKGGQGSVYKAEL----PSGEIVAVKKFHSPLPSEMASQQEFLN---EVKTLTGIRHRN 496
+GKGG G V++ +G+I A+K + + +Q++ + E L ++H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKA--TIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 497 IVKF-YGFCSHARHSFIVYEYLEMGSLAM------ILSNDAAAKDLGWTKRMNVIKGVVD 549
IV Y F + + +++ EYL G L M I D A L +
Sbjct: 62 IVDLIYAFQTGGK-LYLILEYLSGGELFMHLEREGIFMEDTACFYLS---------EISL 111
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVA 609
AL ++H I++RD+ +N+LLD + ++DFG K + + GT Y+A
Sbjct: 112 ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMA 168
Query: 610 PELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
PE+ + D +S G L +++ G P
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 48/199 (24%), Positives = 81/199 (40%), Gaps = 8/199 (4%)
Query: 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTL-TGIRHRNIVKFY 501
IGKG G V A+ G+ AVK + Q+ + E L ++H +V +
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
+ V +++ G L L + + + + + AL Y+H+
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLHS---IN 116
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEK 621
IV+RD+ +N+LLD + ++DFG K S GT Y+APE+
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 622 CDVYSFGVLALEVIKGKHP 640
D + G + E++ G P
Sbjct: 177 VDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 4e-05
Identities = 63/258 (24%), Positives = 102/258 (39%), Gaps = 64/258 (24%)
Query: 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKT----LT 490
DF IGKG G V + +G+I A+K + L SEM + + L VK L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK---TLLKSEMFKKDQ-LAHVKAERDVLA 56
Query: 491 GIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNDAAAKDLGWTKRMNVIKGVVD 549
+V Y A++ +++ E+L G L M++ D ++D+ R + + V+
Sbjct: 57 ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMAECVL- 112
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG-TAKFLKPDSSNW---------- 598
A+ +H F +HRDI N+L+D +SDFG + F K S +
Sbjct: 113 AIEAVHKLGF---IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSN 169
Query: 599 ----------------------AELA--------------GTYGYVAPELAYTMKVTEKC 622
++A GT Y+APE+ ++C
Sbjct: 170 KNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229
Query: 623 DVYSFGVLALEVIKGKHP 640
D +S G + E + G P
Sbjct: 230 DWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 26/96 (27%), Positives = 46/96 (47%), Gaps = 5/96 (5%)
Query: 482 FLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRM 541
F + + H++IV YG C + +V E++E G L + + + W +
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108
Query: 542 NVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE 577
V K + ALSY+ + +VH ++ +KN+LL E
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 48/207 (23%), Positives = 92/207 (44%), Gaps = 21/207 (10%)
Query: 444 IGKGGQGSVYKA-ELPSG-EIVAVKKFHSPLPSEMASQQEFLNEV---KTLTGIRHRNIV 498
IG+G G V+KA +L +G VA+K+ E + EV + L H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQ-TGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 499 KFYGFCSHARHS-----FIVYEYLEMGSLAMILSNDAAAKDLGWTKRM--NVIKGVVDAL 551
+ + C+ +R +V+E+++ L L + G +++ ++ L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK---VPEPGVPTETIKDMMFQLLRGL 123
Query: 552 SYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE 611
++H+ +VHRD+ +N+L+ + ++DFG A+ + + T Y APE
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAPE 179
Query: 612 LAYTMKVTEKCDVYSFGVLALEVIKGK 638
+ D++S G + E+ + K
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 37/139 (26%), Positives = 56/139 (40%), Gaps = 17/139 (12%)
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKC 622
+HR S N+LL + + G+ F P+ S ++APE+ TEK
Sbjct: 33 LHRQAKSGNILLTWD--GLLKLDGSVAFKTPEQSR-----PDPYFMAPEVIQGQSYTEKA 85
Query: 623 DVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM--LDPRLPTPSHNVQDKLI-- 678
D+YS G+ E + + P + +S+ LEI LN M DPR + V
Sbjct: 86 DIYSLGITLYEALDYELPYNEERELSAI---LEILLNGMPADDPRDRSNLEGVSAARSFE 142
Query: 679 SIMEVAISCLDESPESRPT 697
M + C P+ R
Sbjct: 143 DFMRL---CASRLPQRREA 158
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-05
Identities = 75/314 (23%), Positives = 122/314 (38%), Gaps = 87/314 (27%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKT----LT 490
+DF+ IG+G G V + +G I A+KK SEM ++E + V+ L
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL---RKSEML-EKEQVAHVRAERDILA 56
Query: 491 GIRHRNIVKFYGFCSHARHSFIVYEYL---EMGSLAM---ILSNDAAAKDLGWTKRMNVI 544
+ +VK Y + +++ EYL +M +L M + + + T
Sbjct: 57 EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAET------ 110
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK------------ 592
+ A+ +H + +HRDI N+LLD + +SDFG LK
Sbjct: 111 ---ILAIDSIHKLGY---IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 593 -------------PDSS-----NWAE----LA----GTYGYVAPELAYTMKVTEKCDVYS 626
P SS W LA GT Y+APE+ ++CD +S
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224
Query: 627 FGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAIS 686
GV+ E++ G P F S + + +I N ++ L EV +
Sbjct: 225 LGVIMYEMLVGYPP--FCSD-NPQETYRKII--------------NWKETLQFPDEVPL- 266
Query: 687 CLDESPESRPTIQK 700
SPE++ I++
Sbjct: 267 ----SPEAKDLIKR 276
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 32/106 (30%), Positives = 54/106 (50%), Gaps = 5/106 (4%)
Query: 530 AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589
A + LG + V + ++ A+ Y+H + I+HRDI ++NVL++ + + DFG A
Sbjct: 252 ARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAAC 308
Query: 590 FLKPDSSNWAE--LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALE 633
F + S +AGT APE+ T D++S G++ E
Sbjct: 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 58/247 (23%), Positives = 99/247 (40%), Gaps = 56/247 (22%)
Query: 437 DFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSP--LPSE----MASQQEFLNEVKTL 489
DF+ IG+G G V + +G + A+K L E + ++++ L E +L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 490 TGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNDAAAKDLGWTKRMNVIKGVV 548
++ FY F + +++ E+L G + +++ D ++ + I V
Sbjct: 62 WVVK-----MFYSF-QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE----ETQFYIAETV 111
Query: 549 DALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP--------------- 593
A+ +H F +HRDI N+LLD + +SDFG LK
Sbjct: 112 LAIDSIHQLGF---IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLP 168
Query: 594 ------------DSSNWA----ELA----GTYGYVAPELAYTMKVTEKCDVYSFGVLALE 633
+ W +LA GT Y+APE+ + CD +S GV+ E
Sbjct: 169 SDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 634 VIKGKHP 640
++ G P
Sbjct: 229 MLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 35/140 (25%), Positives = 56/140 (40%), Gaps = 46/140 (32%)
Query: 544 IKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG---------TAKFLKP- 593
I + A+ +H F +HRDI N+L+D + ++DFG +K+ +
Sbjct: 107 IAELTCAIESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKG 163
Query: 594 -----DS----SNWAE------------------------LAGTYGYVAPELAYTMKVTE 620
DS W+E L GT Y+APE+ T+
Sbjct: 164 DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 223
Query: 621 KCDVYSFGVLALEVIKGKHP 640
CD +S GV+ E++ G+ P
Sbjct: 224 LCDWWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 444 IGKGGQG---SVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVK 499
+G+G G S AE E VA+KK + ++ +++ L E+K L R H+NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRA-LRELKLLRHFRGHKNITC 66
Query: 500 FYG----FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
Y F + ++ YE L L I+ + D + + I ++ L Y+H
Sbjct: 67 LYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQPLTDAHF---QSFIYQILCGLKYIH 122
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD----SSNWAELAGTYGYVAPE 611
+ ++HRD+ N+L++ + E + DFG A+ + + E T Y APE
Sbjct: 123 S---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 612 LAYTMK-VTEKCDVYSFGVLALEVIKGK 638
+ + + T+ DV+S G + E++ K
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 44/202 (21%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IG G QG V A + +G+ VA+KK P + +++ + E+ + + H+NI+
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIGLLN 82
Query: 503 FCSHAR------HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
+ + ++V E ++ +L ++ D + + + ++ ++ + ++H+
Sbjct: 83 VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSY-----LLYQMLCGIKHLHS 136
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTM 616
I+HRD+ N+++ + + DFG A+ + Y Y APE+ M
Sbjct: 137 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGM 192
Query: 617 KVTEKCDVYSFGVLALEVIKGK 638
E D++S G + E+I+G
Sbjct: 193 GYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 39/153 (25%), Positives = 62/153 (40%), Gaps = 20/153 (13%)
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKD---LGWTKRMNVIKGVVDALS 552
N+V + + F+V ++ E G L +S + W M V AL
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALD 99
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL 612
+H + IV RD++ N+LLD ++ F ++ A Y APE+
Sbjct: 100 ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAV---ENMYCAPEV 153
Query: 613 AYTMKVTEKCDVYSFGVLALEVIKGK-----HP 640
+ TE CD +S G + E++ GK HP
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 3e-04
Identities = 46/190 (24%), Positives = 88/190 (46%), Gaps = 31/190 (16%)
Query: 479 QQEFLNEVKTLTGIRHRNIVKFYG-FCSHARHS-FIVYEYLEMGSLAMILSNDAAAKDLG 536
+ + + EV + ++H+NIV++ F + A +I+ E+ + G L+ + K G
Sbjct: 56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK--CYKMFG 113
Query: 537 WTKR---MNVIKGVVDALSYMHNDCFPP----IVHRDISSKNVLL--------------- 574
+ +++ + ++ AL+Y HN P ++HRD+ +N+ L
Sbjct: 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173
Query: 575 DLENE--AHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY--TMKVTEKCDVYSFGVL 630
+L A + DFG +K + +S + GT Y +PEL T +K D+++ G +
Sbjct: 174 NLNGRPIAKIGDFGLSKNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 631 ALEVIKGKHP 640
E+ GK P
Sbjct: 233 IYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 4e-04
Identities = 22/61 (36%), Positives = 28/61 (45%), Gaps = 2/61 (3%)
Query: 123 NLAFIDLSHNYFYGEISSDW-GRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNH 181
NL +DLS+N I P L LD S NN+T P L+ LDLS N+
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 182 I 182
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 5e-04
Identities = 20/63 (31%), Positives = 31/63 (49%), Gaps = 6/63 (9%)
Query: 195 SLIKLILNSNQLCGQLSLE---LGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSN 251
+L L L++N+L + L L+ LDLS N L++ P++ L L L+LS
Sbjct: 1 NLKSLDLSNNRL---TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSG 57
Query: 252 NQF 254
N
Sbjct: 58 NNL 60
|
Length = 60 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.001
Identities = 55/229 (24%), Positives = 99/229 (43%), Gaps = 46/229 (20%)
Query: 444 IGKGGQGS---VYKA-ELPSGEIVAVKK----FHSPLPSEMASQQEFLNEVKTLTGIR-H 494
+GK G+G+ V KA +G+ A+K F S Q L E++ L + H
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS------LEQVNNLREIQALRRLSPH 57
Query: 495 RNIVKFYGFC---SHARHSFIVYEYLEMGSLAMILSNDAAAKD----LGWTKRMNVIKGV 547
NI++ R + + +E ++M +I K L + + + +
Sbjct: 58 PNILRLIEVLFDRKTGRLALV-FELMDMNLYELI-------KGRKRPLPEKRVKSYMYQL 109
Query: 548 VDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK--FLKPDSSNWAELAGTY 605
+ +L +MH + I HRDI +N+L+ ++ ++DFG+ + + KP + E T
Sbjct: 110 LKSLDHMHRN---GIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPP---YTEYISTR 162
Query: 606 GYVAPELAYTMKV-TEKCDVYSFGVLALEVIK------GKHPRDFISSI 647
Y APE T K D+++ G + E++ G + D I+ I
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI 211
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 27/153 (17%), Positives = 52/153 (33%), Gaps = 26/153 (16%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIV--KFY 501
+ G VY + V +K S + EV L + + + K
Sbjct: 6 LKGGLTNRVYLLGTKDEDYV-LKINPS-----REKGADREREVAILQLLARKGLPVPKVL 59
Query: 502 GFCSHARHSFIVYEYLEMGSL--AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
S+++ E++E +L + A+ L + L+ +H
Sbjct: 60 ASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQLA------------ELLAKLHQ--L 105
Query: 560 PPIV--HRDISSKNVLLDLENEAHVSDFGTAKF 590
P +V H D+ N+L+D + D+ A +
Sbjct: 106 PLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.002
Identities = 21/60 (35%), Positives = 25/60 (41%)
Query: 171 QLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRL 230
LK LDLS+N + L +L L L+ N L L L LDLS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 14/43 (32%), Positives = 23/43 (53%)
Query: 291 SLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNS 333
+L+ L+LS+N L+ F+ L L +D+S N L P +
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEA 43
|
Length = 60 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 31/125 (24%), Positives = 50/125 (40%), Gaps = 47/125 (37%)
Query: 563 VHRDISSKNVLLDLENEAHVSDFG---------TAKF------LKPDSSN----WAE--- 600
+HRDI N+L+DL+ ++DFG +K+ ++ DS W +
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 601 -------------------------LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 635
L GT Y+APE+ T+ CD +S GV+ E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 636 KGKHP 640
G+ P
Sbjct: 243 VGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 29/125 (23%), Positives = 48/125 (38%), Gaps = 47/125 (37%)
Query: 563 VHRDISSKNVLLDLENEAHVSDFG---------------TAKFLKPDSSN----WAE--- 600
+HRDI N+L+D + ++DFG + ++ DS + W +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 601 -------------------------LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 635
L GT Y+APE+ T+ CD +S GV+ E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 636 KGKHP 640
G+ P
Sbjct: 243 VGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.3 bits (85), Expect = 0.002
Identities = 18/43 (41%), Positives = 26/43 (60%), Gaps = 3/43 (6%)
Query: 218 TQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPV 260
T LE LDLS+N+++ +P L NL L L+LS N+ I +
Sbjct: 1 TNLETLDLSNNQIT-DLP-PLSNLPNLETLDLSGNK-ITDLSP 40
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 27/94 (28%), Positives = 45/94 (47%), Gaps = 3/94 (3%)
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG 606
+ AL Y+H+ I++RD+ +N+LLD + ++DFG K S + GT
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE 161
Query: 607 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
Y+APE+ D + G + E++ G P
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN-IVKFY 501
IG+G G VYKA + +G++VA+KK + E L E+ L + IV+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA-LREISLLQMLSESIYIVRLL 67
Query: 502 GFCSHARHS------FIVYEYLEMGSLAMILSN-DAAAKDLGWTKRMNVIKGVVDALSYM 554
H ++V+EYL+ + SN + L + + ++ +++
Sbjct: 68 D-VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEA-HVSDFGTAK-FLKPDSSNWAELAGTYGYVAPEL 612
H ++HRD+ +N+L+D + ++D G + F P S E+ T Y APE+
Sbjct: 127 HKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWYRAPEV 182
Query: 613 -----AYTMKVTEKCDVYSFGVLALEVIKG 637
Y+ V D++S G + E+ +
Sbjct: 183 LLGSTHYSTPV----DIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 707 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.43 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.4 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.37 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.36 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.36 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.34 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.34 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.33 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.33 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.3 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.28 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.27 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.27 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.23 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.21 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.15 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.02 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.02 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.93 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.91 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.89 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.88 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.86 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.84 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.82 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.78 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.76 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.74 | |
| COG5238 | 388 | RNA1 Ran GTPase-activating protein (RanGAP) involv | 98.72 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.66 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-82 Score=746.34 Aligned_cols=681 Identities=32% Similarity=0.525 Sum_probs=490.2
Q ss_pred CCCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCee
Q 038671 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLL 80 (707)
Q Consensus 1 nl~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 80 (707)
++++|++|+|++|.+++.+|..|+++++|++|+|++|++.+..|..+.++++|++|+|++|.+.+..|..+.++++|++|
T Consensus 234 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 313 (968)
T PLN00113 234 GLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEIL 313 (968)
T ss_pred cCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEE
Confidence 46778888888888888888888888888888888888877777778888888888888888877777777888888888
Q ss_pred ecccccccccC-CCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccC
Q 038671 81 TLENNQLRGPI-PNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNIT 159 (707)
Q Consensus 81 ~l~~n~i~~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~ 159 (707)
++++|.+.... ..+..+++|+.|++++|.+.+..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.+.
T Consensus 314 ~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~ 393 (968)
T PLN00113 314 HLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE 393 (968)
T ss_pred ECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEec
Confidence 88888776533 34677777777777777777666666777777777777777766555555555555555555555554
Q ss_pred CCCchhhh------------------------CCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccC
Q 038671 160 GSMPAEII------------------------HSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG 215 (707)
Q Consensus 160 ~~~~~~~~------------------------~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 215 (707)
+..+..+. .+++|+.|++++|.+++..+..+..+++|+.|++++|.+.+..|..+
T Consensus 394 ~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~- 472 (968)
T PLN00113 394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF- 472 (968)
T ss_pred ccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-
Confidence 44444444 44445555555555544444444455555555555555554444433
Q ss_pred CCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceE
Q 038671 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKL 295 (707)
Q Consensus 216 ~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L 295 (707)
..++|+.|++++|++++..|..+.++++|+.|+|++|.+.+..|..+..+++|+.|+|++|.+++..|..+..+++|+.|
T Consensus 473 ~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 552 (968)
T PLN00113 473 GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQL 552 (968)
T ss_pred ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEE
Confidence 34677888888888888888889999999999999999999999999999999999999999999999999999999999
Q ss_pred eccccccCCchhHhhccCCCceeEeeccCcccccCCCccccccCchhhcccCcCcCCCCC--CCCCcCCCccccccccce
Q 038671 296 NLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIK--GFPSCKASKSHKQASRKI 373 (707)
Q Consensus 296 ~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~--~~~~c~~~~~~~~~~~~~ 373 (707)
++++|++++..|..+..++.|+.|++++|++.|.+|....+.......+.+|+..|+... ..++|.... . ...
T Consensus 553 ~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~----~-~~~ 627 (968)
T PLN00113 553 DLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR----K-TPS 627 (968)
T ss_pred ECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc----c-cce
Confidence 999999999999999999999999999999999999887777777888999999998643 245664321 1 223
Q ss_pred EEEEeecchhhHHHHHHhhheeeEEEecCCccCCCCCCCCCCcccccccCccc-hHHHHHHHhcCCCCCceeeecCCeeE
Q 038671 374 WVVIVFPLLGSFALLISLIGLFFMFRRSSSQTQQSSPGNAPGFLSVLSFEGKI-VYEEIIRVTNDFDDEHCIGKGGQGSV 452 (707)
Q Consensus 374 ~~~i~~~~~~~~~~~~~~~~~~~~~rr~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~lg~G~~g~v 452 (707)
|.+++++++++++++++++++++++|+++....+........ .....+.... ...........|...+.||+|+||.|
T Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~V 706 (968)
T PLN00113 628 WWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGT-WELQFFDSKVSKSITINDILSSLKEENVISRGKKGAS 706 (968)
T ss_pred eeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccccccccc-ccccccccccchhhhHHHHHhhCCcccEEccCCCeeE
Confidence 333333333333333333333333333222111111111111 1111111111 11122333456888899999999999
Q ss_pred EEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccCcHHHHHhcccc
Q 038671 453 YKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAA 531 (707)
Q Consensus 453 y~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 531 (707)
|+|.. .+++.||||++...... ...|++.+++++||||+++++++.+++..++||||+++|+|.++++
T Consensus 707 y~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---- 775 (968)
T PLN00113 707 YKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---- 775 (968)
T ss_pred EEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----
Confidence 99965 67899999998643211 1245788999999999999999999999999999999999999985
Q ss_pred cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCccccccccCCCCcc
Q 038671 532 AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE 611 (707)
Q Consensus 532 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE 611 (707)
.++|.++.+++.||++|++|||+.+.++|+||||||+||+++.++.+++. ||........ ....+++.|+|||
T Consensus 776 --~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE 848 (968)
T PLN00113 776 --NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPE 848 (968)
T ss_pred --cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCcc
Confidence 37899999999999999999996655699999999999999999888875 5554432211 2236789999999
Q ss_pred ccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchh------hhhhhhhcCCCCCCCCcchHHHHHHHHHHHH
Q 038671 612 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL------EIALNEMLDPRLPTPSHNVQDKLISIMEVAI 685 (707)
Q Consensus 612 ~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 685 (707)
++.+..++.++||||||+++|||+||+.||+...........+ ........++.+........+...++.+++.
T Consensus 849 ~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 928 (968)
T PLN00113 849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLAL 928 (968)
T ss_pred cccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHH
Confidence 9999999999999999999999999999985322111000000 0112223344443332334456677899999
Q ss_pred hccCCCCCCCCCHHHHHHHhc
Q 038671 686 SCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 686 ~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+||+.||++||+|.|+++.|+
T Consensus 929 ~Cl~~~P~~RPt~~evl~~L~ 949 (968)
T PLN00113 929 HCTATDPTARPCANDVLKTLE 949 (968)
T ss_pred hhCcCCchhCcCHHHHHHHHH
Confidence 999999999999999999885
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-48 Score=394.17 Aligned_cols=281 Identities=40% Similarity=0.690 Sum_probs=234.3
Q ss_pred cCccchHHHHHHHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeee
Q 038671 422 FEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFY 501 (707)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 501 (707)
....+++.++..++++|.....||+|+||.||+|..++|+.||||++....... ..+|..|+.++.+++|||+|+++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEE
Confidence 345578999999999999999999999999999999999999999876543321 35599999999999999999999
Q ss_pred eeeecCC-ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCe
Q 038671 502 GFCSHAR-HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEA 580 (707)
Q Consensus 502 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~ 580 (707)
|||.+.+ ..++||||+.+|+|.++++..... +++|.+|++||.++|+||+|||+.+.|.||||||||+|||+|+++++
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9999998 499999999999999999865544 89999999999999999999999988889999999999999999999
Q ss_pred EEeccccceecCCCCCCcccc-ccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc------cch
Q 038671 581 HVSDFGTAKFLKPDSSNWAEL-AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS------SSN 653 (707)
Q Consensus 581 kl~Dfg~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~~ 653 (707)
||+|||+|+............ .||.+|+|||+...+..+.++||||||+++.|++||+.|.+........ ...
T Consensus 217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 999999996554312222222 8999999999999888999999999999999999999887743211000 011
Q ss_pred h-hhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 654 L-EIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 654 ~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
. .....+++|+++.............+.+++.+|++.+|++||+|.||+++|+
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~ 350 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE 350 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence 1 1257778888876321111256777999999999999999999999999874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=392.94 Aligned_cols=250 Identities=27% Similarity=0.468 Sum_probs=225.7
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.+|...+.||+|+|+.+|.++. .+|+.||+|++.+.........+.+.+|+++.++|+|||||+++++|++....|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999966 889999999998766666667788999999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
|+|..++|.+++++ .+++++.+++++++||+.||.|||++ +|+|||||..|++++++.+|||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Kr---rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR---RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHh---cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence 99999999999864 35699999999999999999999999 9999999999999999999999999999999988
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
+.+..+.+|||.|.|||++....++..+||||+||++|.|++|++||+ ...+......+.......|.
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe--------tk~vkety~~Ik~~~Y~~P~---- 239 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE--------TKTVKETYNKIKLNEYSMPS---- 239 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc--------cchHHHHHHHHHhcCccccc----
Confidence 888889999999999999999999999999999999999999999997 34455566666665555544
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+.+..++|.++++.+|.+|||+++|++
T Consensus 240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 240 HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 33445789999999999999999999985
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=372.19 Aligned_cols=254 Identities=27% Similarity=0.421 Sum_probs=216.3
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc-eeEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH-SFIV 513 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv 513 (707)
.+++..+.||+|..|+||++++ ++++.+|+|++.-. .+.....++.+|++++++.+||+||.+||+|...+. ..++
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 3556678899999999999955 57899999999543 344567889999999999999999999999999984 9999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN-DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||++|+|++++... +.+++...-+++.++++||.|||+ + +||||||||+|||++..|+|||||||.+..+.
T Consensus 157 mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred hhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 9999999999998654 569999999999999999999996 6 99999999999999999999999999998765
Q ss_pred CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
.. ...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||... ..........+..+.+...|..+..
T Consensus 231 nS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~---~~~~~~~~~Ll~~Iv~~ppP~lP~~ 305 (364)
T KOG0581|consen 231 NS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP---NPPYLDIFELLCAIVDEPPPRLPEG 305 (364)
T ss_pred hh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---CCCCCCHHHHHHHHhcCCCCCCCcc
Confidence 43 457789999999999999999999999999999999999999998643 1223445566666666444443222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+.++..+|..|+++||.+||++.|+++.
T Consensus 306 --~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 --EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred --cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 356679999999999999999999998763
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=372.94 Aligned_cols=257 Identities=26% Similarity=0.365 Sum_probs=219.0
Q ss_pred HhcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCch----hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSE----MASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR 508 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 508 (707)
+.+.|.+.+.+|+|+||.|-+| ..++|+.||||++....... ......+.+|+++|++|+|||||++++++..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4577889999999999999999 66789999999998654332 223344679999999999999999999999999
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC---CCeEEecc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE---NEAHVSDF 585 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~---~~~kl~Df 585 (707)
..||||||++||.|.+.+-.. +.+.+..-..+++|++.|+.|||+. ||+||||||+|||+..+ -.+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 999999999999999998654 3477778889999999999999999 99999999999999766 57999999
Q ss_pred ccceecCCCCCCccccccccCCCCccccccCCC---CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhc
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYTMKV---TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML 662 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 662 (707)
|+|+... ..+.+.+++|||.|.|||++.+..+ ..++|+||+||++|-+++|.+||..... .....+.+.
T Consensus 324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-------~~sl~eQI~ 395 (475)
T KOG0615|consen 324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-------DPSLKEQIL 395 (475)
T ss_pred chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC-------CccHHHHHh
Confidence 9999877 5677888999999999999987553 3378999999999999999999963221 112445566
Q ss_pred CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 663 DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 663 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..++...+..+.+...+..++|.+|+..||++|||++|+++.
T Consensus 396 ~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 396 KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 677777667778888999999999999999999999998863
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=379.30 Aligned_cols=256 Identities=29% Similarity=0.539 Sum_probs=211.3
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-ceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR-HSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~ 514 (707)
.++...+.+|+|+||+||+|.++....||||++......... .++|.+|+.++.+++|||||+++|++.++. ..++||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt 119 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT 119 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence 344555669999999999999976666999999876544433 778999999999999999999999999887 799999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCC-eEecCCCCCCeeecCCC-CeEEeccccceecC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP-IVHRDISSKNVLLDLEN-EAHVSDFGTAKFLK 592 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~dlk~~Nil~~~~~-~~kl~Dfg~~~~~~ 592 (707)
||+++|+|.++++.. ..+.+++..+++++.|||+||.|||+. + ||||||||+|||++.++ ++||+|||+++...
T Consensus 120 Ey~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 120 EYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred EeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 999999999999764 356799999999999999999999999 7 99999999999999997 99999999998765
Q ss_pred CCCCCccccccccCCCCccccc--cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCC
Q 038671 593 PDSSNWAELAGTYGYVAPELAY--TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (707)
..........||+.|||||++. ...|+.++||||||+++|||+||+.||...... ............+.++.
T Consensus 196 ~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~----~~~~~v~~~~~Rp~~p~-- 269 (362)
T KOG0192|consen 196 ISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV----QVASAVVVGGLRPPIPK-- 269 (362)
T ss_pred cccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHhcCCCCCCCc--
Confidence 4333334468999999999999 568999999999999999999999999743321 11111222222222222
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
. .+..+..++.+||+.||.+||++.+++..|+
T Consensus 270 ~----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 270 E----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred c----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 1 4456889999999999999999999999875
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=351.16 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=215.1
Q ss_pred cCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeee-eeecCCc-eeE
Q 038671 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG-FCSHARH-SFI 512 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~l 512 (707)
.+|++.++||+|.||.||++ ...+|..+|.|.+.-... +..+.+....|+.++++|+|||||++++ .+.++.. ++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 45888899999999999999 678999999999985433 3346678999999999999999999998 4444454 899
Q ss_pred EEeeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeecCCCCeEEeccccce
Q 038671 513 VYEYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCFPP--IVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
|||+|.+|+|..+++... ..+.+++..+|+++.|++.||.++|+... . |+||||||.||+++.+|.||++|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~-r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP-RGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc-ccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999986543 34569999999999999999999999422 4 8999999999999999999999999999
Q ss_pred ecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
.+..........+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.. ..+...-..+.....+..
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g--------~n~~~L~~KI~qgd~~~~ 248 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG--------DNLLSLCKKIEQGDYPPL 248 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc--------ccHHHHHHHHHcCCCCCC
Confidence 998887777889999999999999999999999999999999999999999973 244444445555544432
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+ ..-++..+.++|..|+..||+.||+...+++
T Consensus 249 p--~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 249 P--DEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred c--HHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 1 1346677999999999999999998544433
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-46 Score=354.75 Aligned_cols=245 Identities=26% Similarity=0.397 Sum_probs=214.6
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.++||+|+||.||.++ ..+++.+|+|++++....+..+.+....|..++.+++||.||+++..|.+.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4679999999999999999995 456899999999887666656678899999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
+||+.||.|..++++.+ .+++..++-++.+|+.||.|||++ |||||||||+|||+|.+|+++|+|||+++..-.
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999997543 489999999999999999999999 999999999999999999999999999997766
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.+....+++||+.|||||++.+.+|+.++|.||||+++|||++|.+||. ........+.+...+.+.++..
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~--------~~~~~~~~~~I~~~k~~~~p~~- 248 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY--------AEDVKKMYDKILKGKLPLPPGY- 248 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc--------CccHHHHHHHHhcCcCCCCCcc-
Confidence 6677778999999999999999999999999999999999999999996 3344555555655554443332
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC
Q 038671 674 QDKLISIMEVAISCLDESPESRP 696 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rp 696 (707)
...+..+++++.+..||++|.
T Consensus 249 --ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 249 --LSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --CCHHHHHHHHHHhccCHHHhc
Confidence 223478899999999999995
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=354.28 Aligned_cols=201 Identities=29% Similarity=0.495 Sum_probs=181.1
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
..++|...+.||+|+||+||+|++ .++..||||.+..... .....+.+..|+.+++.++|||||++++++..++..|+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 346899999999999999999965 4689999999987543 33456778899999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC------CCeEEeccc
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE------NEAHVSDFG 586 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~------~~~kl~Dfg 586 (707)
|||||.||+|.+++++++ .+++..++.++.|||.||++||++ +||||||||+|||++.. -.+||+|||
T Consensus 87 VMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999999999997654 589999999999999999999999 99999999999999765 358999999
Q ss_pred cceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 642 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 642 (707)
+|+.+.+. ....+.+|+|-|||||++....|+.|+|+||+|+++|+|++|+.||+
T Consensus 161 fAR~L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 161 FARFLQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred hhhhCCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 99998743 44567899999999999999999999999999999999999999997
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=340.82 Aligned_cols=261 Identities=22% Similarity=0.370 Sum_probs=210.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
+.|+...++|+|+||+||+++.+ +|+.||||++.....+ ..-.+-..+|++++++++|||+|.++++|......++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd-~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDD-PVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCcc-HHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 35788889999999999999765 6999999999765432 334566789999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
|||+..-|.++=+ ....++...+.+++.|++.|+.|+|++ ++|||||||+||+++.+|.+|+||||+|+.+..+
T Consensus 81 E~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 81 EYCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred eecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9998766665532 234588899999999999999999999 9999999999999999999999999999999877
Q ss_pred CCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhh-------------hhhh
Q 038671 595 SSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEI-------------ALNE 660 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~-------------~~~~ 660 (707)
+..++..+.|..|+|||.+.| .+|+.++||||+||++.||++|.+.|...++++........ .-..
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 788888999999999999887 77999999999999999999999998765544311111100 0001
Q ss_pred hcCCCCCCCCc------chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 661 MLDPRLPTPSH------NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 661 ~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+..-++|.+.+ ..+....-+.++++.|++.||.+|++.+|++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11112232221 12334456889999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=366.91 Aligned_cols=251 Identities=29% Similarity=0.468 Sum_probs=210.9
Q ss_pred CCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEee
Q 038671 437 DFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
.++..+.||+|.||.||.|++.....||+|.++.... ..+.|.+|+++|++|+|++||+++++|..++.++|||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 3456688999999999999998888999999876432 346788999999999999999999999999999999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 596 (707)
++.|+|.++++. .....+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+....+..
T Consensus 283 m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 283 MPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred cccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 999999999976 3446689999999999999999999999 999999999999999999999999999995443322
Q ss_pred Cc-cccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 597 NW-AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 597 ~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.. ....-+..|+|||.+..+.++.+|||||||++||||+| |+.||..+. ..+....-....+++.|..+
T Consensus 359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-------n~ev~~~le~GyRlp~P~~C-- 429 (468)
T KOG0197|consen 359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-------NEEVLELLERGYRLPRPEGC-- 429 (468)
T ss_pred eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-------HHHHHHHHhccCcCCCCCCC--
Confidence 11 12223567999999999999999999999999999999 999986432 33333344445667776543
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.++.+++..||+.+|++|||++.+...|+
T Consensus 430 --P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~ 459 (468)
T KOG0197|consen 430 --PDEVYELMKSCWHEDPEDRPTFETLREVLE 459 (468)
T ss_pred --CHHHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence 445899999999999999999999887764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=355.30 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=219.4
Q ss_pred HHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCce
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 510 (707)
.-..+|..++.||+|+|++|++|+ ..+++.||||+..+.........+.+..|-.+|.+| .||.|++++..|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 445789999999999999999994 567999999999776555555567788999999999 799999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
|+|+||+++|+|.++++..+ .+++...+.++.||+.||+|||++ |||||||||+|||+|+|+++||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999997664 499999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCC-------------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhh
Q 038671 591 LKPDSS-------------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIA 657 (707)
Q Consensus 591 ~~~~~~-------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 657 (707)
+.+... ....++||-.|.+||.+.....++++|+|+|||++|+|+.|++||.. .+....
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra--------~Neyli 295 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRA--------ANEYLI 295 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcc--------ccHHHH
Confidence 753211 12458999999999999999999999999999999999999999973 334556
Q ss_pred hhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 658 LNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
++.+.+-.+..+.... +...+||++.+..||.+|++++|+.+.
T Consensus 296 FqkI~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 FQKIQALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence 6666666665554433 458899999999999999999998753
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=371.07 Aligned_cols=255 Identities=24% Similarity=0.447 Sum_probs=211.2
Q ss_pred cCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
.+....+.||+|.||.||+|+. ++.+.||||.++.. .+....++|++|++.+..++|||||+++|+|.+++.
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 4455567899999999999953 23567999999865 344467899999999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccc-----------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC
Q 038671 510 SFIVYEYLEMGSLAMILSNDAA-----------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN 578 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~ 578 (707)
.++|+|||..|+|.+|+....+ ..+++..+.+.||.|||.||+||-++ .+|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence 9999999999999999964422 12388899999999999999999999 999999999999999999
Q ss_pred CeEEeccccceecCCCC-CCcc-ccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhh
Q 038671 579 EAHVSDFGTAKFLKPDS-SNWA-ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLE 655 (707)
Q Consensus 579 ~~kl~Dfg~~~~~~~~~-~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 655 (707)
.|||+|||+++..-..+ .+.. ...-+.+|||||.+..++++++|||||+||+|||+++ |+.||...+. +
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--------~ 712 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--------Q 712 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------H
Confidence 99999999998653322 2222 2345779999999999999999999999999999999 9999875543 3
Q ss_pred hhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 656 IALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.++.+...+...- ...+|.++++++..||+..|++||+++|+-..|+
T Consensus 713 EVIe~i~~g~lL~~---Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~ 760 (774)
T KOG1026|consen 713 EVIECIRAGQLLSC---PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ 760 (774)
T ss_pred HHHHHHHcCCcccC---CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence 44455555554322 2345567999999999999999999999988874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=337.28 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=212.7
Q ss_pred HhcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
..++|++.+.||.|..++||+| ..+.++.||||++.-..... ..+.+.+|++.|+.++||||++++..|..+..+|+
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV 101 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence 3578999999999999999999 56788999999997654443 46889999999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||.||.+|++.+.++..-+ ..+++..+..|++++++||.|||.+ |.||||||+.|||++.+|.|||+|||.+..+.
T Consensus 102 VmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 9999999999999976544 3489999999999999999999999 99999999999999999999999999987766
Q ss_pred CCCCCc----cccccccCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 593 PDSSNW----AELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 593 ~~~~~~----~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
..+.+. ..++|++.|||||++.. ..|+.|+||||||++..|+.+|..||..+.+ ....+... ....
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-------mkvLl~tL-qn~p 249 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-------MKVLLLTL-QNDP 249 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-------HHHHHHHh-cCCC
Confidence 554432 45689999999998543 4589999999999999999999999974332 22222222 2222
Q ss_pred CC------CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 667 PT------PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 667 ~~------~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
|. ..+........+.+++..|+..||++|||++++++
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 21 11223345568999999999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=342.02 Aligned_cols=253 Identities=28% Similarity=0.437 Sum_probs=202.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC--cee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR--HSF 511 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~ 511 (707)
..+|...+.||+|+||+||++.. ++|+..|||.+...... ..+.+.+|++++++++|||||+++|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 34578889999999999999954 45999999998654211 1567899999999999999999999855444 689
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC-CCCeEEecccccee
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL-ENEAHVSDFGTAKF 590 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~-~~~~kl~Dfg~~~~ 590 (707)
+.|||+.+|+|.+++.+.+. .+++..++++++||++||+|||++ |||||||||+|||++. ++.+||+|||.+..
T Consensus 93 i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 99999999999999976553 699999999999999999999999 9999999999999999 79999999999987
Q ss_pred cCC---CCCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 591 LKP---DSSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 591 ~~~---~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
... .........||+.|||||++..+ ....++||||+||++.||+||+.||... .......+........
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~ 241 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSL 241 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCC
Confidence 663 11223457899999999999953 3345999999999999999999998642 1112222222222223
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
|.. ....+.+..+++.+|+..+|++||||+++++.
T Consensus 242 P~i---p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 242 PEI---PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CCC---CcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 321 12345568899999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=350.70 Aligned_cols=250 Identities=24% Similarity=0.441 Sum_probs=214.3
Q ss_pred hcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
...|+....||+|+.|.||.| ...+++.||||++..... ...+-+..|+.+|+..+|+|||++++.|..++.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 456888899999999999999 567889999999976432 2456789999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||++||+|.+.+... .+++.++..|++++++||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EeecCCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 9999999999998643 389999999999999999999999 999999999999999999999999999999887
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
........+|||.|||||+.....|++++||||||+++.||+.|.+||-.... -.....+...-.+++..+
T Consensus 422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-----lrAlyLIa~ng~P~lk~~---- 492 (550)
T KOG0578|consen 422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRALYLIATNGTPKLKNP---- 492 (550)
T ss_pred ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-----HHHHHHHhhcCCCCcCCc----
Confidence 77777888999999999999999999999999999999999999999853211 111122222223333333
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+..+.+++.+|+..||++||++.|+++
T Consensus 493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 493 EKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 344566999999999999999999999986
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=348.74 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=213.3
Q ss_pred HHhcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCc-hh-hhHHHHHHHHHHHhcCC-CCceeeeeeeeecCC
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPS-EM-ASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHAR 508 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~-~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 508 (707)
...+.|.+.+.||+|+||.|+.| ...+|+.||+|++...... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34578999999999999999999 5567899999977654211 11 23456778999999998 999999999999999
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC-CCeEEecccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE-NEAHVSDFGT 587 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~-~~~kl~Dfg~ 587 (707)
..++||||+.||.|.+++.. .+++.+..+.++++|++.|++|+|++ ||+||||||+||+++.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999965 34688899999999999999999999 99999999999999999 9999999999
Q ss_pred ceecCCCCCCccccccccCCCCccccccCC-CC-ccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCC
Q 038671 588 AKFLKPDSSNWAELAGTYGYVAPELAYTMK-VT-EKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPR 665 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (707)
+.............+|++.|+|||++.+.. |+ .++||||+|+++|.|++|+.||+. .........+....
T Consensus 168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d--------~~~~~l~~ki~~~~ 239 (370)
T KOG0583|consen 168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD--------SNVPNLYRKIRKGE 239 (370)
T ss_pred ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--------ccHHHHHHHHhcCC
Confidence 998754445667889999999999999987 85 789999999999999999999974 22233333355555
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+..+.... +.++..++.+|+..||.+|+++.+++.
T Consensus 240 ~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 240 FKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 54443321 456889999999999999999999873
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=345.31 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=214.5
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|.+.+.||+|+||.||+|+ ..+.+.||+|.+.+....+ .+...+.+|++++++++||||+.++++|+...+.|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 468888999999999999995 5578999999998765443 45677999999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.| +|..++..+ +.++++.+..++.+++.||.|||+. +|.|||+||+||+++..|.+|+||||+|+.+...
T Consensus 81 e~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 99987 999999654 4599999999999999999999999 9999999999999999999999999999998877
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
........|||.|||||...+.+|+..+|+||+||++||+++|++||. ........+.+.......+.
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~--------a~si~~Lv~~I~~d~v~~p~---- 221 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY--------ARSITQLVKSILKDPVKPPS---- 221 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch--------HHHHHHHHHHHhcCCCCCcc----
Confidence 777777889999999999999999999999999999999999999985 22233344444433333332
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.....+..++...+.+||..|.+..+++.
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 44556899999999999999999988764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=316.47 Aligned_cols=239 Identities=25% Similarity=0.343 Sum_probs=207.9
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|+..+.||.|+||.|.+++.+ +|..+|+|++.....-.....+....|..+++.+.||.++++++.+.+.+..||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 57889999999999999999654 68899999998765555556677889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++||-|..++++. +++++..++.+|.||+.|++|||+. +|++||+||+|||+|++|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~---~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS---GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHHhc---CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 999999999999754 4599999999999999999999999 999999999999999999999999999998763
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
...+.+|||.|+|||++...+|..++|.||||+++|||+.|.+||...+ .....+.+...+...|....
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~--------~~~iY~KI~~~~v~fP~~fs- 265 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN--------PIQIYEKILEGKVKFPSYFS- 265 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC--------hHHHHHHHHhCcccCCcccC-
Confidence 3567899999999999999999999999999999999999999996322 24445555555555544333
Q ss_pred HHHHHHHHHHHhccCCCCCCC
Q 038671 675 DKLISIMEVAISCLDESPESR 695 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~R 695 (707)
.++.+++...++.|-.+|
T Consensus 266 ---~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 ---SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ---HHHHHHHHHHHhhhhHhh
Confidence 348889999999998888
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=329.53 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=218.3
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.-+|++.+.+|+|+||.|-+|+ +..|+.||||.+++.........-.+.+|+++|..|+||||+.+|++|+..+...+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 4578889999999999999994 578999999999887766666777799999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||..+|.|++++.+.+ .+++.+++++++||+.|+.|+|.+ +++|||||.+|||+|.++++||+|||++-.+.
T Consensus 132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~- 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA- 204 (668)
T ss_pred EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc-
Confidence 99999999999997654 599999999999999999999999 99999999999999999999999999997765
Q ss_pred CCCCccccccccCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
......+++|+|-|.+||+..|.+| .+.+|.||||+++|.++.|..||+. .+....+..+....+..|..
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG--------~Dhk~lvrQIs~GaYrEP~~- 275 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG--------RDHKRLVRQISRGAYREPET- 275 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC--------chHHHHHHHhhcccccCCCC-
Confidence 3456788999999999999999998 5789999999999999999999974 33344555555555554432
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
+....-+|++|+..+|++|.|+.++...
T Consensus 276 ----PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 276 ----PSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ----CchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1225678999999999999999999764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=347.67 Aligned_cols=262 Identities=25% Similarity=0.400 Sum_probs=213.6
Q ss_pred HHHHHHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 038671 429 EEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR 508 (707)
Q Consensus 429 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 508 (707)
++++...++..+.++||+|.||+||+|++. | .||||++....... +..++|+.|+.++++-+|.||+-+.||+..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 455566677888999999999999999884 3 48999998765554 47889999999999999999999999999988
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
. .||+.+|+|.+|+.++|-.. ..++..+.+.||+||++|+.|||.+ +|||||||..||++.+++.|||+|||++
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred e-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 7 99999999999999997543 4689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCC--CCCCccccccccCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcC
Q 038671 589 KFLKP--DSSNWAELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD 663 (707)
Q Consensus 589 ~~~~~--~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 663 (707)
..-.. .........|...|||||+++. .+|++.+||||||+++|||+||..||. ... .+...........
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~---~dqIifmVGrG~l- 610 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQN---RDQIIFMVGRGYL- 610 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCC---hhheEEEeccccc-
Confidence 75332 2333444567888999999884 468999999999999999999999986 111 1111112222212
Q ss_pred CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 664 PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
++.........+.++.+|+..||..++++||.+.+++..|+
T Consensus 611 --~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~ 651 (678)
T KOG0193|consen 611 --MPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE 651 (678)
T ss_pred --CccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence 23333344556678999999999999999999999998654
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=309.97 Aligned_cols=262 Identities=21% Similarity=0.324 Sum_probs=208.1
Q ss_pred cCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.+|...+++|+|.||.||+| +.++|+.||+|+++.....+.. .....+|++.++.++||||+.++++|...+...+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi-~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI-NRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc-cHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 46888899999999999999 5678999999999865433322 345689999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++ .+|+..++.. ...++..++..++.++++|++|||++ .|+||||||.|+|++++|.+||+|||+|+.+.+.
T Consensus 81 Efm~-tdLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred Eecc-ccHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9996 6888888643 45689999999999999999999999 9999999999999999999999999999999877
Q ss_pred CCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhh--------hh------hh
Q 038671 595 SSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE--------IA------LN 659 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--------~~------~~ 659 (707)
.......+-|..|+|||.+.|. .|+..+|+||.||++.||+.|.+-|...++++.....+. .+ .+
T Consensus 155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 7666666889999999988875 489999999999999999999888765433321100000 00 00
Q ss_pred hhcCCCCCCC--CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 660 EMLDPRLPTP--SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 660 ~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...-...|.+ .........+..+++..|+..||.+|++++|++++
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0000011111 11223344567899999999999999999998864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=346.35 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=219.0
Q ss_pred hcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.+.|.+++.||.|+.|.|-.| ...+|+.+|||++.............+.+|+-+|+-+.||||+++|+++++..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 356899999999999999999 4568999999999765333333456688999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
.||++||-|.+++... +++++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|..-.
T Consensus 91 lEyv~gGELFdylv~k---G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~- 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK---GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV- 163 (786)
T ss_pred EEecCCchhHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc-
Confidence 9999999999999654 4599999999999999999999999 99999999999999999999999999997643
Q ss_pred CCCCccccccccCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
++.-..+.+|+|.|.|||++.|.+| +.++||||+|||+|.++||+.||+ .++....+..+..+.+..|..
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--------DdNir~LLlKV~~G~f~MPs~- 234 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--------DDNIRVLLLKVQRGVFEMPSN- 234 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--------CccHHHHHHHHHcCcccCCCc-
Confidence 4556677899999999999999998 568999999999999999999997 456666677777766665543
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+.+.++++.+|+..||++|-|++||.+.
T Consensus 235 ---Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 235 ---ISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---CCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 34458899999999999999999999874
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=337.87 Aligned_cols=263 Identities=22% Similarity=0.335 Sum_probs=211.0
Q ss_pred HHhcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCC-c
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHAR-H 509 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-~ 509 (707)
.+-++|.+.++||.|+||.||+| ...+|..||||+++..... .++-.=.+|++.+++++ ||||+++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s--~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc--HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 34567999999999999999999 5667999999999875433 23344678999999998 999999999998887 9
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
+|+|||||+ .+|.++++.+ .+.+++..++.|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+|+
T Consensus 85 L~fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 85 LYFVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred EeeeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccc
Confidence 999999996 6899998755 67899999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCCccccccccCCCCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCccccccc-------------ccchhh
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISS-------------SSSNLE 655 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-------------~~~~~~ 655 (707)
..... ..++..+.|..|+|||++. .+-|+.+.|+|++|||++|+.+-++-|...+.++. ......
T Consensus 159 ev~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 159 EVRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 87643 4456678999999999765 56689999999999999999998888865333220 011111
Q ss_pred hhhhhhcCCCCCCC-----CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 656 IALNEMLDPRLPTP-----SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 656 ~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+...+.-++|.. ....+..+.+..+++.+|++.||.+|||+.|.++.
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 22222233233321 11223356788999999999999999999998864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=335.92 Aligned_cols=251 Identities=26% Similarity=0.411 Sum_probs=212.7
Q ss_pred hcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
...|+..+.||+|.||.||+| ...+++.||+|++.-.. ...+.+.+.+|+.++.+++++||.++|+.+..+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 456888899999999999999 56789999999987543 233567899999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+.||++.+.++... .+++..+.-+++++..|+.|||++ +.+|||||+.||++..+|.+|++|||.+..+..
T Consensus 90 Mey~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HHHhcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeec
Confidence 99999999999996432 347788888999999999999999 999999999999999999999999999998887
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
......+++|||.|||||++.+..|+.++||||||++.+||.+|.+||....+ ...+..+-....|...
T Consensus 164 ~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--------mrvlflIpk~~PP~L~--- 232 (467)
T KOG0201|consen 164 TVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--------MRVLFLIPKSAPPRLD--- 232 (467)
T ss_pred hhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--------ceEEEeccCCCCCccc---
Confidence 77667889999999999999998999999999999999999999999863222 1122222222222211
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
......+.+++..|++.||+.||++.++++.
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2556679999999999999999999999863
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=311.75 Aligned_cols=256 Identities=21% Similarity=0.329 Sum_probs=216.3
Q ss_pred HHhcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
.+++.|++.+.||+|.|+.||++ ..++|+.+|+|++........ ..+++.+|+++-+.|+||||+++.+.+.+.+..|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 45678899999999999999999 677899999998865433332 5678999999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC---CCCeEEeccccc
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL---ENEAHVSDFGTA 588 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~---~~~~kl~Dfg~~ 588 (707)
+|+|++.|+.|..-+-.+ ..+++..+-..++||++||.|+|.. +|||||+||+|+++.. ...+|++|||.|
T Consensus 87 lvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceE
Confidence 999999999997665433 3478888899999999999999999 9999999999999954 346999999999
Q ss_pred eecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 589 KFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 589 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
..+. ++..+-.++|||+|||||+.+..+|+.++|||+.|+++|-++.|.+||-. +......+.+.......
T Consensus 161 i~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~--------~~~~rlye~I~~g~yd~ 231 (355)
T KOG0033|consen 161 IEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--------EDQHRLYEQIKAGAYDY 231 (355)
T ss_pred EEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC--------ccHHHHHHHHhccccCC
Confidence 9988 66667778999999999999999999999999999999999999999852 22334444555555544
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
+...+....++..+++++|+..||.+|-|+.|.++.
T Consensus 232 ~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 444555566778999999999999999999998753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=333.61 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=202.4
Q ss_pred hcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--Ccee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA--RHSF 511 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 511 (707)
.+.|+..++||+|+||.||+| +..+|+.||+|++......+ .......+|+.++++|+||||+++.+...+. +.+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 345777788999999999999 56789999999997654332 3345678999999999999999999988766 7899
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+|+|||+. +|.-++.. +.-.|++.++..++.|++.||+|+|++ ||.|||||.+|||||.+|.+||+|||+|+++
T Consensus 195 lVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 99999985 56666643 234699999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCC-CccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhh--------hh-hhh
Q 038671 592 KPDSS-NWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE--------IA-LNE 660 (707)
Q Consensus 592 ~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--------~~-~~~ 660 (707)
..... .+...+.|..|+|||.+.|. .|+.++|+||.|||+.||++|++.|+.-..+......+. .+ ...
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 76543 46778899999999988874 599999999999999999999999875332211100000 00 000
Q ss_pred hcCCCCCCCCc--------chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 661 MLDPRLPTPSH--------NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 661 ~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+-......+.. .....+....+++..+|..||.+|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00000000000 11122345778999999999999999999875
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=301.29 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=215.0
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++++.||+|-||.||.|+ .+++-.||+|++.+..........++.+|+++-+.|+||||.++|++|-+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4689999999999999999995 456788999999765544444567799999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
+||...|.+...+.... .+++++.....+..|+|.|+.|+|.. +|+||||||+|+|++.++.+|++|||-+..-+
T Consensus 101 lEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 99999999999997433 45689999999999999999999999 99999999999999999999999999997643
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.......+||..|.|||...+..++..+|+|++|++.||++.|.+||+.. .......++...++..|..
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~--------~~~etYkrI~k~~~~~p~~-- 244 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ--------SHSETYKRIRKVDLKFPST-- 244 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh--------hhHHHHHHHHHccccCCcc--
Confidence 45556789999999999999999999999999999999999999999732 2333444444444444322
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+....++|.+|+..+|.+|.+..|+++.
T Consensus 245 --is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 245 --ISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --cChhHHHHHHHHhccCccccccHHHHhhh
Confidence 23447899999999999999999998864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=332.46 Aligned_cols=253 Identities=25% Similarity=0.312 Sum_probs=206.2
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|+..++||+|+||.||+|+ ..+|..+|+|++.+.......+.+.++.|-.+|....+|.||+++..|.+...+|+|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 5789999999999999999995 457999999999987766667778899999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||++||++..++.+. ..+++..++.++.+++-|++.+|.. |+|||||||+|+|||..|++||+|||++.-+..
T Consensus 220 MEylPGGD~mTLL~~~---~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRK---DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEecCCccHHHHHHhc---CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 9999999999999654 3589999999999999999999999 999999999999999999999999999853211
Q ss_pred -----------------------CCC----C--------------------ccccccccCCCCccccccCCCCccchhHH
Q 038671 594 -----------------------DSS----N--------------------WAELAGTYGYVAPELAYTMKVTEKCDVYS 626 (707)
Q Consensus 594 -----------------------~~~----~--------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s 626 (707)
+.. . ....+|||.|+|||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 000 0 01247999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 038671 627 FGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPT---IQKVS 702 (707)
Q Consensus 627 lG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~~l~ 702 (707)
||||+|||+.|.+||..... .............-..|... ....+..++|.+|+. ||++|-- ++||.
T Consensus 374 LG~ImyEmLvGyPPF~s~tp----~~T~rkI~nwr~~l~fP~~~----~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETP----QETYRKIVNWRETLKFPEEV----DLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhhhccCCCcC----cccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 99999999999999963221 12222222222222233222 223567899999998 9999964 55554
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=336.13 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=217.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc-eeEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH-SFIV 513 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv 513 (707)
++|..++++|+|+||.++.++++ +++.+++|.+.-....+.. .....+|+.++++++|||||.+.+.|.+++. .+||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 57889999999999999999554 6788999999766555543 3477899999999999999999999999888 9999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|+|++||++.+.+.+.. ...+++..+..|+.||+.|+.|||+. .|+|||||+.||+++.++.|||+|||+|+.+.+
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999997655 46699999999999999999999988 999999999999999999999999999999988
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
+.......+|||.|++||.+.+.+|..|+|||||||++|||++-+++|.. .+.......+....+... .
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a--------~~m~~Li~ki~~~~~~Pl---p 227 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA--------SNMSELILKINRGLYSPL---P 227 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc--------cchHHHHHHHhhccCCCC---C
Confidence 87677888999999999999999999999999999999999999999973 233333333333332221 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+..++..+|+.|++.+|+.||++.+++..
T Consensus 228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2345569999999999999999999999864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=341.39 Aligned_cols=257 Identities=23% Similarity=0.405 Sum_probs=201.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHA 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 507 (707)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.++..+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 46799999999999999999953 2356899999875322 22446788999999999 899999999988764
Q ss_pred -CceeEEEeeeccCcHHHHHhcccc-------------------------------------------------------
Q 038671 508 -RHSFIVYEYLEMGSLAMILSNDAA------------------------------------------------------- 531 (707)
Q Consensus 508 -~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 531 (707)
+..+++|||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 468899999999999999864321
Q ss_pred ----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC--Ccccccccc
Q 038671 532 ----AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS--NWAELAGTY 605 (707)
Q Consensus 532 ----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~ 605 (707)
..++++..+..++.||++||+|||+. ||+||||||+||+++.++.+||+|||+++....... ......+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 13478889999999999999999999 999999999999999999999999999986543322 112234567
Q ss_pred CCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHH
Q 038671 606 GYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVA 684 (707)
Q Consensus 606 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 684 (707)
.|+|||.+.+..++.++||||||+++|||++ |..||..... ..... ....+....... ...+.++.+++
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~----~~~~~---~~~~~~~~~~~~---~~~~~~l~~li 310 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----NEEFC---QRLKDGTRMRAP---ENATPEIYRIM 310 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc----cHHHH---HHHhcCCCCCCC---CCCCHHHHHHH
Confidence 8999999998889999999999999999997 9999864221 11111 111121111111 12345689999
Q ss_pred HhccCCCCCCCCCHHHHHHHhc
Q 038671 685 ISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 685 ~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+||+.||++||++.++++.|+
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l~ 332 (338)
T cd05102 311 LACWQGDPKERPTFSALVEILG 332 (338)
T ss_pred HHHccCChhhCcCHHHHHHHHH
Confidence 9999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=339.78 Aligned_cols=244 Identities=22% Similarity=0.295 Sum_probs=199.5
Q ss_pred ceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccC
Q 038671 442 HCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMG 520 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 520 (707)
+.||+|+||.||++. ..+|+.||+|++.............+.+|++++++++||||+++++++...+..++||||+.++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999995 4578999999987543223334456788999999999999999999999999999999999999
Q ss_pred cHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCccc
Q 038671 521 SLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE 600 (707)
Q Consensus 521 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 600 (707)
+|.+++... +.+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++...........
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence 999988643 4589999999999999999999999 9999999999999999999999999999764433334455
Q ss_pred cccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHH
Q 038671 601 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISI 680 (707)
Q Consensus 601 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (707)
..|++.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.......+. ..+.++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~~~~~~~~~p~----~~~~~~ 222 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEEIRFPR----TLSPEA 222 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCCCCCCC----CCCHHH
Confidence 679999999999999899999999999999999999999985321 12222222222222222 234458
Q ss_pred HHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 681 MEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 681 ~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
.+++.+||+.||++|| ++.++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 8999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=337.83 Aligned_cols=245 Identities=23% Similarity=0.332 Sum_probs=212.0
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 512 (707)
.++|...++||+|+||+|+++. ..+++.+|||++++...-...+.+..+.|.+++... +||.+++++..|....++|.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 4689999999999999999995 456889999999987766666778888898888877 59999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||+.||++..+ ...+.+++..++-++..|+.||+|||++ |||+||||.+|||+|.+|.+||+|||+++...
T Consensus 447 vmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999994333 2335699999999999999999999999 99999999999999999999999999999866
Q ss_pred CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
..+....+++|||.|||||++.+..|+.++|.|||||+||||+.|..||. .+..++.++.++......|.
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~--------gddEee~FdsI~~d~~~yP~-- 589 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP--------GDDEEEVFDSIVNDEVRYPR-- 589 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC--------CCCHHHHHHHHhcCCCCCCC--
Confidence 56667888999999999999999999999999999999999999999996 34445566666655444332
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTI 698 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~ 698 (707)
..+.+...++++++..+|++|.-+
T Consensus 590 --~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 590 --FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --cccHHHHHHHHHHhccCcccccCC
Confidence 344568889999999999999865
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=323.35 Aligned_cols=254 Identities=23% Similarity=0.342 Sum_probs=207.0
Q ss_pred HhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCc-----------hhhhHHHHHHHHHHHhcCCCCceeeee
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPS-----------EMASQQEFLNEVKTLTGIRHRNIVKFY 501 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~niv~~~ 501 (707)
..++|++.+.||+|.||.|-+|+ ..+++.||+|++.+.... .....+.+.+|+.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 45789999999999999999995 567999999998643110 111235799999999999999999999
Q ss_pred eeeecC--CceeEEEeeeccCcHHHHHhcccccCC-CChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC
Q 038671 502 GFCSHA--RHSFIVYEYLEMGSLAMILSNDAAAKD-LGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN 578 (707)
Q Consensus 502 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~ 578 (707)
++..++ +.+|||+|||..|.+... ...++ ++..++++++++++.||+|||.+ |||||||||+|+|++++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 998664 589999999998877533 23344 89999999999999999999999 999999999999999999
Q ss_pred CeEEeccccceecCCCC-----CCccccccccCCCCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCccccccc
Q 038671 579 EAHVSDFGTAKFLKPDS-----SNWAELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSISS 649 (707)
Q Consensus 579 ~~kl~Dfg~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 649 (707)
++||+|||.+....... ......+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||-
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~------- 320 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF------- 320 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc-------
Confidence 99999999998763321 2234478999999999887633 3568899999999999999999985
Q ss_pred ccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 650 SSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+......+.++...+..+. .+++.+++.++|++++.+||+.|.+..+|...
T Consensus 321 -~~~~~~l~~KIvn~pL~fP~--~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 321 -DDFELELFDKIVNDPLEFPE--NPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred -cchHHHHHHHHhcCcccCCC--cccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 34455666677766665543 23556779999999999999999999888654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=333.97 Aligned_cols=248 Identities=25% Similarity=0.326 Sum_probs=203.2
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|++++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4688999999999999999965 478999999986533223334566889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+++|.+++... +.+++..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999998643 3588999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.......+..
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~--- 220 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILAGKLEFPRH--- 220 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCcCCCcc---
Confidence 2345789999999999988899999999999999999999999863221 11222222222222211
Q ss_pred HHHHHHHHHHHhccCCCCCCCCC-----HHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPT-----IQKVSQL 704 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps-----~~~l~~~ 704 (707)
....+.+++.+||+.||.+||+ ++++++.
T Consensus 221 -~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 221 -LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 2345889999999999999995 8887753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=334.01 Aligned_cols=240 Identities=30% Similarity=0.500 Sum_probs=201.4
Q ss_pred CCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeecc
Q 038671 440 DEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 440 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
..+-||.|+-|.||+|+.+ ++.||||+++.. =..+++-+++|+||||+.+.|+|.....++||||||..
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 3467999999999999885 778999987532 12478899999999999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
|-|...++.. +.+.......|..+||.|+.|||.+ .|||||||.-||||..+..|||+|||.++..... ....
T Consensus 197 GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkM 269 (904)
T KOG4721|consen 197 GQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKM 269 (904)
T ss_pred ccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhh
Confidence 9999999654 4578888899999999999999999 9999999999999999999999999999877655 4456
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
.++||..|||||+++..+.++|+|||||||+||||+||..||...+.. ......-... ..++.|.. ++..
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsNs--L~LpvPst----cP~G 339 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSNS--LHLPVPST----CPDG 339 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEeccCCc--ccccCccc----CchH
Confidence 789999999999999999999999999999999999999998643321 1111111111 22333333 3345
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 038671 680 IMEVAISCLDESPESRPTIQKVSQLLKI 707 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rps~~~l~~~L~~ 707 (707)
|.-+++.||+-.|..||++.+++..|+|
T Consensus 340 fklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 340 FKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 8889999999999999999999999987
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=331.44 Aligned_cols=254 Identities=22% Similarity=0.270 Sum_probs=202.7
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
.|+..+.||+|+||.||++. ..+|+.||+|++.............+.+|++++.+++|++++++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 37788999999999999995 46799999999865433333334567889999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 999999998875432 23589999999999999999999999 99999999999999999999999999998754322
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||...... ...+.............+ ..
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~----~~ 227 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER----VKREEVDRRVKEDQEEYS----EK 227 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc----hhHHHHHHHhhcccccCC----cc
Confidence 223457899999999999989999999999999999999999999642211 111111111111111111 12
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 038671 676 KLISIMEVAISCLDESPESRPT-----IQKVSQ 703 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps-----~~~l~~ 703 (707)
.+..+.+++.+||+.||++||+ ++++++
T Consensus 228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 3456889999999999999997 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=326.35 Aligned_cols=246 Identities=22% Similarity=0.329 Sum_probs=198.5
Q ss_pred ceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec----CCceeEEEeee
Q 038671 442 HCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH----ARHSFIVYEYL 517 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 517 (707)
..||+|++|.||+|.. +|+.||||++...........+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6799999999999987 688999999976544333335678899999999999999999999866 34688999999
Q ss_pred ccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCC
Q 038671 518 EMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN 597 (707)
Q Consensus 518 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 597 (707)
++|+|.+++... +.+++....+++.|++.|++|||+.. +++||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 105 TRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence 999999999653 35889999999999999999999842 78899999999999999999999999997654322
Q ss_pred ccccccccCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 598 WAELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 598 ~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .......... ..+.+.+ ..
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~----~~~~~~i~~~--~~~~~~~----~~ 246 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT----KEIYDLIINK--NNSLKLP----LD 246 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhc--CCCCCCC----Cc
Confidence 23467899999999876 6789999999999999999999999974321 1111111111 1122221 12
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.++.+++.+||+.||++|||++++++.|+
T Consensus 247 ~~~~l~~li~~cl~~dp~~Rps~~ell~~l~ 277 (283)
T PHA02988 247 CPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277 (283)
T ss_pred CcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 3456999999999999999999999999885
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=298.25 Aligned_cols=261 Identities=22% Similarity=0.331 Sum_probs=207.9
Q ss_pred HhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA----- 507 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 507 (707)
-.++|++.+.+|+|||+.||.+. ..+++.||+|++.... ....+...+|++..++++|||+++++++...+
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 34689999999999999999994 6788999999998753 34567889999999999999999999987443
Q ss_pred CceeEEEeeeccCcHHHHHhcccccC-CCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAK-DLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
...|++++|+..|+|.+.+......+ .+++.+++.|+.+|++||++||+..+ +++||||||.||++.+++.+++.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEecc
Confidence 35899999999999999987655444 68999999999999999999999832 59999999999999999999999999
Q ss_pred cceecCCCCC---------CccccccccCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchh
Q 038671 587 TAKFLKPDSS---------NWAELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL 654 (707)
Q Consensus 587 ~~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 654 (707)
.+....-.-. .+..-.+|..|+|||.+.- ...++++|||||||++|+|+.|..||+..-. ....-
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSl-- 251 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSL-- 251 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeE--
Confidence 9976542211 1233457999999998763 4468899999999999999999999974221 00011
Q ss_pred hhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 655 EIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.-.+..+.+..|... .+++.+.++|+.|++.||.+||++.+++..++
T Consensus 252 ---aLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d 298 (302)
T KOG2345|consen 252 ---ALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSKLD 298 (302)
T ss_pred ---EEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 111222233333222 26778999999999999999999999998764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=330.54 Aligned_cols=263 Identities=22% Similarity=0.338 Sum_probs=201.0
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC-----------------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCce
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP-----------------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 497 (707)
.++|++.+.||+|+||.||+|..+ ++..||+|++..... ......+.+|++++.+++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCCe
Confidence 357899999999999999999643 234699999875422 2345678999999999999999
Q ss_pred eeeeeeeecCCceeEEEeeeccCcHHHHHhcccc----------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCC
Q 038671 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAA----------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561 (707)
Q Consensus 498 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 561 (707)
+++++++.+.+..+++|||+.+++|.+++..... ...+++..+++++.||+.||+|||+. |
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence 9999999999999999999999999998854321 12468889999999999999999999 9
Q ss_pred eEecCCCCCCeeecCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh--C
Q 038671 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--G 637 (707)
Q Consensus 562 ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g 637 (707)
|+||||||+||+++.++.+||+|||++......... .....++..|+|||.+.+..++.++||||||+++|||++ |
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999999999999999999865433221 122345788999999988889999999999999999997 5
Q ss_pred CCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 638 KHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 638 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..||...... .........................+..+.+++.+||+.||++|||+.++.+.|+
T Consensus 239 ~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 239 EQPYGELTDE----QVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCcCCHH----HHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 6677533221 1111111100000000000001123356899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.96 Aligned_cols=242 Identities=23% Similarity=0.310 Sum_probs=196.4
Q ss_pred eeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccCcH
Q 038671 444 IGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL 522 (707)
Q Consensus 444 lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 522 (707)
||+|+||.||+|+. .+++.||+|++.............+.+|+.++.+++||||+++++++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999955 46889999998643222333456688899999999999999999999999999999999999999
Q ss_pred HHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCccccc
Q 038671 523 AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA 602 (707)
Q Consensus 523 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 602 (707)
.+++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.............
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 154 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC 154 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence 9998643 3589999999999999999999999 999999999999999999999999999976543333344567
Q ss_pred cccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHH
Q 038671 603 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIME 682 (707)
Q Consensus 603 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 682 (707)
|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.... ...............+. ..+.++.+
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~~~ 222 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQEPLRFPD----GFDRDAKD 222 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCCCCCCC----cCCHHHHH
Confidence 9999999999999899999999999999999999999986321 12222222222222221 23456889
Q ss_pred HHHhccCCCCCCCCC---HHHHHH
Q 038671 683 VAISCLDESPESRPT---IQKVSQ 703 (707)
Q Consensus 683 li~~cl~~~P~~Rps---~~~l~~ 703 (707)
++.+||+.||++||+ +.++++
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHc
Confidence 999999999999985 555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=355.09 Aligned_cols=255 Identities=27% Similarity=0.450 Sum_probs=211.1
Q ss_pred cCCCCCceeeecCCeeEEEEEcC--CCc----EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP--SGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
...+..+.||+|+||.||.|... +|. .||+|.+.+. .+..+..+|.+|+.+|+.++|||||+++|++.+.+.
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 44566788999999999999543 343 4888888764 344577899999999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccc----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 510 SFIVYEYLEMGSLAMILSNDAA----AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
.++++|||+||+|..+++..++ ...++..+.+.++.|||+|+.||+++ ++|||||..+|+|+++...|||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence 9999999999999999976533 34589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCC-Ccccc-ccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhc
Q 038671 586 GTAKFLKPDSS-NWAEL-AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEML 662 (707)
Q Consensus 586 g~~~~~~~~~~-~~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 662 (707)
|+|+.+-.... ..... .-+..|||||.+..+.++.|+|||||||++||++| |..||.. ....+.......
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~-------~~n~~v~~~~~~ 919 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS-------RSNFEVLLDVLE 919 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC-------cchHHHHHHHHh
Confidence 99995433322 22222 23468999999999999999999999999999999 9999863 334445554555
Q ss_pred CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 663 DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 663 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+++.|..+ +..+.+++..||+.+|++||++..+++.++
T Consensus 920 ggRL~~P~~C----P~~ly~lM~~CW~~~pe~RP~F~~i~~q~~ 959 (1025)
T KOG1095|consen 920 GGRLDPPSYC----PEKLYQLMLQCWKHDPEDRPSFRTIVEQDP 959 (1025)
T ss_pred CCccCCCCCC----ChHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence 6677776533 345889999999999999999999998653
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=333.91 Aligned_cols=244 Identities=23% Similarity=0.294 Sum_probs=198.2
Q ss_pred ceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccC
Q 038671 442 HCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMG 520 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 520 (707)
+.||+|+||.||+++ ..+|+.||+|++.............+.+|+++++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999995 4578999999987543222334456778999999999999999999999999999999999999
Q ss_pred cHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCccc
Q 038671 521 SLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE 600 (707)
Q Consensus 521 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 600 (707)
+|..++... ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++............
T Consensus 81 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 154 (323)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence 999888543 3589999999999999999999999 9999999999999999999999999998764433333445
Q ss_pred cccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHH
Q 038671 601 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISI 680 (707)
Q Consensus 601 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (707)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ...............+. ..+.++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~~~~~~~~~p~----~~~~~~ 222 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEEIRFPR----TLSPEA 222 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCCCCCCC----CCCHHH
Confidence 679999999999998889999999999999999999999986321 11222222222222221 233558
Q ss_pred HHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 681 MEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 681 ~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
.+++.+||+.||++|| ++.++++
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 223 KSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 8999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.92 Aligned_cols=247 Identities=25% Similarity=0.290 Sum_probs=202.9
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|+. .+++.||+|++...........+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5789999999999999999965 468999999986532222234567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+++|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999998643 3578899999999999999999999 9999999999999999999999999999876432
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.......+..
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~~p~~--- 237 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKILAGRLKFPNW--- 237 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcCCcCCCCC---
Confidence 2345789999999999998899999999999999999999999863221 12222233333322221
Q ss_pred HHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPT-----IQKVSQ 703 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps-----~~~l~~ 703 (707)
.+..+.+++.+||+.||++||+ ++++++
T Consensus 238 -~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 238 -FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 2345789999999999999997 677764
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=336.28 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=205.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC--CC---cEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP--SG---EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~--~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
-++-...+.||+|+||.||+|+.+ ++ ..||||..............++.+|+++|+.++|||||++||++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 345556699999999999999543 23 2389999876443455678899999999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
+++|||+|.||+|.++++... +.++..++..++.++|.||+|||++ +++||||..+|+|++.++.+||+|||+++
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999997543 3689999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhh-c-CCCC
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEM-L-DPRL 666 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~-~~~~ 666 (707)
.............-+..|+|||.+....|+.++|||||||++||+++ |..||...... .....+ . ..++
T Consensus 311 ~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~~~~r~ 382 (474)
T KOG0194|consen 311 AGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVKNGYRM 382 (474)
T ss_pred CCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHhcCccC
Confidence 64311111111134678999999999999999999999999999999 89998754321 112222 1 2223
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.+. ..+.++..++.+||..+|+.||+|.++.+.++
T Consensus 383 ~~~~----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 383 PIPS----KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE 418 (474)
T ss_pred CCCC----CCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence 3332 33455888899999999999999999998875
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=333.43 Aligned_cols=245 Identities=23% Similarity=0.301 Sum_probs=199.6
Q ss_pred ceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccC
Q 038671 442 HCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMG 520 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 520 (707)
+.||+|+||.||+++ ..+|+.||+|++.............+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999995 4578999999987543333344567888999999999999999999999999999999999999
Q ss_pred cHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCccc
Q 038671 521 SLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE 600 (707)
Q Consensus 521 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 600 (707)
+|.+++... +.+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++............
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT 154 (328)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence 999888543 3589999999999999999999999 9999999999999999999999999998764433333445
Q ss_pred cccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHH
Q 038671 601 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISI 680 (707)
Q Consensus 601 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (707)
..|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.......+. ..+.++
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~~~~~~~~~~~~~~p~----~~~~~~ 222 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEDIKFPR----TLSADA 222 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--------HHHHHHhccCCccCCC----CCCHHH
Confidence 6799999999999988899999999999999999999999863211 1222222222222222 233458
Q ss_pred HHHHHhccCCCCCCCC-----CHHHHHHH
Q 038671 681 MEVAISCLDESPESRP-----TIQKVSQL 704 (707)
Q Consensus 681 ~~li~~cl~~~P~~Rp-----s~~~l~~~ 704 (707)
.+++.+||+.||++|| ++.++++.
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 223 KSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 8999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=343.56 Aligned_cols=251 Identities=26% Similarity=0.480 Sum_probs=210.2
Q ss_pred CCCCceeeecCCeeEEEEEcCC----CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 438 FDDEHCIGKGGQGSVYKAELPS----GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
..+.++||.|.||.||+|+++- ...||||.++.. .....+.+|..|+.+|.+++||||+++.|+.......+||
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 4567899999999999997542 356999999865 3445678899999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
.|||++|+|+.|++.+. .++.+.+...++++||.||+||.+. ++|||||..+|||++.+-..|++|||+++.+..
T Consensus 709 TEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999997543 5599999999999999999999999 999999999999999999999999999998866
Q ss_pred CCCC-cccccc--ccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 594 DSSN-WAELAG--TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 594 ~~~~-~~~~~g--~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
+... +....| +.+|.|||.+...+++.+|||||+|++|||.++ |..||=.++ .. +..-.-..+-++|.|
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----NQ--dVIkaIe~gyRLPpP 856 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQ--DVIKAIEQGYRLPPP 856 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----hH--HHHHHHHhccCCCCC
Confidence 5432 222223 468999999999999999999999999999998 999963222 12 222222234456655
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
. +++.++.+++..||++|-.+||++.|++..|+
T Consensus 857 m----DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lD 889 (996)
T KOG0196|consen 857 M----DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLD 889 (996)
T ss_pred C----CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHH
Confidence 4 45667999999999999999999999998874
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.24 Aligned_cols=256 Identities=20% Similarity=0.274 Sum_probs=204.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|+.. +++.||+|++.............+..|++++..++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999654 68999999986543222334566889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999999643 3588999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ...............+.......
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~ 227 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN----ETWENLKYWKETLQRPVYDDPRF 227 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH----HHHHHHHhccccccCCCCCcccc
Confidence 234457899999999999989999999999999999999999999642211 11111111000011111110011
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+.++.+++.+|+..+|.+||+++++++.
T Consensus 228 ~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 228 NLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=333.33 Aligned_cols=248 Identities=23% Similarity=0.299 Sum_probs=201.9
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-C-CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-S-GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
++|++.+.||+|+||.||+|..+ + +..||+|++...........+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 56999999999999999999643 2 368999998643222233456688999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+.+|+|.+++... +.+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 9999999999998643 3588999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+..
T Consensus 184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p~~-- 250 (340)
T PTZ00426 184 R---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKILEGIIYFPKF-- 250 (340)
T ss_pred C---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHhcCCCCCCCC--
Confidence 2 2345799999999999988899999999999999999999999963221 11222222222222221
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRP-----TIQKVSQL 704 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rp-----s~~~l~~~ 704 (707)
.+..+.+++.+|++.||++|+ +++++++.
T Consensus 251 --~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 --LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred --CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 224478999999999999995 88888753
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=310.16 Aligned_cols=264 Identities=25% Similarity=0.402 Sum_probs=205.1
Q ss_pred HHHhcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec----
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH---- 506 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---- 506 (707)
......|...+.||+|+||.|+.+ ...+|+.||+|++..+.... ...++..+|++.+++++|+||+.+.+++..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~-~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQ-IDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhch-HHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 345567777899999999999999 56689999999998665444 345678899999999999999999998854
Q ss_pred -CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 507 -ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 507 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
-...|+|+|+| +.+|...++.. +.++..++..++.||++||+|+|+. +|+|||+||+|++++.+..+||+||
T Consensus 97 ~f~DvYiV~elM-etDL~~iik~~---~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 97 KFNDVYLVFELM-ETDLHQIIKSQ---QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ccceeEEehhHH-hhHHHHHHHcC---ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence 45789999999 57888888654 3489999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCC--CCCccccccccCCCCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCcccccc-----------ccc
Q 038671 586 GTAKFLKPD--SSNWAELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIS-----------SSS 651 (707)
Q Consensus 586 g~~~~~~~~--~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-----------~~~ 651 (707)
|+|+..... ....+..+.|..|+|||... ...|+.+.||||.|||+.||++|++-|.+.+... +..
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 999987642 33456678899999999765 5679999999999999999999999986533221 001
Q ss_pred chhhhh----hhhhcC--CCCCC-C-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 652 SNLEIA----LNEMLD--PRLPT-P-SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 652 ~~~~~~----~~~~~~--~~~~~-~-~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+..... ....+. +..+. + ....+.......+++.+|+..||.+|+|++|.++
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111100 000111 11111 1 0111233445778999999999999999999875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=303.08 Aligned_cols=261 Identities=24% Similarity=0.294 Sum_probs=201.1
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeee--cCCceeE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCS--HARHSFI 512 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~l 512 (707)
++|+..++|++|+||.||+|+ .++++.||+|+++-....+... -.-.+|+.++.+.+|||||.+-++.. +-+..|+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFP-ItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP-ITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCc-chhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 457788999999999999994 5678999999997654333222 23578999999999999999988764 4567999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
|||||+ -+|...++.. .+++...++.-++.|+++|++|||+. .|+||||||+|+|++..|.+||+|||+|+.+.
T Consensus 155 VMe~~E-hDLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVE-HDLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHH-hhHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999997 4788888644 36799999999999999999999999 99999999999999999999999999999998
Q ss_pred CCCCCccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhh----------------
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE---------------- 655 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---------------- 655 (707)
.+...+...+-|..|+|||.+.+.+ |+++.|+||+|||+.||+++++-|...+.+......+.
T Consensus 229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 8877788889999999999988754 89999999999999999999998864332211000000
Q ss_pred hhhhhhcCCCCCCC--CcchHH--HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 656 IALNEMLDPRLPTP--SHNVQD--KLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 656 ~~~~~~~~~~~~~~--~~~~~~--~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.....+..+..+.. ...... ....-.+++..++..||++|.|++|.++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 00000000110000 000000 2245678899999999999999999875
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=332.74 Aligned_cols=245 Identities=22% Similarity=0.292 Sum_probs=198.7
Q ss_pred ceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccC
Q 038671 442 HCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMG 520 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 520 (707)
+.||+|+||.||++. ..+|+.||+|++.............+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999995 4578999999987543223334456788999999999999999999999999999999999999
Q ss_pred cHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 521 SLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN-DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 521 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
+|..++... +.+++..++.++.||+.||+|||+ . ||+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (325)
T cd05594 81 ELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK 154 (325)
T ss_pred cHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence 999888543 358999999999999999999997 6 999999999999999999999999999876543333444
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
...|++.|+|||++.+..++.++||||||+++|+|++|+.||.... .+.....+.......+.. .+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~--------~~~~~~~i~~~~~~~p~~----~~~~ 222 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEEIRFPRT----LSPE 222 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC--------HHHHHHHHhcCCCCCCCC----CCHH
Confidence 5679999999999998889999999999999999999999986321 112222222222222221 2345
Q ss_pred HHHHHHhccCCCCCCCC-----CHHHHHHH
Q 038671 680 IMEVAISCLDESPESRP-----TIQKVSQL 704 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rp-----s~~~l~~~ 704 (707)
+.+++.+|++.||++|+ ++.++++.
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 88999999999999996 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=323.77 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=198.6
Q ss_pred eeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccCcH
Q 038671 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL 522 (707)
Q Consensus 444 lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 522 (707)
||+|+||+||++. ..+|+.||+|++...........+.+..|+++++.++||||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999995 457899999998654333323345678899999999999999999999999999999999999999
Q ss_pred HHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcccc
Q 038671 523 AMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAEL 601 (707)
Q Consensus 523 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 601 (707)
.+.+.... ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||.+.............
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 98874322 234689999999999999999999999 99999999999999999999999999998765544444456
Q ss_pred ccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHH
Q 038671 602 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIM 681 (707)
Q Consensus 602 ~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 681 (707)
.|++.|+|||.+.+..++.++||||+|+++|+|++|+.||...... .................+ ...+.++.
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~----~~~~~~~~ 229 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRILNDSVTYP----DKFSPASK 229 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcc----hhHHHHHHhhcccCCCCc----ccCCHHHH
Confidence 7899999999999999999999999999999999999999642211 011111122222211111 23445688
Q ss_pred HHHHhccCCCCCCCC-----CHHHHHH
Q 038671 682 EVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 682 ~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
+++.+||+.||++|| +++++++
T Consensus 230 ~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 230 SFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 999999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=329.45 Aligned_cols=247 Identities=24% Similarity=0.331 Sum_probs=196.6
Q ss_pred CCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHH---hcCCCCceeeeeeeeecCCceeEE
Q 038671 438 FDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTL---TGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
|++.+.||+|+||.||+|. ..+++.||+|++...........+.+.+|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 6778999999999999995 457899999998653222222344566666554 567899999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+.+++|...++. ..+++..++.++.||+.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988753 3589999999999999999999999 999999999999999999999999999875443
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.........|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+.......+.
T Consensus 154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--------~~~~~~~i~~~~~~~p~--- 222 (324)
T cd05589 154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--------EEEVFDSIVNDEVRYPR--- 222 (324)
T ss_pred CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCC---
Confidence 3344455679999999999999889999999999999999999999986322 11222222222222221
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
..+..+.+++.+||+.||.+|| ++.++++
T Consensus 223 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 223 -FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 2234588999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.77 Aligned_cols=261 Identities=20% Similarity=0.284 Sum_probs=198.4
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|+. .+++.||+|++...... .....+.+|++++++++||||+++++++..++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 5699999999999999999954 57899999998643221 22346778999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++ +|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 83 EYLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred eCCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 99985 888887543 23478899999999999999999999 9999999999999999999999999999765444
Q ss_pred CCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccc-----------cchhh-----hh
Q 038671 595 SSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS-----------SSNLE-----IA 657 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~-----------~~~~~-----~~ 657 (707)
........+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||......... ..... ..
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 333445578999999998865 56899999999999999999999998642210000 00000 00
Q ss_pred hhhhcCCCCCC-C-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 658 LNEMLDPRLPT-P-SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 658 ~~~~~~~~~~~-~-~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
......+.... + ....+....+..+++.+|+..||.+|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000111000 0 00001123457899999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.21 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=202.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHA 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 507 (707)
.++|++.+.||+|+||.||+|+. .++..||||++...... ...+.+.+|++++..+ +||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45799999999999999999952 34668999998654322 2446788999999999 899999999999999
Q ss_pred CceeEEEeeeccCcHHHHHhcccc--------------------------------------------------------
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAA-------------------------------------------------------- 531 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------- 531 (707)
+..++||||+++|+|.++++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 999999999999999999864321
Q ss_pred ----------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 532 ----------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 532 ----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
...+++..+++++.||++||+|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 12478889999999999999999999 99999999999999999999999999998764332
Q ss_pred CC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 596 SN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 596 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... .............. ..+.
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~----~~~~~~~~~~~~~~--~~~~-- 340 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV----DSKFYKMIKEGYRM--LSPE-- 340 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc----hHHHHHHHHhCccC--CCCC--
Confidence 21 112334667999999999899999999999999999998 8889863221 11111111111111 1111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.||++||++.|+++.|+
T Consensus 341 --~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~ 372 (375)
T cd05104 341 --CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372 (375)
T ss_pred --CCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 12346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=335.10 Aligned_cols=332 Identities=26% Similarity=0.285 Sum_probs=268.5
Q ss_pred CCCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCee
Q 038671 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLL 80 (707)
Q Consensus 1 nl~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 80 (707)
||++|+.+.|.+|.++ .+|...+...+|+.|+|.+|.|+.+-.+.++.++.|++|||+.|.|+.+.-..|..=.++++|
T Consensus 100 nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L 178 (873)
T KOG4194|consen 100 NLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKL 178 (873)
T ss_pred cCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEE
Confidence 5777777777777777 667666666677777777777776666777777778888888887776665667766778888
Q ss_pred ecccccccccCC-CCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccC
Q 038671 81 TLENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNIT 159 (707)
Q Consensus 81 ~l~~n~i~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~ 159 (707)
+|++|.|+.+.. .|.++.+|..|.|++|+++.++..+|.++++|+.|+|..|+|....-..|.++++|+.|.|..|.|.
T Consensus 179 ~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~ 258 (873)
T KOG4194|consen 179 NLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDIS 258 (873)
T ss_pred eeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcc
Confidence 888888877655 3777778888888888888888888888888888888888887555667788888888888888888
Q ss_pred CCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCcccc
Q 038671 160 GSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLG 239 (707)
Q Consensus 160 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~ 239 (707)
....++|..+.++++|+|+.|+++.....++.++++|+.|+|++|.|..+.+..+.-.++|++|+|+.|+|+...+.+|.
T Consensus 259 kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~ 338 (873)
T KOG4194|consen 259 KLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFR 338 (873)
T ss_pred cccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHH
Confidence 77788888888888888888888877778888888888888888888878888888888888888888888888888888
Q ss_pred CcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCC---CcccccccccceEeccccccCCchhHhhccCCCc
Q 038671 240 NLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEM---PSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGL 316 (707)
Q Consensus 240 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L 316 (707)
.+..|++|.|+.|.+.......|.++.+|++|||++|.|+..+ ...|..+++|+.|++.+|+|..+....|.++++|
T Consensus 339 ~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~L 418 (873)
T KOG4194|consen 339 VLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEAL 418 (873)
T ss_pred HHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccc
Confidence 8888888888888888777788888899999999999886643 3457788999999999999987777899999999
Q ss_pred eeEeeccCcccccCCCc
Q 038671 317 SYIDISYNELHGSIPNS 333 (707)
Q Consensus 317 ~~l~l~~n~~~~~~~~~ 333 (707)
++|+|.+|.+-..-++.
T Consensus 419 E~LdL~~NaiaSIq~nA 435 (873)
T KOG4194|consen 419 EHLDLGDNAIASIQPNA 435 (873)
T ss_pred ceecCCCCcceeecccc
Confidence 99999999988766554
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=333.56 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=202.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHA 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 507 (707)
.++|++.+.||+|+||.||+|.. .++..||+|++...... ...+.+.+|+++++.+ +||||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 45799999999999999999853 23457999998754322 2456788999999999 899999999999999
Q ss_pred CceeEEEeeeccCcHHHHHhccc---------------------------------------------------------
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDA--------------------------------------------------------- 530 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------------- 530 (707)
+..++||||+++|+|.++++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999885321
Q ss_pred ----------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCC--c
Q 038671 531 ----------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN--W 598 (707)
Q Consensus 531 ----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~ 598 (707)
...++++..+++++.||++||+|||++ |++||||||+||+++.++.+||+|||+++........ .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 112478889999999999999999999 9999999999999999999999999999765433221 1
Q ss_pred cccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHH
Q 038671 599 AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKL 677 (707)
Q Consensus 599 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (707)
....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... .............+..+. ..+
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~----~~~~~~~~~~~~~~~~~~------~~~ 341 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV----NSKFYKMVKRGYQMSRPD------FAP 341 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc----cHHHHHHHHcccCccCCC------CCC
Confidence 12335668999999988889999999999999999997 9999864221 111111111111111111 123
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 678 ISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 678 ~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.++.+++.+||+.||++||++.++++.|+
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~ 370 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQ 370 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 56899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=329.05 Aligned_cols=252 Identities=21% Similarity=0.334 Sum_probs=199.8
Q ss_pred ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEEEeeecc
Q 038671 442 HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
+.||+|+||.||+++. .+++.||+|++.............+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999954 56899999998754333334456688899999888 699999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
|+|.+++... +.+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS 154 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence 9999888543 4589999999999999999999999 999999999999999999999999999875433333444
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccc-chhhhhhhhhcCCCCCCCCcchHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS-SNLEIALNEMLDPRLPTPSHNVQDKLI 678 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (707)
...|++.|+|||++.+..++.++|+||+|+++|+|++|+.||+......... .........+.......+.. .+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~----~~~ 230 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS----LSV 230 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCC----CCH
Confidence 5679999999999999889999999999999999999999997432211111 11111222223322222222 234
Q ss_pred HHHHHHHhccCCCCCCCCC------HHHHHH
Q 038671 679 SIMEVAISCLDESPESRPT------IQKVSQ 703 (707)
Q Consensus 679 ~l~~li~~cl~~~P~~Rps------~~~l~~ 703 (707)
++.+++.+|++.||.+||+ ++++++
T Consensus 231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 5889999999999999997 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.35 Aligned_cols=256 Identities=25% Similarity=0.339 Sum_probs=220.8
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCce
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHS 510 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 510 (707)
.....|++.+.||+|.||.||++..+ +|+.+|+|++.+.........+.+.+|+++|+++. |||||.++++|++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34567999999999999999999655 59999999998766554445678999999999998 99999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC----CCeEEeccc
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE----NEAHVSDFG 586 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~----~~~kl~Dfg 586 (707)
++|||++.||.|.+.+... .+++.++..++.|++.|++|||+. ||+|||+||+|+++... +.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999998654 289999999999999999999999 99999999999999543 479999999
Q ss_pred cceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
++..... .......+||+.|+|||++.+.+|+..+||||+|+++|.|++|..||..... ......+....+
T Consensus 185 la~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~--------~~~~~~i~~~~~ 255 (382)
T KOG0032|consen 185 LAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE--------FEIFLAILRGDF 255 (382)
T ss_pred CceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh--------hHHHHHHHcCCC
Confidence 9999877 5667788999999999999999999999999999999999999999964322 222334455555
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
......+........++|..|+..||.+|+++.++++.
T Consensus 256 ~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 44445556677789999999999999999999999874
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=317.84 Aligned_cols=260 Identities=23% Similarity=0.316 Sum_probs=209.4
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|+. .+++.||+|.+.............+.+|+++++.++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999964 478999999876543334445567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccc-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 515 EYLEMGSLAMILSNDAA-AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
||+++++|.+++..... ...+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988854322 24578899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.........+++.|+|||.+.+..++.++|+||+|+++|||++|+.||.... ...............+. ...
T Consensus 159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~------~~~~~~~~~~~~~~~~~--~~~ 230 (267)
T cd08228 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLFSLCQKIEQCDYPP--LPT 230 (267)
T ss_pred hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc------ccHHHHHHHHhcCCCCC--CCh
Confidence 4333334568889999999988889999999999999999999999985211 11111112221111111 111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+..+.+++.+||+.+|++||++.++++.++
T Consensus 231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~ 263 (267)
T cd08228 231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263 (267)
T ss_pred hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHH
Confidence 234566899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=328.45 Aligned_cols=244 Identities=21% Similarity=0.295 Sum_probs=196.9
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCC-CceeeeeeeeecCCceeEEE
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH-RNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 514 (707)
+|++.+.||+|+||.||+|.. .+++.||+|++...........+.+..|.+++..++| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 588899999999999999954 4678999999875432223345667889999999975 56888999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++|+|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999988543 3588999999999999999999999 9999999999999999999999999998754333
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
........|++.|+|||++.+..++.++||||+|+++|+|+||+.||.... .......+.......+.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--------~~~~~~~i~~~~~~~~~---- 222 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--------EDELFQSIMEHNVSYPK---- 222 (324)
T ss_pred CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCCCCC----
Confidence 333445679999999999999889999999999999999999999996322 11222222222222222
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCH
Q 038671 675 DKLISIMEVAISCLDESPESRPTI 698 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~ 698 (707)
..+.++.+++.+|++.||.+|++.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 223 SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 223458899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=328.75 Aligned_cols=239 Identities=23% Similarity=0.349 Sum_probs=193.5
Q ss_pred ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEEEeeecc
Q 038671 442 HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
+.||+|+||.||+|.. .+++.||+|++...........+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999965 46889999998653222223445677888888776 699999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
|+|.+++... +.+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS 154 (320)
T ss_pred chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence 9999988643 3589999999999999999999999 999999999999999999999999999876543333344
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
...|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.... .......+.......+. ..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~~~~----~~~~~ 222 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDEVVYPT----WLSQD 222 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCCCCCCC----CCCHH
Confidence 5679999999999998889999999999999999999999996322 12222222222222221 12345
Q ss_pred HHHHHHhccCCCCCCCCCH
Q 038671 680 IMEVAISCLDESPESRPTI 698 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rps~ 698 (707)
+.+++.+|++.||++||++
T Consensus 223 ~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 223 AVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHcccCHHHCCCC
Confidence 8899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.59 Aligned_cols=244 Identities=23% Similarity=0.347 Sum_probs=197.8
Q ss_pred ceeeecCCeeEEEEEc----CCCcEEEEEecCCCCC-chhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEee
Q 038671 442 HCIGKGGQGSVYKAEL----PSGEIVAVKKFHSPLP-SEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
+.||+|+||.||+++. .+++.||+|++..... ........+..|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999964 3678999999864321 1112334577899999999999999999999999999999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 596 (707)
+.+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999998643 3478888999999999999999999 999999999999999999999999999876543333
Q ss_pred CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHH
Q 038671 597 NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDK 676 (707)
Q Consensus 597 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (707)
......|++.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.......+.. .
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--------~~~~~~~~~~~~~~~~~~----~ 223 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--------RKKTIDKILKGKLNLPPY----L 223 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCCCCC----C
Confidence 3344679999999999998889999999999999999999999996322 122233333333332222 2
Q ss_pred HHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 677 LISIMEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 677 ~~~l~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
+.++.+++.+||+.||++|| +++++++
T Consensus 224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 34588999999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=326.66 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=203.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||++.. .+|..+|+|++.... .......+.+|++++++++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999954 478889999986542 223456789999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 82 MEHMDGGSLDQVLKEA---KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred eecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999998643 35889999999999999999999862 699999999999999999999999999976543
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc-----------c-----------
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS-----------S----------- 651 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~-----------~----------- 651 (707)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......... .
T Consensus 157 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred c--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 2 223457899999999999988999999999999999999999998532110000 0
Q ss_pred ----------------chhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 652 ----------------SNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 652 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.........+.....+. ......+.++.+++.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000011100010 0011234568999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=326.25 Aligned_cols=243 Identities=24% Similarity=0.363 Sum_probs=192.9
Q ss_pred ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEEEeeecc
Q 038671 442 HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
+.||+|+||.||+|+. .+++.||+|++...........+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999964 56889999998754322223344556666666644 799999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~ 154 (316)
T cd05592 81 GDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS 154 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence 9999988643 3589999999999999999999999 999999999999999999999999999986544444445
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.......+. ..+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~----~~~~~ 222 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDSILNDRPHFPR----WISKE 222 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCC----CCCHH
Confidence 56799999999999988899999999999999999999999963221 1122222222221111 23345
Q ss_pred HHHHHHhccCCCCCCCCCHH-HHH
Q 038671 680 IMEVAISCLDESPESRPTIQ-KVS 702 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rps~~-~l~ 702 (707)
+.+++.+||+.||++||++. +++
T Consensus 223 ~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 223 AKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHH
Confidence 78999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=316.91 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=217.5
Q ss_pred HhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
+.+-|++.+.||+|.|++|-+|+ .-+|++||||++.+...++ .....+.+|++.|+-++|||||++|++......+|+
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 45679999999999999999994 5689999999998765444 356779999999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec-CCCCeEEeccccceec
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD-LENEAHVSDFGTAKFL 591 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~-~~~~~kl~Dfg~~~~~ 591 (707)
|+|.-++|+|.+++..+. ..+.+..+.+++.||+.|+.|+|.. .+|||||||+||.+- .-|-||++|||++-.+
T Consensus 95 iLELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEEecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 999999999999996554 3588999999999999999999999 999999999999875 4689999999999887
Q ss_pred CCCCCCccccccccCCCCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCC
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (707)
.++ ......+|+..|.|||++.|..|+ +++||||||||+|-+++|++||+. .+-.+.+-.++|-++..|.
T Consensus 170 ~PG-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe--------ANDSETLTmImDCKYtvPs 240 (864)
T KOG4717|consen 170 QPG-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE--------ANDSETLTMIMDCKYTVPS 240 (864)
T ss_pred CCc-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc--------ccchhhhhhhhcccccCch
Confidence 755 455678999999999999999985 678999999999999999999973 3334556677777777665
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.. ..+..++|..|+..||++|.+.+++..
T Consensus 241 hv----S~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 241 HV----SKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred hh----hHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 43 445889999999999999999999875
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=338.34 Aligned_cols=254 Identities=24% Similarity=0.321 Sum_probs=205.1
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|+. .+|+.||+|++.............+..|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 4689999999999999999965 478999999986533222234567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998654 4589999999999999999999999 9999999999999999999999999999866543
Q ss_pred C-----------------------------CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 038671 595 S-----------------------------SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS 645 (707)
Q Consensus 595 ~-----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 645 (707)
. .......||+.|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 3 12234578999999999999999999999999999999999999996422
Q ss_pred ccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 038671 646 SISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPT-IQKVSQL 704 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~~l~~~ 704 (707)
. ................+... ..+.++.+++.+|+. ||.+||+ ++++++.
T Consensus 235 ~----~~~~~~i~~~~~~~~~p~~~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 L----QETYNKIINWKESLRFPPDP----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H----HHHHHHHhccCCcccCCCCC----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 11111111111111222211 134568899999997 9999999 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=330.13 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=195.9
Q ss_pred ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEEEeeecc
Q 038671 442 HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
+.||+|+||.||+|+. .+++.||+|++.............+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999964 56889999998764333334456678888888777 799999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
++|..++... +.+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS 154 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence 9999888543 4589999999999999999999999 999999999999999999999999999976443333344
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccc-hhhhhhhhhcCCCCCCCCcchHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSS-NLEIALNEMLDPRLPTPSHNVQDKLI 678 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (707)
...|++.|+|||.+.+..++.++||||||+++|+|++|+.||........... ........+.......+. ..+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~~~~ 230 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSV 230 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC----CCCH
Confidence 56799999999999999999999999999999999999999964322111111 111122222222222222 2234
Q ss_pred HHHHHHHhccCCCCCCCCCH
Q 038671 679 SIMEVAISCLDESPESRPTI 698 (707)
Q Consensus 679 ~l~~li~~cl~~~P~~Rps~ 698 (707)
++.+++.+||+.||++||++
T Consensus 231 ~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 231 KAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHHHHHhcCCHHHcCCC
Confidence 58899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=324.95 Aligned_cols=258 Identities=21% Similarity=0.331 Sum_probs=197.2
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... .....+.+|+.+++.++||||+++++++..+...++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 468999999999999999999654 7899999998654322 2234567899999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+. +++.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 82 FEYVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred EECCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 99996 5676666432 24578899999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhc----------
Q 038671 594 DSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML---------- 662 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 662 (707)
.........+++.|+|||++.+ ..++.++||||+|+++|+|++|+.||....... ...........
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ---DQLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH---HHHHHHHHHhCCCChhhccch
Confidence 3333345678999999998765 457889999999999999999999997432211 00000000000
Q ss_pred -------CCCCCC-CCcchH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 663 -------DPRLPT-PSHNVQ------DKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 663 -------~~~~~~-~~~~~~------~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...... ...... ..+..+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 000000 01235779999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=328.20 Aligned_cols=244 Identities=22% Similarity=0.329 Sum_probs=196.8
Q ss_pred ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEEEeeecc
Q 038671 442 HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
+.||+|+||.||+|+. .+++.||+|++...........+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4689999999999955 46889999998653322233445677788888866 799999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
++|...+... +.+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154 (321)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence 9999888543 3588999999999999999999999 999999999999999999999999999976544433444
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
...|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.... .......+.......+.. .+.+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--------~~~~~~~i~~~~~~~p~~----~~~~ 222 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--------EDDLFESILHDDVLYPVW----LSKE 222 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCCCCC----CCHH
Confidence 5679999999999998889999999999999999999999996322 122222232222222211 2345
Q ss_pred HHHHHHhccCCCCCCCC-------CHHHHHH
Q 038671 680 IMEVAISCLDESPESRP-------TIQKVSQ 703 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rp-------s~~~l~~ 703 (707)
+.+++.+|++.||++|| +++++++
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 88999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=307.49 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=210.8
Q ss_pred cCCCCCceeeecCCeeEEEEEcCC-CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPS-GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
+.|++.+.||+|.-|+||+++..+ +..+|+|++.+..........+...|.++|+.++||.++.+|+.++.++..+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 346777899999999999997654 5899999998776665666677888999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC-
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP- 593 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~- 593 (707)
|||+||+|....++ ++.+.+++..++.++.+++-||+|||-. |||.|||||+||||.++|++.|+||+++.....
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999988764 5567799999999999999999999999 999999999999999999999999998753210
Q ss_pred --------------------------------C-C----------------------CCccccccccCCCCccccccCCC
Q 038671 594 --------------------------------D-S----------------------SNWAELAGTYGYVAPELAYTMKV 618 (707)
Q Consensus 594 --------------------------------~-~----------------------~~~~~~~g~~~y~aPE~~~~~~~ 618 (707)
. . .+...++||-+|.|||++.|..+
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 01223579999999999999999
Q ss_pred CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC-
Q 038671 619 TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPT- 697 (707)
Q Consensus 619 ~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps- 697 (707)
+.++|.|+||+++|||+.|+.||.... -++.+..++......+.. +..+.+..++|++.+.+||++|-.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~--------~~~Tl~NIv~~~l~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSN--------NKETLRNIVGQPLKFPEE--PEVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCC--------chhhHHHHhcCCCcCCCC--CcchhHHHHHHHHHhccChhhhhcc
Confidence 999999999999999999999997432 344455555444433322 144567899999999999999987
Q ss_pred ---HHHHHH
Q 038671 698 ---IQKVSQ 703 (707)
Q Consensus 698 ---~~~l~~ 703 (707)
+.||.+
T Consensus 383 ~rGA~eIK~ 391 (459)
T KOG0610|consen 383 KRGAAEIKR 391 (459)
T ss_pred ccchHHhhc
Confidence 666643
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=316.37 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=201.9
Q ss_pred cCCCCCceeeecCCeeEEEEEc----CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
.+|++.+.||+|+||.||+|.. ..+..||+|.+..... ......+.+|+..+++++||||+++++++..++..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 4688999999999999999954 2467899999876432 223467889999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999986432 3589999999999999999999999 9999999999999999999999999987653
Q ss_pred CCCCC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC-CCCC
Q 038671 592 KPDSS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP-RLPT 668 (707)
Q Consensus 592 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 668 (707)
..... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ......+.+. ..+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~~~~~~~~~ 229 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDVIKAVEDGFRLPA 229 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHHCCCCCCC
Confidence 32211 1112234678999999998899999999999999999875 9999864322 1111111221 1222
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+ ...+..+.+++.+||+.+|.+||+++++.+.|+
T Consensus 230 ~----~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~ 263 (266)
T cd05064 230 P----RNCPNLLHQLMLDCWQKERGERPRFSQIHSILS 263 (266)
T ss_pred C----CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence 2 234456899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=333.10 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=196.1
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||+||+|. ..+++.||+|++.............+..|+.++.+++||+|+++++++.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478999999999999999995 4568999999986533223334567888999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++|+|.+++... +.+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999998643 4589999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC-----------------------------------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCC
Q 038671 595 SS-----------------------------------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 639 (707)
Q Consensus 595 ~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~ 639 (707)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 0123579999999999999899999999999999999999999
Q ss_pred CCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccC--CCCCCCCCHHHHHHH
Q 038671 640 PRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLD--ESPESRPTIQKVSQL 704 (707)
Q Consensus 640 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~P~~Rps~~~l~~~ 704 (707)
||..... ...............++.... ...+..+++.+++. .++..||+++|+++.
T Consensus 235 Pf~~~~~----~~~~~~i~~~~~~~~~p~~~~----~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETP----QETYKKVMNWKETLIFPPEVP----ISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCH----HHHHHHHHcCcCcccCCCcCC----CCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9963221 111111111111111222111 22345666666443 334456899998763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.40 Aligned_cols=244 Identities=21% Similarity=0.301 Sum_probs=197.5
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEEE
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 514 (707)
+|++.+.||+|+||.||+|.. .+++.||+|++.............+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 578899999999999999954 46789999998754322233345567788888777 5899999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++|+|.+.+... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999888543 3588999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
........|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.......+.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~~i~~~~~~~p~---- 222 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPK---- 222 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCC----
Confidence 3344456799999999999999999999999999999999999999963221 2222222222222222
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCH
Q 038671 675 DKLISIMEVAISCLDESPESRPTI 698 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~ 698 (707)
..+.++.+++.+|++.||.+|++.
T Consensus 223 ~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 223 SMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred cCCHHHHHHHHHHcccCHHhcCCC
Confidence 234558899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=336.19 Aligned_cols=251 Identities=23% Similarity=0.325 Sum_probs=199.4
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|+. .+|+.||+|++.............+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4789999999999999999954 578999999986532222334456888999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+|+|.+++... ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 999999999998643 3589999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC--------------------------------------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh
Q 038671 595 SS--------------------------------------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK 636 (707)
Q Consensus 595 ~~--------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t 636 (707)
.. .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10 0112468999999999998889999999999999999999
Q ss_pred CCCCCCcccccccccchhhhhhhhhcC--CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 038671 637 GKHPRDFISSISSSSSNLEIALNEMLD--PRLPTPSHNVQDKLISIMEVAISCLDESPESRPT---IQKVSQ 703 (707)
Q Consensus 637 g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~~l~~ 703 (707)
|..||..... ......+.. .....+.. ...+.++.+++.+|+. +|.+|++ +.++++
T Consensus 235 G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNP--------QETYRKIINWKETLQFPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCH--------HHHHHHHHcCCCccCCCCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999963221 111111111 11111111 1223457889999996 9999998 888765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.12 Aligned_cols=249 Identities=23% Similarity=0.375 Sum_probs=195.6
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|+..+.||+|+||.||+|.. .+++.||+|++.... .......+.+|+++++.++|+||+++++++...+..++||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 4567778999999999999954 578999999986532 2234567899999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+++|.... ..++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999999986432 246677889999999999999999 9999999999999999999999999999876544
Q ss_pred CCCccccccccCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 595 SSNWAELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
........|+..|+|||.+.. ...+.++|||||||++|||++|+.||..... ...............+.
T Consensus 222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~- 295 (353)
T PLN00034 222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----GDWASLMCAICMSQPPE- 295 (353)
T ss_pred cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhccCCCC-
Confidence 333445679999999998743 2235689999999999999999999962111 11111111111111111
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.....+.++.+++.+||+.||++||++.|+++.
T Consensus 296 --~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 296 --APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112334568999999999999999999999864
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=312.71 Aligned_cols=250 Identities=27% Similarity=0.456 Sum_probs=202.5
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
++|++.+.||+|+||.||+++.+++..+|+|.+..... ..+.+.+|++++++++||||+++++++...+..+++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 45888899999999999999888888999998764322 23568889999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++|+|.++++... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+|++|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 80 FMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 999999999986432 3588999999999999999999999 99999999999999999999999999997654322
Q ss_pred CC-ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC-CCCCCCcc
Q 038671 596 SN-WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP-RLPTPSHN 672 (707)
Q Consensus 596 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 672 (707)
.. .....++..|+|||...+..++.++||||||+++|||++ |+.||..... .......... +...+.
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i~~~~~~~~~~-- 224 (256)
T cd05114 155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMISRGFRLYRPK-- 224 (256)
T ss_pred eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCCCCCCC--
Confidence 11 122235568999999988889999999999999999999 8999863221 1111122211 111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.+|++||+++++++.|.
T Consensus 225 --~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 225 --LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred --CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 12346899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.69 Aligned_cols=253 Identities=21% Similarity=0.271 Sum_probs=197.2
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
.|+..+.||+|+||.||+|+ ..+++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58889999999999999994 56789999999865433333345678899999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++|+|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRM---EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 99999999998643 3588899999999999999999999 99999999999999999999999999975431100
Q ss_pred -----------------------------------------------CCccccccccCCCCccccccCCCCccchhHHHH
Q 038671 596 -----------------------------------------------SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFG 628 (707)
Q Consensus 596 -----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG 628 (707)
......+||+.|+|||.+.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 001234799999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHh--ccCCCCCCCCCHHHHHH
Q 038671 629 VLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAIS--CLDESPESRPTIQKVSQ 703 (707)
Q Consensus 629 ~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~P~~Rps~~~l~~ 703 (707)
|++|||++|+.||..... ................+... ..+.++.+++.+ |+..+|..||+++++++
T Consensus 236 ~il~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~----~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP----TETQLKVINWENTLHIPPQV----KLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred hHHHHHHhCCCCCcCCCH----HHHHHHHHccccccCCCCCC----CCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 999999999999963221 01111111111111222211 123457778877 55667777999999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=334.18 Aligned_cols=255 Identities=22% Similarity=0.286 Sum_probs=201.6
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+++. .+++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 46799999999999999999954 56899999998643222223345577899999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++|+|.+++... .+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999998642 478888999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-CccccccccCCCCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 594 DSS-NWAELAGTYGYVAPELAYTM----KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 594 ~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
... ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ......+.......
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~~~ 266 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMDHKNSL 266 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCCcC
Confidence 322 22345799999999988653 378899999999999999999999963221 11222222211111
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPES--RPTIQKVSQL 704 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~~l~~~ 704 (707)
........+.++.+++.+|++.+|++ ||+++++++.
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 01111123456889999999999998 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=325.39 Aligned_cols=244 Identities=24% Similarity=0.327 Sum_probs=197.0
Q ss_pred ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEEEeeecc
Q 038671 442 HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
+.||+|+||.||+|+. .+++.||+|++.............+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999955 46889999998754322233445677888888877 699999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154 (318)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence 9999888643 3589999999999999999999999 999999999999999999999999999976433333344
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
...|++.|+|||.+.+..++.++||||+||++|+|++|+.||..... ......+.......+. ..+.+
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~~~~~i~~~~~~~~~----~~~~~ 222 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DELFQSILEDEVRYPR----WLSKE 222 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCCCCC----cCCHH
Confidence 55789999999999999999999999999999999999999963221 1222222222222221 23345
Q ss_pred HHHHHHhccCCCCCCCCCH-----HHHHH
Q 038671 680 IMEVAISCLDESPESRPTI-----QKVSQ 703 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rps~-----~~l~~ 703 (707)
+.+++.+||+.||.+||++ .++++
T Consensus 223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 223 AKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 8899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.23 Aligned_cols=251 Identities=23% Similarity=0.355 Sum_probs=203.8
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCC-cEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeee-ec------
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSG-EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFC-SH------ 506 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~-~~------ 506 (707)
-++++.++|.+|||+.||.|....+ ..||+|++... +......+.+|+++|+.|+ |||||.+++.. ..
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 4567889999999999999965544 99999998754 4557788999999999997 99999999932 11
Q ss_pred CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 507 ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 507 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
..+++++||||.||.|-+++..+...+ |++.++++|+.|+++|+++||.. .|+|||||||-+|||+..+|..||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 236789999999999999997555444 99999999999999999999998 4579999999999999999999999999
Q ss_pred cceecCCCCCCc---------cccccccCCCCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchh
Q 038671 587 TAKFLKPDSSNW---------AELAGTYGYVAPELA---YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL 654 (707)
Q Consensus 587 ~~~~~~~~~~~~---------~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 654 (707)
.+.......... ....-|+.|+|||.+ .+.++++|+|||+|||+||-++....||+...
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------- 262 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------- 262 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc---------
Confidence 997543322111 123468999999965 47789999999999999999999999997422
Q ss_pred hhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 655 EIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
--.+.+.++..|.. +.+...+.+||..||+.||.+||++.||+..+
T Consensus 263 ---~laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~ 308 (738)
T KOG1989|consen 263 ---KLAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI 308 (738)
T ss_pred ---ceeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence 12333444433321 35667799999999999999999999998765
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=320.63 Aligned_cols=254 Identities=22% Similarity=0.280 Sum_probs=202.7
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
.|++.+.||+|+||.||++.. .+++.||+|++.............+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999954 5789999999865433322334557789999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+.+++|.+++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998885432 34589999999999999999999999 99999999999999999999999999998754322
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
......|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... ....+.....+...... ....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~----~~~~ 227 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE----KVKREEVERRVKEDQEE----YSEK 227 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch----hhHHHHHHHHhhhcccc----cCcc
Confidence 22345789999999999988899999999999999999999999964221 11111111111111111 1123
Q ss_pred HHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 676 KLISIMEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
.+..+.+++.+||+.||++|| +++++++
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 445688999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=318.65 Aligned_cols=255 Identities=25% Similarity=0.431 Sum_probs=205.0
Q ss_pred cCCCCCceeeecCCeeEEEEEcCC------CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPS------GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
++|++.+.||+|+||.||+|.... ...|++|.+.... .......+.+|++.+.+++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 468899999999999999996432 2579999986543 22345678999999999999999999999999899
Q ss_pred eeEEEeeeccCcHHHHHhcccc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC
Q 038671 510 SFIVYEYLEMGSLAMILSNDAA-------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL 576 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~ 576 (707)
.+++|||+++++|.+++..... ...+++..++.++.|++.||+|||+. +++||||||+||+++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence 9999999999999999865322 14578899999999999999999999 9999999999999999
Q ss_pred CCCeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccch
Q 038671 577 ENEAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSN 653 (707)
Q Consensus 577 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 653 (707)
++.++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~------- 232 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN------- 232 (283)
T ss_pred CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence 99999999999976543321 1223456788999999988889999999999999999998 9999863221
Q ss_pred hhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 654 LEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
......+.....+. .....+.++.+++.+||+.||.+||++.++++.|+
T Consensus 233 -~~~~~~i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 233 -QEVIEMIRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred -HHHHHHHHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 11222222222211 11234567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=316.19 Aligned_cols=260 Identities=24% Similarity=0.338 Sum_probs=210.1
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|++|.||++. ..+++.+++|.+...........+++.+|+++++.++|||++++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 468889999999999999996 4588999999876543334445567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 515 EYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
||+++++|.+++.... ....+++..++.++.|+++|++|||+. |++|+||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886422 234589999999999999999999999 999999999999999999999999999887654
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.........++..|+|||...+..++.++|+||||+++|+|++|..||.... ...............+.. ..
T Consensus 159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~--~~ 230 (267)
T cd08229 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEQCDYPPL--PS 230 (267)
T ss_pred CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc------chHHHHhhhhhcCCCCCC--Cc
Confidence 4443444578899999999988889999999999999999999999985321 111111122221111111 11
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+.++.+++.+||+.+|++|||+.+|.+.++
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~ 263 (267)
T cd08229 231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263 (267)
T ss_pred ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence 234567999999999999999999998888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=315.42 Aligned_cols=253 Identities=26% Similarity=0.482 Sum_probs=207.9
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
..+|++.+.||.|+||.||+|...+++.+++|++.... ......+..|+.+++.++|||++++++++...+..+++|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 45689999999999999999988779999999986542 223456889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++.... ...+++..++.++.|++.|++|||+. |++||||+|+||+++.++.+||+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 82 ELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred eecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999997543 35689999999999999999999999 9999999999999999999999999999776543
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcC-CCCCCCCcc
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLD-PRLPTPSHN 672 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 672 (707)
........+++.|+|||...+..++.++||||||+++|+|++ |+.||..... ......... .+.+.+
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~--- 226 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQITAGYRMPCP--- 226 (261)
T ss_pred cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHHhCCcCCCC---
Confidence 322233445678999999988889999999999999999998 8999864321 111111111 122222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+.++.+++.+||+.||++|||+.++++.|+
T Consensus 227 -~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~ 259 (261)
T cd05148 227 -AKCPQEIYKIMLECWAAEPEDRPSFKALREELD 259 (261)
T ss_pred -CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 133456889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=323.96 Aligned_cols=243 Identities=23% Similarity=0.326 Sum_probs=192.9
Q ss_pred ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEEEeeecc
Q 038671 442 HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
+.||+|+||.||+|+. .+|+.||+|++.............+..|..++... +||+|+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999965 46889999998653222222345566777777754 899999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
++|.+++... ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS 154 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence 9999988543 3588999999999999999999999 999999999999999999999999999875433333345
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
...|++.|+|||++.+..++.++||||+|+++|||++|+.||..... ......+.......+. ....+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------~~~~~~~~~~~~~~~~----~~~~~ 222 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------DELFESIRVDTPHYPR----WITKE 222 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCC----CCCHH
Confidence 56799999999999998999999999999999999999999963221 1112222211111111 12345
Q ss_pred HHHHHHhccCCCCCCCCCHH-HHH
Q 038671 680 IMEVAISCLDESPESRPTIQ-KVS 702 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rps~~-~l~ 702 (707)
+.+++.+||+.||++||++. ++.
T Consensus 223 ~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 223 SKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHccCCHHHcCCChHHHH
Confidence 88999999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=320.33 Aligned_cols=261 Identities=25% Similarity=0.367 Sum_probs=201.1
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+++. .+++.||+|++....... ...+.+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc-cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 4689999999999999999965 468899999987543222 23456788999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++++++..+... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 80 EYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred ecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99998877765432 24588999999999999999999999 9999999999999999999999999999876433
Q ss_pred CC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchh-------hhhhh-hhcCC-
Q 038671 595 SS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL-------EIALN-EMLDP- 664 (707)
Q Consensus 595 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~-------~~~~~-~~~~~- 664 (707)
.. ......|++.|+|||++.+..++.++||||+|+++|||++|+.||............. ..... ...++
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 22 2234578999999999998889999999999999999999999996432211000000 00000 00000
Q ss_pred ----CCCC---CCc----chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 665 ----RLPT---PSH----NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 665 ----~~~~---~~~----~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+. +.. .....+.++.+++.+|++.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0010 000 00113456899999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=312.51 Aligned_cols=259 Identities=27% Similarity=0.453 Sum_probs=203.2
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhc--CCCCceeeeeeeeecCC----
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG--IRHRNIVKFYGFCSHAR---- 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~---- 508 (707)
....+..+.+|+|.||.||+|... ++.||||++... ..+.+..|-++++- ++|+||++++++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 345667788999999999999885 589999998542 45667777777664 47999999999886655
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCC------CCeEecCCCCCCeeecCCCCeEE
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF------PPIVHRDISSKNVLLDLENEAHV 582 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~------~~ivH~dlk~~Nil~~~~~~~kl 582 (707)
.+++|+||.+.|+|.+++..+ .++|....+++..+++||+|||+..+ |+|+|||||++||||..|++..|
T Consensus 282 eywLVt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred ceeEEeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 899999999999999999754 48999999999999999999998654 68999999999999999999999
Q ss_pred eccccceecCCCCC--CccccccccCCCCccccccCC-CC-----ccchhHHHHHHHHHHHhCCC------------CCC
Q 038671 583 SDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMK-VT-----EKCDVYSFGVLALEVIKGKH------------PRD 642 (707)
Q Consensus 583 ~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~-~~-----~~~Dv~slG~~l~el~tg~~------------p~~ 642 (707)
+|||+|..+.++.. .....+||.+|||||++.+.- .. .+.||||+|.++|||++.-. ||+
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 99999998875532 233468999999999988743 11 36899999999999997432 222
Q ss_pred c-ccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 643 F-ISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 643 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
. ...-.......+....+..+|.++..+... ..+..+.+.+..||+.||+.|.|+.=+.+.+
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~ 500 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERM 500 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence 1 111112233334456666677777665544 4566799999999999999999988776553
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=316.09 Aligned_cols=248 Identities=35% Similarity=0.565 Sum_probs=192.7
Q ss_pred CCceeeecCCeeEEEEEcC-----CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 440 DEHCIGKGGQGSVYKAELP-----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 440 ~~~~lg~G~~g~vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
+.+.||.|.||.||+|.+. .+..|+||.+... ......+.+.+|++.+++++||||++++|++...+..++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence 4578999999999999655 3577999999653 22334678999999999999999999999999888899999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++|+|.+++... ....+++..+++|+.||++||+|||+. +++||||+++||+++.++.+||+|||++......
T Consensus 81 e~~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp E--TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred ccccccccccccccc-ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999999754 234689999999999999999999999 9999999999999999999999999999876322
Q ss_pred CCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCC-CCCCC
Q 038671 595 SSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPR-LPTPS 670 (707)
Q Consensus 595 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 670 (707)
... .........|+|||.+.+..++.++||||||+++||+++ |+.||..... ......+.+.. .+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~~ 228 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEIIEKLKQGQRLPIPD 228 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHHHHHHHTTEETTSBT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccceecc
Confidence 211 122356778999999998889999999999999999999 7889763221 11122222222 22221
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
..+..+.+++.+||+.+|++||++.++++.|
T Consensus 229 ----~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 ----NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2234588999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=373.76 Aligned_cols=329 Identities=37% Similarity=0.532 Sum_probs=160.4
Q ss_pred CCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecc
Q 038671 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLE 83 (707)
Q Consensus 4 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (707)
+|++|+|++|.+++..|..++.+++|++|+|++|.+.+..|..+.++++|++|+|++|.+.+..|..|+++++|++|+|+
T Consensus 141 ~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 220 (968)
T PLN00113 141 NLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLG 220 (968)
T ss_pred CCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECc
Confidence 34444444444444444444444444444444444444444444444444444444444444444444444444444444
Q ss_pred cccccc-cCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCC
Q 038671 84 NNQLRG-PIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSM 162 (707)
Q Consensus 84 ~n~i~~-~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~ 162 (707)
+|.+.. ++..+..+++|++|++++|.+++..+..+..+++|++|+|++|.+.+..+..+..+++|++|+|++|.+.+..
T Consensus 221 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~ 300 (968)
T PLN00113 221 YNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300 (968)
T ss_pred CCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCC
Confidence 444432 2223444444444444444444444444444444444444444444444444444444444444444444444
Q ss_pred chhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcc
Q 038671 163 PAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLV 242 (707)
Q Consensus 163 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~ 242 (707)
+..+.++++|+.|++++|.+.+..|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+++..|..+..++
T Consensus 301 p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~ 380 (968)
T PLN00113 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSG 380 (968)
T ss_pred ChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcC
Confidence 44444444444444444444444444444444444555544444444444444444555555555544444444444444
Q ss_pred cCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeec
Q 038671 243 KLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDIS 322 (707)
Q Consensus 243 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~ 322 (707)
+|+.|++++|++.+..|..+..+++|+.|++++|.+++..|..+.++++|+.|++++|.+++..+..+..+++|+.|+++
T Consensus 381 ~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 460 (968)
T PLN00113 381 NLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLA 460 (968)
T ss_pred CCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECc
Confidence 44555555555444445555555555555555555555555555555555555555555555555555555555555555
Q ss_pred cCcccccCCC
Q 038671 323 YNELHGSIPN 332 (707)
Q Consensus 323 ~n~~~~~~~~ 332 (707)
+|++.+..|.
T Consensus 461 ~n~~~~~~p~ 470 (968)
T PLN00113 461 RNKFFGGLPD 470 (968)
T ss_pred CceeeeecCc
Confidence 5555554444
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=326.05 Aligned_cols=240 Identities=23% Similarity=0.313 Sum_probs=190.8
Q ss_pred ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHH-HHhcCCCCceeeeeeeeecCCceeEEEeeecc
Q 038671 442 HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVK-TLTGIRHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
+.||+|+||.||+|.. .+|+.||+|++.............+..|.. .++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999955 578999999986532222222334445544 56788999999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
++|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (323)
T cd05575 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS 154 (323)
T ss_pred CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence 9999988643 3588999999999999999999999 999999999999999999999999999876443333344
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
...|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+.......+. ..+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~~~----~~~~~ 222 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILNKPLRLKP----NISVS 222 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCCCCCCC----CCCHH
Confidence 5679999999999999889999999999999999999999986321 11222222222222211 22455
Q ss_pred HHHHHHhccCCCCCCCCCHH
Q 038671 680 IMEVAISCLDESPESRPTIQ 699 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rps~~ 699 (707)
+.+++.+|++.||++||++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCC
Confidence 88999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.22 Aligned_cols=251 Identities=26% Similarity=0.433 Sum_probs=202.5
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
++|++.+.||+|+||.||.|+..++..+|+|.+..... ..+.+.+|+.++++++||||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 45888899999999999999877777799998764322 23568899999999999999999999999899999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+.+++|.+++.... ..+++..++.++.||+.|++|||+. |++|+||+|+||+++.++.+||+|||.+.......
T Consensus 80 ~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 80 YMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 999999999986432 2589999999999999999999999 99999999999999999999999999987654332
Q ss_pred CC-ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 596 SN-WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 596 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.. .....++..|+|||...+..++.++||||||+++|+|++ |+.||..... .................
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~-- 224 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVEKVSQGLRLYRPH-- 224 (256)
T ss_pred eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHhcCCCCCCCC--
Confidence 11 112335678999999988889999999999999999999 9999863221 11111111111111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 225 -~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 -LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=322.47 Aligned_cols=243 Identities=23% Similarity=0.345 Sum_probs=192.2
Q ss_pred ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEEEeeecc
Q 038671 442 HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
+.||+|+||.||+|+. .+++.||+|++.............+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999965 46789999998653221122334566677777754 899999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
|+|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC 154 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence 9999998643 3588999999999999999999999 999999999999999999999999999876433333344
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
...|++.|+|||.+.+..++.++||||+||++|||++|+.||..... ..............+. ....+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~~~~~~~----~~~~~ 222 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EELFQSIRMDNPCYPR----WLTRE 222 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCc----cCCHH
Confidence 56789999999999988899999999999999999999999863221 1111111111111111 12345
Q ss_pred HHHHHHhccCCCCCCCCCHH-HHH
Q 038671 680 IMEVAISCLDESPESRPTIQ-KVS 702 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rps~~-~l~ 702 (707)
+.+++.+||+.||++||++. ++.
T Consensus 223 ~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 223 AKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHHHhccCHhhcCCChHHHH
Confidence 78999999999999999996 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=311.76 Aligned_cols=260 Identities=25% Similarity=0.345 Sum_probs=210.2
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|++|.||+|... +|+.|++|.+...........+.+.+|++++++++|++++++++++...+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999654 89999999886533333344677899999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 515 EYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
||+++++|.+++.... ....+++..++.++.|+++|+.|||+. |++||||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886432 234589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.........+++.|+|||...+..++.++|+||||+++|+|++|+.||.... ...............+... .
T Consensus 159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~--~ 230 (267)
T cd08224 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIEKCDYPPLP--A 230 (267)
T ss_pred CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHhhhhcCCCCCCC--h
Confidence 4333344578899999999988889999999999999999999999985321 1111111111111111110 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+..+.+++.+||..+|++||++.++++.|+
T Consensus 231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~ 263 (267)
T cd08224 231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAK 263 (267)
T ss_pred hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence 134456889999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=347.11 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=202.4
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|.. .+|+.||+|++...........+++.+|++++++++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999954 568999999987644333344567899999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhccc--------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 515 EYLEMGSLAMILSNDA--------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
||++|++|.+++.... .....++..+++++.||++||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 123456778899999999999999999 99999999999999999999999999
Q ss_pred cceecCCCC------------------CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc
Q 038671 587 TAKFLKPDS------------------SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIS 648 (707)
Q Consensus 587 ~~~~~~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 648 (707)
++....... ......+||+.|+|||.+.+..++.++||||+||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998652111 01122468999999999999999999999999999999999999986422100
Q ss_pred cccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHh
Q 038671 649 SSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRP-TIQKVSQLL 705 (707)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~~l~~~L 705 (707)
.........+.-.. ...+.+..+.+++.+|++.||++|| +++++.+.|
T Consensus 239 ------i~~~~~i~~P~~~~---p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L 287 (932)
T PRK13184 239 ------ISYRDVILSPIEVA---PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL 287 (932)
T ss_pred ------hhhhhhccChhhcc---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 00001111111111 1123455688999999999999996 556666554
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=331.37 Aligned_cols=256 Identities=21% Similarity=0.286 Sum_probs=200.2
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
..++|++.+.||+|+||.||+++. .+++.+|+|++.............+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 357899999999999999999965 4688999999864322222334567889999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999998542 478889999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC-CccccccccCCCCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 593 PDSS-NWAELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 593 ~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
.... ......||+.|+|||++.+.. ++.++||||+|+++|+|++|+.||..... ......+.+....
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~ 265 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTYSKIMDHKNS 265 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCcc
Confidence 3322 223567999999999987543 77899999999999999999999963221 1122222221111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPES--RPTIQKVSQL 704 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~~l~~~ 704 (707)
.........+..+.+++..|+..+|.+ ||++.|+++.
T Consensus 266 ~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 266 LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111111223455788899999865544 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=302.07 Aligned_cols=264 Identities=21% Similarity=0.297 Sum_probs=201.0
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCc-eeeeeeeeecCC-----
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN-IVKFYGFCSHAR----- 508 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~----- 508 (707)
..|+..++||+|+||+||+|+ ..+|+.||+|++.-....+ .......+|+.++++++|+| |+++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E-G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE-GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc-CCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 346667789999999999994 5678999999997653322 23345689999999999999 999999997766
Q ss_pred -ceeEEEeeeccCcHHHHHhccccc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 509 -HSFIVYEYLEMGSLAMILSNDAAA-KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 509 -~~~lv~e~~~~~~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
..++|+||++ -+|..++...... +.++...+..++.||++||+|||++ +|+||||||+||+|+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 7899999996 6888888654432 4567788999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchh--------hhh
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL--------EIA 657 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~--------~~~ 657 (707)
+|+...-+......-++|..|+|||++.+. .|+...||||+||+++||++++.-|...+......... ..+
T Consensus 166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 999766455556667889999999999886 68999999999999999999998886533321000000 000
Q ss_pred hhhh-------cCCCCCCCCcchHHH---HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 658 LNEM-------LDPRLPTPSHNVQDK---LISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 658 ~~~~-------~~~~~~~~~~~~~~~---~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
-... ..+....+....... .....+++.+|++.+|.+|.|++..++.
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0000 001111011111111 1367899999999999999999998763
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=318.06 Aligned_cols=262 Identities=23% Similarity=0.361 Sum_probs=211.1
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
..+...+.++||+|-||.|..+....+.+||||..+.... .....+|.+|+++|.+++||||++++|+|..++.++++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 3556778899999999999999888789999999987533 34568899999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
+||+++|+|..++..+.... .......+|+.||+.||+||.+. ++||||+.++|+|++.++++||+|||+++.+-.
T Consensus 614 ~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 99999999999998765433 45667778999999999999999 999999999999999999999999999986544
Q ss_pred CCCC-c-cccccccCCCCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCcccccccccchhhhhhhhhcCCC-CCC
Q 038671 594 DSSN-W-AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFISSISSSSSNLEIALNEMLDPR-LPT 668 (707)
Q Consensus 594 ~~~~-~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 668 (707)
++.. . ...+-+.+|||||.+.-++++++||||+||+++||+++ ...||...... ...+. ...+.+.. ...
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e----~vven-~~~~~~~~~~~~ 764 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE----QVVEN-AGEFFRDQGRQV 764 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH----HHHHh-hhhhcCCCCcce
Confidence 3322 1 23455789999999999999999999999999999876 78898754331 11222 22222222 111
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....++-++.++.+++.+||+.+-++||+++++...|.
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq 802 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQ 802 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence 11222334556889999999999999999999987763
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=334.40 Aligned_cols=254 Identities=21% Similarity=0.276 Sum_probs=197.4
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||++. ..+++.||+|++...........+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 468999999999999999995 5578999999986432222334567888999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++|+|.+++... +.+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999998643 4588999999999999999999999 9999999999999999999999999998643210
Q ss_pred CC-----------------------------------------------CccccccccCCCCccccccCCCCccchhHHH
Q 038671 595 SS-----------------------------------------------NWAELAGTYGYVAPELAYTMKVTEKCDVYSF 627 (707)
Q Consensus 595 ~~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~sl 627 (707)
.. .....+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 0012468999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCC---CCHHHHHHH
Q 038671 628 GVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESR---PTIQKVSQL 704 (707)
Q Consensus 628 G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---ps~~~l~~~ 704 (707)
||++|||++|+.||..... ................+.. ...+.++.+++.+|+. +|.+| +++.++++.
T Consensus 235 Gvil~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~----~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 235 GAIMFECLIGWPPFCSENS----HETYRKIINWRETLYFPDD----IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred chhhhhhhcCCCCCCCCCH----HHHHHHHHccCCccCCCCC----CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 9999999999999963221 0111111111111111211 1123458899999997 66665 599998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=315.87 Aligned_cols=255 Identities=25% Similarity=0.464 Sum_probs=205.9
Q ss_pred cCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
++|.+.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+++++.++|||++++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 46888899999999999999653 357899999875432 2245788999999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccc-----------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC
Q 038671 510 SFIVYEYLEMGSLAMILSNDAA-----------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN 578 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~ 578 (707)
.+++|||+++++|.+++..... ...+++..+..++.|++.|++|||+. |++||||||+||+++.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence 9999999999999999965432 23478899999999999999999999 999999999999999999
Q ss_pred CeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhh
Q 038671 579 EAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLE 655 (707)
Q Consensus 579 ~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 655 (707)
.+||+|||.+........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--------~ 231 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--------E 231 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--------H
Confidence 999999999976533221 1123345788999999999999999999999999999998 9999853221 1
Q ss_pred hhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 656 IALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...........+.+. ...+..+.+++.+||+.||.+||++.|+++.|+
T Consensus 232 ~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 EVIECITQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 122222222222211 123456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=311.09 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=205.2
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|++|.||+|...+++.||+|.+.... ...+.+.+|+.++++++|||++++++++...+..+++|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 35789999999999999999988888899999876432 23467889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+++|.++++... ...+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 81 EYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred ecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999986532 34588999999999999999999999 9999999999999999999999999999876432
Q ss_pred CC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 595 SS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 595 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
.. ......++..|+|||...+..++.++||||||+++|+|++ |+.||..... .......... ...+..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~~~~~~~~--~~~~~~--- 226 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-----SDVMSALQRG--YRMPRM--- 226 (261)
T ss_pred ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-----HHHHHHHHcC--CCCCCC---
Confidence 21 1122345678999999988889999999999999999998 9999853211 1111111111 111211
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+.++.+++.+||+.+|++||+++++.+.|+
T Consensus 227 -~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 227 -ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred -CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 123456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=330.33 Aligned_cols=254 Identities=24% Similarity=0.287 Sum_probs=201.7
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||++. ..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 468899999999999999995 4578999999987543323334566888999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999654 24589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCC-ccccccccCCCCccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 595 SSN-WAELAGTYGYVAPELAY------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 595 ~~~-~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
... .....|++.|+|||++. +..++.++||||||+++|||++|+.||...... ...............+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i~~~~~~~~~~ 231 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA----KTYNNIMNFQRFLKFP 231 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH----HHHHHHHcCCCccCCC
Confidence 322 23347899999999886 455788999999999999999999999632211 1111111111111112
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.. ...+.++.+++..|+. +|.+||+++++++
T Consensus 232 ~~----~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 232 ED----PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CC----CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11 1234558889999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=327.89 Aligned_cols=240 Identities=23% Similarity=0.308 Sum_probs=195.1
Q ss_pred ceeeecCCeeEEEEEc----CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeee
Q 038671 442 HCIGKGGQGSVYKAEL----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYL 517 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 517 (707)
+.||+|+||.||+++. .+|+.||+|++...... ......+..|++++++++||||+++++++..++..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999853 46889999998653221 123445778999999999999999999999999999999999
Q ss_pred ccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCC
Q 038671 518 EMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN 597 (707)
Q Consensus 518 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 597 (707)
.+++|.+++... ..+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 81 RGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 999999998543 3589999999999999999999999 9999999999999999999999999999865544334
Q ss_pred ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHH
Q 038671 598 WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKL 677 (707)
Q Consensus 598 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (707)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......+.......+. ..+
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~~~~~~~p~----~~~ 222 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMILKAKLGMPQ----FLS 222 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHHcCCCCCCC----CCC
Confidence 4456799999999999988899999999999999999999999863221 1222222222222221 223
Q ss_pred HHHHHHHHhccCCCCCCCCCHHH
Q 038671 678 ISIMEVAISCLDESPESRPTIQK 700 (707)
Q Consensus 678 ~~l~~li~~cl~~~P~~Rps~~~ 700 (707)
..+.+++.+||+.||++||++.+
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCC
Confidence 45889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=309.01 Aligned_cols=252 Identities=26% Similarity=0.472 Sum_probs=204.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|++|.||+|...+++.||+|.+..... ..+.+.+|++++++++|||++++++++...+..+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 356899999999999999999877788899999865322 2456889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+++|.+++.... ...+++..+..++.|++.|+.|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 81 ELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred ecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 9999999999986543 34689999999999999999999999 9999999999999999999999999999876532
Q ss_pred CCC-ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcC-CCCCCCCc
Q 038671 595 SSN-WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLD-PRLPTPSH 671 (707)
Q Consensus 595 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 671 (707)
... ......+..|+|||...+..++.++||||||+++|||++ |+.||..... ......+.. ...+.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~-- 226 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQVDQGYRMPCP-- 226 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCC--
Confidence 211 111223457999999998889999999999999999999 9999863221 111111111 111111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+.++.+++.+|++.+|.+||+++++++.|+
T Consensus 227 --~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 227 --PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred --CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 133456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=327.50 Aligned_cols=259 Identities=26% Similarity=0.389 Sum_probs=194.6
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----Cce
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA-----RHS 510 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~ 510 (707)
+|++.+.||+|+||.||+|. ..+|+.||+|++...... ......+.+|+++++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 58889999999999999995 457899999998643222 22345688999999999999999999987543 247
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++||||+. ++|.+++... ..+++..+..++.||++||+|||+. ||+||||||+||+++.++.+||+|||+++.
T Consensus 80 ~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 80 YVVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 99999995 6888887543 3589999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCC---CccccccccCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCccccccc-----------ccc--
Q 038671 591 LKPDSS---NWAELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISS-----------SSS-- 652 (707)
Q Consensus 591 ~~~~~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-----------~~~-- 652 (707)
...... ......|++.|+|||++.+ ..++.++||||||+++|||++|+.||........ ...
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 432221 2234578999999998765 5689999999999999999999999964221100 000
Q ss_pred ------hhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 653 ------NLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 653 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
........+............+..+..+.+++.+||+.||++||+++|+++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000001111111100000011122345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.52 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=196.1
Q ss_pred ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEEEeeecc
Q 038671 442 HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
+.||+|+||.||+|.. .+++.||+|++...........+.+..|+.++.++ +||+|+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999954 56889999998764333334456688899999888 699999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
++|..++... +.+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS 154 (327)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence 9999888543 3589999999999999999999999 999999999999999999999999999976443333345
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
...|++.|+|||.+.+..++.++||||||+++|+|++|+.||+....... ..........+.......+. ..+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~p~----~~~~~ 229 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILEKPIRIPR----FLSVK 229 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHhCCCCCCC----CCCHH
Confidence 56799999999999998999999999999999999999999964322111 11111222222222222222 12345
Q ss_pred HHHHHHhccCCCCCCCCCH
Q 038671 680 IMEVAISCLDESPESRPTI 698 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rps~ 698 (707)
+.+++.+|++.||++|+++
T Consensus 230 ~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHhccCHHHcCCC
Confidence 7899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=326.50 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=203.2
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeec
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSH 506 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 506 (707)
..++|++.+.||+|+||.||+|... .+..||||++..... ....+.+.+|+++++++. ||||+++++++.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3568999999999999999999642 234799999865422 234567899999999996 9999999999999
Q ss_pred CCceeEEEeeeccCcHHHHHhcccc-------------------------------------------------------
Q 038671 507 ARHSFIVYEYLEMGSLAMILSNDAA------------------------------------------------------- 531 (707)
Q Consensus 507 ~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 531 (707)
.+..++||||+++|+|.++++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999998854210
Q ss_pred --------------------------------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCee
Q 038671 532 --------------------------------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVL 573 (707)
Q Consensus 532 --------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 573 (707)
...+++..+.+++.|+++||+|||+. +++||||||+||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 12478888899999999999999999 9999999999999
Q ss_pred ecCCCCeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccc
Q 038671 574 LDLENEAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSS 650 (707)
Q Consensus 574 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~ 650 (707)
++.++.+||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~---- 345 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV---- 345 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccch----
Confidence 99999999999999986543322 1223456788999999988889999999999999999997 9999863211
Q ss_pred cchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 651 SSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
........... .+.+.+ ...+.++.+++.+||+.+|++||++.+|.+.|+
T Consensus 346 ~~~~~~~~~~~--~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 346 DSTFYNKIKSG--YRMAKP----DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred hHHHHHHHhcC--CCCCCC----ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 11111111111 111111 123456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=335.35 Aligned_cols=254 Identities=20% Similarity=0.246 Sum_probs=196.9
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.+|++.+.||+|+||.||+|+ ..+++.||+|++.............+.+|++++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 368999999999999999995 4568999999986432222234466889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++|+|.+++... +.+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999998653 3478889999999999999999999 9999999999999999999999999997532100
Q ss_pred C-------------------------------------------CCccccccccCCCCccccccCCCCccchhHHHHHHH
Q 038671 595 S-------------------------------------------SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLA 631 (707)
Q Consensus 595 ~-------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l 631 (707)
. .......||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 001134699999999999998999999999999999
Q ss_pred HHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCC---CHHHHHHH
Q 038671 632 LEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRP---TIQKVSQL 704 (707)
Q Consensus 632 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp---s~~~l~~~ 704 (707)
|||++|+.||...... ...............+.. ...+.++.+++.+|+ .+|.+|+ ++.++++.
T Consensus 235 yell~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 235 YEMLVGQPPFLADTPA----ETQLKVINWETTLHIPSQ----AKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eehhhCCCCCCCCCHH----HHHHHHhccCccccCCCC----CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999999643211 000111110011111111 123345777888876 4999999 88888753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=313.25 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=202.2
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.++++++|||++++++++..++..++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 3579999999999999999996 46788999999864322 2335678899999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.++++.. .++++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 85 MEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 9999999999998643 3588999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC-C
Q 038671 594 DSSNWAELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT-P 669 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 669 (707)
.........+++.|+|||.+. ...++.++||||+|+++|||++|+.||...... . ....+....... .
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-------~-~~~~~~~~~~~~~~ 230 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-------R-ALFLMSKSNFQPPK 230 (267)
T ss_pred cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-------h-hheeeecCCCCCCC
Confidence 333334457889999999874 344788999999999999999999998532211 0 001111111111 0
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
.......+..+.+++.+||+.+|++||+++++++.|
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111123345789999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=335.67 Aligned_cols=250 Identities=21% Similarity=0.227 Sum_probs=201.5
Q ss_pred CCCCCceeeecCCeeEEEEE-cCC-CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPS-GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.|.+.+.||+|++|.||+|. ..+ ++.||+|.+... .......+..|+.+++.++||||+++++++..++..++||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 48899999999999999994 334 678888876432 2234456788999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcc-cccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 515 EYLEMGSLAMILSND-AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 515 e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
||+++|+|.+++... ....++++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 999999999988543 2234688999999999999999999999 999999999999999999999999999987653
Q ss_pred CCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 594 DSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 594 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .................
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--------~~~~~~~~~~~~~~~~~- 292 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--------QREIMQQVLYGKYDPFP- 292 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCC-
Confidence 322 2334579999999999999889999999999999999999999986321 11222222222221111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+.++.+++.+||+.||++||++.+++.
T Consensus 293 --~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 --CPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 123345889999999999999999999875
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=309.28 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=207.5
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|+..+.||+|++|.||+|.. .+++.|++|.+...... ....+.+.+|++++++++|||++++++++...+..++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 477889999999999999954 56899999998643222 3345678899999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++++|.++++.. ....+++..++.++.|++.||.|||+. |++||||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 80 YAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred eCCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999999753 235689999999999999999999999 99999999999999999999999999998766544
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
.......+++.|+|||+..+..++.++|+||||+++|+|++|+.||.... .............+... ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~---~~ 224 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--------QGALILKIIRGVFPPVS---QM 224 (256)
T ss_pred chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCCCCc---cc
Confidence 44445578899999999998889999999999999999999999986322 11222222222222211 13
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+.++.+++.+||+.+|++||++.++++.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 44568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.36 Aligned_cols=253 Identities=19% Similarity=0.289 Sum_probs=196.2
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
..+|++.+.||+|+||.||++. ..+++.||+|+.. ...+.+|++++++++||||+++++++......++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 4679999999999999999994 5678999999743 23467899999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
+|++. ++|..++... ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 162 ~e~~~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 162 LPRYK-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred EecCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 99985 6787777543 3588999999999999999999999 999999999999999999999999999975432
Q ss_pred C-CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc---cchh---------------
Q 038671 594 D-SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS---SSNL--------------- 654 (707)
Q Consensus 594 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---~~~~--------------- 654 (707)
. ........||+.|+|||++.+..++.++||||+|+++|||++|+.||......... ....
T Consensus 235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 2 22334467999999999999989999999999999999999999886422111000 0000
Q ss_pred -------hhhh-hhhcC-CCCC---CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 655 -------EIAL-NEMLD-PRLP---TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 655 -------~~~~-~~~~~-~~~~---~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.... ..... ...+ ..+......+.++.+++.+||+.||++|||++|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 00000 0000 011112234567899999999999999999999985
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=333.08 Aligned_cols=252 Identities=20% Similarity=0.267 Sum_probs=195.4
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
.|+..+.||+|+||.||+|+ ..+++.||+|++.............+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58889999999999999995 45788999999865332233345678899999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++|+|.+++.+. +.+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999998643 3578899999999999999999999 99999999999999999999999999975321000
Q ss_pred -----------------------------------------------CCccccccccCCCCccccccCCCCccchhHHHH
Q 038671 596 -----------------------------------------------SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFG 628 (707)
Q Consensus 596 -----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG 628 (707)
......+||+.|+|||++.+..++.++||||+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 001124689999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 038671 629 VLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPT---IQKVSQ 703 (707)
Q Consensus 629 ~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~~l~~ 703 (707)
|++|||++|+.||...... ...............+.. ...+.+..+++.+|+ .+|++|++ ++++++
T Consensus 236 vil~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~p~~----~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPL----ETQMKVINWQTSLHIPPQ----AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHHhCCCCCCCCCHH----HHHHHHHccCCCcCCCCc----ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999999999642211 111111111111112211 122344667777765 49999987 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=324.86 Aligned_cols=241 Identities=22% Similarity=0.283 Sum_probs=189.8
Q ss_pred ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHH-HHHhcCCCCceeeeeeeeecCCceeEEEeeecc
Q 038671 442 HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEV-KTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
+.||+|+||.||+|.. .+++.||+|++.............+..|. .+++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999954 46788999998643221122223344444 456788999999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
++|.+++... ..+++..+..++.||++||+|||+. ||+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~ 154 (325)
T cd05602 81 GELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154 (325)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence 9999998643 3478888999999999999999999 999999999999999999999999999976443333445
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
...|++.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+......... ..+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~----~~~~~ 222 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKPLQLKP----NITNS 222 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCCcCCCC----CCCHH
Confidence 56799999999999998999999999999999999999999863221 1112222222222111 23445
Q ss_pred HHHHHHhccCCCCCCCCCHHH
Q 038671 680 IMEVAISCLDESPESRPTIQK 700 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rps~~~ 700 (707)
+.+++.+|++.||.+||++.+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCC
Confidence 889999999999999998764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.78 Aligned_cols=244 Identities=21% Similarity=0.304 Sum_probs=196.1
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCceeEEE
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 514 (707)
+|+..+.||+|+||.||+|. ..+|+.||+|++...........+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 47788999999999999995 4578999999986532222234456778888888875 678888999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++|+|.+++... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999988543 3589999999999999999999999 9999999999999999999999999998765433
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
........|++.|+|||++.+..++.++||||+|+++|+|++|+.||..... ......+.......+.
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~~~~p~---- 222 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHNVSYPK---- 222 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCc----
Confidence 3334456799999999999988899999999999999999999999863221 1222222222222221
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCH
Q 038671 675 DKLISIMEVAISCLDESPESRPTI 698 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~ 698 (707)
..+.++.+++.+|++.+|.+|++.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 223 SLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred cCCHHHHHHHHHHcccCHhhCCCC
Confidence 223457899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=288.05 Aligned_cols=257 Identities=22% Similarity=0.361 Sum_probs=215.7
Q ss_pred HHHhcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCC-----chhhhHHHHHHHHHHHhcC-CCCceeeeeeee
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLP-----SEMASQQEFLNEVKTLTGI-RHRNIVKFYGFC 504 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 504 (707)
..+-..|.-.+.+|.|..++|-++ ..++|+.+|+|++..... ....-.++-.+|+.+++++ .||+|+.+.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 344566778888999999999888 556788999998853211 1122245577899999999 599999999999
Q ss_pred ecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEec
Q 038671 505 SHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSD 584 (707)
Q Consensus 505 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~D 584 (707)
+.+...++|+|.|+.|-|.|++.... .+++...++|++|+.+|++|||.. .||||||||+|||++++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence 99999999999999999999996433 489999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCccccccccCCCCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhh
Q 038671 585 FGTAKFLKPDSSNWAELAGTYGYVAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIAL 658 (707)
Q Consensus 585 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 658 (707)
||+++.+.++ ......+|||+|.|||.+.. ..|+..+|+|++|++||.++.|.+||- ....-..+
T Consensus 167 FGFa~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw--------HRkQmlML 237 (411)
T KOG0599|consen 167 FGFACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW--------HRKQMLML 237 (411)
T ss_pred cceeeccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh--------HHHHHHHH
Confidence 9999988754 55678899999999998874 347889999999999999999999983 12223345
Q ss_pred hhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 659 NEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+..+++...++.+.+.+....++|.+|++.||++|-|++|+++
T Consensus 238 R~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 238 RMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 556666666666677888888999999999999999999999875
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=323.09 Aligned_cols=240 Identities=23% Similarity=0.327 Sum_probs=190.4
Q ss_pred ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHH-HHhcCCCCceeeeeeeeecCCceeEEEeeecc
Q 038671 442 HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVK-TLTGIRHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
+.||+|+||.||+|+. .+++.||+|++.............+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999965 568999999986532222223344555544 67888999999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
++|...+... +.+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 154 (321)
T cd05603 81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS 154 (321)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence 9999888543 3578899999999999999999999 999999999999999999999999999875433333334
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||...+ .......+.......+. ....+
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~~~~~~----~~~~~ 222 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILHKPLQLPG----GKTVA 222 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhcCCCCCCC----CCCHH
Confidence 5678999999999998889999999999999999999999986321 12222333332222222 22345
Q ss_pred HHHHHHhccCCCCCCCCCHH
Q 038671 680 IMEVAISCLDESPESRPTIQ 699 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rps~~ 699 (707)
+.+++.+|++.||.+||++.
T Consensus 223 ~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHccCCHhhcCCCC
Confidence 88999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=313.91 Aligned_cols=248 Identities=23% Similarity=0.299 Sum_probs=195.9
Q ss_pred eeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccCcH
Q 038671 444 IGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL 522 (707)
Q Consensus 444 lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 522 (707)
||+|+||.||+++. .+|+.||+|++.............+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999954 56899999998643322222344566799999999999999999999999999999999999999
Q ss_pred HHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCccccc
Q 038671 523 AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA 602 (707)
Q Consensus 523 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 602 (707)
.+++.... ...+++..+..++.|++.|++|||+. |++||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~ 155 (277)
T cd05607 81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA 155 (277)
T ss_pred HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence 98885432 34588999999999999999999999 99999999999999999999999999998765332 223456
Q ss_pred cccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHH
Q 038671 603 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIME 682 (707)
Q Consensus 603 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 682 (707)
|++.|+|||++.+..++.++||||+|+++|||++|+.||..... .................... ...+.++.+
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 228 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE----KVAKEELKRRTLEDEVKFEH---QNFTEESKD 228 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc----hhhHHHHHHHhhcccccccc---ccCCHHHHH
Confidence 89999999999988899999999999999999999999863221 01111222222222222111 123456899
Q ss_pred HHHhccCCCCCCCCCHHHHHH
Q 038671 683 VAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 683 li~~cl~~~P~~Rps~~~l~~ 703 (707)
++.+||+.||++||++.|+++
T Consensus 229 li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 229 ICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred HHHHHhccCHhhCCCCccchh
Confidence 999999999999999976553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=325.38 Aligned_cols=240 Identities=22% Similarity=0.318 Sum_probs=191.2
Q ss_pred ceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHH-HHhcCCCCceeeeeeeeecCCceeEEEeeecc
Q 038671 442 HCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVK-TLTGIRHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
+.||+|+||.||+|. ..+|+.+|+|++.............+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999995 4578999999986532222223344555554 46778999999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
++|..++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++...........
T Consensus 81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 154 (325)
T cd05604 81 GELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT 154 (325)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence 9999888543 4589999999999999999999999 999999999999999999999999999875443333344
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
...|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ................. ..+..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~~~~~~~~~~~----~~~~~ 222 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------VAEMYDNILHKPLVLRP----GASLT 222 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------HHHHHHHHHcCCccCCC----CCCHH
Confidence 5679999999999999899999999999999999999999986321 11222222222222211 23345
Q ss_pred HHHHHHhccCCCCCCCCCHH
Q 038671 680 IMEVAISCLDESPESRPTIQ 699 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rps~~ 699 (707)
+.+++.+|++.+|.+||++.
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHHHHhccCHHhcCCCC
Confidence 78899999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=324.10 Aligned_cols=253 Identities=20% Similarity=0.285 Sum_probs=198.4
Q ss_pred CCCCCceeeecCCeeEEEEEc----CCCcEEEEEecCCCCC-chhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCce
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL----PSGEIVAVKKFHSPLP-SEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 510 (707)
+|++.+.||+|+||.||+++. .+++.||+|++..... ......+.+..|+.++..+ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488899999999999999854 3688999999864221 1122345678899999999 599999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++||||+.+|+|.+++... ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 9999999999999998643 3588999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCC-CCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 591 LKPDS-SNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 591 ~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
..... .......||+.|+|||.+.+. .++.++||||||+++|||++|+.||...... .........+.....+.
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~~~~~~~~~~~~~ 230 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER----NTQSEVSRRILKCDPPF 230 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC----CCHHHHHHHHhcCCCCC
Confidence 54332 223346799999999998865 3788999999999999999999999642221 11111112222222221
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
+. ..+..+.+++.+||+.||++|| +++++++
T Consensus 231 ~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 231 PS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11 2334588999999999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=312.68 Aligned_cols=257 Identities=21% Similarity=0.356 Sum_probs=202.5
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA 507 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 507 (707)
..++|++.+.||+|+||.||+|... ++..||+|++.... ......++.+|+..++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3567999999999999999998542 35679999986432 222445688999999999999999999999999
Q ss_pred CceeEEEeeeccCcHHHHHhcccc-------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCe
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAA-------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEA 580 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~ 580 (707)
+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence 999999999999999999864321 12367888999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCCc--cccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhh
Q 038671 581 HVSDFGTAKFLKPDSSNW--AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIA 657 (707)
Q Consensus 581 kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 657 (707)
+++|||++.......... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ...
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~~ 230 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQV 230 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence 999999987654322211 12245678999999998889999999999999999999 7888863221 122
Q ss_pred hhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 658 LNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.........+... ...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 231 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 LRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 2222222222111 123346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=337.85 Aligned_cols=257 Identities=25% Similarity=0.306 Sum_probs=205.0
Q ss_pred HHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC---
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR--- 508 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 508 (707)
...++|++.+.||+|+||+||+|+ ..+|+.||+|++...... ......+.+|+..+..++|+|++++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 345789999999999999999995 567999999998654332 234566888999999999999999988765432
Q ss_pred -----ceeEEEeeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEE
Q 038671 509 -----HSFIVYEYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV 582 (707)
Q Consensus 509 -----~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl 582 (707)
..++||||+.+|+|.+++.... ....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence 3689999999999999986432 235689999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCC--CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 583 SDFGTAKFLKPDS--SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 583 ~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... .......
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------~~~~~~~ 256 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------MEEVMHK 256 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHH
Confidence 9999998754321 22344679999999999999899999999999999999999999996321 1122222
Q ss_pred hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
......... ....+.++.+++.+||+.||++||++.++++.
T Consensus 257 ~~~~~~~~~---~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRYDPL---PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 222222111 11234568899999999999999999998763
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=308.40 Aligned_cols=252 Identities=26% Similarity=0.454 Sum_probs=203.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcC----CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
++|++.+.||+|+||.||+|..+ +...||+|++.... .......+..|+..+++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 56899999999999999999653 24579999986543 2234567889999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
++|||+++++|.+++.... ..+++..+++++.|++.|++|||+. +++||||+|+||++++++.++++|||++...
T Consensus 82 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 82 IITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999986532 3689999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCCcc--ccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC-CCC
Q 038671 592 KPDSSNWA--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP-RLP 667 (707)
Q Consensus 592 ~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 667 (707)
........ ...+++.|+|||...+..++.++||||||+++|+|++ |..||..... ......+... ..+
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~ 228 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--------QDVIKAVEDGYRLP 228 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence 52222211 2234578999999998889999999999999999998 9999853211 1111222211 112
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+. +.+..+.+++.+||+.+|++||++.++++.|+
T Consensus 229 ~~~----~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~ 263 (266)
T cd05033 229 PPM----DCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263 (266)
T ss_pred CCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 221 23456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=320.20 Aligned_cols=200 Identities=27% Similarity=0.419 Sum_probs=173.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||++.. .+++.+|+|++..... ......+.+|+++++.++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 46899999999999999999955 4688899998765422 23456788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+.+++|.+++... +.+++..+..++.|++.|+.|||+.+ +++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999998643 34788999999999999999999752 799999999999999999999999999876532
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF 643 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 643 (707)
. ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred h--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 2 12335689999999999988899999999999999999999999863
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=327.86 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=200.9
Q ss_pred HHHHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 431 IIRVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 431 ~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
+....++|++.+.||+|+||.||+++. .+++.+|+|++.............+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 334468899999999999999999955 4688999999864322222334567889999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++||||+++|+|.+++... .+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 99999999999999998542 478888999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC-CccccccccCCCCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC
Q 038671 590 FLKPDSS-NWAELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP 664 (707)
Q Consensus 590 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 664 (707)
....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......+...
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~ 262 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMNH 262 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC
Confidence 7653322 223467999999999987543 78899999999999999999999963221 1122222221
Q ss_pred C--CCCCCcchHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 038671 665 R--LPTPSHNVQDKLISIMEVAISCLDESPES--RPTIQKVSQL 704 (707)
Q Consensus 665 ~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~~l~~~ 704 (707)
. +..+ .....+..+.+++..|+..++.+ ||+++++++.
T Consensus 263 ~~~~~~~--~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 263 KNSLTFP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCcccCC--CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1 1111 11234456888999999844433 7899988764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.78 Aligned_cols=257 Identities=21% Similarity=0.344 Sum_probs=193.5
Q ss_pred cCCCCCceeeecCCeeEEEEEc--CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC---CCCceeeeeeeee-----
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL--PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI---RHRNIVKFYGFCS----- 505 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~----- 505 (707)
++|++.+.||+|+||.||+|+. .+++.||+|++......+. ....+.+|+..++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 4789999999999999999964 3468899998865432221 223455666666655 6999999999885
Q ss_pred cCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
.....++||||+. ++|.+++.... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 3456899999996 58888886432 34589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh-----
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE----- 660 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----- 660 (707)
|++...... .......|++.|+|||.+.+..++.++||||+|+++|||++|++||....... ........
T Consensus 155 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~----~~~~i~~~~~~~~ 229 (290)
T cd07862 155 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD----QLGKILDVIGLPG 229 (290)
T ss_pred cceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH----HHHHHHHHhCCCC
Confidence 999865433 23344578999999999988889999999999999999999999997432211 00000000
Q ss_pred -------------hcCCCCCCCC-cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 661 -------------MLDPRLPTPS-HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 661 -------------~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+....+. ...++.+..+.+++.+|++.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000000000 001223456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=306.81 Aligned_cols=251 Identities=29% Similarity=0.468 Sum_probs=201.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
.+|++.+.||+|+||.||++..+++..+|+|++..... ....+.+|++++++++|||++++++++...+..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 35888999999999999999887778899999864322 23467889999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++......
T Consensus 80 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~ 154 (256)
T cd05059 80 YMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ 154 (256)
T ss_pred cCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence 999999999986433 3589999999999999999999999 99999999999999999999999999997654322
Q ss_pred CC-ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 596 SN-WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 596 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.. .....++..|+|||...+..++.++||||||+++|++++ |+.||+..... ... ....... ....+
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~-~~~~~~~--~~~~~---- 223 (256)
T cd05059 155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----EVV-ESVSAGY--RLYRP---- 223 (256)
T ss_pred ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----HHH-HHHHcCC--cCCCC----
Confidence 11 111223457999999998889999999999999999999 89998642211 111 1111111 11111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+.++.+++.+||+.+|++||++.++++.|.
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 123456999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=303.49 Aligned_cols=255 Identities=25% Similarity=0.335 Sum_probs=193.9
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----ce
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR-----HS 510 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~ 510 (707)
.|...+++|.|+||.||+|.. .+++.||||+.-.+... =.+|+++|+.++|||||++..+|.... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 467789999999999999954 45789999997654322 136899999999999999998884322 45
Q ss_pred eEEEeeeccCcHHHHHhcc-cccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC-CCeEEeccccc
Q 038671 511 FIVYEYLEMGSLAMILSND-AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE-NEAHVSDFGTA 588 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~-~~~kl~Dfg~~ 588 (707)
.+||||++ .+|.+.++.. ...+.++...+.-+..||.+||+|||+. ||+||||||+|+|+|.+ |.+||||||.|
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 68999997 5788777532 2345688888999999999999999998 99999999999999987 89999999999
Q ss_pred eecCCCCCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccc------------hhh
Q 038671 589 KFLKPDSSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSS------------NLE 655 (707)
Q Consensus 589 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~------------~~~ 655 (707)
+.+..+... ....+|..|+|||.+.|. .|+.+.||||.||++.||+-|++-|...++...... ...
T Consensus 174 K~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 174 KVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 998766554 556789999999988864 589999999999999999999999976443221110 000
Q ss_pred hhhh--hhcCCCCCCCC--c-chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 656 IALN--EMLDPRLPTPS--H-NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 656 ~~~~--~~~~~~~~~~~--~-~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.... +...+.+.... . .....+.+..+++.+++..+|.+|.++.|+++
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0011 11112221111 0 12334566889999999999999999999875
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=307.59 Aligned_cols=253 Identities=24% Similarity=0.415 Sum_probs=204.2
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
..++|++.++||+|+||.||+|..++++.||+|++..... ..+.+.+|+.++++++|||++++++++. .+..+++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 3467999999999999999999888899999999865332 3457889999999999999999999874 4678999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+.+++|.+++.... ...+++.+++.++.|++.||+|||+. |++||||+|+||+++.++.++++|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 79 TEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999986533 34689999999999999999999999 999999999999999999999999999977653
Q ss_pred CCC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 594 DSS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 594 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||..... .......... .+.+.+.
T Consensus 155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~--~~~~~~~- 226 (260)
T cd05067 155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-----PEVIQNLERG--YRMPRPD- 226 (260)
T ss_pred CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-----HHHHHHHHcC--CCCCCCC-
Confidence 221 1223345678999999988889999999999999999999 9999863221 1111111111 1112111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.+|++||+++++.+.|+
T Consensus 227 ---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 227 ---NCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred ---CCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence 23456999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=311.12 Aligned_cols=254 Identities=21% Similarity=0.378 Sum_probs=201.9
Q ss_pred cCCCCCceeeecCCeeEEEEEc-----CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
.+|++.+.||+|+||.||+|.. .+++.+++|.+.... .......+.+|++++++++||||+++++++..+...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 4688889999999999999963 356789999987532 223446788999999999999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccc--------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC
Q 038671 511 FIVYEYLEMGSLAMILSNDAA--------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL 576 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~ 576 (707)
+++|||+++++|.+++..... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence 999999999999999853221 23478889999999999999999999 9999999999999999
Q ss_pred CCCeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccch
Q 038671 577 ENEAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSN 653 (707)
Q Consensus 577 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 653 (707)
++.+||+|||++........ ......++..|+|||...+..++.++||||||+++|||++ |..||.....
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------- 232 (283)
T cd05090 160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------- 232 (283)
T ss_pred CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence 99999999999976543321 1223345678999999988889999999999999999998 9999853211
Q ss_pred hhhhhhhhcCCC-CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 654 LEIALNEMLDPR-LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 654 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
........... .+.+. ..+.++.+++.+||+.||++||++.++.+.|+
T Consensus 233 -~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 233 -QEVIEMVRKRQLLPCSE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred -HHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 11111111111 12111 23356889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=312.90 Aligned_cols=254 Identities=24% Similarity=0.440 Sum_probs=202.2
Q ss_pred cCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
.+|.+.+.||+|+||.||++.. .++..+|+|.+.... ......+.+|++++++++|||++++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 5688999999999999999963 234568999886432 2345678899999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccc----------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC
Q 038671 510 SFIVYEYLEMGSLAMILSNDAA----------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE 579 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~ 579 (707)
.+++|||+++++|.+++..... ...+++..++.++.|++.||+|||++ |++||||||+||++++++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 158 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999999864321 23489999999999999999999999 9999999999999999999
Q ss_pred eEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhh
Q 038671 580 AHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEI 656 (707)
Q Consensus 580 ~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 656 (707)
+||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ..
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~ 230 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NE 230 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HH
Confidence 99999999976543221 1122345778999999998889999999999999999998 9999863221 11
Q ss_pred hhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 657 ALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....+.......... ..+.++.+++.+||+.||.+||++.++.+.|+
T Consensus 231 ~~~~i~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~ 277 (288)
T cd05093 231 VIECITQGRVLQRPR---TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277 (288)
T ss_pred HHHHHHcCCcCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 122222222211111 12346899999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=320.44 Aligned_cols=257 Identities=25% Similarity=0.424 Sum_probs=200.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeec-
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSH- 506 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~- 506 (707)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ....+.+..|++++.++ +||||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 35799999999999999999943 2357899999875432 22445678899999999 79999999998864
Q ss_pred CCceeEEEeeeccCcHHHHHhcccc-------------------------------------------------------
Q 038671 507 ARHSFIVYEYLEMGSLAMILSNDAA------------------------------------------------------- 531 (707)
Q Consensus 507 ~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 531 (707)
+...+++|||+++++|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4568899999999999998853211
Q ss_pred ---cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCC--ccccccccC
Q 038671 532 ---AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYG 606 (707)
Q Consensus 532 ---~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~ 606 (707)
..++++..+.+++.||+.||+|||+. ||+||||||+||+++.++.++|+|||++..+...... .....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12588999999999999999999999 9999999999999999999999999999876433221 223345678
Q ss_pred CCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHH
Q 038671 607 YVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAI 685 (707)
Q Consensus 607 y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 685 (707)
|+|||++.+..++.++|||||||++|||++ |..||..... .+.............. + .....++.+++.
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~~~--~----~~~~~~~~~l~~ 310 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI----DEEFCRRLKEGTRMRA--P----EYATPEIYSIML 310 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc----cHHHHHHHhccCCCCC--C----ccCCHHHHHHHH
Confidence 999999999999999999999999999998 9999863211 1111111111111111 1 123356899999
Q ss_pred hccCCCCCCCCCHHHHHHHhc
Q 038671 686 SCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 686 ~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+||+.+|++||++.|+++.|+
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~ 331 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILG 331 (337)
T ss_pred HHccCChhhCcCHHHHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=322.05 Aligned_cols=246 Identities=26% Similarity=0.392 Sum_probs=200.4
Q ss_pred eeeecCCeeEEEEEcCC-CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccCc
Q 038671 443 CIGKGGQGSVYKAELPS-GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGS 521 (707)
Q Consensus 443 ~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 521 (707)
++|+|+||+||.|+..+ ...+|||.+..... ...+-+..|+..-++|+|.|||+++|.+.+++..-|.||.++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 59999999999997654 56799998865432 234568899999999999999999999999999999999999999
Q ss_pred HHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec-CCCCeEEeccccceecCCCCCCccc
Q 038671 522 LAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD-LENEAHVSDFGTAKFLKPDSSNWAE 600 (707)
Q Consensus 522 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 600 (707)
|.++++..-..-.-.+.+.-.+.+||++||.|||.. .|||||||-+||+|+ -.|.+||+|||.++.+..-..-..+
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TET 735 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTET 735 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccc
Confidence 999997543322227788888999999999999999 999999999999996 4799999999999988766666778
Q ss_pred cccccCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHH
Q 038671 601 LAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLI 678 (707)
Q Consensus 601 ~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (707)
+.||..|||||++..++ |+.++|||||||++.||.||++||........ ...+.......|.+| .+...
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---AMFkVGmyKvHP~iP------eelsa 806 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---AMFKVGMYKVHPPIP------EELSA 806 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---hhhhhcceecCCCCc------HHHHH
Confidence 89999999999988654 88999999999999999999999965443211 111111111222222 35566
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 679 SIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 679 ~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+...+|.+|+.+||.+||++.++++
T Consensus 807 eak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHHHhcc
Confidence 7889999999999999999999875
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=312.80 Aligned_cols=254 Identities=25% Similarity=0.482 Sum_probs=203.8
Q ss_pred cCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
++|.+.+.||+|+||.||+|.. .++..+++|.+.... ......+.+|++.+++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 4588889999999999999953 235668899876432 2334678899999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC
Q 038671 510 SFIVYEYLEMGSLAMILSNDAA-------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL 576 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~ 576 (707)
.++||||+++++|.+++..... ...+++..++.++.||+.|++|||++ +++||||||+||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 9999999999999999965431 23489999999999999999999999 9999999999999999
Q ss_pred CCCeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccch
Q 038671 577 ENEAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSN 653 (707)
Q Consensus 577 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 653 (707)
++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------- 231 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------- 231 (291)
T ss_pred CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------
Confidence 99999999999976543321 1223456788999999998889999999999999999999 9999863221
Q ss_pred hhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 654 LEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
......+.....+... ...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 232 -~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 232 -TEVIECITQGRVLERP---RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred -HHHHHHHhCCCCCCCC---ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 1122222222222211 123456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=304.27 Aligned_cols=247 Identities=26% Similarity=0.448 Sum_probs=196.3
Q ss_pred ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccC
Q 038671 442 HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMG 520 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 520 (707)
+.||+|+||.||+|.. .+++.+|+|.+..... ......+.+|+++++.++||||+++++++...+..++||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 4689999999999965 4789999998765432 234467889999999999999999999999999999999999999
Q ss_pred cHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCC--c
Q 038671 521 SLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN--W 598 (707)
Q Consensus 521 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~ 598 (707)
+|.+++... ...+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+|++|||.+......... .
T Consensus 79 ~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 79 DFLTFLRTE--GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred cHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 999998643 23588999999999999999999999 9999999999999999999999999998754422111 1
Q ss_pred cccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHH
Q 038671 599 AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKL 677 (707)
Q Consensus 599 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (707)
.....+..|+|||.+.+..++.++||||||+++|||++ |..||..... ........... ..+.+ ...+
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----~~~~~~~~~~~--~~~~~----~~~~ 222 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----QQTREAIEQGV--RLPCP----ELCP 222 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----HHHHHHHHcCC--CCCCc----ccCC
Confidence 11123457999999988889999999999999999998 8889863221 11111111111 11111 1234
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 678 ISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 678 ~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.+++.+|++.+|++||+++++.+.|+
T Consensus 223 ~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 223 DAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 56889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=307.42 Aligned_cols=251 Identities=22% Similarity=0.330 Sum_probs=204.3
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|++.+.||+|+||.||++.. .+++.+++|.+..... ....+.+..|+.+++.++|||++++++++..++..+++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 478889999999999999954 4788999998864322 2345678889999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|++++++.+++.... ...+++..++.++.|++.||.|||+. |++|+||+|+||++++++.++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 79 YCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred eCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 999999999886432 34578999999999999999999999 99999999999999999999999999998765444
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
.......+++.|+|||...+..++.++|+||+|+++|+|++|+.||.... ................. ..
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~---~~ 223 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------WKNLILKVCQGSYKPLP---SH 223 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--------HHHHHHHHhcCCCCCCC---cc
Confidence 43445678899999999998889999999999999999999999986321 11111111111111111 12
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+..+.+++.+||+.||++||++.+++..
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 34458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=306.51 Aligned_cols=251 Identities=25% Similarity=0.439 Sum_probs=202.2
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.+|++.+.||+|++|.||+|.. +.++.|++|++.... .....+.+|++.+++++|||++++++++..++..+++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 4578889999999999999954 468899999976431 23467889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++.... ...+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 82 EFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999986433 34589999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCC-ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC-CCCCCCc
Q 038671 595 SSN-WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP-RLPTPSH 671 (707)
Q Consensus 595 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 671 (707)
... .....+++.|+|||...+..++.++||||||+++|||++ |..||.... ........... +...+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------~~~~~~~~~~~~~~~~~-- 227 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELLEKGYRMERP-- 227 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCCCCCCC--
Confidence 221 112234568999999988889999999999999999998 999986321 11111111111 11111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+.++.+++.+||+.+|++||++.++++.|+
T Consensus 228 --~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 228 --EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred --CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 123456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=314.06 Aligned_cols=255 Identities=31% Similarity=0.506 Sum_probs=202.3
Q ss_pred CCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEee
Q 038671 438 FDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
|++.+.||+|+||+||+++. .+++.+|+|++....... .......+|+..+++++||||+++++++.+....+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccccccccccc
Confidence 56789999999999999954 567789999998754332 2233445699999999999999999999999999999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 596 (707)
+.+++|.+++. ....+++..++.++.|+++||++||+. +++|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~ 153 (260)
T PF00069_consen 80 CPGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE 153 (260)
T ss_dssp ETTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred ccccccccccc---ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999997 234589999999999999999999999 999999999999999999999999999987533344
Q ss_pred CccccccccCCCCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 597 NWAELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 597 ~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
......+++.|+|||... +..++.++||||+|+++|+|++|..||..... ........................
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 228 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS-----DDQLEIIEKILKRPLPSSSQQSRE 228 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH-----HHHHHHHHHHHHTHHHHHTTSHTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc-----hhhhhhhhhcccccccccccccch
Confidence 455567899999999988 78899999999999999999999999874311 111111111111111110000111
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...++.+++.+||+.||++||++.++++.
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12669999999999999999999999863
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=306.81 Aligned_cols=251 Identities=26% Similarity=0.433 Sum_probs=201.9
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|+||.||+|...++..||+|++..... ..+.+.+|++++++++|||++++++++. ....++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEE
Confidence 356999999999999999999777777899999865322 2356889999999999999999999875 45689999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++.... ...+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 80 EYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999996432 34578999999999999999999999 9999999999999999999999999999766533
Q ss_pred CCC-ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC-CCCCCCc
Q 038671 595 SSN-WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP-RLPTPSH 671 (707)
Q Consensus 595 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 671 (707)
... .....++..|+|||...+..++.++||||||+++|+|++ |+.||..... .......... ..+.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~~~~~~~~~--- 224 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMPC--- 224 (262)
T ss_pred ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHHhcCCCCCC---
Confidence 321 123345678999999988889999999999999999999 8888863221 1111111111 1111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.+..+.+++.+|++.+|++||++.++++.|+
T Consensus 225 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~ 258 (262)
T cd05071 225 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258 (262)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 2345567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=304.28 Aligned_cols=251 Identities=27% Similarity=0.472 Sum_probs=202.9
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++||+++++++++. ....+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT 79 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence 357899999999999999999888888899999865332 2356889999999999999999999875 45688999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+++|.+++.... ...+++.+++.++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 80 EYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 9999999999986432 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCC-ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC-CCCCCCc
Q 038671 595 SSN-WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP-RLPTPSH 671 (707)
Q Consensus 595 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 671 (707)
... .....++..|+|||...+..++.++|+||||+++|+|++ |+.||..... ......+... ..+.+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~-- 225 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQVERGYRMPCP-- 225 (260)
T ss_pred ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCC--
Confidence 221 122345668999999988889999999999999999999 8999863221 1111122111 11111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.+.++.+++.+|+..+|++|||++++.+.|+
T Consensus 226 --~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 258 (260)
T cd05070 226 --QDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258 (260)
T ss_pred --CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 233456999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=299.42 Aligned_cols=248 Identities=28% Similarity=0.446 Sum_probs=210.3
Q ss_pred CCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEee
Q 038671 438 FDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
|++.+++|+|+||.||+| +..+|+.+|+|.+... ...+++..|+.+|.+.+.|+||++||.|.....+|+||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 667888999999999999 5567999999997532 3567899999999999999999999999999999999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 596 (707)
|.-|+..+.++.+ .+++++.++..+++.-++||+|||.. .-+|||||..|||++.+|.+|++|||.+..+...-.
T Consensus 110 CGAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 110 CGAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred cCCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 9999999999644 46799999999999999999999999 889999999999999999999999999987664444
Q ss_pred CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHH
Q 038671 597 NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDK 676 (707)
Q Consensus 597 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 676 (707)
......|||-|||||++..-.|+.++||||||++..||..|++||....+. +.--++....|.........
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---------RAIFMIPT~PPPTF~KPE~W 255 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---------RAIFMIPTKPPPTFKKPEEW 255 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---------ceeEeccCCCCCCCCChHhh
Confidence 456678999999999999989999999999999999999999998643321 11112222333333344556
Q ss_pred HHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 677 LISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 677 ~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
+.++-++++.|+-+.|++|.|+.++++.
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 6789999999999999999999998763
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=313.29 Aligned_cols=263 Identities=23% Similarity=0.380 Sum_probs=203.6
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCC-----------------CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCce
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPS-----------------GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 497 (707)
.++|++.+.||+|+||.||+|.... +..||+|++...... ...+.+.+|++++++++|||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence 3579999999999999999985432 245899998754322 345678899999999999999
Q ss_pred eeeeeeeecCCceeEEEeeeccCcHHHHHhccc--------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 038671 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDA--------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISS 569 (707)
Q Consensus 498 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 569 (707)
+++++++..++..+++|||+.+++|.+++.... ....+++..++.++.|++.||+|||+. +++||||||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp 158 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT 158 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence 999999999999999999999999999986543 123589999999999999999999999 999999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCccc
Q 038671 570 KNVLLDLENEAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFIS 645 (707)
Q Consensus 570 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~ 645 (707)
+||+++.++.++|+|||++........ ......+++.|+|||...+..++.++||||||+++|||++ |..||....
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 999999999999999999976543321 1223446778999999988889999999999999999998 677875322
Q ss_pred ccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 646 SISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
. ..........................+.++.+++.+||+.||++||++.++++.|+
T Consensus 239 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 239 D----QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred h----HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 11111111111111111100111223456999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=309.66 Aligned_cols=255 Identities=23% Similarity=0.362 Sum_probs=204.0
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 508 (707)
.++|++.+.||+|+||.||+|..+ ++..||+|...... .......+.+|+.+++.++|||++++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 357889999999999999999543 34689999986542 2234467889999999999999999999999999
Q ss_pred ceeEEEeeeccCcHHHHHhcccc-------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeE
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAA-------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH 581 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~k 581 (707)
..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence 99999999999999999865432 12368889999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhh
Q 038671 582 VSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIAL 658 (707)
Q Consensus 582 l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 658 (707)
|+|||+++....... ......++..|+|||...+..++.++||||||+++||+++ |+.||..... ....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~~~ 231 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EEVL 231 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--------HHHH
Confidence 999999876543321 1223456788999999988889999999999999999998 9999853221 1112
Q ss_pred hhhcCCCC-CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 659 NEMLDPRL-PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 659 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
........ ..+.. .+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 232 ~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 232 KFVIDGGHLDLPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHhcCCCCCCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 22222221 22221 2456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=311.47 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=201.0
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
.|+..+.||+|+||+||++. ..+++.+|+|.+.............+.+|+++++.++|++++++.+++..++..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 36778899999999999995 45789999999865433333334557889999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+.+++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG- 155 (285)
T ss_pred eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC-
Confidence 999999998886432 34589999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
.......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||..... ....+............. ...
T Consensus 156 ~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~----~~~~~~~~~~~~~~~~~~----~~~ 227 (285)
T cd05632 156 ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE----KVKREEVDRRVLETEEVY----SAK 227 (285)
T ss_pred CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHhhhcccccc----Ccc
Confidence 222345789999999999888899999999999999999999999963221 011111111111111111 122
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 038671 676 KLISIMEVAISCLDESPESRPT-----IQKVSQ 703 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps-----~~~l~~ 703 (707)
.+.++.+++..|++.||++||+ +.++++
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 3455889999999999999999 666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=327.66 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=196.0
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|+..+.||+|+||.||++.. .+++.||+|++.............+..|+.++..++||+++++++++.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688999999999999999954 578999999986432223334567888999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++|+|.+++... ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999998643 3588999999999999999999999 9999999999999999999999999998754321
Q ss_pred CC-----------------------------------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCC
Q 038671 595 SS-----------------------------------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 639 (707)
Q Consensus 595 ~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~ 639 (707)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 00 0113479999999999999999999999999999999999999
Q ss_pred CCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC---HHHHHH
Q 038671 640 PRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPT---IQKVSQ 703 (707)
Q Consensus 640 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~~l~~ 703 (707)
||..... ................+... ..+.++.+++.+|+. ||++|++ ++++++
T Consensus 235 Pf~~~~~----~~~~~~i~~~~~~~~~p~~~----~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 235 PFCSETP----QETYRKVMNWKETLVFPPEV----PISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCH----HHHHHHHHcCCCceecCCCC----CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 9963221 11111111100111111111 123447778877764 9999985 566654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.15 Aligned_cols=252 Identities=24% Similarity=0.467 Sum_probs=198.8
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCc----EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
.+|+..+.||+|+||.||+|.+ .+++ .||+|++.... .....+++.+|+.+++.++||||+++++++... ..
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~ 83 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 83 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence 5699999999999999999964 3343 48999986432 223456788999999999999999999998764 56
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++++||+.+|+|.+++.... ..+++..+++++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 84 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence 79999999999999986432 3578899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCc--cccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 591 LKPDSSNW--AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 591 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
........ ....++..|+|||.+.+..++.++||||||+++|||++ |+.||+.... ......... ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-----~~~~~~~~~--~~~~~ 231 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEK--GERLP 231 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHhC--CCCCC
Confidence 65433221 12234668999999998889999999999999999998 9999863221 111111111 11222
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+. ..+.++.+++.+||+.+|.+||++.+++..+.
T Consensus 232 ~~~----~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~ 266 (316)
T cd05108 232 QPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 266 (316)
T ss_pred CCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 222 12345889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=312.17 Aligned_cols=259 Identities=21% Similarity=0.357 Sum_probs=199.9
Q ss_pred cCCCCCceeeecCCeeEEEEEcCC---------------CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPS---------------GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~ 500 (707)
++|++.+.||+|+||.||+++... ...||+|++..... ......+.+|++++++++|||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 579999999999999999985432 23589999875422 2345678999999999999999999
Q ss_pred eeeeecCCceeEEEeeeccCcHHHHHhcccc---------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 038671 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAA---------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKN 571 (707)
Q Consensus 501 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 571 (707)
++++...+..++||||+.+++|.+++..... ...+++..+++++.|++.|++|||+. +++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence 9999999999999999999999999864321 12368889999999999999999999 99999999999
Q ss_pred eeecCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCccccc
Q 038671 572 VLLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFISSI 647 (707)
Q Consensus 572 il~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~~~ 647 (707)
|+++.++.+||+|||++......... .....+++.|+|||...+..++.++||||||+++|+|++ |..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 99999999999999999765432211 122345678999999988889999999999999999998 66677532211
Q ss_pred ccccchhhhhhh---hhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 648 SSSSSNLEIALN---EMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 648 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
........ ......... .....+..+.+++.+||+.||++||+++++++.|+
T Consensus 240 ----~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 ----QVIENTGEFFRNQGRQIYLS---QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ----HHHHHHHHhhhhccccccCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 11111111 000101111 01123356999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=322.80 Aligned_cols=347 Identities=26% Similarity=0.231 Sum_probs=312.8
Q ss_pred CCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeec
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTL 82 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 82 (707)
+..+.|++++|.+..+.+..|.++++|+++++..|.++ .+|.......+|+.|+|.+|.|++...+.++.++.|+.|||
T Consensus 78 ~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL 156 (873)
T KOG4194|consen 78 SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDL 156 (873)
T ss_pred cceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence 34577999999999999999999999999999999999 77876666677999999999999988899999999999999
Q ss_pred ccccccccCCC-CCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCC
Q 038671 83 ENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGS 161 (707)
Q Consensus 83 ~~n~i~~~~~~-l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~ 161 (707)
|.|.|++++.. |..-.++++|+|++|.|+.+....|..+.+|..|.|+.|+|+.+....|+++++|+.|+|..|+|.-.
T Consensus 157 SrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv 236 (873)
T KOG4194|consen 157 SRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV 236 (873)
T ss_pred hhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee
Confidence 99999998764 77778999999999999999999999999999999999999999999999999999999999999966
Q ss_pred CchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCc
Q 038671 162 MPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNL 241 (707)
Q Consensus 162 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l 241 (707)
....|.++++|+.|.|..|+|.......|..+.++++|+|+.|++......++.+++.|+.|+||+|.|..+.++++.-.
T Consensus 237 e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft 316 (873)
T KOG4194|consen 237 EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT 316 (873)
T ss_pred hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhc
Confidence 67889999999999999999998888899999999999999999998889999999999999999999999999999999
Q ss_pred ccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchh---HhhccCCCcee
Q 038671 242 VKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIP---SCFEELHGLSY 318 (707)
Q Consensus 242 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~---~~~~~~~~L~~ 318 (707)
++|++|+|++|.|+...+..|..+..|++|+|++|.|.......|..+++|++|||++|.|+..+. ..|..++.|+.
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 999999999999999999999999999999999999988888899999999999999999986555 46778999999
Q ss_pred EeeccCcccccCCC-ccccccCchhhcccCcCc
Q 038671 319 IDISYNELHGSIPN-STAFRDAPMEALQGNKGL 350 (707)
Q Consensus 319 l~l~~n~~~~~~~~-~~~~~~~~~~~~~~~~~~ 350 (707)
|.+.||++.....- ...+.......+.+|+..
T Consensus 397 L~l~gNqlk~I~krAfsgl~~LE~LdL~~Naia 429 (873)
T KOG4194|consen 397 LRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIA 429 (873)
T ss_pred eeecCceeeecchhhhccCcccceecCCCCcce
Confidence 99999999854321 223333334455555543
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=315.83 Aligned_cols=248 Identities=28% Similarity=0.442 Sum_probs=205.6
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
.|+..+.||.|+||.||-|+ ..+.+.||||++........+.+..+..|++++.+++|||.+.+-|+|..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46777889999999999995 56788999999987766677788999999999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
||- |+-.|++.- -.+++-+..+..|+.+.+.||+|||++ +.||||||..|||+++.|.||++|||.|....+.
T Consensus 107 YCl-GSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHh-ccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 996 566666632 246788999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCccccccccCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 596 SNWAELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
..++|||.|||||++.. +.|+-++||||||++-.|+...++|+..+.. .... .-+-....|.. .
T Consensus 180 ---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------MSAL-YHIAQNesPtL--q 246 (948)
T KOG0577|consen 180 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSAL-YHIAQNESPTL--Q 246 (948)
T ss_pred ---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------HHHH-HHHHhcCCCCC--C
Confidence 45799999999998874 5699999999999999999999999653221 1111 11111112211 1
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+.+..|..++..|+++-|++|||.+++++.
T Consensus 247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 23556678999999999999999999998763
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=311.37 Aligned_cols=254 Identities=19% Similarity=0.310 Sum_probs=202.0
Q ss_pred CCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 437 DFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
+|++.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.++..++||||+++++++...+..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 4677888999999999999643 357899999875432 22346688999999999999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhccc-------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC
Q 038671 511 FIVYEYLEMGSLAMILSNDA-------------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE 577 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~ 577 (707)
++++||+.+++|.+++.... ....+++..+++++.|++.||+|||++ |++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence 99999999999999985321 123478889999999999999999999 99999999999999999
Q ss_pred CCeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchh
Q 038671 578 NEAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNL 654 (707)
Q Consensus 578 ~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 654 (707)
+.+||+|||+++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.... .
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~ 232 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------N 232 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------H
Confidence 9999999999876543321 1223455788999999988889999999999999999998 888875321 1
Q ss_pred hhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 655 EIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
................ .+.+..+.+++.+||+.+|++||+++++++.|+
T Consensus 233 ~~~~~~i~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 233 QDVIEMIRNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 2222333232222111 133455889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=310.77 Aligned_cols=250 Identities=27% Similarity=0.422 Sum_probs=204.7
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 512 (707)
....|++.+.||+||.+.||++...+.+.||+|++..... +.....-+..|+..|.+|+ |.+|+++++|-..++.+||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 3567999999999999999999888888899988754332 2345667999999999995 9999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||- ..+|..++..... ....| .++.+..|++.|+.++|.+ ||||.||||.|+++- .|.+||+|||.|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 99965 5789999975432 22234 7888999999999999999 999999999999996 7999999999999888
Q ss_pred CCCCC--ccccccccCCCCccccccCC-----------CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhh
Q 038671 593 PDSSN--WAELAGTYGYVAPELAYTMK-----------VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN 659 (707)
Q Consensus 593 ~~~~~--~~~~~g~~~y~aPE~~~~~~-----------~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 659 (707)
.+... ....+||+.||+||.+.... .+.+|||||||||+|+|+.|+.||... ......+.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-------~n~~aKl~ 583 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-------INQIAKLH 583 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-------HHHHHHHH
Confidence 77554 34568999999999887543 457899999999999999999999632 33455667
Q ss_pred hhcCCCC----CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 660 EMLDPRL----PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 660 ~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+.+|.- +..... .++.++++.|+..||++||++.++++
T Consensus 584 aI~~P~~~Iefp~~~~~-----~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 584 AITDPNHEIEFPDIPEN-----DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred hhcCCCccccccCCCCc-----hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 7777633 222211 12889999999999999999999986
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=303.05 Aligned_cols=253 Identities=24% Similarity=0.328 Sum_probs=208.2
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|+..+.||+|+||.||.++ ..+++.+++|.+....... .....+.+|++++++++|+|++++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 48889999999999999994 5578899999886543332 345678899999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 999999999997543 34589999999999999999999999 99999999999999999999999999998765544
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
.......+++.|+|||...+..++.++||||+|+++|+|++|+.||+... .............+... ..
T Consensus 156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~~~~---~~ 224 (256)
T cd08221 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVVKIVQGNYTPVV---SV 224 (256)
T ss_pred ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCCCCCCc---cc
Confidence 33445678999999999988888999999999999999999999986321 11222222222222211 23
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
.+.++.+++.+||+.+|.+||++.++++.+
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 225 YSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 445688999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=310.49 Aligned_cols=261 Identities=21% Similarity=0.367 Sum_probs=200.4
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-----------------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-----------------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIV 498 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv 498 (707)
++|++.+.||+|+||.||+++.. ++..+|+|++.... .......+.+|++.++.++||||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 56999999999999999998432 23468999986542 223456788999999999999999
Q ss_pred eeeeeeecCCceeEEEeeeccCcHHHHHhcccc--------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCC
Q 038671 499 KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAA--------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSK 570 (707)
Q Consensus 499 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~ 570 (707)
++++++...+..+++|||+.+++|.+++..... ...+++.+++.++.|++.|++|||+. |++||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~ 159 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR 159 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence 999999999999999999999999999865321 12477889999999999999999999 9999999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCcccc
Q 038671 571 NVLLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK--GKHPRDFISS 646 (707)
Q Consensus 571 Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t--g~~p~~~~~~ 646 (707)
||+++.++.++++|||++..+...... .....+++.|+|||...+..++.++||||||+++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999999765433211 122334678999998888889999999999999999998 7788753221
Q ss_pred cccccchhhhhhhhh-cCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 647 ISSSSSNLEIALNEM-LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 647 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.... .......... .....+.+. ..+..+.+++.+||+.||.+||++.++++.|+
T Consensus 240 ~~~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 240 EQVI-ENTGEFFRDQGRQVYLPKPA----LCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHH-HHHHHHHhhccccccCCCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1100 0000001000 011111111 23356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=311.40 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=200.8
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
.|+..+.||+|+||.||++. ..+++.||+|.+.............+..|+.++++++|++++++++++...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 36778899999999999995 45789999999865433333334567789999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+.+++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 999999999885432 24589999999999999999999999 99999999999999999999999999987654332
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||........ ........... ....+ ..
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~~~~~~~~-~~~~~------~~ 227 (285)
T cd05630 157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKEV-QEEYS------EK 227 (285)
T ss_pred -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHHHhhhhhh-hhhcC------cc
Confidence 22345789999999999988899999999999999999999999964221100 00111111111 11111 12
Q ss_pred HHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 038671 676 KLISIMEVAISCLDESPESRPT-----IQKVSQ 703 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps-----~~~l~~ 703 (707)
.+.++.+++.+||+.||++||+ ++|+++
T Consensus 228 ~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 228 FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 3345889999999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=302.05 Aligned_cols=250 Identities=25% Similarity=0.435 Sum_probs=201.2
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
++|++.+.||+|++|.||+|....+..+|+|++..... ..+.+.+|++++++++|||++++++++. .+..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 56889999999999999999877777899998764321 2356888999999999999999999875 456889999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+.+++|.+++.... ...+++..+..++.|++.||+|||+. |++||||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 81 FMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999996532 34578999999999999999999999 99999999999999999999999999997764332
Q ss_pred CC-ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcC-CCCCCCCcc
Q 038671 596 SN-WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLD-PRLPTPSHN 672 (707)
Q Consensus 596 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 672 (707)
.. .....++..|+|||...+..++.++||||||+++|+|++ |+.||..... ......+.. ...+.+
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~--- 225 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REVLEQVERGYRMPCP--- 225 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC---
Confidence 21 122345678999999988889999999999999999999 8999863221 111111111 111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.+..+.+++.+||+.||.+||+++++++.|+
T Consensus 226 -~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 258 (260)
T cd05069 226 -QGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258 (260)
T ss_pred -cccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 234567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=307.61 Aligned_cols=254 Identities=25% Similarity=0.420 Sum_probs=200.2
Q ss_pred CCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 437 DFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
+|++.+.||+|+||.||+|... ....+++|.+..... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4788899999999999999542 235688888765432 23456788999999999999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhccc---------------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 038671 511 FIVYEYLEMGSLAMILSNDA---------------------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISS 569 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 569 (707)
++++||+.+++|.+++.... ...++++..++.++.|++.||+|||+. +++||||||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence 99999999999999985421 123578999999999999999999999 999999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccc
Q 038671 570 KNVLLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISS 646 (707)
Q Consensus 570 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~ 646 (707)
+||++++++.+||+|||++......... .....++..|+|||...+..++.++||||||+++|||++ |..||.....
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999999765433221 122345678999999888889999999999999999998 9999853211
Q ss_pred cccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 647 ISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
........... +.+.+ ...+.++.+++.+||+.+|++||++.++++.|+
T Consensus 236 -----~~~~~~~~~~~--~~~~~----~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~ 284 (290)
T cd05045 236 -----ERLFNLLKTGY--RMERP----ENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284 (290)
T ss_pred -----HHHHHHHhCCC--CCCCC----CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 11111111111 11111 123456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=306.28 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=199.9
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|+..+.||+|+||.||+|. ..+++.||+|++..... ......+.+|++++++++|||++++++++..++..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 368888999999999999995 56789999999865422 234467889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++++++..+. .+++..+..++.|++.||+|||+. |++|+||||+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~ 148 (279)
T cd06619 79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS 148 (279)
T ss_pred ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence 999999997552 367888999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......... ..........+...+... ..
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~ 223 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDEDPPVLP--VG 223 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhccCCCCCC--CC
Confidence 2234578999999999998889999999999999999999999986432211111 111111111111111100 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+.++.+++.+|++.+|++||+++++++.
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 233468899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=306.03 Aligned_cols=252 Identities=23% Similarity=0.401 Sum_probs=197.0
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCc----EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
++|++.+.||+|+||.||+|.. .+++ .+++|.+.... ......++..|+..+++++||||+++++++.. ...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~ 83 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL 83 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence 5788999999999999999964 3454 47778875332 22234567888889999999999999998754 557
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++++||+++|+|.+++... ...+++..++.++.||+.||+|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 84 ~~i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred EEEEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 8899999999999999643 24589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 591 LKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 591 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
...... ......++..|+|||...+..++.++||||||+++||+++ |+.||..... .......... ...+
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~--~~~~ 231 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----HEVPDLLEKG--ERLA 231 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCC--CcCC
Confidence 643322 1233456778999999988889999999999999999998 9999863221 1111111111 1112
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.. .+.++.+++.+||..+|.+||++.++++.|+
T Consensus 232 ~~~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~ 266 (279)
T cd05111 232 QPQI----CTIDVYMVMVKCWMIDENVRPTFKELANEFT 266 (279)
T ss_pred CCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1111 2345788999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=299.55 Aligned_cols=247 Identities=25% Similarity=0.415 Sum_probs=198.0
Q ss_pred ceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccCc
Q 038671 442 HCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGS 521 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 521 (707)
+.||+|+||.||+|..++++.+|+|++...... .....+.+|++.++.++|||++++++++...+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ--ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 368999999999998888999999998754322 234568899999999999999999999999999999999999999
Q ss_pred HHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCc-cc
Q 038671 522 LAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW-AE 600 (707)
Q Consensus 522 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~ 600 (707)
|.+++.... ..+++..++.++.|++.||.|+|+. |++||||+|+||+++.++.+|++|||++.......... ..
T Consensus 79 L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (250)
T cd05085 79 FLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153 (250)
T ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence 999986432 3578999999999999999999999 99999999999999999999999999987543322111 12
Q ss_pred cccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 601 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 601 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
..+++.|+|||+..+..++.++||||||+++|++++ |..||..... .......... .+...+. ..+..
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----~~~~~~~~~~--~~~~~~~----~~~~~ 222 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----QQAREQVEKG--YRMSCPQ----KCPDD 222 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHHHcC--CCCCCCC----CCCHH
Confidence 234567999999988889999999999999999998 9999863221 1111111111 1111111 23456
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 680 IMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.+++.+|++.+|++||++.++++.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=314.38 Aligned_cols=260 Identities=17% Similarity=0.275 Sum_probs=197.3
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|+. .+++.||+|++...... .....+.+|++.+++++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 5689999999999999999965 46888999998654222 22345778999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++ ++.+++... ...+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||.+......
T Consensus 84 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 84 EYLDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred eCCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 99975 777776533 23578899999999999999999999 9999999999999999999999999999765444
Q ss_pred CCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccch-----------hhh-----h
Q 038671 595 SSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN-----------LEI-----A 657 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~-----------~~~-----~ 657 (707)
........+++.|+|||.+.+ ..++.++||||+|+++|+|+||+.||............ ... .
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 333344578899999998765 45789999999999999999999999642211000000 000 0
Q ss_pred hhhhcCCCCC-CC-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 658 LNEMLDPRLP-TP-SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 658 ~~~~~~~~~~-~~-~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
......+... .+ ....+..+.++.+++.+|++.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000001000 00 0001123456889999999999999999999886
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=310.50 Aligned_cols=262 Identities=21% Similarity=0.300 Sum_probs=198.7
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|++.+.||+|++|.||+|+. .+++.||+|++......+ .....+.+|+.++++++|||++++++++..++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC-CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 478889999999999999965 478999999986543222 234567889999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+. +++.+++........+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 997 58888886544446689999999999999999999999 99999999999999999999999999997654333
Q ss_pred CCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhh-------------hhhhh
Q 038671 596 SNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEI-------------ALNEM 661 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~-------------~~~~~ 661 (707)
.......+++.|+|||.+.+. .++.++||||||+++|+|+||+.||............... .....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 333344678899999987654 4688999999999999999999998642211000000000 00000
Q ss_pred --cCCCCCC--CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 662 --LDPRLPT--PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 662 --~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+.... ........+.++.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 00001123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=302.49 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=203.3
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCc--hhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPS--EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
+.|++.+.||+|++|.||.+.. .+++.+++|++...... .......+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5689999999999999999954 57899999998654322 12234568889999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
++||+++++|.+++... ..+++..+..++.|++.|++|||+. |++||||+|+||+++.++.++|+|||.+....
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999998643 3578899999999999999999999 99999999999999999999999999997654
Q ss_pred CCCCC---ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 593 PDSSN---WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 593 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
..... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... .............+.
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~- 227 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------MAAIFKIATQPTNPQ- 227 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------HHHHHHHhccCCCCC-
Confidence 32211 1234678899999999998899999999999999999999999853211 111111111111111
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
.....+..+.+++.+||..+|.+||++.++++..
T Consensus 228 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 228 --LPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred --CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 1123345688999999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=303.45 Aligned_cols=248 Identities=29% Similarity=0.482 Sum_probs=202.9
Q ss_pred ceeeecCCeeEEEEEcCC----CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeee
Q 038671 442 HCIGKGGQGSVYKAELPS----GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYL 517 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 517 (707)
+.||+|+||.||+|.... +..+++|++....... ..+.+.+|++.+..++|+|++++++++...+..+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 468999999999996543 7889999987653332 4678899999999999999999999999999999999999
Q ss_pred ccCcHHHHHhcccc------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 518 EMGSLAMILSNDAA------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 518 ~~~~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
++++|.+++..... ...+++..++.++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence 99999999975421 25689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC--CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcC-CCCC
Q 038671 592 KPDS--SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLD-PRLP 667 (707)
Q Consensus 592 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 667 (707)
.... .......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||..... ......... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~ 227 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRKGYRLP 227 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence 5443 22233457889999999988889999999999999999999 6999864321 111222221 1122
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+ ...+.++.+++.+||..+|++||++.|+++.|+
T Consensus 228 ~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 KP----EYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CC----ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 22 123566899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.66 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=202.1
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHA 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 507 (707)
.++|.+.+.||+|+||.||+|++. .++.||+|++...... ...+.+.+|++++.++. ||||+++++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 356888999999999999999643 3468999999764322 23456889999999997 99999999999999
Q ss_pred CceeEEEeeeccCcHHHHHhcccc--------------------------------------------------------
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAA-------------------------------------------------------- 531 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------- 531 (707)
+..++||||+++|+|.++++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999864321
Q ss_pred ---------------------------------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 038671 532 ---------------------------------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572 (707)
Q Consensus 532 ---------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 572 (707)
...+++..+++++.|++.||+|||+. +++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 12367778899999999999999999 999999999999
Q ss_pred eecCCCCeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccc
Q 038671 573 LLDLENEAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISS 649 (707)
Q Consensus 573 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 649 (707)
+++.++.+|++|||+++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--- 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--- 347 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc---
Confidence 999999999999999986543221 1223456788999999988889999999999999999998 8999863221
Q ss_pred ccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 650 SSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.......... ..+.+.+. ..+.++.+++.+||..+|.+||+++++++.|+
T Consensus 348 -~~~~~~~~~~--~~~~~~p~----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~ 397 (401)
T cd05107 348 -NEQFYNAIKR--GYRMAKPA----HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397 (401)
T ss_pred -hHHHHHHHHc--CCCCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 1111111111 11111121 22456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=310.48 Aligned_cols=251 Identities=24% Similarity=0.419 Sum_probs=203.9
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
..+|++.+.||+|++|.||+|. ..+++.|++|.+...... ..+.+.+|+.+++.++|||++++++.+..+...++|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4578999999999999999995 457899999988653322 346688999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++.. ..+++.++..++.|++.||+|||+. |++||||||+||+++.++.++|+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 96 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ecccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 999999999999853 2478899999999999999999999 999999999999999999999999999886554
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.........+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .............+. ...
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~--~~~ 239 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-------LRALYLIATNGTPEL--QNP 239 (296)
T ss_pred cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH-------HHhHHHHhcCCCCCC--CCc
Confidence 43333445788999999999888889999999999999999999999863221 111111111111111 112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...+..+.+++.+||..+|++||++.++++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 2344568899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.97 Aligned_cols=253 Identities=25% Similarity=0.454 Sum_probs=201.6
Q ss_pred cCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
.+|+..++||+|+||.||++.. .++..+++|.+... .......+.+|++.++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 5688889999999999999953 23567899987643 22345678999999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccc------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC
Q 038671 510 SFIVYEYLEMGSLAMILSNDAA------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE 577 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~ 577 (707)
.+++|||+++++|.+++..... ...+++..++.++.|++.|++|||+. |++||||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence 9999999999999999865432 13478999999999999999999999 99999999999999999
Q ss_pred CCeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchh
Q 038671 578 NEAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNL 654 (707)
Q Consensus 578 ~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 654 (707)
+.+||+|||++........ ......+++.|+|||...+..++.++||||||+++|||++ |+.||.....
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------- 230 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-------- 230 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------
Confidence 9999999999976543221 1122345678999999998889999999999999999998 9999853221
Q ss_pred hhhhhhhcCCC-CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 655 EIALNEMLDPR-LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 655 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
........... ...+. ..+..+.+++.+||+.||.+||++.++++.|+
T Consensus 231 ~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 231 TEAIECITQGRELERPR----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHHcCccCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11111121211 11111 23455889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.57 Aligned_cols=256 Identities=24% Similarity=0.377 Sum_probs=200.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 508 (707)
.++|++.+.||+|++|.||+|... .+..|++|.+.... .......+.+|+.+++.++|+||+++++++.+.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 457899999999999999999654 35678999876432 2234466889999999999999999999999989
Q ss_pred ceeEEEeeeccCcHHHHHhcccc----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC---CeE
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAA----AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN---EAH 581 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~---~~k 581 (707)
..+++|||+++++|.+++..... ...+++..+++++.||+.|++|||+. +++||||||+||+++.++ .+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence 99999999999999999865432 12489999999999999999999999 999999999999998765 599
Q ss_pred EeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhh
Q 038671 582 VSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIAL 658 (707)
Q Consensus 582 l~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 658 (707)
++|||+++........ ......+..|+|||++.+..++.++||||||+++|||++ |+.||+.... .......
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-----~~~~~~~ 234 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-----QEVMEFV 234 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHH
Confidence 9999999865322111 112233568999999998889999999999999999997 9999863221 1111111
Q ss_pred hhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 659 NEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.. ..+...+ ...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 235 ~~--~~~~~~~----~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TG--GGRLDPP----KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred Hc--CCcCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11 1111111 123456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=316.98 Aligned_cols=257 Identities=24% Similarity=0.293 Sum_probs=196.9
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+++. .+++.||+|++...........+.+.+|..++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999964 568999999986432222334556888999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+++|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999998642 24588999999999999999999999 9999999999999999999999999999766543
Q ss_pred CCC-ccccccccCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 595 SSN-WAELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 595 ~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
... .....|++.|+|||++.. ..++.++||||+|+++|+|++|+.||..... ................+.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~ 231 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHKEHFQFPP 231 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH----HHHHHHHHcCCCcccCCC
Confidence 322 223468999999999863 3478899999999999999999999863211 011111111111111111
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCC--CCCCHHHHHHH
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPE--SRPTIQKVSQL 704 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~--~Rps~~~l~~~ 704 (707)
.....+.++.+++.+|+..+++ .||++.++++.
T Consensus 232 ---~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 ---DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ---ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1112345678888887755333 37899888753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=307.90 Aligned_cols=257 Identities=22% Similarity=0.365 Sum_probs=201.5
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA 507 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 507 (707)
..++|++.+.||+|+||.||+|..+ .+..||+|.+.... .......+.+|+..+++++||||+++++++.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 3568999999999999999998542 24579999876442 222345678899999999999999999999999
Q ss_pred CceeEEEeeeccCcHHHHHhcccc-------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCe
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAA-------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEA 580 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~ 580 (707)
+..++||||+++|+|.+++..... ....++..+..++.|++.||+|||++ +++||||||+||+++.++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence 999999999999999999964321 12356778889999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhh
Q 038671 581 HVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIA 657 (707)
Q Consensus 581 kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 657 (707)
+++|||+++........ .....++..|+|||...+..++.++||||||+++|||++ |..||..... +..
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~~~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQV 230 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHH
Confidence 99999998765432221 122245678999999988889999999999999999998 7888853221 122
Q ss_pred hhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 658 LNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.....+....... ...+..+.+++.+|++.||++||++.++++.|+
T Consensus 231 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 276 (288)
T cd05061 231 LKFVMDGGYLDQP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276 (288)
T ss_pred HHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 2222222221111 122356999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=308.50 Aligned_cols=254 Identities=23% Similarity=0.353 Sum_probs=197.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCc--EEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGE--IVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 511 (707)
++|++.+.||+|+||.||+|..+ ++. .+++|.+.... .....+.+.+|++++.++ +||||+++++++...+..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 57899999999999999999654 333 47888876432 222346788999999999 7999999999999999999
Q ss_pred EEEeeeccCcHHHHHhccc-------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC
Q 038671 512 IVYEYLEMGSLAMILSNDA-------------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN 578 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~ 578 (707)
+++||+++++|.+++.... ....+++..++.++.|++.|++|||+. |++||||||+||++++++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence 9999999999999996432 123488899999999999999999999 999999999999999999
Q ss_pred CeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhh
Q 038671 579 EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIA 657 (707)
Q Consensus 579 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 657 (707)
.+||+|||++........ ......+..|+|||...+..++.++||||||+++|||++ |..||..... ...
T Consensus 157 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~~~ 227 (297)
T cd05089 157 ASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------AEL 227 (297)
T ss_pred eEEECCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence 999999999864321111 111233567999999988889999999999999999997 9999863221 111
Q ss_pred hhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 658 LNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
............. ...+.++.+++.+||+.+|.+||+++++++.|+
T Consensus 228 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 273 (297)
T cd05089 228 YEKLPQGYRMEKP---RNCDDEVYELMRQCWRDRPYERPPFAQISVQLS 273 (297)
T ss_pred HHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111111111 123356889999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=305.96 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=204.7
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|+..+.||.|++|.||+|.. .+++.|++|++.... .......+.+|+++++.++|||++++++++.++...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 3688889999999999999954 468999999986542 1234466889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++... ++++..++.++.|++.|+.|||+. +++||||+|+||++++++.++++|||.+......
T Consensus 79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 999999999998643 689999999999999999999999 9999999999999999999999999999887654
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
........+++.|+|||...+..++.++||||||+++|+|+||+.||..... ............+.... .
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~~~~~~~~~~~~~~~--~ 221 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLFLIPKNNPPSLEG--N 221 (274)
T ss_pred ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--------HHHHHHhhhcCCCCCcc--c
Confidence 3344456788899999999988899999999999999999999999863221 11111111111111111 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+.++.+++.+||..+|++||+++++++.
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 145568899999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=307.29 Aligned_cols=252 Identities=25% Similarity=0.388 Sum_probs=199.3
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.+++.++|||++++++++..++..+++|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence 467888899999999999995 45789999999865321 23456788999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++... +.+++.+++.++.|++.|++|||+. |++|+||||+||+++.++.++|+|||.+......
T Consensus 86 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 86 EFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred eccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 999999999998643 3589999999999999999999999 9999999999999999999999999999776544
Q ss_pred CCCccccccccCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 595 SSNWAELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
........|++.|+|||.+. ...++.++|+||+|+++|+|++|+.||...... .............+...
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~---- 232 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM---RALFLMTKSNFQPPKLK---- 232 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch---hhHHhhhccCCCCCccc----
Confidence 33334557899999999874 455888999999999999999999998532210 00000000011111111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.....+..+.+++.+|++.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11123446889999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=302.05 Aligned_cols=252 Identities=27% Similarity=0.496 Sum_probs=205.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|++|.||+|..++++.+++|.+..... ..+++.+|+..+++++|||++++++++......+++|
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 467999999999999999999887888999999875322 3456889999999999999999999999989999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+|++|||.+......
T Consensus 81 e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 81 EYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred eccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999996532 34589999999999999999999999 9999999999999999999999999999776532
Q ss_pred CC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcC-CCCCCCCc
Q 038671 595 SS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLD-PRLPTPSH 671 (707)
Q Consensus 595 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 671 (707)
.. ......++..|+|||.+.+..++.++|+||+|+++|++++ |+.||..... ......... ...+.+.
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~- 227 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVLEQVERGYRMPRPP- 227 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCC-
Confidence 11 1122234568999999998889999999999999999999 9999853221 111111111 1122221
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+|++.+|++||+++++.+.|+
T Consensus 228 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 228 ---NCPEELYDLMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred ---CCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence 12456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=309.40 Aligned_cols=255 Identities=24% Similarity=0.398 Sum_probs=202.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHA 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 507 (707)
.++|++.+.||+|+||.||++... ....+|+|.+..... ......+.+|++++.++ +||||+++++++..+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 457889999999999999999643 236799999875422 22345688999999999 799999999999999
Q ss_pred CceeEEEeeeccCcHHHHHhcc-------------cccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee
Q 038671 508 RHSFIVYEYLEMGSLAMILSND-------------AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL 574 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~ 574 (707)
+..+++|||+++++|.++++.. .....+++..+++++.|++.|++|||+. +++||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEE
Confidence 9999999999999999998643 2235689999999999999999999999 99999999999999
Q ss_pred cCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccc
Q 038671 575 DLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSS 651 (707)
Q Consensus 575 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~ 651 (707)
+.++.+||+|||.+......... .....++..|+|||...+..++.++||||||+++||+++ |..||.....
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----- 240 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----- 240 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-----
Confidence 99999999999999876543221 112234578999999888889999999999999999998 9999853211
Q ss_pred chhhhhhhhhcCCC-CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 652 SNLEIALNEMLDPR-LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 652 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
........... ...+. ..+..+.+++.+||+.||++|||+.++++.|+
T Consensus 241 ---~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~ 289 (293)
T cd05053 241 ---EELFKLLKEGYRMEKPQ----NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD 289 (293)
T ss_pred ---HHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence 11111111111 11111 22345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=299.87 Aligned_cols=245 Identities=24% Similarity=0.387 Sum_probs=192.5
Q ss_pred eeeecCCeeEEEEEcC---CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeecc
Q 038671 443 CIGKGGQGSVYKAELP---SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 443 ~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
.||+|+||.||+|... ++..||+|+..... .....+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999543 45579999986542 23345678999999999999999999998854 578999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
++|.+++... ...+++..+++++.|++.||+|||++ |++||||||+||+++.++.+||+|||.+...........
T Consensus 79 ~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 79 GPLNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 9999998642 34689999999999999999999999 999999999999999999999999999976543322211
Q ss_pred ---ccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 600 ---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 600 ---~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
...+++.|+|||...+..++.++||||||+++|++++ |+.||..... ........... +...+ ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~~--~~~~~----~~ 222 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-----PEVMSFIEQGK--RLDCP----AE 222 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHHHHCCC--CCCCC----CC
Confidence 1223568999999888889999999999999999996 9999864321 11111111111 11111 12
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.++.+++.+||..+|++||++.++.+.|+
T Consensus 223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~ 253 (257)
T cd05115 223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253 (257)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 3456889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=302.98 Aligned_cols=252 Identities=27% Similarity=0.423 Sum_probs=204.5
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|++|.||+|.. .+++.+++|++..... ...+.+.+|++++++++|||++++++++...+..+++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5789999999999999999965 4678899999865422 24567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+++|.+++... ...+++..++.++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.+......
T Consensus 80 e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 80 EYCGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred eCCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 999999999988643 24588999999999999999999999 9999999999999999999999999999776544
Q ss_pred CCCccccccccCCCCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC-CCC
Q 038671 595 SSNWAELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP-TPS 670 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 670 (707)
........++..|+|||...+. .++.++|+||||+++|+|++|+.||...... .... ......+. ...
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-------~~~~-~~~~~~~~~~~~ 226 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-------RALF-LISKSNFPPPKL 226 (262)
T ss_pred hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------HHHH-HHHhccCCCccc
Confidence 3333445788899999998776 7889999999999999999999998632211 1111 11111011 111
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
......+.++.+++.+||..+|.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 122345667999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=300.48 Aligned_cols=245 Identities=27% Similarity=0.417 Sum_probs=194.2
Q ss_pred eeeecCCeeEEEEEc---CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeecc
Q 038671 443 CIGKGGQGSVYKAEL---PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 443 ~lg~G~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
.||+|+||.||+|.+ .+++.+|+|++..... .....+++..|+.+++.++||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999953 4578899999865432 2334567899999999999999999999885 4567899999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCc-
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW- 598 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 598 (707)
++|.+++... +.+++..+..++.|++.|++|||+. |++||||||+||+++.++.+||+|||.+..........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 80 GPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999998643 3589999999999999999999999 99999999999999999999999999998765433211
Q ss_pred --cccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 599 --AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 599 --~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
....+++.|+|||.+.+..++.++|+||||+++|||++ |+.||..... ........... ..+.+. .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~i~~~~--~~~~~~----~ 222 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-----NEVTQMIESGE--RMECPQ----R 222 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHCCC--CCCCCC----C
Confidence 12234578999999888888999999999999999998 9999863221 11111111111 111121 2
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.++.+++.+||+.||++||++++|.+.|+
T Consensus 223 ~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~ 253 (257)
T cd05116 223 CPPEMYDLMKLCWTYGVDERPGFAVVELRLR 253 (257)
T ss_pred CCHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence 3456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=310.65 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=197.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCc--EEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGE--IVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 511 (707)
++|++.+.||+|+||.||+|..+ ++. .+++|.+.... .......+.+|++++.++ +||||+++++++..++..+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 57889999999999999999653 454 45777765422 223456788999999999 8999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC
Q 038671 512 IVYEYLEMGSLAMILSNDAA-------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN 578 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~ 578 (707)
+||||+++++|.++++.... ...+++.+++.++.|++.|++|||+. |++||||||+||+++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 161 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence 99999999999999965421 23578999999999999999999999 999999999999999999
Q ss_pred CeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhh
Q 038671 579 EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIA 657 (707)
Q Consensus 579 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 657 (707)
.+||+|||++...... .......++..|+|||.+.+..++.++||||||+++|||+| |..||..... ...
T Consensus 162 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~ 232 (303)
T cd05088 162 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AEL 232 (303)
T ss_pred cEEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------HHH
Confidence 9999999998642211 11111234667999999988889999999999999999998 9999863221 111
Q ss_pred hhhhcCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 658 LNEMLDP-RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 658 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....... ....+. ..+.++.+++.+||+.+|++||+++++++.|+
T Consensus 233 ~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 233 YEKLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred HHHHhcCCcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111 111111 22345889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.61 Aligned_cols=251 Identities=28% Similarity=0.444 Sum_probs=204.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|+..+.||+|++|.||+|... +++.+++|.+.... ..+.+.+|++++++++|||++++++++..+...+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 367999999999999999999665 48899999985431 257889999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
+||+.+++|.+++... ...+++..++.++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+.....
T Consensus 77 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 77 MEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred EecCCCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 9999999999998543 34689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.........++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .. ...... .........
T Consensus 152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~-------~~-~~~~~~-~~~~~~~~~ 222 (256)
T cd06612 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM-------RA-IFMIPN-KPPPTLSDP 222 (256)
T ss_pred CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh-------hh-hhhhcc-CCCCCCCch
Confidence 433334456888999999998888999999999999999999999998642211 00 000000 111111112
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...+..+.+++.+||+.+|++||++.|+++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 2344568999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=308.39 Aligned_cols=256 Identities=23% Similarity=0.434 Sum_probs=203.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 508 (707)
.++|++.+.||+|+||.||+|..+ ++..||+|++..... .....++.+|+.++++++|||++++++++..+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 357899999999999999999643 467899999875432 234467889999999999999999999999999
Q ss_pred ceeEEEeeeccCcHHHHHhccc-------------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 038671 509 HSFIVYEYLEMGSLAMILSNDA-------------------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISS 569 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 569 (707)
..++++||+++++|.+++.... ....+++..++.++.|++.||+|||+. +++||||+|
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p 158 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT 158 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence 9999999999999999986321 113478889999999999999999999 999999999
Q ss_pred CCeeecCCCCeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccc
Q 038671 570 KNVLLDLENEAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISS 646 (707)
Q Consensus 570 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~ 646 (707)
+||+++.++.++|+|||.+........ .......++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999876543221 1122234677999999988889999999999999999998 8888753211
Q ss_pred cccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 647 ISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
........+....... ...+.++.+++.+||+.||++||++.|+++.|+
T Consensus 239 --------~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 --------EEVIYYVRDGNVLSCP---DNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred --------HHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 1222222222222111 123456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=318.79 Aligned_cols=261 Identities=21% Similarity=0.327 Sum_probs=196.8
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC---
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR--- 508 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 508 (707)
...++|++.+.||+|+||.||++.. .+|+.||+|++...... ......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN-QTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccc-hhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 3457899999999999999999954 56899999998754322 234466789999999999999999999986443
Q ss_pred ---ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 509 ---HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 509 ---~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
..++||||+++ ++...+. ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence 47999999976 4555553 2378889999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc----------cchh-
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS----------SSNL- 654 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~----------~~~~- 654 (707)
|++...... .......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||...+..... ....
T Consensus 168 g~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 168 GLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 999764322 2233457899999999999999999999999999999999999999643221100 0000
Q ss_pred ---hhhhhhhc--CCCCCC--------------CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 655 ---EIALNEML--DPRLPT--------------PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 655 ---~~~~~~~~--~~~~~~--------------~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
........ .+..+. ..........++.+++.+|++.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 011110 000011123468899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=303.04 Aligned_cols=252 Identities=25% Similarity=0.454 Sum_probs=201.9
Q ss_pred cCCCCCceeeecCCeeEEEEEcC----CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
++|++.+.||+|+||.||+|... .+..+|+|.+..... ....+.+..|+..+++++||||+++++++..++..+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM 81 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 56889999999999999999643 234799999865432 234567899999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
++|||+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++++|||++...
T Consensus 82 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 9999999999999996432 4589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCcc---ccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC-CC
Q 038671 592 KPDSSNWA---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP-RL 666 (707)
Q Consensus 592 ~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 666 (707)
........ ...++..|+|||.+.+..++.++|+||||+++||+++ |+.||..... ......+.+. +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~~~~~~~ 228 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------QDVIKAIEEGYRL 228 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------HHHHHHHhCCCcC
Confidence 54332211 1223567999999998889999999999999999887 9999863221 1111111111 12
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.+ ...+..+.+++.+|++.+|.+||++.++++.|+
T Consensus 229 ~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 264 (267)
T cd05066 229 PAP----MDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264 (267)
T ss_pred CCC----CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence 221 123456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=302.71 Aligned_cols=253 Identities=22% Similarity=0.374 Sum_probs=195.9
Q ss_pred CCCCceeeecCCeeEEEEEcCC-Cc--EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------C
Q 038671 438 FDDEHCIGKGGQGSVYKAELPS-GE--IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA------R 508 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 508 (707)
|.+.+.||+|+||.||+|.... ++ .+|+|.+..... .....+.+..|++.++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567889999999999996543 33 689998865432 223456788999999999999999999987432 2
Q ss_pred ceeEEEeeeccCcHHHHHhccc---ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDA---AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
..+++|||+.+|+|.+++.... ....+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+||
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence 5689999999999998874322 224588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhc
Q 038671 586 GTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEML 662 (707)
Q Consensus 586 g~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 662 (707)
|++......... .....+++.|+|||...+..++.++||||||+++|||++ |+.||..... ........
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~ 228 (272)
T cd05075 157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIYDYLR 228 (272)
T ss_pred CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHH
Confidence 999876433221 122345678999999998889999999999999999999 8899863221 11111111
Q ss_pred CC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 663 DP-RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 663 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.. ..+.+. ..+..+.+++.+||+.||++|||++++++.|+
T Consensus 229 ~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 269 (272)
T cd05075 229 QGNRLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269 (272)
T ss_pred cCCCCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11 111111 23345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=305.67 Aligned_cols=256 Identities=23% Similarity=0.374 Sum_probs=203.5
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCC-----CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec-CC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPS-----GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH-AR 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~ 508 (707)
.++|++.+.||+|+||.||+|.... +..|++|++.... .......+.+|+..+++++|||++++++++.. +.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4678899999999999999997654 6889999886432 33345778899999999999999999998766 56
Q ss_pred ceeEEEeeeccCcHHHHHhccccc-----CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEe
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAA-----KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVS 583 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~ 583 (707)
..++++||+.+++|.+++...... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+|++
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence 789999999999999998654332 4589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhh
Q 038671 584 DFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 584 Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
|||+++.+...... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||..... .........
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~ 234 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----FEMAAYLKD 234 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----HHHHHHHHc
Confidence 99999865433221 112345678999999988889999999999999999999 9999864221 111111111
Q ss_pred hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
......+ ...+.++.+++.+||+.||++||++.++++.|+
T Consensus 235 --~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 274 (280)
T cd05043 235 --GYRLAQP----INCPDELFAVMACCWALDPEERPSFSQLVQCLT 274 (280)
T ss_pred --CCCCCCC----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 1111111 123456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.33 Aligned_cols=255 Identities=23% Similarity=0.392 Sum_probs=202.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEc--------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL--------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCS 505 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 505 (707)
.++|++.+.||+|+||.||+|+. .++..||+|...... .....+.+.+|+..++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 46789999999999999999953 234579999886432 223456788999999999 7999999999999
Q ss_pred cCCceeEEEeeeccCcHHHHHhcccc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDAA-------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 572 (707)
..+..+++|||+.+++|.+++..... ...+++.+++.++.||++||+|||+. |++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 99999999999999999999965321 23578889999999999999999999 999999999999
Q ss_pred eecCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccc
Q 038671 573 LLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISS 649 (707)
Q Consensus 573 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 649 (707)
+++.++.+||+|||.++........ .....+++.|+|||...+..++.++||||||+++|+|++ |..||....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---- 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---- 244 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence 9999999999999999876543222 122345678999999988889999999999999999998 788875321
Q ss_pred ccchhhhhhhhhcCCC-CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 650 SSSNLEIALNEMLDPR-LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 650 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
............ ...+ ...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 245 ----~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~ 294 (304)
T cd05101 245 ----VEELFKLLKEGHRMDKP----ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD 294 (304)
T ss_pred ----HHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 111122221111 1111 133456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=312.01 Aligned_cols=255 Identities=23% Similarity=0.389 Sum_probs=201.0
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC--------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP--------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCS 505 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 505 (707)
.++|.+.+.||+|+||.||++... ++..+|+|.+..... ......+..|+.++..+ +||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 357999999999999999999542 235799999875422 23446688899999999 7999999999999
Q ss_pred cCCceeEEEeeeccCcHHHHHhcccc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDAA-------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 572 (707)
..+..++||||+.+++|.+++..... ...+++..+++++.|++.||+|||+. |++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence 99999999999999999999965432 13488999999999999999999999 999999999999
Q ss_pred eecCCCCeEEeccccceecCCCCCCc--cccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccc
Q 038671 573 LLDLENEAHVSDFGTAKFLKPDSSNW--AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISS 649 (707)
Q Consensus 573 l~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 649 (707)
+++.++.+||+|||.+.......... ....+++.|+|||...+..++.++||||||+++|||++ |+.||....
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~---- 247 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---- 247 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC----
Confidence 99999999999999987654322111 11224568999999988889999999999999999998 888885321
Q ss_pred ccchhhhhhhhhcCCC-CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 650 SSSNLEIALNEMLDPR-LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 650 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
............ ...+ ...+.++.+++.+||+.+|++||++.++++.|+
T Consensus 248 ----~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~ 297 (307)
T cd05098 248 ----VEELFKLLKEGHRMDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 297 (307)
T ss_pred ----HHHHHHHHHcCCCCCCC----CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 111111111111 1111 123456889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=309.93 Aligned_cols=256 Identities=25% Similarity=0.419 Sum_probs=202.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHA 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 507 (707)
.++|++.+.||+|+||.||++.. .++..+|+|++..... ....+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 35689999999999999999953 2355799998865422 23456789999999999 799999999999999
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
+..+++|||+.+++|.++++... ...+++.+++.++.|++.|++|||+. +++|+||||+||+++.++.++++|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999986433 23489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC
Q 038671 588 AKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP 664 (707)
Q Consensus 588 ~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 664 (707)
+......... .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||..... ............
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~----~~~~~~~~~~~~-- 261 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV----DSKFYKLIKEGY-- 261 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc----hHHHHHHHHcCC--
Confidence 9865433221 122345678999999998889999999999999999998 9999863221 111111111111
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....+ ...+.++.+++.+|++.+|++||++.++++.|+
T Consensus 262 ~~~~~----~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~ 299 (302)
T cd05055 262 RMAQP----EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG 299 (302)
T ss_pred cCCCC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 11111 122346899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=302.23 Aligned_cols=248 Identities=26% Similarity=0.433 Sum_probs=198.7
Q ss_pred ceeeecCCeeEEEEEcCC--C--cEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeee
Q 038671 442 HCIGKGGQGSVYKAELPS--G--EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYL 517 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 517 (707)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+.+.+|++.+++++|||++++++++.. ...++++||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999996532 3 36899998765432 456778999999999999999999999988 8899999999
Q ss_pred ccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCC
Q 038671 518 EMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN 597 (707)
Q Consensus 518 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 597 (707)
++++|.+++..... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.........
T Consensus 78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99999999975433 5689999999999999999999999 9999999999999999999999999999876543221
Q ss_pred ---ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 598 ---WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 598 ---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.....++..|+|||...+..++.++||||||+++|+|++ |+.||...... ........ .....+.+
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~--~~~~~~~~---- 223 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS----QILKKIDK--EGERLERP---- 223 (257)
T ss_pred eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHh--cCCcCCCC----
Confidence 112356788999999988889999999999999999999 99998633221 11111111 11111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 123456899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=303.19 Aligned_cols=257 Identities=28% Similarity=0.447 Sum_probs=206.1
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||.|++|.||+|.. .++..+++|++....... ....+.+|++.++.++|+|++++++.+..++..++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 4789999999999999999964 468899999986543322 5577899999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
|++++++|.++++.......+++..++.++.|++.|++|||+. |++||||+|+||++++++.++|+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 9999999999997544445689999999999999999999999 9999999999999999999999999999776544
Q ss_pred CCC----ccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 595 SSN----WAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 595 ~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
... .....++..|+|||.+... .++.++|+||||+++|+|++|+.||...... ......... ..+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~----~~~~~~~~~-~~~~~~~~ 230 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM----KVLMLTLQN-DPPSLETG 230 (267)
T ss_pred ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh----hhHHHHhcC-CCCCcCCc
Confidence 322 1334688999999988776 6889999999999999999999998643221 111111111 11111111
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
......+.++.+++.+||+.||++||++.++++
T Consensus 231 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 -ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111244567899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=308.93 Aligned_cols=250 Identities=26% Similarity=0.439 Sum_probs=203.4
Q ss_pred CCCCCceeeecCCeeEEEEEc--C-CCc--EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL--P-SGE--IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~--~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
.....+.||.|-||.||+|.. + .|+ .||||.-+... +....+.|.+|+.+|+.++||||++++|+|.+ ...|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 345567899999999999942 2 344 37778766543 33457889999999999999999999999976 4689
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+|||.++.|-|..+++.. ...++......++.||..||+|||+. .+|||||..+|||+.....||++|||+++.+
T Consensus 467 ivmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999999654 34688889999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCCccc-cccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 592 KPDSSNWAE-LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 592 ~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
......... ..-+.-|||||.+.-.+++.+||||.|||++||++. |..||++...- .....--...++|.|
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-------DVI~~iEnGeRlP~P 614 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-------DVIGHIENGERLPCP 614 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc-------ceEEEecCCCCCCCC
Confidence 765443222 123567999999999999999999999999999997 99999854431 122222334556665
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
+. +++.+..++.+||+.+|.+||.+.++...|
T Consensus 615 ~n----CPp~LYslmskcWayeP~kRPrftei~~~l 646 (974)
T KOG4257|consen 615 PN----CPPALYSLMSKCWAYEPSKRPRFTEIKAIL 646 (974)
T ss_pred CC----CChHHHHHHHHHhccCcccCCcHHHHHHHH
Confidence 44 345589999999999999999999988765
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=300.64 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=203.1
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec-CCceeEEE
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH-ARHSFIVY 514 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 514 (707)
+|++.+.||+|++|.||++.. .+++.+++|++...... ....+.+.+|++++++++|||++++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 488899999999999999954 46789999998643222 2344568889999999999999999998764 44678999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++... ....+++.+++.++.|++.|+++||+. |++||||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 80 GFCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred cccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999998643 234589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
........+++.|+|||...+..++.++||||+|+++|+|++|+.||+... .............+.. ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~~~---~~ 224 (257)
T cd08223 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRIIEGKLPPM---PK 224 (257)
T ss_pred CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcCCCCC---cc
Confidence 444445678899999999999889999999999999999999999986321 1111122222222221 12
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+.++.+++.+||+.+|++||++.++++.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 225 DYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 344568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.19 Aligned_cols=243 Identities=23% Similarity=0.273 Sum_probs=188.0
Q ss_pred eeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC---CCCceeeeeeeeecCCceeEEEeeecc
Q 038671 444 IGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI---RHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 444 lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
||+|+||.||+|+. .+++.||+|++.............+..|..++... +||+|+++++++......++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999954 56899999998643222222233445566666555 699999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||++...........
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~ 154 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN 154 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence 9999888643 4589999999999999999999999 999999999999999999999999999876443333344
Q ss_pred ccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHH
Q 038671 600 ELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLI 678 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (707)
...|++.|+|||.+.+. .++.++||||+|+++|+|++|+.||.... .......+.......+.. ..+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~~---~~~~ 223 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--------TQQMYRNIAFGKVRFPKN---VLSD 223 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--------HHHHHHHHHcCCCCCCCc---cCCH
Confidence 56799999999988754 47899999999999999999999986321 112222222222222111 1234
Q ss_pred HHHHHHHhccCCCCCCCC----CHHHHHH
Q 038671 679 SIMEVAISCLDESPESRP----TIQKVSQ 703 (707)
Q Consensus 679 ~l~~li~~cl~~~P~~Rp----s~~~l~~ 703 (707)
++.+++.+||+.||++|| ++.++++
T Consensus 224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 224 EGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 578999999999999998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=305.16 Aligned_cols=258 Identities=24% Similarity=0.378 Sum_probs=197.1
Q ss_pred CCCCceeeecCCeeEEEEE-----cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--Cce
Q 038671 438 FDDEHCIGKGGQGSVYKAE-----LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA--RHS 510 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 510 (707)
|+..+.||+|+||+||.+. ..+++.||+|.+..... ......+.+|+++++.++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 3888999999999998763 34678899999865422 22456788999999999999999999988653 457
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
+++|||+.+++|.+++.. ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccc
Confidence 899999999999999854 2489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccc-----cc-chhhhhhhhh
Q 038671 591 LKPDSSN---WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISS-----SS-SNLEIALNEM 661 (707)
Q Consensus 591 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-----~~-~~~~~~~~~~ 661 (707)
....... .....++..|+|||...+..++.++||||||+++|||++|..||........ .. ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 6543221 1122356679999999888899999999999999999999999853221000 00 0000001111
Q ss_pred cCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 662 LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.....+ .....+.++.+++.+||+.+|++||+++++++.|+
T Consensus 237 ~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~ 279 (283)
T cd05080 237 LERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279 (283)
T ss_pred hhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 11111100 11123456999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.11 Aligned_cols=253 Identities=23% Similarity=0.271 Sum_probs=189.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA------ 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 507 (707)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 46799999999999999999954 578999999875421 2234699999999999999999876431
Q ss_pred --CceeEEEeeeccCcHHHHHhc-ccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC-CeEEe
Q 038671 508 --RHSFIVYEYLEMGSLAMILSN-DAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-EAHVS 583 (707)
Q Consensus 508 --~~~~lv~e~~~~~~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~-~~kl~ 583 (707)
...++||||+++ ++.+++.. ......+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence 246799999985 56665532 22345689999999999999999999999 999999999999998665 79999
Q ss_pred ccccceecCCCCCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh--
Q 038671 584 DFGTAKFLKPDSSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE-- 660 (707)
Q Consensus 584 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 660 (707)
|||+++...... ......|++.|+|||++.+. .++.++||||+||++|||++|++||....... ........
T Consensus 214 DFGla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~----~~~~i~~~~~ 288 (440)
T PTZ00036 214 DFGSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD----QLVRIIQVLG 288 (440)
T ss_pred ccccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhC
Confidence 999998765332 22345789999999987754 68999999999999999999999996432211 00000000
Q ss_pred -------------hcCCCCCCCC-cc-----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 661 -------------MLDPRLPTPS-HN-----VQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 661 -------------~~~~~~~~~~-~~-----~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+..++... .. ....+.++.+++.+||..||.+|||+.|+++
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0011111100 00 0012356889999999999999999999875
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=307.53 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=202.8
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||++..+ +++.||+|.+.... .......+.+|++.+++++|||++++++++...+..++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 36889999999999999999654 78999999886432 2234467889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|..++........+++..+..++.|++.|+.|||+.+ +++||||+|+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999999865433446899999999999999999999632 8999999999999999999999999998765432
Q ss_pred CCCccccccccCCCCccccccCC------CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 595 SSNWAELAGTYGYVAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
. .....+++.|+|||.+.+.. ++.++|+||+|+++|+|++|+.||..... ...............+.
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~ 229 (286)
T cd06622 157 L--AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQLSAIVDGDPPT 229 (286)
T ss_pred c--cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hhHHHHHHHHhhcCCCC
Confidence 2 23346788999999886543 47899999999999999999999863211 11112222222222221
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...+.+.++.+++.+||+.+|++||++.++++.
T Consensus 230 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 230 ---LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 112355668999999999999999999998863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=301.03 Aligned_cols=254 Identities=23% Similarity=0.386 Sum_probs=199.3
Q ss_pred CCCCceeeecCCeeEEEEEcC----CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc----
Q 038671 438 FDDEHCIGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH---- 509 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 509 (707)
|++.+.||+|+||.||+|... .+..||+|++...... ......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 577899999999999999643 2477999998754322 2345678999999999999999999998865544
Q ss_pred --eeEEEeeeccCcHHHHHhccc---ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEec
Q 038671 510 --SFIVYEYLEMGSLAMILSNDA---AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSD 584 (707)
Q Consensus 510 --~~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~D 584 (707)
.++++||+++++|..++.... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d 156 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD 156 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence 799999999999999885432 224589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCc--cccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhh
Q 038671 585 FGTAKFLKPDSSNW--AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEM 661 (707)
Q Consensus 585 fg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 661 (707)
||.++......... ....++..|+|||...+..++.++||||||+++|||++ |..||..... .......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~~~~~ 228 (273)
T cd05035 157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEIYDYL 228 (273)
T ss_pred ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH
Confidence 99998765433211 11234678999999988889999999999999999999 8899863221 1112222
Q ss_pred cCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 662 LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
........ ....+.++.+++.+||+.||++||++.++++.|+
T Consensus 229 ~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~ 270 (273)
T cd05035 229 RHGNRLKQ---PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270 (273)
T ss_pred HcCCCCCC---CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 22211111 1123456899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=304.38 Aligned_cols=248 Identities=23% Similarity=0.386 Sum_probs=198.5
Q ss_pred CCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEee
Q 038671 438 FDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
|++.+.||+|+||.||++... ++..+++|.+.... ....+.+.+|+++++.++|||++++++++..++..++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 677888999999999999654 57888999885432 23456788899999999999999999999999999999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 596 (707)
+++++|..++... ..++++..++.++.|+++||+|||+. |++||||+|+||+++.++.+|++|||++........
T Consensus 84 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 84 CAGGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred cCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 9999999887542 34689999999999999999999999 999999999999999999999999999976544333
Q ss_pred CccccccccCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh--hcCCCCCCC
Q 038671 597 NWAELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE--MLDPRLPTP 669 (707)
Q Consensus 597 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 669 (707)
......+++.|+|||.+. +..++.++||||+|+++|+|++|+.||..... ....... ...+....+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~ 231 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-------MRVLLKIAKSEPPTLAQP 231 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-------HHHHHHHhhcCCCCCCCc
Confidence 334457899999999874 34577899999999999999999999863221 1111111 111111111
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...+.++.+++.+||+.+|.+||+++++++.
T Consensus 232 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 ----SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2234568999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=298.10 Aligned_cols=245 Identities=28% Similarity=0.456 Sum_probs=194.1
Q ss_pred ceeeecCCeeEEEEEc--CC--CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeee
Q 038671 442 HCIGKGGQGSVYKAEL--PS--GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYL 517 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~--~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 517 (707)
+.||+|+||.||+|.. ++ +..+|+|.+...... ...+++.+|+++++.++|||++++++++. ....+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 4699999999999943 22 368999998765332 34567889999999999999999999876 45689999999
Q ss_pred ccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCC
Q 038671 518 EMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN 597 (707)
Q Consensus 518 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 597 (707)
.+++|.+++.... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.........
T Consensus 78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~ 151 (257)
T cd05060 78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY 151 (257)
T ss_pred CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence 9999999996543 589999999999999999999999 9999999999999999999999999999876544332
Q ss_pred ccc---cccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 598 WAE---LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 598 ~~~---~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
... ..++..|+|||...+..++.++||||||+++|+|++ |+.||..... .......... ...+.+
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-----~~~~~~~~~~--~~~~~~---- 220 (257)
T cd05060 152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----AEVIAMLESG--ERLPRP---- 220 (257)
T ss_pred cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHHcC--CcCCCC----
Confidence 211 123467999999998889999999999999999998 9999864322 1111111111 111121
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+.++.+++.+||..+|++||++.++++.|+
T Consensus 221 ~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~ 253 (257)
T cd05060 221 EECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253 (257)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 123456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=307.80 Aligned_cols=249 Identities=26% Similarity=0.465 Sum_probs=202.7
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.+|++.+.||.|++|.||+|. ..+++.|++|.+..... ...+.+.+|+..++.++|||++++++++...+..++|+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 468999999999999999995 56789999998865322 23466888999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+++|.+++.. ..+++.++..++.|++.|++|||+. |++||||+|+||+++.++.+||+|||++......
T Consensus 96 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 96 EYLAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred EecCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 99999999998853 2479999999999999999999999 9999999999999999999999999998876544
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
........+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .. ........+....+ .
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~----~~-~~~~~~~~~~~~~~----~ 239 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR----AL-YLIATNGTPELQNP----E 239 (296)
T ss_pred cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----HH-HHHHhcCCcccCCc----c
Confidence 433344578899999999988889999999999999999999999986432210 00 01111111111111 2
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+..+.+++.+||..||++||++.++++
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 23456889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.58 Aligned_cols=254 Identities=23% Similarity=0.298 Sum_probs=197.9
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+++. .+++.||+|++.............+.+|..++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999964 468899999986432222334456888999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.||+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999643 23588999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCC-ccccccccCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcC--CCC
Q 038671 595 SSN-WAELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD--PRL 666 (707)
Q Consensus 595 ~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 666 (707)
... .....|++.|+|||++.+ ..++.++||||+|+++|+|++|+.||..... ......+.. .+.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~ 227 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHEERF 227 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--------HHHHHHHHcCCCcc
Confidence 322 223569999999998875 4578899999999999999999999863221 111112211 111
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPES--RPTIQKVSQ 703 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~~l~~ 703 (707)
+.+ ....+.+.++.+++.+|+..++++ |++++++++
T Consensus 228 ~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 228 QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 111 111233456888999998865554 467888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=320.00 Aligned_cols=259 Identities=23% Similarity=0.328 Sum_probs=195.9
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----ce
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR-----HS 510 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~ 510 (707)
+|+..+.||+|+||.||++.. .+|+.||+|++..... .......+.+|+++++.++||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 478899999999999999964 5789999999865322 2234467889999999999999999999998766 78
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
|+|+||+. ++|.+.+.. ...+++..++.++.||+.||+|||+. |++||||||+||+++.++.+||+|||++..
T Consensus 80 ~lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99999997 567777643 24589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCC-CccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccch--------hh-----
Q 038671 591 LKPDSS-NWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN--------LE----- 655 (707)
Q Consensus 591 ~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~--------~~----- 655 (707)
...... ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||............ ..
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 543322 22334678999999998774 4789999999999999999999999643321100000 00
Q ss_pred --hhhhhhcC-CCCCCC----CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 656 --IALNEMLD-PRLPTP----SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 656 --~~~~~~~~-~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
........ +..+.. .......+.++.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000000 000000 0001112456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=312.99 Aligned_cols=257 Identities=24% Similarity=0.413 Sum_probs=199.0
Q ss_pred hcCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHA 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 507 (707)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 35799999999999999999952 3578899999865432 22346788999999999 689999999988654
Q ss_pred -CceeEEEeeeccCcHHHHHhcccc-------------------------------------------------------
Q 038671 508 -RHSFIVYEYLEMGSLAMILSNDAA------------------------------------------------------- 531 (707)
Q Consensus 508 -~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 531 (707)
...+++|||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 467899999999999999864210
Q ss_pred ---------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC--Cccc
Q 038671 532 ---------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS--NWAE 600 (707)
Q Consensus 532 ---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~ 600 (707)
...+++..+.+++.||++||+|||+. +++||||||+||+++.++.+||+|||++........ ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12367888899999999999999999 999999999999999999999999999976543222 1122
Q ss_pred cccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 601 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 601 ~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
..+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ............ +.+.+.. .+.+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~~--~~~~~~~----~~~~ 310 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DEEFCRRLKEGT--RMRAPDY----TTPE 310 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc----cHHHHHHHhccC--CCCCCCC----CCHH
Confidence 345678999999988889999999999999999997 9999864221 111111111111 1111111 2345
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 680 IMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.+++..||+.+|++||++.++++.|+
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~ 337 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLG 337 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=304.10 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=200.2
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
+.|++.+.||+|+||.||+|.. .+++.+++|.+... .....+.+.+|+.+++.++|||++++++++..++..++||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence 5689999999999999999965 45889999998643 2334567888999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++++++..++.+. ...+++..++.++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 89 e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 89 EFCPGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred ecCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 999999998887533 23589999999999999999999999 9999999999999999999999999998764433
Q ss_pred CCCccccccccCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 595 SSNWAELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
........+++.|+|||.+. ...++.++||||||+++|+|++|+.||..... ............+..
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~~ 235 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEPPTL 235 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHhcCCCccC
Confidence 33334456889999999874 34467899999999999999999999863221 111111111111110
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
......+.++.+++.+||+.+|++||++.++++
T Consensus 236 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 236 -SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred -CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 011223456889999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=306.63 Aligned_cols=258 Identities=24% Similarity=0.349 Sum_probs=200.5
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||++. ..++..+|+|.+..... ......+.+|++++++++||||+++++++..++..+++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 468999999999999999995 45688899998765322 234456889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.++++.. +.+++..+..++.|+++||+|||+.+ +++||||+|+||+++.++.+||+|||++......
T Consensus 79 ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 79 EHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred eccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999999643 45889999999999999999999732 8999999999999999999999999998765332
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc----------c-------------
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS----------S------------- 651 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~----------~------------- 651 (707)
. .....+++.|+|||...+..++.++|+||||+++|+|++|+.||......... .
T Consensus 154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 M--ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred c--cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 1 23457889999999998888999999999999999999999998532110000 0
Q ss_pred -----chhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 652 -----SNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 652 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...............+.. .....+.++.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKL--PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccC--cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000000000 001134568999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=313.02 Aligned_cols=249 Identities=24% Similarity=0.415 Sum_probs=204.8
Q ss_pred CCCCCceeeecCCeeEEEEEcC--CCc--EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 437 DFDDEHCIGKGGQGSVYKAELP--SGE--IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
+....+.||+|+||+|++|.+. +|+ .||||.+....... ....|.+|+..|.+|+|||++++||+..+ ....|
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mM 187 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMM 187 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhH
Confidence 3456678999999999999553 444 59999998654432 67889999999999999999999999987 67889
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
|+|.+..|+|.+.++. .....+.......++.|||.||.||.++ ++|||||..+|+++-....|||+|||+++-+.
T Consensus 188 V~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred HhhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccC
Confidence 9999999999999986 3445688888899999999999999999 99999999999999999999999999999887
Q ss_pred CCCCCccc---cccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhh-cCCCCC
Q 038671 593 PDSSNWAE---LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEM-LDPRLP 667 (707)
Q Consensus 593 ~~~~~~~~---~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 667 (707)
.....+.. .--...|||||.+....++.+||||+|||++|||+| |..||-...+. ..++.+ ...+++
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------qIL~~iD~~erLp 335 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------QILKNIDAGERLP 335 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------HHHHhccccccCC
Confidence 66554321 223567999999999999999999999999999999 89998644331 122222 234455
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+. .++++++++++.||..+|++||++..+.+.
T Consensus 336 RPk----~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 336 RPK----YCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred CCC----CChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 543 345569999999999999999999998643
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=297.76 Aligned_cols=249 Identities=28% Similarity=0.447 Sum_probs=202.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|++|.||+|... |+.||+|.+..... ..+++..|+.+++.++|+|++++++++...+..++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 357899999999999999999765 78899999865422 4567889999999999999999999999889999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~ 155 (256)
T cd05039 80 EYMAKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG 155 (256)
T ss_pred EecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence 9999999999986543 23589999999999999999999999 9999999999999999999999999999766322
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.. ....+..|+|||.+.+..++.++||||||+++|++++ |+.||..... .......... .+...+
T Consensus 156 ~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~--~~~~~~---- 221 (256)
T cd05039 156 QD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPHVEKG--YRMEAP---- 221 (256)
T ss_pred cc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHhcC--CCCCCc----
Confidence 21 2344667999999988889999999999999999997 9999863211 1111111111 111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+.++.+++.+||..+|++||++.+++++|+
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 254 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence 123456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.13 Aligned_cols=261 Identities=20% Similarity=0.313 Sum_probs=197.1
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC----
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA---- 507 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---- 507 (707)
...++|++.+.||+|+||.||++.. ..++.||+|++...... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 4567899999999999999999954 56889999998764332 23446678899999999999999999988543
Q ss_pred --CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 508 --RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 508 --~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
...++||||+++ ++.+.+. ..+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 357999999975 5555553 2478889999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccch----------h-
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN----------L- 654 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~----------~- 654 (707)
|+++..... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||............ .
T Consensus 164 g~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 164 GLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 999765432 2223457899999999999988999999999999999999999999643211100000 0
Q ss_pred ---hhhhhhhcC--CC--------------CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 655 ---EIALNEMLD--PR--------------LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 655 ---~~~~~~~~~--~~--------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
......... +. .+...........++.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 00 000000111123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=302.07 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=198.4
Q ss_pred HhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
..+.+.....||+|+||.||+|. ..+++.|++|.+.... ....+.+.+|+.++++++|+||+++++++..++..++
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 34556666789999999999996 4567889999876532 2245678899999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC-CCCeEEeccccceec
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL-ENEAHVSDFGTAKFL 591 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~-~~~~kl~Dfg~~~~~ 591 (707)
++||+++++|.+++.........++..+..++.||+.|++|||+. +++||||||+||+++. ++.++|+|||.+...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999986532211227888899999999999999999 9999999999999976 679999999999766
Q ss_pred CCCCCCccccccccCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
...........+++.|+|||...+.. ++.++||||+|+++|+|++|+.||...... .............+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~-- 234 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---QAAMFKVGMFKIHPEIP-- 234 (268)
T ss_pred ccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---hhhHhhhhhhccCCCCC--
Confidence 54333334456889999999886543 788999999999999999999998632210 00000000000111111
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.....++.+++.+||+.+|++||++.++++.
T Consensus 235 ----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 235 ----ESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----cccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1234568899999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=302.22 Aligned_cols=251 Identities=26% Similarity=0.402 Sum_probs=201.4
Q ss_pred CCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCc---hhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 437 DFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPS---EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
+|++.+.||+|+||.||+|...+++.+|+|.+...... .......+.+|++.+++++|+|++++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 58889999999999999998778999999987643221 222345688999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
+||+++++|.+++.+. ..+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998643 3478999999999999999999999 999999999999999999999999999876432
Q ss_pred C------CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcC-CCC
Q 038671 594 D------SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD-PRL 666 (707)
Q Consensus 594 ~------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 666 (707)
. ........++..|+|||...+..++.++||||||+++|+|++|+.||...+. .......... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~ 227 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAMFYIGAHRGLM 227 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-------HHHHHHhhhccCCC
Confidence 1 1112334688999999999988899999999999999999999999863221 1111110000 111
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+.. ....+.++.+++.+||+.+|.+||++.++++
T Consensus 228 ~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 PRL---PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC---CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 1123456889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=306.06 Aligned_cols=252 Identities=24% Similarity=0.384 Sum_probs=198.2
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC----
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHA---- 507 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~---- 507 (707)
+.+.|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.++.++ +|||++++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 456788899999999999999954 568899999986432 1335678899999998 699999999998653
Q ss_pred --CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 508 --RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 508 --~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
...+++|||+.+++|.+++.... ...+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+||
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence 45789999999999999986532 34588999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCccccccccCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
|++..............|++.|+|||++. +..++.++||||+|+++|||++|+.||..... .......
T Consensus 156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~-------~~~~~~~ 228 (272)
T cd06637 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFLI 228 (272)
T ss_pred CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCH-------HHHHHHH
Confidence 99987654333344567899999999876 33578899999999999999999999853221 1111110
Q ss_pred hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+.... .....+.++.+++.+||..+|.+||++.++++
T Consensus 229 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 229 PRNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred hcCCCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11111111 11123446889999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.24 Aligned_cols=250 Identities=30% Similarity=0.452 Sum_probs=200.5
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCch------hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSE------MASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
+|.+.+.||+|++|.||+|.. .+++.+|+|.+....... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 478889999999999999954 568899999886543221 1123568889999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++++||+++++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 99999999999999999643 4588899999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcC
Q 038671 590 FLKPDSS------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD 663 (707)
Q Consensus 590 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 663 (707)
....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..... ... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~-~~~~~~ 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-------LQA-IFKIGE 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-------HHH-HHHHhc
Confidence 7653211 11234578899999999888899999999999999999999999864221 111 111111
Q ss_pred CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 664 PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+.. ....+..+.+++.+||+.||.+||++.++++
T Consensus 227 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 NASPEI---PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cCCCcC---CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111111 1123456889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.27 Aligned_cols=255 Identities=23% Similarity=0.295 Sum_probs=196.9
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||++.. .+++.+|+|++.............+..|+.++..++|++|+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4789999999999999999965 457889999985422222233455788999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+|+|.+++... ...+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999999642 23588999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCC-ccccccccCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCC--C
Q 038671 595 SSN-WAELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPR--L 666 (707)
Q Consensus 595 ~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~ 666 (707)
... .....||+.|+|||++. ...++.++||||||+++|||++|+.||...+. ......+.... .
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~ 227 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKERF 227 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--------HHHHHHHhCCCccc
Confidence 222 23357999999999886 34578899999999999999999999963221 11122221111 1
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPES--RPTIQKVSQL 704 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~~l~~~ 704 (707)
+.+ ......+.++.+++.+|+..+|.+ |++++++++.
T Consensus 228 ~~p-~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 QFP-AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCC-CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 111 111233456888999988654444 6889888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=335.91 Aligned_cols=257 Identities=22% Similarity=0.350 Sum_probs=199.6
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec--CCc
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH--ARH 509 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~ 509 (707)
...++|++.+.||+|+||+||+|.. .+++.+|+|++....... .....+..|+.+++.++||||++++++|.. ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 3457899999999999999999954 467889999886543322 345678999999999999999999998854 456
Q ss_pred eeEEEeeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCC----CCeEecCCCCCCeeecCC-------
Q 038671 510 SFIVYEYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCF----PPIVHRDISSKNVLLDLE------- 577 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~ivH~dlk~~Nil~~~~------- 577 (707)
+|+||||+++++|.+++.... ....+++..++.|+.||+.||+|||+... .+||||||||+|||++.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999986432 23468999999999999999999998521 159999999999999642
Q ss_pred ----------CCeEEeccccceecCCCCCCccccccccCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 038671 578 ----------NEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFIS 645 (707)
Q Consensus 578 ----------~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 645 (707)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||....
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 348999999997654332 2234578999999998854 457899999999999999999999996322
Q ss_pred ccccccchhhhhhhhhcC-CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 646 SISSSSSNLEIALNEMLD-PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
. .......+.. +.++. ...+.++.++|..||+.+|.+||++.|+++
T Consensus 248 ~-------~~qli~~lk~~p~lpi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 N-------FSQLISELKRGPDLPI-----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred c-------HHHHHHHHhcCCCCCc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1 1122222211 22221 123456899999999999999999999884
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=307.97 Aligned_cols=255 Identities=23% Similarity=0.397 Sum_probs=200.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC--------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP--------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCS 505 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 505 (707)
.++|.+.+.||+|+||.||++... ++..+|+|.+..... ......+..|++.++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 457889999999999999999531 245689998875322 23456788999999999 6999999999999
Q ss_pred cCCceeEEEeeeccCcHHHHHhcccc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDAA-------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 572 (707)
..+..+++|||+.+++|.+++..... ...+++.++.+++.|++.||+|||++ |++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeE
Confidence 99999999999999999999965321 23588999999999999999999999 999999999999
Q ss_pred eecCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccc
Q 038671 573 LLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISS 649 (707)
Q Consensus 573 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 649 (707)
+++.++.+||+|||.++........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--- 242 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV--- 242 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---
Confidence 9999999999999999865432211 111234467999999988889999999999999999999 8899853221
Q ss_pred ccchhhhhhhhhcCCC-CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 650 SSSNLEIALNEMLDPR-LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 650 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
........... ...+ ...+.++.+++.+||+.+|++||++.++++.|+
T Consensus 243 -----~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~ 291 (314)
T cd05099 243 -----EELFKLLREGHRMDKP----SNCTHELYMLMRECWHAVPTQRPTFKQLVEALD 291 (314)
T ss_pred -----HHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 11111111111 1111 123346889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=301.71 Aligned_cols=253 Identities=25% Similarity=0.440 Sum_probs=199.2
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCc----EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
..+|+..+.||+|+||+||+|++ .+|+ .||+|++..... .....++.+|+..+..++|||++++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS--PKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC--HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 35788999999999999999963 4454 489999865432 2345678899999999999999999999875 45
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++++||+++|+|.++++.. ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence 77999999999999998643 24589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 590 FLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 590 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
........ .....+++.|+|||...+..++.++||||||+++|||++ |..||+.... ........... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~~--~~ 230 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----REIPDLLEKGE--RL 230 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCCC--cC
Confidence 76533221 112234678999999988889999999999999999998 9999863221 11111111111 11
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.+ ...+.++.+++.+||+.||++||++.++++.|+
T Consensus 231 ~~~----~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~ 266 (279)
T cd05109 231 PQP----PICTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266 (279)
T ss_pred CCC----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111 123456889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=305.19 Aligned_cols=247 Identities=26% Similarity=0.344 Sum_probs=202.9
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|++|.||++.. .+++.+|+|++...........+.+.+|++++++++||||+++++++..++..+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688999999999999999954 468999999986543333334567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++... ..+++..+..++.|++.||+|||+. |++||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998654 4589999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .............+.+..
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~--- 220 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--------PIQIYEKILEGKVRFPSF--- 220 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCCccCCcc---
Confidence 234568899999999988888999999999999999999999986322 122222222322222221
Q ss_pred HHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
.+..+.+++.+||..||.+|| +++++++
T Consensus 221 -~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 221 -FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 245688999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=306.80 Aligned_cols=250 Identities=24% Similarity=0.429 Sum_probs=203.4
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
..+|++.+.||+|++|.||++. ..+++.||+|.+..... ...+.+.+|+.+++.++|||++++++++..++..++|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 4679999999999999999996 45799999999865322 2345688899999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+. |++||||+|+||+++.++.++|+|||.+.....
T Consensus 95 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 95 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred ecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 999999999999853 2478899999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.........+++.|+|||...+..++.++|+||+|+++|++++|+.||...... .......... .+. ....
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~-------~~~~~~~~~~-~~~-~~~~ 238 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-------RALYLIATNG-TPE-LQNP 238 (297)
T ss_pred CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-------hheeeeccCC-CCC-CCCc
Confidence 443334457889999999998888999999999999999999999998632211 1111111111 110 0111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+..+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 234456889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=301.67 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=204.3
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
..|+..+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.++++++|||++++++++.+++..++||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 4578889999999999999965 4688999998864322 234567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++.. .++++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 82 e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 82 EYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred ecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 99999999999853 3478899999999999999999999 9999999999999999999999999999776544
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
........++..|+|||.+.+..++.++|+||||+++|||++|+.||...... ........... .....
T Consensus 155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~~~~~~~---~~~~~ 223 (277)
T cd06640 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RVLFLIPKNNP---PTLTG 223 (277)
T ss_pred ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hHhhhhhcCCC---CCCch
Confidence 33334456788999999998888999999999999999999999998632211 11111111111 12234
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+..+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 566779999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=301.99 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=190.4
Q ss_pred ceeeecCCeeEEEEEcC---CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeec
Q 038671 442 HCIGKGGQGSVYKAELP---SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLE 518 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 518 (707)
+.||+|+||.||+|... ++..+++|.+..... ......+.+|+..+++++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 35899999999999643 346799998865432 2234578889999999999999999999999999999999999
Q ss_pred cCcHHHHHhcccc--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC
Q 038671 519 MGSLAMILSNDAA--AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596 (707)
Q Consensus 519 ~~~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 596 (707)
+|+|.+++..... ....++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.+........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 9999999864332 23456778889999999999999999 999999999999999999999999999865432221
Q ss_pred --CccccccccCCCCccccccC-------CCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 597 --NWAELAGTYGYVAPELAYTM-------KVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 597 --~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
......+++.|+|||.+.+. .++.++|+||||+++|||++ |+.||...... ....... .....+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~----~~~~~~~-~~~~~~~ 230 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE----QVLTYTV-REQQLKL 230 (269)
T ss_pred eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH----HHHHHHh-hcccCCC
Confidence 11234567889999987642 35789999999999999997 99998643211 1000101 1111111
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.+. .....+..+.+++..|| .+|++|||+++|.+.|+
T Consensus 231 ~~~~-~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPR-LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCc-cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111 01122345788999999 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.27 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=201.2
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
.+|++.+.||+|+||.||++...+++.+++|.+..... ....+.+|++++++++||+++++++++......++++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 46888899999999999999777788999998865432 23568889999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+.+++|.+++.... ..+++..++.++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 154 (256)
T cd05112 80 FMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ 154 (256)
T ss_pred cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence 999999999986432 3578999999999999999999999 99999999999999999999999999987654322
Q ss_pred CC-ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC-CCCCCCcc
Q 038671 596 SN-WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP-RLPTPSHN 672 (707)
Q Consensus 596 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 672 (707)
.. .....++..|+|||...+..++.++||||||+++|||++ |+.||.... ........... +...+.
T Consensus 155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~-- 224 (256)
T cd05112 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--------NSEVVETINAGFRLYKPR-- 224 (256)
T ss_pred ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHhCCCCCCCCC--
Confidence 11 112335678999999988889999999999999999998 999985311 11111111111 111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.+|++||++.++++.|.
T Consensus 225 --~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 --LASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 12356899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=299.67 Aligned_cols=247 Identities=28% Similarity=0.411 Sum_probs=197.7
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeee-cCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCS-HARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||++..+ |+.+++|.+.... ..+.+..|+.++++++|+|++++++++. .++..++++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 47889999999999999999764 7789999875431 2456889999999999999999999764 456789999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++.... ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.+|++|||++......
T Consensus 80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 80 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred ECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 9999999999986533 23478999999999999999999999 9999999999999999999999999998764432
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
. ....++..|+|||+..+..++.++||||||+++|+|++ |+.||..... ............+.. .
T Consensus 156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~~~~------~ 221 (256)
T cd05082 156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEKGYKMDA------P 221 (256)
T ss_pred C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhcCCCCCC------C
Confidence 2 22344568999999988889999999999999999998 9999863211 111111111111111 1
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 254 (256)
T cd05082 222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence 233456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=308.76 Aligned_cols=254 Identities=22% Similarity=0.306 Sum_probs=205.4
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|+..+.||+|++|.||+|... +++.||+|.+.............+..|++.++.++||||+++++.+...+..+++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36889999999999999999654 58999999997654443345567899999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+++|.+++... ....+++..+..++.|+++||+|||+. |++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999998643 335689999999999999999999999 9999999999999999999999999998754322
Q ss_pred CC-----------------------------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 038671 595 SS-----------------------------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS 645 (707)
Q Consensus 595 ~~-----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 645 (707)
.. ......|+..|+|||...+..++.++||||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 11 1123467889999999998889999999999999999999999986332
Q ss_pred ccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC----HHHHHH
Q 038671 646 SISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPT----IQKVSQ 703 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps----~~~l~~ 703 (707)
. ......+.......+.. ...+.++.+++.+||..||++||+ ++++++
T Consensus 237 ~--------~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 R--------DETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred h--------HHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 11222222222222111 124567999999999999999999 777765
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=298.07 Aligned_cols=253 Identities=24% Similarity=0.435 Sum_probs=203.5
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
..++|++.+.||+|+||.||++...++..+++|.+... ....+.+.+|+++++.++|+|++++++++.. ...+++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 35689999999999999999998777888999987643 1234678899999999999999999999877 778999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++.... ...+++..++.++.|++.||+|||+. |++||||+|+||+++.++.+||+|||.+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 79 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999999996533 34578899999999999999999999 999999999999999999999999999976543
Q ss_pred CCCC-ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 594 DSSN-WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 594 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
.... .....++..|+|||.+.+..++.++|+||||+++|++++ |+.||..... ......... ....+.+
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~~~~~~~--~~~~~~~-- 225 (260)
T cd05073 155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----PEVIRALER--GYRMPRP-- 225 (260)
T ss_pred CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHhC--CCCCCCc--
Confidence 2221 122345678999999988889999999999999999999 9999863221 111111111 1111111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+.++.+++.+||+.+|++||++.++.+.|+
T Consensus 226 --~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~ 258 (260)
T cd05073 226 --ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258 (260)
T ss_pred --ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence 234456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=297.90 Aligned_cols=252 Identities=21% Similarity=0.329 Sum_probs=204.7
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|+..+.||+|+||.+|.+. ..+|+.|++|++....... ....++.+|+.++++++|||++++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58889999999999999995 4578999999986532222 244678899999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+.+++|.+++.... ...+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 80 YCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred cCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999999886432 23578999999999999999999999 99999999999999999999999999998765443
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
.......+++.|+|||...+..++.++|+||||+++|+|++|+.||.... .............+.. ...
T Consensus 156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~~~---~~~ 224 (256)
T cd08218 156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKIIRGSYPPV---SSH 224 (256)
T ss_pred hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHhcCCCCCC---ccc
Confidence 33334568889999999988889999999999999999999999986321 1112222222222211 123
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+.++.+++.+||+.+|.+||++.++++.
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 225 YSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 34568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=297.64 Aligned_cols=240 Identities=21% Similarity=0.383 Sum_probs=187.5
Q ss_pred ceeeecCCeeEEEEEcCC-------------CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 038671 442 HCIGKGGQGSVYKAELPS-------------GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR 508 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 508 (707)
+.||+|+||.||+|...+ ...+++|++... .......+.+|+..++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999996432 235888887543 2234457888999999999999999999999999
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC-------eE
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE-------AH 581 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~-------~k 581 (707)
..+++|||+++++|..+++... ..+++..+++++.||++||+|||+. +|+||||||+||+++.++. ++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999999999886432 3589999999999999999999999 9999999999999987664 89
Q ss_pred EeccccceecCCCCCCccccccccCCCCccccc-cCCCCccchhHHHHHHHHHHH-hCCCCCCcccccccccchhhhhhh
Q 038671 582 VSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALN 659 (707)
Q Consensus 582 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~ 659 (707)
++|||.+...... ....++..|+|||.+. +..++.++||||||+++|||+ +|+.||..... ... .
T Consensus 153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~----~ 219 (262)
T cd05077 153 LSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-----AEK----E 219 (262)
T ss_pred eCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-----hHH----H
Confidence 9999998654322 2345788899999886 456889999999999999998 58888753211 000 1
Q ss_pred hhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 660 EMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
............ ...++.+++.+||+.||.+||++.++++.|+
T Consensus 220 ~~~~~~~~~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 220 RFYEGQCMLVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred HHHhcCccCCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 111111111111 1345889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=302.69 Aligned_cols=261 Identities=21% Similarity=0.346 Sum_probs=201.1
Q ss_pred cCCCCCceeeecCCeeEEEEE-----cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--C
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-----LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA--R 508 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~ 508 (707)
..|++.+.||+|+||.||.+. ..+++.||+|.+.... .......+.+|+++++.++|||++++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 347889999999999999995 2457889999986542 223456789999999999999999999998765 5
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||.+
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccc
Confidence 6889999999999999985432 3589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCC---ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccc-------ccccchhhhhh
Q 038671 589 KFLKPDSSN---WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI-------SSSSSNLEIAL 658 (707)
Q Consensus 589 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-------~~~~~~~~~~~ 658 (707)
......... .....++..|+|||.+.+..++.++||||||+++|||++++.|+...... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 876543221 12345677899999998888999999999999999999987764211000 00011111111
Q ss_pred hhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 659 NEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
........... ....+..+.+++.+||+.+|++||++.++++.|+
T Consensus 237 ~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 281 (284)
T cd05079 237 RVLEEGKRLPR---PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281 (284)
T ss_pred HHHHcCccCCC---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 11111111111 1124456999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=305.01 Aligned_cols=263 Identities=24% Similarity=0.377 Sum_probs=203.2
Q ss_pred hHHHHHHHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeee
Q 038671 427 VYEEIIRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFC 504 (707)
Q Consensus 427 ~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 504 (707)
.++.+....++|++.+.||+|+||.||++. ..+++.+|+|+..... .....+..|+.+++.+ +|||++++++++
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 344556677899999999999999999995 4568899999875421 1235677899999999 699999999987
Q ss_pred e-----cCCceeEEEeeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC
Q 038671 505 S-----HARHSFIVYEYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN 578 (707)
Q Consensus 505 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~ 578 (707)
. .++..+++|||+++++|.++++... ....+++..+..++.|+++|+.|||+. +++||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 3 3456899999999999999875322 234588999999999999999999999 999999999999999999
Q ss_pred CeEEeccccceecCCCCCCccccccccCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccch
Q 038671 579 EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN 653 (707)
Q Consensus 579 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~ 653 (707)
.++++|||++..............|++.|+|||.+.. ..++.++||||+|+++|||++|+.||...... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----~~ 237 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----RA 237 (286)
T ss_pred CEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh----HH
Confidence 9999999999876544333344578999999998753 44788999999999999999999998632211 00
Q ss_pred hhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 654 LEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
.. .......+....+. ..+..+.+++.+||+.||++||++.++++..
T Consensus 238 ~~-~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 LF-KIPRNPPPTLHQPE----LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred Hh-hccccCCCcccCCC----CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 00111111111111 1234588999999999999999999998764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=311.84 Aligned_cols=195 Identities=26% Similarity=0.389 Sum_probs=170.4
Q ss_pred cCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-C-----CceeeeeeeeecCC
Q 038671 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-H-----RNIVKFYGFCSHAR 508 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~ 508 (707)
-+|.+.+.||+|+||.|-+| +.++++.||||+++... ....+-..|+.+|..++ | -|+|+++++|...+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 38999999999999999999 66789999999997542 23455667899999986 4 38999999999999
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC--CeEEeccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN--EAHVSDFG 586 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~--~~kl~Dfg 586 (707)
+.|||+|.+ .-+|.++++.... ..++...++.++.||+.||.+||.. +|||+||||+|||+...+ .+||+|||
T Consensus 262 HlciVfELL-~~NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence 999999988 5799999986654 5599999999999999999999999 999999999999997544 79999999
Q ss_pred cceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 642 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 642 (707)
.|.+....- ...+.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.
T Consensus 337 SSc~~~q~v---ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 337 SSCFESQRV---YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred cccccCCcc---eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 998755332 25678899999999999999999999999999999999977764
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=297.94 Aligned_cols=252 Identities=27% Similarity=0.491 Sum_probs=201.2
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CC---cEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SG---EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
++|+..+.||+|+||.||+|..+ ++ ..+++|++..... ....+.+..|++.+++++|||++++.+++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 46888899999999999999654 33 3799998865322 234567889999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||+++++|.+++... ...+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||++...
T Consensus 83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 83 IITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999998643 24589999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCCcc---ccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC-CC
Q 038671 592 KPDSSNWA---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP-RL 666 (707)
Q Consensus 592 ~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 666 (707)
........ ....++.|+|||.+.+..++.++||||||+++||+++ |+.||..... ......+... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~~~~~~ 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAINDGFRL 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhcCCCC
Confidence 43322111 1123457999999988889999999999999999998 9999853221 1112222111 22
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.+. +.+.++.+++.+||+.+|++||++.++++.|+
T Consensus 230 ~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~ 265 (268)
T cd05063 230 PAPM----DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD 265 (268)
T ss_pred CCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 2221 23456899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=300.18 Aligned_cols=253 Identities=27% Similarity=0.505 Sum_probs=200.8
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CC---cEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SG---EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
.+|++.+.||+|+||.||+|... ++ ..|++|++.... ......++..|+..++.++|||++++++++..++..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 35788999999999999999653 33 369999986542 2334567999999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||+++++|.+++... ...+++.+++.++.|++.|++|||+. |++||||+|+||+++.++.+|++|||.+...
T Consensus 82 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 82 IITEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence 999999999999998643 24589999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCC--cc-ccc--cccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCC
Q 038671 592 KPDSSN--WA-ELA--GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPR 665 (707)
Q Consensus 592 ~~~~~~--~~-~~~--g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (707)
...... .. ... .+..|+|||.+.+..++.++||||+|+++||+++ |..||..... ........ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----~~~~~~i~--~~~~ 229 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVINAIE--QDYR 229 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----HHHHHHHH--cCCc
Confidence 432211 11 111 2357999999998889999999999999999987 9999853221 11111111 1112
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.+ .+.+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 230 ~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 266 (269)
T cd05065 230 LPPP----MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266 (269)
T ss_pred CCCc----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 2222 233456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=303.66 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=202.0
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|++|.||++.. .+++.+|+|++... .....+.+..|++++++++|||++++++++..++..++||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 5688999999999999999965 46889999998643 2234567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++... ...+++..++.++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||.+......
T Consensus 82 e~~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 82 EFCDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 999999999998643 24589999999999999999999999 9999999999999999999999999998765544
Q ss_pred CCCccccccccCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 595 SSNWAELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
........+++.|+|||.+. +..++.++|+||||+++|+|++|+.||..... ......+.....+..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~ 228 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--------MRVLLKILKSEPPTL 228 (280)
T ss_pred ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--------HHHHHHHhcCCCCCc
Confidence 33344557899999999874 34467899999999999999999999864321 111111111111110
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
......+.++.+++.+||+.+|.+||++.++++.
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 -DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0112234568899999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=316.14 Aligned_cols=260 Identities=21% Similarity=0.318 Sum_probs=196.2
Q ss_pred HhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA----- 507 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 507 (707)
..++|++.+.||+|+||.||++. ...++.||||++....... .....+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ-THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCc-hhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 45789999999999999999995 4568899999987543222 3345678899999999999999999987543
Q ss_pred -CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 508 -RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 508 -~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
...++||||+++ ++.+.+. ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999975 5666653 2378889999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccch----------h--
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN----------L-- 654 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~----------~-- 654 (707)
+++..... .......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+........ .
T Consensus 172 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 172 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred CccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 99765432 2223457899999999999999999999999999999999999999643221100000 0
Q ss_pred --hhhhhhhcC--CCC--------------CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 655 --EIALNEMLD--PRL--------------PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 655 --~~~~~~~~~--~~~--------------~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
......... +.. +...........++.+++.+|++.||.+|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 000 00000011123467899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=304.86 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=201.1
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
.|+..+.||+|+||.||+|. ..+++.||+|.+..... ....+.+.+|++.+++++||||+++++++..++..++|+|
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 46677889999999999995 45688999998764322 2245678899999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++++|.+++.. ..+++..++.++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++.......
T Consensus 83 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 83 YLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred ccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 9999999998853 3578999999999999999999999 99999999999999999999999999997765443
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
.......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...........+. ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~---~~~~ 224 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--------RVLFLIPKNSPPT---LEGQ 224 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--------hHHhhhhcCCCCC---CCcc
Confidence 3333456788999999999888999999999999999999999998532211 1111111111111 1123
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+.++.+++.+||+.+|.+||++.++++.
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 225 YSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 44568899999999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=306.29 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=191.1
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC---CCCceeeeeeeeec-----C
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI---RHRNIVKFYGFCSH-----A 507 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~ 507 (707)
+|++.+.||+|+||.||+|.. .+++.||+|.+....... .....+.+|++.++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 488899999999999999954 478999999886532221 1122345566666555 79999999998754 3
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
...+++|||+.+ +|.+++.... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 457899999974 7888875432 24589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhh------
Q 038671 588 AKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM------ 661 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------ 661 (707)
+....... ......++..|+|||.+.+..++.++||||+|+++|+|++|++||....... .........
T Consensus 155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~----~~~~~~~~~~~~~~~ 229 (288)
T cd07863 155 ARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----QLGKIFDLIGLPPED 229 (288)
T ss_pred cccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH----HHHHHHHHhCCCChh
Confidence 97654322 2234568899999999998889999999999999999999999985322110 010110000
Q ss_pred ------------cCCCCCCC-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 662 ------------LDPRLPTP-SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 662 ------------~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+..+.+ ....+..+.++.+++.+|++.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 0011233456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=293.50 Aligned_cols=261 Identities=25% Similarity=0.391 Sum_probs=201.6
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHh--cCCCCceeeeeeeeecCC--
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLT--GIRHRNIVKFYGFCSHAR-- 508 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~~-- 508 (707)
.+.++.++.+.||+|.||.||+|+++ |+.||||+|.... ++...+|.+++. -|+|+||..+++....+.
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 45678899999999999999999996 8889999997542 234556666655 459999999999875443
Q ss_pred --ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhC-----CCCCeEecCCCCCCeeecCCCCeE
Q 038671 509 --HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHND-----CFPPIVHRDISSKNVLLDLENEAH 581 (707)
Q Consensus 509 --~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-----~~~~ivH~dlk~~Nil~~~~~~~k 581 (707)
++|+|.||.+.|+|.|++.+. .++....++++..+|.||+|||.. .-|.|.|||||+.||||..++...
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 689999999999999999653 478899999999999999999975 237899999999999999999999
Q ss_pred EeccccceecCCCCC----CccccccccCCCCccccccCC----C--CccchhHHHHHHHHHHHh-----C-----CCCC
Q 038671 582 VSDFGTAKFLKPDSS----NWAELAGTYGYVAPELAYTMK----V--TEKCDVYSFGVLALEVIK-----G-----KHPR 641 (707)
Q Consensus 582 l~Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~----~--~~~~Dv~slG~~l~el~t-----g-----~~p~ 641 (707)
|+|+|+|........ .....+||.+|||||++...- + -..+||||||.++||+.. | ++||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 999999988765532 245678999999999976532 1 136899999999999985 2 4666
Q ss_pred Ccccccc-cccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 642 DFISSIS-SSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 642 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
...-+.+ ...+.....-.+...|.+|..+... +....+.++++.||..+|..|-|+-.+.+.|
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~-~~l~~m~klMkeCW~~Np~aRltALriKKtl 500 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSD-PALRVMAKLMKECWYANPAARLTALRIKKTL 500 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCcccccC-HHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence 4322211 2222223333344555566555443 4567789999999999999999998877655
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=305.56 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=203.7
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||+||++. ..+|+.||+|+...... ......+.+|+++++.++|||++++++++...+..++||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 468888999999999999995 45688999998764322 224567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++... +.+++..+..++.+++.|+.|||+.+ +++||||+|+||+++.++.++|+|||++......
T Consensus 83 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 83 EFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred ecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999988643 35899999999999999999999742 8999999999999999999999999998654322
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccc---ccchhhhhhhhhcCCCCCCCCc
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISS---SSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
. .....|+..|+|||.+.+..++.++|+||||+++|++++|+.||+....... ...........+.....+...
T Consensus 158 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (284)
T cd06620 158 I--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP- 234 (284)
T ss_pred c--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC-
Confidence 2 2235789999999998888899999999999999999999999974322100 001111122222222211111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
....+..+.+++.+|++.||++||++.|+++.
T Consensus 235 -~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 235 -SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred -chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11245568999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=306.41 Aligned_cols=260 Identities=18% Similarity=0.274 Sum_probs=197.1
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|+. .+++.||+|.+...... .....+.+|+..++.++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 5689999999999999999955 46889999998643221 22345778999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++ ++|.+++... ...+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 84 e~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 84 EYLD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred eccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 9997 5888887543 23578999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccc-----------ccchhhhhhh--h
Q 038671 595 SSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISS-----------SSSNLEIALN--E 660 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-----------~~~~~~~~~~--~ 660 (707)
........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||........ ....+..... .
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 3333445678999999987653 478899999999999999999999864221000 0000000000 0
Q ss_pred hcCCCCCCCC-----cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 661 MLDPRLPTPS-----HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 661 ~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
......+... ...+..+..+.+++.+|++.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000111100 001122446789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=310.44 Aligned_cols=259 Identities=19% Similarity=0.283 Sum_probs=193.2
Q ss_pred CCceeeec--CCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEee
Q 038671 440 DEHCIGKG--GQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 440 ~~~~lg~G--~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
+.+.||+| +|++||++. .++|+.||+|++...... ....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 45779999 688999994 567899999998654322 22345678899999999999999999999999999999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 596 (707)
+++++|.+++.... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+........
T Consensus 81 ~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 81 MAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred cCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999986432 23589999999999999999999999 999999999999999999999999987544322111
Q ss_pred -------CccccccccCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhh------
Q 038671 597 -------NWAELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM------ 661 (707)
Q Consensus 597 -------~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------ 661 (707)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....................
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI 236 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence 1122356778999999876 4588999999999999999999999964221100000000000000
Q ss_pred -------------cCCCC----------C-----CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 662 -------------LDPRL----------P-----TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 662 -------------~~~~~----------~-----~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+... + ...........++.+++.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000 0 000011223457899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.92 Aligned_cols=253 Identities=28% Similarity=0.395 Sum_probs=204.7
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec--CCceeEE
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH--ARHSFIV 513 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv 513 (707)
+|++.+.+|.|+||.||++. ..+++.+++|++...... ....+++..|+++++.++|||++++++++.. +...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 47888999999999999994 557889999988654332 3345678899999999999999999998753 4567999
Q ss_pred EeeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHH-----hCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 514 YEYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMH-----NDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
|||+++++|.+++.... ...++++..++.++.|++.||+||| +. +++||||+|+||+++.++.+|++|||+
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~ 156 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL 156 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence 99999999999986432 2356899999999999999999999 77 999999999999999999999999999
Q ss_pred ceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 588 AKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
+..............+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.... .............+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~ 228 (265)
T cd08217 157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQLASKIKEGKFR 228 (265)
T ss_pred cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHHHHHHhcCCCC
Confidence 9877654433445678999999999998889999999999999999999999986322 12222222222222
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.. ....+..+.+++.+|++.+|++||++.++++.
T Consensus 229 ~~---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 RI---PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CC---ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 21 12344568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.34 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=198.0
Q ss_pred cCCCCCceeeecCCeeEEEEEc-----CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec--CC
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH--AR 508 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~ 508 (707)
.+|++.+.||+|+||.||++.. .+++.|++|++... .....+.+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4788899999999999999853 35889999998653 22345678899999999999999999998743 34
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
..++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence 6889999999999999986432 3589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCc---cccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc-----cc---cchhhhh
Q 038671 589 KFLKPDSSNW---AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIS-----SS---SSNLEIA 657 (707)
Q Consensus 589 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-----~~---~~~~~~~ 657 (707)
.......... ....++..|+|||...+..++.++||||||+++|||++|..|+....... .. .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 8765432211 11123446999999988889999999999999999999877753211100 00 0000000
Q ss_pred hhhhcCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 658 LNEMLDP-RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 658 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....... ..+.+ ...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 236 ~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05081 236 IELLKNNGRLPAP----PGCPAEIYAIMKECWNNDPSQRPSFSELALQVE 281 (284)
T ss_pred HHHHhcCCcCCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 1111111 11111 123456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=293.88 Aligned_cols=247 Identities=29% Similarity=0.443 Sum_probs=198.2
Q ss_pred ceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccCc
Q 038671 442 HCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGS 521 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 521 (707)
+.||+|++|.||++...+++.|++|++...... .....+.+|++++++++||||+++++++......++||||+.+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 468999999999997766999999998764333 345678999999999999999999999999999999999999999
Q ss_pred HHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCc--c
Q 038671 522 LAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW--A 599 (707)
Q Consensus 522 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~ 599 (707)
|.+++.... ..+++..++.++.+++.|++|||+. +++||||+|+||+++.++.++|+|||.+.......... .
T Consensus 79 l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 79 LLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999986432 3578999999999999999999999 99999999999999999999999999997654221111 1
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLI 678 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 678 (707)
....+..|+|||.+.+..++.++|+||||+++|+|++ |..||..... .......... ...+.+ ...+.
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-----~~~~~~~~~~--~~~~~~----~~~~~ 222 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-----QQTRERIESG--YRMPAP----QLCPE 222 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-----HHHHHHHhcC--CCCCCC----ccCCH
Confidence 1233567999999988889999999999999999999 8888853221 1111111111 111111 12345
Q ss_pred HHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 679 SIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 679 ~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
++.+++.+||..+|++||++.|+++.|+
T Consensus 223 ~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 6999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=278.19 Aligned_cols=249 Identities=23% Similarity=0.374 Sum_probs=196.3
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCceeEEE
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 514 (707)
+.+....+|.|+.|.||+++. .+|...|||.+.+.. ..++.+++...++++..-+ +|.||+.+|||..+...++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 344556799999999999965 468999999998753 3446677888888877665 999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
|.|. .-.+.++.+ ..+++++.-+-++...+++||.||.+++ +|+|||+||+|||+|+.|++|+||||.+.++-..
T Consensus 171 elMs-~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 171 ELMS-TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHH-HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 9885 344445532 2356888888899999999999999986 9999999999999999999999999999887644
Q ss_pred CCCccccccccCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcC---CCCCC
Q 038671 595 SSNWAELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD---PRLPT 668 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 668 (707)
... ....|-+.|||||.+.- ..|+.++||||||++++|+.||+.||..-. .....+..+.+ |.++.
T Consensus 246 kAh-trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~-------tdFe~ltkvln~ePP~L~~ 317 (391)
T KOG0983|consen 246 KAH-TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK-------TDFEVLTKVLNEEPPLLPG 317 (391)
T ss_pred ccc-ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC-------ccHHHHHHHHhcCCCCCCc
Confidence 332 34578899999998763 468899999999999999999999986321 11222222222 33332
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.. ..+..+.+++..|+++|+.+||...++++.
T Consensus 318 ~~----gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 318 HM----GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cc----CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 22 245669999999999999999999998863
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=309.89 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=201.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC--------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP--------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCS 505 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 505 (707)
..+|++.+.||+|+||.||+|+.. .+..||+|.+.... .....+.+.+|+++++++ +||||+++++++.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 356899999999999999999532 12368999876532 223456788999999999 7999999999999
Q ss_pred cCCceeEEEeeeccCcHHHHHhccc-------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDA-------------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 572 (707)
..+..++++||+.+++|.+++.... ....+++.++++++.|++.||+|||+. |++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence 9999999999999999999986532 123478899999999999999999999 999999999999
Q ss_pred eecCCCCeEEeccccceecCCCCCCc--cccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccc
Q 038671 573 LLDLENEAHVSDFGTAKFLKPDSSNW--AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISS 649 (707)
Q Consensus 573 l~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 649 (707)
+++.++.+||+|||+++......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---- 241 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---- 241 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC----
Confidence 99999999999999997654332211 11233567999999998889999999999999999998 888885322
Q ss_pred ccchhhhhhhhhcCCCC-CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 650 SSSNLEIALNEMLDPRL-PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 650 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+........... ..+. ..+.++.+++.+||+.+|++||++.++++.|+
T Consensus 242 ----~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~ 291 (334)
T cd05100 242 ----VEELFKLLKEGHRMDKPA----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291 (334)
T ss_pred ----HHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 1222222222111 1111 22346889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=300.95 Aligned_cols=261 Identities=27% Similarity=0.363 Sum_probs=201.7
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec--CCceeE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH--ARHSFI 512 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 512 (707)
++|+..+.||.|++|.||++.. .+++.+|+|.+..... .....++.+|++++++++||||+++++++.. .+..++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 3678889999999999999965 5688999998865422 2345678999999999999999999998854 347899
Q ss_pred EEeeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 513 VYEYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
||||+++++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999998875322 234578899999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
..... ....++..|+|||...+..++.++||||+|+++|+|++|+.||+.....................+.++....
T Consensus 156 ~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 156 VNSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ccccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 43221 2345788899999998888999999999999999999999999743221001111111111111122222111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.....+.++.+++.+||+.+|.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11234567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=318.00 Aligned_cols=255 Identities=20% Similarity=0.257 Sum_probs=193.2
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
...|.+.+.||+|+||.||++.. ..++.||+|.... ..+.+|++++++++||||+++++++..++..+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 45799999999999999999955 4588899996421 2356799999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
||++. ++|.+++... ...+++..++.++.||++||+|||+. ||+||||||+||+++.++.+||+|||+++....
T Consensus 239 ~e~~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 239 LPKYR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred EEccC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 99995 6787777532 23689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccc---chhhhhhhhhc------
Q 038671 594 DSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS---SNLEIALNEML------ 662 (707)
Q Consensus 594 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~---~~~~~~~~~~~------ 662 (707)
... ......||+.|+|||++.+..++.++|||||||++|||++|..|+.......... ......+....
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~ 392 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF 392 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence 321 1224569999999999999999999999999999999999876642211100000 00011111000
Q ss_pred --------------------CCCCCC-CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 663 --------------------DPRLPT-PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 663 --------------------~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+.... .+.........+.+++.+||+.||.+|||+.|+++.
T Consensus 393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000 000001122368899999999999999999999874
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=299.85 Aligned_cols=256 Identities=24% Similarity=0.419 Sum_probs=203.1
Q ss_pred cCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
++|++.+.||+|+||.||+|+.+ +.+.+++|...... .....+.+.+|++++++++|||++++++++.+.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 56889999999999999999643 34679999876432 22245678999999999999999999999999899
Q ss_pred eeEEEeeeccCcHHHHHhccccc------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEe
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAA------KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVS 583 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~ 583 (707)
.++||||+++++|.+++...... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence 99999999999999999754422 1589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCC-CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhh
Q 038671 584 DFGTAKFLKPDS-SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEM 661 (707)
Q Consensus 584 Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 661 (707)
|||++....... .......++..|+|||.+.+..++.++||||||+++|++++ |..||..... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~~~~ 231 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVLNRL 231 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHHHHH
Confidence 999986543221 22233456778999999888888999999999999999999 8888853221 1111122
Q ss_pred cCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 662 LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.......+. ....+..+.+++.+||+.+|++||++.++++.|+
T Consensus 232 ~~~~~~~~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 QAGKLELPV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HcCCcCCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 211111110 1123456899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=311.82 Aligned_cols=262 Identities=22% Similarity=0.324 Sum_probs=196.7
Q ss_pred HHHHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--
Q 038671 431 IIRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA-- 507 (707)
Q Consensus 431 ~~~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-- 507 (707)
...+.++|++.+.||+|+||.||+|. ..+++.||+|++...... ......+.+|++++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 34567889999999999999999995 457889999998754322 22345677899999999999999999987533
Q ss_pred ----CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEe
Q 038671 508 ----RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVS 583 (707)
Q Consensus 508 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~ 583 (707)
...++++|++ +++|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 3568999987 7888888743 3589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchh-------h
Q 038671 584 DFGTAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL-------E 655 (707)
Q Consensus 584 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~-------~ 655 (707)
|||++...... .....|++.|+|||++.+ ..++.++||||||+++|+|++|+.||............. .
T Consensus 161 Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07878 161 DFGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237 (343)
T ss_pred CCccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999865432 234578999999999876 568899999999999999999999986422110000000 0
Q ss_pred hhhhhh-------cCCCCCCCCc-c----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 656 IALNEM-------LDPRLPTPSH-N----VQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 656 ~~~~~~-------~~~~~~~~~~-~----~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.....+ ....++.... . .......+.+++.+|++.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000000000 0 01122347899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.64 Aligned_cols=194 Identities=21% Similarity=0.366 Sum_probs=158.6
Q ss_pred CceeeecCCeeEEEEEcC---CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec--CCceeEEEe
Q 038671 441 EHCIGKGGQGSVYKAELP---SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH--ARHSFIVYE 515 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 515 (707)
.++||+|+||.||+|+.+ +++.||+|++..... ...+.+|++++++++||||+++++++.. +...+++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 467999999999999653 568899999864321 2346789999999999999999998854 456889999
Q ss_pred eeccCcHHHHHhccc------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee----cCCCCeEEecc
Q 038671 516 YLEMGSLAMILSNDA------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL----DLENEAHVSDF 585 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~----~~~~~~kl~Df 585 (707)
|+. +++.+++.... ....+++..++.++.||+.||+|||+. ||+||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 986 57777764322 123488999999999999999999999 99999999999999 45678999999
Q ss_pred ccceecCCCCC---CccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCc
Q 038671 586 GTAKFLKPDSS---NWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDF 643 (707)
Q Consensus 586 g~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~ 643 (707)
|++........ ......+|+.|+|||++.+. .++.++||||+||++|+|++|++||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 99987643321 22345789999999998764 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=304.04 Aligned_cols=261 Identities=22% Similarity=0.388 Sum_probs=201.3
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|+..+.||+|++|.||+|..+ +|+.||+|++....... ...+.+.+|++++++++|||++++++++..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 46889999999999999999654 68999999886432211 22355788999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++++++..+.... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 80 EYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred eccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 999999998876432 3589999999999999999999999 9999999999999999999999999999876654
Q ss_pred CCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh-------h-----
Q 038671 595 SSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE-------M----- 661 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------~----- 661 (707)
........++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.......... ........ .
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY-LIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCChHHhhhccccc
Confidence 433344567889999998876 457889999999999999999999986432211000 00000000 0
Q ss_pred --cCCCCCCCCc------chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 662 --LDPRLPTPSH------NVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 662 --~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.....+.+.. ..+..+..+.+++.+||+.+|++||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000111100 012234668899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=300.74 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=188.9
Q ss_pred eeeecCCeeEEEEEcCC---CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeecc
Q 038671 443 CIGKGGQGSVYKAELPS---GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 443 ~lg~G~~g~vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
.||+|+||.||+|...+ ...+++|.+.... .......+.+|++.++.++||||+++++++...+..++||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 58999999999995433 4568888775432 223456688899999999999999999999999999999999999
Q ss_pred CcHHHHHhcccc--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC-
Q 038671 520 GSLAMILSNDAA--AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS- 596 (707)
Q Consensus 520 ~~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 596 (707)
|+|.+++..... ....++...+.++.||+.|++|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 999999865432 23356778899999999999999999 999999999999999999999999999865432221
Q ss_pred -CccccccccCCCCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 597 -NWAELAGTYGYVAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 597 -~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
......+++.|+|||+... ..++.++||||||+++|||++ |..||...... ........ ......+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~~~~~~~-~~~~~~~ 231 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE----QVLKQVVR-EQDIKLP 231 (269)
T ss_pred eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH----HHHHHHhh-ccCccCC
Confidence 1122345678999998642 346789999999999999999 78888532211 11111111 1111222
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+. .....+..+.+++..|| .||++||++++|++.|.
T Consensus 232 ~~~-~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQ-LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCc-ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 211 11234455778888998 59999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=286.79 Aligned_cols=244 Identities=24% Similarity=0.297 Sum_probs=206.2
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
-++|+..+++|+|.||.|-+++. .+|+.||+|++++...-...+...-..|-+++...+||.+..+-..|...++++.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 36788999999999999999954 57999999999887665555666677899999999999999999899999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+.||.|.-++.+. +.+++...+.+-..|+.||.|||++ +||.||+|.+|.++|.||++||+|||+++.-..
T Consensus 247 MeyanGGeLf~HLsre---r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE---RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhhh---hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999999888653 3588899999999999999999999 999999999999999999999999999987666
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.+.....++|||.|.|||++....|+.++|.|.+|+++|||++|+.||...+ -++.+..+.-..+..|....
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d--------h~kLFeLIl~ed~kFPr~ls 392 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD--------HEKLFELILMEDLKFPRTLS 392 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc--------hhHHHHHHHhhhccCCccCC
Confidence 6777888999999999999999999999999999999999999999996322 22333333333333332222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC
Q 038671 674 QDKLISIMEVAISCLDESPESRP 696 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rp 696 (707)
.+...++...+.+||++|.
T Consensus 393 ----~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 393 ----PEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ----HHHHHHHHHHhhcChHhhc
Confidence 2366788889999999995
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=301.15 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=204.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|+..+.||+|++|.||++..+ +++.+++|++...... ....++.+|++.+++++|||++++++++..++..++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 36788899999999999999654 6899999998764322 35567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN-DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
||+++++|.+++.... ..+++..+.+++.|++.|++|||+ . +++||||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 79 EYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred EecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 9999999999986542 568899999999999999999999 7 999999999999999999999999999876543
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.... ...++..|+|||...+..++.++||||+|+++|+|++|+.||...... ................+....
T Consensus 154 ~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~-- 226 (265)
T cd06605 154 SLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYIVNEPPPRLPS-- 226 (265)
T ss_pred HHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHHHhcCCCCCCCh--
Confidence 2221 267888999999999888999999999999999999999998633210 111122222222222221111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+.++.+++.+||..+|++||++.++++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 114566899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=296.16 Aligned_cols=254 Identities=27% Similarity=0.435 Sum_probs=209.1
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|++|.||+|... +++.|++|++...... .....+..|++.+.+++|||++++++++..++..++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 36888999999999999999654 5999999998765332 34577899999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN-DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
||+++++|.+++... ..+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 79 EYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999643 458999999999999999999999 8 999999999999999999999999999987765
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.........++..|+|||...+..++.++|+||||+++|+|++|+.||..... .........+.....+....
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~-- 225 (264)
T cd06623 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGPPPSLPA-- 225 (264)
T ss_pred CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCCCCCCCc--
Confidence 44443455788999999999888899999999999999999999999864321 11222223322222222111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...+..+.+++.+||+.+|++||++.++++.
T Consensus 226 ~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 226 EEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1145679999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.27 Aligned_cols=254 Identities=23% Similarity=0.282 Sum_probs=198.3
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|+..+.||+|+||.||++.. .+++.|++|.+.............+.+|+++++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3688999999999999999954 467899999886543222334567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++|++|.+++... ..+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999999643 3588999999999999999999999 9999999999999999999999999988642110
Q ss_pred CC---------------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhh
Q 038671 595 SS---------------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN 659 (707)
Q Consensus 595 ~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 659 (707)
.. ......++..|+|||.+.+..++.++|+||||+++|||++|+.||.... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--------~~~~~~ 226 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--------PEELFG 226 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 00 0112357888999999988889999999999999999999999985211 112222
Q ss_pred hhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 660 EMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.........+... ...+..+.+++.+||+.+|++||++.++.+.
T Consensus 227 ~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~l 270 (305)
T cd05609 227 QVISDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEV 270 (305)
T ss_pred HHHhcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHH
Confidence 2222211111111 1234568999999999999999985444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=294.90 Aligned_cols=250 Identities=30% Similarity=0.482 Sum_probs=200.4
Q ss_pred CCCCceeeecCCeeEEEEEcCC-----CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 438 FDDEHCIGKGGQGSVYKAELPS-----GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
+++.+.||+|+||.||++.... +..+|+|++...... ...+.+..|++.+..++|||++++++++.+.+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 4567889999999999996543 488999998654322 245678899999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
+|||+++++|.+++..... ..+++..++.++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+....
T Consensus 79 i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred EEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence 9999999999999864332 2289999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCcc-ccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCC-CCCC
Q 038671 593 PDSSNWA-ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPR-LPTP 669 (707)
Q Consensus 593 ~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 669 (707)
....... ...+++.|+|||...+..++.++||||+|+++|+|++ |+.||..... ........... ...+
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~ 226 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN--------EEVLEYLKKGYRLPKP 226 (258)
T ss_pred cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCCCC
Confidence 4422111 2236789999999988889999999999999999998 8888763211 11111111111 1111
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
. ..+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 227 ~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 227 E----NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred C----cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1 2445689999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=310.65 Aligned_cols=246 Identities=24% Similarity=0.390 Sum_probs=196.0
Q ss_pred CCCceeeecCCeeEEEE-EcCCCcEEE---EEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC--ceeE
Q 038671 439 DDEHCIGKGGQGSVYKA-ELPSGEIVA---VKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR--HSFI 512 (707)
Q Consensus 439 ~~~~~lg~G~~g~vy~~-~~~~~~~va---vK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~l 512 (707)
+....||+|+|-+||+| +..+|..|| ||.-. ........++|..|+.+++.|+||||+++|++|.+.. ...+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d--~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~ 120 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRD--VTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF 120 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHH--hhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence 34467999999999999 445676666 33221 1233345688999999999999999999999997655 4789
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC-CCCeEEeccccceec
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL-ENEAHVSDFGTAKFL 591 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~-~~~~kl~Dfg~~~~~ 591 (707)
|+|.+..|+|..+..+.+ ..+...+.+|++||++||.|||++ .|+|+|||||-+||+|+. -|.|||+|.|+|...
T Consensus 121 iTEL~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeecccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 999999999999987654 478889999999999999999998 569999999999999976 489999999999987
Q ss_pred CCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
... .....+|||.|||||.+. ..|++.+||||||++++||+|+..||.. ........+.+..+..|....
T Consensus 197 r~s--~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-------C~n~AQIYKKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 197 RKS--HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-------CTNPAQIYKKVTSGIKPAALS 266 (632)
T ss_pred hcc--ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-------hCCHHHHHHHHHcCCCHHHhh
Confidence 643 334479999999999877 5699999999999999999999999852 233334444444444443211
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
... -++++++|.+|+.. ..+|||+.|+++
T Consensus 267 kV~--dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 KVK--DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ccC--CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111 24689999999999 999999999985
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=305.02 Aligned_cols=249 Identities=27% Similarity=0.405 Sum_probs=200.2
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
.|.....||+|+||.||++.. .++..||+|++... .....+.+.+|+..++.++|||++++++.+..++..++|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 344456799999999999954 56889999987543 22345668899999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++++|.+++.. ..+++..++.++.||+.|++|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 100 ~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 100 FLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred CCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 9999999998853 2478999999999999999999999 99999999999999999999999999987654443
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
.......+++.|+|||...+..++.++||||+|+++|||++|+.||...... ...........+..+. ...
T Consensus 173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~----~~~ 243 (292)
T cd06658 173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-----QAMRRIRDNLPPRVKD----SHK 243 (292)
T ss_pred ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcCCCcccc----ccc
Confidence 3334457889999999998888999999999999999999999998632211 1111111122222221 112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+..+.+++.+||..||.+|||++++++.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 34468899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=315.72 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=195.8
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc---CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL---PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
...+|++.+.||+|+||.||++.. ..++.|++|.+... ....+|+++++.++||||+++++++......
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 346799999999999999999953 34678999987542 2345799999999999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
+++||++. ++|.+++.. ...+++..++.++.||+.||+|||+. ||+||||||+||+++.++.++|+|||++..
T Consensus 162 ~lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EEEehhcC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 99999986 577777732 24589999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhh----------
Q 038671 591 LKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIAL---------- 658 (707)
Q Consensus 591 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~---------- 658 (707)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .........
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHhccCcccc
Confidence 554322 1234579999999999999899999999999999999999999985432110 000000000
Q ss_pred ------------hhhc---CCCCCCCCc-chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 659 ------------NEML---DPRLPTPSH-NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 659 ------------~~~~---~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.... .+....+.. .......++.+++.+|+..||++||++.+++.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000 000110000 00112356888999999999999999999876
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=295.86 Aligned_cols=247 Identities=23% Similarity=0.389 Sum_probs=191.9
Q ss_pred ceeeecCCeeEEEEEcC-CCc--EEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEEEeee
Q 038671 442 HCIGKGGQGSVYKAELP-SGE--IVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYL 517 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 517 (707)
+.||+|+||.||+|..+ ++. .+++|...... .....+.+.+|++++.++ +||||+++++++...+..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 35899999999999654 343 46888876432 223456788999999999 7999999999999999999999999
Q ss_pred ccCcHHHHHhcccc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEec
Q 038671 518 EMGSLAMILSNDAA-------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSD 584 (707)
Q Consensus 518 ~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~D 584 (707)
++++|.+++..... ...+++..++.++.|++.|++|||+. |++||||||+||++++++.+|++|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence 99999999865321 23478999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcC
Q 038671 585 FGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLD 663 (707)
Q Consensus 585 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 663 (707)
||++....... .......+..|+|||+..+..++.++||||||+++|||++ |..||..... .........
T Consensus 156 fgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~~~ 226 (270)
T cd05047 156 FGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEKLPQ 226 (270)
T ss_pred CCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHHHHhC
Confidence 99985322111 1111234567999999988889999999999999999997 9999853221 111111111
Q ss_pred C-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 664 P-RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 664 ~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
. ....+. ..+.++.+++.+||+.+|.+||++.++++.|+
T Consensus 227 ~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 266 (270)
T cd05047 227 GYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLN 266 (270)
T ss_pred CCCCCCCC----cCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence 1 111111 22345889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=295.34 Aligned_cols=251 Identities=23% Similarity=0.359 Sum_probs=196.3
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCc--hhhhHHHHHHHHHHHhcCCCCceeeeeeeeec--CCce
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPS--EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH--ARHS 510 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~ 510 (707)
.+|+..+.||+|+||.||+|.. .+++.|++|++...... .......+.+|+.++++++||||+++++++.+ .+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4689999999999999999954 56899999987643221 22334568889999999999999999998865 3577
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++++||+++++|.+++... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 8999999999999998643 3478899999999999999999999 999999999999999999999999999876
Q ss_pred cCCCC---CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 591 LKPDS---SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 591 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
..... .......++..|+|||.+.+..++.++||||+|+++||+++|+.||..... ..........+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~~~~~~~~~~~~~ 228 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAAIFKIATQPTNP 228 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------HHHHHHHhcCCCCC
Confidence 54321 112334578899999999988899999999999999999999999863211 11111111111111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
. ........+..++ .||..+|++||+++|+++
T Consensus 229 ~---~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 Q---LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred C---CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1 1122344566777 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=304.43 Aligned_cols=258 Identities=22% Similarity=0.303 Sum_probs=200.0
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCc--hhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPS--EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
+|+..+.||+|++|.||+|.. .+++.|++|++...... .......+..|++.+++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999964 57899999998754332 112234567899999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+ +++|.+++.... ..+++..++.++.||++||+|||++ |++||||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999996533 3689999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhc----------
Q 038671 594 DSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML---------- 662 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 662 (707)
.........+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||....... ..........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID----QLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH----HHHHHHHHcCCCchhhhhhc
Confidence 4443444466788999998764 457889999999999999999988875322211 0111110000
Q ss_pred ----CC----CCCCC--CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 663 ----DP----RLPTP--SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 663 ----~~----~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
+. ..+.. .......+.++.+++.+||+.+|++||++.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 00000 00112234678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=297.90 Aligned_cols=255 Identities=25% Similarity=0.414 Sum_probs=200.5
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCc-------hhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPS-------EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR 508 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 508 (707)
+|.+.+.||+|++|.||+|. ..+|+.+|+|.+...... .....+.+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 47788999999999999995 457899999987532111 1112346788999999999999999999999999
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
..++||||+++++|.+++... ..+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998654 4588999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC--CccccccccCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcC-
Q 038671 589 KFLKPDSS--NWAELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD- 663 (707)
Q Consensus 589 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~- 663 (707)
........ ......++..|+|||.+.+.. ++.++|+||||+++|++++|+.||..... .+........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAAMFKLGNKR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------HHHHHHhhccc
Confidence 76543211 123346788999999887654 78899999999999999999999853211 1111111111
Q ss_pred CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 664 PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.....+.......+.++.+++.+||+.+|.+||+++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11111222223456679999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=296.24 Aligned_cols=252 Identities=25% Similarity=0.448 Sum_probs=200.1
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC-CCc----EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP-SGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
.++|++.+.||+|+||.||+|..+ +|+ .+|+|....... .....++.+|+..+++++|||++++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 357889999999999999999643 333 589998765432 3345678899999999999999999999887 78
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++++||+.+|+|.+++.... ..+++..++.++.||+.|++|||+. +++||||+|+||+++.++.+||+|||.++
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred eEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence 899999999999999986432 3489999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCCCcc--ccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC-C
Q 038671 590 FLKPDSSNWA--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP-R 665 (707)
Q Consensus 590 ~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 665 (707)
.......... ...++..|+|||.+....++.++|+||||+++||+++ |+.||+.... ......+... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~ 229 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPDLLEKGER 229 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhCCCC
Confidence 7654332221 1223568999999888889999999999999999999 9999864221 1111122221 1
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.+.. .+..+.+++.+||..+|.+||++.++++.|+
T Consensus 230 ~~~~~~----~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~ 266 (279)
T cd05057 230 LPQPPI----CTIDVYMVLVKCWMIDAESRPTFKELINEFS 266 (279)
T ss_pred CCCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 222211 2345889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=295.93 Aligned_cols=252 Identities=30% Similarity=0.471 Sum_probs=202.9
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|+..+.||+|++|.||+|. ..+++.|++|++...... ......+..|++++++++|+||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 58889999999999999995 457899999998765433 3456789999999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++++|.+++... ..+++..++.++.|+++|++|||+. +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 80 YCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred cCCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999998643 3478899999999999999999999 99999999999999999999999999998765443
Q ss_pred CCc----cccccccCCCCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 596 SNW----AELAGTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 596 ~~~----~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
... ....+++.|+|||.+.+.. ++.++||||||+++|++++|+.||..... .............+..+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~ 229 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN----EFQIMFHVGAGHKPPIPD 229 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc----hHHHHHHHhcCCCCCCCc
Confidence 322 2356788999999988766 78899999999999999999999963321 001111111111122222
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
....+..+.+++.+||+.+|++||++.++++
T Consensus 230 ----~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 ----SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ----ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1123456889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=296.40 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=201.6
Q ss_pred CCCCCceeeecCCeeEEEEEcCC--CcEEEEEecCCCCC-------chhhhHHHHHHHHHHHhc-CCCCceeeeeeeeec
Q 038671 437 DFDDEHCIGKGGQGSVYKAELPS--GEIVAVKKFHSPLP-------SEMASQQEFLNEVKTLTG-IRHRNIVKFYGFCSH 506 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~~--~~~vavK~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~ 506 (707)
.|++.+.||+|+||.||+|.... ++.+|+|.+..... .......++.+|+.++.+ ++|||++++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999996544 78899998753221 112234557788888865 699999999999999
Q ss_pred CCceeEEEeeeccCcHHHHHhcc-cccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 507 ARHSFIVYEYLEMGSLAMILSND-AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 507 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
++..+++|||+++++|.+++... .....+++..++.++.|++.|+.|||+.. +++||||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887432 22345899999999999999999999631 8999999999999999999999999
Q ss_pred ccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCC
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPR 665 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (707)
|.+....... ......++..|+|||...+..++.++||||||+++|+|++|+.||.... ............
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--------~~~~~~~~~~~~ 229 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--------MLSLATKIVEAV 229 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--------HHHHHHHHhhcc
Confidence 9998755433 3344578899999999998889999999999999999999999985321 111111222222
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...... ...+.++.+++.+||+.||++||++.|+.++++
T Consensus 230 ~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEPLPE--GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcCCc--ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111111 123456899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=294.38 Aligned_cols=247 Identities=26% Similarity=0.387 Sum_probs=189.6
Q ss_pred ceeeecCCeeEEEEEcC----CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeee-cCCceeEEEee
Q 038671 442 HCIGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCS-HARHSFIVYEY 516 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~ 516 (707)
+.||+|+||.||+|... ++..+|+|++... ......+.+.+|+.+++.++|||++++++++. .++..++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 46899999999999542 3457999987542 22234567889999999999999999999775 45568999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 596 (707)
+.+++|.+++.... ...++..+..++.|+++|++|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 79 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 79 MKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 99999999986432 3467788899999999999999999 999999999999999999999999999976543211
Q ss_pred ----CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 597 ----NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 597 ----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
......++..|+|||...+..++.++||||||+++|||++| .+||..... ............+....
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 225 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--------FDITVYLLQGRRLLQPE 225 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHhcCCCCCCCC
Confidence 11223456789999999888899999999999999999995 556643211 11111122211111111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+..+.+++.+||+.+|++||++.++++.|+
T Consensus 226 ---~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~ 257 (262)
T cd05058 226 ---YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257 (262)
T ss_pred ---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 22346889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=297.83 Aligned_cols=249 Identities=27% Similarity=0.454 Sum_probs=200.3
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC---CCceeeeeeeeecCCceeE
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR---HRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l 512 (707)
.|+..+.||+|+||.||+|. ..+++.|++|.+..... ....+.+.+|+.++++++ |||++++++++..+...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 47788899999999999996 46789999999865422 224456788999998886 9999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
+|||+++++|.+++... .+++..++.++.|+++|+.|||+. |++||||+|+||+++.++.++++|||.+....
T Consensus 80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999999998542 588999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 593 PDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
..........|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||..... ............+...
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--------~~~~~~~~~~~~~~~~- 223 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA--------FRAMMLIPKSKPPRLE- 223 (277)
T ss_pred CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh--------hhhhhccccCCCCCCC-
Confidence 55444455678999999998765 4468899999999999999999999863221 1111111111111111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
....+.++.+++.+||+.||++||++.++++.
T Consensus 224 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 224 -DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 01144568999999999999999999998763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=297.46 Aligned_cols=239 Identities=22% Similarity=0.371 Sum_probs=185.4
Q ss_pred eeeecCCeeEEEEEcCC-------------------------CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCce
Q 038671 443 CIGKGGQGSVYKAELPS-------------------------GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497 (707)
Q Consensus 443 ~lg~G~~g~vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni 497 (707)
.||+|+||.||+|.... ...|++|++... .......+.+|+..++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 58999999999985311 134888887542 22234568889999999999999
Q ss_pred eeeeeeeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC
Q 038671 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE 577 (707)
Q Consensus 498 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~ 577 (707)
+++++++......++||||+++++|..++... ...+++..+..++.||++||+|||+. +|+||||||+||+++..
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 99999999999999999999999999998643 34588999999999999999999999 99999999999999764
Q ss_pred C-------CeEEeccccceecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHH-hCCCCCCcccccc
Q 038671 578 N-------EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVI-KGKHPRDFISSIS 648 (707)
Q Consensus 578 ~-------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~-tg~~p~~~~~~~~ 648 (707)
+ .+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||.....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-- 227 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-- 227 (274)
T ss_pred CcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh--
Confidence 4 3899999988654322 22356788999998865 55789999999999999995 69999863221
Q ss_pred cccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 649 SSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
......... ....+. .. ...+.+++.+||+.+|++||++.++++.|.
T Consensus 228 ---~~~~~~~~~--~~~~~~--~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 228 ---SEKERFYEK--KHRLPE--PS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHHHHHh--ccCCCC--CC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 111111111 111221 11 235889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=305.00 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=199.4
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
.|+....||+|+||.||++.. .+++.||+|++..... ...+.+.+|+..+..++|||++++++++..++..++++|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 344556799999999999954 5789999999854322 234568889999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++++|..++.. ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~ 171 (297)
T cd06659 99 FLQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV 171 (297)
T ss_pred cCCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence 9999999988743 3478999999999999999999999 99999999999999999999999999987655443
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
.......+++.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+.... .........
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~-~~~~~~~~~ 242 (297)
T cd06659 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--------QAMKRLRDSP-PPKLKNAHK 242 (297)
T ss_pred ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhccC-CCCccccCC
Confidence 3344567899999999999888999999999999999999999998632211 1111111111 111111122
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+..+.+++.+||+.+|++||++.++++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 34568899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=303.52 Aligned_cols=261 Identities=22% Similarity=0.376 Sum_probs=200.9
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|..+ +++.||+|++....... ...+.+.+|+++++.++|||++++++++..++..++|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 46889999999999999999654 68999999986543332 23456888999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++++++.++.... ..+++..++.++.||++|++|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 80 EFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred ecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 999999998876532 3489999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchh------hhhh---------
Q 038671 595 SSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL------EIAL--------- 658 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~------~~~~--------- 658 (707)
........++..|+|||...+ ..++.++||||||+++|||++|+.||............. ....
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 443444568899999998875 346789999999999999999999985322110000000 0000
Q ss_pred -hhhcCCCCCCCC---cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 659 -NEMLDPRLPTPS---HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 659 -~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+..+...... ...+..+..+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000001110000 001123456899999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=302.22 Aligned_cols=257 Identities=27% Similarity=0.407 Sum_probs=200.8
Q ss_pred HHHHHHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeec
Q 038671 429 EEIIRVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSH 506 (707)
Q Consensus 429 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 506 (707)
.++..+.++|++.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.++.++ +|||++++++++..
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 33445678899999999999999999954 578899999986431 1235677889999988 79999999999864
Q ss_pred C-----CceeEEEeeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCe
Q 038671 507 A-----RHSFIVYEYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEA 580 (707)
Q Consensus 507 ~-----~~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~ 580 (707)
. +..++|+||+++++|.++++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 3 35899999999999999886422 234689999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCCccccccccCCCCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhh
Q 038671 581 HVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE 655 (707)
Q Consensus 581 kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 655 (707)
||+|||.+..............++..|+|||.+... .++.++||||||+++|||++|+.||..... ..
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-------~~ 240 (291)
T cd06639 168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-------VK 240 (291)
T ss_pred EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-------HH
Confidence 999999998655433333345688999999987543 267899999999999999999999863221 11
Q ss_pred hhhhh--hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 656 IALNE--MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 656 ~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..... ...+....+ ......+.+++.+||+.+|++||++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 241 TLFKIPRNPPPTLLHP----EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHhcCCCCCCCcc----cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 111111111 123446899999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=305.08 Aligned_cols=250 Identities=25% Similarity=0.353 Sum_probs=210.7
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
...|.+.+.||+|.|+.|..|+ ..++..||+|.+.+...... ..+.+.+|+++|+.++|||||+++.+...+..+|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 4679999999999999999995 45799999999987655443 445599999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+.+|.+++++..++. +.+..+..++.|+.+|++|||++ .|||||||++||+++.+.++||+|||++.++.
T Consensus 134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~- 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD- 206 (596)
T ss_pred EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec-
Confidence 999999999999976654 45588888999999999999999 99999999999999999999999999999887
Q ss_pred CCCCccccccccCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
.......++|++.|.|||++.+.+| .+++|+||+|+++|.++.|..||+. ......-...+..++..+...
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG--------~~lk~Lr~rvl~gk~rIp~~m 278 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG--------QNLKELRPRVLRGKYRIPFYM 278 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC--------cccccccchheeeeeccccee
Confidence 4456678899999999999999887 5789999999999999999999973 222222333333333333222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
. .+..+++++++-.+|.+|++++++.+.
T Consensus 279 s----~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 279 S----CDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred e----chhHHHHHHhhccCccccCCHHHhhhh
Confidence 2 337789999999999999999998764
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=299.08 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=202.8
Q ss_pred cCCCCCceeeecCCeeEEEEEc-----CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec--CC
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH--AR 508 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~ 508 (707)
++|+..+.||+|+||.||+|.. .+++.+|+|++...... ...+.+.+|++.++.++|||++++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 4678889999999999999964 24788999998754332 345679999999999999999999999877 55
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
..+++|||+++++|.+++.... ..+++..++.++.|++.||+|||+. |++||||+|+||+++.++.++++|||.+
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 7899999999999999996543 2589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCc---cccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc-------cchhhhhh
Q 038671 589 KFLKPDSSNW---AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS-------SSNLEIAL 658 (707)
Q Consensus 589 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~-------~~~~~~~~ 658 (707)
.......... ....++..|+|||...+..++.++||||||+++|||++|+.|+......... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 8765332211 1223456799999998888999999999999999999999997532211100 00011111
Q ss_pred hhhc-CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 659 NEML-DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 659 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.... ..+.+.+ ...+.++.+++.+||+.+|++||++.+++++|+
T Consensus 237 ~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~ 281 (284)
T cd05038 237 ELLKEGERLPRP----PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281 (284)
T ss_pred HHHHcCCcCCCC----ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence 1111 1111111 123456899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=309.50 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=204.5
Q ss_pred cCCCCCceeeecCCeeEEEEEcCC-CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPS-GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
+-|.+...||.|+||.||+|..++ +-..|.|++.. ...++.+.+.-|++++..++||+||++++.|..++.+||+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 346677789999999999996554 44566777754 33456788999999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
|||.||-.+..+- ...+.+.+.++..+++|++.||.|||+. .|||||||..|||++.+|.++++|||.+......
T Consensus 109 EFC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred eecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH
Confidence 9999999988774 3456799999999999999999999999 9999999999999999999999999998765544
Q ss_pred CCCccccccccCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 595 SSNWAELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
......+.|||.|||||+.. ..+|+.++||||||+++.||..+.+|....... ..-..+..-..|.+..|
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-----RVllKiaKSePPTLlqP 258 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSEPPTLLQP 258 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-----HHHHHHhhcCCCcccCc
Confidence 45566789999999999755 567999999999999999999999997533220 01111122222333333
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
. .....+.+++++|+..||..||++.++++.
T Consensus 259 S----~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 259 S----HWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred c----hhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 2 345669999999999999999999999863
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=301.17 Aligned_cols=257 Identities=23% Similarity=0.381 Sum_probs=200.6
Q ss_pred HHHHHHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeec
Q 038671 429 EEIIRVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSH 506 (707)
Q Consensus 429 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 506 (707)
.+.....+.|++.+.+|+|+||.||+|.. .+++.+|+|++... ......+..|+.++.++ +|||++++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 33444567899999999999999999954 57899999987542 12345678899999998 69999999999842
Q ss_pred ------CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCe
Q 038671 507 ------ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEA 580 (707)
Q Consensus 507 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~ 580 (707)
....+++|||+.+++|.+++.... ...+++..++.++.|++.|++|||+. +++||||+|+||+++.++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 457899999999999999986433 34578888999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCCccccccccCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhh
Q 038671 581 HVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE 655 (707)
Q Consensus 581 kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 655 (707)
+|+|||++..............|++.|+|||.+. +..++.++||||||+++|||++|+.||..... ..
T Consensus 161 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-------~~ 233 (282)
T cd06636 161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-------MR 233 (282)
T ss_pred EEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-------Hh
Confidence 9999999876543333334467899999999875 34578899999999999999999999853221 11
Q ss_pred hhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 656 IALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
. .........+. ......+.++.+++.+||+.||.+||++.|+++
T Consensus 234 ~-~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 234 A-LFLIPRNPPPK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h-hhhHhhCCCCC--CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1 11111111111 111234567999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=295.29 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=198.3
Q ss_pred cCCCCCceeeecCCeeEEEEEcCC----CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPS----GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
++|++.+.||+|+||.||+|...+ ...|++|....... ....+.+.+|+..+++++|||++++++++.+ ...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 468889999999999999996432 34689998865432 2345678999999999999999999998875 5578
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.++++|||++...
T Consensus 83 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999996432 3589999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCCC-ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 592 KPDSSN-WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 592 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
...... .....+++.|+|||.+.+..++.++||||||+++||+++ |+.||..... .+...........+.+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~ 230 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-------NDVIGRIENGERLPMP 230 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHcCCcCCCC
Confidence 543211 112234568999999888889999999999999999996 9999863321 1111111111122222
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
. ..+.++.+++.+|+..+|.+||++.++++.|+
T Consensus 231 ~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~ 263 (270)
T cd05056 231 P----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263 (270)
T ss_pred C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1 23456899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=298.70 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=199.8
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
.|+..+.||+|++|.||++. ..+++.+++|++... .....+.+.+|+.+++.++|||++++++++...+..++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 45566899999999999995 457899999987542 22234568899999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+.+++|.+++.. ..+++..+..++.|++.|++|||+. |++||||+|+||+++.++.++++|||.+.......
T Consensus 97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 97 FLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 9999999999864 3478999999999999999999999 99999999999999999999999999887654433
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||..... ............+.... ...
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~----~~~ 240 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAMKRIRDNLPPKLKN----LHK 240 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHHHHHHhcCCCCCcc----ccc
Confidence 333445689999999999888899999999999999999999999853211 00111111111111111 112
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+..+.+++.+||+.+|++||++.++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 3456899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=337.05 Aligned_cols=255 Identities=29% Similarity=0.455 Sum_probs=207.7
Q ss_pred HHHhcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
..++-+|+....||.|.||.||.| ...+|+..|+|-+.-.... ......+.+|..++..++|||+|+++|+-.+.+..
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 344667888999999999999999 5678999999988765433 34556788999999999999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
+|.||||++|+|.+.+...+. .++.....+..|++.|++|||++ |||||||||.||+++.+|.+|++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeE
Confidence 999999999999999965432 56666677889999999999999 999999999999999999999999999998
Q ss_pred cCCCCC----CccccccccCCCCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcC
Q 038671 591 LKPDSS----NWAELAGTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD 663 (707)
Q Consensus 591 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 663 (707)
+..... ......||+.|||||++.+.. ...+.||||+||++.||+||+.||...+. .+. .+..+-.
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------e~a-IMy~V~~ 1456 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------EWA-IMYHVAA 1456 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------hhH-HHhHHhc
Confidence 876532 234568999999999998654 56689999999999999999999975433 222 2222222
Q ss_pred CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 664 PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+..|+.+ .....+-.+++..|+..||+.|+++.|+++
T Consensus 1457 gh~Pq~P---~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1457 GHKPQIP---ERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred cCCCCCc---hhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 2222221 125566789999999999999999998875
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=294.45 Aligned_cols=238 Identities=25% Similarity=0.442 Sum_probs=188.3
Q ss_pred ceeeecCCeeEEEEEcCCCc-----------EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 442 HCIGKGGQGSVYKAELPSGE-----------IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
+.||+|+||.||+|...... .+++|++..... ....+.+|+.+++.++|||++++++++.. +..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999664322 477777654321 15678899999999999999999999988 778
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC-------CeEEe
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-------EAHVS 583 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~-------~~kl~ 583 (707)
++||||+++++|.+++.... ..+++..++.++.||+.||+|||+. +++||||||+||+++.++ .+|++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 99999999999999986543 2588999999999999999999999 999999999999999887 79999
Q ss_pred ccccceecCCCCCCccccccccCCCCccccccC--CCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhh
Q 038671 584 DFGTAKFLKPDSSNWAELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 584 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
|||++..... .....++..|+|||.+.+. .++.++||||||+++|++++ |..||..... ........
T Consensus 151 Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-----~~~~~~~~- 220 (259)
T cd05037 151 DPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-----SEKERFYQ- 220 (259)
T ss_pred CCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-----hhHHHHHh-
Confidence 9999986543 1234567789999998876 78999999999999999999 5777753321 11111111
Q ss_pred hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.....+.+. ...+.+++.+||..+|.+||++.++++.|+
T Consensus 221 -~~~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -DQHRLPMPD------CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -cCCCCCCCC------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111122211 156889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=293.45 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=198.1
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCC--chhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--Cce
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLP--SEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA--RHS 510 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 510 (707)
.+|++.+.||+|+||.||.+.. .+++.|++|++..... ........+.+|++.+++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788999999999999999954 5689999998754321 1223456788899999999999999999988663 467
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
+++|||+++++|.+++... ..+++..+++++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 8999999999999998643 3478888999999999999999999 999999999999999999999999999976
Q ss_pred cCCCC---CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 591 LKPDS---SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 591 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
..... .......++..|+|||...+..++.++||||||+++|+|++|+.||..... ..........+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~ 228 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-------MAAIFKIATQPTNP 228 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-------HHHHHHHhcCCCCC
Confidence 54321 122334688899999999888899999999999999999999999863211 11111111111111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
. ........+.+++.+|+. +|++||+++++++.
T Consensus 229 ~---~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 229 V---LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred C---CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1 122344567889999995 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=298.41 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=201.4
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCC---
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHAR--- 508 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~--- 508 (707)
..++|++.+.||+|++|.||+|.. .+++.+++|++.... ...+.+.+|+.+++++ +|||++++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 457899999999999999999965 467899999986532 1346788999999999 6999999999996544
Q ss_pred ---ceeEEEeeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEec
Q 038671 509 ---HSFIVYEYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSD 584 (707)
Q Consensus 509 ---~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~D 584 (707)
..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 4899999999999999886432 235689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCccccccccCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhh
Q 038671 585 FGTAKFLKPDSSNWAELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN 659 (707)
Q Consensus 585 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 659 (707)
||.+..............++..|+|||.+.. ..++.++||||||+++|+|++|+.||..... ... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~-~~ 228 (275)
T cd06608 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-------MRA-LF 228 (275)
T ss_pred CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-------HHH-HH
Confidence 9999876544433445678999999998753 3467889999999999999999999863211 111 11
Q ss_pred hhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 660 EMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+.....+. .......+.++.+++.+||+.||++|||+.++++.
T Consensus 229 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 229 KIPRNPPPT-LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred HhhccCCCC-CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111111111 11112245678999999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=293.87 Aligned_cols=246 Identities=27% Similarity=0.475 Sum_probs=197.5
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
++|++.+.||+|+||.||++.. +++.+|+|...... ..+.+.+|+.++++++|||++++++++... ..+++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 4689999999999999999964 67789999986432 235688999999999999999999998664 4789999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+.+++|.+++.... ...+++..++.++.|++.|++|||+. |++||||||+||+++.++.+||+|||.+.......
T Consensus 79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~ 154 (254)
T cd05083 79 LMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV 154 (254)
T ss_pred CCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence 999999999996543 34578999999999999999999999 99999999999999999999999999987643221
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||..... ......... ..+...+ .
T Consensus 155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~--~~~~~~~----~ 220 (254)
T cd05083 155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVKECVEK--GYRMEPP----E 220 (254)
T ss_pred ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHHHHHhC--CCCCCCC----C
Confidence 22334578999999988889999999999999999998 9999863221 111111111 1111111 2
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.+|++||+++++++.|+
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 34566889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=296.27 Aligned_cols=254 Identities=23% Similarity=0.438 Sum_probs=201.6
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCch---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSE---MASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
+|+..+.||+|++|.||++. ..+++.+|+|++....... ....+.+.+|++++++++|||++++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999995 4678999999986433221 1234678999999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC-CeEEeccccceec
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTAKFL 591 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~-~~kl~Dfg~~~~~ 591 (707)
|+||+.+++|.+++... +++++..+..++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||.+...
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998643 3588999999999999999999999 999999999999998776 5999999999776
Q ss_pred CCCCCC----ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 592 KPDSSN----WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 592 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
...... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... ...... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~-~~~~~~~~~~ 229 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH----SNHLAL-IFKIASATTA 229 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC----cchHHH-HHHHhccCCC
Confidence 543211 2234678899999999888899999999999999999999999863221 111111 1111110111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.......+.++.+++.+|++.+|.+||++.++++
T Consensus 230 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 230 --PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred --CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 1112234566889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=295.54 Aligned_cols=249 Identities=27% Similarity=0.411 Sum_probs=202.4
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
+-|+..+.||+|+||.||+|. ..+++.+|+|.+..... ....+.+.+|+..+++++|||++++++++..++..++||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 347888999999999999995 45788999998754322 234467889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++.. ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 82 e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 82 EYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 99999999999853 3578999999999999999999999 9999999999999999999999999998776544
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
........++..|+|||...+..++.++|+||+|+++|+|++|..||..... ............+. ...
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~---~~~ 223 (277)
T cd06641 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLFLIPKNNPPT---LEG 223 (277)
T ss_pred hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHHHHHhcCCCCC---CCc
Confidence 3333445678899999999888889999999999999999999999863221 11111111111111 112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+.++.+++.+||+.+|.+||++.++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 345668899999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=296.04 Aligned_cols=248 Identities=26% Similarity=0.458 Sum_probs=195.5
Q ss_pred ceeeecCCeeEEEEEcCC-------CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 442 HCIGKGGQGSVYKAELPS-------GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
+.||+|+||.||+|+..+ ++.+++|.+.... .......+.+|+.+++.++||||+++++++...+..+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 368999999999996532 2578999876432 1234567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhccc----ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC-----CeEEecc
Q 038671 515 EYLEMGSLAMILSNDA----AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-----EAHVSDF 585 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~-----~~kl~Df 585 (707)
||+++++|.+++.... ....+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++ .++++||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence 9999999999986432 123478899999999999999999999 999999999999999877 8999999
Q ss_pred ccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhc
Q 038671 586 GTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEML 662 (707)
Q Consensus 586 g~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 662 (707)
|++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ........
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------~~~~~~~~ 227 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------QEVLQHVT 227 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--------HHHHHHHh
Confidence 99976543221 1122345678999999998889999999999999999998 9999863221 11111111
Q ss_pred C-CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 663 D-PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 663 ~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
. .....+ ...+..+.+++.+||..+|++||+++++++.|+
T Consensus 228 ~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 228 AGGRLQKP----ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred cCCccCCc----ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 111111 234566889999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=301.15 Aligned_cols=258 Identities=21% Similarity=0.331 Sum_probs=195.9
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|+..+.||+|++|.||+|+. .+|+.+++|++....... .....+.+|++++++++|||++++++++.+.+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~-~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc-cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 478889999999999999955 578999999986532221 223457789999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+.+ +|.+++... ...+++..++.++.||++||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 80 YCDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred cCCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 9974 677766432 24589999999999999999999999 99999999999999999999999999998655443
Q ss_pred CCccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhh--------------h
Q 038671 596 SNWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN--------------E 660 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--------------~ 660 (707)
.......+++.|+|||.+.+.. ++.++||||||+++|+|++|+.|+...... ......... .
T Consensus 154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH---HHHHHHHHHHhCCCChHHhHHhhh
Confidence 3334456788999999887644 688999999999999999999886421110 000000000 0
Q ss_pred hcC-CCCCCCC------cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 661 MLD-PRLPTPS------HNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 661 ~~~-~~~~~~~------~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+ ...+... ...+..+.++.+++.+||+.||.+|||++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 0011000 0011234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=296.37 Aligned_cols=240 Identities=23% Similarity=0.413 Sum_probs=187.2
Q ss_pred ceeeecCCeeEEEEEcC-C-------CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 442 HCIGKGGQGSVYKAELP-S-------GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
+.||+|+||.||+|... . ...+++|..... .....+.+.+|+.+++.++|||++++++++..++..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 46899999999999543 2 234788876432 223446788899999999999999999999998999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC--------eEEecc
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE--------AHVSDF 585 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~--------~kl~Df 585 (707)
|||+++|+|.++++... ..+++..++.++.||+.||+|||+. +++||||||+||+++.++. ++++||
T Consensus 78 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred EecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence 99999999999996543 3578999999999999999999999 9999999999999987765 699999
Q ss_pred ccceecCCCCCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCC-CCCCcccccccccchhhhhhhhhcC
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGK-HPRDFISSISSSSSNLEIALNEMLD 663 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 663 (707)
|.+...... ....++..|+|||.+.+. .++.++||||||+++|+|++|. .||...... ...... ...
T Consensus 153 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~~~~~-~~~ 221 (258)
T cd05078 153 GISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KKLQFY-EDR 221 (258)
T ss_pred ccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HHHHHH-Hcc
Confidence 988654422 234678899999998864 4788999999999999999985 565422110 000010 111
Q ss_pred CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 664 PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..++.+ ...++.+++.+||+.||++|||++++++.|+
T Consensus 222 ~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQLPAP------KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccCCCC------CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 222221 2245889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=300.59 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=194.8
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|. ..+|+.|++|++...... .....+.+|++.++.++|+||+++++++..++..++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4679999999999999999995 457899999998654222 1234567899999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
+||+. +++.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 82 FEYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred Eeccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 99996 5666665432 23477888999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhh-------------
Q 038671 594 DSSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN------------- 659 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~------------- 659 (707)
.........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||+...... ........
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07870 156 PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF---EQLEKIWTVLGVPTEDTWPGV 232 (291)
T ss_pred CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH---HHHHHHHHHcCCCChhhhhhh
Confidence 33333445678999999988754 47889999999999999999999997433210 00000000
Q ss_pred --------hhcCCCCCC----CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 660 --------EMLDPRLPT----PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 660 --------~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.......+. .... ...+.++.+++.+|++.||++|||++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 233 SKLPNYKPEWFLPCKPQQLRVVWKR-LSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhcccccchhccccCCcchhhhccc-cCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000 0000 011346889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=291.40 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=201.7
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|+..+.||+|++|.||++.. .+++.+++|++....... .....+.+|++++++++|||++++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 488889999999999999954 578899999987543222 345678999999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC-CeEEeccccceecCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTAKFLKPD 594 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~ 594 (707)
|+++++|.+++.... ...+++..++.++.|+++|++|||++ +++||||+|+||+++.++ .+|++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 80 YAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred cCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 999999999996532 34588999999999999999999999 999999999999998654 6899999999876543
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.||+.... ................ .
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~---~ 223 (256)
T cd08220 156 SK-AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIMSGTFAPIS---D 223 (256)
T ss_pred cc-ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHHhcCCCCCC---C
Confidence 22 2335688899999999988889999999999999999999999863221 1111111111111111 1
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+..+.+++.+||+.+|.+||++.|+++.
T Consensus 224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 224 RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=299.40 Aligned_cols=250 Identities=24% Similarity=0.419 Sum_probs=202.7
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||++. ..+++.|++|.+.... ....+.+..|+.+++.++|||++++++++...+..++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 679999999999999999995 4578899999985432 223466888999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++.. ..+++..+..++.|++.|+.|||+. |++||||+|+||+++.++.++|+|||.+......
T Consensus 96 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 96 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred ecCCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 99999999999864 2478899999999999999999999 9999999999999999999999999998766544
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
........+++.|+|||.+.+..++.++|+||||+++|++++|+.||....... ........+.... ....
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~~~--~~~~ 239 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGTPEL--QNPE 239 (293)
T ss_pred ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-------heeehhcCCCCCC--CCcc
Confidence 443444578899999999988888999999999999999999999996422210 1000111111111 1112
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+..+.+++.+||+.+|++||++++++..
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 344568899999999999999999998864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.38 Aligned_cols=257 Identities=19% Similarity=0.331 Sum_probs=194.7
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|++|.||+|..+ +++.||+|.+....... ....+.+|++++++++||||+++++++.+++..++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 67899999999999999999654 68999999986543221 2234668999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+ +|.+++.... ..+++..++.++.|+++||.|||+. +++||||+|+||+++.++.+||+|||.++.....
T Consensus 83 e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 83 EYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred ecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 99985 8988885432 3688999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh-------------
Q 038671 595 SSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE------------- 660 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------------- 660 (707)
........++..|+|||...+ ..++.++||||+|+++|+|++|+.||....... .........
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE---DQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH---HHHHHHHHhcCCCChhhhhhhh
Confidence 222233356889999998865 457889999999999999999999986322100 000000000
Q ss_pred ----hcCCCCCC--CCc---chHHH--HHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 661 ----MLDPRLPT--PSH---NVQDK--LISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 661 ----~~~~~~~~--~~~---~~~~~--~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
......+. ... ..... ...+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 000 00001 145789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=298.60 Aligned_cols=253 Identities=27% Similarity=0.451 Sum_probs=205.6
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
..+.|+..+.+|+|++|.||+|..+ +++.+++|++..... ..+.+..|++.++.++|+|++++++++...+..++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 4567888899999999999999654 788999999865322 35678899999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
++||+++++|.+++.... ..+++..++.++.|++.||+|||+. |++|+||+|+||+++.++.++|+|||.+....
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 999999999999997543 3689999999999999999999998 99999999999999999999999999987655
Q ss_pred CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
..........+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... ...........+. ...
T Consensus 168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~-~~~ 238 (286)
T cd06614 168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RALFLITTKGIPP-LKN 238 (286)
T ss_pred cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcCCCC-Ccc
Confidence 4433333446788999999998888999999999999999999999998632211 1111111111111 111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
....+..+.+++.+||+.+|.+||++.++++.
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 12245678999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=298.98 Aligned_cols=247 Identities=25% Similarity=0.297 Sum_probs=194.7
Q ss_pred eeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccCcH
Q 038671 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL 522 (707)
Q Consensus 444 lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 522 (707)
||+|+||+||++. ..+|+.|++|.+.............+..|++++++++|||++++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999995 457899999998654322223345567899999999999999999999999999999999999999
Q ss_pred HHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCccccc
Q 038671 523 AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA 602 (707)
Q Consensus 523 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 602 (707)
.+++..... ..+++..++.++.|++.|+.|||+. |++||||+|+||+++.++.++|+|||.+..... ........
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRA 155 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCcccccc
Confidence 999865432 4589999999999999999999999 999999999999999999999999999876543 22223456
Q ss_pred cccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHH
Q 038671 603 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIME 682 (707)
Q Consensus 603 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 682 (707)
++..|+|||...+..++.++||||+|+++|+|++|+.||....... ............... .....+..+.+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~----~~~~~~~~~~~ 227 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV----EKEELKRRTLEMAVE----YPDKFSPEAKD 227 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc----cHHHHHhcccccccc----CCccCCHHHHH
Confidence 7889999999988889999999999999999999999986432211 111111111111111 11223456889
Q ss_pred HHHhccCCCCCCCC-----CHHHHHH
Q 038671 683 VAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 683 li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
++.+||+.+|.+|| ++.++++
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHh
Confidence 99999999999999 6666754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=296.09 Aligned_cols=251 Identities=26% Similarity=0.353 Sum_probs=204.6
Q ss_pred CCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|++.+.||.|+||.||+|... +++.||+|++...........+.+.+|++++++++|||++++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999654 689999999875443333456788999999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+.+++|.+++... .++++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998643 4688999999999999999999999 99999999999999999999999999998765432
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
......++..|+|||...+..++.++|+||+|+++|+|++|+.||...... ................+ ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~----~~ 224 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQETADVLYP----AT 224 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhccccccCc----cc
Confidence 223456888999999998888999999999999999999999998743321 11111122221222222 12
Q ss_pred HHHHHHHHHHhccCCCCCCCCCH--HHHHH
Q 038671 676 KLISIMEVAISCLDESPESRPTI--QKVSQ 703 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~--~~l~~ 703 (707)
.+..+.+++.+||+.||.+||++ +|+++
T Consensus 225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 225 WSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred CcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 34668899999999999999999 77653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=296.81 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=186.0
Q ss_pred eeeecCCeeEEEEEcCCC---cEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeecc
Q 038671 443 CIGKGGQGSVYKAELPSG---EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 443 ~lg~G~~g~vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
.||+|+||.||++...++ ..+++|.+..... ....+.+.+|+..++.++|||++++++++......++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 589999999999954333 3466776654322 23456789999999999999999999999999999999999999
Q ss_pred CcHHHHHhcccc-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC--C
Q 038671 520 GSLAMILSNDAA-AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS--S 596 (707)
Q Consensus 520 ~~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 596 (707)
|+|.++++.... ....++..++.++.||++||+|||+. +++||||||+||+++.++.++|+|||++....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999999975432 23467777889999999999999999 99999999999999999999999999986432211 1
Q ss_pred CccccccccCCCCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 597 NWAELAGTYGYVAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 597 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
......++..|+|||+... ..++.++||||||+++|||++ |..||..... ........... ....+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~~~~~~~~-~~~~~~ 231 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD----REVLNHVIKDQ-QVKLFK 231 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHhhc-ccccCC
Confidence 1234567889999998743 235779999999999999997 5778753221 11111111111 111111
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
+. ........+.+++..|| .+|++||+++++++.|
T Consensus 232 ~~-~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 232 PQ-LELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred Cc-cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 10 11123355788999999 6799999999999887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=293.42 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=201.5
Q ss_pred CCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCC--chhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 437 DFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLP--SEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
+|+..+.||+|++|.||+|... +++.|++|.+..... ......+.+.+|+++++.++|||++++++++..+...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4788899999999999999654 789999998764321 1223456788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
+||+++++|.+++... ..+++..+..++.|++.|++|||+. |++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998643 3588999999999999999999999 999999999999999999999999999987543
Q ss_pred CCCCccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
.. ......+++.|+|||...... ++.++|+||||+++|+|++|+.||..... .............+..
T Consensus 155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~--- 223 (258)
T cd06632 155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELPPI--- 223 (258)
T ss_pred cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhcccCCCc---
Confidence 33 234456889999999887666 88999999999999999999999863221 1111111111111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.......+.+++.+||+.+|.+||++.++++.
T Consensus 224 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 224 PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 11234568899999999999999999999863
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.61 Aligned_cols=259 Identities=17% Similarity=0.201 Sum_probs=187.3
Q ss_pred HHHHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC------CCceeeeeee
Q 038671 431 IIRVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR------HRNIVKFYGF 503 (707)
Q Consensus 431 ~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~ 503 (707)
+....++|++.+.||+|+||+||+|.. .+++.||||++..... .......|+++++.++ |.++++++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~ 199 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRY 199 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence 334567899999999999999999954 5688999999864211 1233445666555554 5568899998
Q ss_pred eecC-CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeecCCC---
Q 038671 504 CSHA-RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN-DCFPPIVHRDISSKNVLLDLEN--- 578 (707)
Q Consensus 504 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nil~~~~~--- 578 (707)
+..+ +..++|||++ +++|.+++... ..+++..+..++.||+.||+|||+ . |||||||||+||+++.++
T Consensus 200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 200 FQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 8754 5788999987 67788877543 358999999999999999999997 5 999999999999998765
Q ss_pred -------------CeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccc
Q 038671 579 -------------EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS 645 (707)
Q Consensus 579 -------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 645 (707)
.+||+|||.+.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||+...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999886432 22334689999999999999999999999999999999999999997433
Q ss_pred ccccccc----------hh---------hhhhhhhcC--CCCCC---------CCcchHHHHHHHHHHHHhccCCCCCCC
Q 038671 646 SISSSSS----------NL---------EIALNEMLD--PRLPT---------PSHNVQDKLISIMEVAISCLDESPESR 695 (707)
Q Consensus 646 ~~~~~~~----------~~---------~~~~~~~~~--~~~~~---------~~~~~~~~~~~l~~li~~cl~~~P~~R 695 (707)
....... .+ ......... +.... ...........+.+++.+||..||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 2110000 00 000000000 00000 000000112457899999999999999
Q ss_pred CCHHHHHH
Q 038671 696 PTIQKVSQ 703 (707)
Q Consensus 696 ps~~~l~~ 703 (707)
||++|+++
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99999986
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=298.79 Aligned_cols=253 Identities=25% Similarity=0.447 Sum_probs=197.2
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCc----EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
.++|+..+.||+|+||.||+|.. .+|+ .+|+|.+..... .....++.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 35788899999999999999954 3444 578888765322 22345688999999999999999999998654 4
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++++||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred ceeeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence 67899999999999998643 23578999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 590 FLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 590 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
........ .....++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ......... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~--~~~~ 230 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-----REIPDLLEK--GERL 230 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHC--CCCC
Confidence 66533221 122345678999999988889999999999999999998 9999853211 111111111 1112
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.+. ..+..+.+++.+||..+|++||+++++++.|+
T Consensus 231 ~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~ 266 (303)
T cd05110 231 PQPP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFS 266 (303)
T ss_pred CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 2211 12345889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=304.53 Aligned_cols=192 Identities=21% Similarity=0.338 Sum_probs=163.5
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
...+|++.+.||+|+||.||+|.. .+++.||+|+.... ....|+.++++++||||+++++++...+..++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 346799999999999999999955 46788999985432 22468899999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
|+|++. ++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.+....
T Consensus 135 v~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKR--SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEEccC-CcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 999995 5777777532 34689999999999999999999999 99999999999999999999999999997533
Q ss_pred CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPR 641 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~ 641 (707)
.. .......||+.|+|||++.+..++.++||||||+++|||+++..|+
T Consensus 209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 209 VA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 22 2233457899999999999989999999999999999999865543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=279.27 Aligned_cols=253 Identities=20% Similarity=0.339 Sum_probs=213.8
Q ss_pred ceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCceeEEEeeecc
Q 038671 442 HCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 442 ~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
+.||+|+|+.|-.+ ...+|..||||++.+. ....+.++.+|++++.+.+ |+||+.++++|+++...|+|||.+.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 56999999999988 6789999999999875 3456788999999999995 99999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC---CeEEeccccceecCCC--
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN---EAHVSDFGTAKFLKPD-- 594 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~---~~kl~Dfg~~~~~~~~-- 594 (707)
|+|..+++.+ +.+++.++.++.++|+.||.|||.+ ||.|||+||+|||-.... -+|||||+++.-+.-.
T Consensus 161 GplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 161 GPLLSHIQKR---KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred chHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 9999998654 4599999999999999999999999 999999999999996544 5899999987643211
Q ss_pred -----CCCccccccccCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCccc----ccccc---cchhhhh
Q 038671 595 -----SSNWAELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFIS----SISSS---SSNLEIA 657 (707)
Q Consensus 595 -----~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~----~~~~~---~~~~~~~ 657 (707)
.....+++|+..|||||+.. ...|+.+.|.||||+|+|-|+.|.+||...= +|... .......
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 12245578999999999743 2458999999999999999999999996422 22222 2334567
Q ss_pred hhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 658 LNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
++.+.+..+..|...+...+.+..+++...+..|+..|.++.+++.
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 8888888888888888999999999999999999999999988765
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=276.17 Aligned_cols=255 Identities=22% Similarity=0.270 Sum_probs=206.4
Q ss_pred HHhcCCCCC-ceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeec---
Q 038671 433 RVTNDFDDE-HCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSH--- 506 (707)
Q Consensus 433 ~~~~~~~~~-~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~--- 506 (707)
.++++|++. .+||-|-.|.|-.+ ...+|+++|+|++... ...++|++.--.. .|||||.++++|..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 456778776 45899999999999 5568999999998532 2345677655444 59999999999854
Q ss_pred -CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC---CCCeEE
Q 038671 507 -ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL---ENEAHV 582 (707)
Q Consensus 507 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~---~~~~kl 582 (707)
...+.+|||.++||.|...++.++ .+.+++.++..|++||..|+.|||+. +|.||||||+|+|... |..+||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence 456789999999999999997554 46799999999999999999999999 9999999999999964 457999
Q ss_pred eccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhc
Q 038671 583 SDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML 662 (707)
Q Consensus 583 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 662 (707)
+|||+|+.-.. .....+.+-||.|+|||++...+|+...|+||+||++|-|++|.+||.-..+.. .....-..+.
T Consensus 206 tDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----ispgMk~rI~ 280 (400)
T KOG0604|consen 206 TDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKRRIR 280 (400)
T ss_pred cccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----CChhHHhHhh
Confidence 99999986543 234566788999999999999999999999999999999999999996433321 1112223344
Q ss_pred CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 663 DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 663 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...+..|.+.+...+++..++|+.++..+|++|.|+.++++.
T Consensus 281 ~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 281 TGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 455555666777888899999999999999999999998763
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=312.46 Aligned_cols=250 Identities=27% Similarity=0.508 Sum_probs=206.0
Q ss_pred CCCCCceeeecCCeeEEEE-EcCCCc----EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 437 DFDDEHCIGKGGQGSVYKA-ELPSGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~-~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
.....++||+|+||+||+| ..+.|+ +||+|++..... ..+..++.+|+-.|.+++|||++++++++.... ..
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 3556789999999999999 455554 688998876432 335678999999999999999999999997765 88
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
||++|+++|+|.++++.++ ..+.....+.|..|||+||.|||.+ ++|||||..+||||.+...+||+|||+++..
T Consensus 774 lvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 9999999999999997654 4578889999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCCCcccccc--ccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 592 KPDSSNWAELAG--TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 592 ~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
.++...+....| .+.|||-|.+....|+.++|||||||++||++| |..||+.++. ......++. ..+++.
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~-----~eI~dlle~--geRLsq 921 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA-----EEIPDLLEK--GERLSQ 921 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH-----HHhhHHHhc--cccCCC
Confidence 877655444333 567999999999999999999999999999999 9999875432 111222222 234565
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
|+-.. .++..++.+||..|+..||+++++...+
T Consensus 922 PpiCt----iDVy~~mvkCwmid~~~rp~fkel~~~f 954 (1177)
T KOG1025|consen 922 PPICT----IDVYMVMVKCWMIDADSRPTFKELAEEF 954 (1177)
T ss_pred CCCcc----HHHHHHHHHHhccCcccCccHHHHHHHH
Confidence 55443 4588999999999999999999998765
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=301.85 Aligned_cols=194 Identities=21% Similarity=0.374 Sum_probs=157.7
Q ss_pred CceeeecCCeeEEEEEcC---CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec--CCceeEEEe
Q 038671 441 EHCIGKGGQGSVYKAELP---SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH--ARHSFIVYE 515 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 515 (707)
+..||+|+||.||+|+.+ ++..||+|.+.... ....+.+|+++++.++||||+++++++.. +...++++|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 367999999999999754 45789999886432 12356789999999999999999998843 557899999
Q ss_pred eeccCcHHHHHhccc------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee----cCCCCeEEecc
Q 038671 516 YLEMGSLAMILSNDA------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL----DLENEAHVSDF 585 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~----~~~~~~kl~Df 585 (707)
|+.+ ++.+++.... ....+++..+++++.||+.||+|||+. +++||||||+||++ +.++.+||+||
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 9875 6766664221 123488999999999999999999999 99999999999999 55679999999
Q ss_pred ccceecCCCCC---CccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCc
Q 038671 586 GTAKFLKPDSS---NWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDF 643 (707)
Q Consensus 586 g~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~ 643 (707)
|+++....... ......+|+.|+|||.+.+. .++.++||||+|+++|||+||++||..
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 99987653322 22345789999999988764 478999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.27 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=207.9
Q ss_pred HHHhcCCCCCceeeecCCeeEEEEEcCC-CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKAELPS-GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
+-...+.....+||-|.||.||.|.++. .-.||||.++.+ ..+.++|..|+.+|+.++|||+|+++|+|..+..+
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3334566778899999999999997653 556999998754 34678999999999999999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
|||+|||.+|+|.+++++-. ...++..-.++++.||..||+||..+ ++|||||..+|+|+.++..||++|||+++.
T Consensus 339 YIiTEfM~yGNLLdYLRecn-r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECN-RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhc-hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhh
Confidence 99999999999999997543 34567778889999999999999999 999999999999999999999999999999
Q ss_pred cCCCCCCcccccc---ccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 591 LKPDSSNWAELAG---TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 591 ~~~~~~~~~~~~g---~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
+..+.. ....| +.-|.|||-+....++.++|||+|||++||+.| |-.||..++- -.....++. +-++
T Consensus 415 MtgDTY--TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----SqVY~LLEk--gyRM 485 (1157)
T KOG4278|consen 415 MTGDTY--TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYGLLEK--GYRM 485 (1157)
T ss_pred hcCCce--ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----HHHHHHHhc--cccc
Confidence 875532 22233 567999999988889999999999999999999 8888864321 111122222 2233
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..++ .+++.+++++..||+..|.+||++.|+-+.+|
T Consensus 486 ~~Pe----GCPpkVYeLMraCW~WsPsDRPsFaeiHqafE 521 (1157)
T KOG4278|consen 486 DGPE----GCPPKVYELMRACWNWSPSDRPSFAEIHQAFE 521 (1157)
T ss_pred cCCC----CCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence 3333 34556999999999999999999999988775
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=296.96 Aligned_cols=250 Identities=28% Similarity=0.449 Sum_probs=197.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
...|+..+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+++++.++|||++++++++..++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 35688999999999999999965 46899999998654333334456788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
+||+. |++.+.+... .+.+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99997 5666665432 23589999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCCccccccccCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCC
Q 038671 594 DSSNWAELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (707)
. ....+++.|+|||.+. ...++.++||||||+++|||++|+.||..... .. ..........+..
T Consensus 168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~-------~~-~~~~~~~~~~~~~- 234 (307)
T cd06607 168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MS-ALYHIAQNDSPTL- 234 (307)
T ss_pred C----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH-------HH-HHHHHhcCCCCCC-
Confidence 2 2346788999999874 35578899999999999999999999853221 11 1111111111111
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.....+..+.+++.+||+.+|++||++.++++.
T Consensus 235 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 -SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 112345678999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=297.87 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=197.1
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|+..+.||.|++|.||+|+. .+|+.|++|++....... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 478889999999999999954 478999999886543222 233568889999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+. ++|..++.... ...+++..++.++.|++.||+|||+. +++||||+|+||+++.++.+|++|||.+.......
T Consensus 80 ~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 80 FLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred ccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 996 57888875432 34589999999999999999999999 99999999999999999999999999987655433
Q ss_pred CCccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC----------
Q 038671 596 SNWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP---------- 664 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 664 (707)
.......+++.|+|||...+.. ++.++||||||+++|+|+||+.||....... ...........+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID----QLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHhCCCChhhhhhhhH
Confidence 3333445788999999877644 5889999999999999999999986322110 000000000000
Q ss_pred ------CCCCC-C----cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 665 ------RLPTP-S----HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 665 ------~~~~~-~----~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+.. . ...+....++.+++.+||+.||++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000 0 000112345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.89 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=202.6
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeee------
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCS------ 505 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~------ 505 (707)
+...+|+..+.||+||||.||+++.+ ||+.||||++.... .......+.+|+..+++|+|||||+++..|.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 45677888999999999999999765 89999999997654 3345577999999999999999999873210
Q ss_pred ------------------------------------------------------------------------c-------
Q 038671 506 ------------------------------------------------------------------------H------- 506 (707)
Q Consensus 506 ------------------------------------------------------------------------~------- 506 (707)
+
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence 0
Q ss_pred --------------------------C--------CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHH
Q 038671 507 --------------------------A--------RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALS 552 (707)
Q Consensus 507 --------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~ 552 (707)
+ ..+||-||||+..++.+++++..... .....|+++++|+.||+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLA 711 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHH
Confidence 0 23589999999999999987554321 35678999999999999
Q ss_pred HHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC------------------CCCCCccccccccCCCCccccc
Q 038671 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK------------------PDSSNWAELAGTYGYVAPELAY 614 (707)
Q Consensus 553 ~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~------------------~~~~~~~~~~g~~~y~aPE~~~ 614 (707)
|+|+. |+|||||||.||++++++.|||+|||+|+... ......+..+||.-|+|||.+.
T Consensus 712 YIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 99999 99999999999999999999999999998721 0111234568999999999988
Q ss_pred cCC---CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCC
Q 038671 615 TMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDES 691 (707)
Q Consensus 615 ~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 691 (707)
+.. |+.|+|+||||++++||+. ||. ..-.....+....++.+|.+..........=..+|.+|++.|
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~-------TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hd 858 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFG-------TSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHD 858 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCC-------chHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCC
Confidence 654 9999999999999999995 564 223344456666677777764334444555678999999999
Q ss_pred CCCCCCHHHHHH
Q 038671 692 PESRPTIQKVSQ 703 (707)
Q Consensus 692 P~~Rps~~~l~~ 703 (707)
|.+|||+.|++.
T Consensus 859 P~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 859 PSKRPTATELLN 870 (1351)
T ss_pred CccCCCHHHHhh
Confidence 999999999985
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=294.46 Aligned_cols=249 Identities=24% Similarity=0.290 Sum_probs=207.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.+.|+..++||+|+||.||.+.. .+|+.||.|++.+..............|-.++.+++.+.||.+-.+|..++.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 56788899999999999999954 57999999988766555555666788899999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
+..|.||+|..++.+.+. ..+++..++.++.+|+-||++||.. +||.||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999977665 4599999999999999999999999 999999999999999999999999999998875
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhh-hhcCCCCCCCCcc
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN-EMLDPRLPTPSHN 672 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 672 (707)
.. .....+||.+|||||++.+..|+...|.||+||++|||+.|+.||.... ++.-. ++.......+.+.
T Consensus 340 g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K---------eKvk~eEvdrr~~~~~~ey 409 (591)
T KOG0986|consen 340 GK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK---------EKVKREEVDRRTLEDPEEY 409 (591)
T ss_pred CC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh---------hhhhHHHHHHHHhcchhhc
Confidence 54 3455699999999999999999999999999999999999999996311 11111 1111112223333
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCC
Q 038671 673 VQDKLISIMEVAISCLDESPESRPT 697 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps 697 (707)
....+++...+....+..||++|.-
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhcc
Confidence 3445566888888999999999964
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=292.70 Aligned_cols=245 Identities=22% Similarity=0.278 Sum_probs=188.9
Q ss_pred ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHH-hcCCCCceeeeeeeeecCCceeEEEeeecc
Q 038671 442 HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTL-TGIRHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
+.||+|+||.||+|.. .+|+.||+|++.............+..|...+ ...+|||++++++++...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999954 56899999998654322222233344554444 455899999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
++|.+++... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+..... ..
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 151 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK 151 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence 9999998643 3588999999999999999999999 999999999999999999999999999875432 23
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
...+++.|+|||...+..++.++||||+|+++|+|++|..||..... ..............+.......+..
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVFDNILSRRINWPEEVKEFCSPE 223 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcccCCCCcccccCCHH
Confidence 34678899999999888889999999999999999999999863221 1111111111111111111234566
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 680 IMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
+.+++.+||+.+|++||++.++.+.
T Consensus 224 ~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 224 AVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred HHHHHHHHccCCHHHccCCCcHHHH
Confidence 8999999999999999977544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=288.79 Aligned_cols=249 Identities=30% Similarity=0.481 Sum_probs=203.5
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|+..+.||+|++|.||++.. .+++.+++|++..... .....+.+|++.++.++||+++++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 478889999999999999965 4789999999876432 345678899999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++++|.+++.... ..+++..+..++.|++.|+++||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 999999999986532 4689999999999999999999998 99999999999999999999999999998766443
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
. .....++..|+|||...+..++.++|+||||+++|+|++|+.||...+. ............+..+.. ..
T Consensus 153 ~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~----~~ 222 (253)
T cd05122 153 A-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP-----MKALFKIATNGPPGLRNP----EK 222 (253)
T ss_pred c-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch-----HHHHHHHHhcCCCCcCcc----cc
Confidence 2 3445788999999999888889999999999999999999999863221 000111111111111111 11
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+..+.+++.+||+.||++||++.++++
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2456899999999999999999999876
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=298.15 Aligned_cols=261 Identities=22% Similarity=0.295 Sum_probs=197.3
Q ss_pred CCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEee
Q 038671 438 FDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
|++.+.||.|++|.||+|.. .+|+.||+|++....... .....+.+|+++++.++|||++++++++.+++..+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67788999999999999954 579999999986543222 2235678899999999999999999999999999999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 596 (707)
++ ++|.+++..... ..+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 80 LD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred cC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 95 689988864332 4589999999999999999999999 999999999999999999999999999976543333
Q ss_pred CccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhh-----------------hhh
Q 038671 597 NWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE-----------------IAL 658 (707)
Q Consensus 597 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-----------------~~~ 658 (707)
......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.............. ...
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK 234 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence 33334568899999987654 468899999999999999999999864322110000000 000
Q ss_pred hhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 659 NEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..................+.++.+++.+|++.||++||+++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000001112233568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.21 Aligned_cols=243 Identities=27% Similarity=0.354 Sum_probs=197.8
Q ss_pred eeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccCcH
Q 038671 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL 522 (707)
Q Consensus 444 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 522 (707)
||.|++|.||+++.. +++.+++|++...........+.+.+|++++++++|||++++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999654 5899999998765443334557799999999999999999999999999999999999999999
Q ss_pred HHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCccccc
Q 038671 523 AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA 602 (707)
Q Consensus 523 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 602 (707)
.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~ 153 (262)
T cd05572 81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC 153 (262)
T ss_pred HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence 9999653 3488999999999999999999999 99999999999999999999999999998765432 223346
Q ss_pred cccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcC--CCCCCCCcchHHHHHHH
Q 038671 603 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD--PRLPTPSHNVQDKLISI 680 (707)
Q Consensus 603 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 680 (707)
+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||..... ........+.. .....+. ..+.++
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~----~~~~~~ 223 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGNGKLEFPN----YIDKAA 223 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccCCCCCCCc----ccCHHH
Confidence 88899999998888899999999999999999999999863221 11222222221 1112121 124568
Q ss_pred HHHHHhccCCCCCCCCC-----HHHHHH
Q 038671 681 MEVAISCLDESPESRPT-----IQKVSQ 703 (707)
Q Consensus 681 ~~li~~cl~~~P~~Rps-----~~~l~~ 703 (707)
.+++.+||+.+|++||+ +.|+++
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 99999999999999999 788765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=299.31 Aligned_cols=257 Identities=22% Similarity=0.300 Sum_probs=197.3
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CceeE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA--RHSFI 512 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 512 (707)
++|+..+.||+|+||.||+|..+ +++.+++|.+....... .....+.+|+..+.+++||||+++++++... +..++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE-GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc-cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 46889999999999999999654 68899999986543221 2234567899999999999999999998776 89999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
|+||+++ +|.+++.... ..+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||.+....
T Consensus 84 v~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 84 VMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred EehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 9999974 8888886432 3589999999999999999999999 99999999999999999999999999998766
Q ss_pred CCCCCccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhh----------
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM---------- 661 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------- 661 (707)
..........+++.|+|||.+.+.. ++.++|+||+|+++|+|++|+.||....... .........
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~----~~~~~~~~~~~~~~~~~~~ 233 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID----QLNKIFKLLGTPTEKIWPG 233 (293)
T ss_pred CCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCchHHHHH
Confidence 5433334456788999999887644 6889999999999999999999986432110 000000000
Q ss_pred ----c--------CCCCCCCCcchHH--HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 662 ----L--------DPRLPTPSHNVQD--KLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 662 ----~--------~~~~~~~~~~~~~--~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
. ...........+. ....+.+++.+||+.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 0000000000111 2456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=297.25 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=200.2
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|++.+.||+|++|.||+|.. .+|+.|++|++....... .....+.+|+.++++++|||++++++++..+...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 588899999999999999964 578999999987543222 234678899999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+ +++|.+++.... ..+++.+++.++.||++||+|||+. +++|+||+|+||+++.++.++++|||.+.......
T Consensus 80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 99 999999986433 5689999999999999999999999 99999999999999999999999999998765433
Q ss_pred C-CccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhc-----------
Q 038671 596 S-NWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML----------- 662 (707)
Q Consensus 596 ~-~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 662 (707)
. ......++..|+|||.+.+.. ++.++||||+|+++|+|++|++||...... ...........
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI----EQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH----HHHHHHHHHcCCCChHHHhhcc
Confidence 2 233456889999999886544 688999999999999999998887532211 00000000000
Q ss_pred ------CCCCCCCC-----cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 663 ------DPRLPTPS-----HNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 663 ------~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
....+... ....+.+.++.+++.+|++.+|.+||+++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 0011234678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=293.18 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=202.1
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|+..+.||+|+||.||++.. .+|..+|+|.+....... ...+.+.+|+++++.++|+|++++++.+...+..++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 478889999999999999954 468889999986532221 234567899999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC-CeEEeccccceecCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTAKFLKPD 594 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~ 594 (707)
|+.+++|.+++.... ...+++..+..++.|+++|++|||+. +++|+||+|+||++++++ .+|++|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 80 YCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred cCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999986433 23478999999999999999999999 999999999999999886 4699999999876544
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
........|++.|+|||...+..++.++|+||||+++|+|++|+.||.... .............+.. ..
T Consensus 156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~---~~ 224 (257)
T cd08225 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQGYFAPI---SP 224 (257)
T ss_pred cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcccCCCC---CC
Confidence 333344568899999999988889999999999999999999999986321 1111222222222211 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+.++.+++.+||..+|++||++.++++.
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=294.23 Aligned_cols=253 Identities=24% Similarity=0.407 Sum_probs=192.9
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHH-HhcCCCCceeeeeeeeecCCceeEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKT-LTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
++|++.+.||+|+||.||++.. .+|+.||+|++....... ....+..|... ++..+|||++++++++..++..+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 4688999999999999999955 469999999986543222 23345556554 5666899999999999999999999
Q ss_pred EeeeccCcHHHHHhcc-cccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 514 YEYLEMGSLAMILSND-AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
|||++ ++|.+++... .....+++..++.++.||+.||+|||+++ +++||||||+||+++.++.+||+|||.+....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99997 6777776532 22356899999999999999999999853 89999999999999999999999999997654
Q ss_pred CCCCCccccccccCCCCcccccc----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 593 PDSSNWAELAGTYGYVAPELAYT----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||..... ..+. .........+.
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~-~~~~~~~~~~~ 227 (283)
T cd06617 156 DSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT------PFQQ-LKQVVEEPSPQ 227 (283)
T ss_pred ccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc------CHHH-HHHHHhcCCCC
Confidence 321 1223467889999998765 4468899999999999999999999853211 1111 11111111111
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.. ....+.++.+++.+||..+|++||++.++++
T Consensus 228 ~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 228 LP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 1124456899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=295.72 Aligned_cols=257 Identities=20% Similarity=0.345 Sum_probs=198.9
Q ss_pred CCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|+..+.||.|++|.||+|+.. +|+.||+|++...... ...+.+.+|++.+++++|||++++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4888999999999999999654 6899999998754322 234567789999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+.+ ++.+++........+++..+..++.|++.||+|||+. +++||||+|+||++++++.++++|||++.......
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 9985 7888876554445689999999999999999999999 99999999999999999999999999997654433
Q ss_pred CCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh-----------h--
Q 038671 596 SNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE-----------M-- 661 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-----------~-- 661 (707)
.......+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||...... ......... .
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE----DQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCChhhHHHHhc
Confidence 333344678899999987654 4688999999999999999999998643211 000000000 0
Q ss_pred ---cCCCCCCCCc-----chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 662 ---LDPRLPTPSH-----NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 662 ---~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.....+.... ..+..+..+.+++.+|++.||.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0011111000 01123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=290.43 Aligned_cols=253 Identities=25% Similarity=0.410 Sum_probs=195.8
Q ss_pred CCCCceeeecCCeeEEEEEc----CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----
Q 038671 438 FDDEHCIGKGGQGSVYKAEL----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR----- 508 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 508 (707)
|.+.+.||+|+||.||+|.. .+++.||+|++....... ...+++.+|+++++.++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCCh-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 56778999999999999953 246889999987543332 34567889999999999999999999885432
Q ss_pred -ceeEEEeeeccCcHHHHHhccc---ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEec
Q 038671 509 -HSFIVYEYLEMGSLAMILSNDA---AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSD 584 (707)
Q Consensus 509 -~~~lv~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~D 584 (707)
..++++||+.+|+|.+++.... ....+++..++.++.|++.|++|||+. +++||||||+||+++.++.+|++|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence 2478899999999998874322 122478889999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhh
Q 038671 585 FGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEM 661 (707)
Q Consensus 585 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 661 (707)
||.++....... ......+++.|++||...+..++.++||||||+++|+|++ |+.||..... .......
T Consensus 157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~~~~~~ 228 (273)
T cd05074 157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SEIYNYL 228 (273)
T ss_pred ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HHHHHHH
Confidence 999986543221 1122345678999999988889999999999999999999 8899853221 1111111
Q ss_pred cCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 662 LDP-RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 662 ~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
... ....+ ...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 229 ~~~~~~~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~ 270 (273)
T cd05074 229 IKGNRLKQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270 (273)
T ss_pred HcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111 11111 123456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=298.08 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=200.5
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|++|.||+|..+ +++.|++|++...... ......+.+|++++++++|+||+++++++..++..+++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 36889999999999999999654 6889999998653322 223467889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++++.+..+... ...+++..++.++.||+.|++|||+. +++||||+|+||+++.++.+||+|||.+......
T Consensus 80 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 80 EYVERTLLELLEAS---PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred ecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99998877766543 23488999999999999999999999 9999999999999999999999999999876544
Q ss_pred CC-CccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccc----------chhhhhhh---
Q 038671 595 SS-NWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS----------SNLEIALN--- 659 (707)
Q Consensus 595 ~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~----------~~~~~~~~--- 659 (707)
.. ......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||.......... ........
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 32 33445678899999999887 78999999999999999999999986322110000 00000000
Q ss_pred hhcCCCCCCCCc-------chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 660 EMLDPRLPTPSH-------NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 660 ~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.......+.... .....+.++.+++.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000111000 00112567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=294.47 Aligned_cols=245 Identities=21% Similarity=0.253 Sum_probs=186.7
Q ss_pred eeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHH---HHhcCCCCceeeeeeeeecCCceeEEEeeec
Q 038671 443 CIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVK---TLTGIRHRNIVKFYGFCSHARHSFIVYEYLE 518 (707)
Q Consensus 443 ~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 518 (707)
.||+|+||.||++.. .+++.+|+|.+.............+.+|.. .+...+||+++.+++++..++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999964 568999999886543322222233334443 3334479999999999999999999999999
Q ss_pred cCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCc
Q 038671 519 MGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW 598 (707)
Q Consensus 519 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 598 (707)
+++|.+++... +.+++..+..++.|++.||+|||+. +++||||||+||++++++.++++|||++....... .
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 152 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--c
Confidence 99999988643 3589999999999999999999999 99999999999999999999999999987554322 2
Q ss_pred cccccccCCCCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHH
Q 038671 599 AELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKL 677 (707)
Q Consensus 599 ~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (707)
....|++.|+|||... +..++.++||||+|+++|+|++|+.||....... ..... .........+ ....+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~-~~~~~~~~~~------~~~~~ 223 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD--KHEID-RMTLTVNVEL------PDSFS 223 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC--HHHHH-HHhhcCCcCC------ccccC
Confidence 2346899999999876 4568899999999999999999999996432110 00000 1111111111 12334
Q ss_pred HHHHHHHHhccCCCCCCCC-----CHHHHHHH
Q 038671 678 ISIMEVAISCLDESPESRP-----TIQKVSQL 704 (707)
Q Consensus 678 ~~l~~li~~cl~~~P~~Rp-----s~~~l~~~ 704 (707)
.++.+++.+|++.||++|| +++++++.
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 224 PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 5688999999999999999 59988764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=286.76 Aligned_cols=251 Identities=27% Similarity=0.427 Sum_probs=205.8
Q ss_pred CCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CceeEE
Q 038671 437 DFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA--RHSFIV 513 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv 513 (707)
+|+..+.||+|++|.||+|... +++.+++|++...... ....+.+.+|++.+++++|||++++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 4778899999999999999654 7899999998754332 33567889999999999999999999999888 889999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
+||+++++|.+++.... .+++..++.++.|+++|++|||+. +++||||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999986543 689999999999999999999998 999999999999999999999999999987765
Q ss_pred CCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcC-CCCCCCC
Q 038671 594 DSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD-PRLPTPS 670 (707)
Q Consensus 594 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 670 (707)
... ......++..|+|||...+..++.++||||||+++|+|++|+.||..... .. ........ ...+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~-~~~~~~~~~~~~~~-- 224 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN------PM-AALYKIGSSGEPPE-- 224 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hH-HHHHhccccCCCcC--
Confidence 443 13445788999999999888899999999999999999999999864331 11 11111111 11111
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.....+..+.+++.+|++.+|.+||++.++++.
T Consensus 225 -~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 225 -IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred -CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 112235669999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=293.71 Aligned_cols=260 Identities=21% Similarity=0.245 Sum_probs=185.9
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCC----CcEEEEEecCCCCCchhhh--------HHHHHHHHHHHhcCCCCceeeeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPS----GEIVAVKKFHSPLPSEMAS--------QQEFLNEVKTLTGIRHRNIVKFYG 502 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~ 502 (707)
.++|++.+.||+|+||.||+|...+ +..+++|+..........+ ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999996543 4566777543221111000 011223444566778999999999
Q ss_pred eeecCC----ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC
Q 038671 503 FCSHAR----HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN 578 (707)
Q Consensus 503 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~ 578 (707)
++.... ..++++|++. .++.+.+... ...++..+..++.|++.||+|||+. +++||||||+||+++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 775443 3467777664 3555555432 2357788899999999999999999 999999999999999999
Q ss_pred CeEEeccccceecCCCCC-------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccccc
Q 038671 579 EAHVSDFGTAKFLKPDSS-------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS 651 (707)
Q Consensus 579 ~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 651 (707)
.++|+|||+++....... ......||+.|+|||...+..++.++||||||+++|||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643221 1123469999999999999999999999999999999999999997542211000
Q ss_pred c-hhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 652 S-NLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 652 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
. ........+..+.... ...+..+.+++..||..+|++||+++++.+.|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRLHEGKIKI-----KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHhhhhhhcc-----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 0011122222222221 122456889999999999999999999998874
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=296.18 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=194.2
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCceeEEE
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~ 514 (707)
+|+..+.||+|+||.||++. ..+++.+|+|++...... .....+.+|+..+.++. ||||+++++++..++..+++|
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 46667889999999999995 456899999998754322 34567889999999996 999999999999999999999
Q ss_pred eeeccCcHHHHHhc--ccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 515 EYLEMGSLAMILSN--DAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 515 e~~~~~~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||+.. ++.++... ......+++..+..++.|++.||+|||+.+ +++||||||+||+++.++.+||+|||++....
T Consensus 83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 99864 44443211 112356899999999999999999999742 89999999999999999999999999997654
Q ss_pred CCCCCccccccccCCCCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC-
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTM---KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT- 668 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 668 (707)
..... ....+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||.... ..............+.
T Consensus 160 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~ 231 (288)
T cd06616 160 DSIAK-TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKGDPPIL 231 (288)
T ss_pred cCCcc-ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCCCCCcC
Confidence 33221 233678899999998765 68899999999999999999999986322 1111112221111111
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
........+.++.+++.+||+.+|++||+++++++.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111112355679999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=304.25 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=202.0
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------Cc
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA------RH 509 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 509 (707)
.|...+.+|+|+||.||+++ ..+|+.||||.+.... .....+...+|++++++++|||||+++++-.+. ..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 35566789999999999997 5689999999997643 233567788999999999999999999876543 35
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec--CCCC--eEEecc
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD--LENE--AHVSDF 585 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~--~~~~--~kl~Df 585 (707)
..+|||||.||+|+..+....+...+++.+.+.++..++.||.|||.+ |||||||||.||++- ++|+ -||+||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence 789999999999999998888888899999999999999999999999 999999999999983 3443 699999
Q ss_pred ccceecCCCCCCccccccccCCCCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhh-------
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIA------- 657 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~------- 657 (707)
|.|+....+ +.....+||..|.+||... .+.|+..+|.|||||++|+++||..||....+.....+.....
T Consensus 169 G~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 169 GAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 999987754 4678899999999999988 4788999999999999999999999997543321100011000
Q ss_pred ----hhh------hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCC
Q 038671 658 ----LNE------MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRP 696 (707)
Q Consensus 658 ----~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 696 (707)
... .....+|.+....+.....+...+..++..+|++|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 000 011223444444556666777788888899999998
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=287.79 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=206.9
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|++.+.||.|++|.||++.. ++++.+++|++...... ......+.+|++.++.++|||++++++.+..++..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 478889999999999999954 46899999998764332 2345678899999999999999999999999999999999
Q ss_pred eeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 516 YLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
|+++++|.+++.... ....+++..+..++.+++.|+.|||+. |++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999986542 135689999999999999999999999 9999999999999999999999999999876554
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
........+++.|+|||...+..++.++|+||+|+++|+|++|+.||.... .............+....
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~--- 225 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKILKGQYPPIPS--- 225 (258)
T ss_pred cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHhcCCCCCCCC---
Confidence 433344578899999999888889999999999999999999999986322 112222222222222111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+.++.+++.+||+.+|++||++.++++.
T Consensus 226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=285.06 Aligned_cols=249 Identities=24% Similarity=0.430 Sum_probs=204.6
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|++.+.||+|++|.||++.. .+++.|++|.+...... ....+.+.+|++++.+++|||++++++++..++..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 478889999999999999954 46889999998765432 2345679999999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++++|.+++... ..+++..++.++.|++.|+.|||+. |++||||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 80 YAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred cCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999998654 4589999999999999999999999 99999999999999999999999999998876554
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
.......++..|+|||...+..++.++|||++|+++|+|++|+.||..... ....... .....+... ..
T Consensus 154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~~~~-~~~~~~~~~---~~ 222 (254)
T cd06627 154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAALFRI-VQDDHPPLP---EG 222 (254)
T ss_pred ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHH-hccCCCCCC---CC
Confidence 434455788999999998888889999999999999999999999863221 1111111 111111111 12
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+..+.+++.+||..+|++||++.+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 2456889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=292.58 Aligned_cols=246 Identities=25% Similarity=0.373 Sum_probs=196.9
Q ss_pred eeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccCcH
Q 038671 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL 522 (707)
Q Consensus 444 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 522 (707)
||+|+||.||++... +|+.+++|++...........+.+.+|++.+++++|||++++++.+..+...++++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999665 5999999998754433334566788999999999999999999999999999999999999999
Q ss_pred HHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC------
Q 038671 523 AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS------ 596 (707)
Q Consensus 523 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~------ 596 (707)
.+++.... .+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99986533 589999999999999999999999 999999999999999999999999999876443311
Q ss_pred --CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 597 --NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 597 --~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
......++..|+|||...+..++.++||||||+++|++++|+.||.... ...............+...
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~-- 224 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQNILNGKIEWPEDV-- 224 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCCcCCCccc--
Confidence 2234567889999999988888999999999999999999999986322 1122222222222222111
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
..+..+.+++.+||+.+|++||++.++.+.|
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 1245689999999999999999994444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=296.15 Aligned_cols=259 Identities=20% Similarity=0.298 Sum_probs=195.4
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCc----
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARH---- 509 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~---- 509 (707)
++|++.+.||+|+||.||+|.. .+++.||+|+........ .....+.+|+.+++.++ |||++++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEE-GIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcccc-CCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 4688999999999999999964 578999999876543221 22356788999999995 6999999999876655
Q ss_pred -eeEEEeeeccCcHHHHHhcccc--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC-CCCeEEecc
Q 038671 510 -SFIVYEYLEMGSLAMILSNDAA--AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL-ENEAHVSDF 585 (707)
Q Consensus 510 -~~lv~e~~~~~~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~-~~~~kl~Df 585 (707)
.|++|||+++ ++.+++..... ...+++..++.++.||+.||+|||+. +++||||+|+||+++. ++.+||+||
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999986 78777754322 34689999999999999999999999 9999999999999998 889999999
Q ss_pred ccceecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcC-
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD- 663 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~- 663 (707)
|.+..............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....... ...........
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~ 231 (295)
T cd07837 156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ----QLLHIFKLLGTP 231 (295)
T ss_pred ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHHHhCCC
Confidence 999865443333333467889999998765 457899999999999999999999986432211 00000000000
Q ss_pred -----------------CCCCC--CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 664 -----------------PRLPT--PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 664 -----------------~~~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+.... .....+..+.++.+++.+||+.||.+||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 00011224456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=289.03 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=205.2
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|++.+.||+|++|.||++. ..+++.+++|++....... .....+.+|++.++.++||||+++++++......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 47888999999999999994 5578899999986543222 345667889999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccc-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 516 YLEMGSLAMILSNDAA-AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
|+++++|.+++..... ...+++..++.++.|++.|++|||+. |++||||+|+||+++.++.+|++|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999999865322 24589999999999999999999999 9999999999999999999999999999776544
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
......+++.|+|||...+..++.++|+||+|+++|+|++|+.||..... ............+.. ..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~---~~ 223 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--------QDLRYKVQRGKYPPI---PP 223 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCCCCC---ch
Confidence 22334678899999999988899999999999999999999999863221 111122222222221 12
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+.++.+++.+|++.+|++||++.++++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 224 IYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 455679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.80 Aligned_cols=262 Identities=20% Similarity=0.328 Sum_probs=194.7
Q ss_pred CCCCCceeeecCCeeEEEEEcC---CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--Ccee
Q 038671 437 DFDDEHCIGKGGQGSVYKAELP---SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA--RHSF 511 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 511 (707)
+|++.+.||+|++|.||+|... +++.||+|.+...........+.+.+|+.+++.++|||++++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999654 5789999998764322222335678899999999999999999999887 7899
Q ss_pred EEEeeeccCcHHHHHhcccc--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC----CCCeEEecc
Q 038671 512 IVYEYLEMGSLAMILSNDAA--AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL----ENEAHVSDF 585 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~----~~~~kl~Df 585 (707)
+||||+++ ++.+++..... ...+++..++.++.|++.||+|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 56555533221 23688999999999999999999999 9999999999999999 899999999
Q ss_pred ccceecCCCCC---CccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccc-----chhhh
Q 038671 586 GTAKFLKPDSS---NWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS-----SNLEI 656 (707)
Q Consensus 586 g~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-----~~~~~ 656 (707)
|++........ ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||.......... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987543322 12334678899999987664 47899999999999999999999986433211000 00000
Q ss_pred hhh------------------------hhcCCCCCCCCcchH------HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 657 ALN------------------------EMLDPRLPTPSHNVQ------DKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 657 ~~~------------------------~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
... .......+. ..... ....++.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPS-NSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCC-ccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 000001110 00000 22346889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=294.28 Aligned_cols=244 Identities=27% Similarity=0.417 Sum_probs=196.8
Q ss_pred CceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeecc
Q 038671 441 EHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
...||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++|||++++++++...+..+++|||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 46799999999999955 57899999987542 223456688999999999999999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
++|.+++.. ..+++..++.++.|++.|++|||+. |++||||+|+||+++.++.++|+|||.+...........
T Consensus 102 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~ 174 (292)
T cd06657 102 GALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174 (292)
T ss_pred CcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccccccc
Confidence 999998753 2478899999999999999999999 999999999999999999999999999876654333334
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHH
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 679 (707)
...+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...... ................ ....+..
T Consensus 175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~----~~~~~~~ 245 (292)
T cd06657 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----KAMKMIRDNLPPKLKN----LHKVSPS 245 (292)
T ss_pred ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhhCCcccCC----cccCCHH
Confidence 456889999999988888899999999999999999999998632211 1111111111112111 1223456
Q ss_pred HHHHHHhccCCCCCCCCCHHHHHH
Q 038671 680 IMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 680 l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+.+++.+||+.+|.+||++.++++
T Consensus 246 l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 246 LKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHhCCcccCcCHHHHhc
Confidence 889999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.15 Aligned_cols=259 Identities=27% Similarity=0.344 Sum_probs=195.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--Ccee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA--RHSF 511 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~ 511 (707)
.++|++.+.||+|+||.||+|.. .+|+.||+|++....... .....+.+|+.++++++|+|++++++++... +..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 36799999999999999999954 568999999986432221 1223456799999999999999999998654 4689
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||+.+ +|.+++... ...+++..++.++.|+++|++|||+. |++||||+|+||+++.++.+||+|||.+...
T Consensus 85 lv~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 99999974 788887543 24689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhc--------
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML-------- 662 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 662 (707)
...........+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||....... ..........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~----~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE----QLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCChhhch
Confidence 644333333456788999998865 457899999999999999999999986432211 0000000000
Q ss_pred ---------CCCCCC-CCcc----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 663 ---------DPRLPT-PSHN----VQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 663 ---------~~~~~~-~~~~----~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
....+. +... ....+.++.+++.+|++.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000 0000 01124567899999999999999999998863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=294.33 Aligned_cols=250 Identities=28% Similarity=0.436 Sum_probs=196.9
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
..|+..+.||+|+||.||++.. .+++.+|+|++.............+..|++++++++|||++++++++..+...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3477889999999999999964 578999999986543333334567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.| ++.+.+... ..++++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~g-~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCLG-SASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCCC-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 99975 676666432 34589999999999999999999999 9999999999999999999999999998754322
Q ss_pred CCCccccccccCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 595 SSNWAELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
....+++.|+|||.+. +..++.++||||||+++|+|++|+.||..... . ...........+..
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~-~~~~~~~~~~~~~~-- 244 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------M-SALYHIAQNESPTL-- 244 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-------H-HHHHHHHhccCCCC--
Confidence 2346788999999874 45688899999999999999999999853211 1 11111111111111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
.....+..+.+++.+||+.+|.+||++.++++..
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 1122345688999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=294.07 Aligned_cols=258 Identities=22% Similarity=0.327 Sum_probs=195.1
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|++|.||+|.. .+|+.||+|++....... ...+.+.+|++++++++|||++++++++......++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 4688999999999999999965 478999999986542221 23456788999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC-CCCeEEeccccceecCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL-ENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~ 593 (707)
||++ +++.+++.... ...+++..++.++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||++.....
T Consensus 81 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 81 EYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred eccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 9996 47777764332 23467888899999999999999999 9999999999999985 55799999999976544
Q ss_pred CCCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhh-----------
Q 038671 594 DSSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM----------- 661 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------- 661 (707)
.........+++.|+|||.+.+. .++.++||||+|+++|+|+||+.||....... .........
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID----ELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChhhcccc
Confidence 33333445678899999987664 57889999999999999999999986422110 000000000
Q ss_pred --------cCCCCCCC--CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 662 --------LDPRLPTP--SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 662 --------~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+..+.. ....+..+.++.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00010100 0001123456889999999999999999999875
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=292.87 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=204.1
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCceeEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv 513 (707)
++|++.+.||+|++|.||++.. .+|+.|++|++...........+.+..|++++++++ ||||+++++++..++..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3688999999999999999954 479999999987643333344567889999999998 99999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+.+++|.+++... ..+++..++.++.|++.||+|||+. |++|+||+|+||+++.++.++++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 9999999999998654 2589999999999999999999999 999999999999999999999999999986543
Q ss_pred CC--------------------CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccch
Q 038671 594 DS--------------------SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN 653 (707)
Q Consensus 594 ~~--------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~ 653 (707)
.. .......++..|+|||...+..++.++|+||||++++++++|+.||.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------- 227 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------- 227 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-------
Confidence 32 112334578899999998888889999999999999999999999864321
Q ss_pred hhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCH----HHHHH
Q 038671 654 LEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTI----QKVSQ 703 (707)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~----~~l~~ 703 (707)
..............+. ..+..+.+++.+||+.+|.+||++ .++++
T Consensus 228 -~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 -YLTFQKILKLEYSFPP----NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred -HHHHHHHHhcCCCCCC----ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1112222222222221 224558899999999999999999 88775
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=298.80 Aligned_cols=260 Identities=22% Similarity=0.344 Sum_probs=196.9
Q ss_pred HHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC----
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA---- 507 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---- 507 (707)
...++|+..+.||+|+||.||+|. ..+|+.||+|++....... .....+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNV-THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccCh-hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 356789999999999999999995 4578999999986543222 2345677899999999999999999988543
Q ss_pred --CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 508 --RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 508 --~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 92 EFQDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred ccCcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 35799999996 477777643 278889999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccc----------ccchh-
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISS----------SSSNL- 654 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~----------~~~~~- 654 (707)
|.+....... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.... .....
T Consensus 163 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 163 GLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ccceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9998754332 22334678899999999998999999999999999999999999864321100 00000
Q ss_pred ---hhhhhhhcCCCC----------------CCCC-cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 655 ---EIALNEMLDPRL----------------PTPS-HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 655 ---~~~~~~~~~~~~----------------~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..........+. +... ......+..+.+++.+|++.||++||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000000000 0000 001123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=313.35 Aligned_cols=266 Identities=17% Similarity=0.234 Sum_probs=186.8
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEcC--CCcEEEEEe--------------cCCCCCchhhhHHHHHHHHHHHhcCCCCc
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAELP--SGEIVAVKK--------------FHSPLPSEMASQQEFLNEVKTLTGIRHRN 496 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~~--~~~~vavK~--------------~~~~~~~~~~~~~~~~~e~~~l~~l~h~n 496 (707)
.+.++|++.+.||+|+||.||++..+ .+..++.|. +.............+.+|++++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34678999999999999999998543 222222221 11111112223456889999999999999
Q ss_pred eeeeeeeeecCCceeEEEeeeccCcHHHHHhcccc--cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee
Q 038671 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAA--AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL 574 (707)
Q Consensus 497 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~ 574 (707)
|+++++++...+..|+++|++. +++.+++..... ........++.++.||+.||+|||++ ||+||||||+||++
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 9999999999999999999986 456666543221 12234566788999999999999999 99999999999999
Q ss_pred cCCCCeEEeccccceecCCCCC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCC-CCcccccccccc
Q 038671 575 DLENEAHVSDFGTAKFLKPDSS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-RDFISSISSSSS 652 (707)
Q Consensus 575 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p-~~~~~~~~~~~~ 652 (707)
+.++.+||+|||++..+..... ......|++.|+|||++.+..++.++|||||||++|||++|..+ +....... ..
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~--~~ 378 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP--GK 378 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH--HH
Confidence 9999999999999987654322 22346799999999999999999999999999999999998754 43211100 00
Q ss_pred hhhhhh------------------hhhcCCCCCCCCcchH------HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 653 NLEIAL------------------NEMLDPRLPTPSHNVQ------DKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 653 ~~~~~~------------------~~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...... ..+............. ..+..+.+++.+|++.||++|||+.|+++.
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000 0000000000000000 112356778999999999999999999863
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=277.13 Aligned_cols=257 Identities=26% Similarity=0.374 Sum_probs=196.4
Q ss_pred cCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 513 (707)
++.+....||.|+||+|++. ..++|+..|||+++.... ..++.++..|.++..+- ++||||++||+...++..|+.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 34555677999999999999 556899999999986533 34567788888866555 699999999999999999999
Q ss_pred EeeeccCcHHHHHhcc--cccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 514 YEYLEMGSLAMILSND--AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
||.|+ -+++.+.... .....+++.-.-+|+.-.+.||.||.... .|||||+||+|||++..|.+|+||||.+..+
T Consensus 142 MELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 142 MELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred HHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhH
Confidence 99986 4554443221 12345788888888888999999998875 8999999999999999999999999999766
Q ss_pred CCCCCCccccccccCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
...-. ...-+|-..|||||.+.. ..|+.+|||||||+++||+.||+.||+.+.+. .+ ....-...++.....
T Consensus 219 v~SiA-kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv---fe--ql~~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 219 VDSIA-KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV---FE--QLCQVVIGDPPILLF 292 (361)
T ss_pred HHHHH-hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH---HH--HHHHHHcCCCCeecC
Confidence 53222 122367788999998863 34899999999999999999999998744331 11 111122223333333
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..........+..+|..|+.+|-..||+++++.+
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 3344456677999999999999999999999875
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=289.68 Aligned_cols=260 Identities=23% Similarity=0.327 Sum_probs=200.6
Q ss_pred CCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEee
Q 038671 438 FDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
|++.+.||+|++|.||++.. .+++.+++|++....... .....+..|++++++++|||++++++++..++..++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 56778999999999999965 478999999987543332 2346788899999999999999999999999999999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 596 (707)
+++ ++.+++.... ..+++..++.++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 80 MDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred cCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 975 7877775432 4689999999999999999999999 999999999999999999999999999987765442
Q ss_pred CccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchh-------hhhhhhh-------
Q 038671 597 NWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL-------EIALNEM------- 661 (707)
Q Consensus 597 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~-------~~~~~~~------- 661 (707)
......++..|+|||...+. .++.++|+||+|+++|+|++|+.||...+......... .......
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 33345678899999988776 68899999999999999999999986432211000000 0000000
Q ss_pred ----cCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 662 ----LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 662 ----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
............+..+.++.+++.+||+.||.+||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000000011123456779999999999999999999999863
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=283.97 Aligned_cols=252 Identities=22% Similarity=0.319 Sum_probs=198.5
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCC--CchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--Cce
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPL--PSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA--RHS 510 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 510 (707)
.+|++.+.||+|++|.||+|.. .+++.|++|.+.... .........+.+|++++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4689999999999999999954 568999999875321 12233456788999999999999999999998654 468
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++++||+++++|.+++... ..+++..+.+++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 8999999999999998643 3478899999999999999999999 999999999999999999999999999986
Q ss_pred cCCC---CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 591 LKPD---SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 591 ~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
.... ........++..|+|||.+.+..++.++|+||||+++|++++|+.||.... ...........+..+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~ 228 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-------AMAAIFKIATQPTKP 228 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-------HHHHHHHHHcCCCCC
Confidence 5422 112233568899999999988888999999999999999999999986321 112222222111111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
. .......++.+++.+||. +|.+||++.+++..
T Consensus 229 ~---~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 229 M---LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred C---CCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1 112344568999999999 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=298.93 Aligned_cols=262 Identities=21% Similarity=0.291 Sum_probs=197.4
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----C
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA-----R 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 508 (707)
.++|.+.+.||+|+||+||+|+ ..+++.||+|++...... ......+.+|+.+++.++|||++++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 4679999999999999999995 457899999998654322 22345677899999999999999999988643 3
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
..++++||+. ++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 5799999996 6788887543 4589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccc------------------
Q 038671 589 KFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISS------------------ 649 (707)
Q Consensus 589 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------------------ 649 (707)
..............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 876544333344567889999998764 4588999999999999999999999864221000
Q ss_pred -ccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 650 -SSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 650 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.................+......++.+.++.+++.+||+.+|++||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000000000000000112345668899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=291.03 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=194.0
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 512 (707)
.++|++.+.||+|++|.||+|..+ +++.||||++...... .....+..|+..+.+.. ||||+++++++..+...++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 367899999999999999999665 4899999998754322 23445666777676664 9999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
+|||+. +++.++.... ...+++..+.+++.|++.|++|||+.+ +++||||+|+||+++.++.+||+|||++....
T Consensus 92 v~e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 92 CMELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred EeeccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 999985 4666666432 236899999999999999999999732 89999999999999999999999999987654
Q ss_pred CCCCCccccccccCCCCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
.... .....+++.|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .. ...........+.
T Consensus 167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~-~~~~~~~~~~~~~ 238 (296)
T cd06618 167 DSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT------EF-EVLTKILQEEPPS 238 (296)
T ss_pred CCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh------HH-HHHHHHhcCCCCC
Confidence 3322 22345788999999987554 78899999999999999999999863211 11 1111222222111
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.. .....+.++.+++.+||+.||++||+++++++.
T Consensus 239 ~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 LP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 111234568999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=284.47 Aligned_cols=249 Identities=22% Similarity=0.329 Sum_probs=192.8
Q ss_pred HHHHHHhcCCCCCcee--eecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeee
Q 038671 429 EEIIRVTNDFDDEHCI--GKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFC 504 (707)
Q Consensus 429 ~~~~~~~~~~~~~~~l--g~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~ 504 (707)
.+.....++|++.+.+ |+|+||.||++. ..+++.+|+|.+........ |+.....+ +|||++++++++
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEE
Confidence 3445556778887777 999999999995 45788899999764322111 11111112 699999999999
Q ss_pred ecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC-CeEEe
Q 038671 505 SHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-EAHVS 583 (707)
Q Consensus 505 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~-~~kl~ 583 (707)
..++..++||||+++++|.+++.... .+++..++.++.|+++|++|||+. |++||||+|+||+++.++ .++|+
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~ 152 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC 152 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence 99999999999999999999986542 689999999999999999999999 999999999999999988 99999
Q ss_pred ccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcC
Q 038671 584 DFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD 663 (707)
Q Consensus 584 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 663 (707)
|||.+...... ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ........... .
T Consensus 153 dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~-~ 224 (267)
T PHA03390 153 DYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE---ELDLESLLKRQ-Q 224 (267)
T ss_pred cCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc---hhhHHHHHHhh-c
Confidence 99998765432 2346789999999999888999999999999999999999999632211 11111111111 2
Q ss_pred CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 038671 664 PRLPTPSHNVQDKLISIMEVAISCLDESPESRPT-IQKVSQ 703 (707)
Q Consensus 664 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~~l~~ 703 (707)
...+. ....+..+.+++.+||+.+|.+||+ ++++++
T Consensus 225 ~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 KKLPF----IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccCCc----ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11111 1234566899999999999999996 688875
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=298.44 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=193.5
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----C
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA-----R 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~ 508 (707)
.++|++.+.||+|+||.||+|. ..+|+.||+|++.... .......+.+|+.++++++|||++++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 5789999999999999999995 5578999999986422 122345678899999999999999999987543 3
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
..++++||+.+ ++...+.. +.+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred eEEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 57999999974 77777643 3589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC---CccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccc-------chhhhh
Q 038671 589 KFLKPDSS---NWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS-------SNLEIA 657 (707)
Q Consensus 589 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-------~~~~~~ 657 (707)
........ ......|++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.......... ......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 76543222 1223467899999998654 458899999999999999999999985322100000 000000
Q ss_pred hhhhcCC-------CCCCCCc-----chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 658 LNEMLDP-------RLPTPSH-----NVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 658 ~~~~~~~-------~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...+... ..+.... ..+..+.++.+++.+||+.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 0000000 011234568899999999999999999998864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=284.89 Aligned_cols=244 Identities=21% Similarity=0.239 Sum_probs=186.7
Q ss_pred eeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHH---HHHhcCCCCceeeeeeeeecCCceeEEEeeec
Q 038671 443 CIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEV---KTLTGIRHRNIVKFYGFCSHARHSFIVYEYLE 518 (707)
Q Consensus 443 ~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 518 (707)
.||+|+||.||+|.. .+++.||+|.+.............+..|. +.++...||+++++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999954 56889999998654322212222233333 34445679999999999999999999999999
Q ss_pred cCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCc
Q 038671 519 MGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW 598 (707)
Q Consensus 519 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 598 (707)
|++|.+++... ..+++..++.++.|+++|++|||+. +++||||+|+||+++.++.++|+|||++....... .
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~ 152 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P 152 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence 99999988543 4589999999999999999999999 99999999999999999999999999987654322 2
Q ss_pred cccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHH
Q 038671 599 AELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKL 677 (707)
Q Consensus 599 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (707)
....|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||...... ................+. ..+
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~----~~s 223 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLTMAVELPD----SFS 223 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCcc-----chHHHHHHhhccCCCCCC----cCC
Confidence 334789999999998744 5889999999999999999999999643211 111111111111111111 224
Q ss_pred HHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 678 ISIMEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 678 ~~l~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
.++.+++.+|+..+|.+|| ++.++++
T Consensus 224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred HHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 5688999999999999999 9999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=297.60 Aligned_cols=262 Identities=24% Similarity=0.350 Sum_probs=197.1
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec----CCc
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH----ARH 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~ 509 (707)
.++|++.+.||+|++|.||+|. ..+|+.||+|++...... ......+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 4789999999999999999995 457999999998754322 2234567789999999999999999998753 346
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++||||+. ++|.+++... +.+++..++.++.||+.||+|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 899999996 5888888543 3489999999999999999999999 99999999999999999999999999997
Q ss_pred ecCCCCCC----ccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccc-----------ch
Q 038671 590 FLKPDSSN----WAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS-----------SN 653 (707)
Q Consensus 590 ~~~~~~~~----~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-----------~~ 653 (707)
........ .....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.......... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 65433211 123468889999998765 458899999999999999999999996432110000 00
Q ss_pred h----hhhhhhh---cCCCCCCC-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 654 L----EIALNEM---LDPRLPTP-SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 654 ~----~~~~~~~---~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
. ....... .....+.+ ....+..+.++.+++.+||+.+|++||+++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 0000000 00000110 00112345679999999999999999999998864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=298.00 Aligned_cols=262 Identities=23% Similarity=0.351 Sum_probs=196.7
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC--Cc
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHA--RH 509 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~ 509 (707)
+.++|++.+.||+|+||.||+|.. .+++.+|+|++...... ......+.+|+.+++++ +||||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 457899999999999999999965 46889999988643222 22345677899999999 999999999998653 36
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++||||++ ++|..++... .+++..++.++.||+.||+|||+. |++||||+|+||+++.++.+||+|||.+.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 899999997 5888887542 578899999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC-----CccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccc-----------c
Q 038671 590 FLKPDSS-----NWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS-----------S 652 (707)
Q Consensus 590 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-----------~ 652 (707)
....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 6543321 2233568899999998765 457889999999999999999999986422111000 0
Q ss_pred h--------hhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 653 N--------LEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 653 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
. ....................+..+.++.+++.+||+.||.+|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0 000000011111111111112235678999999999999999999998863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=289.06 Aligned_cols=257 Identities=20% Similarity=0.290 Sum_probs=191.6
Q ss_pred CCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecC--CceeEE
Q 038671 438 FDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHA--RHSFIV 513 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv 513 (707)
|++.+.||+|+||.||+|. ..+++.||+|++....... ......+|+..+.++. |||++++++++.+. +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL--EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc--hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6678899999999999995 4578999999986543221 2233457888899885 99999999999877 889999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
+||+.+ ++.+.+.... ..+++..++.++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.+.....
T Consensus 79 ~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 79 FELMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred EecCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 999975 7777765322 4589999999999999999999999 9999999999999999 9999999999987643
Q ss_pred CCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccc----------cchhhhhhhh--
Q 038671 594 DSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS----------SSNLEIALNE-- 660 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~----------~~~~~~~~~~-- 660 (707)
... .....+++.|+|||...+ ..++.++||||+|+++|||++|+.||...+..... ..........
T Consensus 152 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 152 KPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred CCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 322 233467889999997654 45788999999999999999999999643221100 0000000000
Q ss_pred hcCCCCCCC-----CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 661 MLDPRLPTP-----SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 661 ~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
......+.. .......+.++.+++.+||+.+|++||+++++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 00012345779999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=291.70 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=190.8
Q ss_pred ceeeec--CCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeec
Q 038671 442 HCIGKG--GQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLE 518 (707)
Q Consensus 442 ~~lg~G--~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 518 (707)
..||+| +||+||++.. .+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 346666 9999999964 579999999987543222 345678899999999999999999999999999999999999
Q ss_pred cCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCc
Q 038671 519 MGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW 598 (707)
Q Consensus 519 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 598 (707)
++++.+++.... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 83 YGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999987543 23588999999999999999999999 99999999999999999999999998654332211110
Q ss_pred -------cccccccCCCCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchh-------------hh
Q 038671 599 -------AELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL-------------EI 656 (707)
Q Consensus 599 -------~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~-------------~~ 656 (707)
....++..|+|||++.+. .++.++||||+|+++|+|++|+.||............. ..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 112345679999998763 47889999999999999999999996432110000000 00
Q ss_pred hhh------------------------hhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 657 ALN------------------------EMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 657 ~~~------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
... ......+. ..........+.+++.+||..||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 00000000 01122355678999999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=288.58 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=196.2
Q ss_pred CCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CceeEEE
Q 038671 438 FDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA--RHSFIVY 514 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~ 514 (707)
|++.+.||+|++|.||+|... +++.+|+|++.... ........+.+|+++++.++|||++++++++... +..++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 667889999999999999654 58899999997653 2222345678899999999999999999999887 8999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++ +|.+++.... ..+++..++.++.|+++|++|||+. +++|+||+|+||++++++.+||+|||.+......
T Consensus 80 e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 80 EYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 99975 8888875432 4689999999999999999999999 9999999999999999999999999999876544
Q ss_pred CC-CccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhh-----------
Q 038671 595 SS-NWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM----------- 661 (707)
Q Consensus 595 ~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----------- 661 (707)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||+...... .........
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE----QLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCchhhcccc
Confidence 32 1233456788999997765 457899999999999999999999986432210 000000000
Q ss_pred --------cCCCCCCCC---cchHH-HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 662 --------LDPRLPTPS---HNVQD-KLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 662 --------~~~~~~~~~---~~~~~-~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+....+. ..... .+.++.+++.+||+.+|++||++.++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000 00011 15678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=289.76 Aligned_cols=249 Identities=27% Similarity=0.436 Sum_probs=195.4
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
..|+..+.||+|++|.||+|.. .+++.+++|.+............++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3477788899999999999964 468889999886432233334566888999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+. +++.+.+... ..++++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++......
T Consensus 95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 5777766432 24588999999999999999999999 9999999999999999999999999998765432
Q ss_pred CCCccccccccCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 595 SSNWAELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
....+++.|+|||.+. ...++.++||||||+++|+|++|+.||..... ... .........+..
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~-~~~~~~~~~~~~-- 234 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSA-LYHIAQNESPAL-- 234 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH-------HHH-HHHHhhcCCCCc--
Confidence 2346788999999874 34578899999999999999999999753211 111 111111111111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.....+..+.+++.+||+.+|++||+++++++.
T Consensus 235 ~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 112344568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=288.81 Aligned_cols=247 Identities=28% Similarity=0.432 Sum_probs=194.2
Q ss_pred CCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEee
Q 038671 438 FDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
|...+.||+|+||.||+|.. .+++.|++|++.............+..|++.++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66778899999999999954 56889999998654333334456788899999999999999999999999999999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 596 (707)
+. +++.+++... ..++++.+++.++.|++.|++|||+. |++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 5676666432 34589999999999999999999999 999999999999999999999999999864322
Q ss_pred CccccccccCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 597 NWAELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 597 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.....|+..|+|||.+. ...++.++||||||+++|+|++|+.||..... ... .........+.. ..
T Consensus 174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-------~~~-~~~~~~~~~~~~--~~ 242 (313)
T cd06633 174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSA-LYHIAQNDSPTL--QS 242 (313)
T ss_pred -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-------HHH-HHHHHhcCCCCC--Cc
Confidence 23456888999999874 35578899999999999999999999853221 111 111111111111 11
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...+..+.+++.+||+.+|.+||++.++++.
T Consensus 243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 243 NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1233458899999999999999999998863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=316.48 Aligned_cols=252 Identities=24% Similarity=0.306 Sum_probs=206.3
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
-.++|.+.++||+|+||.|..+++ .+++.||+|++.+...-......-|..|-.+|..-+.+=|+.++-+|.++.++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 368899999999999999999965 4688999999876433334455678899999998899999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||++||+|-.++.... ++|+..++.++..|+-||..+|+. |+|||||||+|||+|..|++||+|||.+-.+.
T Consensus 153 VMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 999999999999997654 589999999999999999999999 99999999999999999999999999998887
Q ss_pred CCCC-CccccccccCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC--
Q 038671 593 PDSS-NWAELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP-- 664 (707)
Q Consensus 593 ~~~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 664 (707)
.++. .....+|||.|.+||++.. +.|++.+|.||+||++|||+.|..||.. +........+.+.
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa--------dslveTY~KIm~hk~ 298 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA--------DSLVETYGKIMNHKE 298 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH--------HHHHHHHHHHhchhh
Confidence 5543 4556789999999998762 5689999999999999999999999952 2222333333333
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCC---HHHHH
Q 038671 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPT---IQKVS 702 (707)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps---~~~l~ 702 (707)
.+..| ...+.+.+..++|.+.+. +|+.|.. ++++.
T Consensus 299 ~l~FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 299 SLSFP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred hcCCC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 22222 223466678888887765 7888877 66654
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=286.73 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=194.5
Q ss_pred CCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC---CCCceeeeeeeeecCCc----
Q 038671 438 FDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI---RHRNIVKFYGFCSHARH---- 509 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~---- 509 (707)
|++.+.||+|++|.||+|..+ +++.||+|++......+ .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 677889999999999999765 58999999987543322 1234456677766655 59999999999987776
Q ss_pred -eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 510 -SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 510 -~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
.+++|||+.+ +|.+++.... ...+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||.+
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eeEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999974 7888876433 23589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhc------
Q 038671 589 KFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML------ 662 (707)
Q Consensus 589 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------ 662 (707)
........ .....++..|+|||...+..++.++|+||||+++|+|++|+.||+..... ...........
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA----DQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH----HHHHHHHHHcCCCChHh
Confidence 77643322 23345788999999999888999999999999999999999998643211 11111111000
Q ss_pred ------------CCCCC-CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 663 ------------DPRLP-TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 663 ------------~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
....+ ......++....+.+++.+||+.||.+||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000 001112334567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=280.16 Aligned_cols=242 Identities=26% Similarity=0.348 Sum_probs=198.5
Q ss_pred eeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccCcH
Q 038671 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL 522 (707)
Q Consensus 444 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 522 (707)
||+|+||.||++... +++.+++|++.............+..|++++++++|||++++++.+..++..+++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999654 6899999998765444334566788999999999999999999999999999999999999999
Q ss_pred HHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCccccc
Q 038671 523 AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA 602 (707)
Q Consensus 523 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 602 (707)
.+++... ..+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||.+..............
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC 154 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence 9998643 2589999999999999999999998 999999999999999999999999999987654433344567
Q ss_pred cccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHH
Q 038671 603 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIME 682 (707)
Q Consensus 603 g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 682 (707)
++..|+|||...+...+.++|+||||+++|++++|+.||...+. ............+.+... +..+.+
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~l~~ 222 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILKDPLRFPEFL----SPEARD 222 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcCCCCCCCCC----CHHHHH
Confidence 88899999999888889999999999999999999999863221 222222222333322222 345889
Q ss_pred HHHhccCCCCCCCCCH---HHHHH
Q 038671 683 VAISCLDESPESRPTI---QKVSQ 703 (707)
Q Consensus 683 li~~cl~~~P~~Rps~---~~l~~ 703 (707)
++.+||..||++||++ +++.+
T Consensus 223 ~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 223 LISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred HHHHHhcCCHhhCCCcccHHHHHh
Confidence 9999999999999999 56554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=278.75 Aligned_cols=244 Identities=22% Similarity=0.310 Sum_probs=206.0
Q ss_pred hcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 512 (707)
..+|....+||+|+||.|.+| +..+.+.+|||++++...-.....+--..|-+++.-. +-|.++.++.+|...+++|.
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 457999999999999999999 4456788999999876544444444556677777766 47889999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||+.||+|-..+++.+ .+.++.+..+|.+||-||-+||++ ||+.||||.+|||++.+|++||+|||+++.--
T Consensus 428 VMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999998886543 477889999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
-++....+++|||.|+|||++...+|+.++|.||+|+++|||+.|++||+. +..++.+..+.+....-|.
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG--------eDE~elF~aI~ehnvsyPK-- 571 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG--------EDEDELFQAIMEHNVSYPK-- 571 (683)
T ss_pred cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHHHccCcCcc--
Confidence 566667889999999999999999999999999999999999999999973 4445566666666655443
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCC
Q 038671 673 VQDKLISIMEVAISCLDESPESRP 696 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rp 696 (707)
..+.+...+.+..+...|.+|.
T Consensus 572 --slSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 572 --SLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --cccHHHHHHHHHHhhcCCcccc
Confidence 3445577888889999999995
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=288.25 Aligned_cols=260 Identities=25% Similarity=0.374 Sum_probs=195.8
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC---
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR--- 508 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 508 (707)
...++|++.+.||+|++|.||+|..+ +|+.||+|++...... ......+.+|++++++++|||++++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 44578999999999999999999654 6889999998654322 123346778999999999999999999886544
Q ss_pred -------ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeE
Q 038671 509 -------HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH 581 (707)
Q Consensus 509 -------~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~k 581 (707)
..++++||+++ ++...+... ...+++..++.++.||+.||+|||+. |++||||+|+||+++.++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 666666433 34589999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCC-CccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhh
Q 038671 582 VSDFGTAKFLKPDSS-NWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN 659 (707)
Q Consensus 582 l~Dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 659 (707)
|+|||.+........ ......++..|+|||.+.+ ..++.++||||+|+++|+|++|++||....... .... +.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~----~~~~-~~ 231 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA----QLEL-IS 231 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHH-HH
Confidence 999999987654332 2223356788999998764 346889999999999999999999986422110 0000 00
Q ss_pred hhcCCCCC-----------------------CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 660 EMLDPRLP-----------------------TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 660 ~~~~~~~~-----------------------~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.......+ .........+..+.+++.+||+.||.+||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000000 0000011134568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=283.21 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=197.0
Q ss_pred CCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCc--hhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 437 DFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPS--EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
+|.+.+.||+|+||.||++... .+..+++|+....... .......+..|+.++++++|||++++++++.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4788899999999999999543 3445556555432111 112334567789999999999999999999998999999
Q ss_pred EeeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 514 YEYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
+||+++++|.+++.... ....+++..++.++.|+++|+.|||+. |++|+||+|+||+++. +.++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999886422 234689999999999999999999999 9999999999999974 679999999998765
Q ss_pred CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
..........+++.|+|||...+..++.++|+||+|+++|+|++|..||.... .............+..
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~~~~~~~~--- 225 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIVEGPTPSL--- 225 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHcCCCCCC---
Confidence 54444445568889999999888888999999999999999999999985321 1111122222222221
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
....+.++.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 226 PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1244567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=287.32 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=198.9
Q ss_pred CCCCCceeeecCCeeEEEEEc----CCCcEEEEEecCCCCCc-hhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCce
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL----PSGEIVAVKKFHSPLPS-EMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 510 (707)
+|++.+.||+|++|.||+++. .+++.||+|++...... .....+.+..|++++.++ +||+++++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999853 35788999988643211 122345678899999999 599999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++||||+.+++|.+++... ..+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++++|||++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence 9999999999999988543 3588999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCC-ccccccccCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 591 LKPDSSN-WAELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 591 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
....... .....++..|+|||...+.. .+.++||||||+++|+|++|+.||...... ...............+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~ 230 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRRILKSKPP 230 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHHHHccCCC
Confidence 5443222 22346889999999987655 688999999999999999999998532211 1111111222222222
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+. ..+..+.+++.+||+.||++|||+.++.+.|+
T Consensus 231 ~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 231 FPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 221 23345889999999999999999887776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.11 Aligned_cols=260 Identities=18% Similarity=0.233 Sum_probs=192.0
Q ss_pred CCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeec
Q 038671 439 DDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLE 518 (707)
Q Consensus 439 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 518 (707)
.+++.+|.|+++.+|++.. +++.||+|++..... .....+.+.+|++.++.++||||+++++++...+..+++|||++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence 3444455555555555544 789999999875422 22355679999999999999999999999999999999999999
Q ss_pred cCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC--
Q 038671 519 MGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS-- 596 (707)
Q Consensus 519 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 596 (707)
++++.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.+........
T Consensus 83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 83 YGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 999999997543 23588999999999999999999999 999999999999999999999999998875532221
Q ss_pred -----CccccccccCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhh----------
Q 038671 597 -----NWAELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN---------- 659 (707)
Q Consensus 597 -----~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~---------- 659 (707)
......++..|+|||.+.+ ..++.++|+||+|+++|||++|+.||..................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhh
Confidence 1123456778999998865 34788999999999999999999999643221100000000000
Q ss_pred ---h-------hcCCCC--CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 660 ---E-------MLDPRL--PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 660 ---~-------~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
. ...+.. ............++.+++.+||+.||++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 000000 01111122344578899999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=294.53 Aligned_cols=260 Identities=23% Similarity=0.318 Sum_probs=199.1
Q ss_pred CCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----ce
Q 038671 437 DFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR-----HS 510 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~ 510 (707)
+|++.+.||+|++|.||+|... +++.+++|++..... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5888999999999999999654 589999999875432 2234567889999999999999999999987765 78
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
|++|||+. ++|.+++.... .+++..++.++.|++.||+|||+. |++||||||+||+++.++.++|+|||.+..
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999997 57888886432 689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC---CCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccc----------------
Q 038671 591 LKPDS---SNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS---------------- 650 (707)
Q Consensus 591 ~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---------------- 650 (707)
..... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 65543 123345678899999999887 7899999999999999999999998643211000
Q ss_pred ---cchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 651 ---SSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 651 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.......................+..+..+.+++.+||+.+|.+||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000000000000000011234568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=288.60 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=207.7
Q ss_pred hcCCCC--CceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 435 TNDFDD--EHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 435 ~~~~~~--~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
..-|++ .+++|+|.||+||-| ..++|+.||||++.+...... ..+.++.|+.++..++||.||.+.-.|+..+..+
T Consensus 561 stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 561 STVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 334554 478999999999999 556899999999987655443 4478999999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC---CeEEeccccc
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN---EAHVSDFGTA 588 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~---~~kl~Dfg~~ 588 (707)
.|||.+.|.-|+-.+... ..++++.....++.||+.||.|||.+ +|+|+||||+|||+.... .+||||||+|
T Consensus 640 VVMEKl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfA 714 (888)
T KOG4236|consen 640 VVMEKLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFA 714 (888)
T ss_pred EEehhhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccce
Confidence 999999988888777543 45689999999999999999999999 999999999999996543 7999999999
Q ss_pred eecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 589 KFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 589 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
+.+.. .+..+..+|||.|.|||+++.+.|...-|+||.|+|+|--+.|..||.... .... .+.+..+.-
T Consensus 715 RiIgE-ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-------dInd---QIQNAaFMy 783 (888)
T KOG4236|consen 715 RIIGE-KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-------DIND---QIQNAAFMY 783 (888)
T ss_pred eecch-hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-------chhH---Hhhcccccc
Confidence 98764 355577899999999999999999999999999999999999999985321 2222 222333333
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
|...+.+......++|...++..-.+|-|.++-+.
T Consensus 784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 33334566677889999999999999999887654
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=284.99 Aligned_cols=253 Identities=22% Similarity=0.307 Sum_probs=196.6
Q ss_pred CCCCCceeeecCCeeEEEEEc----CCCcEEEEEecCCCCCc-hhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCce
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL----PSGEIVAVKKFHSPLPS-EMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 510 (707)
.|++.+.||+|+||.||.++. .+|+.||+|++...... .....+.+..|++++.++ +|++|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999964 47899999998653221 122345678899999999 599999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++|+||+++++|.+++... ..+++..+..++.|+++||+|||+. |++||||+|+||+++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 9999999999999998643 3578899999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCC-CccccccccCCCCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 591 LKPDSS-NWAELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 591 ~~~~~~-~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
...... ......|+..|+|||...+. .++.++||||||+++|+|++|+.||..... ................+
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~~~ 230 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSEPP 230 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----cccHHHHHHHhhccCCC
Confidence 543321 22335688999999988753 467899999999999999999999863221 11112222222222222
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
.+ ......+.+++.+||+.||++|| +++++++
T Consensus 231 ~~----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 231 YP----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CC----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 21 12345588999999999999997 6676654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=288.57 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=191.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR----- 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 508 (707)
.++|++.+.||+|+||.||+|.. .+++.||+|++....... .....+.+|++++++++|||++++++++...+
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 35799999999999999999954 578999999886533222 12234567999999999999999999886544
Q ss_pred ---ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 509 ---HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 509 ---~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
..++||||+.+ ++.+.+... ...+++.+++.++.||+.||+|||++ |++|+||+|+||+++.++.+||+||
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 45999999964 777777533 23589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCC----CccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhh--
Q 038671 586 GTAKFLKPDSS----NWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIAL-- 658 (707)
Q Consensus 586 g~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-- 658 (707)
|.+........ ......++..|+|||...+.. ++.++||||+|+++|+|++|+.||........ ........
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~-~~~~~~~~~~ 242 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ-LTLISQLCGS 242 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCC
Confidence 99976543221 122345788899999876643 68899999999999999999999864221100 00000000
Q ss_pred ------------hhhcCCCCCCCCc-chH------HHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 659 ------------NEMLDPRLPTPSH-NVQ------DKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 659 ------------~~~~~~~~~~~~~-~~~------~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
........+.... ... .....+.+++.+||+.||.+||+++++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0000000000000 000 012346789999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=266.41 Aligned_cols=205 Identities=22% Similarity=0.354 Sum_probs=169.1
Q ss_pred HhcCCCCCceeeecCCeeEEEE-EcC--C--CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec-C
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKA-ELP--S--GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH-A 507 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~-~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~ 507 (707)
....|+....||+|+||.||+| +.+ + ...+|+|+++........+ ....+|+..++.++|||++.+..++.. +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS-~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGIS-MSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcC-HHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 3467999999999999999999 332 2 2379999997654333322 345789999999999999999999876 7
Q ss_pred CceeEEEeeeccCcHHHHHhccc--ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC----CCeE
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDA--AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE----NEAH 581 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~----~~~k 581 (707)
...++++||.+. +|.+.++.+. ..+.++...+.+++.||+.|+.|||+. .|+||||||.||++..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 889999999975 5666665433 345689999999999999999999999 99999999999999887 8999
Q ss_pred EeccccceecCCCCCC---ccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCc
Q 038671 582 VSDFGTAKFLKPDSSN---WAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDF 643 (707)
Q Consensus 582 l~Dfg~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~ 643 (707)
|+|+|+++.+..+-.. ....+-|..|+|||.+.|.. |+++.|||+.|||+.||+|-++-|..
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9999999988755332 34467899999999988765 79999999999999999998776643
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.21 Aligned_cols=259 Identities=21% Similarity=0.273 Sum_probs=193.5
Q ss_pred hcCCC-CCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhh-----------hHHHHHHHHHHHhcCCCCceeeee
Q 038671 435 TNDFD-DEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMA-----------SQQEFLNEVKTLTGIRHRNIVKFY 501 (707)
Q Consensus 435 ~~~~~-~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~ 501 (707)
.++|. +.+.||+|+||.||+|. ..+++.||+|++......... ....+.+|+++++.++|||+++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 45779999999999995 457899999998654222100 112477899999999999999999
Q ss_pred eeeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeE
Q 038671 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH 581 (707)
Q Consensus 502 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~k 581 (707)
+++..++..+++|||+. ++|.+++... ..+++.....++.|++.||+|||+. |++||||+|+||+++.++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEE
Confidence 99999999999999997 5888888542 3488999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCC--------------CCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccc
Q 038671 582 VSDFGTAKFLKPD--------------SSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISS 646 (707)
Q Consensus 582 l~Dfg~~~~~~~~--------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 646 (707)
++|||.+...... ........+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999765411 1112233467889999988764 368899999999999999999999864322
Q ss_pred cccccchhhhhhhhhcCCC---C-------------CCCCc----chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 647 ISSSSSNLEIALNEMLDPR---L-------------PTPSH----NVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~---~-------------~~~~~----~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.. ...........+. + ..... .....+.++.+++.+|++.+|++||+++|++..
T Consensus 240 ~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 ID----QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HH----HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 10 0000000000000 0 00000 011124568899999999999999999999863
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=268.50 Aligned_cols=252 Identities=22% Similarity=0.330 Sum_probs=211.6
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 512 (707)
.++|++.++||+|+|+.|..+++ ++.+.||+|++++....+.+..+-+..|-.+..+- +||.+|.++.+|..+.+++.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46899999999999999999965 46788999999876666555555577777777776 69999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
|.||++||+|--++++ .+.++++.++.+...|.-||.|||++ ||+.||+|.+||++|..|.+|++|+|+++.--
T Consensus 329 vieyv~ggdlmfhmqr---qrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeehhh---hhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999999777644 34699999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
.++....+++|||.|.|||++++..|...+|.|+||++++||+.|+.||+......+........++.++...+..|...
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprsl 482 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSL 482 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccccee
Confidence 67777888999999999999999999999999999999999999999998655433444444455555665555544332
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCC
Q 038671 673 VQDKLISIMEVAISCLDESPESRP 696 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rp 696 (707)
. .....+++.-+++||++|.
T Consensus 483 s----vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 483 S----VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred e----hhhHHHHHHhhcCCcHHhc
Confidence 2 2345677788999999985
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=307.85 Aligned_cols=257 Identities=27% Similarity=0.450 Sum_probs=204.9
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC----C----CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP----S----GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCS 505 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 505 (707)
.++..+.+.+|+|.||.|++|... . ...||||........ .+.+.+..|+++|+.+ +|||++.++|++.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 344566779999999999999532 1 457999998876444 4678899999999999 5999999999999
Q ss_pred cCCceeEEEeeeccCcHHHHHhccc-----------cc--CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDA-----------AA--KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 572 (707)
..+..++|+||+..|+|.++++..+ .. ..++..+.+.++.|||.|++||++. ++|||||..+||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence 9999999999999999999997655 01 1388899999999999999999999 999999999999
Q ss_pred eecCCCCeEEeccccceecCCCCCCc-cccc--cccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccc
Q 038671 573 LLDLENEAHVSDFGTAKFLKPDSSNW-AELA--GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSIS 648 (707)
Q Consensus 573 l~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~--g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~ 648 (707)
+++++..+||+|||+|+......... .... -+..|||||.+....|+.+|||||||+++||++| |..||.....
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-- 527 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-- 527 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--
Confidence 99999999999999998765443322 2222 2446999999999999999999999999999999 9999864211
Q ss_pred cccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 649 SSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 649 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.......+... .++..|... ..++.++++.||+.+|++||++.++.+.++
T Consensus 528 --~~~l~~~l~~G--~r~~~P~~c----~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~ 577 (609)
T KOG0200|consen 528 --TEELLEFLKEG--NRMEQPEHC----SDEIYDLMKSCWNADPEDRPTFSECVEFFE 577 (609)
T ss_pred --HHHHHHHHhcC--CCCCCCCCC----CHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence 11111222222 233333333 345889999999999999999999998874
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=292.08 Aligned_cols=262 Identities=21% Similarity=0.313 Sum_probs=197.1
Q ss_pred HHHHHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 038671 430 EIIRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR 508 (707)
Q Consensus 430 ~~~~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 508 (707)
.+..+.++|++.+.||+|+||.||++. ..+|+.||+|++..... .......+.+|++++++++||||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 345567899999999999999999994 56799999999865332 2223456789999999999999999999886543
Q ss_pred ------ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEE
Q 038671 509 ------HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV 582 (707)
Q Consensus 509 ------~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl 582 (707)
..++||||+ +++|.+++.. ..+++..++.++.|+++|++|||+. |++||||||+||+++.++.+++
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence 458999998 7789888753 3589999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccch-------h
Q 038671 583 SDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN-------L 654 (707)
Q Consensus 583 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~-------~ 654 (707)
+|||++...... .....+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||............ .
T Consensus 160 ~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 160 LDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred eecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999999765422 233467889999998876 45788999999999999999999998632211000000 0
Q ss_pred hhhhhhhcC-------CCCCCC-----CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 655 EIALNEMLD-------PRLPTP-----SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 655 ~~~~~~~~~-------~~~~~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
......... ...+.. ....+....++.+++.+|++.||++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 000000 0001123345889999999999999999999874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=285.27 Aligned_cols=259 Identities=24% Similarity=0.349 Sum_probs=198.4
Q ss_pred CCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEee
Q 038671 438 FDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
|+..+.||+|++|.||+|... +++.+++|++..... .....+.+..|+.++++++|||++++++++...+..++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 566788999999999999654 599999999876431 222345677899999999999999999999999999999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 596 (707)
++ ++|.+++.... ..+++..++.++.|++.||+|||+. |++||||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 80 CD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 98 58999986542 3589999999999999999999999 999999999999999999999999999987654433
Q ss_pred CccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccccc----------chhhhhhhhh--cC
Q 038671 597 NWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS----------SNLEIALNEM--LD 663 (707)
Q Consensus 597 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~----------~~~~~~~~~~--~~ 663 (707)
......++..|+|||.+.+. .++.++||||||+++||+++|+.||.......... .......... .+
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK 233 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence 33444567889999988766 78999999999999999999999986422110000 0000000000 01
Q ss_pred CCCCCCC-----cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 664 PRLPTPS-----HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 664 ~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+... ...+..+..+.+++.+||..||++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 1111100 011122457999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=280.92 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=195.3
Q ss_pred CCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCceeEEEe
Q 038671 438 FDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 515 (707)
|++.+.||+|++|.||+|... +++.|++|++...... .......+|+..+++++ |||++++++++..++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 677889999999999999664 5788999998654322 22334567899999998 9999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+ ++++.+.+.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 99 788988886543 24689999999999999999999999 99999999999999999999999999998665332
Q ss_pred CCccccccccCCCCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCccccccccc-----------chh--hhhhhhh
Q 038671 596 SNWAELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS-----------SNL--EIALNEM 661 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-----------~~~--~~~~~~~ 661 (707)
. .....++..|+|||.+. +..++.++|+||||+++++|++|+.||.......... ... .......
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 P-YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred C-cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 2 23356788999999875 4457899999999999999999999985432110000 000 0000000
Q ss_pred cCCCCCCCCc-----chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 662 LDPRLPTPSH-----NVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 662 ~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.....+.... .....+..+.+++.+||+.+|++||++.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 1111111000 001123568899999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=270.65 Aligned_cols=261 Identities=21% Similarity=0.310 Sum_probs=208.0
Q ss_pred HHHHHHhcCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeee
Q 038671 429 EEIIRVTNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502 (707)
Q Consensus 429 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 502 (707)
.++..-..+++....+.+|.||.||.|.+ .+.+.|.||.++... .......+.+|.-.+..+.|||+..+.+
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 34444566788888899999999999933 345667788876542 2335667899999999999999999999
Q ss_pred eeec-CCceeEEEeeeccCcHHHHHh-----cccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC
Q 038671 503 FCSH-ARHSFIVYEYLEMGSLAMILS-----NDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL 576 (707)
Q Consensus 503 ~~~~-~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~ 576 (707)
++.+ ....+.++.+...|+|..++. .....+.++..+...++.|++.|++|||++ ||||.||..+|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 8854 457889999999999999997 344455688889999999999999999999 9999999999999999
Q ss_pred CCCeEEeccccceecCCCCCCc--cccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccch
Q 038671 577 ENEAHVSDFGTAKFLKPDSSNW--AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSN 653 (707)
Q Consensus 577 ~~~~kl~Dfg~~~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 653 (707)
.-++||+|-.+++.+.+.+... ..-..+..||+||.+....|+.++||||||+++|||+| |+.||...++
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP------- 504 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP------- 504 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-------
Confidence 9999999999999887765442 11234567999999999999999999999999999999 9999864332
Q ss_pred hhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 654 LEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
++....-....++.+|. .+ +.++..++.-||+..|++||+++|++..|
T Consensus 505 fEm~~ylkdGyRlaQP~-NC---PDeLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 505 FEMEHYLKDGYRLAQPF-NC---PDELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred HHHHHHHhccceecCCC-CC---cHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 22222222233444443 22 33588999999999999999999998766
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=289.33 Aligned_cols=261 Identities=25% Similarity=0.363 Sum_probs=196.8
Q ss_pred HHHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec-CCc
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH-ARH 509 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 509 (707)
..+.++|++.+.||+|+||.||+|. ..+++.||+|++....... ...+.+..|+++++.++|||++++++++.. ...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP-VLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-chhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 4467889999999999999999995 5579999999886543222 234567789999999999999999998865 557
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++++||+ +++|..++.. .++++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.+.
T Consensus 85 ~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 88999998 5688888753 3478888899999999999999999 99999999999999999999999999987
Q ss_pred ecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccc-------chhhhhhhhh
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS-------SNLEIALNEM 661 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~-------~~~~~~~~~~ 661 (707)
..... .....+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.......... ...+......
T Consensus 157 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 157 IQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred ccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 54322 233467889999998765 568999999999999999999999986432110000 0000000000
Q ss_pred c---------CC--CCCCC-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 662 L---------DP--RLPTP-SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 662 ~---------~~--~~~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
. .. ..+.+ ....+..+.++.+++.+|++.+|++||++++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00 00000 00111234578999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=289.64 Aligned_cols=264 Identities=21% Similarity=0.313 Sum_probs=197.2
Q ss_pred HHHHHHHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec
Q 038671 428 YEEIIRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH 506 (707)
Q Consensus 428 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 506 (707)
.+++..+.++|++.+.||+|+||.||+|. ..+++.||+|++...... ....+.+.+|+.++++++||||+++++++..
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 45567788999999999999999999995 567899999998754322 2234567889999999999999999998754
Q ss_pred C------CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCe
Q 038671 507 A------RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEA 580 (707)
Q Consensus 507 ~------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~ 580 (707)
. ...+++++++ +++|.+++.. +.+++..++.++.|+++|++|||+. +++||||||+||+++.++.+
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence 3 3467888876 7889888753 3489999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccch------
Q 038671 581 HVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN------ 653 (707)
Q Consensus 581 kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~------ 653 (707)
||+|||++...... .....++..|+|||...+ ..++.++||||+|+++|+|++|+.||............
T Consensus 160 kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 160 KILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred EEeccccccccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999998764322 233467889999998766 45788999999999999999999998532211000000
Q ss_pred -hhhhhh--------hhc--CCCCCCCC--cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 654 -LEIALN--------EML--DPRLPTPS--HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 654 -~~~~~~--------~~~--~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...... ... -+..+... ......+.++.+++.+|++.||.+||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 000000 000 00001000 000012446889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=311.11 Aligned_cols=148 Identities=26% Similarity=0.340 Sum_probs=132.1
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|.. .+++.||+|++.............+..|+..+..++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 5789999999999999999965 478999999987543333344567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
||+.+++|.+++... +.+++..++.++.||+.||+|||.. +|+||||||+||+++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998643 3478899999999999999999999 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=292.82 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=208.3
Q ss_pred HHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeee-----
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCS----- 505 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~----- 505 (707)
..++.|++.++||.|.+|.||+++ .++|+.+|+|+...... ..+++..|.++++.+ .|||++.++++|.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 346778999999999999999994 56789999999865432 335667788888888 5999999999984
Q ss_pred cCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
.++.+|+|||||.||+..|+++.-. +..+.|..+..|++.++.|+.+||.. .++|||||-.||+++.++.||++||
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeee
Confidence 3568999999999999999997655 67799999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCccccccccCCCCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
|.+..+...-.+....+|||.|||||++... .|+.++|+||||++..||.-|.+|+-.+. .....+..
T Consensus 168 GvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-------PmraLF~I 240 (953)
T KOG0587|consen 168 GVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-------PMRALFLI 240 (953)
T ss_pred eeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc-------hhhhhccC
Confidence 9998877666666778999999999998753 36779999999999999999999974221 12222222
Q ss_pred hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+|. ...........++-++|..|+..|-++||++.++++
T Consensus 241 pRNPP--PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 241 PRNPP--PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCC--ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11211 112224456778999999999999999999998875
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=288.96 Aligned_cols=262 Identities=23% Similarity=0.318 Sum_probs=190.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA------ 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 507 (707)
.++|++.+.||+|++|.||+|.. .+++.+++|++........ ....+.+|++++++++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 46899999999999999999964 4689999998864322221 223567899999999999999999987443
Q ss_pred --CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 508 --RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 508 --~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
...++++||+.+ ++...+... ...+++..+..++.|+++||+|||+. |++||||||+||++++++.++|+||
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 346999999875 566665432 34689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCC-----------ccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccch
Q 038671 586 GTAKFLKPDSSN-----------WAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN 653 (707)
Q Consensus 586 g~~~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~ 653 (707)
|++......... .....+++.|+|||.+.+. .++.++||||+|+++|||++|++||............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999765432211 1223567889999987654 4788999999999999999999998642221100000
Q ss_pred hh-------------hhhhh----hcCCCCCCC-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 654 LE-------------IALNE----MLDPRLPTP-SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 654 ~~-------------~~~~~----~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.. ..... ......+.. ..........+.+++.+|++.||++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00 00000 000000000 0000112246889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=291.71 Aligned_cols=259 Identities=22% Similarity=0.342 Sum_probs=195.9
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc--
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH-- 509 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-- 509 (707)
.+.++|++.+.||+|++|.||+|+. .+++.||+|++....... .....+.+|+.+++.++|||++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSA-IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchh-hHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 4567899999999999999999965 468899999986543222 234567789999999999999999998865554
Q ss_pred ----eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 510 ----SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 510 ----~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
.++|+||+ +++|.+++.. ..+++..++.++.|+++|++|||+. |++||||+|+||+++.++.++|+||
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 6799988853 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccch-------hhhh
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN-------LEIA 657 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~-------~~~~ 657 (707)
|.+...... .....++..|+|||...+ ..++.++||||+|+++|++++|+.||............ .+..
T Consensus 163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 163 GLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 999865432 233467889999998765 35788999999999999999999998632211000000 0000
Q ss_pred hhhhc--------C--CCCCCC--CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 658 LNEML--------D--PRLPTP--SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 658 ~~~~~--------~--~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+. . +..... .......+.++.+++.+|++.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000 0 000000 0000122457899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=289.47 Aligned_cols=258 Identities=22% Similarity=0.357 Sum_probs=192.2
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC---
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR--- 508 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 508 (707)
...++|...+.||+|+||.||+|.. .+|+.||+|++......+ .....+.+|+++++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 4457899999999999999999964 578999999987543222 22345788999999999999999999886542
Q ss_pred ---ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 509 ---HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 509 ---~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
..++|+||+. .++..+.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 91 EFQDFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred CCceEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence 4689999986 46666542 3488999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhh---------
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE--------- 655 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--------- 655 (707)
|++...... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..............
T Consensus 162 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 162 GLARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CCCcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 998764322 233467889999998876 4588899999999999999999999964221100000000
Q ss_pred -hhh-----hhhc--CCCCCCCC--cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 656 -IAL-----NEML--DPRLPTPS--HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 656 -~~~-----~~~~--~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
... .... .+..+... ...+..+.++.+++.+||+.||++||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 0000 00111000 001123346889999999999999999999985
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=288.43 Aligned_cols=258 Identities=25% Similarity=0.332 Sum_probs=190.0
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA------ 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 507 (707)
..+|++.+.||.|+||.||+|. ..+|+.||+|++..... ...+.+.+|+++++.++|||++++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 4689999999999999999995 45789999999865432 2446688899999999999999999876543
Q ss_pred --------CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC-CC
Q 038671 508 --------RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL-EN 578 (707)
Q Consensus 508 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~-~~ 578 (707)
...++|+||+. ++|.+++.. ..+++..++.++.||+.||.|||+. |++||||||+||+++. ++
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~ 152 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence 35789999997 588887742 3488999999999999999999999 9999999999999974 55
Q ss_pred CeEEeccccceecCCCCC---CccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccc--
Q 038671 579 EAHVSDFGTAKFLKPDSS---NWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSS-- 652 (707)
Q Consensus 579 ~~kl~Dfg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~-- 652 (707)
.+|++|||.+........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 789999999976543211 1122357889999997654 4578899999999999999999999964221100000
Q ss_pred ---------hhhhhh----hhhc-CCCCCC-C-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 653 ---------NLEIAL----NEML-DPRLPT-P-SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 653 ---------~~~~~~----~~~~-~~~~~~-~-~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...... .... ....+. + ....+....++.+++.+|++.||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 0000 000000 0 0001123356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=285.27 Aligned_cols=240 Identities=23% Similarity=0.285 Sum_probs=193.9
Q ss_pred HhcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCcee
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 511 (707)
+.+.|.....+|.|+|+.|-.+ ...+++..+||++...... ..+|+.++... +|||++++.+.+.++...|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceee
Confidence 4677888888999999999888 5567889999999765221 23455555555 6999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee-cCCCCeEEecccccee
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL-DLENEAHVSDFGTAKF 590 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~-~~~~~~kl~Dfg~~~~ 590 (707)
+|||.+.|+-+.+.+.... .....+..|+.+|+.|+.|||++ ||||||+||+|||+ +..++++|+|||.++.
T Consensus 393 ~v~e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~ 465 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSE 465 (612)
T ss_pred eeehhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhh
Confidence 9999999988887775332 23367788999999999999999 99999999999999 6899999999999987
Q ss_pred cCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCC
Q 038671 591 LKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670 (707)
Q Consensus 591 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (707)
.... ....+-|..|+|||+.....|++++|+||||++||+|++|+.||..... -......+..+...
T Consensus 466 ~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~-------~~ei~~~i~~~~~s--- 532 (612)
T KOG0603|consen 466 LERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA-------GIEIHTRIQMPKFS--- 532 (612)
T ss_pred Cchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCc-------hHHHHHhhcCCccc---
Confidence 6644 3345668899999999999999999999999999999999999974322 12333333333333
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+....+++.+|++.||.+||+++++..
T Consensus 533 ---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 ---ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 234456889999999999999999999864
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=283.68 Aligned_cols=259 Identities=22% Similarity=0.315 Sum_probs=189.3
Q ss_pred CCCCCceeeecCCeeEEEEEcC-C--CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeec----CC
Q 038671 437 DFDDEHCIGKGGQGSVYKAELP-S--GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSH----AR 508 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~ 508 (707)
+|++.+.||+|+||.||+++.. + +..||+|++...... ....+.+.+|+++++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 4778899999999999999643 4 788999997643222 12345678899999999 59999999987533 24
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
..++++||+. ++|.+++.. ...+++..++.++.||+.||+|||+. |++||||||+||+++.++.+||+|||.+
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred cEEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 5788888886 688888753 24589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC----CccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccc-------hhhh
Q 038671 589 KFLKPDSS----NWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSS-------NLEI 656 (707)
Q Consensus 589 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~-------~~~~ 656 (707)
........ ......|++.|+|||...+ ..++.++|+||+|+++|+|++|+.||...+....... ....
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 86543221 1233468899999998765 4688999999999999999999999864221100000 0000
Q ss_pred hhhhhcC----------CCCCCC--CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 657 ALNEMLD----------PRLPTP--SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 657 ~~~~~~~----------~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
....... ...+.. ....+.....+.+++.+|++.||++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000 000000 0001112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=279.64 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=204.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCc-EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGE-IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
..+++....||-|+||.|=++..++.. .+|+|.+++...-+....+.+..|-++|...+.|.||++|..|.+..+.|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 345667788999999999998665433 4889988776656666778899999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
||-|-||.+...++.++ .++..+...++..+++|++|||++ |||.|||||+|.+++.+|-+||.|||+|+++..
T Consensus 499 mEaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HHhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999997554 488899999999999999999999 999999999999999999999999999999876
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
+. ...+++|||.|.|||++....++.++|.||||+++||+++|.+||...++. ..+...+..+..-.+|.
T Consensus 573 g~-KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm----ktYn~ILkGid~i~~Pr----- 642 (732)
T KOG0614|consen 573 GR-KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM----KTYNLILKGIDKIEFPR----- 642 (732)
T ss_pred CC-ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH----HHHHHHHhhhhhhhccc-----
Confidence 54 445689999999999999999999999999999999999999999754432 22222222222222222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCC
Q 038671 674 QDKLISIMEVAISCLDESPESRPT 697 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps 697 (707)
.......++|++.+..+|.+|.-
T Consensus 643 -~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 643 -RITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -ccchhHHHHHHHHHhcCcHhhhc
Confidence 23344678889999999999975
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-33 Score=265.71 Aligned_cols=264 Identities=20% Similarity=0.278 Sum_probs=199.6
Q ss_pred HHHHHHHhcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-C-C----ceeee
Q 038671 428 YEEIIRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-H-R----NIVKF 500 (707)
Q Consensus 428 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~~ 500 (707)
++.--....+|.+...+|+|+||.|-.+ ....+..||+|+++. .....++.+-|++++.++. + | -+|.+
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~----V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN----VDKYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH----HHHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 3333445789999999999999999999 445589999999864 2334566778999999993 2 2 35677
Q ss_pred eeeeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC----
Q 038671 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL---- 576 (707)
Q Consensus 501 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~---- 576 (707)
.++|...++.++|+|.+ |-++.+++.... -.+++..+++.|+.|+++++++||+. +++|.||||+||++.+
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence 88899999999999987 669999997544 36799999999999999999999999 9999999999999941
Q ss_pred ----------------CCCeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 038671 577 ----------------ENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640 (707)
Q Consensus 577 ----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p 640 (707)
+..++++|||.|++..... ...+.|..|+|||++.+-++++++||||+||||+|+.||...
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 2358999999998754332 567889999999999999999999999999999999999998
Q ss_pred CCcccccccc------------cchhhh-hhhhhcCCCCCCCCc---------------------chHHHHHHHHHHHHh
Q 038671 641 RDFISSISSS------------SSNLEI-ALNEMLDPRLPTPSH---------------------NVQDKLISIMEVAIS 686 (707)
Q Consensus 641 ~~~~~~~~~~------------~~~~~~-~~~~~~~~~~~~~~~---------------------~~~~~~~~l~~li~~ 686 (707)
|+.-++.... ...... ..+.+...++..+.. ....+..++.+++++
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 8643321100 000000 000000111110000 011234579999999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 038671 687 CLDESPESRPTIQKVSQ 703 (707)
Q Consensus 687 cl~~~P~~Rps~~~l~~ 703 (707)
|+..||.+|+|+.|+++
T Consensus 389 mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 389 MLEFDPARRITLREALS 405 (415)
T ss_pred HHccCccccccHHHHhc
Confidence 99999999999999875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=234.13 Aligned_cols=199 Identities=24% Similarity=0.390 Sum_probs=168.1
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|+..++||+|.||+||+|+ ..+++.||+|+++-...++. ......+|+..++.++|.|||+++++...++..-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddeg-vpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCC-CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 46667889999999999995 45689999999876544443 23456789999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
||+ .+|..+.. .....++.+.+++++.|+++|+.++|++ ++.|||+||+|.+++.+|++|++|||+++-+.-+-
T Consensus 82 ~cd-qdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 82 FCD-QDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred Hhh-HHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 996 46666653 3345689999999999999999999999 99999999999999999999999999998766543
Q ss_pred CCccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHh-CCCCCC
Q 038671 596 SNWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIK-GKHPRD 642 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~t-g~~p~~ 642 (707)
.-+..-+-|..|+||.++.|.+ |++..|+||-||++.|+.. |++.|.
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 3344456789999999998865 7899999999999999998 665554
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=263.79 Aligned_cols=219 Identities=21% Similarity=0.211 Sum_probs=174.4
Q ss_pred cCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccCcHHHH
Q 038671 447 GGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMI 525 (707)
Q Consensus 447 G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 525 (707)
|.+|.||++. ..+++.||+|++.... .+.+|...+....|||++++++++...+..+++|||+++++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8899999995 4578999999986531 223344555556799999999999999999999999999999999
Q ss_pred HhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcccccccc
Q 038671 526 LSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY 605 (707)
Q Consensus 526 l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 605 (707)
+... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.++++|||.+...... .....++.
T Consensus 76 l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~ 146 (237)
T cd05576 76 ISKF---LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVEN 146 (237)
T ss_pred HHHh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCc
Confidence 8643 3489999999999999999999999 9999999999999999999999999987655432 22335577
Q ss_pred CCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHH
Q 038671 606 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAI 685 (707)
Q Consensus 606 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 685 (707)
.|+|||...+..++.++|+||+|+++|||++|+.|++..... .........+ ...+..+.+++.
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------~~~~~~~~~~------~~~~~~~~~li~ 210 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------INTHTTLNIP------EWVSEEARSLLQ 210 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------cccccccCCc------ccCCHHHHHHHH
Confidence 899999998888999999999999999999999887521110 0000011111 123345889999
Q ss_pred hccCCCCCCCCCH
Q 038671 686 SCLDESPESRPTI 698 (707)
Q Consensus 686 ~cl~~~P~~Rps~ 698 (707)
+|++.||++||++
T Consensus 211 ~~l~~dp~~R~~~ 223 (237)
T cd05576 211 QLLQFNPTERLGA 223 (237)
T ss_pred HHccCCHHHhcCC
Confidence 9999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=267.58 Aligned_cols=256 Identities=28% Similarity=0.400 Sum_probs=194.2
Q ss_pred cCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhh----hHHHHHHHHHHHhcCCCCceeeeeeeeec-CCc
Q 038671 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMA----SQQEFLNEVKTLTGIRHRNIVKFYGFCSH-ARH 509 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~ 509 (707)
++|-+...||+|+|+.||+| +....+.||||+-........+ ..+...+|.++-+.|.||.||++|+|+.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 45666788999999999999 6677899999986533222111 12336789999999999999999999964 567
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec---CCCCeEEeccc
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD---LENEAHVSDFG 586 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~---~~~~~kl~Dfg 586 (707)
++-|+|||+|.+|+-+++.+ +.+++.++++|+.||+.||.||.... ++|||=||||.|||+- ..|.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLKQh---klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQH---KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHHhh---hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 88999999999999999765 45899999999999999999999985 4899999999999994 45789999999
Q ss_pred cceecCCCCCC-------ccccccccCCCCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhh
Q 038671 587 TAKFLKPDSSN-------WAELAGTYGYVAPELAYTM----KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE 655 (707)
Q Consensus 587 ~~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 655 (707)
+++.+..+... .....||+.|+|||.+.-+ +.+.++||||.|||+|+++.|+.||...... ...++
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ---QdILq 695 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ---QDILQ 695 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---HHHHh
Confidence 99998765443 2345799999999977633 3678999999999999999999999743221 11111
Q ss_pred -hhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 038671 656 -IALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVS 702 (707)
Q Consensus 656 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~ 702 (707)
..+-....-.+|.. +....+...+|++|++..-++|....++.
T Consensus 696 eNTIlkAtEVqFP~K----PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 ENTILKATEVQFPPK----PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhchhcceeccCCCC----CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11111111112221 12233467899999999999998877765
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=238.56 Aligned_cols=207 Identities=24% Similarity=0.387 Sum_probs=169.3
Q ss_pred HHHHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCC
Q 038671 431 IIRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHAR 508 (707)
Q Consensus 431 ~~~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 508 (707)
++...+.......||+|+||.|=+.+ ..+|+..|+|++...... ....+...|+.+..+. .+|.+|++||.+...+
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~--q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS--QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcCh--HHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 44455666777889999999998884 568999999999875543 3566788888877766 6999999999999999
Q ss_pred ceeEEEeeeccCcHHHHHhcc-cccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 509 HSFIVYEYLEMGSLAMILSND-AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
..|+.||.|+ .+|+.+.+.. ..++.+++.-+-+||..+++||.|||++. .++|||+||+|||++.+|++|+||||.
T Consensus 119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccc
Confidence 9999999986 4666554322 22345888889999999999999999996 899999999999999999999999999
Q ss_pred ceecCCCCCCccccccccCCCCcccccc----CCCCccchhHHHHHHHHHHHhCCCCCCc
Q 038671 588 AKFLKPDSSNWAELAGTYGYVAPELAYT----MKVTEKCDVYSFGVLALEVIKGKHPRDF 643 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~slG~~l~el~tg~~p~~~ 643 (707)
+..+...-. ...-.|-..|||||.+.. ..|+.+|||||||+++.||.+++.||+.
T Consensus 196 sG~L~dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 196 SGYLVDSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ceeehhhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 987653321 122357778999998763 3689999999999999999999999873
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-34 Score=292.28 Aligned_cols=322 Identities=30% Similarity=0.453 Sum_probs=255.2
Q ss_pred CCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcc-cCCccccCCCCCCee
Q 038671 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSG-AIPKEYGNLVKLTLL 80 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L 80 (707)
|+++++|.|..+++. .+|+.++.+.+|++|.+++|++. .+-..++.|+.|+.+.+.+|++.. -+|..+-.+..|..|
T Consensus 31 Mt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~l 108 (1255)
T KOG0444|consen 31 MTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTIL 108 (1255)
T ss_pred hhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceee
Confidence 567888999999888 88999999999999999999988 566678889999999999998764 346677789999999
Q ss_pred ecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCC
Q 038671 81 TLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITG 160 (707)
Q Consensus 81 ~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~ 160 (707)
|||+|++.++|.++...+++..|+|++|+|..++...|-++..|-.||||+|++.. .|.....+.+|++|.|++|++..
T Consensus 109 DLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~-LPPQ~RRL~~LqtL~Ls~NPL~h 187 (1255)
T KOG0444|consen 109 DLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEM-LPPQIRRLSMLQTLKLSNNPLNH 187 (1255)
T ss_pred ecchhhhhhcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhh-cCHHHHHHhhhhhhhcCCChhhH
Confidence 99999999999999999999999999999999998889999999999999999984 45567788888888888887642
Q ss_pred -------------------------CCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccC
Q 038671 161 -------------------------SMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG 215 (707)
Q Consensus 161 -------------------------~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 215 (707)
-.|.++..+.+|..+|++.|.+. ..|+.+.++++|+.|+|++|+|+ .......
T Consensus 188 fQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~ 265 (1255)
T KOG0444|consen 188 FQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEG 265 (1255)
T ss_pred HHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHH
Confidence 24555556667777777777776 77777777777777777777777 4444455
Q ss_pred CCCcccEEEccCCccCCCCCccccCcccCceEeeeccccccc-CchhhhhcccCCeeeecCccCCCCCCcccccccccce
Q 038671 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKK-IPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEK 294 (707)
Q Consensus 216 ~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~ 294 (707)
...+|++|+||+|+++ ..|.++.++++|+.|++.+|+++-. +|..++++..|+.++.++|.+ +..|+.++.+..|+.
T Consensus 266 ~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~L-ElVPEglcRC~kL~k 343 (1255)
T KOG0444|consen 266 EWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKL-ELVPEGLCRCVKLQK 343 (1255)
T ss_pred HHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcccc-ccCchhhhhhHHHHH
Confidence 6677777777777777 6777777777888888877776532 466777777788888777777 677777777788888
Q ss_pred EeccccccCCchhHhhccCCCceeEeeccCcccccCC
Q 038671 295 LNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIP 331 (707)
Q Consensus 295 L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~ 331 (707)
|.|++|++. ..|+.+.-++.|+.|++..|+---.+|
T Consensus 344 L~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 344 LKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred hccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 888888776 457777777888888888777554444
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=290.61 Aligned_cols=260 Identities=19% Similarity=0.207 Sum_probs=167.7
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcC-C----CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeee-----
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELP-S----GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF----- 503 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~----- 503 (707)
..++|++.+.||+|+||.||+|+.. + +..||+|++......+ ....+ .+....+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 4578999999999999999999654 4 6899999875432111 11111 1111122222222211
Q ss_pred -eecCCceeEEEeeeccCcHHHHHhcccccC-----------------CCChHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 038671 504 -CSHARHSFIVYEYLEMGSLAMILSNDAAAK-----------------DLGWTKRMNVIKGVVDALSYMHNDCFPPIVHR 565 (707)
Q Consensus 504 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 565 (707)
...+...++|+||+.+++|.+++....... ......+..++.||+.||+|||++ +|+||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHR 279 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHR 279 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 245667899999999999999986432110 012334567999999999999999 99999
Q ss_pred CCCCCCeeecC-CCCeEEeccccceecCCCC-CCccccccccCCCCccccccCC----------------------CCcc
Q 038671 566 DISSKNVLLDL-ENEAHVSDFGTAKFLKPDS-SNWAELAGTYGYVAPELAYTMK----------------------VTEK 621 (707)
Q Consensus 566 dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~----------------------~~~~ 621 (707)
||||+|||++. ++.+||+|||+++...... .......+++.|+|||.+.... ++.+
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 99999999986 5799999999998654332 2234567899999999654221 3345
Q ss_pred chhHHHHHHHHHHHhCCCCCCcccc-----cccccchhhhhhhhhcCCCCCCC----CcchHHHHHHHHHHHHhccCCCC
Q 038671 622 CDVYSFGVLALEVIKGKHPRDFISS-----ISSSSSNLEIALNEMLDPRLPTP----SHNVQDKLISIMEVAISCLDESP 692 (707)
Q Consensus 622 ~Dv~slG~~l~el~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P 692 (707)
+||||+||++|||+++..|++.... +.........+ .....+..... ............+++.+|++.||
T Consensus 360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAW-RKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHH-HHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 6999999999999998777542100 00000000111 11111111000 00000011234589999999999
Q ss_pred CCCCCHHHHHHH
Q 038671 693 ESRPTIQKVSQL 704 (707)
Q Consensus 693 ~~Rps~~~l~~~ 704 (707)
++|||++|+++.
T Consensus 439 ~kR~ta~e~L~H 450 (566)
T PLN03225 439 RQRISAKAALAH 450 (566)
T ss_pred ccCCCHHHHhCC
Confidence 999999999863
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-33 Score=250.50 Aligned_cols=261 Identities=24% Similarity=0.368 Sum_probs=189.6
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec--------
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH-------- 506 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 506 (707)
..|.....+|+|.||.||+|+. ++|++||+|+..-....+.. .....+|++++..++|+|++.+++.|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGf-pitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGF-PITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCC-cHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 4566677899999999999954 56788899876432222222 2345789999999999999999988743
Q ss_pred CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 507 ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 507 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
....|+||++|+ -+|.-.+... ...++..++.+++.++..||.|+|.. .|+|||+|+.|++|+.+|.+||+|||
T Consensus 96 r~t~ylVf~~ce-hDLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 96 RATFYLVFDFCE-HDLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cceeeeeHHHhh-hhHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence 345899999997 4677777543 34689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCC----CCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccc-------------
Q 038671 587 TAKFLKPD----SSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSIS------------- 648 (707)
Q Consensus 587 ~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------------- 648 (707)
+++.+... ..++...+.|..|++||.+.|. .|+++.|||.-||++.||+||.+-++......
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 99765433 2335566789999999988764 58999999999999999999998875411110
Q ss_pred ----cccchhhhhhhhhcCCCCCCCC-cchHHHH------HHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 649 ----SSSSNLEIALNEMLDPRLPTPS-HNVQDKL------ISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 649 ----~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~------~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
+..+..+ ..+.+.-+.++... ....+.. .+..+++..++..||.+|+.+++++..
T Consensus 250 kevWP~~d~lp-L~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 250 KEVWPNVDNLP-LYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccCCCcccch-HHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0000000 01111000011100 0001111 145688889999999999999998753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=257.96 Aligned_cols=239 Identities=28% Similarity=0.444 Sum_probs=193.8
Q ss_pred CCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccCcHHHHH
Q 038671 448 GQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL 526 (707)
Q Consensus 448 ~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 526 (707)
+||.||+|... +|+.+++|++....... ..+.+.+|++.+++++|+|++++++++......++++||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKK--KRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEeccccccc--HHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999665 58999999987643322 1578899999999999999999999999989999999999999999998
Q ss_pred hcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCccccccccC
Q 038671 527 SNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG 606 (707)
Q Consensus 527 ~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~ 606 (707)
.... .+++..++.++.++++++.+||+. +++|+||+|+||+++.++.++++|||.+....... ......+++.
T Consensus 79 ~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~ 151 (244)
T smart00220 79 KKRG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE 151 (244)
T ss_pred Hhcc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence 6433 278999999999999999999999 99999999999999999999999999998765442 3344568889
Q ss_pred CCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHh
Q 038671 607 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAIS 686 (707)
Q Consensus 607 y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 686 (707)
|+|||...+..++.++|||++|++++++++|..||... .................... ....+.++.+++.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~-------~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~ 223 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD-------DQLLELFKKIGKPKPPFPPP-EWKISPEAKDLIRK 223 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC-------CcHHHHHHHHhccCCCCccc-cccCCHHHHHHHHH
Confidence 99999998888899999999999999999999998632 11222222222222222111 00134568999999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 038671 687 CLDESPESRPTIQKVSQ 703 (707)
Q Consensus 687 cl~~~P~~Rps~~~l~~ 703 (707)
|+..+|.+||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=279.82 Aligned_cols=239 Identities=25% Similarity=0.386 Sum_probs=184.8
Q ss_pred CceeeecCCee-EEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEEEeeec
Q 038671 441 EHCIGKGGQGS-VYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYLE 518 (707)
Q Consensus 441 ~~~lg~G~~g~-vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 518 (707)
.+.+|.|+.|+ ||+|.. +|+.||||++-.. ......+|+..++.- +|||||++++.-.++...||+.|.|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 45688999887 588976 5889999997542 234567899999888 59999999999999999999999995
Q ss_pred cCcHHHHHhccccc-CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC---CC--CeEEeccccceecC
Q 038671 519 MGSLAMILSNDAAA-KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL---EN--EAHVSDFGTAKFLK 592 (707)
Q Consensus 519 ~~~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~---~~--~~kl~Dfg~~~~~~ 592 (707)
.+|.+++...... ........+.+..|+++||++||+. +||||||||+||||+. ++ +++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 7999999764111 1112245678899999999999998 9999999999999976 33 68999999999987
Q ss_pred CCCCC---ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCC-
Q 038671 593 PDSSN---WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLP- 667 (707)
Q Consensus 593 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 667 (707)
.+... .....||.+|+|||.+....-+.++||||+||++|+.++ |.+||... .+ +...++.....
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~---------~~-R~~NIl~~~~~L 732 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS---------LE-RQANILTGNYTL 732 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch---------HH-hhhhhhcCccce
Confidence 66543 344679999999999999888999999999999999999 59999621 11 11112211111
Q ss_pred -CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 668 -TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 668 -~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..... .+. +..++|.+|++++|..||++.+|+.
T Consensus 733 ~~L~~~-~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 733 VHLEPL-PDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eeeccC-chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 10111 111 5778999999999999999999974
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-33 Score=283.55 Aligned_cols=300 Identities=29% Similarity=0.406 Sum_probs=231.3
Q ss_pred CCCCceeeccCCeeee-cCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCee
Q 038671 2 LSNLAFLYLYNNSFSG-SIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLL 80 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~-~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 80 (707)
|+.|+.+.+..|+++. -+|..+-.+..|+.|+||.|+++ +.|..+..-+++-.|+|++|+|.+++...|.++..|-+|
T Consensus 77 Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfL 155 (1255)
T KOG0444|consen 77 LPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFL 155 (1255)
T ss_pred chhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhh
Confidence 3444555555555442 23444555666666666666666 666666666666666666666665555556666666666
Q ss_pred ecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEccccccc-ccCCCCCCCCCCCcEEEcCCCccC
Q 038671 81 TLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFY-GEISSDWGRCPKLGTLDFSSNNIT 159 (707)
Q Consensus 81 ~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~-~~~~~~~~~~~~L~~L~L~~n~i~ 159 (707)
|||+|.+..+|+....+..|++|.|++|.+.......+-.+++|+.|.+++.+-+ .-.|..+..+.+|+.+++|.|.+.
T Consensus 156 DLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp 235 (1255)
T KOG0444|consen 156 DLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP 235 (1255)
T ss_pred ccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC
Confidence 7777766666666666667777777777665444444555666666666665544 345677888999999999999999
Q ss_pred CCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCC-CCCccc
Q 038671 160 GSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSN-SIPKSL 238 (707)
Q Consensus 160 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~-~~~~~l 238 (707)
..|..+..+++|+.|+|++|+|+ .+........+|++|+++.|+++ ..|.++..++.|+.|.+.+|+++- -+|..+
T Consensus 236 -~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGI 312 (1255)
T KOG0444|consen 236 -IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGI 312 (1255)
T ss_pred -cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccch
Confidence 89999999999999999999998 44445667789999999999999 889999999999999999999863 578899
Q ss_pred cCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchh
Q 038671 239 GNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIP 307 (707)
Q Consensus 239 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~ 307 (707)
+++.+|+.+..++|++ ...|..++.+..|+.|.|+.|++ -.+|+++.-++.|+.||+..|+-.-..|
T Consensus 313 GKL~~Levf~aanN~L-ElVPEglcRC~kL~kL~L~~NrL-iTLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 313 GKLIQLEVFHAANNKL-ELVPEGLCRCVKLQKLKLDHNRL-ITLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred hhhhhhHHHHhhcccc-ccCchhhhhhHHHHHhcccccce-eechhhhhhcCCcceeeccCCcCccCCC
Confidence 9999999999999998 68899999999999999999998 4689999999999999999998664444
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=264.67 Aligned_cols=200 Identities=23% Similarity=0.329 Sum_probs=171.3
Q ss_pred CCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEee
Q 038671 438 FDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
|..++.||-|+||.|++++ ..+...||.|.+.+...-.......++.|-.+|..-..+=||++|-.|.+++.+|+||||
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 5557889999999999994 445677999998776555555566788899999999999999999999999999999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC----
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK---- 592 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~---- 592 (707)
++||++-.++-+.+- |++..++.++.++..|+++.|.. |+|||||||+|||||.+|++||+|||++.-++
T Consensus 711 IPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred cCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccc
Confidence 999999998865443 78888889999999999999999 99999999999999999999999999986331
Q ss_pred -----CCCCC---------------------------------ccccccccCCCCccccccCCCCccchhHHHHHHHHHH
Q 038671 593 -----PDSSN---------------------------------WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 634 (707)
Q Consensus 593 -----~~~~~---------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 634 (707)
.++.. .-..+||+.|+|||++....|+..+|.||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 11000 0123699999999999999999999999999999999
Q ss_pred HhCCCCCCc
Q 038671 635 IKGKHPRDF 643 (707)
Q Consensus 635 ~tg~~p~~~ 643 (707)
+.|+.||-.
T Consensus 865 ~~g~~pf~~ 873 (1034)
T KOG0608|consen 865 LVGQPPFLA 873 (1034)
T ss_pred hhCCCCccC
Confidence 999999964
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=269.53 Aligned_cols=265 Identities=17% Similarity=0.202 Sum_probs=180.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-----------------CCCcEEEEEecCCCCCchhh-----------hHHHHHHHH
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-----------------PSGEIVAVKKFHSPLPSEMA-----------SQQEFLNEV 486 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-----------------~~~~~vavK~~~~~~~~~~~-----------~~~~~~~e~ 486 (707)
.++|++.++||+|+||.||+|.. ..++.||||++......... ..+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999842 24567999998643211100 112234577
Q ss_pred HHHhcCCCCce-----eeeeeeeec--------CCceeEEEeeeccCcHHHHHhcccc---------------------c
Q 038671 487 KTLTGIRHRNI-----VKFYGFCSH--------ARHSFIVYEYLEMGSLAMILSNDAA---------------------A 532 (707)
Q Consensus 487 ~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~ 532 (707)
.++.+++|.++ ++++++|.. .+..++||||+.+++|.++++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 667777643 3568999999999999999864211 1
Q ss_pred CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCC-ccccccccCCCCcc
Q 038671 533 KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN-WAELAGTYGYVAPE 611 (707)
Q Consensus 533 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~g~~~y~aPE 611 (707)
..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......... .....+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 2346778899999999999999999 9999999999999999999999999999765433211 11223478999999
Q ss_pred ccccCC--------------------C--CccchhHHHHHHHHHHHhCCC-CCCcccccccccc---hhhhhhhhhcCCC
Q 038671 612 LAYTMK--------------------V--TEKCDVYSFGVLALEVIKGKH-PRDFISSISSSSS---NLEIALNEMLDPR 665 (707)
Q Consensus 612 ~~~~~~--------------------~--~~~~Dv~slG~~l~el~tg~~-p~~~~~~~~~~~~---~~~~~~~~~~~~~ 665 (707)
.+.... + ..+.||||+||++|+|++|.. |+........... .............
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~ 460 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK 460 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence 875422 1 124699999999999999886 6643221110000 0001111111111
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCC---CCCCCHHHHHHH
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESP---ESRPTIQKVSQL 704 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P---~~Rps~~~l~~~ 704 (707)
... ...........+++.+++..+| .+|+|++|+++.
T Consensus 461 ~~~--~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 YDF--SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred CCc--ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 111 1122234567889999998766 689999999863
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=248.53 Aligned_cols=132 Identities=25% Similarity=0.440 Sum_probs=111.5
Q ss_pred cCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC--------CCceeeeeeeeec
Q 038671 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR--------HRNIVKFYGFCSH 506 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~~ 506 (707)
++|.+.++||.|.|++||++ +....+.||+|+.+... ...+....|++++++++ ..+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 78899999999999999999 66788999999987532 23455678899998873 2489999999864
Q ss_pred ----CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec
Q 038671 507 ----ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD 575 (707)
Q Consensus 507 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~ 575 (707)
+.+++||+|++ |.+|..++..... +.++...+.+|++||+.||.|||..| ||||.||||+|||+.
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 45889999988 6778788865443 55899999999999999999999999 999999999999994
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-32 Score=264.34 Aligned_cols=316 Identities=29% Similarity=0.400 Sum_probs=235.8
Q ss_pred CCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeee
Q 038671 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLT 81 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 81 (707)
+.++.+|++++|+++ .+|..++.+..|..|+..+|+++ ..|.++.++.+|..|++.+|++....|..+. |+.|++||
T Consensus 113 ~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld 189 (565)
T KOG0472|consen 113 LISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLD 189 (565)
T ss_pred hhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcc
Confidence 456788888888888 67778888888888888888888 7788888888888888888888866555555 88899999
Q ss_pred cccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCC
Q 038671 82 LENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGS 161 (707)
Q Consensus 82 l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~ 161 (707)
...|-+..+|+.+.++.+|..|+|.+|+|..++ .|.++..|.+|+++.|.|.-+..+..+++++|..|+|.+|+++ .
T Consensus 190 ~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e 266 (565)
T KOG0472|consen 190 CNSNLLETLPPELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-E 266 (565)
T ss_pred cchhhhhcCChhhcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-c
Confidence 999999988889999999999999999998665 6888889999999999998777777788999999999999998 7
Q ss_pred CchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCC-------------------------------
Q 038671 162 MPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQL------------------------------- 210 (707)
Q Consensus 162 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~------------------------------- 210 (707)
.|+.+.-+.+|++||+++|.|+ ..|..++++ +|+.|.+.+|.+..+-
T Consensus 267 ~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~ 344 (565)
T KOG0472|consen 267 VPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGT 344 (565)
T ss_pred CchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccc
Confidence 7888888899999999999998 677778888 8888888888764100
Q ss_pred ------ccc-c---CCC--------------------------CcccEEEccCCccCC----------------------
Q 038671 211 ------SLE-L---GSL--------------------------TQLERLDLSSNRLSN---------------------- 232 (707)
Q Consensus 211 ------~~~-~---~~l--------------------------~~L~~L~l~~n~i~~---------------------- 232 (707)
+.+ + ..+ .-.+..++++|++.+
T Consensus 345 e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~i 424 (565)
T KOG0472|consen 345 ETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKI 424 (565)
T ss_pred cccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCcc
Confidence 000 0 000 013444555554432
Q ss_pred -CCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCC-----------------------CCCCccccc
Q 038671 233 -SIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLG-----------------------EEMPSQICN 288 (707)
Q Consensus 233 -~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-----------------------~~~~~~~~~ 288 (707)
.+|..+..+++|+.|+|++|.+. ..|..++.+..|+.|+++.|++. ...++.+.+
T Consensus 425 sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~n 503 (565)
T KOG0472|consen 425 SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKN 503 (565)
T ss_pred ccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhh
Confidence 33445556677888888888764 45666777777888888877662 223334556
Q ss_pred ccccceEeccccccCCchhHhhccCCCceeEeeccCccc
Q 038671 289 MQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELH 327 (707)
Q Consensus 289 ~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~ 327 (707)
|.+|.+||+.+|.+. .+|..++++.+|++|++.||+|.
T Consensus 504 m~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 504 MRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 666666666666666 44666666666666666666666
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-31 Score=239.77 Aligned_cols=259 Identities=25% Similarity=0.363 Sum_probs=189.6
Q ss_pred CCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----Ccee
Q 038671 438 FDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA-----RHSF 511 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~ 511 (707)
.+-.+.||-|+||.||.+++ ++|+.|++|++.... .....-+++.+|++++...+|.|+...++...-. .+.|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 44567899999999999955 579999999986532 3344567899999999999999999988776432 2467
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+++|.+. .+|...+- ..+.++...+.-+.+||++||+|||+. +|.||||||.|.+++.+-.+||||||+++..
T Consensus 134 V~TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence 7888775 45655553 345688889999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCC-ccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCccccccc-----------ccchh----
Q 038671 592 KPDSSN-WAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISS-----------SSSNL---- 654 (707)
Q Consensus 592 ~~~~~~-~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-----------~~~~~---- 654 (707)
..+... ...-+-|..|+|||++.|.+ |+.+.||||.||++.|++..+..|+....+.. ..+..
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 655432 34456789999999999765 89999999999999999988888875443320 11111
Q ss_pred hhhhhhhcCCCCCCCCc-------chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 655 EIALNEMLDPRLPTPSH-------NVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 655 ~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
+..-..+.......+.. .......+...+...++..||.+|.+..+.+..
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 11111111111111100 001112234567778899999999998877653
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=225.99 Aligned_cols=253 Identities=21% Similarity=0.324 Sum_probs=191.9
Q ss_pred hcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecC--Cce
Q 038671 435 TNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHA--RHS 510 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~ 510 (707)
.++|++.+++|+|-|+.||.| ...+.++++||++++. ..+.+.+|+.++..|. ||||++++++..++ ..+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 467899999999999999999 5677899999998642 4567899999999997 99999999998664 467
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC-CCeEEeccccce
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE-NEAHVSDFGTAK 589 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~-~~~kl~Dfg~~~ 589 (707)
.+++||+.+.+..... ..++..+++..+.++++||.|+|+. ||.|||+||.|+++|.. ..++++|+|+|.
T Consensus 111 aLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 8999999888776654 2377788999999999999999999 99999999999999864 579999999999
Q ss_pred ecCCCCCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccc---------cchhhh---
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS---------SSNLEI--- 656 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---------~~~~~~--- 656 (707)
++.++. ...-.+.+..|.-||.+..- .|+..-|+|||||++..|+..+.||..-.+-... ......
T Consensus 182 FYHp~~-eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 182 FYHPGK-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred hcCCCc-eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 887553 34445778889999988754 4788999999999999999999998531111000 000000
Q ss_pred hhhhhcCCCCCC--------------CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 657 ALNEMLDPRLPT--------------PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 657 ~~~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.....+++++.. ..+...-...+..+++.+.+..|.++|||+.|.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 000111111110 00011111246778999999999999999999764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=256.32 Aligned_cols=200 Identities=23% Similarity=0.324 Sum_probs=169.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhh-----HHHHHHHHHHHhcCC---CCceeeeeeeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMAS-----QQEFLNEVKTLTGIR---HRNIVKFYGFCS 505 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~-----~~~~~~e~~~l~~l~---h~niv~~~~~~~ 505 (707)
..+|.....+|+|+||.|+.|.++ +...|++|.+.+.+.-.... .-.+-.|+++|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 356899999999999999999654 45678889886543221111 112667999999997 999999999999
Q ss_pred cCCceeEEEeeec-cCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEec
Q 038671 506 HARHSFIVYEYLE-MGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSD 584 (707)
Q Consensus 506 ~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~D 584 (707)
+++.+|++||-.. |-+|.+++... ..+++..+..|+.||+.|+++||+. ||||||||-+||.++.+|.+||+|
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 9999999999764 67889998654 3589999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCccccccccCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCC
Q 038671 585 FGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRD 642 (707)
Q Consensus 585 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~ 642 (707)
||.+..... ..+..++||.+|.|||++.|.+| ...-|||++|+++|.++....||.
T Consensus 714 fgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999976553 34567899999999999999998 567899999999999999888874
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-32 Score=262.06 Aligned_cols=222 Identities=30% Similarity=0.433 Sum_probs=143.9
Q ss_pred CCCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCee
Q 038671 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLL 80 (707)
Q Consensus 1 nl~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 80 (707)
||..+++|+++.|++. ..|.+++.+..++.|+.+.|+++ ++|..+..+.+|..|++++|.+. ..|+.++.+..|+.|
T Consensus 66 nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl 142 (565)
T KOG0472|consen 66 NLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDL 142 (565)
T ss_pred cccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhh
Confidence 4556666777777666 55556666666666666666666 55555555555555555555555 334444445555555
Q ss_pred ecccccccccCCCCC-----------------------CCCCccEEEeccCccccccCccccCCCCCcEEEccccccccc
Q 038671 81 TLENNQLRGPIPNLR-----------------------NLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGE 137 (707)
Q Consensus 81 ~l~~n~i~~~~~~l~-----------------------~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~ 137 (707)
+..+|+|+..++++. .++.|++|++..|-++.++ ..++.+.+|+-|||.+|+|...
T Consensus 143 ~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~tlP-~~lg~l~~L~~LyL~~Nki~~l 221 (565)
T KOG0472|consen 143 DATNNQISSLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLETLP-PELGGLESLELLYLRRNKIRFL 221 (565)
T ss_pred hccccccccCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhhcCC-hhhcchhhhHHHHhhhcccccC
Confidence 555555544444443 4555566666665555443 3466677777777777777643
Q ss_pred CCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCC
Q 038671 138 ISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSL 217 (707)
Q Consensus 138 ~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 217 (707)
| .|.+|..|++|.++.|.|.-.......+++++..|||.+|+++ ..|+.+.-+.+|.+|++++|.|+ ..|..++++
T Consensus 222 -P-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl 297 (565)
T KOG0472|consen 222 -P-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL 297 (565)
T ss_pred -C-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc
Confidence 3 6777777777777777777333333446788888888888887 77777888888888888888887 567777777
Q ss_pred CcccEEEccCCccC
Q 038671 218 TQLERLDLSSNRLS 231 (707)
Q Consensus 218 ~~L~~L~l~~n~i~ 231 (707)
.|+.|.+.+|.+.
T Consensus 298 -hL~~L~leGNPlr 310 (565)
T KOG0472|consen 298 -HLKFLALEGNPLR 310 (565)
T ss_pred -eeeehhhcCCchH
Confidence 7888888888764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-28 Score=233.31 Aligned_cols=212 Identities=33% Similarity=0.595 Sum_probs=184.5
Q ss_pred eeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccCcH
Q 038671 444 IGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL 522 (707)
Q Consensus 444 lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 522 (707)
||+|.+|.||++... +++.+++|++....... ..+.+.+|++.++.++|++++++++++......++++|++.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999665 48999999987643221 346789999999999999999999999999999999999999999
Q ss_pred HHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC-CCCeEEeccccceecCCCCCCcccc
Q 038671 523 AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL-ENEAHVSDFGTAKFLKPDSSNWAEL 601 (707)
Q Consensus 523 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~ 601 (707)
.+++.... ..+++..++.++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+.............
T Consensus 79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (215)
T cd00180 79 KDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI 153 (215)
T ss_pred HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence 99986432 3578999999999999999999999 9999999999999998 8999999999998765443223445
Q ss_pred ccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHH
Q 038671 602 AGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISI 680 (707)
Q Consensus 602 ~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 680 (707)
.+...|++||..... .++.++|+|++|++++++ .++
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~~ 190 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PEL 190 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HHH
Confidence 678899999998876 788999999999999999 348
Q ss_pred HHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 681 MEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 681 ~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
.+++.+|++.+|.+||++.++++.+
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhCC
Confidence 8999999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=262.16 Aligned_cols=252 Identities=27% Similarity=0.375 Sum_probs=203.6
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|....++|.|+||.||+++ ..+++..|+|+++-.... ..+-+.+|+-+++..+|||||.+++.|...+..|+.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d---d~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc---cccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 4689999999999999999995 567899999998753322 345577899999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
||||.||+|.+..+ ...++++.++.+++++..+|++|||+. |-+|||||-.||++++.|.+|++|||.+..+..
T Consensus 91 MEycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita 164 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA 164 (829)
T ss_pred EEecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence 99999999998864 356799999999999999999999999 999999999999999999999999999987766
Q ss_pred CCCCccccccccCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC-C
Q 038671 594 DSSNWAELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT-P 669 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 669 (707)
.-.....+.||+.|||||+.. .+.|.+.+|||++|+...|+-.-++|-.... .......+....+.. .
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--------pmr~l~LmTkS~~qpp~ 236 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--------PMRALFLMTKSGFQPPT 236 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--------hHHHHHHhhccCCCCCc
Confidence 556667789999999999753 5568999999999999999987777732111 111111111111111 1
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
-+........+.++++.|+..+|++||+++.+++
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1122334566999999999999999999998765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=235.04 Aligned_cols=257 Identities=20% Similarity=0.304 Sum_probs=194.3
Q ss_pred hcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------
Q 038671 435 TNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA------ 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 507 (707)
..+|.-.+.+|.|.- .|..| +.-.+++||+|+...+... ....++..+|...+..++|+|+++++.++.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 356777788899888 56666 4446899999999887544 44556778999999999999999999998533
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
...|+|||++. .+|...+.. .++-.++.++..|++.|++|||+. ||+||||||+||++..+..+||.|||+
T Consensus 94 ~e~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 94 QEVYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HhHHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 36799999995 678877752 356678889999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc----------cccchhhhh
Q 038671 588 AKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIS----------SSSSNLEIA 657 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~----------~~~~~~~~~ 657 (707)
|+.-... -.....+.+..|.|||++.+..+.+.+||||+||++.||++|+..|.....++ .....+...
T Consensus 165 ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 165 ARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred hcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 9875543 34566788999999999999999999999999999999999998875422211 000000000
Q ss_pred --------------------hhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 658 --------------------LNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 658 --------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+.|..++...+..+-......+++.+|+-.+|++|-+++++++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0011111111111111122335788999999999999999999886
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=229.46 Aligned_cols=254 Identities=21% Similarity=0.320 Sum_probs=188.2
Q ss_pred HHHhcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeee-eeecCC
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYG-FCSHAR 508 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~-~~~~~~ 508 (707)
..+.+.|.+.+.+|+|.||.+-+++++ +.+.+++|.+..+.. ...+|.+|...--.|. |.||+.-|+ .|...+
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 345778999999999999999999654 678899999876533 4577889888777774 899998776 456777
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec-C-CCCeEEeccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD-L-ENEAHVSDFG 586 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~-~-~~~~kl~Dfg 586 (707)
.++.++||++.|+|.+-+.. ..+.+....+++.|+++|+.|+|++ ++||||||.+||||- . ..++|+||||
T Consensus 96 ~YvF~qE~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred eEEEeeccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecc
Confidence 88999999999999987753 3377888899999999999999999 999999999999993 2 3489999999
Q ss_pred cceecCCCCCCccccccccCCCCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhh
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM 661 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 661 (707)
..+..+. .....-.+..|.|||..... ...+.+|+|.||+++|.++||+.||+-..........+..+ ...
T Consensus 169 ~t~k~g~---tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w-~~r 244 (378)
T KOG1345|consen 169 LTRKVGT---TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW-LKR 244 (378)
T ss_pred cccccCc---eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH-hcc
Confidence 9876432 22223345679999976532 25678999999999999999999998322211112222222 222
Q ss_pred cCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 662 LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..++.|. ......+...++.++-+.++|++|-...++.+
T Consensus 245 k~~~~P~---~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 245 KNPALPK---KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred cCccCch---hhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 3333333 33334455778888899999999955444443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=243.71 Aligned_cols=209 Identities=21% Similarity=0.262 Sum_probs=173.6
Q ss_pred ccchHHHHHHHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC------CCc
Q 038671 424 GKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR------HRN 496 (707)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~n 496 (707)
|.+.+.--+....+|.+....|+|-|++|..|.. ..|+.||||++.... . -...=..|+++|++|+ --|
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~-M~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---V-MHKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---H-HhhhhhHHHHHHHHhhccCchhhhH
Confidence 3343333455678999999999999999999954 458899999997532 1 2234567999999995 348
Q ss_pred eeeeeeeeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC
Q 038671 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL 576 (707)
Q Consensus 497 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~ 576 (707)
.++++..|...+++|||+|-+. -+|.+.++..+..-.+....+..+++|+.-||..|-.. ||+|.||||.||||++
T Consensus 496 clrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEecc
Confidence 8999999999999999999774 68999998877766788899999999999999999998 9999999999999997
Q ss_pred CC-CeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 038671 577 EN-EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 642 (707)
Q Consensus 577 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 642 (707)
.. .+||||||.|...... ....+..+.-|.|||++.|-+|+...|+||.||+|||+.||+..|.
T Consensus 572 ~k~iLKLCDfGSA~~~~en--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASEN--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred CcceeeeccCccccccccc--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 65 5899999999775532 2333445667999999999999999999999999999999998774
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=224.97 Aligned_cols=198 Identities=32% Similarity=0.548 Sum_probs=171.0
Q ss_pred CCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEee
Q 038671 438 FDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
|+..+.||+|++|.||++... +++.+++|.+...... ...+.+.+|++.+.+++|+|++++++++......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 567788999999999999665 4889999998764332 2456788999999999999999999999998999999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC-
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS- 595 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~- 595 (707)
+++++|.+++..... .+++..+..++.+++.++.+||+. +++|+|++|+||+++.++.++|+|||.+.......
T Consensus 79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 79 CEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred cCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 999999999865332 178899999999999999999999 99999999999999999999999999998765442
Q ss_pred CCccccccccCCCCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 038671 596 SNWAELAGTYGYVAPELA-YTMKVTEKCDVYSFGVLALEVIKGKHPRD 642 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 642 (707)
.......++..|++||.. ....++.++|+|+||+++++|++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 122345678889999988 66677889999999999999999999995
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=224.18 Aligned_cols=199 Identities=29% Similarity=0.422 Sum_probs=165.7
Q ss_pred HHHHHhcCCCCCceeeecCCeeEEEEEcC----CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeee
Q 038671 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFC 504 (707)
Q Consensus 430 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~ 504 (707)
.+....+.|...++||+|+|++||++... ..+.||+|.+.... ...++..|++++..+. +.||+++.+++
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhh
Confidence 34556778999999999999999999432 46789999986532 3456889999999995 99999999999
Q ss_pred ecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC-CCCeEEe
Q 038671 505 SHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL-ENEAHVS 583 (707)
Q Consensus 505 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~-~~~~kl~ 583 (707)
...+...+|+||++...-.++.. .++...+..+++.+..||+++|+. |||||||||+|++.+. .+.-.|.
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEE
Confidence 99999999999999999988874 367888999999999999999999 9999999999999975 4678899
Q ss_pred ccccceecC-----------------C-CCC--------------------------CccccccccCCCCcccccc-CCC
Q 038671 584 DFGTAKFLK-----------------P-DSS--------------------------NWAELAGTYGYVAPELAYT-MKV 618 (707)
Q Consensus 584 Dfg~~~~~~-----------------~-~~~--------------------------~~~~~~g~~~y~aPE~~~~-~~~ 618 (707)
|||+|.... + .+. ......||++|+|||++.. ...
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 999997210 0 000 0112469999999998775 446
Q ss_pred CccchhHHHHHHHHHHHhCCCCCC
Q 038671 619 TEKCDVYSFGVLALEVIKGKHPRD 642 (707)
Q Consensus 619 ~~~~Dv~slG~~l~el~tg~~p~~ 642 (707)
++++||||.|++++.+++++.||.
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred CCccceeeccceeehhhccccccc
Confidence 889999999999999999999984
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-25 Score=207.31 Aligned_cols=255 Identities=16% Similarity=0.234 Sum_probs=205.8
Q ss_pred hcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 512 (707)
.-.|+++++||+|+||+++.| .+-++++||||.-... .+..++..|.+.++.|. .++|+..|-+..++.+-.+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 457999999999999999999 5668999999985432 23456888999999885 7999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC-----CeEEecccc
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-----EAHVSDFGT 587 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~-----~~kl~Dfg~ 587 (707)
|+|.. |.+|+|+.. -.++.|+..++..+|.|++.-++|+|++ .+|.|||||+|+||...+ .+.++|||+
T Consensus 102 VidLL-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhhh-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 99987 789998873 4567899999999999999999999999 999999999999997655 488999999
Q ss_pred ceecCCCCCC-------ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 588 AKFLKPDSSN-------WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 588 ~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
|+.+..+.+. .....||.+||+-....|.+.+.+.|+-|||-++.+++-|..||+.+.. +......+.
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA-----~tnK~kYeK 250 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-----DTNKEKYEK 250 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC-----cchHHHHHH
Confidence 9988765432 3456799999999999999999999999999999999999999986543 222333333
Q ss_pred hcCCCCC-CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 661 MLDPRLP-TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 661 ~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
+-+.+-. .....+...+.++..-+.-.-+.+-.+-|..+-+...+
T Consensus 251 IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf 296 (449)
T KOG1165|consen 251 IGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLF 296 (449)
T ss_pred hccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 3333333 33344556677777777777777888889887765543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-25 Score=206.32 Aligned_cols=165 Identities=25% Similarity=0.305 Sum_probs=125.8
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcc
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 599 (707)
|+|.++++.. .+.+++.+++.++.||+.||+|||+. + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence 6888888643 34699999999999999999999999 6 999999999999999 99998754322
Q ss_pred ccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHH-
Q 038671 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLI- 678 (707)
Q Consensus 600 ~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 678 (707)
..|++.|+|||++.+..++.++||||||+++|||+||+.||...... ............. ..+...........
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 138 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL---SAILEILLNGMPA-DDPRDRSNLESVSAA 138 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh---cHHHHHHHHHhcc-CCccccccHHHHHhh
Confidence 26889999999999999999999999999999999999998643221 1112222222111 11111111122233
Q ss_pred -HHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 679 -SIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 679 -~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
++.+++.+||+.+|++||++.++++.+.
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 5899999999999999999999998764
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=202.21 Aligned_cols=259 Identities=20% Similarity=0.289 Sum_probs=207.3
Q ss_pred HHhcCCCCCceeeecCCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCce
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHS 510 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 510 (707)
...+.|.+.++||+|+||.+|.| ...+|+.||+|+-.... ....+..|.++...|+ ...|+.+..|+.+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 34678999999999999999999 67889999999965432 3456788999999997 58899999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC---CCeEEecccc
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE---NEAHVSDFGT 587 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~---~~~kl~Dfg~ 587 (707)
.+|||.. |.+|+++... ..+.++..+++-.+-|++.-++|+|.+ +++||||||+|+++.-+ ..+.++|||+
T Consensus 87 vlVMdLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeeeecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccc
Confidence 9999987 7899988743 346689999999999999999999999 99999999999999644 3689999999
Q ss_pred ceecCCCCC-------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 588 AKFLKPDSS-------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 588 ~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
|+.+....+ ......||.+|.+-....+...+.+.|+-|+|.++.++--|..||+.... ....+..+.
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka-----~tk~QKyEk 235 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA-----ATKKQKYEK 235 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch-----hhHHHHHHH
Confidence 987754322 23456899999999988888889999999999999999999999986543 122223333
Q ss_pred hcCCCCCCC-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhcC
Q 038671 661 MLDPRLPTP-SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLKI 707 (707)
Q Consensus 661 ~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~~ 707 (707)
+...++..+ ...+...|.++.-.+..|-..--++-|....+-+.++|
T Consensus 236 I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 236 ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 333344332 22344556678888889988888899998887776653
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-27 Score=230.01 Aligned_cols=310 Identities=21% Similarity=0.237 Sum_probs=243.1
Q ss_pred eeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeeccc-c
Q 038671 7 FLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLEN-N 85 (707)
Q Consensus 7 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~-n 85 (707)
.++-++.+++ .+|..+.. ...++.|..|.|+.+.+++|+.+++|+.|||++|+|+.+.|++|.++++|..|-+.+ |
T Consensus 50 ~VdCr~~GL~-eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred eEEccCCCcc-cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 4566777788 78877764 888999999999988888999999999999999999999999999999988887766 9
Q ss_pred cccccCCC-CCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCch
Q 038671 86 QLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPA 164 (707)
Q Consensus 86 ~i~~~~~~-l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~ 164 (707)
.|++++.+ |.++.+|+.|.+.-|++..+..++|..+++|..|.+.+|.+..+....|..+.+++.+.+..|...
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i----- 201 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI----- 201 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc-----
Confidence 99988874 899999999999999999999999999999999999999999887788999999999999888743
Q ss_pred hhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCC-Ccc-cEEEccCCccCCCCCccccCcc
Q 038671 165 EIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSL-TQL-ERLDLSSNRLSNSIPKSLGNLV 242 (707)
Q Consensus 165 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L-~~L~l~~n~i~~~~~~~l~~l~ 242 (707)
...+++.+... +. ..+-.++...-..-..+.++++....+..|... ..+ ..+.-..+....-+...|..++
T Consensus 202 cdCnL~wla~~-~a------~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~ 274 (498)
T KOG4237|consen 202 CDCNLPWLADD-LA------MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLP 274 (498)
T ss_pred cccccchhhhH-Hh------hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcc
Confidence 11122222211 11 222334444455555566666665545444322 222 1222222333323346788899
Q ss_pred cCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeec
Q 038671 243 KLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDIS 322 (707)
Q Consensus 243 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~ 322 (707)
+|+.|+|++|+|+.+...+|.+...+++|.|..|+|.......|.++..|+.|+|.+|+|+.+.|..|..+..|.+|++-
T Consensus 275 ~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~ 354 (498)
T KOG4237|consen 275 NLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLL 354 (498)
T ss_pred cceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehc
Confidence 99999999999998889999999999999999999977777888999999999999999998899999999999999999
Q ss_pred cCcccccCC
Q 038671 323 YNELHGSIP 331 (707)
Q Consensus 323 ~n~~~~~~~ 331 (707)
.|+|.|.|-
T Consensus 355 ~Np~~CnC~ 363 (498)
T KOG4237|consen 355 SNPFNCNCR 363 (498)
T ss_pred cCcccCccc
Confidence 999998774
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=258.44 Aligned_cols=195 Identities=17% Similarity=0.192 Sum_probs=138.3
Q ss_pred cCCC-Cceeeeeeee-------ecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 038671 491 GIRH-RNIVKFYGFC-------SHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562 (707)
Q Consensus 491 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 562 (707)
+++| +||.++++++ .+...++.++||+ +++|.+++... ...+++.+++.++.||++||+|||++ ||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 3445 5777777776 2334567888877 66999999642 34589999999999999999999999 99
Q ss_pred EecCCCCCCeeecCC-------------------CCeEEeccccceecCCCC----------------CCccccccccCC
Q 038671 563 VHRDISSKNVLLDLE-------------------NEAHVSDFGTAKFLKPDS----------------SNWAELAGTYGY 607 (707)
Q Consensus 563 vH~dlk~~Nil~~~~-------------------~~~kl~Dfg~~~~~~~~~----------------~~~~~~~g~~~y 607 (707)
+||||||+|||++.. +.+|++|||+++...... .......||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999653 455666666665321100 000113578889
Q ss_pred CCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhc
Q 038671 608 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISC 687 (707)
Q Consensus 608 ~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 687 (707)
||||++.+..++.++|||||||++|||++|..|+.... ............+.. .........++.+|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~ 248 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHRVLPPQI-------LLNWPKEASFCLWL 248 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHhhcChhh-------hhcCHHHHHHHHHh
Confidence 99999999999999999999999999999998864211 011111111111111 01123356788899
Q ss_pred cCCCCCCCCCHHHHHHH
Q 038671 688 LDESPESRPTIQKVSQL 704 (707)
Q Consensus 688 l~~~P~~Rps~~~l~~~ 704 (707)
|+.+|.+||++.|+++.
T Consensus 249 L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 249 LHPEPSCRPSMSELLQS 265 (793)
T ss_pred CCCChhhCcChHHHhhc
Confidence 99999999999999863
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-27 Score=248.89 Aligned_cols=345 Identities=31% Similarity=0.383 Sum_probs=198.2
Q ss_pred CCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccC-------------------c
Q 038671 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN-------------------A 62 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n-------------------~ 62 (707)
+.+|++|.|.+|.+. ..|..+..+++|++|++++|.+. ..|..+..++.++++..++| .
T Consensus 90 ~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~ 167 (1081)
T KOG0618|consen 90 MRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNV 167 (1081)
T ss_pred hhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhh
Confidence 445555555555555 55555555555555555555555 33333333333333333332 2
Q ss_pred CcccCCccccCCCCCCeeecccccccccCCCCCCCC--------------------CccEEEeccCccccccCccccCCC
Q 038671 63 LSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLT--------------------SLVRVRLNQNHLTGNISESFGIHP 122 (707)
Q Consensus 63 i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~--------------------~L~~L~l~~n~l~~~~~~~~~~~~ 122 (707)
+.+.++..+..+.+ .|+|..|.+.. ..+..+. +|+.|+.++|.++.+ .......
T Consensus 168 l~~~~~~~i~~l~~--~ldLr~N~~~~--~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~--~~~p~p~ 241 (1081)
T KOG0618|consen 168 LGGSFLIDIYNLTH--QLDLRYNEMEV--LDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTL--DVHPVPL 241 (1081)
T ss_pred cccchhcchhhhhe--eeecccchhhh--hhhhhccchhhhhhhhcccceEEecCcchheeeeccCcceee--ccccccc
Confidence 22222222222222 36666665551 1223333 334444444444422 1122345
Q ss_pred CCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEec
Q 038671 123 NLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILN 202 (707)
Q Consensus 123 ~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 202 (707)
+|+++++++|+++.+. +.+..+.+|+.|+..+|.++ ..+..+....+|+.|++.+|.++ -+|..+..+++|++|+|.
T Consensus 242 nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 242 NLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred cceeeecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeeh
Confidence 7788888888887554 77777888888888888875 55555666666666666666665 445555666777777777
Q ss_pred CCccccCCccccC-------------------------CCCcccEEEccCCccCCCCCccccCcccCceEeeeccccccc
Q 038671 203 SNQLCGQLSLELG-------------------------SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKK 257 (707)
Q Consensus 203 ~n~l~~~~~~~~~-------------------------~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~ 257 (707)
.|+|.......+. .++.|+.|++.+|.+++..-..|.++++|+.|+|++|.+...
T Consensus 319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f 398 (1081)
T KOG0618|consen 319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF 398 (1081)
T ss_pred hccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence 7777632221111 123466666666776665555666777777777777777656
Q ss_pred CchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccC-CCcccc
Q 038671 258 IPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSI-PNSTAF 336 (707)
Q Consensus 258 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~-~~~~~~ 336 (707)
....+.++..|++|+||+|+++ .+|+.+.+++.|++|...+|++..+ | .+..++.|+.+|++-|.++-.. |.....
T Consensus 399 pas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~f-P-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~ 475 (1081)
T KOG0618|consen 399 PASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSF-P-ELAQLPQLKVLDLSCNNLSEVTLPEALPS 475 (1081)
T ss_pred CHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeec-h-hhhhcCcceEEecccchhhhhhhhhhCCC
Confidence 6666777777777777777774 4556677777777777777777643 4 6667777777777777776433 222222
Q ss_pred ccCchhhcccCcCcCCCCCCCCCc
Q 038671 337 RDAPMEALQGNKGLCGDIKGFPSC 360 (707)
Q Consensus 337 ~~~~~~~~~~~~~~c~~~~~~~~c 360 (707)
+......++||.+.-.+-..++.|
T Consensus 476 p~LkyLdlSGN~~l~~d~~~l~~l 499 (1081)
T KOG0618|consen 476 PNLKYLDLSGNTRLVFDHKTLKVL 499 (1081)
T ss_pred cccceeeccCCcccccchhhhHHh
Confidence 445556666776654444444433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=215.81 Aligned_cols=254 Identities=21% Similarity=0.235 Sum_probs=189.3
Q ss_pred CCCCCceeeecCCeeEEEEEcCC--CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC----CCceeeeeeee-ecCCc
Q 038671 437 DFDDEHCIGKGGQGSVYKAELPS--GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR----HRNIVKFYGFC-SHARH 509 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~~~~~~-~~~~~ 509 (707)
+|.+.+.||+|+||.||.+.... ...+|+|......... ...+..|..++..+. .++++.+++.+ ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 79999999999999999996544 3578888875432111 115677888888776 36899999999 57788
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC-----CCeEEec
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE-----NEAHVSD 584 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~-----~~~kl~D 584 (707)
.++||+.+ |.+|.++..... .+.++..++.+++.|++.+|+++|+. |++||||||.|+++... ..+.+.|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 99999976 789999876554 57799999999999999999999999 99999999999999865 3589999
Q ss_pred cccceecC--CCC--------CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchh
Q 038671 585 FGTAKFLK--PDS--------SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL 654 (707)
Q Consensus 585 fg~~~~~~--~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 654 (707)
||+++... ... .....+.||..|++++...+...+.+.|+||++.++.++..|..||........ .
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~----~ 246 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL----K 246 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch----H
Confidence 99998322 111 112345699999999999999999999999999999999999999964332111 1
Q ss_pred hhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 655 EIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
........+..... .....+.++.++...+-..+..++|....+...+
T Consensus 247 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l 294 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELL 294 (322)
T ss_pred HHHHHHhhhhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence 11111111111110 1111223455666666668999999999887765
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.7e-27 Score=225.04 Aligned_cols=321 Identities=22% Similarity=0.243 Sum_probs=241.2
Q ss_pred CCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEccc-CcCcccCCccccCCCCCCeeec
Q 038671 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD-NALSGAIPKEYGNLVKLTLLTL 82 (707)
Q Consensus 4 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~l 82 (707)
+.+.++|..|.|+.+.+++|+.+++|+.||||+|+|+.+.|++|+++.+|.+|.+-+ |+|+....+.|++|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 457899999999999999999999999999999999999999999999998887766 9999888899999999999999
Q ss_pred ccccccccCC-CCCCCCCccEEEeccCccccccCccccCCCCCcEEEccccccc------------ccCCCCCCCCCCCc
Q 038671 83 ENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFY------------GEISSDWGRCPKLG 149 (707)
Q Consensus 83 ~~n~i~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~------------~~~~~~~~~~~~L~ 149 (707)
.-|.+.-+.. .|..+++|..|.+-+|.+..+....|..+..++++.+..|.+- ...+..++......
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~ 227 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS 227 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence 9999987655 5999999999999999999998889999999999999998831 11222222221111
Q ss_pred EEEcC--------------------------CCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecC
Q 038671 150 TLDFS--------------------------SNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNS 203 (707)
Q Consensus 150 ~L~L~--------------------------~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 203 (707)
-..+. .+.........|.++++|+.|+|++|+|+.+.+.+|....++++|.|..
T Consensus 228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~ 307 (498)
T KOG4237|consen 228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR 307 (498)
T ss_pred hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence 11111 1222222344677888999999999999888888888888999999999
Q ss_pred CccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccc-cCchhhhh---------------ccc
Q 038671 204 NQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIK-KIPVELEK---------------LIH 267 (707)
Q Consensus 204 n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~~~~~~---------------l~~ 267 (707)
|+|.......|.++.+|+.|+|.+|+|+...|.+|..+.+|.+|+|-.|++.= -...++++ -..
T Consensus 308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~ 387 (498)
T KOG4237|consen 308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGF 387 (498)
T ss_pred chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCch
Confidence 99887777788888999999999999988888888888888888888776521 11111111 123
Q ss_pred CCeeeecCccCCCC---CCccccc------------------c-------------cccceEeccccccCCchhHhhccC
Q 038671 268 LSELDLSHNFLGEE---MPSQICN------------------M-------------QSLEKLNLSHNNLSGFIPSCFEEL 313 (707)
Q Consensus 268 L~~L~l~~n~l~~~---~~~~~~~------------------~-------------~~L~~L~l~~n~i~~~~~~~~~~~ 313 (707)
++.+.++++.+.+. .|+..+- + ..-.++++.+|.++.+ |+. .+
T Consensus 388 ~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP~d~telyl~gn~~~~v-p~~--~~ 464 (498)
T KOG4237|consen 388 VRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIPVDVTELYLDGNAITSV-PDE--LL 464 (498)
T ss_pred hccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCCchhHHHhcccchhccc-CHH--HH
Confidence 55666666655321 1111000 0 0235688999998844 444 45
Q ss_pred CCceeEeeccCcccc
Q 038671 314 HGLSYIDISYNELHG 328 (707)
Q Consensus 314 ~~L~~l~l~~n~~~~ 328 (707)
..| .+++++|+|.-
T Consensus 465 ~~l-~~dls~n~i~~ 478 (498)
T KOG4237|consen 465 RSL-LLDLSNNRISS 478 (498)
T ss_pred hhh-hcccccCceeh
Confidence 566 88999998873
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-23 Score=243.38 Aligned_cols=325 Identities=24% Similarity=0.286 Sum_probs=221.6
Q ss_pred CCCCCceeeccCCe------eeecCCccccCCC-CCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccC
Q 038671 1 NLSNLAFLYLYNNS------FSGSIPSEIGRLK-SLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGN 73 (707)
Q Consensus 1 nl~~l~~L~l~~n~------i~~~~~~~~~~l~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 73 (707)
+|++|+.|.++.+. +...+|..|..++ +|+.|++.++.++ .+|..| .+.+|+.|+|.+|.+. ..+..+..
T Consensus 556 ~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~ 632 (1153)
T PLN03210 556 GMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHS 632 (1153)
T ss_pred cCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccccccc
Confidence 36677777776553 3334566666654 5888888888777 666666 4678888888888877 55667777
Q ss_pred CCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEc
Q 038671 74 LVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDF 153 (707)
Q Consensus 74 l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L 153 (707)
+++|++|+|+++......+.+..+++|+.|+|++|......+..+..+++|+.|++++|......+..+ ++++|+.|++
T Consensus 633 l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~L 711 (1153)
T PLN03210 633 LTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNL 711 (1153)
T ss_pred CCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeC
Confidence 888888888876533334457778888888888776544556677788888888888764333334333 6778888888
Q ss_pred CCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCcccc-------CCccccCCCCcccEEEcc
Q 038671 154 SSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCG-------QLSLELGSLTQLERLDLS 226 (707)
Q Consensus 154 ~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-------~~~~~~~~l~~L~~L~l~ 226 (707)
++|......+.. ..+|+.|++++|.+. .+|..+ .+++|++|.+.++.... ..+......++|+.|+|+
T Consensus 712 sgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls 786 (1153)
T PLN03210 712 SGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLS 786 (1153)
T ss_pred CCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCC
Confidence 887644333322 357788888888876 455443 46777777776643221 111222335688899999
Q ss_pred CCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCch
Q 038671 227 SNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFI 306 (707)
Q Consensus 227 ~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~ 306 (707)
+|.....+|..++++++|+.|+|++|...+..|... .+++|+.|++++|......|.. ..+|+.|++++|.|+ .+
T Consensus 787 ~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~i 861 (1153)
T PLN03210 787 DIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EV 861 (1153)
T ss_pred CCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cC
Confidence 887766788888889999999998875444555544 6788999999988654555443 357888999999887 45
Q ss_pred hHhhccCCCceeEeecc-CcccccCCCccccccC
Q 038671 307 PSCFEELHGLSYIDISY-NELHGSIPNSTAFRDA 339 (707)
Q Consensus 307 ~~~~~~~~~L~~l~l~~-n~~~~~~~~~~~~~~~ 339 (707)
|..+..+++|+.|++++ |++.+.++....+...
T Consensus 862 P~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L 895 (1153)
T PLN03210 862 PWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHL 895 (1153)
T ss_pred hHHHhcCCCCCEEECCCCCCcCccCcccccccCC
Confidence 77888899999999988 5555544443333333
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=229.70 Aligned_cols=259 Identities=25% Similarity=0.294 Sum_probs=134.4
Q ss_pred CceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeeccc
Q 038671 5 LAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLEN 84 (707)
Q Consensus 5 l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~ 84 (707)
-..|+|+++.++ .+|..+. ++|+.|++++|+++ .+|. .+++|++|+|++|+|+. +|.. .++|+.|++++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccCc-ccCc---ccccceeeccC
Confidence 346777777777 5666554 36777777777777 4453 24667777777777763 3432 34666777777
Q ss_pred ccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCch
Q 038671 85 NQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPA 164 (707)
Q Consensus 85 n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~ 164 (707)
|.++.++.. ..+|+.|++++|+++.++. .+++|+.|+|++|+++.+.. ..++|+.|++++|.++. .|.
T Consensus 272 N~L~~Lp~l---p~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N~L~~Lp~----lp~~L~~L~Ls~N~L~~-LP~ 339 (788)
T PRK15387 272 NPLTHLPAL---PSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPA----LPSELCKLWAYNNQLTS-LPT 339 (788)
T ss_pred Cchhhhhhc---hhhcCEEECcCCccccccc----cccccceeECCCCccccCCC----CcccccccccccCcccc-ccc
Confidence 766654432 2456666666666665532 23566666666666664321 12345556666666552 221
Q ss_pred hhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccC
Q 038671 165 EIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKL 244 (707)
Q Consensus 165 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L 244 (707)
. ..+|+.|+|++|+|+ .+|.. .++|+.|++++|+|+. +|.. ..+|+.|+|++|.|+. +|..
T Consensus 340 l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l------- 400 (788)
T PRK15387 340 L---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL------- 400 (788)
T ss_pred c---ccccceEecCCCccC-CCCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc-------
Confidence 1 134556666666555 23321 1345555555555552 2221 2344555555555542 2211
Q ss_pred ceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccC
Q 038671 245 HYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYN 324 (707)
Q Consensus 245 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n 324 (707)
.++|+.|++++|.++. +|.. ..+|+.|++++|+|+ .+|..+..+++|+.|++++|
T Consensus 401 --------------------~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N 455 (788)
T PRK15387 401 --------------------PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 455 (788)
T ss_pred --------------------ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCC
Confidence 1344455555555432 2321 123444555555554 23444555555555555555
Q ss_pred cccccC
Q 038671 325 ELHGSI 330 (707)
Q Consensus 325 ~~~~~~ 330 (707)
+|++..
T Consensus 456 ~Ls~~~ 461 (788)
T PRK15387 456 PLSERT 461 (788)
T ss_pred CCCchH
Confidence 555443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-26 Score=244.97 Aligned_cols=329 Identities=30% Similarity=0.357 Sum_probs=213.7
Q ss_pred CceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeeccc
Q 038671 5 LAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLEN 84 (707)
Q Consensus 5 l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~ 84 (707)
|+.|+|++|.+. ..|..+-.+.+|+.|+++.|.|. ..|.+..++.+|++|.|.+|.+. ..|..+..+++|++|+++.
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 788999999998 88888888999999999999998 77888889999999999988888 7788899999999999999
Q ss_pred ccccccCCCCCCCCCccEEEeccC-------------------ccccccCccccCCCCCcE-EEcccccccccCCCCCCC
Q 038671 85 NQLRGPIPNLRNLTSLVRVRLNQN-------------------HLTGNISESFGIHPNLAF-IDLSHNYFYGEISSDWGR 144 (707)
Q Consensus 85 n~i~~~~~~l~~l~~L~~L~l~~n-------------------~l~~~~~~~~~~~~~L~~-L~L~~n~i~~~~~~~~~~ 144 (707)
|.+...+..+..++.+..+..++| .+..-..... ..+++ |+|.+|.+... .+..
T Consensus 124 N~f~~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i---~~l~~~ldLr~N~~~~~---dls~ 197 (1081)
T KOG0618|consen 124 NHFGPIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDI---YNLTHQLDLRYNEMEVL---DLSN 197 (1081)
T ss_pred hccCCCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcch---hhhheeeecccchhhhh---hhhh
Confidence 988776655554444444444444 2221111111 22222 55555554411 1111
Q ss_pred C--------------------C----------------------CCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCC
Q 038671 145 C--------------------P----------------------KLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHI 182 (707)
Q Consensus 145 ~--------------------~----------------------~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l 182 (707)
+ + +|+++++++|+++ ..|.++..+.+|+.|++.+|.+
T Consensus 198 ~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l 276 (1081)
T KOG0618|consen 198 LANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRL 276 (1081)
T ss_pred ccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhh-cchHHHHhcccceEecccchhH
Confidence 1 2 3444444444444 2335555555555555555555
Q ss_pred CCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccC----------------------
Q 038671 183 VGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN---------------------- 240 (707)
Q Consensus 183 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~---------------------- 240 (707)
. ..|..+...++|+.|.+..|.+. .+|....+++.|++|+|..|+|...++..|.-
T Consensus 277 ~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~ 354 (1081)
T KOG0618|consen 277 V-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYE 354 (1081)
T ss_pred H-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccccccc
Confidence 4 44555555555555555555555 45555666777777777777776433222211
Q ss_pred ---cccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCce
Q 038671 241 ---LVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLS 317 (707)
Q Consensus 241 ---l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~ 317 (707)
++.|+.|++.+|.+++.....+.+..+|+.|+|++|++.......+.++..|++|+||||+++ .+|+.+..+..|+
T Consensus 355 e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~ 433 (1081)
T KOG0618|consen 355 ENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLH 433 (1081)
T ss_pred chhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhH
Confidence 123566666677776666666777778888888888885555556667788888888888887 4567777888888
Q ss_pred eEeeccCcccccCCCccccccCchhhcccC
Q 038671 318 YIDISYNELHGSIPNSTAFRDAPMEALQGN 347 (707)
Q Consensus 318 ~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~ 347 (707)
+|...+|++.+.| .....+......+.-|
T Consensus 434 tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N 462 (1081)
T KOG0618|consen 434 TLRAHSNQLLSFP-ELAQLPQLKVLDLSCN 462 (1081)
T ss_pred HHhhcCCceeech-hhhhcCcceEEecccc
Confidence 8888888887766 5555555555555544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=212.63 Aligned_cols=167 Identities=20% Similarity=0.240 Sum_probs=130.5
Q ss_pred HHHhcCCCCCceeeecCCeeEEEEEcC--CCcEEEEEecCCCCC--chhhhHHHHHHHHHHHhcCCCCceee-eeeeeec
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKAELP--SGEIVAVKKFHSPLP--SEMASQQEFLNEVKTLTGIRHRNIVK-FYGFCSH 506 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~ 506 (707)
..+.++|++.+.||+|+||+||+|+.+ +++.+|||+...... ......+.+.+|++++++++|+|++. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 455678999999999999999999653 578889998653211 12234567999999999999999985 4432
Q ss_pred CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeeecCCCCeEEecc
Q 038671 507 ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDI-SSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 507 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-k~~Nil~~~~~~~kl~Df 585 (707)
+..++||||++|++|... . . .. ...++.|+++||+|||+. ||+|||| ||+||+++.++.+||+||
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~---~---~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-R---P---HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-C---c---cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 457999999999999632 1 1 11 146789999999999999 9999999 999999999999999999
Q ss_pred ccceecCCCCCC--------ccccccccCCCCcccccc
Q 038671 586 GTAKFLKPDSSN--------WAELAGTYGYVAPELAYT 615 (707)
Q Consensus 586 g~~~~~~~~~~~--------~~~~~g~~~y~aPE~~~~ 615 (707)
|+|+........ .....+++.|+|||.+..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999977654321 134567888999998764
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=221.56 Aligned_cols=236 Identities=25% Similarity=0.263 Sum_probs=144.4
Q ss_pred CCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCC
Q 038671 76 KLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS 155 (707)
Q Consensus 76 ~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~ 155 (707)
+|+.|++++|+++.++. .+++|++|++++|+++.++. ..++|+.|+|++|.++.+.. -.++|+.|+|++
T Consensus 223 ~L~~L~L~~N~Lt~LP~---lp~~Lk~LdLs~N~LtsLP~----lp~sL~~L~Ls~N~L~~Lp~----lp~~L~~L~Ls~ 291 (788)
T PRK15387 223 HITTLVIPDNNLTSLPA---LPPELRTLEVSGNQLTSLPV----LPPGLLELSIFSNPLTHLPA----LPSGLCKLWIFG 291 (788)
T ss_pred CCCEEEccCCcCCCCCC---CCCCCcEEEecCCccCcccC----cccccceeeccCCchhhhhh----chhhcCEEECcC
Confidence 34444444444443322 12445555555555554432 12455555555555553321 123456666666
Q ss_pred CccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCC
Q 038671 156 NNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIP 235 (707)
Q Consensus 156 n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~ 235 (707)
|.++. .+. ..++|+.|++++|++++ +|... .+|+.|++++|++++ +|. -..+|++|+|++|+|+.+ |
T Consensus 292 N~Lt~-LP~---~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~---lp~~Lq~LdLS~N~Ls~L-P 358 (788)
T PRK15387 292 NQLTS-LPV---LPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPT---LPSGLQELSVSDNQLASL-P 358 (788)
T ss_pred Ccccc-ccc---cccccceeECCCCcccc-CCCCc---ccccccccccCcccc-ccc---cccccceEecCCCccCCC-C
Confidence 66652 222 13567777777777663 33321 356677777777763 332 124788888888888843 3
Q ss_pred ccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCC
Q 038671 236 KSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHG 315 (707)
Q Consensus 236 ~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~ 315 (707)
.. .++|+.|++++|+|... |.. ..+|+.|++++|.++. +|.. .++|+.|++++|+|+.+ |.. ..+
T Consensus 359 ~l---p~~L~~L~Ls~N~L~~L-P~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~LssI-P~l---~~~ 423 (788)
T PRK15387 359 TL---PSELYKLWAYNNRLTSL-PAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTSL-PML---PSG 423 (788)
T ss_pred CC---CcccceehhhccccccC-ccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCCC-Ccc---hhh
Confidence 32 24678888888888653 332 3579999999999964 4433 36799999999999864 543 346
Q ss_pred ceeEeeccCcccccCCCccccccCchhhcccCcCc
Q 038671 316 LSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGL 350 (707)
Q Consensus 316 L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~ 350 (707)
|+.|++++|+++..+.....+.......+.+|+..
T Consensus 424 L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 424 LLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred hhhhhhccCcccccChHHhhccCCCeEECCCCCCC
Confidence 88999999999966555555666667778888754
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-22 Score=235.44 Aligned_cols=306 Identities=21% Similarity=0.250 Sum_probs=241.2
Q ss_pred CCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeec
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTL 82 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 82 (707)
++|+.|.+.++.++ .+|..| .+.+|++|++++|++. .+++.+..+++|++|+|++|.....+| .++.+++|++|+|
T Consensus 589 ~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L 664 (1153)
T PLN03210 589 PKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKL 664 (1153)
T ss_pred cccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEe
Confidence 35899999999998 778887 4689999999999998 677888999999999999876444556 4888999999999
Q ss_pred cccc-ccccCCCCCCCCCccEEEeccCc-cccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCC
Q 038671 83 ENNQ-LRGPIPNLRNLTSLVRVRLNQNH-LTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITG 160 (707)
Q Consensus 83 ~~n~-i~~~~~~l~~l~~L~~L~l~~n~-l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~ 160 (707)
++|. +..++..+..+++|+.|++++|. ++.++. .+ .+++|+.|++++|......+. ..++|++|+|++|.+.
T Consensus 665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~-~i-~l~sL~~L~Lsgc~~L~~~p~---~~~nL~~L~L~~n~i~- 738 (1153)
T PLN03210 665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPT-GI-NLKSLYRLNLSGCSRLKSFPD---ISTNISWLDLDETAIE- 738 (1153)
T ss_pred cCCCCccccchhhhccCCCCEEeCCCCCCcCccCC-cC-CCCCCCEEeCCCCCCcccccc---ccCCcCeeecCCCccc-
Confidence 9975 56677789999999999999864 555543 33 789999999999875443332 2468999999999987
Q ss_pred CCchhhhCCCCCCEEeCCCCCCC-------CCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCC
Q 038671 161 SMPAEIIHSSQLKVLDLSSNHIV-------GEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNS 233 (707)
Q Consensus 161 ~~~~~~~~~~~L~~L~l~~n~l~-------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~ 233 (707)
..|..+ .+++|+.|++.++... ...+..+...++|++|++++|.....+|..+.++++|+.|+|++|..-+.
T Consensus 739 ~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~ 817 (1153)
T PLN03210 739 EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLET 817 (1153)
T ss_pred cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCe
Confidence 444443 5788999988875432 12222233457899999999987778899999999999999999854445
Q ss_pred CCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEecccc-ccCCchhHhhcc
Q 038671 234 IPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHN-NLSGFIPSCFEE 312 (707)
Q Consensus 234 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n-~i~~~~~~~~~~ 312 (707)
+|..+ ++++|+.|++++|......|.. ..+|+.|+|++|.++ ..|..+..+++|+.|++++| .+. .+|..+..
T Consensus 818 LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~ 891 (1153)
T PLN03210 818 LPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISK 891 (1153)
T ss_pred eCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCccccc
Confidence 66555 7899999999998654443332 368999999999995 57888999999999999995 554 56667788
Q ss_pred CCCceeEeeccCc
Q 038671 313 LHGLSYIDISYNE 325 (707)
Q Consensus 313 ~~~L~~l~l~~n~ 325 (707)
++.|+.+++++|.
T Consensus 892 L~~L~~L~l~~C~ 904 (1153)
T PLN03210 892 LKHLETVDFSDCG 904 (1153)
T ss_pred ccCCCeeecCCCc
Confidence 9999999999885
|
syringae 6; Provisional |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-23 Score=224.05 Aligned_cols=255 Identities=20% Similarity=0.258 Sum_probs=189.2
Q ss_pred CCCceeeecCCeeEEEEE-cCCCcEEEEEecCC---CCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 439 DDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHS---PLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 439 ~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~---~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
...+.+|.|++|.++.+. ......++.|.+.. +...+......+..|..+-..++|||++..+....+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456779999999888773 33344444444331 22222222233677888888899999988888776666655569
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++ +|..++... ..+...++..++.|++.|++|+|+. |+.|||+|++|++++.+|.+||+|||.+.....+
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999988643 3477788899999999999999999 9999999999999999999999999999877654
Q ss_pred CC----CccccccccCCCCccccccCCCCc-cchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 595 SS----NWAELAGTYGYVAPELAYTMKVTE-KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 595 ~~----~~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
.. .....+|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||.......... .......-......+
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~---~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF---KTNNYSDQRNIFEGP 550 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch---hhhccccccccccCh
Confidence 33 245678999999999999999976 5799999999999999999997543321110 001111111111122
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.......+...+.++.++++.||.+|-+++++++
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 3334556677889999999999999999999876
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.4e-23 Score=188.35 Aligned_cols=247 Identities=19% Similarity=0.333 Sum_probs=183.3
Q ss_pred CCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeee
Q 038671 438 FDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYL 517 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 517 (707)
.....+|.+...|..|+|+++.+ .+++|++....... .....|..|.-.++-+.||||..+++.|..+..+.++..|+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCcccccccccCc-chhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 44556688999999999999754 46667765433222 22356888888888889999999999999999999999999
Q ss_pred ccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeE-ecCCCCCCeeecCCCCeEEe--ccccceecCCC
Q 038671 518 EMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIV-HRDISSKNVLLDLENEAHVS--DFGTAKFLKPD 594 (707)
Q Consensus 518 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv-H~dlk~~Nil~~~~~~~kl~--Dfg~~~~~~~~ 594 (707)
+.|+|+..++.... -..+..++.+++.+|++|++|||+.- +++ .--+.+..|++|++-+.+|+ |--++.. .
T Consensus 270 p~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsfq---e 343 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---E 343 (448)
T ss_pred cchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeeee---c
Confidence 99999999986543 33677899999999999999999984 444 34588999999999877763 3322211 1
Q ss_pred CCCccccccccCCCCccccccCCCC---ccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVT---EKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~---~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
....-.|.||+||.+...+.+ .++|+|||++++||+-|...||...++..-. ....+ +.+...+|
T Consensus 344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---mkial-eglrv~ip---- 411 (448)
T KOG0195|consen 344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---MKIAL-EGLRVHIP---- 411 (448)
T ss_pred ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---hhhhh-ccccccCC----
Confidence 112336789999998876643 4789999999999999999999755442211 11111 12222222
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+..+..+.+++.-|++.||.+||.+++++-.||
T Consensus 412 --pgis~hm~klm~icmnedpgkrpkfdmivpile 444 (448)
T KOG0195|consen 412 --PGISRHMNKLMNICMNEDPGKRPKFDMIVPILE 444 (448)
T ss_pred --CCccHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence 234455888999999999999999999887765
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.1e-21 Score=198.41 Aligned_cols=260 Identities=27% Similarity=0.411 Sum_probs=197.8
Q ss_pred CCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCC-ceeeeeeeeecCCceeEEEee
Q 038671 438 FDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR-NIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 516 (707)
|...+.+|.|+||.||++... ..+++|.+.............+.+|+..+..+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677888999999999999765 78899998776544433467899999999999988 799999999777778999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC-CeEEeccccceecCCCC
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 595 (707)
+.++++.+++........++......++.|++.+++|+|+. +++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997775432112578899999999999999999999 999999999999999988 79999999998655443
Q ss_pred C------CccccccccCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC-C
Q 038671 596 S------NWAELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP-R 665 (707)
Q Consensus 596 ~------~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 665 (707)
. ......|+..|+|||...+ ..+....|+|++|++++++++|..||....... ..............+ .
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS-ATSQTLKIILELPTPSL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc-cHHHHHHHHHhcCCccc
Confidence 2 2356789999999999887 578889999999999999999999975432210 001111111111111 1
Q ss_pred CCCCCcc-hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 666 LPTPSHN-VQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 666 ~~~~~~~-~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
....... .......+.+++..|+..+|..|.+..+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 1111000 0112345788999999999999998877553
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=190.39 Aligned_cols=236 Identities=19% Similarity=0.276 Sum_probs=153.0
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCC----------Cceeeeeeeee
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH----------RNIVKFYGFCS 505 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~niv~~~~~~~ 505 (707)
.+...+.||.|+++.||.+++ .+|+.+|+|++..+........+.+.+|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 455678899999999999955 5699999999876655555566777777766555322 12222222221
Q ss_pred ---------c---CC-----ceeEEEeeeccCcHHHHHhc---ccc-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 038671 506 ---------H---AR-----HSFIVYEYLEMGSLAMILSN---DAA-AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVH 564 (707)
Q Consensus 506 ---------~---~~-----~~~lv~e~~~~~~L~~~l~~---~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 564 (707)
. .. ..+++|+-+ .++|.+++.. ... ...+....++.+..|+++.+++||+. |++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 1 11 235677766 4677776532 111 12244556677889999999999999 9999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCCCCccccccccCCCCcccccc--------CCCCccchhHHHHHHHHHHHh
Q 038671 565 RDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT--------MKVTEKCDVYSFGVLALEVIK 636 (707)
Q Consensus 565 ~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~t 636 (707)
+||+|+|++++++|.++|+||+....... .......+..|.|||.... ..++.+.|.|+||+++|.+++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTE---EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCc---eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999998876432 2222345578999997643 247889999999999999999
Q ss_pred CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCC
Q 038671 637 GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESR 695 (707)
Q Consensus 637 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 695 (707)
|+.||+.......... . ...+.+.+..+..+|..+++.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~~-------~---------f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-------D---------FSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-------G---------GTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-------c---------chhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999975433211111 1 11222667789999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.4e-22 Score=185.29 Aligned_cols=175 Identities=11% Similarity=0.133 Sum_probs=136.3
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHH------HHHHHHHHhcCCCCceeeeeeeeec
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQE------FLNEVKTLTGIRHRNIVKFYGFCSH 506 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~ 506 (707)
...++|+..+.+|.|+||.||.+.. +++.+|+|++...........+. +.+|++.+.+++||+|+.+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999866 57789999997655444333233 6789999999999999999988653
Q ss_pred C--------CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC
Q 038671 507 A--------RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN 578 (707)
Q Consensus 507 ~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~ 578 (707)
. +..+++|||++|.+|.++.. ++. ....+++.++..+|.. |++|||++|+||+++.+|
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 2 35889999999999988732 222 2456999999999999 999999999999999988
Q ss_pred CeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHH
Q 038671 579 EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 635 (707)
Q Consensus 579 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 635 (707)
++++|||........... . .+.....+..++|+|+||+++....
T Consensus 173 -i~liDfg~~~~~~e~~a~-d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-D-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH-H-----------HHHHHhHhcccccccceeEeehHHH
Confidence 999999988654322111 0 0233344667899999999987654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=216.18 Aligned_cols=246 Identities=24% Similarity=0.331 Sum_probs=120.3
Q ss_pred CCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecc
Q 038671 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLE 83 (707)
Q Consensus 4 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (707)
+.+.|++++++++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|++|++++|+++ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 3455666666666 4454443 35666666666666 3444332 35666666666655 3343332 245555555
Q ss_pred cccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCc
Q 038671 84 NNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMP 163 (707)
Q Consensus 84 ~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~ 163 (707)
+|++..++..+. .+|+.|++++|+++.++.. + .++|+.|+|++|+++.+ +
T Consensus 250 ~N~L~~LP~~l~--s~L~~L~Ls~N~L~~LP~~-l--~~sL~~L~Ls~N~Lt~L-------------------------P 299 (754)
T PRK15370 250 INRITELPERLP--SALQSLDLFHNKISCLPEN-L--PEELRYLSVYDNSIRTL-------------------------P 299 (754)
T ss_pred CCccCcCChhHh--CCCCEEECcCCccCccccc-c--CCCCcEEECCCCccccC-------------------------c
Confidence 555554443332 3455555555555543221 1 12455555555544432 2
Q ss_pred hhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCccc
Q 038671 164 AEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVK 243 (707)
Q Consensus 164 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~ 243 (707)
..+. ++|+.|++++|.++ .+|..+. ++|+.|++++|.++. +|..+. ++|+.|++++|+++ .+|..+. ++
T Consensus 300 ~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~ 368 (754)
T PRK15370 300 AHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PT 368 (754)
T ss_pred ccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CC
Confidence 1111 24455555555554 2232221 355555555555553 333221 45666666666655 3333332 45
Q ss_pred CceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccc----cccccceEeccccccC
Q 038671 244 LHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQIC----NMQSLEKLNLSHNNLS 303 (707)
Q Consensus 244 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~----~~~~L~~L~l~~n~i~ 303 (707)
|+.|+|++|+++.. |..+. .+|+.|++++|+++ .+|..+. .++.+..|++.+|+++
T Consensus 369 L~~LdLs~N~Lt~L-P~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 369 ITTLDVSRNALTNL-PENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred cCEEECCCCcCCCC-CHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 66666666666533 33332 24666666666664 3333332 2355666666666665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.1e-21 Score=179.29 Aligned_cols=143 Identities=18% Similarity=0.228 Sum_probs=109.5
Q ss_pred CceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhh-----------------------hHHHHHHHHHHHhcCCCCce
Q 038671 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMA-----------------------SQQEFLNEVKTLTGIRHRNI 497 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~ni 497 (707)
...||+|++|.||+|..++|+.||+|+++........ .......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998779999999998754221110 01123459999999988776
Q ss_pred eeeeeeeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHH-HhCCCCCeEecCCCCCCeeecC
Q 038671 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM-HNDCFPPIVHRDISSKNVLLDL 576 (707)
Q Consensus 498 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~dlk~~Nil~~~ 576 (707)
.....+.. ...++||||++|+++...... ...+++.....++.|++.+|+++ |+. ||+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK---DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh---cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence 44333322 223899999998877654321 23588899999999999999999 688 999999999999998
Q ss_pred CCCeEEeccccceecC
Q 038671 577 ENEAHVSDFGTAKFLK 592 (707)
Q Consensus 577 ~~~~kl~Dfg~~~~~~ 592 (707)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 5889999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.5e-21 Score=209.78 Aligned_cols=249 Identities=28% Similarity=0.372 Sum_probs=178.7
Q ss_pred CCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcc
Q 038671 51 TQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLS 130 (707)
Q Consensus 51 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~ 130 (707)
.+...|++++++++ .+|..+. ++|+.|+|++|.|+.++..+. .+|+.|++++|+++.++.. + .++|+.|+|+
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~LtsLP~~-l--~~~L~~L~Ls 249 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLTSIPAT-L--PDTIQEMELS 249 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccccCChh-h--hccccEEECc
Confidence 34566677766666 3454442 367777777777766555433 4677777777777755432 2 2467888888
Q ss_pred cccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCC
Q 038671 131 HNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQL 210 (707)
Q Consensus 131 ~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 210 (707)
+|.+..+ |..+. ++|+.|+|++|+++. .|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|.++. +
T Consensus 250 ~N~L~~L-P~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-L 319 (754)
T PRK15370 250 INRITEL-PERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-L 319 (754)
T ss_pred CCccCcC-ChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-C
Confidence 8887744 33332 478889999888883 454443 58999999999998 4555443 579999999999994 4
Q ss_pred ccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCccccccc
Q 038671 211 SLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQ 290 (707)
Q Consensus 211 ~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 290 (707)
|..+ .++|+.|++++|.++. +|..+. ++|+.|++++|+++. .|..+. ++|+.|+|++|.++. +|..+. .
T Consensus 320 P~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~N~Lt~-LP~~l~--~ 388 (754)
T PRK15370 320 PETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQITV-LPETLP--PTITTLDVSRNALTN-LPENLP--A 388 (754)
T ss_pred Cccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCCc-CChhhc--CCcCEEECCCCcCCC-CCHhHH--H
Confidence 4433 3789999999999985 555554 799999999999964 455553 689999999999974 555543 3
Q ss_pred ccceEeccccccCCc---hhHhhccCCCceeEeeccCcccc
Q 038671 291 SLEKLNLSHNNLSGF---IPSCFEELHGLSYIDISYNELHG 328 (707)
Q Consensus 291 ~L~~L~l~~n~i~~~---~~~~~~~~~~L~~l~l~~n~~~~ 328 (707)
.|+.|++++|++... ++.....++.+..|++.+|+++.
T Consensus 389 sL~~LdLs~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 389 ALQIMQASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred HHHHHhhccCCcccCchhHHHHhhcCCCccEEEeeCCCccH
Confidence 799999999999854 23344556889999999999974
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=210.90 Aligned_cols=245 Identities=22% Similarity=0.281 Sum_probs=181.9
Q ss_pred CCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCc-hhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPS-EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
++...+.+|++.|=.|.+|+++.|. |+||++.++... ......+-..|++ ...++|||++++.-+-......|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 6777889999999999999998887 899999765432 1222233333444 555689999999888888888888988
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee--cCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF--LKP 593 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~--~~~ 593 (707)
|.. .+|.|.+..+.. +...+.+.|+.|++.|+..+|.. ||+|||||.+||||+.=.-+.|+||..-+- ++.
T Consensus 102 yvk-hnLyDRlSTRPF---L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 102 YVK-HNLYDRLSTRPF---LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred HHh-hhhhhhhccchH---HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 885 688888865432 66777888999999999999999 999999999999999988999999976532 222
Q ss_pred CCC-Cc----cccccccCCCCccccccCC-----------CCccchhHHHHHHHHHHHh-CCCCCCcccccc---cccch
Q 038671 594 DSS-NW----AELAGTYGYVAPELAYTMK-----------VTEKCDVYSFGVLALEVIK-GKHPRDFISSIS---SSSSN 653 (707)
Q Consensus 594 ~~~-~~----~~~~g~~~y~aPE~~~~~~-----------~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~---~~~~~ 653 (707)
++. .+ .+......|.|||.+.... .+++-||||+||+++|+++ |++||...+-.. .....
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~ 254 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADD 254 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccC
Confidence 211 11 2223345699999776421 4668899999999999999 899986422211 11333
Q ss_pred hhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 654 LEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 654 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+..++.+.|. .+++++..|++.||.+|-++++.++.
T Consensus 255 ~e~~Le~Ied~--------------~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 255 PEQLLEKIEDV--------------SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHHhCcCc--------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence 44444444442 37789999999999999999999874
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.8e-20 Score=172.33 Aligned_cols=143 Identities=20% Similarity=0.243 Sum_probs=111.9
Q ss_pred CceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchh-----------------------hhHHHHHHHHHHHhcCCCCce
Q 038671 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEM-----------------------ASQQEFLNEVKTLTGIRHRNI 497 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~h~ni 497 (707)
.+.||+|++|.||+|...+|+.||||++........ .....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 578999999999999877899999999876432100 012234678999999999987
Q ss_pred eeeeeeeecCCceeEEEeeeccCcHHHH-HhcccccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeec
Q 038671 498 VKFYGFCSHARHSFIVYEYLEMGSLAMI-LSNDAAAKDLGWTKRMNVIKGVVDALSYMHN-DCFPPIVHRDISSKNVLLD 575 (707)
Q Consensus 498 v~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nil~~ 575 (707)
.....+... ..++||||++|+++... +.. ..++......++.|++.++.++|+ . ||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 554444333 24899999998865433 321 346788899999999999999999 8 999999999999999
Q ss_pred CCCCeEEeccccceecCC
Q 038671 576 LENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 576 ~~~~~kl~Dfg~~~~~~~ 593 (707)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 89999999999987553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.3e-20 Score=167.54 Aligned_cols=186 Identities=10% Similarity=0.038 Sum_probs=139.1
Q ss_pred CCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCc-hhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCceeEEEe
Q 038671 438 FDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPS-EMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 515 (707)
+.+...+++|+||+||.+.. .+++++.+.+...... .......+.+|++++++++ |+++++++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34567899999999998866 6777887776543211 1112235889999999995 5889999886 34689999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCC-CCCCeeecCCCCeEEeccccceecCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDI-SSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl-k~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
|+.|.+|...... ....++.|++++++++|+. ||+|||| ||+||+++.++.++|+|||++....+.
T Consensus 79 yI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 79 YLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred eecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 9999998754311 1135778999999999999 9999999 799999999999999999999865543
Q ss_pred CCC-----cc--------ccccccCCCCccccccC-CCC-ccchhHHHHHHHHHHHhCCCCC
Q 038671 595 SSN-----WA--------ELAGTYGYVAPELAYTM-KVT-EKCDVYSFGVLALEVIKGKHPR 641 (707)
Q Consensus 595 ~~~-----~~--------~~~g~~~y~aPE~~~~~-~~~-~~~Dv~slG~~l~el~tg~~p~ 641 (707)
... .. ....++.|++|+...-- ..+ .+.+.++-|.-+|.++|+..|+
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 321 00 11247778888854422 233 5678999999999999999885
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.6e-21 Score=197.36 Aligned_cols=227 Identities=24% Similarity=0.318 Sum_probs=179.9
Q ss_pred eeeecCCeeEEEEE----cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCceeEEEeee
Q 038671 443 CIGKGGQGSVYKAE----LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSFIVYEYL 517 (707)
Q Consensus 443 ~lg~G~~g~vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 517 (707)
++|+|+||.|+.++ ...|..++.|+..+......... ....|..++...+ ||.++++...+..+...++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 36899999999873 33467788888765443332222 4556778888886 999999999999999999999999
Q ss_pred ccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCC
Q 038671 518 EMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN 597 (707)
Q Consensus 518 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 597 (707)
.||.+...+.... .+++.....+...++-+++++|+. +++|||+|++||+++.+|.+++.|||.++..-.....
T Consensus 80 rgg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred ccchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999987775433 366777777888999999999999 9999999999999999999999999999875543322
Q ss_pred ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHH
Q 038671 598 WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKL 677 (707)
Q Consensus 598 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (707)
+||..|||||++. .+..++|.||+|++++||+||..||.. .....+...+...|. ...
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~~~~p~----~l~ 211 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAELEMPR----ELS 211 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhccCCch----hhh
Confidence 8999999999998 578899999999999999999999862 334444444444443 344
Q ss_pred HHHHHHHHhccCCCCCCCCCH
Q 038671 678 ISIMEVAISCLDESPESRPTI 698 (707)
Q Consensus 678 ~~l~~li~~cl~~~P~~Rps~ 698 (707)
.....++..+...+|..|.-.
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhcc
Confidence 456777788888899888644
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=187.89 Aligned_cols=211 Identities=27% Similarity=0.442 Sum_probs=159.5
Q ss_pred HhcCCCCceeeeeeeeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCe-EecCC
Q 038671 489 LTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI-VHRDI 567 (707)
Q Consensus 489 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~dl 567 (707)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....+++.....+.++|+.||+|+|+. +| +|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence 3567899999999999999999999999999999999975 345689999999999999999999998 55 99999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCC--CCCccccccccCCCCccccccCC-------CCccchhHHHHHHHHHHHhCC
Q 038671 568 SSKNVLLDLENEAHVSDFGTAKFLKPD--SSNWAELAGTYGYVAPELAYTMK-------VTEKCDVYSFGVLALEVIKGK 638 (707)
Q Consensus 568 k~~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~Dv~slG~~l~el~tg~ 638 (707)
+++|.++|....+|++|||+....... ........-..-|.|||.+.+.. .+.+.||||+|++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998776421 11111223456799999887632 466799999999999999999
Q ss_pred CCCCcccccccccchhhhhhhh-hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 639 HPRDFISSISSSSSNLEIALNE-MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 639 ~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.||+.........+.... +.. ...+..|..+... +.+.++..++..||..+|.+||+++++-..++
T Consensus 156 ~~~~~~~~~~~~~eii~~-~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~ 222 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILR-VKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLL 222 (484)
T ss_pred CccccccccCChHHHHHH-HHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence 999753332211111111 111 1111122221111 34446899999999999999999999987664
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-21 Score=200.99 Aligned_cols=275 Identities=23% Similarity=0.257 Sum_probs=158.8
Q ss_pred eEECCCCccc-cccCcCccCCCCCcEEEcccCcCccc----CCccccCCCCCCeeeccccccccc-------CCCCCCCC
Q 038671 31 DLELSGNKLC-GSIPHSLGNLTQITFLTLFDNALSGA----IPKEYGNLVKLTLLTLENNQLRGP-------IPNLRNLT 98 (707)
Q Consensus 31 ~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~i~~~----~~~~~~~l~~L~~L~l~~n~i~~~-------~~~l~~l~ 98 (707)
.|+|.++.++ ......|..+.+|+.|++++|.++.. ++..+...++|++|+++++.+... +..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4667777776 33444556677788888888877532 234455566677777777666521 11233344
Q ss_pred CccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCC----CchhhhCC-CCCC
Q 038671 99 SLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGS----MPAEIIHS-SQLK 173 (707)
Q Consensus 99 ~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~----~~~~~~~~-~~L~ 173 (707)
+|+.|++++|.+....+..+..+.+ . ++|++|++++|.+++. ....+..+ ++|+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~--------------------~-~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~ 140 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLR--------------------S-SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALE 140 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhc--------------------c-CcccEEEeeCCccchHHHHHHHHHHHhCCCCce
Confidence 5555555555444322222222222 1 2355555555555421 11223334 5666
Q ss_pred EEeCCCCCCCC----CCChhhhCCCCCcEEEecCCccccC----CccccCCCCcccEEEccCCccCCCC----CccccCc
Q 038671 174 VLDLSSNHIVG----EMPSKLGKLSSLIKLILNSNQLCGQ----LSLELGSLTQLERLDLSSNRLSNSI----PKSLGNL 241 (707)
Q Consensus 174 ~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~i~~~~----~~~l~~l 241 (707)
.|++++|.+++ ..+..+..+++|++|++++|.+++. .+..+..+++|++|++++|.+++.. ...+..+
T Consensus 141 ~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~ 220 (319)
T cd00116 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL 220 (319)
T ss_pred EEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhccc
Confidence 66666666552 1233444555666666666666532 2223444567777777777765432 2345566
Q ss_pred ccCceEeeecccccccCchhhhh-----cccCCeeeecCccCCCC----CCcccccccccceEeccccccCCc----hhH
Q 038671 242 VKLHYLNLSNNQFIKKIPVELEK-----LIHLSELDLSHNFLGEE----MPSQICNMQSLEKLNLSHNNLSGF----IPS 308 (707)
Q Consensus 242 ~~L~~L~l~~n~l~~~~~~~~~~-----l~~L~~L~l~~n~l~~~----~~~~~~~~~~L~~L~l~~n~i~~~----~~~ 308 (707)
++|++|++++|.+++.....+.. .+.|++|++++|.+++. ....+..+++|+.+++++|.+... ...
T Consensus 221 ~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~ 300 (319)
T cd00116 221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAE 300 (319)
T ss_pred CCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHH
Confidence 77888888888876544433322 26888888888888632 223445567889999999998855 334
Q ss_pred hhccC-CCceeEeeccCcc
Q 038671 309 CFEEL-HGLSYIDISYNEL 326 (707)
Q Consensus 309 ~~~~~-~~L~~l~l~~n~~ 326 (707)
.+... +.|+.+++.+|+|
T Consensus 301 ~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 301 SLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHhhcCCchhhcccCCCCC
Confidence 55555 6888999888875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=173.99 Aligned_cols=194 Identities=23% Similarity=0.341 Sum_probs=137.2
Q ss_pred CCCceeeeeeeee---------------------------cCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHH
Q 038671 493 RHRNIVKFYGFCS---------------------------HARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIK 545 (707)
Q Consensus 493 ~h~niv~~~~~~~---------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~ 545 (707)
+|||||++.++|. ++...|+||..++ .+|.+++..+ ..+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence 5999999987652 2346799998775 6888888543 346667777899
Q ss_pred HHHHHHHHHHhCCCCCeEecCCCCCCeee--cCCC--CeEEeccccceecCCC------CCCccccccccCCCCcccccc
Q 038671 546 GVVDALSYMHNDCFPPIVHRDISSKNVLL--DLEN--EAHVSDFGTAKFLKPD------SSNWAELAGTYGYVAPELAYT 615 (707)
Q Consensus 546 ~i~~~l~~LH~~~~~~ivH~dlk~~Nil~--~~~~--~~kl~Dfg~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~ 615 (707)
|+++|+.|||.+ ||.|||+|++||++ |+|+ .+.++|||.+---... .+......|.-.-||||+...
T Consensus 349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 999999999999 99999999999999 4444 4789999987432211 122334567788999998775
Q ss_pred CCC------CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhh-hhhhhcCCCCCCCCcchHHHHHHHHHHHHhcc
Q 038671 616 MKV------TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEI-ALNEMLDPRLPTPSHNVQDKLISIMEVAISCL 688 (707)
Q Consensus 616 ~~~------~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 688 (707)
.+- -.++|.|+.|.+.||+++...||..-. ....+. ..++-.-|.++. ..+..+.+++...+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-----em~L~~r~Yqe~qLPalp~------~vpp~~rqlV~~lL 494 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-----EMLLDTRTYQESQLPALPS------RVPPVARQLVFDLL 494 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-----hheechhhhhhhhCCCCcc------cCChHHHHHHHHHh
Confidence 431 237999999999999999999985211 111111 111111222222 23345889999999
Q ss_pred CCCCCCCCCHHHHHHHh
Q 038671 689 DESPESRPTIQKVSQLL 705 (707)
Q Consensus 689 ~~~P~~Rps~~~l~~~L 705 (707)
+.||.+|++..-....|
T Consensus 495 ~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 495 KRDPSKRVSPNIAANVL 511 (598)
T ss_pred cCCccccCCccHHHhHH
Confidence 99999999987665554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.8e-19 Score=197.74 Aligned_cols=194 Identities=23% Similarity=0.278 Sum_probs=163.1
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC---CCceeeeeeeeecCCcee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR---HRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~ 511 (707)
...|.+.+.+|+|+||.||.|...+|+.||+|+-..+...+. .--.+++.||+ -+.|..+..++...+.-+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf------YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF------YICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee------eehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 456778889999999999999877799999999877655442 23334555554 356666777777778889
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC-------CCCeEEec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL-------ENEAHVSD 584 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~-------~~~~kl~D 584 (707)
+|+||.+.|+|.+++. ..+.++|.-++.+..|+++.+++||.. +||||||||+|+++.. ..-++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999985 456799999999999999999999999 9999999999999942 23589999
Q ss_pred cccceecC--CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 038671 585 FGTAKFLK--PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640 (707)
Q Consensus 585 fg~~~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p 640 (707)
||.+..+. ++...+...++|-.+-.+|...|.+.++..|.|.++.+++-|+.|+.-
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99998764 445567788999999999999999999999999999999999998754
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.2e-21 Score=196.77 Aligned_cols=276 Identities=26% Similarity=0.260 Sum_probs=162.5
Q ss_pred eeeccCCeee-ecCCccccCCCCCCeEECCCCccccc----cCcCccCCCCCcEEEcccCcCcc------cCCccccCCC
Q 038671 7 FLYLYNNSFS-GSIPSEIGRLKSLSDLELSGNKLCGS----IPHSLGNLTQITFLTLFDNALSG------AIPKEYGNLV 75 (707)
Q Consensus 7 ~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~------~~~~~~~~l~ 75 (707)
.|+|..+.++ +.....|..+.+|++|+++++.+++. ++..+...++|++|+++++.+.. ..+..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 5788889888 45556678888999999999999532 45566788889999999998872 2345677899
Q ss_pred CCCeeecccccccccCC-CCCCC---CCccEEEeccCcccccc----CccccCC-CCCcEEEccccccccc----CCCCC
Q 038671 76 KLTLLTLENNQLRGPIP-NLRNL---TSLVRVRLNQNHLTGNI----SESFGIH-PNLAFIDLSHNYFYGE----ISSDW 142 (707)
Q Consensus 76 ~L~~L~l~~n~i~~~~~-~l~~l---~~L~~L~l~~n~l~~~~----~~~~~~~-~~L~~L~L~~n~i~~~----~~~~~ 142 (707)
+|++|++++|.+..... .+..+ ++|++|++++|+++... ...+..+ ++|+.|++++|.++.. ....+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 99999999999974222 23333 45888888888876321 1233344 5666666666666521 12233
Q ss_pred CCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccC----CccccCCCC
Q 038671 143 GRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ----LSLELGSLT 218 (707)
Q Consensus 143 ~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~ 218 (707)
..+++|++|++++|.+++.... .++..+..+++|++|++++|.+++. ....+..++
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~--------------------~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~ 221 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIR--------------------ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK 221 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHH--------------------HHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence 3444555555555554421111 1112223334455555555544322 122344556
Q ss_pred cccEEEccCCccCCCCCcccc-----CcccCceEeeecccccccC----chhhhhcccCCeeeecCccCCCCC----Ccc
Q 038671 219 QLERLDLSSNRLSNSIPKSLG-----NLVKLHYLNLSNNQFIKKI----PVELEKLIHLSELDLSHNFLGEEM----PSQ 285 (707)
Q Consensus 219 ~L~~L~l~~n~i~~~~~~~l~-----~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~~----~~~ 285 (707)
+|++|++++|.+++.....+. ..++|+.|++++|.+++.. ...+..+++|+.+++++|.++... ...
T Consensus 222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~ 301 (319)
T cd00116 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAES 301 (319)
T ss_pred CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHH
Confidence 666666666666542222222 1256777777777665321 223444566777777777775432 222
Q ss_pred cccc-cccceEecccccc
Q 038671 286 ICNM-QSLEKLNLSHNNL 302 (707)
Q Consensus 286 ~~~~-~~L~~L~l~~n~i 302 (707)
+... +.|+.+++.+|++
T Consensus 302 ~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 302 LLEPGNELESLWVKDDSF 319 (319)
T ss_pred HhhcCCchhhcccCCCCC
Confidence 2223 5677777776653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=7e-18 Score=159.17 Aligned_cols=137 Identities=14% Similarity=0.222 Sum_probs=104.6
Q ss_pred CCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-----CCCceeeeeeeeecCC---c
Q 038671 438 FDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-----RHRNIVKFYGFCSHAR---H 509 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~ 509 (707)
+.-...||+|+||.||. .-.++.. +||++..... ...+.+.+|+++++.+ .||||+++++++.++. .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 44567899999999996 3334444 7998865322 2346789999999999 5799999999998763 4
Q ss_pred ee-EEEee--eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHH-HHHHhCCCCCeEecCCCCCCeeecCC----CCeE
Q 038671 510 SF-IVYEY--LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDAL-SYMHNDCFPPIVHRDISSKNVLLDLE----NEAH 581 (707)
Q Consensus 510 ~~-lv~e~--~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~dlk~~Nil~~~~----~~~k 581 (707)
.+ +|+|| +.+++|.+++.+. .+++. ..++.|++.++ +|||++ +|+||||||+||+++.. +.++
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEE
Confidence 33 78999 5579999999642 24544 35677888777 999999 99999999999999743 3799
Q ss_pred Eeccccc
Q 038671 582 VSDFGTA 588 (707)
Q Consensus 582 l~Dfg~~ 588 (707)
|+||+-+
T Consensus 150 LiDg~G~ 156 (210)
T PRK10345 150 VCDNIGE 156 (210)
T ss_pred EEECCCC
Confidence 9995444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=161.82 Aligned_cols=149 Identities=18% Similarity=0.216 Sum_probs=114.0
Q ss_pred HHhcCCCCCceeeecCCeeEEEEE--cCCCcEEEEEecCCCCCch---------------------hhhHHHHHHHHHHH
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAE--LPSGEIVAVKKFHSPLPSE---------------------MASQQEFLNEVKTL 489 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~--~~~~~~vavK~~~~~~~~~---------------------~~~~~~~~~e~~~l 489 (707)
....-|++.+.||+|++|.||+|. ..+|+.||+|++....... ......+..|++.+
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 334458899999999999999997 6789999999987532110 00112356899999
Q ss_pred hcCCC--CceeeeeeeeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCC-eEecC
Q 038671 490 TGIRH--RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP-IVHRD 566 (707)
Q Consensus 490 ~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~d 566 (707)
.++.+ ..+++++++ ...++||||++|+++....... ..........++.||+.++++||+. | ++|||
T Consensus 105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~D 174 (237)
T smart00090 105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GELVHGD 174 (237)
T ss_pred HHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCC
Confidence 99975 334555543 2358999999998887654221 2345566789999999999999999 9 99999
Q ss_pred CCCCCeeecCCCCeEEeccccceecC
Q 038671 567 ISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 567 lk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
|||+||+++ ++.++++|||.+....
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999 8899999999987543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7.6e-20 Score=156.43 Aligned_cols=165 Identities=33% Similarity=0.522 Sum_probs=108.3
Q ss_pred ccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcE
Q 038671 47 LGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAF 126 (707)
Q Consensus 47 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~ 126 (707)
+-++++++.|.|++|+++ ..|..++.+++|+.|++++|+|.+++..++++++|+.|++.-|++. +.+..|+.+|.|+.
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 345667777778888887 5666778888888888888888877777777777777777777766 44556666666666
Q ss_pred EEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCcc
Q 038671 127 IDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQL 206 (707)
Q Consensus 127 L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 206 (707)
|||.+|.+.+ ...|+.|..+..|+.|+|++|.+. .+|...+.+++|+.|.+.+|.+
T Consensus 107 ldltynnl~e-----------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndl 162 (264)
T KOG0617|consen 107 LDLTYNNLNE-----------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDL 162 (264)
T ss_pred hhcccccccc-----------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCch
Confidence 6666666542 134444555555555566666555 5555566666666666666666
Q ss_pred ccCCccccCCCCcccEEEccCCccCCCCCcccc
Q 038671 207 CGQLSLELGSLTQLERLDLSSNRLSNSIPKSLG 239 (707)
Q Consensus 207 ~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~ 239 (707)
- ..|..++.++.|+.|++.+|+++ ..|..++
T Consensus 163 l-~lpkeig~lt~lrelhiqgnrl~-vlppel~ 193 (264)
T KOG0617|consen 163 L-SLPKEIGDLTRLRELHIQGNRLT-VLPPELA 193 (264)
T ss_pred h-hCcHHHHHHHHHHHHhcccceee-ecChhhh
Confidence 5 55666666667777777777766 4443333
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-18 Score=173.57 Aligned_cols=175 Identities=22% Similarity=0.365 Sum_probs=139.5
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
.+.|+.|++|...+|.+|+.+.......++.....++.|++.|++| + +.+|+|+||.||++..+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 4688999999999999999877777778999999999999999999 6 899999999999999999999999999
Q ss_pred ceecCCCC------CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhh
Q 038671 588 AKFLKPDS------SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM 661 (707)
Q Consensus 588 ~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 661 (707)
........ .......||..||+||.+.+..|+.++||||||++++|++. +|. ........+..+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~-------T~~er~~t~~d~ 472 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFS-------TQFERIATLTDI 472 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---Hhc-------cHHHHHHhhhhh
Confidence 98776544 12345679999999999999999999999999999999996 222 112233455556
Q ss_pred cCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 038671 662 LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701 (707)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l 701 (707)
.+..+|.. ...+++. =..++.+++...|.+||++.++
T Consensus 473 r~g~ip~~--~~~d~p~-e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 RDGIIPPE--FLQDYPE-EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hcCCCChH--HhhcCcH-HHHHHHHhcCCCcccCchHHHH
Confidence 66666521 2223332 2467889999999999965544
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.9e-17 Score=154.78 Aligned_cols=147 Identities=20% Similarity=0.209 Sum_probs=113.1
Q ss_pred HHHHHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchh-------------------hhHHHHHHHHHHHh
Q 038671 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEM-------------------ASQQEFLNEVKTLT 490 (707)
Q Consensus 430 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~e~~~l~ 490 (707)
++......|.+.+.||+|+||.||++..++|+.||||++........ ........|...+.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 44444445888999999999999999888899999998754321100 01123567888888
Q ss_pred cCCCC--ceeeeeeeeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 038671 491 GIRHR--NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDIS 568 (707)
Q Consensus 491 ~l~h~--niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 568 (707)
.+.|+ .++..++. ...+++|||++|++|...... .....++.+++.++.++|+. |++||||+
T Consensus 89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence 88777 44444432 456899999999998765321 34567889999999999999 99999999
Q ss_pred CCCeeecCCCCeEEeccccceecC
Q 038671 569 SKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 569 ~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
|+||++++++.++|+|||.+....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.9e-17 Score=155.97 Aligned_cols=137 Identities=19% Similarity=0.338 Sum_probs=114.2
Q ss_pred ceeeecCCeeEEEEEcCCCcEEEEEecCCCCCc-----hhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEee
Q 038671 442 HCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPS-----EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
+.||+|++|.||+|.. .|..+++|+....... .......+.+|++.+..++|++++....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5689999999999977 6778999986543221 112234678899999999999988877777777888999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++|++|.+++... .+ .+..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998532 12 7889999999999999999 999999999999999 88999999998865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.9e-17 Score=179.41 Aligned_cols=207 Identities=24% Similarity=0.307 Sum_probs=145.0
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCC-CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPS-GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
..+|..++.|..|+||.||.++++. .+.+|.|. .++. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~--------lilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN--------LILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc--------hhhhc--cccccCCccee---------------
Confidence 4679999999999999999997764 56778743 3221 01110 22223344443
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|+=...++. .++++.. ++.+++|+|+. ||+|||+||+|.+|+.-|++|++|||+++....
T Consensus 136 ------gDc~tllk~---~g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ------GDCATLLKN---IGPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ------chhhhhccc---CCCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 222223322 1223333 27889999999 999999999999999999999999999875321
Q ss_pred CCC---------------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhh
Q 038671 594 DSS---------------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIAL 658 (707)
Q Consensus 594 ~~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 658 (707)
... .....+|||.|+|||++....|...+|.|++|+++||++.|..||.. +..++.+
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG--------dtpeelf 267 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG--------DTPEELF 267 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC--------CCHHHHH
Confidence 100 01235899999999999999999999999999999999999999863 3334444
Q ss_pred hhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCC
Q 038671 659 NEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRP 696 (707)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 696 (707)
..++......++. ....+.+..+++.+.++.+|..|-
T Consensus 268 g~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 268 GQVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence 4444433333333 223445688899999999999995
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.8e-19 Score=151.57 Aligned_cols=156 Identities=33% Similarity=0.499 Sum_probs=86.5
Q ss_pred CCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccE
Q 038671 143 GRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLER 222 (707)
Q Consensus 143 ~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 222 (707)
..+.+++.|.|++|+++ ..+..++.+.+|+.|++.+|+|. ..|..++.++.|+.|+++-|++. ..|..|+.+|.|+.
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 34445555556666655 34444555666666666666665 55555666666666666666655 55555555566666
Q ss_pred EEccCCccCC-CCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccc
Q 038671 223 LDLSSNRLSN-SIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNN 301 (707)
Q Consensus 223 L~l~~n~i~~-~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~ 301 (707)
|||+.|++.+ ..|..|-.+..|+-|+|++|.+ ...|..++++.+|+.|.+.+|.+ -..|..++.+..|++|.+.+|+
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndf-e~lp~dvg~lt~lqil~lrdndl-l~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDF-EILPPDVGKLTNLQILSLRDNDL-LSLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCc-ccCChhhhhhcceeEEeeccCch-hhCcHHHHHHHHHHHHhcccce
Confidence 6665555532 3445555555555555555554 34455555555555555555554 2345555555555555555555
Q ss_pred cC
Q 038671 302 LS 303 (707)
Q Consensus 302 i~ 303 (707)
++
T Consensus 185 l~ 186 (264)
T KOG0617|consen 185 LT 186 (264)
T ss_pred ee
Confidence 54
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-16 Score=152.28 Aligned_cols=133 Identities=20% Similarity=0.350 Sum_probs=107.6
Q ss_pred eeeecCCeeEEEEEcCCCcEEEEEecCCCCCc-----hhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeee
Q 038671 443 CIGKGGQGSVYKAELPSGEIVAVKKFHSPLPS-----EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYL 517 (707)
Q Consensus 443 ~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 517 (707)
.||+|++|.||+|.. +|..+++|+....... ......++.+|++.+..++|+++.....++......+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 5788999986542211 1223466788999999999887665555556667789999999
Q ss_pred ccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 518 EMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 518 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
+|++|.+++..... .++.+++.+|.++|+. |++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999988743211 7899999999999999 999999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.5e-16 Score=170.92 Aligned_cols=141 Identities=21% Similarity=0.311 Sum_probs=113.2
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEec-CCCCC----chhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKF-HSPLP----SEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~-~~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
...|...+.||+|+||.||++...... +++|+. ..... ......+++.+|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345567899999999999999765443 344432 21111 111234568899999999999999988888877778
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++||||++|++|.+++. ....++.++++++.+||+. +++||||||+||++ .++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999998874 3567899999999999999 99999999999999 57899999999997
Q ss_pred ec
Q 038671 590 FL 591 (707)
Q Consensus 590 ~~ 591 (707)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 53
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=144.45 Aligned_cols=139 Identities=21% Similarity=0.260 Sum_probs=98.7
Q ss_pred CceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHH---------------------HHHHHHHHhcCCCC--ce
Q 038671 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQE---------------------FLNEVKTLTGIRHR--NI 497 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~e~~~l~~l~h~--ni 497 (707)
.+.||+|+||.||+|...+++.||||++............. ...|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988889999999986543221111111 13455555555433 24
Q ss_pred eeeeeeeecCCceeEEEeeeccCcHHH-HHhcccccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeec
Q 038671 498 VKFYGFCSHARHSFIVYEYLEMGSLAM-ILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN-DCFPPIVHRDISSKNVLLD 575 (707)
Q Consensus 498 v~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nil~~ 575 (707)
++.+++ ...+++|||++++.+.. .+.... .. .....++.+++.++.++|. . +++||||+|+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence 444443 24689999999854321 111100 01 5678899999999999999 7 999999999999999
Q ss_pred CCCCeEEeccccceecC
Q 038671 576 LENEAHVSDFGTAKFLK 592 (707)
Q Consensus 576 ~~~~~kl~Dfg~~~~~~ 592 (707)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 9999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.4e-15 Score=137.09 Aligned_cols=135 Identities=17% Similarity=0.183 Sum_probs=113.0
Q ss_pred CCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCC--CceeeeeeeeecCCceeEEEeee
Q 038671 440 DEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH--RNIVKFYGFCSHARHSFIVYEYL 517 (707)
Q Consensus 440 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~ 517 (707)
+.+.+|+|.++.||++...+ ..+++|....... ...+..|+..+..++| .+++++++++...+..++++||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 45779999999999998754 7799999865422 3568889999999976 58999999988888999999999
Q ss_pred ccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 518 EMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 518 ~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
+++.+..+ +......++.+++++++++|.....+++|||++|+||++++.+.+++.|||.+..
T Consensus 76 ~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 88776533 4566778899999999999986434799999999999999889999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.2e-16 Score=174.09 Aligned_cols=254 Identities=22% Similarity=0.297 Sum_probs=187.7
Q ss_pred cCCCCCceeeecCCeeEEEEEc--CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCceeE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL--PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l 512 (707)
..|...+.||+|+|+.+-.... .....+|+|.+.... ...........|...-+.+. |+|++++++...+....++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 4577888899999999988844 234556777665543 22233445566777777776 9999999999999999999
Q ss_pred EEeeeccCcHHHHH-hcccccCCCChHHHHHHHHHHHHHHHHHH-hCCCCCeEecCCCCCCeeecCCC-CeEEeccccce
Q 038671 513 VYEYLEMGSLAMIL-SNDAAAKDLGWTKRMNVIKGVVDALSYMH-NDCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTAK 589 (707)
Q Consensus 513 v~e~~~~~~L~~~l-~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~dlk~~Nil~~~~~-~~kl~Dfg~~~ 589 (707)
.+||..|+++.+.+ +... ...+....-.++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..+++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999998887 3222 13566677788999999999999 77 999999999999999999 99999999998
Q ss_pred ecCC-CCC--Ccccccc-ccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC
Q 038671 590 FLKP-DSS--NWAELAG-TYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP 664 (707)
Q Consensus 590 ~~~~-~~~--~~~~~~g-~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 664 (707)
.+.. .+. .....+| ++.|+|||...+.. ..+..|+||.|+++..+++|..||+...... .....+...- ..
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~---~~~~~~~~~~-~~ 249 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD---GRYSSWKSNK-GR 249 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc---ccceeecccc-cc
Confidence 8766 322 2344578 99999999988844 4678899999999999999999997543321 1111111111 11
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 038671 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVS 702 (707)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~ 702 (707)
....+ .........++..+++..+|..|.+.+++.
T Consensus 250 ~~~~~---~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 FTQLP---WNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccCc---cccCChhhhhcccccccCCchhcccccccc
Confidence 01111 122233466778888989999999988764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=141.57 Aligned_cols=138 Identities=16% Similarity=0.262 Sum_probs=106.0
Q ss_pred Cceee-ecCCeeEEEEEcCCCcEEEEEecCCCCC----------chhhhHHHHHHHHHHHhcCCCCce--eeeeeeeecC
Q 038671 441 EHCIG-KGGQGSVYKAELPSGEIVAVKKFHSPLP----------SEMASQQEFLNEVKTLTGIRHRNI--VKFYGFCSHA 507 (707)
Q Consensus 441 ~~~lg-~G~~g~vy~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~ 507 (707)
...|| .|+.|+||.+... +..++||.+..... ........+.+|++.+.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45687 8999999999775 67789998854210 112344568899999999988775 6777764332
Q ss_pred C----ceeEEEeeecc-CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEE
Q 038671 508 R----HSFIVYEYLEM-GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV 582 (707)
Q Consensus 508 ~----~~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl 582 (707)
. ..++|||+++| .+|.+++... +++.. .+.+|+.++.+||+. ||+||||||.||+++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 6998887532 23433 367899999999999 9999999999999999999999
Q ss_pred ecccccee
Q 038671 583 SDFGTAKF 590 (707)
Q Consensus 583 ~Dfg~~~~ 590 (707)
+|||.+..
T Consensus 184 IDfg~~~~ 191 (239)
T PRK01723 184 IDFDRGEL 191 (239)
T ss_pred EECCCccc
Confidence 99998875
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=8.7e-16 Score=147.09 Aligned_cols=232 Identities=25% Similarity=0.325 Sum_probs=162.6
Q ss_pred ccCCCCCCeEECCCCccccc----cCcCccCCCCCcEEEcccC---cCcccCCc-------cccCCCCCCeeeccccccc
Q 038671 23 IGRLKSLSDLELSGNKLCGS----IPHSLGNLTQITFLTLFDN---ALSGAIPK-------EYGNLVKLTLLTLENNQLR 88 (707)
Q Consensus 23 ~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~n---~i~~~~~~-------~~~~l~~L~~L~l~~n~i~ 88 (707)
+..+..+++|+||+|.+... +.+.+.+.++|+..++++= .....+|. ++.+.++|++|+||+|.+.
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 34567888999999988743 3345667788888888753 23334443 3446678999999999886
Q ss_pred cc-CCC----CCCCCCccEEEeccCccccccCcc-------------ccCCCCCcEEEcccccccccC----CCCCCCCC
Q 038671 89 GP-IPN----LRNLTSLVRVRLNQNHLTGNISES-------------FGIHPNLAFIDLSHNYFYGEI----SSDWGRCP 146 (707)
Q Consensus 89 ~~-~~~----l~~l~~L~~L~l~~n~l~~~~~~~-------------~~~~~~L~~L~L~~n~i~~~~----~~~~~~~~ 146 (707)
.- ++. ++++.+|++|+|.+|.++...... ....+.|+.+..++|++.+.. ...|...+
T Consensus 106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~ 185 (382)
T KOG1909|consen 106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHP 185 (382)
T ss_pred ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcc
Confidence 42 222 677899999999999987443332 345678999999999886433 34566778
Q ss_pred CCcEEEcCCCccCCC----CchhhhCCCCCCEEeCCCCCCCC----CCChhhhCCCCCcEEEecCCccccCCcccc----
Q 038671 147 KLGTLDFSSNNITGS----MPAEIIHSSQLKVLDLSSNHIVG----EMPSKLGKLSSLIKLILNSNQLCGQLSLEL---- 214 (707)
Q Consensus 147 ~L~~L~L~~n~i~~~----~~~~~~~~~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---- 214 (707)
.|+.+.++.|.|... ....|..+++|+.|||.+|.++. .+...++.+++|++|++++|.+......+|
T Consensus 186 ~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al 265 (382)
T KOG1909|consen 186 TLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDAL 265 (382)
T ss_pred ccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHH
Confidence 899999999888743 23456778889999999988863 234566677888888888888886555444
Q ss_pred -CCCCcccEEEccCCccCCC----CCccccCcccCceEeeecccc
Q 038671 215 -GSLTQLERLDLSSNRLSNS----IPKSLGNLVKLHYLNLSNNQF 254 (707)
Q Consensus 215 -~~l~~L~~L~l~~n~i~~~----~~~~l~~l~~L~~L~l~~n~l 254 (707)
...|+|+.|.+.+|.|+.. +....+..+.|..|+|++|.+
T Consensus 266 ~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 266 KESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred hccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 2367788888888877642 223344567777777777777
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=7.4e-13 Score=140.31 Aligned_cols=144 Identities=19% Similarity=0.260 Sum_probs=101.4
Q ss_pred CceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhh-------------------------------------HHHHH
Q 038671 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMAS-------------------------------------QQEFL 483 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~-------------------------------------~~~~~ 483 (707)
.+.||.|++|.||+|+.++|+.||||+.++........ +-.+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986542111100 01245
Q ss_pred HHHHHHhcCC-----CCceeeeeeeeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHH-HHHHHHhC
Q 038671 484 NEVKTLTGIR-----HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD-ALSYMHND 557 (707)
Q Consensus 484 ~e~~~l~~l~-----h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~ 557 (707)
+|++.+.+++ ++++.-..-+.......++||||++|+++.++...... .. .+..++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 5666555552 34332222222334457899999999999887643211 11 24456666666 47889988
Q ss_pred CCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 558 ~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
|++|+|++|.||+++.++.++++|||++..+.
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.6e-13 Score=145.93 Aligned_cols=197 Identities=36% Similarity=0.442 Sum_probs=92.9
Q ss_pred EEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCC-CccEEEeccCccccccCccccCCCCCcEEEccccc
Q 038671 55 FLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLT-SLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNY 133 (707)
Q Consensus 55 ~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~-~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~ 133 (707)
.|++..|.+. .....+..++.++.|++.+|.++.+++....+. +|+.|++++|++..++ ..+..+++|+.|++++|+
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i~~~~~~~~~nL~~L~l~~N~i~~l~-~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLP-SPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccccCccccccchhhcccccccccchhhhh-hhhhccccccccccCCch
Confidence 3445444442 122233344455555555555555444444442 5555555555555332 234445555555555555
Q ss_pred ccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccc
Q 038671 134 FYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLE 213 (707)
Q Consensus 134 i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 213 (707)
++.+.+ .....++|+.|++++|.++ ..+........|+.|++++|.+. ..+..+..+.++..|.+.+|++. ..+..
T Consensus 175 l~~l~~-~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~ 250 (394)
T COG4886 175 LSDLPK-LLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPES 250 (394)
T ss_pred hhhhhh-hhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccch
Confidence 553321 1124445555555555555 23333333344555555555322 33344455555555555555554 22344
Q ss_pred cCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCc
Q 038671 214 LGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIP 259 (707)
Q Consensus 214 ~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~ 259 (707)
+..++++++|++++|.++.... ++.+.+|+.|++++|.+....+
T Consensus 251 ~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 251 IGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred hccccccceecccccccccccc--ccccCccCEEeccCccccccch
Confidence 4455555555555555553332 4555555555555555544433
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.5e-13 Score=129.03 Aligned_cols=203 Identities=22% Similarity=0.325 Sum_probs=140.8
Q ss_pred HHHHhcCCCCceeeeeeeeecCC-----ceeEEEeeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCC
Q 038671 486 VKTLTGIRHRNIVKFYGFCSHAR-----HSFIVYEYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCF 559 (707)
Q Consensus 486 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 559 (707)
..-+-++-|.|+|+++.|+.+.. +..++.||+..|++..++++.. ..+.+......+|+.||..||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 34455567999999999986543 5788999999999999997543 345578888899999999999999986 6
Q ss_pred CCeEecCCCCCCeeecCCCCeEEeccccceecCCC----CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHH
Q 038671 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD----SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI 635 (707)
Q Consensus 560 ~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 635 (707)
|.++|+++..+.|++..+|-+|+.--.-......- ......-.+-++|.+||.-.....+.++|||+||....+|.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 79999999999999999999997432211110000 00011124578999999877777788999999999999998
Q ss_pred hCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 636 KGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 636 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
-|..--.. .......+.........--.. . -..++..|++..|..||+|.+++.
T Consensus 277 ilEiq~tn----seS~~~~ee~ia~~i~~len~----l------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTN----SESKVEVEENIANVIIGLENG----L------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCC----CcceeehhhhhhhheeeccCc----c------ccCcCcccccCCCCCCcchhhhhc
Confidence 87643110 011112222222222111110 0 135677899999999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.9e-13 Score=141.83 Aligned_cols=248 Identities=27% Similarity=0.296 Sum_probs=182.7
Q ss_pred hcCCCCCceeee--cCCeeEEEEEc---CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCC
Q 038671 435 TNDFDDEHCIGK--GGQGSVYKAEL---PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHAR 508 (707)
Q Consensus 435 ~~~~~~~~~lg~--G~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 508 (707)
...|...+.+|. |.+|.+|.++. .++..+|+|+-+.+...... ...=.+|+...+.++ |++.++.+..+...+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCcccccCC
Confidence 345778888999 99999999965 56888999986554432211 122245666666664 999999999999999
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHH----HHHHHHhCCCCCeEecCCCCCCeeecCC-CCeEEe
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD----ALSYMHNDCFPPIVHRDISSKNVLLDLE-NEAHVS 583 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~dlk~~Nil~~~~-~~~kl~ 583 (707)
..++-+|++. .++..+.+... ..++....+....+..+ |+.++|+. +++|-|+||.||+...+ ...+++
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred cceeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecC
Confidence 9999999885 77777765432 33677788888888888 99999999 99999999999999999 889999
Q ss_pred ccccceecCCCCCCc-----cccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcc--cccccccchhhh
Q 038671 584 DFGTAKFLKPDSSNW-----AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFI--SSISSSSSNLEI 656 (707)
Q Consensus 584 Dfg~~~~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~--~~~~~~~~~~~~ 656 (707)
|||+...+....-.. ....|...|++||...+. ++..+|+|++|.++.+..+|..+...- ..|..
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~------- 337 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ------- 337 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccc-------
Confidence 999998887654221 122677889999987764 889999999999999999987764321 11111
Q ss_pred hhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 657 ALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..... .+.+.+.....++...+..|++.+|..|++.+.+..
T Consensus 338 -~r~~~-----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 -LRQGY-----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -ccccc-----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11100 111222222344666888999999999999887654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.1e-12 Score=135.12 Aligned_cols=169 Identities=20% Similarity=0.267 Sum_probs=130.2
Q ss_pred EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeeccCcHHHHHhcccccCCC
Q 038671 456 ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDL 535 (707)
Q Consensus 456 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l 535 (707)
+..++.+|.|.++..... ...+...+.++.++.++||+|+++++.+...+..|+|+|.+. .|..++.+ +
T Consensus 33 ~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l 101 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------L 101 (690)
T ss_pred eeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------h
Confidence 455788888888765422 344567788999999999999999999999999999999884 67666653 2
Q ss_pred ChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCccccccccCCCCcccccc
Q 038671 536 GWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT 615 (707)
Q Consensus 536 ~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 615 (707)
........+.||+.||.|||+.| +++|++|....|+|++.|+.||++|.++..............--..|..|+.+..
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence 34566677899999999999776 9999999999999999999999999998765433322222233334667765433
Q ss_pred CCCCccchhHHHHHHHHHHHhCCC
Q 038671 616 MKVTEKCDVYSFGVLALEVIKGKH 639 (707)
Q Consensus 616 ~~~~~~~Dv~slG~~l~el~tg~~ 639 (707)
.. -..|.|.||++++|++.|..
T Consensus 180 s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCccc
Confidence 22 34699999999999999933
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.7e-15 Score=142.85 Aligned_cols=136 Identities=26% Similarity=0.323 Sum_probs=100.9
Q ss_pred CCCCCcEEEecCCccccCCc----cccCCCCcccEEEccCCccCCC----CCccccCcccCceEeeecccccccC----c
Q 038671 192 KLSSLIKLILNSNQLCGQLS----LELGSLTQLERLDLSSNRLSNS----IPKSLGNLVKLHYLNLSNNQFIKKI----P 259 (707)
Q Consensus 192 ~l~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~l~~n~i~~~----~~~~l~~l~~L~~L~l~~n~l~~~~----~ 259 (707)
.-+.|+.+..+.|++..... ..|...+.|+.+.+++|.|... ....|..+++|+.|||.+|.++... .
T Consensus 155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~La 234 (382)
T KOG1909|consen 155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALA 234 (382)
T ss_pred CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHH
Confidence 34678888888888874332 3355678888888888888532 3356778899999999999887553 3
Q ss_pred hhhhhcccCCeeeecCccCCCCCCcccc-----cccccceEeccccccCCc----hhHhhccCCCceeEeeccCccc
Q 038671 260 VELEKLIHLSELDLSHNFLGEEMPSQIC-----NMQSLEKLNLSHNNLSGF----IPSCFEELHGLSYIDISYNELH 327 (707)
Q Consensus 260 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~-----~~~~L~~L~l~~n~i~~~----~~~~~~~~~~L~~l~l~~n~~~ 327 (707)
..++.+++|++|++++|.+......+|. ..++|+.|.+.+|.|+.. +..++...|.|..|+|++|++.
T Consensus 235 kaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 235 KALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 4567788899999999999775544433 257899999999999733 3345566899999999999984
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.8e-13 Score=143.11 Aligned_cols=201 Identities=35% Similarity=0.413 Sum_probs=161.9
Q ss_pred eEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCC-CCCeeecccccccccCCCCCCCCCccEEEeccCc
Q 038671 31 DLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLV-KLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNH 109 (707)
Q Consensus 31 ~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~ 109 (707)
.|.++.+.+. .....+..++.++.|++.+|.++ .++.....++ +|+.|++++|++..++..+..+++|+.|++++|+
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchhhhhhhhhccccccccccCCch
Confidence 6888888885 33445667788999999999998 5566677774 9999999999999887788999999999999999
Q ss_pred cccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChh
Q 038671 110 LTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSK 189 (707)
Q Consensus 110 l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 189 (707)
+..++. ..+..++|+.|++++|++..+.. .......|++|.+++|.+. ..+..+..+.++..+.+.+|++. ..+..
T Consensus 175 l~~l~~-~~~~~~~L~~L~ls~N~i~~l~~-~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~ 250 (394)
T COG4886 175 LSDLPK-LLSNLSNLNNLDLSGNKISDLPP-EIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPES 250 (394)
T ss_pred hhhhhh-hhhhhhhhhheeccCCccccCch-hhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccch
Confidence 997654 23378899999999999986543 2345556999999999644 46667888899999999999987 44777
Q ss_pred hhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCcccc
Q 038671 190 LGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLG 239 (707)
Q Consensus 190 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~ 239 (707)
++.+++++.|++++|.++.... +..+.+++.|++++|.+....+....
T Consensus 251 ~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 251 IGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred hccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhc
Confidence 8889999999999999995444 88999999999999999866654443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.3e-14 Score=138.66 Aligned_cols=186 Identities=28% Similarity=0.291 Sum_probs=104.5
Q ss_pred CCCCCcEEEcCCCccCCC--CchhhhCCCCCCEEeCCCCCCCCCCCh-hhhCCCCCcEEEecCCccccC-CccccCCCCc
Q 038671 144 RCPKLGTLDFSSNNITGS--MPAEIIHSSQLKVLDLSSNHIVGEMPS-KLGKLSSLIKLILNSNQLCGQ-LSLELGSLTQ 219 (707)
Q Consensus 144 ~~~~L~~L~L~~n~i~~~--~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~ 219 (707)
.|++++.|+|++|-+... .......+++|+.|+|+.|++...... .-..+++|+.|.|+.|.++.. ....+..+|+
T Consensus 144 ~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPs 223 (505)
T KOG3207|consen 144 ILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPS 223 (505)
T ss_pred hCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCc
Confidence 344444444444444321 112223345555555555544311100 011345666777777766622 1222345677
Q ss_pred ccEEEccCCccCCCCCccccCcccCceEeeecccccccCc-hhhhhcccCCeeeecCccCCCCC-Ccc-----ccccccc
Q 038671 220 LERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIP-VELEKLIHLSELDLSHNFLGEEM-PSQ-----ICNMQSL 292 (707)
Q Consensus 220 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~-~~~-----~~~~~~L 292 (707)
|+.|+|..|............+..|+.|+|++|++.+... ...+.++.|..|+++.|.++..- |+. ...+++|
T Consensus 224 l~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL 303 (505)
T KOG3207|consen 224 LEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKL 303 (505)
T ss_pred HHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccc
Confidence 7777777774322333344445677777777777755432 23566677777777777775532 222 3456788
Q ss_pred ceEeccccccCCchh-HhhccCCCceeEeeccCccccc
Q 038671 293 EKLNLSHNNLSGFIP-SCFEELHGLSYIDISYNELHGS 329 (707)
Q Consensus 293 ~~L~l~~n~i~~~~~-~~~~~~~~L~~l~l~~n~~~~~ 329 (707)
+.|+++.|+|.++.. ..+..+++|+.|....|+++..
T Consensus 304 ~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~e 341 (505)
T KOG3207|consen 304 EYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNKE 341 (505)
T ss_pred eeeecccCccccccccchhhccchhhhhhccccccccc
Confidence 888888888875532 5566677888888888887744
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.5e-12 Score=142.79 Aligned_cols=118 Identities=31% Similarity=0.536 Sum_probs=72.5
Q ss_pred CceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeecc
Q 038671 244 LHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISY 323 (707)
Q Consensus 244 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~ 323 (707)
++.|+|++|.+.+..|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|+.+..+++|+.|++++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 55666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CcccccCCCccc--cccCchhhcccCcCcCCCCCCCCCcCC
Q 038671 324 NELHGSIPNSTA--FRDAPMEALQGNKGLCGDIKGFPSCKA 362 (707)
Q Consensus 324 n~~~~~~~~~~~--~~~~~~~~~~~~~~~c~~~~~~~~c~~ 362 (707)
|+++|.+|.... ........+.+|+.+|+. +..+.|.+
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~-p~l~~C~~ 539 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGI-PGLRACGP 539 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCC-CCCCCCcc
Confidence 666666654321 112223445666677763 23455643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=5.4e-12 Score=134.90 Aligned_cols=147 Identities=17% Similarity=0.212 Sum_probs=94.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCC-CcEEEEEecCCCCCchh-------------------------------hhHH--
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPS-GEIVAVKKFHSPLPSEM-------------------------------ASQQ-- 480 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~-------------------------------~~~~-- 480 (707)
-..|+. +.+|+|++|.||+|+.++ |+.||||+.++...... +-.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 445776 789999999999998877 99999999875421100 0011
Q ss_pred ----HHHHHHHHHhcCC----CCceeeeeeee-ecCCceeEEEeeeccCcHHHHH--hcccc-cCCCChHHHHHHHHHHH
Q 038671 481 ----EFLNEVKTLTGIR----HRNIVKFYGFC-SHARHSFIVYEYLEMGSLAMIL--SNDAA-AKDLGWTKRMNVIKGVV 548 (707)
Q Consensus 481 ----~~~~e~~~l~~l~----h~niv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l--~~~~~-~~~l~~~~~~~i~~~i~ 548 (707)
.+.+|+..+.+++ +...+.+-.++ ......++||||++|+++.+.- ...+. .+.+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 1444554444442 33223322222 2245678999999999998753 21110 0112222333334443
Q ss_pred HHHHHHHhCCCCCeEecCCCCCCeeecCCC----CeEEeccccceecC
Q 038671 549 DALSYMHNDCFPPIVHRDISSKNVLLDLEN----EAHVSDFGTAKFLK 592 (707)
Q Consensus 549 ~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~----~~kl~Dfg~~~~~~ 592 (707)
... |++|+|++|.||+++.++ .+++.|||++..+.
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 446 999999999999999888 99999999998764
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-13 Score=136.28 Aligned_cols=209 Identities=26% Similarity=0.284 Sum_probs=118.2
Q ss_pred CCCCCccEEEeccCccccccC-ccccCCCCCcEEEcccccccccC--CCCCCCCCCCcEEEcCCCccCCCCchh-hhCCC
Q 038671 95 RNLTSLVRVRLNQNHLTGNIS-ESFGIHPNLAFIDLSHNYFYGEI--SSDWGRCPKLGTLDFSSNNITGSMPAE-IIHSS 170 (707)
Q Consensus 95 ~~l~~L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~L~~n~i~~~~--~~~~~~~~~L~~L~L~~n~i~~~~~~~-~~~~~ 170 (707)
+++.+|+++.|.++.+..... +....+++++.|||+.|-++... ......+|+|+.|+|+.|++....... -..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 455667777777766664432 23455677777777777666322 233456677777777777665221111 11356
Q ss_pred CCCEEeCCCCCCC-CCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCC-CccccCcccCceEe
Q 038671 171 QLKVLDLSSNHIV-GEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSI-PKSLGNLVKLHYLN 248 (707)
Q Consensus 171 ~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~-~~~l~~l~~L~~L~ 248 (707)
+|+.|.|+.|.++ ..+...+..+|+|+.|+|..|..-.........+..|+.|+|++|.+-+.. -...+.++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 6777777777665 222333445677777777777422233333445666777777777665322 13445666777777
Q ss_pred eecccccccC-chh-----hhhcccCCeeeecCccCCCC-CCcccccccccceEeccccccC
Q 038671 249 LSNNQFIKKI-PVE-----LEKLIHLSELDLSHNFLGEE-MPSQICNMQSLEKLNLSHNNLS 303 (707)
Q Consensus 249 l~~n~l~~~~-~~~-----~~~l~~L~~L~l~~n~l~~~-~~~~~~~~~~L~~L~l~~n~i~ 303 (707)
++.+.+..+. |+. ...+++|+.|+++.|+|.+. ....+..+++|+.|.+..|.++
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 7776665442 221 24456677777777776431 1233445566666666677665
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.34 E-value=2e-13 Score=127.77 Aligned_cols=204 Identities=23% Similarity=0.207 Sum_probs=137.1
Q ss_pred CCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCC-CCCCCChhhhCCCCCcE
Q 038671 120 IHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNH-IVGEMPSKLGKLSSLIK 198 (707)
Q Consensus 120 ~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~ 198 (707)
...+|..+.++++.-..+. +....-|.|.++.+.+..+.. ...+.....+....-+.-. .++.....+.....|++
T Consensus 212 ~f~~l~~~~~s~~~~~~i~-~~~~~kptl~t~~v~~s~~~~--~~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~Lte 288 (490)
T KOG1259|consen 212 AFRNLKTLKFSALSTENIV-DIELLKPTLQTICVHNTTIQD--VPSLLPETILADPSGSEPSTSNGSALVSADTWQELTE 288 (490)
T ss_pred Hhhhhheeeeeccchhhee-ceeecCchhheeeeecccccc--cccccchhhhcCccCCCCCccCCceEEecchHhhhhh
Confidence 3455555555555443221 112223556666665554431 1112222222222222111 11222333445578999
Q ss_pred EEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccC
Q 038671 199 LILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFL 278 (707)
Q Consensus 199 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 278 (707)
|+|++|.|+ .+.....-.|.++.|++|+|.|+.+ ..++.+++|+.||||+|.++.. ..+-.++-+++.|.|++|.|
T Consensus 289 lDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~-~Gwh~KLGNIKtL~La~N~i 364 (490)
T KOG1259|consen 289 LDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAEC-VGWHLKLGNIKTLKLAQNKI 364 (490)
T ss_pred ccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhh-hhhHhhhcCEeeeehhhhhH
Confidence 999999998 5666777789999999999999744 3388899999999999998643 44556778899999999999
Q ss_pred CCCCCcccccccccceEeccccccCCchh-HhhccCCCceeEeeccCcccccCCC
Q 038671 279 GEEMPSQICNMQSLEKLNLSHNNLSGFIP-SCFEELHGLSYIDISYNELHGSIPN 332 (707)
Q Consensus 279 ~~~~~~~~~~~~~L~~L~l~~n~i~~~~~-~~~~~~~~L~~l~l~~n~~~~~~~~ 332 (707)
.+ ...+.++-+|..||+++|+|..... ..++++|-|+++.+.+||+.+.+.-
T Consensus 365 E~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vdY 417 (490)
T KOG1259|consen 365 ET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVDY 417 (490)
T ss_pred hh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccchH
Confidence 43 3567888999999999999986533 6788999999999999999987654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.1e-13 Score=127.76 Aligned_cols=128 Identities=32% Similarity=0.330 Sum_probs=61.1
Q ss_pred CCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEe
Q 038671 122 PNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLIL 201 (707)
Q Consensus 122 ~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 201 (707)
..|++||||+|.|+.+ .+...-.|.++.|++++|.|+.+. .++.+++|+.|||++|.++ ....+-..+-++++|.|
T Consensus 284 q~LtelDLS~N~I~~i-DESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLITQI-DESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchhhh-hhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 4455555555555522 233444555555555555555221 2445555555555555554 33333334445555555
Q ss_pred cCCccccCCccccCCCCcccEEEccCCccCCCC-CccccCcccCceEeeeccccc
Q 038671 202 NSNQLCGQLSLELGSLTQLERLDLSSNRLSNSI-PKSLGNLVKLHYLNLSNNQFI 255 (707)
Q Consensus 202 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~-~~~l~~l~~L~~L~l~~n~l~ 255 (707)
++|.|.. ...+..+-+|.+||+++|+|.... ...++++|.|+.|.|.+|++.
T Consensus 360 a~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 360 AQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 5555541 222344444555555555554321 134445555555555555543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.9e-14 Score=147.82 Aligned_cols=242 Identities=30% Similarity=0.299 Sum_probs=110.0
Q ss_pred CCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcc
Q 038671 51 TQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLS 130 (707)
Q Consensus 51 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~ 130 (707)
..++.+++..|.|. .+-..+..+.+|+.|++.+|+|..+...+..+++|++|++++|.|+.+ ..+..++.|+.|+++
T Consensus 72 ~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 72 TSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLS 148 (414)
T ss_pred HhHHhhccchhhhh-hhhcccccccceeeeeccccchhhcccchhhhhcchheeccccccccc--cchhhccchhhheec
Confidence 33444444444444 122234444444444444444443322244444444444444444433 223334444445555
Q ss_pred cccccccCCCCCCCCCCCcEEEcCCCccCCCCc-hhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccC
Q 038671 131 HNYFYGEISSDWGRCPKLGTLDFSSNNITGSMP-AEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ 209 (707)
Q Consensus 131 ~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~-~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 209 (707)
+|.|+.+ ..+..++.|+.+++++|.+..... . ...+.+++.+++.+|.+.. ...+..+..+..+++..|.++..
T Consensus 149 ~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~ 223 (414)
T KOG0531|consen 149 GNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKL 223 (414)
T ss_pred cCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceec
Confidence 5544433 223334455555555555442222 1 2344455555555555431 12233333444445555555422
Q ss_pred CccccCCCC--cccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCC---CCc
Q 038671 210 LSLELGSLT--QLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEE---MPS 284 (707)
Q Consensus 210 ~~~~~~~l~--~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~ 284 (707)
.+ +..+. .|+.+++++|++. ..+..+..++.+..|++.+|++... ..+.....+..+....|.+... ...
T Consensus 224 ~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (414)
T KOG0531|consen 224 EG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQE 298 (414)
T ss_pred cC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhcc
Confidence 11 11222 2556666666555 2224455556666666666665432 2233344555555555555321 111
Q ss_pred -ccccccccceEeccccccCCc
Q 038671 285 -QICNMQSLEKLNLSHNNLSGF 305 (707)
Q Consensus 285 -~~~~~~~L~~L~l~~n~i~~~ 305 (707)
.....+.+..+.+.+|++...
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~ 320 (414)
T KOG0531|consen 299 YITSAAPTLVTLTLELNPIRKI 320 (414)
T ss_pred ccccccccccccccccCccccc
Confidence 134556777777777777654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-12 Score=118.33 Aligned_cols=127 Identities=28% Similarity=0.280 Sum_probs=38.8
Q ss_pred cCCCCCcEEEcccCcCcccCCcccc-CCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcE
Q 038671 48 GNLTQITFLTLFDNALSGAIPKEYG-NLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAF 126 (707)
Q Consensus 48 ~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~ 126 (707)
.+...+++|+|++|.|+.+ +.++ .+.+|+.|+|++|.|+.+ +++..++.|++|++++|+|+.+.......+++|++
T Consensus 16 ~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 16 NNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE 92 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred ccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence 3444455666666665532 2333 355566666666666643 34556666666666666666553322234666777
Q ss_pred EEcccccccccCC-CCCCCCCCCcEEEcCCCccCCCC---chhhhCCCCCCEEeC
Q 038671 127 IDLSHNYFYGEIS-SDWGRCPKLGTLDFSSNNITGSM---PAEIIHSSQLKVLDL 177 (707)
Q Consensus 127 L~L~~n~i~~~~~-~~~~~~~~L~~L~L~~n~i~~~~---~~~~~~~~~L~~L~l 177 (707)
|+|++|+|.+... ..++.+++|+.|+|.+|+++... ...+..+|+|+.||-
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 7777776664322 34556677777777777766321 223455667776653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.3e-12 Score=118.32 Aligned_cols=125 Identities=26% Similarity=0.351 Sum_probs=39.6
Q ss_pred CCCCCeEECCCCccccccCcCcc-CCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCC-CCCCCccEE
Q 038671 26 LKSLSDLELSGNKLCGSIPHSLG-NLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNL-RNLTSLVRV 103 (707)
Q Consensus 26 l~~L~~L~l~~n~i~~~~~~~~~-~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l-~~l~~L~~L 103 (707)
..++++|+|++|.|+.+ +.+. .+.+|+.|+|++|.|+.. +.+..+++|+.|++++|.|+.+.+.+ ..+++|++|
T Consensus 18 ~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 18 PVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQEL 93 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EE
T ss_pred ccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEE
Confidence 34566666666666632 2243 456666666666666633 24666666666666666666554333 246666666
Q ss_pred EeccCccccccC-ccccCCCCCcEEEcccccccccCC---CCCCCCCCCcEEEcC
Q 038671 104 RLNQNHLTGNIS-ESFGIHPNLAFIDLSHNYFYGEIS---SDWGRCPKLGTLDFS 154 (707)
Q Consensus 104 ~l~~n~l~~~~~-~~~~~~~~L~~L~L~~n~i~~~~~---~~~~~~~~L~~L~L~ 154 (707)
++++|+|..+.. ..+..+++|+.|+|.+|.++.... ..+..+|+|+.||-.
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETTE
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCCE
Confidence 666666665432 445566777777777777663311 123456777766543
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.9e-13 Score=138.86 Aligned_cols=199 Identities=32% Similarity=0.436 Sum_probs=149.0
Q ss_pred EEeccCccccccCccc-cCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCC
Q 038671 103 VRLNQNHLTGNISESF-GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNH 181 (707)
Q Consensus 103 L~l~~n~l~~~~~~~~-~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~ 181 (707)
|.|++-++...+..++ -.+..-...||+.|++. ..+..+..+-.|+.+.|..|.+. ..+..+..+..|++|||+.|+
T Consensus 55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nq 132 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQ 132 (722)
T ss_pred cccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccch
Confidence 3344444443333333 34566677888899888 55667778888888889988888 778888888889999999998
Q ss_pred CCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchh
Q 038671 182 IVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE 261 (707)
Q Consensus 182 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 261 (707)
++ ..|..+..++ |+.|.+++|+++ .+|..++..+.|..||.+.|.+. ..|..++++.+|+.|.+..|.+.. .|..
T Consensus 133 lS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~-lp~E 207 (722)
T KOG0532|consen 133 LS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLED-LPEE 207 (722)
T ss_pred hh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhh-CCHH
Confidence 88 7777777764 888888888888 67777888888888888888887 566678888888888888888754 4555
Q ss_pred hhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhc
Q 038671 262 LEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFE 311 (707)
Q Consensus 262 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~ 311 (707)
+.. -.|..||+|.|+++ .+|-.|.+|+.|++|-|.+|+++. .|..++
T Consensus 208 l~~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS-PPAqIC 254 (722)
T KOG0532|consen 208 LCS-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS-PPAQIC 254 (722)
T ss_pred HhC-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC-ChHHHH
Confidence 554 35788888888884 577788888888888888888873 344433
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.8e-11 Score=109.41 Aligned_cols=141 Identities=17% Similarity=0.240 Sum_probs=101.1
Q ss_pred CceeeecCCeeEEEEEcCC-------CcEEEEEecCCCCC-----------c--------hhhhHHHHH----HHHHHHh
Q 038671 441 EHCIGKGGQGSVYKAELPS-------GEIVAVKKFHSPLP-----------S--------EMASQQEFL----NEVKTLT 490 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~~-------~~~vavK~~~~~~~-----------~--------~~~~~~~~~----~e~~~l~ 490 (707)
...||.|--+.||.|...+ +..+|||+++.... . .......+. +|.+.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999996442 57899998743210 0 011123344 7999999
Q ss_pred cCC--CCceeeeeeeeecCCceeEEEeeeccCcHHH-HHhcccccCCCChHHHHHHHHHHHHHHHHH-HhCCCCCeEecC
Q 038671 491 GIR--HRNIVKFYGFCSHARHSFIVYEYLEMGSLAM-ILSNDAAAKDLGWTKRMNVIKGVVDALSYM-HNDCFPPIVHRD 566 (707)
Q Consensus 491 ~l~--h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~d 566 (707)
++. .-+++.++++ ...++||||+.++.+.. .++. ..++..+...+..+++.+|..+ |.. |+||||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 985 3566777765 45679999998654421 2221 1244456677889999999999 788 999999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCC
Q 038671 567 ISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 567 lk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
+++.||+++ ++.+.++|||.+.....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 999999997 57899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.4e-10 Score=112.89 Aligned_cols=255 Identities=18% Similarity=0.246 Sum_probs=165.7
Q ss_pred CCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeee------eecCC-ce
Q 038671 439 DDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGF------CSHAR-HS 510 (707)
Q Consensus 439 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~------~~~~~-~~ 510 (707)
..++.+|+|+.+.+|..-.- +..+.|+++.+.... . .+.+.+|... .||-+-.-+.+ ..+.+ ..
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~---~---aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAA---Q---AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCCchH---H---HHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 45677999999999976321 223668877654322 1 1223344433 56654331211 12222 35
Q ss_pred eEEEeeeccC-cHHHHHhcc---cccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 511 FIVYEYLEMG-SLAMILSND---AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 511 ~lv~e~~~~~-~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
.++|..+.|. ...++.... +.-....|...+++++.++.+.+.||.+ |.+-||+.++|+|+.+++.|.+.|-+
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence 6778877653 344443221 2222378999999999999999999999 99999999999999999999999877
Q ss_pred cceecCCCCCCccccccccCCCCccccc-----cCCCCccchhHHHHHHHHHHHhC-CCCCCcccccccccchhhhhhhh
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
.-... ..+......+|...|.+||... +...+...|.|.||+++++++.| ++||..+..........+..+..
T Consensus 163 sfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 163 SFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred ceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 55443 3344567788999999999765 33456789999999999999985 99998655444333333322111
Q ss_pred --------hcCCCCCCCCc-chHHHHHHHHHHHHhccCC--CCCCCCCHHHHHHHh
Q 038671 661 --------MLDPRLPTPSH-NVQDKLISIMEVAISCLDE--SPESRPTIQKVSQLL 705 (707)
Q Consensus 661 --------~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~--~P~~Rps~~~l~~~L 705 (707)
...+..+.+.. -..-.+.++..+..+|+.. .|.-||+++.++..|
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl 297 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAAL 297 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence 11122222211 1122345677777888854 467999999887765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.5e-11 Score=114.18 Aligned_cols=131 Identities=18% Similarity=0.167 Sum_probs=95.1
Q ss_pred CceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCc-eeeeeeeeecCCceeEEEeeecc
Q 038671 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN-IVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
.+.++.|.++.||+++.. ++.+++|+...... ....+..|+..++.+.+.+ +++++.+.. ...++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCC
Confidence 356889999999999865 77899999754321 1224567888888885444 345555543 345799999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCC--CCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC--FPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
.++... .. .....+.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 76 ~~l~~~--------~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE--------DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc--------cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 877543 01 11245678999999999982 11259999999999999 67899999998853
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.3e-13 Score=142.65 Aligned_cols=247 Identities=28% Similarity=0.318 Sum_probs=188.1
Q ss_pred cCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEE
Q 038671 24 GRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRV 103 (707)
Q Consensus 24 ~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L 103 (707)
..+..++.+++..|.|+. ....+..+++|+.|++.+|.|.. +...+..+++|++|++++|.|+. ..++..++.|+.|
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~-i~~l~~l~~L~~L 145 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITK-LEGLSTLTLLKEL 145 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheecccccccc-ccchhhccchhhh
Confidence 456788888899999883 44557888999999999999984 33447889999999999999985 4457777789999
Q ss_pred EeccCccccccCccccCCCCCcEEEcccccccccCC-CCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCC
Q 038671 104 RLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEIS-SDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHI 182 (707)
Q Consensus 104 ~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~-~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l 182 (707)
++.+|.|+.+ ..+..+..|+.+++++|++..+.. . ...+.+++.+++.+|.+.. ...+..+..+..+++..|.+
T Consensus 146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKI 220 (414)
T ss_pred eeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccc
Confidence 9999999976 345668999999999999987655 3 5788999999999999883 33344455666669999998
Q ss_pred CCCCChhhhCCC--CCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeeccccccc---
Q 038671 183 VGEMPSKLGKLS--SLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKK--- 257 (707)
Q Consensus 183 ~~~~~~~~~~l~--~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~--- 257 (707)
+...+ +..+. .|+++++++|.+. ..+..+..++++..|++..|++... ..+...+.+..+..+.|++...
T Consensus 221 ~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (414)
T KOG0531|consen 221 SKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAI 295 (414)
T ss_pred eeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhh
Confidence 74332 22333 3899999999998 4436677899999999999999744 3355667888888888887532
Q ss_pred Cchh-hhhcccCCeeeecCccCCCCCC
Q 038671 258 IPVE-LEKLIHLSELDLSHNFLGEEMP 283 (707)
Q Consensus 258 ~~~~-~~~l~~L~~L~l~~n~l~~~~~ 283 (707)
.... ....+.+..+.+..|.+....+
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 296 SQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred hccccccccccccccccccCccccccc
Confidence 1111 4566789999999998866444
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.5e-11 Score=104.51 Aligned_cols=134 Identities=23% Similarity=0.341 Sum_probs=102.1
Q ss_pred ceeeecCCeeEEEEEcCCCcEEEEEec-----CCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEee
Q 038671 442 HCIGKGGQGSVYKAELPSGEIVAVKKF-----HSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~~~~~vavK~~-----~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
..+++|+-+.+|.+.+. |.++++|.- ..+..++.-...+..+|++++..++--.|...+-+..+++...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999764 434555532 223333444556688899999998765665555566677778899999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++|..|.+.+... ...++..+-+-+.-||.. ||+|||+.++||++..+ .+.++|||++.+
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~-~i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGG-RIYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCC-cEEEEECCcccc
Confidence 9999999888543 245677788888999999 99999999999999754 499999999975
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.2e-13 Score=138.45 Aligned_cols=195 Identities=28% Similarity=0.387 Sum_probs=135.6
Q ss_pred CCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEE
Q 038671 25 RLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVR 104 (707)
Q Consensus 25 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~ 104 (707)
.+..-...+|+.|++. ++|..+..+..|+.|.|..|.|. .+|..++++..|.+|+|+.|+++.++..+..| -|+.|.
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~l-pLkvli 149 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHLPDGLCDL-PLKVLI 149 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcCChhhhcC-cceeEE
Confidence 3445556777777777 77777777777777777777777 66777777777788888888777766665555 367777
Q ss_pred eccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCC
Q 038671 105 LNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVG 184 (707)
Q Consensus 105 l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~ 184 (707)
+++|+++.++ +.++..+.|..||.+.|.+.. .+..+..+.+|+.|++..|.+. ..+..+. .-.|..||++.|++.
T Consensus 150 ~sNNkl~~lp-~~ig~~~tl~~ld~s~nei~s-lpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis- 224 (722)
T KOG0532|consen 150 VSNNKLTSLP-EEIGLLPTLAHLDVSKNEIQS-LPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS- 224 (722)
T ss_pred EecCccccCC-cccccchhHHHhhhhhhhhhh-chHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee-
Confidence 7777777553 445577778888888887773 3456677777888888888777 3444555 346777888888877
Q ss_pred CCChhhhCCCCCcEEEecCCccccCCccccCCC---CcccEEEccCC
Q 038671 185 EMPSKLGKLSSLIKLILNSNQLCGQLSLELGSL---TQLERLDLSSN 228 (707)
Q Consensus 185 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l---~~L~~L~l~~n 228 (707)
.+|-.|.+|..|++|-|.+|.++ ..|..+... -=.++|+...+
T Consensus 225 ~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~ 270 (722)
T KOG0532|consen 225 YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC 270 (722)
T ss_pred ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence 77777888888888888888887 444444322 22356666655
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.6e-10 Score=101.72 Aligned_cols=147 Identities=16% Similarity=0.263 Sum_probs=108.6
Q ss_pred CCceeeecCCeeEEEEEcCCCcEEEEE-----ecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 440 DEHCIGKGGQGSVYKAELPSGEIVAVK-----KFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 440 ~~~~lg~G~~g~vy~~~~~~~~~vavK-----~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
....+-+|+-+.|+++... |+...|| .++.+..+......+..+|++.+.+++--.|....-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999875 6665555 344454455555677889999999886545544444555555566899
Q ss_pred eeecc-CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC---CeEEecccccee
Q 038671 515 EYLEM-GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN---EAHVSDFGTAKF 590 (707)
Q Consensus 515 e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~---~~kl~Dfg~~~~ 590 (707)
||++| .++.+++....... ........++++|-+.+.-||.. +++||||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 57777775443322 22333367889999999999999 999999999999997766 358999999965
Q ss_pred c
Q 038671 591 L 591 (707)
Q Consensus 591 ~ 591 (707)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.2e-11 Score=128.66 Aligned_cols=247 Identities=21% Similarity=0.195 Sum_probs=175.8
Q ss_pred HHhcCCCCCceeeecCCeeEEEEE--cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCc
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAE--LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARH 509 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 509 (707)
....+|..+..||.|.|+.++... ..++..|++|.......... ....-..|+.+...+ .|.++++++..|.....
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~-~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA-SDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH-hhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 445789999999999999999984 34678899998766543332 222234455555555 48899998888888888
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC-CCeEEeccccc
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE-NEAHVSDFGTA 588 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~-~~~kl~Dfg~~ 588 (707)
.|+--||+.+++..... .-...+++..++++..|++.++.++|+. .++|+|++|+||++..+ +..+++|||.+
T Consensus 341 ~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 88999999999988766 2234578888999999999999999999 99999999999999876 78899999998
Q ss_pred eecCCCCCCccccccccCCC--CccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 589 KFLKPDSSNWAELAGTYGYV--APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 589 ~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
..+.- ......+.-++. +|+......+..+.|+|+||..+.+.++|..--.-. .....+....+
T Consensus 415 t~~~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-----------~~~~~i~~~~~ 480 (524)
T KOG0601|consen 415 TRLAF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-----------VQSLTIRSGDT 480 (524)
T ss_pred cccce---ecccccccccccccchhhccccccccccccccccccccccccCcccCccc-----------ccceeeecccc
Confidence 64211 111122233344 555555667888999999999999999987542110 01111222222
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
+.... ....+..+.+.+..+++..||.+.++...
T Consensus 481 p~~~~----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 481 PNLPG----LKLQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred cCCCc----hHHhhhhhhhhhcCCccccchhhhhhccc
Confidence 22211 12446777888999999999998887543
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.4e-11 Score=137.63 Aligned_cols=288 Identities=20% Similarity=0.210 Sum_probs=172.6
Q ss_pred CCCceeeccCCeeeecCCccccCCCCCCeEECCCCc--cccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCee
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNK--LCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLL 80 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~--i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 80 (707)
..+.+..+.+|.+. .++.... .+.|+.|-+.+|. +..+..+.|..++.|+.|||++|.-.+..|..+++|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 34567777888887 5555544 3578888888886 554445557888999999999887666888899999999999
Q ss_pred ecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEccccccc--ccCCCCCCCCCCCcEEEcCCCcc
Q 038671 81 TLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFY--GEISSDWGRCPKLGTLDFSSNNI 158 (707)
Q Consensus 81 ~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~--~~~~~~~~~~~~L~~L~L~~n~i 158 (707)
++++..++.+|.++.++++|.+|++..+.-....+.....+++|++|.+...... ......+..+.+|+.+.......
T Consensus 601 ~L~~t~I~~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~ 680 (889)
T KOG4658|consen 601 DLSDTGISHLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV 680 (889)
T ss_pred cccCCCccccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh
Confidence 9999999888888889999999999887655455666777888888888776522 22223334455555555533322
Q ss_pred CCCCchhhhCCCCCC----EEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCC------CCcccEEEccCC
Q 038671 159 TGSMPAEIIHSSQLK----VLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGS------LTQLERLDLSSN 228 (707)
Q Consensus 159 ~~~~~~~~~~~~~L~----~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~------l~~L~~L~l~~n 228 (707)
.....+..+..|. .+.+.++... ..+..+..+.+|+.|.+.++.+.......... ++++..+.+.++
T Consensus 681 --~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~ 757 (889)
T KOG4658|consen 681 --LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNC 757 (889)
T ss_pred --HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhcc
Confidence 0111122222222 3333333322 44455667778888888887776433322221 222322222222
Q ss_pred c-cCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCC-CCcccccccccceEec
Q 038671 229 R-LSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEE-MPSQICNMQSLEKLNL 297 (707)
Q Consensus 229 ~-i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~~~~L~~L~l 297 (707)
. .....+. .-.++|+.|++..+.....+......+..++++-+..+.+.+. .....+.++++..+.+
T Consensus 758 ~~~r~l~~~--~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l 826 (889)
T KOG4658|consen 758 HMLRDLTWL--LFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPL 826 (889)
T ss_pred ccccccchh--hccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEeccc
Confidence 1 1111111 2236777777777766555555566666666656666655443 2333344444444433
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.5e-11 Score=132.71 Aligned_cols=250 Identities=20% Similarity=0.258 Sum_probs=173.9
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.+.+.+.+.+.+|.++.++.+.- ..|...+.|+......-.....+....+-...-..++|.+++....+......+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 35667777888999999998843 23433444433221111111112222333333334567777666655566778999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
++|+.++++...++... ..+....+.....+..+.++||.. .+.|+|++|.|.+...++..+++|||......-
T Consensus 883 ~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 99999999999987654 245555666777889999999998 799999999999999999999999984332110
Q ss_pred ---------------------CC----------CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 038671 594 ---------------------DS----------SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 642 (707)
Q Consensus 594 ---------------------~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 642 (707)
.. .......+|+.|.+||...+......+|.|+.|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 00 00122468999999999999999999999999999999999999986
Q ss_pred cccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHH
Q 038671 643 FISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQ 699 (707)
Q Consensus 643 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~ 699 (707)
. ...++.++.+....++.+. ..........+++...+..+|.+|-.+.
T Consensus 1037 a--------~tpq~~f~ni~~~~~~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 A--------ETPQQIFENILNRDIPWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred C--------cchhhhhhccccCCCCCCC-CccccChhhhhhhhhhhccCchhccCcc
Confidence 3 3344556666666665542 2223445577888888999999997654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.8e-10 Score=109.21 Aligned_cols=143 Identities=20% Similarity=0.255 Sum_probs=108.7
Q ss_pred ceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCC--CceeeeeeeeecC---CceeEEEee
Q 038671 442 HCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH--RNIVKFYGFCSHA---RHSFIVYEY 516 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~ 516 (707)
+.++.|..+.+|+++..+|+.+++|........ .....+..|+++++.+++ ..+++++.+.... +..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 568999999999998776788999997654321 123567889999999865 4467777777654 367899999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC-------------------------------------- 558 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------------- 558 (707)
++|.++.+.+.. ..++..+...++.++++++..||+..
T Consensus 82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999988765421 23566777788888888888888531
Q ss_pred ---------------CCCeEecCCCCCCeeecC--CCCeEEecccccee
Q 038671 559 ---------------FPPIVHRDISSKNVLLDL--ENEAHVSDFGTAKF 590 (707)
Q Consensus 559 ---------------~~~ivH~dlk~~Nil~~~--~~~~kl~Dfg~~~~ 590 (707)
...++|||+.|.||+++. ++.+.++||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 136799999999999998 56789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=3e-09 Score=98.29 Aligned_cols=129 Identities=26% Similarity=0.350 Sum_probs=86.7
Q ss_pred eEEEEEcCCCcEEEEEecCCCC-----------------------CchhhhHHHHHHHHHHHhcCCCC--ceeeeeeeee
Q 038671 451 SVYKAELPSGEIVAVKKFHSPL-----------------------PSEMASQQEFLNEVKTLTGIRHR--NIVKFYGFCS 505 (707)
Q Consensus 451 ~vy~~~~~~~~~vavK~~~~~~-----------------------~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~ 505 (707)
.||.|..++|..+|+|+..... ...........+|.+.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 3899988899999999874321 11122234578899999999754 567777653
Q ss_pred cCCceeEEEeeec--cCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHH-HHhCCCCCeEecCCCCCCeeecCCCCeEE
Q 038671 506 HARHSFIVYEYLE--MGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY-MHNDCFPPIVHRDISSKNVLLDLENEAHV 582 (707)
Q Consensus 506 ~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~dlk~~Nil~~~~~~~kl 582 (707)
..++||||++ |..+..+.... ++......++.+++..+.. +|.. |++|||+.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence 3569999999 76666544321 1134556778888886666 5677 99999999999999876 9999
Q ss_pred eccccceecC
Q 038671 583 SDFGTAKFLK 592 (707)
Q Consensus 583 ~Dfg~~~~~~ 592 (707)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=8.5e-11 Score=133.23 Aligned_cols=251 Identities=24% Similarity=0.245 Sum_probs=163.0
Q ss_pred CCCCceeeccCCe--eeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCe
Q 038671 2 LSNLAFLYLYNNS--FSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTL 79 (707)
Q Consensus 2 l~~l~~L~l~~n~--i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~ 79 (707)
.++|+.|-+.+|. +....+..|..++.|+.|||++|.-.+.+|+.+++|-+|++|+|+++.|+ ..|..++++++|.+
T Consensus 544 ~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 544 NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIY 622 (889)
T ss_pred CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence 4578888888886 56455566899999999999998766699999999999999999999999 77999999999999
Q ss_pred eecccccccccCCC-CCCCCCccEEEeccCccc--cccCccccCCCCCcEEEcccccccccCCCCCCCCCCCc----EEE
Q 038671 80 LTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLT--GNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLG----TLD 152 (707)
Q Consensus 80 L~l~~n~i~~~~~~-l~~l~~L~~L~l~~n~l~--~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~----~L~ 152 (707)
|++..+.-...+++ ...+++|++|.+...... ......+..+.+|+.+....... .....+...+.|. .+.
T Consensus 623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~ 700 (889)
T KOG4658|consen 623 LNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLS 700 (889)
T ss_pred eccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhh
Confidence 99998876555555 555999999999776522 22223334455555555533332 1112233333333 333
Q ss_pred cCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhC------CCCCcEEEecCCccccCCccccCCCCcccEEEcc
Q 038671 153 FSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGK------LSSLIKLILNSNQLCGQLSLELGSLTQLERLDLS 226 (707)
Q Consensus 153 L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~------l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 226 (707)
+.++... .....+..+.+|+.|.+.++.+.......+.. ++++..+...++..- ..+.+..-.++|+.|++.
T Consensus 701 ~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~ 778 (889)
T KOG4658|consen 701 IEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLV 778 (889)
T ss_pred hcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEe
Confidence 3232222 45666777889999999988876333222211 122333333332222 233334456899999999
Q ss_pred CCccCCCCCccccCcccCceEeeeccccccc
Q 038671 227 SNRLSNSIPKSLGNLVKLHYLNLSNNQFIKK 257 (707)
Q Consensus 227 ~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~ 257 (707)
.+...+.+......+..+..+.+..+.+.+.
T Consensus 779 ~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 779 SCRLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred cccccccCCCHHHHhhhcccEEecccccccc
Confidence 8877666655566666666655555555444
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=4e-10 Score=125.38 Aligned_cols=114 Identities=30% Similarity=0.422 Sum_probs=105.6
Q ss_pred cccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEecc
Q 038671 219 QLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLS 298 (707)
Q Consensus 219 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~ 298 (707)
.++.|+|++|.+.+..|..+..+++|+.|+|++|.+.+..|..+..+++|+.|+|++|.+++..|..++.+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCchhHhhccC-CCceeEeeccCcccccCCC
Q 038671 299 HNNLSGFIPSCFEEL-HGLSYIDISYNELHGSIPN 332 (707)
Q Consensus 299 ~n~i~~~~~~~~~~~-~~L~~l~l~~n~~~~~~~~ 332 (707)
+|++++.+|..+..+ .++..+++.+|+..|..|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence 999999999888763 5678899999998887653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.3e-08 Score=99.93 Aligned_cols=215 Identities=16% Similarity=0.189 Sum_probs=148.0
Q ss_pred CCeeEEEE-EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeee----cCCceeEEEeeecc-Cc
Q 038671 448 GQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCS----HARHSFIVYEYLEM-GS 521 (707)
Q Consensus 448 ~~g~vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~-~~ 521 (707)
-..+.|++ ...+|..|++|+++........ ....-+++++++.|+|+|++.+++. .+...++|++|+++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 34678999 4568999999999543322211 1224577889999999999999885 24468999999985 67
Q ss_pred HHHHHhccc------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 522 LAMILSNDA------------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 522 L~~~l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
|.+..-... .....++..+|.++.|+..||.++|+. |+..+-+.|.+|+++.+.+++|+.+|...
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D 441 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD 441 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence 776542211 122367899999999999999999999 99999999999999998899999999887
Q ss_pred ecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhh-hhhhcCCCCCC
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIA-LNEMLDPRLPT 668 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 668 (707)
....+.. |.+. --++-|.=.||.+++.+.||..---. ....... ...+.
T Consensus 442 vl~~d~~--------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~-------~d~~~~s~~~~I~------ 491 (655)
T KOG3741|consen 442 VLQEDPT--------------EPLE---SQQQNDLRDLGLLLLALATGTENSNR-------TDSTQSSHLTRIT------ 491 (655)
T ss_pred eecCCCC--------------cchh---HHhhhhHHHHHHHHHHHhhccccccc-------ccchHHHHHHHhh------
Confidence 7665431 1111 22457899999999999999654100 0011111 11111
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+..++++++.......+.+ -++.+++.+
T Consensus 492 -----~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 492 -----TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred -----hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 233445667777777767765 566666544
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.5e-09 Score=80.80 Aligned_cols=61 Identities=34% Similarity=0.468 Sum_probs=38.7
Q ss_pred CCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCcc
Q 038671 98 TSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNI 158 (707)
Q Consensus 98 ~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i 158 (707)
++|++|++++|+++.++++.|..+++|++|++++|.++.+.+.+|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3556666666666666666666666666666666666666666666666666666666653
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.4e-09 Score=80.99 Aligned_cols=59 Identities=34% Similarity=0.503 Sum_probs=32.8
Q ss_pred CCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCc
Q 038671 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA 62 (707)
Q Consensus 4 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 62 (707)
+|++|++++|+|+...++.|..+++|++|++++|+++...+++|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 45555555555555544555555555555555555555555555555555555555554
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=3.4e-08 Score=97.16 Aligned_cols=144 Identities=22% Similarity=0.165 Sum_probs=100.4
Q ss_pred ceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchh--------hhHHHHHHHHHHHhcCCCC--ceeeeeeeeec-----
Q 038671 442 HCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEM--------ASQQEFLNEVKTLTGIRHR--NIVKFYGFCSH----- 506 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~----- 506 (707)
+.+-......|+++.. +|+.|.||+.....-.+. .....+.+|.+.+.++... .++..++++..
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455667755 577899997743321110 1112367888888888433 33444555533
Q ss_pred CCceeEEEeeeccC-cHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC-------CC
Q 038671 507 ARHSFIVYEYLEMG-SLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL-------EN 578 (707)
Q Consensus 507 ~~~~~lv~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~-------~~ 578 (707)
...-++|+|++++. +|.+++.... ..+.+......++.++++.+.-||.. ||+|||++++||+++. ++
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence 23568999999986 8998875322 23455667789999999999999999 9999999999999975 46
Q ss_pred CeEEecccccee
Q 038671 579 EAHVSDFGTAKF 590 (707)
Q Consensus 579 ~~kl~Dfg~~~~ 590 (707)
.+.++||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 799999998864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.5e-08 Score=95.76 Aligned_cols=139 Identities=23% Similarity=0.246 Sum_probs=99.9
Q ss_pred CCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCC-----------------ch--hhhHHHHHHHHHHHhcCCCC--c
Q 038671 438 FDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLP-----------------SE--MASQQEFLNEVKTLTGIRHR--N 496 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~-----------------~~--~~~~~~~~~e~~~l~~l~h~--n 496 (707)
+.++..||-|--+.||.|..+.|.++|||.-+.... .. ........+|.+.|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456788999999999999999999999996432110 00 11233467788999988644 6
Q ss_pred eeeeeeeeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC
Q 038671 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL 576 (707)
Q Consensus 497 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~ 576 (707)
|++.+++ +...+|||+++|-.|...- ++....-.++..|+.-+.-+-.. |+||||+++-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 7777665 5567999999987765431 12333344555555555555566 9999999999999999
Q ss_pred CCCeEEeccccceec
Q 038671 577 ENEAHVSDFGTAKFL 591 (707)
Q Consensus 577 ~~~~kl~Dfg~~~~~ 591 (707)
||.+.++||-.+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999777543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.4e-10 Score=106.47 Aligned_cols=213 Identities=23% Similarity=0.273 Sum_probs=128.5
Q ss_pred CCCCccEEEeccCccccccCc-cc-cCCCCCcEEEcccccccc--cCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCC
Q 038671 96 NLTSLVRVRLNQNHLTGNISE-SF-GIHPNLAFIDLSHNYFYG--EISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQ 171 (707)
Q Consensus 96 ~l~~L~~L~l~~n~l~~~~~~-~~-~~~~~L~~L~L~~n~i~~--~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~ 171 (707)
.++.++.|.+.++.|..+... .| ..++.++.|||.+|.|+. .....+.++|.|++|+|+.|++...+...-....+
T Consensus 43 s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~n 122 (418)
T KOG2982|consen 43 SLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKN 122 (418)
T ss_pred cccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccc
Confidence 344556666777766655432 22 345778888888888873 23344667888888888888877433222245667
Q ss_pred CCEEeCCCCCCC-CCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCC--ccccCcccCceEe
Q 038671 172 LKVLDLSSNHIV-GEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIP--KSLGNLVKLHYLN 248 (707)
Q Consensus 172 L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~--~~l~~l~~L~~L~ 248 (707)
|+.|-|.+..+. ......+..+|.+++|+++.|.+.. +.+..|.+....+ ..+..++++..++
T Consensus 123 l~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq--------------~n~Dd~c~e~~s~~v~tlh~~~c~~~~w 188 (418)
T KOG2982|consen 123 LRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQ--------------LNLDDNCIEDWSTEVLTLHQLPCLEQLW 188 (418)
T ss_pred eEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhh--------------hccccccccccchhhhhhhcCCcHHHHH
Confidence 777777777665 2333445566777777777765431 2222333322111 1112223333333
Q ss_pred eecccccccCchhhhhcccCCeeeecCccCCCC-CCcccccccccceEeccccccCCchh-HhhccCCCceeEeeccCcc
Q 038671 249 LSNNQFIKKIPVELEKLIHLSELDLSHNFLGEE-MPSQICNMQSLEKLNLSHNNLSGFIP-SCFEELHGLSYIDISYNEL 326 (707)
Q Consensus 249 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~~~~L~~L~l~~n~i~~~~~-~~~~~~~~L~~l~l~~n~~ 326 (707)
++-|++. .-++++..+-+..|++.+. ....+..++.+..|+|+.|+|..+.. +.+.+++.|+.|.+++||+
T Consensus 189 ~~~~~l~-------r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl 261 (418)
T KOG2982|consen 189 LNKNKLS-------RIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPL 261 (418)
T ss_pred HHHHhHH-------hhcccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcc
Confidence 4444432 2346777788888877543 23445567778888899998887644 7788888899998888887
Q ss_pred ccc
Q 038671 327 HGS 329 (707)
Q Consensus 327 ~~~ 329 (707)
...
T Consensus 262 ~d~ 264 (418)
T KOG2982|consen 262 SDP 264 (418)
T ss_pred ccc
Confidence 633
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.5e-11 Score=126.92 Aligned_cols=180 Identities=31% Similarity=0.318 Sum_probs=130.9
Q ss_pred CccccCCCCCCeEECCCCccccccCcCccCC-CCCcEEEcccCcCc---ccCC---ccccC---CCCCCeeecccccccc
Q 038671 20 PSEIGRLKSLSDLELSGNKLCGSIPHSLGNL-TQITFLTLFDNALS---GAIP---KEYGN---LVKLTLLTLENNQLRG 89 (707)
Q Consensus 20 ~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l-~~L~~L~L~~n~i~---~~~~---~~~~~---l~~L~~L~l~~n~i~~ 89 (707)
|=.+-.+..|++|.|.+|.+.. ...+..+ .+|++|-.. |.+. ..+. +.|++ +-+|...+++.|.+..
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~~ 178 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLVL 178 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHHh
Confidence 4456678899999999999883 2333333 456666432 3222 1111 11111 3368888899999987
Q ss_pred cCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCC
Q 038671 90 PIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS 169 (707)
Q Consensus 90 ~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~ 169 (707)
....+.-++.|+.|+|++|+++... .+..+++|++|||++|.+..+..-....|. |..|+|++|.++ ....+.++
T Consensus 179 mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~--tL~gie~L 253 (1096)
T KOG1859|consen 179 MDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALT--TLRGIENL 253 (1096)
T ss_pred HHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHH--hhhhHHhh
Confidence 7777888899999999999998663 788999999999999999866555555665 999999999988 34457888
Q ss_pred CCCCEEeCCCCCCCCCC-ChhhhCCCCCcEEEecCCccc
Q 038671 170 SQLKVLDLSSNHIVGEM-PSKLGKLSSLIKLILNSNQLC 207 (707)
Q Consensus 170 ~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~ 207 (707)
.+|+.||+++|-|.+.- ...+..+..|+.|+|.+|.+.
T Consensus 254 ksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 254 KSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 99999999999886322 334566788999999999886
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.82 E-value=1.9e-10 Score=106.66 Aligned_cols=210 Identities=20% Similarity=0.234 Sum_probs=137.1
Q ss_pred ccCCCCCCeEECCCCccccccC----cCccCCCCCcEEEcccCcCc---ccC-------CccccCCCCCCeeeccccccc
Q 038671 23 IGRLKSLSDLELSGNKLCGSIP----HSLGNLTQITFLTLFDNALS---GAI-------PKEYGNLVKLTLLTLENNQLR 88 (707)
Q Consensus 23 ~~~l~~L~~L~l~~n~i~~~~~----~~~~~l~~L~~L~L~~n~i~---~~~-------~~~~~~l~~L~~L~l~~n~i~ 88 (707)
+..+..+..++||+|.|+.+-. +.+++-.+|+..++++-... +.+ -.++.++++|+..+||+|.+.
T Consensus 26 l~~~d~~~evdLSGNtigtEA~e~l~~~ia~~~~L~vvnfsd~ftgr~kde~~~~L~~Ll~aLlkcp~l~~v~LSDNAfg 105 (388)
T COG5238 26 LEMMDELVEVDLSGNTIGTEAMEELCNVIANVRNLRVVNFSDAFTGRDKDELYSNLVMLLKALLKCPRLQKVDLSDNAFG 105 (388)
T ss_pred HHhhcceeEEeccCCcccHHHHHHHHHHHhhhcceeEeehhhhhhcccHHHHHHHHHHHHHHHhcCCcceeeeccccccC
Confidence 3446777888888888774433 33445567777777643221 112 234567788888888888886
Q ss_pred ccCC-C----CCCCCCccEEEeccCccccccCccc-------------cCCCCCcEEEcccccccccCC----CCCCCCC
Q 038671 89 GPIP-N----LRNLTSLVRVRLNQNHLTGNISESF-------------GIHPNLAFIDLSHNYFYGEIS----SDWGRCP 146 (707)
Q Consensus 89 ~~~~-~----l~~l~~L~~L~l~~n~l~~~~~~~~-------------~~~~~L~~L~L~~n~i~~~~~----~~~~~~~ 146 (707)
.-.+ . +++.+.|++|.|++|.+..+...-+ ..-|.|+..+...|++..-.. ..|..-.
T Consensus 106 ~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrNRlengs~~~~a~~l~sh~ 185 (388)
T COG5238 106 SEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRNRLENGSKELSAALLESHE 185 (388)
T ss_pred cccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccchhccCcHHHHHHHHHhhc
Confidence 5222 1 6777889999999998875433222 345889999999999863221 1222235
Q ss_pred CCcEEEcCCCccCCCCch--h---hhCCCCCCEEeCCCCCCCCC----CChhhhCCCCCcEEEecCCccccCCcccc---
Q 038671 147 KLGTLDFSSNNITGSMPA--E---IIHSSQLKVLDLSSNHIVGE----MPSKLGKLSSLIKLILNSNQLCGQLSLEL--- 214 (707)
Q Consensus 147 ~L~~L~L~~n~i~~~~~~--~---~~~~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~--- 214 (707)
+|+++.+..|.|...... . +.-+.+|+.|||.+|-++.. ...++...+.|++|.+.+|-++......+
T Consensus 186 ~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrEL~lnDClls~~G~~~v~~~ 265 (388)
T COG5238 186 NLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRELRLNDCLLSNEGVKSVLRR 265 (388)
T ss_pred CceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhhccccchhhccccHHHHHHH
Confidence 799999999998744222 2 23368899999999988732 34455667778889988888875544432
Q ss_pred ---CCCCcccEEEccCCccCC
Q 038671 215 ---GSLTQLERLDLSSNRLSN 232 (707)
Q Consensus 215 ---~~l~~L~~L~l~~n~i~~ 232 (707)
...|+|..|....|.+.+
T Consensus 266 f~e~~~p~l~~L~~~Yne~~~ 286 (388)
T COG5238 266 FNEKFVPNLMPLPGDYNERRG 286 (388)
T ss_pred hhhhcCCCccccccchhhhcC
Confidence 134677777777776653
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.78 E-value=1e-09 Score=103.35 Aligned_cols=209 Identities=22% Similarity=0.135 Sum_probs=117.2
Q ss_pred ccCCCCCCeEECCCCccccccC-cCc-cCCCCCcEEEcccCcCcc--cCCccccCCCCCCeeecccccccccCCCC-CCC
Q 038671 23 IGRLKSLSDLELSGNKLCGSIP-HSL-GNLTQITFLTLFDNALSG--AIPKEYGNLVKLTLLTLENNQLRGPIPNL-RNL 97 (707)
Q Consensus 23 ~~~l~~L~~L~l~~n~i~~~~~-~~~-~~l~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~l~~n~i~~~~~~l-~~l 97 (707)
+..+..++.|-+.++.|..+.. ..| ...+.++.|||.+|.|+. .+...+.+||.|+.|+|+.|++...+..+ ..+
T Consensus 41 v~s~ra~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~ 120 (418)
T KOG2982|consen 41 VSSLRALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPL 120 (418)
T ss_pred eccccchhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccc
Confidence 3344456677777887763322 122 345778899999998883 33345668889999999999988777666 467
Q ss_pred CCccEEEeccCccccccC-ccccCCCCCcEEEccccccccc--CCCCCCCC-CCCcEEEcCCCccCCC--CchhhhCCCC
Q 038671 98 TSLVRVRLNQNHLTGNIS-ESFGIHPNLAFIDLSHNYFYGE--ISSDWGRC-PKLGTLDFSSNNITGS--MPAEIIHSSQ 171 (707)
Q Consensus 98 ~~L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~L~~n~i~~~--~~~~~~~~-~~L~~L~L~~n~i~~~--~~~~~~~~~~ 171 (707)
.+|+.|.|++..+..... ..+..+|.++.|.++.|.+... ..+..... +.+++|....|..... ....-.-+++
T Consensus 121 ~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpn 200 (418)
T KOG2982|consen 121 KNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPN 200 (418)
T ss_pred cceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhccc
Confidence 788999998888764433 3456678888888888744311 11111111 2344444443332200 0011112455
Q ss_pred CCEEeCCCCCCCCC-CChhhhCCCCCcEEEecCCccccCC-ccccCCCCcccEEEccCCccC
Q 038671 172 LKVLDLSSNHIVGE-MPSKLGKLSSLIKLILNSNQLCGQL-SLELGSLTQLERLDLSSNRLS 231 (707)
Q Consensus 172 L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~i~ 231 (707)
+..+.+..|.+++. ....+..++.+--|.|+.|+|.+.. ..++..+++|..|.+++|.+.
T Consensus 201 v~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 201 VNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred chheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 55555556655422 1233344455555555555555321 223445555555555555554
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2.2e-09 Score=113.38 Aligned_cols=149 Identities=18% Similarity=0.269 Sum_probs=103.8
Q ss_pred HHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCC----cc-----ccccccCCCCcccccc
Q 038671 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN----WA-----ELAGTYGYVAPELAYT 615 (707)
Q Consensus 545 ~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----~~-----~~~g~~~y~aPE~~~~ 615 (707)
.+++.|+.|+|... ++||++|.|++|.++..+.+||+.|+++.....+... +. .......|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 44559999999985 9999999999999999999999999998765542211 00 0123567999999998
Q ss_pred CCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCC
Q 038671 616 MKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPES 694 (707)
Q Consensus 616 ~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~ 694 (707)
...+.++|+||+|+.+|.+.. |+.-+....... .........+..... .....+.++.+=+.+++..++..
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-----~~~~~~~~~~~~~~~---~s~~~p~el~~~l~k~l~~~~~~ 255 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-----SYSFSRNLLNAGAFG---YSNNLPSELRESLKKLLNGDSAV 255 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcc-----hhhhhhccccccccc---ccccCcHHHHHHHHHHhcCCccc
Confidence 888999999999999999994 555544221110 011111111111111 11344566888888999999999
Q ss_pred CCCHHHHHH
Q 038671 695 RPTIQKVSQ 703 (707)
Q Consensus 695 Rps~~~l~~ 703 (707)
||++.++.+
T Consensus 256 rp~~~~l~~ 264 (700)
T KOG2137|consen 256 RPTLDLLLS 264 (700)
T ss_pred Ccchhhhhc
Confidence 998877654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.4e-10 Score=119.74 Aligned_cols=181 Identities=24% Similarity=0.210 Sum_probs=108.7
Q ss_pred CCCCCCCCCCcEEEcCCCccCCCCchhhhCC-CCCCEEeCCCCCCCCCCChhhh----------CCCCCcEEEecCCccc
Q 038671 139 SSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLDLSSNHIVGEMPSKLG----------KLSSLIKLILNSNQLC 207 (707)
Q Consensus 139 ~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~----------~l~~L~~L~l~~n~l~ 207 (707)
|-.+..+.+|+.|.|.++.+.. ...+..+ ..|+.|- .+|.+. .....|. ....|...+.+.|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LI-C~~Sl~-Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~ 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLI-CHNSLD-ALRHVFASCGGDISNSPVWNKLATASFSYNRLV 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhh-hhccHH-HHHHHHHHhccccccchhhhhHhhhhcchhhHH
Confidence 4456678899999999998862 2222221 2233332 222221 1111111 1235666677777776
Q ss_pred cCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccc
Q 038671 208 GQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQIC 287 (707)
Q Consensus 208 ~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 287 (707)
.....+.-++.|+.|+|++|+++... .+..+++|+.|||++|.+....--...++. |+.|.|++|.+++. ..+.
T Consensus 178 -~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie 251 (1096)
T KOG1859|consen 178 -LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIE 251 (1096)
T ss_pred -hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHH
Confidence 45555666677777777777776442 566777777777777777554433344443 77777777777442 3466
Q ss_pred cccccceEeccccccCCchh-HhhccCCCceeEeeccCccccc
Q 038671 288 NMQSLEKLNLSHNNLSGFIP-SCFEELHGLSYIDISYNELHGS 329 (707)
Q Consensus 288 ~~~~L~~L~l~~n~i~~~~~-~~~~~~~~L~~l~l~~n~~~~~ 329 (707)
++.+|+.||++.|-|.+... ..++.+..|+.|+|.|||+-|-
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 77777777777777765432 3455566777777777777664
|
|
| >COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.72 E-value=3.7e-10 Score=104.80 Aligned_cols=187 Identities=22% Similarity=0.197 Sum_probs=102.4
Q ss_pred CCCCCCCCcEEEcCCCccCCCCc----hhhhCCCCCCEEeCCCCCCCCCCChh-------------hhCCCCCcEEEecC
Q 038671 141 DWGRCPKLGTLDFSSNNITGSMP----AEIIHSSQLKVLDLSSNHIVGEMPSK-------------LGKLSSLIKLILNS 203 (707)
Q Consensus 141 ~~~~~~~L~~L~L~~n~i~~~~~----~~~~~~~~L~~L~l~~n~l~~~~~~~-------------~~~l~~L~~L~l~~ 203 (707)
++..||+|+.++||+|.+....+ +.+++...|++|.|++|.+..+...- ...-|.|+......
T Consensus 87 aLlkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgr 166 (388)
T COG5238 87 ALLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGR 166 (388)
T ss_pred HHhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEecc
Confidence 34455555555555555543322 23344556666666666554221111 12346777777777
Q ss_pred CccccCCc----cccCCCCcccEEEccCCccCCCC-----CccccCcccCceEeeecccccccCc----hhhhhcccCCe
Q 038671 204 NQLCGQLS----LELGSLTQLERLDLSSNRLSNSI-----PKSLGNLVKLHYLNLSNNQFIKKIP----VELEKLIHLSE 270 (707)
Q Consensus 204 n~l~~~~~----~~~~~l~~L~~L~l~~n~i~~~~-----~~~l~~l~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~ 270 (707)
|++..-.. ..+....+|+.+.+.+|.|.-.. -..+..+.+|+.|||.+|.++.... ..++.++.|++
T Consensus 167 NRlengs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrE 246 (388)
T COG5238 167 NRLENGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRE 246 (388)
T ss_pred chhccCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhh
Confidence 77763211 12333467788888888775321 1233456778888888887765433 33556667788
Q ss_pred eeecCccCCCCCCcccc------cccccceEeccccccCCch------hHh-hccCCCceeEeeccCccc
Q 038671 271 LDLSHNFLGEEMPSQIC------NMQSLEKLNLSHNNLSGFI------PSC-FEELHGLSYIDISYNELH 327 (707)
Q Consensus 271 L~l~~n~l~~~~~~~~~------~~~~L~~L~l~~n~i~~~~------~~~-~~~~~~L~~l~l~~n~~~ 327 (707)
|.+.+|-++......+- ..++|..|-...|-+.+-. +.. -..+|-|..|.+.+|++.
T Consensus 247 L~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~ 316 (388)
T COG5238 247 LRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIK 316 (388)
T ss_pred ccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcch
Confidence 88888877664433221 2466677777777654321 111 123555666666666655
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=4e-07 Score=84.41 Aligned_cols=155 Identities=18% Similarity=0.170 Sum_probs=109.3
Q ss_pred HHHHHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCch---hhhHHHHHHHHHHHhcCCC--Cceeeeeeee
Q 038671 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSE---MASQQEFLNEVKTLTGIRH--RNIVKFYGFC 504 (707)
Q Consensus 430 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h--~niv~~~~~~ 504 (707)
.+-....++-...=-|+||-+.|+..... |+.+-+|+-....... ......|.+|...+.++.. -.+++.. ++
T Consensus 12 ~~w~~~~~wve~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~ 89 (216)
T PRK09902 12 HWWATEGDWVEEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FG 89 (216)
T ss_pred HHHhCCCceecCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-ee
Confidence 33333444444444678899999998764 4468888865211111 2356789999999998852 2255555 33
Q ss_pred e-c--C--CceeEEEeeecc-CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC
Q 038671 505 S-H--A--RHSFIVYEYLEM-GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN 578 (707)
Q Consensus 505 ~-~--~--~~~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~ 578 (707)
. . + -.-+||+|-+.+ .+|.+++.... ..+.+......++.+++++++-||+. |+.|+|+.+.||+++.++
T Consensus 90 ~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g 165 (216)
T PRK09902 90 EAVKIEGEWRALLVTEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEG 165 (216)
T ss_pred eeeccCCceEEEEEEEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCC
Confidence 2 1 1 235799997753 68888885432 23467778889999999999999999 999999999999998667
Q ss_pred C--eEEecccccee
Q 038671 579 E--AHVSDFGTAKF 590 (707)
Q Consensus 579 ~--~kl~Dfg~~~~ 590 (707)
. ++++||.-++.
T Consensus 166 ~~~v~lIDlEk~r~ 179 (216)
T PRK09902 166 KAEAGFLDLEKSRR 179 (216)
T ss_pred CeeEEEEEhhccch
Confidence 6 99999976653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 707 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-38 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-37 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-36 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-27 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-26 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-25 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-22 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 7e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-18 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 9e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-15 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-15 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-15 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 9e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 8e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 9e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 7e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-07 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 1e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 2e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 6e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 6e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 6e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 6e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-05 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 7e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 8e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 707 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-113 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-96 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 9e-95 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-93 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-78 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-74 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-65 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 1e-09 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-04 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 3e-88 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-78 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-67 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-66 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 8e-66 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-63 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-63 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 4e-54 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-37 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-18 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-13 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 2e-76 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 5e-75 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 7e-67 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 8e-70 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-69 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 5e-69 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 4e-47 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-31 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-69 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 4e-61 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 2e-55 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-53 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-35 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-33 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-10 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-65 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-62 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-61 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-57 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-56 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-54 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 4e-37 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-31 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-28 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-19 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-59 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-59 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-56 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 7e-55 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 6e-51 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 7e-50 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-40 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 4e-37 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-29 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 8e-26 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 6e-59 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-58 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-57 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-50 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 6e-45 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 8e-38 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-23 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 5e-53 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-52 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-50 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 4e-50 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 7e-50 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-49 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-48 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 6e-41 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-41 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 8e-49 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-49 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-47 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 7e-42 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-34 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-32 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 7e-25 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-48 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-48 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-43 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-38 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 7e-32 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 7e-19 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 9e-10 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 6e-05 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-48 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-47 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-46 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-33 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-21 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 4e-47 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-47 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 4e-46 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 8e-46 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-43 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-35 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-21 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-17 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-14 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-44 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-40 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 7e-36 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-28 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-18 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 8e-13 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-04 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-44 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-39 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-33 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-26 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 5e-26 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 8e-20 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-13 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 6e-43 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-39 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-27 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-42 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 7e-39 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-35 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-29 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-22 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-15 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-12 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-08 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-42 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-39 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 8e-37 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-29 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 9e-25 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-18 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-15 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-40 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-39 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-34 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-31 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-30 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 5e-30 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-08 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-40 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-36 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 1e-25 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-39 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-39 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-38 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 4e-36 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-28 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-38 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 8e-38 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-34 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-24 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-15 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-38 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-31 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-17 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 1e-07 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 1e-37 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 5e-37 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 9e-37 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-34 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-32 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 3e-27 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-26 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-18 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 2e-15 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 3e-36 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 3e-36 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-36 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 9e-36 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-33 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-30 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-26 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 6e-25 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 3e-17 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-35 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-33 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-27 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 8e-35 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-34 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 5e-34 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 6e-34 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-33 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-31 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 6e-11 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-33 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 2e-33 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 4e-33 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 2e-32 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-32 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 1e-28 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-32 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-32 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 7e-32 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 7e-32 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-31 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-31 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-28 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 9e-28 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-27 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 6e-22 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 5e-16 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-31 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-31 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-31 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 5e-31 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 6e-31 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-30 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-30 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-30 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-30 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-29 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-29 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-12 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 8e-12 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-08 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-30 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-30 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 3e-30 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-25 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-23 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 5e-30 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 5e-30 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 6e-30 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 6e-30 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 8e-30 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 8e-30 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 9e-30 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 9e-30 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 1e-29 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-29 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-29 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-29 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-29 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-22 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 8e-18 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-13 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 7e-12 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-07 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-29 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-29 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-29 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-29 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 2e-29 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-29 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 3e-29 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-28 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-27 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-29 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 4e-29 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 4e-29 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 4e-29 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-29 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 6e-29 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 6e-29 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 9e-29 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-21 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 1e-15 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 7e-29 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 8e-29 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 1e-28 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-28 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-28 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-28 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-28 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-28 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 3e-28 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 4e-28 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 5e-28 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 8e-28 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 6e-27 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 9e-26 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-23 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 7e-19 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 9e-28 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 1e-27 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-27 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-27 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-19 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-19 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-11 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-08 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-27 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 3e-27 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 5e-27 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-27 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 7e-27 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 9e-27 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 9e-27 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 9e-27 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-26 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-26 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-26 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 1e-26 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-26 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-26 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 6e-26 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 8e-26 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 8e-26 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-25 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-21 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 8e-26 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-25 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-23 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-23 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 8e-23 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-22 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-17 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-13 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 1e-25 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 1e-25 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-25 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-25 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-25 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-23 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-18 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 7e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 8e-12 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-25 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-25 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 3e-25 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 3e-25 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 4e-25 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 4e-25 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 4e-25 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 7e-25 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-24 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-24 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-24 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-24 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-24 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-21 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-20 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-19 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-24 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-24 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-24 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 8e-21 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-18 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-17 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-16 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 4e-24 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-24 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 5e-24 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 5e-24 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-24 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 6e-24 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 6e-24 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 6e-24 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 7e-24 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 9e-24 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 9e-24 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-23 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-23 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-23 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-18 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-12 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-11 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-23 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-23 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-23 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-23 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 9e-23 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-16 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 4e-16 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 7e-16 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 5e-23 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 7e-23 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 8e-23 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 9e-23 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-22 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 6e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-07 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 6e-07 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 4e-22 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 4e-22 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 7e-22 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 8e-22 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-14 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 7e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 4e-07 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 1e-21 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-21 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-19 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-04 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 7e-21 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-20 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-20 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-20 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-20 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 1e-16 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-16 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 9e-15 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-14 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-11 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 9e-20 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 1e-19 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-19 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 2e-19 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-19 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-19 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 3e-19 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-18 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 4e-16 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-19 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 4e-19 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 6e-19 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-18 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-18 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-18 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-18 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-17 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-17 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-17 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 9e-17 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-14 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-10 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 8e-17 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-16 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-16 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 6e-16 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 7e-16 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 7e-14 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-13 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-10 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-08 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-04 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-15 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 1e-15 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-15 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 4e-15 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 4e-15 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-15 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-13 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 7e-13 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 8e-08 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-05 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-05 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 5e-15 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 6e-15 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 6e-15 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 6e-15 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-13 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 1e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-10 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 6e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-14 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-12 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-08 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-08 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 8e-15 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-14 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-14 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-14 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-14 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-12 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-11 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 6e-10 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-09 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 2e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 4e-07 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 3e-14 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-14 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 3e-14 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 4e-14 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 5e-14 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-14 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-14 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-09 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-09 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-08 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 5e-05 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 4e-14 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 4e-14 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 7e-14 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 7e-14 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 1e-13 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-13 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-13 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-13 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 2e-13 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-13 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-13 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 4e-13 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 5e-13 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 5e-13 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 5e-13 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 5e-13 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 5e-13 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 7e-13 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 7e-13 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 8e-13 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-12 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-12 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-11 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-09 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 5e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-07 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 3e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-12 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-11 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 9e-11 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 5e-10 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 8e-06 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-12 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-12 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 2e-12 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 1e-10 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-12 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 4e-12 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-12 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-11 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 7e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-04 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-11 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-11 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-11 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-07 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-06 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-06 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-11 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-11 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 7e-08 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 2e-07 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 3e-05 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 8e-05 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-11 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 8e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-06 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 5e-11 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 1e-10 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 1e-10 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-10 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 4e-09 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 3e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 1e-06 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 1e-06 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-10 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-10 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-10 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 3e-10 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 4e-10 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 8e-10 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 3e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-06 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 5e-10 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 8e-10 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 1e-09 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 1e-04 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 7e-04 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-09 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-07 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-06 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 4e-09 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 7e-09 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-08 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-08 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 2e-08 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 5e-07 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 5e-05 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 7e-04 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 2e-08 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 1e-07 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 6e-07 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 5e-08 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 5e-08 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 6e-08 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 2e-07 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-07 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 4e-07 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 5e-07 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 8e-07 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 3e-06 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 8e-05 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 8e-07 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 2e-04 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 2e-04 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 9e-07 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 1e-06 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 1e-06 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 3e-06 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-06 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-06 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-06 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 5e-06 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 6e-06 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 8e-06 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 1e-05 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 4e-04 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 2e-04 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 3e-04 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 4e-04 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 9e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 358 bits (922), Expect = e-113
Identities = 121/375 (32%), Positives = 180/375 (48%), Gaps = 9/375 (2%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+ L LYL NN F+G IP + L L LS N L G+IP SLG+L+++ L L+
Sbjct: 392 PKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 451
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFG 119
N L G IP+E + L L L+ N L G IP+ L N T+L + L+ N LTG I + G
Sbjct: 452 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG 511
Query: 120 IHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS 179
NLA + LS+N F G I ++ G C L LD ++N G++PA + S +++
Sbjct: 512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAA 567
Query: 180 NHIVGEMPSKLGKLSSLIKLIL--NSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKS 237
N I G+ + + N + G S +L L+ +++S +
Sbjct: 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
Query: 238 LGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNL 297
N + +L++S N IP E+ + +L L+L HN + +P ++ +++ L L+L
Sbjct: 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDL 687
Query: 298 SHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIKGF 357
S N L G IP L L+ ID+S N L G IP F P N GLCG
Sbjct: 688 SSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG--YPL 745
Query: 358 PSCKASKSHKQASRK 372
P C S + A +
Sbjct: 746 PRCDPSNADGYAHHQ 760
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 314 bits (806), Expect = 2e-96
Identities = 114/339 (33%), Positives = 170/339 (50%), Gaps = 12/339 (3%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTLF 59
+ L L + +N F G IP LKSL L L+ NK G IP L G +T L L
Sbjct: 245 TCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLS 302
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISES 117
N GA+P +G+ L L L +N G +P L + L + L+ N +G + ES
Sbjct: 303 GNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362
Query: 118 FG-IHPNLAFIDLSHNYFYGEISSDWGRCPK--LGTLDFSSNNITGSMPAEIIHSSQLKV 174
+ +L +DLS N F G I + + PK L L +N TG +P + + S+L
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS 422
Query: 175 LDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSI 234
L LS N++ G +PS LG LS L L L N L G++ EL + LE L L N L+ I
Sbjct: 423 LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEI 482
Query: 235 PKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEK 294
P L N L++++LSNN+ +IP + +L +L+ L LS+N +P+++ + +SL
Sbjct: 483 PSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIW 542
Query: 295 LNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNS 333
L+L+ N +G IP+ + G I+ N + G
Sbjct: 543 LDLNTNLFNGTIPAAMFKQSG----KIAANFIAGKRYVY 577
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = 9e-95
Identities = 106/342 (30%), Positives = 156/342 (45%), Gaps = 13/342 (3%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIG-RLKSLSDLELSGNKLCGSIPHSL---GNLTQITFL 56
+ S L FL + +N+ G +L SL L+LS N + G+ ++ L
Sbjct: 124 SCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHL 183
Query: 57 TLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISE 116
+ N +SG + V L L + +N IP L + ++L + ++ N L+G+ S
Sbjct: 184 AISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSR 241
Query: 117 SFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVL 175
+ L +++S N F G I L L + N TG +P + + L L
Sbjct: 242 AISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGL 299
Query: 176 DLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLE-LGSLTQLERLDLSSNRLSNSI 234
DLS NH G +P G S L L L+SN G+L ++ L + L+ LDLS N S +
Sbjct: 300 DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGEL 359
Query: 235 PKSLGNL-VKLHYLNLSNNQFIKKIPVELEK--LIHLSELDLSHNFLGEEMPSQICNMQS 291
P+SL NL L L+LS+N F I L + L EL L +N ++P + N
Sbjct: 360 PESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSE 419
Query: 292 LEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNS 333
L L+LS N LSG IPS L L + + N L G IP
Sbjct: 420 LVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE 461
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 304 bits (782), Expect = 4e-93
Identities = 105/361 (29%), Positives = 166/361 (45%), Gaps = 28/361 (7%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
L +L +L L N F+G IP + G +L+ L+LSGN G++P G+ + + L L
Sbjct: 267 PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALS 326
Query: 60 DNALSGAIPKEY-GNLVKLTLLTLENNQLRGPIPN-LRNLT-SLVRVRLNQNHLTGNISE 116
N SG +P + + L +L L N+ G +P L NL+ SL+ + L+ N+ +G I
Sbjct: 327 SNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILP 386
Query: 117 SFGIHP--NLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKV 174
+ +P L + L +N F G+I C +L +L S N ++G++P+ + S+L+
Sbjct: 387 NLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRD 446
Query: 175 LDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSI 234
L L N + GE+P +L + +L LIL+ N L G++ L + T L + LS+NRL+ I
Sbjct: 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506
Query: 235 PKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEK 294
PK +G L L L LSNN F IP EL L LDL+ N +P+ +
Sbjct: 507 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIA 566
Query: 295 LNL----------------------SHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332
N + G L + +I+ G
Sbjct: 567 ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSP 626
Query: 333 S 333
+
Sbjct: 627 T 627
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 4e-78
Identities = 95/343 (27%), Positives = 147/343 (42%), Gaps = 21/343 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+LS+ N ++ S + L L L LS + + GS+ +T L L
Sbjct: 56 DLSSKPL-----NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSR 109
Query: 61 NALSGAIPKEY--GNLVKLTLLTLENNQLRG--PIPNLRNLTSLVRVRLNQNHLTGNISE 116
N+LSG + G+ L L + +N L + L SL + L+ N ++G
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVV 169
Query: 117 SFGIH---PNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLK 173
+ + L + +S N G++ RC L LD SSNN + +P + S L+
Sbjct: 170 GWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIP-FLGDCSALQ 226
Query: 174 VLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNS 233
LD+S N + G+ + + L L ++SNQ G + L L+ L L+ N+ +
Sbjct: 227 HLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGE 284
Query: 234 IPKSL-GNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMP-SQICNMQS 291
IP L G L L+LS N F +P L L LS N E+P + M+
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG 344
Query: 292 LEKLNLSHNNLSGFIPSCFEELHG-LSYIDISYNELHGSIPNS 333
L+ L+LS N SG +P L L +D+S N G I +
Sbjct: 345 LKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 7e-74
Identities = 97/319 (30%), Positives = 154/319 (48%), Gaps = 15/319 (4%)
Query: 24 GRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLE 83
++ S+ N ++ SL +LT + L L ++ ++G++ + LT L L
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 84 NNQLRGPIP---NLRNLTSLVRVRLNQNHLTGNISESFGIH-PNLAFIDLSHNYFYGEIS 139
N L GP+ +L + + L + ++ N L S G+ +L +DLS N G
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 140 SDW---GRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSL 196
W C +L L S N I+G + + L+ LD+SSN+ +P LG S+L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSAL 225
Query: 197 IKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIK 256
L ++ N+L G S + + T+L+ L++SSN+ IP L L YL+L+ N+F
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTG 283
Query: 257 KIPVELE-KLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIP-SCFEELH 314
+IP L L+ LDLS N +P + LE L LS NN SG +P ++
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMR 343
Query: 315 GLSYIDISYNELHGSIPNS 333
GL +D+S+NE G +P S
Sbjct: 344 GLKVLDLSFNEFSGELPES 362
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 4e-65
Identities = 79/296 (26%), Positives = 134/296 (45%), Gaps = 12/296 (4%)
Query: 46 SLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRL 105
+T I + N A+ +L L L L N+ + G + + SL + L
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDL 107
Query: 106 NQNHLTGNISESFGIH--PNLAFIDLSHNYFYGEISSDWG-RCPKLGTLDFSSNNITGSM 162
++N L+G ++ + L F+++S N G + L LD S+N+I+G+
Sbjct: 108 SRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGAN 167
Query: 163 PAEIIHS---SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQ 219
+ S +LK L +S N I G++ + + +L L ++SN + LG +
Sbjct: 168 VVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSA 224
Query: 220 LERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLG 279
L+ LD+S N+LS +++ +L LN+S+NQF+ IP L L L L+ N
Sbjct: 225 LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP--PLPLKSLQYLSLAENKFT 282
Query: 280 EEMPSQIC-NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST 334
E+P + +L L+LS N+ G +P F L + +S N G +P T
Sbjct: 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-09
Identities = 19/73 (26%), Positives = 38/73 (52%), Gaps = 4/73 (5%)
Query: 267 HLSELDLSHNFL---GEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISY 323
++ +DLS L + S + ++ LE L LS+++++G + F+ L+ +D+S
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSR 109
Query: 324 NELHGSIPNSTAF 336
N L G + T+
Sbjct: 110 NSLSGPVTTLTSL 122
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 2e-04
Identities = 11/49 (22%), Positives = 22/49 (44%), Gaps = 3/49 (6%)
Query: 287 CNMQSLEKLNLSHNNLSGF---IPSCFEELHGLSYIDISYNELHGSIPN 332
C + ++LS L+ + S L GL + +S + ++GS+
Sbjct: 47 CRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG 95
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 3e-88
Identities = 91/290 (31%), Positives = 151/290 (52%), Gaps = 15/290 (5%)
Query: 428 YEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVK 487
E+ +++F +++ +G+GG G VYK L G +VAVK+ + +F EV+
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE--RTQGGELQFQTEVE 79
Query: 488 TLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKD-LGWTKRMNVIKG 546
++ HRN+++ GFC +VY Y+ GS+A L ++ L W KR + G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA-ELAGTY 605
L+Y+H+ C P I+HRD+ + N+LLD E EA V DFG AK + ++ + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199
Query: 606 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL---------EI 656
G++APE T K +EK DV+ +GV+ LE+I G+ D + L E
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 657 ALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
L ++D L + +++ +++VA+ C SP RP + +V ++L+
Sbjct: 260 KLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 2e-78
Identities = 68/365 (18%), Positives = 118/365 (32%), Gaps = 37/365 (10%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKL--------CGSIPHSLGNLTQ 52
NL +L + +YN +P+ + L + + ++ N+ +
Sbjct: 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
Query: 53 ITFLTLFDNAL-SGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLT 111
I + + N L + + + KL +L NQL G +P + L + L N +T
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQIT 366
Query: 112 GNISESFGIHPNLAFIDLSHNYFYG-EISSDWGRCPKLGTLDFSSNNITG-------SMP 163
+ G + + +HN D + +DFS N I +
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 164 AEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQL-------CGQLSLELGS 216
+ ++LS+N I S L + L N L + +
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKN 486
Query: 217 LTQLERLDLSSNRLSNSIPKSL--GNLVKLHYLNLSNNQFIKKIPVELEKLIHLSEL--- 271
L +DL N+L+ + L L ++LS N F K P + L
Sbjct: 487 TYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIR 544
Query: 272 ---DLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHG 328
D N E P I SL +L + N++ +S +DI N
Sbjct: 545 NQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITP---NISVLDIKDNPNIS 601
Query: 329 SIPNS 333
+
Sbjct: 602 IDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-67
Identities = 58/359 (16%), Positives = 118/359 (32%), Gaps = 39/359 (10%)
Query: 1 NLSNLAFLYLYNNSF--------SGSIPSEIGRLKSLSDLELSGNKLC-GSIPHSLGNLT 51
L + + + N ++ + + + + N L + SL +
Sbjct: 271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMK 330
Query: 52 QITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNL-RNLTSLVRVRLNQNHL 110
++ L N L G +P +G+ +KL L L NQ+ N + + N L
Sbjct: 331 KLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL 389
Query: 111 TGNISESFGIH--PNLAFIDLSHNYFYG-------EISSDWGRCPKLGTLDFSSNNITGS 161
I F ++ ID S+N + + + +++ S+N I+
Sbjct: 390 KY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKF 448
Query: 162 MPAEIIHSSQLKVLDLSSNHIVG-------EMPSKLGKLSSLIKLILNSNQLCG-QLSLE 213
S L ++L N + + L + L N+L
Sbjct: 449 PKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFR 508
Query: 214 LGSLTQLERLDLSSNRLSNSIPKSLGNLVKL------HYLNLSNNQFIKKIPVELEKLIH 267
+L L +DLS N S P N L + + N+ +++ P +
Sbjct: 509 ATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567
Query: 268 LSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326
L++L + N + ++ +I ++ L++ N S + Y++
Sbjct: 568 LTQLQIGSNDI-RKVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKT 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 1e-66
Identities = 61/350 (17%), Positives = 114/350 (32%), Gaps = 39/350 (11%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L+ L Y+ N+ F E ++ + NL +T + +++
Sbjct: 204 RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNLKDLTDVEVYN 258
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
+P L ++ L+ + N+ Q +
Sbjct: 259 CPNLTKLPTFLKALPEMQLINVACNRGIS---------------GEQLKDDWQALADAPV 303
Query: 121 HPNLAFIDLSHNYF-YGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS 179
+ I + +N + + + KLG L+ N + G +P +L L+L+
Sbjct: 304 GEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362
Query: 180 NHIVGEMPSKLGKLSSLIKLILNSNQLCG-QLSLELGSLTQLERLDLSSNRLS------- 231
N I + G + L N+L + S++ + +D S N +
Sbjct: 363 NQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF 422
Query: 232 NSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFL-------GEEMPS 284
+ + + + + +NLSNNQ K LS ++L N L ++
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482
Query: 285 QICNMQSLEKLNLSHNNLSGFIPS-CFEELHGLSYIDISYNELHGSIPNS 333
N L ++L N L+ L L ID+SYN P
Sbjct: 483 NFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQ 531
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 8e-66
Identities = 55/333 (16%), Positives = 126/333 (37%), Gaps = 30/333 (9%)
Query: 1 NLSNLAFLYLYNNSF-SGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
+ +Y+ N+ + + + + ++K L LE N+L G +P + G+ ++ L L
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLA 361
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQLRG--PIPNLRNLTSLVRVRLNQNHLTG----- 112
N ++ G ++ L+ +N+L+ I + ++++ + + + N +
Sbjct: 362 YNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN 421
Query: 113 --NISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITG-------SMP 163
+ + N++ I+LS+N + L +++ N +T
Sbjct: 422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481
Query: 164 AEIIHSSQLKVLDLSSNHIVGEMPS-KLGKLSSLIKLILNSNQLCGQLSLELGSLTQLER 222
++ L +DL N + + L L+ + L+ N + + + + L+
Sbjct: 482 ENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKG 540
Query: 223 L------DLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHN 276
D NR P+ + L L + +N I+K+ ++ ++S LD+ N
Sbjct: 541 FGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND-IRKVNEKI--TPNISVLDIKDN 597
Query: 277 FLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSC 309
S +C L ++ I C
Sbjct: 598 PNISIDLSYVCPYIEAGMYMLFYDKTQD-IRGC 629
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 1e-63
Identities = 52/358 (14%), Positives = 121/358 (33%), Gaps = 33/358 (9%)
Query: 1 NLSNLAFLYLYNNSFSG----SIPSEIGRLKSLSDLELSGNKLCGSIPHSLG--NLTQIT 54
L+ L L L ++ P I S + + + + +
Sbjct: 103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLI 162
Query: 55 FLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNI 114
+ + +I K +K T + +N + + LT L + + +
Sbjct: 163 KDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAEN 222
Query: 115 SESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKV 174
+ N + Y W L ++ + +P + ++++
Sbjct: 223 ICEAWENEN-----SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQL 277
Query: 175 LDLSSNHIV--------GEMPSKLGKLSSLIKLILNSNQLC-GQLSLELGSLTQLERLDL 225
++++ N + + + + + + N L + L + +L L+
Sbjct: 278 INVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLEC 337
Query: 226 SSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDLSHNFLGEEMPS 284
N+L +P + G+ +KL LNL+ NQ I +IP + L +HN L + +P+
Sbjct: 338 LYNQLEGKLP-AFGSEIKLASLNLAYNQ-ITEIPANFCGFTEQVENLSFAHNKL-KYIPN 394
Query: 285 --QICNMQSLEKLNLSHNNLSGFIPSCFEE-------LHGLSYIDISYNELHGSIPNS 333
++ + ++ S+N + F+ +S I++S N++
Sbjct: 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL 452
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 2e-63
Identities = 62/352 (17%), Positives = 124/352 (35%), Gaps = 28/352 (7%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCG----SIPHSLGNLTQITFL 56
+ + L L SG +P IG+L L L L + P +
Sbjct: 79 SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 57 TLFDNALSGAIPKEYGNLV--KLTLLTLENNQLRGPIPNL-RNLTSLVRVRLNQNHLTGN 113
L + ++ + I R ++ N++T
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF- 197
Query: 114 ISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLK 173
+S++ L + ++ F E C + + + + L
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENI-----CEAWENENSEYAQQYKTEDLKWDNLKDLT 252
Query: 174 VLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSL--------ELGSLTQLERLDL 225
+++ + + ++P+ L L + + + N+ L + +++ + +
Sbjct: 253 DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYI 312
Query: 226 SSNRLSN-SIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPS 284
N L + SL + KL L NQ K+P I L+ L+L++N + E+P+
Sbjct: 313 GYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQI-TEIPA 370
Query: 285 QIC-NMQSLEKLNLSHNNLSGFIPSCFE--ELHGLSYIDISYNELHGSIPNS 333
C + +E L+ +HN L IP+ F+ + +S ID SYNE+ +
Sbjct: 371 NFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKN 421
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 4e-54
Identities = 54/337 (16%), Positives = 123/337 (36%), Gaps = 27/337 (8%)
Query: 12 NNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEY 71
N S G +L++ G + S L + ++T L+L SG +P
Sbjct: 46 NWSQQGFGTQPGANWNFNKELDMWGAQPGVS----LNSNGRVTGLSLEGFGASGRVPDAI 101
Query: 72 GNLVKLTLLTLENNQLRGPI-----PNLRNLTSLVRVRLNQNHLTGNISESFG--IHPNL 124
G L +L +L L ++ + + S + + + H + +L
Sbjct: 102 GQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDL 161
Query: 125 AFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVG 184
++ + I K + SNNIT + ++ ++L+ + ++ V
Sbjct: 162 IKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVA 220
Query: 185 EMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKL 244
E + + + L+ +L L +++ + +P L L ++
Sbjct: 221 ENICEAWENENSEYAQQYKT-----EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEM 275
Query: 245 HYLNLSNNQFIK--------KIPVELEKLIHLSELDLSHNFLGE-EMPSQICNMQSLEKL 295
+N++ N+ I + + + + + +N L + + + M+ L L
Sbjct: 276 QLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGML 335
Query: 296 NLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332
+N L G +P+ F L+ ++++YN++ N
Sbjct: 336 ECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPAN 371
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-37
Identities = 27/255 (10%), Positives = 74/255 (29%), Gaps = 21/255 (8%)
Query: 94 LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYG----EISSDWGRCPKLG 149
L + + + L +G + ++ G L + L +
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 150 TLDFSSNNITGSMPAEII--HSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLC 207
+ + S L ++S+ + ++ SN +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196
Query: 208 GQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIH 267
+S + LT+L + + ++ Y ++ + L
Sbjct: 197 F-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNLKD 250
Query: 268 LSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNL--------SGFIPSCFEELHGLSYI 319
L+++++ + ++P+ + + ++ +N++ N + + I
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310
Query: 320 DISYNEL-HGSIPNS 333
I YN L + S
Sbjct: 311 YIGYNNLKTFPVETS 325
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 18/136 (13%), Positives = 40/136 (29%), Gaps = 7/136 (5%)
Query: 204 NQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQF----IKKIP 259
+ Q + L S ++ L L S +P ++G L +L L L ++ P
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 260 VELEKLIHLSELDLSHNFLGEEMPSQI--CNMQSLEKLNLSHNNLSGFIPSCFEELHGLS 317
+ + + + + L K ++ + I +
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 318 YIDISYNELHGSIPNS 333
I N + + +
Sbjct: 187 QIGQLSNNI-TFVSKA 201
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 7e-13
Identities = 18/116 (15%), Positives = 33/116 (28%), Gaps = 6/116 (5%)
Query: 224 DLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFL----G 279
+ + SL + ++ L+L ++P + +L L L L +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 280 EEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELH--GLSYIDISYNELHGSIPNS 333
P I S E+ + L I+ + SI S
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 2e-76
Identities = 95/323 (29%), Positives = 144/323 (44%), Gaps = 30/323 (9%)
Query: 400 RSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPS 459
S+ S V ++ ++ TN+FD + IG G G VYK L
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 460 GEIVAVKKFHSPLPSEMASQQ---EFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516
G VA+K+ S Q EF E++TL+ RH ++V GFC ++Y+Y
Sbjct: 63 GAKVALKRRTP------ESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY 116
Query: 517 LEMGSLAMILS-NDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD 575
+E G+L L +D + W +R+ + G L Y+H I+HRD+ S N+LLD
Sbjct: 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLD 173
Query: 576 LENEAHVSDFGTAKFLKPDSSNW---AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLAL 632
++DFG +K + + GT GY+ PE ++TEK DVYSFGV+
Sbjct: 174 ENFVPKITDFGISK-KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232
Query: 633 EVIKGKHPRDFISSISSSSSNL-EIA--------LNEMLDPRLPTPSHNVQDKLISIMEV 683
EV+ + S+ NL E A L +++DP L + L +
Sbjct: 233 EVLCARSAIV--QSLPREMVNLAEWAVESHNNGQLEQIVDPNL--ADKIRPESLRKFGDT 288
Query: 684 AISCLDESPESRPTIQKVSQLLK 706
A+ CL S E RP++ V L+
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKLE 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 243 bits (623), Expect = 5e-75
Identities = 78/349 (22%), Positives = 128/349 (36%), Gaps = 55/349 (15%)
Query: 18 SIPSEIGRLKSLSD----LELSGNKLCGSIPHSLGNLTQITFLTLFDNALSG--AIPKEY 71
I ++G +LS + G + + ++ L L L IP
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 72 GNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSH 131
NL L L + N+L G I + L ++ ++H
Sbjct: 73 ANLPYLNFLYIGGI----------------------NNLVGPIPPAIAKLTQLHYLYITH 110
Query: 132 NYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLG 191
G I + L TLDFS N ++G++P I L + N I G +P G
Sbjct: 111 TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYG 170
Query: 192 KLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSN 251
S L + +S NRL+ IP + NL L +++LS
Sbjct: 171 SFSKL-----------------------FTSMTISRNRLTGKIPPTFANL-NLAFVDLSR 206
Query: 252 NQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFE 311
N V + ++ L+ N L ++ + ++L L+L +N + G +P
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLT 265
Query: 312 ELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIKGFPSC 360
+L L +++S+N L G IP + + A NK LCG P+C
Sbjct: 266 QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG--SPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 7e-67
Identities = 71/232 (30%), Positives = 118/232 (50%), Gaps = 6/232 (2%)
Query: 1 NLSNLAFLYLYN-NSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
NL L FLY+ N+ G IP I +L L L ++ + G+IP L + + L
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRV-RLNQNHLTGNISES 117
NALSG +P +L L +T + N++ G IP+ + + L +++N LTG I +
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 118 FGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDL 177
F + NLAF+DLS N G+ S +G + + N++ + ++ S L LDL
Sbjct: 194 FA-NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDL 251
Query: 178 SSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNR 229
+N I G +P L +L L L ++ N LCG++ + G+L + + ++N+
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 8e-70
Identities = 91/301 (30%), Positives = 145/301 (48%), Gaps = 37/301 (12%)
Query: 428 YEEIIRVTNDFDDEHC------IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQ- 480
+ E+ VTN+FD+ +G+GG G VYK + VAVKK + + ++ +++
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMV--DITTEEL 73
Query: 481 --EFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWT 538
+F E+K + +H N+V+ GF S +VY Y+ GSL LS L W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 539 KRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW 598
R + +G + ++++H + +HRDI S N+LLD A +SDFG A+ +
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQT 189
Query: 599 A---ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL- 654
+ GT Y+APE A ++T K D+YSFGV+ LE+I G D L
Sbjct: 190 VMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE----HREPQLLL 244
Query: 655 EIA---------LNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
+I + + +D ++ + + ++ VA CL E RP I+KV QLL
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKM---NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301
Query: 706 K 706
+
Sbjct: 302 Q 302
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 2e-69
Identities = 83/361 (22%), Positives = 134/361 (37%), Gaps = 17/361 (4%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
+N+ L L +N + R L+ L++ N + P L + L L N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 62 ALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGI 120
LS K + LT L L +N ++ N +L+ + L+ N L+ +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 121 HPNLAFIDLSHNYFYGEISSD--WGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
NL + LS+N S + L L+ SSN I P +L L L+
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203
Query: 179 SNHIVGEMPSKLG---KLSSLIKLILNSNQLCGQLSLELGSL--TQLERLDLSSNRLSNS 233
+ + + KL +S+ L L+++QL + L T L LDLS N L+
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263
Query: 234 IPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNF---------LGEEMPS 284
S L +L Y L N L L ++ L+L +F L +
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323
Query: 285 QICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEAL 344
++ LE LN+ N++ G + F L L Y+ +S + + F L
Sbjct: 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL 383
Query: 345 Q 345
Sbjct: 384 H 384
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 5e-69
Identities = 82/380 (21%), Positives = 131/380 (34%), Gaps = 26/380 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGN---------KLCGSIPHSLGNLT 51
L L + +L N+ + L ++ L L + L S L
Sbjct: 270 WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329
Query: 52 QITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNL-----TSLVRVRLN 106
+ L + DN + G + L+ L L+L N+ + L + L
Sbjct: 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLT 389
Query: 107 QNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSD-WGRCPKLGTLDFSSNNITGSMPAE 165
+N ++ S++F +L +DL N E++ W + + S N
Sbjct: 390 KNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS 449
Query: 166 IIHSSQLKVLDLSSNHI--VGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERL 223
L+ L L + V PS L +L L L++N + L L +LE L
Sbjct: 450 FALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEIL 509
Query: 224 DLSSNRLS--------NSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275
DL N L+ L L LH LNL +N F + + L L +DL
Sbjct: 510 DLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEE-LHGLSYIDISYNELHGSIPNST 334
N L S N SL+ LNL N ++ F L+ +D+ +N + +
Sbjct: 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIA 629
Query: 335 AFRDAPMEALQGNKGLCGDI 354
F + E L
Sbjct: 630 WFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-47
Identities = 65/267 (24%), Positives = 105/267 (39%), Gaps = 11/267 (4%)
Query: 75 VKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNY 133
V + + +L P N+T L L N L + +F + L +D+ N
Sbjct: 4 VSHEVADCSHLKLTQVPDDLPTNITVL---NLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 134 FYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKL 193
+ P L L+ N ++ + L L L SN I + K
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 194 SSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLG--NLVKLHYLNLSN 251
+LI L L+ N L L L+ L LS+N++ + L L L LS+
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 252 NQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQIC---NMQSLEKLNLSHNNLSGFIPS 308
NQ + P + L L L++ LG + ++C S+ L+LS++ LS +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 309 CFEELHG--LSYIDISYNELHGSIPNS 333
F L L+ +D+SYN L+ +S
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDS 267
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-31
Identities = 40/168 (23%), Positives = 69/168 (41%), Gaps = 3/168 (1%)
Query: 169 SSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSN 228
+ +V D S + ++P L +++ L L NQL + +QL LD+ N
Sbjct: 3 TVSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 229 RLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICN 288
+S P+ L L LNL +N+ + +L+EL L N + + +
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 289 MQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAF 336
++L L+LSHN LS +L L + +S N++
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDI 167
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 2e-69
Identities = 72/381 (18%), Positives = 130/381 (34%), Gaps = 40/381 (10%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKL---------CGSIPHSLGNLT 51
NL +L + LYN +P + L L L ++ N+ +
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP 548
Query: 52 QITFLTLFDNALSGAIPKEY--GNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNH 109
+I + N L P +VKL LL +N++R + L ++L+ N
Sbjct: 549 KIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYNQ 606
Query: 110 LTGNISESFGIHPNLAFIDLSHNYFYG-EISSDWGRCPKLGTLDFSSNNITG-----SMP 163
+ + + + SHN + +G++DFS N I S
Sbjct: 607 IEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCS 666
Query: 164 AEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQL-------CGQLSLELGS 216
+ + LS N I S + +IL++N + +
Sbjct: 667 MDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKN 726
Query: 217 LTQLERLDLSSNRLSNSIPKSL--GNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLS 274
L +DL N+L+ S+ L L +++S N F P + L +
Sbjct: 727 TYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIR 784
Query: 275 H------NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL-H 327
H N + + P+ I SL +L + N++ + L +DI+ N
Sbjct: 785 HQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNIS 841
Query: 328 GSIPNSTAFRDAPMEALQGNK 348
+ + + +A M L +K
Sbjct: 842 IDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 4e-61
Identities = 70/416 (16%), Positives = 139/416 (33%), Gaps = 69/416 (16%)
Query: 1 NLSNLAFLYLYNNSFSG-------------------SIPSEIGRLKSLSDLELSGNKLCG 41
L+ L +Y N+ F+ + LK L+D+EL
Sbjct: 446 RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMT 505
Query: 42 SIPHSLGNLTQITFLTLFDNALSG---------AIPKEYGNLVKLTLLTLENNQLRG--P 90
+P L +L ++ L + N + + K+ + + N L
Sbjct: 506 QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPA 565
Query: 91 IPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGR-CPKLG 149
+L+ + L + N + E+FG + L + L +N EI D+ ++
Sbjct: 566 SASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQI-EEIPEDFCAFTDQVE 622
Query: 150 TLDFSSNNITGSMPAEIIHS-SQLKVLDLSSNHIVGEMPS-----KLGKLSSLIKLILNS 203
L FS N + S + +D S N I E + K + + L+
Sbjct: 623 GLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSY 682
Query: 204 NQLCGQLSLELGSLTQLERLDLSSNRLSN-------SIPKSLGNLVKLHYLNLSNNQFIK 256
N++ + + + + + LS+N +++ + N L ++L N+ +
Sbjct: 683 NEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNK-LT 741
Query: 257 KIPVELE--KLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSH------NNLSGFIPS 308
+ + L +LS +D+S+N P+Q N L+ + H N + P+
Sbjct: 742 SLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800
Query: 309 CFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQ-----GNKGLCGDIKGFPS 359
L + I N++ + L N + D+
Sbjct: 801 GITTCPSLIQLQIGSNDI-RKVDEKL------TPQLYILDIADNPNISIDVTSVCP 849
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 2e-55
Identities = 65/360 (18%), Positives = 127/360 (35%), Gaps = 32/360 (8%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
N + L L G +P IG+L L L + S
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 61 NALSGAIPKEYG-NLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGN------ 113
+ + K + +L L L + + P ++ + R+ L +
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISLKDTQIGNLTNRITF 439
Query: 114 ISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLK 173
IS++ L I +++ F + + + + L
Sbjct: 440 ISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYAKQYENEELSWSNLKDLT 494
Query: 174 VLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQL---------CGQLSLELGSLTQLERLD 224
++L + + ++P L L L L + N+ +L+ + + +++
Sbjct: 495 DVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554
Query: 225 LSSNRLSNSIPKS--LGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEM 282
+ N L P S L +VKL L+ +N+ ++ + + L++L L +N + EE+
Sbjct: 555 MGYNNLE-EFPASASLQKMVKLGLLDCVHNK-VRHLE-AFGTNVKLTDLKLDYNQI-EEI 610
Query: 283 PSQIC-NMQSLEKLNLSHNNLSGFIPSCFE--ELHGLSYIDISYNELHGSIPNSTAFRDA 339
P C +E L SHN L IP+ F ++ + +D SYN++ N + D
Sbjct: 611 PEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDD 669
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 7e-53
Identities = 55/332 (16%), Positives = 116/332 (34%), Gaps = 31/332 (9%)
Query: 1 NLSNLAFLYLYNNSFSGSIPS-EIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
+ Y+ N+ S + ++ L L+ NK+ + G ++T L L
Sbjct: 546 TGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLD 603
Query: 60 DNALSGAIPKEYG-NLVKLTLLTLENNQLRG--PIPNLRNLTSLVRVRLNQNHLTGNISE 116
N + IP+++ ++ L +N+L+ I N +++ + V + N +
Sbjct: 604 YNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRN 662
Query: 117 SFGIHP-----NLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNIT-------GSMPA 164
N + + LS+N + + + T+ S+N +T
Sbjct: 663 ISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDG 722
Query: 165 EIIHSSQLKVLDLSSNHIVGEMPS-KLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERL 223
++ L +DL N + + L L + ++ N + + +QL+
Sbjct: 723 NYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAF 781
Query: 224 DL------SSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNF 277
+ NR+ P + L L + +N I+K+ +L L LD++ N
Sbjct: 782 GIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND-IRKVDEKL--TPQLYILDIADNP 838
Query: 278 LGEEMPSQICNMQSLEKLNLSHNNLSGFIPSC 309
+ +C L ++ I C
Sbjct: 839 NISIDVTSVCPYIEAGMYVLLYDKTQ-DIRGC 869
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 7e-35
Identities = 38/332 (11%), Positives = 98/332 (29%), Gaps = 38/332 (11%)
Query: 16 SGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLV 75
+ I L+ + ++ + F D + N
Sbjct: 265 AEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDM-WGDQPGVDLDNNG 323
Query: 76 KLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYF 134
++T L+L +G +P+ + LT L + + T + + +
Sbjct: 324 RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 135 YGEISSDWGRCP-KLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKL 193
+ +L D + I + E+ + + L
Sbjct: 384 RMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQ------------ 429
Query: 194 SSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQ 253
+ +N++ +S + LT+L+ + +++ + N +
Sbjct: 430 -----IGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWED-----ANSDYAK 478
Query: 254 FIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGF-------- 305
+ + L L++++L + ++P + ++ L+ LN++ N
Sbjct: 479 QYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT 538
Query: 306 -IPSCFEELHGLSYIDISYNELHGSIPNSTAF 336
+ + + + YN L P S +
Sbjct: 539 RLADDEDTGPKIQIFYMGYNNLE-EFPASASL 569
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 7e-33
Identities = 45/348 (12%), Positives = 101/348 (29%), Gaps = 26/348 (7%)
Query: 8 LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAI 67
Y+ S E ++ + NKL T+ + + + I
Sbjct: 221 YTTYSQSGIKRSELETQSVRG-ESFTVIDNKL-----------TKDANVPIQLKETAEYI 268
Query: 68 PKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFI 127
L +N + N + + + + +
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL 328
Query: 128 DLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHI----- 182
L+ G + G+ +L L F +++ T S + + + I
Sbjct: 329 SLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYK 388
Query: 183 --VGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN 240
+ +L L I + ++ SL + + +NR++ I K++
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ-IGNLTNRIT-FISKAIQR 446
Query: 241 LVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHN 300
L KL + +N+ F + + + + E N++ L + L +
Sbjct: 447 LTKLQIIYFANSPF-----TYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501
Query: 301 NLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNK 348
+P +L L ++I+ N + + + G K
Sbjct: 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 23/231 (9%), Positives = 65/231 (28%), Gaps = 10/231 (4%)
Query: 123 NLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHI 182
L + +++ E + K + ++ + +PA S
Sbjct: 172 ELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTTYSQSGIKR 231
Query: 183 V----GEMPS-----KLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNS 233
+ KL+ + + + + E LD + R +
Sbjct: 232 SELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSG 291
Query: 234 IPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLE 293
+ + + + N + + + V+L+ ++ L L+ +P I + L+
Sbjct: 292 TINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELK 350
Query: 294 KLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEAL 344
L+ ++ + +E + + + D +
Sbjct: 351 VLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLS 401
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 4e-65
Identities = 74/311 (23%), Positives = 121/311 (38%), Gaps = 44/311 (14%)
Query: 428 YEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVK 487
E + + +G G V+KA+L E VAVK F P + + EV
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIF----PIQDKQSWQNEYEVY 70
Query: 488 TLTGIRHRNIVKFYGFCSHARHS----FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNV 543
+L G++H NI++F G +++ + E GSL+ L + + W + ++
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHI 126
Query: 544 IKGVVDALSYMHNDCF-------PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596
+ + L+Y+H D P I HRDI SKNVLL A ++DFG A + S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 597 NWA--ELAGTYGYVAPELA-----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS---- 645
GT Y+APE+ + + D+Y+ G++ E+ D
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 646 --------SISSSSSNLEIALNEMLDPRLP--TPSHNVQDKLISIMEVAISCLDESPESR 695
S E+ +++ P L H L +E C D E+R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE---ECWDHDAEAR 303
Query: 696 PTIQKVSQLLK 706
+ V + +
Sbjct: 304 LSAGCVGERIT 314
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-62
Identities = 72/272 (26%), Positives = 130/272 (47%), Gaps = 21/272 (7%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+ + E +G+G G V KA+ + VA+K+ S + ++ F+ E++ L+ + H
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHP 61
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
NIVK YG C + +V EY E GSL +L M+ ++Y+H
Sbjct: 62 NIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 556 NDCFPPIVHRDISSKNVLLDLENE-AHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
+ ++HRD+ N+LL + DFGTA ++ +N G+ ++APE+
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN---NKGSAAWMAPEVFE 176
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674
+EKCDV+S+G++ EVI + P F I + + A++ R P N+
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKP--F-DEIGGPAFRIMWAVHNGT--RPPLIK-NLP 230
Query: 675 DKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ S+M C + P RP+++++ +++
Sbjct: 231 KPIESLMT---RCWSKDPSQRPSMEEIVKIMT 259
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 4e-61
Identities = 59/344 (17%), Positives = 114/344 (33%), Gaps = 10/344 (2%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
++ L N + RL +L+ L+L+ ++ + + ++ L L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 62 ALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGI 120
L L L + L N +L + L NH++
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLG--TLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
L +D +N + D + +L+ + N+I + S+ + L+
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFG 210
Query: 179 SNHIVGEMPSKLG--KLSSLIKLILNSNQLCG--QLSLELGSLTQLERLDLSSNRLSNSI 234
+ + L + SL E +E ++L + N
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270
Query: 235 PKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEK 294
+ L L+L+ + ++P L L L +L LS N N SL
Sbjct: 271 SNTFHCFSGLQELDLTATH-LSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTH 329
Query: 295 LNLSHNNLSGFIPS-CFEELHGLSYIDISYNELHGSIPNSTAFR 337
L++ N + + C E L L +D+S++++ S + R
Sbjct: 330 LSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-57
Identities = 68/343 (19%), Positives = 123/343 (35%), Gaps = 11/343 (3%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L L+ S + K+L L L N + ++ L +
Sbjct: 103 GPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQN 162
Query: 61 NALSGAIPKEYGNLVKLTLLTL--ENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESF 118
NA+ ++ +L + T L+L N + G P + + I +
Sbjct: 163 NAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGL 222
Query: 119 GIH--PNLAFIDLSHNYFYGEISSDWGRCPKLG--TLDFSSNNITGSMPAEIIHSSQLKV 174
+L + + ++ +++ + S L+
Sbjct: 223 KNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQE 282
Query: 175 LDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSI 234
LDL++ H+ E+PS L LS+L KL+L++N+ + + L L + N +
Sbjct: 283 LDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341
Query: 235 -PKSLGNLVKLHYLNLSNNQ--FIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQS 291
L NL L L+LS++ ++L L HL L+LS+N
Sbjct: 342 GTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ 401
Query: 292 LEKLNLSHNNLSGFIP-SCFEELHGLSYIDISYNELHGSIPNS 333
LE L+L+ L S F+ LH L +++S++ L S
Sbjct: 402 LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-56
Identities = 71/340 (20%), Positives = 121/340 (35%), Gaps = 11/340 (3%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+L F + + S ++ + + S+ + L + ++ + + L L
Sbjct: 229 SLWLGTFEDMDDEDISPAVFEGLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNI-SESF 118
LS +P L L L L N+ N SL + + N + +
Sbjct: 288 THLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL 346
Query: 119 GIHPNLAFIDLSHN--YFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLD 176
NL +DLSH+ + L +L+ S N QL++LD
Sbjct: 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLD 406
Query: 177 LSSNHIVG-EMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSI- 234
L+ + + S L L L L+ + L L L+ L+L N
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466
Query: 235 --PKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSL 292
SL L +L L LS L ++ +DLSHN L + +++ +
Sbjct: 467 QKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI 526
Query: 293 EKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332
LNL+ N++S +PS L I++ N L + N
Sbjct: 527 Y-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN 565
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 5e-54
Identities = 68/344 (19%), Positives = 122/344 (35%), Gaps = 12/344 (3%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIG--RLKSLSDLELSGNKLCGSIPHSLGNL--TQITFL 56
+ + L I + ++SL P L + +
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI 259
Query: 57 TLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISE 116
L + + L L L L L L++L ++ L+ N
Sbjct: 260 NLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQI 319
Query: 117 SFGIHPNLAFIDLSHNYFYGEISSDW-GRCPKLGTLDFSSNNITGS--MPAEIIHSSQLK 173
S P+L + + N E+ + L LD S ++I S ++ + S L+
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQ 379
Query: 174 VLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLE-LGSLTQLERLDLSSNRLSN 232
L+LS N + + L L L +L + + +L L+ L+LS + L
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 233 SIPKSLGNLVKLHYLNLSNNQF---IKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNM 289
S + L L +LNL N F + L+ L L L LS L ++
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL 499
Query: 290 QSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNS 333
+ + ++LSHN L+ L G+ Y++++ N + +P+
Sbjct: 500 KMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSL 542
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-37
Identities = 50/260 (19%), Positives = 85/260 (32%), Gaps = 9/260 (3%)
Query: 80 LTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEIS 139
EN L L S + + N L + +F NL F+DL+ Y
Sbjct: 17 YNCENLGLNEIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHE 74
Query: 140 SDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKL 199
+ +L TL ++N + + LK L I L +L L
Sbjct: 75 DTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESL 134
Query: 200 ILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLH--YLNLSNNQFIKK 257
L SN + + +L+ LD +N + + + +L + LNL+ N I
Sbjct: 135 YLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND-IAG 193
Query: 258 IPVELEKLIHLSELDLSHNFLGEEMPSQI--CNMQSLEKLNLSHNNLSGFIPSCFEELHG 315
I L+ + + +QSL + P+ FE L
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 316 LS--YIDISYNELHGSIPNS 333
+S I++ + N+
Sbjct: 254 MSVESINLQKHYFFNISSNT 273
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-31
Identities = 35/217 (16%), Positives = 72/217 (33%), Gaps = 5/217 (2%)
Query: 150 TLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ 209
T + + + +P + + + L+ S N + + +L +L L L Q+
Sbjct: 16 TYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 210 LSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLS 269
S +L+ L L++N L +L L +L + L L
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLE 132
Query: 270 ELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLS--YIDISYNELH 327
L L N + + + L+ L+ +N + L + ++++ N++
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 328 GSIPNSTAFRDAPMEALQGNKGLCGDIKGFPSCKASK 364
G P + G + L KG +
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 35/175 (20%), Positives = 58/175 (33%), Gaps = 3/175 (1%)
Query: 159 TGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLT 218
T S + I K + + + E+P L +S L + N L + L
Sbjct: 1 TTSSDQKCIEKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLI 57
Query: 219 QLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFL 278
L LDL+ ++ + + +L L L+ N I L L L +
Sbjct: 58 NLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGI 117
Query: 279 GEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNS 333
+ N ++LE L L N++S L +D N +H
Sbjct: 118 SSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKED 172
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-19
Identities = 33/146 (22%), Positives = 54/146 (36%), Gaps = 5/146 (3%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSI---PHSLGNLTQITFLT 57
NL L L L ++ S L +L L L GN +SL L ++ L
Sbjct: 423 NLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILV 482
Query: 58 LFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISE 116
L LS + +L + + L +N+L L +L + + L NH++ +
Sbjct: 483 LSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPS 541
Query: 117 SFGIHPNLAFIDLSHNYFYGEISSDW 142
I I+L N S+ +
Sbjct: 542 LLPILSQQRTINLRQNPLDCTCSNIY 567
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-59
Identities = 84/274 (30%), Positives = 129/274 (47%), Gaps = 19/274 (6%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
D + + IG G G+V++AE G VAVK EFL EV + +RH
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHP 94
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
NIV F G + + IV EYL GSL +L A + L +R+++ V ++Y+H
Sbjct: 95 NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT 615
N PPIVHR++ S N+L+D + V DFG ++ + AGT ++APE+
Sbjct: 155 N-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213
Query: 616 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIA---LNEMLDPRLPTPSHN 672
EK DVYSFGV+ E+ + P + + ++ + RL P N
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNL-------NPAQVVAAVGFKCK--RLEIPR-N 263
Query: 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ ++ +I+E C P RP+ + LL+
Sbjct: 264 LNPQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 3e-59
Identities = 73/348 (20%), Positives = 123/348 (35%), Gaps = 23/348 (6%)
Query: 1 NLSNLAFLYLYNNSFSGS------IPSEIGRLKSLSDLELSGNKL---CGSIPHSLGNLT 51
L+ L L F S + L +L+ E L I LT
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282
Query: 52 QITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHL 110
++ +L + + L L N + P L++L L
Sbjct: 283 NVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRL-----TFTSN 335
Query: 111 TGNISESFGIHPNLAFIDLSHN--YFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIH 168
G + S P+L F+DLS N F G S L LD S N + M + +
Sbjct: 336 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLG 394
Query: 169 SSQLKVLDLSSNHIVGEMP-SKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSS 227
QL+ LD +++ S L +LI L ++ + L+ LE L ++
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 228 NRLSNSI-PKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQI 286
N + P L L +L+LS Q + P L L L++SHN
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 514
Query: 287 CNMQSLEKLNLSHNNLSGFIPSCFEELHG-LSYIDISYNELHGSIPNS 333
+ SL+ L+ S N++ + L++++++ N+ + +
Sbjct: 515 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 6e-56
Identities = 80/376 (21%), Positives = 133/376 (35%), Gaps = 50/376 (13%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKL-CGSIPHSLGNLTQITFLTLF 59
LS+L L + + IG LK+L +L ++ N + +P NLT + L L
Sbjct: 98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 60 DNALSGAIPKEYGNLVKLTL----LTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNIS 115
N + + L ++ L L L N + P L ++ L N + N+
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVM 217
Query: 116 E-----------------SFGIHPNLAFIDLSH-----------------NYFYGEISSD 141
+ F NL D S +Y+ +I
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
Query: 142 WGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLIL 201
+ + + S I ++ + L+L + G+ P+ KL SL +L
Sbjct: 278 FNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF-GQFPT--LKLKSLKRLTF 332
Query: 202 NSNQLCGQLSLELGSLTQLERLDLSSNRLS--NSIPKSLGNLVKLHYLNLSNNQFIKKIP 259
SN+ S L LE LDLS N LS +S L YL+LS N + +
Sbjct: 333 TSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG-VITMS 389
Query: 260 VELEKLIHLSELDLSHNFLGEEMPSQI-CNMQSLEKLNLSHNNLSGFIPSCFEELHGLSY 318
L L LD H+ L + + ++++L L++SH + F L L
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 449
Query: 319 IDISYNELHGSIPNST 334
+ ++ N +
Sbjct: 450 LKMAGNSFQENFLPDI 465
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 7e-55
Identities = 67/367 (18%), Positives = 119/367 (32%), Gaps = 40/367 (10%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA 62
+ L L N L L+LS ++ + +L+ ++ L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 63 LSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTG-NISESFGI 120
+ + L L L L + +L +L + + N + + E F
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLG----TLDFSSNNITGSMPAEIIHSSQLKVLD 176
NL +DLS N +D ++ +LD S N + + +L L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLT 206
Query: 177 LSSNHIVGEMPSK-LGKLSSLIKLILNSNQLCGQLSLE---LGSLTQLERLDLSSNRLS- 231
L +N + + L+ L L + + +LE +L L L + RL+
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 232 -----NSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGE------ 280
+ I L + +L + + + L+L + G+
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQFPTLKL 324
Query: 281 -------------EMPSQICNMQSLEKLNLSHNNLS--GFIPSCFEELHGLSYIDISYNE 325
++ SLE L+LS N LS G L Y+D+S+N
Sbjct: 325 KSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 326 LHGSIPN 332
+ N
Sbjct: 385 VITMSSN 391
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 6e-51
Identities = 74/354 (20%), Positives = 120/354 (33%), Gaps = 40/354 (11%)
Query: 1 NLSNLAFLYL---YNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLT 57
L NL Y + + I L ++S L + L
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLE 310
Query: 58 LFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISES 117
L + + +L +LT + + +L +L L + N G S+S
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNA-FSEVDLPSLEFL-DLSRNGLSFKGCCSQS 368
Query: 118 FGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLD 176
+L ++DLS N +SS++ +L LDF +N+ + S L LD
Sbjct: 369 DFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 427
Query: 177 LSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLE-LGSLTQLERLDLSSNRLSNSIP 235
+S H LSSL L + N + L L LDLS +L P
Sbjct: 428 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 236 KSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNM-QSLEK 294
+ +L L LN+S+N F + L L LD S N + ++ + SL
Sbjct: 488 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAF 547
Query: 295 LNLSHNNLS--------------------------GFIPSCFEELHGLSYIDIS 322
LNL+ N+ + PS + G+ + ++
Sbjct: 548 LNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS---DKQGMPVLSLN 598
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 7e-50
Identities = 66/352 (18%), Positives = 118/352 (33%), Gaps = 27/352 (7%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+LS+L+ L L N L SL L L +G+L + L +
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133
Query: 61 NAL-SGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSL----VRVRLNQNHLTGNI 114
N + S +P+ + NL L L L +N+++ LR L + + + L+ N +
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ 193
Query: 115 SESFGIHPNLAFIDLSHNYFYGEISSDW-GRCPKLGTLDFSSNNITGSMPAEIIHSSQ-- 171
+F L + L +N+ + L E S
Sbjct: 194 PGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252
Query: 172 -LKVLDLSSNHI------VGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLD 224
L L + + + ++ L+++ L S + + + + L+
Sbjct: 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLE 310
Query: 225 LSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLG--EEM 282
L + + L +L +L + + L L LDLS N L
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSRNGLSFKGCC 365
Query: 283 PSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST 334
SL+ L+LS N + + S F L L ++D ++ L S
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-40
Identities = 56/219 (25%), Positives = 85/219 (38%), Gaps = 7/219 (3%)
Query: 119 GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
+ + +DLS N S + P+L LD S I S L L L+
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 179 SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSN-SIPKS 237
N I LSSL KL+ L + +G L L+ L+++ N + + +P+
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 238 LGNLVKLHYLNLSNNQFIKKIPVELEKLIHLS----ELDLSHNFLGEEMPSQICNMQSLE 293
NL L +L+LS+N+ +L L + LDLS N + P + L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLH 203
Query: 294 KLNLSHNNLSGFIPS-CFEELHGLSYIDISYNELHGSIP 331
KL L +N S + C + L GL + E
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 4e-37
Identities = 46/194 (23%), Positives = 77/194 (39%), Gaps = 6/194 (3%)
Query: 146 PKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQ 205
LD S N + +L+VLDLS I LS L LIL N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 206 LCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIK-KIPVELEK 264
+ L+ L++L L++ +G+L L LN+++N K+P
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 265 LIHLSELDLSHNFLGEEMPSQICNMQSLE----KLNLSHNNLSGFIPSCFEELHGLSYID 320
L +L LDLS N + + + + + L+LS N ++ P F+E+ L +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLT 206
Query: 321 ISYNELHGSIPNST 334
+ N ++ +
Sbjct: 207 LRNNFDSLNVMKTC 220
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-29
Identities = 37/162 (22%), Positives = 63/162 (38%), Gaps = 4/162 (2%)
Query: 173 KVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSN 232
+ ++P L S L L+ N L S S +L+ LDLS +
Sbjct: 10 ITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 233 SIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSL 292
+ +L L L L+ N L L +L L I ++++L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 293 EKLNLSHNNLSGF-IPSCFEELHGLSYIDISYNELHGSIPNS 333
++LN++HN + F +P F L L ++D+S N++
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-26
Identities = 36/186 (19%), Positives = 69/186 (37%), Gaps = 6/186 (3%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSI-PHSLGNLTQITFLTLF 59
+L NL +L + + + L SL L+++GN + P L +TFL L
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESF 118
L P + +L L +L + +N + L SL + + NH+ + +
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQEL 538
Query: 119 G-IHPNLAFIDLSHNYFYGEISSDWGR--CPKLGTLDFSSNNITGSMPAEIIHSSQLKVL 175
+LAF++L+ N F L + + P++ + L
Sbjct: 539 QHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD-KQGMPVLSL 597
Query: 176 DLSSNH 181
+++
Sbjct: 598 NITCQM 603
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 6e-59
Identities = 76/283 (26%), Positives = 124/283 (43%), Gaps = 32/283 (11%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMA-SQQEFLNEVKTLTGIRH 494
+ E IG GG G VY+A G+ VAVK +++ + + E K ++H
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
NI+ G C + +V E+ G L +LS K + +N + ++Y+
Sbjct: 66 PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYL 121
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAH--------VSDFGTAKFLKPDSSNWAELAGTYG 606
H++ PI+HRD+ S N+L+ + E ++DFG A+ + A AG Y
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA--AGAYA 179
Query: 607 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIA---LNEMLD 663
++APE+ ++ DV+S+GVL E++ G+ P I L +A L
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-------DGLAVAYGVAMNKL- 231
Query: 664 PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
LP PS + +ME C + P SRP+ + L
Sbjct: 232 -ALPIPS-TCPEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-58
Identities = 80/283 (28%), Positives = 124/283 (43%), Gaps = 28/283 (9%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPS-GEIVAVKKFHSPLPSEMASQ----QEFLNEVKTLT 490
N+ + E IGKGG G V+K L +VA+K QEF EV ++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 491 GIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDA 550
+ H NIVK YG + +V E++ G L L + A + W+ ++ ++ +
Sbjct: 79 NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENE-----AHVSDFGTAKFLKPDSSNWAELAGTY 605
+ YM N PPIVHRD+ S N+ L +E A V+DFG ++ S L G +
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG---LLGNF 190
Query: 606 GYVAPEL--AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD 663
++APE A TEK D YSF ++ ++ G+ P D S N+
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL--- 247
Query: 664 PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
R P + +L +++E C P+ RP + + L
Sbjct: 248 -RPTIPE-DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 2e-57
Identities = 82/331 (24%), Positives = 149/331 (45%), Gaps = 22/331 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+L+ L S + + L+S++ L ++G K+ SI + LT + +L L
Sbjct: 20 DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV-ASIQ-GIEYLTNLEYLNLNG 75
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
N ++ P NLVKLT L + N++ I L+NLT+L + LN+++++
Sbjct: 76 NQITDISP--LSNLVKLTNLYIGTNKITD-ISALQNLTNLRELYLNEDNISD--ISPLAN 130
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
+ ++L N+ ++S L L + + + P I + + L L L+ N
Sbjct: 131 LTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187
Query: 181 HIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN 240
I E S L L+SL NQ+ + ++T+L L + +N++++ P L N
Sbjct: 188 QI--EDISPLASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP--LAN 241
Query: 241 LVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHN 300
L +L +L + NQ I I ++ L L L++ N + + S + N+ L L L++N
Sbjct: 242 LSQLTWLEIGTNQ-ISDIN-AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNN 297
Query: 301 NLSGFIPSCFEELHGLSYIDISYNELHGSIP 331
L L L+ + +S N + P
Sbjct: 298 QLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 2e-50
Identities = 74/303 (24%), Positives = 137/303 (45%), Gaps = 20/303 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L+NL +L L N + P + L L++L + NK+ + +L NLT + L L +
Sbjct: 64 YLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNE 119
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
+ +S P NL K+ L L N + L N+T L + + ++ +
Sbjct: 120 DNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKD--VTPIAN 175
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
+L + L++N S L N IT P + + ++L L + +N
Sbjct: 176 LTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN 231
Query: 181 HIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN 240
I S L LS L L + +NQ+ ++ + LT+L+ L++ SN++S+ L N
Sbjct: 232 KITD--LSPLANLSQLTWLEIGTNQI-SDIN-AVKDLTKLKMLNVGSNQISD--ISVLNN 285
Query: 241 LVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHN 300
L +L+ L L+NNQ + + L +L+ L LS N + + P + ++ ++ + ++
Sbjct: 286 LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343
Query: 301 NLS 303
+
Sbjct: 344 VIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-45
Identities = 60/298 (20%), Positives = 122/298 (40%), Gaps = 22/298 (7%)
Query: 29 LSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLR 88
+ L + P +L + L +++ + +E L +T L + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA 57
Query: 89 GPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKL 148
I + LT+L + LN N +T L + + N S L
Sbjct: 58 S-IQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI--TDISALQNLTNL 112
Query: 149 GTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCG 208
L + +NI+ P + + +++ L+L +NH + + S L ++ L L + +++
Sbjct: 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKD 169
Query: 209 QLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHL 268
+ +LT L L L+ N++ + P L +L LHY NQ I I + + L
Sbjct: 170 --VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQ-ITDIT-PVANMTRL 223
Query: 269 SELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326
+ L + +N + S + N+ L L + N +S + ++L L +++ N++
Sbjct: 224 NSLKIGNNKI--TDLSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI 277
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 8e-38
Identities = 52/257 (20%), Positives = 105/257 (40%), Gaps = 22/257 (8%)
Query: 77 LTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYG 136
L + I +L +R L + +T + ++ + ++
Sbjct: 2 AATLATLPAPINQ-IFPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGE---- 54
Query: 137 EISS--DWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLS 194
+++S L L+ + N IT P + + +L L + +N I S L L+
Sbjct: 55 KVASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLT 110
Query: 195 SLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQF 254
+L +L LN + + L +LT++ L+L +N S L N+ L+YL ++ ++
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESK- 166
Query: 255 IKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELH 314
+K + + L L L L++N + E S + ++ SL N ++ P +
Sbjct: 167 VKDVT-PIANLTDLYSLSLNYNQI--EDISPLASLTSLHYFTAYVNQITDITP--VANMT 221
Query: 315 GLSYIDISYNELHGSIP 331
L+ + I N++ P
Sbjct: 222 RLNSLKIGNNKITDLSP 238
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 32/161 (19%), Positives = 64/161 (39%), Gaps = 12/161 (7%)
Query: 172 LKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLS 231
L I L+ I+ +L + + L + +L ++ +++
Sbjct: 2 AATLATLPAPI--NQIFPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 232 NSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQS 291
+ + + L L YLNL+ NQ I I L L+ L+ L + N + S + N+ +
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQ-ITDIS-PLSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 292 LEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332
L +L L+ +N+S P L + +++ N +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-53
Identities = 52/276 (18%), Positives = 109/276 (39%), Gaps = 24/276 (8%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+ + + G ++K G + VK S S+ +F E L H
Sbjct: 10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSR-DFNEECPRLRIFSHP 67
Query: 496 NIVKFYGFCSH--ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
N++ G C A H ++ ++ GSL +L ++ + ++ + + +++
Sbjct: 68 NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL- 612
+H P I ++S++V++D + A +S + +VAPE
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-----MYAPAWVAPEAL 180
Query: 613 --AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670
D++SF VL E++ + P F + +S+ +++AL + R P
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVP--F-ADLSNMEIGMKVALEGL---RPTIPP 234
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ + +M+ C++E P RP + +L+
Sbjct: 235 -GISPHVSKLMK---ICMNEDPAKRPKFDMIVPILE 266
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 1e-52
Identities = 71/321 (22%), Positives = 113/321 (35%), Gaps = 53/321 (16%)
Query: 428 YEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVK 487
E ++ IG+G G+VYK L VAVK F ++Q F+NE
Sbjct: 5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA------NRQNFINEKN 57
Query: 488 --TLTGIRHRNIVKFYGFCSHARHS-----FIVYEYLEMGSLAMILSNDAAAKDLGWTKR 540
+ + H NI +F +V EY GSL LS W
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSS 113
Query: 541 MNVIKGVVDALSYMHND------CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594
+ V L+Y+H + P I HRD++S+NVL+ + +SDFG + L +
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 595 SSNWAE--------LAGTYGYVAPE-------LAYTMKVTEKCDVYSFGVLALEVIKGKH 639
GT Y+APE L ++ D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 640 PR--------------DFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAI 685
+ + + + E P+ P + S+ E
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 686 SCLDESPESRPTIQKVSQLLK 706
C D+ E+R T Q + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMA 314
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-50
Identities = 71/286 (24%), Positives = 121/286 (42%), Gaps = 32/286 (11%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+D +GKG G K +GE++ +K+ +Q+ FL EVK + + H
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE---TQRTFLKEVKVMRCLEH 66
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
N++KF G + + EY++ G+L I+ + W++R++ K + ++Y+
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYL 124
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL--------------KPDSSNWAE 600
H+ I+HRD++S N L+ V+DFG A+ + KPD
Sbjct: 125 HS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 601 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660
+ G ++APE+ EK DV+SFG++ E+I + ++ LN
Sbjct: 182 VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-----LPRTMDFGLNV 236
Query: 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
P N I C D PE RP+ K+ L+
Sbjct: 237 RGFLDRYCPP-NCPPSFFPITV---RCCDLDPEKRPSFVKLEHWLE 278
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 4e-50
Identities = 72/276 (26%), Positives = 126/276 (45%), Gaps = 20/276 (7%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
IG G G+VYK + G+ VAVK + P+ Q F NEV L RH
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHV 80
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
NI+ F G+ + + + IV ++ E SL L K +++ + + Y+H
Sbjct: 81 NILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLH 137
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK--PDSSNWAELAGTYGYVAPEL- 612
I+HRD+ S N+ L +N + DFG A S + +L+G+ ++APE+
Sbjct: 138 A---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194
Query: 613 --AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670
+ + + DVY+FG++ E++ G+ P S+I++ +E+ L P L
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIEMVGRGSLSPDLSKVR 251
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
N ++ +M CL + + RP+ ++ ++
Sbjct: 252 SNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 7e-50
Identities = 61/285 (21%), Positives = 104/285 (36%), Gaps = 33/285 (11%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+ IGKG G VY GE VA++ +E + F EV RH
Sbjct: 33 EQLEIGELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNE-DQLKAFKREVMAYRQTRHE 89
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
N+V F G C H I+ + +L ++ + A L K + + +V + Y+H
Sbjct: 90 NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK-----FLKPDSSNWAELAGTYGYVAP 610
I+H+D+ SKNV D + ++DFG G ++AP
Sbjct: 148 A---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
Query: 611 EL---------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM 661
E+ + ++ DV++ G + E+ + P F + I
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP--F-----KTQPAEAIIWQMG 256
Query: 662 LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ + ++ I+ C E RPT K+ +L+
Sbjct: 257 TGMKPNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLE 298
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 5e-49
Identities = 91/333 (27%), Positives = 145/333 (43%), Gaps = 30/333 (9%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L+ L + + ++ L ++ L+ + + L +T + +
Sbjct: 22 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSN 77
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
N L+ P NL KL + + NNQ+ I L NLT+L + L N +T +
Sbjct: 78 NQLTDITP--LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITD--IDPLKN 132
Query: 121 HPNLAFIDLSHNYFYGEIS--SDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
NL ++LS N IS S L L F N +T P + + + L+ LD+S
Sbjct: 133 LTNLNRLELSSN----TISDISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDIS 185
Query: 179 SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSL 238
SN + S L KL++L LI +NQ+ LG LT L+ L L+ N+L + +L
Sbjct: 186 SNKVSD--ISVLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD--IGTL 239
Query: 239 GNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLS 298
+L L L+L+NNQ I + L L L+EL L N + S + + +L L L+
Sbjct: 240 ASLTNLTDLDLANNQ-ISNLA-PLSGLTKLTELKLGANQI--SNISPLAGLTALTNLELN 295
Query: 299 HNNLSGFIPSCFEELHGLSYIDISYNELHGSIP 331
N L P L L+Y+ + +N + P
Sbjct: 296 ENQLEDISP--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-48
Identities = 84/326 (25%), Positives = 142/326 (43%), Gaps = 24/326 (7%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
NL+NL L L+NN + P + L +L+ LELS N + S +L LT + L+
Sbjct: 110 NLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSF-G 164
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
N ++ P NL L L + +N++ I L LT+L + N ++ GI
Sbjct: 165 NQVTDLKP--LANLTTLERLDISSNKVSD-ISVLAKLTNLESLIATNNQISD--ITPLGI 219
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
NL + L+ N +I + L LD ++N I+ P + ++L L L +N
Sbjct: 220 LTNLDELSLNGNQL-KDIGT-LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 275
Query: 181 HIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN 240
I S L L++L L LN NQL + +L L L L N +S+ P + +
Sbjct: 276 QISN--ISPLAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSS 329
Query: 241 LVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHN 300
L KL L NN+ + + L L +++ L HN + + + + N+ + +L L+
Sbjct: 330 LTKLQRLFFYNNK-VSDVS-SLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQ 385
Query: 301 NLSGFIPSCFEELHGLSYIDISYNEL 326
+ + + + + L
Sbjct: 386 AWTNAPVNYKANVSIPNTVKNVTGAL 411
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-41
Identities = 67/307 (21%), Positives = 115/307 (37%), Gaps = 20/307 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
NL+ L L + +N S S + +L +L L + N++ P LG LT + L+L
Sbjct: 175 NLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNG 230
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
N L +L LT L L NNQ+ + L LT L ++L N ++
Sbjct: 231 NQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQISN--ISPLAG 285
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
L ++L+ N S L L NNI+ P + ++L+ L +N
Sbjct: 286 LTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNN 341
Query: 181 HIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN 240
+ S L L+++ L NQ+ L +LT++ +L L+ +N+ N
Sbjct: 342 KV--SDVSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKAN 397
Query: 241 LVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHN 300
+ + + I P + +E D++ N +
Sbjct: 398 VSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLP-SYTNEVSYTFSQPVTIGKGTT 454
Query: 301 NLSGFIP 307
SG +
Sbjct: 455 TFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-41
Identities = 74/304 (24%), Positives = 128/304 (42%), Gaps = 23/304 (7%)
Query: 28 SLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQL 87
L ++ + I + L + L ++ + + +L ++T L + +
Sbjct: 2 PLGSATITQDTPINQIF-TDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI 58
Query: 88 RGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPK 147
+ I + L +L ++ + N LT L I +++N +
Sbjct: 59 KS-IDGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQI--ADITPLANLTN 113
Query: 148 LGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLC 207
L L +N IT P + + + L L+LSSN I S L L+SL +L +
Sbjct: 114 LTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVT- 168
Query: 208 GQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIH 267
L +LT LERLD+SSN++S+ L L L L +NNQ I I L L +
Sbjct: 169 --DLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQ-ISDIT-PLGILTN 222
Query: 268 LSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELH 327
L EL L+ N L + + ++ +L L+L++N +S P L L+ + + N++
Sbjct: 223 LDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 278
Query: 328 GSIP 331
P
Sbjct: 279 NISP 282
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 8e-49
Identities = 70/307 (22%), Positives = 122/307 (39%), Gaps = 48/307 (15%)
Query: 434 VTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVK--TLTG 491
V D C+GKG G V++ GE VAVK F S ++ + E +
Sbjct: 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR------DEKSWFRETELYNTVM 58
Query: 492 IRHRNIVKFYGFCSHARHS----FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGV 547
+RH NI+ F +RHS +++ Y EMGSL L L + ++ +
Sbjct: 59 LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSI 114
Query: 548 VDALSYMHNDCF-----PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAEL- 601
L+++H + F P I HRD+ SKN+L+ + ++D G A ++
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGN 174
Query: 602 ---AGTYGYVAPEL------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIS---S 649
GT Y+APE+ ++ D+++FG++ EV + +
Sbjct: 175 NPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234
Query: 650 SSSNLEIALNEMLD--------PRLPT--PSHNVQDKLISIMEVAISCLDESPESRPTIQ 699
+ + +M P +P S L +M+ C ++P +R T
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTAL 291
Query: 700 KVSQLLK 706
++ + L
Sbjct: 292 RIKKTLT 298
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 9e-49
Identities = 51/315 (16%), Positives = 104/315 (33%), Gaps = 22/315 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+ S LY ++ + + + + + + N T
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTG 65
Query: 61 NALSGAIPKEYGNL--VKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISES 117
AL A + L L + L P+ L+ L + ++ L + ++
Sbjct: 66 RALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDT 122
Query: 118 FGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEI---------IH 168
L + L+ N + + +L L + +P +
Sbjct: 123 MQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181
Query: 169 SSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSN 228
L+ L L I +P+ + L +L L + ++ L L + L +LE LDL
Sbjct: 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGC 239
Query: 229 RLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICN 288
+ P G L L L + + +P+++ +L L +LDL +PS I
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299
Query: 289 MQSLEKLNLSHNNLS 303
+ + + + + +
Sbjct: 300 LPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-47
Identities = 59/327 (18%), Positives = 106/327 (32%), Gaps = 20/327 (6%)
Query: 17 GSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVK 76
GS +L G+ L + D N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQR---HYNADRNRW-HSAWRQANSNN 57
Query: 77 LTLLTLENNQLRGPIPNLRNLTSLVRVRLN--QNHLTGNISESFGIHPNLAFIDLSHNYF 134
+ T L+ L + T RV L L + +L + +
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116
Query: 135 YGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGK-- 192
E+ + L TL + N + ++PA I ++L+ L + + + E+P L
Sbjct: 117 -MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD 174
Query: 193 -------LSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLH 245
L +L L L + L + +L L+ L + ++ LS ++ ++ +L KL
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE 232
Query: 246 YLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGF 305
L+L ++ P L L L +P I + LEKL+L
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 306 IPSCFEELHGLSYIDISYNELHGSIPN 332
+PS +L I + + +
Sbjct: 293 LPSLIAQLPANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 7e-42
Identities = 49/284 (17%), Positives = 90/284 (31%), Gaps = 26/284 (9%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKS--LSDLELSGNKLCGSIPHSLGNLTQITFLTL 58
N +N + + + LEL L P L+ + +T+
Sbjct: 54 NSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTI 111
Query: 59 FDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISES 117
L +P L LTL N LR +P + +L L + + + E
Sbjct: 112 DAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEP 169
Query: 118 FGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDL 177
L +L I S+PA I + LK L +
Sbjct: 170 LASTDASGEH---------------QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKI 213
Query: 178 SSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSS-NRLSNSIPK 236
++ + + + L L +L L G L+RL L + L ++P
Sbjct: 214 RNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPL 271
Query: 237 SLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGE 280
+ L +L L+L + ++P + +L + + + +
Sbjct: 272 DIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 44/251 (17%), Positives = 82/251 (32%), Gaps = 15/251 (5%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L L + P + RL L + + L +P ++ + LTL
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLAR 136
Query: 61 NALSGAIPKEYGNLVKLTLLTL-ENNQLR---------GPIPNLRNLTSLVRVRLNQNHL 110
N L A+P +L +L L++ +L + L +L +RL +
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195
Query: 111 TGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSS 170
++ S NL + + ++ + PKL LD + P +
Sbjct: 196 R-SLPASIANLQNLKSLKIRNSPL-SALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253
Query: 171 QLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRL 230
LK L L + +P + +L+ L KL L +L + L + + +
Sbjct: 254 PLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
Query: 231 SNSIPKSLGNL 241
+
Sbjct: 314 AQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 40/255 (15%), Positives = 88/255 (34%), Gaps = 25/255 (9%)
Query: 92 PNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTL 151
+ + + + + + D + R
Sbjct: 6 HHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRN-------RWHSAWRQANSNNP 58
Query: 152 DFSSNNITG--SMPAEI--IHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLC 207
+ + + L+L S + + P + +LS L + +++ L
Sbjct: 59 QIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL- 116
Query: 208 GQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIP-------- 259
+L + LE L L+ N L ++P S+ +L +L L++ + ++P
Sbjct: 117 MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA 175
Query: 260 -VELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSY 318
E + L++L L L + +P+ I N+Q+L+ L + ++ LS + L L
Sbjct: 176 SGEHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEE 233
Query: 319 IDISYNELHGSIPNS 333
+D+ + P
Sbjct: 234 LDLRGCTALRNYPPI 248
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 30/176 (17%), Positives = 55/176 (31%), Gaps = 10/176 (5%)
Query: 160 GSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQ 219
GS HSS + L + + L + N + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 220 LERLDLSSNRLSNSIPKSLGNL--VKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNF 277
+ + L + L + L L + + + P + +L HL + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVP-LPQFPDQAFRLSHLQHMTIDAAG 115
Query: 278 LGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNS 333
L E+P + LE L L+ N L +P+ L+ L + I +P
Sbjct: 116 L-MELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEP 169
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-48
Identities = 78/356 (21%), Positives = 139/356 (39%), Gaps = 28/356 (7%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
L+N + N++ +P+ + + + L L+ ++ ++ I L +
Sbjct: 43 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 101
Query: 60 DNALSGAIPKEY-GNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISE 116
NA+ +P N+ LT+L LE N L +P N L + ++ N+L +
Sbjct: 102 FNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDD 159
Query: 117 SFGIHPNLAFIDLSHNYFYGEISS-DWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVL 175
+F +L + LS N ++ D P L + S N ++ + ++ L
Sbjct: 160 TFQATTSLQNLQLSSN----RLTHVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEEL 210
Query: 176 DLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIP 235
D S N I + + L L L N L + L + L +DLS N L +
Sbjct: 211 DASHNSIN-VVRGPV--NVELTILKLQHNNL-TDTA-WLLNYPGLVEVDLSYNELEKIMY 265
Query: 236 KSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKL 295
+ +L L +SNN+ + + + + + L LDLSHN L + LE L
Sbjct: 266 HPFVKMQRLERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENL 323
Query: 296 NLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLC 351
L HN++ + H L + +S+N+ FR+ A+ C
Sbjct: 324 YLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-43
Identities = 68/331 (20%), Positives = 130/331 (39%), Gaps = 23/331 (6%)
Query: 8 LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAI 67
+++ + E L + + + + L + Q+ L L D +
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 85
Query: 68 PKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGIHPNLA 125
+ + L + N +R +P +N+ L + L +N L+ F P L
Sbjct: 86 TYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 144
Query: 126 FIDLSHNYFYGEISSDWGR-CPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVG 184
+ +S+N I D + L L SSN +T + +I S L ++S N +
Sbjct: 145 TLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS--LFHANVSYNLL-- 198
Query: 185 EMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKL 244
S L ++ +L + N + + +L L L N L++ L N L
Sbjct: 199 ---STLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTD--TAWLLNYPGL 250
Query: 245 HYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLS 303
++LS N+ ++KI K+ L L +S+N L + + +L+ L+LSHN+L
Sbjct: 251 VEVDLSYNE-LEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL 308
Query: 304 GFIPSCFEELHGLSYIDISYNELHGSIPNST 334
+ + L + + +N + ++ ST
Sbjct: 309 -HVERNQPQFDRLENLYLDHNSIV-TLKLST 337
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-38
Identities = 61/290 (21%), Positives = 118/290 (40%), Gaps = 18/290 (6%)
Query: 40 CGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN--LRNL 97
I +L + + E L ++T +N+ +R +P L +
Sbjct: 10 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSF 68
Query: 98 TSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNN 157
+ + LN + + +F + + + N + P L L N+
Sbjct: 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128
Query: 158 ITGSMPAEIIHS-SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGS 216
++ S+P I H+ +L L +S+N++ +SL L L+SN+L ++L
Sbjct: 129 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL---THVDLSL 184
Query: 217 LTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHN 276
+ L ++S N LS +L + + L+ S+N I + + + L+ L L HN
Sbjct: 185 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS-INVVRGPV--NVELTILKLQHN 236
Query: 277 FLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326
L + + + N L +++LS+N L + F ++ L + IS N L
Sbjct: 237 NLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 284
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-32
Identities = 56/293 (19%), Positives = 107/293 (36%), Gaps = 27/293 (9%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
N+ L L L N S S+P I L+ L +S N L + T + L L
Sbjct: 115 NVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS 173
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFG 119
N L+ + + L + N L L ++ + + N + +
Sbjct: 174 SNRLT-HVDL--SLIPSLFHANVSYNLLS----TLAIPIAVEELDASHNSIN-VVRG--P 223
Query: 120 IHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLDLS 178
++ L + L HN ++ P L +D S N + + +L+ L +S
Sbjct: 224 VNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYIS 280
Query: 179 SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSL 238
+N +V + + +L L L+ N L + +LE L L N + ++ L
Sbjct: 281 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--L 335
Query: 239 GNLVKLHYLNLSNNQF----IKKIPVELEKLIHLSELDLSHNFLGEEMPSQIC 287
L L LS+N + ++ + + + + + D + ++ +C
Sbjct: 336 STHHTLKNLTLSHNDWDCNSLRALFRNVARP-AVDDADQHCK-IDYQLEHGLC 386
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 7e-19
Identities = 28/149 (18%), Positives = 54/149 (36%), Gaps = 3/149 (2%)
Query: 187 PSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHY 246
S L + ++ E +L + + ++ + L + ++
Sbjct: 14 DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 73
Query: 247 LNLSNNQFIKKIPVE-LEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGF 305
LNL++ Q I++I + +L + N + P N+ L L L N+LS
Sbjct: 74 LNLNDLQ-IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSL 132
Query: 306 IPSCFEELHGLSYIDISYNELHGSIPNST 334
F L+ + +S N L I + T
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLE-RIEDDT 160
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 12/103 (11%), Positives = 36/103 (34%), Gaps = 1/103 (0%)
Query: 232 NSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQS 291
I +L + +++ E L + + ++ + + + + + +
Sbjct: 11 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 292 LEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST 334
+E LNL+ + F H + + + +N + +P
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV 112
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 4/84 (4%), Positives = 25/84 (29%), Gaps = 1/84 (1%)
Query: 251 NNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCF 310
K I L+ ++ + + + + + + ++ + +
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 311 EELHGLSYIDISYNELHGSIPNST 334
+ + ++++ ++ I
Sbjct: 66 DSFRQVELLNLNDLQIE-EIDTYA 88
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-48
Identities = 67/349 (19%), Positives = 122/349 (34%), Gaps = 23/349 (6%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA 62
S+ + L N L L+LS ++ + L ++ L L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 63 LSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTG-NISESFGI 120
+ P + L L L +L + L +L ++ + N + + F
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 121 HPNLAFIDLSHNYF----YGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLD 176
NL +DLS+NY ++ +LD S N I + + +L L
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELT 210
Query: 177 LSSNHIVGEMPSKLGK-LSSLIKLILNSNQLCGQLSLE------LGSLTQL--ERLDLSS 227
L N + + L+ L L + + +LE + L + + L+
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270
Query: 228 NRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQIC 287
+ L + ++L+ IK + ++ K L + L ++ P+
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVS-IKYLE-DVPKHFKWQSLSIIRCQL-KQFPTL-- 325
Query: 288 NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAF 336
++ L+ L L+ N S I L LSY+D+S N L S S +
Sbjct: 326 DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSD 372
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-47
Identities = 72/344 (20%), Positives = 122/344 (35%), Gaps = 25/344 (7%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
N S L +L L L LS+L L+GN + P S LT + L +
Sbjct: 54 NFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVE 113
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRG--PIPNLRNLTSLVRVRLNQNHLTGNISESF 118
L+ G L+ L L + +N + NLT+LV V L+ N++
Sbjct: 114 TKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDL 173
Query: 119 ----GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLK 173
+D+S N I + KL L N + ++ + + + L
Sbjct: 174 QFLRENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLH 232
Query: 174 VLDLSSNHIVGE------MPSKLGKLSSL--IKLILNSNQLCGQLSLELGSLTQLERLDL 225
V L E PS + L + + L ++ L + + L
Sbjct: 233 VHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSL 292
Query: 226 SSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQ 285
+ + + + K L++ Q +K+ P L L L L+ N + +
Sbjct: 293 AGVSIKY--LEDVPKHFKWQSLSIIRCQ-LKQFP--TLDLPFLKSLTLTMNKG--SISFK 345
Query: 286 ICNMQSLEKLNLSHNNLSGFIPSCFEELHGLS--YIDISYNELH 327
+ SL L+LS N LS + +L S ++D+S+N
Sbjct: 346 KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-46
Identities = 68/309 (22%), Positives = 118/309 (38%), Gaps = 13/309 (4%)
Query: 1 NLSNLAF--LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTL 58
L ++ L + + L ++S + L+G + + + L++
Sbjct: 257 GLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSI 314
Query: 59 FDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESF 118
L P +L L LTL N+ L SL + L++N L+ + S+
Sbjct: 315 IRCQLKQ-FPT--LDLPFLKSLTLTMNKGSI-SFKKVALPSLSYLDLSRNALSFSGCCSY 370
Query: 119 GI--HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVL 175
+L +DLS N +S+++ +L LDF + + S +L L
Sbjct: 371 SDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429
Query: 176 DLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQL-SLELGSLTQLERLDLSSNRLSNSI 234
D+S + + L+SL L + N S + T L LDLS +L
Sbjct: 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489
Query: 235 PKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEK 294
L +L LN+S+N + +L LS LD S N + +SL
Sbjct: 490 WGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAF 549
Query: 295 LNLSHNNLS 303
NL++N+++
Sbjct: 550 FNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-33
Identities = 56/252 (22%), Positives = 91/252 (36%), Gaps = 10/252 (3%)
Query: 89 GPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKL 148
G + + + + L+ + + I + IDLS N S + +L
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLS-KVPD--DIPSSTKNIDLSFNPLKILKSYSFSNFSEL 58
Query: 149 GTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCG 208
LD S I L L L+ N I P L+SL L+ +L
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 209 QLSLELGSLTQLERLDLSSNRLSN-SIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIH 267
S +G L L++L+++ N + + +P NL L +++LS N +L+ L
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178
Query: 268 LS----ELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPS-CFEELHGLSYIDIS 322
LD+S N + + + Q L +L L N S I C + L GL +
Sbjct: 179 NPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 323 YNELHGSIPNST 334
E
Sbjct: 238 LGEFKDERNLEI 249
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-21
Identities = 30/121 (24%), Positives = 49/121 (40%), Gaps = 1/121 (0%)
Query: 218 TQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNF 277
+ + +DLS N L S N +L +L+LS + L HLS L L+ N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 278 LGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFR 337
+ P + SLE L L+ +L L +++++N +H S F
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH-SCKLPAYFS 150
Query: 338 D 338
+
Sbjct: 151 N 151
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 4e-47
Identities = 75/340 (22%), Positives = 122/340 (35%), Gaps = 60/340 (17%)
Query: 401 SSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSG 460
Q+Q S G+ L + I IGKG G V+ + G
Sbjct: 14 LIEQSQSSGSGSGLPLLV----------QRTI--AKQIQMVKQIGKGRYGEVWMGKW-RG 60
Query: 461 EIVAVKKFHSPLPSEMASQQEFLNEVK--TLTGIRHRNIVKFYGFCSHARHS----FIVY 514
E VAVK F + + + E + +RH NI+ F S +++
Sbjct: 61 EKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT 114
Query: 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF-----PPIVHRDISS 569
+Y E GSL L + L + + V L ++H + F P I HRD+ S
Sbjct: 115 DYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170
Query: 570 KNVLLDLENEAHVSDFGTAKFLKPDSSNWAEL----AGTYGYVAPEL------AYTMKVT 619
KN+L+ ++D G A D++ GT Y+ PE+ +
Sbjct: 171 KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230
Query: 620 EKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL---EIALNEMLD--------PRLPT 668
D+YSFG++ EV + + +L + + +M + P P
Sbjct: 231 IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN 290
Query: 669 --PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
S ++ +M C +P SR T +V + L
Sbjct: 291 RWSSDECLRQMGKLMT---ECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-46
Identities = 67/315 (21%), Positives = 119/315 (37%), Gaps = 51/315 (16%)
Query: 426 IVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNE 485
+V I R + IGKG G V++ + GE VAVK F S ++ + E
Sbjct: 35 LVQRTIAR---TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR------EERSWFRE 84
Query: 486 --VKTLTGIRHRNIVKFYGFCSHARHS----FIVYEYLEMGSLAMILSNDAAAKDLGWTK 539
+ +RH NI+ F + + ++V +Y E GSL L+ +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEG 140
Query: 540 RMNVIKGVVDALSYMHNDCF-----PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594
+ + L+++H + P I HRD+ SKN+L+ ++D G A
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200
Query: 595 SSNWAEL----AGTYGYVAPEL------AYTMKVTEKCDVYSFGVLALEVIKGKHP---- 640
+ GT Y+APE+ + ++ D+Y+ G++ E+ +
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
Query: 641 -------RDFISSISSSSSNLEIALNEMLDPRLP--TPSHNVQDKLISIMEVAISCLDES 691
D + S S ++ + L P +P S + IM C +
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYAN 317
Query: 692 PESRPTIQKVSQLLK 706
+R T ++ + L
Sbjct: 318 GAARLTALRIKKTLS 332
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 8e-46
Identities = 58/311 (18%), Positives = 117/311 (37%), Gaps = 25/311 (8%)
Query: 18 SIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKL 77
+I +++ + L ++ + + L L N LS + KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 78 TLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGE 137
LL L +N L +L +L++L + LN N++ + P++ + ++N
Sbjct: 61 ELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SR 113
Query: 138 ISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVG-EMPSKLGKLSSL 196
+S G+ + ++N IT + S+++ LDL N I +L
Sbjct: 114 VSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 197 IKLILNSNQLCGQLSLELGS-LTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFI 255
L L N + ++ +L+ LDLSSN+L+ + + + +++L NN+ +
Sbjct: 172 EHLNLQYNFI---YDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK-L 226
Query: 256 KKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHG 315
I L +L DL N + +L + + ++L G
Sbjct: 227 VLIEKALRFSQNLEHFDLRGNGF---------HCGTLRDFFSKNQRVQTVAKQTVKKLTG 277
Query: 316 LSYIDISYNEL 326
+ + + L
Sbjct: 278 QNEEECTVPTL 288
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-43
Identities = 61/328 (18%), Positives = 120/328 (36%), Gaps = 20/328 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
N + + ++S ++ S ++ +L+LSGN L L T++ L L
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
N L + +L L L L NN ++ + ++ +L N+++ +S S G
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYVQE-LLVGPSIETL---HAANNNIS-RVSCSRG- 119
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITG-SMPAEIIHSSQLKVLDLSS 179
I L++N D G ++ LD N I + S L+ L+L
Sbjct: 120 -QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 180 NHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLG 239
N I ++ ++ + L L L+SN+L + E S + + L +N+L I K+L
Sbjct: 179 NFIY-DVKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234
Query: 240 NLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSH 299
L + +L N + + ++ + ++ E +
Sbjct: 235 FSQNLEHFDLRGNG-FHCGTLRDFFSKNQRVQTVAKQTV-----KKLTGQNEEECTVPTL 288
Query: 300 NNLSGFIPSCFEELHGLSYIDISYNELH 327
+ + I + ++ H
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 54/300 (18%), Positives = 97/300 (32%), Gaps = 39/300 (13%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+ N+ L L N S +++ L L LS N L L +L+ + L L +
Sbjct: 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL--YETLDLESLSTLRTLDLNN 89
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHLTGNISESFG 119
N + E + L NN + + ++ L N +T G
Sbjct: 90 NYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKKNI---YLANNKITMLRDLDEG 141
Query: 120 IHPNLAFIDLSHNYFYG-EISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
+ ++DL N + L L+ N I + +++ + LK LDLS
Sbjct: 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAK-LKTLDLS 199
Query: 179 SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLS-NSIPKS 237
SN + M + + + + L +N+L + L LE DL N ++
Sbjct: 200 SNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257
Query: 238 LGNLVKLHYLNLSNNQFIKKIPVE----------------------LEKLIHLSELDLSH 275
++ + + + E ++LI L H
Sbjct: 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHHHHHH 317
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 34/141 (24%), Positives = 61/141 (43%), Gaps = 10/141 (7%)
Query: 193 LSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNN 252
+ + + L L+ S ++ LDLS N LS L KL LNLS+N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 253 QFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEE 312
+ + +LE L L LDL++N++ ++ S+E L+ ++NN+S S +
Sbjct: 69 V-LYETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCSRGQG 121
Query: 313 LHGLSYIDISYNELHGSIPNS 333
+ ++ N++
Sbjct: 122 KKNI---YLANNKITMLRDLD 139
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 19/119 (15%), Positives = 46/119 (38%), Gaps = 8/119 (6%)
Query: 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275
+ + + ++ + L ++ + + L+LS N + +L L L+LS
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST 334
N L E + ++ +L L+L++N + + + + N + + S
Sbjct: 68 NVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSR 118
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 22/103 (21%), Positives = 44/103 (42%), Gaps = 3/103 (2%)
Query: 233 SIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSL 292
+I + N + ++++ + + + ++ ELDLS N L + + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 293 EKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA 335
E LNLS N L + E L L +D++ N + + +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVGPS 100
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-44
Identities = 78/354 (22%), Positives = 138/354 (38%), Gaps = 24/354 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
L+N + N++ +P+ + + + L L+ ++ ++ I L +
Sbjct: 49 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 107
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHLTGNISESF 118
NA+ P + N+ LT+L LE N L P N L + ++ N+L ++F
Sbjct: 108 FNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 167
Query: 119 GIHPNLAFIDLSHNYFYGEISS-DWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDL 177
+L + LS N ++ D P L + S N ++ + ++ LD
Sbjct: 168 QATTSLQNLQLSSN----RLTHVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDA 218
Query: 178 SSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKS 237
S N I + + L L L N L + L + L +DLS N L +
Sbjct: 219 SHNSIN-VVRGPV--NVELTILKLQHNNL-TDTA-WLLNYPGLVEVDLSYNELEKIMYHP 273
Query: 238 LGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNL 297
+ +L L +SNN+ + + + + + L LDLSHN L + LE L L
Sbjct: 274 FVKMQRLERLYISNNR-LVALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYL 331
Query: 298 SHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLC 351
HN++ + H L + +S+N+ FR+ A+ C
Sbjct: 332 DHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CNSLRALFRNVARPAVDDADQHC 381
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-40
Identities = 68/331 (20%), Positives = 130/331 (39%), Gaps = 23/331 (6%)
Query: 8 LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAI 67
+++ + E L + + + + L + Q+ L L D +
Sbjct: 32 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEID 91
Query: 68 PKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGIHPNLA 125
+ + L + N +R +P +N+ L + L +N L+ F P L
Sbjct: 92 TYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150
Query: 126 FIDLSHNYFYGEISSDWGR-CPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVG 184
+ +S+N I D + L L SSN +T + +I S L ++S N +
Sbjct: 151 TLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS--LFHANVSYNLL-- 204
Query: 185 EMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKL 244
S L ++ +L + N + + +L L L N L++ L N L
Sbjct: 205 ---STLAIPIAVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTD--TAWLLNYPGL 256
Query: 245 HYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLS 303
++LS N+ ++KI K+ L L +S+N L + + +L+ L+LSHN+L
Sbjct: 257 VEVDLSYNE-LEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL 314
Query: 304 GFIPSCFEELHGLSYIDISYNELHGSIPNST 334
+ + L + + +N + ++ ST
Sbjct: 315 -HVERNQPQFDRLENLYLDHNSIV-TLKLST 343
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 7e-36
Identities = 61/290 (21%), Positives = 118/290 (40%), Gaps = 18/290 (6%)
Query: 40 CGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLT 98
I +L + + E L ++T +N+ +R P L +
Sbjct: 16 YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75
Query: 99 SLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGR-CPKLGTLDFSSNN 157
+ + LN + + +F + + + N + + P L L N+
Sbjct: 76 QVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND 134
Query: 158 ITGSMPAEIIHS-SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGS 216
++ S+P I H+ +L L +S+N++ +SL L L+SN+L ++L
Sbjct: 135 LS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL---THVDLSL 190
Query: 217 LTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHN 276
+ L ++S N LS +L + + L+ S+N I + + + L+ L L HN
Sbjct: 191 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS-INVVRGPV--NVELTILKLQHN 242
Query: 277 FLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326
L + + + N L +++LS+N L + F ++ L + IS N L
Sbjct: 243 NLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 290
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-28
Identities = 76/359 (21%), Positives = 137/359 (38%), Gaps = 35/359 (9%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGR-LKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
N L L + NN+ I + + SL +L+LS N+L + L + + +
Sbjct: 145 NTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIPSLFHANVS 200
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHLTGNISESF 118
N LS + + L +N + P LT L +L N+LT + +
Sbjct: 201 YNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHNNLT-DTA-WL 250
Query: 119 GIHPNLAFIDLSHNYFYGEISSD-WGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDL 177
+P L +DLS+N +I + + +L L S+N + ++ LKVLDL
Sbjct: 251 LNYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 308
Query: 178 SSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKS 237
S NH++ + + L L L+ N + +L+L + L+ L LS N + ++
Sbjct: 309 SHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRA 364
Query: 238 LGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNF----------LGEEMPSQIC 287
L + + + KI +LE + E D + + E++
Sbjct: 365 L--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQG 422
Query: 288 NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQG 346
+ + +N + L G ++ NEL + T + + LQG
Sbjct: 423 RCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQG 481
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 4e-18
Identities = 28/151 (18%), Positives = 55/151 (36%), Gaps = 3/151 (1%)
Query: 185 EMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKL 244
+ S L + ++ E +L + + ++ + L + ++
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 245 HYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLS 303
LNL++ Q I++I + +L + N + P N+ L L L N+LS
Sbjct: 78 ELLNLNDLQ-IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 304 GFIPSCFEELHGLSYIDISYNELHGSIPNST 334
F L+ + +S N L I + T
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDT 166
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 8e-13
Identities = 21/140 (15%), Positives = 48/140 (34%), Gaps = 8/140 (5%)
Query: 201 LNSNQLCGQLSL---ELGSLTQLERLDLSSNRLSNSIPKSL--GNLVKLHYLNLSNNQFI 255
N Q + D+ + + + L + N+ +
Sbjct: 5 QRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST-M 63
Query: 256 KKIPVE-LEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELH 314
+K+P L+ + L+L+ + E +++KL + N + P F+ +
Sbjct: 64 RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP 123
Query: 315 GLSYIDISYNELHGSIPNST 334
L+ + + N+L S+P
Sbjct: 124 LLTVLVLERNDLS-SLPRGI 142
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 5/92 (5%), Positives = 27/92 (29%), Gaps = 1/92 (1%)
Query: 243 KLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNL 302
+ Y K I L+ ++ + + + + + + ++ +
Sbjct: 4 QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM 63
Query: 303 SGFIPSCFEELHGLSYIDISYNELHGSIPNST 334
+ + + ++++ ++ I
Sbjct: 64 RKLPAALLDSFRQVELLNLNDLQIE-EIDTYA 94
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-44
Identities = 56/310 (18%), Positives = 114/310 (36%), Gaps = 15/310 (4%)
Query: 18 SIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKL 77
+I +++ + L ++ + + L L N LS + KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 78 TLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGE 137
LL L +N L +L +L++L + LN N++ + P++ + ++N
Sbjct: 61 ELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SR 113
Query: 138 ISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVG-EMPSKLGKLSSL 196
+S G+ + ++N IT + S+++ LDL N I +L
Sbjct: 114 VSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 197 IKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIK 256
L L N + + ++ +L+ LDLSSN+L+ + + + +++L NN+ +
Sbjct: 172 EHLNLQYNFI-YDVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK-LV 227
Query: 257 KIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGL 316
I L +L DL N + ++ ++ + EE
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGF-HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
Query: 317 SYIDISYNEL 326
+
Sbjct: 287 TLGHYGAYCC 296
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-39
Identities = 58/362 (16%), Positives = 111/362 (30%), Gaps = 43/362 (11%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+ N+ L L N S +++ L L LS N L L +L+ + L L +
Sbjct: 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL--YETLDLESLSTLRTLDLNN 89
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHLTGNISESFG 119
N + E + L NN + + ++ L N +T G
Sbjct: 90 NYVQ-----ELLVGPSIETLHAANNNISRVSCSRGQGKKNI---YLANNKITMLRDLDEG 141
Query: 120 IHPNLAFIDLSHNYFYG-EISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
+ ++DL N + L L+ N I + +++ + LK LDLS
Sbjct: 142 CRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAK-LKTLDLS 199
Query: 179 SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLS-NSIPKS 237
SN + M + + + + L +N+L + L LE DL N ++
Sbjct: 200 SNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257
Query: 238 LGNLVKLHYLNLSNNQFIKKIPVE----------------------LEKLIHLSELDLSH 275
++ + + + E ++LI L + +
Sbjct: 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHAL 317
Query: 276 NFLG----EEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIP 331
E + + N +++ I ++ L +
Sbjct: 318 LSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377
Query: 332 NS 333
N
Sbjct: 378 NG 379
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 3e-33
Identities = 41/338 (12%), Positives = 95/338 (28%), Gaps = 14/338 (4%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
++ L+ NN+ S + + ++ L+ NK+ G +++ +L L
Sbjct: 97 VGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL 153
Query: 61 NALSG-AIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFG 119
N + + + L L L+ N + + L + L+ N L + F
Sbjct: 154 NEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQ 211
Query: 120 IHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS 179
+ +I L +N I L D N S +V ++
Sbjct: 212 SAAGVTWISLRNNKL-VLIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAK 269
Query: 180 NHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNS----IP 235
+ + + + + L L+R + + S +
Sbjct: 270 QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLE 329
Query: 236 KSLGNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDLSHNFLGEEMPSQICNMQSLEK 294
N + ++ Q + + ++ + L+ L E++ + L+
Sbjct: 330 CERENQARQREIDALKEQ-YRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDG 388
Query: 295 LNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332
+ E+ I +
Sbjct: 389 TLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQ 426
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-26
Identities = 35/171 (20%), Positives = 74/171 (43%), Gaps = 11/171 (6%)
Query: 168 HSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSS 227
+ ++ K+ ++ + + + S ++ +L L+ N L + +L T+LE L+LSS
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 228 NRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQIC 287
N L ++ L +L L L+L+NN EL + L ++N + S
Sbjct: 68 NVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRVSCS--- 117
Query: 288 NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRD 338
Q + + L++N ++ + Y+D+ NE+ ++ +
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAAS 167
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-26
Identities = 39/336 (11%), Positives = 88/336 (26%), Gaps = 37/336 (11%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCG-SIPHSLGNLTQITFLTLF 59
+YL NN + + G + L+L N++ + + + L L
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFG 119
N + + + KL L L +N+L P ++ + + L N L I ++
Sbjct: 178 YNFIY-DVKGQ-VVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234
Query: 120 IHPNLAFIDLSHNYFYGEISSDW-----------------------GRCPKLGTLDFSSN 156
NL DL N F+ D+ C + +
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAY 294
Query: 157 NITGSMPA-----EIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLS 211
+ + +L + + + + ++ Q +
Sbjct: 295 CCEDLPAPFADRLIALKRKEHALLSGQGSET-ERLECERENQARQREIDALKEQYRTVID 353
Query: 212 LELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQ--FIKKIPVELEKLIHLS 269
L+ L + +L ++ E L L
Sbjct: 354 QVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLR 413
Query: 270 ELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGF 305
+ + + Q ++ ++ + +
Sbjct: 414 AIVKRYEEMYV--EQQSVQNNAIRDWDMYQHKETQL 447
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 8e-20
Identities = 38/310 (12%), Positives = 87/310 (28%), Gaps = 23/310 (7%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+ L L L N + ++ L L+LS NKL + + +T+++L +
Sbjct: 167 SSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRN 223
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
N L I K L L N + + + + ++
Sbjct: 224 NKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFS----SNNITGSMPAEIIHSSQLKVLD 176
+ R L + + + T + E + ++ + +D
Sbjct: 283 CTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREID 342
Query: 177 LSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPK 236
+ + + I L L + ++ + +
Sbjct: 343 ALKEQYRTVIDQVTLRKQAKITLEQKKKAL-----------DEQVSNGRRAHAELDGTLQ 391
Query: 237 SLGNLVKLHYL--NLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEK 294
++L + S Q ++ I E++ + ++ +M L +
Sbjct: 392 QAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQH--KETQLAE 449
Query: 295 LNLSHNNLSG 304
N L+G
Sbjct: 450 ENARLKKLNG 459
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 1e-13
Identities = 22/102 (21%), Positives = 43/102 (42%), Gaps = 3/102 (2%)
Query: 233 SIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSL 292
+I + N + ++++ + + + ++ ELDLS N L + + + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 293 EKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST 334
E LNLS N L + E L L +D++ N + +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVGP 99
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 6e-43
Identities = 73/324 (22%), Positives = 124/324 (38%), Gaps = 10/324 (3%)
Query: 8 LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAI 67
+ + F ++P I L+L N++ + + L L +N +S
Sbjct: 16 VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72
Query: 68 PKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGIHPNLA 125
P + NL L L L +N+L+ IP L++L ++ +++N + + F NL
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLK 131
Query: 126 FIDLSHNYFYGEISSDW-GRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVG 184
+++ N IS L L N+T + H L VL L +I
Sbjct: 132 SLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA 190
Query: 185 EMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKL 244
+L L L ++ ++ L L ++ L+ ++ +LV L
Sbjct: 191 IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250
Query: 245 HYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLS 303
+LNLS N I I L +L+ L E+ L L P + L LN+S N L+
Sbjct: 251 RFLNLSYNP-ISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309
Query: 304 GFIPSCFEELHGLSYIDISYNELH 327
S F + L + + N L
Sbjct: 310 TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-39
Identities = 73/341 (21%), Positives = 132/341 (38%), Gaps = 31/341 (9%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIP-HSLGNLTQITFLTL 58
+ +L L L N S ++ L +L L L N+L IP L+ +T L +
Sbjct: 54 SFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDI 111
Query: 59 FDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISE 116
+N + + + +L L L + +N L I + L SL ++ L + +LT +E
Sbjct: 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLTSIPTE 170
Query: 117 SFGIHPNLAFIDLSHNYFYGEISSD-WGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVL 175
+ L + L H I + R +L L+ S +M ++ L L
Sbjct: 171 ALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL 229
Query: 176 DLSSNHIVGEMPSK-LGKLSSLIKLILNSNQLCGQLSLELGS---LTQLERLDLSSNRLS 231
++ ++ +P + L L L L+ N + ++E L +L+ + L +L+
Sbjct: 230 SITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS---TIEGSMLHELLRLQEIQLVGGQLA 285
Query: 232 NSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDLSHNFLGEEMPSQICN-- 288
P + L L LN+S NQ + + + + +L L L N L C+
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQ-LTTLEESVFHSVGNLETLILDSNPL-------ACDCR 337
Query: 289 MQSLEKLNLSHNNLSGFIPSCF--EELHGLSYIDISYNELH 327
+ + N + P+C E + G + D L
Sbjct: 338 LLWV-FRRRWRLNFNRQQPTCATPEFVQGKEFKDFPDVLLP 377
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-27
Identities = 44/191 (23%), Positives = 76/191 (39%), Gaps = 4/191 (2%)
Query: 146 PKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQ 205
+ LD N I E L+ L+L+ N + P L +L L L SN+
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 206 LCGQLSLE-LGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE-LE 263
L + L L+ L +LD+S N++ + +L L L + +N + I
Sbjct: 92 L-KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDND-LVYISHRAFS 149
Query: 264 KLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISY 323
L L +L L L + ++ L L L H N++ F+ L+ L ++IS+
Sbjct: 150 GLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 324 NELHGSIPNST 334
++ +
Sbjct: 210 WPYLDTMTPNC 220
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-42
Identities = 74/350 (21%), Positives = 121/350 (34%), Gaps = 23/350 (6%)
Query: 4 NLAFLYLYNNSFSGSIPSE-IGRLKSLSDLEL------SGNKLCGSIPHSLGNLTQITFL 56
L L L NN S ++ I L L L + L +L L +T
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 57 TL---FDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGN 113
+ + I + L ++ +L + + + + + L
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQF 319
Query: 114 ISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNIT--GSMPAEIIHSSQ 171
+ +L + + N S P L LD S N ++ G ++
Sbjct: 320 PTLKL---KSLKRLTFTSNKGGNAFSEVD--LPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374
Query: 172 LKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQL--CGQLSLELGSLTQLERLDLSSNR 229
LK LDLS N ++ M S L L L + L + S+ SL L LD+S
Sbjct: 375 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV-FLSLRNLIYLDISHTH 432
Query: 230 LSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHNFLGEEMPSQICN 288
+ L L L ++ N F + + +L +L+ LDLS L + P+ +
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 289 MQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRD 338
+ SL+ LN++ N L F+ L L I + N S P
Sbjct: 493 LSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 542
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 7e-39
Identities = 71/369 (19%), Positives = 127/369 (34%), Gaps = 43/369 (11%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA 62
+ L L N L L+LS ++ + +L+ ++ L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 63 LSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLT-GNISESFGI 120
+ + L L L L + +L +L + + N + + E F
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKL----GTLDFSSNNITGSMPAEIIHSSQLKVLD 176
NL +DLS N +D ++ +LD S N + + +L L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLT 206
Query: 177 LSSNHIVGEMPSK-LGKLSSL--IKLILNSNQLCGQL-SLELGSLTQLERLDLSSNRLS- 231
L +N + + L+ L +L+L + G L + +L L L + RL+
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 232 -----NSIPKSLGNLVKLHYLNLSNNQFIKKIP--------------------VELEKLI 266
+ I L + +L + I+++ KL
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVT-IERVKDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 267 HLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLS--GFIPSCFEELHGLSYIDISYN 324
L L + N G ++ SLE L+LS N LS G L Y+D+S+N
Sbjct: 326 SLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 325 ELHGSIPNS 333
+ ++ ++
Sbjct: 384 GVI-TMSSN 391
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-35
Identities = 66/357 (18%), Positives = 126/357 (35%), Gaps = 32/357 (8%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+LS+L+ L L N L SL L L +G+L + L +
Sbjct: 74 SLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133
Query: 61 NAL-SGAIPKEYGNLVKLTLLTLENNQLRGPIP----NLRNLT-SLVRVRLNQNHLTGNI 114
N + S +P+ + NL L L L +N+++ L + + + L+ N + I
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-I 192
Query: 115 SESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLD---------FSSNNITGSMPAE 165
L + L +N+ + L L+ + N+ +
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMK--TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 166 IIHSSQLKVLDLSSNHI---VGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLER 222
+ L + + ++ + ++ L+++ L S + + + +
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQH 308
Query: 223 LDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLG--E 280
L+L + + P L L L ++N+ E+ L L LDLS N L
Sbjct: 309 LELVNCKF-GQFPT--LKLKSLKRLTFTSNK-GGNAFSEV-DLPSLEFLDLSRNGLSFKG 363
Query: 281 EMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFR 337
SL+ L+LS N + + S F L L ++D ++ L + + F
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFL 418
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-29
Identities = 59/233 (25%), Positives = 91/233 (39%), Gaps = 8/233 (3%)
Query: 119 GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
+ + +DLS N S + P+L LD S I S L L L+
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILT 84
Query: 179 SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSN-SIPKS 237
N I LSSL KL+ L + +G L L+ L+++ N + + +P+
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 238 LGNLVKLHYLNLSNNQFIKKIPVELEKLIHLS----ELDLSHNFLGEEMPSQICNMQSLE 293
NL L +L+LS+N+ +L L + LDLS N + + L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLH 203
Query: 294 KLNLSHNNLSGFIPS-CFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQ 345
KL L +N S + C + L GL + E + N F + +E L
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR-NEGNLEKFDKSALEGLC 255
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-22
Identities = 38/163 (23%), Positives = 67/163 (41%), Gaps = 6/163 (3%)
Query: 173 KVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSN 232
+ ++P L S L L+ N L S S +L+ LDLS +
Sbjct: 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 233 SIPKSLGNLVKLHYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHNFLGEEMPSQICNMQS 291
+ +L L L L+ N I+ + + L L +L L I ++++
Sbjct: 67 IEDGAYQSLSHLSTLILTGNP-IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
Query: 292 LEKLNLSHNNLSGF-IPSCFEELHGLSYIDISYNELHGSIPNS 333
L++LN++HN + F +P F L L ++D+S N++
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 28/136 (20%), Positives = 47/136 (34%), Gaps = 5/136 (3%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI--GRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTL 58
L L L +++ + L++L L++S + L+ + L +
Sbjct: 394 GLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 59 FDNALSGAIPKEY-GNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISE 116
N+ + L LT L L QL P +L+SL + + N L
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDG 512
Query: 117 SFGIHPNLAFIDLSHN 132
F +L I L N
Sbjct: 513 IFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 30/117 (25%), Positives = 50/117 (42%), Gaps = 2/117 (1%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSI-PHSLGNLTQITFLTLF 59
+L NL +L + + + L SL L+++GN + P L +TFL L
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNIS 115
L P + +L L +L + +NQL+ LTSL ++ L+ N +
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 25/103 (24%), Positives = 44/103 (42%), Gaps = 1/103 (0%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
LS+L L + NSF + +I L++L+ L+LS +L P + +L+ + L +
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMA 502
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVR 102
N L + L L + L N P + L+ +
Sbjct: 503 SNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLN 545
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 4e-42
Identities = 77/355 (21%), Positives = 133/355 (37%), Gaps = 29/355 (8%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSI-PHSLGNLTQITFLTLF 59
L+ L L N S L+ L LEL +I + NL + L L
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN---LRNLTSLVRVRLNQNHLTG-NIS 115
+ + P + L L L L L + RNL +L R+ L++N + +
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 116 ESFGIHPNLAFIDLSHNYFYGEISSD--WGRCPKLGTLDFSSNNITGSMPAEIIHSSQ-- 171
SFG +L ID S N + + + L ++N++ + +
Sbjct: 142 PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF 201
Query: 172 ----LKVLDLSSNHIVGEMPS------------KLGKLSSLIKLILNSNQLCG--QLSLE 213
L++LD+S N ++ L ++ + + Q +
Sbjct: 202 RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261
Query: 214 LGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE-LEKLIHLSELD 272
+ + + LDLS + + + L L LNL+ N+ I KI E L +L L+
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNK-INKIADEAFYGLDNLQVLN 320
Query: 273 LSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELH 327
LS+N LGE S + + ++L N+++ F+ L L +D+ N L
Sbjct: 321 LSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-39
Identities = 81/362 (22%), Positives = 138/362 (38%), Gaps = 25/362 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNL--TQITFLTL 58
N + ++N+ S S + + + + ++ L + + L L
Sbjct: 214 NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDL 273
Query: 59 FDNALSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHLTGNISES 117
+ + + L L +L L N++ L +L + L+ N L S +
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333
Query: 118 FGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDL 177
F P +A+IDL N+ + KL TLD N +T I + + L
Sbjct: 334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFL 388
Query: 178 SSNHIVGEMPSKLGKLS-SLIKLILNSNQLCG-QLSLELGSLTQLERLDLSSNRLSN-SI 234
S N + L K++ + + L+ N+L + L + L+ L L+ NR S+ S
Sbjct: 389 SGNKL-----VTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSG 443
Query: 235 PKSLGNLVKLHYLNLSNNQFIKKIPVELEK-----LIHLSELDLSHNFLGEEMPSQICNM 289
++ L L L N EL L HL L L+HN+L P ++
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHL 503
Query: 290 QSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKG 349
+L L+L+ N L+ + L +DIS N+L PN F + + NK
Sbjct: 504 TALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQL--LAPNPDVFVSLSVLDITHNKF 559
Query: 350 LC 351
+C
Sbjct: 560 IC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-37
Identities = 79/354 (22%), Positives = 136/354 (38%), Gaps = 39/354 (11%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIG------RLKSLSDLELSGNK------------LCGSI 43
L+F L NS + + G R L L++SGN + S
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQ 232
Query: 44 PHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTL--LTLENNQLRGPIPN--LRNLTS 99
SL I + + + L + ++ L L + + + + L
Sbjct: 233 AFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS-LNSRVFETLKD 291
Query: 100 LVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNIT 159
L + L N + E+F NL ++LS+N SS++ PK+ +D N+I
Sbjct: 292 LKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
Query: 160 GSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQ 219
+L+ LDL N + + + + S+ + L+ N+L ++L +L
Sbjct: 352 IIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKL---VTLPKINL-T 402
Query: 220 LERLDLSSNRLSN-SIPKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDLSHNF 277
+ LS NRL N I L + L L L+ N+F + + L +L L N
Sbjct: 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462
Query: 278 LGEEMPSQIC-----NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326
L +++C + L+ L L+HN L+ P F L L + ++ N L
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-29
Identities = 52/267 (19%), Positives = 97/267 (36%), Gaps = 29/267 (10%)
Query: 95 RNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDW-GRCPKLGTLDF 153
+ L + R+ L+ N++ + SF L ++L Y I + P L LD
Sbjct: 21 QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80
Query: 154 SSNNITGSMPAEIIHS-SQLKVLDLSSNHIVGEM--PSKLGKLSSLIKLILNSNQL-CGQ 209
S+ I + + L L L + + L +L +L L+ NQ+
Sbjct: 81 GSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY 139
Query: 210 LSLELGSLTQLERLDLSSNRLSNSIPKSLGNL--VKLHYLNLSNNQFIKKIPVELEKL-- 265
L G L L+ +D SSN++ L L L + +L+ N ++ V+ K
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 266 ----IHLSELDLSHNFLGEEMPSQICN------------MQSLEKLNLSHNNLSGFIPSC 309
+ L LD+S N ++ N + +N+ +
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259
Query: 310 FEELH--GLSYIDISYNELHGSIPNST 334
F L + ++D+S+ + S+ +
Sbjct: 260 FAGLARSSVRHLDLSHGFVF-SLNSRV 285
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-25
Identities = 55/247 (22%), Positives = 90/247 (36%), Gaps = 27/247 (10%)
Query: 113 NISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQ 171
N+++ + + LS NY +S + +L L+ S ++ E +
Sbjct: 15 NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 172 LKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQL--CGQLSLELGSLTQLERLDLSSNR 229
L++LDL S+ I P L L +L L L +L L RLDLS N+
Sbjct: 75 LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQ 134
Query: 230 LSN-SIPKSLGNLVKLHYLNLSNNQFIKKIPVE-LEKL--IHLSELDLSHNFLGEEMPSQ 285
+ + + S G L L ++ S+NQ I + LE L LS L+ N L +
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQ-IFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVD 193
Query: 286 ICNMQ------SLEKLNLSHNNLSGFIPSCF------------EELHGLSYIDISYNELH 327
LE L++S N + I F H + ++ +
Sbjct: 194 WGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK 253
Query: 328 GSIPNST 334
+T
Sbjct: 254 -DPDQNT 259
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-18
Identities = 33/124 (26%), Positives = 49/124 (39%), Gaps = 4/124 (3%)
Query: 217 LTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE-LEKLIHLSELDLSH 275
L ERL LS N + S L +L L L + I E L +L LDL
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFI--PSCFEELHGLSYIDISYNELHGSIPNS 333
+ + P + L +L L LS + F L L+ +D+S N++ S+
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR-SLYLH 141
Query: 334 TAFR 337
+F
Sbjct: 142 PSFG 145
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 4e-15
Identities = 23/120 (19%), Positives = 44/120 (36%), Gaps = 7/120 (5%)
Query: 223 LDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHNFLGEE 281
L+ +P+ L L LS N I+ + L L L+L +
Sbjct: 9 AFYRFCNLT-QVPQVLNTT---ERLLLSFNY-IRTVTASSFPFLEQLQLLELGSQYTPLT 63
Query: 282 MPSQIC-NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAP 340
+ + N+ +L L+L + + P F+ L L + + + L ++ FR+
Sbjct: 64 IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-40
Identities = 64/346 (18%), Positives = 129/346 (37%), Gaps = 52/346 (15%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+ + L ++++ + +P E +KS ++ + ++ + P G ++ L D
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 61 NALSG------------AIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQN 108
++P+ +L L N L ++L SL+ N
Sbjct: 68 CLDRQAHELELNNLGLSSLPELPPHLES---LVASCNSLTELPELPQSLKSLLVDNNNLK 124
Query: 109 HLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIH 168
L+ P L ++ +S+N E + L +D +N++ +P
Sbjct: 125 ALSDLP-------PLLEYLGVSNNQL--EKLPELQNSSFLKIIDVDNNSLK-KLPDLP-- 172
Query: 169 SSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLEL-GSLTQLERLDLSS 227
L+ + +N + E +L L L + ++N L +L LE + +
Sbjct: 173 -PSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSL-----KKLPDLPLSLESIVAGN 224
Query: 228 NRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQIC 287
N L L NL L + NN +K +P + L L++ N+L ++P
Sbjct: 225 NIL--EELPELQNLPFLTTIYADNNL-LKTLP---DLPPSLEALNVRDNYL-TDLPELPQ 277
Query: 288 NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNS 333
++ L+ + LS P+ L Y++ S NE+ S+ +
Sbjct: 278 SLTFLDVSENIFSGLSELPPN-------LYYLNASSNEIR-SLCDL 315
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-36
Identities = 76/326 (23%), Positives = 133/326 (40%), Gaps = 44/326 (13%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
+L F+ NN +P E+ L L+ + N L +P +L + +N
Sbjct: 172 PPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSL-KKLPDLPLSLES---IVAGNN 225
Query: 62 ALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIH 121
L E NL LT + +NN L+ +P+L SL + + N+LT ++ E
Sbjct: 226 ILE--ELPELQNLPFLTTIYADNNLLKT-LPDL--PPSLEALNVRDNYLT-DLPELPQ-- 277
Query: 122 PNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNH 181
+L F+D+S N F +S P L L+ SSN I S+ L+ L++S+N
Sbjct: 278 -SLTFLDVSENIF-SGLSE---LPPNLYYLNASSNEIR-SLCDLP---PSLEELNVSNNK 328
Query: 182 IVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNL 241
++ E+P+ +L +LI + N L ++ +L QL + N L P ++
Sbjct: 329 LI-ELPALPPRLE---RLIASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFPDIPESV 379
Query: 242 VKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNN 301
L + + ++P + L +L + N L E P +S+E L ++
Sbjct: 380 EDLRMNSH-----LAEVPELPQNL---KQLHVETNPL-REFPDIP---ESVEDLRMNSER 427
Query: 302 LSGFIPSCFEELHGLSYIDISYNELH 327
+ E L ++ H
Sbjct: 428 VVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 51/269 (18%), Positives = 98/269 (36%), Gaps = 46/269 (17%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+L + NN E+ L L+ + N L ++P +L L + D
Sbjct: 213 LPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLL-KTLPDLPPSLEA---LNVRD 266
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
N L+ +P+ +L L + + L PNL L + N + ++ +
Sbjct: 267 NYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLN------ASSNEIR-SLCDLP-- 316
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
P+L +++S+N E+ + P+L L S N++ +P LK L + N
Sbjct: 317 -PSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPELP---QNLKQLHVEYN 367
Query: 181 HIVGEMPSKLGKL----------------SSLIKLILNSNQLCGQLSLELGSLTQLERLD 224
+ E P + +L +L + +N L + S+ E L
Sbjct: 368 PLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESV---EDLR 422
Query: 225 LSSNRLSNSIPKSLGNLVKLHYLNLSNNQ 253
++S R+ + + KL ++
Sbjct: 423 MNSERVVDPYEFAHETTDKLEDDVFEHHH 451
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 60/271 (22%), Positives = 111/271 (40%), Gaps = 28/271 (10%)
Query: 443 CIGKGGQGSVYKA-ELPSGEIVAVKKFH-SPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
IG+G +VYK + + VA + L +Q F E + L G++H NIV+F
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHPNIVRF 90
Query: 501 YG----FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
Y + +V E + G+L L K + + + ++ L ++H
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLH- 146
Query: 557 DCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT 615
PPI+HRD+ N+ + + D G A + + + GT ++APE+ Y
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEM-YE 203
Query: 616 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675
K E DVY+FG+ LE+ ++P S +++ + + +
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYPY---SECQNAAQIYRRVTSGVKPASFDKVAIPEVK 260
Query: 676 KLISIMEVAISCLDESPESRPTIQKVSQLLK 706
++I C+ ++ + R + + LL
Sbjct: 261 EIIE------GCIRQNKDERYS---IKDLLN 282
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-39
Identities = 65/375 (17%), Positives = 129/375 (34%), Gaps = 58/375 (15%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L++L L + S + ++ + L L ++ + L+ + +L L D
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRD 205
Query: 61 NALSG-------------------------------AIPKEYGNLVKLTLLTLENNQLRG 89
L+ + K +++L+ + ++ L G
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265
Query: 90 ----------PIPNLRNL--TSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGE 137
+ L + ++ R+ + Q +L ++S + + + I + ++ +
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325
Query: 138 ISSDWGRCPKLGTLDFSSNNIT---GSMPAEIIHSSQLKVLDLSSNHI--VGEMPSKLGK 192
S L LD S N + A L+ L LS NH+ + + L
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLT 385
Query: 193 LSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNN 252
L +L L ++ N + ++ L+LSS + + L L++SNN
Sbjct: 386 LKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQTLEVLDVSNN 441
Query: 253 QFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEE 312
+ + L +L EL +S N L + +P L + +S N L F+
Sbjct: 442 N-LDSFSLFLPRL---QELYISRNKL-KTLPD-ASLFPVLLVMKISRNQLKSVPDGIFDR 495
Query: 313 LHGLSYIDISYNELH 327
L L I + N
Sbjct: 496 LTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-38
Identities = 67/343 (19%), Positives = 119/343 (34%), Gaps = 19/343 (5%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSE-IGRLKSLSDLELSGNKL-CGSIPHSLGNLTQITFLTL 58
+L +L L L +N S S+ S G L SL L L GN + NLT + L +
Sbjct: 72 SLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRI 130
Query: 59 FDNALSGAIPKEY-GNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISE 116
+ I + L L L ++ LR L+++ + + L+ + +
Sbjct: 131 GNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEI 190
Query: 117 SFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLD 176
I ++ +++L S + + + +L
Sbjct: 191 FADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYI 250
Query: 177 LSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPK 236
L + + + + N ++ L + RL + L +
Sbjct: 251 LELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304
Query: 237 SLGNLVKLHYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHNFLGEEMPSQ---ICNMQSL 292
L K+ + + N++ + +P + L L LDLS N + EE SL
Sbjct: 305 VYSLLEKVKRITVENSK-VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363
Query: 293 EKLNLSHNNLS--GFIPSCFEELHGLSYIDISYNELHGSIPNS 333
+ L LS N+L L L+ +DIS N H +P+S
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDS 405
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-36
Identities = 57/352 (16%), Positives = 127/352 (36%), Gaps = 26/352 (7%)
Query: 10 LYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPK 69
+ SF+ SIPS + ++ L+LS NK+ L + L L + ++
Sbjct: 12 GRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68
Query: 70 EYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTG-NISESFGIHPNLAF 126
+ +L L L L +N L + + L+SL + L N ++ F NL
Sbjct: 69 AFYSLGSLEHLDLSDNHLSS-LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127
Query: 127 IDLSHNYFYGEISSDW-GRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGE 185
+ + + + EI L L+ + ++ + + L L +
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187
Query: 186 MPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSN----------SIP 235
+ LSS+ L L L L + + R S +
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247
Query: 236 KSLGNLVKLHYLNLSNNQFIKKIPVELE--------KLIHLSELDLSHNFLGEEMPSQIC 287
+ + L ++ + + + N P E + + + + L + +L ++ +
Sbjct: 248 RYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYS 307
Query: 288 NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDA 339
++ ++++ + ++ + S + L L ++D+S N + ++A + A
Sbjct: 308 LLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-28
Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 9/187 (4%)
Query: 145 CPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSN 204
C G D S + T S+P+ + ++ +K LDLS N I L ++L LIL S+
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 205 QLCGQLSLE-LGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPV--E 261
++ + + SL LE LDLS N LS+ G L L YLNL N + + V
Sbjct: 61 RI-NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNP-YQTLGVTSL 118
Query: 262 LEKLIHLSELDLSHNFLGEEMPSQ-ICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYID 320
L +L L + + E+ + SL +L + +L + + + + ++
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 321 ISYNELH 327
+ +E
Sbjct: 179 LHLSESA 185
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-38
Identities = 68/312 (21%), Positives = 122/312 (39%), Gaps = 64/312 (20%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
+++ L + +N+ + S+P+ L++ LE+SGN+L S+P L +++ +
Sbjct: 60 PAHITTLVIPDNNLT-SLPALPPELRT---LEVSGNQL-TSLPVLPPGLLELSIFSNPLT 114
Query: 62 ALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIH 121
L L L + NQL L L ++ N L ++
Sbjct: 115 HLPALPS-------GLCKLWIFGNQLTSLPVLPPGLQEL---SVSDNQLA-SLPALPS-- 161
Query: 122 PNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNH 181
+L L +N +T S+P S L+ L +S N
Sbjct: 162 -------------------------ELCKLWAYNNQLT-SLPMLP---SGLQELSVSDNQ 192
Query: 182 IVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNL 241
+ +P+ +L KL +N+L SL + L+ L +S NRL+ S+P L
Sbjct: 193 LA-SLPTLPSELY---KLWAYNNRLT---SLP-ALPSGLKELIVSGNRLT-SLPVLPSEL 243
Query: 242 VKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNN 301
+ L +S N+ + +P+ L+ L + N L +P + ++ S +NL N
Sbjct: 244 KE---LMVSGNR-LTSLPMLPSGLLS---LSVYRNQL-TRLPESLIHLSSETTVNLEGNP 295
Query: 302 LSGFIPSCFEEL 313
LS E+
Sbjct: 296 LSERTLQALREI 307
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-38
Identities = 71/302 (23%), Positives = 113/302 (37%), Gaps = 43/302 (14%)
Query: 25 RLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLEN 84
+ L + + L ++P L IT L + DN L+ ++P L L +
Sbjct: 38 LNNGNAVLNVGESGL-TTLPDCLP--AHITTLVIPDNNLT-SLPALPPELRT---LEVSG 90
Query: 85 NQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGR 144
NQL L L HL S L + + N +++S
Sbjct: 91 NQLTSLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGN----QLTSLPVL 139
Query: 145 CPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSN 204
P L L S N + S+PA S+L L +N + +P L +L ++ N
Sbjct: 140 PPGLQELSVSDNQLA-SLPALP---SELCKLWAYNNQLT-SLPMLPS---GLQELSVSDN 191
Query: 205 QLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEK 264
QL L L +L +NRL S+P L +L +S N+ + +PV
Sbjct: 192 QLA-SLPTLPSELY---KLWAYNNRL-TSLPALPSGLKELI---VSGNR-LTSLPVLPS- 241
Query: 265 LIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYN 324
L EL +S N L +P L L++ N L+ +P L + +++ N
Sbjct: 242 --ELKELMVSGNRL-TSLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 325 EL 326
L
Sbjct: 295 PL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-34
Identities = 65/320 (20%), Positives = 115/320 (35%), Gaps = 43/320 (13%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L L + N + S+P L LS L P L + L +F
Sbjct: 79 LPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCK---LWIFG 130
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
N L+ ++P L L++ +NQL L L N LT ++
Sbjct: 131 NQLT-SLPVLPPGL---QELSVSDNQLASLPALPSELCKL---WAYNNQLT-SLPMLPS- 181
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
L + +S N + + +L L +N +T S+PA S LK L +S N
Sbjct: 182 --GLQELSVSDNQL-ASLPTLPS---ELYKLWAYNNRLT-SLPALP---SGLKELIVSGN 231
Query: 181 HIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN 240
+ +P +L +L+++ N+L L + L L + N+L+ +P+SL +
Sbjct: 232 RL-TSLPVLPSELK---ELMVSGNRL-TSLPMLPSGLL---SLSVYRNQLT-RLPESLIH 282
Query: 241 LVKLHYLNLSNNQFIKKIPVELEKLIHLSELD----LSHNFLGEEMPSQICNMQSLEKLN 296
L +NL N + + ++ + I + + + G P + +
Sbjct: 283 LSSETTVNLEGNP-LSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW 341
Query: 297 LSHNNLSGFIPSCFEELHGL 316
L P+ + H
Sbjct: 342 LVPAREGE--PAPADRWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-24
Identities = 41/190 (21%), Positives = 73/190 (38%), Gaps = 28/190 (14%)
Query: 144 RCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNS 203
L+ + +T ++P + + + L + N++ +P+ +L + L ++
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRT---LEVSG 90
Query: 204 NQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELE 263
NQL L + L +L L L L + NQ + +PV
Sbjct: 91 NQL-TSLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQ-LTSLPVLPP 141
Query: 264 KLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISY 323
L EL +S N L +P+ L KL +N L+ +P GL + +S
Sbjct: 142 ---GLQELSVSDNQL-ASLPALPSE---LCKLWAYNNQLT-SLP---MLPSGLQELSVSD 190
Query: 324 NELHGSIPNS 333
N+L S+P
Sbjct: 191 NQLA-SLPTL 199
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 1e-15
Identities = 22/123 (17%), Positives = 43/123 (34%), Gaps = 16/123 (13%)
Query: 211 SLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSE 270
+ L++ + L+ ++P L + L + +N + +P L
Sbjct: 33 KMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNN-LTSLPALPP---ELRT 85
Query: 271 LDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSI 330
L++S N L +P + L + +L GL + I N+L S+
Sbjct: 86 LEVSGNQL-TSLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT-SL 136
Query: 331 PNS 333
P
Sbjct: 137 PVL 139
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-38
Identities = 76/355 (21%), Positives = 136/355 (38%), Gaps = 37/355 (10%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHS-LGNLTQITFLTL 58
L +L FL + + I + L SL L+L N+ + L + LTL
Sbjct: 52 RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF-LQLETGAFNGLANLEVLTL 110
Query: 59 FDNAL-SGAIPKEY-GNLVKLTLLTLENNQLR--GPIPNLRNLTSLVRVRLNQNHLTGNI 114
L + + L L +L L +N ++ P N+ + L N +
Sbjct: 111 TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSIC 170
Query: 115 SESFGIHPNLAFI----------DLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPA 164
E F D++ + E + + + TLD S N SM
Sbjct: 171 EEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAK 230
Query: 165 EI---IHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLE 221
I ++++ L LS+++ +G + + + + + ++
Sbjct: 231 RFFDAIAGTKIQSLILSNSYNMGS------------SFGHTNFKDPDNFTFKGLEASGVK 278
Query: 222 RLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHNFLGE 280
DLS +++ + + L L L+ N+ I KI L HL +L+LS NFLG
Sbjct: 279 TCDLSKSKIFALLKSVFSHFTDLEQLTLAQNE-INKIDDNAFWGLTHLLKLNLSQNFLGS 337
Query: 281 EMPSQIC-NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST 334
+ S++ N+ LE L+LS+N++ F L L + + N+L S+P+
Sbjct: 338 -IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGI 390
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-31
Identities = 78/337 (23%), Positives = 128/337 (37%), Gaps = 41/337 (12%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGS-IPH-SLGNLTQITFLT 57
LS+L L L N F + + L +L L L+ L G+ + LT + L
Sbjct: 77 GLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLV 135
Query: 58 LFDNALSGAIPKEY-GNLVKLTLLTLENNQL----RGPIPNLR-------NLTSLVRVRL 105
L DN + P + N+ + +L L N++ + N + L+S+ +
Sbjct: 136 LRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDM 195
Query: 106 NQNHLTGNISESFGIHPNLAFIDLSHNYF-------------YGEISSDWGRCPKLGTLD 152
N+ L + + ++ +DLS N F +I S
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255
Query: 153 FSSNNITGSMPAEI---IHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ 209
F N + +S +K DLS + I + S + L +L L N++
Sbjct: 256 FGHTNFK-DPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-- 312
Query: 210 LSLELG---SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKL 265
++ LT L +L+LS N L + + NL KL L+LS N I+ + + L
Sbjct: 313 -KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH-IRALGDQSFLGL 370
Query: 266 IHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNL 302
+L EL L N L + SL+K+ L N
Sbjct: 371 PNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 32/207 (15%), Positives = 61/207 (29%), Gaps = 10/207 (4%)
Query: 150 TLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ 209
+ + +P + + +DLS N I + +L L L +
Sbjct: 14 NAICINRGLH-QVPEL---PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV 69
Query: 210 LSLEL-GSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE---LEKL 265
+ L+ L L L N+ + L L L L+ + + + L
Sbjct: 70 IRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCN-LDGAVLSGNFFKPL 128
Query: 266 IHLSELDLSHNFLGEEMPSQI-CNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYN 324
L L L N + + P+ NM+ L+L+ N + G + + +
Sbjct: 129 TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS 188
Query: 325 ELHGSIPNSTAFRDAPMEALQGNKGLC 351
+ N N +
Sbjct: 189 SITLQDMNEYWLGWEKCGNPFKNTSIT 215
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 25/91 (27%), Positives = 37/91 (40%), Gaps = 6/91 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPH-SLGNLTQITFLTL 58
L++L L L N SI S + L L L+LS N + ++ S L + L L
Sbjct: 321 GLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELAL 378
Query: 59 FDNALSGAIPKE-YGNLVKLTLLTLENNQLR 88
N L ++P + L L + L N
Sbjct: 379 DTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 57/302 (18%), Positives = 124/302 (41%), Gaps = 52/302 (17%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG 491
R DF+ C+G+GG G V++A+ A+K+ LP+ ++++ + EVK L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR--IRLPNRELAREKVMREVKALAK 59
Query: 492 IRHRNIVKFYGFC------------SHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTK 539
+ H IV+++ S + +I + +L ++ ++ +
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 540 RMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK------- 592
+++ + +A+ ++H+ ++HRD+ N+ +++ V DFG +
Sbjct: 120 CLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 593 -----PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI 647
P + GT Y++PE + + K D++S G++ E++ +P F
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP--F---- 227
Query: 648 SSSSSNLEIALNEMLD---PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704
S+ L ++ + P L T + + ++ L SP RP +
Sbjct: 228 -STQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ------DMLSPSPMERPEA---INI 277
Query: 705 LK 706
++
Sbjct: 278 IE 279
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 66/322 (20%), Positives = 117/322 (36%), Gaps = 47/322 (14%)
Query: 401 SSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTN-DFDDEHCIGKGGQGSVYKAE-LP 458
SS L F+G +V + N + +G+GG V E L
Sbjct: 2 GSSHHHHHHSSGREN----LYFQGHMV-----IIDNKHYLFIQKLGEGGFSYVDLVEGLH 52
Query: 459 SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS----FIVY 514
G A+K+ E ++E E H NI++ +C R + +++
Sbjct: 53 DGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLL 109
Query: 515 EYLEMGSLAMILSNDAAAKDLGWTKR--MNVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572
+ + G+L + K T+ + ++ G+ L +H HRD+ N+
Sbjct: 110 PFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNI 165
Query: 573 LLDLENEAHVSDFGTAKFLKPDSSN---------WAELAGTYGYVAPEL----AYTMKVT 619
LL E + + D G+ WA T Y APEL ++ + +
Sbjct: 166 LLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV-ID 224
Query: 620 EKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679
E+ DV+S G + ++ G+ P + S N++ P+ P S + L++
Sbjct: 225 ERTDVWSLGCVLYAMMFGEGP--YDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQ-LLN 281
Query: 680 IMEVAISCLDESPESRPTIQKV 701
M + P RP I +
Sbjct: 282 SM------MTVDPHQRPHIPLL 297
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-37
Identities = 70/331 (21%), Positives = 127/331 (38%), Gaps = 43/331 (12%)
Query: 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNAL 63
+L + + +P ++ + L+L NK+ NL + L L +N +
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 64 SGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHLTGNISESFGIHP 122
S P + LVKL L L NQL+ P + L L R+++N +T F
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQEL---RVHENEITKVRKSVFNGLN 145
Query: 123 NLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHI 182
+ ++L N L + + G +L + ++ +I
Sbjct: 146 QMIVVELGTN--------------PLKSSGIENGAFQGM--------KKLSYIRIADTNI 183
Query: 183 VGEMPSKLGKLSSLIKLILNSNQLCGQLSLE-LGSLTQLERLDLSSNRLSNSIPKSLGNL 241
+P L SL +L L+ N++ ++ L L L +L LS N +S SL N
Sbjct: 184 T-TIPQGL--PPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 239
Query: 242 VKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGE------EMPSQICNMQSLEKL 295
L L+L+NN+ + K+P L ++ + L +N + P S +
Sbjct: 240 PHLRELHLNNNK-LVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 298
Query: 296 NLSHNNLSGFI--PSCFEELHGLSYIDISYN 324
+L N + + PS F ++ + + +
Sbjct: 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 70/309 (22%), Positives = 111/309 (35%), Gaps = 42/309 (13%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA 62
+ A L L NN + + LK+L L L NK+ P + L ++ L L N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 63 LSGAIPKEYGNLVKLTLLTLENNQLRGPIP--NLRNLTSLVRVRLNQNHLTGNISESFGI 120
L +P+ L L + N++ + L ++ V L N L S GI
Sbjct: 112 LK-ELPE--KMPKTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLK-----SSGI 162
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
AF + KL + + NIT ++P + L L L N
Sbjct: 163 ENG-AFQGM----------------KKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGN 202
Query: 181 HIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN 240
I + L L++L KL L+ N + + L + L L L++N+L +P L +
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261
Query: 241 LVKLHYLNLSNNQFIKKIPVE-------LEKLIHLSELDLSHNFLGEEM--PSQICNMQS 291
+ + L NN I I K S + L N + PS +
Sbjct: 262 HKYIQVVYLHNNN-ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 320
Query: 292 LEKLNLSHN 300
+ L +
Sbjct: 321 RAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 60/277 (21%), Positives = 111/277 (40%), Gaps = 24/277 (8%)
Query: 77 LTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYF 134
LL L+NN++ I + +NL +L + L N ++ +F L + LS N
Sbjct: 54 TALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN-- 110
Query: 135 YGEISSDWGRCPK-LGTLDFSSNNITGSMPAEIIHS-SQLKVLDLSSNHIVGEM--PSKL 190
++ + PK L L N IT + + + +Q+ V++L +N +
Sbjct: 111 --QLKELPEKMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 191 GKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLS 250
+ L + + + ++ G L L L N+++ SL L L L LS
Sbjct: 168 QGMKKLSYIRIADTNI---TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 224
Query: 251 NNQFIKKIPVE-LEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSC 309
N I + L HL EL L++N L ++P + + + ++ + L +NN+S +
Sbjct: 225 FNS-ISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSND 282
Query: 310 F------EELHGLSYIDISYNELHGSIPNSTAFRDAP 340
F + S + + N + + FR
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 54/237 (22%), Positives = 102/237 (43%), Gaps = 14/237 (5%)
Query: 99 SLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNI 158
L V+ + L + + + P+ A +DL +N D+ L TL +N I
Sbjct: 32 HLRVVQCSDLGLE-KVPK--DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 159 TGSMPAEIIHS-SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSL 217
+ + +L+ L LS N + E+P K+ +L +L ++ N++ L
Sbjct: 89 S-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGL 144
Query: 218 TQLERLDLSSNRLSNSI--PKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275
Q+ ++L +N L +S + + KL Y+ +++ I IP L L+EL L
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN-ITTIPQGL--PPSLTELHLDG 201
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332
N + + + + + +L KL LS N++S L + ++ N+L +P
Sbjct: 202 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPG 257
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 52/246 (21%), Positives = 95/246 (38%), Gaps = 30/246 (12%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIP-HSLGNLTQITFLTLF 59
L L LYL N +P ++ K+L +L + N++ + L Q+ + L
Sbjct: 98 PLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEI-TKVRKSVFNGLNQMIVVELG 153
Query: 60 DNAL-SGAIPKEY-GNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHLTGNISE 116
N L S I + KL+ + + + + P +LT L L+ N +T +
Sbjct: 154 TNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTEL---HLDGNKITKVDAA 210
Query: 117 SFGIHPNLAFIDLSHNYFYGEISS----DWGRCPKLGTLDFSSNNITGSMPAEIIHSSQL 172
S NLA + LS N IS+ P L L ++N + +P + +
Sbjct: 211 SLKGLNNLAKLGLSFN----SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 265
Query: 173 KVLDLSSNHI------VGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGS---LTQLERL 223
+V+ L +N+I P K +S + L SN + ++ + + +
Sbjct: 266 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV-QYWEIQPSTFRCVYVRAAV 324
Query: 224 DLSSNR 229
L + +
Sbjct: 325 QLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 9/166 (5%)
Query: 171 QLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRL 230
L+V+ S + ++P L L L +N++ + +L L L L +N++
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 231 SNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQ 290
S P + LVKL L LS NQ +K++P ++ L EL + N + + S +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQ-LKELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145
Query: 291 SLEKLNLSHNNL--SGFIPSCFEELHGLSYIDISYNELHGSIPNST 334
+ + L N L SG F+ + LSYI I+ + +IP
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL 190
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 5/124 (4%)
Query: 218 TQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHN 276
LDL +N+++ NL LH L L NN+ I KI L+ L L LS N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK-ISKISPGAFAPLVKLERLYLSKN 110
Query: 277 FLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAF 336
L +E+P ++ ++L++L + N ++ S F L+ + +++ N L S + AF
Sbjct: 111 QL-KELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 337 RDAP 340
+
Sbjct: 168 QGMK 171
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 70/310 (22%), Positives = 122/310 (39%), Gaps = 21/310 (6%)
Query: 402 SSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAE-LPSG 460
Q+Q P F + + Y + +F E IG+G VY+A L G
Sbjct: 2 DEQSQGMQGPPVPQFQPQKALRPDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDG 57
Query: 461 EIVAVKKFHSPLPSEMASQ--QEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLE 518
VA+KK + M ++ + + E+ L + H N++K+Y IV E +
Sbjct: 58 VPVALKKV--QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115
Query: 519 MGSLAMILSNDAAAKD-LGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE 577
G L+ ++ + K + + AL +MH+ ++HRDI NV +
Sbjct: 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITAT 172
Query: 578 NEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG 637
+ D G +F ++ L GT Y++PE + K D++S G L E+
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232
Query: 638 KHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPT 697
+ P F + + P PS + ++L ++ C++ PE RP
Sbjct: 233 QSP--F---YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPD 284
Query: 698 IQKVSQLLKI 707
+ V + K
Sbjct: 285 VTYVYDVAKR 294
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 60/292 (20%), Positives = 111/292 (38%), Gaps = 50/292 (17%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG 491
R DF + IG GG G V+KA+ G+ +K+ + ++ EVK L
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY-------NNEKAEREVKALAK 60
Query: 492 IRHRNIVKFYGF----------------CSHARHSFIVYEYLEMGSLAMILSNDAAAKDL 535
+ H NIV + G S + FI E+ + G+L + + L
Sbjct: 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKL 119
Query: 536 GWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595
+ + + + + Y+H+ +++RD+ N+ L + + DFG LK D
Sbjct: 120 DKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176
Query: 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE 655
GT Y++PE + ++ D+Y+ G++ E++ S
Sbjct: 177 KR-TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF-------- 227
Query: 656 IALNEMLDPRLPTP-SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
++ D + + L+ L + PE RP S++L+
Sbjct: 228 --FTDLRDGIISDIFDKKEKT-LLQ------KLLSKKPEDRPNT---SEILR 267
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-36
Identities = 69/285 (24%), Positives = 114/285 (40%), Gaps = 32/285 (11%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEI-VAVKKFHSPLPSEMASQQEFLNEVKT 488
+ D IG+G G V+ L + VAVK LP ++ + +FL E +
Sbjct: 110 VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL--KAKFLQEARI 165
Query: 489 LTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVV 548
L H NIV+ G C+ + +IV E ++ G L + L + ++
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAA 223
Query: 549 DALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAG----- 603
+ Y+ + C +HRD++++N L+ +N +SDFG ++ +
Sbjct: 224 AGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
Query: 604 -TYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEM 661
T APE + + + DV+SFG+L E G P + SN +
Sbjct: 281 WT----APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL-------SNQQTREFVE 329
Query: 662 LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
RLP P D + +ME C P RP+ + Q L+
Sbjct: 330 KGGRLPCP-ELCPDAVFRLME---QCWAYEPGQRPSFSTIYQELQ 370
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-36
Identities = 68/331 (20%), Positives = 122/331 (36%), Gaps = 44/331 (13%)
Query: 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNAL 63
+L + + ++P EI + L+L N + L + L L +N +
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 64 SGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPN 123
S K + L KL L + N L PNL +SLV +R++ N +
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLVEIPPNL--PSSLVELRIHDNRIR------------ 136
Query: 124 LAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSM-PAEIIHSSQLKVLDLSSNHI 182
+ F G + ++ N + S +L L +S +
Sbjct: 137 ----KVPKGVFSG--------LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKL 184
Query: 183 VGEMPSKLGKLSSLIKLILNSNQLCGQLSLE-LGSLTQLERLDLSSNRLSNSIPKSLGNL 241
+P L +L +L L+ N++ + LE L ++L RL L N++ SL L
Sbjct: 185 T-GIPKDL--PETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL 240
Query: 242 VKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQ------SLEKL 295
L L+L NN+ + ++P L L L + L N + + + C + +
Sbjct: 241 PTLRELHLDNNK-LSRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299
Query: 296 NLSHNNLSGFI--PSCFEELHGLSYIDISYN 324
+L +N + + P+ F + I
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 69/309 (22%), Positives = 111/309 (35%), Gaps = 43/309 (13%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA 62
+ L L NN S + L+ L L L NK+ + L ++ L + N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 63 LSGAIPKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGI 120
L IP L L + +N++R +P L ++ + + N L + G
Sbjct: 114 LV-EIPP--NLPSSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLE-----NSGF 164
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
P AF L KL L S +T +P ++ + L L L N
Sbjct: 165 EPG-AFDGL-----------------KLNYLRISEAKLT-GIPKDLPET--LNELHLDHN 203
Query: 181 HIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN 240
I L + S L +L L NQ+ + L L L L L +N+LS +P L +
Sbjct: 204 KIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262
Query: 241 LVKLHYLNLSNNQFIKKIPVE-------LEKLIHLSELDLSHNFLGEEM--PSQICNMQS 291
L L + L N I K+ V K + + + L +N + P+ +
Sbjct: 263 LKLLQVVYLHTNN-ITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTD 321
Query: 292 LEKLNLSHN 300
+ +
Sbjct: 322 RLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 62/263 (23%), Positives = 105/263 (39%), Gaps = 40/263 (15%)
Query: 77 LTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYF 134
TLL L+NN + + + L L + L N ++ IH AF L
Sbjct: 56 TTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISK-------IHEK-AFSPL----- 101
Query: 135 YGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLS 194
KL L S N++ +P + S L L + N I L
Sbjct: 102 -----------RKLQKLYISKNHLV-EIPPNLPSS--LVELRIHDNRIRKVPKGVFSGLR 147
Query: 195 SLIKLILNSNQLCGQLSLELGSLT--QLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNN 252
++ + + N L E G+ +L L +S +L+ IPK L L+ L+L +N
Sbjct: 148 NMNCIEMGGNPL-ENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHN 203
Query: 253 QFIKKIPVE-LEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFE 311
+ I+ I +E L + L L L HN + + + +L +L+L +N LS +P+
Sbjct: 204 K-IQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLP 261
Query: 312 ELHGLSYIDISYNELHGSIPNST 334
+L L + + N + + +
Sbjct: 262 DLKLLQVVYLHTNNIT-KVGVND 283
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 8/215 (3%)
Query: 119 GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
I P+ +DL +N D+ L L +N I+ +L+ L +S
Sbjct: 51 EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110
Query: 179 SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNS-IPKS 237
NH+V E+P L SSL++L ++ N++ L + +++ N L NS
Sbjct: 111 KNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167
Query: 238 LGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNL 297
+ +KL+YL +S + + IP +L L+EL L HN + + L +L L
Sbjct: 168 AFDGLKLNYLRISEAK-LTGIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGL 224
Query: 298 SHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332
HN + L L + + N+L +P
Sbjct: 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPA 258
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 58/272 (21%), Positives = 96/272 (35%), Gaps = 35/272 (12%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
L +L L L NN S I + L+ L L +S N L IP +L + + L +
Sbjct: 76 GLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHL-VEIPPNL--PSSLVELRIH 131
Query: 60 DNALSGAIPKEY-GNLVKLTLLTLENNQLR-GPIPN--LRNLTSLVRVRLNQNHLTGNIS 115
DN + +PK L + + + N L L L +R+++ LTG
Sbjct: 132 DNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPK 189
Query: 116 ESFGIHPNLAFIDLSHNYFYGEISS----DWGRCPKLGTLDFSSNNITGSMPAEIIHSSQ 171
+ L + L HN +I + D R KL L N I +
Sbjct: 190 DLP---ETLNELHLDHN----KIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPT 242
Query: 172 LKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQL--------CGQLSLELGSLTQLERL 223
L+ L L +N + +P+ L L L + L++N + C +
Sbjct: 243 LRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCP--VGFGVKRAYYNGI 299
Query: 224 DLSSNRLSNSI--PKSLGNLVKLHYLNLSNNQ 253
L +N + P + + + N +
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 53/230 (23%), Positives = 88/230 (38%), Gaps = 49/230 (21%)
Query: 112 GNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPK-----LGTLDFSSNNITGSMPAEI 166
+ +E+ P+L + +++ CP L + S + ++P EI
Sbjct: 4 ASGAETTSGIPDLDSLPPTYS----------AMCPFGCHCHLRVVQCSDLGLK-AVPKEI 52
Query: 167 IHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLS 226
S +LDL +N I L + G L L L L
Sbjct: 53 --SPDTTLLDLQNNDIS----------------ELRKDDFKG--------LQHLYALVLV 86
Query: 227 SNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQI 286
+N++S K+ L KL L +S N + +IP L L EL + N + +
Sbjct: 87 NNKISKIHEKAFSPLRKLQKLYISKNH-LVEIPPNL--PSSLVELRIHDNRIRKVPKGVF 143
Query: 287 CNMQSLEKLNLSHNNL--SGFIPSCFEELHGLSYIDISYNELHGSIPNST 334
++++ + + N L SGF P F+ L L+Y+ IS +L IP
Sbjct: 144 SGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRISEAKLT-GIPKDL 191
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-35
Identities = 65/326 (19%), Positives = 115/326 (35%), Gaps = 36/326 (11%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA 62
N A + +L +L+ L+ + + + + LT +T L N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI-TDMT-GIEKLTGLTKLICTSNN 75
Query: 63 LSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHLTGNISESFGIH 121
++ + LT L ++N+L + L LT L + N LT +
Sbjct: 76 ITTL---DLSQNTNLTYLACDSNKLTNLDVTPLTKLTYL---NCDTNKLT---KLDVSQN 126
Query: 122 PNLAFIDLSHNYFYGEISS-DWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
P L +++ + N ++ D +L LD N + + +QL LD S N
Sbjct: 127 PLLTYLNCARN----TLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFN 180
Query: 181 HIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN 240
I + + L +L ++N + L+L QL LD SSN+L+ I +
Sbjct: 181 KITE---LDVSQNKLLNRLNCDTNNI---TKLDLNQNIQLTFLDCSSNKLT-EID--VTP 231
Query: 241 LVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHN 300
L +L Y + S N + ++ V L L+ L L E + + L
Sbjct: 232 LTQLTYFDCSVNP-LTELDV--STLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGC 285
Query: 301 NLSGFIPSCFEELHGLSYIDISYNEL 326
+ L +D +
Sbjct: 286 RKIKELD--VTHNTQLYLLDCQAAGI 309
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-33
Identities = 75/345 (21%), Positives = 127/345 (36%), Gaps = 52/345 (15%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L+ L L +N+S + + I +L L+ L + N + ++ L T +T+L
Sbjct: 40 QLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDS 94
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHLTGNISESFG 119
N L+ + L KLT L + N+L + LT L +N LT
Sbjct: 95 NKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYL---NCARNTLT---EIDVS 145
Query: 120 IHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS 179
+ L +D N D +L TLD S N IT ++ + L L+ +
Sbjct: 146 HNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDT 200
Query: 180 NHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLG 239
N+I ++ L + L L +SN+L +++ LTQL D S N L+ +L
Sbjct: 201 NNIT-KLD--LNQNIQLTFLDCSSNKL---TEIDVTPLTQLTYFDCSVNPLTELDVSTLS 254
Query: 240 NLVKLH------------------YLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEE 281
L LH Y + IK++ ++ L LD + E
Sbjct: 255 KLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGI-TE 311
Query: 282 MPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326
+ + L L L++ L+ + L + +
Sbjct: 312 LD--LSQNPKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHI 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-27
Identities = 53/315 (16%), Positives = 104/315 (33%), Gaps = 37/315 (11%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+ + L L + N + + L+ L+ S NK+ + + + L
Sbjct: 146 HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI-TELD--VSQNKLLNRLNCDT 200
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHLTGNISESFG 119
N ++ + ++LT L +N+L + L LT + N LT
Sbjct: 201 NNIT-KLD--LNQNIQLTFLDCSSNKLTEIDVTPLTQLTYF---DCSVNPLT---ELDVS 251
Query: 120 IHPNLAFIDLSHNYFYGEISS-DWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
L + ++ D +L ++ H++QL +LD
Sbjct: 252 TLSKLTTLHCIQT----DLLEIDLTHNTQLIYFQAEGCRKIKE--LDVTHNTQLYLLDCQ 305
Query: 179 SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSL 238
+ I L + L+ L LN+ +L L++ T+L+ L + + S+
Sbjct: 306 AAGIT---ELDLSQNPKLVYLYLNNTELT---ELDVSHNTKLKSLSCVNAHIQ-DFS-SV 357
Query: 239 GNLVKLHYLNLSNNQFIKKIPVELEKL-----IHLSELDLSHNFLGEEMPSQICNMQSLE 293
G + L+ + Q I L + LD N + + +
Sbjct: 358 GKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFGNPM--NIEPGDGGVYDQA 415
Query: 294 KLNLSHNNLSGFIPS 308
++ NLS P+
Sbjct: 416 TNTITWENLSTDNPA 430
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 8e-35
Identities = 71/279 (25%), Positives = 120/279 (43%), Gaps = 25/279 (8%)
Query: 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
D++ + IG G G K G+I+ K+ +E A +Q ++EV L ++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKH 64
Query: 495 RNIVKFYG--FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKR-MNVIKGVVDAL 551
NIV++Y +IV EY E G LA +++ + + + V+ + AL
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 552 SYMH--NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVA 609
H +D ++HRD+ NV LD + + DFG A+ L D+S GT Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 610 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669
PE M EK D++S G L E+ P F ++ S E+A P
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPP--F-----TAFSQKELAGKIREGKFRRIP 237
Query: 670 SHNVQD--KLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ ++I+ L+ RP++ ++L+
Sbjct: 238 YRYSDELNEIIT------RMLNLKDYHRPSV---EEILE 267
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 67/326 (20%), Positives = 119/326 (36%), Gaps = 36/326 (11%)
Query: 388 LISLIGLFFMFRRSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKG 447
L SL + + + N L+ Y E + + +G+G
Sbjct: 13 LASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVH---WMTHQPRVGRG 69
Query: 448 GQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH 506
G V++ + +G AVK ++ + + E+ G+ IV YG
Sbjct: 70 SFGEVHRMKDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYGAVRE 121
Query: 507 ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRD 566
I E LE GSL ++ + + + + ++ L Y+H I+H D
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTRR---ILHGD 175
Query: 567 ISSKNVLLDLE-NEAHVSDFGTAKFLKPDSSNWAE-----LAGTYGYVAPELAYTMKVTE 620
+ + NVLL + + A + DFG A L+PD + + GT ++APE+
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235
Query: 621 KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISI 680
K D++S + L ++ G HP + L+IA P P
Sbjct: 236 KVDIWSSCCMMLHMLNGCHPW---TQYFRGPLCLKIASEPP--PIREIPPS-CAPLTAQA 289
Query: 681 MEVAISCLDESPESRPTIQKVSQLLK 706
++ L + P R + +L +
Sbjct: 290 IQ---EGLRKEPVHRAS---AMELRR 309
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-34
Identities = 60/272 (22%), Positives = 107/272 (39%), Gaps = 20/272 (7%)
Query: 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+ IG+G G + G +K+ + S ++E EV L ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKH 82
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
NIV++ +IV +Y E G L + N + ++ + AL ++
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
H+ I+HRDI S+N+ L + + DFG A+ L GT Y++PE+
Sbjct: 142 HD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICE 198
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674
K D+++ G + E+ KH F + S + L + P H
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA--F-----EAGSMKNLVLKIISGSFPPVSLH-YS 250
Query: 675 DKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
L S++ +P RP++ + +L+
Sbjct: 251 YDLRSLVS---QLFKRNPRDRPSV---NSILE 276
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 6e-34
Identities = 75/309 (24%), Positives = 116/309 (37%), Gaps = 63/309 (20%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG 491
R +DF++ +G+G G V KA A+KK + L+EV L
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK----IRHTEEKLSTILSEVMLLAS 58
Query: 492 IRHRNIVKFYGFCSHARHS-------------FIVYEYLEMGSLA--MILSNDAAAKDLG 536
+ H+ +V++Y R+ FI EY E G+L + N +D
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 537 WTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596
W + + +++ALSY+H+ I+HRD+ N+ +D + DFG AK +
Sbjct: 119 W----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 597 NWAELA--------------GTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIK----G 637
+ GT YVA E L T EK D+YS G++ E+I G
Sbjct: 172 ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTG 231
Query: 638 KHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPT 697
+ + + S S P V+ K+I +D P RP
Sbjct: 232 MERVNILKKLRSVSIE--------FPPDFDDNKMKVEKKIIR------LLIDHDPNKRPG 277
Query: 698 IQKVSQLLK 706
LL
Sbjct: 278 A---RTLLN 283
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 60/237 (25%), Positives = 96/237 (40%), Gaps = 9/237 (3%)
Query: 102 RVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNIT-- 159
+R N LT S GI + ++L N + + +L L SSN ++
Sbjct: 11 EIRCNSKGLT---SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 160 GSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLEL-GSLT 218
G ++ LK LDLS N ++ M S L L L + L + SL
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 219 QLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHNF 277
L LD+S + L L L ++ N F + + +L +L+ LDLS
Sbjct: 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 278 LGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST 334
L + P+ ++ SL+ LN+SHNN ++ L+ L +D S N + +
Sbjct: 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQE 242
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 65/254 (25%), Positives = 98/254 (38%), Gaps = 10/254 (3%)
Query: 7 FLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALS-- 64
+ + + S+P+ I S + LEL NKL LTQ+T L+L N LS
Sbjct: 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 65 GAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISES-FGIHPN 123
G + L L L N + N L L + ++L S F N
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127
Query: 124 LAFIDLSHNYFYGEISSDW-GRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLDLSSNH 181
L ++D+SH + + L L + N+ + +I L LDLS
Sbjct: 128 LIYLDISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186
Query: 182 IVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNL 241
+ P+ LSSL L ++ N + L L+ LD S N + S + L +
Sbjct: 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246
Query: 242 VK-LHYLNLSNNQF 254
L +LNL+ N F
Sbjct: 247 PSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 28/112 (25%), Positives = 49/112 (43%), Gaps = 5/112 (4%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIP-HSLGNLTQITFLTL 58
LS+L L + NSF + +I L++L+ L+LS +L + + +L+ + L +
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNM 206
Query: 59 FDNALSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNL-TSLVRVRLNQN 108
N Y L L +L N + L++ +SL + L QN
Sbjct: 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 71/274 (25%), Positives = 119/274 (43%), Gaps = 30/274 (10%)
Query: 437 DFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
F IGKG G V+K + + ++VA+K L ++ E+ L+
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
+ K+YG +I+ EYL GS +L L T+ +++ ++ L Y+H
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLH 136
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT 615
++ +HRDI + NVLL E ++DFG A L GT ++APE+
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 616 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEI--ALNEMLDPRLPTPSHNV 673
K D++S G+ A+E+ +G+ P S L L L P+ P+ +
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPH----------SELHPMKVL--FLIPKNNPPT--L 239
Query: 674 QDKLISIMEVAIS-CLDESPESRPTIQKVSQLLK 706
+ ++ + CL++ P RPT +LLK
Sbjct: 240 EGNYSKPLKEFVEACLNKEPSFRPT---AKELLK 270
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 65/285 (22%), Positives = 130/285 (45%), Gaps = 47/285 (16%)
Query: 435 TNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR 493
+ IG+G G+VY A ++ +G+ VA+++ L + ++ +NE+ + +
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQP-KKELIINEILVMRENK 75
Query: 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN------VIKGV 547
+ NIV + ++V EYL GSL +++ M+ V +
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----------TCMDEGQIAAVCREC 125
Query: 548 VDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGY 607
+ AL ++H++ ++HRDI S N+LL ++ ++DFG + P+ S + + GT +
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 608 VAPELAYTMKVTEKCDVYSFGVLALEVIKGK------HPRDFISSISSSSSNLEIALNEM 661
+APE+ K D++S G++A+E+I+G+ +P + I+++ +
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT--------- 233
Query: 662 LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
P L P + + CL+ E R + +LL+
Sbjct: 234 --PELQNP-EKLSAIFRDFLNR---CLEMDVEKRGS---AKELLQ 269
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 66/276 (23%), Positives = 108/276 (39%), Gaps = 38/276 (13%)
Query: 443 CIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFY 501
+GKG G VY +L + +A+K+ Q E+ ++H+NIV++
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEEIALHKHLKHKNIVQYL 85
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
G S I E + GSL+ +L + K +++ L Y+H++
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142
Query: 562 IVHRDISSKNVLLDLEN-EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE--LAYTMKV 618
IVHRDI NVL++ + +SDFGT+K L + GT Y+APE
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 619 TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM-------LDPRLPTP-S 670
+ D++S G +E+ GK P L M + P +P S
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPF----------YELGEPQAAMFKVGMFKVHPEIPESMS 252
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ + + C + P+ R + LL
Sbjct: 253 AEAKAFI-------LKCFEPDPDKRAC---ANDLLV 278
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 78/276 (28%), Positives = 128/276 (46%), Gaps = 35/276 (12%)
Query: 438 FDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
FD +G+G GSVYKA +G+IVA+K+ P+ S++ QE + E+ + +
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDL---QEIIKEISIMQQCDSPH 85
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN------VIKGVVDA 550
+VK+YG +IV EY GS++ I+ K + +++ +
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN--------KTLTEDEIATILQSTLKG 137
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAP 610
L Y+H +HRDI + N+LL+ E A ++DFG A L + + GT ++AP
Sbjct: 138 LEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAP 194
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670
E+ + D++S G+ A+E+ +GK P + I + I N P P
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGKPPY---ADIHPMRAIFMIPTNP--PPTFRKP- 248
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
D ++ CL +SPE R T +QLL+
Sbjct: 249 ELWSDNFTDFVKQ---CLVKSPEQRAT---ATQLLQ 278
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 132 bits (332), Expect = 2e-32
Identities = 55/312 (17%), Positives = 110/312 (35%), Gaps = 36/312 (11%)
Query: 42 SIPHSLGNLTQITFLTLFDNALSGAIPKEY----GNLVKLTLLTLENNQLRGPIPNLRNL 97
SI + N ++ F N +S +Y K L N+ + +
Sbjct: 2 SIMLPINNNFSLS-QNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECL-I 58
Query: 98 TSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNN 157
++LN+ +L+ ++ ++ P + ++++ N + L LD N
Sbjct: 59 NQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLPELPA---SLEYLDACDNR 111
Query: 158 ITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSL 217
++ ++P + LK LD+ +N + +P L + ++NQL L
Sbjct: 112 LS-TLPELP---ASLKHLDVDNNQLT-MLPELPALLE---YINADNNQL-TMLP---ELP 159
Query: 218 TQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSE----LDL 273
T LE L + +N+L +P+ +L L++S N ++ +P + H E
Sbjct: 160 TSLEVLSVRNNQL-TFLPELPESL---EALDVSTNL-LESLPAVPVRNHHSEETEIFFRC 214
Query: 274 SHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNS 333
N + +P I ++ + L N LS I + S
Sbjct: 215 RENRI-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
Query: 334 TAFRDAPMEALQ 345
+A+
Sbjct: 274 NTLHRPLADAVT 285
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 54/319 (16%), Positives = 108/319 (33%), Gaps = 34/319 (10%)
Query: 1 NLSNLAFLYLYNN--SFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTL 58
N +L+ YN S + + + + N+ + L + Q + L L
Sbjct: 9 NNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQL 66
Query: 59 FDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESF 118
LS ++P ++T+L + N L +P L SL + N L+ + E
Sbjct: 67 NRLNLS-SLPDNLPP--QITVLEITQNALI-SLPEL--PASLEYLDACDNRLS-TLPELP 119
Query: 119 GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
+L +D+ +N + L ++ +N +T +P + L+VL +
Sbjct: 120 A---SLKHLDVDNNQL-TMLPELPA---LLEYINADNNQLT-MLPELP---TSLEVLSVR 168
Query: 179 SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLER----LDLSSNRLSNSI 234
+N + +P L L +++N L L E NR++ I
Sbjct: 169 NNQL-TFLPELPESLE---ALDVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRIT-HI 222
Query: 235 PKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEK 294
P+++ +L + L +N +I L + + + M N
Sbjct: 223 PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSDGQQNTLHRPL 280
Query: 295 LNLSHNNLSGFIPSCFEEL 313
+ S ++
Sbjct: 281 ADAVTAWFPENKQSDVSQI 299
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 74/282 (26%), Positives = 119/282 (42%), Gaps = 47/282 (16%)
Query: 438 FDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
D IG+G G V A E SG VAVK L + ++ NEV + +H N
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQ-RRELLFNEVVIMRDYQHFN 103
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN------VIKGVVDA 550
+V+ Y +++ E+L+ G+L I+S R+N V + V+ A
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----------VRLNEEQIATVCEAVLQA 153
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAP 610
L+Y+H ++HRDI S ++LL L+ +SDFG + D L GT ++AP
Sbjct: 154 LAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 210
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIKGK------HPRDFISSISSSSSNLEIALNEMLDP 664
E+ + D++S G++ +E++ G+ P + + S P
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-----------P 259
Query: 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+L H V L +E L P+ R T +LL
Sbjct: 260 KLKNS-HKVSPVLRDFLER---MLVRDPQERAT---AQELLD 294
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-32
Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 48/285 (16%)
Query: 437 DFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHR 495
F + +G G +G++ + VAVK+ + E S + EV+ L H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR----ILPECFSFAD--REVQLLRESDEHP 78
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLA-MILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
N+++++ + +I E +L + D A L + + +++ L+++
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL---EPITLLQQTTSGLAHL 134
Query: 555 HNDCFPPIVHRDISSKNVLLDLENE-----AHVSDFGTAKFLKPDSS---NWAELAGTYG 606
H+ IVHRD+ N+L+ + N A +SDFG K L + + GT G
Sbjct: 135 HSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 607 YVAPEL---AYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEM- 661
++APE+ T D++S G + VI +G HP +L+ N +
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG---------KSLQRQANILL 242
Query: 662 ----LDPRLPTPSHNVQDK-LISIMEVAISCLDESPESRPTIQKV 701
LD P +V + LI + P+ RP+ + V
Sbjct: 243 GACSLDCLHPEKHEDVIARELIE------KMIAMDPQKRPSAKHV 281
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 71/294 (24%), Positives = 135/294 (45%), Gaps = 41/294 (13%)
Query: 428 YEEIIRVTN---DFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFL 483
YE + R + ++ +G G G VYKA +G + A K SE ++++
Sbjct: 8 YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEE-ELEDYI 64
Query: 484 NEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN- 542
E++ L H IVK G H +I+ E+ G++ I+ + +
Sbjct: 65 VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL--------DRGLTE 116
Query: 543 -----VIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN 597
V + +++AL+++H+ I+HRD+ + NVL+ LE + ++DFG +
Sbjct: 117 PQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173
Query: 598 WAELAGTYGYVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSISSSSS 652
GT ++APE+ + + K D++S G+ +E+ + + P ++
Sbjct: 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH---HELNPMRV 230
Query: 653 NLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
L+IA ++ P L TPS + +++ LD++PE+RP+ +QLL+
Sbjct: 231 LLKIAKSD--PPTLLTPS-KWSVEFRDFLKI---ALDKNPETRPS---AAQLLE 275
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-32
Identities = 72/290 (24%), Positives = 120/290 (41%), Gaps = 46/290 (15%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTL 489
I ++ IG G G V+ + + VA+K + S+++F+ E + +
Sbjct: 4 VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT----IREGAMSEEDFIEEAEVM 57
Query: 490 TGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD 549
+ H +V+ YG C +V E++E G L+ L + + V +
Sbjct: 58 MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCE 115
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD----SSN------WA 599
++Y+ C +HRD++++N L+ VSDFG +F+ D S+ WA
Sbjct: 116 GMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 172
Query: 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIAL 658
+PE+ + + K DV+SFGVL EV +GK P + SN E+
Sbjct: 173 ---------SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-------SNSEVV- 215
Query: 659 NEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
E + RL P + IM C E PE RP ++ + L
Sbjct: 216 -EDISTGFRLYKP-RLASTHVYQIM---NHCWRERPEDRPAFSRLLRQLA 260
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 72/299 (24%), Positives = 126/299 (42%), Gaps = 54/299 (18%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+D++ + IG G V A P E VA+K+ L S E L E++ ++ H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHH 72
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN------VIKGVV 548
NIV +Y ++V + L GS+ I+ + AK + ++ +++ V+
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKH-IVAKGEHKSGVLDESTIATILREVL 131
Query: 549 DALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAEL-----AG 603
+ L Y+H + +HRD+ + N+LL + ++DFG + FL G
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 604 TYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE--I 656
T ++APE+ Y K D++SFG+ A+E+ G P
Sbjct: 189 TPCWMAPEVMEQVRGYD----FKADIWSFGITAIELATGAAPY----------HKYPPMK 234
Query: 657 ALNEMLDPRLPTPSHNVQDKLISIME---------VAISCLDESPESRPTIQKVSQLLK 706
L ML + PS + +++ ++ CL + PE RPT ++LL+
Sbjct: 235 VL--MLTLQNDPPSLETGVQDKEMLKKYGKSFRKMIS-LCLQKDPEKRPT---AAELLR 287
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 2e-31
Identities = 71/382 (18%), Positives = 134/382 (35%), Gaps = 56/382 (14%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHS--LGNLTQITFLTL 58
L +L L +N I +L L+LS N ++P GN++Q+ FL L
Sbjct: 67 FNQELEYLDLSHNKLV-KISC--HPTVNLKHLDLSFNAF-DALPICKEFGNMSQLKFLGL 122
Query: 59 FDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIP--NLRNL--TSLVRVRLNQNHLTGNI 114
L + +L +L + L++ SL V +
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFIL 182
Query: 115 SESFGIHPNLAFIDLSHNYFYGEIS------SDWGRCPKLGTLDFSSNNITGSMPAEIIH 168
S NL ++ + S + PKL L ++ T + I+
Sbjct: 183 DVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ 242
Query: 169 ---SSQLKVLDLSSNHIVGEMPSKLG-----------------------------KLSSL 196
+ + +S+ + G++ + S++
Sbjct: 243 LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNM 302
Query: 197 IKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIK 256
+ L ++ LD S+N L++++ ++ G+L +L L L NQ +K
Sbjct: 303 NIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ-LK 361
Query: 257 KIPVE---LEKLIHLSELDLSHNFLGEEMPSQIC-NMQSLEKLNLSHNNLSGFIPSCFEE 312
++ ++ L +LD+S N + + C +SL LN+S N L+ I C
Sbjct: 362 ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL-- 419
Query: 313 LHGLSYIDISYNELHGSIPNST 334
+ +D+ N++ SIP
Sbjct: 420 PPRIKVLDLHSNKIK-SIPKQV 440
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-28
Identities = 67/359 (18%), Positives = 125/359 (34%), Gaps = 32/359 (8%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+LS L L + +N S + L L+LS NKL I + L L
Sbjct: 43 SLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL-VKIS--CHPTVNLKHLDLSF 99
Query: 61 NAL-SGAIPKEYGNLVKLTLLTLENNQL-RGPIPNLRNLTSL-VRVRLNQNHLTGNISES 117
NA + I KE+GN+ +L L L L + + + +L V + L + + E
Sbjct: 100 NAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEG 159
Query: 118 FGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITG-----------SMPAEI 166
+ L + + + +NI S+ A++
Sbjct: 160 L---QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKL 216
Query: 167 IHSSQLKVLDLSSNHIVGEMPSKLGKL---SSLIKLILNSNQLCGQLSLELG-----SLT 218
+ +L L L++ ++ +L +++ +++ +L GQL SL
Sbjct: 217 QTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLK 276
Query: 219 QLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDLSHNF 277
L + S+ ++ N + + + + + K+ LD S+N
Sbjct: 277 ALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG-TRMVHMLCPSKISPFLHLDFSNNL 335
Query: 278 LGEEMPSQICNMQSLEKLNLSHNNLS--GFIPSCFEELHGLSYIDISYNELHGSIPNST 334
L + + ++ LE L L N L I ++ L +DIS N +
Sbjct: 336 LTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGD 394
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-28
Identities = 69/371 (18%), Positives = 121/371 (32%), Gaps = 52/371 (14%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
N+S L FL L S I L L + G L +L
Sbjct: 113 NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHI 170
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRG------------------------------- 89
+ ++ T+ LE + ++
Sbjct: 171 VFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNI 230
Query: 90 --------PIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPN-----LAFIDLSHNYFYG 136
I L T++ ++ L G + + L+ + + F
Sbjct: 231 ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290
Query: 137 EISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSL 196
S + + +F+ + S LD S+N + + G L+ L
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350
Query: 197 IKLILNSNQL--CGQLSLELGSLTQLERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSNNQ 253
LIL NQL +++ + L++LD+S N +S K L LN+S+N
Sbjct: 351 ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI 410
Query: 254 FIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEEL 313
I L + LDL N + + +P Q+ +++L++LN++ N L F+ L
Sbjct: 411 LTDTIFRCL--PPRIKVLDLHSNKI-KSIPKQVVKLEALQELNVASNQLKSVPDGIFDRL 467
Query: 314 HGLSYIDISYN 324
L I + N
Sbjct: 468 TSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 63/321 (19%), Positives = 128/321 (39%), Gaps = 23/321 (7%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCG------SIPHSLGNLTQIT 54
N +L ++ N F + + + +L + SI L +++
Sbjct: 164 NTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLS 223
Query: 55 FLTLFDNALSGAIPKEYGNLVK---LTLLTLENNQLRGPIP------NLRNLTSLVRVRL 105
LTL + + LV + ++ N +L+G + + +L +L ++
Sbjct: 224 NLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQV 283
Query: 106 NQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAE 165
+ S + I N+ + + + + LDFS+N +T E
Sbjct: 284 VSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DTVFE 342
Query: 166 IIHS-SQLKVLDLSSNHI--VGEMPSKLGKLSSLIKLILNSNQLCGQLSLEL-GSLTQLE 221
++L+ L L N + + ++ ++ SL +L ++ N + L
Sbjct: 343 NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402
Query: 222 RLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEE 281
L++SSN L+++I + L ++ L+L +N+ IK IP ++ KL L EL+++ N L
Sbjct: 403 SLNMSSNILTDTIFRCL--PPRIKVLDLHSNK-IKSIPKQVVKLEALQELNVASNQLKSV 459
Query: 282 MPSQICNMQSLEKLNLSHNNL 302
+ SL+K+ L N
Sbjct: 460 PDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 6e-22
Identities = 54/371 (14%), Positives = 108/371 (29%), Gaps = 50/371 (13%)
Query: 7 FLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGA 66
+ N +P ++ + + L +S N + + +L+++ L + N +
Sbjct: 4 LVDRSKNGLI-HVPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL 60
Query: 67 IPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHLTG-NISESFGIHPNL 124
+ +L L L +N+L NL L L+ N I + FG L
Sbjct: 61 DISVFKFNQELEYLDLSHNKLVKISCHPTVNLKHL---DLSFNAFDALPICKEFGNMSQL 117
Query: 125 AFIDLSHN----------------YFYGEISSDWGRC------PKLGTLDFSSNNITGSM 162
F+ LS + +G T T
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKE 177
Query: 163 PAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLT---- 218
I+ S V +L ++I + I L +N L+L T
Sbjct: 178 FHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSF 237
Query: 219 ----------QLERLDLSSNRL-----SNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELE 263
+ +S+ +L S +L L + ++ F E
Sbjct: 238 IRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYE 297
Query: 264 KLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISY 323
+++ + + + + L+ S+N L+ + L L + +
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 324 NELHGSIPNST 334
N+L +
Sbjct: 358 NQLK-ELSKIA 367
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 5e-16
Identities = 45/212 (21%), Positives = 82/212 (38%), Gaps = 32/212 (15%)
Query: 150 TLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ 209
+D S N + +P ++ S + +L++S N+I S+L
Sbjct: 4 LVDRSKNGLI-HVPKDL--SQKTTILNISQNYI-----SELW------------------ 37
Query: 210 LSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLS 269
+ ++ SL++L L +S NR+ +L YL+LS+N+ + KI ++L
Sbjct: 38 -TSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK-LVKIS--CHPTVNLK 93
Query: 270 ELDLSHNFLGE-EMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHG 328
LDLS N + + NM L+ L LS +L L+ + + E +G
Sbjct: 94 HLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNIS-KVLLVLGETYG 152
Query: 329 SIPNSTAFRDAPMEALQGNKGLCGDIKGFPSC 360
+ +D E+L +
Sbjct: 153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDV 184
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 60/294 (20%), Positives = 106/294 (36%), Gaps = 42/294 (14%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG 491
R T +F + IG G GSV+K + G I A+K+ PL +Q L EV
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAV 66
Query: 492 I-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLA-MILSNDAAAKDLGWTKRMNVIKGVVD 549
+ +H ++V+++ + H I EY GSLA I N + +++ V
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA------- 602
L Y+H+ +VH DI N+ + + + + + + ++
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 603 --------GTYGYVAPE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN 653
G ++A E L K D+++ + + +
Sbjct: 184 ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW------ 237
Query: 654 LEIALNEMLDPRLPTP-SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
EI + PR+P S + L+ + PE RP+ L+K
Sbjct: 238 HEIRQGRL--PRIPQVLSQEFTE-LLK------VMIHPDPERRPSA---MALVK 279
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 82/290 (28%), Positives = 130/290 (44%), Gaps = 46/290 (15%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTL 489
E+ R + +G G G V + VAVK + S+ EF E +T+
Sbjct: 4 ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKM----IKEGSMSEDEFFQEAQTM 57
Query: 490 TGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD 549
+ H +VKFYG CS +IV EY+ G L L + K L ++ + + V +
Sbjct: 58 MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCE 115
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD----SSN------WA 599
++++ + F +HRD++++N L+D + VSDFG +++ D S W+
Sbjct: 116 GMAFLESHQF---IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS 172
Query: 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIAL 658
APE+ + K + K DV++FG+L EV GK P D +N E+
Sbjct: 173 ---------APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY-------TNSEVV- 215
Query: 659 NEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ RL P H D + IM SC E PE RPT Q++ ++
Sbjct: 216 -LKVSQGHRLYRP-HLASDTIYQIM---YSCWHELPEKRPTFQQLLSSIE 260
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 66/256 (25%), Positives = 117/256 (45%), Gaps = 17/256 (6%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G GG +VY AE VA+K P + + + F EV + + H+NIV
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
++V EY+E +L+ + + L +N ++D + + H+ I
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM---RI 132
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS-SNWAELAGTYGYVAPELAYTMKVTEK 621
VHRDI +N+L+D + DFG AK L S + + GT Y +PE A E
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 622 CDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKL-ISI 680
D+YS G++ E++ G+ P + +++S IA+ + D +P + +V+ + S+
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIKHIQDS-VPNVTTDVRKDIPQSL 244
Query: 681 MEVAISCLDESPESRP 696
V + ++ +R
Sbjct: 245 SNVILRATEKDKANRY 260
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-31
Identities = 64/270 (23%), Positives = 118/270 (43%), Gaps = 26/270 (9%)
Query: 441 EHCIGKGGQGSVYKAELPSGEI-VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
+H +G G G VY+ + VAVK L + +EFL E + I+H N+V+
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKT----LKEDTMEVEEFLKEAAVMKEIKHPNLVQ 280
Query: 500 FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
G C+ +I+ E++ G+L L +++ + + + A+ Y+ F
Sbjct: 281 LLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNF 339
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD---SSNWAELAGTYGYVAPELAYTM 616
+HR+++++N L+ + V+DFG ++ + D + A+ + APE
Sbjct: 340 ---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYN 394
Query: 617 KVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675
K + K DV++FGVL E+ G P I ++ D R+ P +
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGI-------DLSQVYELLEKDYRMERP-EGCPE 446
Query: 676 KLISIMEVAISCLDESPESRPTIQKVSQLL 705
K+ +M +C +P RP+ ++ Q
Sbjct: 447 KVYELM---RACWQWNPSDRPSFAEIHQAF 473
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-31
Identities = 72/299 (24%), Positives = 123/299 (41%), Gaps = 47/299 (15%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI 492
+ N E +G G G+V G VAVK+ L E+K LT
Sbjct: 12 SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI------DFCDIALMEIKLLTES 65
Query: 493 -RHRNIVKFYGFCSHARHSFIVYEYLEMGSLA-MILSNDAAAKDLGWTKRM---NVIKGV 547
H N++++Y + R +I E +L ++ S + + ++L K ++++ +
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 548 VDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH-------------VSDFGTAKFLKPD 594
++++H+ I+HRD+ +N+L+ + +SDFG K L
Sbjct: 125 ASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 595 SSNWA----ELAGTYGYVAPEL-------AYTMKVTEKCDVYSFGVLALEVI-KGKHPRD 642
S++ +GT G+ APEL ++T D++S G + ++ KGKHP
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 643 FISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
S S+ +L+EM + D LIS +D P RPT KV
Sbjct: 242 DKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD-LIS------QMIDHDPLKRPTAMKV 293
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 76/289 (26%), Positives = 125/289 (43%), Gaps = 46/289 (15%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTL 489
EI D +G G G V + VA+K + S+ EF+ E K +
Sbjct: 20 EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM----IKEGSMSEDEFIEEAKVM 73
Query: 490 TGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD 549
+ H +V+ YG C+ R FI+ EY+ G L L + + + K V +
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCE 131
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD----SSN------WA 599
A+ Y+ + F +HRD++++N L++ + VSDFG ++++ D S W+
Sbjct: 132 AMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIAL 658
PE+ K + K D+++FGVL E+ GK P + +N E A
Sbjct: 189 ---------PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-------TNSETA- 231
Query: 659 NEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
E + RL P H +K+ +IM SC E + RPT + + +
Sbjct: 232 -EHIAQGLRLYRP-HLASEKVYTIM---YSCWHEKADERPTFKILLSNI 275
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 55/257 (21%), Positives = 100/257 (38%), Gaps = 21/257 (8%)
Query: 444 IGKGGQGSVYKAELPS-GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G+GG G VY+AE IVA+K L S+ + E +T ++ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
F ++ + LA +L L + + +++ + AL H
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---GA 155
Query: 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW---AELAGTYGYVAPELAYTMKVT 619
HRD+ +N+L+ ++ A++ DFG A GT Y+APE T
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 620 EKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS 679
+ D+Y+ + E + G P + L + + +P PS ++
Sbjct: 214 YRADIYALTCVLYECLTGSPP--Y------QGDQLSVMGAHINQA-IPRPSTVRPGIPVA 264
Query: 680 IMEVAISCLDESPESRP 696
V + ++PE R
Sbjct: 265 FDAVIARGMAKNPEDRY 281
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 66/296 (22%), Positives = 118/296 (39%), Gaps = 43/296 (14%)
Query: 430 EIIRVTN-DFDDEHCIGKGGQGSVYKAELPSGEIVAVK--KFHSPLPSEMASQQEFLNEV 486
E I V + IG GG V++ +I A+K + + NE+
Sbjct: 2 ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEI 58
Query: 487 KTLTGIRH--RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVI 544
L ++ I++ Y + ++ ++V E L L K + +R +
Sbjct: 59 AYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK---KSIDPWERKSYW 114
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE--LA 602
K +++A+ +H IVH D+ N L+ + + DFG A ++PD+++ +
Sbjct: 115 KNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 603 GTYGYVAPEL-----------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS 651
GT Y+ PE K++ K DV+S G + + GK P F I +
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-QQIINQI 227
Query: 652 SNLEIALNEMLDPRLP-TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
S L ++ + P P ++QD ++ CL P+ R +I +LL
Sbjct: 228 SKLHAIIDPNHEIEFPDIPEKDLQD-VLK------CCLKRDPKQRISIP---ELLA 273
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-30
Identities = 62/258 (24%), Positives = 100/258 (38%), Gaps = 15/258 (5%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA 62
+ + + S +P I + L L N + + +L + L L N+
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 63 LSGAIPKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGI 120
+ + L L L L +N L IP+ L+ L + L N + S +F
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIESIPSYAFNR 169
Query: 121 HPNLAFIDLSHNYFYGEISSD-WGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS 179
P+L +DL IS + L L+ NI MP + L+ L++S
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSG 227
Query: 180 NHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGS---LTQLERLDLSSNRLSNSIPK 236
NH P LSSL KL + ++Q+ +E + L L L+L+ N LS+
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVS---LIERNAFDGLASLVELNLAHNNLSSLPHD 284
Query: 237 SLGNLVKLHYLNLSNNQF 254
L L L+L +N +
Sbjct: 285 LFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-29
Identities = 58/240 (24%), Positives = 99/240 (41%), Gaps = 13/240 (5%)
Query: 99 SLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNI 158
+V + L+ + + GI N +++L N + + L L N+I
Sbjct: 55 QFSKVVCTRRGLS-EVPQ--GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 159 TGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGS-- 216
+ L L+L N + LS L +L L +N + S+ +
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI---ESIPSYAFN 168
Query: 217 -LTQLERLDLSS-NRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLS 274
+ L RLDL +L + L L YLNL IK +P L L+ L EL++S
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN-IKDMP-NLTPLVGLEELEMS 226
Query: 275 HNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST 334
N E P + SL+KL + ++ +S + F+ L L +++++N L S+P+
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDL 285
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-29
Identities = 60/256 (23%), Positives = 101/256 (39%), Gaps = 34/256 (13%)
Query: 77 LTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFY 135
L L N ++ + R+L L ++L +N + I AF L
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-------IEVG-AFNGL------ 122
Query: 136 GEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLDLSSNHIVGEMPSKLGKLS 194
L TL+ N +T +P+ S+L+ L L +N I ++
Sbjct: 123 ----------ASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVP 171
Query: 195 SLIKLIL-NSNQLCGQLSLE-LGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNN 252
SL++L L +L +S L L+ L+L + +P +L LV L L +S N
Sbjct: 172 SLMRLDLGELKKL-EYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGN 228
Query: 253 QFIKKIPVE-LEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFE 311
+I L L +L + ++ + + + SL +LNL+HNNLS F
Sbjct: 229 H-FPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT 287
Query: 312 ELHGLSYIDISYNELH 327
L L + + +N +
Sbjct: 288 PLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 30/109 (27%), Positives = 47/109 (43%), Gaps = 3/109 (2%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L NL +L L + +P+ + L L +LE+SGN P S L+ + L + +
Sbjct: 194 GLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQN 108
+ +S + L L L L +N L P L LV + L+ N
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 33/121 (27%), Positives = 49/121 (40%), Gaps = 7/121 (5%)
Query: 219 QLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHNF 277
Q ++ + LS +P+ + YLNL N I+ I + L HL L L N
Sbjct: 55 QFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENN-IQMIQADTFRHLHHLEVLQLGRNS 110
Query: 278 LGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFR 337
+ + + SL L L N L+ FE L L + + N + SIP+ AF
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSY-AFN 168
Query: 338 D 338
Sbjct: 169 R 169
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 22/90 (24%), Positives = 35/90 (38%), Gaps = 4/90 (4%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSE-IGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
L L L + N F I L SL L + +++ ++ L + L L
Sbjct: 216 PLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLA 274
Query: 60 DNALSGAIPKE-YGNLVKLTLLTLENNQLR 88
N LS ++P + + L L L L +N
Sbjct: 275 HNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 61/316 (19%), Positives = 101/316 (31%), Gaps = 35/316 (11%)
Query: 397 MFRRSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKA- 455
++ +S Q Q L G F +G G G V+K
Sbjct: 18 LYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVR 77
Query: 456 ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVY 514
G + AVK+ SP + L EV + + +H V+ ++
Sbjct: 78 SKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136
Query: 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL 574
E SL L + ++ + AL+++H+ +VH D+ N+ L
Sbjct: 137 ELCG-PSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFL 190
Query: 575 DLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL---AYTMKVTEKCDVYSFGVLA 631
+ DFG L + + G Y+APEL +Y DV+S G+
Sbjct: 191 GPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAPELLQGSY----GTAADVFSLGLTI 245
Query: 632 LEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP-SHNVQDKLISIMEVAISCLDE 690
LEV + L P S ++ ++ L+
Sbjct: 246 LEVACNMEL-------PHGGEGWQQLRQGYLPPEFTAGLSSELRS-VLV------MMLEP 291
Query: 691 SPESRPTIQKVSQLLK 706
P+ R T + LL
Sbjct: 292 DPKLRATAE---ALLA 304
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 73/324 (22%), Positives = 118/324 (36%), Gaps = 47/324 (14%)
Query: 406 QQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVA 464
S G A G F G+ V +R+ + +GG VY+A+ + SG A
Sbjct: 3 GPGSLGGASGRDQS-DFVGQTVELGELRLR----VRRVLAEGGFAFVYEAQDVGSGREYA 57
Query: 465 VKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHS-------FIVYEY 516
+K+ S E + + EV + + H NIV+F S + F++
Sbjct: 58 LKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTE 114
Query: 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL 576
L G L L + L + + A+ +MH PPI+HRD+ +N+LL
Sbjct: 115 LCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSN 173
Query: 577 ENEAHVSDFGTAKFLKPDSSN------------WAELAGTYGYVAPELAYTMK---VTEK 621
+ + DFG+A + T Y PE+ + EK
Sbjct: 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK 233
Query: 622 CDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIM 681
D+++ G + + +HP + + L I + P T LI M
Sbjct: 234 QDIWALGCILYLLCFRQHPFE-------DGAKLRIVNGKYSIPPHDTQYTVFHS-LIRAM 285
Query: 682 EVAISCLDESPESRPTIQKVSQLL 705
L +PE R +I +V L
Sbjct: 286 ------LQVNPEERLSIAEVVHQL 303
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 59/314 (18%), Positives = 118/314 (37%), Gaps = 43/314 (13%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61
+ S + SIPS + +++ L+LS N++ L + L L N
Sbjct: 30 CDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN 86
Query: 62 ALSGAIPKE-YGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESF 118
++ I ++ + +L L L L N L + + + L+SL + L N
Sbjct: 87 GIN-TIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKT------ 138
Query: 119 GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLDL 177
+ F L KL L + + + + + L+ L++
Sbjct: 139 -LGETSLFSHL----------------TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEI 181
Query: 178 SSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLS----NS 233
++ + P L + ++ LIL+ Q L + + + +E L+L L +
Sbjct: 182 DASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSE 241
Query: 234 IPK----SLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQIC-N 288
+ SL + +++ + ++ L ++ L EL+ S N L + +P I
Sbjct: 242 LSTGETNSLIKKFTFRNVKITDES-LFQVMKLLNQISGLLELEFSRNQL-KSVPDGIFDR 299
Query: 289 MQSLEKLNLSHNNL 302
+ SL+K+ L N
Sbjct: 300 LTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 52/272 (19%), Positives = 102/272 (37%), Gaps = 43/272 (15%)
Query: 77 LTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYF 134
+ L L NN++ I N L+ +L + L N + I + +F L
Sbjct: 54 VKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSNGINT-------IEED-SFSSL----- 99
Query: 135 YGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLDLSSNHIVGEMPSKL-GK 192
L LD S N ++ ++ + S L L+L N + L
Sbjct: 100 -----------GSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSH 147
Query: 193 LSSLIKLILNSNQLCGQLSLE-LGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSN 251
L+ L L + + ++ + LT LE L++ ++ L + PKSL ++ + +L L
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM 207
Query: 252 NQFIKKIPVEL-EKLIHLSELDLSHNFLGEEMPSQIC--------NMQSLEKLNLSHNNL 302
Q + + + L+L L S++ + + ++ +L
Sbjct: 208 KQ-HILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266
Query: 303 SGFIPSCFEELHGLSYIDISYNELHGSIPNST 334
+ ++ GL ++ S N+L S+P+
Sbjct: 267 FQ-VMKLLNQISGLLELEFSRNQLK-SVPDGI 296
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 51/266 (19%), Positives = 84/266 (31%), Gaps = 42/266 (15%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
NL L L +N + +I + L SL L+LS N L ++ S F
Sbjct: 74 RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL-SNLSSS-----------WF 120
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQLR--GPIPNLRNLTSLVRVRLNQNHLTGNISE- 116
L LT L L N + G +LT L +R+ I
Sbjct: 121 K------------PLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
Query: 117 SFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEII-HSSQLKVL 175
F L +++ + + L + + +S ++ L
Sbjct: 169 DFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECL 227
Query: 176 DLSSNHIVGEMPS--------KLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSS 227
+L + S L K + + + L + L L ++ L L+ S
Sbjct: 228 ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKL-LNQISGLLELEFSR 286
Query: 228 NRLSNSIPKS-LGNLVKLHYLNLSNN 252
N+L S+P L L + L N
Sbjct: 287 NQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 73/276 (26%), Positives = 113/276 (40%), Gaps = 42/276 (15%)
Query: 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
IGKG G V + G VAVK A+ Q FL E +T +RH N+V+
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCIK-----NDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 501 YGFCSHARHS-FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
G + +IV EY+ GSL L + LG + V +A+ Y+ + F
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNF 138
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN------WAELAGTYGYVAPELA 613
VHRD++++NVL+ +N A VSDFG K W APE
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEAL 186
Query: 614 YTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPS 670
K + K DV+SFG+L E+ G+ P I ++ ++ ++ P
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------PLKDVV--PRVEKGYKMDAP- 236
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ +M +C RP+ ++ + L+
Sbjct: 237 DGCPPAVYEVM---KNCWHLDAAMRPSFLQLREQLE 269
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 71/295 (24%), Positives = 120/295 (40%), Gaps = 50/295 (16%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAEL---PSGEI-VAVKKFHSPLPSEMASQQEFLNE 485
EI + E IG G G V L ++ VA+K + +++FL+E
Sbjct: 45 EIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLSE 100
Query: 486 VKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIK 545
+ H NI++ G + R + IV EY+E GSL L + + +++
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLR 158
Query: 546 GVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY 605
GV + Y+ + + VHRD++++NVL+D VSDFG ++ L+ D
Sbjct: 159 GVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP---------D 206
Query: 606 GYV------------APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSS 652
APE + DV+SFGV+ EV+ G+ P + +
Sbjct: 207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW-------NMT 259
Query: 653 NLEIALNEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
N ++ ++ RLP P L +M + C + RP ++ +L
Sbjct: 260 NRDVI--SSVEEGYRLPAP-MGCPHALHQLM---LDCWHKDRAQRPRFSQIVSVL 308
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-30
Identities = 57/325 (17%), Positives = 109/325 (33%), Gaps = 68/325 (20%)
Query: 435 TNDFDDEHCIGKGGQ--GSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFL-NEVKTLT 490
++ IGKG + +V A P+GE V V++ L + FL E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVSK 81
Query: 491 GIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN------VI 544
H NIV + ++V ++ GS ++ + MN ++
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-------HFMDGMNELAIAYIL 134
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL-------KPDSSN 597
+GV+ AL Y+H+ VHR + + ++L+ ++ + ++S + + +
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 598 WAELAGTYGYVAPELAYTMKV--TEKCDVYSFGVLALEVIKGK------HP--------- 640
+++PE+ K D+YS G+ A E+ G
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251
Query: 641 -----------------RDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLIS--IM 681
S ++S + P + + S
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311
Query: 682 EVAISCLDESPESRPTIQKVSQLLK 706
CL +P++RP+ S LL
Sbjct: 312 HFVEQCLQRNPDARPS---ASTLLN 333
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 6e-30
Identities = 68/288 (23%), Positives = 121/288 (42%), Gaps = 42/288 (14%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEI-VAVKKFHSPLPSEMASQQEFLNEVKT 488
E+ R D +H +G G G VY+ + VAVK L + +EFL E
Sbjct: 9 EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT----LKEDTMEVEEFLKEAAV 62
Query: 489 LTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVV 548
+ I+H N+V+ G C+ +I+ E++ G+L L + +++ + + +
Sbjct: 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQIS 121
Query: 549 DALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD----SSN------W 598
A+ Y+ F +HRD++++N L+ + V+DFG ++ + D + W
Sbjct: 122 SAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178
Query: 599 AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIA 657
APE K + K DV++FGVL E+ G P I ++
Sbjct: 179 T---------APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-------DLSQVY 222
Query: 658 LNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
D R+ P +K+ +M +C +P RP+ ++ Q
Sbjct: 223 ELLEKDYRMERP-EGCPEKVYELM---RACWQWNPSDRPSFAEIHQAF 266
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-30
Identities = 64/266 (24%), Positives = 103/266 (38%), Gaps = 14/266 (5%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+DF+ +G G G V+K PSG ++A K H L + A + + + E++ L
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 90
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
IV FYG I E+++ GSL +L A + V V+ L+Y+
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYL 147
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
I+HRD+ N+L++ E + DFG + L S GT Y++PE
Sbjct: 148 REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFVGTRSYMSPERLQ 203
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHP----RDFISSISSSSSNLEIALNEMLDPRLPTPS 670
+ + D++S G+ +E+ G++P + A PR P
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263
Query: 671 HNVQDKLISIMEVAISCLDESPESRP 696
N LD P
Sbjct: 264 LNKFGMDSRPPMAIFELLDYIVNEPP 289
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 8e-30
Identities = 70/275 (25%), Positives = 112/275 (40%), Gaps = 36/275 (13%)
Query: 444 IGKGGQGSVYKAEL--PSGEI-VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
+G G G+V K VAVK ++ A + E L E + + + IV+
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
G C +V E E+G L L + + + + ++ V + Y+ F
Sbjct: 84 IGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESNF- 138
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT------YGYVAPELAY 614
VHRD++++NVLL ++ A +SDFG +K L+ D + + Y APE
Sbjct: 139 --VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY---APECIN 193
Query: 615 TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPSH 671
K + K DV+SFGVL E G+ P + E+ ML+ R+ P
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-------KGSEVT--AMLEKGERMGCP-A 243
Query: 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
++ +M C E+RP V L+
Sbjct: 244 GCPREMYDLM---NLCWTYDVENRPGFAAVELRLR 275
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-30
Identities = 66/327 (20%), Positives = 127/327 (38%), Gaps = 43/327 (13%)
Query: 399 RRSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTN-DFDDEHCIGKGGQGSVYKAEL 457
+ +++ + ++P + + E I V + IG GG V++
Sbjct: 18 KETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN 77
Query: 458 PSGEIVAVK--KFHSPLPSEMASQQEFLNEVKTLTGIRH--RNIVKFYGFCSHARHSFIV 513
+I A+K + + NE+ L ++ I++ Y + ++ ++V
Sbjct: 78 EKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134
Query: 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVL 573
E L L K + +R + K +++A+ +H IVH D+ N L
Sbjct: 135 MECGN-IDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFL 187
Query: 574 LDLENEAHVSDFGTAKFLKPDSSNWAE--LAGTYGYVAPEL-----------AYTMKVTE 620
+ + + DFG A ++PD+++ + G Y+ PE K++
Sbjct: 188 IV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISP 246
Query: 621 KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP-TPSHNVQDKLIS 679
K DV+S G + + GK P F I + S L ++ + P P ++QD ++
Sbjct: 247 KSDVWSLGCILYYMTYGKTP--F-QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD-VLK 302
Query: 680 IMEVAISCLDESPESRPTIQKVSQLLK 706
CL P+ R +I +LL
Sbjct: 303 ------CCLKRDPKQRISIP---ELLA 320
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-30
Identities = 65/273 (23%), Positives = 112/273 (41%), Gaps = 30/273 (10%)
Query: 444 IGKGGQGSVYKAEL--PSGEI--VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
+G G G V + E PSG+ VAVK + S+ + +F+ EV + + HRN+++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 500 FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
YG +V E +GSL L V + + Y+ + F
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKRF 142
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT---YGYVAPELAYTM 616
+HRD++++N+LL + + DFG + L + ++ + + APE T
Sbjct: 143 ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 617 KVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP---RLPTPSHN 672
+ D + FGV E+ G+ P + + +I +D RLP P +
Sbjct: 200 TFSHASDTWMFGVTLWEMFTYGQEPWIGL-------NGSQIL--HKIDKEGERLPRP-ED 249
Query: 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
+ ++M + C PE RPT + L
Sbjct: 250 CPQDIYNVM---VQCWAHKPEDRPTFVALRDFL 279
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-29
Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 32/272 (11%)
Query: 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
E +G+G G V+ VA+K P M S + FL E + + +RH +V+
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTM-SPEAFLQEAQVMKKLRHEKLVQL 244
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMIL-SNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
Y S +IV EY+ GSL L K L + +++ + ++Y+ +
Sbjct: 245 YAVVSE-EPIYIVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT---YGYVAPELAYTM 616
VHRD+ + N+L+ V+DFG A+ ++ + + G + APE A
Sbjct: 302 ---VHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYG 356
Query: 617 KVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPSHNV 673
+ T K DV+SFG+L E+ KG+ P + N E+ + ++ R+P P
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVL--DQVERGYRMPCP-PEC 406
Query: 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
+ L +M C + PE RPT + + L
Sbjct: 407 PESLHDLM---CQCWRKEPEERPTFEYLQAFL 435
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 30/275 (10%)
Query: 441 EHCIGKGGQGSVYKAEL--PSGEI-VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
+ +G G GSV + +I VA+K +E + E + + + + I
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYI 72
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHND 557
V+ G C +V E G L L +++ + ++ V + Y+
Sbjct: 73 VRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT---YGYVAPELAY 614
F VHRD++++NVLL + A +SDFG +K L D S + + + APE
Sbjct: 130 NF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 186
Query: 615 TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPSH 671
K + + DV+S+GV E + G+ P + E+ ++ R+ P
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-------KGPEVM--AFIEQGKRMECP-P 236
Query: 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+L ++M C E RP V Q ++
Sbjct: 237 ECPPELYALM---SDCWIYKWEDRPDFLTVEQRMR 268
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 63/281 (22%), Positives = 118/281 (41%), Gaps = 40/281 (14%)
Query: 443 CIGKGGQGSVYKAELPSGEIVAVKKFH-SPLPSEMASQQEFLNEVKTLTGIRHRN--IVK 499
IG GG V++ +I A+K + ++ + + NE+ L ++ + I++
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQ--TLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 500 FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
Y + ++ ++V E L L K + +R + K +++A+ +H
Sbjct: 93 LYDYEITDQYIYMVMECGN-IDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG- 147
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE--LAGTYGYVAPEL----- 612
IVH D+ N L+ + + DFG A ++PD+++ + GT Y+ PE
Sbjct: 148 --IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 613 ------AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666
K++ K DV+S G + + GK P F I + S L ++ +
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-QQIINQISKLHAIIDPNHEIEF 261
Query: 667 P-TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
P P ++QD ++ CL P+ R +I +LL
Sbjct: 262 PDIPEKDLQD-VLK------CCLKRDPKQRISIP---ELLA 292
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 63/273 (23%), Positives = 93/273 (34%), Gaps = 23/273 (8%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHS---LGNLTQITFLT 57
S L + ++I + SL L + ++ I + ++ + LT
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 58 LFDNALSGAIPKEYGNLVKLTL--LTLENNQLRGPIPNLRNL-----TSLVRVRLNQNHL 110
L + ++G P L L L N L L L + + Q H
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 111 TGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRC----PKLGTLDFSSNNIT---GSMP 163
E + P L+ +DLS N GE C P L L + + G
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
Query: 164 AEIIHSSQLKVLDLSSNHIVG-EMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLER 222
A QL+ LDLS N + S L L L+ L + G +L
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL---KQVPKGLPAKLSV 278
Query: 223 LDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFI 255
LDLS NRL P L ++ L+L N F+
Sbjct: 279 LDLSYNRLD-RNPSPDE-LPQVGNLSLKGNPFL 309
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 57/275 (20%), Positives = 95/275 (34%), Gaps = 23/275 (8%)
Query: 48 GNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIP----NLRNLTSLVRV 103
G + L D + + L LT+ ++ I + ++ L +
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 104 RLNQNHLTGNISESFGI--HPNLAFIDLSHNYFYGEISSDWGRCPKLGT----LDFSSNN 157
L +TG P+L ++L + + + L L + +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 158 ITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSK----LGKLSSLIKLILNSNQLC---GQL 210
++ L LDLS N +GE K +L L L + + G
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 211 SLELGSLTQLERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSNNQFIKKIPVELEKLIHLS 269
S + QL+ LDLS N L ++ +L+ LNLS +K++P L LS
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG-LKQVPKGLPA--KLS 277
Query: 270 ELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSG 304
LDLS+N L + + L+L N
Sbjct: 278 VLDLSYNRLDR--NPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 7e-22
Identities = 58/283 (20%), Positives = 85/283 (30%), Gaps = 38/283 (13%)
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
N L A + YG L L + + SL L + + S +
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSL---SLKRLTVRAARIPSRIL 85
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEII--HSSQLKVLDLS 178
L + +S L L + +TG+ P ++ L +L+L
Sbjct: 86 FGALRVLGISG----------------LQELTLENLEVTGTAPPPLLEATGPDLNILNLR 129
Query: 179 SNHIVGEMPSKLGKLS-----SLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNS 233
+ + L +L L L + ++ L LDLS N
Sbjct: 130 NVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 234 IPKS----LGNLVKLHYLNLSNNQF---IKKIPVELEKLIHLSELDLSHNFLGEEMPSQI 286
L L L N + L LDLSHN L + +
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 287 C-NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHG 328
C L LNLS L +P LS +D+SYN L
Sbjct: 249 CDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLDR 288
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 8e-18
Identities = 40/188 (21%), Positives = 72/188 (38%), Gaps = 16/188 (8%)
Query: 163 PAEIIHSSQLKVLDLSSNHIVGEMPSKLGKL---SSLIKLILNSNQLCGQLSLELGSLT- 218
+II S LK L + + I + ++ S L +L L + ++ G L T
Sbjct: 61 FTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATG 120
Query: 219 -QLERLDLSSNRLSN--SIPKSLGNLVK--LHYLNLSNNQFIKKIPVELEKLIHLSELDL 273
L L+L + + + L +K L L+++ + ++ LS LDL
Sbjct: 121 PDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDL 180
Query: 274 SHNFL--GEEMPSQIC--NMQSLEKLNLSHNN---LSGFIPSCFEELHGLSYIDISYNEL 326
S N + S +C +L+ L L + SG + L +D+S+N L
Sbjct: 181 SDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSL 240
Query: 327 HGSIPNST 334
+ +
Sbjct: 241 RDAAGAPS 248
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 34/169 (20%), Positives = 54/169 (31%), Gaps = 14/169 (8%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHS----LGNLTQITFLT 57
L L + ++ +LS L+LS N G + L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 58 LFDN---ALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLR--NLTSLVRVRLNQNHLTG 112
L + SG V+L L L +N LR + L + L+ L
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK- 266
Query: 113 NISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGS 161
G+ L+ +DLS+N + + P++G L N S
Sbjct: 267 --QVPKGLPAKLSVLDLSYNRL--DRNPSPDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 31/166 (18%), Positives = 55/166 (33%), Gaps = 10/166 (6%)
Query: 190 LGKLSSLIKLILNSNQLCGQL-SLELGSLTQLERLDLSSNRLSNSIPKS---LGNLVKLH 245
G SL L+ + ++ L+RL + + R+ + I + + L
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98
Query: 246 YLNLSNNQFIKKIPVELEKLIH--LSELDLSHNFLGEEMPS----QICNMQSLEKLNLSH 299
L L N + P L + L+ L+L + Q L+ L+++
Sbjct: 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158
Query: 300 NNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQ 345
+ F LS +D+S N G +A LQ
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 29/116 (25%), Positives = 42/116 (36%), Gaps = 8/116 (6%)
Query: 1 NLSNLAFLYLYNN---SFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFL 56
L L L N + SG + L L+LS N L + +Q+ L
Sbjct: 199 KFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSL 258
Query: 57 TLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTG 112
L L +PK G KL++L L N+L P+ L + + L N
Sbjct: 259 NLSFTGLK-QVPK--GLPAKLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNPFLD 310
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 65/263 (24%), Positives = 112/263 (42%), Gaps = 26/263 (9%)
Query: 444 IGKGGQGSVYKAE---LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
+G GG V+ A VAVK + L + + F E + + H IV
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 501 Y--GF--CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
Y G +IV EY++ +L I+ + + + + VI AL++ H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ 134
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE---LAGTYGYVAPELA 613
+ I+HRD+ N+++ N V DFG A+ + ++ + + GT Y++PE A
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 614 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673
V + DVYS G + EV+ G+ P F + S + +A + + PS
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP--F-----TGDSPVSVAYQHVRED-PIPPSARH 243
Query: 674 QDKLISIMEVAISCLDESPESRP 696
+ + V + L ++PE+R
Sbjct: 244 EGLSADLDAVVLKALAKNPENRY 266
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 1e-29
Identities = 29/294 (9%), Positives = 68/294 (23%), Gaps = 49/294 (16%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+ G + V+ ++ E A+K F + + + + + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 503 FCSHAR--------------------------HSFIVYEYLEMGSLAMILS----NDAAA 532
+ ++ L ++ S
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188
Query: 533 KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592
D G + ++ + + + +VH + N+ + + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL---W 242
Query: 593 PDSSNWAELAGTYGYVAPEL--AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS 650
+ + Y E A T T + + G+ V P ++
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 651 SSNLEIALNEMLDPRLPTPSHNVQD---KLISIMEVAISCLDESPESRPTIQKV 701
S D + D LI L+ R +
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIG------RFLNFDRRRRLLPLEA 350
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 77/273 (28%), Positives = 132/273 (48%), Gaps = 27/273 (9%)
Query: 438 FDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
F D IG G G+VY A ++ + E+VA+KK Q+ + EV+ L +RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
+++ G +++V EY GS + +L + K L + V G + L+Y+H+
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTM 616
++HRD+ + N+LL + DFG+A + P +S GT ++APE+ M
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAM 225
Query: 617 KVTE---KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673
+ K DV+S G+ +E+ + K P ++++ S+ IA NE P L + +
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPPL---FNMNAMSALYHIAQNE--SPALQSG--HW 278
Query: 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ + ++ CL + P+ RPT LLK
Sbjct: 279 SEYFRNFVDS---CLQKIPQDRPT---SEVLLK 305
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-29
Identities = 61/244 (25%), Positives = 99/244 (40%), Gaps = 41/244 (16%)
Query: 411 GNAPGFLSVLSFEGKIV---YEEIIRVTNDFDDEHCIGKGGQGSVYKAE---LPSGEIVA 464
G+ FL L+ G IV YE + CI GG G +Y A + +G V
Sbjct: 63 GSPYSFLPQLN-PGDIVAGQYE-VKG---------CIAHGGLGWIYLALDRNV-NGRPVV 110
Query: 465 VKKFHSPLPSEMASQQE-FLNEVKTLTGIRHRNIVKFYGFCSHARHS-----FIVYEYLE 518
+K S A Q + E + L + H +IV+ + F H +IV EY+
Sbjct: 111 LKGLV---HSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVG 167
Query: 519 MGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN 578
SL + L + + + ++ ALSY+H+ +V+ D+ +N++L E
Sbjct: 168 GQSLKRSK-----GQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLT-EE 218
Query: 579 EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 638
+ + D G + L GT G+ APE+ T T D+Y+ G +
Sbjct: 219 QLKLIDLGAVSRINSFGY----LYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDL 273
Query: 639 HPRD 642
R+
Sbjct: 274 PTRN 277
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-29
Identities = 69/271 (25%), Positives = 122/271 (45%), Gaps = 30/271 (11%)
Query: 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
E +G G G V+ A VAVK P M S + FL E + ++H +VK
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMK---PGSM-SVEAFLAEANVMKTLQHDKLVKL 248
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
+ + +I+ E++ GSL L +D K ++ + + ++++ +
Sbjct: 249 HAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRNY- 305
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV---APELAYTMK 617
+HRD+ + N+L+ ++DFG A+ ++ + + G + APE
Sbjct: 306 --IHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGS 361
Query: 618 VTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPSHNVQ 674
T K DV+SFG+L +E++ G+ P + SN E+ L+ R+P P N
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGM-------SNPEVI--RALERGYRMPRP-ENCP 411
Query: 675 DKLISIMEVAISCLDESPESRPTIQKVSQLL 705
++L +IM + C PE RPT + + +L
Sbjct: 412 EELYNIM---MRCWKNRPEERPTFEYIQSVL 439
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 71/296 (23%), Positives = 118/296 (39%), Gaps = 56/296 (18%)
Query: 435 TNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTL-TGI 492
F+ +G G G VYK + +G++ A+K + ++E E+ L
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV----MDVTGDEEEEIKQEINMLKKYS 78
Query: 493 RHRNIVKFYG------FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN---- 542
HRNI +YG ++V E+ GS+ ++ N +
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWI 131
Query: 543 --VIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE 600
+ + ++ LS++H ++HRDI +NVLL E + DFG + L
Sbjct: 132 AYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 601 LAGTYGYVAPELAYTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE 655
GT ++APE+ + + K D++S G+ A+E+ +G P ++
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL----------CDMH 238
Query: 656 I--ALNEMLDPRLPTP---SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
AL L PR P P S K S +E CL ++ RP QL+K
Sbjct: 239 PMRAL--FLIPRNPAPRLKSKKWSKKFQSFIES---CLVKNHSQRPA---TEQLMK 286
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 47/238 (19%), Positives = 98/238 (41%), Gaps = 22/238 (9%)
Query: 91 IPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISS--DWGRCPKL 148
I L + +++ ++++T + + + + +++ L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGT----GVTTIEGVQYLNNL 65
Query: 149 GTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCG 208
L+ N IT A + + +++ L+LS N + + S + L S+ L L S Q+
Sbjct: 66 IGLELKDNQIT--DLAPLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD 121
Query: 209 QLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHL 268
L L+ L+ L L N+++N P L L L YL++ N Q + + L L L
Sbjct: 122 VTPLA--GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQ-VSDLT-PLANLSKL 175
Query: 269 SELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326
+ L N + S + ++ +L +++L +N +S P L + ++ +
Sbjct: 176 TTLKADDNKI--SDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 57/249 (22%), Positives = 102/249 (40%), Gaps = 21/249 (8%)
Query: 73 NLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHN 132
L + + + +L + + +T I E NL ++L N
Sbjct: 17 ALANAIKIAAGKSNVTD-TVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDN 73
Query: 133 YFYGEIS--SDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKL 190
+I+ + K+ L+ S N + + I +K LDL+S I + L
Sbjct: 74 ----QITDLAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQI--TDVTPL 125
Query: 191 GKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLS 250
LS+L L L+ NQ+ +S L LT L+ L + + ++S+ P L NL KL L
Sbjct: 126 AGLSNLQVLYLDLNQI-TNIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKAD 181
Query: 251 NNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCF 310
+N+ I I L L +L E+ L +N + + P + N +L + L++ ++
Sbjct: 182 DNK-ISDIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYN 237
Query: 311 EELHGLSYI 319
L + +
Sbjct: 238 NNLVVPNVV 246
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 57/281 (20%), Positives = 106/281 (37%), Gaps = 25/281 (8%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L+N + ++ + L ++ L G + +I + L + L L D
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKD 72
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
N ++ P NL K+T L L N L+ + + L S+ + L +T
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITD--VTPLAG 127
Query: 121 HPNLAFIDLSHNYFYGEIS--SDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
NL + L N +I+ S L L + ++ P + + S+L L
Sbjct: 128 LSNLQVLYLDLN----QITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKAD 181
Query: 179 SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLE-LGSLTQLERLDLSSNRLSNSIPKS 237
N I S L L +LI++ L +NQ+ + L + + L + L++ ++N
Sbjct: 182 DNKI--SDISPLASLPNLIEVHLKNNQI---SDVSPLANTSNLFIVTLTNQTITNQPVFY 236
Query: 238 LGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFL 278
NLV + + + I P + + +L+ N
Sbjct: 237 NNNLVVPNVVKGPSGAPIA--PATISDNGTYASPNLTWNLT 275
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-29
Identities = 72/271 (26%), Positives = 121/271 (44%), Gaps = 30/271 (11%)
Query: 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
E +G+G G V+ VA+K P M S + FL E + + +RH +V+
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTM-SPEAFLQEAQVMKKLRHEKLVQL 327
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
Y S +IV EY+ GSL L + K L + +++ + ++Y+ +
Sbjct: 328 YAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY- 384
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT---YGYVAPELAYTMK 617
VHRD+ + N+L+ V+DFG A+ ++ + + G + APE A +
Sbjct: 385 --VHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGR 440
Query: 618 VTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPSHNVQ 674
T K DV+SFG+L E+ KG+ P + N E+ + ++ R+P P
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVL--DQVERGYRMPCP-PECP 490
Query: 675 DKLISIMEVAISCLDESPESRPTIQKVSQLL 705
+ L +M C + PE RPT + + L
Sbjct: 491 ESLHDLM---CQCWRKEPEERPTFEYLQAFL 518
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 39/276 (14%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
DF+ +GKG G+VY A E S I+A+K + + + EV+ + +RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSL------AMILSNDAAAKDLGWTKRMNVIKGVV 548
NI++ YG+ A +++ EY +G++ A I +
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT---------YITELA 119
Query: 549 DALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV 608
+ALSY H+ ++HRDI +N+LL E ++DFG + SS +L GT Y+
Sbjct: 120 NALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTDLCGTLDYL 174
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668
PE+ EK D++S GVL E + GK P + ++ + +
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE--------ANTYQETYKRISRVEFTF 226
Query: 669 PSH---NVQDKLISIMEVAISCLDESPESRPTIQKV 701
P +D LIS + L +P RP +++V
Sbjct: 227 PDFVTEGARD-LISRL------LKHNPSQRPMLREV 255
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 63/278 (22%), Positives = 110/278 (39%), Gaps = 39/278 (14%)
Query: 437 DFDDEHCIGKGGQGSVYKA-ELPSGEIVAVK-KFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+ +GKGG ++ + + E+ A K S L ++ E+ + H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAH 74
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLA-MI-----LSNDAAAKDLGWTKRMNVIKGVV 548
+++V F+GF F+V E SL + L+ A ++ +V
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY---------YLRQIV 125
Query: 549 DALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV 608
Y+H + ++HRD+ N+ L+ + E + DFG A ++ D L GT Y+
Sbjct: 126 LGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYI 182
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668
APE+ + + DV+S G + ++ GK P + +S L+ +
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE--------TSCLKETYLRIKKNEYSI 234
Query: 669 PSH---NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
P H LI M L P +RPTI ++
Sbjct: 235 PKHINPVAAS-LIQKM------LQTDPTARPTINELLN 265
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 66/270 (24%), Positives = 114/270 (42%), Gaps = 44/270 (16%)
Query: 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
+G G G V+ VAVK L S FL E + ++H+ +V+
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKS----LKQGSMSPDAFLAEANLMKQLQHQRLVRL 73
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
Y + +I+ EY+E GSL L + K L K +++ + + ++++ +
Sbjct: 74 YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY- 130
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD----SSN------WAELAGTYGYVAP 610
+HRD+ + N+L+ ++DFG A+ ++ + W AP
Sbjct: 131 --IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT---------AP 179
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLP 667
E T K DV+SFG+L E++ G+ P + +N E+ + L+ R+
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-------TNPEVI--QNLERGYRMV 230
Query: 668 TPSHNVQDKLISIMEVAISCLDESPESRPT 697
P N ++L +M C E PE RPT
Sbjct: 231 RP-DNCPEELYQLM---RLCWKERPEDRPT 256
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-29
Identities = 74/276 (26%), Positives = 113/276 (40%), Gaps = 42/276 (15%)
Query: 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
IGKG G V + G VAVK A+ Q FL E +T +RH N+V+
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIK-----NDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 501 YGFCSHARHSF-IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF 559
G + IV EY+ GSL L + LG + V +A+ Y+ + F
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNF 310
Query: 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN------WAELAGTYGYVAPELA 613
VHRD++++NVL+ +N A VSDFG K W APE
Sbjct: 311 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEAL 358
Query: 614 YTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPS 670
K + K DV+SFG+L E+ G+ P I ++ ++ ++ P
Sbjct: 359 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------PLKDVV--PRVEKGYKMDAP- 408
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ +M +C +RPT ++ + L+
Sbjct: 409 DGCPPAVYDVM---KNCWHLDAATRPTFLQLREQLE 441
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 63/288 (21%), Positives = 113/288 (39%), Gaps = 39/288 (13%)
Query: 441 EHCIGKGGQGSVYKAELP-----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+G+G G V +GE VAVK + E++ L + H
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN--HIADLKKEIEILRNLYHE 83
Query: 496 NIVKFYGFCSHARHS--FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
NIVK+ G C+ + ++ E+L GSL L + + +++ + + Y
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDY 141
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT------YGY 607
+ + + VHRD++++NVL++ E++ + DFG K ++ D + Y
Sbjct: 142 LGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-- 196
Query: 608 VAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSS-------SNLEIALN 659
APE K DV+SFGV E++ ++ + +
Sbjct: 197 -APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV-- 253
Query: 660 EMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
L RLP P N D++ +M C + P +R + Q + +
Sbjct: 254 NTLKEGKRLPCP-PNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGF 297
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 6e-29
Identities = 54/260 (20%), Positives = 97/260 (37%), Gaps = 23/260 (8%)
Query: 77 LTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYG 136
+ + ++ I ++ L + +T ++++ ++ I +++
Sbjct: 1 MGETITVSTPIKQ-IFPDDAFAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNS---- 53
Query: 137 EISS--DWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLS 194
+I S P + L + N +T P + + L L L N I + S L L
Sbjct: 54 DIKSVQGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKI--KDLSSLKDLK 109
Query: 195 SLIKLILNSNQLCGQLSLE-LGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQ 253
L L L N + + L L QLE L L +N++++ L L KL L+L +NQ
Sbjct: 110 KLKSLSLEHNGIS---DINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ 164
Query: 254 FIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEEL 313
I I L L L L LS N + + +++L+ L L + L
Sbjct: 165 -ISDIV-PLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNL 220
Query: 314 HGLSYIDISYNELHGSIPNS 333
+ + + L S
Sbjct: 221 VVPNTVKNTDGSLVTPEIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-29
Identities = 59/279 (21%), Positives = 111/279 (39%), Gaps = 23/279 (8%)
Query: 47 LGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLN 106
+ L +++ A+ + L + + N+ ++ + ++ L ++ ++ LN
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLN 73
Query: 107 QNHLTGNISESFGIHPNLAFIDLSHNYFYGEIS--SDWGRCPKLGTLDFSSNNITGSMPA 164
N LT +I NL ++ L N +I S KL +L N I+ +
Sbjct: 74 GNKLT-DIK-PLTNLKNLGWLFLDEN----KIKDLSSLKDLKKLKSLSLEHNGIS-DING 126
Query: 165 EIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLE-LGSLTQLERL 223
++H QL+ L L +N I + L +L+ L L L NQ+ + L LT+L+ L
Sbjct: 127 -LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS---DIVPLAGLTKLQNL 180
Query: 224 DLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMP 283
LS N +S+ ++L L L L L + + + K L+ + + + L P
Sbjct: 181 YLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTP 236
Query: 284 SQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDIS 322
I + EK N+ + F ++
Sbjct: 237 EIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAK 275
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 96.7 bits (240), Expect = 4e-21
Identities = 53/254 (20%), Positives = 94/254 (37%), Gaps = 19/254 (7%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L+++ + N+ S+ I L +++ L L+GNKL I L NL + +L L +
Sbjct: 41 ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKL-TDIK-PLTNLKNLGWLFLDE 96
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
N + + +L KL L+LE+N + I L +L L + L N +T +I+
Sbjct: 97 NKIKDLSSLK--DLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKIT-DIT-VLSR 151
Query: 121 HPNLAFIDLSHNYFYGEIS--SDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
L + L N +IS KL L S N+I+ + L VL+L
Sbjct: 152 LTKLDTLSLEDN----QISDIVPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELF 205
Query: 179 SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSL 238
S + + + L + L + E+ ++ + + S
Sbjct: 206 SQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS--DDGDYEKPNVKWHLPEFTNEVSF 263
Query: 239 GNLVKLHYLNLSNN 252
+
Sbjct: 264 IFYQPVTIGKAKAR 277
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 79.8 bits (196), Expect = 1e-15
Identities = 45/231 (19%), Positives = 79/231 (34%), Gaps = 15/231 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L N+ L+L N + I + LK+L L L NK+ + SL +L ++ L+L
Sbjct: 63 YLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEH 118
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
N +S +L +L L L NN++ I L LT L + L N ++ +I
Sbjct: 119 NGISDINGLV--HLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQIS-DIV-PLAG 173
Query: 121 HPNLAFIDLSHNYFYGEISSDWG--RCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
L + LS N IS L L+ S + + +
Sbjct: 174 LTKLQNLYLSKN----HISDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNT 229
Query: 179 SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNR 229
+V + + + ++S + + +
Sbjct: 230 DGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHG 280
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 7e-29
Identities = 62/267 (23%), Positives = 108/267 (40%), Gaps = 37/267 (13%)
Query: 444 IGKGGQGSVYKAEL----PSGEI-VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIV 498
+G G G+VYK +I VA+K+ + + +E L+E + + + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVC 80
Query: 499 KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC 558
+ G C ++ + + G L + ++G +N + ++Y+ +
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV-----APELA 613
VHRD++++NVL+ ++DFG AK L + E G V A E
Sbjct: 138 L---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKWMALESI 191
Query: 614 YTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPS 670
T + DV+S+GV E++ G P D I EI+ +L+ RLP P
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-------PASEIS--SILEKGERLPQP- 241
Query: 671 HNVQDKLISIMEVAISCLDESPESRPT 697
+ IM C +SRP
Sbjct: 242 PICTIDVYMIM---RKCWMIDADSRPK 265
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 41/286 (14%)
Query: 444 IGKGGQGSVYKAELP-----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIV 498
+GKG GSV +GE+VAVKK S ++F E++ L ++H NIV
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 499 KFYGFCSHARHS--FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
K+ G C A ++ EYL GSL L + + K + + + Y+
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT 132
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT------YGYVAP 610
+ +HRD++++N+L++ EN + DFG K L D + Y AP
Sbjct: 133 KRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY---AP 186
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS---------SNLEIALNEM 661
E K + DV+SFGV+ E+ + + E+
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI--EL 244
Query: 662 LDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
L RLP P D++ IM C + + RP+ + ++ +
Sbjct: 245 LKNNGRLPRP-DGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRV 286
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 33/288 (11%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAEL--PSGEI---VAVKKFHSPLPSEMASQQEFLN 484
EI + + IG G G VYK L SG+ VA+K + + + +FL
Sbjct: 40 EIHP--SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLG 95
Query: 485 EVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVI 544
E + H NI++ G S + I+ EY+E G+L L + + + ++
Sbjct: 96 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK--DGEFSVLQLVGML 153
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT 604
+G+ + Y+ N + VHRD++++N+L++ VSDFG ++ L+ D +G
Sbjct: 154 RGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210
Query: 605 YGYV---APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNE 660
+ APE K T DV+SFG++ EV+ G+ P SN E+ +
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-------ELSNHEVM--K 261
Query: 661 MLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
++ RLPTP + + +M + C + RP + +L
Sbjct: 262 AINDGFRLPTP-MDCPSAIYQLM---MQCWQQERARRPKFADIVSILD 305
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 69/285 (24%), Positives = 113/285 (39%), Gaps = 34/285 (11%)
Query: 441 EHCIGKGGQGSVYKAELP-----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+GKG GSV +G +VAVK+ S Q++F E++ L +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ---HSGPDQQRDFQREIQILKALHSD 84
Query: 496 NIVKFYGFCSHARHS--FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
IVK+ G +V EYL G L L A L ++ + + + Y
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEY 142
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV----- 608
+ + VHRD++++N+L++ E ++DFG AK L D + G
Sbjct: 143 LGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV--VREPGQSPIFWY 197
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLE--IALNEMLDP- 664
APE + + DV+SFGV+ E+ + AL+ +L+
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 665 ----RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
RLP P ++ +M+ C SP+ RP+ + L
Sbjct: 258 EEGQRLPAP-PACPAEVHELMK---LCWAPSPQDRPSFSALGPQL 298
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 63/271 (23%), Positives = 109/271 (40%), Gaps = 39/271 (14%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVK-KFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFY 501
+GKGG ++ + + E+ A K S L ++ E+ + H+++V F+
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 502 GFCSHARHSFIVYEYLEMGSLA-MI-----LSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
GF F+V E SL + L+ A ++ +V Y+H
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY---------YLRQIVLGCQYLH 158
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT 615
+ ++HRD+ N+ L+ + E + DFG A ++ D L GT Y+APE+
Sbjct: 159 RNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK 215
Query: 616 MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH---N 672
+ + DV+S G + ++ GK P + +S L+ + P H
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFE--------TSCLKETYLRIKKNEYSIPKHINPV 267
Query: 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
LI M L P +RPTI ++
Sbjct: 268 AAS-LIQKM------LQTDPTARPTINELLN 291
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 69/287 (24%), Positives = 118/287 (41%), Gaps = 37/287 (12%)
Query: 441 EHCIGKGGQGSVYKAELP-----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+GKG GSV +GE+VAVKK S ++F E++ L ++H
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ---HSTEEHLRDFEREIEILKSLQHD 102
Query: 496 NIVKFYGFCSHARHS--FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
NIVK+ G C A ++ EYL GSL L + + K + + + Y
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEY 160
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT------YGY 607
+ + +HRD++++N+L++ EN + DFG K L D + Y
Sbjct: 161 LGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY-- 215
Query: 608 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE----IALNEMLD 663
APE K + DV+SFGV+ E+ + + + + +++
Sbjct: 216 -APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274
Query: 664 P-----RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
RLP P D++ IM C + + RP+ + ++ +
Sbjct: 275 LLKNNGRLPRP-DGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRV 317
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 39/285 (13%)
Query: 444 IGKGGQGSVYKAEL-----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIV 498
+G+G G V +GE+VAVK + + + + E+ L + H +I+
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--HRSGWKQEIDILRTLYHEHII 96
Query: 499 KFYGFCSHARHS--FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
K+ G C A + +V EY+ +GSL L +G + + + + + ++Y+H
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHA 152
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV-----APE 611
+ +HRD++++NVLLD + + DFG AK + G APE
Sbjct: 153 QHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE--YYRVREDGDSPVFWYAPE 207
Query: 612 LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSS-------SNLEIALNEMLD 663
K DV+SFGV E++ + + + L L E+L+
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR--LTELLE 265
Query: 664 P--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
RLP P ++ +M+ +C + RPT + + +LK
Sbjct: 266 RGERLPRP-DKCPAEVYHLMK---NCWETEASFRPTFENLIPILK 306
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 54/305 (17%), Positives = 112/305 (36%), Gaps = 59/305 (19%)
Query: 427 VYEEIIRVTNDFDDEHCIGKGGQGSVYKAEL-------PSGEI-VAVKKFHSPLPSEMAS 478
V+ +I D +G+G ++K E V +K +
Sbjct: 1 VFHKIRN--EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD---KAHRNY 55
Query: 479 QQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWT 538
+ F ++ + H+++V YG C + +V E+++ GSL L + ++ W
Sbjct: 56 SESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK 115
Query: 539 KRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH--------VSDFGTAKF 590
+ K + A+ ++ + +H ++ +KN+LL E + +SD G +
Sbjct: 116 LEV--AKQLAAAMHFLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
Query: 591 LKPDSSNWAELAGTYGYV-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDF 643
+ P PE + + D +SFG E+ G P
Sbjct: 171 VLPKD---------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--- 218
Query: 644 ISSISSSSSNLEIALNEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
S+ + + + +LP P +L +++ +C+D P+ RP+ + +
Sbjct: 219 ----LSALDSQRKL--QFYEDRHQLPAPKA---AELANLI---NNCMDYEPDHRPSFRAI 266
Query: 702 SQLLK 706
+ L
Sbjct: 267 IRDLN 271
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-28
Identities = 62/272 (22%), Positives = 108/272 (39%), Gaps = 30/272 (11%)
Query: 444 IGKGGQGSVYKAEL--PSGEI-VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
+G G GSV + +I VA+K +E + E + + + + IV+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRL 401
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
G C +V E G L L +++ + ++ V + Y+ F
Sbjct: 402 IGVCQAEAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNF- 457
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT---YGYVAPELAYTMK 617
VHR+++++NVLL + A +SDFG +K L D S + + + APE K
Sbjct: 458 --VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 618 VTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPSHNVQ 674
+ + DV+S+GV E + G+ P E+ ++ R+ P
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYK-------KMKGPEVM--AFIEQGKRMECP-PECP 565
Query: 675 DKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+L ++M C E RP V Q ++
Sbjct: 566 PELYALM---SDCWIYKWEDRPDFLTVEQRMR 594
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 65/280 (23%), Positives = 117/280 (41%), Gaps = 40/280 (14%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKK-FHSPLPSEMASQQEFLNEVKTLTGIR 493
DF + +GKG VY+A + +G VA+K + Q+ NEVK ++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLK 69
Query: 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSL-------AMILSNDAAAKDLGWTKRMNVIKG 546
H +I++ Y + + + ++V E G + S + A +
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH---------FMHQ 120
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG 606
++ + Y+H+ I+HRD++ N+LL ++DFG A LK L GT
Sbjct: 121 IITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 607 YVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666
Y++PE+A + DV+S G + ++ G+ P D + ++ LN+++
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD--------TDTVKNTLNKVVLADY 229
Query: 667 PTPSH---NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
PS +D LI + L +P R ++ V
Sbjct: 230 EMPSFLSIEAKD-LIHQL------LRRNPADRLSLSSVLD 262
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 67/275 (24%), Positives = 121/275 (44%), Gaps = 30/275 (10%)
Query: 441 EHCIGKGGQGSVYKAEL---PSGEI-VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
+ +G G G V L EI VA+K + +++FL E + H N
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFLGEASIMGQFDHPN 107
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
I++ G + ++ IV EY+E GSL L + + +++G+ + Y+ +
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSD 165
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV---APELA 613
+ VHRD++++N+L++ VSDFG + L+ D G + +PE
Sbjct: 166 MGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 614 YTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPS 670
K T DV+S+G++ EV+ G+ P SN ++ + +D RLP P
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYW-------EMSNQDVI--KAVDEGYRLPPP- 272
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
+ L +M + C + +RP +++ +L
Sbjct: 273 MDCPAALYQLM---LDCWQKDRNNRPKFEQIVSIL 304
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 48/203 (23%), Positives = 78/203 (38%), Gaps = 9/203 (4%)
Query: 146 PKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQ 205
+ N I+ A L +L L SN + + L+ L +L L+ N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 206 LCGQLSLE-LGSLTQLERLDLSSNRLSNSIPK-SLGNLVKLHYLNLSNNQFIKKIPVE-L 262
+ L +L L L L + L L YL L +N ++ +P +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA-LQALPDDTF 149
Query: 263 EKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDIS 322
L +L+ L L N + + SL++L L N ++ P F +L L + +
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209
Query: 323 YNELHGSIPNSTAFRDAPMEALQ 345
N L ++P A AP+ ALQ
Sbjct: 210 ANNLS-ALPTE-AL--APLRALQ 228
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-27
Identities = 54/214 (25%), Positives = 75/214 (35%), Gaps = 9/214 (4%)
Query: 119 GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
GI I L N ++ + C L L SN + A + L+ LDLS
Sbjct: 29 GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88
Query: 179 SNHIVGEMPSK-LGKLSSLIKLILNSNQLCGQLSLELGS---LTQLERLDLSSNRLSNSI 234
N + + L L L L+ L L G L L+ L L N L
Sbjct: 89 DNAQLRSVDPATFHGLGRLHTLHLDRCGL---QELGPGLFRGLAALQYLYLQDNALQALP 145
Query: 235 PKSLGNLVKLHYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHNFLGEEMPSQICNMQSLE 293
+ +L L +L L N+ I +P L L L L N + P ++ L
Sbjct: 146 DDTFRDLGNLTHLFLHGNR-ISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLM 204
Query: 294 KLNLSHNNLSGFIPSCFEELHGLSYIDISYNELH 327
L L NNLS L L Y+ ++ N
Sbjct: 205 TLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 50/229 (21%), Positives = 74/229 (32%), Gaps = 28/229 (12%)
Query: 77 LTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFY 135
+ L N++ R +L + L+ N L I AF L
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR-------IDAA-AFTGL------ 79
Query: 136 GEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLDLSSNHIVGEMPSKLGKLS 194
L LD S N S+ H +L L L + P L+
Sbjct: 80 ----------ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLA 129
Query: 195 SLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQF 254
+L L L N L L L L L NR+S+ ++ L L L L N+
Sbjct: 130 ALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNR- 188
Query: 255 IKKIPVE-LEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNL 302
+ + L L L L N L + +++L+ L L+ N
Sbjct: 189 VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 54/258 (20%), Positives = 89/258 (34%), Gaps = 58/258 (22%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA 62
+ ++L+ N S + ++L+ L L N L + L + L L DNA
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 63 LSGAIPKE-YGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFG 119
++ + L +L L L+ L+ + R L +L + L N L +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-AL----- 144
Query: 120 IHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS 179
P+ F DL L L L
Sbjct: 145 --PDDTFRDL----------------------------------------GNLTHLFLHG 162
Query: 180 NHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGS---LTQLERLDLSSNRLSNSIPK 236
N I L SL +L+L+ N++ + + L +L L L +N LS +
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRV---AHVHPHAFRDLGRLMTLYLFANNLSALPTE 219
Query: 237 SLGNLVKLHYLNLSNNQF 254
+L L L YL L++N +
Sbjct: 220 ALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 52/186 (27%), Positives = 80/186 (43%), Gaps = 34/186 (18%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPH-SLGNLTQITFLTL 58
L+ L L L +N+ S+ L L L L L + L + +L L
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYL 136
Query: 59 FDNALSGAIPKE-YGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNIS 115
DNAL A+P + + +L LT L L N++ +P R L SL R+ L+QN +
Sbjct: 137 QDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVA---- 190
Query: 116 ESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKV 174
+HP+ AF DL +L TL +NN++ ++P E + L+
Sbjct: 191 ---HVHPH-AFRDL----------------GRLMTLYLFANNLS-ALPTEALAPLRALQY 229
Query: 175 LDLSSN 180
L L+ N
Sbjct: 230 LRLNDN 235
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 71/287 (24%), Positives = 115/287 (40%), Gaps = 39/287 (13%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKT-LTGIR 493
D D IG+G GSV K PSG+I+AVK+ + Q++ L ++ +
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVMRSSD 79
Query: 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRM--NVIKGVVDAL 551
IV+FYG +I E + S + D + + + V AL
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 552 SYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE 611
+++ + I+HRDI N+LLD + DFG + L DS AG Y+APE
Sbjct: 139 NHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPE 195
Query: 612 ----LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD---P 664
A + DV+S G+ E+ G+ P +S+ L +++ P
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------QLTQVVKGDPP 248
Query: 665 RLPTP-----SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+L S + + ++ CL + RP + +LLK
Sbjct: 249 QLSNSEEREFSPSFIN-FVN------LCLTKDESKRPKYK---ELLK 285
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 62/284 (21%), Positives = 108/284 (38%), Gaps = 38/284 (13%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTL-TGIR 493
ND ++ +G G G V+K +G ++AVK+ + L ++ +
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR--RSGNKEENKRILMDLDVVLKSHD 82
Query: 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
IV+ +G FI E + + + + + +V AL Y
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK---RMQGPIPERILGKMTVAIVKALYY 139
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELA 613
+ ++HRD+ N+LLD + + DFG + L D AG Y+APE
Sbjct: 140 LKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPERI 196
Query: 614 YTMKVTE-----KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD---PR 665
T+ + DV+S G+ +E+ G+ P + ++ E L ++L P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFP------YKNCKTDFE-VLTKVLQEEPPL 249
Query: 666 LPTP---SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
LP S + Q + CL + RP +LL+
Sbjct: 250 LPGHMGFSGDFQS-FVK------DCLTKDHRKRPKYN---KLLE 283
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 64/257 (24%), Positives = 98/257 (38%), Gaps = 38/257 (14%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIP-HSLGNLTQITFLTLFDN 61
+N L L+ N + L+ L L+LS N + +I + L + L LFDN
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDN 122
Query: 62 ALSGAIPKE-YGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRL-NQNHLTGNISESF 118
L+ IP + L KL L L NN + P + SL R+ L L+
Sbjct: 123 RLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS------- 174
Query: 119 GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
I AF L L L+ + N+ +P + +L LDLS
Sbjct: 175 YISEG-AFEGL----------------SNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLS 215
Query: 179 SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGS---LTQLERLDLSSNRLSNSIP 235
NH+ P L L KL + +Q+ +E + L L ++L+ N L+
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQ---VIERNAFDNLQSLVEINLAHNNLTLLPH 272
Query: 236 KSLGNLVKLHYLNLSNN 252
L L ++L +N
Sbjct: 273 DLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-27
Identities = 70/280 (25%), Positives = 104/280 (37%), Gaps = 37/280 (13%)
Query: 28 SLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQL 87
S + L +P + T L L +N + + +L L +L L N +
Sbjct: 44 QFSKVICVRKNL-REVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 88 RGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCP 146
R L +L + L N LT I AF+ L
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLTT-------IPNG-AFVYL----------------S 136
Query: 147 KLGTLDFSSNNITGSMPAEIIHS-SQLKVLDLSS-NHIVGEMPSKLGKLSSLIKLILNSN 204
KL L +N I S+P+ + L+ LDL + LS+L L L
Sbjct: 137 KLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMC 195
Query: 205 QLCGQLSL-ELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE-L 262
L + L L +L+ LDLS N LS P S L+ L L + +Q I+ I
Sbjct: 196 NL---REIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQ-IQVIERNAF 251
Query: 263 EKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNL 302
+ L L E++L+HN L + LE+++L HN
Sbjct: 252 DNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-19
Identities = 50/210 (23%), Positives = 79/210 (37%), Gaps = 32/210 (15%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIP-HSLGNLTQITFLTL 58
L+NL L L++N + +IP+ L L +L L N + SIP ++ + + L L
Sbjct: 110 GLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDL 167
Query: 59 FD-NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISES 117
+ LS + L L L L LR IPNL L L + L+ NHL+
Sbjct: 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLS------ 220
Query: 118 FGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLD 176
I P +F L L L + I + + L ++
Sbjct: 221 -AIRPG-SFQGL----------------MHLQKLWMIQSQIQ-VIERNAFDNLQSLVEIN 261
Query: 177 LSSNHIVGEMPSKLGKLSSLIKLILNSNQL 206
L+ N++ L L ++ L+ N
Sbjct: 262 LAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-19
Identities = 46/192 (23%), Positives = 70/192 (36%), Gaps = 32/192 (16%)
Query: 144 RC-PKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILN 202
C + + N+ +P I S+ ++L+L N I I+
Sbjct: 40 SCSNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQ----------------IIK 80
Query: 203 SNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE- 261
N L LE L LS N + + L L+ L L +N+ + IP
Sbjct: 81 VNSFKH--------LRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR-LTTIPNGA 131
Query: 262 LEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNN-LSGFIPSCFEELHGLSYID 320
L L EL L +N + + SL +L+L LS FE L L Y++
Sbjct: 132 FVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191
Query: 321 ISYNELHGSIPN 332
++ L IPN
Sbjct: 192 LAMCNLR-EIPN 202
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 32/121 (26%), Positives = 46/121 (38%), Gaps = 7/121 (5%)
Query: 219 QLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHNF 277
Q ++ L +P + LNL NQ I+ I V + L HL L LS N
Sbjct: 44 QFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQ-IQIIKVNSFKHLRHLEILQLSRNH 99
Query: 278 LGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFR 337
+ + +L L L N L+ F L L + + N + SIP+ AF
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSY-AFN 157
Query: 338 D 338
Sbjct: 158 R 158
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 19/89 (21%), Positives = 32/89 (35%), Gaps = 2/89 (2%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
L L L L N S +I L L L + +++ ++ NL + + L
Sbjct: 205 PLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA 263
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQLR 88
N L+ + L L + L +N
Sbjct: 264 HNNLTLLPHDLFTPLHHLERIHLHHNPWN 292
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 51/212 (24%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G+G +V++ +G++ A+K F++ S + + E + L + H+NIVK +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNI--SFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 503 F--CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
+ RH ++ E+ GSL +L + A L ++ + V++ VV ++++ +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 561 PIVHRDISSKNVLLDLENEAH----VSDFGTAKFLKPDSSNWAELAGTYGYVAPEL---- 612
IVHR+I N++ + + ++DFG A+ L+ D + L GT Y+ P++
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERA 190
Query: 613 ----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
+ K D++S GV G P
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 3e-27
Identities = 63/299 (21%), Positives = 107/299 (35%), Gaps = 40/299 (13%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG 491
+ ++ + +G GG G V + +GE VA+K+ L + ++ + E++ +
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKK 68
Query: 492 IRHRNIVKFY------GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIK 545
+ H N+V + + EY E G L L+ L ++
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 546 GVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH---VSDFGTAKFLKPDSSNWAELA 602
+ AL Y+H + I+HRD+ +N++L + + D G AK L E
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFV 184
Query: 603 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-----------------RDFIS 645
GT Y+APEL K T D +SFG LA E I G P +
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244
Query: 646 SISSSSSNLEIALNEMLDP-RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
+ + + + P L ++ + M L R T +
Sbjct: 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM------LMWHQRQRGTDPQNPN 297
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 66/289 (22%), Positives = 120/289 (41%), Gaps = 47/289 (16%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVK-TLTGIR 493
+D + +G+G G V K +PSG+I+AVK+ Q+ L ++ ++ +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISMRTVD 64
Query: 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN------VIKGV 547
V FYG +I E ++ SL + + + + + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMD-TSLDKFY-----KQVIDKGQTIPEDILGKIAVSI 118
Query: 548 VDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGY 607
V AL ++H+ ++HRD+ NVL++ + + DFG + +L D AG Y
Sbjct: 119 VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPY 175
Query: 608 VAPE--------LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN 659
+APE Y++ K D++S G+ +E+ + P S + L+ +
Sbjct: 176 MAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFP---YDSWGTPFQQLKQVVE 228
Query: 660 EMLDPRLPTP--SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
E P+LP S D S CL ++ + RPT +L++
Sbjct: 229 E-PSPQLPADKFSAEFVD-FTS------QCLKKNSKERPT---YPELMQ 266
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-27
Identities = 57/278 (20%), Positives = 116/278 (41%), Gaps = 25/278 (8%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G+G +V++ +G++ A+K F++ Q E + L + H+NIVK +
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM--REFEVLKKLNHKNIVKLFA 74
Query: 503 F--CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
+ RH ++ E+ GSL +L + A L ++ + V++ VV ++++ +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 561 PIVHRDISSKNVLLDLENEAH----VSDFGTAKFLKPDSSNWAELAGTYGYVAPEL---- 612
IVHR+I N++ + + ++DFG A+ L+ D + L GT Y+ P++
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERA 190
Query: 613 ----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668
+ K D++S GV G P F + + +++ +
Sbjct: 191 VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRP--FEGPRRNKEVMYKIITGKPSG 246
Query: 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
VQ ++ + SR ++ +L
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 7e-27
Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 44/285 (15%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG 491
++ + + +GKG G V + +G+ AVK + ++ L EV+ L
Sbjct: 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 492 IRHRNIVKFYGFCSHARHSFIVYEYLEMGSL--AMI----LSNDAAAKDLGWTKRMNVIK 545
+ H NI+K Y F + ++V E G L +I S AA+ +I+
Sbjct: 83 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---------IIR 133
Query: 546 GVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH---VSDFGTAKFLKPDSSNWAELA 602
V+ ++YMH + IVHRD+ +N+LL+ +++ + DFG + + +
Sbjct: 134 QVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKI 189
Query: 603 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP------RDFISSISSSSSNLEI 656
GT Y+APE+ EKCDV+S GV+ ++ G P D + + E
Sbjct: 190 GTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE- 247
Query: 657 ALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
P+ S + +D LI M L P R + +
Sbjct: 248 ------LPQWKKVSESAKD-LIRKM------LTYVPSMRISARDA 279
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 34/259 (13%), Positives = 62/259 (23%), Gaps = 45/259 (17%)
Query: 441 EHCIGKGGQGSVYKAE---LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
G ++A L VA+ QE L+ L+ I +
Sbjct: 36 LIFHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV 93
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHND 557
+ +V E++ GSL + A + ++ + A H
Sbjct: 94 ARVLDVVHTRAGGLVVAEWIRGGSLQ-----EVADTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMK 617
+ V VS G +
Sbjct: 149 ---GVALSIDHPSRVR--------VSIDGDVV------------LAYPATMPD------- 178
Query: 618 VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKL 677
+ D+ G ++ + P + S L A + + P+ +D
Sbjct: 179 ANPQDDIRGIGASLYALLVNRWPLP----EAGVRSGLAPAERD-TAGQPIEPADIDRDIP 233
Query: 678 ISIMEVAISCLDESPESRP 696
I VA + R
Sbjct: 234 FQISAVAARSVQGDGGIRS 252
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-27
Identities = 71/315 (22%), Positives = 122/315 (38%), Gaps = 47/315 (14%)
Query: 404 QTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEI 462
S N + + G + + ++ + +G G G V + +
Sbjct: 5 HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 463 VAVKKFH-SPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGS 521
A+K + + + S + L EV L + H NI+K Y F R+ ++V E + G
Sbjct: 65 RAIKIIRKTSVSTS--SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122
Query: 522 L------AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD 575
L M + AA +IK V+ ++Y+H IVHRD+ +N+LL+
Sbjct: 123 LFDEIIHRMKFNEVDAAV---------IIKQVLSGVTYLHKHN---IVHRDLKPENLLLE 170
Query: 576 LENEAH---VSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLAL 632
+ + + DFG + + E GT Y+APE+ K EKCDV+S GV+
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKK-MKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILF 228
Query: 633 EVIKGKHP------RDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAIS 686
++ G P ++ + + + P S +D LI M
Sbjct: 229 ILLAGYPPFGGQTDQEILRKVEKGKYTFD-------SPEWKNVSEGAKD-LIKQM----- 275
Query: 687 CLDESPESRPTIQKV 701
L + R + Q+
Sbjct: 276 -LQFDSQRRISAQQA 289
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 40/297 (13%), Positives = 90/297 (30%), Gaps = 60/297 (20%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEV---KTLTGIRH----- 494
+G+ + +A +GE V + + ++ EV + L GI++
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 495 --------------RNIVKFYGFCSHARHSFIVYEYLEM----GSLAM----ILSNDAAA 532
K R +++ + +L +LS+ +
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 533 KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592
K L R+ + V+ L+ +H+ +VH + +++LD ++ F +
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 260
Query: 593 PDSSNWAELAGTYG---YVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFI 644
+S + + + A + +T D ++ G+ + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NT 318
Query: 645 SSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
++ E +P P V+ L+ L E R +
Sbjct: 319 D--DAALGGSEWIFRS--CKNIPQP---VRA-LLE------GFLRYPKEDRLLPLQA 361
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 62/267 (23%), Positives = 109/267 (40%), Gaps = 37/267 (13%)
Query: 444 IGKGGQGSVYKAEL----PSGEI-VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIV 498
+G G G+VYK +I VA+K+ + + +E L+E + + + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVC 80
Query: 499 KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC 558
+ G C ++ + + G L + ++G +N + ++Y+ +
Sbjct: 81 RLLGICL-TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV-----APELA 613
VHRD++++NVL+ ++DFG AK L + E G V A E
Sbjct: 138 L---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKWMALESI 191
Query: 614 YTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPS 670
T + DV+S+GV E++ G P D I EI+ +L+ RLP P
Sbjct: 192 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-------PASEIS--SILEKGERLPQP- 241
Query: 671 HNVQDKLISIMEVAISCLDESPESRPT 697
+ IM + C +SRP
Sbjct: 242 PICTIDVYMIM---VKCWMIDADSRPK 265
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 64/270 (23%), Positives = 107/270 (39%), Gaps = 37/270 (13%)
Query: 441 EHCIGKGGQGSVYKAEL----PSGEI-VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+G G G+V+K S +I V +K S Q + + + + H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQ-SFQAVTDHMLAIGSLDHA 75
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
+IV+ G C +V +YL +GSL + LG +N + + Y+
Sbjct: 76 HIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLE 132
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV-----AP 610
VHR+++++NVLL ++ V+DFG A L PD +L + A
Sbjct: 133 EHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDD---KQLLYSEAKTPIKWMAL 186
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLP 667
E + K T + DV+S+GV E++ G P + E+ ++L+ RL
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL-------RLAEVP--DLLEKGERLA 237
Query: 668 TPSHNVQDKLISIMEVAISCLDESPESRPT 697
P + +M + C RPT
Sbjct: 238 QP-QICTIDVYMVM---VKCWMIDENIRPT 263
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 38/233 (16%), Positives = 74/233 (31%), Gaps = 27/233 (11%)
Query: 429 EEIIRVTNDFDDEHCIGKGGQGSVYKAE------LPSGEIVAVKKFHSPLPSEMASQQEF 482
E + H +G+G VY+A + + +K P E
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF---YIG 114
Query: 483 LNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL--AMILSNDAAAKDLGWTKR 540
++ L +KFY S +V E G+L A+ L + K +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 541 MNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH-----------VSDFGTAK 589
++ ++ + +H+ I+H DI N +L + D G +
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 590 FLK--PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
+K P + + T G+ E+ + D + ++ G +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 62/286 (21%), Positives = 108/286 (37%), Gaps = 53/286 (18%)
Query: 441 EHCIGKGGQGSVYKAEL--PSGEI--VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
+G+G G VY+ GE VAVK + ++++F++E + + H +
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVIMKNLDHPH 74
Query: 497 IVKFYGFCSHARHS-FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
IVK G +I+ E G L L + L + + A++Y+
Sbjct: 75 IVKLIGIIE--EEPTWIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLE 130
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV------- 608
+ VHRDI+ +N+L+ + DFG +++++ + Y
Sbjct: 131 SINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDED-----------YYKASVTRL 176
Query: 609 -----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEML 662
+PE + T DV+ F V E++ GK P N ++ +L
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF-------WLENKDVI--GVL 227
Query: 663 DP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ RLP P L ++M C D P RP ++ L
Sbjct: 228 EKGDRLPKP-DLCPPVLYTLM---TRCWDYDPSDRPRFTELVCSLS 269
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 73/326 (22%), Positives = 124/326 (38%), Gaps = 57/326 (17%)
Query: 404 QTQQSSPGNAPGFLSVLSFE-GKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKA-ELPSGE 461
S G + ++ G V ++ ++ + +G G G V E
Sbjct: 3 HHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHS 62
Query: 462 IVAVK----------KFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511
A+K ++ + +E NE+ L + H NI+K + ++ +
Sbjct: 63 EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122
Query: 512 IVYEYLEMGSL-AMILS------NDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVH 564
+V E+ E G L I++ DAA N++K ++ + Y+H IVH
Sbjct: 123 LVTEFYEGGELFEQIINRHKFDECDAA----------NIMKQILSGICYLHKHN---IVH 169
Query: 565 RDISSKNVLLDLENEAH---VSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEK 621
RDI +N+LL+ +N + DFG + F D + GT Y+APE K EK
Sbjct: 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRLGTAYYIAPE-VLKKKYNEK 227
Query: 622 CDVYSFGVLALEVIKGKHP------RDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675
CDV+S GV+ ++ G P +D I + + S ++
Sbjct: 228 CDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD-------FNDWKNISDEAKE 280
Query: 676 KLISIMEVAISCLDESPESRPTIQKV 701
LI +M L R T ++
Sbjct: 281 -LIKLM------LTYDYNKRCTAEEA 299
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 48/207 (23%), Positives = 83/207 (40%), Gaps = 36/207 (17%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVK-----KFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
IGKG V + +G+ AVK KF S S S ++ E ++H +I
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTS---SPGLSTEDLKREASICHMLKHPHI 88
Query: 498 VKFYGFCSHARHSFIVYEYL----------EMGSLAMILSNDAAAKDLGWTKRMNVIKGV 547
V+ S ++V+E++ + + S A+ + ++ +
Sbjct: 89 VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS---------HYMRQI 139
Query: 548 VDALSYMH-NDCFPPIVHRDISSKNVLLDLENEAH---VSDFGTAKFLKPDSSNWAELAG 603
++AL Y H N+ I+HRD+ VLL + + + FG A L G
Sbjct: 140 LEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195
Query: 604 TYGYVAPELAYTMKVTEKCDVYSFGVL 630
T ++APE+ + DV+ GV+
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 35/201 (17%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFH-SPLPSEMASQQEFLNEVKTLTGIRHRNIVKFY 501
+GKG G V K + + + AVK + + ++ L EV+ L + H NI+K +
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK--DTSTILREVELLKKLDHPNIMKLF 87
Query: 502 GFCSHARHSFIVYEYLEMGSL-AMILSN------DAAAKDLGWTKRMNVIKGVVDALSYM 554
+ +IV E G L I+ DAA +IK V ++YM
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQVFSGITYM 137
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAH---VSDFGTAKFLKPDSSNWAELAGTYGYVAPE 611
H IVHRD+ +N+LL+ + + + DFG + + ++ + GT Y+APE
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPE 193
Query: 612 L---AYTMKVTEKCDVYSFGV 629
+ Y EKCDV+S GV
Sbjct: 194 VLRGTY----DEKCDVWSAGV 210
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 52/252 (20%), Positives = 93/252 (36%), Gaps = 23/252 (9%)
Query: 78 TLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGE 137
+ ++ I + ++ L + +T + ++ I +++ +
Sbjct: 5 SETITVPTPIKQ-IFSDDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNS----D 57
Query: 138 ISS--DWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSS 195
I S P + L + N +T P + + L L L N + + S L L
Sbjct: 58 IKSVQGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKV--KDLSSLKDLKK 113
Query: 196 LIKLILNSNQLCGQLSLE-LGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQF 254
L L L N + + L L QLE L L +N++++ L L KL L+L +NQ
Sbjct: 114 LKSLSLEHNGIS---DINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQ- 167
Query: 255 IKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELH 314
I I L L L L LS N + + +++L+ L L + L
Sbjct: 168 ISDIV-PLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLV 224
Query: 315 GLSYIDISYNEL 326
+ + + L
Sbjct: 225 VPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 50/255 (19%), Positives = 95/255 (37%), Gaps = 23/255 (9%)
Query: 73 NLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHN 132
+ L+ + L S+ ++ N + + ++ + PN+ + L+ N
Sbjct: 22 AFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGN 78
Query: 133 YFYGEIS--SDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKL 190
+++ LG L N + + +LK L L N I + L
Sbjct: 79 ----KLTDIKPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGI--SDINGL 130
Query: 191 GKLSSLIKLILNSNQLCGQLSLE-LGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNL 249
L L L L +N++ + L LT+L+ L L N++S+ +P L L KL L L
Sbjct: 131 VHLPQLESLYLGNNKI---TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL 185
Query: 250 SNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSC 309
S N I + L L +L L+L + + N+ + + +L P
Sbjct: 186 SKNH-ISDLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEI 241
Query: 310 FEELHGLSYIDISYN 324
+ ++ ++
Sbjct: 242 ISDDGDYEKPNVKWH 256
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 52/256 (20%), Positives = 92/256 (35%), Gaps = 21/256 (8%)
Query: 25 RLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLEN 84
L + + + L I + ++ + + L +T L L
Sbjct: 22 AFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNG 77
Query: 85 NQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEIS--SDW 142
N+L I L NL +L + L++N + ++ S L + L HN IS +
Sbjct: 78 NKLTD-IKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHN----GISDINGL 130
Query: 143 GRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILN 202
P+L +L +N IT + ++L L L N I L L+ L L L+
Sbjct: 131 VHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLS 186
Query: 203 SNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL 262
N + L L L L+ L+L S N NLV + + ++ + P +
Sbjct: 187 KNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEII 242
Query: 263 EKLIHLSELDLSHNFL 278
+ ++ +
Sbjct: 243 SDDGDYEKPNVKWHLP 258
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 8e-26
Identities = 66/277 (23%), Positives = 112/277 (40%), Gaps = 37/277 (13%)
Query: 441 EHCIGKGGQGSVYKAEL---PSGEI-VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
CIG+G G V++ + + VA+K + + +++FL E T+ H +
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQEALTMRQFDHPH 77
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
IVK G + +I+ E +G L L L + + AL+Y+ +
Sbjct: 78 IVKLIGVITENPV-WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLES 134
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV-----APE 611
F VHRDI+++NVL+ + + DFG +++++ + G + APE
Sbjct: 135 KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAPE 187
Query: 612 LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLPT 668
+ T DV+ FGV E++ G P N ++ ++ RLP
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQ-------GVKNNDVI--GRIENGERLPM 238
Query: 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
P N L S+M C P RP ++ L
Sbjct: 239 P-PNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 271
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-25
Identities = 65/355 (18%), Positives = 127/355 (35%), Gaps = 29/355 (8%)
Query: 1 NLSNLAFLYLYNNSFSGSIP--SEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQIT-FLT 57
+++L L L N F +P E G L L+ L LS K + +L L
Sbjct: 119 PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLD 177
Query: 58 LFDNALSGAIPK--EYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVR---LNQNHLTG 112
L + G + + N L L+ N+ + N +++ LN +
Sbjct: 178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQR 237
Query: 113 NISESFGIHPNLAFIDLSHNYFYGE-------ISSDWGRCPKLGTLDFSSNNITGSMPAE 165
++ + ++++ + W R + L+ + IT + E
Sbjct: 238 LMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRP--VEYLNIYNLTITERIDRE 295
Query: 166 IIHSS-----QLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQL 220
S L + + + + + + + +L+ + + S +
Sbjct: 296 EFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSF 355
Query: 221 ERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQF--IKKIPVELEKLIHLSELDLSHNFL 278
L+ + N ++S+ + L +L L L N K+ + + + L LD+S N L
Sbjct: 356 TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSL 415
Query: 279 GEEMPSQICN-MQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332
+ C +S+ LNLS N L+G + C + +D+ N + SIP
Sbjct: 416 NSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPK 467
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 64/348 (18%), Positives = 125/348 (35%), Gaps = 26/348 (7%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
LS L L L +N S+ + + L L++S N+L +I + + L L
Sbjct: 74 FLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL-QNIS--CCPMASLRHLDLS 129
Query: 60 DNAL-SGAIPKEYGNLVKLTLLTLENNQL-RGPIPNLRNL-TSLVRVRLNQNHLTGNISE 116
N + KE+GNL KLT L L + + + + +L S + + L H+ G +E
Sbjct: 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETE 189
Query: 117 SFGIHP----NLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITG--SMPAEIIHSS 170
S I +L F S +S + +L + + N + +E+
Sbjct: 190 SLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGP 249
Query: 171 QLKVLDLSSNHIVGEMPSKLGKL---SSLIKLILNSNQLCG-----QLSLELGSLTQLER 222
L + L + KL + + L + + + + + +L L
Sbjct: 250 TLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMI 309
Query: 223 LDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHNFLGEE 281
+ + S +++ LS + I + + L+ + N +
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISD-TPFIHMVCPPSPSSFTFLNFTQNVFTDS 368
Query: 282 MPSQICNMQSLEKLNLSHNNLS--GFIPSCFEELHGLSYIDISYNELH 327
+ ++ L+ L L N L + + + L +D+S N L+
Sbjct: 369 VFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLN 416
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-23
Identities = 61/322 (18%), Positives = 109/322 (33%), Gaps = 26/322 (8%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKL----CGSIPHSLGNLTQ---I 53
+ N L+L + S + +L L+LS KL C + L LT+ +
Sbjct: 192 QIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTL 251
Query: 54 TFLTLFDNALSGAIPKEYGNLVK---LTLLTLENNQLRGPIP------NLRNLTSLVRVR 104
+TL + + + L + N + I + L SL+
Sbjct: 252 LNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEH 311
Query: 105 LNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPA 164
+ + + + + LS + L+F+ N T
Sbjct: 312 VKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFT-DSVF 370
Query: 165 EIIHS-SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQ---- 219
+ + +L+ L L N + ++ L L S
Sbjct: 371 QGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES 429
Query: 220 LERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLG 279
+ L+LSSN L+ S+ + L K+ L+L NN+ I IP ++ L L EL+++ N L
Sbjct: 430 ILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNR-IMSIPKDVTHLQALQELNVASNQLK 486
Query: 280 EEMPSQICNMQSLEKLNLSHNN 301
+ SL+ + L N
Sbjct: 487 SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-23
Identities = 66/367 (17%), Positives = 123/367 (33%), Gaps = 46/367 (12%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLK-SLSDLELSGNKLCGSIPHSLGNL--------- 50
NL+ L FL L F + L S L+L + G SL
Sbjct: 144 NLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVF 203
Query: 51 --------------TQITFLTLFDNALSGAIPKEYGNLV-------KLTLLTLENNQLRG 89
+ L L + L+ + + L +TL++ +
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263
Query: 90 P----IPNLRNLTSLVRVRLNQNHLTGNISESFGIH-----PNLAFIDLSHNYFYGEISS 140
+ + + + +T I + +L + + F +
Sbjct: 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEA 323
Query: 141 DWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLI 200
+ ++ S ++ S L+ + N + L L LI
Sbjct: 324 LYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLI 383
Query: 201 LNSNQL--CGQLSLELGSLTQLERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSNNQFIKK 257
L N L +++L +++ LE LD+S N L++ + LNLS+N
Sbjct: 384 LQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443
Query: 258 IPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLS 317
+ L + LDL +N + +P + ++Q+L++LN++ N L F+ L L
Sbjct: 444 VFRCL--PPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQ 500
Query: 318 YIDISYN 324
YI + N
Sbjct: 501 YIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 62/364 (17%), Positives = 115/364 (31%), Gaps = 30/364 (8%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTLFDN 61
L L NS S +I L L L LS N++ S+ + + +L + N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSHN 110
Query: 62 ALSGAIPKEYGNLVKLTLLTLENNQLR--GPIPNLRNLTSLVRVRLNQNHLTGNISESFG 119
L I + L L L N NLT L + L+
Sbjct: 111 RLQ-NIS--CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR---QLDLL 164
Query: 120 IHPNL----AFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSS----Q 171
+L +DL + G + N S+ + ++ Q
Sbjct: 165 PVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQ 224
Query: 172 LKVLDLSSNHIVG--EMPSKLGKLSSLIKLILNSNQLCGQLSLELGSL---TQLERLDLS 226
L + L+ + S+L + +L+ + L + + S++L +E L++
Sbjct: 225 LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIY 284
Query: 227 SNRLSNSIPK-----SLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEE 281
+ ++ I + S L L ++ N F+ ++ LS +
Sbjct: 285 NLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFI 344
Query: 282 MPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPM 341
+ S LN + N + + L L + + N L + A M
Sbjct: 345 HMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFF-KVALMTKNM 402
Query: 342 EALQ 345
+L+
Sbjct: 403 SSLE 406
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 3e-17
Identities = 38/234 (16%), Positives = 88/234 (37%), Gaps = 11/234 (4%)
Query: 28 SLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQL 87
++ +L ++ +S L + + + + Y ++ + L +
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 88 RG-PIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCP 146
+ + +S + QN T ++ + L + L N
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL-KNFFKVALMTK 400
Query: 147 KLGTLDFSSNNITG--SMPAEIIHS--SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILN 202
+ +L+ ++ S + + + VL+LSSN + G + L + L L+
Sbjct: 401 NMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLH 458
Query: 203 SNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPK-SLGNLVKLHYLNLSNNQFI 255
+N++ + ++ L L+ L+++SN+L S+P L L Y+ L +N +
Sbjct: 459 NNRI-MSIPKDVTHLQALQELNVASNQL-KSVPDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 42/218 (19%), Positives = 75/218 (34%), Gaps = 6/218 (2%)
Query: 119 GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLDL 177
+ P + LS N D +L L S N I S+ + L+ LD+
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDV 107
Query: 178 SSNHIVGEMPSKLGKLSSLIKLILNSNQL-CGQLSLELGSLTQLERLDLSSNRLSNSIPK 236
S N + + ++SL L L+ N + E G+LT+L L LS+ +
Sbjct: 108 SHNRLQ-NISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLL 164
Query: 237 SLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLN 296
+ +L L + IK E ++ + + L L + ++ +L L
Sbjct: 165 PVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQ 224
Query: 297 LSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST 334
LS+ L+ + + +T
Sbjct: 225 LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 53/197 (26%), Positives = 85/197 (43%), Gaps = 29/197 (14%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G G V+ + +G++ A+K S NE+ L I+H NIV
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKK---SPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 503 FCSHARHSFIVYEYLEMGSL-AMILS------NDAAAKDLGWTKRMNVIKGVVDALSYMH 555
H ++V + + G L IL DA+ VI+ V+ A+ Y+H
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS----------LVIQQVLSAVKYLH 123
Query: 556 NDCFPPIVHRDISSKNVLL-DLENEAHV--SDFGTAKFLKPDSSNWAELAGTYGYVAPEL 612
+ IVHRD+ +N+L E + + +DFG +K + + GT GYVAPE+
Sbjct: 124 ENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEV 178
Query: 613 AYTMKVTEKCDVYSFGV 629
++ D +S GV
Sbjct: 179 LAQKPYSKAVDCWSIGV 195
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-25
Identities = 51/243 (20%), Positives = 95/243 (39%), Gaps = 26/243 (10%)
Query: 399 RRSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKA-EL 457
+ + SS + F + + V + V + +D +G G G V++ E
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179
Query: 458 PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYL 517
+G A K + + ++ E++T++ +RH +V + ++YE++
Sbjct: 180 ATGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236
Query: 518 EMGSL-------AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSK 570
G L +S D A ++ V L +MH + VH D+ +
Sbjct: 237 SGGELFEKVADEHNKMSEDEAV---------EYMRQVCKGLCHMHEN---NYVHLDLKPE 284
Query: 571 NVLLDLENEAHV--SDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFG 628
N++ + + DFG L P + GT + APE+A V D++S G
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVG 343
Query: 629 VLA 631
VL+
Sbjct: 344 VLS 346
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 47/208 (22%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG 491
R T ++ +GKG V + ++ +G+ A ++ Q+ E +
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK-KLSARDHQKLEREARICRL 66
Query: 492 IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLA-MILS------NDAAAKDLGWTKRMNVI 544
++H NIV+ + S H +++++ + G L I++ DA+ + I
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS----------HCI 116
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLL-DLENEAHV--SDFGTAKFLKPDSSNWAEL 601
+ +++A+ + H +VHR++ +N+LL A V +DFG A ++ + W
Sbjct: 117 QQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 173
Query: 602 AGTYGYVAPELAYTMKVTEKCDVYSFGV 629
AGT GY++PE+ + D+++ GV
Sbjct: 174 AGTPGYLSPEVLRKDPYGKPVDLWACGV 201
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 66/276 (23%), Positives = 114/276 (41%), Gaps = 39/276 (14%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+DFD +GKG G+VY A E + I+A+K + + + E++ + +RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSL------AMILSNDAAAKDLGWTKRMNVIKGVV 548
NI++ Y + + +++ E+ G L +A ++ +
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT---------FMEELA 124
Query: 549 DALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV 608
DAL Y H ++HRDI +N+L+ + E ++DFG + P + GT Y+
Sbjct: 125 DALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRT-MCGTLDYL 179
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668
PE+ EK D++ GVL E + G P D S + +++ L
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD--------SPSHTETHRRIVNVDLKF 231
Query: 669 PSH---NVQDKLISIMEVAISCLDESPESRPTIQKV 701
P +D LIS + L P R ++ V
Sbjct: 232 PPFLSDGSKD-LISKL------LRYHPPQRLPLKGV 260
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 35/159 (22%), Positives = 68/159 (42%), Gaps = 7/159 (4%)
Query: 146 PKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQ 205
L + ++ N+T I ++ +K L +++ H + + LS+L +L +
Sbjct: 44 NSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIMGKD 99
Query: 206 LCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKL 265
+ L LT L LD+S + +SI + L K++ ++LS N I I L+ L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTL 158
Query: 266 IHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSG 304
L L++ + + + I + L +L + G
Sbjct: 159 PELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 25/157 (15%), Positives = 67/157 (42%), Gaps = 7/157 (4%)
Query: 170 SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNR 229
+ L + L++ ++ + + ++ L +N+ + + L+ LERL +
Sbjct: 44 NSLTYITLANINV--TDLTGIEYAHNIKDLTINNIHA-TNYN-PISGLSNLERLRIMGKD 99
Query: 230 LSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNM 289
+++ +L L L L++S++ I ++ L ++ +DLS+N + + +
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IMPLKTL 158
Query: 290 QSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326
L+ LN+ + + + E+ L+ + +
Sbjct: 159 PELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-19
Identities = 31/253 (12%), Positives = 73/253 (28%), Gaps = 81/253 (32%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L +S + ++ + SL+ + L+ N+T +T +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQ---MNSLTYITLANI-----------NVTDLTGI---- 62
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
+ LT+ N + L++L R
Sbjct: 63 -----------EYAHNIKDLTINNIHATN-YNPISGLSNLER------------------ 92
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
L ++T + + L +LD+S +
Sbjct: 93 ------------------------------LRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122
Query: 181 HIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN 240
+ +K+ L + + L+ N + L +L +L+ L++ + + + + +
Sbjct: 123 AHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IED 179
Query: 241 LVKLHYLNLSNNQ 253
KL+ L +
Sbjct: 180 FPKLNQLYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 20/132 (15%), Positives = 51/132 (38%), Gaps = 7/132 (5%)
Query: 193 LSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNN 252
+ + +L + ++ + L + L++ +++ + + L ++N
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 253 QFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEE 312
+ L +L L + + + + + SL L++SH+ I +
Sbjct: 77 H-ATNYN-PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 313 LHGLSYIDISYN 324
L ++ ID+SYN
Sbjct: 135 LPKVNSIDLSYN 146
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-17
Identities = 27/163 (16%), Positives = 60/163 (36%), Gaps = 12/163 (7%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+++L ++ L N + + + + I ++ DL ++ P + L+ + L +
Sbjct: 42 QMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMG 97
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHLTGNISESFG 119
++ L LTLL + ++ + + L + + L+ N +I
Sbjct: 98 KDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLK 156
Query: 120 IHPNLAFIDLSHNYFYGEIS--SDWGRCPKLGTLDFSSNNITG 160
P L +++ + + PKL L S I G
Sbjct: 157 TLPELKSLNIQFD----GVHDYRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 8e-12
Identities = 18/118 (15%), Positives = 46/118 (38%), Gaps = 7/118 (5%)
Query: 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275
+ L + + + + L Y+ L+N + + +E ++ +L +++
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANIN-VTDLT-GIEYAHNIKDLTINN 75
Query: 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNS 333
+ I + +LE+L + +++ L L+ +DIS++ SI
Sbjct: 76 IHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 71/287 (24%), Positives = 118/287 (41%), Gaps = 49/287 (17%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFH-SPLPSEMASQQEFLNEVKTLT 490
++ +GKG G V K + + + AVK + + ++ L EV+ L
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK--DTSTILREVELLK 76
Query: 491 GIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILS------NDAAAKDLGWTKRMNV 543
+ H NI+K + + +IV E G L I+ +DAA +
Sbjct: 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RI 126
Query: 544 IKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH---VSDFGTAKFLKPDSSNWAE 600
IK V ++YMH IVHRD+ +N+LL+ + + + DFG + + ++ +
Sbjct: 127 IKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKD 182
Query: 601 LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP------RDFISSISSSSSNL 654
GT Y+APE+ EKCDV+S GV+ ++ G P D + + +
Sbjct: 183 RIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF 241
Query: 655 EIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
+ P+ T S + +D LI M L P R T +
Sbjct: 242 D-------LPQWRTISDDAKD-LIRKM------LTFHPSLRITATQC 274
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 78/363 (21%), Positives = 135/363 (37%), Gaps = 41/363 (11%)
Query: 361 KASKSHKQASRKIWVVIVFPLLGSFALLISLIGLFFMFRRSSSQTQQSSPGNAPGFLSVL 420
+ + I V P L + L + S + Q + ++
Sbjct: 13 HHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN 72
Query: 421 SFEGKIVYE-EIIRVTNDFDDEHCIGKGGQGSVYKAELPSGE----IVAVKKFHSPLPSE 475
+ V I + IG+G G VY L + AVK + ++
Sbjct: 73 PELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TD 130
Query: 476 MASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS-FIVYEYLEMGSLAMIL---SNDAA 531
+ +FL E + H N++ G C + S +V Y++ G L + +++
Sbjct: 131 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT 190
Query: 532 AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591
KDL + V + ++ + F VHRD++++N +LD + V+DFG A+ +
Sbjct: 191 VKDL-----IGFGLQVAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDM 242
Query: 592 KPDSSNWAELAGTYGYV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFIS 645
D + T + A E T K T K DV+SFGVL E++ +G P +
Sbjct: 243 Y-DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV- 300
Query: 646 SISSSSSNLEIALNEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
+ +I L RL P D L +M + C E RP+ ++
Sbjct: 301 ------NTFDIT--VYLLQGRRLLQP-EYCPDPLYEVM---LKCWHPKAEMRPSFSELVS 348
Query: 704 LLK 706
+
Sbjct: 349 RIS 351
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 45/222 (20%), Positives = 83/222 (37%), Gaps = 28/222 (12%)
Query: 421 SFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQ 479
+ + V + V + +D +G G G V++ E +G + K ++ +
Sbjct: 36 KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT---PYPLDK 92
Query: 480 QEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL-------AMILSNDAAA 532
NE+ + + H ++ + ++ E+L G L +S
Sbjct: 93 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI 152
Query: 533 KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAKF 590
N ++ + L +MH IVH DI +N++ + + + V DFG A
Sbjct: 153 ---------NYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATK 200
Query: 591 LKPDSSNWAELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLA 631
L PD T + APE + V D+++ GVL
Sbjct: 201 LNPD-EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLG 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 48/206 (23%), Positives = 85/206 (41%), Gaps = 28/206 (13%)
Query: 437 DFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+G G G V+K E +G +A K + M ++E NE+ + + H
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT---RGMKDKEEVKNEISVMNQLDHA 146
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSL-------AMILSNDAAAKDLGWTKRMNVIKGVV 548
N+++ Y +V EY++ G L + L+ +K +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI---------LFMKQIC 197
Query: 549 DALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAKFLKPDSSNWAELAGTYG 606
+ + +MH I+H D+ +N+L + + DFG A+ KP GT
Sbjct: 198 EGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPE 253
Query: 607 YVAPE-LAYTMKVTEKCDVYSFGVLA 631
++APE + Y V+ D++S GV+A
Sbjct: 254 FLAPEVVNYD-FVSFPTDMWSVGVIA 278
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-25
Identities = 48/210 (22%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 435 TNDFDDE----HCIGKGGQGSVYKA-ELPSGEIVAVKKFH-SPLPSEMASQQEFLNEVKT 488
+ F D +GKG V + +G A K + L + Q+ E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARI 58
Query: 489 LTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL------AMILSNDAAAKDLGWTKRMN 542
++H NIV+ + ++V++ + G L S A+
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH--------- 109
Query: 543 VIKGVVDALSYMHNDCFPPIVHRDISSKNVLL-DLENEAHV--SDFGTAKFLKPDSSNWA 599
I+ ++++++Y H++ IVHR++ +N+LL A V +DFG A + + W
Sbjct: 110 CIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WH 165
Query: 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGV 629
AGT GY++PE+ ++ D+++ GV
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGV 195
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 56/204 (27%), Positives = 80/204 (39%), Gaps = 32/204 (15%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVK-----KFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
+G G G V A E + + VA+K KF E E++ L + H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSL------AMILSNDAAAKDLGWTKRMNVIKGVVDAL 551
+K F A +IV E +E G L L ++ A+
Sbjct: 78 IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---------YFYQMLLAV 127
Query: 552 SYMHNDCFPPIVHRDISSKNVLLDLENEAH---VSDFGTAKFLKPDSSNWAELAGTYGYV 608
Y+H + I+HRD+ +NVLL + E ++DFG +K L S L GT Y+
Sbjct: 128 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYL 183
Query: 609 APE-LAYTMKV--TEKCDVYSFGV 629
APE L D +S GV
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGV 207
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 66/290 (22%), Positives = 111/290 (38%), Gaps = 34/290 (11%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELPSGE----IVAVKKFHSPLPSEMASQQEFLNE 485
I + IGKG G VY E A+K + + FL E
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQ-QVEAFLRE 72
Query: 486 VKTLTGIRHRNIVKFYGFCSHAR-HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVI 544
+ G+ H N++ G ++ Y+ G L + + ++ ++
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFG 130
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT 604
V + Y+ F VHRD++++N +LD V+DFG A+ + D ++
Sbjct: 131 LQVARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHR 186
Query: 605 YGYV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIAL 658
+ + A E T + T K DV+SFGVL E++ +G P I ++
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-------DPFDLT- 238
Query: 659 NEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
L RLP P D L +M+ C + P RPT + + ++
Sbjct: 239 -HFLAQGRRLPQP-EYCPDSLYQVMQ---QCWEADPAVRPTFRVLVGEVE 283
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-25
Identities = 55/205 (26%), Positives = 81/205 (39%), Gaps = 32/205 (15%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVK-----KFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
+G G G V A E + + VA++ KF E E++ L + H I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSL------AMILSNDAAAKDLGWTKRMNVIKGVVDAL 551
+K F A +IV E +E G L L ++ A+
Sbjct: 203 IKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKL---------YFYQMLLAV 252
Query: 552 SYMHNDCFPPIVHRDISSKNVLLDLENEAH---VSDFGTAKFLKPDSSNWAELAGTYGYV 608
Y+H + I+HRD+ +NVLL + E ++DFG +K L S L GT Y+
Sbjct: 253 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYL 308
Query: 609 APE-LAYTMKV--TEKCDVYSFGVL 630
APE L D +S GV+
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVI 333
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 70/282 (24%), Positives = 114/282 (40%), Gaps = 40/282 (14%)
Query: 441 EHCIGKGGQGSVYKAELPSGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
IG+G G VY L + AVK + +FL E + H N
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE--VSQFLTEGIIMKDFSHPN 87
Query: 497 IVKFYGFCSHARHS-FIVYEYLEMGSLAMIL---SNDAAAKDLGWTKRMNVIKGVVDALS 552
++ G C + S +V Y++ G L + +++ KDL + V +
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMK 142
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV---- 608
Y+ + F VHRD++++N +LD + V+DFG A+ + D ++ T +
Sbjct: 143 YLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKW 198
Query: 609 -APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP-- 664
A E T K T K DV+SFGVL E++ +G P + + +I L
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------NTFDIT--VYLLQGR 249
Query: 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
RL P D L +M + C E RP+ ++ +
Sbjct: 250 RLLQP-EYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 287
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 44/210 (20%), Positives = 82/210 (39%), Gaps = 29/210 (13%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG 491
+ + +G+G G V++ E S + K + + Q E+ L
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKF----VKVKGTDQVLVKKEISILNI 57
Query: 492 IRHRNIVKFYGFCSHARHSFIVYEYLEMGSL-------AMILSNDAAAKDLGWTKRMNVI 544
RHRNI+ + +++E++ + A L+ + +
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV---------SYV 108
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAKFLKPDSSNWAELA 602
V +AL ++H+ I H DI +N++ + + +FG A+ LKP N+ L
Sbjct: 109 HQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLF 164
Query: 603 GTYGYVAPE-LAYTMKVTEKCDVYSFGVLA 631
Y APE + + V+ D++S G L
Sbjct: 165 TAPEYYAPEVHQHDV-VSTATDMWSLGTLV 193
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 41/280 (14%), Positives = 99/280 (35%), Gaps = 37/280 (13%)
Query: 442 HCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFY 501
+ K + EI + S + +++ + +N V
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
S + +I + +L ++ + +D +++ + +A+ ++H+
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--- 184
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA------------GTYGYVA 609
++HRD+ N+ +++ V DFG + D L GT Y++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 610 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD---PRL 666
PE + + K D++S G++ E++ + S+ + ++ + P L
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELL---YSF-------STQMERVRIITDVRNLKFPLL 294
Query: 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
T + + ++ L SP RP + +++
Sbjct: 295 FTQKYPQEHMMVQ------DMLSPSPTERPEA---TDIIE 325
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 74/288 (25%), Positives = 112/288 (38%), Gaps = 50/288 (17%)
Query: 444 IGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTGIRH 494
+G G G VY+ ++ PS VAVK E+ S+Q+ FL E ++ H
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-----PEVCSEQDELDFLMEALIISKFNH 92
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL----SNDAAAKDLGWTKRMNVIKGVVDA 550
+NIV+ G + FI+ E + G L L + L ++V + +
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHV---SDFGTAKFLKPDSSNWAELAGTYGY 607
Y+ + F +HRDI+++N LL V DFG A+ + S G
Sbjct: 153 CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---YYRKGGCAM 206
Query: 608 V-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNE 660
+ PE T K D +SFGVL E+ G P S SN E+ E
Sbjct: 207 LPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP-------YPSKSNQEVL--E 256
Query: 661 MLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ R+ P N + IM C PE RP + + ++
Sbjct: 257 FVTSGGRMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIE 300
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 10/213 (4%)
Query: 119 GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLDL 177
+ + +DLS N S + P+L LD S I ++ S S L L L
Sbjct: 25 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLIL 83
Query: 178 SSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSN-SIPK 236
+ N I LSSL KL+ L + +G L L+ L+++ N + + +P+
Sbjct: 84 TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE 143
Query: 237 SLGNLVKLHYLNLSNNQFIKKIPVE----LEKLIHLS-ELDLSHNFLGEEMPSQICNMQS 291
NL L +L+LS+N+ I+ I L ++ L+ LDLS N + +
Sbjct: 144 YFSNLTNLEHLDLSSNK-IQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIR 201
Query: 292 LEKLNLSHNNLSGFIPSCFEELHGLSYIDISYN 324
L++L L N L F+ L L I + N
Sbjct: 202 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 51/244 (20%), Positives = 91/244 (37%), Gaps = 39/244 (15%)
Query: 18 SIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKE-YGNLVK 76
IP + S +L+LS N L +S + ++ L L + I Y +L
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 77 LTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYF 134
L+ L L N ++ + L+SL ++ + +L + G L ++++HN
Sbjct: 78 LSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHN-- 134
Query: 135 YGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIV---GEMPSKLG 191
I S + + L+ LDLSSN I L
Sbjct: 135 --LIQS----FKLPEYFS---------------NLTNLEHLDLSSNKIQSIYCTDLRVLH 173
Query: 192 KLSSL-IKLILNSNQLCGQLSLELGSLT--QLERLDLSSNRLSNSIPKSLGNLVKLHYLN 248
++ L + L L+ N + ++ G+ +L+ L L +N+L + L L +
Sbjct: 174 QMPLLNLSLDLSLNPM---NFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIW 230
Query: 249 LSNN 252
L N
Sbjct: 231 LHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-20
Identities = 44/194 (22%), Positives = 78/194 (40%), Gaps = 18/194 (9%)
Query: 154 SSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLE 213
N +P + K LDLS N + L L L+ ++ ++E
Sbjct: 15 MELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI---QTIE 68
Query: 214 LG---SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIP-VELEKLIHLS 269
G SL+ L L L+ N + + + L L L + + + L L
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN-LASLENFPIGHLKTLK 127
Query: 270 ELDLSHNFLGE-EMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYI----DISYN 324
EL+++HN + ++P N+ +LE L+LS N + + LH + + D+S N
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 325 ELHGSIPNSTAFRD 338
++ I AF++
Sbjct: 188 PMN-FIQPG-AFKE 199
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 44/208 (21%), Positives = 77/208 (37%), Gaps = 27/208 (12%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTL 58
+ L L L +I L LS L L+GN + S+ L+ + L
Sbjct: 50 SFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI-QSLALGAFSGLSSLQKLVA 107
Query: 59 FDNALSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNL-RNLTSLVRVRLNQNHLTGNISE 116
+ L+ G+L L L + +N ++ +P NLT+L + L+ N +
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167
Query: 117 SFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLD 176
+ + ++LS LD S N + + +LK L
Sbjct: 168 DLRVLHQMPLLNLS--------------------LDLSLNPMN-FIQPGAFKEIRLKELA 206
Query: 177 LSSNHIVGEMPSKLGKLSSLIKLILNSN 204
L +N + +L+SL K+ L++N
Sbjct: 207 LDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 49/203 (24%), Positives = 87/203 (42%), Gaps = 29/203 (14%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVK---KFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
+G G V K + +G+ A K K S++E EV L IRH NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 500 FYGFCSHARHSFIVYEYLEMGSL------AMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
+ + ++ E + G L L+ D A +K ++D + Y
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT---------QFLKQILDGVHY 123
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAH----VSDFGTAKFLKPDSSNWAELAGTYGYVA 609
+H+ I H D+ +N++L +N + + DFG A ++ + + + GT +VA
Sbjct: 124 LHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEFVA 179
Query: 610 PE-LAYTMKVTEKCDVYSFGVLA 631
PE + Y + + D++S GV+
Sbjct: 180 PEIVNYE-PLGLEADMWSIGVIT 201
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-24
Identities = 74/380 (19%), Positives = 127/380 (33%), Gaps = 77/380 (20%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGR-LKS----LSDLELSGNKL----CGSIPHSLGNLT 51
LA L L +N + + L++ + L L L CG + +L L
Sbjct: 54 VNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLP 113
Query: 52 QITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLT 111
+ L L DN L A L L L+ L +++L L+
Sbjct: 114 TLQELHLSDNLLGDA------GLQLLCEGLLDPQ------------CRLEKLQLEYCSLS 155
Query: 112 ----GNISESFGIHPNLAFIDLSHNYFYGEISSDWG--------RCP--KLGTLDFSSNN 157
++ P+ + +S+N ++ G + +L L S
Sbjct: 156 AASCEPLASVLRAKPDFKELTVSNNDI-----NEAGVRVLCQGLKDSPCQLEALKLESCG 210
Query: 158 ITGSMPAEI----IHSSQLKVLDLSSNHIVGE-----MPSKLGKLSSLIKLILNSNQL-- 206
+T ++ + L+ L L SN + P L S L L + +
Sbjct: 211 VTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITA 270
Query: 207 --CGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVK-----LHYLNLSNNQF----I 255
CG L L + L+ L L+ N L + + L + L L + + F
Sbjct: 271 KGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACC 330
Query: 256 KKIPVELEKLIHLSELDLSHNFLGEEMPSQIC-----NMQSLEKLNLSHNNLS----GFI 306
L + L EL +S+N L + ++C L L L+ ++S +
Sbjct: 331 SHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSL 390
Query: 307 PSCFEELHGLSYIDISYNEL 326
+ H L +D+S N L
Sbjct: 391 AATLLANHSLRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 71/374 (18%), Positives = 113/374 (30%), Gaps = 73/374 (19%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGR-LKSLSDLELSGNKL----CGSIPHSLGNLTQITFLT 57
++ L + S + +E+ L+ + L L C I +L + L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 58 LFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLT----GN 113
L N L V L L+ + ++ L LT G
Sbjct: 63 LRSNELGDV-------GVHCVLQGLQTPS-----------CKIQKLSLQNCCLTGAGCGV 104
Query: 114 ISESFGIHPNLAFIDLSHNYFYGEISSDWG----------RCPKLGTLDFSSNNIT---- 159
+S + P L + LS N D G +L L +++
Sbjct: 105 LSSTLRTLPTLQELHLSDNLL-----GDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC 159
Query: 160 GSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKL-----SSLIKLILNSNQL----CGQL 210
+ + + K L +S+N I L + L L L S + C L
Sbjct: 160 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL 219
Query: 211 SLELGSLTQLERLDLSSNRLSNSIPKSLGNLVK-----LHYLNLSNNQF----IKKIPVE 261
+ S L L L SN+L + L + L L + +
Sbjct: 220 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279
Query: 262 LEKLIHLSELDLSHNFLGEEMPSQICNM-----QSLEKLNLSHNNLSG----FIPSCFEE 312
L L EL L+ N LG+E +C LE L + + + S +
Sbjct: 280 LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQ 339
Query: 313 LHGLSYIDISYNEL 326
L + IS N L
Sbjct: 340 NRFLLELQISNNRL 353
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 8e-21
Identities = 74/358 (20%), Positives = 116/358 (32%), Gaps = 61/358 (17%)
Query: 4 NLAFLYLYNNSFS----GSIPSEIGRLKSLSDLELSGNKLCGSIPHSLG-----NLTQIT 54
+ L L N + G + S + L +L +L LS N L + L ++
Sbjct: 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145
Query: 55 FLTLFDNALS----GAIPKEYGNLVKLTLLTLENNQL---------RGPIPNLRNLTSLV 101
L L +LS + LT+ NN + +G + L +L
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEAL- 204
Query: 102 RVRLNQNHLT----GNISESFGIHPNLAFIDLSHNYFYGE----ISSDWGRC-PKLGTLD 152
+L +T ++ +L + L N + +L TL
Sbjct: 205 --KLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLW 262
Query: 153 FSSNNIT----GSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKL-----SSLIKLILNS 203
IT G + + LK L L+ N + E L + L L + S
Sbjct: 263 IWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 322
Query: 204 NQL----CGQLSLELGSLTQLERLDLSSNRLSNSIPKSLG-----NLVKLHYLNLSNNQF 254
C S L L L +S+NRL ++ + L L L L++
Sbjct: 323 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382
Query: 255 ----IKKIPVELEKLIHLSELDLSHNFLGEEMPSQIC-----NMQSLEKLNLSHNNLS 303
+ L L ELDLS+N LG+ Q+ LE+L L S
Sbjct: 383 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-18
Identities = 44/244 (18%), Positives = 80/244 (32%), Gaps = 42/244 (17%)
Query: 123 NLAFIDLSHNYFYGEISSDWGRC------PKLGTLDFSSNNITGSMPAEI----IHSSQL 172
++ +D+ SD + + +T + +I + L
Sbjct: 4 DIQSLDIQCEEL-----SDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 58
Query: 173 KVLDLSSNHIVGEMPSKLGKL-----SSLIKLILNSNQL----CGQLSLELGSLTQLERL 223
L+L SN + + + + KL L + L CG LS L +L L+ L
Sbjct: 59 AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 224 DLSSNRLSNSIPKSLGNLV-----KLHYLNLSNNQF----IKKIPVELEKLIHLSELDLS 274
LS N L ++ + L + +L L L + + L EL +S
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178
Query: 275 HNFLGEEMPSQIC-----NMQSLEKLNLSHNNLS----GFIPSCFEELHGLSYIDISYNE 325
+N + E +C + LE L L ++ + L + + N+
Sbjct: 179 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238
Query: 326 LHGS 329
L
Sbjct: 239 LGDV 242
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-17
Identities = 40/181 (22%), Positives = 66/181 (36%), Gaps = 23/181 (12%)
Query: 169 SSQLKVLDLSSNHIVGEMPSKLGK-LSSLIKLILNSNQL----CGQLSLELGSLTQLERL 223
S ++ LD+ + ++L L + L+ L C +S L L L
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 224 DLSSNRLSNSIPKSLGNLVK-----LHYLNLSNNQF----IKKIPVELEKLIHLSELDLS 274
+L SN L + + ++ + L+L N + L L L EL LS
Sbjct: 62 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121
Query: 275 HNFLGEEMPSQICNMQ-----SLEKLNLSHNNLS----GFIPSCFEELHGLSYIDISYNE 325
N LG+ +C LEKL L + +LS + S + +S N+
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 326 L 326
+
Sbjct: 182 I 182
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-16
Identities = 63/358 (17%), Positives = 118/358 (32%), Gaps = 69/358 (19%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRL-----KSLSDLELSGNKL----CGSIPHSLGNLT 51
L L L+L +N + + L L+L L C + L
Sbjct: 111 TLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKP 170
Query: 52 QITFLTLFDN--------ALSGAIPKEYGNLVKLTLLTLENNQLRGP-----IPNLRNLT 98
LT+ +N L + + +L L LE+ + + +
Sbjct: 171 DFKELTVSNNDINEAGVRVLCQGLKD---SPCQLEALKLESCGVTSDNCRDLCGIVASKA 227
Query: 99 SLVRVRLNQNHLTG----NISESFGIHPN--LAFIDLSHNYFYGE----ISSDWGRCPKL 148
SL + L N L + +HP+ L + + + + L
Sbjct: 228 SLRELALGSNKLGDVGMAELCPGL-LHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL 286
Query: 149 GTLDFSSNNITGS-----MPAEIIHSSQLKVLDLSSNHI-------VGEMPSKLGKLSSL 196
L + N + + QL+ L + S + L + L
Sbjct: 287 KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV---LAQNRFL 343
Query: 197 IKLILNSNQL----CGQLSLELGS-LTQLERLDLSSNRLSN----SIPKSLGNLVKLHYL 247
++L +++N+L +L LG + L L L+ +S+ S+ +L L L
Sbjct: 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 403
Query: 248 NLSNNQF----IKKIPVELEKL-IHLSELDLSHNFLGEEMPSQIC----NMQSLEKLN 296
+LSNN I ++ + + L +L L + EEM ++ + SL ++
Sbjct: 404 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 49/200 (24%), Positives = 80/200 (40%), Gaps = 35/200 (17%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IG+G G V A + + A KK + F E++ + + H NI++ Y
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPK---YFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 503 FCSHARHSFIVYEYLEMGSL-AMILS------NDAAAKDLGWTKRMNVIKGVVDALSYMH 555
++V E G L ++ +DAA ++K V+ A++Y H
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA----------RIMKDVLSAVAYCH 123
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAH---VSDFGTAKFLKPDSSNWAELAGTYGYVAPEL 612
+ HRD+ +N L ++ + DFG A KP GT YV+P++
Sbjct: 124 KL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQV 179
Query: 613 ---AYTMKVTEKCDVYSFGV 629
Y +CD +S GV
Sbjct: 180 LEGLY----GPECDEWSAGV 195
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 53/254 (20%), Positives = 94/254 (37%), Gaps = 36/254 (14%)
Query: 399 RRSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDE----HCIGKGGQGSVYK 454
+ + + G +F + IG+G V +
Sbjct: 53 NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR 112
Query: 455 A-ELPSGEIVAVK-----KFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHA 507
+G AVK ++ E L + H +I+ +
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172
Query: 508 RHSFIVYEYLEMGSL------AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
F+V++ + G L + LS +++ +++A+S++H +
Sbjct: 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRS---------IMRSLLEAVSFLHANN--- 220
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE-LAYTMKVTE 620
IVHRD+ +N+LLD + +SDFG + L+P EL GT GY+APE L +M T
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELCGTPGYLAPEILKCSMDETH 279
Query: 621 K-----CDVYSFGV 629
D+++ GV
Sbjct: 280 PGYGKEVDLWACGV 293
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 53/242 (21%), Positives = 101/242 (41%), Gaps = 30/242 (12%)
Query: 399 RRSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKA-EL 457
Q+ S +A + L + I +++ F+ E +G+G VY+ +
Sbjct: 16 ENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQK 75
Query: 458 PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYL 517
+ + A+K + ++ E+ L + H NI+K +V E +
Sbjct: 76 GTQKPYALKVL-----KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELV 130
Query: 518 EMGSL-AMILS------NDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSK 570
G L I+ DAA + +K +++A++Y+H + IVHRD+ +
Sbjct: 131 TGGELFDRIVEKGYYSERDAA----------DAVKQILEAVAYLHENG---IVHRDLKPE 177
Query: 571 NVLL-DLENEAHV--SDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSF 627
N+L +A + +DFG +K ++ + GT GY APE+ + D++S
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVCGTPGYCAPEILRGCAYGPEVDMWSV 236
Query: 628 GV 629
G+
Sbjct: 237 GI 238
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 29/203 (14%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVK---KFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
+G G V K E +G A K K S S++E EV L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 500 FYGFCSHARHSFIVYEYLEMGSL------AMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
+ + ++ E + G L LS + A + IK ++D ++Y
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---------SFIKQILDGVNY 130
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAH----VSDFGTAKFLKPDSSNWAELAGTYGYVA 609
+H I H D+ +N++L +N + DFG A ++ + + GT +VA
Sbjct: 131 LHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPEFVA 186
Query: 610 PE-LAYTMKVTEKCDVYSFGVLA 631
PE + Y + + D++S GV+
Sbjct: 187 PEIVNYE-PLGLEADMWSIGVIT 208
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 33/206 (16%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVK-----KFHSPLPSEMASQQE-FLNEVKTLTGI-RHR 495
+G+G V + P+ + AVK S E+ +E L EV L + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSL------AMILSNDAAAKDLGWTKRMNVIKGVVD 549
NI++ F+V++ ++ G L + LS K +++ +++
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK---------IMRALLE 135
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVA 609
+ +H IVHRD+ +N+LLD + ++DFG + L P E+ GT Y+A
Sbjct: 136 VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVCGTPSYLA 191
Query: 610 PE-LAYTMKV-----TEKCDVYSFGV 629
PE + +M ++ D++S GV
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGV 217
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVK---KFHSPLPSEMASQQEFLNEVKT 488
+V + +D +G G V K E +G A K K S ++E EV
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 489 LTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL------AMILSNDAAAKDLGWTKRMN 542
L + H NI+ + + ++ E + G L LS + A +
Sbjct: 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT---------S 119
Query: 543 VIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH----VSDFGTAKFLKPDSSNW 598
IK ++D ++Y+H I H D+ +N++L +N + DFG A ++ +
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-F 175
Query: 599 AELAGTYGYVAPE-LAYTMKVTEKCDVYSFGVLA 631
+ GT +VAPE + Y + + D++S GV+
Sbjct: 176 KNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 208
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 45/203 (22%), Positives = 84/203 (41%), Gaps = 29/203 (14%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVK---KFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
+G G V K E +G A K K + S+++ EV L I+H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 500 FYGFCSHARHSFIVYEYLEMGSL------AMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
+ + ++ E + G L L+ + A +K +++ + Y
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT---------EFLKQILNGVYY 129
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAH----VSDFGTAKFLKPDSSNWAELAGTYGYVA 609
+H+ I H D+ +N++L N + DFG A + + + + GT +VA
Sbjct: 130 LHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVA 185
Query: 610 PE-LAYTMKVTEKCDVYSFGVLA 631
PE + Y + + D++S GV+
Sbjct: 186 PEIVNYE-PLGLEADMWSIGVIT 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 49/216 (22%), Positives = 94/216 (43%), Gaps = 30/216 (13%)
Query: 429 EEIIRVTNDFDDE----HCIGKGGQGSVYKA-ELPSGEIVAVKKFH-SPLPSEMASQQEF 482
E ++ + F D +GKG V + +G A K + L + Q+
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKL 75
Query: 483 LNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL------AMILSNDAAAKDLG 536
E + ++H NIV+ + ++V++ + G L S A+
Sbjct: 76 EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---- 131
Query: 537 WTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL-DLENEAHV--SDFGTAKFLKP 593
+ I+ ++++++Y H++ IVHR++ +N+LL A V +DFG A +
Sbjct: 132 -----HCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
Query: 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGV 629
+ W AGT GY++PE+ ++ D+++ GV
Sbjct: 184 SEA-WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 7e-24
Identities = 40/300 (13%), Positives = 92/300 (30%), Gaps = 65/300 (21%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVK---KFHSPLPSEMASQQEFLNEVKTLTGIRH----- 494
+G+ + +A + +GE V P + + +E + ++ L GI++
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 495 --------------RNIVKFYGFCSHARHSFIVYEYLEM----GSLAM----ILSNDAAA 532
K R +++ + +L +LS+ +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 533 KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592
K L R+ + V+ L+ +H+ +VH + +++LD ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 593 PDSSNWAELAGTYGYVAPEL-----------AYTMKVTEKCDVYSFGVLALEVIKGKHPR 641
+ + G+ PEL +T D ++ G++ + P
Sbjct: 258 ARVV----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312
Query: 642 DFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
+ + + +E + V+ L+ L E R +
Sbjct: 313 -I-------TKDAALGGSEWIFRSCKNIPQPVRA-LLE------GFLRYPKEDRLLPLQA 357
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 60/195 (30%), Positives = 90/195 (46%), Gaps = 20/195 (10%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVK---KFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
+G G G V+ E SG +K K S +P E E++ L + H NI+K
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-----IEAEIEVLKSLDHPNIIK 84
Query: 500 FYGFCSHARHSFIVYEYLEMGSL-AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC 558
+ + +IV E E G L I+S A K L ++K +++AL+Y H+
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ- 143
Query: 559 FPPIVHRDISSKNVLLDLENEAH---VSDFGTAKFLKPDSSNWAELAGTYGYVAPE-LAY 614
+VH+D+ +N+L + + DFG A+ K D AGT Y+APE
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAAGTALYMAPEVFKR 200
Query: 615 TMKVTEKCDVYSFGV 629
VT KCD++S GV
Sbjct: 201 --DVTFKCDIWSAGV 213
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 73/288 (25%), Positives = 111/288 (38%), Gaps = 50/288 (17%)
Query: 444 IGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTGIRH 494
+G G G VY+ ++ PS VAVK E+ S+Q+ FL E ++ H
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-----PEVCSEQDELDFLMEALIISKFNH 133
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL----SNDAAAKDLGWTKRMNVIKGVVDA 550
+NIV+ G + FI+ E + G L L + L ++V + +
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHV---SDFGTAKFLKPDSSNWAELAGTYGY 607
Y+ + F +HRDI+++N LL V DFG A+ + G
Sbjct: 194 CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---YYRKGGCAM 247
Query: 608 V-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNE 660
+ PE T K D +SFGVL E+ G P S SN E+ E
Sbjct: 248 LPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP-------YPSKSNQEVL--E 297
Query: 661 MLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ R+ P N + IM C PE RP + + ++
Sbjct: 298 FVTSGGRMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIE 341
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 53/247 (21%), Positives = 86/247 (34%), Gaps = 51/247 (20%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFH-SPLPSEMASQQE-FLNEVKTL 489
+ + + IG+G G V A E + I A+K + + + E EV+ +
Sbjct: 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82
Query: 490 TGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL--------------------------- 522
+ H NI + Y ++ +V E G L
Sbjct: 83 KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 523 --------AMILSNDAAAKDLGWTKRM--NVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572
+ + D +++ N+++ + AL Y+HN I HRDI +N
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENF 199
Query: 573 LLDLENEAHV--SDFGTAKFLKP----DSSNWAELAGTYGYVAPEL--AYTMKVTEKCDV 624
L + DFG +K + AGT +VAPE+ KCD
Sbjct: 200 LFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259
Query: 625 YSFGVLA 631
+S GVL
Sbjct: 260 WSAGVLL 266
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 67/288 (23%), Positives = 113/288 (39%), Gaps = 46/288 (15%)
Query: 441 EHCIGKGGQGSVYKAELPSGE----IVAVKKFHSPLPSEMASQQE---FLNEVKTLTGIR 493
+G+G GSV + L + VAVK + + +SQ+E FL+E +
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKT----MKLDNSSQREIEEFLSEAACMKDFS 94
Query: 494 HRNIVKFYGFCS-----HARHSFIVYEYLEMGSLAMIL---SNDAAAKDLGWTKRMNVIK 545
H N+++ G C ++ +++ G L L + K + + +
Sbjct: 95 HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 546 GVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY 605
+ + Y+ N F +HRD++++N +L + V+DFG +K + G
Sbjct: 155 DIALGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---YYRQGRI 208
Query: 606 GYV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALN 659
+ A E T K DV++FGV E+ +G P + N E+
Sbjct: 209 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-------QNHEMY-- 259
Query: 660 EMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
+ L RL P + D+L IM SC P RPT + L
Sbjct: 260 DYLLHGHRLKQP-EDCLDELYEIMY---SCWRTDPLDRPTFSVLRLQL 303
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 59/312 (18%), Positives = 106/312 (33%), Gaps = 47/312 (15%)
Query: 8 LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIP-HSLGNLTQITFLTLFDNALSGA 66
+ + IPS++ ++ +L KL I + + + + N +
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKL-RVIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 67 IPKE-YGNLVKLTLLTLEN-NQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGIHP 122
I + + NL KL + +E N L I +NL +L + ++ +
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLLY-INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 128
Query: 123 NLAFIDLSHNYFYGEISSDW--GRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
+D+ N I + G + L + N I + + +QL L+LS N
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDN 187
Query: 181 HIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN 240
+ L L + + + LD+S R+ + L N
Sbjct: 188 N----------NLEELPNDVFHG-------------ASGPVILDISRTRIHSLPSYGLEN 224
Query: 241 LVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHN 300
L KL + N KK+P LEKL+ L E L++ PS C + + +
Sbjct: 225 LKKLRARSTYNL---KKLPT-LEKLVALMEASLTY-------PSHCCAFANWRRQISELH 273
Query: 301 NLSGFIPSCFEE 312
+ E
Sbjct: 274 PICNKSILRQEV 285
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 39/240 (16%), Positives = 85/240 (35%), Gaps = 12/240 (5%)
Query: 103 VRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSM 162
++ +T I + N + + L ++ S N++ +
Sbjct: 14 FLCQESKVT-EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 163 PAEIIHS-SQLKVLDLS-SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQL 220
A++ + +L + + +N+++ P L +L L++++ + + Q
Sbjct: 71 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 130
Query: 221 ERLDLSSNRLSNSIPKSL--GNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFL 278
LD+ N ++I ++ G + L L+ N I++I L EL+LS N
Sbjct: 131 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG-IQEIHNSAFNGTQLDELNLSDNNN 189
Query: 279 GEEMPSQIC-NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFR 337
EE+P+ + L++S + E L L + +P
Sbjct: 190 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTLEKLV 246
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 18/121 (14%), Positives = 38/121 (31%), Gaps = 3/121 (2%)
Query: 220 LERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE-LEKLIHLSELDLSHNFL 278
L +L + L + +S N ++ I + L L E+ +
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 279 GEEMPSQIC-NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFR 337
+ + N+ +L+ L +S+ + +DI N +I +F
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIER-NSFV 150
Query: 338 D 338
Sbjct: 151 G 151
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 42/212 (19%), Positives = 76/212 (35%), Gaps = 34/212 (16%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPH-SLGNLTQITFLTL 58
NL L + + + I E L +L L +S + +P + Q L +
Sbjct: 77 NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDI 135
Query: 59 FDNALSGAIPKE--YGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISE 116
DN I + G + +L L N ++ + N T L + L+ N+ N+ E
Sbjct: 136 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNN---NLEE 192
Query: 117 SFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVL 175
+ + F S LD S I S+P+ + + +L+
Sbjct: 193 ---LPND-VFHGASG----------------PVILDISRTRIH-SLPSYGLENLKKLRAR 231
Query: 176 DLSSNHIVGEMPSKLGKLSSLIKLILNSNQLC 207
+ ++P+ L KL +L++ L C
Sbjct: 232 STYNLK---KLPT-LEKLVALMEASLTYPSHC 259
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 62/287 (21%), Positives = 115/287 (40%), Gaps = 48/287 (16%)
Query: 444 IGKGGQGSVYKAELPSGE------IVAVKKFHSPLPSEMASQQE---FLNEVKTLTGIRH 494
+G+G G VY+ VA+K +E AS +E FLNE +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-----NEAASMRERIEFLNEASVMKEFNC 87
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL-------SNDAAAKDLGWTKRMNVIKGV 547
++V+ G S + + ++ E + G L L +N+ +K + + +
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 548 VDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGY 607
D ++Y++ + F VHRD++++N ++ + + DFG + + G G
Sbjct: 148 ADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD---YYRKGGKGL 201
Query: 608 V-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEM 661
+ +PE T DV+SFGV+ E+ + P + SN ++
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQGL----SNEQVL--RF 252
Query: 662 LDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ L P N D L +M C +P+ RP+ ++ +K
Sbjct: 253 VMEGGLLDKP-DNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIK 295
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 75/292 (25%), Positives = 124/292 (42%), Gaps = 54/292 (18%)
Query: 444 IGKGGQGSVYKAELPSGE------IVAVK--KFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+G+G G V+ AE + +VAVK K S +++Q+F E + LT ++H+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-----ESARQDFQREAELLTMLQHQ 103
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSL------------AMILSNDAAAKDLGWTKRMNV 543
+IV+F+G C+ R +V+EY+ G L + D A LG + + V
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 544 IKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAG 603
V + Y+ F VHRD++++N L+ + DFG ++ + G
Sbjct: 164 ASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYRVG 217
Query: 604 TYGYV-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEI 656
+ PE + Y K T + DV+SFGV+ E+ GK P SN E
Sbjct: 218 GRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQP-------WYQLSNTEA 269
Query: 657 ALNEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ + L P ++ +IM C P+ R +I+ V L+
Sbjct: 270 I--DCITQGRELERP-RACPPEVYAIMR---GCWQREPQQRHSIKDVHARLQ 315
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 53/190 (27%), Positives = 89/190 (46%), Gaps = 14/190 (7%)
Query: 150 TLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ 209
++ N+T ++P ++ +L LS N + + L + L +L L+ +L
Sbjct: 14 EVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-- 68
Query: 210 LSLEL-GSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKLIH 267
L++ G+L L LDLS N+L S+P L L L++S N+ + +P+ L
Sbjct: 69 -KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNR-LTSLPLGALRGLGE 125
Query: 268 LSELDLSHNFLGEEMPSQIC-NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326
L EL L N L + +P + LEKL+L++NNL+ L L + + N L
Sbjct: 126 LQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 327 HGSIPNSTAF 336
+ +IP F
Sbjct: 185 Y-TIPKG-FF 192
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 55/229 (24%), Positives = 78/229 (34%), Gaps = 38/229 (16%)
Query: 28 SLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQL 87
S ++ L ++P L T L L +N L +LT L L+ +L
Sbjct: 11 SHLEVNCDKRNL-TALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 88 RGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPK 147
+ L L + L+ N L ++ L P
Sbjct: 68 TK-LQVDGTLPVLGTLDLSHNQLQ-SLPLLG---QTL---------------------PA 101
Query: 148 LGTLDFSSNNITGSMPAEIIHS-SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQL 206
L LD S N +T S+P + +L+ L L N + P L L KL L +N L
Sbjct: 102 LTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160
Query: 207 CGQLSLELG---SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNN 252
L G L L+ L L N L +IPK L + L N
Sbjct: 161 ---TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 9e-23
Identities = 53/211 (25%), Positives = 85/211 (40%), Gaps = 17/211 (8%)
Query: 95 RNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFS 154
+ S + V ++ +LT + + + + LS N Y + +L L+
Sbjct: 7 SKVASHLEVNCDKRNLT---ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 155 SNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLEL 214
+T + + L LDLS N + +P L +L L ++ N+L SL L
Sbjct: 64 RAELT-KLQVDG-TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL---TSLPL 117
Query: 215 G---SLTQLERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLS 269
G L +L+ L L N L ++P L KL L+L+NN + ++P L L +L
Sbjct: 118 GALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNN-LTELPAGLLNGLENLD 175
Query: 270 ELDLSHNFLGEEMPSQICNMQSLEKLNLSHN 300
L L N L +P L L N
Sbjct: 176 TLLLQENSL-YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 41/136 (30%), Positives = 58/136 (42%), Gaps = 9/136 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTLF 59
L L L L +N S+P L +L+ L++S N+L S+P L ++ L L
Sbjct: 75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL-TSLPLGALRGLGELQELYLK 132
Query: 60 DNALSGAIPKE-YGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISE 116
N L +P KL L+L NN L +P L L +L + L +N L I +
Sbjct: 133 GNELK-TLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TIPK 189
Query: 117 SFGIHPNLAFIDLSHN 132
F L F L N
Sbjct: 190 GFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 41/182 (22%), Positives = 64/182 (35%), Gaps = 31/182 (17%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+ L L L + + + G L L L+LS N+L S+P L +T L +
Sbjct: 53 PYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSF 109
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESF 118
N L+ L +L L L+ N+L+ +P L L ++ L N+LT
Sbjct: 110 NRLTSLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLT------- 161
Query: 119 GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
+ L L TL N++ ++P S L L
Sbjct: 162 ELPAG-LLNGL----------------ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLH 203
Query: 179 SN 180
N
Sbjct: 204 GN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 46/205 (22%), Positives = 72/205 (35%), Gaps = 33/205 (16%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA 62
+ L+L N + + L+ L L +L + G L + L L N
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQ-VDGTLPVLGTLDLSHNQ 88
Query: 63 LSGAIPKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGI 120
L ++P L LT+L + N+L +P LR L L + L N L +
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TL------ 139
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLDLSS 179
P PKL L ++NN+T +PA +++ L L L
Sbjct: 140 -PPGLLTPT----------------PKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQE 181
Query: 180 NHIVGEMPSKLGKLSSLIKLILNSN 204
N + +P L L+ N
Sbjct: 182 NSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 60/284 (21%), Positives = 109/284 (38%), Gaps = 41/284 (14%)
Query: 444 IGKGGQGSVYKAELPSGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
+GKG GSV +A+L + VAVK + + + +EFL E + H ++ K
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD-IEEFLREAACMKEFDHPHVAK 89
Query: 500 FYGFCS------HARHSFIVYEYLEMGSLAMIL---SNDAAAKDLGWTKRMNVIKGVVDA 550
G ++ +++ G L L +L + + +
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV-- 608
+ Y+ + F +HRD++++N +L + V+DFG ++ + G +
Sbjct: 150 MEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD---YYRQGCASKLPV 203
Query: 609 ---APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP 664
A E T DV++FGV E++ +G+ P I N EI L
Sbjct: 204 KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-------ENAEIY--NYLIG 254
Query: 665 --RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
RL P +++ +M C P+ RP+ + L+
Sbjct: 255 GNRLKQP-PECMEEVYDLMY---QCWSADPKQRPSFTCLRMELE 294
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 70/291 (24%), Positives = 126/291 (43%), Gaps = 51/291 (17%)
Query: 444 IGKGGQGSVYKAELPSGE------IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
+G+G G V+ AE + +VAVK +A++++F E + LT ++H +I
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK---DPTLAARKDFQREAELLTNLQHEHI 79
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSL-------------AMILSNDAAAKDLGWTKRMNVI 544
VKFYG C +V+EY++ G L + A +LG ++ +++
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT 604
+ + Y+ + F VHRD++++N L+ + DFG ++ + G
Sbjct: 140 SQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD---YYRVGG 193
Query: 605 YGYV-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIA 657
+ + PE + Y K T + DV+SFGV+ E+ GK P SN E+
Sbjct: 194 HTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQP-------WFQLSNTEVI 245
Query: 658 LNEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
E + L P ++ +M C P+ R I+++ ++L
Sbjct: 246 --ECITQGRVLERP-RVCPKEVYDVML---GCWQREPQQRLNIKEIYKILH 290
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-23
Identities = 66/279 (23%), Positives = 113/279 (40%), Gaps = 39/279 (13%)
Query: 441 EHCIGKGGQGSVYKAEL---PSGEI-VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
CIG+G G V++ + + VA+K + + +++FL E T+ H +
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV--REKFLQEALTMRQFDHPH 452
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMIL-SNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
IVK G + +I+ E +G L L L + + AL+Y+
Sbjct: 453 IVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLE 508
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV-----AP 610
+ F VHRDI+++NVL+ + + DFG +++++ + G + AP
Sbjct: 509 SKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAP 561
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDP--RLP 667
E + T DV+ FGV E++ G P + N ++ ++ RLP
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNNDVI--GRIENGERLP 612
Query: 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
P N L S+M C P RP ++ L
Sbjct: 613 MP-PNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLS 647
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 9e-23
Identities = 57/304 (18%), Positives = 111/304 (36%), Gaps = 48/304 (15%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVK--------------KFHSPLPSEMASQQE 481
ND+ + +G + E + A+K K ++ S + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 482 FLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL-----AMILSNDAAAKDLG 536
F NE++ +T I++ + G ++ +I+YEY+E S+ + + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 537 WTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596
+IK V+++ SY+HN I HRD+ N+L+D +SDFG ++++
Sbjct: 150 IQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DK 205
Query: 597 NWAELAGTYGYVAPELAYTMKVT--EKCDVYSFGVLALEVIKGKHPRDFISSI------- 647
GTY ++ PE K D++S G+ + P S+
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 648 --------SSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQ 699
+ L N+ S+ D + + L ++P R T +
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDID-FLKLF------LRKNPAERITSE 318
Query: 700 KVSQ 703
+
Sbjct: 319 DALK 322
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 50/246 (20%), Positives = 84/246 (34%), Gaps = 15/246 (6%)
Query: 80 LTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEIS 139
L ++ + L R L+ T + L ++ + + I
Sbjct: 331 CVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI- 388
Query: 140 SDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKL 199
L L + + + + + LD + + E + + + L
Sbjct: 389 --ILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVL 446
Query: 200 ILNSNQLCGQLSLE-LGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKI 258
L L L L L + LDLS NRL ++P +L L L L S+N ++ +
Sbjct: 447 HLAHKDLT---VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA-LENV 501
Query: 259 PVELEKLIHLSELDLSHNFLGE-EMPSQICNMQSLEKLNLSHNNLS---GFIPSCFEELH 314
+ L L EL L +N L + + + L LNL N+L G E L
Sbjct: 502 D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 560
Query: 315 GLSYID 320
+S I
Sbjct: 561 SVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.2 bits (158), Expect = 4e-11
Identities = 33/174 (18%), Positives = 61/174 (35%), Gaps = 11/174 (6%)
Query: 155 SNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLEL 214
+ + QL +LS + S+L L +L + + L +
Sbjct: 334 LKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLM 392
Query: 215 GSLTQLERLDLSSNRLSNSIPKSLGNLVKLH--YLNLSNNQFIKKIPVELEKLIHLSELD 272
+L L + S L + + YL+ ++F+ + V + + L
Sbjct: 393 RALDPLLYEKETLQYFST-----LKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLH 447
Query: 273 LSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326
L+H L + + + + L+LSHN L +P L L + S N L
Sbjct: 448 LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNAL 498
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 6e-09
Identities = 24/97 (24%), Positives = 43/97 (44%), Gaps = 5/97 (5%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L + L L +N ++P + L+ L L+ S N L ++ + NL ++ L L +
Sbjct: 461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCN 517
Query: 61 NALSG-AIPKEYGNLVKLTLLTLENNQLRGPIPNLRN 96
N L A + + +L LL L+ N L ++
Sbjct: 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQE 553
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 4e-07
Identities = 29/169 (17%), Positives = 54/169 (31%), Gaps = 21/169 (12%)
Query: 21 SEIGRLKSLSDLELSGNKLCGSI-----PHSLGNLTQITFLTLFDNALSGAIPKEYGNLV 75
LK++ + + S + L L L+ + L+
Sbjct: 406 QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLL 463
Query: 76 KLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFY 135
+T L L +N+LR P L L L ++ + N L N+ P L + L +N
Sbjct: 464 LVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNN--- 518
Query: 136 GEISS-----DWGRCPKLGTLDFSSNNITGSMPAE---IIHSSQLKVLD 176
+ CP+L L+ N++ + + +
Sbjct: 519 -RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 6e-07
Identities = 33/257 (12%), Positives = 75/257 (29%), Gaps = 13/257 (5%)
Query: 85 NQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGR 144
R + L V +++ ++ S + L +S +W
Sbjct: 230 FYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRT 289
Query: 145 CPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSN 204
+ + + + E + +
Sbjct: 290 PDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDE 349
Query: 205 QLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEK 264
QL + L + T L+ S L P++ L+ + L + + L+
Sbjct: 350 QLF-RCELSVEKSTVLQSELESCKELQELEPENKWCLLTII-LLMRALDPLLYEKETLQY 407
Query: 265 LIHLSELD--------LSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGL 316
L +D + E + L+L+H +L+ E+L +
Sbjct: 408 FSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH--LEQLLLV 465
Query: 317 SYIDISYNELHGSIPNS 333
+++D+S+N L ++P +
Sbjct: 466 THLDLSHNRLR-ALPPA 481
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 54/204 (26%), Positives = 82/204 (40%), Gaps = 41/204 (20%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVK-----KFHSPLPSEMASQQEFLNEVKTLTGIR-HRN 496
+G+G K S + AVK + E+ L H N
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ-----------KEITALKLCEGHPN 67
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSL-AMILS------NDAAAKDLGWTKRMNVIKGVVD 549
IVK + H+F+V E L G L I +A+ +++ +V
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS----------YIMRKLVS 117
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAH---VSDFGTAKFLKPDSSNWAELAGTYG 606
A+S+MH+ +VHRD+ +N+L EN+ + DFG A+ PD+ T
Sbjct: 118 AVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174
Query: 607 YVAPELAYTMKVTEKCDVYSFGVL 630
Y APEL E CD++S GV+
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVI 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 50/221 (22%), Positives = 88/221 (39%), Gaps = 37/221 (16%)
Query: 427 VYEEIIRVTNDFDDE----HCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQE 481
+ +++ R + F D IG G + + AVK S+++
Sbjct: 9 IVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-------SKRD 61
Query: 482 FLNEVKTL-TGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILS------NDAAAK 533
E++ L +H NI+ ++ ++V E ++ G L IL +A+A
Sbjct: 62 PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA- 120
Query: 534 DLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH----VSDFGTAK 589
V+ + + Y+H +VHRD+ N+L E+ + DFG AK
Sbjct: 121 ---------VLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 590 FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 630
L+ ++ T +VAPE+ CD++S GVL
Sbjct: 169 QLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 42/202 (20%), Positives = 84/202 (41%), Gaps = 29/202 (14%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR-NIVKFY 501
+G+G V + +G+ A K + + E L+E+ L + ++ +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLH 95
Query: 502 GFCSHARHSFIVYEYLEMGSL--------AMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
+ ++ EY G + A ++S + +IK +++ + Y
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI---------RLIKQILEGVYY 146
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAH---VSDFGTAKFLKPDSSNWAELAGTYGYVAP 610
+H + IVH D+ +N+LL + DFG ++ + E+ GT Y+AP
Sbjct: 147 LHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAP 202
Query: 611 E-LAYTMKVTEKCDVYSFGVLA 631
E L Y +T D+++ G++A
Sbjct: 203 EILNYD-PITTATDMWNIGIIA 223
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 8e-22
Identities = 46/187 (24%), Positives = 72/187 (38%), Gaps = 18/187 (9%)
Query: 150 TLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSK-LGKLSSLIKLILNSNQLCG 208
L S + ++P + S +LDLS N++ +L++L L+L+ N L
Sbjct: 22 ILSCSKQQLP-NVPQSL--PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-- 76
Query: 209 QLSLELGS---LTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE-LEK 264
+ + + L LDLSSN L +L L L L NN I + E
Sbjct: 77 -NFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNH-IVVVDRNAFED 134
Query: 265 LIHLSELDLSHN---FLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDI 321
+ L +L LS N E+ + L L+LS N L + ++L +
Sbjct: 135 MAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 322 SYNELHG 328
LH
Sbjct: 195 Y---LHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 33/141 (23%), Positives = 59/141 (41%), Gaps = 12/141 (8%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIP-HSLGNLTQITFLTL 58
L+NL L L +N + I SE + +L L+LS N L ++ +L + L L
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLL 119
Query: 59 FDNALSGAIPKE-YGNLVKLTLLTLENNQLR----GPIPNLRNLTSLVRVRLNQNHLTGN 113
++N + + + + ++ +L L L NQ+ I + L L+ + L+ N L
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKL 178
Query: 114 ISESFGIHPNL--AFIDLSHN 132
P + L +N
Sbjct: 179 PLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 43/187 (22%), Positives = 71/187 (37%), Gaps = 35/187 (18%)
Query: 3 SNLAFLYLYNNSFSGSIPSEI--GRLKSLSDLELSGNKLCGSIP-HSLGNLTQITFLTLF 59
S A L L +N+ S + +E RL +L L LS N L I + + + +L L
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLS 96
Query: 60 DNALSGAIPKEY-GNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISE 116
N L + + +L L +L L NN + + ++ L ++ L+QN ++
Sbjct: 97 SNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQIS----- 149
Query: 117 SFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEII---HSSQLK 173
D + PKL LD SSN + +P + +
Sbjct: 150 --RFPVE-LIKDGNK-------------LPKLMLLDLSSNKLK-KLPLTDLQKLPAWVKN 192
Query: 174 VLDLSSN 180
L L +N
Sbjct: 193 GLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 24/95 (25%), Positives = 32/95 (33%), Gaps = 9/95 (9%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIP----HSLGNLTQITF 55
+L L L LYNN + + L L LS N++ P L ++
Sbjct: 110 DLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQI-SRFPVELIKDGNKLPKLML 167
Query: 56 LTLFDNALSGAIPKEYGNLVKLTL--LTLENNQLR 88
L L N L + L L L NN L
Sbjct: 168 LDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 73/311 (23%), Positives = 119/311 (38%), Gaps = 65/311 (20%)
Query: 427 VYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGE---IVAVKKFHSPLPSEMASQQE-- 481
+Y + ND + IG+G G V KA + A+K+ E AS+ +
Sbjct: 18 IYPVLDW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-----EYASKDDHR 70
Query: 482 -FLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTK 539
F E++ L + H NI+ G C H + ++ EY G+L L +
Sbjct: 71 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 130
Query: 540 RMNVIKGVVDA----------------LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVS 583
N + + LS +HRD++++N+L+ A ++
Sbjct: 131 IANSTASTLSSQQLLHFAADVARGMDYLSQKQ------FIHRDLAARNILVGENYVAKIA 184
Query: 584 DFGTAKFLKPDSSNWAELAGTYGYV-----APE-LAYTMKVTEKCDVYSFGVLALEVI-K 636
DFG ++ + + T G + A E L Y+ T DV+S+GVL E++
Sbjct: 185 DFGLSR----GQEVY--VKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSL 237
Query: 637 GKHPRDFISSISSSSSNLEIALNEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPES 694
G P + E L E L RL P N D++ +M C E P
Sbjct: 238 GGTP-------YCGMTCAE--LYEKLPQGYRLEKP-LNCDDEVYDLM---RQCWREKPYE 284
Query: 695 RPTIQKVSQLL 705
RP+ ++ L
Sbjct: 285 RPSFAQILVSL 295
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 48/247 (19%), Positives = 86/247 (34%), Gaps = 40/247 (16%)
Query: 80 LTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEIS 139
+ + L + V+ L + +T ++
Sbjct: 2 SIQRPTPINQ-VFPDPGLANAVKQNLGKQSVT-DLV------------SQKE-------- 39
Query: 140 SDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKL 199
+ + ++NI S+ + + LK L LS N I S L L+ L +L
Sbjct: 40 -----LSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQI--SDLSPLKDLTKLEEL 90
Query: 200 ILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIP 259
+N N+L +L L RL L +N L + SL +L L L++ NN+ +K I
Sbjct: 91 SVNRNRLK---NLNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNK-LKSIV 144
Query: 260 VELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYI 319
L L L LDL N + + ++ + ++L+ EL+ + +
Sbjct: 145 -MLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTV 201
Query: 320 DISYNEL 326
Sbjct: 202 KDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 35/234 (14%), Positives = 88/234 (37%), Gaps = 20/234 (8%)
Query: 47 LGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLN 106
L L +++ + ++ L + +N+ ++ + ++ T+L + L+
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQS-LAGMQFFTNLKELHLS 71
Query: 107 QNHLTGNISESFGIHPNLAFIDLSHNYFYGEISS-DWGRCPKLGTLDFSSNNITGSMPAE 165
N ++ ++ L + ++ N + + + L L +N +
Sbjct: 72 HNQIS-DL-SPLKDLTKLEELSVNRN----RLKNLNGIPSACLSRLFLDNNELRD--TDS 123
Query: 166 IIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLE-LGSLTQLERLD 224
+IH L++L + +N + + LG LS L L L+ N++ + L L ++ +D
Sbjct: 124 LIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEIT---NTGGLTRLKKVNWID 178
Query: 225 LSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFL 278
L+ + N K L + + + ++I P + + +
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELP 230
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 38/161 (23%), Positives = 68/161 (42%), Gaps = 16/161 (9%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
LS + N++ S+ + + +L +L LS N++ + L +LT++ L++
Sbjct: 39 ELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHLSHNQI-SDLS-PLKDLTKLEELSVNR 94
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
N L L+ L L+NN+LR +L +L +L + + N L +I G
Sbjct: 95 NRLKNL---NGIPSACLSRLFLDNNELRD-TDSLIHLKNLEILSIRNNKLK-SIV-MLGF 148
Query: 121 HPNLAFIDLSHNYFYGEIS--SDWGRCPKLGTLDFSSNNIT 159
L +DL N EI+ R K+ +D +
Sbjct: 149 LSKLEVLDLHGN----EITNTGGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 27/120 (22%), Positives = 43/120 (35%), Gaps = 7/120 (5%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+L NL L + NN SI +G L L L+L GN++ + L L ++ ++ L
Sbjct: 126 HLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT-NTG-GLTRLKKVNWIDLTG 181
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGP--IPNLRNLTSLVRVRLNQNHLTGNISESF 118
K L + + + P I N + V T +S F
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDG-CVLWELPVYTDEVSYKF 240
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 61/300 (20%), Positives = 114/300 (38%), Gaps = 62/300 (20%)
Query: 441 EHCIGKGGQGSVYKAELPSGE------IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+G+ G VYK L VA+K + ++EF +E ++H
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL--REEFRHEAMLRARLQH 71
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDA---- 550
N+V G + + +++ Y G L L + D+G T +K ++
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 551 ------------LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW 598
LS H +VH+D++++NVL+ + +SD G + + ++++
Sbjct: 132 HLVAQIAAGMEYLSSHH------VVHKDLATRNVLVYDKLNVKISDLGLFREV--YAADY 183
Query: 599 AELAGTYGYV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHP------RDFISS 646
+ + APE K + D++S+GV+ EV G P +D +
Sbjct: 184 YK-LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242
Query: 647 ISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
I + LP P + + ++M I C +E P RP + + L+
Sbjct: 243 IRNRQ-------------VLPCP-DDCPAWVYALM---IECWNEFPSRRPRFKDIHSRLR 285
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 50/228 (21%), Positives = 89/228 (39%), Gaps = 51/228 (22%)
Query: 435 TNDFDD-----EHCIGKGGQGSVYKA-ELPSGEIVAVK---KFHSPLPSEMASQQEFLNE 485
+ F+D E +G+G V L + + AVK K + E
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEK------QPGHIRSRVFRE 60
Query: 486 VKTLTGIR-HRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSN------DAAAKDLGW 537
V+ L + HRN+++ F ++V+E + GS+ + I +A+
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS------ 114
Query: 538 TKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH---VSDFGTAKFLKPD 594
V++ V AL ++HN I HRD+ +N+L + N+ + DF +K +
Sbjct: 115 ----VVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 595 SS-------NWAELAGTYGYVAPE-----LAYTMKVTEKCDVYSFGVL 630
G+ Y+APE ++CD++S GV+
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 65/297 (21%), Positives = 113/297 (38%), Gaps = 62/297 (20%)
Query: 444 IGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTGI-R 493
+G G G V +A + VAVK L A E ++E+K ++ + +
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKM----LK-STAHADEKEALMSELKIMSHLGQ 108
Query: 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSL-----------AMILSNDAAAKDLGWTKRMN 542
H NIV G C+H ++ EY G L + A ++
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 543 VIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA 602
V ++++ + +HRD++++NVLL + A + DFG A+ + DS +
Sbjct: 169 FSSQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS---NYIV 222
Query: 603 GTYGYV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHP-------RDFISSISS 649
+ APE + T + DV+S+G+L E+ G +P F +
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 650 SSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
++ P + SIM+ +C P RPT Q++ L+
Sbjct: 283 GY-------------QMAQP-AFAPKNIYSIMQ---ACWALEPTHRPTFQQICSFLQ 322
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 12/180 (6%)
Query: 151 LDFSSNNITGSMPAEIIHS-SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ 209
LD SN ++ S+P++ H ++L++L L+ N + +L +L L + N+L
Sbjct: 42 LDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL--- 97
Query: 210 LSLELG---SLTQLERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSNNQFIKKIPVEL-EK 264
+L +G L L L L N+L S+P + +L KL YL+L N+ ++ +P + +K
Sbjct: 98 QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE-LQSLPKGVFDK 155
Query: 265 LIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYN 324
L L EL L +N L + L+ L L +N L F+ L L + + N
Sbjct: 156 LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-20
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 141 DWGRC---PKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLI 197
D G C ++D SS +T ++P+ I + K LDL SN + +L+ L
Sbjct: 8 DGGVCSCNNNKNSVDCSSKKLT-AIPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLR 64
Query: 198 KLILNSNQLCGQLSLELG---SLTQLERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSNNQ 253
L LN N+L +L G L LE L ++ N+L ++P + LV L L L NQ
Sbjct: 65 LLYLNDNKL---QTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQ 120
Query: 254 FIKKIPVEL-EKLIHLSELDLSHNFLGEEMPSQIC-NMQSLEKLNLSHNNLSGFIPSCFE 311
+K +P + + L L+ L L +N L + +P + + SL++L L +N L F+
Sbjct: 121 -LKSLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFD 178
Query: 312 ELHGLSYIDISYNELHGSIPNST 334
+L L + + N+L +P
Sbjct: 179 KLTELKTLKLDNNQLK-RVPEGA 200
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 56/209 (26%), Positives = 84/209 (40%), Gaps = 37/209 (17%)
Query: 51 TQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQN 108
L L N LS K + L KL LL L +N+L+ +P + L +L + + N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDN 95
Query: 109 HLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIH 168
L + P F L L L N + S+P +
Sbjct: 96 KLQ-----AL---PIGVFDQLV----------------NLAELRLDRNQLK-SLPPRVFD 130
Query: 169 S-SQLKVLDLSSNHIVGEMPSKL-GKLSSLIKLILNSNQLCGQLSLELG---SLTQLERL 223
S ++L L L N + +P + KL+SL +L L +NQL + G LT+L+ L
Sbjct: 131 SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL---KRVPEGAFDKLTELKTL 186
Query: 224 DLSSNRLSNSIPKSLGNLVKLHYLNLSNN 252
L +N+L + +L KL L L N
Sbjct: 187 KLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 42/137 (30%), Positives = 70/137 (51%), Gaps = 9/137 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTL 58
L NL L++ +N ++P + +L +L++L L N+L S+P + +LT++T+L+L
Sbjct: 83 ELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSL 140
Query: 59 FDNALSGAIPKE-YGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNIS 115
N L ++PK + L L L L NNQL+ +P LT L ++L+ N L
Sbjct: 141 GYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVPE 198
Query: 116 ESFGIHPNLAFIDLSHN 132
+F L + L N
Sbjct: 199 GAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 9e-15
Identities = 52/202 (25%), Positives = 76/202 (37%), Gaps = 33/202 (16%)
Query: 8 LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTLFDNALSGA 66
L L +N S RL L L L+ NKL ++P + L + L + DN L A
Sbjct: 42 LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ-A 99
Query: 67 IPKE-YGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGIHPN 123
+P + LV L L L+ NQL+ +P +LT L + L N L ++ P
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SL-------PK 150
Query: 124 LAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLDLSSNHI 182
F L+ L L +N + +P ++LK L L +N +
Sbjct: 151 GVFDKLT----------------SLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQL 193
Query: 183 VGEMPSKLGKLSSLIKLILNSN 204
L L L L N
Sbjct: 194 KRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 54/185 (29%), Positives = 81/185 (43%), Gaps = 33/185 (17%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTL 58
L+ L LYL +N ++P+ I LK+L L ++ NKL ++P + L + L L
Sbjct: 59 RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRL 116
Query: 59 FDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISE 116
N L P+ + +L KLT L+L N+L+ +P LTSL +RL N L
Sbjct: 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLKRV--- 172
Query: 117 SFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVL 175
P AF L+ +L TL +N + +P S +LK+L
Sbjct: 173 -----PEGAFDKLT----------------ELKTLKLDNNQLK-RVPEGAFDSLEKLKML 210
Query: 176 DLSSN 180
L N
Sbjct: 211 QLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 38/122 (31%), Positives = 66/122 (54%), Gaps = 6/122 (4%)
Query: 218 TQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDLSHN 276
++LDL SN+LS+ K+ L KL L L++N+ ++ +P + ++L +L L ++ N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNK-LQTLPAGIFKELKNLETLWVTDN 95
Query: 277 FLGEEMPSQI-CNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA 335
L + +P + + +L +L L N L P F+ L L+Y+ + YNEL S+P
Sbjct: 96 KL-QALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKG-V 152
Query: 336 FR 337
F
Sbjct: 153 FD 154
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 64/296 (21%), Positives = 117/296 (39%), Gaps = 56/296 (18%)
Query: 444 IGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTGI-R 493
+G G G V +A + VAVK A E ++E+K L+ +
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-----PSAHLTEREALMSELKVLSYLGN 85
Query: 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG------- 546
H NIV G C+ + ++ EY G L L + T +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 547 --------VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW 598
V ++++ + +HRD++++N+LL + DFG A+ +K DS
Sbjct: 146 DLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDS--- 199
Query: 599 AELAGTYGYV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSS 652
+ + APE + T + DV+S+G+ E+ G P +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM------PV 253
Query: 653 NLEIALNEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ + +M+ R+ +P + ++ IM+ +C D P RPT +++ QL++
Sbjct: 254 DSK--FYKMIKEGFRMLSP-EHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIE 303
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 71/298 (23%), Positives = 117/298 (39%), Gaps = 58/298 (19%)
Query: 444 IGKGGQGSVYKAELPSGE------IVAVKKFHSPLPSEMASQQE---FLNEVKTLTGIRH 494
+G+G G V KA + VAVK L E AS E L+E L + H
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKM----LK-ENASPSELRDLLSEFNVLKQVNH 85
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL-----SNDAAAKDLGWTKRMNVIKGVVD 549
+++K YG CS ++ EY + GSL L G ++
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 550 ALSYMHNDCF-------------PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596
AL+ F +VHRD++++N+L+ + +SDFG ++ + + S
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 597 NWAELAGTYGYV-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISS 649
+ + G + A E L T + DV+SFGVL E++ G +P
Sbjct: 206 Y---VKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP-------YP 254
Query: 650 SSSNLEIALNEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
+ +L R+ P N +++ +M C + P+ RP +S+ L
Sbjct: 255 GIPPERLF--NLLKTGHRMERP-DNCSEEMYRLML---QCWKQEPDKRPVFADISKDL 306
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 64/295 (21%), Positives = 120/295 (40%), Gaps = 57/295 (19%)
Query: 444 IGKGGQGSVYKAELPSGE--------IVAVKKFHSPLPSEMASQQE---FLNEVKTLTGI 492
+G+G G V AE + VAVK + A++++ ++E++ + I
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-----DDATEKDLSDLVSEMEMMKMI 97
Query: 493 -RHRNIVKFYGFCSHARHSFIVYEYLEMGSL-------------AMILSNDAAAKDLGWT 538
+H+NI+ G C+ +++ EY G+L N + + +
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 539 KRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW 598
++ + + Y+ + +HRD++++NVL+ N ++DFG A+ +
Sbjct: 158 DLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDY-- 212
Query: 599 AELAGTYGYV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSS 652
T G + APE + T + DV+SFGVL E+ G P
Sbjct: 213 -YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-------YPGIP 264
Query: 653 NLEIALNEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
E+ ++L R+ P N ++L +M C P RPT +++ + L
Sbjct: 265 VEELF--KLLKEGHRMDKP-ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 313
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 64/294 (21%), Positives = 116/294 (39%), Gaps = 53/294 (18%)
Query: 444 IGKGGQGSVYKAELP--------SGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTGI 492
+G+G G V AE VAVK A++++ ++E++ + I
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-----SDATEKDLSDLISEMEMMKMI 131
Query: 493 -RHRNIVKFYGFCSHARHSFIVYEYLEMGSL-------------AMILSNDAAAKDLGWT 538
+H+NI+ G C+ +++ EY G+L + + L
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 539 KRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW 598
++ V + Y+ + +HRD++++NVL+ +N ++DFG A+ +
Sbjct: 192 DLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY-- 246
Query: 599 AELAGTYGYV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSS 652
T G + APE + T + DV+SFGVL E+ G P +
Sbjct: 247 -YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-------P 298
Query: 653 NLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
E+ R+ P N ++L +M C P RPT +++ + L
Sbjct: 299 VEELFKLLKEGHRMDKP-SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLD 348
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 45/218 (20%), Positives = 81/218 (37%), Gaps = 44/218 (20%)
Query: 435 TNDFDD-----EHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKT 488
D + +G G G V + +G+ A+K + + EV
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL--------LYDSPKARQEVDH 74
Query: 489 LTGI-RHRNIVKFYGFCSHARHS----FIVYEYLEMGSL--------AMILSNDAAAKDL 535
+IV + H I+ E +E G L + AA+
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE-- 132
Query: 536 GWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH---VSDFGTAKFLK 592
+++ + A+ ++H+ I HRD+ +N+L + + ++DFG AK
Sbjct: 133 -------IMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVL 630
++ T YVAPE+ K + CD++S GV+
Sbjct: 183 QNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 62/308 (20%), Positives = 110/308 (35%), Gaps = 75/308 (24%)
Query: 444 IGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTGI-R 493
+G G G V A VAVK E A E ++E+K +T +
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-----EKADSSEREALMSELKMMTQLGS 107
Query: 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
H NIV G C+ + ++++EY G L + +KR + ++ +
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDL----------LNYLRSKREKFSEDEIEYENQ 157
Query: 554 MHNDCFPP---------------------------IVHRDISSKNVLLDLENEAHVSDFG 586
+ VHRD++++NVL+ + DFG
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 587 TAKFLKPDSSNWAELAGTYGYV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHP 640
A+ + DS + + APE + T K DV+S+G+L E+ G +P
Sbjct: 218 LARDIMSDS---NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
Query: 641 RDFISSISSSSSNLEIALNEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTI 698
I + +++ ++ P +++ IM+ SC RP+
Sbjct: 275 YPGI------PVDAN--FYKLIQNGFKMDQP-FYATEEIYIIMQ---SCWAFDSRKRPSF 322
Query: 699 QKVSQLLK 706
++ L
Sbjct: 323 PNLTSFLG 330
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 44/321 (13%), Positives = 95/321 (29%), Gaps = 69/321 (21%)
Query: 47 LGNLTQITFLTLFDNALSG----AIPKEYGNLVKLTLLTLENNQLRGPI------PNLRN 96
+ + I +L +A++ ++ + + L N + G N+ +
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIAS 58
Query: 97 LTSLVRVRLNQNHL----------TGNISESFGIHPNLAFIDLSHNYFYGE----ISSDW 142
L + + ++ P L + LS N F +
Sbjct: 59 KKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 118
Query: 143 GRCPKLGTLDFSSNNIT-------------GSMPAEIIHSSQLKVLDLSSNHI------- 182
+ L L +N + ++ + ++ L+ + N +
Sbjct: 119 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE 178
Query: 183 VGEMPSKLGKLSSLIKLILNSNQL-----CGQLSLELGSLTQLERLDLSSNRLSN----S 233
+ L + + N + L L +L+ LDL N ++ +
Sbjct: 179 WAKT---FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA 235
Query: 234 IPKSLGNLVKLHYLNLSNNQF----IKKIPVELEKLIH--LSELDLSHNFLGEEMPSQIC 287
+ +L + L L L++ + KL + L L L +N + + +
Sbjct: 236 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 295
Query: 288 -----NMQSLEKLNLSHNNLS 303
M L L L+ N S
Sbjct: 296 TVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 55/331 (16%), Positives = 101/331 (30%), Gaps = 64/331 (19%)
Query: 2 LSNLAF--LYLYNNSFSG----SIPSEIGRLKSLSDLELSGNKL----CGSIPHSLGNLT 51
++ + L ++ + S+ + + S+ ++ LSGN + + ++ +
Sbjct: 1 MARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 60
Query: 52 QITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLT 111
+ D + L L L L VRL+ N
Sbjct: 61 DLEIAEFSDIFTGRVKDEIPEALRLLL-------------QALLKCPKLHTVRLSDNAFG 107
Query: 112 GN----ISESFGIHPNLAFIDLSHNYF-------------YGEISSDWGRCPKLGTLDFS 154
+ + H L + L +N ++ P L ++
Sbjct: 108 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 167
Query: 155 SNNIT-GSMPA---EIIHSSQLKVLDLSSNHI-----VGEMPSKLGKLSSLIKLILNSNQ 205
N + GSM L + + N I + L L L L N
Sbjct: 168 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 227
Query: 206 L----CGQLSLELGSLTQLERLDLSSNRLSN----SIPKSLGNLV--KLHYLNLSNNQF- 254
L++ L S L L L+ LS ++ + L L L L N+
Sbjct: 228 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
Query: 255 ---IKKIPVEL-EKLIHLSELDLSHNFLGEE 281
++ + + EK+ L L+L+ N EE
Sbjct: 288 LDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 57/293 (19%), Positives = 105/293 (35%), Gaps = 55/293 (18%)
Query: 77 LTLLTLENNQL-----RGPIPNLRNLTSLVRVRLNQNHLTGN----ISESFGIHPNLAFI 127
+ +L+ + + + L S+ + L+ N + +SE+ +L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 128 DLSHNYFYGEISSDWG-----------RCPKLGTLDFSSNNIT--GSMP--AEIIHSSQL 172
+ S F G + + +CPKL T+ S N P + + L
Sbjct: 66 EFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124
Query: 173 KVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSN 232
+ L L +N + + +K+ + +L +L +N + L + NRL N
Sbjct: 125 EHLYLHNNGLGPQAGAKIAR--ALQELAVNKK---------AKNAPPLRSIICGRNRLEN 173
Query: 233 ----SIPKSLGNLVKLHYLNLSNNQF----IKKIPVE-LEKLIHLSELDLSHNFLGEEMP 283
K+ + LH + + N I+ + +E L L LDL N
Sbjct: 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS 233
Query: 284 SQICNM----QSLEKLNLSHNNLSG----FIPSCFEELH--GLSYIDISYNEL 326
S + +L +L L+ LS + F +L GL + + YNE+
Sbjct: 234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEI 286
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 64/294 (21%), Positives = 112/294 (38%), Gaps = 55/294 (18%)
Query: 444 IGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTGI-R 493
+G+G G V +A+ + VAVK E A+ E ++E+K L I
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK-----EGATHSEHRALMSELKILIHIGH 89
Query: 494 HRNIVKFYGFCSHA-RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG------ 546
H N+V G C+ ++ E+ + G+L+ L + ++ K
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 547 -------VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599
V + ++ + +HRD++++N+LL +N + DFG A+ + D
Sbjct: 150 LICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-- 204
Query: 600 ELAGTYGYV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSN 653
+ + APE + T + DV+SFGVL E+ G P + +
Sbjct: 205 -VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV------KID 257
Query: 654 LEIALNEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
E L R+ P ++ M C P RPT ++ + L
Sbjct: 258 EEFC--RRLKEGTRMRAP-DYTTPEMYQTML---DCWHGEPSQRPTFSELVEHL 305
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 62/305 (20%), Positives = 111/305 (36%), Gaps = 70/305 (22%)
Query: 444 IGKGGQGSVYKAELPSGE------IVAVKKFHSPLPSEMASQQE---FLNEVKTLTGIRH 494
IG+G G V++A P +VAVK E AS F E + +
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-----EEASADMQADFQREAALMAEFDN 109
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDA---- 550
NIVK G C+ + +++EY+ G L L + + + + V +
Sbjct: 110 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 551 --------------------LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590
LS VHRD++++N L+ ++DFG ++
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERK------FVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 591 LKPDSSNWAELAGTYGYV-----APE-LAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDF 643
+ A + PE + Y + T + DV+++GV+ E+ G P
Sbjct: 224 IYSAD---YYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQP--- 276
Query: 644 ISSISSSSSNLEIALNEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
++ E+ + L P N +L ++M C + P RP+ +
Sbjct: 277 ----YYGMAHEEVI--YYVRDGNILACP-ENCPLELYNLMR---LCWSKLPADRPSFCSI 326
Query: 702 SQLLK 706
++L+
Sbjct: 327 HRILQ 331
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 64/295 (21%), Positives = 119/295 (40%), Gaps = 57/295 (19%)
Query: 444 IGKGGQGSVYKAEL--------PSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTGI 492
+G+G G V AE VAVK + A++++ ++E++ + I
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK-----DDATEKDLSDLVSEMEMMKMI 143
Query: 493 -RHRNIVKFYGFCSHARHSFIVYEYLEMGSL-------------AMILSNDAAAKDLGWT 538
+H+NI+ G C+ +++ EY G+L N + + +
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 539 KRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW 598
++ + + Y+ + +HRD++++NVL+ N ++DFG A+ +
Sbjct: 204 DLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY- 259
Query: 599 AELAGTYGYV-----APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSS 652
T G + APE + T + DV+SFGVL E+ G P
Sbjct: 260 --KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-------YPGIP 310
Query: 653 NLEIALNEMLDP--RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705
E+ ++L R+ P N ++L +M C P RPT +++ + L
Sbjct: 311 VEELF--KLLKEGHRMDKP-ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 359
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 56/242 (23%), Positives = 92/242 (38%), Gaps = 30/242 (12%)
Query: 400 RSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKA-ELP 458
+Q P P F + K II +G G G V +
Sbjct: 30 HPPAQPPPPPPQQFPQFHVKSGLQIK--KNAIIDDYKVTSQV--LGLGINGKVLQIFNKR 85
Query: 459 SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFC----SHARHSFIV 513
+ E A+K + + EV+ + +IV+ + + IV
Sbjct: 86 TQEKFALKM--------LQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 137
Query: 514 YEYLEMGSLAMILSNDAAAKDLGWTKRM--NVIKGVVDALSYMHNDCFPPIVHRDISSKN 571
E L+ G L S D +T+R ++K + +A+ Y+H+ I HRD+ +N
Sbjct: 138 MECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPEN 191
Query: 572 VLLDLENEAH---VSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFG 628
+L + ++DFG AK +S T YVAPE+ K + CD++S G
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 250
Query: 629 VL 630
V+
Sbjct: 251 VI 252
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 66/277 (23%), Positives = 112/277 (40%), Gaps = 52/277 (18%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IGKG V A + +G VA+K + + Q+ F EV+ + + H NIVK +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG------VVDALSYMHN 556
+ +++ EY G + L RM + +V A+ Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAH---------GRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA---GTYGYVAPEL- 612
IVHRD+ ++N+LLD + ++DFG + +L G Y APEL
Sbjct: 133 KR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG----KLDAFCGAPPYAAPELF 185
Query: 613 ---AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669
Y + DV+S GV+ ++ G P D NL+ +L + P
Sbjct: 186 QGKKYDGP---EVDVWSLGVILYTLVSGSLPFD--------GQNLKELRERVLRGKYRIP 234
Query: 670 SH---NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
+ + ++ L+ L +P R T++++ +
Sbjct: 235 FYMSTDCEN-LLKRF------LVLNPIKRGTLEQIMK 264
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 61/276 (22%), Positives = 99/276 (35%), Gaps = 47/276 (17%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVK---KFHSPLPSEMASQQEFLNEVKTL----TGIRHR 495
+GKGG G+V+ L VA+K + S ++ EV L G H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGS--LAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
+++ + +V E I + R VV A+ +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS---R-CFFGQVVAAIQH 154
Query: 554 MHNDCFPPIVHRDISSKNVLLDLE-NEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL 612
H+ +VHRDI +N+L+DL A + DFG+ L + + GT Y PE
Sbjct: 155 CHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDGTRVYSPPEW 209
Query: 613 ----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668
Y V+S G+L +++ G P + I + + P
Sbjct: 210 ISRHQYHAL---PATVWSLGILLYDMVCGDIPFERDQEILEA------------ELHFPA 254
Query: 669 P-SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
S + LI CL P SRP+++++
Sbjct: 255 HVSPDCCA-LIR------RCLAPKPSSRPSLEEILL 283
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 36/226 (15%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKK-FHSPLPSEMASQQEFLNEVKTLT 490
+ + F E G+G G+V E +G VA+KK P +E L ++ L
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP----RFRNRE-LQIMQDLA 74
Query: 491 GIRHRNIVK-FYGFCSHARHSF------IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNV 543
+ H NIV+ F + +V EY+ +L N + +
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV---APPPIL 130
Query: 544 IKG----VVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTAKFLKPDSSNW 598
IK ++ ++ +H + HRDI NVL++ + + DFG+AK L P N
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189
Query: 599 AELAGTYGYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 638
A + Y Y APEL YT V D++S G + A E++ G+
Sbjct: 190 AYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFA-EMMLGE 229
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 57/281 (20%), Positives = 103/281 (36%), Gaps = 59/281 (20%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVK-----KFHSPLPSEMASQQEFLNEVKTLTGIRHRNI 497
+G G G V+ A + V VK K E + E+ L+ + H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 498 VKFYGFCSHARHSFIVYEYLEMG-------SLAMILSNDAAAKDLGWTKRMNVIKGVVDA 550
+K + +V E G L A+ + + +V A
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY---------IFRQLVSA 142
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS--SNWAELAGTYGYV 608
+ Y+ I+HRDI +N+++ + + DFG+A +L+ + GT Y
Sbjct: 143 VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---CGTIEYC 196
Query: 609 APEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP 664
APE+ Y + +++S GV ++ ++P L E ++
Sbjct: 197 APEVLMGNPYRGP---ELEMWSLGVTLYTLVFEENPFC--------------ELEETVEA 239
Query: 665 RLPTPSHNVQD--KLISIMEVAISCLDESPESRPTIQKVSQ 703
+ P ++ L+S + L PE R T++K+
Sbjct: 240 AIHPPYLVSKELMSLVSGL------LQPVPERRTTLEKLVT 274
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 41/232 (17%), Positives = 90/232 (38%), Gaps = 16/232 (6%)
Query: 77 LTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYG 136
+ ++ IP+L S ++L + HL S +F PN++ I +S +
Sbjct: 13 EEDFRVTCKDIQR-IPSL--PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 137 EISSDW-GRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLDLSSNHIVGEMP--SKLGK 192
++ S K+ ++ + + + + LK L + + + P +K+
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYS 128
Query: 193 LSSLIKLILNSNQLCGQLSLEL--GSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLS 250
L + N + + G + L L +N + S+ N KL + L+
Sbjct: 129 TDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLN 187
Query: 251 NNQFIKKIPVE-LEKLIH-LSELDLSHNFLGEEMPSQICNMQSLEKLNLSHN 300
N+++ I + + S LD+S + +PS+ ++ L++L +
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSV-TALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 34/200 (17%), Positives = 76/200 (38%), Gaps = 12/200 (6%)
Query: 146 PKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKL-GKLSSLIKLILNSN 204
P TL ++ + + + +S + + ++ S LS + + + +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 205 QLCGQLSLE-LGSLTQLERLDLSSNRLSNSIP--KSLGNLVKLHYLNLSNNQFIKKIPVE 261
+ + + L L L+ L + + L P + + L +++N ++ IPV
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
Query: 262 -LEKLIHLS-ELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPS-CFEELH-GLS 317
+ L + + L L +N + N L+ + L+ N I F ++ G S
Sbjct: 150 AFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 318 YIDISYNELHGSIPNSTAFR 337
+D+S + ++P S
Sbjct: 209 LLDVSQTSVT-ALP-SKGLE 226
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 9e-17
Identities = 47/258 (18%), Positives = 86/258 (33%), Gaps = 39/258 (15%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIP-HSLGNLTQITFLTLFDN 61
+ IPS S L+L L +IP H+ NL I+ + + +
Sbjct: 11 HQEEDFRVTCKDIQ-RIPS---LPPSTQTLKLIETHL-RTIPSHAFSNLPNISRIYVSID 65
Query: 62 ALSGAIPKEY-GNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESF 118
+ NL K+T + + N + I L+ L L + + L F
Sbjct: 66 VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-----MF 120
Query: 119 GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIH--SSQLKVLD 176
P+L + + L+ + N S+P ++ L
Sbjct: 121 ---PDLTKVYST---------------DIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162
Query: 177 LSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLEL--GSLTQLERLDLSSNRLSNSI 234
L +N + + L + LN N+ + + G + LD+S ++ ++
Sbjct: 163 LYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-AL 220
Query: 235 P-KSLGNLVKLHYLNLSN 251
P K L +L +L N
Sbjct: 221 PSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 34/208 (16%), Positives = 71/208 (34%), Gaps = 23/208 (11%)
Query: 144 RCPKLGTLDFSSNNITG--SMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLIL 201
C + + +I S+P + L L H+ L ++ ++ +
Sbjct: 9 ECHQEEDFRVTCKDIQRIPSLPPS------TQTLKLIETHLRTIPSHAFSNLPNISRIYV 62
Query: 202 NSNQLCGQLS-LELGS---LTQLERLDLSSNRLSNSIPKS-LGNLVKLHYLNLSNNQFIK 256
+ + L LE S L+++ +++ + R I L L L +L + N +K
Sbjct: 63 SID---VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTG-LK 118
Query: 257 KIP--VELEKLIHLSELDLSHNFLGEEMPSQI-CNMQS-LEKLNLSHNNLSGFIPSCFEE 312
P ++ L+++ N +P + + L L +N + F
Sbjct: 119 MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG 178
Query: 313 LHGLSYIDISYNELHGSIPNSTAFRDAP 340
L + ++ N+ I AF
Sbjct: 179 TK-LDAVYLNKNKYLTVIDKD-AFGGVY 204
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 39/213 (18%), Positives = 71/213 (33%), Gaps = 38/213 (17%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHS-LGNLTQITFLTL 58
NL N++ +Y+ + + S L ++ +E+ + I L L + FL +
Sbjct: 53 NLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI 112
Query: 59 FDNALSGAIPKEY--GNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRV-RLNQNHLTGN 113
F+ L P + +L + +N IP + L + +L N T
Sbjct: 113 FNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-- 169
Query: 114 ISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIH--SSQ 171
+ AF KL + + N + + S
Sbjct: 170 -----SVQGY-AFNGT-----------------KLDAVYLNKNKYLTVIDKDAFGGVYSG 206
Query: 172 LKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSN 204
+LD+S + +PSK L L +LI +
Sbjct: 207 PSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 42/187 (22%), Positives = 64/187 (34%), Gaps = 33/187 (17%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPH--SLGNLTQITFLT 57
NLS + + + N I + L L L + L P + + L
Sbjct: 78 NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL-KMFPDLTKVYSTDIFFILE 136
Query: 58 LFDNALSGAIPKE-YGNLVKLTL-LTLENNQLRGPIPNLRNLTSLVRVRLNQN-HLTGNI 114
+ DN +IP + L TL L L NN N T L V LN+N +LT
Sbjct: 137 ITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLT--- 193
Query: 115 SESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKV 174
I + AF + LD S ++T ++P++ + LK
Sbjct: 194 ----VIDKD-AFGGVYSG---------------PSLLDVSQTSVT-ALPSKGLEH--LKE 230
Query: 175 LDLSSNH 181
L +
Sbjct: 231 LIARNTW 237
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 62/279 (22%), Positives = 100/279 (35%), Gaps = 55/279 (19%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVK---KFHSPLPSEMASQQEFLNEVKTLTGIRHR--NI 497
+G GG GSVY + VA+K K E+ + EV L + +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 498 VKFYGFCSHARHSFIVYEYLE-MGSL-AMI-----LSNDAAAKDLGWTKRMNVIKGVVDA 550
++ + ++ E E + L I L + A V++A
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS---------FFWQVLEA 161
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLE-NEAHVSDFGTAKFLKPDSSNWAELAGTYGYVA 609
+ + HN ++HRDI +N+L+DL E + DFG+ LK + + + GT Y
Sbjct: 162 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSP 216
Query: 610 PEL----AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPR 665
PE Y + V+S G+L +++ G P + I
Sbjct: 217 PEWIRYHRYHGR---SAAVWSLGILLYDMVCGDIPFEHDEEIIRG------------QVF 261
Query: 666 LPT-PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
S Q LI CL P RPT +++
Sbjct: 262 FRQRVSSECQH-LIR------WCLALRPSDRPTFEEIQN 293
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 1e-16
Identities = 64/272 (23%), Positives = 102/272 (37%), Gaps = 41/272 (15%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G+G G V A + E VAVK + + E+ + H N+VKFYG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYG 72
Query: 503 FCSHARHSFIVYEYLEMGSL-AMI-----LSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
++ EY G L I + A + ++ + Y+H
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---------FFHQLMAGVVYLHG 123
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA---GTYGYVAPEL- 612
I HRDI +N+LLD + +SDFG A + ++ L GT YVAPEL
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPYVAPELL 179
Query: 613 ---AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669
+ E DV+S G++ ++ G+ P + S + +
Sbjct: 180 KRREFH---AEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
L+ + L E+P +R TI +
Sbjct: 235 DSAPLA-LLHKI------LVENPSARITIPDI 259
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 60/279 (21%), Positives = 110/279 (39%), Gaps = 47/279 (16%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFH-SPLPSEMASQQEFLNEVKTLTGIRHRNIVKFY 501
+G+G G V + + AVK L + E++ L +RH+N+++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 502 GFCSHA--RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG------VVDALSY 553
+ + ++V EY G M+ D+ + KR V + ++D L Y
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEML---DSVPE-----KRFPVCQAHGYFCQLIDGLEY 124
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA----GTYGYVA 609
+H+ IVH+DI N+LL +S G A+ L P +++ + G+ +
Sbjct: 125 LHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD--DTCRTSQGSPAFQP 179
Query: 610 PELAYTMKVTE--KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667
PE+A + K D++S GV + G +P + N+ +
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE--------GDNIYKLFENIGKGSYA 231
Query: 668 TP---SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
P + D L+ M L+ P R +I+++ Q
Sbjct: 232 IPGDCGPPLSD-LLKGM------LEYEPAKRFSIRQIRQ 263
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 71/271 (26%), Positives = 114/271 (42%), Gaps = 52/271 (19%)
Query: 399 RRSSSQTQQSSPGNAPGFLSVLSF----EGKIVYEEII--------RVTNDFDDEHCIGK 446
R++S + P P + +G V + + D IG
Sbjct: 5 PRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGN 64
Query: 447 GGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLN-EVKTLTGIRHRNIVKFYGFC 504
G G VY+A+L SGE+VA+KK + + F N E++ + + H NIV+ F
Sbjct: 65 GSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 505 SHARHSF------IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG----VVDALSYM 554
+ +V +Y+ + A + L + +K + +L+Y+
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP----VIYVKLYMYQLFRSLAYI 172
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEA-HVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL- 612
H+ I HRDI +N+LLD + + DFG+AK L N + + Y Y APEL
Sbjct: 173 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YRAPELI 228
Query: 613 ----AYTMKVTEKCDVYSFG-VLALEVIKGK 638
YT + DV+S G VLA E++ G+
Sbjct: 229 FGATDYTSSI----DVWSAGCVLA-ELLLGQ 254
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 7e-16
Identities = 37/157 (23%), Positives = 64/157 (40%), Gaps = 14/157 (8%)
Query: 150 TLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPS-KLGKLSSLIKLILNSNQLCG 208
T+D S+ + +P I L L++N + KL L K+ ++N++
Sbjct: 15 TVDCSNQKLN-KIPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-- 69
Query: 209 QLSLELG---SLTQLERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSNNQFIKKIPVEL-E 263
+E G + + + L+SNRL ++ + L L L L +N+ I + +
Sbjct: 70 -TDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNR-ITCVGNDSFI 126
Query: 264 KLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHN 300
L + L L N + P + SL LNL N
Sbjct: 127 GLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 7e-14
Identities = 36/142 (25%), Positives = 63/142 (44%), Gaps = 11/142 (7%)
Query: 119 GIHPNLAFIDLSHNYFYG-EISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLD 176
I A + L++N F E + + + P+L ++FS+N IT + S + +
Sbjct: 29 HIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEIL 87
Query: 177 LSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGS---LTQLERLDLSSNRLSNS 233
L+SN + L SL L+L SN++ + S L+ + L L N+++ +
Sbjct: 88 LTSNRLENVQHKMFKGLESLKTLMLRSNRI---TCVGNDSFIGLSSVRLLSLYDNQIT-T 143
Query: 234 IPK-SLGNLVKLHYLNLSNNQF 254
+ + L L LNL N F
Sbjct: 144 VAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 25/120 (20%), Positives = 51/120 (42%), Gaps = 6/120 (5%)
Query: 218 TQLERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSNNQFIKKIPVE-LEKLIHLSELDLSH 275
L L++N + + L +L +N SNN+ I I E ++E+ L+
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNK-ITDIEEGAFEGASGVNEILLTS 90
Query: 276 NFLGEEMPSQIC-NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST 334
N L E + ++ ++SL+ L L N ++ F L + + + N++ ++
Sbjct: 91 NRL-ENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 27/129 (20%), Positives = 63/129 (48%), Gaps = 3/129 (2%)
Query: 198 KLILNSNQLCG-QLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIK 256
+L LN+N+ + + L QL +++ S+N++++ + ++ + L++N+ ++
Sbjct: 36 ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR-LE 94
Query: 257 KIPVEL-EKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHG 315
+ ++ + L L L L N + + S+ L+L N ++ P F+ LH
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154
Query: 316 LSYIDISYN 324
LS +++ N
Sbjct: 155 LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 24/113 (21%), Positives = 47/113 (41%), Gaps = 9/113 (7%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTL 58
L L + NN + I ++++ L+ N+L ++ H + L + L L
Sbjct: 55 KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLML 112
Query: 59 FDNALSGAIPKE-YGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQN 108
N ++ + + + L + LL+L +NQ+ + L SL + L N
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 31/129 (24%), Positives = 54/129 (41%), Gaps = 6/129 (4%)
Query: 8 LYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPH-SLGNLTQITFLTLFDNALSG 65
L L NN F+ + I +L L + S NK+ I + + + + L N L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRLEN 95
Query: 66 AIPKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGIHPN 123
K + L L L L +N++ + N L+S+ + L N +T +F +
Sbjct: 96 VQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154
Query: 124 LAFIDLSHN 132
L+ ++L N
Sbjct: 155 LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 20/89 (22%), Positives = 41/89 (46%), Gaps = 6/89 (6%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPH-SLGNLTQITFLTLF 59
S + + L +N ++ ++ L+SL L L N++ + + S L+ + L+L+
Sbjct: 80 ASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLY 137
Query: 60 DNALSGAIPKE-YGNLVKLTLLTLENNQL 87
DN ++ + + L L+ L L N
Sbjct: 138 DNQIT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 14/65 (21%), Positives = 28/65 (43%), Gaps = 4/65 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPH-SLGNLTQITFLTL 58
L +L L L +N + + ++ L S+ L L N++ ++ + L ++ L L
Sbjct: 103 GLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQI-TTVAPGAFDTLHSLSTLNL 160
Query: 59 FDNAL 63
N
Sbjct: 161 LANPF 165
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTG 491
+DF+ IG+G V ++ +G++ A+K + +M + E F E L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNK---WDMLKRGEVSCFREERDVLVN 117
Query: 492 IRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDA 550
R I + + F + ++V EY G L +LS + + +V A
Sbjct: 118 GDRRWITQLHFAFQD-ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY--LAEIVMA 174
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAKFLKPDSSNWAELA-GTYGY 607
+ +H VHRDI N+LLD H+ +DFG+ L+ D + + +A GT Y
Sbjct: 175 IDSVHRLG---YVHRDIKPDNILLD--RCGHIRLADFGSCLKLRADGTVRSLVAVGTPDY 229
Query: 608 VAPELAYTMKVTEK-------CDVYSFGVLALEVIKGKHP 640
++PE+ + CD ++ GV A E+ G+ P
Sbjct: 230 LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 64/272 (23%), Positives = 102/272 (37%), Gaps = 41/272 (15%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G+G G V A + E VAVK + + E+ + H N+VKFYG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYG 72
Query: 503 FCSHARHSFIVYEYLEMGSL-AMI-----LSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
++ EY G L I + A + ++ + Y+H
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR---------FFHQLMAGVVYLHG 123
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA---GTYGYVAPEL- 612
I HRDI +N+LLD + +SDFG A + ++ L GT YVAPEL
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPYVAPELL 179
Query: 613 ---AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669
+ E DV+S G++ ++ G+ P + S + +
Sbjct: 180 KRREFH---AEPVDVWSCGIVLTAMLAGELP--WDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
L+ + L E+P +R TI +
Sbjct: 235 DSAPLA-LLHKI------LVENPSARITIPDI 259
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 51/219 (23%), Positives = 84/219 (38%), Gaps = 31/219 (14%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
DF +G+G +V A EL + A+K + E ++ + H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL------SNDAA----AKDLGWTKRMNVI 544
VK Y + Y + G L + A+
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE----------- 138
Query: 545 KGVVDALSYMH-NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE--L 601
+V AL Y+H I+HRD+ +N+LL+ + ++DFGTAK L P+S
Sbjct: 139 --IVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 602 AGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
GT YV+PEL + D+++ G + +++ G P
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLN-----EVKTLTGIRHRNI 497
+G+G G V K +G IVA+KKF + + + E+K L +RH N+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHND 557
V C + ++V+E+++ ++ L + L + + +++ + + H+
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL----- 612
I+HRDI +N+L+ + DFG A+ L + + T Y APEL
Sbjct: 144 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 613 AYTMKVTEKCDVYSFGVLALEVIKGK 638
Y V DV++ G L E+ G+
Sbjct: 201 KYGKAV----DVWAIGCLVTEMFMGE 222
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 60/291 (20%), Positives = 107/291 (36%), Gaps = 50/291 (17%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVK------------KFHSPLPSEMASQQEFLN------ 484
IGKG G V A A+K P P
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 485 -----EVKTLTGIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNDAAAKDLGW 537
E+ L + H N+VK H ++V+E + G + + + ++D
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 538 TKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN 597
+ ++ + Y+H I+HRDI N+L+ + ++DFG + K +
Sbjct: 141 ----FYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 598 WAELAGTYGYVAPELAYTMKVT---EKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL 654
+ GT ++APE + + DV++ GV + G+ P L
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM-----DERIMCL 248
Query: 655 --EIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
+I + P P + +++D LI+ M LD++PESR + ++
Sbjct: 249 HSKIKSQALEFPDQPDIAEDLKD-LITRM------LDKNPESRIVVPEIKL 292
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 32/128 (25%), Positives = 53/128 (41%), Gaps = 9/128 (7%)
Query: 175 LDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLE-LGSLTQLERLDLSSNRLSNS 233
L I +M + L L + L L++N + + L + L L L N +
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNI---EKISSLSGMENLRILSLGRNLIK-K 84
Query: 234 IPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGE-EMPSQICNMQSL 292
I L L +S NQ I + +EKL++L L +S+N + ++ + L
Sbjct: 85 IENLDAVADTLEELWISYNQ-IASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKL 142
Query: 293 EKLNLSHN 300
E L L+ N
Sbjct: 143 EDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 34/144 (23%), Positives = 61/144 (42%), Gaps = 7/144 (4%)
Query: 196 LIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFI 255
++L + ++ L +L + L LS+N + I SL + L L+L N I
Sbjct: 27 KVELHGMIPPI-EKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNL-I 82
Query: 256 KKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIP-SCFEELH 314
KKI L EL +S+N + S I + +L L +S+N ++ + L
Sbjct: 83 KKIENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALD 140
Query: 315 GLSYIDISYNELHGSIPNSTAFRD 338
L + ++ N L+ + A +
Sbjct: 141 KLEDLLLAGNPLYNDYKENNATSE 164
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 7e-13
Identities = 28/117 (23%), Positives = 56/117 (47%), Gaps = 8/117 (6%)
Query: 212 LELGSLTQLERLDL--SSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLS 269
+ T+ E+++L + + +L L +L LS N I+KI L + +L
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNN-IEKI-SSLSGMENLR 73
Query: 270 ELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326
L L N + +++ + +LE+L +S+N ++ S E+L L + +S N++
Sbjct: 74 ILSLGRNLI-KKIENLDAVADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKI 127
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 30/161 (18%), Positives = 59/161 (36%), Gaps = 23/161 (14%)
Query: 67 IPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAF 126
+ L L L N + I +L + +L + L +N + I + L
Sbjct: 40 MDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEE 97
Query: 127 IDLSHNYFYGEIS--SDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLDLSSNHIV 183
+ +S+N +I+ S + L L S+N IT + + + +L+ L L+ N +
Sbjct: 98 LWISYN----QIASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153
Query: 184 GEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLD 224
+ I+++ L L++LD
Sbjct: 154 NDYKENNATSEYRIEVVKR--------------LPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 21/111 (18%), Positives = 41/111 (36%), Gaps = 10/111 (9%)
Query: 220 LERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNN-QFIKKIPVELEKLIHLSELDLSHNFL 278
+ + + + + + + L I+K+ L L L LS N +
Sbjct: 1 MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI 60
Query: 279 GEEMPSQICN---MQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326
+I + M++L L+L N + I + L + ISYN++
Sbjct: 61 -----EKISSLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQI 105
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 32/157 (20%), Positives = 55/157 (35%), Gaps = 18/157 (11%)
Query: 8 LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAI 67
L+ + + + LK+ L LS N + I L + + L+L N + I
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNI-EKISS-LSGMENLRILSLGRNLIK-KI 85
Query: 68 PKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISE--SFGIHPNLA 125
L L + NQ+ + + L +L + ++ N +T N E L
Sbjct: 86 ENLDAVADTLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLE 143
Query: 126 FIDLSHNYFYGEISSDWG----------RCPKLGTLD 152
+ L+ N Y + + R P L LD
Sbjct: 144 DLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 32/140 (22%), Positives = 51/140 (36%), Gaps = 17/140 (12%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L L L N+ I S + +++L L L N + I + + L +
Sbjct: 46 TLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISY 102
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLR--GPIPNLRNLTSLVRVRLNQNHLTGNISESF 118
N ++ LV L +L + NN++ G I L L L + L N L + E+
Sbjct: 103 NQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENN 160
Query: 119 GIH----------PNLAFID 128
PNL +D
Sbjct: 161 ATSEYRIEVVKRLPNLKKLD 180
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 27/206 (13%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLN-----EVKTLTGIRHRNI 497
IG+G G V+K +G+IVA+KKF + + E++ L ++H N+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFL------ESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHND 557
V R +V+EY + ++ L K ++ + A+++ H
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK--SITWQTLQAVNFCHKH 121
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL----- 612
+HRD+ +N+L+ + + DFG A+ L S + + T Y +PEL
Sbjct: 122 N---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDT 178
Query: 613 AYTMKVTEKCDVYSFGVLALEVIKGK 638
Y V DV++ G + E++ G
Sbjct: 179 QYGPPV----DVWAIGCVFAELLSGV 200
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 6e-15
Identities = 64/275 (23%), Positives = 109/275 (39%), Gaps = 47/275 (17%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G G G V E +G VAVK + + + E++ L RH +I+K Y
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 503 FCSHARHSFIVYEYLEMGSL-AMI-----LSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
S F+V EY+ G L I + A + + + ++ A+ Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR---------LFQQILSAVDYCHR 129
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA-GTYGYVAPEL--- 612
+VHRD+ +NVLLD A ++DFG + + + + G+ Y APE+
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISG 184
Query: 613 -AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671
Y + D++S GV+ ++ G P D ++ ++ P +
Sbjct: 185 RLYA---GPEVDIWSCGVILYALLCGTLPFD--------DEHVPTLFKKIRGGVFYIPEY 233
Query: 672 ---NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
+V L+ M L P R TI+ + +
Sbjct: 234 LNRSVAT-LLMHM------LQVDPLKRATIKDIRE 261
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 67/264 (25%), Positives = 117/264 (44%), Gaps = 43/264 (16%)
Query: 393 GLFFMFRRSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSV 452
G F M + + + + + VL+ +GK + I + + IG G G V
Sbjct: 1 GSFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIA----YTNCKVIGNGSFGVV 56
Query: 453 YKAELPSGEIVAVKKFHSPLPSEMASQQEFLN-EVKTLTGIRHRNIVK-FYGFCSHARHS 510
++A+L + VA+KK + + F N E++ + ++H N+V F S+
Sbjct: 57 FQAKLVESDEVAIKK--------VLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKK 108
Query: 511 -----FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG----VVDALSYMHNDCFPP 561
+V EY+ + + M +IK ++ +L+Y+H+
Sbjct: 109 DEVFLNLVLEYVPETVYRASRHYAKLKQTMP----MLLIKLYMYQLLRSLAYIHSIG--- 161
Query: 562 IVHRDISSKNVLLDLEN-EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL-----AYT 615
I HRDI +N+LLD + + DFG+AK L N + + Y Y APEL YT
Sbjct: 162 ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-YRAPELIFGATNYT 220
Query: 616 MKVTEKCDVYSFG-VLALEVIKGK 638
+ D++S G V+A E+++G+
Sbjct: 221 TNI----DIWSTGCVMA-ELMQGQ 239
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 6e-15
Identities = 53/216 (24%), Positives = 82/216 (37%), Gaps = 44/216 (20%)
Query: 51 TQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLR--GPIPNLRNLTSLVRVRLNQN 108
+ L +++ A+ + L + + N+ ++ I L N+ L L N
Sbjct: 19 AETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQYLPNVRYL---ALGGN 73
Query: 109 HLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIH 168
L A +L+ L L + N + S+P +
Sbjct: 74 KLH-----DIS-----ALKELT----------------NLTYLILTGNQLQ-SLPNGVFD 106
Query: 169 S-SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG---SLTQLERLD 224
+ LK L L N + KL++L L L NQL SL G LT L LD
Sbjct: 107 KLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQL---QSLPKGVFDKLTNLTELD 163
Query: 225 LSSNRLSNSIPKSL-GNLVKLHYLNLSNNQFIKKIP 259
LS N+L S+P+ + L +L L L NQ +K +P
Sbjct: 164 LSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQ-LKSVP 197
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 43/195 (22%), Positives = 86/195 (44%), Gaps = 18/195 (9%)
Query: 144 RCPKLGT-LDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILN 202
+ ++T + + + + +++ I + L ++ L L
Sbjct: 16 DAFAETIKANLKKKSVT-DAVTQN-ELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALG 71
Query: 203 SNQLCGQLSLELG---SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIP 259
N+L ++ LT L L L+ N+L + L L L L NQ ++ +P
Sbjct: 72 GNKLH-----DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQ-LQSLP 125
Query: 260 VEL-EKLIHLSELDLSHNFLGEEMPSQIC-NMQSLEKLNLSHNNLSGFIPSCFEELHGLS 317
+ +KL +L+ L+L+HN L + +P + + +L +L+LS+N L F++L L
Sbjct: 126 DGVFDKLTNLTYLNLAHNQL-QSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLK 184
Query: 318 YIDISYNELHGSIPN 332
+ + N+L S+P+
Sbjct: 185 DLRLYQNQLK-SVPD 198
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 9/112 (8%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTLF 59
L+NL L L N S+P + +L +L+ L L+ N+L S+P + LT +T L L
Sbjct: 108 LTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQL-QSLPKGVFDKLTNLTELDLS 165
Query: 60 DNALSGAIPKE-YGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQN 108
N L ++P+ + L +L L L NQL+ +P+ LTSL + L+ N
Sbjct: 166 YNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 60/258 (23%), Positives = 89/258 (34%), Gaps = 85/258 (32%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLG---NLTQITFLT 57
L+++ + N+ S+ I L ++ L L GNKL H + LT +T+L
Sbjct: 39 ELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKL-----HDISALKELTNLTYLI 91
Query: 58 LFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISES 117
L N L + L L L L NQ L SL
Sbjct: 92 LTGNQLQSLPNGVFDKLTNLKELVLVENQ----------LQSL----------------- 124
Query: 118 FGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLD 176
P+ F L+ L L+ + N + S+P + + L LD
Sbjct: 125 ----PDGVFDKLT----------------NLTYLNLAHNQLQ-SLPKGVFDKLTNLTELD 163
Query: 177 LSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPK 236
LS N +L SL + + + LTQL+ L L N+L S+P
Sbjct: 164 LSYN-----------QLQSLPEGVFD-------------KLTQLKDLRLYQNQL-KSVPD 198
Query: 237 -SLGNLVKLHYLNLSNNQ 253
L L Y+ L +N
Sbjct: 199 GVFDRLTSLQYIWLHDNP 216
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-15
Identities = 31/119 (26%), Positives = 57/119 (47%), Gaps = 5/119 (4%)
Query: 218 TQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDLSHN 276
+ + L N + P + KL ++LSNNQ I ++ + + L L+ L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQ-ISELAPDAFQGLRSLNSLVLYGN 90
Query: 277 FLGEEMPSQI-CNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST 334
+ E+P + + SL+ L L+ N ++ F++LH L+ + + N+L +I T
Sbjct: 91 KI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGT 147
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 33/131 (25%), Positives = 57/131 (43%), Gaps = 8/131 (6%)
Query: 198 KLILNSNQLCGQLSLELG---SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQF 254
++ L N + + G +L R+DLS+N++S P + L L+ L L N+
Sbjct: 36 EIRLEQNTIK---VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK- 91
Query: 255 IKKIPVEL-EKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEEL 313
I ++P L E L L L L+ N + ++ +L L+L N L F L
Sbjct: 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151
Query: 314 HGLSYIDISYN 324
+ + ++ N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 31/112 (27%), Positives = 52/112 (46%), Gaps = 7/112 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTL 58
L + L NN S + + L+SL+ L L GNK+ +P SL L + L L
Sbjct: 54 PYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLL 111
Query: 59 FDNALSGAIPKE-YGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQN 108
N ++ + + + +L L LL+L +N+L+ L ++ + L QN
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 34/141 (24%), Positives = 53/141 (37%), Gaps = 8/141 (5%)
Query: 119 GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLDL 177
+ + I L N + KL +D S+N I+ + + L L L
Sbjct: 29 NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVL 87
Query: 178 SSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG---SLTQLERLDLSSNRLSNSI 234
N I S L SL L+LN+N++ L + L L L L N+L
Sbjct: 88 YGNKITELPKSLFEGLFSLQLLLLNANKI---NCLRVDAFQDLHNLNLLSLYDNKLQTIA 144
Query: 235 PKSLGNLVKLHYLNLSNNQFI 255
+ L + ++L+ N FI
Sbjct: 145 KGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 31/167 (18%), Positives = 61/167 (36%), Gaps = 33/167 (19%)
Query: 18 SIPSEIGRLKSLSDLELSGNKLCGSIPH-SLGNLTQITFLTLFDNALSGAIPKEYGNLVK 76
IP+ + ++++++ L N + IP + ++ + L +N +S P + L
Sbjct: 25 EIPTNL--PETITEIRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRS 81
Query: 77 LTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYF 134
L L L N++ +P L SL + LN N + + + AF DL
Sbjct: 82 LNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKIN-------CLRVD-AFQDL----- 127
Query: 135 YGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS-SQLKVLDLSSN 180
L L N + ++ ++ + L+ N
Sbjct: 128 -----------HNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-08
Identities = 35/179 (19%), Positives = 54/179 (30%), Gaps = 49/179 (27%)
Query: 51 TQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHL 110
IT + L N + P + KL + L NNQ ++ L
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQ----------ISEL---------- 71
Query: 111 TGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS- 169
AF L L +L N IT +P +
Sbjct: 72 -----------APDAFQGLRS----------------LNSLVLYGNKIT-ELPKSLFEGL 103
Query: 170 SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSN 228
L++L L++N I L +L L L N+L L ++ + L+ N
Sbjct: 104 FSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 41/224 (18%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+ F+ IGKG G V + + ++ A+K + E + E++ + G+ H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 495 RNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDA----------AAKDLGWTKRMNV 543
+V +Y F F+V + L G L L + +
Sbjct: 75 PFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE---------- 123
Query: 544 IKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAG 603
+V AL Y+ N I+HRD+ N+LLD H++DF A L ++ +AG
Sbjct: 124 ---LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAG 176
Query: 604 TYGYVAPEL-------AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
T Y+APE+ Y+ V D +S GV A E+++G+ P
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 48/225 (21%), Positives = 86/225 (38%), Gaps = 44/225 (19%)
Query: 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI 492
V + + IG G QG V A + VA+KK P ++ +++ E+ + +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA-YRELVLMKCV 81
Query: 493 RHRNIVKFY------GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG 546
H+NI+ + +IV E ++ +L VI+
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA--------------NLC-----QVIQM 122
Query: 547 VVD-------------ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593
+D + ++H+ I+HRD+ N+++ + + DFG A+
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179
Query: 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 638
T Y APE+ M E D++S G + E+IKG
Sbjct: 180 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 57/212 (26%), Positives = 91/212 (42%), Gaps = 15/212 (7%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+ F D +G+GG G V+ ++ +G++ A KK + + Q + E K L +
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 495 RNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNV-IKGVVDALS 552
R IV Y F + +V + G + + N R +V L
Sbjct: 245 RFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL 612
++H I++RD+ +NVLLD + +SD G A LK + AGT G++APEL
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPEL 360
Query: 613 ----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
Y V D ++ GV E+I + P
Sbjct: 361 LLGEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 24/218 (11%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTG 491
DF+ IG+G G V +L + ++ A+K + EM + E F E L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNK---WEMLKRAETACFREERDVLVN 130
Query: 492 IRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDA 550
+ I Y F + ++V +Y G L +LS + + +V A
Sbjct: 131 GDSKWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--LAEMVIA 187
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAKFLKPDSSNWAELA-GTYGY 607
+ +H VHRDI N+L+D H+ +DFG+ L D + + +A GT Y
Sbjct: 188 IDSVHQLH---YVHRDIKPDNILMD--MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 242
Query: 608 VAPELAYTMKVTEK-----CDVYSFGVLALEVIKGKHP 640
++PE+ M+ + CD +S GV E++ G+ P
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLN-----EVKTLTGIRHRNIV 498
IG+G G VYKA+ GE A+KK + + E + E+ L ++H NIV
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 499 KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC 558
K Y + +V+E+L+ L +L + K + +++ ++Y H+
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF--LLQLLNGIAYCHDRR 120
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAK-FLKPDSSNWAELAGTYGYVAPEL----- 612
++HRD+ +N+L++ E E ++DFG A+ F P E+ T Y AP++
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSK 176
Query: 613 AYTMKVTEKCDVYSFGVLALEVIKGK 638
Y+ + D++S G + E++ G
Sbjct: 177 KYSTTI----DIWSVGCIFAEMVNGT 198
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 54/195 (27%), Positives = 92/195 (47%), Gaps = 24/195 (12%)
Query: 145 CPKLG---------TLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSS 195
C + +D ++ S+P+ I ++ LDL S + + L+
Sbjct: 4 CETVTGCTCNEGKKEVDCQGKSLD-SVPSGIPADTE--KLDLQSTGLATLSDATFRGLTK 60
Query: 196 LIKLILNSNQLCGQLSLELG---SLTQLERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSN 251
L L L+ NQL +L G LT+L L L++N+L+ S+P + +L +L L L
Sbjct: 61 LTWLNLDYNQL---QTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGG 116
Query: 252 NQFIKKIPVEL-EKLIHLSELDLSHNFLGEEMPSQICN-MQSLEKLNLSHNNLSGFIPSC 309
NQ +K +P + ++L L EL L+ N L + +P+ + + +L+ L+LS N L
Sbjct: 117 NQ-LKSLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGA 174
Query: 310 FEELHGLSYIDISYN 324
F+ L L I + N
Sbjct: 175 FDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 56/204 (27%), Positives = 78/204 (38%), Gaps = 57/204 (27%)
Query: 56 LTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHLTGNI 114
L L L+ + L KLT L L+ NQL+ +LT L + L N L
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA--- 96
Query: 115 SESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKV 174
S P F L+ +L L N + S+P+ V
Sbjct: 97 --SL---PLGVFDHLT----------------QLDKLYLGGNQLK-SLPS--------GV 126
Query: 175 LDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG---SLTQLERLDLSSNRLS 231
D +L+ L +L LN+NQL S+ G LT L+ L LS+N+L
Sbjct: 127 FD---------------RLTKLKELRLNTNQL---QSIPAGAFDKLTNLQTLSLSTNQLQ 168
Query: 232 NSIPK-SLGNLVKLHYLNLSNNQF 254
S+P + L KL + L NQF
Sbjct: 169 -SVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 37/111 (33%), Positives = 51/111 (45%), Gaps = 7/111 (6%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTLF 59
L+ L L L NN + S+P + L L L L GN+L S+P + LT++ L L
Sbjct: 82 LTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLN 139
Query: 60 DNALSGAIPKE-YGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQN 108
N L +IP + L L L+L NQL+ P L L + L N
Sbjct: 140 TNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 43/142 (30%), Positives = 72/142 (50%), Gaps = 8/142 (5%)
Query: 198 KLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSNNQFIK 256
KL L S L LT+L L+L N+L ++ + +L +L L L+NNQ +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQ-LA 96
Query: 257 KIPVEL-EKLIHLSELDLSHNFLGEEMPSQIC-NMQSLEKLNLSHNNLSGFIPSCFEELH 314
+P+ + + L L +L L N L + +PS + + L++L L+ N L F++L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155
Query: 315 GLSYIDISYNELHGSIPNSTAF 336
L + +S N+L S+P+ AF
Sbjct: 156 NLQTLSLSTNQLQ-SVPHG-AF 175
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 5/107 (4%)
Query: 8 LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTLFDNALSGA 66
L L + + + L L+ L L N+L ++ + +LT++ L L +N L+
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLASL 98
Query: 67 IPKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLT 111
+ +L +L L L NQL+ +P+ LT L +RLN N L
Sbjct: 99 PLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ 144
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 32/88 (36%), Positives = 43/88 (48%), Gaps = 4/88 (4%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTL 58
+L+ L LYL N S+PS + RL L +L L+ N+L SIP LT + L+L
Sbjct: 105 HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSL 162
Query: 59 FDNALSGAIPKEYGNLVKLTLLTLENNQ 86
N L + L KL +TL NQ
Sbjct: 163 STNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 5/114 (4%)
Query: 221 ERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDLSHNFLG 279
E+LDL S L+ + L KL +LNL NQ ++ + + + L L L L++N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQ-LQTLSAGVFDDLTELGTLGLANNQL- 95
Query: 280 EEMPSQI-CNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332
+P + ++ L+KL L N L F+ L L + ++ N+L SIP
Sbjct: 96 ASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPA 148
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-14
Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 41/230 (17%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQE-F----LNEV 486
+ ++ IG+G G V+KA +G+ VA+KK M +++E F L E+
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREI 67
Query: 487 KTLTGIRHRNIVKFYGFCSHARHS--------FIVYEYLEMGSLAMILSNDAAAKDLGWT 538
K L ++H N+V C ++V+++ E LA +LSN L
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEI 126
Query: 539 KRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA-KFLKPDSSN 597
KR+ ++ +++ L Y+H + I+HRD+ + NVL+ + ++DFG A F +S
Sbjct: 127 KRV--MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181
Query: 598 WAELAG---TYGYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 638
T Y PEL Y + D++ G ++A E+
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMA-EMWTRS 226
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 3e-14
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 20/213 (9%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
N F +GKGG G V ++ +G++ A KK + + LNE + L +
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 495 RNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG--VVDAL 551
R +V Y + + +V + G L + + G+ + V + L
Sbjct: 244 RFVVSLAYAYETKD-ALCLVLTLMNGGDLKFHIYH---MGQAGFPEARAVFYAAEICCGL 299
Query: 552 SYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE 611
+H + IV+RD+ +N+LLD +SD G A + + GT GY+APE
Sbjct: 300 EDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPE 355
Query: 612 L----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
+ YT D ++ G L E+I G+ P
Sbjct: 356 VVKNERYTFSP----DWWALGCLLYEMIAGQSP 384
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 3e-14
Identities = 49/265 (18%), Positives = 94/265 (35%), Gaps = 43/265 (16%)
Query: 105 LNQNHLTGN----ISESFGIHPNLAFIDLSHNYFYGE----ISSDWGRCP-KLGTLDFSS 155
+N + E I + +DLS N Y + + P + +L+ S
Sbjct: 1 MNYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSG 60
Query: 156 NNITGSMPAEII-----HSSQLKVLDLSSNHIVGEMPSKLGKL-----SSLIKLILNSNQ 205
N++ E++ + + L+LS N + + +L K ++ L L N
Sbjct: 61 NSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 206 L----CGQLSLELGSL-TQLERLDLSSNRLSNSIPKSLGNLVK-----LHYLNLSNNQF- 254
+ +L + L+L N L L ++ ++ LNL N
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
Query: 255 ---IKKIPVELEKL-IHLSELDLSHNFLGEEMPSQIC-----NMQSLEKLNLSHNNLSG- 304
++ L + ++ LDLS N LG + +++ + LNL N L G
Sbjct: 181 SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240
Query: 305 ---FIPSCFEELHGLSYIDISYNEL 326
+ + L L + + Y+ +
Sbjct: 241 SLENLKLLKDSLKHLQTVYLDYDIV 265
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-14
Identities = 58/345 (16%), Positives = 107/345 (31%), Gaps = 71/345 (20%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRL-----KSLSDLELSGNKL----CGSIPHSL-GNL 50
+ L L N+ E+ + S++ L LSGN L + L
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79
Query: 51 TQITFLTLFDN--------ALSGAIPKEYGNLVKLTLLTLENNQLRGP-----IPNLRNL 97
+T L L N L + +T+L L N NL
Sbjct: 80 ANVTSLNLSGNFLSYKSSDELVKTLAA---IPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 98 -TSLVRVRLNQNHLTGN----ISESFGIHP-NLAFIDLSHNYFYGEISSD---------W 142
S+ + L N L + + P N+ ++L N ++S
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGN----NLASKNCAELAKFLA 192
Query: 143 GRCPKLGTLDFSSNNITGSMPAEII-----HSSQLKVLDLSSNHI----VGEMPSKLGKL 193
+ +LD S+N + AE+ + + L+L N + + + L
Sbjct: 193 SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSL 252
Query: 194 SSLIKLILNSNQL-------CGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVK--- 243
L + L+ + + C L ++ ++ +D + + S + NL++
Sbjct: 253 KHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELS 312
Query: 244 --LHYLNLSNNQFI-----KKIPVELEKLIHLSELDLSHNFLGEE 281
+L N I + +L L E + L E
Sbjct: 313 GKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLLEH 357
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 54/329 (16%), Positives = 108/329 (32%), Gaps = 66/329 (20%)
Query: 34 LSGNKLCGSIPHSLGNLTQITFLTLFDN--------ALSGAIPKEYGNLVKLTLLTLENN 85
L+ + + +T L L N L A +T L L N
Sbjct: 5 LTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFAN---TPASVTSLNLSGN 61
Query: 86 QL---------RGPIPNLRNLTSLVRVRLNQNHLTGN----ISESF-GIHPNLAFIDLSH 131
L + N+TSL L+ N L+ + ++ I + +DL
Sbjct: 62 SLGFKNSDELVQILAAIPANVTSL---NLSGNFLSYKSSDELVKTLAAIPFTITVLDLGW 118
Query: 132 NYFYGE----ISSDWGRCPK-LGTLDFSSNNITGSMPAEII------HSSQLKVLDLSSN 180
N F + + P + +L+ N++ G ++ + + + L+L N
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSLNLRGNDL-GIKSSDELIQILAAIPANVNSLNLRGN 177
Query: 181 HIVGEMPSKLGKL-----SSLIKLILNSNQLCGQLSLELGSL-----TQLERLDLSSNRL 230
++ + ++L K +S+ L L++N L + EL + + L+L N L
Sbjct: 178 NLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCL 237
Query: 231 SNSIPKSLGNLVK----LHYLNLSNNQF-------IKKIPVELEKLIHLSELDLSHNFLG 279
++L L L + L + K + + + +D + +
Sbjct: 238 HGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297
Query: 280 EEMPSQICNM-----QSLEKLNLSHNNLS 303
I N+ + +L + L
Sbjct: 298 PSHSIPISNLIRELSGKADVPSLLNQCLI 326
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 45/219 (20%), Positives = 93/219 (42%), Gaps = 18/219 (8%)
Query: 427 VYEEIIRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNE 485
V + V + + IG G QG V A + VA+KK P ++ +++ E
Sbjct: 53 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-YRE 111
Query: 486 VKTLTGIRHRNIVKFY------GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTK 539
+ + + H+NI+ + ++V E ++ +L ++ +L +
Sbjct: 112 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ-----MELDHER 165
Query: 540 RMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599
++ ++ + ++H+ I+HRD+ N+++ + + DFG A+ S
Sbjct: 166 MSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMT 221
Query: 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 638
T Y APE+ M E D++S G + E+++ K
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-14
Identities = 49/145 (33%), Positives = 71/145 (48%), Gaps = 12/145 (8%)
Query: 161 SMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG---SL 217
S+PA I ++Q +L L N I P L +L +L L SNQL +L +G SL
Sbjct: 33 SVPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQL---GALPVGVFDSL 87
Query: 218 TQLERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHN 276
TQL LDL +N+L+ +P ++ LV L L + N+ ++P +E+L HL+ L L N
Sbjct: 88 TQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQN 145
Query: 277 FLGEEMPSQICNMQSLEKLNLSHNN 301
L + SL L N
Sbjct: 146 QLKSIPHGAFDRLSSLTHAYL-FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 39/127 (30%), Positives = 60/127 (47%), Gaps = 4/127 (3%)
Query: 8 LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTLFDNALSGA 66
LYL++N + P L +L +L L N+L G++P + +LTQ+T L L N L+
Sbjct: 45 LYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLTVL 103
Query: 67 IPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGIHPNLA 125
+ LV L L + N+L +P + LT L + L+QN L +F +L
Sbjct: 104 PSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLT 162
Query: 126 FIDLSHN 132
L N
Sbjct: 163 HAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 27/86 (31%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L+ L L L N + +PS + RL L +L + NKL +P + LT +T L L
Sbjct: 87 LTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQ 144
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQ 86
N L + L LT L N
Sbjct: 145 NQLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 37/121 (30%), Positives = 64/121 (52%), Gaps = 7/121 (5%)
Query: 218 TQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDLSHN 276
T + L L N+++ P +L+ L L L +NQ + +PV + + L L+ LDL N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ-LGALPVGVFDSLTQLTVLDLGTN 98
Query: 277 FLGEEMPSQICN-MQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA 335
L +PS + + + L++L + N L+ +P E L L+++ + N+L SIP+ A
Sbjct: 99 QL-TVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPHG-A 154
Query: 336 F 336
F
Sbjct: 155 F 155
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 40/179 (22%), Positives = 62/179 (34%), Gaps = 50/179 (27%)
Query: 51 TQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHL 110
T L L DN ++ P + +L+ L L L +NQ L +L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ----------LGAL---------- 79
Query: 111 TGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS- 169
P F L+ +L LD +N +T +P+ +
Sbjct: 80 -----------PVGVFDSLT----------------QLTVLDLGTNQLT-VLPSAVFDRL 111
Query: 170 SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSN 228
LK L + N + E+P + +L+ L L L+ NQL L+ L L N
Sbjct: 112 VHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 57/222 (25%), Positives = 94/222 (42%), Gaps = 56/222 (25%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEF--------LNEVKTLTGIRH 494
+G+G +VYKA + + +IVA+KK + + E L E+K L + H
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIK------LGHRSEAKDGINRTALREIKLLQELSH 71
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG----VVDA 550
NI+ H + +V++++E L +I+ KD + IK +
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMET-DLEVII------KDNSLVLTPSHIKAYMLMTLQG 124
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF----LKPDSSN----WAELA 602
L Y+H I+HRD+ N+LLD ++DFG AK + + W
Sbjct: 125 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRW---- 177
Query: 603 GTYGYVAPEL-----AYTMKVTEKCDVYSFG-VLALEVIKGK 638
Y APEL Y + V D+++ G +LA E++
Sbjct: 178 ----YRAPELLFGARMYGVGV----DMWAVGCILA-ELLLRV 210
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 43/226 (19%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTG 491
D++ IG+G G V + ++ A+K EM + + F E +
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK---FEMIKRSDSAFFWEERDIMAF 125
Query: 492 IRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDA---------AAKDLGWTKRM 541
+V+ FY F R+ ++V EY+ G L ++SN A+
Sbjct: 126 ANSPWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAE-------- 176
Query: 542 NVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAKFLKPDSSNWA 599
VV AL +H+ +HRD+ N+LLD H+ +DFGT + +
Sbjct: 177 -----VVLALDAIHSMG---FIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVRC 226
Query: 600 ELA-GTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
+ A GT Y++PE+ +CD +S GV E++ G P
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 7e-14
Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 42/213 (19%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLN-----EVKTLTGIRHRNIV 498
+G+G G VYKA+ G IVA+K+ + ++ E + E+ L + H NIV
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 499 KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC 558
R +V+E++E L +L + K + ++ +++ H
Sbjct: 83 SLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIY--LYQLLRGVAHCHQHR 139
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKF----LKPDSSN----WAELAGTYGYVAP 610
I+HRD+ +N+L++ + ++DFG A+ ++ + W Y AP
Sbjct: 140 ---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW--------YRAP 188
Query: 611 EL-----AYTMKVTEKCDVYSFGVLALEVIKGK 638
++ Y+ V D++S G + E+I GK
Sbjct: 189 DVLMGSKKYSTSV----DIWSIGCIFAEMITGK 217
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 39/221 (17%)
Query: 433 RVTNDFDDEHC-IGKGGQGSVYKA---ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKT 488
RV + F+ E C +G+G G VYKA + + A+K+ S A E+
Sbjct: 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA-----CREIAL 71
Query: 489 LTGIRHRNIVKFYG-FCSHARHS-FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN--VI 544
L ++H N++ F SHA +++++Y E L I+ A+K ++ ++
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 545 KGVV----DALSYMHNDCFPPIVHRDISSKNVLLDLENEAH----VSDFGTAKF----LK 592
K ++ D + Y+H + ++HRD+ N+L+ E ++D G A+ LK
Sbjct: 131 KSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 593 PDSSNWAELAGTYGYVAPEL-----AYTMKVTEKCDVYSFG 628
P + + T+ Y APEL YT + D+++ G
Sbjct: 188 PLADLDPVVV-TFWYRAPELLLGARHYTKAI----DIWAIG 223
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 48/209 (22%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLN-----EVKTLTGIRHRNI 497
IG+G G+V+KA + EIVA+K+ + E + E+ L ++H+NI
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKELKHKNI 63
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHND 557
V+ + + +V+E+ + L + D K + ++ L + H+
Sbjct: 64 VRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF--LFQLLKGLGFCHSR 120
Query: 558 CFPPIVHRDISSKNVLLDLENEAHVSDFGTAK-FLKPDSSNWAELAGTYGYVAPEL---- 612
++HRD+ +N+L++ E +++FG A+ F P AE+ T Y P++
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGA 176
Query: 613 -AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
Y+ + D++S G + E+ P
Sbjct: 177 KLYSTSI----DMWSAGCIFAELANAGRP 201
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 56/202 (27%), Positives = 77/202 (38%), Gaps = 39/202 (19%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
IG G G + E+VAVK + A + E+ +RH NIV+F
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKY----IERGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 503 FCSHARHSFIVYEYLEMGSL------AMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
H I+ EY G L A S D A + ++ +SY H+
Sbjct: 84 VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARF---------FFQQLLSGVSYCHS 134
Query: 557 DCFPPIVHRDISSKNVLLDLENEAH--VSDFGTAKFLKPDSSNWAELA---GTYGYVAPE 611
I HRD+ +N LLD + DFG +K S + GT Y+APE
Sbjct: 135 MQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPE 187
Query: 612 L----AYTMKVTEKCDVYSFGV 629
+ Y K DV+S GV
Sbjct: 188 VLLRQEYDGK---IADVWSCGV 206
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 37/184 (20%), Positives = 77/184 (41%), Gaps = 36/184 (19%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEF----LNEVKTLTGIRHRNIV 498
+G G +VYK +G VA+K+ + S++ + E+ + ++H NIV
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVK------LDSEEGTPSTAIREISLMKELKHENIV 66
Query: 499 KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVV----DALSYM 554
+ Y +V+E+++ L + + + +N++K L++
Sbjct: 67 RLYDVIHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
H + I+HRD+ +N+L++ + + DFG LA +G P +
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFG--------------LARAFG--IPVNTF 165
Query: 615 TMKV 618
+ +V
Sbjct: 166 SSEV 169
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 47/245 (19%), Positives = 79/245 (32%), Gaps = 59/245 (24%)
Query: 427 VYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLN-- 484
+ E+ + + + + I G G+V G VA+K+ + + +
Sbjct: 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI-LSDSF 71
Query: 485 -------EVKTLTGIRHRNIVKFYG-FCSHARHSF----IVYEYLEMGSLAMILSNDAAA 532
E++ L H NI+ F + +V E +
Sbjct: 72 LCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT------------- 118
Query: 533 KDLGWTKRMNVIKGVVDALS----------------YMH--NDCFPPIVHRDISSKNVLL 574
DL VI +S +H +VHRD+ N+LL
Sbjct: 119 -DLA-----QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG-----VVHRDLHPGNILL 167
Query: 575 DLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALE 633
N+ + DF A+ D +N Y APEL T+ D++S G + E
Sbjct: 168 ADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAE 226
Query: 634 VIKGK 638
+ K
Sbjct: 227 MFNRK 231
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 2e-13
Identities = 56/225 (24%), Positives = 87/225 (38%), Gaps = 43/225 (19%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-- 492
NDF IG+GG G VY +G++ A+K + LNE L+ +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 493 -RHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDA----------AAKDLGWTKR 540
IV Y F + + + + G L LS AA+
Sbjct: 249 GDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE------- 300
Query: 541 MNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE 600
++ L +MHN +V+RD+ N+LLD +SD G A +
Sbjct: 301 ------IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--A 349
Query: 601 LAGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
GT+GY+APE+ AY D +S G + ++++G P
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 53/258 (20%), Positives = 98/258 (37%), Gaps = 54/258 (20%)
Query: 403 SQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKA-ELPSGE 461
+ P F K ++E V + + +G G GSV A + +G
Sbjct: 2 AHHHHHHSQERPTFYRQELN--KTIWE----VPERYQNLSPVGSGAYGSVCAAFDTKTGL 55
Query: 462 IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFC--SHARHSF----IVYE 515
VAVKK P S + +++ E++ L ++H N++ + + F +V
Sbjct: 56 RVAVKKLSRPFQSIIHAKRT-YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 114
Query: 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKG--------------VVDALSYMHNDCFPP 561
+ DL N++K ++ L Y+H+
Sbjct: 115 LMG--------------ADLN-----NIVKCQKLTDDHVQFLIYQILRGLKYIHS---AD 152
Query: 562 IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTE 620
I+HRD+ N+ ++ + E + DFG A + + T Y APE+ M +
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLA---RHTADEMTGYVATRWYRAPEIMLNWMHYNQ 209
Query: 621 KCDVYSFGVLALEVIKGK 638
D++S G + E++ G+
Sbjct: 210 TVDIWSVGCIMAELLTGR 227
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 49/226 (21%), Positives = 90/226 (39%), Gaps = 47/226 (20%)
Query: 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI 492
+ + +G G GSV A + SGE VA+KK P SE+ +++ E+ L +
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA-YRELLLLKHM 80
Query: 493 RHRNIVKFYG-FCSHARHS-----FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG 546
+H N++ F + ++V +++ DL ++
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ--------------TDLQ-----KIMGL 121
Query: 547 VVD-------------ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593
L Y+H+ +VHRD+ N+ ++ + E + DFG A +
Sbjct: 122 KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA---RH 175
Query: 594 DSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 638
+ T Y APE+ + M + D++S G + E++ GK
Sbjct: 176 ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 52/252 (20%), Positives = 90/252 (35%), Gaps = 64/252 (25%)
Query: 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLN-EVKTLTG 491
+ + +G G G V + ++ SG+ A+KK + N E+ +
Sbjct: 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ--------DPRYKNRELDIMKV 56
Query: 492 IRHRNIVK----FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMN----- 542
+ H NI+K FY + N+ + +
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 543 ----------VIKGVVD-------------------ALSYMHNDCFPPIVHRDISSKNVL 573
V+K + A+ ++H+ I HRDI +N+L
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLL 173
Query: 574 LDLEN-EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL-----AYTMKVTEKCDVYSF 627
++ ++ + DFG+AK L P + A + + Y APEL YT + D++S
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-YRAPELMLGATEYTPSI----DLWSI 228
Query: 628 G-VLALEVIKGK 638
G V E+I GK
Sbjct: 229 GCVFG-ELILGK 239
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 56/245 (22%), Positives = 97/245 (39%), Gaps = 71/245 (28%)
Query: 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKK--FHSPLPSEMASQQEFLNEVKTLT 490
+ + + D +G GG G V+ A + + VA+KK P S + L E+K +
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ-----SVKHALREIKIIR 63
Query: 491 GIRHRNIVKFY----------GFCSHARHSF----IVYEYLEMGSLAMILSNDAAAKDLG 536
+ H NIVK + + IV EY+E DL
Sbjct: 64 RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET--------------DLA 109
Query: 537 WTKRMNVIKG--------------VVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-EAH 581
NV++ ++ L Y+H+ ++HRD+ N+ ++ E+
Sbjct: 110 -----NVLEQGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLK 161
Query: 582 VSDFGTAKFLKPDSSNWAELAG---TYGYVAPEL-----AYTMKVTEKCDVYSFGVLALE 633
+ DFG A+ + P S+ L+ T Y +P L YT + D+++ G + E
Sbjct: 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAE 217
Query: 634 VIKGK 638
++ GK
Sbjct: 218 MLTGK 222
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI 492
V + D +G G G+V A + +G VA+KK + P SE+ +++ E++ L +
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-YRELRLLKHM 81
Query: 493 RHRNIVKFY------GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG 546
RH N++ ++V ++ L ++ ++ LG + ++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE----KLGEDRIQFLVYQ 136
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYG 606
++ L Y+H I+HRD+ N+ ++ + E + DFG A + S T
Sbjct: 137 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA---RQADSEMTGYVVTRW 190
Query: 607 YVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK 638
Y APE+ M+ T+ D++S G + E+I GK
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 62/275 (22%), Positives = 107/275 (38%), Gaps = 48/275 (17%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G+G G V A + + VA+K L + E+ L +RH +I+K Y
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 503 FCSHARHSFIVYEYLEMGSL-AMI-----LSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
+ +V EY G L I ++ D + + ++ A+ Y H
Sbjct: 77 VITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRR---------FFQQIICAIEYCHR 126
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA-GTYGYVAPEL--- 612
IVHRD+ +N+LLD ++DFG + + N+ + + G+ Y APE+
Sbjct: 127 HK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVING 181
Query: 613 -AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671
Y + DV+S G++ ++ G+ P D + ++ P
Sbjct: 182 KLYA---GPEVDVWSCGIVLYVMLVGRLPFD--------DEFIPNLFKKVNSCVYVMPDF 230
Query: 672 ---NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
Q LI M + P R TIQ++ +
Sbjct: 231 LSPGAQS-LIRRM------IVADPMQRITIQEIRR 258
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 49/223 (21%), Positives = 93/223 (41%), Gaps = 57/223 (25%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQE-----FLNEVKTLTGIRHRNI 497
+G+G G VYKA + + E VA+K+ + ++E + EV L ++HRNI
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVV----DALSY 553
++ H +++EY E L + D+ M VIK + + +++
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN-DLKKYMDK---NPDVS----MRVIKSFLYQLINGVNF 147
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAH-----VSDFGTAKF----LKPDSSN----WAE 600
H+ +HRD+ +N+LL + + + + DFG A+ ++ + W
Sbjct: 148 CHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW-- 202
Query: 601 LAGTYGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGK 638
Y PE+ Y+ V D++S + E++
Sbjct: 203 ------YRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKT 235
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 65/277 (23%), Positives = 109/277 (39%), Gaps = 51/277 (18%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G G G V + +G VAVK + + + E++ L RH +I+K Y
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 503 FCSHARHSFIVYEYLEMGSL-AMI-----LSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
S F+V EY+ G L I L + + + + ++ + Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRR---------LFQQILSGVDYCHR 134
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELA---GTYGYVAPEL- 612
+VHRD+ +NVLLD A ++DFG + + L G+ Y APE+
Sbjct: 135 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF----LRTSCGSPNYAAPEVI 187
Query: 613 ---AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669
Y + D++S GV+ ++ G P D ++ ++ D TP
Sbjct: 188 SGRLYA---GPEVDIWSSGVILYALLCGTLPFD--------DDHVPTLFKKICDGIFYTP 236
Query: 670 SH---NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
+ +V L+ M L P R TI+ + +
Sbjct: 237 QYLNPSVIS-LLKHM------LQVDPMKRATIKDIRE 266
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 8e-13
Identities = 60/254 (23%), Positives = 102/254 (40%), Gaps = 77/254 (30%)
Query: 425 KIVYEEIIRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKK---FHSPLPSEMASQQ 480
+IVY +++DF + +G+G G V A P+GEIVA+KK F PL
Sbjct: 4 RIVYN----ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL-----FAL 54
Query: 481 EFLNEVKTLTGIRHRNIVKFYG-FCSHARHSF----IVYEYLEMGSLAMILSNDAAAKDL 535
L E+K L +H NI+ + + +F I+ E ++ DL
Sbjct: 55 RTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT--------------DL 100
Query: 536 GWTKRMNVIKG--------------VVDALSYMH--NDCFPPIVHRDISSKNVLLDLENE 579
VI + A+ +H N ++HRD+ N+L++ +
Sbjct: 101 H-----RVISTQMLSDDHIQYFIYQTLRAVKVLHGSN-----VIHRDLKPSNLLINSNCD 150
Query: 580 AHVSDFGTAKFLKPDSSNWAELAGTYG----YV------APEL-----AYTMKVTEKCDV 624
V DFG A+ + +++ +E G +V APE+ Y+ + DV
Sbjct: 151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DV 206
Query: 625 YSFGVLALEVIKGK 638
+S G + E+ +
Sbjct: 207 WSCGCILAELFLRR 220
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 59/249 (23%), Positives = 99/249 (39%), Gaps = 62/249 (24%)
Query: 421 SFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQ 479
+ ++V ++ V + + IG+G G V A + + VA+KK SP + Q
Sbjct: 12 AAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQ 70
Query: 480 QEFLNEVKTLTGIRHRNIVKFYG-FCSHARHSF----IVYEYLEMGSLAMILSNDAAAKD 534
+ L E+K L RH NI+ + IV + +E D
Sbjct: 71 RT-LREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET--------------D 115
Query: 535 LGWTKRMNVIKG--------------VVDALSYMH--NDCFPPIVHRDISSKNVLLDLEN 578
L ++K ++ L Y+H N ++HRD+ N+LL+
Sbjct: 116 LY-----KLLKTQHLSNDHICYFLYQILRGLKYIHSAN-----VLHRDLKPSNLLLNTTC 165
Query: 579 EAHVSDFGTAKFLKPDSSNWAELAG---TYGYVAPEL-----AYTMKVTEKCDVYSFG-V 629
+ + DFG A+ PD + L T Y APE+ YT + D++S G +
Sbjct: 166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI----DIWSVGCI 221
Query: 630 LALEVIKGK 638
LA E++ +
Sbjct: 222 LA-EMLSNR 229
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-12
Identities = 32/104 (30%), Positives = 51/104 (49%), Gaps = 6/104 (5%)
Query: 8 LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAI 67
LYL N F+ +P E+ K L+ ++LS N++ S N+TQ+ L L N L I
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 68 PKE-YGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQN 108
P + L L LL+L N + +P +L++L + + N
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 33/116 (28%), Positives = 46/116 (39%), Gaps = 16/116 (13%)
Query: 161 SMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG---SL 217
+P I L L N P +L L + L++N++ +L ++
Sbjct: 24 VLPKGIPRDVT--ELYLDGNQFTLV-PKELSNYKHLTLIDLSNNRI---STLSNQSFSNM 77
Query: 218 TQLERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSNNQFIKKIPV----ELEKLIHL 268
TQL L LS NRL IP L L L+L N I +P +L L HL
Sbjct: 78 TQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGND-ISVVPEGAFNDLSALSHL 131
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 28/108 (25%), Positives = 47/108 (43%), Gaps = 9/108 (8%)
Query: 151 LDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQL 210
L N T +P E+ + L ++DLS+N I ++ L+ LIL+ N+L
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL---R 91
Query: 211 SLELG---SLTQLERLDLSSNRLSNSIPK-SLGNLVKLHYLNLSNNQF 254
+ L L L L N +S +P+ + +L L +L + N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 32/106 (30%), Positives = 53/106 (50%), Gaps = 5/106 (4%)
Query: 221 ERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDLSHNFLG 279
L L N+ + +PK L N L ++LSNN+ I + + + L L LS+N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNR-ISTLSNQSFSNMTQLLTLILSYNRL- 90
Query: 280 EEMPSQICN-MQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYN 324
+P + + ++SL L+L N++S F +L LS++ I N
Sbjct: 91 RCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 6/95 (6%)
Query: 18 SIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKL 77
+P I R +++L L GN+ +P L N +T + L +N +S + + N+ +L
Sbjct: 24 VLPKGIPR--DVTELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 78 TLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHL 110
L L N+LR IP L SL + L+ N +
Sbjct: 81 LTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDI 114
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 25/90 (27%), Positives = 42/90 (46%), Gaps = 6/90 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTL 58
N +L + L NN S ++ ++ + L L LS N+L IP L + L+L
Sbjct: 52 NYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL-RCIPPRTFDGLKSLRLLSL 109
Query: 59 FDNALSGAIPKE-YGNLVKLTLLTLENNQL 87
N +S +P+ + +L L+ L + N L
Sbjct: 110 HGNDIS-VVPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 3e-04
Identities = 21/63 (33%), Positives = 32/63 (50%), Gaps = 4/63 (6%)
Query: 51 TQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQN 108
+T L L N + +PKE N LTL+ L NN++ + N N+T L+ + L+ N
Sbjct: 31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88
Query: 109 HLT 111
L
Sbjct: 89 RLR 91
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-12
Identities = 27/128 (21%), Positives = 56/128 (43%), Gaps = 6/128 (4%)
Query: 174 VLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNS 233
++ L++ I E ++ +L L ++ + +L Q + +D S N +
Sbjct: 1 MVKLTAELI--EQAAQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-K 56
Query: 234 IPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMP-SQICNMQSL 292
+ L +L L ++NN+ + + L L+EL L++N L E + +++SL
Sbjct: 57 L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 115
Query: 293 EKLNLSHN 300
L + N
Sbjct: 116 TYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 26/130 (20%), Positives = 53/130 (40%), Gaps = 12/130 (9%)
Query: 151 LDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGK-LSSLIKLILNSNQLCGQ 209
+ ++ I + + ++ + + LDL I + LG L + + N++
Sbjct: 2 VKLTAELIEQAA--QYTNAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNEIR-- 55
Query: 210 LSLE-LGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPV--ELEKLI 266
L+ L +L+ L +++NR+ L L L L+NN + ++ L L
Sbjct: 56 -KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS-LVELGDLDPLASLK 113
Query: 267 HLSELDLSHN 276
L+ L + N
Sbjct: 114 SLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 9e-11
Identities = 18/104 (17%), Positives = 40/104 (38%), Gaps = 5/104 (4%)
Query: 223 LDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEM 282
+ L++ + + N V+ L+L + I I L +D S N +
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEI--RK 56
Query: 283 PSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326
++ L+ L +++N + + L L+ + ++ N L
Sbjct: 57 LDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-10
Identities = 29/157 (18%), Positives = 52/157 (33%), Gaps = 24/157 (15%)
Query: 80 LTLENNQLRGPIPNLRNLTSLVRVRLNQNHLT--GNISESFGIHPNLAFIDLSHNYFYGE 137
+ L + N + L + N+ + ID S N E
Sbjct: 2 VKLTAELIEQ-AAQYTNAVRDRELDLRGYKIPVIENLGATL---DQFDAIDFSDN----E 53
Query: 138 ISS--DWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHI--VGEMPSKLGKL 193
I + +L TL ++N I L L L++N + +G++ L L
Sbjct: 54 IRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASL 112
Query: 194 SSLIKLILNSNQLCGQLSLE------LGSLTQLERLD 224
SL L + N + + + + + Q+ LD
Sbjct: 113 KSLTYLCILRNPVT---NKKHYRLYVIYKVPQVRVLD 146
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 8e-06
Identities = 23/110 (20%), Positives = 39/110 (35%), Gaps = 5/110 (4%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
N L L I + L ++ S N++ + L ++ L + +
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNN 73
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGP--IPNLRNLTSLVRVRLNQN 108
N + L LT L L NN L + L +L SL + + +N
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 63/346 (18%), Positives = 107/346 (30%), Gaps = 107/346 (30%)
Query: 444 IGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQ--QEFLNEVKTLTGI-RH 494
+G+G G V +A+ + VAVK L + ++E+K L I H
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKM----LKEGATHSEHRALMSELKILIHIGHH 85
Query: 495 RNIVKFYGFCSHARHSFIV----------YEYL-------------------EMGSLAMI 525
N+V G C+ +V YL + I
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 526 LSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP------------------------ 561
+ D + + + G V+ S +
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 562 --------IVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV----- 608
+HRD++++N+LL +N + DFG A+ + D + +
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---VRKGDARLPLKWM 262
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVIK-GKHP-------RDFISSISSSSSNLEIALNE 660
APE + T + DV+SFGVL E+ G P +F + +
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT--------- 313
Query: 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
R+ P ++ M C P RPT ++ + L
Sbjct: 314 ----RMRAP-DYTTPEMYQTML---DCWHGEPSQRPTFSELVEHLG 351
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 38/220 (17%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+ FD +G G G V + SG A+K ++ + LNE + L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDA----------AAKDLGWTKRMNVI 544
+VK + ++V EY+ G + L AA+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ----------- 149
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT 604
+V Y+H+ +++RD+ +N+L+D + V+DFG AK + W L GT
Sbjct: 150 --IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWT-LCGT 201
Query: 605 YGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
+APE+ Y V D ++ GVL E+ G P
Sbjct: 202 PEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP 237
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 68.1 bits (165), Expect = 2e-12
Identities = 31/229 (13%), Positives = 77/229 (33%), Gaps = 33/229 (14%)
Query: 86 QLRGPIPNLRNLTSLVRVRLNQNHLT----GNISESFGIHPNLAFIDLSHNYFYGEISSD 141
+ + + L + + ++ ++S P L + + +S
Sbjct: 133 ENKEKFAHFEGLF-WGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT---NNLSIG 188
Query: 142 WGRCPKLGTLDFSSNNITGSMPAEIIHS--SQLKVLDLSSNHIVGEMPSKLGKLSSLIKL 199
P L +L+ S + S+ +I+ S L+ L L + L
Sbjct: 189 KKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL--- 245
Query: 200 ILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN---LVKLHYLNLSNNQF-- 254
L+ L + N + + L +L +++S
Sbjct: 246 ------------FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD 293
Query: 255 --IKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNN 301
+ + ++K+ HL +++ +N+L +EM ++ + K+++S +
Sbjct: 294 EGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPM-KIDVSDSQ 341
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 63.0 bits (152), Expect = 1e-10
Identities = 25/165 (15%), Positives = 52/165 (31%), Gaps = 17/165 (10%)
Query: 155 SNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLEL 214
S + + L L + + + L SL ++I +
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL-EIISGGLPDSVVEDILG 215
Query: 215 GSLTQLERLDL---SSNRLSNSIPKSL------GNLVKLHYLNLSNNQFIKKIPVEL--- 262
L LE+L L + + L +L + + + +
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES 275
Query: 263 EKLIHLSELDLSHNFLGEEMPSQIC----NMQSLEKLNLSHNNLS 303
+ L L +D+S L +E + ++ L+ +N+ +N LS
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 3e-12
Identities = 44/164 (26%), Positives = 72/164 (43%), Gaps = 28/164 (17%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEF----LNEV---KTLTGIRHR 495
IG G G+VYKA + SG VA+K +P+ + EV + L H
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 496 NIVKFYGFCSHARHS-----FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVV-- 548
N+V+ C+ +R +V+E+++ L L A G IK ++
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK---APPPGLP--AETIKDLMRQ 128
Query: 549 --DALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590
L ++H +C IVHRD+ +N+L+ ++DFG A+
Sbjct: 129 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 45/206 (21%), Positives = 92/206 (44%), Gaps = 28/206 (13%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEF----LNEVKTLTGIRHRNIV 498
+G+G +VYK + +VA+K+ + ++ + EV L ++H NIV
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIR------LEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 499 KFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC 558
+ + +V+EYL+ L L + ++ K + ++ L+Y H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCHRQK 120
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAK-FLKPDSSNWAELAGTYGYVAPEL----- 612
++HRD+ +N+L++ E ++DFG A+ P + E+ T Y P++
Sbjct: 121 ---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGST 176
Query: 613 AYTMKVTEKCDVYSFGVLALEVIKGK 638
Y+ ++ D++ G + E+ G+
Sbjct: 177 DYSTQI----DMWGVGCIFYEMATGR 198
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-12
Identities = 33/111 (29%), Positives = 53/111 (47%), Gaps = 8/111 (7%)
Query: 170 SQLKVLDLSSNHI-VGEMPSKLGKLSSLIKLILNSNQLCGQLSLE-LGSLTQLERLDLSS 227
S +K L L ++ G++ + L L + L S+ L L +L++L+LS
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL---TSIANLPKLNKLKKLELSD 73
Query: 228 NRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPV--ELEKLIHLSELDLSHN 276
NR+S + L +LNLS N+ IK + L+KL +L LDL +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNK-IKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-11
Identities = 36/134 (26%), Positives = 68/134 (50%), Gaps = 7/134 (5%)
Query: 192 KLSSLIKLILNSNQLCGQLSLELG-SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLS 250
S + +L+L++++ L +LE L + L+ SI +L L KL L LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 251 NNQFIKKIPVELEKLIHLSELDLSHNFLGE-EMPSQICNMQSLEKLNLSHN---NLSGFI 306
+N+ + V EK +L+ L+LS N + + + +++L+ L+L + NL+ +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYR 132
Query: 307 PSCFEELHGLSYID 320
+ F+ L L+Y+D
Sbjct: 133 ENVFKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 19/91 (20%), Positives = 43/91 (47%), Gaps = 4/91 (4%)
Query: 236 KSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKL 295
++ ++ +L N +N K+ ++ L L + L + + + L+KL
Sbjct: 14 RTPSDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLTS--IANLPKLNKLKKL 69
Query: 296 NLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326
LS N +SG + E+ L+++++S N++
Sbjct: 70 ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-07
Identities = 29/114 (25%), Positives = 47/114 (41%), Gaps = 5/114 (4%)
Query: 1 NLSNLAFLYLYNNSFS-GSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
S++ L L N+ + G + + L L L SI + L L ++ L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSIAN-LPKLNKLKKLELS 72
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQLRGP--IPNLRNLTSLVRVRLNQNHLT 111
DN +SG + LT L L N+++ I L+ L +L + L +T
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 3e-06
Identities = 29/140 (20%), Positives = 52/140 (37%), Gaps = 13/140 (9%)
Query: 93 NLRNLTSLVRVRLNQNHLT-GNISESFGIHPNLAFIDLSHNYFYGEISS--DWGRCPKLG 149
R + + + L+ + G + L F+ + ++S + + KL
Sbjct: 12 RNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV----GLTSIANLPKLNKLK 67
Query: 150 TLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVG-EMPSKLGKLSSLIKLILNSNQLCG 208
L+ S N ++G + L L+LS N I L KL +L L L + ++
Sbjct: 68 KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTN 127
Query: 209 Q----LSLELGSLTQLERLD 224
++ L QL LD
Sbjct: 128 LNDYRENV-FKLLPQLTYLD 146
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 33/140 (23%), Positives = 53/140 (37%), Gaps = 20/140 (14%)
Query: 49 NLTQITFLTLFDNALSGAIPKEYG--NLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLN 106
+ + L L DN+ S E +L L+ N L I NL L L ++ L+
Sbjct: 15 TPSDVKELVL-DNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELS 72
Query: 107 QNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWG------RCPKLGTLDFSSNNITG 160
N ++G + PNL ++LS N D + L +LD + +T
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKI-----KDLSTIEPLKKLENLKSLDLFNCEVT- 126
Query: 161 SMP---AEIIHS-SQLKVLD 176
++ + QL LD
Sbjct: 127 NLNDYRENVFKLLPQLTYLD 146
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 48/221 (21%), Positives = 88/221 (39%), Gaps = 38/221 (17%)
Query: 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI 492
+D+ +G+G V++A + + E V VK +++ E+K L +
Sbjct: 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK------PVKKKKIKREIKILENL 87
Query: 493 R-HRNIVKFYGFCSHARHSFI---VYEYLEMGSLAMI---LSNDAAAKDLGWTKRMNVIK 545
R NI+ S V+E++ + L++ +
Sbjct: 88 RGGPNIITLAD-IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF---------YMY 137
Query: 546 GVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTAKFLKPDSSNWAELAGT 604
++ AL Y H+ I+HRD+ NV++D E+ + + D+G A+F P +A
Sbjct: 138 EILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 194
Query: 605 YGYVAPEL-----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
Y + PEL Y + D++S G + +I K P
Sbjct: 195 Y-FKGPELLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-11
Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 8/111 (7%)
Query: 170 SQLKVLDLSSNHI-VGEMPSKLGKLSSLIKLILNSNQLCGQLSLE-LGSLTQLERLDLSS 227
+ ++ L L + G++ + +L L L + L +S+ L L +L++L+LS
Sbjct: 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL---ISVSNLPKLPKLKKLELSE 80
Query: 228 NRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIP--VELEKLIHLSELDLSHN 276
NR+ + L L +LNLS N+ +K I L+KL L LDL +
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNK-LKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-11
Identities = 37/133 (27%), Positives = 67/133 (50%), Gaps = 7/133 (5%)
Query: 193 LSSLIKLILNSNQLCGQLSLELGS-LTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSN 251
+++ +L+L++ + L + LE L L + L S+ +L L KL L LS
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSE 80
Query: 252 NQFIKKIPVELEKLIHLSELDLSHNFLGE-EMPSQICNMQSLEKLNLSHN---NLSGFIP 307
N+ + + EKL +L+ L+LS N L + + ++ L+ L+L + NL+ +
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRE 140
Query: 308 SCFEELHGLSYID 320
S F+ L L+Y+D
Sbjct: 141 SVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 23/88 (26%), Positives = 41/88 (46%), Gaps = 3/88 (3%)
Query: 240 NLVKLHYLNLSNNQF-IKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLS 298
+ L L N + KI + ++L L L + L S + + L+KL LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS--VSNLPKLPKLKKLELS 79
Query: 299 HNNLSGFIPSCFEELHGLSYIDISYNEL 326
N + G + E+L L+++++S N+L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKL 107
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 28/114 (24%), Positives = 45/114 (39%), Gaps = 5/114 (4%)
Query: 1 NLSNLAFLYLYNNSFS-GSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLF 59
+ + L L N + G I +L L L L S+ +L L ++ L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQLRGP--IPNLRNLTSLVRVRLNQNHLT 111
+N + G + L LT L L N+L+ + L+ L L + L +T
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 34/141 (24%), Positives = 53/141 (37%), Gaps = 19/141 (13%)
Query: 95 RNLTSLVRVRLNQNHLT-GNISESFGIHPNLAFIDLSHNYFYGEISS--DWGRCPKLGTL 151
R ++ + L+ G I NL F+ L + + S + + PKL L
Sbjct: 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINV----GLISVSNLPKLPKLKKL 76
Query: 152 DFSSNNITGSMPAEIIHSSQLKVLDLSSNHI--VGEMPSKLGKLSSLIKLILNSNQLCGQ 209
+ S N I G + L L+LS N + + + L KL L L L + ++
Sbjct: 77 ELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT-- 133
Query: 210 LSLE------LGSLTQLERLD 224
+L L QL LD
Sbjct: 134 -NLNDYRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 6e-06
Identities = 33/140 (23%), Positives = 52/140 (37%), Gaps = 12/140 (8%)
Query: 45 HSLGNLTQITFLTLFDNALSGAIPKE--YGNLVKLTLLTLENNQLRGPIPNLRNLTSLVR 102
+ L L DN S E V L L+L N L + NL L L +
Sbjct: 18 LRNRTPAAVRELVL-DNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKK 75
Query: 103 VRLNQNHLTGNISESFGIHPNLAFIDLSHNYF--YGEISSDWGRCPKLGTLDFSSNNITG 160
+ L++N + G + PNL ++LS N + + L +LD + +T
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP-LKKLECLKSLDLFNCEVT- 133
Query: 161 SMP---AEIIHS-SQLKVLD 176
++ + QL LD
Sbjct: 134 NLNDYRESVFKLLPQLTYLD 153
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 59/224 (26%), Positives = 92/224 (41%), Gaps = 42/224 (18%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVK---KFHSPLPSEMASQQEFLNEVKTLTG 491
N+F+ +GKG G V + +G A+K K E+A L E + L
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT---LTENRVLQN 204
Query: 492 IRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDA----------AAKDLGWTKR 540
RH + Y F +H V EY G L LS + A+
Sbjct: 205 SRHPFLTALKYSFQTHD-RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE------- 256
Query: 541 MNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE 600
+V AL Y+H++ +V+RD+ +N++LD + ++DFG K D +
Sbjct: 257 ------IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
Query: 601 LAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
GT Y+APE+ Y V D + GV+ E++ G+ P
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 348
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 14/157 (8%)
Query: 150 TLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ 209
T++ S T S+P I + LDL +N + +L+SL +L L N+L
Sbjct: 11 TVECYSQGRT-SVPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL--- 64
Query: 210 LSLELG---SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKL 265
SL G LT L L+LS+N+L + L +L L L+ NQ ++ +P + +KL
Sbjct: 65 QSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQ-LQSLPDGVFDKL 123
Query: 266 IHLSELDLSHNFLGEEMPSQIC-NMQSLEKLNLSHNN 301
L +L L N L + +P + + SL+ + L H+N
Sbjct: 124 TQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWL-HDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 40/113 (35%), Positives = 61/113 (53%), Gaps = 9/113 (7%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTL 58
L++L LYL N S+P+ + +L SL+ L LS N+L S+P+ + LTQ+ L L
Sbjct: 50 ELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQL-QSLPNGVFDKLTQLKELAL 107
Query: 59 FDNALSGAIPKE-YGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQN 108
N L ++P + L +L L L NQL+ +P+ LTSL + L+ N
Sbjct: 108 NTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 39/106 (36%), Positives = 51/106 (48%), Gaps = 5/106 (4%)
Query: 8 LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGN-LTQITFLTLFDNALSGA 66
L L NS L SL+ L L GNKL S+P+ + N LT +T+L L N L
Sbjct: 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQSL 91
Query: 67 IPKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHL 110
+ L +L L L NQL+ +P+ LT L +RL QN L
Sbjct: 92 PNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQL 136
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 33/117 (28%), Positives = 58/117 (49%), Gaps = 5/117 (4%)
Query: 218 TQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDLSHN 276
Q LDL +N L + L L L L N+ ++ +P + KL L+ L+LS N
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNK-LQSLPNGVFNKLTSLTYLNLSTN 86
Query: 277 FLGEEMPSQICN-MQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332
L + +P+ + + + L++L L+ N L F++L L + + N+L S+P+
Sbjct: 87 QL-QSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPD 141
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 27/88 (30%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTLF 59
L++L +L L N S+P+ + +L L +L L+ N+L S+P + LTQ+ L L+
Sbjct: 75 LTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLY 132
Query: 60 DNALSGAIPKE-YGNLVKLTLLTLENNQ 86
N L ++P + L L + L +N
Sbjct: 133 QNQLK-SVPDGVFDRLTSLQYIWLHDNP 159
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 41/129 (31%), Positives = 60/129 (46%), Gaps = 4/129 (3%)
Query: 198 KLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKK 257
L L +N L + LT L +L L N+L + L L YLNLS NQ ++
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ-LQS 90
Query: 258 IPVEL-EKLIHLSELDLSHNFLGEEMPSQICN-MQSLEKLNLSHNNLSGFIPSCFEELHG 315
+P + +KL L EL L+ N L + +P + + + L+ L L N L F+ L
Sbjct: 91 LPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS 149
Query: 316 LSYIDISYN 324
L YI + N
Sbjct: 150 LQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 31/96 (32%), Positives = 40/96 (41%), Gaps = 5/96 (5%)
Query: 18 SIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKL 77
S+P+ I + L+L N L LT +T L L N L + L L
Sbjct: 21 SVPTGIP--AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSL 78
Query: 78 TLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLT 111
T L L NQL+ +PN LT L + LN N L
Sbjct: 79 TYLNLSTNQLQS-LPNGVFDKLTQLKELALNTNQLQ 113
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 49/206 (23%), Positives = 71/206 (34%), Gaps = 75/206 (36%)
Query: 51 TQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHL 110
Q T+L L N+L + L LT L L N+ L SL
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNK----------LQSL---------- 67
Query: 111 TGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS- 169
PN F L+ L L+ S+N + S+P +
Sbjct: 68 -----------PNGVFNKLT----------------SLTYLNLSTNQLQ-SLPNGVFDKL 99
Query: 170 SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNR 229
+QLK L L++N +L SL + + LTQL+ L L N+
Sbjct: 100 TQLKELALNTN-----------QLQSLPDGVFD-------------KLTQLKDLRLYQNQ 135
Query: 230 LSNSIPK-SLGNLVKLHYLNLSNNQF 254
L S+P L L Y+ L +N +
Sbjct: 136 L-KSVPDGVFDRLTSLQYIWLHDNPW 160
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 49/224 (21%), Positives = 89/224 (39%), Gaps = 45/224 (20%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVK------KFHSPLPSEMASQQEFLNEVKTLTGIR--- 493
+G G +V+ A+ + + VA+K + + +E+K L +
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----------EAAEDEIKLLQRVNDAD 76
Query: 494 --------HRNIVKFYGFCSH----ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRM 541
+I+K +H H +V+E L LA+I + L + K++
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136
Query: 542 NVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH------VSDFGTAKFLKPDS 595
K ++ L YMH C I+H DI +NVL+++ + ++D G A +
Sbjct: 137 --SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKH 639
+N + T Y +PE+ D++S L E+I G
Sbjct: 193 TNSIQ---TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 5e-11
Identities = 27/127 (21%), Positives = 47/127 (37%), Gaps = 7/127 (5%)
Query: 185 EMPSKLGKLSSLIKLILNSNQLCGQLSLE-LGSLTQLERLDLSSNRLSNSIPKSLGNLVK 243
+ L +L +L + + Q L L L L +L L + + L P + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 244 LHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLS 303
L LNLS N ++ + + + + L EL LS N L C ++ L++
Sbjct: 82 LSRLNLSFNA-LESLSWKTVQGLSLQELVLSGNPL-----HCSCALRWLQRWEEEGLGGV 135
Query: 304 GFIPSCF 310
Sbjct: 136 PEQKLQC 142
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 5e-10
Identities = 21/127 (16%), Positives = 39/127 (30%), Gaps = 27/127 (21%)
Query: 227 SNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQI 286
+ + L L L + N Q ++ + +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLE-----------------------LRDL 52
Query: 287 CNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPME--AL 344
+ L L + + L P F LS +++S+N L S+ T + ++ L
Sbjct: 53 RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKT-VQGLSLQELVL 110
Query: 345 QGNKGLC 351
GN C
Sbjct: 111 SGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 7e-10
Identities = 21/115 (18%), Positives = 38/115 (33%), Gaps = 9/115 (7%)
Query: 144 RCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSK-LGKLSSLIKLILN 202
L + + + + L L + + + + + L L L L +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 203 SNQLCGQLSLELGS---LTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQF 254
+ L + + +L RL+LS N L S+ + L L LS N
Sbjct: 65 KSGL---RFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 17/96 (17%), Positives = 36/96 (37%), Gaps = 3/96 (3%)
Query: 18 SIPSEIGRLKSLSDLELSGNKLCGSIP-HSLGNLTQITFLTLFDNALSGAIPKE-YGNLV 75
+ ++L++L + + + L L ++ LT+ + L + + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 76 KLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLT 111
+L+ L L N L SL + L+ N L
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 8e-07
Identities = 25/125 (20%), Positives = 42/125 (33%), Gaps = 27/125 (21%)
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESF 118
+ LT L +EN Q + LR L L + + ++ L
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR------- 69
Query: 119 GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
+ P+ AF P+L L+ S N + S+ + + L+ L LS
Sbjct: 70 FVAPD-AFHFT----------------PRLSRLNLSFNALE-SLSWKTVQGLSLQELVLS 111
Query: 179 SNHIV 183
N +
Sbjct: 112 GNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 20/90 (22%), Positives = 35/90 (38%), Gaps = 4/90 (4%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSE-IGRLKSLSDLELSGNKLCGSI-PHSLGNLTQITFLTL 58
NL LY+ N + + L L +L + + L + P + +++ L L
Sbjct: 29 GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDAFHFTPRLSRLNL 87
Query: 59 FDNALSGAIPKEYGNLVKLTLLTLENNQLR 88
NAL ++ + + L L L N L
Sbjct: 88 SFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 39/204 (19%), Positives = 71/204 (34%), Gaps = 59/204 (28%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFY 501
+G G G V + + E A+K + + EV+ + +IV+
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKM--------LQDCPKARREVELHWRASQCPHIVRIV 77
Query: 502 GFC----SHARHSFIVYEYLEMGSL--------AMILSNDAAAKDLGWTKRMNVIKGVVD 549
+ + IV E L+ G L + A+ ++K + +
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS---------EIMKSIGE 128
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAH---VSDFGTAKFLKPDSSNWAELAGTYG 606
A+ Y+H+ I HRD+ +N+L + ++DFG AK Y
Sbjct: 129 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET---------TGEKYD 176
Query: 607 YVAPELAYTMKVTEKCDVYSFGVL 630
+ CD++S GV+
Sbjct: 177 -------------KSCDMWSLGVI 187
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 41/182 (22%), Positives = 73/182 (40%), Gaps = 42/182 (23%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVK---------KFHSPLPSEM-----ASQQEFLNEVKTL 489
IG+GG G +Y A++ S E V + PL +E+ A++ E + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 490 TGIRHRNIVKFYGFCSH----ARHSFIVYEYLEMG-SLAMILSNDAAAKDLGWTKRMNVI 544
+++ + K++G H + F++ + G L I +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYE---------ANAKRFSR 151
Query: 545 KGV-------VDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAKFLKPDS 595
K V +D L Y+H + VH DI + N+LL+ +N V D+G A P+
Sbjct: 152 KTVLQLSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 596 SN 597
+
Sbjct: 209 VH 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 38/171 (22%), Positives = 73/171 (42%), Gaps = 26/171 (15%)
Query: 444 IGKGGQGSVYKAE---------LPSGEIVAVK--KFHSPLPSEM-----ASQQEFLNEVK 487
+ QG +Y+A P + ++K L +E A++ +N+ K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 488 TLTGIRHRNIVKFYGFCSH-ARHSFIVYEYLEMG-SLAMILSNDAAAKDLGWTKRMNVIK 545
L I GF H ++ F+V L G SL L + + L + V
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSAL-DVSPKHVLSERSVLQVAC 166
Query: 546 GVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAKFLKPD 594
++DAL ++H + + VH +++++N+ +D E+++ V + +G A P
Sbjct: 167 RLLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 40/127 (31%), Positives = 57/127 (44%), Gaps = 16/127 (12%)
Query: 150 TLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ 209
+ +S +T S+P I S L+L SN + KL+ L KL L+ NQ+
Sbjct: 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI--- 64
Query: 210 LSLELG---SLTQLERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSNNQFIKKIPV----E 261
SL G LT+L L L N+L S+P + L +L L L NQ +K +P
Sbjct: 65 QSLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQ-LKSVPDGIFDR 122
Query: 262 LEKLIHL 268
L L +
Sbjct: 123 LTSLQKI 129
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 33/105 (31%), Positives = 54/105 (51%), Gaps = 7/105 (6%)
Query: 8 LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTLFDNALSGA 66
L L +N +L L+ L LS N++ S+P + LT++T L L +N L +
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQ-S 90
Query: 67 IPKE-YGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQN 108
+P + L +L L L+ NQL+ +P+ LTSL ++ L+ N
Sbjct: 91 LPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-08
Identities = 27/87 (31%), Positives = 38/87 (43%), Gaps = 4/87 (4%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTLF 59
L+ L L L N S+P + +L L+ L L NKL S+P+ + LTQ+ L L
Sbjct: 51 LTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKL-QSLPNGVFDKLTQLKELALD 108
Query: 60 DNALSGAIPKEYGNLVKLTLLTLENNQ 86
N L + L L + L N
Sbjct: 109 TNQLKSVPDGIFDRLTSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 33/109 (30%), Positives = 53/109 (48%), Gaps = 4/109 (3%)
Query: 218 TQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDLSHN 276
+ RL+L SN+L + L +L L+LS NQ I+ +P + +KL L+ L L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQ-IQSLPDGVFDKLTKLTILYLHEN 86
Query: 277 FLGEEMPSQIC-NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYN 324
L + +P+ + + L++L L N L F+ L L I + N
Sbjct: 87 KL-QSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 38/117 (32%), Positives = 52/117 (44%), Gaps = 5/117 (4%)
Query: 18 SIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKL 77
S+P+ I S + LEL NKL LTQ+T L+L N + + L KL
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL 78
Query: 78 TLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHN 132
T+L L N+L+ +PN LT L + L+ N L F +L I L N
Sbjct: 79 TILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 50/258 (19%), Positives = 88/258 (34%), Gaps = 81/258 (31%)
Query: 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI 492
V +++ +H IG+G G VY A + + + VA+KK + + ++ L E+ L +
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-ILREITILNRL 82
Query: 493 RHRNIVKFYG-FCSHARHSF----IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGV 547
+ I++ Y F IV E + DL + K
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIADS--------------DLK-----KLFKTP 123
Query: 548 VD---------------ALSYMH--NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590
+ +++H I+HRD+ N LL+ + V DFG A+
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHESG-----IIHRDLKPANCLLNQDCSVKVCDFGLART 178
Query: 591 LKPDSSNWAELAGTY----------------GYV------APEL-----AYTMKVTEKCD 623
+ + +V APEL YT + D
Sbjct: 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----D 234
Query: 624 VYSFG-VLALEVIKGKHP 640
++S G + A E++
Sbjct: 235 IWSTGCIFA-ELLNMLQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 49/235 (20%), Positives = 87/235 (37%), Gaps = 54/235 (22%)
Query: 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI 492
+ + ++ H IG G G V +A + +VA+KK + ++ L E+ L +
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI-LREIAILNRL 109
Query: 493 RHRNIVKFYG-FCSHARHSF----IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGV 547
H ++VK F +V E + + + + T N++ G
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVG- 168
Query: 548 VDALSYMH--NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY 605
+ Y+H I+HRD+ N L++ + V DFG A+ + + ++L +
Sbjct: 169 ---VKYVHSAG-----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220
Query: 606 ---------------------GYV------APEL-----AYTMKVTEKCDVYSFG 628
G+V APEL YT + DV+S G
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI----DVWSIG 271
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 40/180 (22%), Positives = 69/180 (38%), Gaps = 41/180 (22%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVK------KFHSPLPSEM-----ASQQEFLNEVKTLTG 491
IG GG G +Y A E A + + PL SE+ ++++ + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 492 IRHRNIVKFYGFCSHA----RHSFIVYEYLEMG-SLAMILSNDAAAKDLGWTKRMNVIKG 546
+ + I FYG + F+V E L G L I
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISG---------QNGTFK-KST 152
Query: 547 V-------VDALSYMHNDCFPPIVHRDISSKNVLLDLENE--AHVSDFGTAKFLKPDSSN 597
V +D L Y+H + + VH DI + N+LL +N +++D+G + P+ ++
Sbjct: 153 VLQLGIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 31/117 (26%), Positives = 48/117 (41%), Gaps = 16/117 (13%)
Query: 161 SMPAEIIHSSQLKVLDLSSNHIVGEMPSKL-GKLSSLIKLILNSNQLCGQLSLELG---S 216
+P +I + L L+ N + L G+L L+KL L NQL +E
Sbjct: 22 EIPRDIPLHTT--ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT---GIEPNAFEG 76
Query: 217 LTQLERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSNNQFIKKIPV----ELEKLIHL 268
+ ++ L L N++ I + L +L LNL +NQ I + L L L
Sbjct: 77 ASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQ-ISCVMPGSFEHLNSLTSL 131
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 27/109 (24%), Positives = 46/109 (42%), Gaps = 9/109 (8%)
Query: 151 LDFSSNNITGSMPAEIIHS-SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ 209
L + N + + L L+L N + G P+ S + +L L N++
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI--- 90
Query: 210 LSLELG---SLTQLERLDLSSNRLSNSIPK-SLGNLVKLHYLNLSNNQF 254
+ L QL+ L+L N++S + S +L L LNL++N F
Sbjct: 91 KEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 8e-10
Identities = 31/107 (28%), Positives = 46/107 (42%), Gaps = 10/107 (9%)
Query: 8 LYLYNNSFSGSIPSE--IGRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTLFDNALS 64
L L +N I S+ GRL L LEL N+L I + + I L L +N +
Sbjct: 34 LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIK 91
Query: 65 GAIPKE-YGNLVKLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQN 108
I + + L +L L L +NQ+ + +L SL + L N
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 24/88 (27%), Positives = 39/88 (44%), Gaps = 6/88 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTL 58
L +L L L N + I + +L+L NK+ I + + L Q+ L L
Sbjct: 52 RLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI-KEISNKMFLGLHQLKTLNL 109
Query: 59 FDNALSGAIPKE-YGNLVKLTLLTLENN 85
+DN +S + + +L LT L L +N
Sbjct: 110 YDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 5/107 (4%)
Query: 221 ERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDLSHNFL 278
L L+ N L L G L L L L NQ + I E H+ EL L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ-LTGIEPNAFEGASHIQELQLGENKI 90
Query: 279 GEEMPSQICN-MQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYN 324
+E+ +++ + L+ LNL N +S +P FE L+ L+ ++++ N
Sbjct: 91 -KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 26/98 (26%), Positives = 41/98 (41%), Gaps = 8/98 (8%)
Query: 18 SIPSEIGRLKSLSDLELSGNKLCGSIPHS--LGNLTQITFLTLFDNALSGAIPKEYGNLV 75
IP +I ++L L+ N+L G I G L + L L N L+G P +
Sbjct: 22 EIPRDI--PLHTTELLLNDNEL-GRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS 78
Query: 76 KLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQNHLT 111
+ L L N+++ I N L L + L N ++
Sbjct: 79 HIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQIS 115
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-10
Identities = 50/231 (21%), Positives = 87/231 (37%), Gaps = 69/231 (29%)
Query: 444 IGKGGQGSVYKA--ELPSGEIVAVKKFHSPLPSEMASQQE-----FLNEVKTL---TGIR 493
IG+G G V+KA G VA+K+ + + +E + EV L
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVLRHLETFE 72
Query: 494 HRNIVK----FYGFCSHARHS-FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG-- 546
H N+V+ + +V+E+++ L L + G IK
Sbjct: 73 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK---VPEPGVP--TETIKDMM 126
Query: 547 --VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT 604
++ L ++H+ +VHRD+ +N+L+ + ++DFG LA
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG--------------LARI 169
Query: 605 YG-------------YVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGK 638
Y Y APE+ +Y V D++S G + E+ + K
Sbjct: 170 YSFQMALTSVVVTLWYRAPEVLLQSSYATPV----DLWSVGCIFAEMFRRK 216
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 58/266 (21%), Positives = 100/266 (37%), Gaps = 89/266 (33%)
Query: 424 GKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEF 482
G++ V ++ +GKG G V+K+ + +GE+VAVKK + +Q+
Sbjct: 1 GRVDRH----VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT- 55
Query: 483 LNEVKTLTGIR-HRNIVKFY------GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDL 535
E+ LT + H NIV R ++V++Y+E DL
Sbjct: 56 FREIMILTELSGHENIVNLLNVLRADND----RDVYLVFDYMET--------------DL 97
Query: 536 GWTKRMNVIKG--------------VVDALSYMH--NDCFPPIVHRDISSKNVLLDLENE 579
VI+ ++ + Y+H ++HRD+ N+LL+ E
Sbjct: 98 H-----AVIRANILEPVHKQYVVYQLIKVIKYLHSGG-----LLHRDMKPSNILLNAECH 147
Query: 580 AHVSDFGTAKFLKPDSSNWAELAGTY---------------GYV------APEL-----A 613
V+DFG ++ + + YV APE+
Sbjct: 148 VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTK 207
Query: 614 YTMKVTEKCDVYSFG-VLALEVIKGK 638
YT + D++S G +L E++ GK
Sbjct: 208 YTKGI----DMWSLGCILG-EILCGK 228
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 36/279 (12%), Positives = 76/279 (27%), Gaps = 75/279 (26%)
Query: 73 NLVKLTLLTLENNQLRGP------IPNLRNLTSLVRVRLNQNHLTGN----ISESFGIHP 122
L + L + QL P +P L L N L + +
Sbjct: 99 GRHALDEVNLASCQL-DPAGLRTLLPVFLRARKL---GLQLNSLGPEACKDLRDL----- 149
Query: 123 NLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGS----MPAEIIHSSQLKVLDLS 178
L H+ ++ TL S+N +T + + + ++ + L L
Sbjct: 150 ------LLHD------------QCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLL 191
Query: 179 SNHI----VGEMPSKLGKLSSLIKLILNSNQL----CGQLSLELGSLTQLERLDLSSNRL 230
+ + + ++L + L +L + N L+ LE L L N L
Sbjct: 192 HTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251
Query: 231 SNS-------IPKSLGNLVKLHYLNLSNNQFIKK---------------IPVELEKLIHL 268
S+ + + ++ + +++ + L
Sbjct: 252 SSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLEL 311
Query: 269 SELDLSHNFLGEEMPSQICNM----QSLEKLNLSHNNLS 303
DL + P + + + L +
Sbjct: 312 LLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQLGSSG 350
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 24/138 (17%), Positives = 47/138 (34%), Gaps = 15/138 (10%)
Query: 199 LILNSNQ-LCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKK 257
L+ N+ + QL + +L LE +L + L L +L +
Sbjct: 6 LLSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYE--FQN 63
Query: 258 IPVELEKLIHLSELDLSHNFLGEEMPSQIC-----NMQSLEKLNLSHNNLSGFIPSCFEE 312
E L L +L+L+ + + + +L+++NL+ L P+
Sbjct: 64 QRFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLD---PAGLRT 120
Query: 313 L----HGLSYIDISYNEL 326
L + + N L
Sbjct: 121 LLPVFLRARKLGLQLNSL 138
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 34/257 (13%), Positives = 71/257 (27%), Gaps = 57/257 (22%)
Query: 27 KSLSDLELSGNKL----CGSIPHSLGNLTQITFLTLFDN--------ALSGAIPKEYGNL 74
+L ++ L+ +L ++ + L L N L + +
Sbjct: 101 HALDEVNLASCQLDPAGLRTLLPVFLRARK---LGLQLNSLGPEACKDLRDLLLH---DQ 154
Query: 75 VKLTLLTLENNQLRGP-----IPNLRNLTSLVRVRLNQNHLTGN----ISESFGIHPNLA 125
++T L L NN L + L TS+ + L L ++ + L
Sbjct: 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQ 214
Query: 126 FIDLSHNYFYGE----ISSDWGRCPKLGTLDFSSNNITG------SMPAEIIHSSQLKVL 175
+++++N ++ P L L N ++ V+
Sbjct: 215 ELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVV 274
Query: 176 DLSSNHIVGE-----MPSKLGKLSSLIKLILNSNQLCGQLSLE---------------LG 215
L+ V E + L+S + + + LE L
Sbjct: 275 SLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLR 334
Query: 216 SLTQLERLDLSSNRLSN 232
++ L +
Sbjct: 335 VEGEVRALLEQLGSSGS 351
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 2e-09
Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 40/221 (18%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
DF +G G G V+ +G A+K + + + +E L+ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDA----------AAKDLGWTKRMNVI 544
I++ +G A+ F++ +Y+E G L +L AA+
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE----------- 114
Query: 545 KGVVDALSYMH-NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAG 603
V AL Y+H D I++RD+ +N+LLD ++DFG AK + L G
Sbjct: 115 --VCLALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAK--YVPDVTYT-LCG 165
Query: 604 TYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
T Y+APE+ Y + D +SFG+L E++ G P
Sbjct: 166 TPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.9 bits (144), Expect = 2e-09
Identities = 98/625 (15%), Positives = 170/625 (27%), Gaps = 222/625 (35%)
Query: 125 AFIDLSHNYFYGEISSDWG---RCPKLGTLDFSS--NNITGSMP---------AEIIHSS 170
F++ Y + S R P + T + + + +
Sbjct: 81 KFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKL 140
Query: 171 QLKVLDLSSNHIV---GEMPSKLGKLSSLIKLILNSNQLCGQLS-----LELGSLTQLER 222
+ +L+L V G + GK + + + S ++ ++ L L + E
Sbjct: 141 RQALLELRPAKNVLIDG-VLG-SGK-TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPET 197
Query: 223 LDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSE-----LDLSHNF 277
+ +L I + + H N+ I I EL +L+ L L +
Sbjct: 198 VLEMLQKLLYQIDPNWTSRSD-HSSNIKLR--IHSIQAELRRLLKSKPYENCLLVLLN-- 252
Query: 278 LGEEMPSQICNMQSLEKLNLS--------------------------HNNLSGFIPSCFE 311
+ N ++ NLS ++ P +
Sbjct: 253 --------VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP---D 301
Query: 312 ELHGL--SYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIKGFPSCKASKSHKQA 369
E+ L Y+D +L P E L N I S A
Sbjct: 302 EVKSLLLKYLDCRPQDL-------------PREVLTTNPRRLSIIA------ESIRDGLA 342
Query: 370 SRKIWVVIVFPLLGSFALLISLIGL-----------FFMFRRSSSQTQQSSPGNAP-GFL 417
+ W + L + + SL L +F S+ + P L
Sbjct: 343 TWDNWKHVNCDKLTT-IIESSLNVLEPAEYRKMFDRLSVFPPSA---------HIPTILL 392
Query: 418 SVLSFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMA 477
S++ F+ ++ +++ V N + K + S +PS + K
Sbjct: 393 SLIWFD--VIKSDVMVVVNKLHKYSLVEKQPKESTI--SIPSIYLELKVK---------- 438
Query: 478 SQQEFLNEVKTLTGIRHRNIVKFY----GFCSHAR---------HSFIVYEYLEMGSLAM 524
L L HR+IV Y F S +S I +
Sbjct: 439 -----LENEYAL----HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHH--------- 480
Query: 525 ILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSD 584
L N + + F V LD
Sbjct: 481 -LKNIEHPERM---------------------TLFR----------MVFLDF-------R 501
Query: 585 FGTAKFLKPDSSNWAELAGTYGYVAPELA----YTMKVTEKCDVYSFGVLALEVIKGKHP 640
F K ++ DS+ W G + L Y + + Y V A+
Sbjct: 502 FLEQK-IRHDSTAW----NASGSILNTLQQLKFYKPYICDNDPKYERLVNAIL------- 549
Query: 641 RDFI-----SSISSSSSNL-EIALN 659
DF+ + I S ++L IAL
Sbjct: 550 -DFLPKIEENLICSKYTDLLRIALM 573
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 1e-07
Identities = 108/678 (15%), Positives = 200/678 (29%), Gaps = 190/678 (28%)
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
H ++ F H Y Y +I S + +F ++ MP I+ ++
Sbjct: 4 HHHMDFETGEHQYQYKDILSVF--EDAF-VDNFDCKDVQ-DMPKSILSKEEID------- 52
Query: 181 HIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIP----- 235
HI+ + L +L+ + Q +E E L ++ L + I
Sbjct: 53 HIIMS-KDAVSGTLRLFWTLLSKQEEMVQKFVE-------EVLRINYKFLMSPIKTEQRQ 104
Query: 236 KSLGNLVKLHYLN-LSN-NQFIKKIPVELEKLI-----HLSELDLSHNFLGEEMP----- 283
S+ + + + L N NQ K V + L EL + N L + +
Sbjct: 105 PSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKT 164
Query: 284 ---SQICNMQSLEK--------LNLSHNNLSGFIPSCFEELHGLSY-IDISYNELHGSIP 331
+C ++ LNL + N + E L L Y ID ++
Sbjct: 165 WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE---TVLEMLQKLLYQIDPNWTSRSDHSS 221
Query: 332 NSTAFRDAPMEALQGNKGLCGDIKGFPSCKASKSHKQA---SRKIW---VVIVFPLLGSF 385
N + L +K SK ++ + F L
Sbjct: 222 N------IKLRIHSIQAELRRLLK-------SKPYENCLLVLLNVQNAKAWNAF-NLSCK 267
Query: 386 ALLISLIGLFFMFRRSSSQTQQSSPGNAPGFLSVLSFEGKIVYEEIIRVTNDFDDEH--- 442
LL + R T FLS + + + +
Sbjct: 268 ILLTT---------RFKQVTD---------FLSA----ATTTHISLDHHSMTLTPDEVKS 305
Query: 443 ----CIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEM--ASQQEFLNEVKTLTGIRHRN 496
+ Q +LP E++ +P + S ++ L T +H N
Sbjct: 306 LLLKYLDCRPQ------DLPR-EVLTT----NPRRLSIIAESIRDGLA---TWDNWKHVN 351
Query: 497 IVKFYGFCSHARHSFI----VYEYLEM-GSLAMILSNDA--AAKDLG--WT--------- 538
K + S + EY +M L+ + A L W
Sbjct: 352 CDKL----TTIIESSLNVLEPAEYRKMFDRLS-VFPPSAHIPTILLSLIWFDVIKSDVMV 406
Query: 539 ------KRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL- 591
K V K ++ + + ++ ++ K L+ E H +
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPS------IYLELKVK---LENEYALH------RSIVD 451
Query: 592 ---KPDSSNWAELAGTY--GYVAPELAYTMKVTEKCD-------VY-SFGVLALEVIKGK 638
P + + +L Y Y + + +K E + V+ F L ++
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDS 511
Query: 639 HPRDFISSISSSSSNLE-----IALNEMLDPR--------LPTPSHN-VQDKLISIMEVA 684
+ SI ++ L+ I N+ R LP N + K ++ +A
Sbjct: 512 TAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIA 571
Query: 685 ISCLDES--PESRPTIQK 700
+ DE+ E+ +Q+
Sbjct: 572 LMAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 6e-06
Identities = 63/368 (17%), Positives = 118/368 (32%), Gaps = 110/368 (29%)
Query: 25 RLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALS---GAIPKE--YGNLVKLTL 79
R K ++D + S+ H LT +L L +P+E N +L++
Sbjct: 273 RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI 332
Query: 80 L--TLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGE 137
+ ++ + N + +N + LT I S L + +
Sbjct: 333 IAESIRDGLAT--WDNWK--------HVNCDKLTTIIESSLN---VLEPAEYRKMFDRLS 379
Query: 138 ISSDWGRCPKLGTLDFSSN-NITGSMPAEIIHSSQLKVL--DLSSNHIVGEMPSKLGKLS 194
+ F + +I P + L ++ D+ + V + +KL K S
Sbjct: 380 V--------------FPPSAHI----PTIL-----LSLIWFDVIKS-DVMVVVNKLHKYS 415
Query: 195 SLIK------LILNSNQLCGQLSLELGSLTQLERL--------------DLSSNRLSNSI 234
+ K + + S L +L ++L + L R DL L
Sbjct: 416 LVEKQPKESTISIPSIYL--ELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYF 473
Query: 235 PKSLG------------NLVKLHYLNLSNNQFIKKIPVELEKLIHL--------SELDLS 274
+G L ++ +L+ F+++ K+ H S L+
Sbjct: 474 YSHIGHHLKNIEHPERMTLFRMVFLDFR---FLEQ------KIRHDSTAWNASGSILNTL 524
Query: 275 HNFLGEEMPSQIC-NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSI--P 331
+ IC N E+L N + F+P E L Y D+ L ++
Sbjct: 525 QQL--KFYKPYICDNDPKYERL---VNAILDFLPKIEENLICSKYTDL----LRIALMAE 575
Query: 332 NSTAFRDA 339
+ F +A
Sbjct: 576 DEAIFEEA 583
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 47/214 (21%), Positives = 83/214 (38%), Gaps = 41/214 (19%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVK------KFHSPLPSEMASQQEFLNEVKTLTGIRHR- 495
IGKG G V KA + VA+K +FH ++ E++ L +R +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----------RQAAEEIRILEHLRKQD 154
Query: 496 -----NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDA 550
N++ + H + +E L M +I N L ++ ++
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKF--AHSILQC 212
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAH--VSDFGTAKFLKPDSSNWAELAGTY--- 605
L +H I+H D+ +N+LL + + V DFG++ + TY
Sbjct: 213 LDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY-------TYIQS 262
Query: 606 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 638
Y APE+ + D++S G + E++ G
Sbjct: 263 RFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 38/175 (21%), Positives = 64/175 (36%), Gaps = 38/175 (21%)
Query: 432 IRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEV---K 487
+ V +F IG G G + + L + E VA+K L + + E K
Sbjct: 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYK 59
Query: 488 TLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMG-SLAMILSNDAAAKDLGWTKRMNVIKG 546
L I + Y F +++ +V E L G SL + R +K
Sbjct: 60 QLGSGDG--IPQVYYFGPCGKYNAMVLELL--GPSLEDLFD---------LCDRTFSLKT 106
Query: 547 V-------VDALSYMHNDCFPPIVHRDISSKNVLLDL-----ENEAHVSDFGTAK 589
V + + Y+H+ ++RD+ +N L+ + H+ DF AK
Sbjct: 107 VLMIAIQLISRMEYVHSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 47/214 (21%), Positives = 78/214 (36%), Gaps = 39/214 (18%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVK------KFHSPLPSEMASQQEFLNEVKTLTGIRHR- 495
IGKG G V KA E VA+K F Q EV+ L +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFL---------NQA-QIEVRLLELMNKHD 111
Query: 496 -----NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDA 550
IV H +V+E L ++ + + L T++ + + A
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKF--AQQMCTA 169
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAH--VSDFGTAKFLKPDSSNWAELAGTY--- 605
L ++ I+H D+ +N+LL + + DFG++ L Y
Sbjct: 170 LLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY-------QYIQS 221
Query: 606 -GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK 638
Y +PE+ M D++S G + +E+ G+
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 61/224 (27%), Positives = 90/224 (40%), Gaps = 43/224 (19%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVK---KFHSPLPSEMASQQEFLNEVKTLTG 491
NDFD +GKG G V +G A+K K E+A + E + L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQN 61
Query: 492 IRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDA----------AAKDLGWTKR 540
RH + Y F +H V EY G L LS + A+
Sbjct: 62 TRHPFLTALKYAFQTHD-RLCFVMEYANGGELFFHLSRERVFTEERARFYGAE------- 113
Query: 541 MNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE 600
+V AL Y+H+ +V+RDI +N++LD + ++DFG K D +
Sbjct: 114 ------IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
Query: 601 LAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
GT Y+APE+ Y V D + GV+ E++ G+ P
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 46/327 (14%), Positives = 103/327 (31%), Gaps = 40/327 (12%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSG------NKLCGSIPHSLGNLTQIT 54
NL L L + + + R L +L G + + +L ++
Sbjct: 209 RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELR 268
Query: 55 FLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGP-----IPNLRNLTSLVRVRLNQNH 109
L+ F +A+ +P Y +LT L L ++ + L L + ++
Sbjct: 269 CLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDA 328
Query: 110 LTGNISESFGIHPNLAFIDLSHNYFYGEIS----SDWG------RCPKLGTLDFSSNNIT 159
++ + +L + + + + ++ G CPKL ++ + +T
Sbjct: 329 GLEVLASTC---KDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMT 385
Query: 160 GSMPAEIIHS-SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLT 218
+ I + + L L L I+ +
Sbjct: 386 NAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCK------------- 432
Query: 219 QLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKK-IPVELEKLIHLSELDLSH-N 276
L RL LS K+ L+++ + L L +L++
Sbjct: 433 DLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCP 492
Query: 277 FLGEEMPSQICNMQSLEKLNLSHNNLS 303
F + + + ++++ L +S ++S
Sbjct: 493 FGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 31/175 (17%), Positives = 50/175 (28%), Gaps = 15/175 (8%)
Query: 144 RCPKLGTLDFSS-NNITGSMPAEII-HSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLI- 200
L SS + A I LK LDL + + L +
Sbjct: 128 SFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187
Query: 201 -LNSNQLCGQLSLE-----LGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLS---- 250
LN + L ++S + L+ L L+ + L +L L
Sbjct: 188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTA 247
Query: 251 --NNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLS 303
+ V L L L + + +P+ L LNLS+ +
Sbjct: 248 EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQ 302
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 5e-05
Identities = 51/348 (14%), Positives = 97/348 (27%), Gaps = 52/348 (14%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGR-LKSLSDLELSGNKL--CGSIPHSLGNLTQITFLT 57
+ + L + L + I + K+ L LS + + + L
Sbjct: 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELD 162
Query: 58 LFDNALSG-------AIPKEYGNLVKLTLLTLENNQLRGPIPNL-RNLTSLVRVRLNQNH 109
L ++ + P Y +LV L + L + + L +L ++LN+
Sbjct: 163 LRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAV 222
Query: 110 LTGNISESFGIHPNLAFIDLSHNY------FYGEISSDWGRCPKLGTLDFSSNNITGSMP 163
++ P L + Y +S C +L L + + +P
Sbjct: 223 PLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLP 282
Query: 164 AEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERL 223
A S+L L+LS + L+KL+ +L+RL
Sbjct: 283 AVYSVCSRLTTLNLSYATVQSY---------DLVKLL--------------CQCPKLQRL 319
Query: 224 DLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIP------VELEKLI----HLSELDL 273
+ + L L + ++ P L + L +
Sbjct: 320 WVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLY 379
Query: 274 SHNFLGEEMPSQI-CNMQSLEKLNLSHNNLSGFIPSCFEEL-HGLSYI 319
+ I N ++ + L E L G I
Sbjct: 380 FCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAI 427
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 48/336 (14%), Positives = 98/336 (29%), Gaps = 41/336 (12%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCG-SIPHSLGNLTQITFLTLF 59
L L + ++ +P+ L+ L LS + + L ++ L +
Sbjct: 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVL 322
Query: 60 ----DNALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-----------NLRNLTSLVRVR 104
D L + +L +L + E + + L S++
Sbjct: 323 DYIEDAGLE-VLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVL--- 378
Query: 105 LNQNHLTGNISESFGIH-PNLAFIDLSHNYFYGEIS-----SDWG------RCPKLGTLD 152
+T + + PN+ L D G C L L
Sbjct: 379 YFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLS 438
Query: 153 FSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGE-MPSKLGKLSSLIKLILNSNQLCGQLS 211
S ++ ++++L ++ M L SL KL + +
Sbjct: 439 LSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKAL 498
Query: 212 LEL-GSLTQLERLDLSSNRLSNSIPKSLGN---LVKLHYLNLSNNQFIKKIPVELEKLIH 267
L L + L +SS +S K LG + + ++ + +E++
Sbjct: 499 LANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPDSRPESCPVERVFI 558
Query: 268 LSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLS 303
+ +MP + NM + S ++
Sbjct: 559 YRTVAGPRF----DMPGFVWNMDQDSTMRFSRQIIT 590
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 40/336 (11%), Positives = 91/336 (27%), Gaps = 41/336 (12%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTL-- 58
N +L + + + + +L + +P NL L
Sbjct: 218 NCRSLVSVKV-GDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLG 276
Query: 59 FDNALSGAIPKEYGNLVKLTLLTLENNQLRGP--IPNLRNLTSLVRVRLNQNHLTGNISE 116
+P + ++ L L L ++ +L + +N + E
Sbjct: 277 LSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLET-RNVIGDRGLE 335
Query: 117 SFGIH-PNLAFIDLSHNYFYGEISSDWGR------------CPKLGTLDFSSNNITGSMP 163
+ L + + + + G C +L + ++IT
Sbjct: 336 VLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESL 395
Query: 164 AEIIHS----SQLKVLDLSSNHIVGEMPSKLG------KLSSLIKLILNSNQLCGQLS-- 211
I +++ L + ++P G L + G L+
Sbjct: 396 ESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLR--QGGLTDL 453
Query: 212 --LELGSL-TQLERLDLSSNRLS-NSIPKSLGNLVKLHYLNLSNNQFIKK-IPVELEKLI 266
+G + + L S + + L L + F ++ I + KL
Sbjct: 454 GLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLP 513
Query: 267 HLSELDLSHNFL---GEEMPSQICNMQSLEKLNLSH 299
L L + G+++ ++E +
Sbjct: 514 SLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRR 549
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 47/335 (14%), Positives = 97/335 (28%), Gaps = 44/335 (13%)
Query: 12 NNSFSGSIPSEIGRLKSLSDLELSG------------------NKLCGSIPHSLGNLTQI 53
++ + R +L L+L G I ++L L +
Sbjct: 58 ALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSV 117
Query: 54 TF--LTLFDNALSGAIPKEYGNLVKLTL---LTLENNQLRGPIPNLRNLTSLVRVRLNQN 108
F + + D L +L L L + L + + R + +L+ + +
Sbjct: 118 HFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFS 177
Query: 109 HLTGNISESFGIH-PNLAFIDLSHNYFYG----EISSDWGRCPKLGTLDFSSNNITGSMP 163
G H +L ++ F ++ + C L ++ + +
Sbjct: 178 EKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVG-DFEILELV 236
Query: 164 AEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLE--LGSLTQLE 221
++ L+ S + MP K L KL G + Q+
Sbjct: 237 GFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIR 296
Query: 222 RLDLSSNRL-SNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGE 280
+LDL L + + L L N + + V + L L + +
Sbjct: 297 KLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQ 356
Query: 281 EMPSQIC------------NMQSLEKLNLSHNNLS 303
M + Q LE + + ++++
Sbjct: 357 GMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDIT 391
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 39/264 (14%), Positives = 84/264 (31%), Gaps = 27/264 (10%)
Query: 77 LTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYG 136
+T+ NL SL + + I E++G + ++S+N
Sbjct: 55 VTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNN---- 110
Query: 137 EISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS--SQLKVLDLSSNHIVGE--MPSKLGK 192
+L ++ F ++ + + L+ L L + S +
Sbjct: 111 --------LRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTH 162
Query: 193 LSSLIKLILNSNQLCGQLSLELGSL----TQLERLDLSSNRLSNSIPKSLGNLVK----L 244
+ L++ + + L L T LE L+ + PK L + + L
Sbjct: 163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSL 222
Query: 245 HYLNLSNNQFI--KKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNL 302
+ + + + + L L+ + E + + L +L LS+
Sbjct: 223 VSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP 282
Query: 303 SGFIPSCFEELHGLSYIDISYNEL 326
+ +P F + +D+ Y L
Sbjct: 283 NE-MPILFPFAAQIRKLDLLYALL 305
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 5e-08
Identities = 53/222 (23%), Positives = 92/222 (41%), Gaps = 37/222 (16%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG 491
+ F+ +G+G G V+ + + ++ A+K + E L
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVE 82
Query: 492 IRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDA----------AAKDLGWTKR 540
+ H IVK Y F + + +++ ++L G L LS + A+
Sbjct: 83 VNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE------- 134
Query: 541 MNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAKFLKPDSSNW 598
+ AL ++H+ I++RD+ +N+LLD E H+ +DFG +K
Sbjct: 135 ------LALALDHLHSLG---IIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKA 183
Query: 599 AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
GT Y+APE+ T+ D +SFGVL E++ G P
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 44/196 (22%), Positives = 73/196 (37%), Gaps = 39/196 (19%)
Query: 432 IRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLT 490
+RV N + IG G G +Y + +GE VA+K + E K
Sbjct: 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-----ECVKTKHPQLHIESKIYK 59
Query: 491 GIRH-RNIVKFYGFCSHARHSFIVYEYLEMG-SLAMILSNDAAAKDLGWTKRMNVIKGVV 548
++ I + ++ +V E L G SL + + + R +K V+
Sbjct: 60 MMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFN---------FCSRKFSLKTVL 108
Query: 549 -------DALSYMHNDCFPPIVHRDISSKNVLLDL---ENEAHVSDFGTAKFLKPDSSNW 598
+ Y+H+ F +HRD+ N L+ L N ++ DFG AK + ++
Sbjct: 109 LLADQMISRIEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
Query: 599 -------AELAGTYGY 607
L GT Y
Sbjct: 166 HIPYRENKNLTGTARY 181
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 53/220 (24%), Positives = 86/220 (39%), Gaps = 34/220 (15%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVK---KFHSPLPSEMASQQEFLNEVKTL-T 490
DF+ +GKG G V +E + E+ AVK K ++ + E + L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT---MVEKRVLAL 397
Query: 491 GIRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSND-----AAAKDLGWTKRMNVI 544
+ + + F + R + V EY+ G L + A
Sbjct: 398 PGKPPFLTQLHSCFQTMDRL-YFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--------A 448
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGT 604
+ L ++ + I++RD+ NV+LD E ++DFG K D GT
Sbjct: 449 AEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGT 505
Query: 605 YGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
Y+APE+ Y V D ++FGVL E++ G+ P
Sbjct: 506 PDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 541
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 37/173 (21%), Positives = 60/173 (34%), Gaps = 34/173 (19%)
Query: 432 IRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLT 490
V + IG+G G +++ L + + VA+K + + +E +T
Sbjct: 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-----EPRRSDAPQLRDEYRTYK 60
Query: 491 GIRH-RNIVKFYGFCSHARHSFIVYEYLEMG-SLAMILSNDAAAKDLGWTKRMNVIKGVV 548
+ I Y F H+ +V + L G SL +L R +K V
Sbjct: 61 LLAGCTGIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLD---------LCGRKFSVKTVA 109
Query: 549 -------DALSYMHNDCFPPIVHRDISSKNVLLDL-----ENEAHVSDFGTAK 589
+ +H V+RDI N L+ N +V DFG K
Sbjct: 110 MAAKQMLARVQSIHEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 2e-07
Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 37/223 (16%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEF-LNEVKTLT 490
F+ +GKGG G V++ +G+I A+K + A E L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 491 GIRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDA----------AAKDLGWTK 539
++H IV Y F + + +++ EYL G L M L + A+
Sbjct: 77 EVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLAE------ 129
Query: 540 RMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAKFLKPDSSN 597
+ AL ++H I++RD+ +N++L+ ++ HV +DFG K D +
Sbjct: 130 -------ISMALGHLHQK---GIIYRDLKPENIMLN--HQGHVKLTDFGLCKESIHDGTV 177
Query: 598 WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640
GT Y+APE+ D +S G L +++ G P
Sbjct: 178 THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 47/198 (23%), Positives = 76/198 (38%), Gaps = 43/198 (21%)
Query: 432 IRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEV---K 487
RV N F IG G G +Y + + E VA+K + + L E +
Sbjct: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLLYESKIYR 57
Query: 488 TLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMG-SLAMILSNDAAAKDLGWTKRMNVIKG 546
L G I F ++ +V + L G SL + + + R +K
Sbjct: 58 ILQGGTG--IPNVRWFGVEGDYNVLVMDLL--GPSLEDLFN---------FCSRKLSLKT 104
Query: 547 V-------VDALSYMHNDCFPPIVHRDISSKNVLLDL---ENEAHVSDFGTAKFLKPDSS 596
V ++ + ++H+ F +HRDI N L+ L N+ ++ DFG AK + S+
Sbjct: 105 VLMLADQMINRVEFVHSKSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161
Query: 597 NW-------AELAGTYGY 607
+ L GT Y
Sbjct: 162 HQHIPYRENKNLTGTARY 179
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 59/229 (25%), Positives = 92/229 (40%), Gaps = 52/229 (22%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVK---KFHSPLPSEMASQQEFLNEVKTL-T 490
DF +GKG G V+ AE + + A+K K + ++ + E + L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT---MVEKRVLSL 73
Query: 491 GIRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSND-----------AAAKDLGWT 538
H + F F + F V EYL G L + + AA
Sbjct: 74 AWEHPFLTHMFCTFQTKENL-FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE------ 126
Query: 539 KRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAK-FLKPDS 595
++ L ++H+ IV+RD+ N+LLD + H+ +DFG K + D+
Sbjct: 127 --------IILGLQFLHSK---GIVYRDLKLDNILLD--KDGHIKIADFGMCKENMLGDA 173
Query: 596 SNWAELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
GT Y+APE+ Y V D +SFGVL E++ G+ P
Sbjct: 174 KTNT-FCGTPDYIAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-07
Identities = 24/66 (36%), Positives = 39/66 (59%), Gaps = 9/66 (13%)
Query: 198 KLILNSNQLCGQLSLELG---SLTQLERLDLSSNRLSNSIPKSL-GNLVKLHYLNLSNNQ 253
+L LN+NQ+ LE G L L++L +SN+L+ +IP + L +L L+L++N
Sbjct: 37 RLWLNNNQI---TKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNH 92
Query: 254 FIKKIP 259
+K IP
Sbjct: 93 -LKSIP 97
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 3e-06
Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 9/95 (9%)
Query: 18 SIPSEIGRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTLFDNALSGAIPKE-YGNLV 75
S+P+ I L L+ N++ + + +L + L N L+ AIP + L
Sbjct: 26 SVPAGI--PTDKQRLWLNNNQI-TKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLT 81
Query: 76 KLTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQN 108
+LT L L +N L+ IP NL SL + L N
Sbjct: 82 QLTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 8e-05
Identities = 22/62 (35%), Positives = 36/62 (58%), Gaps = 4/62 (6%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPH-SLGNLTQITFLTLF 59
L NL LY +N + +IP+ + +L L+ L+L+ N L SIP + NL +T + L+
Sbjct: 56 LVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHL-KSIPRGAFDNLKSLTHIYLY 113
Query: 60 DN 61
+N
Sbjct: 114 NN 115
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-07
Identities = 32/94 (34%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 18 SIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKE-YGNLVK 76
S+P+ I + L L N++ P LTQ+T L L +N L+ +P + L +
Sbjct: 23 SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79
Query: 77 LTLLTLENNQLRGPIPN--LRNLTSLVRVRLNQN 108
LT L+L +NQL+ IP NL SL + L N
Sbjct: 80 LTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 21/62 (33%), Positives = 34/62 (54%), Gaps = 4/62 (6%)
Query: 2 LSNLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKLCGSIPH-SLGNLTQITFLTLF 59
L+ L L L NN + +P+ + +L L+ L L+ N+L SIP + NL +T + L
Sbjct: 53 LTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQL-KSIPRGAFDNLKSLTHIWLL 110
Query: 60 DN 61
+N
Sbjct: 111 NN 112
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 21/65 (32%), Positives = 34/65 (52%), Gaps = 2/65 (3%)
Query: 215 GSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDL 273
G T + L L N+++ P L +L L+L NNQ + +P + +KL L++L L
Sbjct: 27 GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQ-LTVLPAGVFDKLTQLTQLSL 85
Query: 274 SHNFL 278
+ N L
Sbjct: 86 NDNQL 90
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 9e-07
Identities = 44/259 (16%), Positives = 86/259 (33%), Gaps = 73/259 (28%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIV-KFY 501
+G G +V+ + + + VA+K + S + L+E++ L +R+ +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKV----VKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 502 GFCSHARHSF-----------IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDA 550
F +V+E L L I+ ++ L K++ I+ V+
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI--IQQVLQG 158
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLEN-------------------------------- 578
L Y+H C I+H DI +N+LL +
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 579 -----------------EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEK 621
+ ++D G A ++ + E T Y + E+
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT---EDIQTRQYRSLEVLIGSGYNTP 273
Query: 622 CDVYSFGVLALEVIKGKHP 640
D++S +A E+ G +
Sbjct: 274 ADIWSTACMAFELATGDYL 292
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.3 bits (119), Expect = 1e-06
Identities = 36/255 (14%), Positives = 63/255 (24%), Gaps = 62/255 (24%)
Query: 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFH-----SPLPSEMASQQEFLNEVKTL 489
T IG+G G V++ VA+K S + +E L E+
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 490 ---------TGIRHRNIVKFYGFC------------------------------SHARHS 510
R +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSK 570
FIV E+ G + K +++ + +L+ HRD+
Sbjct: 138 FIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWG 191
Query: 571 NVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEK--CDVYSFG 628
NVLL + + K + G + YT+ E+ V+
Sbjct: 192 NVLLKKTSLKKLHYTLNGKSSTI---------PSCGLQVSIIDYTLSRLERDGIVVFCDV 242
Query: 629 VLALEVIKGKHPRDF 643
+ ++ G F
Sbjct: 243 SMDEDLFTGDGDYQF 257
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 35/169 (20%), Positives = 66/169 (39%), Gaps = 16/169 (9%)
Query: 144 RCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGE--MPSKLGKLSSLIKLIL 201
+C KL L ++ + + +S L L+LS E + + L S L +L L
Sbjct: 116 QCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNL 175
Query: 202 NSNQLCGQLS------LELGSLTQLERLDLS--SNRLSNSIPKSLG-NLVKLHYLNLSNN 252
+ C + + +L+LS L S +L L +L+LS++
Sbjct: 176 SW---CFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDS 232
Query: 253 QFIKKIPVE-LEKLIHLSELDLSH-NFLGEEMPSQICNMQSLEKLNLSH 299
+K + +L +L L LS + E ++ + +L+ L +
Sbjct: 233 VMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 40/186 (21%), Positives = 68/186 (36%), Gaps = 17/186 (9%)
Query: 150 TLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ 209
TLD + N+ + ++ S + + + + + NS
Sbjct: 51 TLDLTGKNLHPDVTGRLL-SQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 109
Query: 210 LSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE--LEKLIH 267
L L ++L+ L L RLS+ I +L L LNLS + ++ L
Sbjct: 110 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 169
Query: 268 LSELDLSHNF-LGEEMPSQIC--NMQSLEKLNLSHNN-------LSGFIPSCFEELHGLS 317
L EL+LS F E+ +++ +LNLS LS + C L
Sbjct: 170 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRC----PNLV 225
Query: 318 YIDISY 323
++D+S
Sbjct: 226 HLDLSD 231
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 56/231 (24%), Positives = 92/231 (39%), Gaps = 49/231 (21%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEF-LNEVKTLT 490
+F+ +G G G V+ +G++ A+K + A E E + L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 491 GIRHRN-IVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDA----------AAKDLGWT 538
IR +V Y F + + ++ +Y+ G L LS +
Sbjct: 114 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGE----- 167
Query: 539 KRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAKFLKPDSS 596
+V AL ++H I++RDI +N+LLD + HV +DFG +K D +
Sbjct: 168 --------IVLALEHLHKL---GIIYRDIKLENILLD--SNGHVVLTDFGLSKEFVADET 214
Query: 597 NWAE-LAGTYGYVAPEL------AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
A GT Y+AP++ + V D +S GVL E++ G P
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 59/227 (25%), Positives = 94/227 (41%), Gaps = 48/227 (21%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKT-----L 489
DFD IG+G V L + I A+K + E+ + E ++ V+T
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV----VKKELVNDDEDIDWVQTEKHVFE 64
Query: 490 TGIRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDA----------AAKDLGWT 538
H +V F + +R F V EY+ G L + +A+
Sbjct: 65 QASNHPFLVGLHSCFQTESRL-FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE----- 118
Query: 539 KRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK-FLKPDSSN 597
+ AL+Y+H I++RD+ NVLLD E ++D+G K L+P +
Sbjct: 119 --------ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167
Query: 598 WAELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
+ GT Y+APE+ Y V D ++ GVL E++ G+ P
Sbjct: 168 -STFCGTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 46/226 (20%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVK---KFHSPLPSEMASQQEFLNEVKTLTG 491
++F+ +GKG G V A + +G++ AVK K ++ + E + L+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT---MTEKRILSL 79
Query: 492 I-RHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDA----------AAKDLGWTK 539
H + + F F + R F V E++ G L + AA+
Sbjct: 80 ARNHPFLTQLFCCFQTPDRL-FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE------ 132
Query: 540 RMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK-FLKPDSSNW 598
++ AL ++H+ I++RD+ NVLLD E ++DFG K + +
Sbjct: 133 -------IISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT- 181
Query: 599 AELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
A GT Y+APE+ Y V D ++ GVL E++ G P
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 46/226 (20%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVK---KFHSPLPSEMASQQEFLNEVKTLTG 491
DFD IG+G V L + I A++ K ++ E
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWV---QTEKHVFEQ 108
Query: 492 I-RHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDA----------AAKDLGWTK 539
H +V F + +R F V EY+ G L + +A+
Sbjct: 109 ASNHPFLVGLHSCFQTESRL-FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE------ 161
Query: 540 RMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK-FLKPDSSNW 598
+ AL+Y+H I++RD+ NVLLD E ++D+G K L+P +
Sbjct: 162 -------ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT- 210
Query: 599 AELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
+ GT Y+APE+ Y V D ++ GVL E++ G+ P
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 6e-06
Identities = 55/227 (24%), Positives = 90/227 (39%), Gaps = 48/227 (21%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVK---KFHSPLPSEMASQQEFLNEVKTL-T 490
DF+ +GKG G V +E + E+ AVK K ++ + E + L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT---MVEKRVLAL 76
Query: 491 GIRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDA----------AAKDLGWTK 539
+ + + F + R + V EY+ G L + AA+
Sbjct: 77 PGKPPFLTQLHSCFQTMDRL-YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE------ 129
Query: 540 RMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAKFLKPDSSN 597
+ L ++ + I++RD+ NV+LD +E H+ +DFG K D
Sbjct: 130 -------IAIGLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVT 177
Query: 598 WAELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
GT Y+APE+ Y V D ++FGVL E++ G+ P
Sbjct: 178 TKTFCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 8e-06
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 44/225 (19%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLT-GIR 493
+DF IGKG G V A AVK + ++ ++E L ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 494 HRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNDA----------AAKDLGWTKRMN 542
H +V + F + + + V +Y+ G L L + AA+
Sbjct: 98 HPFLVGLHFSFQTADK-LYFVLDYINGGELFYHLQRERCFLEPRARFYAAE--------- 147
Query: 543 VIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAK-FLKPDSSNWA 599
+ AL Y+H+ IV+RD+ +N+LLD ++ H+ +DFG K ++ +S+
Sbjct: 148 ----IASALGYLHSL---NIVYRDLKPENILLD--SQGHIVLTDFGLCKENIEHNSTTST 198
Query: 600 ELAGTYGYVAPEL----AYTMKVTEKCDVYSFGVLALEVIKGKHP 640
GT Y+APE+ Y V D + G + E++ G P
Sbjct: 199 -FCGTPEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 24/130 (18%), Positives = 48/130 (36%), Gaps = 19/130 (14%)
Query: 194 SSLIKLIL-NSNQL----CGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVK----L 244
L ++ L N + + L + T +++ + R ++ + +L ++K L
Sbjct: 36 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTL 95
Query: 245 HYLNLSNNQF----IKKIPVELEKLIHLSELDLSHNF--LGEEMPSQICNM----QSLEK 294
LN+ +N I + L+ L EL + + LG + +I NM +L K
Sbjct: 96 KSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLK 155
Query: 295 LNLSHNNLSG 304
Sbjct: 156 FGYHFTQQGP 165
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 25/157 (15%), Positives = 49/157 (31%), Gaps = 43/157 (27%)
Query: 145 CPKLGTLDFSSNNITGSMPAEII-----HSSQLKVLDLSSNHI-------VGEMPSKLGK 192
P L ++ ++ + ++ +K + + EM L
Sbjct: 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEM---LKV 91
Query: 193 LSSLIKLILNSNQLCGQLSLELG-------SLTQLERLDLSSNRLSNSIPKSLGNLVKLH 245
++L L + SN + G L L SL +L R+D S L N++ + N+++
Sbjct: 92 NNTLKSLNVESNFISGSGILALVEALQSNTSLIEL-RIDNQSQPLGNNVEMEIANMLE-- 148
Query: 246 YLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEM 282
N L + G +
Sbjct: 149 ----KNT--------------TLLKFGYHFTQQGPRL 167
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 20/162 (12%), Positives = 49/162 (30%), Gaps = 22/162 (13%)
Query: 208 GQLSLELGSLTQLERLDLSSNRLSN------SIPKSLGNLVKLHYLNLSNNQFI-----K 256
G + Q + + N I + + L +N++N + + +
Sbjct: 1 GSHGTTFNGIMQSYVPRIVPDEPDNDTDVESCINRLREDDTDLKEVNINNMKRVSKERIR 60
Query: 257 KIPVELEKLIHLSELDLSHNFLGEEMPSQICNM----QSLEKLNLSHNNLSG-FIPSCFE 311
+ H+ + L++ + + + + SL LN+ N L+ +
Sbjct: 61 SLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120
Query: 312 ELH---GLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGL 350
+ N+ + N A++ N+ L
Sbjct: 121 STLVTQSIVEFKAD-NQRQSVLGNQVEMDMM--MAIEENESL 159
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 10/96 (10%), Positives = 37/96 (38%), Gaps = 6/96 (6%)
Query: 210 LSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFI-----KKIPVELEK 264
L +++ +D + + + + + L + + L +I +++
Sbjct: 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENL 112
Query: 265 LIHLSELDLSHNF-LGEEMPSQICNMQSLEKLNLSH 299
+ E+++ + ++ + + ++L+ L LS
Sbjct: 113 QKSMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSD 148
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Length = 176 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 21/133 (15%), Positives = 47/133 (35%), Gaps = 21/133 (15%)
Query: 144 RCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNS 203
K+ +D + + I + ++ + L H + + L +LS L L +
Sbjct: 59 DKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIED--GCLERLSQLENLQKS- 115
Query: 204 NQLCGQLSLELGSLTQLERLDLSSN-RLSNSIPKSLGNLVKLHYLNLSNNQFIKKIP-VE 261
+ +++ S +++ +L + L YL LS+ +K+ +
Sbjct: 116 ----------------MLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLPGVKEKEKIV 159
Query: 262 LEKLIHLSELDLS 274
L L+L
Sbjct: 160 QAFKTSLPSLELK 172
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 | Back alignment and structure |
|---|
Score = 39.0 bits (91), Expect = 9e-04
Identities = 15/53 (28%), Positives = 20/53 (37%), Gaps = 5/53 (9%)
Query: 207 CGQLSLELGSL-----TQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQF 254
CG+ L SL L L+ N L+ P L L L +L N +
Sbjct: 15 CGRRGLTWASLPTAFPVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 707 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.98 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.98 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.88 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.83 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.83 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.82 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.81 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.79 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.72 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.7 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.7 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.7 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.64 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.59 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.55 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.45 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.42 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.41 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.38 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.37 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.26 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.2 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.12 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.09 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.04 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.94 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.69 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.62 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.61 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.43 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.32 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.32 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.32 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.28 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 98.25 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.12 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.01 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.99 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.85 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.85 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.8 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.72 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.59 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.54 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.45 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.35 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.28 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.16 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.07 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.07 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.02 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.7 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.51 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.46 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.37 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.12 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.41 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.19 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.75 | |
| 2lz0_A | 100 | Uncharacterized protein; hypothetical leucine rich | 84.73 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=420.32 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=203.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.+++++.++||+|+||+||+|+++. .||||+++.... .....++|.+|++++++++|||||++++++.+ +..++||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence 3578889999999999999998753 589999875433 33456789999999999999999999998865 5689999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++|+|.++++.. ..++++.++++++.||++||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 111 Ey~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp ECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999999643 24699999999999999999999999 9999999999999999999999999999876533
Q ss_pred C--CCccccccccCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 595 S--SNWAELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 595 ~--~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
. ......+||+.|||||++.+ .+|+.++|||||||++|||+||+.||...... .............+..+.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~~~~~~~~~~~~~p~~~~- 261 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---DQIIFMVGRGYASPDLSK- 261 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHHHHTTCCCCCSTT-
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---HHHHHHHhcCCCCCCccc-
Confidence 2 23445689999999999864 45899999999999999999999999643221 111111122222232222
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+.+.++.+++.+||+.||++|||++||++.|+
T Consensus 262 --~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 262 --LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp --SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred --ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 22334566899999999999999999999998875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-53 Score=430.41 Aligned_cols=252 Identities=21% Similarity=0.337 Sum_probs=206.0
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||+||+|+ ..+|+.||||++....... ...+.+.+|++++++++|||||++++++.+++.+|+||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 579999999999999999995 4679999999997654433 34678999999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++||+|.+++.... ...+++..++.++.||+.||+|||++ |||||||||+|||++.+|.+||+|||+|+.....
T Consensus 103 Ey~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp ECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred eCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 9999999999996433 34578999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+ ....+..+.....+..+.
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~~~~~~~--- 247 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKIISGSFPPVSL--- 247 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTCCCCCCT---
T ss_pred cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcCCCCCCCc---
Confidence 333455689999999999999999999999999999999999999996422 222233333333322211
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+.++.+++.+||+.||++|||++|+++
T Consensus 248 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 23456899999999999999999999975
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=422.10 Aligned_cols=253 Identities=25% Similarity=0.449 Sum_probs=207.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
++|.+.+.||+|+||.||+|++. +++.||||++... .....++|.+|++++++++|||||++++++.+++.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 56888899999999999999653 4788999999753 23356789999999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhccc----------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC
Q 038671 510 SFIVYEYLEMGSLAMILSNDA----------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE 579 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~ 579 (707)
.++||||+++|+|.++++..+ ....++|.++++++.||++||+|||++ +||||||||+|||++.++.
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCc
Confidence 999999999999999997543 234699999999999999999999999 9999999999999999999
Q ss_pred eEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhh
Q 038671 580 AHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEI 656 (707)
Q Consensus 580 ~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 656 (707)
+||+|||+|+........ .....||+.|||||++.+..|+.++|||||||++|||+| |+.||..... ..
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~ 238 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NE 238 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HH
Confidence 999999999876543222 223468999999999999999999999999999999999 9999974322 11
Q ss_pred hhhhhcCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 657 ALNEMLDP-RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 657 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....+... +.+.+. ..+.++.+++.+||+.||++|||++|+.+.|+
T Consensus 239 ~~~~i~~~~~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~ 285 (299)
T 4asz_A 239 VIECITQGRVLQRPR----TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ 285 (299)
T ss_dssp HHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 12222222 222222 23456899999999999999999999998875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=421.58 Aligned_cols=254 Identities=22% Similarity=0.356 Sum_probs=208.7
Q ss_pred cCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
.++++.+.||+|+||+||+|++ .+++.||||++..... ....++|.+|+.++++++|||||+++|++.+++.
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~--~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~ 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC--C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC--hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence 3466778999999999999975 3568899999975432 2345789999999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC
Q 038671 510 SFIVYEYLEMGSLAMILSNDAA-------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL 576 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~ 576 (707)
.++||||+++|+|.+++..... ...++|..+++++.|||+||+|||++ +||||||||+|||+++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence 9999999999999999965422 24589999999999999999999999 9999999999999999
Q ss_pred CCCeEEeccccceecCCCC--CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccch
Q 038671 577 ENEAHVSDFGTAKFLKPDS--SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSN 653 (707)
Q Consensus 577 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~ 653 (707)
++.+||+|||+++...... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.....
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------- 253 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------- 253 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH-------
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH-------
Confidence 9999999999998764332 22345679999999999999999999999999999999998 8999974322
Q ss_pred hhhhhhhhcCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 654 LEIALNEMLDP-RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 654 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
......+... +.+.+. +.+.++.+++.+||+.||++||||+||++.|+
T Consensus 254 -~~~~~~i~~~~~~~~p~----~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 254 -QDVVEMIRNRQVLPCPD----DCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp -HHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHHHHHcCCCCCCcc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 1122222222 233332 23456899999999999999999999999885
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=422.72 Aligned_cols=249 Identities=21% Similarity=0.319 Sum_probs=210.4
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||+||+|+ ..+|+.||+|++...........+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999995 5679999999986532223334577999999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++||+|.+++... +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 999999999999643 4599999999999999999999999 9999999999999999999999999999987644
Q ss_pred C--CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 595 S--SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 595 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||...+ .......+....+..+..
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~~~~~p~~- 256 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EGLIFAKIIKLEYDFPEK- 256 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCCCTT-
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCCCCcc-
Confidence 3 33456789999999999999999999999999999999999999996321 222233333333333322
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVS 702 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~ 702 (707)
.+.++.+++.+|+..||++|||++|+.
T Consensus 257 ---~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 257 ---FFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 234588999999999999999999863
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=423.42 Aligned_cols=249 Identities=27% Similarity=0.416 Sum_probs=210.3
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
..|+..+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+++++.++|||||++++++.+++.+|+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5699999999999999999954 5799999999864322 22356889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++||+|.+++.. ..+++..++.++.||+.||+|||++ |||||||||+|||++.+|.+||+|||+|+.....
T Consensus 151 Ey~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 151 EFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 99999999999864 3589999999999999999999999 9999999999999999999999999999988766
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+.....+..+ ...
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i~~~~~~~~~----~~~ 294 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIRDNLPPRLK----NLH 294 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSSCCCCS----CGG
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHcCCCCCCC----ccc
Confidence 6666778999999999999999999999999999999999999999964221 1111112222222222 223
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+.++.+++.+||..||++|||++|+++
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 34556899999999999999999999976
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=423.09 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=202.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
++|.+.+.||+|+||.||+|+++ +++.||||++... .....++|.+|++++++++|||||+++++|.+++.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 45677889999999999999753 4788999999753 23356789999999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccc------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC
Q 038671 510 SFIVYEYLEMGSLAMILSNDAA------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE 577 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~ 577 (707)
.++||||+++|+|.++++.... ..+++|.++++++.||++||+|||++ +||||||||+|||++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQG 194 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETT
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCC
Confidence 9999999999999999976432 24589999999999999999999999 99999999999999999
Q ss_pred CCeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchh
Q 038671 578 NEAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNL 654 (707)
Q Consensus 578 ~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 654 (707)
+.+||+|||+++....... ......||+.|||||++.+..|+.++|||||||++|||+| |+.||...... . .
T Consensus 195 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~----~-~ 269 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT----E-A 269 (329)
T ss_dssp TEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH----H-H
T ss_pred CcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH----H-H
Confidence 9999999999987654322 2234679999999999999999999999999999999999 99999743221 1 1
Q ss_pred hhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 655 EIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+.. ..+++.+.. .+.++.+++.+||+.||++|||++||++.|+
T Consensus 270 ~~~i~~--g~~~~~p~~----~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 315 (329)
T 4aoj_A 270 IDCITQ--GRELERPRA----CPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315 (329)
T ss_dssp HHHHHH--TCCCCCCTT----CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHc--CCCCCCccc----ccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 111111 122333322 3456899999999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-52 Score=409.30 Aligned_cols=248 Identities=22% Similarity=0.331 Sum_probs=193.4
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||+||+|+. .+|+.||+|++.............+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999964 579999999997655444445677999999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+ +|+|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 67898888643 4599999999999999999999999 9999999999999999999999999999876533
Q ss_pred CCCccccccccCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
......+||+.|||||++.+..+ +.++||||+||++|+|+||+.||... ........+.....+.+..
T Consensus 166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~--------~~~~~~~~i~~~~~~~p~~-- 234 (275)
T 3hyh_A 166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE--------SIPVLFKNISNGVYTLPKF-- 234 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCCCCCTT--
T ss_pred -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHcCCCCCCCC--
Confidence 33455789999999999998886 57999999999999999999999632 1222233333333333222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+.++.+++.+||+.||++|||++|+++
T Consensus 235 --~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 235 --LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2345889999999999999999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=424.17 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=210.8
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
+.|+..+.||+|+||.||+|+ ..+|+.||||++...... ..+.+.+|+.+++.++|||||++++++.+++.+|+||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 569999999999999999995 457999999999754322 2356889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
|||+||+|.++++. ..+++..+..++.||+.||+|||++ |||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 228 Ey~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 228 EFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp ECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred eCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 99999999999863 3489999999999999999999999 9999999999999999999999999999988766
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.......+||+.|||||++.+..|+.++|||||||++|||++|+.||..... ......+.....+.+....
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i~~~~~~~~~~~~---- 371 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-----LKAMKMIRDNLPPRLKNLH---- 371 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSCCCCCSCTT----
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHHHHcCCCCCCcccc----
Confidence 6666778999999999999999999999999999999999999999964221 1111122222222332222
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+.++.+++.+||..||++|||++|+++
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 23456889999999999999999999986
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=405.17 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=199.0
Q ss_pred CCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec----CCceeEE
Q 038671 439 DDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH----ARHSFIV 513 (707)
Q Consensus 439 ~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 513 (707)
+..+.||+|+||+||+|. ..+++.||+|++...... ....+.|.+|++++++++|||||++++++.. ++.+|+|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 566789999999999995 457899999998654332 2345779999999999999999999999864 3568999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeec-CCCCeEEecccccee
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP--IVHRDISSKNVLLD-LENEAHVSDFGTAKF 590 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nil~~-~~~~~kl~Dfg~~~~ 590 (707)
|||++||+|.+++.+. ..+++..++.++.||+.||+|||++ + ||||||||+|||++ .++.+||+|||+|+.
T Consensus 108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 9999999999999643 4589999999999999999999998 6 99999999999997 479999999999975
Q ss_pred cCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCC
Q 038671 591 LKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670 (707)
Q Consensus 591 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (707)
.. .......+||+.|||||++.+ +|+.++|||||||++|||+||+.||..... .......+.....+.
T Consensus 182 ~~--~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~~~~~i~~~~~~~-- 249 (290)
T 3fpq_A 182 KR--ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKPA-- 249 (290)
T ss_dssp CC--TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTCCCG--
T ss_pred CC--CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHHHHHHHHcCCCCC--
Confidence 43 234456789999999998865 699999999999999999999999963221 122222222222221
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
......+.++.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122345889999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=413.24 Aligned_cols=249 Identities=22% Similarity=0.301 Sum_probs=200.4
Q ss_pred cCCCCCceeeecCCeeEEEEEc----CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
++|++.+.||+|+||+||+|+. .+++.||+|++....... .....+.+|++++++++|||||++++++.+++..|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 5799999999999999999964 357899999987543222 12346788999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||++||+|.+++.+. +.+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+|+..
T Consensus 103 ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 999999999999999653 4599999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
..........+||+.|||||++.+..|+.++||||+||++|||+||+.||...+ .......+.....+.+..
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~~~~p~~ 248 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--------RKETMTMILKAKLGMPQF 248 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCTT
T ss_pred cCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--------HHHHHHHHHcCCCCCCCc
Confidence 655555567799999999999999999999999999999999999999996322 222233333333333322
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTI-----QKVSQ 703 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~-----~~l~~ 703 (707)
.+.++.+++.+||+.||++|||+ +|+++
T Consensus 249 ----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 249 ----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 33458899999999999999984 57664
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=411.87 Aligned_cols=247 Identities=23% Similarity=0.307 Sum_probs=200.6
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
+.|+..++||+|+||.||+|+ ..+|+.||||++..... ..+|+.++++++|||||++++++.+++.+|+||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 457788899999999999995 45799999999875422 236999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC-CeEEeccccceecCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTAKFLKP 593 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~-~~kl~Dfg~~~~~~~ 593 (707)
||++||+|.++++.. +.+++..++.++.||+.||+|||++ +||||||||+|||++.+| .+||+|||+|+....
T Consensus 130 Ey~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp CCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred eccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 999999999999653 4599999999999999999999999 999999999999999988 699999999988754
Q ss_pred CCCC-----ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 594 DSSN-----WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 594 ~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
.... ....+||+.|||||++.+..|+.++||||+||++|||+||+.||...... ......... ..+.
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~i~~~----~~~~ 275 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG----PLCLKIASE----PPPI 275 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS----CCHHHHHHS----CCGG
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH----HHHHHHHcC----CCCc
Confidence 3221 23357999999999999999999999999999999999999999643221 111111111 1110
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
....+..+..+.+++.+||+.||++|||+.|+++.|
T Consensus 276 -~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l 311 (336)
T 4g3f_A 276 -REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKV 311 (336)
T ss_dssp -GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 011123345688999999999999999999998865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=412.30 Aligned_cols=263 Identities=23% Similarity=0.380 Sum_probs=212.2
Q ss_pred HHHHHHhcCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCC-Cceeeee
Q 038671 429 EEIIRVTNDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH-RNIVKFY 501 (707)
Q Consensus 429 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~ 501 (707)
.+++...++|++.+.||+|+||.||+|++. .++.||||++..... ....+++.+|++++.+++| ||||+++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 344445678999999999999999999643 246899999876433 2345779999999999965 9999999
Q ss_pred eeeecC-CceeEEEeeeccCcHHHHHhcccc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 038671 502 GFCSHA-RHSFIVYEYLEMGSLAMILSNDAA-------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDI 567 (707)
Q Consensus 502 ~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 567 (707)
++|.+. +..++|||||++|+|.++++.... ...+++.+++.++.|||+||+|||++ +||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 999664 568999999999999999975432 23489999999999999999999999 9999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcc
Q 038671 568 SSKNVLLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFI 644 (707)
Q Consensus 568 k~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~ 644 (707)
||+|||+++++.+||+|||+|+........ .....||+.|||||++.+..|+.++|||||||++|||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544332 234678999999999999999999999999999999998 99999743
Q ss_pred cccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 645 SSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.. .......+.... +++.+.. .+.++.+++.+||+.||++|||++|+++.|+
T Consensus 292 ~~----~~~~~~~i~~g~--~~~~p~~----~~~~~~~li~~c~~~dP~~RPt~~eil~~L~ 343 (353)
T 4ase_A 292 KI----DEEFCRRLKEGT--RMRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 343 (353)
T ss_dssp CC----SHHHHHHHHHTC--CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CH----HHHHHHHHHcCC--CCCCCcc----CCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 21 122222232222 2232322 2345889999999999999999999999874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=400.53 Aligned_cols=251 Identities=20% Similarity=0.397 Sum_probs=195.3
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR----- 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 508 (707)
.++|++.+.||+|+||+||+|+ ..+|+.||||++.... .....+.+.+|++++++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 3469999999999999999995 4579999999986543 2334567899999999999999999999986543
Q ss_pred -------ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeE
Q 038671 509 -------HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH 581 (707)
Q Consensus 509 -------~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~k 581 (707)
..|+||||+++|+|.+++.........++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence 3689999999999999998665555567778899999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCC------------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccc
Q 038671 582 VSDFGTAKFLKPDSS------------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISS 649 (707)
Q Consensus 582 l~Dfg~~~~~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 649 (707)
|+|||+|+....... .....+||+.|||||++.+..|+.++|||||||++|||++ ||...
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~----- 230 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ----- 230 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----
Confidence 999999987654321 1234579999999999999999999999999999999996 76421
Q ss_pred ccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 650 SSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...............+. ..........+++.+||+.||++|||+.|+++
T Consensus 231 --~~~~~~~~~~~~~~~p~---~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 231 --MERVRTLTDVRNLKFPP---LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp --HHHHHHHHHHHTTCCCH---HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --cHHHHHHHHHhcCCCCC---CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122223333333332 23344456788999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=401.13 Aligned_cols=261 Identities=23% Similarity=0.331 Sum_probs=199.4
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC----cee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR----HSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~ 511 (707)
++|.+.+.||+|+||+||+|++ +|+.||||++... .........|+..+.+++|||||++++++.+++ .++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 5678889999999999999987 5899999998542 112223345667777899999999999997654 579
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC-----FPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
+||||+++|+|.++++. .+++|..+.+++.|+++||+|||+++ .++||||||||+|||++.++.+||+|||
T Consensus 78 lV~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 99999999999999964 35899999999999999999999762 3489999999999999999999999999
Q ss_pred cceecCCCCCC----ccccccccCCCCccccccC------CCCccchhHHHHHHHHHHHhCCCCCCcccccc-------c
Q 038671 587 TAKFLKPDSSN----WAELAGTYGYVAPELAYTM------KVTEKCDVYSFGVLALEVIKGKHPRDFISSIS-------S 649 (707)
Q Consensus 587 ~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-------~ 649 (707)
+|+........ ....+||+.|||||++.+. .++.++|||||||++|||+||+.||....... .
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 99876544322 2345799999999998764 36789999999999999999988875322111 1
Q ss_pred ccchhhhhhh----hhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 650 SSSNLEIALN----EMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 650 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.....+.... ...++.+|... ...+.+..+.+++.+||+.||++||||.||++.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~rp~~p~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 234 SDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGG-GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred ccchHHHHHHHHhcccCCCCCCccc-cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 1111222222 22233333221 12345667899999999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=391.38 Aligned_cols=257 Identities=23% Similarity=0.350 Sum_probs=200.5
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec------C
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH------A 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~ 507 (707)
.++|++.+.||+|+||+||+|+ ..+|+.||||++....... ...+.+.+|++++++++|||||++++++.. .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSH-HHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccch-HHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 3579999999999999999995 5679999999997654332 345678899999999999999999998753 4
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
+..|+||||++ |+|.+++... +.+++..+..++.||+.||+|||++ |||||||||+|||++.++.+||+|||+
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 67899999996 6798888643 4699999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCC----CCCccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh--
Q 038671 588 AKFLKPD----SSNWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE-- 660 (707)
Q Consensus 588 ~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-- 660 (707)
|+.+... .......+||+.|||||++.+.. ++.++||||+||++|||++|++||...+... ........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~----~l~~I~~~~g 280 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH----QLQLIMMVLG 280 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH----HHHHHHHHHC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH----HHHHHHHhcC
Confidence 9876432 22345678999999999988754 6999999999999999999999996432211 00000000
Q ss_pred --------------------hcCCCCCCCCc-chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 661 --------------------MLDPRLPTPSH-NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 661 --------------------~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+..+.+.. ..+..+.++.+++.+||..||++|||++|+++
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00111111100 00112346889999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=381.47 Aligned_cols=200 Identities=29% Similarity=0.362 Sum_probs=171.7
Q ss_pred HHHHHHhcCCCCCceeeecCCeeEEEEEc----CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeee
Q 038671 429 EEIIRVTNDFDDEHCIGKGGQGSVYKAEL----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGF 503 (707)
Q Consensus 429 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~ 503 (707)
+.+....++|++.+.||+|+||+||+|+. .+++.||+|++.... ...++.+|+++++.+ +||||++++++
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~ 88 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYC 88 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence 34445678999999999999999999954 357889999986532 234678899999988 69999999999
Q ss_pred eecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC-CCeEE
Q 038671 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE-NEAHV 582 (707)
Q Consensus 504 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~-~~~kl 582 (707)
+.+.+..|+||||++||+|.+++. .+++.+++.++.||+.||+|||++ ||+||||||+|||++.+ +.+||
T Consensus 89 ~~~~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl 159 (361)
T 4f9c_A 89 FRKNDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYAL 159 (361)
T ss_dssp EEETTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred EEECCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEE
Confidence 999999999999999999999983 389999999999999999999999 99999999999999877 79999
Q ss_pred eccccceecCCCCC----------------------------CccccccccCCCCccccccCC-CCccchhHHHHHHHHH
Q 038671 583 SDFGTAKFLKPDSS----------------------------NWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALE 633 (707)
Q Consensus 583 ~Dfg~~~~~~~~~~----------------------------~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~e 633 (707)
+|||+|+....... .....+||+.|+|||++.+.. |+.++||||+||++||
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e 239 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence 99999986543211 123457999999999988754 8999999999999999
Q ss_pred HHhCCCCCC
Q 038671 634 VIKGKHPRD 642 (707)
Q Consensus 634 l~tg~~p~~ 642 (707)
|++|+.||.
T Consensus 240 ll~G~~Pf~ 248 (361)
T 4f9c_A 240 LLSGRYPFY 248 (361)
T ss_dssp HHHTCSSSS
T ss_pred HHHCCCCCC
Confidence 999999985
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=400.90 Aligned_cols=252 Identities=21% Similarity=0.235 Sum_probs=201.4
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHH---HHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQE---FLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~---~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
-++|++.+.||+|+||.||+|+ ..+|+.||+|++............. ...++.+++.++|||||++++++.+++.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 3679999999999999999995 4579999999986432111112222 33456777888999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
|+||||+.||+|.+++.+. ..+++..++.++.||+.||+|||++ |||||||||+|||++.+|.+||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence 9999999999999999653 4599999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCCCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 591 LKPDSSNWAELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 591 ~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
..... ....+||+.|||||++. +..|+.++|+||+||++|||++|++||..... .................+
T Consensus 342 ~~~~~--~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~-----~~~~~i~~~i~~~~~~~p 414 (689)
T 3v5w_A 342 FSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMTLTMAVELP 414 (689)
T ss_dssp CSSCC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC-----CCHHHHHHHHHHCCCCCC
T ss_pred cCCCC--CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhhcCCCCCCC
Confidence 65432 34578999999999986 45799999999999999999999999964221 111222222222233222
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPT-----IQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~l~~ 703 (707)
.. .+.++.++|.+||..||.+|++ ++|+++
T Consensus 415 ~~----~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 415 DS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp TT----SCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred cc----CCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 22 3345889999999999999998 677754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=415.69 Aligned_cols=360 Identities=33% Similarity=0.525 Sum_probs=290.4
Q ss_pred CCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcC-ccCCCCCcEEEcccCcCcccCCccccCCC-CCCe
Q 038671 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHS-LGNLTQITFLTLFDNALSGAIPKEYGNLV-KLTL 79 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~-~~~l~~L~~L~L~~n~i~~~~~~~~~~l~-~L~~ 79 (707)
+++|++|+|++|.+++..|..|+.+++|++|+|++|++++.+|.. |.++++|++|+|++|.+++.+|..+.+++ +|++
T Consensus 293 ~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~ 372 (768)
T 3rgz_A 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLT 372 (768)
T ss_dssp CTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSE
T ss_pred cCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcE
Confidence 367888888888888777888888888888888888777666654 77777777777777777766666666554 4555
Q ss_pred eecccc--------------------------cccc-cCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccc
Q 038671 80 LTLENN--------------------------QLRG-PIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHN 132 (707)
Q Consensus 80 L~l~~n--------------------------~i~~-~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n 132 (707)
|++++| .+.+ ++..+..+++|++|++++|++++..+..+..+++|+.|++++|
T Consensus 373 L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n 452 (768)
T 3rgz_A 373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452 (768)
T ss_dssp EECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred EEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCC
Confidence 555554 4443 2234666677777777777777666677777777777777777
Q ss_pred cccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCcc
Q 038671 133 YFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSL 212 (707)
Q Consensus 133 ~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 212 (707)
.+++..+..+..+++|++|+|++|.+++..+..+..+++|++|+|++|++++.+|..+..+++|++|++++|++++..|.
T Consensus 453 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 532 (768)
T 3rgz_A 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532 (768)
T ss_dssp CCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCG
T ss_pred cccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCH
Confidence 77777777777778888888888888877788888888888888888888888888888888888888888888888888
Q ss_pred ccCCCCcccEEEccCCccCCCCCcc-------------------------------------------------------
Q 038671 213 ELGSLTQLERLDLSSNRLSNSIPKS------------------------------------------------------- 237 (707)
Q Consensus 213 ~~~~l~~L~~L~l~~n~i~~~~~~~------------------------------------------------------- 237 (707)
.+..+++|++|++++|.+++.+|..
T Consensus 533 ~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 612 (768)
T 3rgz_A 533 ELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP 612 (768)
T ss_dssp GGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCC
T ss_pred HHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccc
Confidence 8888888888888888887655543
Q ss_pred ---------------ccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEecccccc
Q 038671 238 ---------------LGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNL 302 (707)
Q Consensus 238 ---------------l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i 302 (707)
+..+++|+.|+|++|++++..|..++.+++|+.|+|++|.+++.+|..++.+++|+.|++++|++
T Consensus 613 ~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l 692 (768)
T 3rgz_A 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692 (768)
T ss_dssp SCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred cccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcc
Confidence 33456788999999999999999999999999999999999999999999999999999999999
Q ss_pred CCchhHhhccCCCceeEeeccCcccccCCCccccccCchhhcccCcCcCCCCCCCCCcCCC
Q 038671 303 SGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIKGFPSCKAS 363 (707)
Q Consensus 303 ~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~c~~~ 363 (707)
++.+|..+..++.|+.|++++|+++|.+|....+.......+.+|+.+|+.+ .+.|...
T Consensus 693 ~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~--l~~C~~~ 751 (768)
T 3rgz_A 693 DGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP--LPRCDPS 751 (768)
T ss_dssp EECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTT--SCCCCSC
T ss_pred cCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCC--CcCCCCC
Confidence 9999999999999999999999999999998888888899999999999976 3467654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=402.04 Aligned_cols=252 Identities=21% Similarity=0.324 Sum_probs=212.1
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|. ..+|+.||+|++.... ....+.+.+|+++|+.++|||||++++++.+++.+|+|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3689999999999999999995 4679999999987542 23456788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC--CCeEEeccccceec
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE--NEAHVSDFGTAKFL 591 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~--~~~kl~Dfg~~~~~ 591 (707)
|||++||+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 233 ~E~~~gg~L~~~i~~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 233 YEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EECCCCCBHHHHHTCT--TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EeecCCCcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 9999999999998543 24589999999999999999999999 99999999999999854 89999999999987
Q ss_pred CCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ....+..+.......+..
T Consensus 308 ~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~~ 378 (573)
T 3uto_A 308 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCDWNMDDS 378 (573)
T ss_dssp CTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTCCCCCSG
T ss_pred cCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHhCCCCCCcc
Confidence 643 33456789999999999999999999999999999999999999996322 223333333333333333
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.....+.++.+++.+||+.||.+|||++|+++
T Consensus 379 ~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33344566889999999999999999999986
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=363.04 Aligned_cols=262 Identities=30% Similarity=0.436 Sum_probs=204.7
Q ss_pred HHHHHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 430 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
.+....++|++.+.||+|+||.||+|+. +|+.||||++...... ....+.+.+|++++++++||||+++++++...+.
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFH-AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 3334467899999999999999999976 5888999998765433 3445678999999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeecCCCCeEEecccc
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP--IVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
.++||||+++++|.+++........+++..++.++.|++.||+|||+. | |+||||||+||+++.++.+||+|||+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 999999999999999997655445589999999999999999999999 8 99999999999999999999999999
Q ss_pred ceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 588 AKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
++.............||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...... ........
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~----~~~~~~--~~~~~~~~ 259 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA----QVVAAV--GFKCKRLE 259 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH----HHHHHH--HHSCCCCC
T ss_pred CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH--HhcCCCCC
Confidence 986554444445568999999999999999999999999999999999999999643211 111111 11122222
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+. ..+.++.+++.+||+.||++|||++++++.|+
T Consensus 260 ~~~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~ 294 (309)
T 3p86_A 260 IPR----NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294 (309)
T ss_dssp CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 222 23345899999999999999999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=365.30 Aligned_cols=278 Identities=32% Similarity=0.599 Sum_probs=225.6
Q ss_pred cchHHHHHHHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeee
Q 038671 425 KIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFC 504 (707)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~ 504 (707)
.++..++....++|++.+.||+|+||.||+|+.++|+.||+|++....... ....+.+|+++++.++||||+++++++
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456788889999999999999999999999988889999999987643221 223688999999999999999999999
Q ss_pred ecCCceeEEEeeeccCcHHHHHhcccc-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEe
Q 038671 505 SHARHSFIVYEYLEMGSLAMILSNDAA-AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVS 583 (707)
Q Consensus 505 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~ 583 (707)
..++..++||||+.+++|.+++..... ...+++..++.++.|++.||+|||+.+.+||+||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 999999999999999999999976543 3458999999999999999999999876789999999999999999999999
Q ss_pred ccccceecCCCCCC-ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhh----
Q 038671 584 DFGTAKFLKPDSSN-WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIAL---- 658 (707)
Q Consensus 584 Dfg~~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~---- 658 (707)
|||++......... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||+................
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99999876544332 3345699999999999888899999999999999999999999963221111111111111
Q ss_pred -----hhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 659 -----NEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 659 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....+.... .......+..+.+++.+||+.||.+|||++|+++.|+
T Consensus 257 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 257 KEKKLEALVDVDLQ--GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp SSCCSTTSSCTTCT--TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hchhhhhhcChhhc--cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 111222221 2234667788999999999999999999999999985
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=354.78 Aligned_cols=250 Identities=24% Similarity=0.445 Sum_probs=209.5
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|. ..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 5689999999999999999996 46799999999864322 2346788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++... .+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 9999999999998643 489999999999999999999999 999999999999999999999999999988776
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.........||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...........+....+
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~---- 239 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYLIATNGTPELQNP---- 239 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHHCSCCCSCG----
T ss_pred cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCCCCCCCc----
Confidence 655556678999999999999999999999999999999999999999632211 11111111122222222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+..+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 233456889999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=361.21 Aligned_cols=268 Identities=32% Similarity=0.521 Sum_probs=219.1
Q ss_pred HHHHHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 430 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
++....++|++.+.||+|+||.||+|..++|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+.
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 44556789999999999999999999988899999999875432 245678999999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccc-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 510 SFIVYEYLEMGSLAMILSNDAA-AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
.++||||+++++|.+++..... ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999865432 23589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhh--------hh
Q 038671 589 KFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEI--------AL 658 (707)
Q Consensus 589 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~--------~~ 658 (707)
........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..... ..
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV-NLAEWAVESHNNGQL 265 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC-CHHHHTHHHHTTTCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHH-HHHHHhhhccccccH
Confidence 87543222 223456899999999998889999999999999999999999998643321111 11110 11
Q ss_pred hhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 659 NEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....++... .....+.+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 266 ~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 266 EQIVDPNLA--DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp CSSSSSSCT--TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcChhhc--cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 112222222 2234677888999999999999999999999999885
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=359.81 Aligned_cols=250 Identities=24% Similarity=0.305 Sum_probs=208.0
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|+. .+|+.||+|++.............+.+|+++++.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 5789999999999999999965 579999999986432222234567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++||+|.+++... +.+++..++.++.||+.||+|||++ ||+||||||+||+++.+|.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 999999999998643 4589999999999999999999999 9999999999999999999999999999875544
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.......+||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.......+..
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~p~~--- 227 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEEIRFPRT--- 227 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCTT---
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCCCCC---
Confidence 455566789999999999999999999999999999999999999996321 112222222222222222
Q ss_pred HHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
.+.++.+++.+||+.||++|| +++|+++
T Consensus 228 -~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 228 -LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 234588999999999999999 8998875
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=358.96 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=209.4
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
..++|++.+.||+|+||.||+|++ .+|+.||+|++...... ....+.+.+|+++++.++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 356899999999999999999964 68999999998654322 2345678899999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||+++++|.+++... +.+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++....
T Consensus 92 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp EECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999998643 4589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccccccCCCCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
.. ......+||+.|+|||.+.+..+. .++||||+|+++|+|++|+.||+... .......+.......+..
T Consensus 166 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~p~~ 236 (328)
T 3fe3_A 166 VG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERVLRGKYRIPFY 236 (328)
T ss_dssp SS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCTT
T ss_pred CC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCCC
Confidence 43 334556899999999999888775 79999999999999999999996422 222222333333333322
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
. +.++.+++.+||..||.+|||++|+++.
T Consensus 237 ~----s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 237 M----STDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp S----CHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred C----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2 3458899999999999999999999863
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=355.22 Aligned_cols=259 Identities=26% Similarity=0.386 Sum_probs=207.3
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|+ ..+++.||+|++...........+.+.+|+..+++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 4689999999999999999995 457899999998765555555667899999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++... .++++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 9999999999999643 3589999999999999999999999 999999999999999999999999999986553
Q ss_pred CC-CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 594 DS-SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 594 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
.. .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...................
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~ 236 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-------VSIAIKHIQDSVPNVTTDV 236 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-------HHHHHHHHSSCCCCHHHHS
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHhhccCCCcchhc
Confidence 32 223345799999999999999999999999999999999999999964221 1112222222111111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRP-TIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rp-s~~~l~~~L~ 706 (707)
..+.+..+.+++.+||+.||++|| +++++.+.|+
T Consensus 237 ~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 123445689999999999999999 8888888764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=361.10 Aligned_cols=255 Identities=21% Similarity=0.279 Sum_probs=210.7
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCch---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSE---MASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
+.+.|++.+.||+|+||.||+|.. .+|+.||+|++....... ....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 457899999999999999999954 579999999987543221 1235678999999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC----CeEEecc
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN----EAHVSDF 585 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~----~~kl~Df 585 (707)
.++||||+.||+|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999999999643 4589999999999999999999999 999999999999998877 7999999
Q ss_pred ccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCC
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPR 665 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (707)
|++...... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... .......+....
T Consensus 164 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--------~~~~~~~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITAVS 234 (361)
T ss_dssp SSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTC
T ss_pred CCceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcC
Confidence 999876543 23345689999999999999899999999999999999999999996321 222233333333
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+.......+..+.+++.+||..||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 33222222234456899999999999999999999986
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=371.05 Aligned_cols=257 Identities=20% Similarity=0.279 Sum_probs=211.7
Q ss_pred HHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
.+.++|++.+.||+|+||.||+|. ..+|+.+|+|++...... ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence 456789999999999999999994 567999999998765433 234567899999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec---CCCCeEEeccccc
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD---LENEAHVSDFGTA 588 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~---~~~~~kl~Dfg~~ 588 (707)
+||||+.||+|.+.+... ..+++..+..++.||+.||+|||+. ||+||||||+||+++ .++.+||+|||++
T Consensus 87 lv~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EEECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 999999999999988643 4589999999999999999999999 999999999999998 4678999999999
Q ss_pred eecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 589 KFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 589 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
..............||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... .......+.......
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~~ 232 (444)
T 3soa_A 161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--------QHRLYQQIKAGAYDF 232 (444)
T ss_dssp BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTCCCC
T ss_pred EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHhCCCCC
Confidence 877665555566789999999999999899999999999999999999999985321 122222222222222
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
+.......+.++.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 222222344568999999999999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=351.15 Aligned_cols=254 Identities=26% Similarity=0.463 Sum_probs=207.1
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence 35789999999999999999954 57999999988543 334567899999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++... ...+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EECCTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 9999999999999643 34689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCc--------------cccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccc-ccchhhhhh
Q 038671 594 DSSNW--------------AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISS-SSSNLEIAL 658 (707)
Q Consensus 594 ~~~~~--------------~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~ 658 (707)
..... ....||+.|+|||.+.+..++.++||||||+++|||++|..||........ .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc
Confidence 32211 145799999999999999999999999999999999999999864322111 111111122
Q ss_pred hhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 659 NEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.....+.+ +..+.+++.+||+.||++|||+.++++.|+
T Consensus 241 ~~~~~~~~----------~~~l~~li~~~l~~dP~~Rps~~~l~~~L~ 278 (310)
T 3s95_A 241 DRYCPPNC----------PPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278 (310)
T ss_dssp HHTCCTTC----------CTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccCCCCC----------CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 22212222 234889999999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=362.39 Aligned_cols=251 Identities=22% Similarity=0.344 Sum_probs=202.9
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 512 (707)
.++|++.+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|.+++..+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 47899999999999999999964 56899999998653222333456688899999988 69999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||+.||+|.+++... +.+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 99999999999998643 4589999999999999999999999 99999999999999999999999999998655
Q ss_pred CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
.........+||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.......+..
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~~~~p~~- 246 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDEVVYPTW- 246 (353)
T ss_dssp C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCTT-
T ss_pred cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCCCCCCC-
Confidence 44455566789999999999999889999999999999999999999996322 122233333333333222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCH------HHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTI------QKVSQ 703 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~------~~l~~ 703 (707)
.+.++.+++.+|++.||++||++ +++++
T Consensus 247 ---~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 247 ---LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ---CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 23458899999999999999998 66654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=356.10 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=209.5
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 46899999999999999999954 568999999986431 2446688999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC--CCCeEEeccccceec
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL--ENEAHVSDFGTAKFL 591 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~--~~~~kl~Dfg~~~~~ 591 (707)
|||+++++|.+++... ...+++..++.++.||+.||+|||+. ||+||||||+||+++. ++.+||+|||++...
T Consensus 80 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 80 FEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 9999999999999643 24589999999999999999999999 9999999999999987 789999999999887
Q ss_pred CCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
... .......||+.|+|||++.+..++.++||||+|+++|+|++|+.||.... .......+.......+..
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~~~~ 225 (321)
T 1tki_A 155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEYTFDEE 225 (321)
T ss_dssp CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCCCHH
T ss_pred CCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHcCCCCCChh
Confidence 543 33455679999999999998888999999999999999999999996322 122223333333332222
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.....+.++.+++.+||..||++|||+.|+++.
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 222345678999999999999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=350.52 Aligned_cols=262 Identities=26% Similarity=0.386 Sum_probs=213.3
Q ss_pred ccchHHHHHHHhcC----------CCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC
Q 038671 424 GKIVYEEIIRVTND----------FDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI 492 (707)
Q Consensus 424 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l 492 (707)
+.++.+++..+.+. |+..+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.+++++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDY 99 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhC
Confidence 34556666665543 667789999999999999654 799999999865432 2356788999999999
Q ss_pred CCCceeeeeeeeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 038671 493 RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572 (707)
Q Consensus 493 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 572 (707)
+||||+++++++...+..++||||+++++|.+++.. ..+++..++.++.|++.||+|||+. ||+||||||+||
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI 172 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI 172 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHE
Confidence 999999999999999999999999999999999863 3589999999999999999999999 999999999999
Q ss_pred eecCCCCeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccc
Q 038671 573 LLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSS 652 (707)
Q Consensus 573 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 652 (707)
+++.++.+||+|||++..............||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... .
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-----~ 247 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-----V 247 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----H
T ss_pred EECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H
Confidence 99999999999999998876554445567899999999999998999999999999999999999999863221 1
Q ss_pred hhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 653 NLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 653 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...........+.... ....+..+.+++.+||+.||++|||++++++.
T Consensus 248 ~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 QAMKRLRDSPPPKLKN----SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHHSSCCCCTT----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcCCCCCcCc----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111122222222221 12234568899999999999999999999863
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=358.66 Aligned_cols=255 Identities=22% Similarity=0.394 Sum_probs=208.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEc--------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL--------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCS 505 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 505 (707)
.++|++.+.||+|+||.||+|+. .++..||+|++.... .....+.+.+|+++++++ +||||+++++++.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 36789999999999999999964 245679999997643 233567799999999999 8999999999999
Q ss_pred cCCceeEEEeeeccCcHHHHHhcccc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDAA-------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 572 (707)
..+..|+||||+++|+|.+++..... ...+++..++.++.||+.||+|||++ ||+||||||+||
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI 234 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 234 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence 99999999999999999999975432 23588999999999999999999999 999999999999
Q ss_pred eecCCCCeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccc
Q 038671 573 LLDLENEAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISS 649 (707)
Q Consensus 573 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 649 (707)
+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~--- 311 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 311 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 999999999999999987654332 2233456789999999999999999999999999999999 9999864321
Q ss_pred ccchhhhhhhhhcCCC-CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 650 SSSNLEIALNEMLDPR-LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 650 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
........... ...+. ..+.++.+++.+||+.||.+||++.|+++.|+
T Consensus 312 -----~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 360 (370)
T 2psq_A 312 -----EELFKLLKEGHRMDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360 (370)
T ss_dssp -----GGHHHHHHTTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----HHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11111122111 11111 23345899999999999999999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=362.25 Aligned_cols=254 Identities=23% Similarity=0.344 Sum_probs=204.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 512 (707)
.++|++.+.||+|+||.||+|+. .+++.||+|++...........+.+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 46799999999999999999965 56889999998754333333445678899999887 89999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||++||+|.+++... +.+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 99999999999998643 4589999999999999999999999 99999999999999999999999999998755
Q ss_pred CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccc-ccchhhhhhhhhcCCCCCCCCc
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISS-SSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
.........+||+.|+|||++.+..++.++||||||+++|||++|+.||+....... ...........+.......+..
T Consensus 205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 455556677899999999999999999999999999999999999999964322111 1111222233333333333322
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTI 698 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~ 698 (707)
.+.++.+++.+||+.||++||++
T Consensus 285 ----~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 285 ----LSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----CCHHHHHHHHHHhcCCHhHcCCC
Confidence 23458899999999999999985
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=343.77 Aligned_cols=275 Identities=33% Similarity=0.529 Sum_probs=223.6
Q ss_pred ccchHHHHHHHhcCCCCC------ceeeecCCeeEEEEEcCCCcEEEEEecCCCCC-chhhhHHHHHHHHHHHhcCCCCc
Q 038671 424 GKIVYEEIIRVTNDFDDE------HCIGKGGQGSVYKAELPSGEIVAVKKFHSPLP-SEMASQQEFLNEVKTLTGIRHRN 496 (707)
Q Consensus 424 ~~~~~~~~~~~~~~~~~~------~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~n 496 (707)
..+.+.++..+++.|... +.||+|+||.||+|.. +++.||+|++..... ......+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 345678888898888877 8999999999999987 588999999875432 22334577999999999999999
Q ss_pred eeeeeeeeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC
Q 038671 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL 576 (707)
Q Consensus 497 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~ 576 (707)
|+++++++.+.+..++||||+++++|.+++.......++++..++.++.|++.||+|||+. |++||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999997655556799999999999999999999999 9999999999999999
Q ss_pred CCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchh
Q 038671 577 ENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL 654 (707)
Q Consensus 577 ~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 654 (707)
++.+||+|||++......... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||+............
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 999999999999876543222 233578999999998765 48899999999999999999999997533221111111
Q ss_pred h------hhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 655 E------IALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 655 ~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
. ..+....++.++. .....+..+.+++.+||+.||.+||++.++++.|+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~ 302 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMND---ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCSC---CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHhhhhhhhhhhhccccccc---cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1 1122233333322 33566778999999999999999999999999875
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=350.30 Aligned_cols=265 Identities=20% Similarity=0.326 Sum_probs=212.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC--cee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR--HSF 511 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~ 511 (707)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ....+.+.+|++++++++||||+++++++.... ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 36799999999999999999955 4699999999864322 223567789999999999999999999987655 779
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee----cCCCCeEEecccc
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL----DLENEAHVSDFGT 587 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~----~~~~~~kl~Dfg~ 587 (707)
+||||+++++|.+++........+++..++.++.||+.||+|||+. ||+||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 9999999999999998765555699999999999999999999999 99999999999999 7778899999999
Q ss_pred ceecCCCCCCccccccccCCCCccccc--------cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhh
Q 038671 588 AKFLKPDSSNWAELAGTYGYVAPELAY--------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN 659 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 659 (707)
++...... ......||+.|+|||++. +..++.++||||||+++|||++|+.||..................
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (319)
T 4euu_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (319)
T ss_dssp CEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred ceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence 98765443 334467999999999876 467899999999999999999999999643322211111222111
Q ss_pred hhc-----------------CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 660 EML-----------------DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 660 ~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
... ....+.........+..+.+++.+||+.||++|||++|+++..
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 111 0122333344567788899999999999999999999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=362.42 Aligned_cols=258 Identities=21% Similarity=0.267 Sum_probs=208.4
Q ss_pred HhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCC--chhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLP--SEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
+.++|++.+.||+|+||.||+|. ..+|+.||+|++..... ......+.+.+|+++++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 34679999999999999999995 45799999999853210 0111356789999999999999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC---eEEeccc
Q 038671 511 FIVYEYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE---AHVSDFG 586 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~---~kl~Dfg 586 (707)
++||||+++++|.+.+.... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999988875433 233589999999999999999999999 9999999999999987654 9999999
Q ss_pred cceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
++..............||+.|+|||++.+..++.++||||||+++|+|++|+.||.... ......+.....
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~~~~~ 249 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGIIKGKY 249 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHHHTCC
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHHcCCC
Confidence 99887655444455689999999999999899999999999999999999999996321 122222222222
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..........+.++.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2221111233456899999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=358.73 Aligned_cols=256 Identities=20% Similarity=0.315 Sum_probs=210.3
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
.+.++|++.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 4457899999999999999999954 57899999999765433 234567899999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC---CeEEeccccc
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN---EAHVSDFGTA 588 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~---~~kl~Dfg~~ 588 (707)
+||||+.+++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .+||+|||++
T Consensus 105 lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EEECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 999999999999998643 4589999999999999999999999 999999999999998654 5999999999
Q ss_pred eecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 589 KFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 589 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .......+.......
T Consensus 179 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--------~~~~~~~i~~~~~~~ 249 (362)
T 2bdw_A 179 IEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYAQIKAGAYDY 249 (362)
T ss_dssp BCCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCC
T ss_pred eEecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCCCC
Confidence 876533 23345689999999999999899999999999999999999999986321 112222222222222
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
+.......+.++.+++.+||+.||++||++.++++.
T Consensus 250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 222233445668999999999999999999998763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=356.08 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=203.0
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|. ..+++.||+|++.............+.+|+++++.++||||+++++++..++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3689999999999999999996 468999999998643222222335788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+ +|+|.+++... +.+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 67888887543 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
. ......+||+.|+|||.+.+..+ +.++||||+|+++|+|++|+.||+.... ......+.......+..
T Consensus 161 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~~i~~~~~~~p~~- 230 (336)
T 3h4j_B 161 G-NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI--------PNLFKKVNSCVYVMPDF- 230 (336)
T ss_dssp S-BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS--------TTCBCCCCSSCCCCCTT-
T ss_pred C-cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHcCCCCCccc-
Confidence 3 23345689999999999988776 6899999999999999999999963211 11111222222222221
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+.++.+++.+||+.||.+|||++|+++
T Consensus 231 ---~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 231 ---LSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ---SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ---CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 2345889999999999999999999976
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=354.32 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=206.1
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv 513 (707)
++|++.+.||+|+||.||+|+. .+++.||+|++...........+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5789999999999999999965 56899999999765444444566788999999988 899999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++|+|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 9999999999998643 4589999999999999999999999 999999999999999999999999999987554
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc-cchhhhhhhhhcCCCCCCCCcc
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS-SSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
........+||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..........+.......+..
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~- 241 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS- 241 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT-
T ss_pred CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC-
Confidence 444556678999999999999999999999999999999999999999643221110 111122222222233322222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTI 698 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~ 698 (707)
.+.++.+++.+||+.||++||++
T Consensus 242 ---~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 242 ---LSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ---SCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ---CCHHHHHHHHHHhcCCHhHCCCC
Confidence 23458899999999999999995
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=351.32 Aligned_cols=253 Identities=26% Similarity=0.445 Sum_probs=204.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC----CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
.++|++.+.||+|+||.||+|... .+..||||++.... .....+.+.+|+.++++++||||+++++++.+++..
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 467888999999999999999653 35569999997543 233557799999999999999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++||||+++++|.++++.. ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++..
T Consensus 126 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 9999999999999999643 24589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCCc---cccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcC-CC
Q 038671 591 LKPDSSNW---AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLD-PR 665 (707)
Q Consensus 591 ~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 665 (707)
........ ....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ......+.. ..
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~~~~~~~ 272 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVISSVEEGYR 272 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHTTCC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcCCC
Confidence 65443221 22345778999999998889999999999999999999 9999863221 111111111 12
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.+. ..+.++.+++.+||+.||++||++.++++.|+
T Consensus 273 ~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~ 309 (325)
T 3kul_A 273 LPAPM----GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLD 309 (325)
T ss_dssp CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCC----CcCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 22222 23356899999999999999999999999885
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=353.71 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=207.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCch---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSE---MASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
.+.|++.+.||+|+||.||+|.. .+|+.||+|++....... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45699999999999999999964 578999999986543221 12356789999999999999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC----CeEEeccc
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN----EAHVSDFG 586 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~----~~kl~Dfg 586 (707)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999999643 4589999999999999999999999 999999999999999887 79999999
Q ss_pred cceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+.....
T Consensus 164 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~~~~~~~ 234 (326)
T 2y0a_A 164 LAHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANVSAVNY 234 (326)
T ss_dssp TCEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHTCC
T ss_pred CCeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHHHhcCC
Confidence 998765432 33456799999999999988999999999999999999999999863221 111111211122
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+.......+..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 21111112334568899999999999999999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=358.01 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=206.0
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCce
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 510 (707)
...++|++.+.||+|+||.||+|+. .+|+.||+|++...........+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3457899999999999999999965 56899999998643211222345678889998877 899999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
|+||||++||+|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+||+++.+|.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 9999999999999998643 4589999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCC
Q 038671 591 LKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670 (707)
Q Consensus 591 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (707)
...........+||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.......+.
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p~ 239 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDNPFYPR 239 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCT
T ss_pred cccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCCCCCCc
Confidence 55444455667899999999999999999999999999999999999999963221 1122222222222221
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRPTIQ-KVSQ 703 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~-~l~~ 703 (707)
..+.++.+++.+||..||++||++. ++++
T Consensus 240 ----~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 240 ----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----ccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1234588999999999999999987 6543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=348.22 Aligned_cols=260 Identities=20% Similarity=0.316 Sum_probs=203.2
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
.+.++|++.+.||+|+||+||+|+..+|+.||+|++..... .......+.+|++++++++||||+++++++.+++..++
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34578999999999999999999888899999999865432 22234678899999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||+++ ++.+++... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++....
T Consensus 97 v~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp EEECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred EEcCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9999985 777777543 24589999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC-------
Q 038671 593 PDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP------- 664 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 664 (707)
..........||+.|+|||.+.+ ..++.++||||+|+++|+|++|+.||....... ...........+
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 171 IPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD----QLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp SCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT----HHHHHHHHHCCCCTTTSGG
T ss_pred CCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHHCCCChHHhhh
Confidence 55555556688999999999876 558999999999999999999999996433211 111111111000
Q ss_pred ----------CCCCCCc-----chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 665 ----------RLPTPSH-----NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 665 ----------~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
....... ..+..+.++.+++.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000 00112346889999999999999999999986
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=386.72 Aligned_cols=348 Identities=34% Similarity=0.523 Sum_probs=285.5
Q ss_pred CCCCCceeeccCCeeeecCCccccCC-CCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCcc-ccCCCCCC
Q 038671 1 NLSNLAFLYLYNNSFSGSIPSEIGRL-KSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKE-YGNLVKLT 78 (707)
Q Consensus 1 nl~~l~~L~l~~n~i~~~~~~~~~~l-~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~-~~~l~~L~ 78 (707)
++++|++|+|++|.+++.+|..+... ++|++|+|++|++++..|..|.++++|++|+|++|.+++.+|.. |.++++|+
T Consensus 267 ~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~ 346 (768)
T 3rgz_A 267 PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLK 346 (768)
T ss_dssp CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCC
T ss_pred ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCC
Confidence 47899999999999999999999876 99999999999999999999999999999999999999777765 99999999
Q ss_pred eeecccccccc-cCCCCCC---------------------------CCCccEEEeccCccccccCccccCCCCCcEEEcc
Q 038671 79 LLTLENNQLRG-PIPNLRN---------------------------LTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLS 130 (707)
Q Consensus 79 ~L~l~~n~i~~-~~~~l~~---------------------------l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~ 130 (707)
+|++++|.+.. ++..+.. +++|++|++++|++++..+..+..+++|++|+|+
T Consensus 347 ~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 426 (768)
T 3rgz_A 347 VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426 (768)
T ss_dssp EEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECC
T ss_pred EEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECc
Confidence 99999999973 3333333 4456666666666666667777778888888888
Q ss_pred cccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCC
Q 038671 131 HNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQL 210 (707)
Q Consensus 131 ~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 210 (707)
+|.+++..+..+..+++|+.|+|++|.+++..+..+..+++|+.|++++|++++..|..+..+++|++|++++|++++..
T Consensus 427 ~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 506 (768)
T 3rgz_A 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEI 506 (768)
T ss_dssp SSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCC
T ss_pred CCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcC
Confidence 88888777777888888888888888888778888888888888888888888778888888888888888888888888
Q ss_pred ccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhh----------------------------
Q 038671 211 SLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL---------------------------- 262 (707)
Q Consensus 211 ~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~---------------------------- 262 (707)
|.++..+++|++|+|++|++++.+|..+.++++|+.|++++|++.+..|..+
T Consensus 507 p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 586 (768)
T 3rgz_A 507 PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKE 586 (768)
T ss_dssp CGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTT
T ss_pred ChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccc
Confidence 8888888888888888888888888888888888888888888776555433
Q ss_pred ------------------------------------------hhcccCCeeeecCccCCCCCCcccccccccceEecccc
Q 038671 263 ------------------------------------------EKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHN 300 (707)
Q Consensus 263 ------------------------------------------~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n 300 (707)
..+++|+.|+|++|.+++.+|..++.+++|+.|++++|
T Consensus 587 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N 666 (768)
T 3rgz_A 587 CHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHN 666 (768)
T ss_dssp CCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCC
Confidence 22456788888888888888888888888888888888
Q ss_pred ccCCchhHhhccCCCceeEeeccCcccccCCCc-cccccCchhhcccCc
Q 038671 301 NLSGFIPSCFEELHGLSYIDISYNELHGSIPNS-TAFRDAPMEALQGNK 348 (707)
Q Consensus 301 ~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~-~~~~~~~~~~~~~~~ 348 (707)
++++.+|..+..+++|+.|++++|+++|.+|.. ..+.......+..|+
T Consensus 667 ~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~ 715 (768)
T 3rgz_A 667 DISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN 715 (768)
T ss_dssp CCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSE
T ss_pred ccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCc
Confidence 888888888888888888888888888887753 334445555566554
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=340.63 Aligned_cols=252 Identities=29% Similarity=0.471 Sum_probs=207.6
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|+||.||+|+.+++..||+|++..... ..+++.+|++++.+++||||+++++++.+.+..++||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT 82 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence 467999999999999999999988888999999875432 2356889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||.+......
T Consensus 83 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 83 EYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp ECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EccCCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999999643 34589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 595 SS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 595 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
.. ......+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||+.... ...............+..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~- 229 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-------SEVVLKVSQGHRLYRPHL- 229 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHTTCCCCCCTT-
T ss_pred hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-------HHHHHHHHcCCCCCCCCc-
Confidence 22 1223345678999999998889999999999999999999 9999864322 111111111111222211
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+..+.+++.+||+.||++|||+.++++.|+
T Consensus 230 ---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (268)
T 3sxs_A 230 ---ASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260 (268)
T ss_dssp ---SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHG
T ss_pred ---ChHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 2345889999999999999999999999886
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.84 Aligned_cols=247 Identities=24% Similarity=0.362 Sum_probs=205.2
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 5789999999999999999965 579999999986432222234567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++||+|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+||+++.+|.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 999999999999643 3589999999999999999999999 9999999999999999999999999999875432
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
....+||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.......+..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~p~~--- 225 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAELRFPPF--- 225 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCCCCCCTT---
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCCC---
Confidence 345689999999999999999999999999999999999999996322 112222222222222222
Q ss_pred HHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
.+.++.+++.+|+..||++|| +++++++
T Consensus 226 -~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 226 -FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 234588999999999999999 8888875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=354.95 Aligned_cols=252 Identities=20% Similarity=0.283 Sum_probs=207.2
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCcee
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 511 (707)
..++|++.+.||+|+||.||+|+.+ +|+.||+|++...........+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3578999999999999999999654 5889999998653222223456688899999988 7999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||++||+|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+||+++.+|.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 999999999999998643 3589999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
..........+||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.......+.
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~~~~p~- 242 (353)
T 2i0e_A 172 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHNVAYPK- 242 (353)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCT-
T ss_pred ccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhCCCCCCC-
Confidence 544445566789999999999999999999999999999999999999996322 12222233323332222
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPT-----IQKVSQ 703 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~l~~ 703 (707)
..+.++.+++.+||+.||++||+ ++++++
T Consensus 243 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 243 ---SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 23345889999999999999995 466654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=341.41 Aligned_cols=251 Identities=25% Similarity=0.436 Sum_probs=207.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence 357899999999999999999888899999999976432 2356899999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp ECCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred EeCCCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999999999643 24589999999999999999999999 9999999999999999999999999999865432
Q ss_pred C-CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC-CCCCCCc
Q 038671 595 S-SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP-RLPTPSH 671 (707)
Q Consensus 595 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 671 (707)
. .......+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||..... .......... ....+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~ 231 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFRLYKPRL 231 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCCCCCCTT
T ss_pred ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhcCccCCCCCc
Confidence 1 12233456778999999998899999999999999999999 9999864221 1112222221 1111111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+..+.+++.+||+.||++||++.++++.|+
T Consensus 232 ----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~ 262 (269)
T 4hcu_A 232 ----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 262 (269)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----CCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 2345889999999999999999999999875
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=355.21 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=205.6
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|. ..+++.||+|++.............+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 679999999999999999995 4568999999986432223334567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.||+|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.+|.+||+|||++......
T Consensus 95 e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 999999999999653 3589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCCccccccccCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 595 SSNWAELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
......+||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .........+.......+..
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-----~~~~~~~~~~~~~~~~~p~~ 242 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-----TSSKEIVHTFETTVVTYPSA 242 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT-----SCHHHHHHHHHHCCCCCCTT
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhhcccCCCCc
Confidence 33456789999999999864 4589999999999999999999999964322 11122222222222222222
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCC-HHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPT-IQKVSQ 703 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps-~~~l~~ 703 (707)
.+..+.+++.+||+.||.+||+ ++++.+
T Consensus 243 ----~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 243 ----WSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----SCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----CCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 2345889999999999999998 777654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=352.59 Aligned_cols=248 Identities=22% Similarity=0.279 Sum_probs=206.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 36789999999999999999965 57999999998643222223456788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||++||+|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 9999999999999643 3589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
. ....+||+.|+|||++.+..++.++||||||+++|||++|+.||.... .......+.......+..
T Consensus 194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~p~~-- 260 (350)
T 1rdq_E 194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSGKVRFPSH-- 260 (350)
T ss_dssp C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCTT--
T ss_pred C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHcCCCCCCCC--
Confidence 2 344689999999999999999999999999999999999999996322 122222222223322222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPT-----IQKVSQ 703 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps-----~~~l~~ 703 (707)
.+.++.+++.+||+.||++||+ ++++++
T Consensus 261 --~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 261 --FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 2345889999999999999998 888765
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.55 Aligned_cols=254 Identities=24% Similarity=0.412 Sum_probs=206.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|... +++.||||++.... .....+.+.+|++++++++||||+++++++..++..++|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 357889999999999999999764 78999999987542 223445788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++|+|.+++... ...+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||+++....
T Consensus 191 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp EECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999999643 34589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCC
Q 038671 594 DSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670 (707)
Q Consensus 594 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (707)
.... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......... ..+++.+.
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----~~~~~~~~~--~~~~~~~~ 338 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----QQTREFVEK--GGRLPCPE 338 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----HHHHHHHHT--TCCCCCCT
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHc--CCCCCCCC
Confidence 2111 112235778999999998889999999999999999998 9999864322 111111111 12233322
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
. .+.++.+++.+||+.||++|||++++++.|+
T Consensus 339 ~----~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 370 (377)
T 3cbl_A 339 L----CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370 (377)
T ss_dssp T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 2 2345889999999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=350.89 Aligned_cols=253 Identities=20% Similarity=0.376 Sum_probs=205.7
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC----
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR---- 508 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 508 (707)
+.++|++.+.||+|+||.||+|+.+ +|+.||||++.... .....+.+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 4567999999999999999999654 89999999987543 2234577999999999999999999999885543
Q ss_pred -----------------------------------------------------ceeEEEeeeccCcHHHHHhcccccCCC
Q 038671 509 -----------------------------------------------------HSFIVYEYLEMGSLAMILSNDAAAKDL 535 (707)
Q Consensus 509 -----------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~l 535 (707)
..++||||+++++|.+++.........
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 379999999999999999876665667
Q ss_pred ChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC------------Ccccccc
Q 038671 536 GWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS------------NWAELAG 603 (707)
Q Consensus 536 ~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~------------~~~~~~g 603 (707)
++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++........ ......|
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 7888999999999999999999 999999999999999999999999999988765421 2234579
Q ss_pred ccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHH
Q 038671 604 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEV 683 (707)
Q Consensus 604 ~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 683 (707)
|+.|+|||.+.+..++.++||||||+++|||++|..|+.. .............+ ........++.++
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~~~~~~~~~~---~~~~~~~~~~~~l 305 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRIITDVRNLKFP---LLFTQKYPQEHMM 305 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHHHHHHTTCCC---HHHHHHCHHHHHH
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHHHHhhccCCC---cccccCChhHHHH
Confidence 9999999999999999999999999999999999877531 11122222222222 2234455678899
Q ss_pred HHhccCCCCCCCCCHHHHHHH
Q 038671 684 AISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 684 i~~cl~~~P~~Rps~~~l~~~ 704 (707)
+.+||+.||++|||++|+++.
T Consensus 306 i~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 306 VQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHccCCCCcCCCHHHHhhc
Confidence 999999999999999999873
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=347.42 Aligned_cols=258 Identities=26% Similarity=0.432 Sum_probs=198.8
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhc--CCCCceeeeeeeeec----C
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG--IRHRNIVKFYGFCSH----A 507 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~ 507 (707)
..++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++.. .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 357899999999999999999977 6899999998532 23445556666555 799999999998644 3
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCeeecCCCC
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH--------NDCFPPIVHRDISSKNVLLDLENE 579 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~dlk~~Nil~~~~~~ 579 (707)
...++||||+++|+|.++++. ..+++..+++++.|++.||+||| +. +|+||||||+||+++.++.
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSC
T ss_pred ceeEEehhhccCCCHHHHHhh----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCC
Confidence 468999999999999999953 35899999999999999999999 77 9999999999999999999
Q ss_pred eEEeccccceecCCCCCC----ccccccccCCCCccccccC------CCCccchhHHHHHHHHHHHhC----------CC
Q 038671 580 AHVSDFGTAKFLKPDSSN----WAELAGTYGYVAPELAYTM------KVTEKCDVYSFGVLALEVIKG----------KH 639 (707)
Q Consensus 580 ~kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~tg----------~~ 639 (707)
+||+|||++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~ 231 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccc
Confidence 999999999876544322 2334799999999998876 455799999999999999999 77
Q ss_pred CCCcccccccccchhhhh-hhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 640 PRDFISSISSSSSNLEIA-LNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 640 p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
||................ ......+..+. .......+.++.+++.+||+.||++|||+.++++.|+
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 298 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPN-RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCG-GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccCCCCCCCh-hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence 775322211111111111 11111112211 1122346678999999999999999999999999885
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=351.26 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=187.3
Q ss_pred CceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCceeEEEeeec
Q 038671 441 EHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSFIVYEYLE 518 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 518 (707)
.+.||+|+||.||+|.. .+++.||||++... ....+.+|+..++.+. ||||+++++++.+++..++||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 47899999999999954 57899999998532 3456788999999997 9999999999999999999999999
Q ss_pred cCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC---CeEEeccccceecCCCC
Q 038671 519 MGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN---EAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 519 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~---~~kl~Dfg~~~~~~~~~ 595 (707)
+++|.+++... +.+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .+||+|||++.......
T Consensus 90 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 90 GGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp SCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 99999999653 4589999999999999999999999 999999999999998766 89999999998776655
Q ss_pred CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 596 SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
.......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ...........+.......+......
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL-TCTSAVEIMKKIKKGDFSFEGEAWKN 242 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTCCCCCSHHHHT
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccc-ccccHHHHHHHHHcCCCCCCcccccC
Confidence 55566788999999999999999999999999999999999999997433211 11222334444555555444444445
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+.++.+++.+||+.||++|||++|+++
T Consensus 243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 5677999999999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=348.49 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=195.9
Q ss_pred hcCCCCCceeeecCCeeEEEEEc----CCCcEEEEEecCCCCCc-hhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL----PSGEIVAVKKFHSPLPS-EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
.++|++.+.||+|+||.||+++. .+|+.||+|++...... .......+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999965 57899999998764321 22234567889999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++||||+++++|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 99999999999999998643 3588999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
.............||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.......+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~p 241 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKILKCKLNLP 241 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCCCC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence 655444444556899999999999998899999999999999999999999963221 122222222222222
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
.. .+.++.+++.+||+.||++|| ++.++++
T Consensus 242 ~~----~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 242 PY----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp TT----SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CC----CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 22 234588999999999999999 7778765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=354.37 Aligned_cols=254 Identities=25% Similarity=0.458 Sum_probs=195.9
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC----CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
.++|++.+.||+|+||.||+|+.. ++..||||++.... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence 357999999999999999999754 57789999987543 233557799999999999999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++||||+++++|.++++.. ...+++..++.++.||++||+|||+. ||+||||||+||+++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV 196 (373)
T ss_dssp EEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence 9999999999999999653 34589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 591 LKPDSSN---WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 591 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .......... .+.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-----~~~~~~i~~~--~~~ 269 (373)
T 2qol_A 197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-----QDVIKAVDEG--YRL 269 (373)
T ss_dssp -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-----HHHHHHHHTT--EEC
T ss_pred cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcC--CCC
Confidence 6543221 122235678999999999999999999999999999998 9999863221 1111111111 112
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.+. ..+.++.+++.+||+.||++||++.++++.|+
T Consensus 270 ~~~~----~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~ 305 (373)
T 2qol_A 270 PPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVSILD 305 (373)
T ss_dssp CCCT----TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCc----cccHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence 2221 23456899999999999999999999999874
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=354.38 Aligned_cols=253 Identities=19% Similarity=0.285 Sum_probs=207.1
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 46799999999999999999954 578999999987542 22345788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC--CCCeEEeccccceec
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL--ENEAHVSDFGTAKFL 591 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~--~~~~kl~Dfg~~~~~ 591 (707)
|||+.+++|.+++... ...+++..++.++.||+.||+|||+. ||+||||||+||+++. ++.+||+|||++...
T Consensus 127 ~E~~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 127 LEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp EECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence 9999999999998643 24589999999999999999999999 9999999999999974 468999999999876
Q ss_pred CCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..... ......+.......+..
T Consensus 202 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~i~~~~~~~~~~ 272 (387)
T 1kob_A 202 NPDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKRCDWEFDED 272 (387)
T ss_dssp CTTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHCCCCCCSS
T ss_pred CCCc-ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCcc
Confidence 5432 33445799999999999998899999999999999999999999964221 11112222112211111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.....+.++.+++.+||+.||++|||+.|+++.
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 222334568999999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=341.89 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=185.0
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|.. .+|+.||+|++...........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999964 67999999998543222222346789999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++... ...+++..++.++.|+++||+|||+. |++||||||+||+++.++.+||+|||.+.....
T Consensus 90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999999643 34689999999999999999999999 999999999999999999999999999987664
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.........|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .............+.
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~--- 233 (278)
T 3cok_A 165 PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK--------NTLNKVVLADYEMPS--- 233 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSCCCCCT---
T ss_pred CCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH--------HHHHHHhhcccCCcc---
Confidence 444444567899999999999888999999999999999999999999642211 111111111222221
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+.++.+++.+||+.||++||+++++++
T Consensus 234 -~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 234 -FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 12345889999999999999999999986
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=364.93 Aligned_cols=332 Identities=23% Similarity=0.232 Sum_probs=289.8
Q ss_pred CCCceeeccCCeeeecCCccccCCCCCCeEECCCCcccc-ccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeee
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCG-SIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLT 81 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 81 (707)
++|++|+|++|.|++..|..|+++++|++|+|++|.+.+ ..+..|.++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 579999999999999989999999999999999999974 4567899999999999999999988899999999999999
Q ss_pred ccccccccc-CC--CCCCCCCccEEEeccCccccccCcc-ccCCCCCcEEEcccccccccCCCCCCCC--CCCcEEEcCC
Q 038671 82 LENNQLRGP-IP--NLRNLTSLVRVRLNQNHLTGNISES-FGIHPNLAFIDLSHNYFYGEISSDWGRC--PKLGTLDFSS 155 (707)
Q Consensus 82 l~~n~i~~~-~~--~l~~l~~L~~L~l~~n~l~~~~~~~-~~~~~~L~~L~L~~n~i~~~~~~~~~~~--~~L~~L~L~~ 155 (707)
+++|.+++. +. .+..+++|++|++++|+++.+.+.. +..+++|++|++++|.+++..+..+..+ ++|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 999999862 33 3899999999999999999886665 8999999999999999998888777765 5677777777
Q ss_pred CccCCCCchh--------hhCCCCCCEEeCCCCCCCCCCChhhhC-----------------------------------
Q 038671 156 NNITGSMPAE--------IIHSSQLKVLDLSSNHIVGEMPSKLGK----------------------------------- 192 (707)
Q Consensus 156 n~i~~~~~~~--------~~~~~~L~~L~l~~n~l~~~~~~~~~~----------------------------------- 192 (707)
|.+.+..+.. +..+++|+.|++++|.+++..+..+..
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~ 269 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTF 269 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTT
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCccccc
Confidence 7776544332 224566777777777665433333221
Q ss_pred ----CCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccC
Q 038671 193 ----LSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHL 268 (707)
Q Consensus 193 ----l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 268 (707)
.++|++|++++|.+++..+..+..+++|++|+|++|.+++..+..|.++++|++|+|++|.+++..+..+..+++|
T Consensus 270 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 349 (455)
T 3v47_A 270 KGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKL 349 (455)
T ss_dssp GGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTC
T ss_pred ccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccC
Confidence 2689999999999998889999999999999999999998889999999999999999999998889999999999
Q ss_pred CeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCCcc
Q 038671 269 SELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST 334 (707)
Q Consensus 269 ~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~ 334 (707)
++|+|++|.+++..|..+..+++|+.|++++|++++..+..+..+++|+.|++++|+|+|.+|...
T Consensus 350 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 415 (455)
T 3v47_A 350 EVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 415 (455)
T ss_dssp CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred CEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence 999999999988889999999999999999999998877888999999999999999999998654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=342.54 Aligned_cols=258 Identities=20% Similarity=0.287 Sum_probs=201.9
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||+||+|.. .+|+.||+|++...... ......+.+|++++++++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 5789999999999999999954 57899999999765432 234567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++++.+..+... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 81 EFCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp ECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred ecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 99987555544432 24589999999999999999999999 9999999999999999999999999999887655
Q ss_pred CCCccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC---------
Q 038671 595 SSNWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP--------- 664 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--------- 664 (707)
........||+.|+|||.+.+.. ++.++||||+|+++|+|++|..||...... .............+
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH---HHHHHHHHHHHCCCCTTTCTTGG
T ss_pred cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHHhCCCChhhhhhhc
Confidence 55555668899999999988766 799999999999999999988885321110 00011111000000
Q ss_pred ---------C---CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 665 ---------R---LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 665 ---------~---~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
. ........+..+.++.+++.+|++.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00001111233456889999999999999999999986
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=356.22 Aligned_cols=247 Identities=22% Similarity=0.281 Sum_probs=195.5
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHH-HhcCCCCceeeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKT-LTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
.++|++.+.||+|+||.||+|+. .+++.||+|++.............+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 36799999999999999999965 4688999999875433333344556677776 567899999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||+.||+|.+++... +.+++..++.++.||+.||+|||++ ||+||||||+||+++.+|.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 99999999999998643 4589999999999999999999999 99999999999999999999999999998755
Q ss_pred CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
.........+||+.|+|||++.+..++.++|+||||+++|||++|+.||.... .......+.......+..
T Consensus 191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~~- 261 (373)
T 2r5t_A 191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNKPLQLKPN- 261 (373)
T ss_dssp CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--------HHHHHHHHHHSCCCCCSS-
T ss_pred cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcccCCCCC-
Confidence 44455566789999999999999999999999999999999999999996322 122222222222222222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQ 699 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~ 699 (707)
.+.++.+++.+||+.||++||++.
T Consensus 262 ---~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 262 ---ITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred ---CCHHHHHHHHHHcccCHHhCCCCC
Confidence 234588999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=342.58 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=199.8
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
++|++.+.||+|+||.||+|+..+|+.||+|++...... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 578999999999999999998888999999998754322 2234668899999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++ +|.+++... ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CCSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ecCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 9985 888888643 24589999999999999999999999 99999999999999999999999999998765444
Q ss_pred CCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh--------------
Q 038671 596 SNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE-------------- 660 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------------- 660 (707)
.......||+.|+|||.+.+. .++.++||||+|+++|+|++|+.||....... ........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTGGG
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHHCCCChhhchhhhc
Confidence 444556789999999998764 58999999999999999999999996432211 01111000
Q ss_pred --hcCCCCCCC-----CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 661 --MLDPRLPTP-----SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 661 --~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..++..... .......+.++.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 001111100 00011234568899999999999999999999863
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=361.70 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=207.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|.+.+.||+|+||.||+|+. .+|+.||||++.............+.+|+++++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 36799999999999999999965 47999999998643222222356789999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 9999999999998643 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
. ......+||+.|+|||.+.+..+ +.++||||+|+++|+|++|+.||+... .......+.+.....+...
T Consensus 169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~~~~p~~~ 239 (476)
T 2y94_A 169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--------VPTLFKKICDGIFYTPQYL 239 (476)
T ss_dssp T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------SHHHHHHHHTTCCCCCTTC
T ss_pred c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCCcCCCccC
Confidence 3 33455689999999999988766 689999999999999999999996322 1222333333333333222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+.++.+++.+||+.||++|||++|+++
T Consensus 240 ----s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 240 ----NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 345889999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=352.17 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=199.0
Q ss_pred HhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce--
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS-- 510 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-- 510 (707)
+.++|++.+.||+|+||.||+|+ ..+++.||+|++.............+.+|++.+++++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 35789999999999999999996 467999999999876555555567899999999999999999999998765543
Q ss_pred --eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 511 --FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 511 --~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 9999999999999999643 3589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC---CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCC
Q 038671 589 KFLKPDSS---NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPR 665 (707)
Q Consensus 589 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (707)
........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ............
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~~~~~~~~~~~~ 236 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAYQHVREDP 236 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHhcCCC
Confidence 87654322 22345689999999999999999999999999999999999999964221 111111111111
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+ +.......+.++.+++.+||+.||++||++.++++
T Consensus 237 ~~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 237 IP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CC-HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CC-cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 11 11111123456899999999999999998777654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=362.36 Aligned_cols=348 Identities=20% Similarity=0.203 Sum_probs=314.1
Q ss_pred ceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccc
Q 038671 6 AFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENN 85 (707)
Q Consensus 6 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n 85 (707)
+.++.++++++ .+|..+. +++++|+|++|++++..+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 57889999999 7787665 59999999999999888899999999999999999999999999999999999999999
Q ss_pred cccccCCC-CCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCch
Q 038671 86 QLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPA 164 (707)
Q Consensus 86 ~i~~~~~~-l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~ 164 (707)
.++.+++. |.++++|++|+|++|+++.+.+..|..+++|++|+|++|.++.+.+..|..+++|++|+|++|.+++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 99988775 78999999999999999999999999999999999999999999999999999999999999999988888
Q ss_pred hhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccC
Q 038671 165 EIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKL 244 (707)
Q Consensus 165 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L 244 (707)
.+..+++|+.|+|++|.+.+..+..|..+++|++|++++|...+..+.......+|++|+|++|.+++..+..|..+++|
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 250 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcccc
Confidence 89999999999999999998888899999999999999998877777777777899999999999997777889999999
Q ss_pred ceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccC
Q 038671 245 HYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYN 324 (707)
Q Consensus 245 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n 324 (707)
+.|+|++|.+++..+..|..+++|++|+|++|.+++..+..|..+++|+.|++++|+|++..+..|..+++|+.|++++|
T Consensus 251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 330 (477)
T 2id5_A 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330 (477)
T ss_dssp CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence 99999999999888888999999999999999999988999999999999999999999988888999999999999999
Q ss_pred cccccCCCccccccCchhhcccCcCcCCCCCC
Q 038671 325 ELHGSIPNSTAFRDAPMEALQGNKGLCGDIKG 356 (707)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~ 356 (707)
+|.|.++..-.........+.++...|..+..
T Consensus 331 ~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~ 362 (477)
T 2id5_A 331 PLACDCRLLWVFRRRWRLNFNRQQPTCATPEF 362 (477)
T ss_dssp CEECSGGGHHHHTTTTSSCCTTCCCBEEESGG
T ss_pred CccCccchHhHHhhhhccccCccCceeCCchH
Confidence 99998865332222222334555666655443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=349.44 Aligned_cols=263 Identities=26% Similarity=0.365 Sum_probs=203.6
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC----ce
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR----HS 510 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 510 (707)
.++|++.+.||+|+||.||+|+.. ++.||||++... ........+|+..+++++||||+++++++.... ..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 97 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL 97 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence 367999999999999999999775 789999998542 223445667999999999999999999997754 36
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCC-------CCCeEecCCCCCCeeecCCCCeEEe
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC-------FPPIVHRDISSKNVLLDLENEAHVS 583 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------~~~ivH~dlk~~Nil~~~~~~~kl~ 583 (707)
++||||+++|+|.++++. ..+++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+
T Consensus 98 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 98 WLITAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEEEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 999999999999999964 34899999999999999999999761 2389999999999999999999999
Q ss_pred ccccceecCCCCC--CccccccccCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccc------
Q 038671 584 DFGTAKFLKPDSS--NWAELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS------ 650 (707)
Q Consensus 584 Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------ 650 (707)
|||+++....... ......||+.|+|||.+.+ ..++.++||||||+++|||+||+.||.........
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 9999987654432 2334579999999999886 34667899999999999999999998643221100
Q ss_pred --cchhhhhhhhhcCCCC-CCCCc--chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 651 --SSNLEIALNEMLDPRL-PTPSH--NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 651 --~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
................ +.... .....+.++.+++.+||+.||++|||+.|+++.|+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 314 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 0011111111111111 11111 12245567999999999999999999999999885
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=342.23 Aligned_cols=252 Identities=22% Similarity=0.333 Sum_probs=198.1
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCch-----------------------hhhHHHHHHHHHHHh
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSE-----------------------MASQQEFLNEVKTLT 490 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~e~~~l~ 490 (707)
.++|++.+.||+|+||.||+|. ..+++.||+|++....... ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999995 4578999999986543211 112356889999999
Q ss_pred cCCCCceeeeeeeeec--CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 038671 491 GIRHRNIVKFYGFCSH--ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDIS 568 (707)
Q Consensus 491 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 568 (707)
+++||||+++++++.+ .+..++||||+++++|.++.. ...+++..++.++.||+.||+|||+. ||+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCC
Confidence 9999999999999976 567899999999999987643 24689999999999999999999999 99999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCCCccccccccCCCCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCccc
Q 038671 569 SKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFIS 645 (707)
Q Consensus 569 ~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~ 645 (707)
|+||+++.++.+||+|||++..............||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||....
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999999988765544445568999999999988765 3778999999999999999999996321
Q ss_pred ccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 646 SISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
. ......+.......+. ....+.++.+++.+||+.||++||+++|+++
T Consensus 245 ~--------~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 245 I--------MCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H--------HHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H--------HHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 1111111111111110 1123345899999999999999999999976
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=340.06 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=210.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|.. .+++.+|+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 46799999999999999999965 46889999998654434445567889999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||.+.....
T Consensus 94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 9999999999988543 4589999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.........|++.|+|||.+.+..++.++||||||+++|+|++|+.||+.... ..............+..
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~-- 237 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKKNEYSIPKH-- 237 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCCCCCTT--
T ss_pred CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhhccCCCccc--
Confidence 54545556899999999999988899999999999999999999999963221 11122222222222222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+..+.+++.+||+.||++||+++|+++.
T Consensus 238 --~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 238 --INPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --cCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 23458899999999999999999998863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=339.93 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=204.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|+||.||+++..+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 467899999999999999999988888999999975432 2356889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+++|.+++... ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||.+......
T Consensus 99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 999999999999653 34589999999999999999999999 9999999999999999999999999999865432
Q ss_pred C-CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 595 S-SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 595 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
. .......+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||..... ............... +..
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-----~~~~~~~~~~~~~~~--~~~- 245 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----SETAEHIAQGLRLYR--PHL- 245 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHHHHTTCCCCC--CTT-
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-----hHHHHHHhcccCCCC--CCc-
Confidence 1 11223456788999999998889999999999999999998 9999964322 111111111111111 111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+..+.+++.+||+.||++|||++++++.|+
T Consensus 246 ---~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 276 (283)
T 3gen_A 246 ---ASEKVYTIMYSCWHEKADERPTFKILLSNIL 276 (283)
T ss_dssp ---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 1345889999999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=350.34 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=205.2
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCce
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 510 (707)
.+.++|++.+.||+|+||.||+|.. .+|+.||+|++...... ..+|++++.++ +||||+++++++.+++..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 3567899999999999999999954 57899999998754322 24577778777 799999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC-C---CeEEeccc
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE-N---EAHVSDFG 586 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~-~---~~kl~Dfg 586 (707)
|+||||+.||+|.+++... +.+++..++.++.||+.||+|||++ ||+||||||+||++..+ + .+||+|||
T Consensus 92 ~lv~E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EEEECCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 9999999999999998653 3589999999999999999999999 99999999999998543 3 59999999
Q ss_pred cceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
++.............+||+.|+|||++.+..++.++||||||+++|+|++|+.||..... .........+.....
T Consensus 166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~~~~i~~~~~ 240 (342)
T 2qr7_A 166 FAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-----DTPEEILARIGSGKF 240 (342)
T ss_dssp TCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-----SCHHHHHHHHHHCCC
T ss_pred CcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-----CCHHHHHHHHccCCc
Confidence 999876655555667899999999999888899999999999999999999999963211 122222333333333
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+.......+.++.+++.+||+.||++||++.++++
T Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 3222222334456899999999999999999999876
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=351.28 Aligned_cols=252 Identities=20% Similarity=0.313 Sum_probs=192.0
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
+.++|++.+.||+|+||.||+|+.. +++.||+|++.... ..+.+.+|++++++++||||+++++++...+..++
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 4578999999999999999999654 68899999987532 33567889999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC---CCCeEEeccccce
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL---ENEAHVSDFGTAK 589 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~---~~~~kl~Dfg~~~ 589 (707)
||||+++++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++. ++.+||+|||+++
T Consensus 126 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~ 199 (349)
T 2w4o_A 126 VLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK 199 (349)
T ss_dssp EECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred EEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence 99999999999998643 3589999999999999999999999 9999999999999975 8899999999998
Q ss_pred ecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .......+.......+
T Consensus 200 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~i~~~~~~~~ 271 (349)
T 2w4o_A 200 IVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG-------DQFMFRRILNCEYYFI 271 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-------HHHHHHHHHTTCCCCC
T ss_pred ccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc-------cHHHHHHHHhCCCccC
Confidence 65432 223446789999999999998999999999999999999999999863221 1112222223222222
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.......+.++.+++.+||+.||++|||+.|+++.
T Consensus 272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22222344568999999999999999999999863
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=336.78 Aligned_cols=251 Identities=28% Similarity=0.465 Sum_probs=193.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCch-hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSE-MASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|... ++.||+|++....... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357899999999999999999874 8899999987543222 22346788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCC---eEecCCCCCCeeecC--------CCCeEE
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP---IVHRDISSKNVLLDL--------ENEAHV 582 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~---ivH~dlk~~Nil~~~--------~~~~kl 582 (707)
|||+++++|.+++.. +.+++..++.++.|++.||+|||++ + |+||||||+||+++. ++.+||
T Consensus 85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEE
Confidence 999999999999853 3589999999999999999999999 7 999999999999986 678999
Q ss_pred eccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhc
Q 038671 583 SDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML 662 (707)
Q Consensus 583 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 662 (707)
+|||.+........ ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... .........
T Consensus 158 ~Dfg~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~ 228 (271)
T 3dtc_A 158 TDFGLAREWHRTTK--MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-------LAVAYGVAM 228 (271)
T ss_dssp CCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-------HHHHHHHHT
T ss_pred ccCCcccccccccc--cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHhhhc
Confidence 99999986553322 345789999999999998899999999999999999999999964221 111111111
Q ss_pred -CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 663 -DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 663 -~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....+.+. ..+..+.+++.+||+.||++|||+.|+++.|+
T Consensus 229 ~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~ 269 (271)
T 3dtc_A 229 NKLALPIPS----TCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269 (271)
T ss_dssp SCCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCc----ccCHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence 11112121 22345899999999999999999999999885
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=368.10 Aligned_cols=251 Identities=23% Similarity=0.300 Sum_probs=197.3
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|. ..+|+.||+|++.............+.+|+++++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 4679999999999999999995 567999999998643222223345678899999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN-DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
|||+++++|.+++... +.+++..++.++.||+.||+|||+ . ||+||||||+||+++.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 9999999999998643 458999999999999999999998 8 99999999999999999999999999998655
Q ss_pred CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
..........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.......+..
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p~~- 371 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEEIRFPRT- 371 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTT-
T ss_pred CCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHHhCCCCCCcc-
Confidence 454555667899999999999999999999999999999999999999963221 12222222222222222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
.+.++.+++.+||+.||.+|| +++|+++
T Consensus 372 ---~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 372 ---LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 234588999999999999999 9999886
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=354.87 Aligned_cols=263 Identities=23% Similarity=0.380 Sum_probs=210.3
Q ss_pred HHHHHHhcCCCCCceeeecCCeeEEEEE------cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeee
Q 038671 429 EEIIRVTNDFDDEHCIGKGGQGSVYKAE------LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFY 501 (707)
Q Consensus 429 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~ 501 (707)
..+....++|++.+.||+|+||.||+|+ ..+++.||||++..... ....+.+.+|++++.++ +||||++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCC--HHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 4445567889999999999999999995 23568999999975432 23456799999999999 799999999
Q ss_pred eeeecCC-ceeEEEeeeccCcHHHHHhcccc-------------------------------------------------
Q 038671 502 GFCSHAR-HSFIVYEYLEMGSLAMILSNDAA------------------------------------------------- 531 (707)
Q Consensus 502 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------- 531 (707)
+++.+.+ ..++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9987755 48999999999999999975432
Q ss_pred --------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC-
Q 038671 532 --------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS- 596 (707)
Q Consensus 532 --------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 596 (707)
...+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 11288999999999999999999999 999999999999999999999999999987644332
Q ss_pred -CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 597 -NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 597 -~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
......||+.|+|||++.+..++.++||||||+++|||++ |+.||..... ................+.
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~------ 319 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----DEEFCRRLKEGTRMRAPD------ 319 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC----SHHHHHHHHHTCCCCCCT------
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch----hHHHHHHHHcCCCCCCCC------
Confidence 2334568899999999999999999999999999999998 9999964321 112222222222222221
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.||.+|||+.|+++.|+
T Consensus 320 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 351 (359)
T 3vhe_A 320 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 351 (359)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 12345889999999999999999999999885
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.90 Aligned_cols=255 Identities=24% Similarity=0.387 Sum_probs=208.6
Q ss_pred hcCCCCCceeeecCCeeEEEEEc--------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL--------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCS 505 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 505 (707)
.++|++.+.||+|+||.||+|+. ..++.||+|++.... .....+.+.+|+++++++ +||||+++++++.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 46799999999999999999964 234679999987653 233557789999999999 8999999999999
Q ss_pred cCCceeEEEeeeccCcHHHHHhcccc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDAA-------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 572 (707)
.++..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+. ||+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 99999999999999999999975432 23589999999999999999999999 999999999999
Q ss_pred eecCCCCeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccc
Q 038671 573 LLDLENEAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISS 649 (707)
Q Consensus 573 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 649 (707)
+++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~--- 299 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 299 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 999999999999999987654322 2233467889999999999999999999999999999999 9999863221
Q ss_pred ccchhhhhhhhhcCCC-CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 650 SSSNLEIALNEMLDPR-LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 650 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
......+.... ...+. ..+.++.+++.+||+.||++||+++|+++.|+
T Consensus 300 -----~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 348 (382)
T 3tt0_A 300 -----EELFKLLKEGHRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348 (382)
T ss_dssp -----HHHHHHHHTTCCCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----HHHHHHHHcCCCCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11222222221 11121 22345889999999999999999999999875
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=352.57 Aligned_cols=256 Identities=24% Similarity=0.372 Sum_probs=205.6
Q ss_pred hcCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 508 (707)
.++|++.+.||+|+||.||+|.. .+++.||||++.... .......+.+|+.++++++||||+++++++...+
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 36789999999999999999973 256789999986532 2334567889999999999999999999999999
Q ss_pred ceeEEEeeeccCcHHHHHhcccc----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC---CeE
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAA----AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN---EAH 581 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~---~~k 581 (707)
..++||||+.+|+|.+++..... ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence 99999999999999999975432 23589999999999999999999999 999999999999999655 599
Q ss_pred EeccccceecCCCC--CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhh
Q 038671 582 VSDFGTAKFLKPDS--SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIAL 658 (707)
Q Consensus 582 l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 658 (707)
|+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~~ 296 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVL 296 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH
Confidence 99999997543221 22334567899999999999899999999999999999998 9999864221 1222
Q ss_pred hhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 659 NEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.......... ..+..+.+++.+||+.||++||++.++++.|+
T Consensus 297 ~~i~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~ 341 (367)
T 3l9p_A 297 EFVTSGGRMDPPK---NCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 341 (367)
T ss_dssp HHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHcCCCCCCCc---cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 2222222111111 22345889999999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=346.01 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=202.6
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
+.++|++.+.||+|+||.||+|.. .+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 347899999999999999999954 47999999998654322 234568899999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||+++++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++....
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 99999999999988543 3589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC--CCccccccccCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 593 PDS--SNWAELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 593 ~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
... .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||+..... ..... ..........
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~----~~~~~~~~~~ 229 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYS----DWKEKKTYLN 229 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT---SHHHH----HHHTTCTTST
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH---HHHHH----HHhcccccCC
Confidence 322 22345689999999999987765 77899999999999999999999743221 01111 1111111110
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.....+.++.+++.+||+.||++|||++|+++.
T Consensus 230 --~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 --PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 112234568899999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=364.07 Aligned_cols=258 Identities=21% Similarity=0.285 Sum_probs=205.8
Q ss_pred HHHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
....++|++.+.||+|+||.||+|+. .+++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 144 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 33467899999999999999999965 46899999998542111111223478899999999999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
|+||||++||+|.++++. ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++.
T Consensus 145 ~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~ 217 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 217 (410)
T ss_dssp EEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence 999999999999999864 2489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-CccccccccCCCCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCC
Q 038671 591 LKPDSS-NWAELAGTYGYVAPELAYTMK----VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPR 665 (707)
Q Consensus 591 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (707)
...... .....+||+.|+|||++.+.. ++.++||||||+++|||++|+.||..... ...............
T Consensus 218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~~~~ 293 (410)
T 3v8s_A 218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIMNHKNSLT 293 (410)
T ss_dssp CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTHHHHCC
T ss_pred eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh----hhHHHHHHhcccccc
Confidence 654432 234568999999999988765 78899999999999999999999963221 111122222111122
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCC--CCCHHHHHHH
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESPES--RPTIQKVSQL 704 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~~l~~~ 704 (707)
.+.... .+.++.+++.+|+..+|++ ||+++|+++.
T Consensus 294 ~p~~~~----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 294 FPDDND----ISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCTTCC----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CCCccc----ccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 332211 2345889999999999998 9999999863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=349.46 Aligned_cols=259 Identities=22% Similarity=0.405 Sum_probs=209.8
Q ss_pred HHHhcCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeee
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCS 505 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 505 (707)
....++|++.+.||+|+||.||+|+.. +++.||+|++..... ....+.+.+|++++++++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 334678999999999999999999653 458899999976432 334577999999999999999999999999
Q ss_pred cCCceeEEEeeeccCcHHHHHhcccc---------------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDAA---------------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVH 564 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 564 (707)
+.+..++||||+++++|.+++..... ...+++..++.++.||++||+|||++ ||+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 99999999999999999999975321 14689999999999999999999999 9999
Q ss_pred cCCCCCCeeecCCCCeEEeccccceecCCCC--CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCC
Q 038671 565 RDISSKNVLLDLENEAHVSDFGTAKFLKPDS--SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPR 641 (707)
Q Consensus 565 ~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~ 641 (707)
|||||+||+++.++.+||+|||++....... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 9999999999999999999999997654322 12234567889999999998889999999999999999999 99998
Q ss_pred CcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 642 DFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 642 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..... ......+.....+.... ..+.++.+++.+||+.||++||++.++++.|+
T Consensus 278 ~~~~~--------~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~ 331 (343)
T 1luf_A 278 YGMAH--------EEVIYYVRDGNILACPE---NCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 331 (343)
T ss_dssp TTSCH--------HHHHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCh--------HHHHHHHhCCCcCCCCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence 63221 12222222222222111 23346899999999999999999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=338.59 Aligned_cols=254 Identities=20% Similarity=0.316 Sum_probs=206.9
Q ss_pred HhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
+.++|++.+.||+|+||.||+|. ..+|+.||+|++...... ....+.+.+|++++++++||||+++++++..++..++
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence 45789999999999999999995 456899999998654322 2345678899999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC---eEEeccccce
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE---AHVSDFGTAK 589 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~---~kl~Dfg~~~ 589 (707)
||||+.+++|.+.+... ..+++..++.++.|++.||+|||+. |++||||||+||+++.++. +||+|||.+.
T Consensus 83 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 99999999999888643 4589999999999999999999999 9999999999999987665 9999999998
Q ss_pred ecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
..... .......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||..... ..............+
T Consensus 157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~ 227 (284)
T 3kk8_A 157 EVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIKAGAYDYP 227 (284)
T ss_dssp ECCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCCC
T ss_pred EcccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--------hHHHHHHHhccccCC
Confidence 76543 233456799999999999999999999999999999999999999863221 111111111222111
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.......+.++.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1122233456899999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=345.49 Aligned_cols=256 Identities=21% Similarity=0.279 Sum_probs=209.1
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCch---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSE---MASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
+.++|++.+.||+|+||.||+|+. .+|+.||+|++....... ....+++.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 346799999999999999999964 578999999986543221 1135678999999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC----CeEEecc
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN----EAHVSDF 585 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~----~~kl~Df 585 (707)
.++||||+++++|.+++... ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 99999999999999999653 4589999999999999999999999 999999999999999888 7999999
Q ss_pred ccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCC
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPR 665 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (707)
|++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+....
T Consensus 164 g~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~ 234 (321)
T 2a2a_A 164 GLAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITSVS 234 (321)
T ss_dssp TTCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTC
T ss_pred ccceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhcc
Confidence 9998765432 2345679999999999998899999999999999999999999996322 112222222222
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...+.......+..+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 222211112234568999999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=338.30 Aligned_cols=250 Identities=26% Similarity=0.450 Sum_probs=202.3
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|. ..+++.||+|++.............+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4679999999999999999995 556789999998643222223356788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 9999999999998643 4589999999999999999999999 999999999999999999999999999865432
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .......+.......+..
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~-- 229 (279)
T 3fdn_A 162 S--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVEFTFPDF-- 229 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCCCTT--
T ss_pred c--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--------HHHHHHHHHhCCCCCCCc--
Confidence 2 2344578999999999999889999999999999999999999996322 111222222222222221
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+..+.+++.+||+.||++||+++|+++.
T Consensus 230 --~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 230 --VTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --SCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 23458899999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=344.67 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=199.9
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
...++|++.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+..+++++||||+++++++..++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY 110 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence 3458899999999999999999965 478999999987654444445578999999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||+++++|.+++... ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++...
T Consensus 111 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 111 VDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999999999999643 4589999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCC-CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCC
Q 038671 592 KPDS-SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670 (707)
Q Consensus 592 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (707)
.... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... . ..........+.+.
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~-~~~~~~~~~~~~~~ 255 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL--------S-VMGAHINQAIPRPS 255 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH--------H-HHHHHHHSCCCCGG
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH--------H-HHHHHhccCCCCcc
Confidence 5432 223345789999999999998899999999999999999999999964221 1 11111111111111
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHhc
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRP-TIQKVSQLLK 706 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~~l~~~L~ 706 (707)
......+.++.+++.+||+.||++|| +++++++.|+
T Consensus 256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~ 292 (309)
T 2h34_A 256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH 292 (309)
T ss_dssp GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence 11223345688999999999999999 9999998874
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=342.62 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=208.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 508 (707)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 46789999999999999999964 345889999987543 2345577899999999999999999999999999
Q ss_pred ceeEEEeeeccCcHHHHHhcccc---------------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAA---------------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDI 567 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 567 (707)
..++||||+++++|.+++..... ...+++..++.++.||++||+|||++ ||+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccccc
Confidence 99999999999999999975432 23488999999999999999999999 9999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcc
Q 038671 568 SSKNVLLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFI 644 (707)
Q Consensus 568 k~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~ 644 (707)
||+||+++.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544322 233456788999999998889999999999999999999 99998643
Q ss_pred cccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 645 SSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.. ...............+ . ..+.++.+++.+||+.||++||++.++++.|+
T Consensus 257 ~~-----~~~~~~~~~~~~~~~~--~----~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 257 PP-----ERLFNLLKTGHRMERP--D----NCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307 (314)
T ss_dssp CG-----GGHHHHHHTTCCCCCC--T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CH-----HHHHHHhhcCCcCCCC--c----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 22 1111122211111111 1 23356899999999999999999999999875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=341.18 Aligned_cols=260 Identities=25% Similarity=0.409 Sum_probs=202.0
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-----CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA-- 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-- 507 (707)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 46799999999999999999973 46899999998753 233456789999999999999999999998553
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred CceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 46899999999999999996542 3589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC---CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccc--------ccccchhhh
Q 038671 588 AKFLKPDSS---NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI--------SSSSSNLEI 656 (707)
Q Consensus 588 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~--------~~~~~~~~~ 656 (707)
+........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||...... .........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 987654322 122345677899999999999999999999999999999999998632110 000000111
Q ss_pred hhhhhc-CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 657 ALNEML-DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 657 ~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...... ..+.+.+. ..+.++.+++.+||+.||++|||+.|+++.|+
T Consensus 241 ~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~ 287 (295)
T 3ugc_A 241 LIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287 (295)
T ss_dssp HHHHHHTTCCCCCCT----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhccCcCCCCc----CcCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 111111 12222222 23456899999999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.67 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=209.6
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|.+.+.||+|+||.||++.. .+++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 46799999999999999999954 56889999998754433445567889999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+.+++|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 9999999999988643 4589999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.........|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..............+..
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~-- 263 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKKNEYSIPKH-- 263 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCCCTT--
T ss_pred CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHHhcCCCCCCcc--
Confidence 55555567899999999999998899999999999999999999999963221 11111111112222211
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+..+.+++.+||+.||++||+++|+++
T Consensus 264 --~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 264 --INPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2345889999999999999999999886
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=343.53 Aligned_cols=259 Identities=20% Similarity=0.367 Sum_probs=190.1
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|.. .+|+.||+|++..... ....+.+.+|++++++++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 36799999999999999999965 4689999999865432 22335678999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhccc---ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 514 YEYLEMGSLAMILSNDA---AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
|||++ ++|.+++.... ....+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 99998 58988885432 123589999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhh--------
Q 038671 591 LKPDSSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM-------- 661 (707)
Q Consensus 591 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------- 661 (707)
............||+.|+|||++.+. .++.++||||||+++|+|++|+.||....... .........
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE----QLKLIFDIMGTPNESLW 233 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCSCCTTTC
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChhHh
Confidence 76554445556889999999998764 58999999999999999999999996432210 000000000
Q ss_pred --------cCCCCCC-CCcch---------HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 662 --------LDPRLPT-PSHNV---------QDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 662 --------~~~~~~~-~~~~~---------~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+.... +.... ...+.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000000 00000 012346899999999999999999999976
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=351.27 Aligned_cols=255 Identities=17% Similarity=0.233 Sum_probs=205.1
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 512 (707)
.++|++.+.||+|+||.||+|. ..+|+.||||++..... .+.+.+|+++++.+ +||||+++++++..++..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 4679999999999999999996 46799999999865422 23578899999999 89999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC-----eEEecccc
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE-----AHVSDFGT 587 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~-----~kl~Dfg~ 587 (707)
||||+ +++|.+++... .+.+++..++.++.|++.||+|||+. ||+||||||+||+++.++. +||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EEEeC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 99999 99999999643 34699999999999999999999999 9999999999999998887 99999999
Q ss_pred ceecCCCCCC-------ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 588 AKFLKPDSSN-------WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 588 ~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
+......... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .........
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~-----~~~~~~~~~ 231 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA-----DTLKERYQK 231 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----SSHHHHHHH
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc-----ccHHHHHHH
Confidence 9876543321 2456799999999999999999999999999999999999999975322 111111111
Q ss_pred hcCCCCCCCCcc-hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 661 MLDPRLPTPSHN-VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 661 ~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.....+.+... ....+ ++.+++..||+.||.+||+++++.+.|+
T Consensus 232 i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~ 277 (330)
T 2izr_A 232 IGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT 277 (330)
T ss_dssp HHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred HHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence 111111111000 01122 6999999999999999999999998774
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=362.64 Aligned_cols=258 Identities=22% Similarity=0.306 Sum_probs=210.0
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|++++++++||||+++++++...+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 36788999999999999999965 57999999998643222223456788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccc-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 514 YEYLEMGSLAMILSNDAA-AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
|||++||+|.+++..... ...+++..++.++.||+.||+|||++ ||+||||||+||+++.+|.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999875432 34689999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .........+.......+.
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~----~~~~~~~~~i~~~~~~~p~-- 414 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRVLEQAVTYPD-- 414 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC----CCHHHHHHHHHHCCCCCCT--
T ss_pred CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc----hhHHHHHHHHhhcccCCCc--
Confidence 5554455568999999999999999999999999999999999999999743211 1112222222222222222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTI-----QKVSQ 703 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~-----~~l~~ 703 (707)
..+..+.+++.+||+.||++||++ +++++
T Consensus 415 --~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 415 --KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 223458899999999999999975 55553
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=351.14 Aligned_cols=246 Identities=24% Similarity=0.310 Sum_probs=198.2
Q ss_pred CceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeecc
Q 038671 441 EHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
.+.||+|+||.||+|. ..+|+.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 5679999999999995 4679999999987542 23456789999999999999999999999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee--cCCCCeEEeccccceecCCCCCC
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL--DLENEAHVSDFGTAKFLKPDSSN 597 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~--~~~~~~kl~Dfg~~~~~~~~~~~ 597 (707)
++|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||++....... .
T Consensus 171 ~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~ 244 (373)
T 2x4f_A 171 GELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-K 244 (373)
T ss_dssp CEEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-B
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-c
Confidence 9999988543 23589999999999999999999999 99999999999999 567899999999998765433 2
Q ss_pred ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHH
Q 038671 598 WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKL 677 (707)
Q Consensus 598 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 677 (707)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+.......+.......+
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~~~~~~~~~~~ 316 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--------AETLNNILACRWDLEDEEFQDIS 316 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCSCSGGGTTSC
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhccCCCChhhhccCC
Confidence 3445799999999999988899999999999999999999999964221 12222222222222222233445
Q ss_pred HHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 678 ISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 678 ~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.++.+++.+||+.||.+||++.|+++
T Consensus 317 ~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 317 EEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 67899999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.58 Aligned_cols=257 Identities=22% Similarity=0.375 Sum_probs=191.2
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcCCC----cEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELPSG----EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
..++|++.+.||+|+||.||+|..... ..||+|++...... ....+.+.+|++++++++||||+++++++.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 356799999999999999999976543 27999998764322 2346779999999999999999999999987665
Q ss_pred e------eEEEeeeccCcHHHHHhccccc---CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCe
Q 038671 510 S------FIVYEYLEMGSLAMILSNDAAA---KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEA 580 (707)
Q Consensus 510 ~------~lv~e~~~~~~L~~~l~~~~~~---~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~ 580 (707)
. ++||||+.+++|.+++...... ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 5 9999999999999998644322 2589999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhh
Q 038671 581 HVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIA 657 (707)
Q Consensus 581 kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 657 (707)
||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ...
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~ 248 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--------AEI 248 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGH
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh--------HHH
Confidence 9999999987644322 1223456788999999999999999999999999999999 9999874322 111
Q ss_pred hhhhcC-CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 658 LNEMLD-PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 658 ~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...... .....+. ..+.++.+++.+||+.||++|||+.++++.|+
T Consensus 249 ~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 294 (323)
T 3qup_A 249 YNYLIGGNRLKQPP----ECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294 (323)
T ss_dssp HHHHHTTCCCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhcCCCCCCCC----ccCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111111 1122222 23345899999999999999999999998875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=342.38 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=199.4
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|. ..+|+.||+|++...........+.+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 4579999999999999999995 467999999998764444445667899999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 514 YEYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 99999999999986432 234589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
..........|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ..............+...
T Consensus 188 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~-- 259 (310)
T 2wqm_A 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEQCDYPPLP-- 259 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------CHHHHHHHHHTTCSCCCC--
T ss_pred CCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------hHHHHHHHhhcccCCCCc--
Confidence 544444456789999999999988899999999999999999999999863211 111111222222222111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....+.++.+++.+||+.||.+||+++++++.|+
T Consensus 260 ~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~ 293 (310)
T 2wqm_A 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293 (310)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 1123456899999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=354.20 Aligned_cols=266 Identities=20% Similarity=0.324 Sum_probs=211.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC--cee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR--HSF 511 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~ 511 (707)
.++|++.+.||+|+||.||+|+. .+|+.||+|++.... .....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS--FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG--GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc--ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 35799999999999999999965 469999999986432 1223567789999999999999999999997655 679
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee----cCCCCeEEecccc
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL----DLENEAHVSDFGT 587 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~----~~~~~~kl~Dfg~ 587 (707)
+||||+++++|.+++........+++..++.++.||+.||+|||+. ||+||||||+||++ +.++.+||+|||+
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 9999999999999997665555599999999999999999999999 99999999999999 7777899999999
Q ss_pred ceecCCCCCCccccccccCCCCcccccc--------CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhh
Q 038671 588 AKFLKPDSSNWAELAGTYGYVAPELAYT--------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN 659 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 659 (707)
++...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..................
T Consensus 163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~ 241 (396)
T 4eut_A 163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241 (396)
T ss_dssp CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence 98765432 2344679999999998865 45788999999999999999999999643322111111111111
Q ss_pred hhc-----------------CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 660 EML-----------------DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 660 ~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
... ....+.........+..+.+++.+||+.||++||+++++++.++
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~ 305 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence 100 01222233344677888999999999999999999999988763
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=333.52 Aligned_cols=254 Identities=30% Similarity=0.477 Sum_probs=201.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhh----HHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMAS----QQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
.++|++.+.||+|+||.||+|+. .+++.||+|++.......... .+.+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36799999999999999999954 679999999987543332211 167899999999999999999999986654
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeecCCCC-----eEE
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP--IVHRDISSKNVLLDLENE-----AHV 582 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nil~~~~~~-----~kl 582 (707)
++||||+++++|.+++... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++. +||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 6999999999999888643 34689999999999999999999999 8 999999999999988776 999
Q ss_pred eccccceecCCCCCCccccccccCCCCccccc--cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 583 SDFGTAKFLKPDSSNWAELAGTYGYVAPELAY--TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 583 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
+|||++..... ......|++.|+|||.+. ...++.++||||||+++|+|++|+.||....... ..........
T Consensus 171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~ 245 (287)
T 4f0f_A 171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK--IKFINMIREE 245 (287)
T ss_dssp CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH--HHHHHHHHHS
T ss_pred CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH--HHHHHHHhcc
Confidence 99999975432 334567999999999984 4557889999999999999999999996432210 0001111111
Q ss_pred hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+..+. ..+.++.+++.+||+.||++|||++++++.|+
T Consensus 246 ~~~~~~~~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 285 (287)
T 4f0f_A 246 GLRPTIPE------DCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285 (287)
T ss_dssp CCCCCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCc------ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 11222221 23456899999999999999999999999885
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=336.11 Aligned_cols=251 Identities=22% Similarity=0.322 Sum_probs=205.9
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
+.++|++.+.||+|+||.||+|.. .+++.+|+|++..... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL 83 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence 456799999999999999999954 5678999999865322 235678999999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---cCCCCeEEeccccce
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL---DLENEAHVSDFGTAK 589 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~---~~~~~~kl~Dfg~~~ 589 (707)
||||+++++|.+++... ..+++..++.++.|++.||+|||++ |++||||||+||++ +.++.+||+|||++.
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~ 157 (277)
T 3f3z_A 84 VMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157 (277)
T ss_dssp EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence 99999999999988643 4589999999999999999999999 99999999999999 788899999999998
Q ss_pred ecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
...... ......||+.|+|||.+.+. ++.++||||||+++|+|++|+.||..... ......+.......+
T Consensus 158 ~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~ 227 (277)
T 3f3z_A 158 RFKPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SEVMLKIREGTFTFP 227 (277)
T ss_dssp ECCTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCC
T ss_pred eccCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence 765433 33456799999999988765 89999999999999999999999963221 122222222222222
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.......+.++.+++.+||+.||++||++.++++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2222234567899999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=351.44 Aligned_cols=262 Identities=23% Similarity=0.289 Sum_probs=204.7
Q ss_pred HHHHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCC--chhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC
Q 038671 431 IIRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLP--SEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA 507 (707)
Q Consensus 431 ~~~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 507 (707)
+..+.++|++.+.||+|+||.||+|. ..+++.||+|++..... ......+.+.+|++++++++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 35667889999999999999999995 46788999999853211 1123456799999999999999999999999999
Q ss_pred CceeEEEeeeccCcHHHHHhcccc-------------------------------------cCCCChHHHHHHHHHHHHH
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAA-------------------------------------AKDLGWTKRMNVIKGVVDA 550 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~i~~~ 550 (707)
+..++||||+++|+|.+++..... ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999999852110 1123577788999999999
Q ss_pred HHHHHhCCCCCeEecCCCCCCeeecCCC--CeEEeccccceecCCCCC----CccccccccCCCCcccccc--CCCCccc
Q 038671 551 LSYMHNDCFPPIVHRDISSKNVLLDLEN--EAHVSDFGTAKFLKPDSS----NWAELAGTYGYVAPELAYT--MKVTEKC 622 (707)
Q Consensus 551 l~~LH~~~~~~ivH~dlk~~Nil~~~~~--~~kl~Dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~--~~~~~~~ 622 (707)
|+|||+. +|+||||||+||+++.++ .+||+|||++........ ......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999 999999999999998776 899999999987643221 2345679999999999875 6788999
Q ss_pred hhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 038671 623 DVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVS 702 (707)
Q Consensus 623 Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~ 702 (707)
||||||+++|+|++|+.||..... ..............+.......+.++.+++.+||+.||.+||++.+++
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l 329 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVND--------ADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 999999999999999999964322 122222222233222223333456789999999999999999999998
Q ss_pred H
Q 038671 703 Q 703 (707)
Q Consensus 703 ~ 703 (707)
+
T Consensus 330 ~ 330 (345)
T 3hko_A 330 Q 330 (345)
T ss_dssp H
T ss_pred c
Confidence 6
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=352.30 Aligned_cols=258 Identities=23% Similarity=0.382 Sum_probs=206.7
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeec
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSH 506 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 506 (707)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 457899999999999999999964 346789999987542 222446789999999999 89999999999999
Q ss_pred CCceeEEEeeeccCcHHHHHhccccc--------------------CCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecC
Q 038671 507 ARHSFIVYEYLEMGSLAMILSNDAAA--------------------KDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRD 566 (707)
Q Consensus 507 ~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~d 566 (707)
.+..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+. ||+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 99999999999999999999754321 3479999999999999999999999 999999
Q ss_pred CCCCCeeecCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCc
Q 038671 567 ISSKNVLLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDF 643 (707)
Q Consensus 567 lk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~ 643 (707)
|||+||+++.++.+||+|||++......... .....+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999876544322 233467889999999998899999999999999999998 9999964
Q ss_pred ccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 644 ISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 644 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
... ................+ . ..+.++.+++.+||+.||.+||++.++++.|+
T Consensus 278 ~~~----~~~~~~~~~~~~~~~~~--~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 278 IPV----DANFYKLIQNGFKMDQP--F----YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CCC----SHHHHHHHHTTCCCCCC--T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCc----HHHHHHHHhcCCCCCCC--C----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 321 11122222222222111 1 12355899999999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=336.68 Aligned_cols=257 Identities=27% Similarity=0.439 Sum_probs=194.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|+||.||+|+... .+|+|++..... .....+.+.+|++++++++||||+++++++ .....++||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 5789999999999999999997643 599999876533 334567799999999999999999999965 456689999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+++|.+++... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 99 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 99 QWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp ECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred EecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccc
Confidence 999999999999543 34689999999999999999999999 9999999999999999999999999999765432
Q ss_pred --CCCccccccccCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 595 --SSNWAELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 595 --~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
........||+.|+|||.+. +..++.++||||||+++|+|++|+.||...... .............+....
T Consensus 174 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~- 249 (289)
T 3og7_A 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEMVGRGSLSPDLSK- 249 (289)
T ss_dssp ----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH---HHHHHHHHHTSCCCCTTS-
T ss_pred cccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH---HHHHHHhcccccCcchhh-
Confidence 22234457899999999886 566888999999999999999999999643221 111111111111222111
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.....+.++.+++.+||+.||.+||++.++++.|+
T Consensus 250 --~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 284 (289)
T 3og7_A 250 --VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284 (289)
T ss_dssp --SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 12234456999999999999999999999999885
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=359.88 Aligned_cols=252 Identities=24% Similarity=0.434 Sum_probs=206.5
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|+||.||+|..++++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 46788999999999999999998888999999987543 23567999999999999999999999986 56789999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+|+|.++++... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 262 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred eecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 9999999999997542 23578999999999999999999999 9999999999999999999999999999875432
Q ss_pred CC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 595 SS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 595 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
.. ......+++.|+|||.+.+..++.++||||||+++|||+| |+.||..... ......... ..+++.+.
T Consensus 338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-----~~~~~~i~~--~~~~~~~~-- 408 (454)
T 1qcf_A 338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----PEVIRALER--GYRMPRPE-- 408 (454)
T ss_dssp HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHHHHH--TCCCCCCT--
T ss_pred ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHc--CCCCCCCC--
Confidence 11 1122346778999999998899999999999999999999 9999964322 111111111 12233332
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.||++|||++++++.|+
T Consensus 409 --~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~ 440 (454)
T 1qcf_A 409 --NCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 440 (454)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --CCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 23456899999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=338.47 Aligned_cols=251 Identities=27% Similarity=0.477 Sum_probs=196.0
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
++|++.+.||+|+||.||+|+.. ++.||+|++... ...+.+.+|++++++++||||+++++++.+ ..++|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 57889999999999999999874 788999998642 245678999999999999999999998874 4889999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC-eEEeccccceecCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE-AHVSDFGTAKFLKPD 594 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~-~kl~Dfg~~~~~~~~ 594 (707)
|+++++|.+++........+++..++.++.|+++||+|||+.+..||+||||||+||+++.++. +||+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 9999999999986655456889999999999999999999932129999999999999998886 799999999765432
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||+.... .... ..........+.. ..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~-~~~~~~~~~~~~~---~~ 227 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG-----PAFR-IMWAVHNGTRPPL---IK 227 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS-----SHHH-HHHHHHTTCCCCC---BT
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc-----cHHH-HHHHHhcCCCCCc---cc
Confidence 2334689999999999998999999999999999999999999964321 1111 1111111111111 11
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+..+.+++.+||+.||++|||++++++.|+
T Consensus 228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 259 (307)
T 2eva_A 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259 (307)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 23345889999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=342.48 Aligned_cols=257 Identities=24% Similarity=0.413 Sum_probs=209.6
Q ss_pred hcCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHA 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 507 (707)
.++|++.+.||+|+||.||+|+. .+++.||+|++..... ....+.+.+|+++++++ +||||+++++++..+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 46799999999999999999963 3578899999875432 23457799999999999 899999999999999
Q ss_pred CceeEEEeeeccCcHHHHHhcccc---------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAA---------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 572 (707)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||++ |++||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence 999999999999999999975432 12489999999999999999999999 999999999999
Q ss_pred eecCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccc
Q 038671 573 LLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISS 649 (707)
Q Consensus 573 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 649 (707)
+++.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.....
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 253 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--- 253 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc---
Confidence 9999999999999999876544332 233457889999999999899999999999999999999 9999864321
Q ss_pred ccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 650 SSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
................+ . ..+.++.+++.+||+.||.+|||+.++++.|+
T Consensus 254 -~~~~~~~~~~~~~~~~~--~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 303 (313)
T 1t46_A 254 -DSKFYKMIKEGFRMLSP--E----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (313)
T ss_dssp -SHHHHHHHHHTCCCCCC--T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -hhHHHHHhccCCCCCCc--c----cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 11122222222221111 1 22345899999999999999999999999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=347.64 Aligned_cols=264 Identities=23% Similarity=0.378 Sum_probs=211.4
Q ss_pred cchHHHHHHHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCc-----hhhhHHHHHHHHHHHhcC-CCCce
Q 038671 425 KIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPS-----EMASQQEFLNEVKTLTGI-RHRNI 497 (707)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l-~h~ni 497 (707)
...+.....+.++|++.+.||+|+||.||+|.. .+|+.||||++...... .....+.+.+|+.+++++ +||||
T Consensus 83 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i 162 (365)
T 2y7j_A 83 LPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI 162 (365)
T ss_dssp BCHHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred cccchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence 344555567778899999999999999999976 47999999998654321 112245688999999999 79999
Q ss_pred eeeeeeeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC
Q 038671 498 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE 577 (707)
Q Consensus 498 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~ 577 (707)
+++++++...+..++||||+++++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.+
T Consensus 163 v~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 163 ITLIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDN 236 (365)
T ss_dssp CCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred eEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence 99999999999999999999999999998642 4589999999999999999999999 99999999999999999
Q ss_pred CCeEEeccccceecCCCCCCccccccccCCCCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCccccccccc
Q 038671 578 NEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS 651 (707)
Q Consensus 578 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 651 (707)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.....
T Consensus 237 ~~ikl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----- 310 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ----- 310 (365)
T ss_dssp CCEEECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred CCEEEEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-----
Confidence 999999999998766432 3345689999999998864 3578899999999999999999999863221
Q ss_pred chhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 652 SNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
......+...............+..+.+++.+||+.||++||++.++++
T Consensus 311 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 311 ---ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111222222222111111123456899999999999999999999986
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=334.65 Aligned_cols=252 Identities=23% Similarity=0.393 Sum_probs=193.6
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC----CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
.++|++.+.||+|+||.||+|... .+..||+|+..... .....+.+.+|+..+++++||||+++++++. ++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 467999999999999999999653 35579999987542 2335567999999999999999999999984 4678
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++||||+.+++|.+++... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 9999999999999999643 23589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC-CCC
Q 038671 591 LKPDSS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP-RLP 667 (707)
Q Consensus 591 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 667 (707)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+... ..+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--------~~~~~i~~~~~~~ 237 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENGERLP 237 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHTTCCCC
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--------HHHHHHHcCCCCC
Confidence 654322 1223456788999999998889999999999999999997 99998643221 111111111 112
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+. ..+.++.+++.+||+.||++||++.++++.|+
T Consensus 238 ~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 272 (281)
T 1mp8_A 238 MPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 272 (281)
T ss_dssp CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 221 23456889999999999999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.11 Aligned_cols=248 Identities=22% Similarity=0.266 Sum_probs=194.5
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 512 (707)
.++|++.+.||+|+||+||+|... +|+.||||++........ .......|+..+.++ +||||+++++++.+++..++
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH-HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 367999999999999999999654 799999999876544433 334445555555555 89999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||+ +++|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 135 v~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 67888887543 34699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
... ......||+.|+|||++.+ .++.++||||||+++|||++|..|+.... .. ..+.....+. ..
T Consensus 209 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-------~~----~~~~~~~~~~--~~ 273 (311)
T 3p1a_A 209 TAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-------GW----QQLRQGYLPP--EF 273 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-------HH----HHHTTTCCCH--HH
T ss_pred cCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HH----HHHhccCCCc--cc
Confidence 432 2344579999999998876 69999999999999999999976653211 11 1111111111 11
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
....+.++.+++.+||+.||++|||++|+++.
T Consensus 274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 274 TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 12234568999999999999999999999863
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=338.77 Aligned_cols=262 Identities=21% Similarity=0.339 Sum_probs=199.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+.+|++++++++||||+++++++...+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 36799999999999999999965 5699999999876533 333456788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp EECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999999988643 4589999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhh-------------hhhh
Q 038671 594 DSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE-------------IALN 659 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-------------~~~~ 659 (707)
.........|++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.............. ....
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 5554556689999999999876 5679999999999999999999999964332110000000 0000
Q ss_pred hhcCCCCCCCCcc------hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 660 EMLDPRLPTPSHN------VQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 660 ~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.......+.+... .+..+.++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0111111111110 1123456889999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=352.08 Aligned_cols=264 Identities=19% Similarity=0.291 Sum_probs=203.4
Q ss_pred hcCCCCCceeeec--CCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 435 TNDFDDEHCIGKG--GQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 435 ~~~~~~~~~lg~G--~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
.++|++.+.||+| +||.||+|+. .+|+.||||++...... ....+.+.+|+++++.++||||+++++++.+++..+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACS-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 4679999999999 9999999965 47999999998754322 235567889999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||.+...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999996542 24589999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCC-------CCccccccccCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhc
Q 038671 592 KPDS-------SNWAELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML 662 (707)
Q Consensus 592 ~~~~-------~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 662 (707)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....................
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 3221 11233478999999999987 57899999999999999999999999643221100000000000000
Q ss_pred CCC---------------------------CC-------CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 663 DPR---------------------------LP-------TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 663 ~~~---------------------------~~-------~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+.. .+ .........+.++.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000 00 000011223456899999999999999999999985
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=345.30 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=195.2
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+++. .+++.||+|++..... ..+.+.+|+..++.++||||+++++++...+..++|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 46799999999999999999965 4799999999875432 225678999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC--eEEeccccceec
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE--AHVSDFGTAKFL 591 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~--~kl~Dfg~~~~~ 591 (707)
|||+.+|+|.+++... +.+++..++.++.|++.||+|||++ ||+||||||+||+++.++. +||+|||+++..
T Consensus 95 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 95 MEYASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred EEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 9999999999998543 3589999999999999999999999 9999999999999987765 999999999754
Q ss_pred CCCCCCccccccccCCCCccccccCCCCcc-chhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCC
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYTMKVTEK-CDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (707)
... .......||+.|+|||++.+..++.+ +||||+|+++|+|++|+.||..... ..................+.
T Consensus 169 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~~ 243 (361)
T 3uc3_A 169 VLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE----PRDYRKTIQRILSVKYSIPD 243 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--------CCCHHHHHHHHHTTCCCCCT
T ss_pred ccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHHhcCCCCCCC
Confidence 322 22344579999999999988877655 8999999999999999999974332 12222333333333322221
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
. ...+.++.+++.+||+.||++|||+.|+++.
T Consensus 244 ~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 D--IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp T--SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred c--CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1 1123458899999999999999999999863
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=357.65 Aligned_cols=262 Identities=22% Similarity=0.271 Sum_probs=206.8
Q ss_pred HHHHHhcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 038671 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR 508 (707)
Q Consensus 430 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 508 (707)
++....++|++.+.||+|+||.||+|+.+ +++.||+|++.............+.+|..++..++||||+++++++.+++
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 33445688999999999999999999654 58899999986421111122234888999999999999999999999999
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
..|+||||+.||+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 999999999999999999653 24589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCC-ccccccccCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhc
Q 038671 589 KFLKPDSSN-WAELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML 662 (707)
Q Consensus 589 ~~~~~~~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 662 (707)
+........ ....+||+.|+|||++. ...++.++||||||+++|||++|+.||..... ............
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~----~~~~~~i~~~~~ 298 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHKE 298 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTHHH
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh----hHHHHhhhhccc
Confidence 876544332 23468999999999987 45689999999999999999999999964221 111122221111
Q ss_pred CCCCCCCCcchHHHHHHHHHHHHhccCCCCCC--CCCHHHHHH
Q 038671 663 DPRLPTPSHNVQDKLISIMEVAISCLDESPES--RPTIQKVSQ 703 (707)
Q Consensus 663 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rps~~~l~~ 703 (707)
...++... ...+.++.+++.+|+..+|++ ||+++|+++
T Consensus 299 ~~~~p~~~---~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 299 RFQFPTQV---TDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HCCCCSSC---CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cccCCccc---ccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 12222211 112345889999999988888 999999876
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=354.98 Aligned_cols=248 Identities=29% Similarity=0.438 Sum_probs=202.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-ceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR-HSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv 513 (707)
.++|++.+.||+|+||.||+|... |+.||||++.... ..+.+.+|++++++++||||+++++++.... ..++|
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 467888999999999999999875 7899999987542 3467899999999999999999999987655 78999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 266 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 99999999999997532 23478999999999999999999999 999999999999999999999999999986442
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
.. ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. ........ .+++.+.
T Consensus 342 ~~---~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~----~~-~~~~i~~~--~~~~~p~-- 409 (450)
T 1k9a_A 342 TQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KD-VVPRVEKG--YKMDAPD-- 409 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT----TT-HHHHHHTT--CCCCCCT--
T ss_pred cc---cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HH-HHHHHHcC--CCCCCCC--
Confidence 21 22357889999999999999999999999999999998 9999974322 11 11111111 1222222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.||++|||+.++++.|+
T Consensus 410 --~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~ 441 (450)
T 1k9a_A 410 --GCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441 (450)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 23456899999999999999999999998875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=341.33 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=206.2
Q ss_pred hcCCCCCceeeecCCeeEEEEEc--------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL--------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCS 505 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 505 (707)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... .....+.+.+|+++++++ +||||+++++++.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 46899999999999999999965 357789999987543 233557789999999999 8999999999999
Q ss_pred cCCceeEEEeeeccCcHHHHHhcccc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDAA-------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 572 (707)
..+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+. ||+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence 99999999999999999999975432 23489999999999999999999999 999999999999
Q ss_pred eecCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccc
Q 038671 573 LLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISS 649 (707)
Q Consensus 573 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 649 (707)
+++.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.....
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--- 265 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--- 265 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH---
Confidence 9999999999999999876543321 223456788999999988889999999999999999999 9999864221
Q ss_pred ccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 650 SSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
............... +. ..+.++.+++.+||+.||.+||++.++++.|+
T Consensus 266 --~~~~~~~~~~~~~~~--~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 314 (334)
T 2pvf_A 266 --EELFKLLKEGHRMDK--PA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314 (334)
T ss_dssp --HHHHHHHHHTCCCCC--CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --HHHHHHHhcCCCCCC--Cc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 111111111111111 11 22345889999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=338.13 Aligned_cols=257 Identities=18% Similarity=0.235 Sum_probs=205.6
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l 512 (707)
.++|++.+.||+|+||.||+|. ..+|+.||+|++..... .+.+.+|++.++.+ +|++++++++++......++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 4679999999999999999996 46799999999865322 23477899999999 79999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC-----eEEecccc
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE-----AHVSDFGT 587 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~-----~kl~Dfg~ 587 (707)
||||+ +++|.+++... ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++. +||+|||+
T Consensus 84 v~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~ 157 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157 (298)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence 99999 99999999643 34589999999999999999999999 9999999999999988776 99999999
Q ss_pred ceecCCCCC-------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 588 AKFLKPDSS-------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 588 ~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
+........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~ 236 (298)
T 1csn_A 158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-KQKYERIGEK 236 (298)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-HHHHHHHHHH
T ss_pred ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-HHHHHHHHhh
Confidence 987664432 13445799999999999998999999999999999999999999975332111 0111111111
Q ss_pred hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
......+ ......+.++.+++.+||+.||++||+++++++.|+
T Consensus 237 ~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~ 279 (298)
T 1csn_A 237 KQSTPLR---ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 279 (298)
T ss_dssp HHHSCHH---HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred ccCccHH---HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 1101000 001123456899999999999999999999998874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=343.95 Aligned_cols=247 Identities=21% Similarity=0.318 Sum_probs=204.7
Q ss_pred HHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchh-----hhHHHHHHHHHHHhcCCCCceeeeeeeeec
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEM-----ASQQEFLNEVKTLTGIRHRNIVKFYGFCSH 506 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 506 (707)
...++|++.+.||+|+||.||+|. ..+++.||+|++........ .....+.+|++++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 356789999999999999999995 56789999999876432211 123457789999999999999999999999
Q ss_pred CCceeEEEeeeccC-cHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 507 ARHSFIVYEYLEMG-SLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 507 ~~~~~lv~e~~~~~-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
.+..++||||+.+| +|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRH---PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999999766 999998653 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCCCccccccccCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP 664 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 664 (707)
|++....... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||..... ....
T Consensus 175 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------~~~~ 239 (335)
T 3dls_A 175 GSAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------TVEA 239 (335)
T ss_dssp TTCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------GTTT
T ss_pred ccceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------HHhh
Confidence 9998765443 3345679999999999988776 7899999999999999999999863211 1111
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
....+.. .+.++.+++.+||+.||++|||++++++.
T Consensus 240 ~~~~~~~----~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 240 AIHPPYL----VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp CCCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ccCCCcc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122211 23458899999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=337.94 Aligned_cols=260 Identities=23% Similarity=0.370 Sum_probs=205.0
Q ss_pred cCCCCCceeeecCCeeEEEEE-----cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--C
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-----LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA--R 508 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~ 508 (707)
+.|++.+.||+|+||.||+|+ ..+++.||+|++..... ....+.+.+|+++++.++||||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 458899999999999999997 35689999999875432 23456789999999999999999999999876 6
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred eEEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 689999999999999999543 24589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC---CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccc-------cccccchhhhhh
Q 038671 589 KFLKPDSS---NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS-------ISSSSSNLEIAL 658 (707)
Q Consensus 589 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~-------~~~~~~~~~~~~ 658 (707)
........ ......+|..|+|||.+.+..++.++||||||+++|+|++|..|+..... ............
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV 253 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence 88765432 22345678889999999998899999999999999999999998642110 000111111222
Q ss_pred hhhcCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 659 NEMLDP-RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 659 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...... ..+.+. ..+.++.+++.+||+.||.+|||+.++++.|+
T Consensus 254 ~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 298 (302)
T 4e5w_A 254 NTLKEGKRLPCPP----NCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298 (302)
T ss_dssp HHHHTTCCCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhccCCCCCCC----CCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 222221 222222 23356899999999999999999999999885
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=335.57 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=204.1
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCch---hhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSE---MASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
.++|++.+.||+|+||.||+|... +|+.||+|++....... ....+.+.+|++++++++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999654 79999999986543221 12357789999999999999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC----CeEEeccc
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN----EAHVSDFG 586 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~----~~kl~Dfg 586 (707)
++||||+++++|.+++... ..+++..++.++.||+.||+|||+. |++||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999999998642 4589999999999999999999999 999999999999998877 89999999
Q ss_pred cceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
.+....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.....
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QETLTNISAVNY 228 (283)
T ss_dssp TCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCC
T ss_pred cceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHHHHHhHhccc
Confidence 998765432 23445789999999999988899999999999999999999999864221 112222222222
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+.......+..+.+++.+||+.||++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 2211111233456899999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=331.87 Aligned_cols=250 Identities=25% Similarity=0.425 Sum_probs=206.2
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 57889999999999999999888889999999976432 23578899999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++++|.+++... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||.+.......
T Consensus 84 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CCTTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 99999999999643 24589999999999999999999999 99999999999999999999999999998654321
Q ss_pred -CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC-CCCCCCcc
Q 038671 596 -SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP-RLPTPSHN 672 (707)
Q Consensus 596 -~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 672 (707)
.......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ......+... ....+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~i~~~~~~~~~~-- 228 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFRLYKPR-- 228 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCCCCCCT--
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH--------HHHHHHHhcCCcCCCCc--
Confidence 11223456788999999998889999999999999999999 8999864221 1111122211 111111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+..+.+++.+||+.||++||+++++++.|+
T Consensus 229 --~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (267)
T 3t9t_A 229 --LASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260 (267)
T ss_dssp --TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --cCcHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 12345889999999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=361.09 Aligned_cols=256 Identities=21% Similarity=0.275 Sum_probs=207.5
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|+. .+|+.||+|++.............+.+|+++++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999965 57999999998643222223456688999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||++||+|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+||+++.+|.+||+|||++.....
T Consensus 263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 99999999999987543 24589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.. .....+||+.|+|||++.+..++.++||||||+++|||++|+.||...... .........+.......+.
T Consensus 339 ~~-~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~----~~~~~i~~~i~~~~~~~p~--- 410 (576)
T 2acx_A 339 GQ-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKREEVERLVKEVPEEYSE--- 410 (576)
T ss_dssp TC-CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC----CCHHHHHHHHHHCCCCCCT---
T ss_pred Cc-cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc----hhHHHHHHHhhcccccCCc---
Confidence 32 334568999999999999988999999999999999999999999743221 1111111111111111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
..+.++.+++.+||+.||++|| +++|+++
T Consensus 411 -~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 411 -RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 2334588999999999999999 7888875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=329.94 Aligned_cols=251 Identities=19% Similarity=0.289 Sum_probs=203.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--CceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA--RHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l 512 (707)
.++|++.+.||+|+||.||+|+.. ++.||+|++...... ....+.+.+|+.++++++||||+++++++.+. +..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWS-TRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCC-HHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccC-HHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 357999999999999999999875 889999999765333 33456799999999999999999999999876 78899
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeecCCCCeEEecccccee
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP--IVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+. + ++||||||+||+++.++.++++|||++..
T Consensus 87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999997533 23589999999999999999999998 8 99999999999999999999999998764
Q ss_pred cCCCCCCccccccccCCCCccccccCCCCc---cchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 591 LKPDSSNWAELAGTYGYVAPELAYTMKVTE---KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 591 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
... ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||..... .............+..+
T Consensus 163 ~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~ 233 (271)
T 3kmu_A 163 FQS-----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN----MEIGMKVALEGLRPTIP 233 (271)
T ss_dssp TSC-----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH----HHHHHHHHHSCCCCCCC
T ss_pred ecc-----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh----HHHHHHHHhcCCCCCCC
Confidence 322 2347899999999988765544 79999999999999999999964321 11111111121222222
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
. ..+.++.+++.+||+.||++|||++++++.|+
T Consensus 234 ~------~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~ 266 (271)
T 3kmu_A 234 P------GISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266 (271)
T ss_dssp T------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1 23345899999999999999999999999875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=334.16 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=205.2
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|.. .+++.||+|++.............+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 36799999999999999999955 46889999998543222222346789999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 9999999999998643 3589999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||+.... ......+.......+..
T Consensus 167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~~~~~~~~-- 234 (284)
T 2vgo_A 167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------TETHRRIVNVDLKFPPF-- 234 (284)
T ss_dssp S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCCCCCTT--
T ss_pred c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--------hHHHHHHhccccCCCCc--
Confidence 2 23445789999999999998899999999999999999999999964221 11122222222222221
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+.++.+++.+||+.||.+||+++++++
T Consensus 235 --~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 235 --LSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 2345889999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=363.70 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=210.6
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
+.++|++.+.||+|+||.||+|.. .+|+.||||++...........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 346799999999999999999965 4799999999876544434456789999999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---cCCCCeEEeccccce
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL---DLENEAHVSDFGTAK 589 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~---~~~~~~kl~Dfg~~~ 589 (707)
||||+.+++|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+||++ +.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 99999999999998653 3589999999999999999999999 99999999999999 567899999999998
Q ss_pred ecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
..... .......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||..... ......+.......+
T Consensus 178 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 178 HFEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YDILKKVEKGKYTFE 247 (484)
T ss_dssp HBCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCC
T ss_pred Ecccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCCCC
Confidence 76543 33455679999999999876 699999999999999999999999964221 222222333333322
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.......+.++.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 2233345567899999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=357.01 Aligned_cols=261 Identities=23% Similarity=0.265 Sum_probs=205.1
Q ss_pred HHHHHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 038671 430 EIIRVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR 508 (707)
Q Consensus 430 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 508 (707)
+.....++|++.+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|..++..++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 3334468899999999999999999965 579999999986422112223345788999999999999999999999999
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
..|+||||++||+|.+++... ...+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhh
Confidence 999999999999999999643 23689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCC-ccccccccCCCCccccc-------cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 589 KFLKPDSSN-WAELAGTYGYVAPELAY-------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 589 ~~~~~~~~~-~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
+........ ....+||+.|+|||++. +..++.++||||||+++|||++|+.||..... ..........
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~i~~~ 285 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST----AETYGKIVHY 285 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH----HHHHHHHHTH
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH----HHHHHHHHhc
Confidence 877644332 23468999999999987 35689999999999999999999999964221 1111111111
Q ss_pred hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCC---CCHHHHHH
Q 038671 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESR---PTIQKVSQ 703 (707)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---ps~~~l~~ 703 (707)
......+.. ....+.++.+++.+||. +|++| |+++|+++
T Consensus 286 ~~~~~~p~~---~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 286 KEHLSLPLV---DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHCCCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ccCcCCCcc---ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 111122211 11234568899999999 99998 58998875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=342.62 Aligned_cols=253 Identities=24% Similarity=0.451 Sum_probs=197.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCc----EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
.++|++.+.||+|+||.||+|+. .+++ +||+|.+.... .....+++.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-
Confidence 35799999999999999999964 3444 36888876432 2234567899999999999999999999998754
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++++||+.+|+|.+++... ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred eEEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence 78999999999999999653 24689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 590 FLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 590 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
........ .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||+.... .......... ...
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~~~~~--~~~ 238 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEKG--ERL 238 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHTT--CCC
T ss_pred EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----HHHHHHHHcC--CCC
Confidence 76544322 223456789999999999999999999999999999999 9999974322 1111222211 122
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.+.. .+.++.+++.+||+.||++||++.++++.|+
T Consensus 239 ~~~~~----~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 274 (327)
T 3poz_A 239 PQPPI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp CCCTT----BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred CCCcc----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 22222 2345889999999999999999999998874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=338.30 Aligned_cols=257 Identities=27% Similarity=0.373 Sum_probs=205.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeee--cCCcee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCS--HARHSF 511 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~ 511 (707)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++. ..+..+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 46799999999999999999955 57899999998764433 335677999999999999999999999874 456889
Q ss_pred EEEeeeccCcHHHHHhcccc-cCCCChHHHHHHHHHHHHHHHHHHhCCCCC-----eEecCCCCCCeeecCCCCeEEecc
Q 038671 512 IVYEYLEMGSLAMILSNDAA-AKDLGWTKRMNVIKGVVDALSYMHNDCFPP-----IVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
+||||+++++|.+++..... ...+++..++.++.|++.||+|||+. + ++||||||+||+++.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 99999999999999965432 34589999999999999999999999 7 999999999999999999999999
Q ss_pred ccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCC
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPR 665 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (707)
|.+..............|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ............+.
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~i~~~~~~~ 235 (279)
T 2w5a_A 161 GLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIREGKFRR 235 (279)
T ss_dssp CHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCCCC
T ss_pred chheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----HHHHHHHhhccccc
Confidence 9998765443333445789999999999988899999999999999999999999864321 11111111111112
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
++. ..+.++.+++.+||+.||++||+++|+++.+.
T Consensus 236 ~~~------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 236 IPY------RYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp CCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred CCc------ccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 221 23356899999999999999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=345.87 Aligned_cols=253 Identities=21% Similarity=0.267 Sum_probs=191.7
Q ss_pred hcCCCCC-ceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhc-CCCCceeeeeeeeec----C
Q 038671 435 TNDFDDE-HCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG-IRHRNIVKFYGFCSH----A 507 (707)
Q Consensus 435 ~~~~~~~-~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~----~ 507 (707)
.++|.+. +.||+|+||.||++. ..+|+.||||++... ..+.+|+.++.+ .+||||+++++++.. .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 3567666 689999999999995 457899999998532 345677877644 489999999998865 5
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC---CCCeEEec
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL---ENEAHVSD 584 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~---~~~~kl~D 584 (707)
+..|+||||+.||+|.+++.... ...+++..++.++.||+.||+|||+. ||+||||||+||+++. ++.+||+|
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~D 207 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 207 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEe
Confidence 67899999999999999997543 34589999999999999999999999 9999999999999987 78999999
Q ss_pred cccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC
Q 038671 585 FGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP 664 (707)
Q Consensus 585 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 664 (707)
||+++..... ......+||+.|+|||++.+..++.++||||||+++|+|++|+.||................. ..
T Consensus 208 FG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~----~~ 282 (400)
T 1nxk_A 208 FGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR----MG 282 (400)
T ss_dssp CTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH----HT
T ss_pred cccccccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH----cC
Confidence 9999876533 223456889999999999999999999999999999999999999975433221111111111 11
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
....+.......+.++.+++.+||+.||++|||+.|+++.
T Consensus 283 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111111112334568999999999999999999999863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=342.38 Aligned_cols=249 Identities=28% Similarity=0.450 Sum_probs=201.9
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
+.|+..+.||+|+||.||+|+ ..+|+.||||++...........+.+.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 458899999999999999996 4689999999987654444455678999999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+. |++.+++... ...+++..++.++.|+++||+|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 5777777432 34689999999999999999999999 9999999999999999999999999999765432
Q ss_pred CCCccccccccCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 595 SSNWAELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
....||+.|+|||++. +..++.++||||||+++|||++|+.||...... ..... ......+....
T Consensus 208 ----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~----~~~~~-~~~~~~~~~~~--- 275 (348)
T 1u5q_A 208 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYH-IAQNESPALQS--- 275 (348)
T ss_dssp ----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH-HHHSCCCCCCC---
T ss_pred ----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHH-HHhcCCCCCCC---
Confidence 3457999999999874 566899999999999999999999998642211 01111 11111111111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...+..+.+++.+||+.||++|||++++++.
T Consensus 276 --~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 276 --GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred --CCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1223458899999999999999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=344.18 Aligned_cols=259 Identities=20% Similarity=0.349 Sum_probs=209.3
Q ss_pred HHHhcCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeee
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCS 505 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 505 (707)
....++|++.+.||+|+||.||+|... +++.||+|++.... .......+.+|+++++.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 445678999999999999999999543 47889999987543 2234567899999999999999999999999
Q ss_pred cCCceeEEEeeeccCcHHHHHhcccc-------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDAA-------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN 578 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~ 578 (707)
+.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTC
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCC
Confidence 99999999999999999999865332 14578999999999999999999999 999999999999999999
Q ss_pred CeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhh
Q 038671 579 EAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLE 655 (707)
Q Consensus 579 ~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 655 (707)
.+||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... .
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~ 247 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------E 247 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------H
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH--------H
Confidence 999999999976543321 1223456889999999998889999999999999999999 8999864221 1
Q ss_pred hhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 656 IALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...........+... ...+..+.+++.+||+.||++|||+.++++.|+
T Consensus 248 ~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~ 295 (322)
T 1p4o_A 248 QVLRFVMEGGLLDKP---DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295 (322)
T ss_dssp HHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred HHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 222222222222111 123345889999999999999999999999875
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=367.56 Aligned_cols=206 Identities=27% Similarity=0.272 Sum_probs=155.0
Q ss_pred CCCcEEEcCCCccCCC--CchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCc-cccCCCCcccE
Q 038671 146 PKLGTLDFSSNNITGS--MPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLS-LELGSLTQLER 222 (707)
Q Consensus 146 ~~L~~L~L~~n~i~~~--~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~ 222 (707)
++|++|++++|.+++. .+..+..+++|+.|++++|.++ ..|..+..+++|++|++++|.+.+..+ ..+..+++|++
T Consensus 350 ~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 428 (606)
T 3vq2_A 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLY 428 (606)
T ss_dssp TTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCE
T ss_pred CCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCE
Confidence 3444444444444433 1455556666666666666665 344667777777777777777776655 56778888888
Q ss_pred EEccCCccCCCCCccccCcccCceEeeecccccc-cCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccc
Q 038671 223 LDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIK-KIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNN 301 (707)
Q Consensus 223 L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~ 301 (707)
|++++|.+++..|..+.++++|++|++++|.+.+ ..+..+..+++|+.|++++|.+++..|..+..+++|+.|++++|+
T Consensus 429 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 508 (606)
T 3vq2_A 429 LDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNN 508 (606)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCc
Confidence 8888888887778888888888888888888876 367778888889999999998888888888888999999999999
Q ss_pred cCCchhHhhccCCCceeEeeccCcccccCCCccccc-cCchhhcccCcCcCC
Q 038671 302 LSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFR-DAPMEALQGNKGLCG 352 (707)
Q Consensus 302 i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~~-~~~~~~~~~~~~~c~ 352 (707)
+++..|..+..+++|+.|++++|+++..++....+. ......+.+|+..|.
T Consensus 509 l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~ 560 (606)
T 3vq2_A 509 LLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI 560 (606)
T ss_dssp CSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCS
T ss_pred CCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccC
Confidence 988888888888999999999999886665544443 366677888888773
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=356.21 Aligned_cols=251 Identities=26% Similarity=0.445 Sum_probs=201.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|+||.||+|..+++..||||++..... ..+++.+|++++++++||||+++++++.+ +..++||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 467889999999999999999888888899999875432 24678999999999999999999999876 6789999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 999999999999642 234589999999999999999999999 9999999999999999999999999999876533
Q ss_pred CC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhc-CCCCCCCCc
Q 038671 595 SS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEML-DPRLPTPSH 671 (707)
Q Consensus 595 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 671 (707)
.. ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+. ..+++.+.
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~~~~~~~~- 404 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMPCPP- 404 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCCT-
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCC-
Confidence 21 1223456788999999998899999999999999999999 9999864321 11111111 12233222
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+..+.+++.+||+.||++|||++++++.|+
T Consensus 405 ---~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~ 436 (452)
T 1fmk_A 405 ---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 436 (452)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 23456889999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.73 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=208.1
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEcC-CC-----cEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeee
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAELP-SG-----EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCS 505 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 505 (707)
...++|++.+.||+|+||.||+|... ++ ..||+|++..... ....+.+.+|+++++++ +||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34578999999999999999999643 23 4799999876432 23457789999999999 8999999999999
Q ss_pred cCCceeEEEeeeccCcHHHHHhcccc-----------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDAA-----------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL 574 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~ 574 (707)
..+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+. ||+||||||+||++
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 99999999999999999999865321 24579999999999999999999999 99999999999999
Q ss_pred cCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccccc
Q 038671 575 DLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSS 651 (707)
Q Consensus 575 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~ 651 (707)
+.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|+| |..||..... .
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~ 273 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV----N 273 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS----S
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch----h
Confidence 99999999999999866443322 233457889999999998889999999999999999999 9999864321 1
Q ss_pred chhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 652 SNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...............+. ..+..+.+++.+||+.||.+|||+.++++.|+
T Consensus 274 ~~~~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 322 (333)
T 2i1m_A 274 SKFYKLVKDGYQMAQPA------FAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322 (333)
T ss_dssp HHHHHHHHHTCCCCCCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCC------CCCHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence 11222222222211111 12345889999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=338.46 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=208.6
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence 456799999999999999999965 458899999986532 245678899999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||.+....
T Consensus 87 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999996533 35589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCC
Q 038671 593 PDSS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670 (707)
Q Consensus 593 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (707)
.... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ............. ..+.
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~~~~~~~~~~~~~--~~~~ 235 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKDYRM--ERPE 235 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHHHTTCCC--CCCT
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhccCCC--CCCC
Confidence 4332 2233456788999999998899999999999999999999 9999864321 1111222221111 1111
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+..+.+++.+||+.||++||+++++++.|+
T Consensus 236 ----~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~ 267 (288)
T 3kfa_A 236 ----GCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 267 (288)
T ss_dssp ----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence 22355899999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=359.41 Aligned_cols=253 Identities=25% Similarity=0.422 Sum_probs=207.5
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
..+|++.+.||+|+||.||+|..+ +++.||||++..... ..+++.+|++++++++||||+++++++...+..++|
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 356888999999999999999665 488999999875422 356789999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+.+|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 295 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp EECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999997533 34589999999999999999999999 999999999999999999999999999987653
Q ss_pred CCC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 594 DSS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 594 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .......... .++..+.
T Consensus 371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~--~~~~~~~- 442 (495)
T 1opk_A 371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVYELLEKD--YRMERPE- 442 (495)
T ss_dssp CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHHHHHHTT--CCCCCCT-
T ss_pred CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcC--CCCCCCC-
Confidence 321 1223345778999999998889999999999999999999 9999864322 1111112211 1222222
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.||++|||+.++++.|+
T Consensus 443 ---~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~ 474 (495)
T 1opk_A 443 ---GCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 474 (495)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 23345889999999999999999999999885
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=329.58 Aligned_cols=251 Identities=23% Similarity=0.418 Sum_probs=204.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.. +..++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 86 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence 467899999999999999999888888999999875432 34678899999999999999999999864 5689999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++++|.+++.... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||.+......
T Consensus 87 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred ecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 9999999999986432 23589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC-CCCCCCc
Q 038671 595 SS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP-RLPTPSH 671 (707)
Q Consensus 595 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 671 (707)
.. ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ......+... ....+.
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~- 233 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--------PEVIQNLERGYRMVRPD- 233 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCCT-
T ss_pred ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--------HHHHHHHhcccCCCCcc-
Confidence 21 1233456788999999988889999999999999999999 9999864221 1111111111 111111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.||++|||++++++.|+
T Consensus 234 ---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 265 (279)
T 1qpc_A 234 ---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (279)
T ss_dssp ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---cccHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 23356899999999999999999999999875
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=341.95 Aligned_cols=252 Identities=23% Similarity=0.356 Sum_probs=197.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCC--CceeeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH--RNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~l 512 (707)
.++|++.+.||+|+||.||++...+++.||+|++..... .....+.+.+|+.++.+++| |||+++++++..++..++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 457999999999999999999888899999999875433 23345778999999999976 999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||| +.+++|.+++... +.+++..++.++.||+.||+|||+. ||+||||||+||+++ ++.+||+|||++....
T Consensus 87 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 5678999999653 4589999999999999999999999 999999999999997 6889999999998765
Q ss_pred CCCC--CccccccccCCCCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhh
Q 038671 593 PDSS--NWAELAGTYGYVAPELAYT-----------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN 659 (707)
Q Consensus 593 ~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 659 (707)
.... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..... ......
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~ 231 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLH 231 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-------HHHHHH
Confidence 4432 2235679999999999865 6688999999999999999999999963211 111222
Q ss_pred hhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 660 EMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...++........ ..+.++.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~--~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 232 AIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhcCCcccCCcc--cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 2222222111000 112358899999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=331.42 Aligned_cols=250 Identities=26% Similarity=0.429 Sum_probs=208.1
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.+.|++.+.||+|+||.||+|. ..+++.||+|++...... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 4569999999999999999995 567999999998754322 2457789999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||.+.....
T Consensus 99 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp EECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred EEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence 999999999999853 3589999999999999999999999 999999999999999999999999999988765
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.........|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...........+..+.
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~----- 241 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-----KVLFLIPKNNPPTLEG----- 241 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSCCCCCCS-----
T ss_pred cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-----HHHHHhhcCCCCCCcc-----
Confidence 544445567999999999999988999999999999999999999998643211 1111111111111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+..+.+++.+||+.||++|||+.++++.
T Consensus 242 -~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 242 -NYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -SCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -ccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 223458899999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=351.23 Aligned_cols=261 Identities=18% Similarity=0.251 Sum_probs=198.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCC------CcEEEEEecCCCCCchhhh--------HHHHHHHHHHHhcCCCCceeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPS------GEIVAVKKFHSPLPSEMAS--------QQEFLNEVKTLTGIRHRNIVKF 500 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~~ 500 (707)
.++|++.+.||+|+||.||+|..+. ++.||+|++.........+ ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4589999999999999999997654 4789999986543211111 1124456667788899999999
Q ss_pred eeeeecC----CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec-
Q 038671 501 YGFCSHA----RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD- 575 (707)
Q Consensus 501 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~- 575 (707)
++++... ...++||||+ +++|.+++... ...+++..++.++.||+.||+|||+. ||+||||||+||+++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEec
Confidence 9998764 4589999999 99999999643 35699999999999999999999999 999999999999999
Q ss_pred -CCCCeEEeccccceecCCCCC-------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccc
Q 038671 576 -LENEAHVSDFGTAKFLKPDSS-------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI 647 (707)
Q Consensus 576 -~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 647 (707)
.++.+||+|||+++.+..... ......||+.|+|||.+.+..++.++||||||+++|||+||+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 889999999999987653321 123446999999999999999999999999999999999999999742211
Q ss_pred ccccc----hhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 648 SSSSS----NLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 648 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..... ..........++.++. ...+.++.+++..||+.||++||+++++++.|+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~ 325 (364)
T 3op5_A 268 PKYVRDSKIRYRENIASLMDKCFPA-----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325 (364)
T ss_dssp HHHHHHHHHHHHHCHHHHHHHHSCT-----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHhhhhHHHHHHHhccc-----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence 00000 0001111111111111 112346899999999999999999999998874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=336.21 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=203.0
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
+.++|++.+.||+|+||.||+++. .+|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 456799999999999999999965 5799999999875422 234568899999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---cCCCCeEEeccccce
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL---DLENEAHVSDFGTAK 589 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~---~~~~~~kl~Dfg~~~ 589 (707)
||||+++++|.+++... +.+++..++.++.|++.||+|||+. |++||||||+||++ +.++.+||+|||++.
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 84 VMQLVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp EECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred EEEcCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 99999999999998543 3589999999999999999999999 99999999999999 778899999999997
Q ss_pred ecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
..... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+.......+
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~~~~ 227 (304)
T 2jam_A 158 MEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLFEKIKEGYYEFE 227 (304)
T ss_dssp CCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHCCCCCC
T ss_pred ecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCCCC
Confidence 54322 23445789999999999998999999999999999999999999863221 111122222221111
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.......+.++.+++.+||+.||++||+++|+++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1122234456899999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=341.19 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=198.4
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcE----EEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEI----VAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
++|++.+.||+|+||.||+|.. .+++. ||+|++...... .....+.+|+..+++++||||+++++++. ++..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR--QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC--SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 5789999999999999999964 44543 888887543221 12345678999999999999999999986 4668
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++||||+.+|+|.+++... ...+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++.
T Consensus 90 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 8999999999999999654 24689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 591 LKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 591 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ............ ..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~~~--~~ 237 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----AEVPDLLEKGER--LA 237 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----THHHHHHHTTCB--CC
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----HHHHHHHHcCCC--CC
Confidence 654432 2344567889999999998899999999999999999999 9999974321 111122222111 11
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.. .+.++.+++.+||+.||.+||++.++++.|+
T Consensus 238 ~~~~----~~~~~~~li~~~l~~dp~~Rps~~el~~~l~ 272 (325)
T 3kex_A 238 QPQI----CTIDVYMVMVKCWMIDENIRPTFKELANEFT 272 (325)
T ss_dssp CCTT----BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred CCCc----CcHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111 2234788999999999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=330.90 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=197.5
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|.. .+++.+|+|++..... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence 35799999999999999999954 5789999999865422 22456789999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---cCCCCeEEeccccce
Q 038671 514 YEYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL---DLENEAHVSDFGTAK 589 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~---~~~~~~kl~Dfg~~~ 589 (707)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+. ||+||||||+||++ +.++.+||+|||++.
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 99999999999885432 235689999999999999999999999 99999999999999 456789999999997
Q ss_pred ecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
...... ......|++.|+|||.+. ..++.++||||||+++|+|++|+.||..... ...... .....+.....
T Consensus 176 ~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-----~~~~~~-~~~~~~~~~~~ 247 (285)
T 3is5_A 176 LFKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-----EEVQQK-ATYKEPNYAVE 247 (285)
T ss_dssp C-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH-HHHCCCCCCC-
T ss_pred ecCCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-----HHHHhh-hccCCcccccc
Confidence 655432 234567899999999876 4689999999999999999999999964221 111111 11111111111
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
. ...+.++.+++.+||+.||++|||+.|+++
T Consensus 248 ~---~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 C---RPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred c---CcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 112345889999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=368.88 Aligned_cols=252 Identities=20% Similarity=0.285 Sum_probs=210.2
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCcee
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 511 (707)
..++|++.+.||+|+||.||+|+. .+++.||||++...........+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 457899999999999999999954 56889999998643222223446678899999988 6999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||+.||+|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 999999999999999653 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
..........+||+.|+|||++.+..++.++||||||+++|||++|+.||... ........+.......+..
T Consensus 493 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~--------~~~~~~~~i~~~~~~~p~~ 564 (674)
T 3pfq_A 493 IWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE--------DEDELFQSIMEHNVAYPKS 564 (674)
T ss_dssp CCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHSSCCCCCTT
T ss_pred ccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC--------CHHHHHHHHHhCCCCCCcc
Confidence 55555566778999999999999999999999999999999999999999632 2223334444444433322
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCH-----HHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTI-----QKVSQ 703 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~-----~~l~~ 703 (707)
.+.++.+++.+||+.||++||++ +|+++
T Consensus 565 ----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 565 ----MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----SCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----CCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 33458899999999999999997 66654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=345.95 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=198.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC--CCceeeeeeeeecCCceeEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR--HRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv 513 (707)
++|++.+.||+|+||.||+|...+++.||||++..... .....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 45999999999999999999888899999999875433 2345677999999999996 59999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|| +.+++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++ ++.+||+|||+++....
T Consensus 135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 6788999999653 3588999999999999999999999 999999999999996 68999999999987654
Q ss_pred CCC--CccccccccCCCCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 594 DSS--NWAELAGTYGYVAPELAYT-----------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 594 ~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
... .....+||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .......
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~~~ 279 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLHA 279 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HHHHHHH
Confidence 332 2344679999999999865 3688899999999999999999999963211 1112222
Q ss_pred hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
+.++........ ..+.++.+++.+||+.||++||++.|+++.
T Consensus 280 ~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 IIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCccccCCCCc--cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 333222111100 113458899999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=329.45 Aligned_cols=252 Identities=24% Similarity=0.351 Sum_probs=203.2
Q ss_pred cCCCCCc-eeeecCCeeEEEEEc---CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEH-CIGKGGQGSVYKAEL---PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~-~lg~G~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
++|.+.+ .||+|+||.||+|.. .+++.||+|++.... .....+.+.+|++++++++||||+++++++ ..+..+
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence 4566665 899999999999964 367889999997642 334567799999999999999999999999 456789
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhC--CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 999999999999999643 34589999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCC---ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 592 KPDSSN---WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 592 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ............+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~i~~~~~~~~- 234 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQGKRMEC- 234 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HHHHHHHHTTCCCCC-
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHhcCCcCCC-
Confidence 544322 223356789999999988889999999999999999998 9999964322 111111211111111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+. ..+.++.+++.+||+.||++||++.++++.|+
T Consensus 235 -~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 235 -PP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp -CT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -CC----CcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11 23456899999999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=358.69 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=204.6
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCch----------hhhHHHHHHHHHHHhcCCCCceeeeee
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSE----------MASQQEFLNEVKTLTGIRHRNIVKFYG 502 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~----------~~~~~~~~~e~~~l~~l~h~niv~~~~ 502 (707)
+.++|++.+.||+|+||+||+|.. .+++.||+|++....... ....+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 467899999999999999999964 568999999987543221 123567899999999999999999999
Q ss_pred eeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC---C
Q 038671 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN---E 579 (707)
Q Consensus 503 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~---~ 579 (707)
++.+++..++||||+.+|+|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 999999999999999999999988643 4589999999999999999999999 999999999999998776 6
Q ss_pred eEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhh
Q 038671 580 AHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN 659 (707)
Q Consensus 580 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 659 (707)
+||+|||++...... .......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||.... ......
T Consensus 188 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~ 257 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN--------DQDIIK 257 (504)
T ss_dssp EEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred EEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence 999999999876543 23445679999999999874 59999999999999999999999996422 122233
Q ss_pred hhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 660 EMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+.......+.......+.++.+++.+||+.||.+|||++|+++
T Consensus 258 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 258 KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 33333332222222234566899999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=329.04 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=199.6
Q ss_pred CCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
+|.....||+|+||.||+|. ..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 45556689999999999995 56789999999875422 245678899999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC-CCCeEEeccccceecCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL-ENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~-~~~~kl~Dfg~~~~~~~~ 594 (707)
|+++++|.+++........+++..++.++.|++.||+|||+. |++||||||+||+++. ++.+||+|||.+......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999997654444577899999999999999999999 9999999999999987 899999999999876654
Q ss_pred CCCccccccccCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 595 SSNWAELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
........|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .............+..+.
T Consensus 177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~---- 249 (295)
T 2clq_A 177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP---QAAMFKVGMFKVHPEIPE---- 249 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH---HHHHHHHHHHCCCCCCCT----
T ss_pred CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch---hHHHHhhccccccccccc----
Confidence 44345567899999999987654 788999999999999999999998632211 001111111111222221
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+.++.+++.+||+.||++||++.++++
T Consensus 250 --~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 250 --SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp --TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred --cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22345889999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=338.01 Aligned_cols=263 Identities=25% Similarity=0.402 Sum_probs=198.8
Q ss_pred HHHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC--CCCceeeeeeeeecC--
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI--RHRNIVKFYGFCSHA-- 507 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~-- 507 (707)
....++|++.+.||+|+||.||+|+.. ++.||||++... .......|.+++... +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 445678999999999999999999875 899999998532 223444555555544 899999999999876
Q ss_pred --CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeeecCCCCe
Q 038671 508 --RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC-----FPPIVHRDISSKNVLLDLENEA 580 (707)
Q Consensus 508 --~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlk~~Nil~~~~~~~ 580 (707)
...++||||+++|+|.++++. ..+++..++.++.|++.||+|||+.+ .+||+||||||+||+++.++.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred CCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence 678999999999999999964 25899999999999999999999762 2389999999999999999999
Q ss_pred EEeccccceecCCCCCC----ccccccccCCCCccccccCCCCcc------chhHHHHHHHHHHHhC----------CCC
Q 038671 581 HVSDFGTAKFLKPDSSN----WAELAGTYGYVAPELAYTMKVTEK------CDVYSFGVLALEVIKG----------KHP 640 (707)
Q Consensus 581 kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~------~Dv~slG~~l~el~tg----------~~p 640 (707)
||+|||++......... .....||+.|+|||.+.+..++.+ +||||||+++|||++| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 99999999876543322 124579999999999987766655 9999999999999999 555
Q ss_pred CCcccccccccchhhh-hhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 641 RDFISSISSSSSNLEI-ALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
|............... .......+..+.. ......+.++.+++.+||+.||++|||+.++++.|+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 327 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNR-WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGG-GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HhhhcCCCCchhhhHHHHhhhccCcccccc-chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence 5432221111111111 1111111222111 112356778999999999999999999999999885
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.69 Aligned_cols=252 Identities=27% Similarity=0.472 Sum_probs=198.4
Q ss_pred cCCCCCceeeecCCeeEEEEEcCC-----CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPS-----GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
.+|++.+.||+|+||.||+|.... +..||+|++.... .......+.+|++++++++||||+++++++...+..
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 467778999999999999996432 3469999987543 233456789999999999999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++||||+++++|.+++... ...+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++..
T Consensus 122 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999999643 34689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC-C
Q 038671 591 LKPDSSN---WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP-R 665 (707)
Q Consensus 591 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 665 (707)
....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+... +
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~~~ 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAINDGFR 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTCC
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHCCCc
Confidence 6543221 122345778999999998889999999999999999999 9999863221 1112222221 2
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.+. ..+.++.+++.+||+.||++||++.++++.|+
T Consensus 269 ~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 305 (333)
T 1mqb_A 269 LPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILD 305 (333)
T ss_dssp CCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 22222 23445899999999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=346.18 Aligned_cols=255 Identities=22% Similarity=0.283 Sum_probs=202.1
Q ss_pred HHHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-----CCceeeeeeeee
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-----HRNIVKFYGFCS 505 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~ 505 (707)
..+.++|++.+.||+|+||.||+|+. .+++.||||++... ......+..|+.+++.++ ||||+++++++.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 34568899999999999999999954 67899999998642 234456778999999886 999999999999
Q ss_pred cCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC---------
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL--------- 576 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~--------- 576 (707)
..+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+. ||+||||||+||+++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~ 181 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLIT 181 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEE
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccc
Confidence 999999999999 899999997543 23589999999999999999999999 9999999999999975
Q ss_pred ----------------CCCeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 038671 577 ----------------ENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640 (707)
Q Consensus 577 ----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p 640 (707)
++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp EECTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred hhcccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 789999999999875432 2346789999999999999999999999999999999999999
Q ss_pred CCcccccccccchhhhhhhhhcC-------------------------CCCCCCCcchHH--------------HHHHHH
Q 038671 641 RDFISSISSSSSNLEIALNEMLD-------------------------PRLPTPSHNVQD--------------KLISIM 681 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~--------------~~~~l~ 681 (707)
|....... ....+..... ...+........ ....+.
T Consensus 259 f~~~~~~~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 333 (360)
T 3llt_A 259 FRTHEHME-----HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFC 333 (360)
T ss_dssp CCCSSHHH-----HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHH
T ss_pred CCCCcHHH-----HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHH
Confidence 96422110 0000000000 001111110000 114578
Q ss_pred HHHHhccCCCCCCCCCHHHHHH
Q 038671 682 EVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 682 ~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+++.+||+.||++|||++|+++
T Consensus 334 ~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 334 DFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHhcCChhhCCCHHHHhc
Confidence 9999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=341.36 Aligned_cols=256 Identities=18% Similarity=0.277 Sum_probs=191.9
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|+. .+++.||+|++...... .....+.+|++++++++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 5789999999999999999965 47899999998653221 11223557999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++ ++|.+++... ...+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++......
T Consensus 80 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp ECCS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cccc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 9998 5888887543 34589999999999999999999999 9999999999999999999999999999876555
Q ss_pred CCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhc-----------
Q 038671 595 SSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML----------- 662 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 662 (707)
........||+.|+|||.+.+ ..++.++||||+|+++|+|++|+.||....... ..........
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE----QLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTGG
T ss_pred ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHhchhhh
Confidence 444555678999999999876 568999999999999999999999996432110 0111111000
Q ss_pred ---------CCCCCCC--CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 663 ---------DPRLPTP--SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 663 ---------~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+..... ....+..+.++.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000 0001122356889999999999999999999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.61 Aligned_cols=259 Identities=20% Similarity=0.306 Sum_probs=195.5
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA------ 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------ 507 (707)
.++|++.+.||+|+||.||+|. ..+|+.||||++..... .....+.+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 5789999999999999999995 56799999999875422 233456788999999999999999999999654
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
...|+||||++++ +.+.+. ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 3569999999865 555553 2388999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchh-------------
Q 038671 588 AKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL------------- 654 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~------------- 654 (707)
++..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+.........
T Consensus 211 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~ 289 (464)
T 3ttj_A 211 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 289 (464)
T ss_dssp C-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred eeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 9876533 23455689999999999999999999999999999999999999997432211000000
Q ss_pred -hhhhhhhcCCC----------------CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 655 -EIALNEMLDPR----------------LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 655 -~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
........... .+.........+.++.+++.+||..||++|||++|+++.
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000001100 011111112235678999999999999999999999863
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=340.78 Aligned_cols=262 Identities=23% Similarity=0.326 Sum_probs=198.3
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchh--hhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEM--ASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
...++|++.+.||+|+||.||+|... +|+.||+|++........ ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 44578999999999999999999764 689999999875332211 112467899999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++||||+++ +|.+++... ...+++..++.++.|+++||+|||+. ||+||||||+||+++.++.+||+|||++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999986 888888543 34688999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC----
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP---- 664 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 664 (707)
.............||+.|+|||.+.+. .++.++||||||+++|+|++|.+||....... ...........+
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~----~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRIFETLGTPTEEQ 236 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCTTT
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHcCCCChhh
Confidence 776555455567899999999998764 47899999999999999999999986432211 111111111000
Q ss_pred --------------CCCCCC--cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 665 --------------RLPTPS--HNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 665 --------------~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..+... ......+.++.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000 0001233568999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=330.56 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=196.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|... +|+.||+|++...........+.+.+|++.++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 468999999999999999999654 7999999998643222223356788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++... ..+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||.+.....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 9999999999998643 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCCccccccccCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
.. ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||+... .......+.......+..
T Consensus 164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~- 233 (276)
T 2h6d_A 164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTLFKKIRGGVFYIPEY- 233 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCTT-
T ss_pred Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHhhcCcccCchh-
Confidence 32 2344578999999999987765 689999999999999999999986321 111122222222222221
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.+.++.+++.+||+.||.+|||+.++++.
T Consensus 234 ---~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 234 ---LNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 23458899999999999999999999863
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=341.95 Aligned_cols=263 Identities=18% Similarity=0.286 Sum_probs=206.3
Q ss_pred HHHHHHHhcCCCCC-ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeee
Q 038671 428 YEEIIRVTNDFDDE-HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFC 504 (707)
Q Consensus 428 ~~~~~~~~~~~~~~-~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~ 504 (707)
++....+.++|.+. +.||+|+||.||+|.. .+++.||+|++...... ......+.+|+.++..++ ||||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 33445667788887 8899999999999954 57999999998754322 224567889999999995 79999999999
Q ss_pred ecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC---CCCeE
Q 038671 505 SHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL---ENEAH 581 (707)
Q Consensus 505 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~---~~~~k 581 (707)
.+.+..++||||+.+++|.+++... ....+++..++.++.|++.||+|||++ ||+||||||+||+++. ++.+|
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 9999999999999999999988543 235689999999999999999999999 9999999999999987 78999
Q ss_pred EeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhh
Q 038671 582 VSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM 661 (707)
Q Consensus 582 l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 661 (707)
|+|||++....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ......+
T Consensus 175 L~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i 245 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN--------QETYLNI 245 (327)
T ss_dssp ECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred EeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------hHHHHHH
Confidence 99999998765432 23446799999999999999999999999999999999999999964221 1111111
Q ss_pred cCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 662 LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.......+.......+..+.+++.+||+.||++|||++++++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 246 SQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111111111222334568899999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=357.46 Aligned_cols=252 Identities=25% Similarity=0.364 Sum_probs=201.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|+. .+++.||+|++....... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45799999999999999999965 578999999987543222 2346788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC---CCeEEecccccee
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE---NEAHVSDFGTAKF 590 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~---~~~kl~Dfg~~~~ 590 (707)
|||+.+|+|.+.+... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.. +.+||+|||++..
T Consensus 115 ~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 9999999999888543 4589999999999999999999999 99999999999999764 4599999999987
Q ss_pred cCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCC
Q 038671 591 LKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670 (707)
Q Consensus 591 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (707)
..... ......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||..... ......+.......+.
T Consensus 189 ~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~~ 258 (494)
T 3lij_A 189 FENQK-KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEILRKVEKGKYTFDS 258 (494)
T ss_dssp CBTTB-CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCCCS
T ss_pred CCCCc-cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCc
Confidence 65432 3345679999999998764 699999999999999999999999964221 2222223333333222
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
......+..+.+++.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 259 PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 223344566899999999999999999999885
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=337.45 Aligned_cols=263 Identities=23% Similarity=0.379 Sum_probs=210.0
Q ss_pred HHHHHHhcCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeee
Q 038671 429 EEIIRVTNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFY 501 (707)
Q Consensus 429 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~ 501 (707)
..+....++|++.+.||+|+||.||+|+. .+++.||+|++..... ....+.+.+|++++.++ +||||++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCC--cHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 34444568899999999999999999963 4578999999876432 23456789999999999 699999999
Q ss_pred eeeecCC-ceeEEEeeeccCcHHHHHhcccc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCC
Q 038671 502 GFCSHAR-HSFIVYEYLEMGSLAMILSNDAA-------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDI 567 (707)
Q Consensus 502 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dl 567 (707)
+++...+ ..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+. ||+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence 9987654 58999999999999999975432 12278999999999999999999999 9999999
Q ss_pred CCCCeeecCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcc
Q 038671 568 SSKNVLLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFI 644 (707)
Q Consensus 568 k~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~ 644 (707)
||+||+++.++.+||+|||++......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999999999999999999876544322 234567889999999999899999999999999999998 99998643
Q ss_pred cccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 645 SSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.. ................+ .. .+..+.+++.+||+.||.+|||+.++++.|+
T Consensus 255 ~~----~~~~~~~~~~~~~~~~~--~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 306 (316)
T 2xir_A 255 KI----DEEFCRRLKEGTRMRAP--DY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306 (316)
T ss_dssp CC----SHHHHHHHHHTCCCCCC--TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ch----hHHHHHHhccCccCCCC--CC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 21 11122222222222222 11 2345889999999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=337.51 Aligned_cols=260 Identities=25% Similarity=0.361 Sum_probs=206.6
Q ss_pred hcCCCCCceeeecCCeeEEEEE-----cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeee--cC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-----LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCS--HA 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~ 507 (707)
.++|++.+.||+|+||.||+|+ ..+++.||+|++... .....+.+.+|++++++++||||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 3679999999999999999997 356889999998754 2234567899999999999999999999886 45
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||.
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred ceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence 66899999999999999996432 3589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC---CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc-------cccchhhhh
Q 038671 588 AKFLKPDSS---NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIS-------SSSSNLEIA 657 (707)
Q Consensus 588 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-------~~~~~~~~~ 657 (707)
+........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .........
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 987654432 1233457888999999999889999999999999999999999985322100 001111111
Q ss_pred hhhhcCCC-CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 658 LNEMLDPR-LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 658 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
........ .+.+ ...+.++.+++.+||+.||++|||++++++.|+
T Consensus 254 ~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 299 (327)
T 3lxl_A 254 LELLEEGQRLPAP----PACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299 (327)
T ss_dssp HHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhhcccCCCCC----CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 22222111 1111 123456899999999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=337.91 Aligned_cols=261 Identities=19% Similarity=0.320 Sum_probs=199.9
Q ss_pred hcCCCCC-ceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCcee
Q 038671 435 TNDFDDE-HCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 435 ~~~~~~~-~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 511 (707)
.+.|++. +.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++.++ +||||+++++++.+++..+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4678884 7899999999999964 5799999999875422 2356788999999885 7999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC---eEEeccccc
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE---AHVSDFGTA 588 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~---~kl~Dfg~~ 588 (707)
+||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++. +||+|||++
T Consensus 88 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~ 161 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG 161 (316)
T ss_dssp EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred EEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence 999999999999999653 4589999999999999999999999 9999999999999998776 999999999
Q ss_pred eecCCCC-------CCccccccccCCCCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCcccccccc------
Q 038671 589 KFLKPDS-------SNWAELAGTYGYVAPELAYT-----MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS------ 650 (707)
Q Consensus 589 ~~~~~~~-------~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------ 650 (707)
....... .......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 241 (316)
T 2ac3_A 162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241 (316)
T ss_dssp C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence 7654221 11233468999999999875 45889999999999999999999999643221100
Q ss_pred -cchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 651 -SSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 651 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..........+.......+.......+.++.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000111222222333322211112234568999999999999999999999873
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=339.74 Aligned_cols=259 Identities=20% Similarity=0.292 Sum_probs=192.9
Q ss_pred HHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
...++|++.+.||+|+||.||+|. ..+++.||+|++..... .......+.+|++++++++||||+++++++.+++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 445789999999999999999995 56799999999975432 2233456789999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec-----CCCCeEEeccc
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD-----LENEAHVSDFG 586 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~-----~~~~~kl~Dfg 586 (707)
+||||+++ +|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++ .++.+||+|||
T Consensus 110 lv~e~~~~-~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAEN-DLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCSE-EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCCC-CHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99999985 899988643 3489999999999999999999999 999999999999994 44569999999
Q ss_pred cceecCCCCCCccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC-
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP- 664 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~- 664 (707)
++..............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....... ...........+
T Consensus 183 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 183 LARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID----QLFKIFEVLGLPD 258 (329)
T ss_dssp HHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCC
T ss_pred CccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH----HHHHHHHHhCCCc
Confidence 9987765544455567899999999988744 7999999999999999999999996432211 111111110000
Q ss_pred ---------------CCCCCC-cchH-----HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 665 ---------------RLPTPS-HNVQ-----DKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 665 ---------------~~~~~~-~~~~-----~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+... .... ..+.++.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000 0000 12356889999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=337.16 Aligned_cols=253 Identities=24% Similarity=0.444 Sum_probs=196.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCc----EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
.++|++.+.||+|+||.||+|.. .+++ +|++|.+..... ....+.+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence 46799999999999999999964 4454 357777754322 234577899999999999999999999998754
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++++||+.+|+|.+++... ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ceEEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 78999999999999999643 34589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 590 FLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 590 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||+.... .......... ...
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~~~~~~~~~--~~~ 238 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEKG--ERL 238 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGHHHHHHTT--CCC
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcC--CCC
Confidence 76543222 233456788999999999999999999999999999999 9999974322 1111122111 122
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.+.. .+.++.+++.+||+.||.+||++.|+++.|+
T Consensus 239 ~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 274 (327)
T 3lzb_A 239 PQPPI----CTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp CCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 22222 2345889999999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.99 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=202.4
Q ss_pred CCCCceeeecCCeeEEEEEc-----CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC--Cce
Q 038671 438 FDDEHCIGKGGQGSVYKAEL-----PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA--RHS 510 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~ 510 (707)
|++.+.||+|+||.||++.. .+++.||+|++.... .....+.+.+|++++++++||||+++++++.+. ...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 110 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL 110 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence 48999999999999988843 368899999997653 233567799999999999999999999999874 578
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++||||+++++|.+++... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++..
T Consensus 111 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 111 QLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 9999999999999998643 389999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCCC---ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccc-------ccccchhhhhhhh
Q 038671 591 LKPDSSN---WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI-------SSSSSNLEIALNE 660 (707)
Q Consensus 591 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-------~~~~~~~~~~~~~ 660 (707)
....... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .............
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence 7644321 23346788899999999988999999999999999999999998632110 0000001111111
Q ss_pred hcCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 661 MLDP-RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 661 ~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.... ..+.+. ..+.++.+++.+||+.||++|||++++++.|+
T Consensus 264 ~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 306 (318)
T 3lxp_A 264 LERGERLPRPD----KCPAEVYHLMKNCWETEASFRPTFENLIPILK 306 (318)
T ss_dssp HHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HhcccCCCCCc----cccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1111 112221 23456899999999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.38 Aligned_cols=259 Identities=24% Similarity=0.369 Sum_probs=191.7
Q ss_pred HHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCC--
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHAR-- 508 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~-- 508 (707)
...++|++.+.||+|+||.||+|. ..+|+.||+|++...... ......+.+|+.++.++. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN-STDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccC-hHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 456899999999999999999995 567999999998654333 334567889999999997 999999999997544
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
..|+||||++ ++|..++.. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 6899999998 588888864 3589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCC---------------------CCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccc
Q 038671 589 KFLKPD---------------------SSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISS 646 (707)
Q Consensus 589 ~~~~~~---------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 646 (707)
+..... .......+||+.|+|||++.+ ..++.++||||+||++|||++|++||...+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 236 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST 236 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 875431 112334579999999999876 6689999999999999999999999964322
Q ss_pred cccccchhhhhhhhhcCCC--------------------------CCCCCcchH-------------HHHHHHHHHHHhc
Q 038671 647 ISSSSSNLEIALNEMLDPR--------------------------LPTPSHNVQ-------------DKLISIMEVAISC 687 (707)
Q Consensus 647 ~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~-------------~~~~~l~~li~~c 687 (707)
.. ...........+. ........+ ..+.++.+++.+|
T Consensus 237 ~~----~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~ 312 (388)
T 3oz6_A 237 MN----QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKL 312 (388)
T ss_dssp HH----HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHH
T ss_pred HH----HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHh
Confidence 11 1111110000000 000000000 1234688999999
Q ss_pred cCCCCCCCCCHHHHHHH
Q 038671 688 LDESPESRPTIQKVSQL 704 (707)
Q Consensus 688 l~~~P~~Rps~~~l~~~ 704 (707)
|..||++|||++|+++.
T Consensus 313 L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 313 LQFNPNKRISANDALKH 329 (388)
T ss_dssp CCSSGGGSCCHHHHTTS
T ss_pred hccCcccCCCHHHHhCC
Confidence 99999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=351.41 Aligned_cols=257 Identities=22% Similarity=0.304 Sum_probs=194.0
Q ss_pred HHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCc-----hhhhHHHHHHHHHHHhcCCCCceeeeeeeeec
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPS-----EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH 506 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 506 (707)
.+.++|++.+.||+|+||.||+|. ..+++.||+|++...... .......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 456899999999999999999995 567899999998643211 11122358899999999999999999999865
Q ss_pred CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC---CeEEe
Q 038671 507 ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN---EAHVS 583 (707)
Q Consensus 507 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~---~~kl~ 583 (707)
+..++||||+++++|.+++... +.+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 4578999999999999887543 4589999999999999999999999 999999999999997544 59999
Q ss_pred ccccceecCCCCCCccccccccCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 584 DFGTAKFLKPDSSNWAELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 584 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... ... ...
T Consensus 285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----~~~---~~~ 356 (419)
T 3i6u_A 285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSL---KDQ 356 (419)
T ss_dssp CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS----CCH---HHH
T ss_pred ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch----HHH---HHH
Confidence 99999876533 23345689999999999863 56788999999999999999999999642211 111 111
Q ss_pred hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
+...............+.++.+++.+||+.||++||+++|+++.
T Consensus 357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 22222222211222335568999999999999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=358.38 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=205.3
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
+.++|++.+.||+|+||+||+|.. .+++.||+|++...... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 446799999999999999999965 57999999998542111 1235678999999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec---CCCCeEEeccccce
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD---LENEAHVSDFGTAK 589 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~---~~~~~kl~Dfg~~~ 589 (707)
||||+.+++|.+.+... +.+++..++.++.||+.||+|||++ ||+||||||+||+++ .++.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 99999999999988543 4589999999999999999999999 999999999999995 45679999999998
Q ss_pred ecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
..... .......||+.|+|||++.+ .++.++||||+|+++|+|++|+.||.... .......+........
T Consensus 173 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~~~ 242 (486)
T 3mwu_A 173 CFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVETGKYAFD 242 (486)
T ss_dssp TBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCSC
T ss_pred ECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCC
Confidence 66543 23345679999999999876 49999999999999999999999996322 1222222333333322
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.......+.++.+++.+||+.||++|||+.++++.
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 22333445678999999999999999999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=343.44 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=191.0
Q ss_pred CCCCCceeeecCCeeEEEEEcC--CC--cEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeee-cCCcee
Q 038671 437 DFDDEHCIGKGGQGSVYKAELP--SG--EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCS-HARHSF 511 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~ 511 (707)
.|++.+.||+|+||.||+|... ++ ..||+|.+.... .....+.+.+|+.++++++||||+++++++. .++..+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 4667789999999999999643 22 468999986532 2345678999999999999999999999875 456889
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||+++++|.+++... ...+++..++.++.||++||+|||+. ||+||||||+||+++.++.+||+|||+++..
T Consensus 168 lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEEECCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEECCCCCCHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence 999999999999999643 34578999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCC----CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 592 KPDSS----NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 592 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |.+||...... . ....... ..+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~----~-~~~~~~~--~~~~ 315 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----D-ITVYLLQ--GRRL 315 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS----C-HHHHHHT--TCCC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH----H-HHHHHHc--CCCC
Confidence 43321 1233456788999999999999999999999999999999 67787643221 1 1111111 1122
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+. ..+..+.+++.+||+.||++||++.++++.|+
T Consensus 316 ~~p~----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 351 (373)
T 3c1x_A 316 LQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351 (373)
T ss_dssp CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 2222 12345889999999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.86 Aligned_cols=257 Identities=24% Similarity=0.377 Sum_probs=195.5
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcC----CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR- 508 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~- 508 (707)
..++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSS-QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCC-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccc-hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 3567889999999999999999543 3568999998754332 334567899999999999999999999997654
Q ss_pred ----ceeEEEeeeccCcHHHHHhcc---cccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeE
Q 038671 509 ----HSFIVYEYLEMGSLAMILSND---AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAH 581 (707)
Q Consensus 509 ----~~~lv~e~~~~~~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~k 581 (707)
..++||||+++++|.+++... .....+++..++.++.||++||+|||+. ||+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 359999999999999998432 2235689999999999999999999999 999999999999999999999
Q ss_pred EeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhh
Q 038671 582 VSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIAL 658 (707)
Q Consensus 582 l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 658 (707)
|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... . ...
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~---~~~ 259 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----H---EMY 259 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----G---GHH
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-----H---HHH
Confidence 999999987654321 1233457889999999999899999999999999999999 8999864322 1 111
Q ss_pred hhhcCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 659 NEMLDP-RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 659 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...... ....+. ..+.++.+++.+||+.||.+||++.++++.|+
T Consensus 260 ~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 304 (313)
T 3brb_A 260 DYLLHGHRLKQPE----DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304 (313)
T ss_dssp HHHHTTCCCCCBT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHcCCCCCCCc----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111111 111111 23346899999999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=330.76 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=199.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCC----CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeee-ecCCc
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPS----GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFC-SHARH 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~ 509 (707)
..+|++.+.||+|+||.||+|...+ +..+|+|++.... .....+.+.+|+.++++++||||+++++++ ..++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 4568889999999999999996432 2368999987542 334567789999999999999999999985 45668
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++.
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred eEEEEeCCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence 89999999999999999643 34589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCC----CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC
Q 038671 590 FLKPDS----SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP 664 (707)
Q Consensus 590 ~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 664 (707)
...... .......+|+.|+|||.+.+..++.++||||+|+++|+|++ |.+||..... ......... ..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-----~~~~~~~~~--~~ 249 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVYLLQ--GR 249 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-----TTHHHHHHT--TC
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH-----HHHHHHHhc--CC
Confidence 664332 11233467789999999999899999999999999999999 5566643221 111111111 11
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....+.. .+..+.+++.+||+.||++||++.++++.|+
T Consensus 250 ~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 287 (298)
T 3f66_A 250 RLLQPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287 (298)
T ss_dssp CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111 2345889999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=342.11 Aligned_cols=261 Identities=20% Similarity=0.251 Sum_probs=196.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC----CCcEEEEEecCCCCCchhh--------hHHHHHHHHHHHhcCCCCceeeeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMA--------SQQEFLNEVKTLTGIRHRNIVKFYG 502 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~ 502 (707)
.++|++.+.||+|+||.||+|... ++..+|+|+.......... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999654 5788999998765322111 1123667889999999999999999
Q ss_pred eeec----CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC
Q 038671 503 FCSH----ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN 578 (707)
Q Consensus 503 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~ 578 (707)
++.. ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+. ||+||||||+||+++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 9977 67899999999 999999986433 689999999999999999999999 999999999999999887
Q ss_pred --CeEEeccccceecCCCCC-------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccc
Q 038671 579 --EAHVSDFGTAKFLKPDSS-------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISS 649 (707)
Q Consensus 579 --~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~ 649 (707)
.+||+|||+++.+..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-- 266 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD-- 266 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC--
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc--
Confidence 999999999987643221 124457999999999999988999999999999999999999999532110
Q ss_pred ccchhhhhhhhhcCCCCCCCCc---chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 650 SSSNLEIALNEMLDPRLPTPSH---NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....... ........+.... .....+.++.+++.+||+.||++||+++++++.|+
T Consensus 267 -~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 324 (345)
T 2v62_A 267 -PVAVQTA-KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILN 324 (345)
T ss_dssp -HHHHHHH-HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred -cHHHHHH-HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 0111111 1111111110000 00023346999999999999999999999999886
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.01 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=197.1
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCc--hhhhHHHHHHHHHHHhcC---CCCceeeeeeeeecC
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPS--EMASQQEFLNEVKTLTGI---RHRNIVKFYGFCSHA 507 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~ 507 (707)
..++|++.+.||+|+||+||+|+. .+++.||+|++...... .......+.+|+..++++ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999965 57899999998632211 111123455666666666 599999999999765
Q ss_pred C-----ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEE
Q 038671 508 R-----HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV 582 (707)
Q Consensus 508 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl 582 (707)
. ..++||||+. ++|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 4 4799999997 599999875432 3489999999999999999999999 9999999999999999999999
Q ss_pred eccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhc
Q 038671 583 SDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML 662 (707)
Q Consensus 583 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 662 (707)
+|||++...... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ..........
T Consensus 162 ~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~ 236 (308)
T 3g33_A 162 ADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----QLGKIFDLIG 236 (308)
T ss_dssp CSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH----HHHHHHHHHC
T ss_pred eeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhC
Confidence 999999866533 23355688999999999999999999999999999999999999996432211 1111111100
Q ss_pred C---CCC---------------CCC-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 663 D---PRL---------------PTP-SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 663 ~---~~~---------------~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
. ..+ +.+ ....++.+.++.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0 000 000 00011234568899999999999999999999863
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=377.00 Aligned_cols=350 Identities=24% Similarity=0.240 Sum_probs=235.2
Q ss_pred CCCCceeeccCCeeeecCCccccCCCCCCeEECCCCcccc-ccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCee
Q 038671 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCG-SIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLL 80 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 80 (707)
.++|++|+|++|.|++..|..|+++++|++|+|++|.... +.|++|.++++|++|+|++|.|++..|.+|+++++|++|
T Consensus 23 p~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 102 (844)
T 3j0a_A 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFEL 102 (844)
T ss_dssp CTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCE
T ss_pred CCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEe
Confidence 3678888888888887778888888888888888884433 336778888888888888888887778888888888888
Q ss_pred eccccccccc-CCC--CCCCCCccEEEeccCccccccC-ccccCCCCCcEEEcccccccccCCCCCC-------------
Q 038671 81 TLENNQLRGP-IPN--LRNLTSLVRVRLNQNHLTGNIS-ESFGIHPNLAFIDLSHNYFYGEISSDWG------------- 143 (707)
Q Consensus 81 ~l~~n~i~~~-~~~--l~~l~~L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~L~~n~i~~~~~~~~~------------- 143 (707)
+|++|.+.+. +.. +.++++|++|+|++|.++++.+ ..|+.+++|++|+|++|.++.+.+..+.
T Consensus 103 ~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~ 182 (844)
T 3j0a_A 103 RLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLA 182 (844)
T ss_dssp ECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEEC
T ss_pred eCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECC
Confidence 8888887752 333 7778888888888888776644 4677777777777777776543222111
Q ss_pred -------------C------------------------------------------------------------------
Q 038671 144 -------------R------------------------------------------------------------------ 144 (707)
Q Consensus 144 -------------~------------------------------------------------------------------ 144 (707)
.
T Consensus 183 ~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~ 262 (844)
T 3j0a_A 183 ANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAG 262 (844)
T ss_dssp CSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTT
T ss_pred CCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhc
Confidence 1
Q ss_pred --CCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccE
Q 038671 145 --CPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLER 222 (707)
Q Consensus 145 --~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 222 (707)
.++|+.|+|++|.+++..+..|..+++|+.|+|++|.+++..+..|..+++|++|++++|.+++..+..|..+++|++
T Consensus 263 l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 342 (844)
T 3j0a_A 263 LARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342 (844)
T ss_dssp TTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCE
T ss_pred cccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCE
Confidence 133445555555554444555666677777777777777666667777777777777777777666777777777777
Q ss_pred EEccCCccCCCCCccccCcccCceEeeecccccccC----------------------------------------chhh
Q 038671 223 LDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKI----------------------------------------PVEL 262 (707)
Q Consensus 223 L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~----------------------------------------~~~~ 262 (707)
|++++|.++...+..|.++++|+.|+|++|.+++.. +..+
T Consensus 343 L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~ 422 (844)
T 3j0a_A 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFL 422 (844)
T ss_dssp EECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHH
T ss_pred EECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhh
Confidence 777777777666666777777777777777654321 0112
Q ss_pred hhcccCCeeeecCccCCCC------------------------------CCcccccccccceEeccccccCCchhHhhcc
Q 038671 263 EKLIHLSELDLSHNFLGEE------------------------------MPSQICNMQSLEKLNLSHNNLSGFIPSCFEE 312 (707)
Q Consensus 263 ~~l~~L~~L~l~~n~l~~~------------------------------~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~ 312 (707)
..+++|+.|+|++|.+++. .+..|..+++|+.|+|++|.+++..+..+..
T Consensus 423 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 502 (844)
T 3j0a_A 423 LRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSH 502 (844)
T ss_dssp TTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSS
T ss_pred hcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccc
Confidence 2445555555555555321 1234566777888888888888777777777
Q ss_pred CCCceeEeeccCcccccCCCcc--------------------ccccCchhhcccCcCcC
Q 038671 313 LHGLSYIDISYNELHGSIPNST--------------------AFRDAPMEALQGNKGLC 351 (707)
Q Consensus 313 ~~~L~~l~l~~n~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~c 351 (707)
+++|+.|++++|++++.++... .+.......+.+|++.|
T Consensus 503 l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C 561 (844)
T 3j0a_A 503 LTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFIC 561 (844)
T ss_dssp CCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCC
T ss_pred hhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEecCCCccc
Confidence 7777777777777776544321 12344456677888877
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=328.08 Aligned_cols=254 Identities=25% Similarity=0.354 Sum_probs=204.6
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
+.++|++.+.||+|+||.||+|.. .+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 456799999999999999999965 4789999999864322 2345678999999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||+++++|.+++... ..+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||.+....
T Consensus 83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp EEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEEecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 99999999999988543 4589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC--CCccccccccCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 593 PDS--SNWAELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 593 ~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
... .......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||+..... ...... .........
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~~~~~~~~ 229 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSD----WKEKKTYLN 229 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT---SHHHHH----HHTTCTTST
T ss_pred CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH---HHHHHH----hhhcccccC
Confidence 322 22344678999999999987665 77899999999999999999999743221 011111 111111110
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.....+..+.+++.+||+.||++|||++|+++.
T Consensus 230 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 230 --PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 112334568899999999999999999999863
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.37 Aligned_cols=253 Identities=23% Similarity=0.378 Sum_probs=200.6
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC----CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
.++|++.+.||+|+||.||+|... ++..||+|++.... .....+.+.+|+.++++++||||+++++++.+ +..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence 467999999999999999999643 23469999987643 23356779999999999999999999999865 457
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++||||+++++|.+++... ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||.+..
T Consensus 88 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 8999999999999999643 34589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 591 LKPDSS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 591 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... .......... ...+.
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-----~~~~~~~~~~--~~~~~ 235 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-----KDVIGVLEKG--DRLPK 235 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-----GGHHHHHHHT--CCCCC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-----HHHHHHHhcC--CCCCC
Confidence 654322 2233456889999999998889999999999999999998 9999864322 1111111111 11222
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.. .+..+.+++.+||+.||++||++.++++.|+
T Consensus 236 ~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 269 (281)
T 3cc6_A 236 PDL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269 (281)
T ss_dssp CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence 221 2345889999999999999999999999875
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=360.13 Aligned_cols=299 Identities=22% Similarity=0.225 Sum_probs=256.6
Q ss_pred CCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEccc
Q 038671 52 QITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSH 131 (707)
Q Consensus 52 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~ 131 (707)
+|++|++++|.+++..+..|+.+++|++|++++|.++.++..+..+++|++|++++|+++.+.+..+..+++|++|++++
T Consensus 255 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 334 (606)
T 3t6q_A 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKG 334 (606)
T ss_dssp EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCS
T ss_pred ceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCC
Confidence 34555555566665556668888999999999999998888899999999999999999988888899999999999999
Q ss_pred cccc-ccCCCCCCCCCCCcEEEcCCCccCCCC--chhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCcccc
Q 038671 132 NYFY-GEISSDWGRCPKLGTLDFSSNNITGSM--PAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCG 208 (707)
Q Consensus 132 n~i~-~~~~~~~~~~~~L~~L~L~~n~i~~~~--~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 208 (707)
|.+. .+.+..+..+++|++|++++|.+++.. +..+..+++|+.|++++|.+.+..+..|..+++|++|++++|.+++
T Consensus 335 n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 414 (606)
T 3t6q_A 335 NTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414 (606)
T ss_dssp CSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEEC
T ss_pred CCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCC
Confidence 9987 444556889999999999999998665 6778899999999999999988888899999999999999999986
Q ss_pred CCcc-ccCCCCcccEEEccCCccCCCCCccccCcccCceEeeeccccccc---CchhhhhcccCCeeeecCccCCCCCCc
Q 038671 209 QLSL-ELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKK---IPVELEKLIHLSELDLSHNFLGEEMPS 284 (707)
Q Consensus 209 ~~~~-~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~---~~~~~~~l~~L~~L~l~~n~l~~~~~~ 284 (707)
..+. .+..+++|++|++++|.+++..+..+..+++|++|++++|++.+. .+..+..+++|+.|++++|.+++..|.
T Consensus 415 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 494 (606)
T 3t6q_A 415 KDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494 (606)
T ss_dssp CTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTT
T ss_pred cccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChh
Confidence 6554 488999999999999999988888999999999999999998763 335688899999999999999888888
Q ss_pred ccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCCc-cccccCchhhcccCcCcC
Q 038671 285 QICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNS-TAFRDAPMEALQGNKGLC 351 (707)
Q Consensus 285 ~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~-~~~~~~~~~~~~~~~~~c 351 (707)
.|..+++|+.|++++|++++..|..+..++.| .|++++|++++.+|.. ..+.......+.+|++.|
T Consensus 495 ~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 561 (606)
T 3t6q_A 495 AFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561 (606)
T ss_dssp TTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEEC
T ss_pred hhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccc
Confidence 99999999999999999999889999999999 9999999999877653 445666777888888877
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=329.06 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=201.3
Q ss_pred hcCCCCCc-eeeecCCeeEEEEEc---CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 435 TNDFDDEH-CIGKGGQGSVYKAEL---PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 435 ~~~~~~~~-~lg~G~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
.++|++.+ .||+|+||.||+|.. .+++.||||++..... .....+++.+|+++++.++||||+++++++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 45688877 999999999999943 3478899999876432 223457799999999999999999999999 56778
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++..
T Consensus 93 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp EEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 9999999999999999653 3589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 591 LKPDSSN---WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 591 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
....... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ............+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~~~~ 241 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKGERMGC 241 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTCCCCC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCCCCC
Confidence 6544322 122345688999999998889999999999999999999 9999964322 111111211111111
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+ . ..+..+.+++.+||+.||++||++.++++.|+
T Consensus 242 ~--~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 275 (291)
T 1xbb_A 242 P--A----GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275 (291)
T ss_dssp C--T----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred C--C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1 1 23456899999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.41 Aligned_cols=257 Identities=23% Similarity=0.373 Sum_probs=204.2
Q ss_pred HHHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhc--CCCCceeeeeeeeecCC-
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG--IRHRNIVKFYGFCSHAR- 508 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~- 508 (707)
..+.++|++.+.||+|+||.||+|+. +|+.||+|++... ....+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 45667899999999999999999987 4899999998532 33567788888877 78999999999998775
Q ss_pred ---ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHH--------hCCCCCeEecCCCCCCeeecCC
Q 038671 509 ---HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH--------NDCFPPIVHRDISSKNVLLDLE 577 (707)
Q Consensus 509 ---~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~dlk~~Nil~~~~ 577 (707)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +. +|+||||||+||+++.+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN 183 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT
T ss_pred ccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC
Confidence 78999999999999999964 35899999999999999999999 77 99999999999999999
Q ss_pred CCeEEeccccceecCCCCCC----ccccccccCCCCccccccC------CCCccchhHHHHHHHHHHHhC----------
Q 038671 578 NEAHVSDFGTAKFLKPDSSN----WAELAGTYGYVAPELAYTM------KVTEKCDVYSFGVLALEVIKG---------- 637 (707)
Q Consensus 578 ~~~kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~slG~~l~el~tg---------- 637 (707)
+.+||+|||++......... .....||+.|+|||.+.+. .++.++||||||+++|||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 99999999999876544321 2345789999999998765 234689999999999999999
Q ss_pred CCCCCcccccccccchhhhhhhhh----cCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 638 KHPRDFISSISSSSSNLEIALNEM----LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 638 ~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.||....... .......... ..+..+... ...+.+..+.+++.+||+.||++|||+.++++.|+
T Consensus 264 ~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 264 QLPYYDLVPSD---PSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp CCTTTTTSCSS---CCHHHHHHHHTTSCCCCCCCGGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred ccCccccCcCc---ccHHHHHHHHHHHHhCCCCcccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 67775332211 1112222222 222222111 12356677999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=328.10 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=199.0
Q ss_pred CCCCCceeeecCCeeEEEEEcC-C---CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce-e
Q 038671 437 DFDDEHCIGKGGQGSVYKAELP-S---GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS-F 511 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~ 511 (707)
.|+..+.||+|+||.||+|... + +..+|+|++... ......+.+.+|+.++++++||||+++++++.+.+.. +
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 4566789999999999999642 2 337999998753 2334567889999999999999999999999766654 9
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
++|||+.+++|.+++... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++...
T Consensus 100 ~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp EEECCCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EEEecccCCCHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 999999999999999653 34689999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCC----CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCC-CCcccccccccchhhhhhhhhcCCCC
Q 038671 592 KPDS----SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP-RDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 592 ~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
.... .......+++.|+|||.+.+..++.++||||||+++|+|++|..| |..... ........... ..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~-----~~~~~~~~~~~--~~ 247 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP-----FDLTHFLAQGR--RL 247 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG-----GGHHHHHHTTC--CC
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH-----HHHHHHhhcCC--CC
Confidence 4321 223345678899999999999999999999999999999996555 432111 11111111111 12
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.+. ..+.++.+++.+||+.||.+|||+.++++.|+
T Consensus 248 ~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~ 283 (298)
T 3pls_A 248 PQPE----YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283 (298)
T ss_dssp CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCc----cchHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 2221 12345889999999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.89 Aligned_cols=259 Identities=19% Similarity=0.270 Sum_probs=198.6
Q ss_pred HHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeee-ecCCce
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFC-SHARHS 510 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~ 510 (707)
.+.++|++.+.||+|+||.||+|+ ..+++.||+|++..... .+.+.+|+++++.++|++++..++++ ...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 80 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence 456789999999999999999996 46789999998654322 23477899999999887766666555 667788
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---cCCCCeEEecccc
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL---DLENEAHVSDFGT 587 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~---~~~~~~kl~Dfg~ 587 (707)
++||||+ +++|.+++... ...+++..++.++.||+.||+|||++ ||+||||||+||++ +.++.+||+|||+
T Consensus 81 ~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEEECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEEEcc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 9999999 99999998632 34589999999999999999999999 99999999999999 7889999999999
Q ss_pred ceecCCCCC-------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 588 AKFLKPDSS-------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 588 ~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
+........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... .........
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~ 233 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEK 233 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-hhhhhhhcc
Confidence 987654432 223457899999999999999999999999999999999999999754332211 111111111
Q ss_pred hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....... ......+.++.+++.+||+.||++||+++++++.|+
T Consensus 234 ~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (296)
T 4hgt_A 234 KMSTPIE---VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276 (296)
T ss_dssp HHHSCHH---HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred cccchhh---hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHH
Confidence 1110000 000112356899999999999999999999999874
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=365.03 Aligned_cols=347 Identities=21% Similarity=0.301 Sum_probs=304.4
Q ss_pred CCCCCceeeccCCeeeec-----------------CCcccc--CCCCCCeEECCCCccccccCcCccCCCCCcEEEcccC
Q 038671 1 NLSNLAFLYLYNNSFSGS-----------------IPSEIG--RLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61 (707)
Q Consensus 1 nl~~l~~L~l~~n~i~~~-----------------~~~~~~--~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 61 (707)
++++|++|+|++|.+++. +|..++ ++++|++|+|++|++.+.+|..|.++++|++|+|++|
T Consensus 204 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n 283 (636)
T 4eco_A 204 RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283 (636)
T ss_dssp GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTC
T ss_pred cccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCC
Confidence 478999999999999985 899999 9999999999999999999999999999999999999
Q ss_pred c-Ccc-cCCccccCC------CCCCeeecccccccccCC--CCCCCCCccEEEeccCccccccCccccCCCCCcEEEccc
Q 038671 62 A-LSG-AIPKEYGNL------VKLTLLTLENNQLRGPIP--NLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSH 131 (707)
Q Consensus 62 ~-i~~-~~~~~~~~l------~~L~~L~l~~n~i~~~~~--~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~ 131 (707)
+ +++ .+|..++++ ++|++|++++|+++.++. .+..+++|+.|++++|++++..+ .|..+++|++|+|++
T Consensus 284 ~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAY 362 (636)
T ss_dssp TTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCS
T ss_pred CCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCC
Confidence 8 987 788888877 999999999999998777 79999999999999999995555 899999999999999
Q ss_pred ccccccCCCCCCCCCC-CcEEEcCCCccCCCCchhhhCCC--CCCEEeCCCCCCCCCCChhhh-------CCCCCcEEEe
Q 038671 132 NYFYGEISSDWGRCPK-LGTLDFSSNNITGSMPAEIIHSS--QLKVLDLSSNHIVGEMPSKLG-------KLSSLIKLIL 201 (707)
Q Consensus 132 n~i~~~~~~~~~~~~~-L~~L~L~~n~i~~~~~~~~~~~~--~L~~L~l~~n~l~~~~~~~~~-------~l~~L~~L~l 201 (707)
|.++ ..+..+..+++ |++|++++|.++ ..+..+.... +|+.|++++|.+++..|..+. .+++|++|++
T Consensus 363 N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~L 440 (636)
T 4eco_A 363 NQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440 (636)
T ss_dssp SEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEEC
T ss_pred Cccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEEC
Confidence 9999 56667999999 999999999999 6677776654 899999999999988888888 7889999999
Q ss_pred cCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcc-------cCceEeeecccccccCchhhh--hcccCCeee
Q 038671 202 NSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLV-------KLHYLNLSNNQFIKKIPVELE--KLIHLSELD 272 (707)
Q Consensus 202 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~-------~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~ 272 (707)
++|.++...+..+..+++|++|+|++|.++.+.+..+.... +|+.|+|++|+++ ..|..+. .+++|+.|+
T Consensus 441 s~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~ 519 (636)
T 4eco_A 441 SNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGID 519 (636)
T ss_dssp CSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEE
T ss_pred cCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEE
Confidence 99999965555667799999999999999955555554433 9999999999998 5566665 899999999
Q ss_pred ecCccCCCCCCcccccccccceEec------cccccCCchhHhhccCCCceeEeeccCcccccCCCccccccCchhhccc
Q 038671 273 LSHNFLGEEMPSQICNMQSLEKLNL------SHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQG 346 (707)
Q Consensus 273 l~~n~l~~~~~~~~~~~~~L~~L~l------~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~ 346 (707)
|++|.+++ +|..+..+++|+.|++ ++|++.+..|..+..+++|+.|++++|++ +.+|... .+......+.+
T Consensus 520 Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~-~~~L~~L~Ls~ 596 (636)
T 4eco_A 520 LSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI-TPNISVLDIKD 596 (636)
T ss_dssp CCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC-CTTCCEEECCS
T ss_pred CCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhH-hCcCCEEECcC
Confidence 99999987 8889999999999999 56888889999999999999999999999 4555432 25677777888
Q ss_pred CcCcCCCC
Q 038671 347 NKGLCGDI 354 (707)
Q Consensus 347 ~~~~c~~~ 354 (707)
|+..|.+.
T Consensus 597 N~l~~~~~ 604 (636)
T 4eco_A 597 NPNISIDL 604 (636)
T ss_dssp CTTCEEEC
T ss_pred CCCccccH
Confidence 88877553
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=340.67 Aligned_cols=262 Identities=23% Similarity=0.383 Sum_probs=199.9
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|+. .+|+.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence 36799999999999999999965 5689999999865433 233456688999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||++++++.++.... ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++.....
T Consensus 103 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 103 FEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp EECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999999887543 3589999999999999999999999 999999999999999999999999999987665
Q ss_pred CCCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchh----------hh------
Q 038671 594 DSSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL----------EI------ 656 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~----------~~------ 656 (707)
.........|++.|+|||.+.+. .++.++||||||+++|+|++|+.||............. ..
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 54445566899999999998875 68999999999999999999999996433211000000 00
Q ss_pred hhhhhcCCCCCCCCc---chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 657 ALNEMLDPRLPTPSH---NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 657 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.......+....... ..+..+..+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000011111111100 01123456899999999999999999999876
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.11 Aligned_cols=247 Identities=21% Similarity=0.392 Sum_probs=198.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC-CC-------cEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP-SG-------EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH 506 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 506 (707)
.++|++.+.||+|+||.||+|... ++ +.||+|++... .....+.+.+|++++++++||||+++++++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence 367899999999999999999543 33 57999998542 23345779999999999999999999999999
Q ss_pred CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC-------
Q 038671 507 ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE------- 579 (707)
Q Consensus 507 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~------- 579 (707)
++..++||||+++++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred CCCCEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 99999999999999999999653 23489999999999999999999999 9999999999999998887
Q ss_pred -eEEeccccceecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCC-CCCCcccccccccchhhh
Q 038671 580 -AHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGK-HPRDFISSISSSSSNLEI 656 (707)
Q Consensus 580 -~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~ 656 (707)
+||+|||.+..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|. +||..... ...
T Consensus 159 ~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------~~~ 227 (289)
T 4fvq_A 159 FIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-------QRK 227 (289)
T ss_dssp EEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHH
T ss_pred eeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-------HHH
Confidence 99999999865432 234568899999999887 66899999999999999999955 45432111 111
Q ss_pred hhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 657 ALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..........+... +.++.+++.+||+.||++|||++++++.|+
T Consensus 228 ~~~~~~~~~~~~~~------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 271 (289)
T 4fvq_A 228 LQFYEDRHQLPAPK------AAELANLINNCMDYEPDHRPSFRAIIRDLN 271 (289)
T ss_dssp HHHHHTTCCCCCCS------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHhhccCCCCCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11111122222211 234789999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=335.17 Aligned_cols=253 Identities=24% Similarity=0.394 Sum_probs=200.3
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEE--EEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIV--AVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~v--avK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 511 (707)
++|++.+.||+|+||.||+|+. .+++.+ ++|++.... .....+.+.+|+++++++ +||||+++++++.+.+..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 5799999999999999999964 456644 899886532 223446688999999999 8999999999999999999
Q ss_pred EEEeeeccCcHHHHHhccc-------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC
Q 038671 512 IVYEYLEMGSLAMILSNDA-------------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN 578 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~ 578 (707)
+||||+++++|.+++.... ....+++..++.++.||+.||+|||++ ||+||||||+||+++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence 9999999999999997543 234689999999999999999999999 999999999999999999
Q ss_pred CeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhh
Q 038671 579 EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIA 657 (707)
Q Consensus 579 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 657 (707)
.+||+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ...
T Consensus 180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~ 250 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AEL 250 (327)
T ss_dssp CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHH
T ss_pred eEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------HHH
Confidence 9999999999743322 12233456889999999998889999999999999999998 9999964221 111
Q ss_pred hhhhcCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 658 LNEMLDP-RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 658 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+... ....+. ..+.++.+++.+||+.||.+||+++++++.|+
T Consensus 251 ~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 296 (327)
T 1fvr_A 251 YEKLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296 (327)
T ss_dssp HHHGGGTCCCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhhcCCCCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1111111 111111 22345889999999999999999999998874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=330.25 Aligned_cols=257 Identities=21% Similarity=0.333 Sum_probs=206.6
Q ss_pred HHHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCc------hhhhHHHHHHHHHHHhcCC-CCceeeeeee
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPS------EMASQQEFLNEVKTLTGIR-HRNIVKFYGF 503 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~-h~niv~~~~~ 503 (707)
..+.++|++.+.||+|+||.||+|.. .+|+.||+|++...... .....+.+.+|+++++++. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 34567899999999999999999965 57899999998654311 1223456889999999996 9999999999
Q ss_pred eecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEe
Q 038671 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVS 583 (707)
Q Consensus 504 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~ 583 (707)
+...+..++||||+++++|.+++... ..+++..++.++.||+.||+|||+. |++||||+|+||+++.++.+||+
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred eccCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEe
Confidence 99999999999999999999999643 4589999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCCccccccccCCCCccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhh
Q 038671 584 DFGTAKFLKPDSSNWAELAGTYGYVAPELAY------TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIA 657 (707)
Q Consensus 584 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 657 (707)
|||.+....... ......+++.|+|||.+. ...++.++||||||+++|+|++|+.||..... ...
T Consensus 167 dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~ 237 (298)
T 1phk_A 167 DFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLM 237 (298)
T ss_dssp CCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH
T ss_pred cccchhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH--------HHH
Confidence 999998765432 334567899999999875 44678899999999999999999999863221 111
Q ss_pred hhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 658 LNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+.......+.......+.++.+++.+||+.||++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1112222222221222344566999999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=334.98 Aligned_cols=256 Identities=24% Similarity=0.373 Sum_probs=202.1
Q ss_pred hcCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 508 (707)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... .......+.+|+.++++++||||+++++++...+
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 46899999999999999999963 357789999986542 2334567899999999999999999999999999
Q ss_pred ceeEEEeeeccCcHHHHHhcccc----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC---CCeE
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAA----AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE---NEAH 581 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~---~~~k 581 (707)
..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+. |++||||||+||+++.+ ..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999975432 13488999999999999999999999 99999999999999844 4699
Q ss_pred EeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhh
Q 038671 582 VSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIAL 658 (707)
Q Consensus 582 l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 658 (707)
|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ....
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~ 255 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVL 255 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HHHH
Confidence 999999976543321 2234567889999999998889999999999999999998 9999863221 1112
Q ss_pred hhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 659 NEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.....+... ...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 256 ~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 300 (327)
T 2yfx_A 256 EFVTSGGRMDPP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIE 300 (327)
T ss_dssp HHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHhcCCCCCCC---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 222222111111 122345889999999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=329.30 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=200.8
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCcee
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 511 (707)
..++|++.+.||+|+||.||+|.. .+++.||+|++....... ....++.+|+..+..+ +||||+++++++.+++..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 457799999999999999999965 479999999987653333 3456788899999999 8999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccc-cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC-------------
Q 038671 512 IVYEYLEMGSLAMILSNDAA-AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE------------- 577 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~------------- 577 (707)
+||||+++++|.+++..... ...+++..++.++.||+.||+|||++ ||+||||||+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999965432 24589999999999999999999999 99999999999999844
Q ss_pred ------CCeEEeccccceecCCCCCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccc
Q 038671 578 ------NEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS 650 (707)
Q Consensus 578 ------~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 650 (707)
..+||+|||.+....... ...|++.|+|||.+.+. .++.++||||||+++|+|++|.+|+...
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------ 234 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------ 234 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS------
T ss_pred cccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch------
Confidence 479999999998765432 24689999999998765 5668999999999999999999876421
Q ss_pred cchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 651 SSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.... .......+.... ..+.++.+++.+||+.||++|||+.|+++.
T Consensus 235 -~~~~----~~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 -DQWH----EIRQGRLPRIPQ---VLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HHHH----HHHTTCCCCCSS---CCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -hHHH----HHHcCCCCCCCc---ccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 1111 111222222111 123458899999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.04 Aligned_cols=245 Identities=15% Similarity=0.168 Sum_probs=190.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHH---HHHhcCCCCceeeee-------ee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEV---KTLTGIRHRNIVKFY-------GF 503 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~ 503 (707)
.++|++.+.||+|+||.||+|+. .+|+.||||++...........+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 36788899999999999999975 56999999998754333344567889999 556666899999998 55
Q ss_pred eecCC-----------------ceeEEEeeeccCcHHHHHhcccc----cCCCChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 038671 504 CSHAR-----------------HSFIVYEYLEMGSLAMILSNDAA----AKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562 (707)
Q Consensus 504 ~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 562 (707)
+..++ ..++||||+ +|+|.+++..... ...+++..++.++.||+.||+|||++ ||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 6899999965321 11234588889999999999999999 99
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCCCccccccccCCCCccccccC-----------CCCccchhHHHHHHH
Q 038671 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTM-----------KVTEKCDVYSFGVLA 631 (707)
Q Consensus 563 vH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~slG~~l 631 (707)
+||||||+||+++.++.+||+|||+++... .......| +.|+|||++.+. .++.++||||||+++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 999999999999999999999999998633 23345567 999999999887 799999999999999
Q ss_pred HHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 632 LEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 632 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
|||++|+.||....... ....... ..+ ..+.++.+++.+||+.||++||++.|+++
T Consensus 304 ~elltg~~Pf~~~~~~~--------~~~~~~~-~~~-------~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 304 YWIWCADLPITKDAALG--------GSEWIFR-SCK-------NIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHSSCCC------C--------CSGGGGS-SCC-------CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHCCCCCccccccc--------chhhhhh-hcc-------CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999996432211 1111111 111 12345889999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=339.56 Aligned_cols=258 Identities=21% Similarity=0.307 Sum_probs=195.8
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC----
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR---- 508 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 508 (707)
..++|++.+.||+|+||.||+|.. .+|+.||+|++...... ....+++.+|+++++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 357899999999999999999954 67999999998765433 334567899999999999999999999997653
Q ss_pred --ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 509 --HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 509 --~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence 469999999 8899999864 3589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccch------------
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN------------ 653 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~------------ 653 (707)
+++..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||............
T Consensus 174 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 174 LARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp TCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 99875432 344678999999999877 67899999999999999999999999743221100000
Q ss_pred -------hhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 654 -------LEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 654 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.......................+..+.+++.+||..||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000000000000000011223456889999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=329.10 Aligned_cols=258 Identities=18% Similarity=0.265 Sum_probs=202.0
Q ss_pred HhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeee-ecCCcee
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFC-SHARHSF 511 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~~ 511 (707)
..++|++.+.||+|+||.||+|+ ..+|+.||+|++..... .+.+.+|+.+++.++|++++..+.++ ...+..+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 35789999999999999999996 46899999999865432 23578899999999987766655554 6677889
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---cCCCCeEEeccccc
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL---DLENEAHVSDFGTA 588 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~---~~~~~~kl~Dfg~~ 588 (707)
+||||+ +++|.+++... ...+++..++.++.|++.||+|||++ ||+||||||+||++ +.++.+||+|||.+
T Consensus 82 lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEEEec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCc
Confidence 999999 99999999632 34689999999999999999999999 99999999999999 47889999999999
Q ss_pred eecCCCCC-------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhh
Q 038671 589 KFLKPDSS-------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM 661 (707)
Q Consensus 589 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 661 (707)
........ ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........ ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~ 234 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKK 234 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSS-SSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhh-hhhhhhhcccc
Confidence 87665432 12445799999999999998999999999999999999999999975332111 11111111111
Q ss_pred cCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 662 LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.....+ ......+.++.+++.+||+.||++||+++++++.|+
T Consensus 235 ~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 276 (296)
T 3uzp_A 235 MSTPIE---VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 276 (296)
T ss_dssp HHSCHH---HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred cCCchH---HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence 110000 000122356899999999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=330.25 Aligned_cols=252 Identities=28% Similarity=0.420 Sum_probs=201.6
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
...++|++.+.||+|+||.||+|.. .+|+.||+|++.... ..+.+.+|+.++++++||||+++++++...+..+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 4567899999999999999999965 469999999986532 2356889999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||.+...
T Consensus 101 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp EEEECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 999999999999998532 34689999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
...........|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...........+....
T Consensus 176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~--- 247 (314)
T 3com_A 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----RAIFMIPTNPPPTFRK--- 247 (314)
T ss_dssp BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSCCCCCSS---
T ss_pred hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHhcCCCcccCC---
Confidence 65544445567899999999999988999999999999999999999999643211 0011111111111111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
....+..+.+++.+||+.||.+||++.++++
T Consensus 248 -~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 -PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp -GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1223456899999999999999999999976
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=327.37 Aligned_cols=248 Identities=29% Similarity=0.428 Sum_probs=194.6
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec-CCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH-ARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv 513 (707)
.++|++.+.||+|+||.||+++.. |+.||+|++.... ..+.+.+|++++++++||||+++++++.+ .+..++|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 467999999999999999999774 8899999987532 34678899999999999999999998754 4578999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++.... ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp ECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 99999999999996432 23478999999999999999999999 999999999999999999999999999976543
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
. .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ............ ...+
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-----~~~~~~~~~~~~--~~~~--- 236 (278)
T 1byg_A 170 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEKGYK--MDAP--- 236 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHHHHTTTCC--CCCC---
T ss_pred c---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhcCCC--CCCc---
Confidence 2 223467889999999998889999999999999999998 9999864321 111111111111 1111
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+..+.+++.+||+.||.+||++.++++.|+
T Consensus 237 -~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 269 (278)
T 1byg_A 237 -DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269 (278)
T ss_dssp -TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence 123456899999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=338.07 Aligned_cols=261 Identities=27% Similarity=0.391 Sum_probs=196.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHH--HHHHhcCCCCceeeeeeeee-----cC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNE--VKTLTGIRHRNIVKFYGFCS-----HA 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e--~~~l~~l~h~niv~~~~~~~-----~~ 507 (707)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+..| +..+..++||||+++++++. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA------NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc------chhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 46799999999999999999976 6899999998532 12333344 44455689999999998553 23
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCC------CCeEecCCCCCCeeecCCCCeE
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCF------PPIVHRDISSKNVLLDLENEAH 581 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~------~~ivH~dlk~~Nil~~~~~~~k 581 (707)
...++||||+++|+|.+++... ..++..++.++.||++||+|||+.+. +||+||||||+||+++.++.+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred ceEEEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 3678999999999999999643 34889999999999999999998732 2899999999999999999999
Q ss_pred EeccccceecCCCC--------CCccccccccCCCCcccccc-------CCCCccchhHHHHHHHHHHHhCCCCCCcccc
Q 038671 582 VSDFGTAKFLKPDS--------SNWAELAGTYGYVAPELAYT-------MKVTEKCDVYSFGVLALEVIKGKHPRDFISS 646 (707)
Q Consensus 582 l~Dfg~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 646 (707)
|+|||++....... .......||+.|+|||++.+ ..++.++||||||+++|||++|..||.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 99999998765321 11234579999999999876 4567789999999999999999877643221
Q ss_pred cccccch----------h----hhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 647 ISSSSSN----------L----EIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 647 ~~~~~~~----------~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....... . .........+.++.........+.++.+++.+||+.||++|||++|+++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 1110000 0 0111222233444433334456778999999999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=344.62 Aligned_cols=256 Identities=9% Similarity=0.022 Sum_probs=184.8
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC--CCCceeeee-------eeee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI--RHRNIVKFY-------GFCS 505 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~-------~~~~ 505 (707)
.+|++.+.||+|+||.||+|.. .+|+.||+|++...........+.+.+|+.++..+ +|||+++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4588999999999999999964 57999999999876554555667788885444444 699988755 4443
Q ss_pred cC-----------------CceeEEEeeeccCcHHHHHhcccccCCCChHHH------HHHHHHHHHHHHHHHhCCCCCe
Q 038671 506 HA-----------------RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKR------MNVIKGVVDALSYMHNDCFPPI 562 (707)
Q Consensus 506 ~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~i 562 (707)
.. ...++||||++ ++|.+++.... ..+++..+ +.++.||+.||+|||++ ||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSK---GL 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence 32 33799999999 89999997542 23566666 78889999999999999 99
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCCCccccccccCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCC
Q 038671 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHP 640 (707)
Q Consensus 563 vH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p 640 (707)
+||||||+||+++.++.+||+|||+++..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.|
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999875422 224567799999999987 6789999999999999999999999
Q ss_pred CCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 641 RDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
|............ ..............+ .....+..+.+++.+||+.||++|||+.++++
T Consensus 293 f~~~~~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGSWK-RPSLRVPGTDSLAFG--SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTCCC-BCCTTSCCCCSCCCT--TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccchh-hhhhhhccccccchh--hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9753221100000 000000011111111 11133456899999999999999999999875
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=354.97 Aligned_cols=344 Identities=22% Similarity=0.219 Sum_probs=201.6
Q ss_pred CCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecc
Q 038671 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLE 83 (707)
Q Consensus 4 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (707)
++++|+|++|.|++..|..|+++++|++|+|++|+++++.|++|.++++|++|+|++|.+++..|..|+++++|++|+++
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 113 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence 34555555555555555555555555555555555554445555555555555555555554545555555555555555
Q ss_pred ccccccc-CCCCCCCCCccEEEeccCccc------------------------cccCccccCCCCCc--EEEcccccccc
Q 038671 84 NNQLRGP-IPNLRNLTSLVRVRLNQNHLT------------------------GNISESFGIHPNLA--FIDLSHNYFYG 136 (707)
Q Consensus 84 ~n~i~~~-~~~l~~l~~L~~L~l~~n~l~------------------------~~~~~~~~~~~~L~--~L~L~~n~i~~ 136 (707)
+|.++.+ +..+..+++|++|++++|+++ .+.+..|..+++|+ .|++++|.++.
T Consensus 114 ~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~ 193 (606)
T 3t6q_A 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193 (606)
T ss_dssp TSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCE
T ss_pred ccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCc
Confidence 5555443 223444445555555555444 44444444444444 44444444443
Q ss_pred cCCCCCCCC---------------------------------------------------CCCcEEEcCCCccCCCCchh
Q 038671 137 EISSDWGRC---------------------------------------------------PKLGTLDFSSNNITGSMPAE 165 (707)
Q Consensus 137 ~~~~~~~~~---------------------------------------------------~~L~~L~L~~n~i~~~~~~~ 165 (707)
+.+..|... .+|+.|++++|.+++..+..
T Consensus 194 ~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~ 273 (606)
T 3t6q_A 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273 (606)
T ss_dssp ECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTT
T ss_pred cChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHH
Confidence 333222110 03444445555555445555
Q ss_pred hhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCC-CccccCcccC
Q 038671 166 IIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSI-PKSLGNLVKL 244 (707)
Q Consensus 166 ~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~-~~~l~~l~~L 244 (707)
|..+++|+.|++++|.++ .+|..+..+++|++|++++|.+++..+..+..+++|++|++++|.+.+.. +..+..+++|
T Consensus 274 ~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L 352 (606)
T 3t6q_A 274 FHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352 (606)
T ss_dssp TTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTC
T ss_pred hccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcC
Confidence 667777888888888777 66667777778888888888777666667777777777777777766433 3446677777
Q ss_pred ceEeeecccccccC--chhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhH-hhccCCCceeEee
Q 038671 245 HYLNLSNNQFIKKI--PVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPS-CFEELHGLSYIDI 321 (707)
Q Consensus 245 ~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~-~~~~~~~L~~l~l 321 (707)
++|++++|.+.+.. +..+..+++|++|++++|.+++..+..+..+++|+.|++++|++.+..+. .+..+++|+.|++
T Consensus 353 ~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l 432 (606)
T 3t6q_A 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432 (606)
T ss_dssp CEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEEC
T ss_pred CEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEEC
Confidence 77777777776554 55667777777777777777666666677777777777777777655443 3666677777777
Q ss_pred ccCcccccCCC-ccccccCchhhcccCc
Q 038671 322 SYNELHGSIPN-STAFRDAPMEALQGNK 348 (707)
Q Consensus 322 ~~n~~~~~~~~-~~~~~~~~~~~~~~~~ 348 (707)
++|.+++..+. ...++......+.+|+
T Consensus 433 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 460 (606)
T 3t6q_A 433 SHSLLDISSEQLFDGLPALQHLNLQGNH 460 (606)
T ss_dssp TTCCCBTTCTTTTTTCTTCCEEECTTCB
T ss_pred CCCccCCcCHHHHhCCCCCCEEECCCCC
Confidence 77777665443 2233444444455554
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=328.40 Aligned_cols=254 Identities=20% Similarity=0.307 Sum_probs=198.7
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCch-hhhHHHHHHHHHHHhcCCCCceeeeeeee--ecCCc
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSE-MASQQEFLNEVKTLTGIRHRNIVKFYGFC--SHARH 509 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~--~~~~~ 509 (707)
..++|++.+.||+|+||.||++.. .+++.||+|++....... ....+.+.+|++++++++||||+++++++ .+.+.
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 457899999999999999999965 578999999986432111 22456799999999999999999999998 44568
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++||||+.++ +.+++.... ...+++..++.++.||+.||+|||++ |++||||||+||+++.++.+||+|||.+.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999877 666665432 35689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCC--CCccccccccCCCCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCC
Q 038671 590 FLKPDS--SNWAELAGTYGYVAPELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPR 665 (707)
Q Consensus 590 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (707)
...... .......|++.|+|||...+.. ++.++||||||+++|+|++|+.||.... .......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~~~~ 229 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFENIGKGS 229 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHHHhcCC
Confidence 765332 2233457899999999987644 3779999999999999999999996322 112222222222
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...+.. .+..+.+++.+||+.||.+||+++|+++.
T Consensus 230 ~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 YAIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp CCCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred CCCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 222222 23458899999999999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=326.79 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=199.5
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec----CCce
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH----ARHS 510 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~ 510 (707)
..|++.+.||+|+||.||+|. ..++..||+|++...... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 347788899999999999995 457889999998654322 3356778999999999999999999998865 4568
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeec-CCCCeEEecccc
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP--IVHRDISSKNVLLD-LENEAHVSDFGT 587 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nil~~-~~~~~kl~Dfg~ 587 (707)
++||||+++++|.+++... ..+++..++.++.|++.||+|||+. + ++||||||+||+++ .++.+||+|||+
T Consensus 105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999999643 4589999999999999999999999 7 99999999999997 789999999999
Q ss_pred ceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 588 AKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
+..... .......|++.|+|||.+.+ .++.++||||||+++|+|++|+.||..... .............+
T Consensus 179 ~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~ 248 (290)
T 1t4h_A 179 ATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKP 248 (290)
T ss_dssp GGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTCCC
T ss_pred cccccc--cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-------HHHHHHHHhccCCc
Confidence 975432 23345679999999998765 589999999999999999999999963221 11222222222111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
. ......+.++.+++.+||+.||.+|||++++++.
T Consensus 249 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 A--SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp G--GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred c--ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 1111223458999999999999999999999863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=328.64 Aligned_cols=246 Identities=23% Similarity=0.390 Sum_probs=203.3
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec-----
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH----- 506 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----- 506 (707)
.+..+|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 34567999999999999999999654 79999999986532 245689999999999999999998854
Q ss_pred -----------CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec
Q 038671 507 -----------ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD 575 (707)
Q Consensus 507 -----------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~ 575 (707)
....++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. |++||||||+||+++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 445899999999999999996532 35689999999999999999999999 999999999999999
Q ss_pred CCCCeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhh
Q 038671 576 LENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE 655 (707)
Q Consensus 576 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 655 (707)
.++.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|..|+... .
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~ 225 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDGK-RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------S 225 (284)
T ss_dssp ETTEEEECCCTTCEESSCCSC-CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------H
T ss_pred CCCCEEECcchhheecccccc-ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------H
Confidence 999999999999987764432 33457899999999999988999999999999999999999986421 1
Q ss_pred hhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 656 IALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...........+.. .+..+.+++.+||+.||++||++.|+++.|+
T Consensus 226 ~~~~~~~~~~~~~~------~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~ 270 (284)
T 2a19_B 226 KFFTDLRDGIISDI------FDKKEKTLLQKLLSKKPEDRPNTSEILRTLT 270 (284)
T ss_dssp HHHHHHHTTCCCTT------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhhccccccc------CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11122222222221 2245889999999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.54 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=197.4
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCc-----hhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPS-----EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA 507 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 507 (707)
..++|++.+.||+|+||.||+|.. .+++.||||++...... .......+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 456799999999999999999954 56899999998654221 112234588999999999999999999998765
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC---eEEec
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE---AHVSD 584 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~---~kl~D 584 (707)
. .++||||+++++|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 89999999999999998643 4589999999999999999999999 9999999999999987664 99999
Q ss_pred cccceecCCCCCCccccccccCCCCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhh
Q 038671 585 FGTAKFLKPDSSNWAELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM 661 (707)
Q Consensus 585 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 661 (707)
||++...... .......|++.|+|||.+. +..++.++||||||+++|+|++|+.||...... ........
T Consensus 161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~-- 233 (322)
T 2ycf_A 161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLKDQIT-- 233 (322)
T ss_dssp CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS----SCHHHHHH--
T ss_pred Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH----HHHHHHHH--
Confidence 9999876432 2223457899999999864 456889999999999999999999999643221 11111111
Q ss_pred cCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 662 LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..............+.++.+++.+||+.||++||++.++++
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 -SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -hCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11111111111223456899999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=349.10 Aligned_cols=195 Identities=24% Similarity=0.361 Sum_probs=154.8
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec-----CC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH-----AR 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~ 508 (707)
.++|++.+.||+|+||.||+|. ..+|+.||||++..... .....+.+.+|++++++++||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 4689999999999999999995 45789999999865433 33455778999999999999999999999843 35
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
..|+||||+ +++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-ccchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 789999987 47888888643 4589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC---------------------------CccccccccCCCCcccc-ccCCCCccchhHHHHHHHHHHHhC
Q 038671 589 KFLKPDSS---------------------------NWAELAGTYGYVAPELA-YTMKVTEKCDVYSFGVLALEVIKG 637 (707)
Q Consensus 589 ~~~~~~~~---------------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg 637 (707)
+....... .....+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 87643211 22345789999999976 456699999999999999999993
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=339.39 Aligned_cols=246 Identities=16% Similarity=0.163 Sum_probs=197.2
Q ss_pred hcCCCCCceeeecCCeeEEEE------EcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC---CCceeeeeeeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKA------ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR---HRNIVKFYGFCS 505 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~ 505 (707)
.++|++.+.||+|+||.||+| ...+++.||+|++... ...++..|++.+.+++ |+|++++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA------NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC------CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC------ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 467999999999999999999 3556889999998653 2345677777777776 999999999999
Q ss_pred cCCceeEEEeeeccCcHHHHHhccc--ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC-------
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDA--AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL------- 576 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~------- 576 (707)
..+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||++ ||+||||||+||+++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccc
Confidence 9999999999999999999996432 235699999999999999999999999 9999999999999998
Q ss_pred ----CCCeEEeccccceecCC--CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc
Q 038671 577 ----ENEAHVSDFGTAKFLKP--DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS 650 (707)
Q Consensus 577 ----~~~~kl~Dfg~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 650 (707)
++.+||+|||+++.+.. ........+||+.|+|||++.+..++.++||||||+++|||+||+.||......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--- 291 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG--- 291 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT---
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC---
Confidence 89999999999976542 223345567999999999999999999999999999999999999998532110
Q ss_pred cchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCC-CCHHHHHHHh
Q 038671 651 SSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESR-PTIQKVSQLL 705 (707)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-ps~~~l~~~L 705 (707)
.......+...+ ....+.+++..|++.+|.+| |+++++.+.|
T Consensus 292 --------~~~~~~~~~~~~-----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 292 --------ECKPEGLFRRLP-----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp --------EEEECSCCTTCS-----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred --------ceeechhccccC-----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 000111111111 13347789999999999999 5677776655
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.81 Aligned_cols=252 Identities=26% Similarity=0.441 Sum_probs=205.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|+||.||+|.+..+..||||++..... ..+++.+|++++++++||||+++++++.+ +..++||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEee
Confidence 467889999999999999999888888899999875432 24678999999999999999999999876 6789999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+|+|.+++... ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 341 e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp CCCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred ehhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 999999999999642 234589999999999999999999999 9999999999999999999999999999765422
Q ss_pred C-CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 595 S-SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 595 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
. .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+.. ..+++.+.
T Consensus 417 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-----~~~~~~i~~--~~~~~~~~-- 487 (535)
T 2h8h_A 417 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----REVLDQVER--GYRMPCPP-- 487 (535)
T ss_dssp HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-----HHHHHHHHT--TCCCCCCT--
T ss_pred ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHc--CCCCCCCC--
Confidence 1 11123346788999999998899999999999999999999 9999864321 111111111 12222222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.||++||++++|++.|+
T Consensus 488 --~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~ 519 (535)
T 2h8h_A 488 --ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519 (535)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 23345889999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=329.31 Aligned_cols=254 Identities=26% Similarity=0.444 Sum_probs=195.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEc--CCCc--EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL--PSGE--IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~--~~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
.++|++.+.||+|+||.||+|++ .+++ .||+|++...........+.+.+|++++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 35799999999999999999964 2333 68999987654444456678999999999999999999999998755 8
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++|+||+.+++|.+++... ...+++..++.++.|++.||+|||++ |++||||||+||+++.++.+||+|||++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 8999999999999998643 24589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcC--C
Q 038671 591 LKPDSSN---WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLD--P 664 (707)
Q Consensus 591 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 664 (707)
....... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ......... .
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~ 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKEGE 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTSCC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH--------HHHHHHHHccCC
Confidence 6544322 223457788999999998889999999999999999999 9999864321 111122211 1
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.+. ..+.++.+++.+||+.||++||++.++++.|+
T Consensus 243 ~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 280 (291)
T 1u46_A 243 RLPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280 (291)
T ss_dssp CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCc----CcCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 222221 23456899999999999999999999999874
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=344.80 Aligned_cols=201 Identities=23% Similarity=0.380 Sum_probs=168.8
Q ss_pred HhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA----- 507 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 507 (707)
+.++|++.+.||+|+||.||+|. ..+++.||||++..... .....+.+.+|++++++++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 35789999999999999999995 45789999999976433 334557789999999999999999999999765
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
+..|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CeEEEEEecCC-cCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 57899999986 5999998643 4589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC----------------------CccccccccCCCCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 038671 588 AKFLKPDSS----------------------NWAELAGTYGYVAPELA-YTMKVTEKCDVYSFGVLALEVIKGKHPRD 642 (707)
Q Consensus 588 ~~~~~~~~~----------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 642 (707)
++....... .....+||+.|+|||++ .+..++.++||||+||++|||++|..||.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 987654321 23556899999999985 55669999999999999999998666553
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=357.63 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=195.5
Q ss_pred eeeecCCeeEEEEEcC---CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeecc
Q 038671 443 CIGKGGQGSVYKAELP---SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 443 ~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
.||+|+||.||+|..+ ++..||||++..... ....+++.+|++++++++||||+++++++.. +..++||||+.+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence 7999999999999543 567799999976432 2356789999999999999999999999976 568999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCC--
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN-- 597 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 597 (707)
|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 420 g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 420 GPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp CBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred CcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 9999999643 34689999999999999999999999 9999999999999999999999999999876533221
Q ss_pred -ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHH
Q 038671 598 -WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQD 675 (707)
Q Consensus 598 -~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 675 (707)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+... .+++.+. .
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~~~~i~~~--~~~~~p~----~ 563 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQG--KRMECPP----E 563 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-----HHHHHHHHTT--CCCCCCT----T
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcC--CCCCCCC----c
Confidence 122345688999999998899999999999999999998 9999974332 1111112111 1222222 2
Q ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 676 KLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 676 ~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.++.+++.+||+.||++||++.++++.|+
T Consensus 564 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 594 (613)
T 2ozo_A 564 CPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594 (613)
T ss_dssp CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 3456899999999999999999999998875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=331.54 Aligned_cols=253 Identities=23% Similarity=0.391 Sum_probs=198.1
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence 356899999999999999999965 468999999986542 2245678899999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
||||+++++|.+++... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||++....
T Consensus 94 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp EEECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EEEeCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 99999999999988542 34589999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCCCccccccccCCCCcccc-----ccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 593 PDSSNWAELAGTYGYVAPELA-----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
..........|++.|+|||.+ .+..++.++||||||+++|+|++|+.||...... ...........+...
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~ 243 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLKIAKSDPPTLL 243 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHHHSCCCCCS
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-----HHHHHHhccCCcccC
Confidence 221222345789999999987 3567889999999999999999999998643221 011111111111111
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
. ....+.++.+++.+||+.||++|||+.++++
T Consensus 244 ~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 T----PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp S----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred C----ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1 1223456899999999999999999999976
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=356.65 Aligned_cols=169 Identities=26% Similarity=0.286 Sum_probs=107.7
Q ss_pred hhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCc-cccCCCCcccEEEccCCccCCCCCccccCcc
Q 038671 164 AEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLS-LELGSLTQLERLDLSSNRLSNSIPKSLGNLV 242 (707)
Q Consensus 164 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~ 242 (707)
..+..+++|++|++++|.+.+..+. +..+++|++|++++|.+++..+ ..+..+++|++|++++|.+++..+..|.+++
T Consensus 367 ~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 445 (570)
T 2z63_A 367 QSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445 (570)
T ss_dssp HHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCT
T ss_pred ccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCC
Confidence 3344444555555555554422222 5555566666666666654433 3456666666777766666666666666677
Q ss_pred cCceEeeeccccc-ccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEee
Q 038671 243 KLHYLNLSNNQFI-KKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDI 321 (707)
Q Consensus 243 ~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l 321 (707)
+|+.|++++|.+. +..|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|++++..+..+..+++|+.|++
T Consensus 446 ~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 525 (570)
T 2z63_A 446 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWL 525 (570)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred cCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEe
Confidence 7777777777665 345566667777777777777776666667777777777777777777666666777777777777
Q ss_pred ccCcccccCCCc
Q 038671 322 SYNELHGSIPNS 333 (707)
Q Consensus 322 ~~n~~~~~~~~~ 333 (707)
++|+|+|.+|..
T Consensus 526 ~~N~~~~~~~~~ 537 (570)
T 2z63_A 526 HTNPWDCSCPRI 537 (570)
T ss_dssp CSSCBCCCTTTT
T ss_pred cCCcccCCCcch
Confidence 777777777654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=335.53 Aligned_cols=258 Identities=22% Similarity=0.319 Sum_probs=197.9
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec-------
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH------- 506 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------- 506 (707)
.++|++.+.||+|+||.||+|+. .+|+.||+|++....... .....+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 36799999999999999999965 679999999986543322 234567889999999999999999999876
Q ss_pred -CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecc
Q 038671 507 -ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDF 585 (707)
Q Consensus 507 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Df 585 (707)
.+..++||||+.+ ++.+.+... ...+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 4468999999986 666666433 24589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCC----CCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 586 GTAKFLKPDS----SNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 586 g~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
|++....... .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... .....+..
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~i~~ 243 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-----HQLALISQ 243 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-----HHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHH
Confidence 9998765322 22345678999999998876 45799999999999999999999999742211 00000000
Q ss_pred hcCCCC------------------CC-CCcchHH------HHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 661 MLDPRL------------------PT-PSHNVQD------KLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 661 ~~~~~~------------------~~-~~~~~~~------~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
...... .. ......+ ....+.+++.+||+.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 244 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000 00 0000111 13458899999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=336.78 Aligned_cols=254 Identities=21% Similarity=0.320 Sum_probs=192.5
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-----
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR----- 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 508 (707)
.++|++.+.||+|+||.||+|. ..+++.||||++...... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 4689999999999999999995 457899999998764332 334567889999999999999999999997654
Q ss_pred -ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 509 -HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 509 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
..++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 67999999975 6777774 2488999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh-------
Q 038671 588 AKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE------- 660 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------- 660 (707)
+...... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ........
T Consensus 174 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 174 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID----QWNKVIEQLGTPCPE 248 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHC-CCCCCHH
T ss_pred ccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCHH
Confidence 9865432 22344678999999999999899999999999999999999999996432211 00000000
Q ss_pred -----------h--cCCC--------------CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 661 -----------M--LDPR--------------LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 661 -----------~--~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
. ..+. .+.........+.++.+++.+||..||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 0011 01111112334667999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=342.75 Aligned_cols=256 Identities=17% Similarity=0.239 Sum_probs=199.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC---------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceee------
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP---------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK------ 499 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~------ 499 (707)
.++|++.+.||+|+||.||+|+.. +++.||+|++... +.+.+|++++++++|||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 367999999999999999999665 3789999998643 35778999999999999887
Q ss_pred ---------eeeeeec-CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCC
Q 038671 500 ---------FYGFCSH-ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISS 569 (707)
Q Consensus 500 ---------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~ 569 (707)
+++++.. .+..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp 187 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA 187 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence 5666665 67889999999 999999997542 35699999999999999999999999 999999999
Q ss_pred CCeeecCCC--CeEEeccccceecCCCCC-------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 038671 570 KNVLLDLEN--EAHVSDFGTAKFLKPDSS-------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640 (707)
Q Consensus 570 ~Nil~~~~~--~~kl~Dfg~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p 640 (707)
+||+++.++ .+||+|||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 999999999987653321 12345799999999999998999999999999999999999999
Q ss_pred CCcccccccccchhhhhhhhhcC--CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 641 RDFISSISSSSSNLEIALNEMLD--PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 641 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
|...... ............. ..+..........+.++.+++.+||+.||++||+++++++.|+
T Consensus 268 f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 332 (352)
T 2jii_A 268 WTNCLPN---TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE 332 (352)
T ss_dssp TGGGTTC---HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred cccCCcC---HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence 9743211 1111111111111 1111111011122356899999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=332.22 Aligned_cols=257 Identities=21% Similarity=0.348 Sum_probs=201.1
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeee----cCCc
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCS----HARH 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~----~~~~ 509 (707)
.++|++.+.||+|+||.||++.. .+|+.||+|++... .....+.+.+|+++++.++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 46799999999999999999964 67999999988542 2335677899999999999999999999986 3457
Q ss_pred eeEEEeeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 510 SFIVYEYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
.++||||+.+++|.+++.... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 899999999999999986532 235689999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCC---------ccccccccCCCCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhh
Q 038671 589 KFLKPDSSN---------WAELAGTYGYVAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEI 656 (707)
Q Consensus 589 ~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 656 (707)
......... .....|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||+..... ......
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~ 258 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK---GDSVAL 258 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT---TSCHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc---cchhhH
Confidence 765322111 12345799999999987554 688999999999999999999998632110 111111
Q ss_pred hhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 657 ALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 657 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.... ....+... ..+.++.+++.+||+.||.+||++.++++.|+
T Consensus 259 ~~~~--~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~ 302 (317)
T 2buj_A 259 AVQN--QLSIPQSP----RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLE 302 (317)
T ss_dssp HHHC--C--CCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred Hhhc--cCCCCccc----cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence 1111 11122211 23356899999999999999999999999875
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=340.24 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=201.5
Q ss_pred cCCCCCceeeecCCeeEEEEEc----CCCcEEEEEecCCCCCc-hhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCc
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL----PSGEIVAVKKFHSPLPS-EMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARH 509 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 509 (707)
++|++.+.||+|+||.||+|+. .+++.||||++...... .....+.+.+|+++++++ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999965 47899999998643211 112234567789999999 69999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.++||||+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 99999999999999999643 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCC-CCccccccccCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 590 FLKPDS-SNWAELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 590 ~~~~~~-~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
...... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ...............
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~~~ 283 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSEP 283 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHHHHHHHCCC
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc----chHHHHHHHHhccCC
Confidence 754332 22334679999999999885 34788999999999999999999999643221 111122222222222
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHHHh
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRP-----TIQKVSQLL 705 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----s~~~l~~~L 705 (707)
+.+. ..+..+.+++.+||+.||++|| +++++++..
T Consensus 284 ~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 284 PYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCCc----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 2222 2234588999999999999999 999998753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=339.77 Aligned_cols=259 Identities=23% Similarity=0.356 Sum_probs=203.1
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 46799999999999999999955 578999999987643 233457789999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ||+||||||+||+++.++.+||+|||++.....
T Consensus 110 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp ECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999999643 35899999999999999999999842 899999999999999999999999999875432
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccccc------------------------
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISS------------------------ 649 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~------------------------ 649 (707)
. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||........
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp H--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred c--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 2 22345789999999999999999999999999999999999999964221000
Q ss_pred ----------ccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 650 ----------SSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 650 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.................+... ....+.++.+++.+||+.||++|||++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCC--cccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000011111111111100 01124468999999999999999999999863
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=332.58 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=186.3
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
...++|++.+.||+|+||.||+|.. .+++.||+|++..... ....+++.+|++.+++++||||+++++++...+..+
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 4467899999999999999999965 4789999999865422 224567889999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcc-----cccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 512 IVYEYLEMGSLAMILSND-----AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
+||||+++++|.+++... .....+++..++.++.||+.||+|||+. |++||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999998632 1234589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCC-----CccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 587 TAKFLKPDSS-----NWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 587 ~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
++........ ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ........
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~ 242 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK----VLMLTLQN 242 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHHHHHTS
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh----HHHHHhcc
Confidence 9976543321 1234578999999998875 568999999999999999999999997432211 11111110
Q ss_pred hcCCCCCC---CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 661 MLDPRLPT---PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 661 ~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+.... ........+.++.+++.+||+.||.+||++.++++
T Consensus 243 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 -DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0001100 00011123356889999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=325.83 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=205.5
Q ss_pred HHHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
..+.++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++...+..
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 45677899999999999999999965 47899999998643222 22456789999999999999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC---CCeEEecccc
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE---NEAHVSDFGT 587 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~---~~~kl~Dfg~ 587 (707)
++||||+.+++|.+++... ..+++..++.++.||+.||+|||+. |++||||||+||+++.+ +.+||+|||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 9999999999999888543 3589999999999999999999999 99999999999999764 4699999999
Q ss_pred ceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 588 AKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
+....... ......+++.|+|||.+.+. ++.++||||||+++|+|++|+.||..... ......+......
T Consensus 171 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~ 240 (287)
T 2wei_A 171 STCFQQNT-KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVETGKYA 240 (287)
T ss_dssp GGTBCCCS-SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCC
T ss_pred ceeecCCC-ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCC
Confidence 98665432 23345689999999988764 89999999999999999999999864221 1112222222222
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+.......+.++.+++.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 221122233456899999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=324.68 Aligned_cols=255 Identities=23% Similarity=0.374 Sum_probs=188.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|+. .+|+.||+|++...... ....+.+.++...++.++||||+++++++.+++..++|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CH-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCc-HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 46799999999999999999964 67999999998764322 23344455666668888999999999999999999999
Q ss_pred EeeeccCcHHHHHhcc-cccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 514 YEYLEMGSLAMILSND-AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
|||+++ +|.+++... .....+++..++.++.|++.||+|||+++ |++||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999975 887776532 22356999999999999999999999853 89999999999999999999999999998765
Q ss_pred CCCCCccccccccCCCCcccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 593 PDSSNWAELAGTYGYVAPELA----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
.... .....|++.|+|||.+ .+..++.++||||+|+++|+|++|+.||+.... ................
T Consensus 162 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~ 234 (290)
T 3fme_A 162 DDVA-KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------PFQQLKQVVEEPSPQL 234 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC------HHHHHHHHHHSCCCCC
T ss_pred cccc-ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc------hHHHHHHHhccCCCCc
Confidence 4322 2334789999999995 556789999999999999999999999963211 1111111122222111
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+. ...+.++.+++.+||+.||++|||+.|+++
T Consensus 235 ~~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 PA---DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cc---ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11 123455899999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.77 Aligned_cols=253 Identities=25% Similarity=0.401 Sum_probs=195.5
Q ss_pred HHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeec----
Q 038671 433 RVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSH---- 506 (707)
Q Consensus 433 ~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~---- 506 (707)
...++|++.+.||+|+||.||+|+. .+|+.||+|++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3467899999999999999999965 5799999999865322 235788999999999 79999999999976
Q ss_pred --CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEec
Q 038671 507 --ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSD 584 (707)
Q Consensus 507 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~D 584 (707)
.+..++||||+++++|.+++.... ...+++..++.++.||+.||+|||+. |++||||||+||+++.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 467899999999999999997543 34689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCccccccccCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhh
Q 038671 585 FGTAKFLKPDSSNWAELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN 659 (707)
Q Consensus 585 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 659 (707)
||++..............|++.|+|||.+. +..++.++||||||+++|+|++|+.||...... .......
T Consensus 173 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~ 247 (326)
T 2x7f_A 173 FGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFLIP 247 (326)
T ss_dssp CTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHHH
T ss_pred CcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----HHHHHhh
Confidence 999987654433344567899999999987 556889999999999999999999998632211 0001111
Q ss_pred hhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 660 EMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
....+.... ...+..+.+++.+||+.||.+||+++++++
T Consensus 248 ~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNPAPRLKS-----KKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSCCCCCSC-----SCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCccccCCc-----cccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111111111 122346889999999999999999999986
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=345.58 Aligned_cols=329 Identities=21% Similarity=0.177 Sum_probs=298.8
Q ss_pred CCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeec
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTL 82 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 82 (707)
+++++|+|++|+|++..+..|..+++|++|+|++|.+++..|.+|.++++|++|+|++|.++...+..|.++++|++|+|
T Consensus 32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 111 (477)
T 2id5_A 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI 111 (477)
T ss_dssp TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence 47899999999999998999999999999999999999888999999999999999999999887788999999999999
Q ss_pred ccccccccCC-CCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCC
Q 038671 83 ENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGS 161 (707)
Q Consensus 83 ~~n~i~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~ 161 (707)
++|.+..+.+ .+..+++|++|++++|.++.+.+..|..+++|++|+|++|.++.+.+..|..+++|+.|+|++|.+.+.
T Consensus 112 s~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~ 191 (477)
T 2id5_A 112 SENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI 191 (477)
T ss_dssp TTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEE
T ss_pred CCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEe
Confidence 9999998755 589999999999999999999999999999999999999999988878899999999999999999988
Q ss_pred CchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCc
Q 038671 162 MPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNL 241 (707)
Q Consensus 162 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l 241 (707)
.+..|..+++|+.|++++|...+..+.......+|++|++++|.++...+..+..+++|+.|+|++|.+++..+..|.++
T Consensus 192 ~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 271 (477)
T 2id5_A 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHEL 271 (477)
T ss_dssp CTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTC
T ss_pred ChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhcccc
Confidence 88899999999999999998877777777777799999999999997766789999999999999999998888899999
Q ss_pred ccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEee
Q 038671 242 VKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDI 321 (707)
Q Consensus 242 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l 321 (707)
++|+.|+|++|++.+..+..|.++++|+.|+|++|.+++..+..|..+++|+.|++++|++.+.....+ -......+.+
T Consensus 272 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~-~~~~~~~~~~ 350 (477)
T 2id5_A 272 LRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLW-VFRRRWRLNF 350 (477)
T ss_dssp TTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHH-HHTTTTSSCC
T ss_pred ccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHh-HHhhhhcccc
Confidence 999999999999999999999999999999999999988888888999999999999999986544222 2233445667
Q ss_pred ccCcccccCCC
Q 038671 322 SYNELHGSIPN 332 (707)
Q Consensus 322 ~~n~~~~~~~~ 332 (707)
.++...|..|.
T Consensus 351 ~~~~~~C~~p~ 361 (477)
T 2id5_A 351 NRQQPTCATPE 361 (477)
T ss_dssp TTCCCBEEESG
T ss_pred CccCceeCCch
Confidence 78888887654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=371.37 Aligned_cols=328 Identities=24% Similarity=0.219 Sum_probs=197.5
Q ss_pred CCCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcC--ccCCCCCcEEEcccCcCcccCC-ccccCCCCC
Q 038671 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHS--LGNLTQITFLTLFDNALSGAIP-KEYGNLVKL 77 (707)
Q Consensus 1 nl~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~--~~~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L 77 (707)
+|++|++|+|++|.|++..|+.|+++++|++|+|++|.+++..+.. |.++++|++|+|++|.+++..+ ..|+++++|
T Consensus 71 ~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L 150 (844)
T 3j0a_A 71 NLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSL 150 (844)
T ss_dssp SCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSC
T ss_pred CCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCC
Confidence 3566777777777777666677777777777777777766544443 6677777777777777665543 456777777
Q ss_pred CeeecccccccccCC-CC--------------------------CC----------------------------------
Q 038671 78 TLLTLENNQLRGPIP-NL--------------------------RN---------------------------------- 96 (707)
Q Consensus 78 ~~L~l~~n~i~~~~~-~l--------------------------~~---------------------------------- 96 (707)
++|+|++|.++...+ .+ ..
T Consensus 151 ~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~ 230 (844)
T 3j0a_A 151 KSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISK 230 (844)
T ss_dssp CEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCS
T ss_pred CEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCc
Confidence 777777766543111 00 00
Q ss_pred ----------------------------------CCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCC
Q 038671 97 ----------------------------------LTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDW 142 (707)
Q Consensus 97 ----------------------------------l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~ 142 (707)
.++|+.|++++|.++.+.+..|..+++|+.|+|++|.++.+.+..|
T Consensus 231 ~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~ 310 (844)
T 3j0a_A 231 SQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAF 310 (844)
T ss_dssp CCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTT
T ss_pred ccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHh
Confidence 0234444444444444444555556666666666666666666666
Q ss_pred CCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCc-----------
Q 038671 143 GRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLS----------- 211 (707)
Q Consensus 143 ~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----------- 211 (707)
..+++|++|+|++|.+++..+..|..+++|+.|++++|.+....+..|..+++|++|++++|.+++...
T Consensus 311 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~ 390 (844)
T 3j0a_A 311 YGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSG 390 (844)
T ss_dssp TTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEES
T ss_pred cCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCC
Confidence 666666666666666665556666666666666666666665555556666666666666666553110
Q ss_pred -----------------------------cccCCCCcccEEEccCCccCCCC----------------------------
Q 038671 212 -----------------------------LELGSLTQLERLDLSSNRLSNSI---------------------------- 234 (707)
Q Consensus 212 -----------------------------~~~~~l~~L~~L~l~~n~i~~~~---------------------------- 234 (707)
..+..+++|++|+|++|++++..
T Consensus 391 N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~ 470 (844)
T 3j0a_A 391 NKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETE 470 (844)
T ss_dssp CCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSC
T ss_pred CCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccc
Confidence 00123445555555555544221
Q ss_pred --CccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhcc
Q 038671 235 --PKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEE 312 (707)
Q Consensus 235 --~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~ 312 (707)
+..|.++++|+.|+|++|.+++..+..|.++++|+.|+|++|.+++..+..+. ++|+.|++++|++++..|+.
T Consensus 471 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--- 545 (844)
T 3j0a_A 471 LCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--- 545 (844)
T ss_dssp CCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC---
T ss_pred cchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH---
Confidence 12344555666666666666665566666666666666666666655554444 56667777777776665544
Q ss_pred CCCceeEeeccCcccccCCCc
Q 038671 313 LHGLSYIDISYNELHGSIPNS 333 (707)
Q Consensus 313 ~~~L~~l~l~~n~~~~~~~~~ 333 (707)
+.+|+.|++++|+|.|.|+..
T Consensus 546 ~~~L~~l~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 546 FVSLSVLDITHNKFICECELS 566 (844)
T ss_dssp CSSCCEEEEEEECCCCSSSCC
T ss_pred hCCcCEEEecCCCcccccccH
Confidence 347888999999999988753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=333.21 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=185.1
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeee-------
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCS------- 505 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~------- 505 (707)
..+|++.+.||+|+||.||+|+ ..+++.||+|++... .....+.+.+|+..+.++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 4579999999999999999996 457999999988543 2334567899999999996 999999999983
Q ss_pred -cCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeecCCCCeEE
Q 038671 506 -HARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP--IVHRDISSKNVLLDLENEAHV 582 (707)
Q Consensus 506 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nil~~~~~~~kl 582 (707)
.....+++|||+. |+|.+++........+++..++.++.||+.||+|||+. + |+||||||+||+++.++.+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 3445799999996 78888886544455799999999999999999999999 8 999999999999999999999
Q ss_pred eccccceecCCCCCC------------ccccccccCCCCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCccccc
Q 038671 583 SDFGTAKFLKPDSSN------------WAELAGTYGYVAPELA---YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI 647 (707)
Q Consensus 583 ~Dfg~~~~~~~~~~~------------~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 647 (707)
+|||++......... .....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 999999876543221 1134689999999988 5667889999999999999999999998632211
Q ss_pred ccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 648 SSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 648 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
........ .+.... .+..+.+++.+||+.||++||++.|+++.|+
T Consensus 260 --------~~~~~~~~--~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 260 --------RIVNGKYS--IPPHDT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp --------------CC--CCTTCC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred --------HhhcCccc--CCcccc----cchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 11111111 111111 1223788999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=329.68 Aligned_cols=260 Identities=25% Similarity=0.400 Sum_probs=204.3
Q ss_pred hcCCCCCceeeecCCeeEEEEE-----cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC-
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-----LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR- 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~- 508 (707)
.++|++.+.||+|+||.||+++ ..+|+.||+|++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 4568999999999999999997 3468999999987532 234567899999999999999999999886544
Q ss_pred -ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 509 -HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 509 -~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+|||+
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred CceEEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence 789999999999999999653 24589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCC---ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccc-------ccccchh-hh
Q 038671 588 AKFLKPDSSN---WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI-------SSSSSNL-EI 656 (707)
Q Consensus 588 ~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~-------~~~~~~~-~~ 656 (707)
+......... .....++..|+|||.+.+..++.++||||||+++|+|+||..||...... ....... ..
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 9876544321 12235677899999999888999999999999999999999997532100 0000000 01
Q ss_pred hhhhhcC-CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 657 ALNEMLD-PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 657 ~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....... .+.+.+. ..+.++.+++.+||+.||++||++.++++.|+
T Consensus 272 ~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~ 318 (326)
T 2w1i_A 272 LIELLKNNGRLPRPD----GCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 318 (326)
T ss_dssp HHHHHHTTCCCCCCT----TCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCC----cccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 1111111 1222222 23456899999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=337.40 Aligned_cols=256 Identities=21% Similarity=0.325 Sum_probs=183.6
Q ss_pred HhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA----- 507 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 507 (707)
..++|++.+.||+|+||.||+|. ..+|+.||+|++...... ......+.+|+++++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 35789999999999999999995 567999999998764332 33556788999999999999999999998654
Q ss_pred -CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 508 -RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 508 -~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
...++|+|++ +++|.+++.. +.+++..++.++.||++||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999998 6899988853 3589999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccch------------
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN------------ 653 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~------------ 653 (707)
+++..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||............
T Consensus 178 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 178 LARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred cccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99865432 344678999999999876 67899999999999999999999999643321100000
Q ss_pred -------hhhhhhhhcCCCCCCCC--cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 654 -------LEIALNEMLDPRLPTPS--HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 654 -------~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
........ +..+... ......+..+.+++.+||..||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 255 KKISSESARNYIQSL--TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TTCCCHHHHHHHHTS--CCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhHHHHHHHhcc--CCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000000 0011000 000112356889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=337.93 Aligned_cols=258 Identities=21% Similarity=0.275 Sum_probs=195.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC------
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR------ 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------ 508 (707)
..+|++.+.||+|+||.||+|+...+..+|+|++...... ..+|+++++.++||||+++++++...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4579999999999999999998877777999988653221 236899999999999999999985443
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec-CCCCeEEecccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD-LENEAHVSDFGT 587 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~-~~~~~kl~Dfg~ 587 (707)
..++||||++++.+............+++..++.++.||++||+|||++ ||+||||||+||+++ .++.+||+|||+
T Consensus 112 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 112 FLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 3789999998876655544333445699999999999999999999999 999999999999999 799999999999
Q ss_pred ceecCCCCCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccch-----------hh
Q 038671 588 AKFLKPDSSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN-----------LE 655 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~-----------~~ 655 (707)
++....... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||............ ..
T Consensus 189 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 189 AKILIAGEP-NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CEECCTTCC-CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccccCCCC-CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 987654433 3446789999999998764 5899999999999999999999999753321100000 00
Q ss_pred hhhhhhcCCCCCCCCcc------hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 656 IALNEMLDPRLPTPSHN------VQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 656 ~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..........++..... ....+.++.+++.+||+.||++|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00011111112111100 0113456899999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=337.29 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=204.2
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchh--------------hhHHHHHHHHHHHhcCCCCceeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEM--------------ASQQEFLNEVKTLTGIRHRNIVKF 500 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~~ 500 (707)
.++|++.+.||+|+||.||+|.. +|+.||+|++........ ...+.+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999987 899999999864211110 012678999999999999999999
Q ss_pred eeeeecCCceeEEEeeeccCcHHHH------HhcccccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCee
Q 038671 501 YGFCSHARHSFIVYEYLEMGSLAMI------LSNDAAAKDLGWTKRMNVIKGVVDALSYMHN-DCFPPIVHRDISSKNVL 573 (707)
Q Consensus 501 ~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nil 573 (707)
++++.+.+..++||||+++++|.++ +.. .....+++..++.++.|++.||+|||+ . |++||||||+||+
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence 9999999999999999999999988 532 124568999999999999999999999 8 9999999999999
Q ss_pred ecCCCCeEEeccccceecCCCCCCccccccccCCCCccccccC-CCCc-cchhHHHHHHHHHHHhCCCCCCccccccccc
Q 038671 574 LDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTM-KVTE-KCDVYSFGVLALEVIKGKHPRDFISSISSSS 651 (707)
Q Consensus 574 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 651 (707)
++.++.+||+|||.+...... ......|++.|+|||.+.+. .++. ++||||||+++|+|++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence 999999999999999876433 33456789999999999877 5666 999999999999999999999643220
Q ss_pred chhhhhhhhhcCCCCCCCCc---------------chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 652 SNLEIALNEMLDPRLPTPSH---------------NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 652 ~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
......+.......+.. .....+.++.+++.+||+.||.+||++.|+++
T Consensus 259 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 ---VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ---HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11122222221111100 00233456899999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=355.85 Aligned_cols=246 Identities=27% Similarity=0.412 Sum_probs=195.6
Q ss_pred ceeeecCCeeEEEEEc---CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeec
Q 038671 442 HCIGKGGQGSVYKAEL---PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLE 518 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 518 (707)
+.||+|+||.||+|.. ..++.||||++.... ......+++.+|++++++++||||+++++++.. +..++||||+.
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 4799999999999943 356889999987542 222345789999999999999999999999964 56889999999
Q ss_pred cCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCC-
Q 038671 519 MGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN- 597 (707)
Q Consensus 519 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 597 (707)
+|+|.+++... +.+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 453 ~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 453 LGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp TEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999999643 4589999999999999999999999 9999999999999999999999999999876544321
Q ss_pred --ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 598 --WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 598 --~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.....+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ......+.... +...+.
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~~~~i~~~~--~~~~p~---- 595 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKGE--RMGCPA---- 595 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTC--CCCCCT----
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCC--CCCCCC----
Confidence 223346788999999999999999999999999999998 9999964322 11112222222 222222
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++..||+.||++||++++|++.|+
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~ 627 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 627 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 23456899999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.29 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=194.3
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec------
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH------ 506 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------ 506 (707)
+.++|++.+.||+|+||.||+|+. .+|+.||+|++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhh
Confidence 456799999999999999999964 5799999999853 23345778999999999999999999998754
Q ss_pred -------CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC
Q 038671 507 -------ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE 579 (707)
Q Consensus 507 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~ 579 (707)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.
T Consensus 80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 80 PMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred hhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 457899999999999999996432 3578899999999999999999999 9999999999999999999
Q ss_pred eEEeccccceecCCCC--------------CCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcc
Q 038671 580 AHVSDFGTAKFLKPDS--------------SNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFI 644 (707)
Q Consensus 580 ~kl~Dfg~~~~~~~~~--------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~ 644 (707)
+||+|||.+....... .......|++.|+|||.+.+. .++.++||||||+++|+|++ ||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 9999999997654321 122345689999999998764 68999999999999999998 54311
Q ss_pred cccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 645 SSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 645 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.........+.......+.......+..+.+++.+||+.||.+|||+.++++.
T Consensus 232 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 -------MERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -------HHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------hhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 11111222222222222222223344568899999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=339.13 Aligned_cols=272 Identities=20% Similarity=0.273 Sum_probs=199.6
Q ss_pred chHHHHHHHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCc--------hhhhHHHHHHHHHHHhcCCCCce
Q 038671 426 IVYEEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPS--------EMASQQEFLNEVKTLTGIRHRNI 497 (707)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~~~~e~~~l~~l~h~ni 497 (707)
....++..+.++|++.+.||+|+||.||+|...+|+.||||++...... .....+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3456778889999999999999999999998888999999998643221 12234678999999999999999
Q ss_pred eeeeeeeec-----CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 038671 498 VKFYGFCSH-----ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572 (707)
Q Consensus 498 v~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 572 (707)
+++++++.. ....++||||+. |+|.+++... ...+++..++.++.||+.||+|||+. ||+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ--RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999999843 346799999998 5777777533 34689999999999999999999999 999999999999
Q ss_pred eecCCCCeEEeccccceecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccc
Q 038671 573 LLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS 651 (707)
Q Consensus 573 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 651 (707)
+++.++.+||+|||++....... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA-NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp EECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EEcCCCCEEEEecCccccccccc-ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999997544332 2344578999999998876 668999999999999999999999997432111000
Q ss_pred chhh---------------hhhhhhcCCCCC-CCCcc----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 652 SNLE---------------IALNEMLDPRLP-TPSHN----VQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 652 ~~~~---------------~~~~~~~~~~~~-~~~~~----~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.... ............ .+... .+..+..+.+++.+||+.||++|||+.|+++.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0000 000000101110 11111 11224568899999999999999999999863
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=334.18 Aligned_cols=260 Identities=22% Similarity=0.293 Sum_probs=199.4
Q ss_pred HhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA----- 507 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 507 (707)
..++|++.+.||+|+||.||+|. ..+++.||+|++.... .....+.+.+|++++++++||||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 34689999999999999999995 4578899999987532 233456789999999999999999999998654
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
...++||||+. ++|.+++.. ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence 46899999997 589888853 3589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC---CccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchh---------
Q 038671 588 AKFLKPDSS---NWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL--------- 654 (707)
Q Consensus 588 ~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~--------- 654 (707)
+........ ......||+.|+|||++.+ ..++.++||||+|+++|+|++|+.||.............
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 254 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 987653322 1244589999999998654 458999999999999999999999996433211000000
Q ss_pred ----------hhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 655 ----------EIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 655 ----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
......................+.++.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000000001122456889999999999999999999986
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=341.83 Aligned_cols=343 Identities=20% Similarity=0.230 Sum_probs=300.1
Q ss_pred ceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCc-ccCCccccCCCCCCeeeccc
Q 038671 6 AFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALS-GAIPKEYGNLVKLTLLTLEN 84 (707)
Q Consensus 6 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~l~~ 84 (707)
+.++.++++++ .+|. +. ++|++|+|++|++++..|..|.++++|++|+|++|.+. ...+..|.++++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 46888899998 6676 43 69999999999999888999999999999999999997 35578899999999999999
Q ss_pred ccccccC-CCCCCCCCccEEEeccCccccc--cCccccCCCCCcEEEcccccccccCCCC-CCCCCCCcEEEcCCCccCC
Q 038671 85 NQLRGPI-PNLRNLTSLVRVRLNQNHLTGN--ISESFGIHPNLAFIDLSHNYFYGEISSD-WGRCPKLGTLDFSSNNITG 160 (707)
Q Consensus 85 n~i~~~~-~~l~~l~~L~~L~l~~n~l~~~--~~~~~~~~~~L~~L~L~~n~i~~~~~~~-~~~~~~L~~L~L~~n~i~~ 160 (707)
|.+.... ..+.++++|++|++++|++++. ....|..+++|++|+|++|.++.+.+.. +..+++|++|++++|.+++
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~ 168 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence 9998874 4699999999999999999873 3445899999999999999999887765 8999999999999999998
Q ss_pred CCchhhhCC--CCCCEEeCCCCCCCCCCChh--------hhCCCCCcEEEecCCccccCCccccC---------------
Q 038671 161 SMPAEIIHS--SQLKVLDLSSNHIVGEMPSK--------LGKLSSLIKLILNSNQLCGQLSLELG--------------- 215 (707)
Q Consensus 161 ~~~~~~~~~--~~L~~L~l~~n~l~~~~~~~--------~~~l~~L~~L~l~~n~l~~~~~~~~~--------------- 215 (707)
..+..+..+ .+|+.|++++|.+.+..+.. +..+++|++|++++|.+++..+..+.
T Consensus 169 ~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~ 248 (455)
T 3v47_A 169 ICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN 248 (455)
T ss_dssp CCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTT
T ss_pred cChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecc
Confidence 888888776 78999999999998655443 33668999999999998754443321
Q ss_pred ------------------------CCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCee
Q 038671 216 ------------------------SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSEL 271 (707)
Q Consensus 216 ------------------------~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 271 (707)
..++|++|++++|.+++..+..|..+++|+.|+|++|.+.+..+..|.++++|+.|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 328 (455)
T 3v47_A 249 SYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKL 328 (455)
T ss_dssp CTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEE
Confidence 12689999999999998899999999999999999999999989999999999999
Q ss_pred eecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCCc-cccccCchhhcccCcCc
Q 038671 272 DLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNS-TAFRDAPMEALQGNKGL 350 (707)
Q Consensus 272 ~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~-~~~~~~~~~~~~~~~~~ 350 (707)
++++|.+++..+..+..+++|+.|++++|++++..|..+..+++|+.|++++|++++.++.. ..+.......+.+|+..
T Consensus 329 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 408 (455)
T 3v47_A 329 NLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408 (455)
T ss_dssp ECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcc
Confidence 99999998888889999999999999999999888999999999999999999999877654 45667777888899887
Q ss_pred CC
Q 038671 351 CG 352 (707)
Q Consensus 351 c~ 352 (707)
|.
T Consensus 409 ~~ 410 (455)
T 3v47_A 409 CS 410 (455)
T ss_dssp CC
T ss_pred cC
Confidence 64
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=341.14 Aligned_cols=257 Identities=19% Similarity=0.281 Sum_probs=202.4
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCC-CceeeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH-RNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~l 512 (707)
.++|++.+.||+|+||.||+|. ..+++.||||++...... ..+.+|+++++.++| ++++.+..++...+..++
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 4789999999999999999996 467999999987654322 347789999999976 666667777788888999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee---cCCCCeEEeccccce
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL---DLENEAHVSDFGTAK 589 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~---~~~~~~kl~Dfg~~~ 589 (707)
||||+ +++|.+++... .+.+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 81 vme~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (483)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEECC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence 99999 99999999632 34699999999999999999999999 99999999999999 578999999999998
Q ss_pred ecCCCCCC-------ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhc
Q 038671 590 FLKPDSSN-------WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML 662 (707)
Q Consensus 590 ~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 662 (707)
........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~ 233 (483)
T 3sv0_A 155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKV 233 (483)
T ss_dssp ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSH-HHHHHHHHHHHH
T ss_pred eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhH-HHHHHHHhhccc
Confidence 76644321 2256799999999999999999999999999999999999999975332110 111111111111
Q ss_pred CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 663 DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 663 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..... ......+.++.+++..||+.||++||++++|++.|+
T Consensus 234 ~~~~~---~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~ 274 (483)
T 3sv0_A 234 ATSIE---ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR 274 (483)
T ss_dssp HSCHH---HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred cccHH---HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 10000 001122456899999999999999999999998874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.72 Aligned_cols=197 Identities=20% Similarity=0.305 Sum_probs=169.9
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC------CCCceeeeeeeeecC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI------RHRNIVKFYGFCSHA 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~ 507 (707)
..+|++.+.||+|+||.||+|. ..+++.||||++... ......+.+|+++++.+ +|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 4679999999999999999995 556899999998643 22345566777777766 578999999999999
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC--eEEecc
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE--AHVSDF 585 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~--~kl~Df 585 (707)
+..++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++. +||+||
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF 246 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF 246 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred CeEEEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence 99999999996 68888886543 24589999999999999999999999 9999999999999999887 999999
Q ss_pred ccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF 643 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 643 (707)
|++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 247 G~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 247 GSSCYEHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp TTCEETTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccceecCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 999765432 3346889999999999999999999999999999999999999964
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=350.70 Aligned_cols=348 Identities=21% Similarity=0.199 Sum_probs=252.9
Q ss_pred CCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeec
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTL 82 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 82 (707)
+++++|+|++|.+++..+..|.++++|++|+|++|++++..++.|.++++|++|+|++|.+++..|..|+++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 35777777777777777777777777777777777777666677777777777777777777776777777777777777
Q ss_pred ccccccccCC-CCCCCCCccEEEeccCccccc-cCccccCCCCCcEEEcccccccccCCCCCC-----------------
Q 038671 83 ENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGN-ISESFGIHPNLAFIDLSHNYFYGEISSDWG----------------- 143 (707)
Q Consensus 83 ~~n~i~~~~~-~l~~l~~L~~L~l~~n~l~~~-~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~----------------- 143 (707)
++|.++.+++ .+.++++|++|++++|.++.+ .+..|+.+++|++|++++|.++.+.+..+.
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 7777776655 477777777777777777764 356677777777777777766544332222
Q ss_pred --------------------------------------------------------------------------------
Q 038671 144 -------------------------------------------------------------------------------- 143 (707)
Q Consensus 144 -------------------------------------------------------------------------------- 143 (707)
T Consensus 188 ~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~ 267 (570)
T 2z63_A 188 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267 (570)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEET
T ss_pred CceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcc
Confidence
Q ss_pred ------------CCCCCcEEEcCCCccCCCCchhh------------------------------------------hCC
Q 038671 144 ------------RCPKLGTLDFSSNNITGSMPAEI------------------------------------------IHS 169 (707)
Q Consensus 144 ------------~~~~L~~L~L~~n~i~~~~~~~~------------------------------------------~~~ 169 (707)
.+++|++|++++|.++. .+..+ ..+
T Consensus 268 ~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~ 346 (570)
T 2z63_A 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDL 346 (570)
T ss_dssp TEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBC
T ss_pred hhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccC
Confidence 23445555555444442 22111 234
Q ss_pred CCCCEEeCCCCCCCCCC--ChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCC-ccccCcccCce
Q 038671 170 SQLKVLDLSSNHIVGEM--PSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIP-KSLGNLVKLHY 246 (707)
Q Consensus 170 ~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~l~~l~~L~~ 246 (707)
++|+.|++++|.+++.. +..+..+++|++|++++|.+++..+. +..+++|++|++++|.+++..+ ..+.++++|++
T Consensus 347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 425 (570)
T 2z63_A 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425 (570)
T ss_dssp TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCE
T ss_pred CCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCE
Confidence 55666666666665332 55666777777777777777754443 7788888888888888876655 56788888999
Q ss_pred EeeecccccccCchhhhhcccCCeeeecCccCC-CCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCc
Q 038671 247 LNLSNNQFIKKIPVELEKLIHLSELDLSHNFLG-EEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNE 325 (707)
Q Consensus 247 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~ 325 (707)
|++++|.+.+..+..+.++++|+.|++++|.++ +..|..+..+++|+.|++++|++++..|..+..+++|+.|++++|+
T Consensus 426 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 505 (570)
T 2z63_A 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505 (570)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCc
Confidence 999999888888888888899999999999886 4678888889999999999999988878888889999999999999
Q ss_pred ccccCCC-ccccccCchhhcccCcCcCC
Q 038671 326 LHGSIPN-STAFRDAPMEALQGNKGLCG 352 (707)
Q Consensus 326 ~~~~~~~-~~~~~~~~~~~~~~~~~~c~ 352 (707)
+++.++. ...+.......+.+|+..|.
T Consensus 506 l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 506 LKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 9887765 34456666777788877663
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=331.78 Aligned_cols=258 Identities=20% Similarity=0.307 Sum_probs=196.7
Q ss_pred HhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce--
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS-- 510 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-- 510 (707)
+.++|.+.+.||+|+||.||+|. ..+|+.||+|++...... ......+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 35789999999999999999995 557999999999765433 23457788999999999999999999999876654
Q ss_pred ----eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 511 ----FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 511 ----~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
++||||+. ++|.+.+. ..+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred ceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999997 58887763 3489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccch------------
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN------------ 653 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~------------ 653 (707)
++...... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||............
T Consensus 190 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 190 LARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp CC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 99865432 344578999999999887 67899999999999999999999999743211100000
Q ss_pred -------hhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 654 -------LEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 654 -------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.......................+.++.+++.+||+.||++|||++|+++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000000000000011224568999999999999999999999863
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=349.56 Aligned_cols=328 Identities=25% Similarity=0.281 Sum_probs=169.1
Q ss_pred CceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcc-----cCC----ccccCCC
Q 038671 5 LAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSG-----AIP----KEYGNLV 75 (707)
Q Consensus 5 l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~-----~~~----~~~~~l~ 75 (707)
|++|+|++|.+++..|..|+.+++|++|+|++|++++..+..|.++++|++|++++|...+ .+| ..|..++
T Consensus 250 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~ 329 (680)
T 1ziw_A 250 LTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLK 329 (680)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCT
T ss_pred CCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCC
Confidence 5555555555555555555555555555555555554444444444444444444332211 011 1344444
Q ss_pred CCCeeecccccccccCCC-CCCCCCccEEEecc----------------------------CccccccCccccCCCCCcE
Q 038671 76 KLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQ----------------------------NHLTGNISESFGIHPNLAF 126 (707)
Q Consensus 76 ~L~~L~l~~n~i~~~~~~-l~~l~~L~~L~l~~----------------------------n~l~~~~~~~~~~~~~L~~ 126 (707)
+|++|++++|.+..+.+. +.++++|++|++++ |+++.+.+..|..+++|+.
T Consensus 330 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 409 (680)
T 1ziw_A 330 CLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV 409 (680)
T ss_dssp TCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCE
Confidence 455555555555443332 44444444444443 3333333444444444444
Q ss_pred EEccccccccc-CCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCC--CCCChhhhCCCCCcEEEecC
Q 038671 127 IDLSHNYFYGE-ISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIV--GEMPSKLGKLSSLIKLILNS 203 (707)
Q Consensus 127 L~L~~n~i~~~-~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~l~~ 203 (707)
|+|++|.+++. .+..|..+++|++|++++|.+++..+..|..+++|+.|++++|.+. +..|..|..+++|+.|++++
T Consensus 410 L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~ 489 (680)
T 1ziw_A 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489 (680)
T ss_dssp EECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCS
T ss_pred EeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCC
Confidence 44444444422 2234444444444444444444444444444455555555555443 23455555556666666666
Q ss_pred CccccCCccccCCCCcccEEEccCCccCCCCC--------ccccCcccCceEeeecccccccCchhhhhcccCCeeeecC
Q 038671 204 NQLCGQLSLELGSLTQLERLDLSSNRLSNSIP--------KSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275 (707)
Q Consensus 204 n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~--------~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 275 (707)
|++++..+..|..+++|++|++++|.+++..+ ..|.++++|+.|+|++|+++.+.+..|.++++|+.|++++
T Consensus 490 N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 569 (680)
T 1ziw_A 490 NNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGL 569 (680)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCC
Confidence 66665555555566666666666666553311 1245556666666666666544444566666666666666
Q ss_pred ccCCCCCCcccccccccceEeccccccCCchhHhhc-cCCCceeEeeccCcccccCCC
Q 038671 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFE-ELHGLSYIDISYNELHGSIPN 332 (707)
Q Consensus 276 n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~-~~~~L~~l~l~~n~~~~~~~~ 332 (707)
|.+++..+..|..+++|+.|++++|++++..+..+. .+++|+.|++++|+|.|.|+.
T Consensus 570 N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 570 NNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred CCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 666555555555666666666666666655555555 556666666666666666553
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=335.58 Aligned_cols=260 Identities=22% Similarity=0.276 Sum_probs=193.6
Q ss_pred HHHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec----
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH---- 506 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---- 506 (707)
....++|++.+.||+|+||.||+|. ..+|+.||+|++...... ..+|+++++.++||||+++++++..
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 3456789999999999999999995 568999999998654221 2369999999999999999999843
Q ss_pred ----------------------------------CCceeEEEeeeccCcHHHHHhcc-cccCCCChHHHHHHHHHHHHHH
Q 038671 507 ----------------------------------ARHSFIVYEYLEMGSLAMILSND-AAAKDLGWTKRMNVIKGVVDAL 551 (707)
Q Consensus 507 ----------------------------------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l 551 (707)
....++||||++ ++|.+.+... .....+++..++.++.||++||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 334889999998 4777766432 2235689999999999999999
Q ss_pred HHHHhCCCCCeEecCCCCCCeeec-CCCCeEEeccccceecCCCCCCccccccccCCCCccccccCC-CCccchhHHHHH
Q 038671 552 SYMHNDCFPPIVHRDISSKNVLLD-LENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGV 629 (707)
Q Consensus 552 ~~LH~~~~~~ivH~dlk~~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~ 629 (707)
+|||+. ||+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||.+.+.. ++.++||||+|+
T Consensus 155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC-CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC-CcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 999999 999999999999997 688999999999987654432 34457899999999887654 899999999999
Q ss_pred HHHHHHhCCCCCCcccccccccchh--------hh---hhhhhcCCCCCCCC-cc-----hHHHHHHHHHHHHhccCCCC
Q 038671 630 LALEVIKGKHPRDFISSISSSSSNL--------EI---ALNEMLDPRLPTPS-HN-----VQDKLISIMEVAISCLDESP 692 (707)
Q Consensus 630 ~l~el~tg~~p~~~~~~~~~~~~~~--------~~---~~~~~~~~~~~~~~-~~-----~~~~~~~l~~li~~cl~~~P 692 (707)
++|||++|+.||............. +. .........++... .. ....+.++.+++.+||+.||
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 9999999999997433211000000 00 00000011111100 00 01134458899999999999
Q ss_pred CCCCCHHHHHH
Q 038671 693 ESRPTIQKVSQ 703 (707)
Q Consensus 693 ~~Rps~~~l~~ 703 (707)
++|||+.|+++
T Consensus 311 ~~R~t~~e~l~ 321 (383)
T 3eb0_A 311 DLRINPYEAMA 321 (383)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHhc
Confidence 99999999985
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=326.93 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=198.4
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeec--CCce
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSH--ARHS 510 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~ 510 (707)
.++|++.+.||+|+||.||+|. ..+++.||+|++... ..+.+.+|++++++++ ||||+++++++.. ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 4679999999999999999995 567999999998642 2356889999999997 9999999999987 6678
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC-CeEEeccccce
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTAK 589 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~-~~kl~Dfg~~~ 589 (707)
++||||+.+++|.+++. .+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus 109 ~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 99999999999999874 378899999999999999999999 999999999999999777 89999999998
Q ss_pred ecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccc---------cchhhhhhh
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS---------SSNLEIALN 659 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---------~~~~~~~~~ 659 (707)
...... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......... .........
T Consensus 180 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 180 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp ECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred EcCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 765443 2345678999999999877 66899999999999999999999998432110000 000000000
Q ss_pred h-----------hcCCCCC------CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 660 E-----------MLDPRLP------TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 660 ~-----------~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
. ....... .........+.++.+++.+||+.||++|||++|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 0000000 0000111234568999999999999999999999873
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=328.84 Aligned_cols=253 Identities=20% Similarity=0.260 Sum_probs=172.8
Q ss_pred HhcCCCCCc-eeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec----C
Q 038671 434 VTNDFDDEH-CIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH----A 507 (707)
Q Consensus 434 ~~~~~~~~~-~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~ 507 (707)
+.++|++.+ .||+|+||.||+|.. .+|+.||+|++... .... .+....+..++||||+++++++.. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 456888855 699999999999965 47999999998542 1111 222334556689999999999876 4
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC---CCCeEEec
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL---ENEAHVSD 584 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~---~~~~kl~D 584 (707)
...++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+. ||+||||||+||+++. ++.+||+|
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred ceEEEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence 55899999999999999997543 34689999999999999999999999 9999999999999976 44599999
Q ss_pred cccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC
Q 038671 585 FGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP 664 (707)
Q Consensus 585 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 664 (707)
||++...... ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||........ ...........
T Consensus 175 fg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~ 248 (336)
T 3fhr_A 175 FGFAKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI----SPGMKRRIRLG 248 (336)
T ss_dssp CTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------------
T ss_pred cccceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh----hhhHHHhhhcc
Confidence 9999875532 23445789999999999888899999999999999999999999964322110 00011111111
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
....+.......+.++.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111111234456899999999999999999999986
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=351.36 Aligned_cols=344 Identities=21% Similarity=0.202 Sum_probs=235.0
Q ss_pred CCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeec
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTL 82 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 82 (707)
++|++|+|++|.+++..+..|+++++|++|+|++|++++..|.+|.++++|++|+|++|.+++..|..|+++++|++|++
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 46788888888888777778888888888888888888777778888888888888888888777888888888888888
Q ss_pred ccccccccC-CCCCCCCCccEEEeccCcccccc-CccccCCCCCcEEEcccccccccCCCCCCCCC--------------
Q 038671 83 ENNQLRGPI-PNLRNLTSLVRVRLNQNHLTGNI-SESFGIHPNLAFIDLSHNYFYGEISSDWGRCP-------------- 146 (707)
Q Consensus 83 ~~n~i~~~~-~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~-------------- 146 (707)
++|.+..++ ..+.++++|++|++++|.++++. +..|+.+++|++|++++|.++++.+..|..++
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 888887766 35788888888888888887643 66778888888888888877655444332221
Q ss_pred -------------CCcEEEcCC----------------------------------------------------------
Q 038671 147 -------------KLGTLDFSS---------------------------------------------------------- 155 (707)
Q Consensus 147 -------------~L~~L~L~~---------------------------------------------------------- 155 (707)
+|++|++++
T Consensus 192 ~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~ 271 (606)
T 3vq2_A 192 PIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYT 271 (606)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCC
T ss_pred CcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecccc
Confidence 222222222
Q ss_pred ---------------------------------------------CccCCCCc--------------------hhhhCCC
Q 038671 156 ---------------------------------------------NNITGSMP--------------------AEIIHSS 170 (707)
Q Consensus 156 ---------------------------------------------n~i~~~~~--------------------~~~~~~~ 170 (707)
|.++ ..+ ..+..++
T Consensus 272 ~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~-~lp~~~l~~L~~L~l~~n~~~~~~~~~~l~ 350 (606)
T 3vq2_A 272 NDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK-QFPTLDLPFLKSLTLTMNKGSISFKKVALP 350 (606)
T ss_dssp TTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCS-SCCCCCCSSCCEEEEESCSSCEECCCCCCT
T ss_pred ccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCc-ccccCCCCccceeeccCCcCccchhhccCC
Confidence 2221 111 0122334
Q ss_pred CCCEEeCCCCCCCCC--CChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCC-ccccCcccCceE
Q 038671 171 QLKVLDLSSNHIVGE--MPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIP-KSLGNLVKLHYL 247 (707)
Q Consensus 171 ~L~~L~l~~n~l~~~--~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~l~~l~~L~~L 247 (707)
+|+.|++++|.+++. .+..+..+++|++|++++|.+++ .+..+..+++|+.|++++|.+.+..+ ..+.++++|+.|
T Consensus 351 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 429 (606)
T 3vq2_A 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429 (606)
T ss_dssp TCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEE
T ss_pred CCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEE
Confidence 555555555555433 25556666666666666666663 34566677777777777777776655 567777777777
Q ss_pred eeecccccccCchhhhhcccCCeeeecCccCCC-CCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcc
Q 038671 248 NLSNNQFIKKIPVELEKLIHLSELDLSHNFLGE-EMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNEL 326 (707)
Q Consensus 248 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~ 326 (707)
++++|.+.+..+..+..+++|++|++++|.+++ ..|..+..+++|+.|++++|++++..|..+..+++|+.|++++|++
T Consensus 430 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 509 (606)
T 3vq2_A 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNL 509 (606)
T ss_dssp ECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred ECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcC
Confidence 777777777677777777777777777777765 3566777777777777777777777677777777777777777777
Q ss_pred cccCCC-ccccccCchhhcccCc
Q 038671 327 HGSIPN-STAFRDAPMEALQGNK 348 (707)
Q Consensus 327 ~~~~~~-~~~~~~~~~~~~~~~~ 348 (707)
++.+|. ...+.......+.+|+
T Consensus 510 ~~~~~~~~~~l~~L~~L~l~~N~ 532 (606)
T 3vq2_A 510 LFLDSSHYNQLYSLSTLDCSFNR 532 (606)
T ss_dssp SCEEGGGTTTCTTCCEEECTTSC
T ss_pred CCcCHHHccCCCcCCEEECCCCc
Confidence 766443 2333444455555554
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=351.80 Aligned_cols=350 Identities=23% Similarity=0.241 Sum_probs=286.0
Q ss_pred CCCceeeccCCeeeecCCccccCCCC--CCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCee
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKS--LSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLL 80 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~--L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 80 (707)
++|+.|++++|.+++..|..|..++. |++|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|
T Consensus 222 ~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 301 (680)
T 1ziw_A 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEE
T ss_pred ccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEE
Confidence 67999999999999999999998865 9999999999998888999999999999999999999999999999999999
Q ss_pred ecccccccc------cC---C-CCCCCCCccEEEeccCccccccCccccCCCCCcEEEccccc-----------------
Q 038671 81 TLENNQLRG------PI---P-NLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNY----------------- 133 (707)
Q Consensus 81 ~l~~n~i~~------~~---~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~----------------- 133 (707)
++++|.... ++ . .+..+++|++|++++|.++++.+..|..+++|++|++++|.
T Consensus 302 ~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~ 381 (680)
T 1ziw_A 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381 (680)
T ss_dssp ECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTS
T ss_pred eccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccC
Confidence 999875442 22 1 58899999999999999999988888888877777776654
Q ss_pred -----------ccccCCCCCCCCCCCcEEEcCCCccCCCC-chhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEe
Q 038671 134 -----------FYGEISSDWGRCPKLGTLDFSSNNITGSM-PAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLIL 201 (707)
Q Consensus 134 -----------i~~~~~~~~~~~~~L~~L~L~~n~i~~~~-~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 201 (707)
++.+.+.+|..+++|+.|+|++|.+++.. ...+.++++|+.|++++|++.+..+..|..+++|++|++
T Consensus 382 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l 461 (680)
T 1ziw_A 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLML 461 (680)
T ss_dssp CCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEEC
T ss_pred cCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchh
Confidence 44445556666777777777777765433 356666777777777777776666667777777777777
Q ss_pred cCCccc--cCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCc--------hhhhhcccCCee
Q 038671 202 NSNQLC--GQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIP--------VELEKLIHLSEL 271 (707)
Q Consensus 202 ~~n~l~--~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~--------~~~~~l~~L~~L 271 (707)
++|.++ +..|..+..+++|++|++++|.++++.+..|.++++|++|++++|++++... ..+.++++|+.|
T Consensus 462 ~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L 541 (680)
T 1ziw_A 462 RRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHIL 541 (680)
T ss_dssp TTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEE
T ss_pred ccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEE
Confidence 777775 3567778888999999999999988888888999999999999998876532 237888999999
Q ss_pred eecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCCcc--ccccCchhhcccCcC
Q 038671 272 DLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST--AFRDAPMEALQGNKG 349 (707)
Q Consensus 272 ~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~--~~~~~~~~~~~~~~~ 349 (707)
+|++|.++...+..|..+++|+.|++++|++++..+..|..+++|+.|++++|++++.++... .+.......+.+|++
T Consensus 542 ~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~ 621 (680)
T 1ziw_A 542 NLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621 (680)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCC
T ss_pred ECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCc
Confidence 999999976666678999999999999999998877888899999999999999998776532 356667778889998
Q ss_pred cCC
Q 038671 350 LCG 352 (707)
Q Consensus 350 ~c~ 352 (707)
.|.
T Consensus 622 ~c~ 624 (680)
T 1ziw_A 622 DCT 624 (680)
T ss_dssp CBC
T ss_pred ccC
Confidence 884
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=330.45 Aligned_cols=258 Identities=23% Similarity=0.340 Sum_probs=197.7
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC-----
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA----- 507 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 507 (707)
+.++|++.+.||+|+||.||+|.. .+|+.||||++... ........+.+|++++++++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 356899999999999999999965 57899999998643 2233456788999999999999999999987654
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
...++||||+. ++|.+++.. +.+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 67899999997 589888864 3589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCC----------CccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCccccccccc-----
Q 038671 588 AKFLKPDSS----------NWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS----- 651 (707)
Q Consensus 588 ~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~----- 651 (707)
+........ ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 238 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI 238 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 987653321 1223578999999998764 678999999999999999999999996432110000
Q ss_pred ---------------chhhhhhhhhcCCCCCCC--CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 652 ---------------SNLEIALNEMLDPRLPTP--SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 652 ---------------~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.......... +..+.. ....+..+.++.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSL--PMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTS--CCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCchhccccccccchhhHHhhcc--cCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000 000100 0001123456889999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=335.32 Aligned_cols=259 Identities=20% Similarity=0.311 Sum_probs=198.8
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC--------CCceeeeeeeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR--------HRNIVKFYGFCS 505 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~ 505 (707)
.++|++.+.||+|+||.||+|+ ..+++.||+|++... ....+.+.+|+++++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 4789999999999999999995 567899999998642 234567889999999885 788999999987
Q ss_pred ----cCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC---
Q 038671 506 ----HARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN--- 578 (707)
Q Consensus 506 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~--- 578 (707)
.....++||||+.+ ++.+.+... ....+++..++.++.||+.||+|||+++ ||+||||||+||+++.++
T Consensus 112 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EEETTEEEEEEEECCCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred ecCCCCceEEEEEeccCc-cHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence 55689999999955 554444322 2245899999999999999999999964 899999999999999775
Q ss_pred ----------------------------------------------CeEEeccccceecCCCCCCccccccccCCCCccc
Q 038671 579 ----------------------------------------------EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL 612 (707)
Q Consensus 579 ----------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~ 612 (707)
.+||+|||.+...... .....||+.|+|||+
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence 7999999999876533 334578999999999
Q ss_pred cccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccc-hhhhhhhhhcC------------------C-----CCC-
Q 038671 613 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSS-NLEIALNEMLD------------------P-----RLP- 667 (707)
Q Consensus 613 ~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~------------------~-----~~~- 667 (707)
+.+..++.++||||||+++|||++|+.||........... ........... . ...
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 9999999999999999999999999999975332111000 00000000000 0 000
Q ss_pred -C----------CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 668 -T----------PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 668 -~----------~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
. ........+..+.+++.+||+.||++|||++|+++.
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 001234566789999999999999999999999863
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=329.56 Aligned_cols=254 Identities=23% Similarity=0.357 Sum_probs=197.7
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
..++|++.+.||+|+||.||+|..+. .+|+|++....... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv 107 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence 35789999999999999999997753 48999987543221 2234577899999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++... ...+++..++.++.||+.||+|||++ |++||||||+||+++ ++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 108 TSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred eecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 9999999999999643 34689999999999999999999999 999999999999998 78999999999875432
Q ss_pred C-----CCCccccccccCCCCcccccc---------CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhh
Q 038671 594 D-----SSNWAELAGTYGYVAPELAYT---------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN 659 (707)
Q Consensus 594 ~-----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 659 (707)
. ........|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ........
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~ 256 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-----EAIIWQMG 256 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-----HHHHHHHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHhc
Confidence 1 122334568999999998874 3478899999999999999999999964221 11111111
Q ss_pred hhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 660 EMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 660 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
....+..... ..+.++.+++.+||+.||++|||+.++++.|+
T Consensus 257 ~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 298 (319)
T 2y4i_B 257 TGMKPNLSQI-----GMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298 (319)
T ss_dssp TTCCCCCCCS-----SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred cCCCCCCCcC-----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 1111211110 12234889999999999999999999999886
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.64 Aligned_cols=264 Identities=22% Similarity=0.246 Sum_probs=187.5
Q ss_pred HHHHHHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC
Q 038671 429 EEIIRVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA 507 (707)
Q Consensus 429 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 507 (707)
.+.....++|++.+.||+|+||.||+|+. .+|+.||||++...... .....++++.+..++||||+++++++...
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 34456678999999999999999999965 57899999988653222 23456778888888999999999998654
Q ss_pred Cc-------eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHH--hCCCCCeEecCCCCCCeeecC-C
Q 038671 508 RH-------SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH--NDCFPPIVHRDISSKNVLLDL-E 577 (707)
Q Consensus 508 ~~-------~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~dlk~~Nil~~~-~ 577 (707)
+. .++||||+.++.+............+++..++.++.|++.||+||| +. ||+||||||+||+++. +
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp CSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred ccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence 33 7899999987544433322233456899999999999999999999 88 9999999999999997 8
Q ss_pred CCeEEeccccceecCCCCCCccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhh
Q 038671 578 NEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEI 656 (707)
Q Consensus 578 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 656 (707)
+.+||+|||++........ .....||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||....... ....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~----~~~~ 243 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSEP-NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG----QLHE 243 (360)
T ss_dssp TEEEECCCTTCBCCCTTSC-CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH
T ss_pred CcEEEeeCCCceecCCCCC-cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH----HHHH
Confidence 9999999999987654332 34457899999999986654 8999999999999999999999997432211 0111
Q ss_pred hhhhh----------cCCCCC---------CC-----CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 657 ALNEM----------LDPRLP---------TP-----SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 657 ~~~~~----------~~~~~~---------~~-----~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
..... ..+... .+ .......+.++.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11000 000000 00 00001134679999999999999999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=339.97 Aligned_cols=262 Identities=20% Similarity=0.285 Sum_probs=181.8
Q ss_pred HhcCCCC-CceeeecCCeeEEEEEcC---CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeee--cC
Q 038671 434 VTNDFDD-EHCIGKGGQGSVYKAELP---SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCS--HA 507 (707)
Q Consensus 434 ~~~~~~~-~~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~ 507 (707)
+.+.|++ +++||+|+||.||+|+.+ +++.||+|++..... ...+.+|++++++++||||+++++++. ..
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHAD 92 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCC
Confidence 3455766 558999999999999754 578999999875422 235778999999999999999999994 46
Q ss_pred CceeEEEeeeccCcHHHHHhcccc------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee----cCC
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAA------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL----DLE 577 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~----~~~ 577 (707)
...++||||+.+ +|.+++..... ...+++..++.++.||+.||+|||+. ||+||||||+||++ +.+
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 93 RKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTT
T ss_pred CeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCC
Confidence 789999999975 77776643221 22489999999999999999999999 99999999999999 677
Q ss_pred CCeEEeccccceecCCCC---CCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCccccccc----
Q 038671 578 NEAHVSDFGTAKFLKPDS---SNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISS---- 649 (707)
Q Consensus 578 ~~~kl~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~---- 649 (707)
+.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 899999999998765332 223446789999999998874 489999999999999999999999964222100
Q ss_pred -ccchhhhhhhhhcCCCCCCC----------------------CcchH--------HHHHHHHHHHHhccCCCCCCCCCH
Q 038671 650 -SSSNLEIALNEMLDPRLPTP----------------------SHNVQ--------DKLISIMEVAISCLDESPESRPTI 698 (707)
Q Consensus 650 -~~~~~~~~~~~~~~~~~~~~----------------------~~~~~--------~~~~~l~~li~~cl~~~P~~Rps~ 698 (707)
...........+..+..... ..... .....+.+++.+||+.||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 00011111111100000000 00000 003457899999999999999999
Q ss_pred HHHHHH
Q 038671 699 QKVSQL 704 (707)
Q Consensus 699 ~~l~~~ 704 (707)
+|+++.
T Consensus 329 ~e~L~h 334 (405)
T 3rgf_A 329 EQAMQD 334 (405)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=333.94 Aligned_cols=256 Identities=25% Similarity=0.317 Sum_probs=191.2
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------C
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA------R 508 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~ 508 (707)
.+|++.+.||+|+||.||+|+. .+|+.||||++..... ...+|+++++.++||||+++++++... .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 4688999999999999999965 5699999999865321 123699999999999999999988432 2
Q ss_pred ceeEEEeeeccCcHHHHHhc-ccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC-CCeEEeccc
Q 038671 509 HSFIVYEYLEMGSLAMILSN-DAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE-NEAHVSDFG 586 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~-~~~kl~Dfg 586 (707)
..++||||+++ ++.+.+.. ......+++..++.++.||++||+|||++ ||+||||||+||+++.+ +.+||+|||
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccch
Confidence 36799999986 55554432 22345689999999999999999999999 99999999999999965 568999999
Q ss_pred cceecCCCCCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhh-------hhh
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE-------IAL 658 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-------~~~ 658 (707)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.............. ..+
T Consensus 203 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 203 SAKQLVRGEP-NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp TCEECCTTCC-CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhhhcccCCC-ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9987654332 3446789999999998764 689999999999999999999999975332110000000 000
Q ss_pred hhh----cCCCCCCCCc-ch-----HHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 659 NEM----LDPRLPTPSH-NV-----QDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 659 ~~~----~~~~~~~~~~-~~-----~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+ ....++.... .. ...+.++.+++.+||..||++||++.|+++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000 1111111100 00 122456899999999999999999999975
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.20 Aligned_cols=333 Identities=23% Similarity=0.240 Sum_probs=288.3
Q ss_pred CCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeee
Q 038671 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLT 81 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 81 (707)
++++++|++++|.++...+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 123 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence 57899999999999977666689999999999999999988888999999999999999999998899999999999999
Q ss_pred cccccccccCCC-CCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCC
Q 038671 82 LENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITG 160 (707)
Q Consensus 82 l~~n~i~~~~~~-l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~ 160 (707)
+++|.++.+++. +..+++|++|++++|+++.+.+..|..+++|++|++++|.++.+ .+..+++|+.|++++|.+++
T Consensus 124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~ 200 (390)
T 3o6n_A 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST 200 (390)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc
Confidence 999999988876 68999999999999999999999999999999999999999876 46778999999999999873
Q ss_pred CCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccC
Q 038671 161 SMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN 240 (707)
Q Consensus 161 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~ 240 (707)
+...++|+.|++++|.+... +. ...++|++|++++|.+++. ..+..+++|++|+|++|.+++..|..|..
T Consensus 201 -----~~~~~~L~~L~l~~n~l~~~-~~--~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~ 270 (390)
T 3o6n_A 201 -----LAIPIAVEELDASHNSINVV-RG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVK 270 (390)
T ss_dssp -----EECCSSCSEEECCSSCCCEE-EC--CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTT
T ss_pred -----cCCCCcceEEECCCCeeeec-cc--cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccc
Confidence 34457899999999999844 33 2347999999999999854 57889999999999999999888999999
Q ss_pred cccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEe
Q 038671 241 LVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYID 320 (707)
Q Consensus 241 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~ 320 (707)
+++|+.|+|++|++++. +..+..+++|+.|++++|.++ ..|..+..+++|+.|++++|++++.. +..+++|+.|+
T Consensus 271 l~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~ 345 (390)
T 3o6n_A 271 MQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLT 345 (390)
T ss_dssp CSSCCEEECCSSCCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEE
T ss_pred cccCCEEECCCCcCccc-CcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC---chhhccCCEEE
Confidence 99999999999999764 555678899999999999996 56677889999999999999998763 67889999999
Q ss_pred eccCcccccCCCccccccCchhhcccCcCcCCC
Q 038671 321 ISYNELHGSIPNSTAFRDAPMEALQGNKGLCGD 353 (707)
Q Consensus 321 l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~c~~ 353 (707)
+++|+|+|.+... .+..........++..|..
T Consensus 346 l~~N~~~~~~~~~-~~~~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 346 LSHNDWDCNSLRA-LFRNVARPAVDDADQHCKI 377 (390)
T ss_dssp CCSSCEEHHHHHH-HTTTCCTTTBCCCCSCCCT
T ss_pred cCCCCccchhHHH-HHHHHHhhcccccCceecc
Confidence 9999999975431 2233333344555555643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=322.45 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=196.9
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC--CCceeeeeeeeecCCcee
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR--HRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~ 511 (707)
..++|++.+.||+|+||.||++...+++.||+|++...... ....+.+.+|++++.+++ ||||+++++++..++..+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 35679999999999999999998888999999998654332 335677899999999997 599999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||| +.+++|.+++... ..+++..++.++.|+++||+|||+. +++||||||+||+++ ++.+||+|||++...
T Consensus 105 lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp EEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred EEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 9999 6688999998643 3589999999999999999999999 999999999999996 589999999999876
Q ss_pred CCCCC--CccccccccCCCCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhh
Q 038671 592 KPDSS--NWAELAGTYGYVAPELAYT-----------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIAL 658 (707)
Q Consensus 592 ~~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 658 (707)
..... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||..... . ....
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~-~~~~ 249 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------Q-ISKL 249 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS------H-HHHH
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH------H-HHHH
Confidence 54322 1234578999999999875 4688899999999999999999999963221 1 1112
Q ss_pred hhhcCCCCC--CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 659 NEMLDPRLP--TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 659 ~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
....++... .+.. .+.++.+++.+||+.||++||++.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 250 HAIIDPNHEIEFPDI----PEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHCTTSCCCCCCC----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhcccccCCccc----chHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 222222211 1111 13458899999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.53 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=178.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHH-HHhcCCCCceeeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVK-TLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
.++|++.+.||+|+||.||+|.. .+|+.||+|++...... ....++..|+. +++.++||||+++++++..++..++
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCH--HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCc--hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 36799999999999999999965 57999999999764322 23344555555 7778899999999999999999999
Q ss_pred EEeeeccCcHHHHHhcc--cccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 513 VYEYLEMGSLAMILSND--AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
||||+.+ +|.+++... .....+++..+..++.|++.||.|||+.. |++||||||+||+++.++.+||+|||++..
T Consensus 99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 9999985 777776431 12356899999999999999999999953 899999999999999999999999999987
Q ss_pred cCCCCCCccccccccCCCCcccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 591 LKPDSSNWAELAGTYGYVAPELA----YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 591 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
...... .....|++.|+|||.+ .+..++.++||||||+++|+|++|+.||...... ............
T Consensus 176 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~ 247 (327)
T 3aln_A 176 LVDSIA-KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------FDQLTQVVKGDP 247 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCC
T ss_pred cccccc-cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------HHHHHHHhcCCC
Confidence 653322 2334789999999998 4566899999999999999999999999642211 111111111111
Q ss_pred CC-CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 667 PT-PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 667 ~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+. +.......+.++.+++.+||+.||++||++.++++
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 11 11111123456899999999999999999999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=336.10 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=188.0
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 514 (707)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+++..++||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~ 88 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL 88 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence 445567889999999998776678999999997532 234577899999876 8999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCC----CChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC-------------
Q 038671 515 EYLEMGSLAMILSNDAAAKD----LGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE------------- 577 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~----l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~------------- 577 (707)
||+. |+|.+++........ .++..++.++.||+.||+|||+. ||+||||||+||+++.+
T Consensus 89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~ 164 (434)
T 2rio_A 89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAEN 164 (434)
T ss_dssp CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCc
Confidence 9996 699999975433211 23445678999999999999999 99999999999999754
Q ss_pred CCeEEeccccceecCCCCCC----ccccccccCCCCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCccc
Q 038671 578 NEAHVSDFGTAKFLKPDSSN----WAELAGTYGYVAPELAYT-------MKVTEKCDVYSFGVLALEVIK-GKHPRDFIS 645 (707)
Q Consensus 578 ~~~kl~Dfg~~~~~~~~~~~----~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~ 645 (707)
+.+||+|||++......... .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||....
T Consensus 165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 48999999999887644322 234579999999999875 568999999999999999999 999986321
Q ss_pred ccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 646 SISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
. ............... ........+.++.+++.+||+.||.+|||+.++++
T Consensus 245 ~------~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 S------RESNIIRGIFSLDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp T------HHHHHHHTCCCCCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred h------hHHHHhcCCCCcccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 111111111111111 11123456678999999999999999999999986
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=345.95 Aligned_cols=321 Identities=24% Similarity=0.247 Sum_probs=207.9
Q ss_pred CCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeec
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTL 82 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 82 (707)
++|++|+|++|.|++..+..|+.+++|++|+|++|++++..|++|.++++|++|+|++|.|+. +|.. .+++|++|++
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-ISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCE-ECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCc-cCcc--ccccCCEEEC
Confidence 356666666666665555666666666666666666666666666666666666666666663 3333 5666666666
Q ss_pred ccccccccC--CCCCCCCCccEEEeccCccccccCccccCCCCC--cEEEcccccc--cccCCCCCCCCC----------
Q 038671 83 ENNQLRGPI--PNLRNLTSLVRVRLNQNHLTGNISESFGIHPNL--AFIDLSHNYF--YGEISSDWGRCP---------- 146 (707)
Q Consensus 83 ~~n~i~~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L--~~L~L~~n~i--~~~~~~~~~~~~---------- 146 (707)
++|.++.++ ..+.++++|++|++++|+++.. .+..+++| ++|++++|.+ +...+..+..+.
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 205 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHP 205 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECS
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecC
Confidence 666666543 3466666666666666666542 23333333 6666666555 333333222211
Q ss_pred -----------------------------------------------------------------------CCcEEEcCC
Q 038671 147 -----------------------------------------------------------------------KLGTLDFSS 155 (707)
Q Consensus 147 -----------------------------------------------------------------------~L~~L~L~~ 155 (707)
+|++|++++
T Consensus 206 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~ 285 (562)
T 3a79_B 206 NSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285 (562)
T ss_dssp SSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEE
T ss_pred ccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEec
Confidence 455555555
Q ss_pred CccCCCCchhh-----------------------------------------------------hCCCCCCEEeCCCCCC
Q 038671 156 NNITGSMPAEI-----------------------------------------------------IHSSQLKVLDLSSNHI 182 (707)
Q Consensus 156 n~i~~~~~~~~-----------------------------------------------------~~~~~L~~L~l~~n~l 182 (707)
|.+++..+..+ ..+++|++|++++|.+
T Consensus 286 n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l 365 (562)
T 3a79_B 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF 365 (562)
T ss_dssp EEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCC
T ss_pred cEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEEECCCCcc
Confidence 55543333322 4567778888888887
Q ss_pred CCCCChhhhCCCCCcEEEecCCccccCC--ccccCCCCcccEEEccCCccCC-CCCccccCcccCceEeeecccccccCc
Q 038671 183 VGEMPSKLGKLSSLIKLILNSNQLCGQL--SLELGSLTQLERLDLSSNRLSN-SIPKSLGNLVKLHYLNLSNNQFIKKIP 259 (707)
Q Consensus 183 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~i~~-~~~~~l~~l~~L~~L~l~~n~l~~~~~ 259 (707)
++..|..+..+++|++|++++|++++.. +..+..+++|++|++++|.+++ ..+..+..+++|+.|++++|++++..+
T Consensus 366 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 445 (562)
T 3a79_B 366 TDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVF 445 (562)
T ss_dssp CTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGG
T ss_pred ccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchh
Confidence 7767777777888888888888877532 3557777888888888888876 444457777788888888887765544
Q ss_pred hhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCC
Q 038671 260 VELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332 (707)
Q Consensus 260 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~ 332 (707)
..+. ++|+.|++++|.++ .+|..+..+++|+.|++++|++++..+..+..+++|+.|++++|+|.|.|+.
T Consensus 446 ~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 446 RCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp SSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred hhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 4333 57888888888885 4555555778888888888888754444477788888888888888887764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=347.75 Aligned_cols=262 Identities=26% Similarity=0.315 Sum_probs=202.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec------C
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH------A 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~ 507 (707)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... .....+.+.+|++++++++||||+++++++.. .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 37899999999999999999965 568999999987643 23356779999999999999999999998755 6
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCC---eEEec
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENE---AHVSD 584 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~---~kl~D 584 (707)
+..++||||+++++|.+++........+++..++.++.|++.||+|||+. ||+||||||+||+++.++. +||+|
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence 77899999999999999998765555799999999999999999999999 9999999999999997765 99999
Q ss_pred cccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc------cchhhhhh
Q 038671 585 FGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS------SSNLEIAL 658 (707)
Q Consensus 585 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~------~~~~~~~~ 658 (707)
||.+....... ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||......... ........
T Consensus 168 FG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 168 LGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred ccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence 99998765433 334568999999999999999999999999999999999999998532110000 00000000
Q ss_pred h------hhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 038671 659 N------EMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVS 702 (707)
Q Consensus 659 ~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~ 702 (707)
. .......+.+.......+..+.+++.+||+.||++|||+.+++
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 0 0011122233333445677899999999999999999997754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=327.97 Aligned_cols=256 Identities=20% Similarity=0.302 Sum_probs=195.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc----
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH---- 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 509 (707)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... ......+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 46799999999999999999954 57999999998765433 2345678899999999999999999999977654
Q ss_pred --eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 510 --SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 510 --~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
.++||||+. ++|.+++. ..+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 58877663 2489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccch-------------
Q 038671 588 AKFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN------------- 653 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~------------- 653 (707)
+...... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||............
T Consensus 173 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 173 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp TTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred ccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9764422 334578999999998876 67899999999999999999999999743321100000
Q ss_pred ------hhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 654 ------LEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 654 ------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.......................+.++.+++.+||+.||++|||++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000000000001111233456899999999999999999999986
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=355.30 Aligned_cols=343 Identities=21% Similarity=0.276 Sum_probs=288.9
Q ss_pred CCCCCceeeccCCeeee-----------------cCCcccc--CCCCCCeEECCCCccccccCcCccCCCCCcEEEcccC
Q 038671 1 NLSNLAFLYLYNNSFSG-----------------SIPSEIG--RLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN 61 (707)
Q Consensus 1 nl~~l~~L~l~~n~i~~-----------------~~~~~~~--~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n 61 (707)
+|++|++|+|++|.+++ .+|..++ ++++|++|+|++|++.+.+|..|.++++|++|+|++|
T Consensus 446 ~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N 525 (876)
T 4ecn_A 446 RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525 (876)
T ss_dssp GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTC
T ss_pred cCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCC
Confidence 47899999999999998 3899988 9999999999999999899999999999999999999
Q ss_pred c-Ccc-cCCccccCCC-------CCCeeecccccccccCC--CCCCCCCccEEEeccCccccccCccccCCCCCcEEEcc
Q 038671 62 A-LSG-AIPKEYGNLV-------KLTLLTLENNQLRGPIP--NLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLS 130 (707)
Q Consensus 62 ~-i~~-~~~~~~~~l~-------~L~~L~l~~n~i~~~~~--~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~ 130 (707)
+ +++ .+|..+++++ +|++|+|++|.+..++. .+..+++|+.|+|++|+++.++ .|..+++|+.|+|+
T Consensus 526 ~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~Ls~N~l~~lp--~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLE--AFGTNVKLTDLKLD 603 (876)
T ss_dssp TTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEEECTTSCCCBCC--CCCTTSEESEEECC
T ss_pred CCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEEECCCCCcccch--hhcCCCcceEEECc
Confidence 8 887 6787666655 99999999999998777 7999999999999999999555 89999999999999
Q ss_pred cccccccCCCCCCCCCC-CcEEEcCCCccCCCCchhhhCCC--CCCEEeCCCCCCCCCCChh---hh--CCCCCcEEEec
Q 038671 131 HNYFYGEISSDWGRCPK-LGTLDFSSNNITGSMPAEIIHSS--QLKVLDLSSNHIVGEMPSK---LG--KLSSLIKLILN 202 (707)
Q Consensus 131 ~n~i~~~~~~~~~~~~~-L~~L~L~~n~i~~~~~~~~~~~~--~L~~L~l~~n~l~~~~~~~---~~--~l~~L~~L~l~ 202 (707)
+|.++ ..+..+..+++ |+.|+|++|.++ ..+..+..++ +|+.|+|++|.+.+.+|.. +. .+++|+.|+++
T Consensus 604 ~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls 681 (876)
T 4ecn_A 604 YNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLS 681 (876)
T ss_dssp SSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECC
T ss_pred CCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEcc
Confidence 99999 66677999999 999999999999 6677776654 4999999999998665532 22 34589999999
Q ss_pred CCccccCCccccCCCCcccEEEccCCccCCCCCccccC-------cccCceEeeecccccccCchhhh--hcccCCeeee
Q 038671 203 SNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN-------LVKLHYLNLSNNQFIKKIPVELE--KLIHLSELDL 273 (707)
Q Consensus 203 ~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~-------l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l 273 (707)
+|.++......+..+++|+.|+|++|.++.+.+..+.. +++|+.|+|++|+++ ..|..+. .+++|+.|+|
T Consensus 682 ~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~L 760 (876)
T 4ecn_A 682 YNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDV 760 (876)
T ss_dssp SSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEEC
T ss_pred CCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEe
Confidence 99999554444568999999999999999544444432 349999999999997 5566676 8999999999
Q ss_pred cCccCCCCCCcccccccccceEeccc------cccCCchhHhhccCCCceeEeeccCcccccCCCccccccCchhhcccC
Q 038671 274 SHNFLGEEMPSQICNMQSLEKLNLSH------NNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGN 347 (707)
Q Consensus 274 ~~n~l~~~~~~~~~~~~~L~~L~l~~------n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~ 347 (707)
++|.+++ +|..+..+++|+.|++++ |.+.+..|..+..+++|+.|++++|++ +.+|... .+......+.+|
T Consensus 761 s~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l-~~~L~~LdLs~N 837 (876)
T 4ecn_A 761 SYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL-TPQLYILDIADN 837 (876)
T ss_dssp CSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC-CSSSCEEECCSC
T ss_pred CCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhh-cCCCCEEECCCC
Confidence 9999977 688899999999999976 778888999999999999999999999 5555432 245555666677
Q ss_pred cCcC
Q 038671 348 KGLC 351 (707)
Q Consensus 348 ~~~c 351 (707)
+...
T Consensus 838 ~l~~ 841 (876)
T 4ecn_A 838 PNIS 841 (876)
T ss_dssp TTCE
T ss_pred CCCc
Confidence 6543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=344.00 Aligned_cols=321 Identities=24% Similarity=0.232 Sum_probs=193.2
Q ss_pred CCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeec
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTL 82 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 82 (707)
++|++|+|++|.+++..|..|..+++|++|+|++|++++..|++|.++++|++|+|++|+|+. +|.. .+++|++|++
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK-ISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCE-EECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceee-cCcc--ccCCccEEec
Confidence 356666666666665555666666666666666666665556666666666666666666663 3333 5666666666
Q ss_pred cccccccc--CCCCCCCCCccEEEeccCccccccCccccCCCCC--cEEEcccccc--cccCCCCCCCCC----------
Q 038671 83 ENNQLRGP--IPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNL--AFIDLSHNYF--YGEISSDWGRCP---------- 146 (707)
Q Consensus 83 ~~n~i~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L--~~L~L~~n~i--~~~~~~~~~~~~---------- 146 (707)
++|.++.+ +..+..+++|++|++++|+++. ..+..+++| ++|++++|.+ ....+..+..+.
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~ 174 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPT 174 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCS
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEecc
Confidence 66666542 2346666666666666666553 223333333 4444444444 222222222211
Q ss_pred -------------------------------------------------------------------------CCcEEEc
Q 038671 147 -------------------------------------------------------------------------KLGTLDF 153 (707)
Q Consensus 147 -------------------------------------------------------------------------~L~~L~L 153 (707)
+|++|++
T Consensus 175 n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l 254 (520)
T 2z7x_B 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254 (520)
T ss_dssp SSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEE
T ss_pred CcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEe
Confidence 3333333
Q ss_pred CCCccCCCCchhh-----------------------------------------------------hCCCCCCEEeCCCC
Q 038671 154 SSNNITGSMPAEI-----------------------------------------------------IHSSQLKVLDLSSN 180 (707)
Q Consensus 154 ~~n~i~~~~~~~~-----------------------------------------------------~~~~~L~~L~l~~n 180 (707)
++|.+++..+..+ ..+++|++|++++|
T Consensus 255 ~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n 334 (520)
T 2z7x_B 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334 (520)
T ss_dssp EEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSS
T ss_pred ecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECC
Confidence 3333332222222 45667777777777
Q ss_pred CCCCCCChhhhCCCCCcEEEecCCcccc--CCccccCCCCcccEEEccCCccCCCCC-ccccCcccCceEeeeccccccc
Q 038671 181 HIVGEMPSKLGKLSSLIKLILNSNQLCG--QLSLELGSLTQLERLDLSSNRLSNSIP-KSLGNLVKLHYLNLSNNQFIKK 257 (707)
Q Consensus 181 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~i~~~~~-~~l~~l~~L~~L~l~~n~l~~~ 257 (707)
++++..|..+..+++|++|++++|++++ ..+..+..+++|++|++++|.+++..| ..+..+++|+.|++++|++++.
T Consensus 335 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~ 414 (520)
T 2z7x_B 335 LLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT 414 (520)
T ss_dssp CCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGG
T ss_pred ccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcc
Confidence 7776666667777777777777777764 334556677777777777777766233 3466667777777777777655
Q ss_pred CchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCC
Q 038671 258 IPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332 (707)
Q Consensus 258 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~ 332 (707)
.+..+. ++|+.|++++|.++ .+|..+..+++|+.|++++|++++..+..+..+++|+.|++++|+|+|.|+.
T Consensus 415 ~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 415 IFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp GGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred hhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence 544443 56777777777775 5566566777777777777777754444466777777777777777776653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=350.15 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=200.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC----CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
.++|++.+.||+|+||.||+|... .+..||+|+..... .....+.+.+|+.++++++||||+++++++. ++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 467888999999999999999653 35679999986542 2334577999999999999999999999985 4678
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCee
Confidence 9999999999999999643 23589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCC
Q 038671 591 LKPDSS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668 (707)
Q Consensus 591 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (707)
...... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||..... .......... ...+.
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-----~~~~~~i~~~--~~~~~ 613 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDVIGRIENG--ERLPM 613 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHHT--CCCCC
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHcC--CCCCC
Confidence 654322 1223456789999999998899999999999999999997 9999864321 1111111111 12222
Q ss_pred CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 669 ~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+. ..+..+.+++.+||+.||++||++.++++.|+
T Consensus 614 ~~----~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~ 647 (656)
T 2j0j_A 614 PP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647 (656)
T ss_dssp CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred Cc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 22 23356889999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.31 Aligned_cols=252 Identities=20% Similarity=0.302 Sum_probs=199.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEc--CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCC------ceeeeeeeeec
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL--PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR------NIVKFYGFCSH 506 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~ 506 (707)
.++|++.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|+++++.++|+ +++++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 46899999999999999999964 46899999998642 23456788899988888655 59999999999
Q ss_pred CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC----------
Q 038671 507 ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL---------- 576 (707)
Q Consensus 507 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~---------- 576 (707)
.+..++||||+ +++|.+++.... ..++++..++.++.||+.||+|||++ ||+||||||+||+++.
T Consensus 89 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 89 HGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred CCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence 99999999999 889999886543 24588999999999999999999999 9999999999999987
Q ss_pred ---------CCCeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccc
Q 038671 577 ---------ENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI 647 (707)
Q Consensus 577 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 647 (707)
++.+||+|||.+...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 668999999999875432 23457899999999999989999999999999999999999999643221
Q ss_pred ccccchhhhhhhhhcCC-------------------------------------CCCCCCcchHHHHHHHHHHHHhccCC
Q 038671 648 SSSSSNLEIALNEMLDP-------------------------------------RLPTPSHNVQDKLISIMEVAISCLDE 690 (707)
Q Consensus 648 ~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~~~l~~li~~cl~~ 690 (707)
. ..........+ ............+.++.+++.+||+.
T Consensus 241 ~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 241 E-----HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp H-----HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred H-----HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 0 00000000000 00000011123466799999999999
Q ss_pred CCCCCCCHHHHHH
Q 038671 691 SPESRPTIQKVSQ 703 (707)
Q Consensus 691 ~P~~Rps~~~l~~ 703 (707)
||.+|||+.|+++
T Consensus 316 dP~~Rpt~~ell~ 328 (339)
T 1z57_A 316 DPAKRITLREALK 328 (339)
T ss_dssp STTTSCCHHHHTT
T ss_pred CcccccCHHHHhc
Confidence 9999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=323.55 Aligned_cols=257 Identities=24% Similarity=0.341 Sum_probs=190.5
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeee--------
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCS-------- 505 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-------- 505 (707)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 468999999999999999999654 5899999998653 2335577899999999999999999999873
Q ss_pred ------cCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec-CCC
Q 038671 506 ------HARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD-LEN 578 (707)
Q Consensus 506 ------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~-~~~ 578 (707)
+.+..++||||++ ++|.+++.. .++++..++.++.|++.||+|||++ ||+||||||+||+++ .++
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL 158 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence 3467899999998 599999853 3589999999999999999999999 999999999999997 567
Q ss_pred CeEEeccccceecCCCC---CCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchh
Q 038671 579 EAHVSDFGTAKFLKPDS---SNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL 654 (707)
Q Consensus 579 ~~kl~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 654 (707)
.+||+|||++....... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.............
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999998764321 12234567899999998765 678999999999999999999999997433211000000
Q ss_pred h-------hhhh------------hhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 655 E-------IALN------------EMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 655 ~-------~~~~------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
. .... ....+..+. .......+.++.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPL-TQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCH-HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCCh-hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0 0000 000000000 0001123456899999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=326.94 Aligned_cols=259 Identities=21% Similarity=0.328 Sum_probs=197.4
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc--CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC---CCCceeeeeeeee---
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL--PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI---RHRNIVKFYGFCS--- 505 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~--- 505 (707)
+.++|++.+.||+|+||.||+|+. .+|+.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 457899999999999999999975 468899999986432111 1112355666666655 8999999999987
Q ss_pred --cCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEe
Q 038671 506 --HARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVS 583 (707)
Q Consensus 506 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~ 583 (707)
.....++||||+. ++|.+++.... ...+++..++.++.|++.||+|||+. |++||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 5667899999998 69999986433 23489999999999999999999999 99999999999999999999999
Q ss_pred ccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhc-
Q 038671 584 DFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML- 662 (707)
Q Consensus 584 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 662 (707)
|||.+...... .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ..........
T Consensus 163 Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD----QLGKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCC
T ss_pred cCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHHHcCC
Confidence 99999765432 22344578999999999998889999999999999999999999997432211 0111110000
Q ss_pred ------------------CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 663 ------------------DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 663 ------------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..............+..+.+++.+||+.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000111223456889999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=322.64 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=191.5
Q ss_pred HHHHHhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchh---hhHHHHHHHHHHHhcC----CCCceeeee
Q 038671 430 EIIRVTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEM---ASQQEFLNEVKTLTGI----RHRNIVKFY 501 (707)
Q Consensus 430 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l----~h~niv~~~ 501 (707)
+...+.++|++.+.||+|+||.||+|+. .+++.||+|++........ .....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 4456678999999999999999999965 5789999999865432211 1223456788888888 899999999
Q ss_pred eeeecCCceeEEEee-eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec-CCCC
Q 038671 502 GFCSHARHSFIVYEY-LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD-LENE 579 (707)
Q Consensus 502 ~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~-~~~~ 579 (707)
+++...+..++|+|+ +.+++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++ .++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCe
Confidence 999999999999999 7899999999653 3589999999999999999999999 999999999999999 7899
Q ss_pred eEEeccccceecCCCCCCccccccccCCCCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhh
Q 038671 580 AHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVT-EKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIAL 658 (707)
Q Consensus 580 ~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 658 (707)
+||+|||++...... ......|++.|+|||.+.+..+. .++||||||+++|+|++|+.||..... ..
T Consensus 179 ~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----------~~ 246 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE----------IL 246 (312)
T ss_dssp EEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------HH
T ss_pred EEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----------Hh
Confidence 999999999876543 23456789999999998876664 589999999999999999999863211 11
Q ss_pred hhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 659 NEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
. .....+. ..+.++.+++.+||+.||++||+++|+++.
T Consensus 247 ~----~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 247 E----AELHFPA----HVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp H----TCCCCCT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred h----hccCCcc----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 1111111 123458899999999999999999999873
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=342.90 Aligned_cols=157 Identities=18% Similarity=0.149 Sum_probs=138.0
Q ss_pred CCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeec
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTL 82 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 82 (707)
++|++|+|++|++++..|..|+.+++|++|+|++|++++..|++|.++++|++|+|++|.+++..+..|+++++|++|++
T Consensus 26 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 105 (549)
T 2z81_A 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNL 105 (549)
T ss_dssp TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEEC
Confidence 57999999999999998999999999999999999999888899999999999999999999888888999999999999
Q ss_pred cccccccc--CCCCCCCCCccEEEeccCc-cccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccC
Q 038671 83 ENNQLRGP--IPNLRNLTSLVRVRLNQNH-LTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNIT 159 (707)
Q Consensus 83 ~~n~i~~~--~~~l~~l~~L~~L~l~~n~-l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~ 159 (707)
++|.++.+ +..+.++++|++|++++|+ ++.+++..|..+++|++|++++|.+++..+..+..+++|++|++++|.+.
T Consensus 106 s~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~ 185 (549)
T 2z81_A 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185 (549)
T ss_dssp TTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST
T ss_pred CCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccc
Confidence 99999853 4579999999999999998 67777788999999999999999999888877776555555544444433
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=342.42 Aligned_cols=310 Identities=20% Similarity=0.238 Sum_probs=213.5
Q ss_pred ceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccc
Q 038671 6 AFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENN 85 (707)
Q Consensus 6 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n 85 (707)
++|++++|+++ .+|..+. ++|++|+|++|++++..|.+|.++++|++|+|++|+|++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 58999999999 6787776 89999999999999777789999999999999999999888999999999999999999
Q ss_pred cccccCCCCCCCCCccEEEeccCccccc-cCccccCCCCCcEEEcccccccccCCCCCCCCCCC--cEEEcCCCcc--CC
Q 038671 86 QLRGPIPNLRNLTSLVRVRLNQNHLTGN-ISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKL--GTLDFSSNNI--TG 160 (707)
Q Consensus 86 ~i~~~~~~l~~l~~L~~L~l~~n~l~~~-~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L--~~L~L~~n~i--~~ 160 (707)
+++.++.. .+++|++|++++|+++++ .+..|+.+++|++|++++|.++. ..+..+++| +.|++++|.+ .+
T Consensus 80 ~l~~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~ 154 (520)
T 2z7x_B 80 KLVKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEK 154 (520)
T ss_dssp CCCEEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSS
T ss_pred ceeecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccc
Confidence 99987766 899999999999999985 46889999999999999999986 457778888 9999999998 55
Q ss_pred CCchhhhCCC----------------------------------------------------------------------
Q 038671 161 SMPAEIIHSS---------------------------------------------------------------------- 170 (707)
Q Consensus 161 ~~~~~~~~~~---------------------------------------------------------------------- 170 (707)
..+..+..+.
T Consensus 155 ~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~ 234 (520)
T 2z7x_B 155 EDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTW 234 (520)
T ss_dssp CCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEH
T ss_pred cccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCH
Confidence 5555444422
Q ss_pred -------------CCCEEeCCCCCCCCCCChhh-----hCCCCCcEEEecCCcc--------------------------
Q 038671 171 -------------QLKVLDLSSNHIVGEMPSKL-----GKLSSLIKLILNSNQL-------------------------- 206 (707)
Q Consensus 171 -------------~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~l~~n~l-------------------------- 206 (707)
+|+.|++++|.+++.+|..+ ..+++|+.+++++|.+
T Consensus 235 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l 314 (520)
T 2z7x_B 235 NSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314 (520)
T ss_dssp HHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCC
T ss_pred HHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCcc
Confidence 67777777777776666555 3333333333333322
Q ss_pred ccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccc--cCchhhhhcccCCeeeecCccCCCCCCc
Q 038671 207 CGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIK--KIPVELEKLIHLSELDLSHNFLGEEMPS 284 (707)
Q Consensus 207 ~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 284 (707)
.... .+..+++|++|++++|.+++..|..+..+++|++|++++|++++ ..+..+..+++|+.|++++|.+++..|.
T Consensus 315 ~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~ 392 (520)
T 2z7x_B 315 VHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392 (520)
T ss_dssp CCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGG
T ss_pred cccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCccccc
Confidence 1000 01345555566666665555555555555556666665555554 2234455555555555555555442222
Q ss_pred -ccccccccceEeccccccCCchhHhhccCCCceeEeeccCccc
Q 038671 285 -QICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELH 327 (707)
Q Consensus 285 -~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~ 327 (707)
.+..+++|+.|++++|++++..+..+. ++|+.|++++|+++
T Consensus 393 ~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 393 GDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK 434 (520)
T ss_dssp CSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC
T ss_pred chhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc
Confidence 244444455555555544433333221 34444444444444
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=349.27 Aligned_cols=322 Identities=21% Similarity=0.239 Sum_probs=284.9
Q ss_pred CCCCCceeeccCCeeeecCCccccCCCCCCeEECCCCc-ccc-ccCcCccCC------CCCcEEEcccCcCcccCCc--c
Q 038671 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNK-LCG-SIPHSLGNL------TQITFLTLFDNALSGAIPK--E 70 (707)
Q Consensus 1 nl~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~-i~~-~~~~~~~~l------~~L~~L~L~~n~i~~~~~~--~ 70 (707)
+|++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ .+|..+.++ ++|++|+|++|.++ .+|. .
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~ 325 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETS 325 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHH
T ss_pred ccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhh
Confidence 47899999999999999999999999999999999998 998 788888876 99999999999999 7788 9
Q ss_pred ccCCCCCCeeeccccccc-ccCCCCCCCCCccEEEeccCccccccCccccCCCC-CcEEEcccccccccCCCCCCCCC--
Q 038671 71 YGNLVKLTLLTLENNQLR-GPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPN-LAFIDLSHNYFYGEISSDWGRCP-- 146 (707)
Q Consensus 71 ~~~l~~L~~L~l~~n~i~-~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~-L~~L~L~~n~i~~~~~~~~~~~~-- 146 (707)
|+++++|++|++++|.+. .++ .+..+++|++|++++|+++.+ +..+..+++ |++|++++|.++ ..+..+..++
T Consensus 326 l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~~l-p~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~ 402 (636)
T 4eco_A 326 LQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEI-PANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVS 402 (636)
T ss_dssp HTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEEEC-CTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSS
T ss_pred hccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccccc-cHhhhhhcccCcEEEccCCcCc-ccchhhhhcccC
Confidence 999999999999999999 566 899999999999999999955 456889999 999999999999 5566676654
Q ss_pred CCcEEEcCCCccCCCCchhhh-------CCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCC-
Q 038671 147 KLGTLDFSSNNITGSMPAEII-------HSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLT- 218 (707)
Q Consensus 147 ~L~~L~L~~n~i~~~~~~~~~-------~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~- 218 (707)
+|++|++++|.+++..+..+. .+++|+.|+|++|.++...+..+..+++|++|++++|+++......+....
T Consensus 403 ~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~ 482 (636)
T 4eco_A 403 VMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482 (636)
T ss_dssp CEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTE
T ss_pred ccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccc
Confidence 899999999999988888887 788999999999999965556677799999999999999954444444333
Q ss_pred ------cccEEEccCCccCCCCCcccc--CcccCceEeeecccccccCchhhhhcccCCeeee------cCccCCCCCCc
Q 038671 219 ------QLERLDLSSNRLSNSIPKSLG--NLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDL------SHNFLGEEMPS 284 (707)
Q Consensus 219 ------~L~~L~l~~n~i~~~~~~~l~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l------~~n~l~~~~~~ 284 (707)
+|++|+|++|.++ .+|..+. .+++|+.|+|++|++++ .|..+..+++|+.|+| ++|.+.+..|.
T Consensus 483 ~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~ 560 (636)
T 4eco_A 483 NFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560 (636)
T ss_dssp ECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCT
T ss_pred cccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChH
Confidence 9999999999999 6677776 99999999999999987 7888999999999999 56778889999
Q ss_pred ccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCC
Q 038671 285 QICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIP 331 (707)
Q Consensus 285 ~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~ 331 (707)
.+..+++|+.|++++|++. .+|..+. ++|+.|++++|++.+...
T Consensus 561 ~l~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~~~ 604 (636)
T 4eco_A 561 GITLCPSLTQLQIGSNDIR-KVNEKIT--PNISVLDIKDNPNISIDL 604 (636)
T ss_dssp TGGGCSSCCEEECCSSCCC-BCCSCCC--TTCCEEECCSCTTCEEEC
T ss_pred HHhcCCCCCEEECCCCcCC-ccCHhHh--CcCCEEECcCCCCccccH
Confidence 9999999999999999995 5676655 799999999999997543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=341.89 Aligned_cols=337 Identities=19% Similarity=0.188 Sum_probs=252.8
Q ss_pred CCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecc
Q 038671 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLE 83 (707)
Q Consensus 4 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (707)
..+++++++|+++ .+|..+. ++|++|+|++|.+++..+.+|.++++|++|+|++|.|++..|+.|+++++|++|+++
T Consensus 32 ~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 108 (562)
T 3a79_B 32 LESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108 (562)
T ss_dssp -CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECT
T ss_pred CCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECC
Confidence 3478999999999 5777665 799999999999998877899999999999999999999989999999999999999
Q ss_pred cccccccCCCCCCCCCccEEEeccCcccccc-CccccCCCCCcEEEcccccccccCCCCCCCCCCC--cEEEcCCCcc--
Q 038671 84 NNQLRGPIPNLRNLTSLVRVRLNQNHLTGNI-SESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKL--GTLDFSSNNI-- 158 (707)
Q Consensus 84 ~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L--~~L~L~~n~i-- 158 (707)
+|.++.++.. .+++|++|++++|+++.+. +..|+.+++|++|++++|.++.. .+..+++| ++|++++|.+
T Consensus 109 ~N~l~~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 109 HNRLQNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp TSCCCEECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred CCcCCccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence 9999987776 8999999999999999876 47899999999999999999863 45556666 9999999998
Q ss_pred CCCCchhhhCCC--------------------------------------------------------------------
Q 038671 159 TGSMPAEIIHSS-------------------------------------------------------------------- 170 (707)
Q Consensus 159 ~~~~~~~~~~~~-------------------------------------------------------------------- 170 (707)
++..+..+..+.
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~ 263 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECH
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcH
Confidence 555555544422
Q ss_pred -------------CCCEEeCCCCCCCCCCChhh-----------------------------------------------
Q 038671 171 -------------QLKVLDLSSNHIVGEMPSKL----------------------------------------------- 190 (707)
Q Consensus 171 -------------~L~~L~l~~n~l~~~~~~~~----------------------------------------------- 190 (707)
+|++|++++|.+++.+|..+
T Consensus 264 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~ 343 (562)
T 3a79_B 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPF 343 (562)
T ss_dssp HHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCC
T ss_pred HHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCc
Confidence 66777777777765555443
Q ss_pred ------hCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCC--CccccCcccCceEeeecccccc-cCchh
Q 038671 191 ------GKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSI--PKSLGNLVKLHYLNLSNNQFIK-KIPVE 261 (707)
Q Consensus 191 ------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~--~~~l~~l~~L~~L~l~~n~l~~-~~~~~ 261 (707)
..+++|++|++++|.+++..+..+..+++|++|++++|.+++.. |..+.++++|+.|++++|++++ .....
T Consensus 344 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 423 (562)
T 3a79_B 344 IHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRT 423 (562)
T ss_dssp CCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCC
T ss_pred ccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhh
Confidence 45566777777777776666666667777777777777776532 3456666777777777777665 33334
Q ss_pred hhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCC-ccccccCc
Q 038671 262 LEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN-STAFRDAP 340 (707)
Q Consensus 262 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~-~~~~~~~~ 340 (707)
+..+++|++|++++|.+++..+..+. ++|+.|++++|+|+. +|..+..+++|+.|++++|+++..++. ...++...
T Consensus 424 ~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~ 500 (562)
T 3a79_B 424 CAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQ 500 (562)
T ss_dssp CCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCC-CCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCC
T ss_pred hcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcc-cChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCC
Confidence 66667777777777776654444332 577777777777773 444445777777788888877755544 44455555
Q ss_pred hhhcccCcCcC
Q 038671 341 MEALQGNKGLC 351 (707)
Q Consensus 341 ~~~~~~~~~~c 351 (707)
...+.+|++.|
T Consensus 501 ~L~l~~N~~~c 511 (562)
T 3a79_B 501 YIWLHDNPWDC 511 (562)
T ss_dssp CEECCSCCBCC
T ss_pred EEEecCCCcCC
Confidence 66677777665
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=326.69 Aligned_cols=248 Identities=21% Similarity=0.328 Sum_probs=199.8
Q ss_pred HHHHhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCch---hhhHHHHHHHHHHHhcCC--CCceeeeeeee
Q 038671 431 IIRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSE---MASQQEFLNEVKTLTGIR--HRNIVKFYGFC 504 (707)
Q Consensus 431 ~~~~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~--h~niv~~~~~~ 504 (707)
.....++|++.+.||+|+||.||+|. ..+++.||+|++....... ......+.+|+.++++++ |||++++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 34457889999999999999999995 5678999999986532211 012244667899999996 59999999999
Q ss_pred ecCCceeEEEeeecc-CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec-CCCCeEE
Q 038671 505 SHARHSFIVYEYLEM-GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD-LENEAHV 582 (707)
Q Consensus 505 ~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~-~~~~~kl 582 (707)
..++..++|+|++.+ ++|.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++ .++.+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEE
Confidence 999999999999976 8999998643 4589999999999999999999999 999999999999999 7889999
Q ss_pred eccccceecCCCCCCccccccccCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhh
Q 038671 583 SDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM 661 (707)
Q Consensus 583 ~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 661 (707)
+|||++...... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||+.... ...
T Consensus 192 ~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----------~~~-- 257 (320)
T 3a99_A 192 IDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIR-- 257 (320)
T ss_dssp CCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----------HHH--
T ss_pred eeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh----------hhc--
Confidence 999999876533 2344578999999999887666 6789999999999999999999863211 111
Q ss_pred cCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 662 LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 662 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
.....+. ..+.++.+++.+||+.||++||+++|+++.
T Consensus 258 --~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 --GQVFFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --CCCCCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --ccccccc----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111 123458899999999999999999999873
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=323.25 Aligned_cols=200 Identities=24% Similarity=0.286 Sum_probs=168.9
Q ss_pred HhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CC-----ceeeeeeeeec
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HR-----NIVKFYGFCSH 506 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~ 506 (707)
+.++|++.+.||+|+||.||+|. ..+++.||||++... .....++..|+++++.++ |+ +++++++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 45789999999999999999995 457889999998642 223456777888888774 44 49999999999
Q ss_pred CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec--CCCCeEEec
Q 038671 507 ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD--LENEAHVSD 584 (707)
Q Consensus 507 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~--~~~~~kl~D 584 (707)
.+..++||||+. ++|.+++.... .+.+++..++.++.|++.||+|||++. .||+||||||+||+++ .++.+||+|
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred CCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 999999999996 59999886543 245899999999999999999999521 1999999999999995 477899999
Q ss_pred cccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCc
Q 038671 585 FGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDF 643 (707)
Q Consensus 585 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 643 (707)
||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 205 FG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 205 FGSSCQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CTTCEETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCceecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999876432 3346789999999999999999999999999999999999999974
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=330.42 Aligned_cols=247 Identities=22% Similarity=0.301 Sum_probs=186.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.+|+..+.||+|+||+||.....+|+.||||++...... .+.+|+++++.+ +||||+++++++.+.+..++||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 468888999999999977666668999999998654322 245799999999 7999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC---C--CCeEEeccccce
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL---E--NEAHVSDFGTAK 589 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~---~--~~~kl~Dfg~~~ 589 (707)
||+. |+|.+++.... ...++..++.++.||+.||+|||+. ||+||||||+||+++. + ..+||+|||+++
T Consensus 98 E~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp ECCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred ECCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 9996 59999986543 2355567789999999999999999 9999999999999953 2 357899999998
Q ss_pred ecCCCC---CCccccccccCCCCccccc---cCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhc
Q 038671 590 FLKPDS---SNWAELAGTYGYVAPELAY---TMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEML 662 (707)
Q Consensus 590 ~~~~~~---~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 662 (707)
...... .......||+.|+|||++. +..++.++|||||||++|||++ |+.||.... ...........
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~------~~~~~~~~~~~ 245 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL------QRQANILLGAC 245 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT------THHHHHHTTCC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh------HHHHHHHhccC
Confidence 765432 2234467999999999987 4567889999999999999999 999985211 11111111111
Q ss_pred CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 663 DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 663 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...... ........+.+++.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SLDCLH---PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCTTSC---TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccccC---ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111111 11234556889999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=316.72 Aligned_cols=253 Identities=22% Similarity=0.323 Sum_probs=181.2
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+.++..+++.++||||+++++++..++..++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence 36789999999999999999965 47999999998765322 22334455566678888999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN-DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
|||+ ++.+..+... ....+++..++.++.|++.||+|||+ . |++||||||+||+++.++.+||+|||++....
T Consensus 103 ~e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 103 MELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp ECCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred Eecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 9999 5566655532 23468999999999999999999998 6 89999999999999999999999999997655
Q ss_pred CCCCCccccccccCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 593 PDSSNWAELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
... ......+++.|+|||.+. +..++.++||||||+++|+|++|+.||..... .............+..+
T Consensus 177 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~ 251 (318)
T 2dyl_A 177 DDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT----DFEVLTKVLQEEPPLLP 251 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS----HHHHHHHHHHSCCCCCC
T ss_pred CCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc----cHHHHHHHhccCCCCCC
Confidence 332 223457899999999984 45688899999999999999999999963211 01111111111112222
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
... ..+.++.+++.+||+.||.+||+++++++
T Consensus 252 ~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 252 GHM----GFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp SSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccC----CCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 211 22345889999999999999999999876
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=326.41 Aligned_cols=258 Identities=19% Similarity=0.290 Sum_probs=197.5
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-----------CCceeeeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-----------HRNIVKFYG 502 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~ 502 (707)
.++|++.+.||+|+||.||+|. ..+++.||+|++... ....+.+.+|++++++++ ||||+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~ 93 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 93 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence 3679999999999999999996 467899999998642 234566788999988876 899999999
Q ss_pred eeecCC----ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec---
Q 038671 503 FCSHAR----HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD--- 575 (707)
Q Consensus 503 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~--- 575 (707)
++...+ ..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ ||+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred HhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence 987654 789999999 899999986533 345899999999999999999999953 899999999999994
Q ss_pred ---CCCCeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc--
Q 038671 576 ---LENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS-- 650 (707)
Q Consensus 576 ---~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~-- 650 (707)
..+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 3447999999999876533 23457899999999999999999999999999999999999999743321100
Q ss_pred cchhhhhhhhh-----------------cCC-----CCC------------CCCcchHHHHHHHHHHHHhccCCCCCCCC
Q 038671 651 SSNLEIALNEM-----------------LDP-----RLP------------TPSHNVQDKLISIMEVAISCLDESPESRP 696 (707)
Q Consensus 651 ~~~~~~~~~~~-----------------~~~-----~~~------------~~~~~~~~~~~~l~~li~~cl~~~P~~Rp 696 (707)
........... ... ... .........+.++.+++.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 00000000000 000 000 00112245677899999999999999999
Q ss_pred CHHHHHH
Q 038671 697 TIQKVSQ 703 (707)
Q Consensus 697 s~~~l~~ 703 (707)
|++|+++
T Consensus 327 t~~ell~ 333 (373)
T 1q8y_A 327 DAGGLVN 333 (373)
T ss_dssp CHHHHHT
T ss_pred CHHHHhh
Confidence 9999986
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=343.58 Aligned_cols=330 Identities=20% Similarity=0.198 Sum_probs=268.4
Q ss_pred CCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeec
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTL 82 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 82 (707)
+++++|||++|+|++..+.+|+++++|++|+|++|+|+++.+++|.++++|++|+|++|+|++..+++|+++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 37999999999999888899999999999999999999888889999999999999999999888889999999999999
Q ss_pred ccccccccCC-CCCCCCCccEEEeccCcccccc-CccccCCCCCcEEEcccccccccCCCCCCC----------------
Q 038671 83 ENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNI-SESFGIHPNLAFIDLSHNYFYGEISSDWGR---------------- 144 (707)
Q Consensus 83 ~~n~i~~~~~-~l~~l~~L~~L~l~~n~l~~~~-~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~---------------- 144 (707)
++|+++.+++ .|.++++|++|++++|+++.+. +..+..+++|++|+|++|.++.+.+..|..
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 9999998876 4899999999999999998764 567888999999999999886543322211
Q ss_pred --------------------------------------------------------------------------------
Q 038671 145 -------------------------------------------------------------------------------- 144 (707)
Q Consensus 145 -------------------------------------------------------------------------------- 144 (707)
T Consensus 212 ~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~ 291 (635)
T 4g8a_A 212 PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 291 (635)
T ss_dssp CCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECC
T ss_pred cccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhh
Confidence
Q ss_pred -----------------------------------CCCCcEEEcCCCccCCCCch-------------------hhhCCC
Q 038671 145 -----------------------------------CPKLGTLDFSSNNITGSMPA-------------------EIIHSS 170 (707)
Q Consensus 145 -----------------------------------~~~L~~L~L~~n~i~~~~~~-------------------~~~~~~ 170 (707)
..+|+.|++.+|.+...... ....++
T Consensus 292 ~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~ 371 (635)
T 4g8a_A 292 DYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP 371 (635)
T ss_dssp CSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCT
T ss_pred cccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccccc
Confidence 11223333333332211100 111245
Q ss_pred CCCEEeCCCCCCCC--------------------------------------------------CCChhhhCCCCCcEEE
Q 038671 171 QLKVLDLSSNHIVG--------------------------------------------------EMPSKLGKLSSLIKLI 200 (707)
Q Consensus 171 ~L~~L~l~~n~l~~--------------------------------------------------~~~~~~~~l~~L~~L~ 200 (707)
+|+.|++++|.+.. .....|..+++++.++
T Consensus 372 ~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ 451 (635)
T 4g8a_A 372 SLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 451 (635)
T ss_dssp TCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEE
T ss_pred ccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcccccccccccccccccccccc
Confidence 56666666655421 1123455667777888
Q ss_pred ecCCccccCCccccCCCCcccEEEccCCcc-CCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCC
Q 038671 201 LNSNQLCGQLSLELGSLTQLERLDLSSNRL-SNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLG 279 (707)
Q Consensus 201 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i-~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 279 (707)
++.|.+....+..+..+++|+.|+|++|.+ ....|..|..+++|++|+|++|++++..+..|.++++|++|+|++|+|+
T Consensus 452 ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~ 531 (635)
T 4g8a_A 452 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 531 (635)
T ss_dssp CTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred ccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCC
Confidence 888888877788888899999999999975 4467888999999999999999999999999999999999999999998
Q ss_pred CCCCcccccccccceEeccccccCCchhHhhccC-CCceeEeeccCcccccCCC
Q 038671 280 EEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEEL-HGLSYIDISYNELHGSIPN 332 (707)
Q Consensus 280 ~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~-~~L~~l~l~~n~~~~~~~~ 332 (707)
+..+..|..+++|+.|++++|+|++..|..+..+ ++|+.|++++|+|+|.|..
T Consensus 532 ~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 532 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp BCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 8888889999999999999999999988888887 6899999999999999864
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=340.97 Aligned_cols=334 Identities=23% Similarity=0.239 Sum_probs=292.4
Q ss_pred CCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeee
Q 038671 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLT 81 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 81 (707)
+++++.|++++|.++...+..|+.+++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 57889999999999988777789999999999999999988888999999999999999999999899999999999999
Q ss_pred cccccccccCCC-CCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCC
Q 038671 82 LENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITG 160 (707)
Q Consensus 82 l~~n~i~~~~~~-l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~ 160 (707)
|++|.++.+++. |..+++|++|+|++|.++++.+..|..+++|++|+|++|.++.+ .+..+++|+.|++++|.+++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST 206 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCSE
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCcccc
Confidence 999999988876 68999999999999999999999999999999999999999876 36678999999999999874
Q ss_pred CCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccC
Q 038671 161 SMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN 240 (707)
Q Consensus 161 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~ 240 (707)
+...++|+.|++++|.+....+. + .++|+.|++++|.+++ +..+..+++|+.|+|++|.+++..|..|.+
T Consensus 207 -----l~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 276 (597)
T 3oja_B 207 -----LAIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVK 276 (597)
T ss_dssp -----EECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTT
T ss_pred -----ccCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcC
Confidence 34567899999999999844332 2 3689999999999985 467899999999999999999999999999
Q ss_pred cccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEe
Q 038671 241 LVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYID 320 (707)
Q Consensus 241 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~ 320 (707)
+++|+.|+|++|.+++. +..+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|++.+.. +..+++|+.|+
T Consensus 277 l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~ 351 (597)
T 3oja_B 277 MQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLT 351 (597)
T ss_dssp CSSCCEEECTTSCCCEE-ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEE
T ss_pred ccCCCEEECCCCCCCCC-CcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEE
Confidence 99999999999999774 556677999999999999996 56777899999999999999998763 67789999999
Q ss_pred eccCcccccCCCccccccCchhhcccCcCcCCCC
Q 038671 321 ISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDI 354 (707)
Q Consensus 321 l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~c~~~ 354 (707)
+++|+|+|.+.. ..+.......+.++...|+..
T Consensus 352 l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 352 LSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp CCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred eeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence 999999997632 223334444556666777653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=320.22 Aligned_cols=252 Identities=19% Similarity=0.302 Sum_probs=195.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCC-cEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCc------eeeeeeeeec
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSG-EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN------IVKFYGFCSH 506 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~ 506 (707)
.++|++.+.||+|+||.||+|.. .++ +.||+|++... ....+.+.+|+.+++.++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 47899999999999999999964 344 78999998642 234567888999999887655 8999999999
Q ss_pred CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeee------------
Q 038671 507 ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLL------------ 574 (707)
Q Consensus 507 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~------------ 574 (707)
.+..++||||+ ++++.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+||++
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred CCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence 99999999999 555655654332 24589999999999999999999999 99999999999999
Q ss_pred -------cCCCCeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCccccc
Q 038671 575 -------DLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSI 647 (707)
Q Consensus 575 -------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 647 (707)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999875432 23457999999999999989999999999999999999999999743221
Q ss_pred ccccchhhhhhhhhcCC-------------------------------------CCCCCCcchHHHHHHHHHHHHhccCC
Q 038671 648 SSSSSNLEIALNEMLDP-------------------------------------RLPTPSHNVQDKLISIMEVAISCLDE 690 (707)
Q Consensus 648 ~~~~~~~~~~~~~~~~~-------------------------------------~~~~~~~~~~~~~~~l~~li~~cl~~ 690 (707)
. ....+.....+ ............+.++.+++.+||+.
T Consensus 246 ~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 246 E-----HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp H-----HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred H-----HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 0 00000000000 00000001123355789999999999
Q ss_pred CCCCCCCHHHHHH
Q 038671 691 SPESRPTIQKVSQ 703 (707)
Q Consensus 691 ~P~~Rps~~~l~~ 703 (707)
||++|||+.|+++
T Consensus 321 dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 321 DPAQRITLAEALL 333 (355)
T ss_dssp STTTSCCHHHHTT
T ss_pred ChhhCcCHHHHhc
Confidence 9999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=310.95 Aligned_cols=231 Identities=13% Similarity=0.083 Sum_probs=184.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|+. .+|+.||+|++...........+.+.+|+..+.+++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 36799999999999999999965 46899999999876554445567899999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||++|++|.+++... ....++.+++.|++.||+|||++ ||+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999998532 35567889999999999999999 99999999999999999999998543
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
|++ .++.++||||||+++|||+||+.||......... .... .......+.+....
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~----~~~~-~~~~~~~~~~~~~~ 229 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL----APAE-RDTAGQPIEPADID 229 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS----EECC-BCTTSCBCCHHHHC
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh----HHHH-HHhccCCCChhhcc
Confidence 333 2788999999999999999999999753321100 0000 00111111111111
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+.++.+++.+||+.||++| |+.|+++.|+
T Consensus 230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~ 261 (286)
T 3uqc_A 230 RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQ 261 (286)
T ss_dssp TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHH
Confidence 2234568999999999999999 9999999874
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=339.60 Aligned_cols=327 Identities=25% Similarity=0.285 Sum_probs=207.8
Q ss_pred CCCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCccc-CCccccCCCCCCe
Q 038671 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGA-IPKEYGNLVKLTL 79 (707)
Q Consensus 1 nl~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~ 79 (707)
++++|++|+|++|.+++..|+.|+.+++|++|+|++|++++..+..|.++++|++|+|++|.+++. .|..|+++++|++
T Consensus 48 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~ 127 (549)
T 2z81_A 48 ACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127 (549)
T ss_dssp SCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCE
T ss_pred cCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccE
Confidence 478999999999999999889999999999999999999977777799999999999999999864 4678999999999
Q ss_pred eeccccc-ccccCC-CCCCCCCccEEEeccCccccccCccccC------------------------CCCCcEEEccccc
Q 038671 80 LTLENNQ-LRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFGI------------------------HPNLAFIDLSHNY 133 (707)
Q Consensus 80 L~l~~n~-i~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~------------------------~~~L~~L~L~~n~ 133 (707)
|++++|. +..+++ .+.++++|++|++++|++++..+..+.. +++|++|++++|.
T Consensus 128 L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~ 207 (549)
T 2z81_A 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTN 207 (549)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCB
T ss_pred EECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCc
Confidence 9999998 565654 6899999999999999998876666654 4566666666666
Q ss_pred ccccC--C-CCCCCC-----------------------------------------------------------------
Q 038671 134 FYGEI--S-SDWGRC----------------------------------------------------------------- 145 (707)
Q Consensus 134 i~~~~--~-~~~~~~----------------------------------------------------------------- 145 (707)
+++.. + .....+
T Consensus 208 l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~ 287 (549)
T 2z81_A 208 LARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVT 287 (549)
T ss_dssp CTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEE
T ss_pred cccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhccccccc
Confidence 65421 0 000011
Q ss_pred ----------------------CCCcEEEcCCCccCCCCchhh-hCCCCCCEEeCCCCCCCCCCC---hhhhCCCCCcEE
Q 038671 146 ----------------------PKLGTLDFSSNNITGSMPAEI-IHSSQLKVLDLSSNHIVGEMP---SKLGKLSSLIKL 199 (707)
Q Consensus 146 ----------------------~~L~~L~L~~n~i~~~~~~~~-~~~~~L~~L~l~~n~l~~~~~---~~~~~l~~L~~L 199 (707)
++|+.|++++|.++ ..+..+ ..+++|+.|++++|++.+..| ..+..+++|++|
T Consensus 288 l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L 366 (549)
T 2z81_A 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366 (549)
T ss_dssp EESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEE
T ss_pred ccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEE
Confidence 22333333333333 122222 345666666666666654332 224555666666
Q ss_pred EecCCccccCCc--cccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchh----------------
Q 038671 200 ILNSNQLCGQLS--LELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE---------------- 261 (707)
Q Consensus 200 ~l~~n~l~~~~~--~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~---------------- 261 (707)
++++|++++..+ ..+..+++|++|++++|+++ .+|..+..+++|++|++++|.++......
T Consensus 367 ~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~ 445 (549)
T 2z81_A 367 VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDS 445 (549)
T ss_dssp ECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSC
T ss_pred EccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhh
Confidence 666666653321 33556666666666666666 34555555566666666666654322110
Q ss_pred -hhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCC
Q 038671 262 -LEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIP 331 (707)
Q Consensus 262 -~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~ 331 (707)
...+++|++|++++|+++ .+|. ...+++|+.|++++|++++..+..+..+++|+.|++++|+|.|.+|
T Consensus 446 ~~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 446 FSLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp CCCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred hcccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 123444555555555553 2232 2344555555555555555444445555555555555555555544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.77 Aligned_cols=304 Identities=25% Similarity=0.371 Sum_probs=254.6
Q ss_pred CCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeee
Q 038671 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLT 81 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 81 (707)
+++|++|++++|.++ .++ .+..+++|++|++++|++++..+ +.++++|++|++++|.+++. ..|.++++|++|+
T Consensus 43 l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~ 116 (347)
T 4fmz_A 43 LESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELY 116 (347)
T ss_dssp HTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred cccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEE
Confidence 468899999999998 444 48889999999999999985433 88999999999999999853 4689999999999
Q ss_pred cccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCC
Q 038671 82 LENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGS 161 (707)
Q Consensus 82 l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~ 161 (707)
+++|.+..+++ +..+++|+.|++++|...... ..+..+++|++|++++|.+....+ +..+++|++|++++|.+++.
T Consensus 117 l~~n~i~~~~~-~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~ 192 (347)
T 4fmz_A 117 LNEDNISDISP-LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI 192 (347)
T ss_dssp CTTSCCCCCGG-GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCC
T ss_pred CcCCcccCchh-hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccc
Confidence 99999987655 888999999999999655333 348889999999999999886544 78899999999999998854
Q ss_pred CchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCc
Q 038671 162 MPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNL 241 (707)
Q Consensus 162 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l 241 (707)
.+ +..+++|+.|++++|.+.+..+ +..+++|++|++++|.+++..+ +..+++|++|++++|.+++. ..+..+
T Consensus 193 ~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l 264 (347)
T 4fmz_A 193 SP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDL 264 (347)
T ss_dssp GG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTC
T ss_pred cc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcC
Confidence 43 7888999999999999875443 7888999999999999985544 88899999999999999864 468888
Q ss_pred ccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEee
Q 038671 242 VKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDI 321 (707)
Q Consensus 242 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l 321 (707)
++|++|++++|++++. ..+..+++|+.|++++|.+++..+..+..+++|+.|++++|++++..| +..+++|+.|++
T Consensus 265 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l 340 (347)
T 4fmz_A 265 TKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340 (347)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESS
T ss_pred CCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeeh
Confidence 9999999999998765 458888999999999999988888888899999999999999988766 788999999999
Q ss_pred ccCccc
Q 038671 322 SYNELH 327 (707)
Q Consensus 322 ~~n~~~ 327 (707)
++|+++
T Consensus 341 ~~N~i~ 346 (347)
T 4fmz_A 341 ANQVIK 346 (347)
T ss_dssp SCC---
T ss_pred hhhccc
Confidence 999875
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=343.91 Aligned_cols=321 Identities=23% Similarity=0.302 Sum_probs=276.0
Q ss_pred CCCCCceeeccCCeeeecCCccccCCCCCCeEECCCCc-ccc-ccCcCccCC-------CCCcEEEcccCcCcccCCc--
Q 038671 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNK-LCG-SIPHSLGNL-------TQITFLTLFDNALSGAIPK-- 69 (707)
Q Consensus 1 nl~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~-i~~-~~~~~~~~l-------~~L~~L~L~~n~i~~~~~~-- 69 (707)
+|++|++|+|++|++.+.+|..|+++++|++|+|++|+ +++ .+|..+.++ ++|++|+|++|.++ .+|.
T Consensus 489 ~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~ 567 (876)
T 4ecn_A 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASA 567 (876)
T ss_dssp GCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHH
T ss_pred cCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChh
Confidence 47899999999999999999999999999999999998 887 677765555 49999999999999 7787
Q ss_pred cccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCC-CcEEEcccccccccCCCCCCCCCC-
Q 038671 70 EYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPN-LAFIDLSHNYFYGEISSDWGRCPK- 147 (707)
Q Consensus 70 ~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~-L~~L~L~~n~i~~~~~~~~~~~~~- 147 (707)
.|+++++|++|+|++|.++.++ .+..+++|+.|+|++|+++. .+..+..+++ |+.|+|++|.++ ..+..+..++.
T Consensus 568 ~l~~L~~L~~L~Ls~N~l~~lp-~~~~L~~L~~L~Ls~N~l~~-lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~ 644 (876)
T 4ecn_A 568 SLQKMVKLGLLDCVHNKVRHLE-AFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVY 644 (876)
T ss_dssp HHTTCTTCCEEECTTSCCCBCC-CCCTTSEESEEECCSSCCSC-CCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSS
T ss_pred hhhcCCCCCEEECCCCCcccch-hhcCCCcceEEECcCCcccc-chHHHhhccccCCEEECcCCCCC-cCchhhhccccC
Confidence 9999999999999999999666 89999999999999999994 4556888998 999999999999 45667776654
Q ss_pred -CcEEEcCCCccCCCCchhh---h--CCCCCCEEeCCCCCCCCCCChh-hhCCCCCcEEEecCCccccCCccccCC----
Q 038671 148 -LGTLDFSSNNITGSMPAEI---I--HSSQLKVLDLSSNHIVGEMPSK-LGKLSSLIKLILNSNQLCGQLSLELGS---- 216 (707)
Q Consensus 148 -L~~L~L~~n~i~~~~~~~~---~--~~~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~---- 216 (707)
|+.|+|++|.+++..+... . .+++|+.|+|++|.++ .+|.. +..+++|+.|+|++|+++......+..
T Consensus 645 ~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~ 723 (876)
T 4ecn_A 645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGN 723 (876)
T ss_dssp CEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSC
T ss_pred CCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccChHHhcccccc
Confidence 9999999999987654322 2 3458999999999999 45554 458999999999999999443333332
Q ss_pred ---CCcccEEEccCCccCCCCCcccc--CcccCceEeeecccccccCchhhhhcccCCeeeecC------ccCCCCCCcc
Q 038671 217 ---LTQLERLDLSSNRLSNSIPKSLG--NLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH------NFLGEEMPSQ 285 (707)
Q Consensus 217 ---l~~L~~L~l~~n~i~~~~~~~l~--~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~------n~l~~~~~~~ 285 (707)
+++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ .|..+..+++|+.|+|++ |.+.+..|..
T Consensus 724 l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~ 801 (876)
T 4ecn_A 724 YKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801 (876)
T ss_dssp CTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTT
T ss_pred ccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHH
Confidence 239999999999999 6677776 89999999999999987 677889999999999976 7788899999
Q ss_pred cccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCC
Q 038671 286 ICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIP 331 (707)
Q Consensus 286 ~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~ 331 (707)
+..+++|+.|++++|++ +.+|..+. ++|+.|++++|++....+
T Consensus 802 l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~ 844 (876)
T 4ecn_A 802 ITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDV 844 (876)
T ss_dssp GGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEEC
T ss_pred HhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccCh
Confidence 99999999999999999 56676655 699999999999986544
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=317.93 Aligned_cols=322 Identities=27% Similarity=0.378 Sum_probs=184.8
Q ss_pred CCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecc
Q 038671 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLE 83 (707)
Q Consensus 4 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (707)
+|+.|+++++.++ .+| .+..+++|++|+|++|.+++..+ +.++++|++|++++|.+++..+ ++++++|++|+++
T Consensus 47 ~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~ 120 (466)
T 1o6v_A 47 QVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 120 (466)
T ss_dssp TCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred cccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECC
Confidence 4455555555554 233 24445555555555555553222 4555555555555555543322 4455555555555
Q ss_pred cccccccCCCCCCCCCccEEEeccCccccccC-------------------ccccCCCCCcEEEcccccccccCCCCCCC
Q 038671 84 NNQLRGPIPNLRNLTSLVRVRLNQNHLTGNIS-------------------ESFGIHPNLAFIDLSHNYFYGEISSDWGR 144 (707)
Q Consensus 84 ~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~-------------------~~~~~~~~L~~L~L~~n~i~~~~~~~~~~ 144 (707)
+|.+..+++ +..+++|++|++++|.+..+.. ..+..+++|++|++++|.++.+ ..+..
T Consensus 121 ~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~ 197 (466)
T 1o6v_A 121 NNQITDIDP-LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAK 197 (466)
T ss_dssp SSCCCCCGG-GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGG
T ss_pred CCCCCCChH-HcCCCCCCEEECCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhcc
Confidence 555544332 4445555555555554443321 1255666666666666666544 23566
Q ss_pred CCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEE
Q 038671 145 CPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLD 224 (707)
Q Consensus 145 ~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 224 (707)
+++|++|++++|.+++..+ +..+++|+.|++++|.+++. ..+..+++|++|++++|.+++..+ +..+++|+.|+
T Consensus 198 l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 271 (466)
T 1o6v_A 198 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 271 (466)
T ss_dssp CTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred CCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEE
Confidence 6667777776666664433 55566677777777666532 346666677777777777664433 66667777777
Q ss_pred ccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCC
Q 038671 225 LSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSG 304 (707)
Q Consensus 225 l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~ 304 (707)
+++|.+++..+ +..+++|+.|++++|++.+..+ +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++
T Consensus 272 l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 272 LGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred CCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCC
Confidence 77777765443 6666777777777777655433 5666777777777777765443 5666777777777777765
Q ss_pred chhHhhccCCCceeEeeccCcccccCCCccccccCchhhcccCcC
Q 038671 305 FIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKG 349 (707)
Q Consensus 305 ~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~ 349 (707)
. ..+..+++|+.|++++|++++.+| ...+.......+.+|+.
T Consensus 346 ~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~ 387 (466)
T 1o6v_A 346 V--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAW 387 (466)
T ss_dssp C--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEE
T ss_pred c--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcc
Confidence 4 356667777777777777766655 33444444444444443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=304.64 Aligned_cols=231 Identities=20% Similarity=0.278 Sum_probs=179.1
Q ss_pred hcCCCCC-ceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHH-hcCCCCceeeeeeeeec----C
Q 038671 435 TNDFDDE-HCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTL-TGIRHRNIVKFYGFCSH----A 507 (707)
Q Consensus 435 ~~~~~~~-~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~ 507 (707)
.++|.+. +.||+|+||.||+|. ..+++.||+|++... ..+.+|+..+ +..+||||+++++++.. .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4567776 779999999999995 467899999998532 3456788877 55589999999999876 6
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC---CCCeEEec
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL---ENEAHVSD 584 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~---~~~~kl~D 584 (707)
...++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. ||+||||||+||+++. ++.+||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~D 163 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 163 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred ceEEEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEec
Confidence 78899999999999999997543 34689999999999999999999999 9999999999999998 78899999
Q ss_pred cccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC
Q 038671 585 FGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP 664 (707)
Q Consensus 585 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 664 (707)
||++.... +..++.++||||||+++|+|++|+.||........ ...........
T Consensus 164 fg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----~~~~~~~~~~~ 217 (299)
T 3m2w_A 164 FGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----SPGMKTRIRMG 217 (299)
T ss_dssp CTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------CCSCCSSCTT
T ss_pred cccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----hHHHHHHHhhc
Confidence 99986533 23477899999999999999999999964322110 00011111111
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
....+.......+.++.+++.+||+.||.+|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 121111111234567999999999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=337.44 Aligned_cols=236 Identities=25% Similarity=0.355 Sum_probs=191.1
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC--CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc---
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP--SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH--- 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--- 509 (707)
.++|++.+.||+|+||.||+|... +|+.||||++.... .......+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 478999999999999999999654 68999999986532 23355678999999999999999999999987665
Q ss_pred --eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccc
Q 038671 510 --SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587 (707)
Q Consensus 510 --~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~ 587 (707)
.|+||||++|++|.+++.. .+++..++.++.||+.||+|||++ ||+||||||+||+++.+ .+||+|||+
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 6999999999999987643 589999999999999999999999 99999999999999875 999999999
Q ss_pred ceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 588 AKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 588 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
++..... ....||+.|+|||++.+. ++.++||||||+++|+|++|..||..... ...+
T Consensus 228 a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~-----------------~~~~ 285 (681)
T 2pzi_A 228 VSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV-----------------DGLP 285 (681)
T ss_dssp CEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC-----------------SSCC
T ss_pred chhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc-----------------cccc
Confidence 9876543 345799999999998775 48899999999999999999988752110 0011
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCC-HHHHHHH
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPT-IQKVSQL 704 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-~~~l~~~ 704 (707)
. .......+..+.+++.+||+.||++||+ ++++.+.
T Consensus 286 ~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~ 322 (681)
T 2pzi_A 286 E-DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ 322 (681)
T ss_dssp T-TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred c-cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHH
Confidence 1 1112234467899999999999999995 4445443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=319.57 Aligned_cols=244 Identities=14% Similarity=0.136 Sum_probs=180.6
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCC-Cceeee-------------
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH-RNIVKF------------- 500 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~------------- 500 (707)
..|...+.||+|+||.||+|. ..+|+.||||++...........+.+.+|+.+++.++| ++....
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 457778899999999999996 66799999999875444443446779999999999977 322111
Q ss_pred --------eeeeec-----CCceeEEEeeeccCcHHHHHhcc----cccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 038671 501 --------YGFCSH-----ARHSFIVYEYLEMGSLAMILSND----AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIV 563 (707)
Q Consensus 501 --------~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 563 (707)
..++.. ....+++|+++ +++|.+++... .....+++..++.++.||++||+|||++ ||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111111 12356667654 68999888421 1234578889999999999999999999 999
Q ss_pred ecCCCCCCeeecCCCCeEEeccccceecCCCCCCccccccccCCCCcccc----------ccCCCCccchhHHHHHHHHH
Q 038671 564 HRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELA----------YTMKVTEKCDVYSFGVLALE 633 (707)
Q Consensus 564 H~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Dv~slG~~l~e 633 (707)
||||||+||+++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||||||+++||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999999865432 344567 999999998 55568889999999999999
Q ss_pred HHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 634 VIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 634 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
|++|+.||....... ......... . ..+.++.+++.+||+.||++||++.++++
T Consensus 310 lltg~~Pf~~~~~~~--------~~~~~~~~~-~-------~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 310 IWCADLPNTDDAALG--------GSEWIFRSC-K-------NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHSSCCCCTTGGGS--------CSGGGGSSC-C-------CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHCCCCCCCcchhh--------hHHHHHhhc-c-------cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999996432211 111111111 1 11245899999999999999999988765
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=311.70 Aligned_cols=306 Identities=28% Similarity=0.417 Sum_probs=267.2
Q ss_pred CCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeee
Q 038671 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLT 81 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 81 (707)
+++|++|+|++|.+++..+ ++.+++|++|++++|.+++..+ +.++++|++|++++|.+++..+ +..+++|++|+
T Consensus 67 l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~ 140 (466)
T 1o6v_A 67 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLE 140 (466)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEE
T ss_pred hcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEE
Confidence 6789999999999996544 8999999999999999985544 8999999999999999986533 88999999999
Q ss_pred cccccccccCC--------------------CCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCC
Q 038671 82 LENNQLRGPIP--------------------NLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSD 141 (707)
Q Consensus 82 l~~n~i~~~~~--------------------~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~ 141 (707)
+++|.+..++. .+..+++|+.|++++|.++.+ ..+..+++|++|++++|.+++..+
T Consensus 141 l~~n~l~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-- 216 (466)
T 1o6v_A 141 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP-- 216 (466)
T ss_dssp EEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--
T ss_pred CCCCccCCChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCccccccc--
Confidence 99998876432 256778899999999999876 358899999999999999987654
Q ss_pred CCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCccc
Q 038671 142 WGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLE 221 (707)
Q Consensus 142 ~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 221 (707)
+..+++|++|++++|.+++. ..+..+++|+.|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|+
T Consensus 217 ~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~ 290 (466)
T 1o6v_A 217 LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALT 290 (466)
T ss_dssp GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCS
T ss_pred ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccC
Confidence 77899999999999999854 468889999999999999985544 8899999999999999996544 88999999
Q ss_pred EEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccc
Q 038671 222 RLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNN 301 (707)
Q Consensus 222 ~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~ 301 (707)
.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|.+++. ..+..+++|+.|++++|+
T Consensus 291 ~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~ 364 (466)
T 1o6v_A 291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQ 364 (466)
T ss_dssp EEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSC
T ss_pred eEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCc
Confidence 99999999997655 8899999999999999987765 78999999999999999765 578899999999999999
Q ss_pred cCCchhHhhccCCCceeEeeccCcccccCC
Q 038671 302 LSGFIPSCFEELHGLSYIDISYNELHGSIP 331 (707)
Q Consensus 302 i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~ 331 (707)
+++..| +..+++|+.|++++|+|++.+.
T Consensus 365 l~~~~~--~~~l~~L~~L~l~~n~~~~~p~ 392 (466)
T 1o6v_A 365 ISDLTP--LANLTRITQLGLNDQAWTNAPV 392 (466)
T ss_dssp CCBCGG--GTTCTTCCEEECCCEEEECCCB
T ss_pred cCccch--hhcCCCCCEEeccCCcccCCch
Confidence 998877 8899999999999999998643
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=293.91 Aligned_cols=288 Identities=22% Similarity=0.256 Sum_probs=162.3
Q ss_pred CCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeeccccccccc-CCCCCCCCCccEEEec
Q 038671 28 SLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGP-IPNLRNLTSLVRVRLN 106 (707)
Q Consensus 28 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~-~~~l~~l~~L~~L~l~ 106 (707)
+++.++++++.++ .+|..+. +.|++|+|++|.|++..+..|+++++|++|++++|.++.+ +..+..+++|++|+++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4455555555554 3333322 3455555555555544444455555555555555555444 2234555555555555
Q ss_pred cCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCC--CCchhhhCCCCCCEEeCCCCCCCC
Q 038671 107 QNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITG--SMPAEIIHSSQLKVLDLSSNHIVG 184 (707)
Q Consensus 107 ~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~--~~~~~~~~~~~L~~L~l~~n~l~~ 184 (707)
+|+++.++...+ ++|++|++++|.++.+.+..|..+++|++|++++|.++. ..+..+.++++|+.|++++|.++
T Consensus 109 ~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~- 184 (330)
T 1xku_A 109 KNQLKELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT- 184 (330)
T ss_dssp SSCCSBCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred CCcCCccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-
Confidence 555554433222 455555555555555444445555555555555555542 34445555666666666666655
Q ss_pred CCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhh
Q 038671 185 EMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEK 264 (707)
Q Consensus 185 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 264 (707)
.+|..+. ++|++|++++|.+++..+..+..+++|++|+|++|.+++..+..+..+++|++|++++|+++ ..|..+..
T Consensus 185 ~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 261 (330)
T 1xku_A 185 TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261 (330)
T ss_dssp SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhcc
Confidence 2333222 56666666666666555666666666666666666666555556666666666666666665 44555666
Q ss_pred cccCCeeeecCccCCCCCCccccc------ccccceEeccccccCC--chhHhhccCCCceeEeeccCc
Q 038671 265 LIHLSELDLSHNFLGEEMPSQICN------MQSLEKLNLSHNNLSG--FIPSCFEELHGLSYIDISYNE 325 (707)
Q Consensus 265 l~~L~~L~l~~n~l~~~~~~~~~~------~~~L~~L~l~~n~i~~--~~~~~~~~~~~L~~l~l~~n~ 325 (707)
+++|++|++++|.+++..+..|.. .+.|+.|++++|++.. ..|..|..+.+++.+++++|+
T Consensus 262 l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 666777777777766655555543 3567778888887763 455677778888888888774
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=295.02 Aligned_cols=287 Identities=21% Similarity=0.265 Sum_probs=193.0
Q ss_pred CCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCC-CCCCCCCccEEEec
Q 038671 28 SLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLN 106 (707)
Q Consensus 28 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~l~~l~~L~~L~l~ 106 (707)
+++.++++++.++ .+|..+ .++|++|+|++|.|++..+..|+++++|++|++++|.++.+.+ .+.++++|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCC--CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCC--CCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 5666666666666 445444 2466666666666665556666666666666666666665533 46666666666666
Q ss_pred cCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCC--CCchhhhCCCCCCEEeCCCCCCCC
Q 038671 107 QNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITG--SMPAEIIHSSQLKVLDLSSNHIVG 184 (707)
Q Consensus 107 ~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~--~~~~~~~~~~~L~~L~l~~n~l~~ 184 (707)
+|+++.++...+ ++|++|++++|.++.+.+..|..+++|++|++++|.++. ..+..+..+ +|+.|++++|.+++
T Consensus 111 ~n~l~~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLVEIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCCSCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCCccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 666665544333 566666777666666655566666777777777776642 445555555 77777777777763
Q ss_pred CCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhh
Q 038671 185 EMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEK 264 (707)
Q Consensus 185 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 264 (707)
+|..+. ++|++|++++|.+++..+..+..+++|++|+|++|.+++..+..|..+++|+.|++++|+++ ..|..+..
T Consensus 187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 443333 57777777777777666677777788888888888887777777777788888888888776 45556777
Q ss_pred cccCCeeeecCccCCCCCCccccc------ccccceEeccccccC--CchhHhhccCCCceeEeeccCc
Q 038671 265 LIHLSELDLSHNFLGEEMPSQICN------MQSLEKLNLSHNNLS--GFIPSCFEELHGLSYIDISYNE 325 (707)
Q Consensus 265 l~~L~~L~l~~n~l~~~~~~~~~~------~~~L~~L~l~~n~i~--~~~~~~~~~~~~L~~l~l~~n~ 325 (707)
+++|+.|++++|.+++..+..|.. ...|+.|++++|++. +..+..+..+++|+.+++++|+
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 788888888888887666666654 356788888888887 5667778888888888888874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=311.48 Aligned_cols=245 Identities=16% Similarity=0.143 Sum_probs=184.6
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCc-----hhhhHHHHHHHHHHHhcCC---------CCceeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPS-----EMASQQEFLNEVKTLTGIR---------HRNIVKF 500 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~---------h~niv~~ 500 (707)
.++|++.+.||+|+||.||+|+. +|+.||||++...... .....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35689999999999999999987 6899999999754321 1223466788888888775 5555555
Q ss_pred e-----------------eeeec-------------CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHH
Q 038671 501 Y-----------------GFCSH-------------ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDA 550 (707)
Q Consensus 501 ~-----------------~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~ 550 (707)
. +++.+ .+..++||||+++|++.+.+.. +.+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 4 44443 6789999999999976665532 458999999999999999
Q ss_pred HHHHH-hCCCCCeEecCCCCCCeeecCCC--------------------CeEEeccccceecCCCCCCccccccccCCCC
Q 038671 551 LSYMH-NDCFPPIVHRDISSKNVLLDLEN--------------------EAHVSDFGTAKFLKPDSSNWAELAGTYGYVA 609 (707)
Q Consensus 551 l~~LH-~~~~~~ivH~dlk~~Nil~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~a 609 (707)
|+||| +. ||+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|
T Consensus 174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a 245 (336)
T 2vuw_A 174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence 99999 88 999999999999999887 8999999999876532 3479999999
Q ss_pred ccccccCCCCccchhHHHHHH-HHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhcc
Q 038671 610 PELAYTMKVTEKCDVYSFGVL-ALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCL 688 (707)
Q Consensus 610 PE~~~~~~~~~~~Dv~slG~~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 688 (707)
||++.+.. +.++||||+|++ .+++++|..||....+. ............. ............+.++.+++.+||
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~~L 320 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL---HYLTDKMLKQMTF-KTKCNTPAMKQIKRKIQEFHRTML 320 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH---HHHHHHHHHTCCC-SSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh---hHHHHhhhhhhcc-CcccchhhhhhcCHHHHHHHHHHh
Confidence 99998775 899999998777 77888899997421100 0011111111111 111222334567888999999999
Q ss_pred CCCCCCCCCHHHHH
Q 038671 689 DESPESRPTIQKVS 702 (707)
Q Consensus 689 ~~~P~~Rps~~~l~ 702 (707)
+.| |++|++
T Consensus 321 ~~d-----sa~e~l 329 (336)
T 2vuw_A 321 NFS-----SATDLL 329 (336)
T ss_dssp GSS-----SHHHHH
T ss_pred ccC-----CHHHHH
Confidence 976 999988
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=302.41 Aligned_cols=311 Identities=20% Similarity=0.178 Sum_probs=274.0
Q ss_pred CCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCC-CCCCCCccEE
Q 038671 25 RLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRV 103 (707)
Q Consensus 25 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~-l~~l~~L~~L 103 (707)
.+++++.|++++|.++...+..|.++++|++|+|++|.+++..+..|+.+++|++|++++|.+..+++. +.++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 468999999999999966555689999999999999999988888999999999999999999988765 8999999999
Q ss_pred EeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCC
Q 038671 104 RLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIV 183 (707)
Q Consensus 104 ~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~ 183 (707)
++++|+++.++...|..+++|++|++++|.++.+.+..|..+++|++|++++|.+++. .+..+++|+.|++++|.++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence 9999999999888899999999999999999999888999999999999999999865 3566899999999999987
Q ss_pred CCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhh
Q 038671 184 GEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELE 263 (707)
Q Consensus 184 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~ 263 (707)
+ +...++|++|++++|.++.. +. ...++|+.|++++|.+++. ..+..+++|++|++++|.+.+..+..+.
T Consensus 200 ~-----~~~~~~L~~L~l~~n~l~~~-~~--~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~ 269 (390)
T 3o6n_A 200 T-----LAIPIAVEELDASHNSINVV-RG--PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFV 269 (390)
T ss_dssp E-----EECCSSCSEEECCSSCCCEE-EC--CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred c-----cCCCCcceEEECCCCeeeec-cc--cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHcc
Confidence 3 34456899999999999854 33 2358999999999999864 5789999999999999999998899999
Q ss_pred hcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCCccccccCchhh
Q 038671 264 KLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEA 343 (707)
Q Consensus 264 ~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~ 343 (707)
.+++|+.|++++|.+++ .+..+..+++|+.|++++|++.+ +|..+..+++|+.|++++|+++... ...+.......
T Consensus 270 ~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~L~~L~ 345 (390)
T 3o6n_A 270 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLT 345 (390)
T ss_dssp TCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEE
T ss_pred ccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCccceeC--chhhccCCEEE
Confidence 99999999999999965 45566789999999999999985 4666888999999999999998764 34556677778
Q ss_pred cccCcCcCC
Q 038671 344 LQGNKGLCG 352 (707)
Q Consensus 344 ~~~~~~~c~ 352 (707)
+.+|+..|.
T Consensus 346 l~~N~~~~~ 354 (390)
T 3o6n_A 346 LSHNDWDCN 354 (390)
T ss_dssp CCSSCEEHH
T ss_pred cCCCCccch
Confidence 888887763
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=293.93 Aligned_cols=306 Identities=25% Similarity=0.360 Sum_probs=265.3
Q ss_pred cccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCcc
Q 038671 22 EIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLV 101 (707)
Q Consensus 22 ~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~ 101 (707)
.+..+++|++|++++|.++ .++ .+..+++|++|++++|.+++..+ +..+++|++|++++|.+..+ +.+..+++|+
T Consensus 39 ~~~~l~~L~~L~l~~~~i~-~~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~-~~~~~l~~L~ 113 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI-SALQNLTNLR 113 (347)
T ss_dssp CHHHHTTCSEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GGGTTCTTCS
T ss_pred cchhcccccEEEEeCCccc-cch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc-hHHcCCCcCC
Confidence 3567899999999999999 444 48999999999999999996544 99999999999999999975 4699999999
Q ss_pred EEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCC
Q 038671 102 RVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNH 181 (707)
Q Consensus 102 ~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~ 181 (707)
+|++++|+++.+.. +..+++|++|++++|...... ..+..+++|++|++++|.+.+..+ +..+++|+.|++++|.
T Consensus 114 ~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~ 188 (347)
T 4fmz_A 114 ELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQ 188 (347)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSC
T ss_pred EEECcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCc
Confidence 99999999997755 889999999999999665433 348999999999999999985544 8899999999999999
Q ss_pred CCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchh
Q 038671 182 IVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE 261 (707)
Q Consensus 182 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 261 (707)
+.+..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.+++..+ +..+++|++|++++|.+++. ..
T Consensus 189 l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~ 260 (347)
T 4fmz_A 189 IEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NA 260 (347)
T ss_dssp CCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GG
T ss_pred cccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hh
Confidence 984433 8899999999999999996544 8899999999999999996655 88999999999999999765 56
Q ss_pred hhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCCccccccCch
Q 038671 262 LEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPM 341 (707)
Q Consensus 262 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~~~ 341 (707)
+..+++|+.|++++|.+++. ..+..+++|+.|++++|++++..+..+..+++|+.|++++|++++.+| ...++....
T Consensus 261 ~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~ 337 (347)
T 4fmz_A 261 VKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDS 337 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSE
T ss_pred HhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhccce
Confidence 88999999999999999764 568899999999999999999999999999999999999999998876 445555555
Q ss_pred hhcccCc
Q 038671 342 EALQGNK 348 (707)
Q Consensus 342 ~~~~~~~ 348 (707)
..+.+|+
T Consensus 338 L~l~~N~ 344 (347)
T 4fmz_A 338 ADFANQV 344 (347)
T ss_dssp ESSSCC-
T ss_pred eehhhhc
Confidence 5555554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=299.48 Aligned_cols=299 Identities=24% Similarity=0.239 Sum_probs=255.1
Q ss_pred CCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeee
Q 038671 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLT 81 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 81 (707)
+++|++|++++|.+++. | .|+.+++|++|+|++|++++. + +.++++|++|++++|.+++. + ++++++|++|+
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~ 112 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLN 112 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEE
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEE
Confidence 67899999999999964 5 699999999999999999964 4 89999999999999999965 3 89999999999
Q ss_pred cccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCC
Q 038671 82 LENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGS 161 (707)
Q Consensus 82 l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~ 161 (707)
+++|.++.++ +..+++|++|++++|+++++ .++.+++|++|++++|...+.. .+..+++|++|++++|.+++.
T Consensus 113 L~~N~l~~l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l 185 (457)
T 3bz5_A 113 CDTNKLTKLD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITEL 185 (457)
T ss_dssp CCSSCCSCCC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCC
T ss_pred CCCCcCCeec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCcccee
Confidence 9999999863 89999999999999999986 3788999999999999543332 588999999999999999964
Q ss_pred CchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCc
Q 038671 162 MPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNL 241 (707)
Q Consensus 162 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l 241 (707)
+ +..+++|+.|++++|.+++. .+..+++|++|++++|++++ .| +..+++|++|++++|.+++..+..+.++
T Consensus 186 -~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L 256 (457)
T 3bz5_A 186 -D--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKL 256 (457)
T ss_dssp -C--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTC
T ss_pred -c--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCC
Confidence 3 78899999999999999865 38889999999999999996 44 8899999999999999998766555555
Q ss_pred c-------cCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCc--------ccccccccceEeccccccCCch
Q 038671 242 V-------KLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPS--------QICNMQSLEKLNLSHNNLSGFI 306 (707)
Q Consensus 242 ~-------~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~--------~~~~~~~L~~L~l~~n~i~~~~ 306 (707)
. +|+.|++++|.+.+..| +..+++|+.|++++|...+..|. .+..+++|+.|++++|++++.
T Consensus 257 ~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l- 333 (457)
T 3bz5_A 257 TTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL- 333 (457)
T ss_dssp CEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-
T ss_pred CEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-
Confidence 4 55666777776555444 56789999999999986554432 356678999999999999985
Q ss_pred hHhhccCCCceeEeeccCccccc
Q 038671 307 PSCFEELHGLSYIDISYNELHGS 329 (707)
Q Consensus 307 ~~~~~~~~~L~~l~l~~n~~~~~ 329 (707)
.+..+++|+.|++++|++++.
T Consensus 334 --~l~~l~~L~~L~l~~N~l~~l 354 (457)
T 3bz5_A 334 --DVSHNTKLKSLSCVNAHIQDF 354 (457)
T ss_dssp --CCTTCTTCSEEECCSSCCCBC
T ss_pred --ccccCCcCcEEECCCCCCCCc
Confidence 388899999999999999973
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=316.10 Aligned_cols=342 Identities=23% Similarity=0.229 Sum_probs=276.3
Q ss_pred eeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeeccccc
Q 038671 7 FLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQ 86 (707)
Q Consensus 7 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~ 86 (707)
..+-++.+++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|+|++|+|+++.+++|+++++|++|+|++|+
T Consensus 35 ~~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~ 111 (635)
T 4g8a_A 35 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 111 (635)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred EEECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCc
Confidence 4567777888 7887765 489999999999998888899999999999999999998889999999999999999999
Q ss_pred ccccCCC-CCCCCCccEEEeccCccccccCccccCCCCCcEEEccccccccc-CCCCCCCCCCCcEEEcCCCccCCCCch
Q 038671 87 LRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGE-ISSDWGRCPKLGTLDFSSNNITGSMPA 164 (707)
Q Consensus 87 i~~~~~~-l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~-~~~~~~~~~~L~~L~L~~n~i~~~~~~ 164 (707)
|+.+++. |.++++|++|+|++|+++.+++..|+.+++|++|+|++|.++.+ .+..+..+++|++|+|++|.+++..+.
T Consensus 112 l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 191 (635)
T 4g8a_A 112 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 191 (635)
T ss_dssp CCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred CCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccc
Confidence 9988764 89999999999999999999999999999999999999999865 467788999999999999988754433
Q ss_pred hhhCC---------------------------------------------------------------------------
Q 038671 165 EIIHS--------------------------------------------------------------------------- 169 (707)
Q Consensus 165 ~~~~~--------------------------------------------------------------------------- 169 (707)
.+..+
T Consensus 192 ~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~ 271 (635)
T 4g8a_A 192 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 271 (635)
T ss_dssp GGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCC
T ss_pred cccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCccccccccccccccccccccccc
Confidence 33211
Q ss_pred --------------------------------------------------------CCCCEEeCCCCCCCCCCCh-----
Q 038671 170 --------------------------------------------------------SQLKVLDLSSNHIVGEMPS----- 188 (707)
Q Consensus 170 --------------------------------------------------------~~L~~L~l~~n~l~~~~~~----- 188 (707)
..|+.|++.+|.+....+.
T Consensus 272 ~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L 351 (635)
T 4g8a_A 272 KSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL 351 (635)
T ss_dssp TTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTC
T ss_pred ccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhh
Confidence 1233333333333211111
Q ss_pred --------------hhhCCCCCcEEEecCCccccC---------------------------------------------
Q 038671 189 --------------KLGKLSSLIKLILNSNQLCGQ--------------------------------------------- 209 (707)
Q Consensus 189 --------------~~~~l~~L~~L~l~~n~l~~~--------------------------------------------- 209 (707)
....+++|+.|+++.|.+...
T Consensus 352 ~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~ 431 (635)
T 4g8a_A 352 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSN 431 (635)
T ss_dssp CEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSE
T ss_pred hhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhcc
Confidence 112356677777777766311
Q ss_pred -----CccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeeccccc-ccCchhhhhcccCCeeeecCccCCCCCC
Q 038671 210 -----LSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFI-KKIPVELEKLIHLSELDLSHNFLGEEMP 283 (707)
Q Consensus 210 -----~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 283 (707)
....+..+++++.++++.|.+....+..+..+++|+.|++++|.+. ...+..|..+++|+.|+|++|.+++..|
T Consensus 432 ~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~ 511 (635)
T 4g8a_A 432 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 511 (635)
T ss_dssp EESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECT
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcCh
Confidence 1123455677777888888887777888888999999999999754 4567789999999999999999999999
Q ss_pred cccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCCccc-c-ccCchhhcccCcCcC
Q 038671 284 SQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTA-F-RDAPMEALQGNKGLC 351 (707)
Q Consensus 284 ~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~-~-~~~~~~~~~~~~~~c 351 (707)
..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|++++.+|.... + .......+.+||+.|
T Consensus 512 ~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 512 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp TTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred HHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 9999999999999999999998889999999999999999999998876432 2 346667888999887
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-33 Score=287.54 Aligned_cols=289 Identities=22% Similarity=0.269 Sum_probs=233.7
Q ss_pred CCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecc
Q 038671 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLE 83 (707)
Q Consensus 4 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (707)
+++.++++++.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+++
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 5788888888888 6676654 588889999998887777788888999999999998888878888888899999999
Q ss_pred cccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccc--cCCCCCCCCCCCcEEEcCCCccCCC
Q 038671 84 NNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYG--EISSDWGRCPKLGTLDFSSNNITGS 161 (707)
Q Consensus 84 ~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~--~~~~~~~~~~~L~~L~L~~n~i~~~ 161 (707)
+|.++.++..+. ++|++|++++|+++.+.+..|..+++|++|++++|.++. ..+..|..+++|++|++++|.++..
T Consensus 109 ~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l 186 (330)
T 1xku_A 109 KNQLKELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI 186 (330)
T ss_dssp SSCCSBCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC
T ss_pred CCcCCccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccC
Confidence 988887766554 788899999998888888888888899999999988864 6667788888899999998888843
Q ss_pred CchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCc
Q 038671 162 MPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNL 241 (707)
Q Consensus 162 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l 241 (707)
+..+. ++|+.|++++|.+++..+..|..+++|++|++++|.+++..+..+..+++|++|+|++|.++ .+|..+..+
T Consensus 187 -~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 262 (330)
T 1xku_A 187 -PQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 262 (330)
T ss_dssp -CSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC
T ss_pred -Ccccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccC
Confidence 33332 78889999999888777888888888999999999888777778888888999999999888 667778888
Q ss_pred ccCceEeeecccccccCchhhhh------cccCCeeeecCccCCC--CCCcccccccccceEeccccc
Q 038671 242 VKLHYLNLSNNQFIKKIPVELEK------LIHLSELDLSHNFLGE--EMPSQICNMQSLEKLNLSHNN 301 (707)
Q Consensus 242 ~~L~~L~l~~n~l~~~~~~~~~~------l~~L~~L~l~~n~l~~--~~~~~~~~~~~L~~L~l~~n~ 301 (707)
++|++|++++|++++..+..|.. ...|+.|++++|.+.. ..|..|..+.+++.+++++|+
T Consensus 263 ~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 263 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 88999999999888777766643 3678888898888854 556778888888888888884
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=289.84 Aligned_cols=288 Identities=24% Similarity=0.287 Sum_probs=226.1
Q ss_pred CCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecc
Q 038671 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLE 83 (707)
Q Consensus 4 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (707)
+++.++++++.++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.+++..|..|+++++|++|+++
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 4778888888888 6676654 588888888888887777788888888888888888887778888888888888888
Q ss_pred cccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccc--cCCCCCCCCCCCcEEEcCCCccCCC
Q 038671 84 NNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYG--EISSDWGRCPKLGTLDFSSNNITGS 161 (707)
Q Consensus 84 ~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~--~~~~~~~~~~~L~~L~L~~n~i~~~ 161 (707)
+|.+..++..+. ++|++|++++|+++.+++..|..+++|++|++++|.++. ..+..+..+ +|++|++++|.+++.
T Consensus 111 ~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~l 187 (332)
T 2ft3_A 111 KNHLVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGI 187 (332)
T ss_dssp SSCCCSCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSSC
T ss_pred CCcCCccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCcc
Confidence 888887766554 788888888888888877778888888888888888863 566677777 888888888888753
Q ss_pred CchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCc
Q 038671 162 MPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNL 241 (707)
Q Consensus 162 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l 241 (707)
+..+. ++|+.|++++|.+++..+..|..+++|++|++++|.+++..+..+..+++|++|+|++|.++ .+|..+..+
T Consensus 188 -~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 263 (332)
T 2ft3_A 188 -PKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL 263 (332)
T ss_dssp -CSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGC
T ss_pred -Ccccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcC
Confidence 33332 67888888888888777778888888888888888888777777888888888888888888 566678888
Q ss_pred ccCceEeeecccccccCchhhhhc------ccCCeeeecCccCC--CCCCcccccccccceEeccccc
Q 038671 242 VKLHYLNLSNNQFIKKIPVELEKL------IHLSELDLSHNFLG--EEMPSQICNMQSLEKLNLSHNN 301 (707)
Q Consensus 242 ~~L~~L~l~~n~l~~~~~~~~~~l------~~L~~L~l~~n~l~--~~~~~~~~~~~~L~~L~l~~n~ 301 (707)
++|+.|++++|++++..+..|... .+|+.|++++|++. +..+..|..+++|+.+++++|+
T Consensus 264 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 264 KLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp TTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 888888888888887776666543 56788888888876 4667778888888888888874
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=312.19 Aligned_cols=311 Identities=20% Similarity=0.174 Sum_probs=275.4
Q ss_pred CCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCC-CCCCCCccEE
Q 038671 25 RLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRV 103 (707)
Q Consensus 25 ~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~-l~~l~~L~~L 103 (707)
.+.+++.|++++|.++...+..|.++++|++|+|++|.|++..|..|+.+++|++|+|++|.++.+++. |.++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 357899999999999976666789999999999999999999889999999999999999999988775 7999999999
Q ss_pred EeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCC
Q 038671 104 RLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIV 183 (707)
Q Consensus 104 ~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~ 183 (707)
+|++|.++.+++..|..+++|++|+|++|.++.+.+..|..+++|++|+|++|.+++.. +..+++|+.|++++|.++
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccc
Confidence 99999999999888999999999999999999999999999999999999999998653 556889999999999987
Q ss_pred CCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhh
Q 038671 184 GEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELE 263 (707)
Q Consensus 184 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~ 263 (707)
+ +...++|++|++++|.++...+. ..++|+.|+|++|.+++. ..+..+++|+.|+|++|.+.+..|..|.
T Consensus 206 ~-----l~~~~~L~~L~ls~n~l~~~~~~---~~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 275 (597)
T 3oja_B 206 T-----LAIPIAVEELDASHNSINVVRGP---VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFV 275 (597)
T ss_dssp E-----EECCTTCSEEECCSSCCCEEECS---CCSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGT
T ss_pred c-----ccCCchhheeeccCCcccccccc---cCCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhc
Confidence 3 34557899999999999854332 237899999999999863 6789999999999999999999999999
Q ss_pred hcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCCccccccCchhh
Q 038671 264 KLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEA 343 (707)
Q Consensus 264 ~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~ 343 (707)
.+++|+.|+|++|.+++ .|..+..+++|+.|++++|+++. +|..+..+++|+.|++++|++++.. ...+.......
T Consensus 276 ~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~L~~L~ 351 (597)
T 3oja_B 276 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK--LSTHHTLKNLT 351 (597)
T ss_dssp TCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC--CCTTCCCSEEE
T ss_pred CccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCCc-cCcccccCCCCCEEECCCCCCCCcC--hhhcCCCCEEE
Confidence 99999999999999976 46667789999999999999994 5777889999999999999998764 34456677778
Q ss_pred cccCcCcCC
Q 038671 344 LQGNKGLCG 352 (707)
Q Consensus 344 ~~~~~~~c~ 352 (707)
+.+|++.|.
T Consensus 352 l~~N~~~~~ 360 (597)
T 3oja_B 352 LSHNDWDCN 360 (597)
T ss_dssp CCSSCEEHH
T ss_pred eeCCCCCCh
Confidence 888887764
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-32 Score=291.55 Aligned_cols=293 Identities=23% Similarity=0.228 Sum_probs=239.4
Q ss_pred CCCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCee
Q 038671 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLL 80 (707)
Q Consensus 1 nl~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 80 (707)
++++|++|+|++|++++. | ++.+++|++|++++|++++. + +.++++|++|++++|.+++. + ++.+++|++|
T Consensus 62 ~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L 132 (457)
T 3bz5_A 62 KLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYL 132 (457)
T ss_dssp GCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEE
T ss_pred ccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEE
Confidence 378999999999999964 4 89999999999999999964 3 89999999999999999964 4 8999999999
Q ss_pred ecccccccccCCCCCCCCCccEEEeccCc-cccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccC
Q 038671 81 TLENNQLRGPIPNLRNLTSLVRVRLNQNH-LTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNIT 159 (707)
Q Consensus 81 ~l~~n~i~~~~~~l~~l~~L~~L~l~~n~-l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~ 159 (707)
++++|+++.+ .+..+++|++|++++|+ ++.+ .+..+++|++|++++|.++++. +..+++|+.|++++|.++
T Consensus 133 ~l~~N~l~~l--~l~~l~~L~~L~l~~n~~~~~~---~~~~l~~L~~L~ls~n~l~~l~---l~~l~~L~~L~l~~N~l~ 204 (457)
T 3bz5_A 133 NCARNTLTEI--DVSHNTQLTELDCHLNKKITKL---DVTPQTQLTTLDCSFNKITELD---VSQNKLLNRLNCDTNNIT 204 (457)
T ss_dssp ECTTSCCSCC--CCTTCTTCCEEECTTCSCCCCC---CCTTCTTCCEEECCSSCCCCCC---CTTCTTCCEEECCSSCCS
T ss_pred ECCCCcccee--ccccCCcCCEEECCCCCccccc---ccccCCcCCEEECCCCccceec---cccCCCCCEEECcCCcCC
Confidence 9999999986 48899999999999995 4433 5788999999999999999753 889999999999999999
Q ss_pred CCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCC-------cccEEEccCCccCC
Q 038671 160 GSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLT-------QLERLDLSSNRLSN 232 (707)
Q Consensus 160 ~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-------~L~~L~l~~n~i~~ 232 (707)
+. .+..+++|+.|++++|++++ +| +..+++|+.|++++|++++..+..+..++ +|+.|++++|.+.+
T Consensus 205 ~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~ 278 (457)
T 3bz5_A 205 KL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLI 278 (457)
T ss_dssp CC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCC
T ss_pred ee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCC
Confidence 65 38889999999999999996 55 88999999999999999976544444333 44455555555444
Q ss_pred CCCccccCcccCceEeeecccccccCch--------hhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCC
Q 038671 233 SIPKSLGNLVKLHYLNLSNNQFIKKIPV--------ELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSG 304 (707)
Q Consensus 233 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~--------~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~ 304 (707)
..| ++.+++|+.|++++|...+..+. .+..+++|+.|++++|.+++. .+..+++|+.|++++|++++
T Consensus 279 ~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 279 YFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp EEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB
T ss_pred ccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc---ccccCCcCcEEECCCCCCCC
Confidence 433 56789999999999986554432 366778999999999999874 38899999999999999986
Q ss_pred chhHhhccCCCceeEeeccCccccc
Q 038671 305 FIPSCFEELHGLSYIDISYNELHGS 329 (707)
Q Consensus 305 ~~~~~~~~~~~L~~l~l~~n~~~~~ 329 (707)
. +.|..|++++|.++|.
T Consensus 354 l--------~~L~~L~l~~n~l~g~ 370 (457)
T 3bz5_A 354 F--------SSVGKIPALNNNFEAE 370 (457)
T ss_dssp C--------TTGGGSSGGGTSEEEE
T ss_pred c--------cccccccccCCcEEec
Confidence 3 3344444444444443
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=280.44 Aligned_cols=253 Identities=25% Similarity=0.447 Sum_probs=140.6
Q ss_pred CccEEEeccCcccc--ccCccccCCCCCcEEEccc-ccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEE
Q 038671 99 SLVRVRLNQNHLTG--NISESFGIHPNLAFIDLSH-NYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVL 175 (707)
Q Consensus 99 ~L~~L~l~~n~l~~--~~~~~~~~~~~L~~L~L~~-n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L 175 (707)
+++.|++++|++++ ..+..|..+++|++|+|++ |.+.+..+..|..+++|++|+|++|.+++..+..|..+++|++|
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L 130 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEE
Confidence 45555555555544 3444555555555555552 55554445555555555555555555554455555555555555
Q ss_pred eCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCC-cccEEEccCCccCCCCCccccCcccCceEeeecccc
Q 038671 176 DLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLT-QLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQF 254 (707)
Q Consensus 176 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l 254 (707)
++++|.+++..|..+..+++|++|++++|.+++..|..+..++ +|++|++++|.+++..|..+..++ |+.|++++|.+
T Consensus 131 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred eCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 5555555555555555555555555555555555555555554 555555555555555555555554 55555555555
Q ss_pred cccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCCcc
Q 038671 255 IKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST 334 (707)
Q Consensus 255 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~ 334 (707)
++..+..+..+++|+.|++++|.+++..+. +..+++|+.|++++|++++..|..+..+++|+.|++++|++++.+|...
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~ 288 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence 555555555555566666665555443333 4555566666666666655555556666666666666666666555555
Q ss_pred ccccCchhhcccCcCcCCC
Q 038671 335 AFRDAPMEALQGNKGLCGD 353 (707)
Q Consensus 335 ~~~~~~~~~~~~~~~~c~~ 353 (707)
.++......+.+|+..|+.
T Consensus 289 ~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 289 NLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp TGGGSCGGGTCSSSEEEST
T ss_pred cccccChHHhcCCCCccCC
Confidence 5555555556666666654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-32 Score=282.23 Aligned_cols=248 Identities=30% Similarity=0.444 Sum_probs=209.5
Q ss_pred CCCCeEECCCCcccc--ccCcCccCCCCCcEEEccc-CcCcccCCccccCCCCCCeeecccccccc-cCCCCCCCCCccE
Q 038671 27 KSLSDLELSGNKLCG--SIPHSLGNLTQITFLTLFD-NALSGAIPKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVR 102 (707)
Q Consensus 27 ~~L~~L~l~~n~i~~--~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~l~~n~i~~-~~~~l~~l~~L~~ 102 (707)
.+++.|+|++|++++ .+|..|.++++|++|+|++ |.+.+.+|..|+++++|++|++++|.+.. ++..+..+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 478888888888887 7788888888888888884 88887788888888888888888888874 4445888888888
Q ss_pred EEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCC-CCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCC
Q 038671 103 VRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCP-KLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNH 181 (707)
Q Consensus 103 L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~-~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~ 181 (707)
|++++|.+++..+..+..+++|++|+|++|.+++..+..+..++ +|++|+|++|.+++..+..+..+. |+.|++++|.
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 88888888877777888888888888888888877788888887 888899988888878888888886 9999999998
Q ss_pred CCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchh
Q 038671 182 IVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVE 261 (707)
Q Consensus 182 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 261 (707)
+++..+..|..+++|++|++++|.+++..+. +..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~ 287 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC
Confidence 8888888888899999999999999855554 778899999999999998888889999999999999999998877765
Q ss_pred hhhcccCCeeeecCcc
Q 038671 262 LEKLIHLSELDLSHNF 277 (707)
Q Consensus 262 ~~~l~~L~~L~l~~n~ 277 (707)
..+++|+.|++++|+
T Consensus 288 -~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 288 -GNLQRFDVSAYANNK 302 (313)
T ss_dssp -TTGGGSCGGGTCSSS
T ss_pred -ccccccChHHhcCCC
Confidence 788899999999997
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=269.11 Aligned_cols=280 Identities=24% Similarity=0.252 Sum_probs=206.5
Q ss_pred ceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccC--CccccCCCCCCeeecc
Q 038671 6 AFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAI--PKEYGNLVKLTLLTLE 83 (707)
Q Consensus 6 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~--~~~~~~l~~L~~L~l~ 83 (707)
+.++++++.++ .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|.++... +..+..+++|++|+++
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 57888888888 6676554 58999999999988555556788999999999999887443 5667778889999999
Q ss_pred cccccccCCCCCCCCCccEEEeccCccccccC-ccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCC-C
Q 038671 84 NNQLRGPIPNLRNLTSLVRVRLNQNHLTGNIS-ESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITG-S 161 (707)
Q Consensus 84 ~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~-~ 161 (707)
+|.+..++..+..+++|++|++++|+++.+.. ..+..+++|++|++++|.++...+..+..+++|++|+|++|.+++ .
T Consensus 87 ~n~i~~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 166 (306)
T 2z66_A 87 FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166 (306)
T ss_dssp SCSEEEEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred CCccccChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccccc
Confidence 98888777778888888888888888887765 567788888888888888887777778888888888888888775 4
Q ss_pred CchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCc
Q 038671 162 MPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNL 241 (707)
Q Consensus 162 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l 241 (707)
.+..+..+++|+.|++++|.+++..+..+..+++|++|++++|.+++..+..+..+++|++|+|++|.+++..+..+..+
T Consensus 167 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 246 (306)
T 2z66_A 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246 (306)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCC
T ss_pred chhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhh
Confidence 56677777888888888888776667777777778888888887776666667777777777777777777777777776
Q ss_pred c-cCceEeeecccccccCc--hhhhhcccCCeeeecCccCCCCCCccccc
Q 038671 242 V-KLHYLNLSNNQFIKKIP--VELEKLIHLSELDLSHNFLGEEMPSQICN 288 (707)
Q Consensus 242 ~-~L~~L~l~~n~l~~~~~--~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 288 (707)
+ +|++|+|++|++..... .....+...+.+.+..+.+....|..+.+
T Consensus 247 ~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g 296 (306)
T 2z66_A 247 PSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG 296 (306)
T ss_dssp CTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTT
T ss_pred hccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCC
Confidence 4 77777777777754321 11222334444444455554444444433
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-33 Score=303.82 Aligned_cols=325 Identities=22% Similarity=0.237 Sum_probs=138.7
Q ss_pred CCCceeeccCCeeee----cCCccccCCCCCCeEECCCCccccccCcCc-cCCC----CCcEEEcccCcCcc----cCCc
Q 038671 3 SNLAFLYLYNNSFSG----SIPSEIGRLKSLSDLELSGNKLCGSIPHSL-GNLT----QITFLTLFDNALSG----AIPK 69 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~----~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~-~~l~----~L~~L~L~~n~i~~----~~~~ 69 (707)
++|++|+|++|.+++ .++..+..+++|++|+|++|.+++..+..+ ..++ +|++|+|++|.|++ .++.
T Consensus 28 ~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~ 107 (461)
T 1z7x_W 28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 107 (461)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHH
Confidence 344444444444442 123334444445555555544443222211 1122 34455555554442 1244
Q ss_pred cccCCCCCCeeecccccccccCC-----C-CCCCCCccEEEeccCcccccc----CccccCCCCCcEEEcccccccccCC
Q 038671 70 EYGNLVKLTLLTLENNQLRGPIP-----N-LRNLTSLVRVRLNQNHLTGNI----SESFGIHPNLAFIDLSHNYFYGEIS 139 (707)
Q Consensus 70 ~~~~l~~L~~L~l~~n~i~~~~~-----~-l~~l~~L~~L~l~~n~l~~~~----~~~~~~~~~L~~L~L~~n~i~~~~~ 139 (707)
.|..+++|++|++++|.++.... . ....++|++|++++|+++... +..+..+++|++|++++|.++....
T Consensus 108 ~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 187 (461)
T 1z7x_W 108 TLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGV 187 (461)
T ss_dssp HTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHH
T ss_pred HHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHH
Confidence 44444455555555544432100 0 122334455555555444322 2223334455555555554443222
Q ss_pred CCCC-----CCCCCcEEEcCCCccCCC----CchhhhCCCCCCEEeCCCCCCCCCC-----ChhhhCCCCCcEEEecCCc
Q 038671 140 SDWG-----RCPKLGTLDFSSNNITGS----MPAEIIHSSQLKVLDLSSNHIVGEM-----PSKLGKLSSLIKLILNSNQ 205 (707)
Q Consensus 140 ~~~~-----~~~~L~~L~L~~n~i~~~----~~~~~~~~~~L~~L~l~~n~l~~~~-----~~~~~~l~~L~~L~l~~n~ 205 (707)
..+. ..++|++|+|++|.+++. .+..+..+++|+.|++++|.+++.. +..+..+++|++|++++|.
T Consensus 188 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~ 267 (461)
T 1z7x_W 188 RVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECG 267 (461)
T ss_dssp HHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCC
Confidence 2221 133455555555554432 2333344455555555555443221 1111134455555555555
Q ss_pred cccC----CccccCCCCcccEEEccCCccCCCCCccccCc-----ccCceEeeecccccccC----chhhhhcccCCeee
Q 038671 206 LCGQ----LSLELGSLTQLERLDLSSNRLSNSIPKSLGNL-----VKLHYLNLSNNQFIKKI----PVELEKLIHLSELD 272 (707)
Q Consensus 206 l~~~----~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l-----~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~ 272 (707)
++.. .+..+..+++|++|++++|.+++..+..+... ++|+.|++++|.+++.. +..+..+++|++|+
T Consensus 268 l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~ 347 (461)
T 1z7x_W 268 ITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQ 347 (461)
T ss_dssp CCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEE
T ss_pred CCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEE
Confidence 5432 23333444555555555555443322222221 34555555555544332 22333445555555
Q ss_pred ecCccCCCCCCccccc-----ccccceEeccccccCC----chhHhhccCCCceeEeeccCccc
Q 038671 273 LSHNFLGEEMPSQICN-----MQSLEKLNLSHNNLSG----FIPSCFEELHGLSYIDISYNELH 327 (707)
Q Consensus 273 l~~n~l~~~~~~~~~~-----~~~L~~L~l~~n~i~~----~~~~~~~~~~~L~~l~l~~n~~~ 327 (707)
+++|.+++..+..+.. .++|+.|++++|++++ .++..+..+++|+.|++++|+++
T Consensus 348 Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 348 ISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp CCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred ccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 5555554333322222 3455555555555543 34444445555555555555544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-29 Score=271.24 Aligned_cols=240 Identities=27% Similarity=0.283 Sum_probs=123.0
Q ss_pred CCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcc
Q 038671 51 TQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLS 130 (707)
Q Consensus 51 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~ 130 (707)
++|++|++++|.+++ +| .|+++++|++|++++|+++.++..+ .+|++|++++|++++++ .+..+++|++|+++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~~---~~L~~L~L~~n~l~~l~--~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDLP---PSLEFIAAGNNQLEELP--ELQNLPFLTAIYAD 203 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSSCC--CCTTCTTCCEEECC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCCCc---ccccEEECcCCcCCcCc--cccCCCCCCEEECC
Confidence 345555555555553 33 3555555555555555555433221 25555555555555432 34555555555555
Q ss_pred cccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCC
Q 038671 131 HNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQL 210 (707)
Q Consensus 131 ~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 210 (707)
+|.++++.. ..++|++|++++|.++ ..+ .+..+++|+.|++++|++++ +|.. +++|++|++++|++++ .
T Consensus 204 ~N~l~~l~~----~~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l 272 (454)
T 1jl5_A 204 NNSLKKLPD----LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-L 272 (454)
T ss_dssp SSCCSSCCC----CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-C
T ss_pred CCcCCcCCC----CcCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-c
Confidence 555543211 1134555555555554 223 24455555555555555542 2221 2455555555555553 2
Q ss_pred ccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhc-ccCCeeeecCccCCCCCCcccccc
Q 038671 211 SLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKL-IHLSELDLSHNFLGEEMPSQICNM 289 (707)
Q Consensus 211 ~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~~ 289 (707)
+.. +++|++|++++|.+++.. . + .++|+.|++++|++++. ..+ ++|+.|++++|.+++ .|.. +
T Consensus 273 ~~~---~~~L~~L~ls~N~l~~l~-~-~--~~~L~~L~l~~N~l~~i-----~~~~~~L~~L~Ls~N~l~~-lp~~---~ 336 (454)
T 1jl5_A 273 PEL---PQSLTFLDVSENIFSGLS-E-L--PPNLYYLNASSNEIRSL-----CDLPPSLEELNVSNNKLIE-LPAL---P 336 (454)
T ss_dssp CCC---CTTCCEEECCSSCCSEES-C-C--CTTCCEEECCSSCCSEE-----CCCCTTCCEEECCSSCCSC-CCCC---C
T ss_pred Ccc---cCcCCEEECcCCccCccc-C-c--CCcCCEEECcCCcCCcc-----cCCcCcCCEEECCCCcccc-cccc---C
Confidence 221 245555555555555311 0 0 13455555555555432 122 467777777777754 3332 4
Q ss_pred cccceEeccccccCCchhHhhccCCCceeEeeccCcccc
Q 038671 290 QSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHG 328 (707)
Q Consensus 290 ~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~ 328 (707)
++|+.|++++|.++.. |. .+++|+.|++++|++++
T Consensus 337 ~~L~~L~L~~N~l~~l-p~---~l~~L~~L~L~~N~l~~ 371 (454)
T 1jl5_A 337 PRLERLIASFNHLAEV-PE---LPQNLKQLHVEYNPLRE 371 (454)
T ss_dssp TTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSS
T ss_pred CcCCEEECCCCccccc-cc---hhhhccEEECCCCCCCc
Confidence 6777777777777743 33 35677777777777777
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-34 Score=307.94 Aligned_cols=327 Identities=20% Similarity=0.139 Sum_probs=265.8
Q ss_pred CCCCceeeccCCeeeecCCcc-ccCCCCCCeEECCCCcccc----ccCcCccCCCCCcEEEcccCcCcccCCcccc-CCC
Q 038671 2 LSNLAFLYLYNNSFSGSIPSE-IGRLKSLSDLELSGNKLCG----SIPHSLGNLTQITFLTLFDNALSGAIPKEYG-NLV 75 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~~~~~~-~~~l~~L~~L~l~~n~i~~----~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~ 75 (707)
+++|++|+|++|++++..... +..+++|++|+|++|++++ .++..+..+++|++|+|++|.+++..+..+. .++
T Consensus 2 ~~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp CEEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 467899999999998665444 7889999999999999985 3466788899999999999999875554443 455
Q ss_pred ----CCCeeecccccccc-----cCCCCCCCCCccEEEeccCccccccCcccc-----CCCCCcEEEcccccccccC---
Q 038671 76 ----KLTLLTLENNQLRG-----PIPNLRNLTSLVRVRLNQNHLTGNISESFG-----IHPNLAFIDLSHNYFYGEI--- 138 (707)
Q Consensus 76 ----~L~~L~l~~n~i~~-----~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~-----~~~~L~~L~L~~n~i~~~~--- 138 (707)
+|++|++++|.++. ++..+..+++|++|++++|.++......+. ..++|++|+|++|.++...
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~ 161 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 161 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence 69999999999984 345689999999999999999865444333 3568999999999998643
Q ss_pred -CCCCCCCCCCcEEEcCCCccCCCCchhhhC-----CCCCCEEeCCCCCCCCC----CChhhhCCCCCcEEEecCCcccc
Q 038671 139 -SSDWGRCPKLGTLDFSSNNITGSMPAEIIH-----SSQLKVLDLSSNHIVGE----MPSKLGKLSSLIKLILNSNQLCG 208 (707)
Q Consensus 139 -~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~-----~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~ 208 (707)
+..+..+++|++|++++|.+++.....+.. .++|+.|++++|.+++. ++..+..+++|++|++++|.++.
T Consensus 162 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 241 (461)
T 1z7x_W 162 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 241 (461)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCCh
Confidence 455667899999999999988655554443 67999999999999854 46778889999999999999985
Q ss_pred CC-----ccccCCCCcccEEEccCCccCCC----CCccccCcccCceEeeecccccccCchhhhhc-----ccCCeeeec
Q 038671 209 QL-----SLELGSLTQLERLDLSSNRLSNS----IPKSLGNLVKLHYLNLSNNQFIKKIPVELEKL-----IHLSELDLS 274 (707)
Q Consensus 209 ~~-----~~~~~~l~~L~~L~l~~n~i~~~----~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l-----~~L~~L~l~ 274 (707)
.. +..+..+++|++|++++|.+++. .+..+..+++|++|++++|.+.+..+..+... ++|++|+++
T Consensus 242 ~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~ 321 (461)
T 1z7x_W 242 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321 (461)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence 43 22334689999999999999864 46677789999999999999987766666554 699999999
Q ss_pred CccCCCC----CCcccccccccceEeccccccCCchhHhhcc-----CCCceeEeeccCcccc
Q 038671 275 HNFLGEE----MPSQICNMQSLEKLNLSHNNLSGFIPSCFEE-----LHGLSYIDISYNELHG 328 (707)
Q Consensus 275 ~n~l~~~----~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~-----~~~L~~l~l~~n~~~~ 328 (707)
+|.+++. .+..+..+++|+.|++++|++++..+..+.. .++|+.|++++|+++.
T Consensus 322 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384 (461)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred CCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCCh
Confidence 9999765 3455667799999999999998776655553 6799999999999984
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.6e-30 Score=274.48 Aligned_cols=252 Identities=25% Similarity=0.268 Sum_probs=163.1
Q ss_pred CCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCC
Q 038671 77 LTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSN 156 (707)
Q Consensus 77 L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n 156 (707)
...++.+++.++.++..+. ++++.|+|++|+++.+.+..|..+++|++|+|++|.++.+.+..|..+++|++|+|++|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp SCEEECCSCCCSSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CCEEEeCCCCcCcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 3445555555554444433 45555555555555555555556666666666666665555555666666666666666
Q ss_pred ccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecC-CccccCCccccCCCCcccEEEccCCccCCCCC
Q 038671 157 NITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNS-NQLCGQLSLELGSLTQLERLDLSSNRLSNSIP 235 (707)
Q Consensus 157 ~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~ 235 (707)
.++...+..|..+++|+.|+|++|.++...+..|..+++|++|++++ |.++...+..|..+++|++|+|++|.++.. |
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~ 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-P 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-C
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc-c
Confidence 66655555556666666666666666555555566666666666666 344434444566677777777777777633 3
Q ss_pred ccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCC
Q 038671 236 KSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHG 315 (707)
Q Consensus 236 ~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~ 315 (707)
.+..+++|+.|+|++|++++..+..|.++++|+.|+|++|.+++..+..|..+++|+.|++++|++++..+..+..+++
T Consensus 202 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 280 (440)
T 3zyj_A 202 -NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280 (440)
T ss_dssp -CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTT
T ss_pred -ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccC
Confidence 3666777777777777777777777777777777777777777777777777777777777777777776677777778
Q ss_pred ceeEeeccCcccccCCC
Q 038671 316 LSYIDISYNELHGSIPN 332 (707)
Q Consensus 316 L~~l~l~~n~~~~~~~~ 332 (707)
|+.|++++|+|.|.|..
T Consensus 281 L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 281 LERIHLHHNPWNCNCDI 297 (440)
T ss_dssp CCEEECCSSCEECSSTT
T ss_pred CCEEEcCCCCccCCCCc
Confidence 88888888888877753
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=272.51 Aligned_cols=277 Identities=21% Similarity=0.206 Sum_probs=178.0
Q ss_pred CCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCC-CCCCCCCccEEEec
Q 038671 28 SLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLN 106 (707)
Q Consensus 28 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~l~~l~~L~~L~l~ 106 (707)
.....++++++++ .+|..+. ++|++|++++|.+++..+..|.++++|++|++++|.++.+.+ .+.++++|++|+++
T Consensus 32 ~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (353)
T 2z80_A 32 RNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108 (353)
T ss_dssp TTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence 3344555555555 4444332 356666666666665555556666666666666666655443 35566666666666
Q ss_pred cCccccccCccccCCCCCcEEEcccccccccCC-CCCCCCCCCcEEEcCCC-ccCCCCchhhhCCCCCCEEeCCCCCCCC
Q 038671 107 QNHLTGNISESFGIHPNLAFIDLSHNYFYGEIS-SDWGRCPKLGTLDFSSN-NITGSMPAEIIHSSQLKVLDLSSNHIVG 184 (707)
Q Consensus 107 ~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~-~~~~~~~~L~~L~L~~n-~i~~~~~~~~~~~~~L~~L~l~~n~l~~ 184 (707)
+|+++.++...|..+++|++|++++|.++.+.. ..|..+++|++|++++| .++...+..+.++++|+.|++++|.+++
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~ 188 (353)
T 2z80_A 109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS 188 (353)
T ss_dssp SSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCE
T ss_pred CCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCc
Confidence 666665555556666666666666666665444 45666666666666666 3554455566666666666666666665
Q ss_pred CCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCcccc---CcccCceEeeeccccccc----
Q 038671 185 EMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLG---NLVKLHYLNLSNNQFIKK---- 257 (707)
Q Consensus 185 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~---~l~~L~~L~l~~n~l~~~---- 257 (707)
..|..+..+++|++|++++|.++......+..+++|+.|++++|.+++..+..+. ....++.++++++.+.+.
T Consensus 189 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~ 268 (353)
T 2z80_A 189 YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ 268 (353)
T ss_dssp ECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHH
T ss_pred cCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhh
Confidence 5666666667777777777776543333344567777777777777655444333 345677888888777653
Q ss_pred CchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchh
Q 038671 258 IPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIP 307 (707)
Q Consensus 258 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~ 307 (707)
.|..+..+++|++|++++|.++...+..|..+++|+.|++++|++.+..+
T Consensus 269 l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 269 VMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp HHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 45678889999999999999975554556899999999999999997655
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-30 Score=274.60 Aligned_cols=252 Identities=21% Similarity=0.209 Sum_probs=166.4
Q ss_pred CCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCC
Q 038671 77 LTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSN 156 (707)
Q Consensus 77 L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n 156 (707)
...++.+++.++.++..+. ++|+.|+|++|+++.+.+..|..+++|++|+|++|.++.+.+..|..+++|++|+|++|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp SCEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CcEEEECCCCcCccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 3445555555555544433 45666666666666666666666666666666666666666666666666666666666
Q ss_pred ccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecC-CccccCCccccCCCCcccEEEccCCccCCCCC
Q 038671 157 NITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNS-NQLCGQLSLELGSLTQLERLDLSSNRLSNSIP 235 (707)
Q Consensus 157 ~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~ 235 (707)
.++...+..|..+++|++|+|++|.++...+..|..+++|++|++++ |.++...+..|..+++|++|+|++|.+++. |
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~ 212 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P 212 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c
Confidence 66655555566666666666666666655555666666666666666 444444444566677777777777777643 2
Q ss_pred ccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCC
Q 038671 236 KSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHG 315 (707)
Q Consensus 236 ~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~ 315 (707)
.+..+++|+.|+|++|.+++..+..|.++++|+.|++++|.+++..+..|..+++|+.|++++|+|++..+..+..+++
T Consensus 213 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 291 (452)
T 3zyi_A 213 -NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY 291 (452)
T ss_dssp -CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTT
T ss_pred -cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccC
Confidence 3666777777777777777777777777777777777777777666777777777777777777777666666777777
Q ss_pred ceeEeeccCcccccCCC
Q 038671 316 LSYIDISYNELHGSIPN 332 (707)
Q Consensus 316 L~~l~l~~n~~~~~~~~ 332 (707)
|+.|++++|+|.|.|..
T Consensus 292 L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 292 LVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CCEEECCSSCEECSTTT
T ss_pred CCEEEccCCCcCCCCCc
Confidence 77777777777777653
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=269.46 Aligned_cols=283 Identities=18% Similarity=0.168 Sum_probs=240.1
Q ss_pred cCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCC-CCCCCCCccEEEeccCccccccCccccCCCCCcE
Q 038671 48 GNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAF 126 (707)
Q Consensus 48 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~ 126 (707)
..++.....+++++.++ .+|..+. ++|++|++++|.++.+++ .+.++++|++|++++|+++.+.+..|..+++|++
T Consensus 28 ~~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (353)
T 2z80_A 28 LSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH 104 (353)
T ss_dssp CEECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCE
Confidence 34555667899999999 5566554 489999999999998777 6999999999999999999998889999999999
Q ss_pred EEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCc-hhhhCCCCCCEEeCCCC-CCCCCCChhhhCCCCCcEEEecCC
Q 038671 127 IDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMP-AEIIHSSQLKVLDLSSN-HIVGEMPSKLGKLSSLIKLILNSN 204 (707)
Q Consensus 127 L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~-~~~~~~~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~n 204 (707)
|+|++|.++.+.+..|..+++|++|+|++|.++.... ..+..+++|++|++++| .+....+..|..+++|++|++++|
T Consensus 105 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 184 (353)
T 2z80_A 105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184 (353)
T ss_dssp EECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred EECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCC
Confidence 9999999998777778999999999999999996555 57889999999999999 577667788999999999999999
Q ss_pred ccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhh---hcccCCeeeecCccCCC-
Q 038671 205 QLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELE---KLIHLSELDLSHNFLGE- 280 (707)
Q Consensus 205 ~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~---~l~~L~~L~l~~n~l~~- 280 (707)
.+++..+..+..+++|++|++++|.++......+..+++|+.|++++|.+++..+..+. ....++.+++++|.+++
T Consensus 185 ~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~ 264 (353)
T 2z80_A 185 DLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264 (353)
T ss_dssp TCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHH
T ss_pred CcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCc
Confidence 99988899999999999999999999855555566789999999999999876554433 35678888999888865
Q ss_pred ---CCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCCc
Q 038671 281 ---EMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNS 333 (707)
Q Consensus 281 ---~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~ 333 (707)
..|..+..+++|+.|++++|+++...+..+..+++|+.|++++|+|.|.+|..
T Consensus 265 ~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~l 320 (353)
T 2z80_A 265 SLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 320 (353)
T ss_dssp HHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHHH
T ss_pred chhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCCc
Confidence 35667788999999999999999665555789999999999999999998743
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=264.05 Aligned_cols=275 Identities=24% Similarity=0.267 Sum_probs=179.6
Q ss_pred CeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeeccccccccc---CCCCCCCCCccEEEec
Q 038671 30 SDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGP---IPNLRNLTSLVRVRLN 106 (707)
Q Consensus 30 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~---~~~l~~l~~L~~L~l~ 106 (707)
+.++.+++.++ .+|..+. ++|++|+|++|.++...+..|+++++|++|++++|.++.. +..+..+++|++|+++
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 35666666666 4454332 4666666666666654444566666666666666665532 1223344455555555
Q ss_pred cCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCc-hhhhCCCCCCEEeCCCCCCCCC
Q 038671 107 QNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMP-AEIIHSSQLKVLDLSSNHIVGE 185 (707)
Q Consensus 107 ~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~-~~~~~~~~L~~L~l~~n~l~~~ 185 (707)
+|.++.++ ..+..+++|++|++++|.+++... ..+..+++|++|++++|.+.+.
T Consensus 87 ~n~i~~l~-------------------------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~ 141 (306)
T 2z66_A 87 FNGVITMS-------------------------SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 141 (306)
T ss_dssp SCSEEEEE-------------------------EEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEEC
T ss_pred CCccccCh-------------------------hhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCcc
Confidence 55544332 224445555555555555543332 3455566666666666666655
Q ss_pred CChhhhCCCCCcEEEecCCcccc-CCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhh
Q 038671 186 MPSKLGKLSSLIKLILNSNQLCG-QLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEK 264 (707)
Q Consensus 186 ~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 264 (707)
.+..+..+++|++|++++|.+++ ..+..+..+++|++|++++|.+++..+..|..+++|+.|++++|++++..+..+..
T Consensus 142 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 221 (306)
T 2z66_A 142 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221 (306)
T ss_dssp STTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTT
T ss_pred chhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccC
Confidence 66666667777777777777764 45667777788888888888887777777888888888888888887777777888
Q ss_pred cccCCeeeecCccCCCCCCccccccc-ccceEeccccccCCchh--HhhccCCCceeEeeccCcccccCCC
Q 038671 265 LIHLSELDLSHNFLGEEMPSQICNMQ-SLEKLNLSHNNLSGFIP--SCFEELHGLSYIDISYNELHGSIPN 332 (707)
Q Consensus 265 l~~L~~L~l~~n~l~~~~~~~~~~~~-~L~~L~l~~n~i~~~~~--~~~~~~~~L~~l~l~~n~~~~~~~~ 332 (707)
+++|+.|++++|.+++..+..+..++ +|+.|++++|++++... ....-+...+.+.+..+.+.|..|.
T Consensus 222 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~ 292 (306)
T 2z66_A 222 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 292 (306)
T ss_dssp CTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESG
T ss_pred cccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCch
Confidence 88888888888888888888888874 89999999999876532 2222344555667777888887664
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-29 Score=271.93 Aligned_cols=185 Identities=19% Similarity=0.233 Sum_probs=81.8
Q ss_pred CCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCC-------------cEEEcccCcCcccCCc
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQI-------------TFLTLFDNALSGAIPK 69 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L-------------~~L~L~~n~i~~~~~~ 69 (707)
+.|++|++++|.+ +.+|..|+++++|++|++++|++++.+|..++++++| ++|++++|.+++. |.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l-p~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL-PE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC-CS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccC-CC
Confidence 5677788888888 4777778888888888888888777777777776653 6777777766642 22
Q ss_pred cccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCc
Q 038671 70 EYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLG 149 (707)
Q Consensus 70 ~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~ 149 (707)
. .++|++|++++|.+++++.. +++|++|++++|++++++. ..++|++|++++|.++++ + .|..+++|+
T Consensus 89 ~---~~~L~~L~l~~n~l~~lp~~---~~~L~~L~l~~n~l~~l~~----~~~~L~~L~L~~n~l~~l-p-~~~~l~~L~ 156 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKALSD----LPPLLEYLGVSNNQLEKL-P-ELQNSSFLK 156 (454)
T ss_dssp C---CTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCCS----CCTTCCEEECCSSCCSSC-C-CCTTCTTCC
T ss_pred C---cCCCCEEEccCCcCCccccc---cCCCcEEECCCCccCcccC----CCCCCCEEECcCCCCCCC-c-ccCCCCCCC
Confidence 1 24566666666666554322 2444555555554443321 013444444444444432 2 244444444
Q ss_pred EEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccc
Q 038671 150 TLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLC 207 (707)
Q Consensus 150 ~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 207 (707)
+|++++|.+++ .+.. ..+|++|++++|.+++ +| .+..+++|++|++++|.++
T Consensus 157 ~L~l~~N~l~~-lp~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~ 208 (454)
T 1jl5_A 157 IIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLK 208 (454)
T ss_dssp EEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS
T ss_pred EEECCCCcCcc-cCCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCC
Confidence 44444444442 1111 1244444444444442 22 2444444444444444444
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-29 Score=269.71 Aligned_cols=245 Identities=24% Similarity=0.258 Sum_probs=132.8
Q ss_pred CeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCC-CCCCCCCccEEEeccC
Q 038671 30 SDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLNQN 108 (707)
Q Consensus 30 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~l~~l~~L~~L~l~~n 108 (707)
..++.+++.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.|+.+.+ .|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 34444444444 3333322 345555555555554444555555555555555555544432 3445555555555555
Q ss_pred ccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCC-CccCCCCchhhhCCCCCCEEeCCCCCCCCCCC
Q 038671 109 HLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS-NNITGSMPAEIIHSSQLKVLDLSSNHIVGEMP 187 (707)
Q Consensus 109 ~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~-n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 187 (707)
+++.+++..|..+++|++|+|++|.++.+.+..|..+++|+.|+|++ |.++......|.++++|+.|+|++|.+++ +|
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~ 212 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP 212 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc
Confidence 55555544555555555555555555555445555555555555555 33333333445555555555555555552 22
Q ss_pred hhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhccc
Q 038671 188 SKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIH 267 (707)
Q Consensus 188 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 267 (707)
.+..+++|++|++++|.+++..+..|..+++|+.|+|++|.+++..+..|.++++|+.|+|++|++++..+..|..+++
T Consensus 213 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 291 (452)
T 3zyi_A 213 -NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRY 291 (452)
T ss_dssp -CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTT
T ss_pred -cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccC
Confidence 2455566666666666666555566666666666666666666555666666666666666666666555555666666
Q ss_pred CCeeeecCccCC
Q 038671 268 LSELDLSHNFLG 279 (707)
Q Consensus 268 L~~L~l~~n~l~ 279 (707)
|+.|+|++|++.
T Consensus 292 L~~L~L~~Np~~ 303 (452)
T 3zyi_A 292 LVELHLHHNPWN 303 (452)
T ss_dssp CCEEECCSSCEE
T ss_pred CCEEEccCCCcC
Confidence 666666666653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-29 Score=268.15 Aligned_cols=245 Identities=21% Similarity=0.244 Sum_probs=138.1
Q ss_pred CceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeeccc
Q 038671 5 LAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLEN 84 (707)
Q Consensus 5 l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~ 84 (707)
...++.++++++ .+|..+. ++++.|+|++|+++...+..|.++++|++|+|++|.|++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 345566666666 5555444 4666666666666655556666666666666666666655556666666666666666
Q ss_pred ccccccCC-CCCCCCCccEEEeccCccccccCccccCCCCCcEEEccc-ccccccCCCCCCCCCCCcEEEcCCCccCCCC
Q 038671 85 NQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSH-NYFYGEISSDWGRCPKLGTLDFSSNNITGSM 162 (707)
Q Consensus 85 n~i~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~-n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~ 162 (707)
|+++.+++ .+..+++|++|+|++|+++.+....|..+++|++|+|++ |.+..+.+..|..+++|++|+|++|.++..
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~- 200 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI- 200 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc-
Confidence 66665554 355666666666666666666555566666666666665 344444444555555666666666555522
Q ss_pred chhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcc
Q 038671 163 PAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLV 242 (707)
Q Consensus 163 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~ 242 (707)
+ .+..+++|+.|+|++|.+++..+..|..+++|++|++++|+++...+..|..+++|+.|+|++|+++...+..|..++
T Consensus 201 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 279 (440)
T 3zyj_A 201 P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279 (440)
T ss_dssp C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence 2 244455555555555555544455555555555555555555544444455555555555555555544444444455
Q ss_pred cCceEeeecccc
Q 038671 243 KLHYLNLSNNQF 254 (707)
Q Consensus 243 ~L~~L~l~~n~l 254 (707)
+|+.|+|++|++
T Consensus 280 ~L~~L~L~~Np~ 291 (440)
T 3zyj_A 280 HLERIHLHHNPW 291 (440)
T ss_dssp TCCEEECCSSCE
T ss_pred CCCEEEcCCCCc
Confidence 555555555543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-29 Score=254.79 Aligned_cols=225 Identities=22% Similarity=0.212 Sum_probs=131.9
Q ss_pred CeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCc
Q 038671 78 TLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNN 157 (707)
Q Consensus 78 ~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~ 157 (707)
+.++.+++.++.++.++ .++|++|++++|.++.+.+..|..+++|++|+|++|.++.+.+..|..+++|++|+|++|.
T Consensus 14 ~~~~c~~~~l~~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 91 (285)
T 1ozn_A 14 VTTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (285)
T ss_dssp CEEECCSSCCSSCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred eEEEcCcCCcccCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCC
Confidence 55666666666655433 3466666666666666666666666666666666666666666666666666666666665
Q ss_pred -cCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCc
Q 038671 158 -ITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPK 236 (707)
Q Consensus 158 -i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~ 236 (707)
++...+..+..+++|++|++++|.+++..+..|..+++|++|++++|.++...+..+..+++|++|+|++|.+++..+.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 171 (285)
T 1ozn_A 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (285)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred CccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHH
Confidence 5555455566666666666666666655555555566666666666666544444455555555555555555544444
Q ss_pred cccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCC
Q 038671 237 SLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSG 304 (707)
Q Consensus 237 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~ 304 (707)
.|.++++|+.|++++|.+++..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|++.+
T Consensus 172 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c 239 (285)
T 1ozn_A 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (285)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred HhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence 45555555555555555555555555555555555555555544433444555555555555555543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=253.45 Aligned_cols=268 Identities=20% Similarity=0.198 Sum_probs=150.2
Q ss_pred ceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccc
Q 038671 6 AFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENN 85 (707)
Q Consensus 6 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n 85 (707)
+.++.+++.++ .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 44556666665 444333 245666666666666555555566666666666666665555555555555555555555
Q ss_pred c-ccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCch
Q 038671 86 Q-LRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPA 164 (707)
Q Consensus 86 ~-i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~ 164 (707)
. +..+ .+..|..+++|++|++++|.++.+.+..|..+++|++|++++|.++...+.
T Consensus 91 ~~l~~~-----------------------~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 147 (285)
T 1ozn_A 91 AQLRSV-----------------------DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147 (285)
T ss_dssp TTCCCC-----------------------CTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred CCcccc-----------------------CHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHh
Confidence 4 4443 344444444445555555554444444455555555555555555544444
Q ss_pred hhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccC
Q 038671 165 EIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKL 244 (707)
Q Consensus 165 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L 244 (707)
.|..+++|+.|+|++|++++..+..|..+++|++|++++|.+++..+..+..+++|+.|++++|.+++..+..+..+++|
T Consensus 148 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 227 (285)
T 1ozn_A 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL 227 (285)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTC
T ss_pred HhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCccc
Confidence 45555556666666665554444456666666666666666665556666666777777777777766655667777777
Q ss_pred ceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCccccc--ccccceEecccc
Q 038671 245 HYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICN--MQSLEKLNLSHN 300 (707)
Q Consensus 245 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~--~~~L~~L~l~~n 300 (707)
+.|++++|++....+. ..-...++.+..+.+.+....|..+.+ +..+...++.+|
T Consensus 228 ~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l~g~~l~~l~~~~l~~C 284 (285)
T 1ozn_A 228 QYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQGC 284 (285)
T ss_dssp CEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTTCBGGGSCGGGSCCC
T ss_pred CEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHhCCcChhhcCHHHhccC
Confidence 7777777776432211 111233455556666666666665543 334444444433
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-28 Score=267.38 Aligned_cols=268 Identities=24% Similarity=0.266 Sum_probs=183.9
Q ss_pred CCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecc
Q 038671 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLE 83 (707)
Q Consensus 4 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (707)
+++.|++++|+++ .+|..+. ++|++|+|++|+++ .+|. .+++|++|+|++|+|++ +|. .+++|++|+++
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls 109 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIF 109 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEEC
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECc
Confidence 4778888888888 6676665 68888888888888 4554 56788888888888874 444 56788888888
Q ss_pred cccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCc
Q 038671 84 NNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMP 163 (707)
Q Consensus 84 ~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~ 163 (707)
+|.++.++. .+++|+.|++++|+++.++. .+++|++|+|++|.++.+.. .+++|+.|++++|.++.. +
T Consensus 110 ~N~l~~l~~---~l~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~l-~ 177 (622)
T 3g06_A 110 SNPLTHLPA---LPSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPA----LPSELCKLWAYNNQLTSL-P 177 (622)
T ss_dssp SCCCCCCCC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCC-C
T ss_pred CCcCCCCCC---CCCCcCEEECCCCCCCcCCC----CCCCCCEEECcCCcCCCcCC----ccCCCCEEECCCCCCCCC-c
Confidence 888877655 56778888888888876654 24778888888887775432 346777788888877743 3
Q ss_pred hhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCccc
Q 038671 164 AEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVK 243 (707)
Q Consensus 164 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~ 243 (707)
..+++|+.|++++|.+++ +|.. +++|+.|++++|.++. .+. .+++|++|+|++|.++++ | ..+++
T Consensus 178 ---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~-l~~---~~~~L~~L~Ls~N~L~~l-p---~~l~~ 242 (622)
T 3g06_A 178 ---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPA---LPSGLKELIVSGNRLTSL-P---VLPSE 242 (622)
T ss_dssp ---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS-CCC---CCTTCCEEECCSSCCSCC-C---CCCTT
T ss_pred ---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccc-cCC---CCCCCCEEEccCCccCcC-C---CCCCc
Confidence 345777777777777763 3332 3677777777777773 332 246777777777777743 3 34466
Q ss_pred CceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCC
Q 038671 244 LHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELH 314 (707)
Q Consensus 244 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~ 314 (707)
|+.|+|++|+|+.... .+++|+.|+|++|.|+ .+|..+.++++|+.|++++|++++..+..+..++
T Consensus 243 L~~L~Ls~N~L~~lp~----~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 243 LKELMVSGNRLTSLPM----LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CCEEECCSSCCSCCCC----CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CcEEECCCCCCCcCCc----ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 7777777777764333 4566777777777775 4566677777777777777777766666555443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=285.69 Aligned_cols=187 Identities=19% Similarity=0.159 Sum_probs=132.6
Q ss_pred eeecCCeeEEEE-EcCCCcEEEEEecCCCCCc-------hhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCceeEEE
Q 038671 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPS-------EMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 444 lg~G~~g~vy~~-~~~~~~~vavK~~~~~~~~-------~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.+.|+.|....+ +...|+.+++|++...... .....+++.+|+++|+++ +|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 455666655555 3445888999998654211 122346699999999999 6999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++|++|.+.+...+ +++.. +|+.||+.||+|+|++ |||||||||+|||++.+|.+||+|||+|+.....
T Consensus 322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999997543 35543 5889999999999999 9999999999999999999999999999887766
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p 640 (707)
.......+||+.|||||++.+. +..++|+||+|++++++.+|..+
T Consensus 393 ~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 CSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 6666778899999999998764 67789999999998877665444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.6e-30 Score=262.66 Aligned_cols=256 Identities=21% Similarity=0.223 Sum_probs=148.8
Q ss_pred EECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccc
Q 038671 32 LELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLT 111 (707)
Q Consensus 32 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~ 111 (707)
++++.+.+.......+..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+...++ +..+++|++|++++|+++
T Consensus 15 ~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls~n~l~ 93 (317)
T 3o53_A 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQ 93 (317)
T ss_dssp ESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECCSSEEE
T ss_pred eeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECcCCccc
Confidence 3444455443333344445555555555555555545555555555555555555554333 555555555555555555
Q ss_pred cccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhh
Q 038671 112 GNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLG 191 (707)
Q Consensus 112 ~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~ 191 (707)
++. ..++|++|++++|.++.+.+.. +++|++|++++|.+++..+..+..+++|++|++++|.+++..+..+.
T Consensus 94 ~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 165 (317)
T 3o53_A 94 ELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELA 165 (317)
T ss_dssp EEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGG
T ss_pred ccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHh
Confidence 433 2256666666666665543322 45566666666666655555566666666666666666654444443
Q ss_pred -CCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCe
Q 038671 192 -KLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSE 270 (707)
Q Consensus 192 -~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 270 (707)
.+++|++|++++|.+++.. ....+++|++|+|++|.+++..+ .+..+++|+.|++++|+++. .|..+..+++|+.
T Consensus 166 ~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~ 241 (317)
T 3o53_A 166 ASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEH 241 (317)
T ss_dssp GGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCE
T ss_pred hccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCcccc-hhhHhhcCCCCCE
Confidence 5666666666666666432 22246677777777777764333 36666777777777777654 3445666677777
Q ss_pred eeecCccCC-CCCCcccccccccceEecccc
Q 038671 271 LDLSHNFLG-EEMPSQICNMQSLEKLNLSHN 300 (707)
Q Consensus 271 L~l~~n~l~-~~~~~~~~~~~~L~~L~l~~n 300 (707)
|++++|.++ +..+..+..++.|+.+++++|
T Consensus 242 L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~ 272 (317)
T 3o53_A 242 FDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272 (317)
T ss_dssp EECTTCCCBHHHHHHHHHTCHHHHHHHHHHH
T ss_pred EEccCCCccCcCHHHHHhccccceEEECCCc
Confidence 777777775 455566666677777776643
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-28 Score=248.26 Aligned_cols=233 Identities=20% Similarity=0.253 Sum_probs=123.9
Q ss_pred CCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEec
Q 038671 27 KSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLN 106 (707)
Q Consensus 27 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~ 106 (707)
++++.|+|++|+++ .+|..+.++++|++|+|++|.++ .+|..|+++++|++|+|++|.++.++..+..+++|++|+++
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~ 158 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIR 158 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECC
Confidence 44555555555555 44444445555555555555555 44444555555555555555555444444445555555555
Q ss_pred cCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCC
Q 038671 107 QNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEM 186 (707)
Q Consensus 107 ~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 186 (707)
+|++.+..+..+.. . .....|..+++|++|+|++|.++ ..+..+..+++|+.|+|++|.++ .+
T Consensus 159 ~n~~~~~~p~~~~~------~---------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l 221 (328)
T 4fcg_A 159 ACPELTELPEPLAS------T---------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-AL 221 (328)
T ss_dssp EETTCCCCCSCSEE------E---------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CC
T ss_pred CCCCccccChhHhh------c---------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cC
Confidence 44433333322221 0 00111233555555555555555 44444555555555555555555 34
Q ss_pred ChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcc
Q 038671 187 PSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLI 266 (707)
Q Consensus 187 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 266 (707)
|..+..+++|++|++++|.+.+..|..+..+++|++|+|++|.+.+..|..+.++++|+.|+|++|++.+..|..+..++
T Consensus 222 ~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~ 301 (328)
T 4fcg_A 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLP 301 (328)
T ss_dssp CGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSC
T ss_pred chhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhcc
Confidence 44455566666666666665555555666666666666666666556666666666666666666666666666666666
Q ss_pred cCCeeeecCccC
Q 038671 267 HLSELDLSHNFL 278 (707)
Q Consensus 267 ~L~~L~l~~n~l 278 (707)
+|+.+++..|.+
T Consensus 302 ~L~~l~l~~~~~ 313 (328)
T 4fcg_A 302 ANCIILVPPHLQ 313 (328)
T ss_dssp TTCEEECCGGGS
T ss_pred CceEEeCCHHHH
Confidence 666666665554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-27 Score=259.35 Aligned_cols=262 Identities=25% Similarity=0.245 Sum_probs=222.2
Q ss_pred CCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEecc
Q 038671 28 SLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQ 107 (707)
Q Consensus 28 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~ 107 (707)
+++.|++++|+++ .+|..+. ++|++|+|++|.|+. +|. .+++|++|+|++|+|+.++. .+++|++|++++
T Consensus 41 ~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~ 110 (622)
T 3g06_A 41 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLPV---LPPGLLELSIFS 110 (622)
T ss_dssp CCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-CCC---CCTTCCEEEECSCCCSCCCC---CCTTCCEEEECS
T ss_pred CCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-CCC---cCCCCCEEEcCCCcCCcCCC---CCCCCCEEECcC
Confidence 6899999999999 7787665 899999999999994 454 57899999999999998766 779999999999
Q ss_pred CccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCC
Q 038671 108 NHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMP 187 (707)
Q Consensus 108 n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 187 (707)
|+++.++. .+++|+.|++++|.++.+.. .+++|++|+|++|.+++. +. .+++|+.|++++|.++. +|
T Consensus 111 N~l~~l~~----~l~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~~-l~ 177 (622)
T 3g06_A 111 NPLTHLPA----LPSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLTS-LP 177 (622)
T ss_dssp CCCCCCCC----CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-CC
T ss_pred CcCCCCCC----CCCCcCEEECCCCCCCcCCC----CCCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCCC-Cc
Confidence 99998765 67899999999999997543 358999999999999854 32 35789999999999984 55
Q ss_pred hhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhccc
Q 038671 188 SKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIH 267 (707)
Q Consensus 188 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 267 (707)
..+++|+.|++++|.+++ ++. .+++|+.|++++|.++.. |. .+++|+.|+|++|++++.. ..+++
T Consensus 178 ---~~~~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~l-~~---~~~~L~~L~Ls~N~L~~lp----~~l~~ 242 (622)
T 3g06_A 178 ---MLPSGLQELSVSDNQLAS-LPT---LPSELYKLWAYNNRLTSL-PA---LPSGLKELIVSGNRLTSLP----VLPSE 242 (622)
T ss_dssp ---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSSC-CC---CCTTCCEEECCSSCCSCCC----CCCTT
T ss_pred ---ccCCCCcEEECCCCCCCC-CCC---ccchhhEEECcCCccccc-CC---CCCCCCEEEccCCccCcCC----CCCCc
Confidence 456899999999999995 333 358999999999999854 43 2478999999999998743 45689
Q ss_pred CCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCC
Q 038671 268 LSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332 (707)
Q Consensus 268 L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~ 332 (707)
|+.|++++|.|+. +|. .+++|+.|++++|+|+ .+|..+..+++|+.|++++|++++.++.
T Consensus 243 L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 243 LKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp CCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred CcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 9999999999974 454 6789999999999999 5588899999999999999999987654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-30 Score=261.41 Aligned_cols=263 Identities=23% Similarity=0.224 Sum_probs=178.8
Q ss_pred CcEEEcccCcCcccCCccccCCCCCCeeecccccccccCC-CCCCCCCccEEEeccCccccccCccccCCCCCcEEEccc
Q 038671 53 ITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSH 131 (707)
Q Consensus 53 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~ 131 (707)
++.++++++.+.......+..+++|++|+|++|.++.+++ .+..+++|++|++++|++++..+ +..+++|++|+|++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 3444566666665555556666777777777777776553 46777777777777777776543 77777777777777
Q ss_pred ccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCc
Q 038671 132 NYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLS 211 (707)
Q Consensus 132 n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 211 (707)
|.++++. ..++|++|++++|.+++..+. .+++|+.|++++|++++..+..+..+++|++|++++|.+++..+
T Consensus 90 n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 161 (317)
T 3o53_A 90 NYVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF 161 (317)
T ss_dssp SEEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEG
T ss_pred Ccccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccH
Confidence 7776543 236777777777777754433 25667777777777776666677777777777777777776555
Q ss_pred ccc-CCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCccccccc
Q 038671 212 LEL-GSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQ 290 (707)
Q Consensus 212 ~~~-~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~ 290 (707)
..+ ..+++|++|+|++|.+++.. ....+++|++|+|++|++++..+. +..+++|+.|++++|.++ .+|..+..++
T Consensus 162 ~~~~~~l~~L~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l~~~-~~~l~~L~~L~L~~N~l~-~l~~~~~~l~ 237 (317)
T 3o53_A 162 AELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLV-LIEKALRFSQ 237 (317)
T ss_dssp GGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCC-EECTTCCCCT
T ss_pred HHHhhccCcCCEEECCCCcCcccc--cccccccCCEEECCCCcCCcchhh-hcccCcccEEECcCCccc-chhhHhhcCC
Confidence 555 35777777777777776542 223467777777777777655443 777777777777777775 3566677777
Q ss_pred ccceEeccccccC-CchhHhhccCCCceeEeecc-Cccccc
Q 038671 291 SLEKLNLSHNNLS-GFIPSCFEELHGLSYIDISY-NELHGS 329 (707)
Q Consensus 291 ~L~~L~l~~n~i~-~~~~~~~~~~~~L~~l~l~~-n~~~~~ 329 (707)
+|+.|++++|++. +..+..+..+++|+.+++.+ +.+.+.
T Consensus 238 ~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~ 278 (317)
T 3o53_A 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278 (317)
T ss_dssp TCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSS
T ss_pred CCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCC
Confidence 7777777777777 55666777777777777773 334443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=244.95 Aligned_cols=237 Identities=20% Similarity=0.238 Sum_probs=194.3
Q ss_pred CCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEc
Q 038671 50 LTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDL 129 (707)
Q Consensus 50 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L 129 (707)
.++++.|+|++|.++ .+|..+.++++|++|+|++|.+..++..+..+++|++|+|++|+++.+ +..+..+++|++|+|
T Consensus 80 ~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~l-p~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 80 QPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSI 157 (328)
T ss_dssp STTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCC-CGGGGGCTTCCEEEE
T ss_pred ccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccC-cHHHhcCcCCCEEEC
Confidence 467778888888777 556667777778888888877776666677777777777777777743 455677777777777
Q ss_pred ccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccC
Q 038671 130 SHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ 209 (707)
Q Consensus 130 ~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 209 (707)
++|.+.+..+..+.. .. ....+.++++|++|+|++|.++ .+|..+..+++|++|++++|.+++
T Consensus 158 ~~n~~~~~~p~~~~~------~~---------~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~- 220 (328)
T 4fcg_A 158 RACPELTELPEPLAS------TD---------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA- 220 (328)
T ss_dssp EEETTCCCCCSCSEE------EC----------CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-
T ss_pred CCCCCccccChhHhh------cc---------chhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-
Confidence 776665444443322 11 1223566999999999999999 888899999999999999999995
Q ss_pred CccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccc
Q 038671 210 LSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNM 289 (707)
Q Consensus 210 ~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 289 (707)
.+..+..+++|++|+|++|.+.+..|..+.++++|+.|+|++|.+.+..|..+..+++|+.|+|++|.+.+.+|..+..+
T Consensus 221 l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L 300 (328)
T 4fcg_A 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300 (328)
T ss_dssp CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGS
T ss_pred CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhc
Confidence 56679999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccceEeccccccCCc
Q 038671 290 QSLEKLNLSHNNLSGF 305 (707)
Q Consensus 290 ~~L~~L~l~~n~i~~~ 305 (707)
++|+.+++..|.+...
T Consensus 301 ~~L~~l~l~~~~~~~l 316 (328)
T 4fcg_A 301 PANCIILVPPHLQAQL 316 (328)
T ss_dssp CTTCEEECCGGGSCC-
T ss_pred cCceEEeCCHHHHHHH
Confidence 9999999998887643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-29 Score=257.44 Aligned_cols=248 Identities=24% Similarity=0.245 Sum_probs=191.8
Q ss_pred ccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCc-ccCCcccc-------CCCCCCeeecccccccc-cCCC
Q 038671 23 IGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALS-GAIPKEYG-------NLVKLTLLTLENNQLRG-PIPN 93 (707)
Q Consensus 23 ~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~-------~l~~L~~L~l~~n~i~~-~~~~ 93 (707)
+...++|++|++++|.+ .+|..+... |+.|+|++|.++ ...|..+. ++++|++|++++|.+++ .+..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 45566788888888888 456655443 888888888884 34555554 68888888888888875 4444
Q ss_pred C--CCCCCccEEEeccCccccccCccccCC-----CCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCC--Cch
Q 038671 94 L--RNLTSLVRVRLNQNHLTGNISESFGIH-----PNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGS--MPA 164 (707)
Q Consensus 94 l--~~l~~L~~L~l~~n~l~~~~~~~~~~~-----~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~--~~~ 164 (707)
+ ..+++|++|++++|++++. +..+..+ ++|++|+|++|.++.+.+..|..+++|++|+|++|.+.+. .+.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 4 7888888888888888877 5666665 8899999999999888888888899999999999987643 222
Q ss_pred hh--hCCCCCCEEeCCCCCCCC---CCChhhhCCCCCcEEEecCCccccCCc-cccCCCCcccEEEccCCccCCCCCccc
Q 038671 165 EI--IHSSQLKVLDLSSNHIVG---EMPSKLGKLSSLIKLILNSNQLCGQLS-LELGSLTQLERLDLSSNRLSNSIPKSL 238 (707)
Q Consensus 165 ~~--~~~~~L~~L~l~~n~l~~---~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~i~~~~~~~l 238 (707)
.+ ..+++|++|+|++|++++ .....+..+++|++|++++|++++..+ ..+..+++|++|+|++|.++ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 33 778899999999998872 222444577899999999999987664 45667889999999999998 556656
Q ss_pred cCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCC
Q 038671 239 GNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGE 280 (707)
Q Consensus 239 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 280 (707)
. ++|++|+|++|++++. |. +..+++|++|++++|++++
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 5 7899999999999776 44 8888999999999999865
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.7e-29 Score=254.52 Aligned_cols=250 Identities=20% Similarity=0.208 Sum_probs=182.1
Q ss_pred cccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCcccccc-Ccccc-------CCCCCcEEEcccccccccCCCC
Q 038671 70 EYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNI-SESFG-------IHPNLAFIDLSHNYFYGEISSD 141 (707)
Q Consensus 70 ~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~-~~~~~-------~~~~L~~L~L~~n~i~~~~~~~ 141 (707)
.++..++|++|++++|.+ .++..+... |+.|++++|.++... +..+. .+++|++|+|++|.+++..+..
T Consensus 38 ~~~~~~~L~~l~l~~n~l-~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE-ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEEECTTHHHHCCTT-CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EEccCCCceeEeeccccc-ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 345556677777777766 444333322 666677777664322 22222 5778888888888887666665
Q ss_pred C--CCCCCCcEEEcCCCccCCCCchhhhCC-----CCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccC--Ccc
Q 038671 142 W--GRCPKLGTLDFSSNNITGSMPAEIIHS-----SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ--LSL 212 (707)
Q Consensus 142 ~--~~~~~L~~L~L~~n~i~~~~~~~~~~~-----~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~ 212 (707)
+ ..+++|++|+|++|.+++. +..+..+ ++|++|+|++|++.+..+..|..+++|++|++++|++.+. .+.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 4 7788888888888888866 6666665 7888888888888877778888888888888888887643 222
Q ss_pred cc--CCCCcccEEEccCCccCCC---CCccccCcccCceEeeecccccccCc-hhhhhcccCCeeeecCccCCCCCCccc
Q 038671 213 EL--GSLTQLERLDLSSNRLSNS---IPKSLGNLVKLHYLNLSNNQFIKKIP-VELEKLIHLSELDLSHNFLGEEMPSQI 286 (707)
Q Consensus 213 ~~--~~l~~L~~L~l~~n~i~~~---~~~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~ 286 (707)
.+ ..+++|++|+|++|.+++. ....+.++++|++|++++|++++..+ ..+..+++|+.|++++|.++ .+|..+
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~ 272 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhc
Confidence 33 7888888888888888732 22344577889999999998877664 44666788999999999986 566665
Q ss_pred ccccccceEeccccccCCchhHhhccCCCceeEeeccCcccc
Q 038671 287 CNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHG 328 (707)
Q Consensus 287 ~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~ 328 (707)
. ++|+.|++++|+|++. |. +..+++|+.|++++|++++
T Consensus 273 ~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 273 P--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp C--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred c--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 5 7899999999999876 54 8888999999999998875
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.9e-28 Score=260.13 Aligned_cols=238 Identities=24% Similarity=0.224 Sum_probs=158.1
Q ss_pred cCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEE
Q 038671 48 GNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFI 127 (707)
Q Consensus 48 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L 127 (707)
..+++|++|+|++|.+++..|..|+.+++|++|+|++|.++..++ +..+++|++|+|++|.++++++ .++|++|
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L 104 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQELLV-----GPSIETL 104 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEEEEEE-----CTTCCEE
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCCCCCC-----CCCcCEE
Confidence 344578888888888887777778888888888888887775444 6666777777777776665432 2555666
Q ss_pred EcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccc
Q 038671 128 DLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLC 207 (707)
Q Consensus 128 ~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 207 (707)
++++|.++.+.+. .+ ++|+.|+|++|.+++..|..+..+++|+.|++++|.++
T Consensus 105 ~L~~N~l~~~~~~---~l------------------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 157 (487)
T 3oja_A 105 HAANNNISRVSCS---RG------------------------QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157 (487)
T ss_dssp ECCSSCCCCEEEC---CC------------------------SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCC
T ss_pred ECcCCcCCCCCcc---cc------------------------CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCC
Confidence 6666555544322 22 34555555555555444445555555555555555555
Q ss_pred cCCccccC-CCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCccc
Q 038671 208 GQLSLELG-SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQI 286 (707)
Q Consensus 208 ~~~~~~~~-~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 286 (707)
+..+..+. .+++|++|+|++|.+++..+ +..+++|+.|+|++|.+++..+. +..+++|+.|++++|.+++ +|..+
T Consensus 158 ~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l 233 (487)
T 3oja_A 158 TVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKAL 233 (487)
T ss_dssp EEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTC
T ss_pred CcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchhh
Confidence 54455544 56666666666666664422 33467778888888887765544 7778888888888888864 56677
Q ss_pred ccccccceEeccccccC-CchhHhhccCCCceeEeec
Q 038671 287 CNMQSLEKLNLSHNNLS-GFIPSCFEELHGLSYIDIS 322 (707)
Q Consensus 287 ~~~~~L~~L~l~~n~i~-~~~~~~~~~~~~L~~l~l~ 322 (707)
..+++|+.|++++|++. +..|..+..++.|+.+++.
T Consensus 234 ~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred ccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 88888999999999887 5566778888888888776
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-26 Score=230.58 Aligned_cols=212 Identities=27% Similarity=0.287 Sum_probs=157.0
Q ss_pred CCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEe
Q 038671 122 PNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLIL 201 (707)
Q Consensus 122 ~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 201 (707)
++|++|++++|.++.+.+..|..+++|++|+|++|.+++..+..|..+++|++|++++|.+++..+..|..+++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 34566666666665555555666666666666666666555555666666666666666666555566677777777777
Q ss_pred cCCccccCCccccCCCCcccEEEccCCccCCC-CCccccCcccCceEeeecccccccCchhhhhcccCC----eeeecCc
Q 038671 202 NSNQLCGQLSLELGSLTQLERLDLSSNRLSNS-IPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLS----ELDLSHN 276 (707)
Q Consensus 202 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~-~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~----~L~l~~n 276 (707)
++|.+++..+..+..+++|++|++++|.+++. .|..|+++++|+.|++++|++++..+..+..+.+|+ .|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 77777766665677778888888888888764 477888888888888888888877777777777777 8899999
Q ss_pred cCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCCcc
Q 038671 277 FLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST 334 (707)
Q Consensus 277 ~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~ 334 (707)
.+++..+..+. ..+|+.|++++|++++..+..+..+++|+.|++++|+|+|.++...
T Consensus 188 ~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l~ 244 (276)
T 2z62_A 188 PMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 244 (276)
T ss_dssp CCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTTH
T ss_pred cccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCchH
Confidence 99766555554 4489999999999998877778899999999999999999988654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.1e-28 Score=260.43 Aligned_cols=236 Identities=24% Similarity=0.220 Sum_probs=191.3
Q ss_pred CCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEe
Q 038671 26 LKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRL 105 (707)
Q Consensus 26 l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l 105 (707)
+++|++|+|++|.+++..|..|.++++|++|+|++|.+++..| |..+++|++|+|++|.++.+++. ++|+.|++
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~----~~L~~L~L 106 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVG----PSIETLHA 106 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEEC----TTCCEEEC
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCC----CCcCEEEC
Confidence 3489999999999998888899999999999999999987655 99999999999999999876543 89999999
Q ss_pred ccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhh-CCCCCCEEeCCCCCCCC
Q 038671 106 NQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEII-HSSQLKVLDLSSNHIVG 184 (707)
Q Consensus 106 ~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~-~~~~L~~L~l~~n~l~~ 184 (707)
++|.++.+.+. .+++|+.|+|++|.+++..+..+..+++|+.|+|++|.+++..+..+. .+++|+.|+|++|.+++
T Consensus 107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~ 183 (487)
T 3oja_A 107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (487)
T ss_dssp CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence 99999987664 458899999999999988888899999999999999999987777776 68899999999998875
Q ss_pred CCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeeccccc-ccCchhhh
Q 038671 185 EMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFI-KKIPVELE 263 (707)
Q Consensus 185 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~ 263 (707)
..+ +..+++|+.|+|++|.+++..+ .+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|.+. +..+..+.
T Consensus 184 ~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~ 259 (487)
T 3oja_A 184 VKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (487)
T ss_dssp EEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred ccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence 422 3357788888888888875444 47777888888888888874 5556777777778888777775 44455566
Q ss_pred hcccCCeeeec
Q 038671 264 KLIHLSELDLS 274 (707)
Q Consensus 264 ~l~~L~~L~l~ 274 (707)
.++.|+.|+++
T Consensus 260 ~l~~L~~l~~~ 270 (487)
T 3oja_A 260 KNQRVQTVAKQ 270 (487)
T ss_dssp TCHHHHHHHHH
T ss_pred hCCCCcEEecc
Confidence 66666666654
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=226.33 Aligned_cols=206 Identities=27% Similarity=0.229 Sum_probs=130.3
Q ss_pred CccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCC
Q 038671 99 SLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178 (707)
Q Consensus 99 ~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~ 178 (707)
+|++|++++|+++.+.+..|..+++|++|+|++|.++.+.+..|..+++|++|+|++|.+++..+..|.++++|++|+++
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 45555555555555544455555555555555555555555555555555555555555555555555555666666666
Q ss_pred CCCCCCCCChhhhCCCCCcEEEecCCccccC-CccccCCCCcccEEEccCCccCCCCCccccCcccCc----eEeeeccc
Q 038671 179 SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ-LSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLH----YLNLSNNQ 253 (707)
Q Consensus 179 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~----~L~l~~n~ 253 (707)
+|.+.+..+..+..+++|++|++++|.+++. .+..+..+++|++|++++|.+++..+..+..+++|+ .|++++|.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 6665544444566666666666666666543 356666677777777777777666666666666666 77778887
Q ss_pred ccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCc
Q 038671 254 FIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGF 305 (707)
Q Consensus 254 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~ 305 (707)
+.+..+..+.. .+|++|++++|.+++..+..+..+++|+.|++++|++.+.
T Consensus 189 l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 189 MNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp CCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred ccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence 77665554443 4788888888888776666677888888888888888754
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-25 Score=221.31 Aligned_cols=186 Identities=24% Similarity=0.303 Sum_probs=117.8
Q ss_pred CCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEcc
Q 038671 147 KLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLS 226 (707)
Q Consensus 147 ~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 226 (707)
+|++|+|++|.++...+..|.++++|++|+|++|.++...+..|..+++|++|++++|.++...+..|..+++|++|+++
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 44555555555544444445555555555555555554444444555555555555555554444555566666666666
Q ss_pred CCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCch
Q 038671 227 SNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFI 306 (707)
Q Consensus 227 ~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~ 306 (707)
+|.+++..+..|.++++|++|+|++|.+.+..+..|..+++|++|++++|.+++..+..|..+++|+.|++++|++++..
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence 66666565666666666666666666666655555666777777777777776666666777777777777777777666
Q ss_pred hHhhccCCCceeEeeccCcccccCCC
Q 038671 307 PSCFEELHGLSYIDISYNELHGSIPN 332 (707)
Q Consensus 307 ~~~~~~~~~L~~l~l~~n~~~~~~~~ 332 (707)
+..+..+++|+.|++++|+|.|.+..
T Consensus 198 ~~~~~~l~~L~~L~l~~N~~~c~c~~ 223 (270)
T 2o6q_A 198 EGAFDSLEKLKMLQLQENPWDCTCNG 223 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred HHHhccccCCCEEEecCCCeeCCCcc
Confidence 66677778888888888888887764
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-24 Score=217.49 Aligned_cols=201 Identities=26% Similarity=0.281 Sum_probs=131.1
Q ss_pred CCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCC-CCCCCCccEEEec
Q 038671 28 SLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLN 106 (707)
Q Consensus 28 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~-l~~l~~L~~L~l~ 106 (707)
+.+.+++++++++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|++++|.++.+++. +..+++|++|+++
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 3455666666665 3444332 4566666666666655555566666666666666666555443 4556666666666
Q ss_pred cCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCC
Q 038671 107 QNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEM 186 (707)
Q Consensus 107 ~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 186 (707)
+|+++.+++..|..+++|++|+|++|.++.+.+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|.+++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 66666666666666666666666666666666666667777777777777776655556666777777777777777665
Q ss_pred ChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccC
Q 038671 187 PSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLS 231 (707)
Q Consensus 187 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~ 231 (707)
+..|..+++|++|++++|++++..+..+..+++|+.|+|++|.+.
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 666777777777777777777666666777777777888777765
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-24 Score=219.04 Aligned_cols=203 Identities=21% Similarity=0.196 Sum_probs=127.0
Q ss_pred ccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccE
Q 038671 23 IGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVR 102 (707)
Q Consensus 23 ~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~ 102 (707)
++++++++++++++++++ .+|..+. ++++.|+|++|.+++..+..|.++++|++|+|++|.++.++.. ..+++|++
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-~~l~~L~~ 81 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLGT 81 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCCE
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC-CCCCcCCE
Confidence 445556666666666665 3443332 4566666666666655555566666666666666666554332 55566666
Q ss_pred EEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCC
Q 038671 103 VRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHI 182 (707)
Q Consensus 103 L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l 182 (707)
|++++|+++.++ ..+..+++|++|+|++|+++.+.+..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|+|
T Consensus 82 L~Ls~N~l~~l~-~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 160 (290)
T 1p9a_G 82 LDLSHNQLQSLP-LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (290)
T ss_dssp EECCSSCCSSCC-CCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred EECCCCcCCcCc-hhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcC
Confidence 666666666443 3455666666666666666666666666666666666666666665566666667777777777777
Q ss_pred CCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccC
Q 038671 183 VGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLS 231 (707)
Q Consensus 183 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~ 231 (707)
+...+..|..+++|++|++++|+++ .+|..+..+++|+.|+|++|.+.
T Consensus 161 ~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred CccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 6555555666777777777777776 45555666677777777777764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=9.5e-25 Score=220.04 Aligned_cols=180 Identities=28% Similarity=0.256 Sum_probs=104.0
Q ss_pred CCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEcc
Q 038671 147 KLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLS 226 (707)
Q Consensus 147 ~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 226 (707)
+++.|+|++|.+++..+..|..+++|+.|+|++|.|++..+. ..+++|++|++++|+++ ..+..+..+++|++|+++
T Consensus 32 ~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~ 108 (290)
T 1p9a_G 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (290)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECC
Confidence 444444444444444444444444555555555544422221 44555555555555555 344455556666666666
Q ss_pred CCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCch
Q 038671 227 SNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFI 306 (707)
Q Consensus 227 ~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~ 306 (707)
+|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++|.++...+..|..+++|+.|++++|+|+ .+
T Consensus 109 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~i 187 (290)
T 1p9a_G 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187 (290)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred CCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-cc
Confidence 66666555556666666666666666666555555666666666666666665555555566666666777666666 33
Q ss_pred hHhhccCCCceeEeeccCcccccC
Q 038671 307 PSCFEELHGLSYIDISYNELHGSI 330 (707)
Q Consensus 307 ~~~~~~~~~L~~l~l~~n~~~~~~ 330 (707)
|..+...++|+.+++++|+|.|.+
T Consensus 188 p~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 188 PKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CTTTTTTCCCSEEECCSCCBCCSG
T ss_pred ChhhcccccCCeEEeCCCCccCcC
Confidence 555555667777777777777765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=223.31 Aligned_cols=228 Identities=20% Similarity=0.182 Sum_probs=140.3
Q ss_pred CCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEecc
Q 038671 28 SLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQ 107 (707)
Q Consensus 28 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~ 107 (707)
++..+++.++.+.+. ..+..+++|+.|++++|.++.. ..+..+++|++|++++|.+..+ +.+..+++|++|++++
T Consensus 20 ~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~ 94 (272)
T 3rfs_A 20 ETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDI-SALKELTNLTYLILTG 94 (272)
T ss_dssp HHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCC-GGGTTCTTCCEEECTT
T ss_pred HHHHHHhcCcccccc--cccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCc-hhhcCCCCCCEEECCC
Confidence 333444555554432 2234555556666665555522 2355555666666666655543 3455566666666666
Q ss_pred CccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCC
Q 038671 108 NHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMP 187 (707)
Q Consensus 108 n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 187 (707)
|.++.+.+..|..+++|++|+|++|.++.+.+..|..+++|++|+|++|.+++..+..+..+++|+.|++++|++++..+
T Consensus 95 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 174 (272)
T 3rfs_A 95 NQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPE 174 (272)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCH
Confidence 66666655556666666666666666666655556666666666666666665555556666667777777776665555
Q ss_pred hhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhccc
Q 038671 188 SKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIH 267 (707)
Q Consensus 188 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 267 (707)
..+..+++|++|++++|.+++..+..+..+++|++|++++|.+.. .+++|+.|+++.|.+++..|..++.+..
T Consensus 175 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 175 GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc-------cCcHHHHHHHHHHhCCCcccCcccccCC
Confidence 556666777777777777776666666777777777777776652 2456777777777777777766655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.4e-26 Score=247.79 Aligned_cols=186 Identities=16% Similarity=0.189 Sum_probs=146.5
Q ss_pred CCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCc-----hhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 439 DDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPS-----EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 439 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
...+.||+|+||.||++.. .++.+++|+....... .....+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3456899999999999955 4778888876543221 112245689999999999999999766666677788999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+||+++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999854 558999999999999999 9999999999999998 999999999998754
Q ss_pred CCCC-------ccccccccCCCCcccccc--CCCCccchhHHHHHHHHHHHhCCCCC
Q 038671 594 DSSN-------WAELAGTYGYVAPELAYT--MKVTEKCDVYSFGVLALEVIKGKHPR 641 (707)
Q Consensus 594 ~~~~-------~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~p~ 641 (707)
.... .....||+.|+|||++.. ..|+..+|+|+...-..+-+.++.+|
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 3221 135689999999999886 56888899999999988888877775
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-25 Score=219.82 Aligned_cols=225 Identities=21% Similarity=0.192 Sum_probs=118.2
Q ss_pred CcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccc
Q 038671 53 ITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHN 132 (707)
Q Consensus 53 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n 132 (707)
+..+++.++.+.+. ..+..+++|+.|++++|.+..+ +++..+++|++|++++|+++++ ..+
T Consensus 21 l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~-~~l~~l~~L~~L~l~~n~l~~~--~~l-------------- 81 (272)
T 3rfs_A 21 TIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV-QGIQYLPNVRYLALGGNKLHDI--SAL-------------- 81 (272)
T ss_dssp HHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC-TTGGGCTTCCEEECTTSCCCCC--GGG--------------
T ss_pred HHHHHhcCcccccc--cccccccceeeeeeCCCCcccc-cccccCCCCcEEECCCCCCCCc--hhh--------------
Confidence 33444444444422 2234455555555555555432 2344455555555555555433 234
Q ss_pred cccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCcc
Q 038671 133 YFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSL 212 (707)
Q Consensus 133 ~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 212 (707)
..+++|++|+|++|.+++..+..|..+++|++|++++|++++..+..|..+++|++|++++|.+++..+.
T Consensus 82 ----------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 151 (272)
T 3rfs_A 82 ----------KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKG 151 (272)
T ss_dssp ----------TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred ----------cCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHH
Confidence 4444555555555554444444444455555555555555544444455555555555555555544444
Q ss_pred ccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCccccccccc
Q 038671 213 ELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSL 292 (707)
Q Consensus 213 ~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L 292 (707)
.+..+++|++|++++|.+++..+..|.++++|+.|++++|++++..+..+..+++|+.|++++|.+.+ .+++|
T Consensus 152 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l 224 (272)
T 3rfs_A 152 VFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGI 224 (272)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC-------CTTTT
T ss_pred HhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc-------cCcHH
Confidence 45555555555555555555555555555666666666666655555555556666666666665532 23456
Q ss_pred ceEeccccccCCchhHhhccC
Q 038671 293 EKLNLSHNNLSGFIPSCFEEL 313 (707)
Q Consensus 293 ~~L~l~~n~i~~~~~~~~~~~ 313 (707)
+.++++.|.+++.+|..++.+
T Consensus 225 ~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 225 RYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp HHHHHHHHHTGGGBBCTTSCB
T ss_pred HHHHHHHHhCCCcccCccccc
Confidence 666666666666666555543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-26 Score=259.49 Aligned_cols=325 Identities=15% Similarity=0.091 Sum_probs=222.7
Q ss_pred CCCCceeeccCCeeeec----CCccccCCCCCCeEECCCCccc----cccCcCccCCCCCcEEEcccCcCcccCCccccC
Q 038671 2 LSNLAFLYLYNNSFSGS----IPSEIGRLKSLSDLELSGNKLC----GSIPHSLGNLTQITFLTLFDNALSGAIPKEYGN 73 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~~----~~~~~~~l~~L~~L~l~~n~i~----~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~ 73 (707)
+++|++|+|++|.+++. ++..+..+++|++|+|++|.++ ..++..+.++++|++|+|++|.+.+ .+..+.+
T Consensus 163 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~ 241 (592)
T 3ogk_B 163 CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKA 241 (592)
T ss_dssp CTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHH
T ss_pred CCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhh
Confidence 46677777777776654 2223445667777777777665 2233344566777777777777664 4566677
Q ss_pred CCCCCeeeccccccc----ccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCC-CCCCCCCCC
Q 038671 74 LVKLTLLTLENNQLR----GPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEIS-SDWGRCPKL 148 (707)
Q Consensus 74 l~~L~~L~l~~n~i~----~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~-~~~~~~~~L 148 (707)
+++|++|+++..... .....+..+++|+.|+++++... ..+..+..+++|++|+|++|.++.... ..+..+++|
T Consensus 242 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L 320 (592)
T 3ogk_B 242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNL 320 (592)
T ss_dssp CTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTC
T ss_pred hhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCC
Confidence 777777777643222 12234667778888888775443 334566778899999999998764332 335788999
Q ss_pred cEEEcCCCccCCC-CchhhhCCCCCCEEeCCC-----------CCCCCCC-ChhhhCCCCCcEEEecCCccccCCccccC
Q 038671 149 GTLDFSSNNITGS-MPAEIIHSSQLKVLDLSS-----------NHIVGEM-PSKLGKLSSLIKLILNSNQLCGQLSLELG 215 (707)
Q Consensus 149 ~~L~L~~n~i~~~-~~~~~~~~~~L~~L~l~~-----------n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 215 (707)
++|+++ +.+.+. .+..+..+++|+.|++++ |.+++.. +..+..+++|++|+++.|.+++.....+.
T Consensus 321 ~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~ 399 (592)
T 3ogk_B 321 EVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIG 399 (592)
T ss_dssp CEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHH
T ss_pred CEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHH
Confidence 999998 444433 233345688999999993 5665332 22345689999999999998876666666
Q ss_pred C-CCcccEEEcc----CCccCCC-----CCccccCcccCceEeeeccc--ccccCchhhhh-cccCCeeeecCccCCCC-
Q 038671 216 S-LTQLERLDLS----SNRLSNS-----IPKSLGNLVKLHYLNLSNNQ--FIKKIPVELEK-LIHLSELDLSHNFLGEE- 281 (707)
Q Consensus 216 ~-l~~L~~L~l~----~n~i~~~-----~~~~l~~l~~L~~L~l~~n~--l~~~~~~~~~~-l~~L~~L~l~~n~l~~~- 281 (707)
. +++|+.|+++ .|.+++. .+..+.++++|+.|++++|. +++.....+.. +++|+.|++++|.+++.
T Consensus 400 ~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~ 479 (592)
T 3ogk_B 400 TYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEG 479 (592)
T ss_dssp HHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHH
T ss_pred hhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHH
Confidence 5 8899999996 6777754 23336678999999997543 66555555544 78899999999998763
Q ss_pred CCcccccccccceEeccccccCCch-hHhhccCCCceeEeeccCccccc
Q 038671 282 MPSQICNMQSLEKLNLSHNNLSGFI-PSCFEELHGLSYIDISYNELHGS 329 (707)
Q Consensus 282 ~~~~~~~~~~L~~L~l~~n~i~~~~-~~~~~~~~~L~~l~l~~n~~~~~ 329 (707)
.+..+..+++|+.|++++|++++.. +..+..+++|+.|++++|+++..
T Consensus 480 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 480 LMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 3344567899999999999987553 34456789999999999997754
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.91 E-value=8e-26 Score=236.32 Aligned_cols=255 Identities=19% Similarity=0.166 Sum_probs=145.7
Q ss_pred eeeccCCeeeecCCccccCCCCCCeEECCCCccccccC----cCccCCC-CCcEEEcccCcCcccCCccccCC-----CC
Q 038671 7 FLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIP----HSLGNLT-QITFLTLFDNALSGAIPKEYGNL-----VK 76 (707)
Q Consensus 7 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~----~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l-----~~ 76 (707)
+++|++|++++.+|..+...++|++|+|++|.+++..+ +.|.+++ +|++|+|++|.|++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 56788888888888777777778888888888886655 6777787 88888888888887777777765 77
Q ss_pred CCeeecccccccccCCC-----CCCC-CCccEEEeccCccccccCcccc----C-CCCCcEEEcccccccccCCC----C
Q 038671 77 LTLLTLENNQLRGPIPN-----LRNL-TSLVRVRLNQNHLTGNISESFG----I-HPNLAFIDLSHNYFYGEISS----D 141 (707)
Q Consensus 77 L~~L~l~~n~i~~~~~~-----l~~l-~~L~~L~l~~n~l~~~~~~~~~----~-~~~L~~L~L~~n~i~~~~~~----~ 141 (707)
|++|+|++|.++..... +..+ ++|++|++++|+++......+. . .++|++|+|++|.++..... .
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 88888888877754332 3344 5666667766666655443332 2 23556666666555532211 1
Q ss_pred CCCCC-CCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCC-CCCcEEEecCCccccCC----ccccC
Q 038671 142 WGRCP-KLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKL-SSLIKLILNSNQLCGQL----SLELG 215 (707)
Q Consensus 142 ~~~~~-~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~----~~~~~ 215 (707)
+..++ +|++|+|++|.+++..+..+.. .+..+ ++|++|+|++|.++... +..+.
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~--------------------~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~ 221 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAK--------------------FLASIPASVTSLDLSANLLGLKSYAELAYIFS 221 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHH--------------------HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHH--------------------HHHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence 22222 4555555555554333322221 12222 24555555555544321 22222
Q ss_pred C-CCcccEEEccCCccCCCCC----ccccCcccCceEeeecccccccCch-------hhhhcccCCeeeecCccCCCC
Q 038671 216 S-LTQLERLDLSSNRLSNSIP----KSLGNLVKLHYLNLSNNQFIKKIPV-------ELEKLIHLSELDLSHNFLGEE 281 (707)
Q Consensus 216 ~-l~~L~~L~l~~n~i~~~~~----~~l~~l~~L~~L~l~~n~l~~~~~~-------~~~~l~~L~~L~l~~n~l~~~ 281 (707)
. .++|++|+|++|.+++..+ ..+..+++|+.|+|++|.+.+..+. .+..+++|+.|++++|.+.+.
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 2 2355555555555554333 2234445566666666654333222 234455666666666666544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.4e-24 Score=207.75 Aligned_cols=207 Identities=19% Similarity=0.176 Sum_probs=170.1
Q ss_pred CCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCc-CcccCCccccCCCCCCeeeccc-ccccc
Q 038671 12 NNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA-LSGAIPKEYGNLVKLTLLTLEN-NQLRG 89 (707)
Q Consensus 12 ~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~l~~-n~i~~ 89 (707)
.++++ .+|. +.. +|++|+|++|++++..+..|.++++|++|++++|. ++...+..|.++++|++|++++ |.++.
T Consensus 20 c~~l~-~ip~-~~~--~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~ 95 (239)
T 2xwt_C 20 CKDIQ-RIPS-LPP--STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY 95 (239)
T ss_dssp ECSCS-SCCC-CCT--TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCE
T ss_pred ccCcc-ccCC-CCC--cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeE
Confidence 33355 5666 443 89999999999997777788899999999999996 8877777899999999999998 88888
Q ss_pred cCC-CCCCCCCccEEEeccCccccccCccccCCCCCc---EEEcccc-cccccCCCCCCCCCCCc-EEEcCCCccCCCCc
Q 038671 90 PIP-NLRNLTSLVRVRLNQNHLTGNISESFGIHPNLA---FIDLSHN-YFYGEISSDWGRCPKLG-TLDFSSNNITGSMP 163 (707)
Q Consensus 90 ~~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~---~L~L~~n-~i~~~~~~~~~~~~~L~-~L~L~~n~i~~~~~ 163 (707)
+++ .|.++++|++|++++|+++.++. |..+++|+ +|++++| .++.+.+..|..+++|+ +|++++|.++....
T Consensus 96 i~~~~f~~l~~L~~L~l~~n~l~~lp~--~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~ 173 (239)
T 2xwt_C 96 IDPDALKELPLLKFLGIFNTGLKMFPD--LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQG 173 (239)
T ss_dssp ECTTSEECCTTCCEEEEEEECCCSCCC--CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECT
T ss_pred cCHHHhCCCCCCCEEeCCCCCCccccc--cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCH
Confidence 765 47888999999999999887654 78888888 9999999 89888888899999999 99999999885555
Q ss_pred hhhhCCCCCCEEeCCCCC-CCCCCChhhhCC-CCCcEEEecCCccccCCccccCCCCcccEEEccCC
Q 038671 164 AEIIHSSQLKVLDLSSNH-IVGEMPSKLGKL-SSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSN 228 (707)
Q Consensus 164 ~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 228 (707)
..+.. ++|+.|++++|+ ++...+..|..+ ++|++|++++|+++...+. .+++|+.|+++++
T Consensus 174 ~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 174 YAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp TTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred hhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 55555 789999999995 886777888888 8999999999999854433 6788889988876
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.9e-25 Score=230.34 Aligned_cols=255 Identities=20% Similarity=0.197 Sum_probs=129.1
Q ss_pred EEEcccCcCcccCCccccCCCCCCeeecccccccccC-----CCCCCCC-CccEEEeccCccccccCccccCC-----CC
Q 038671 55 FLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPI-----PNLRNLT-SLVRVRLNQNHLTGNISESFGIH-----PN 123 (707)
Q Consensus 55 ~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~-----~~l~~l~-~L~~L~l~~n~l~~~~~~~~~~~-----~~ 123 (707)
.+.|++|.+++.+|..+...++|++|+|++|.++... ..+..++ +|++|+|++|+++...+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 4567778888777766666666888888888777654 2355566 67777777777766555555443 66
Q ss_pred CcEEEcccccccccCCCC----CCCC-CCCcEEEcCCCccCCCCchhhhC-----CCCCCEEeCCCCCCCCCCChh----
Q 038671 124 LAFIDLSHNYFYGEISSD----WGRC-PKLGTLDFSSNNITGSMPAEIIH-----SSQLKVLDLSSNHIVGEMPSK---- 189 (707)
Q Consensus 124 L~~L~L~~n~i~~~~~~~----~~~~-~~L~~L~L~~n~i~~~~~~~~~~-----~~~L~~L~l~~n~l~~~~~~~---- 189 (707)
|++|+|++|.++...+.. +..+ ++|++|+|++|.+++.....+.. .++|++|+|++|.+++.....
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 666666666665443332 2223 55566666666555444433322 235555555555554322222
Q ss_pred hhCCC-CCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCc-ccCceEeeecccccccCch----hhh
Q 038671 190 LGKLS-SLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNL-VKLHYLNLSNNQFIKKIPV----ELE 263 (707)
Q Consensus 190 ~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l-~~L~~L~l~~n~l~~~~~~----~~~ 263 (707)
+..++ +|++|++++|++++..+..+.. .+..+ ++|+.|+|++|.+++.... .+.
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~--------------------~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~ 221 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAK--------------------FLASIPASVTSLDLSANLLGLKSYAELAYIFS 221 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHH--------------------HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHH
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHH--------------------HHHhCCCCCCEEECCCCCCChhHHHHHHHHHh
Confidence 22232 4555555555544333322211 11122 2455555555554442222 222
Q ss_pred h-cccCCeeeecCccCCCCCC----cccccccccceEeccccccCCchh-------HhhccCCCceeEeeccCccccc
Q 038671 264 K-LIHLSELDLSHNFLGEEMP----SQICNMQSLEKLNLSHNNLSGFIP-------SCFEELHGLSYIDISYNELHGS 329 (707)
Q Consensus 264 ~-l~~L~~L~l~~n~l~~~~~----~~~~~~~~L~~L~l~~n~i~~~~~-------~~~~~~~~L~~l~l~~n~~~~~ 329 (707)
. .++|++|+|++|.+++..+ ..+..+++|+.|++++|.+.+..+ ..+..+++|+.|++++|++...
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 2 2355555555555544322 122334555555555555333222 2344455566666666665543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=206.55 Aligned_cols=178 Identities=20% Similarity=0.181 Sum_probs=77.2
Q ss_pred CccEEEeccCccccccCccccCCCCCcEEEccccc-ccccCCCCCCCCCCCcEEEcCC-CccCCCCchhhhCCCCCCEEe
Q 038671 99 SLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNY-FYGEISSDWGRCPKLGTLDFSS-NNITGSMPAEIIHSSQLKVLD 176 (707)
Q Consensus 99 ~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~-i~~~~~~~~~~~~~L~~L~L~~-n~i~~~~~~~~~~~~~L~~L~ 176 (707)
+|++|++++|+++.+++..|..+++|++|++++|. ++.+.+..|..+++|++|++++ |.++...+..|.++++|+.|+
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~ 111 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence 34444444444444444444444444444444443 4433333444444444444444 444433333344444444444
Q ss_pred CCCCCCCCCCChhhhCCCCCc---EEEecCC-ccccCCccccCCCCccc-EEEccCCccCCCCCccccCcccCceEeeec
Q 038671 177 LSSNHIVGEMPSKLGKLSSLI---KLILNSN-QLCGQLSLELGSLTQLE-RLDLSSNRLSNSIPKSLGNLVKLHYLNLSN 251 (707)
Q Consensus 177 l~~n~l~~~~~~~~~~l~~L~---~L~l~~n-~l~~~~~~~~~~l~~L~-~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~ 251 (707)
+++|.+++ +|. |..+++|+ +|++++| .++...+..|..+++|+ +|++++|.++.+.+..|.. ++|+.|++++
T Consensus 112 l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~ 188 (239)
T 2xwt_C 112 IFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNK 188 (239)
T ss_dssp EEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTT
T ss_pred CCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCC
Confidence 44444432 222 33444444 4444444 44433334444444444 4555444444333333333 4455555555
Q ss_pred cc-ccccCchhhhhc-ccCCeeeecCccCC
Q 038671 252 NQ-FIKKIPVELEKL-IHLSELDLSHNFLG 279 (707)
Q Consensus 252 n~-l~~~~~~~~~~l-~~L~~L~l~~n~l~ 279 (707)
|+ +++..+..|.++ ++|+.|++++|.++
T Consensus 189 n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~ 218 (239)
T 2xwt_C 189 NKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218 (239)
T ss_dssp CTTCCEECTTTTTTCSBCCSEEECTTCCCC
T ss_pred CCCcccCCHHHhhccccCCcEEECCCCccc
Confidence 52 444444444444 44555555555443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.3e-26 Score=240.25 Aligned_cols=263 Identities=21% Similarity=0.221 Sum_probs=153.3
Q ss_pred cCCccccCCCCCCeEECCCCccccccC----cCccCCCCCcEEEcccCcCc---ccCCccc-------cCCCCCCeeecc
Q 038671 18 SIPSEIGRLKSLSDLELSGNKLCGSIP----HSLGNLTQITFLTLFDNALS---GAIPKEY-------GNLVKLTLLTLE 83 (707)
Q Consensus 18 ~~~~~~~~l~~L~~L~l~~n~i~~~~~----~~~~~l~~L~~L~L~~n~i~---~~~~~~~-------~~l~~L~~L~l~ 83 (707)
.++..+..+++|++|+|++|++++..+ ..+.++++|++|+|++|.+. +.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 455566667777777777777765432 33566777777777775333 3333333 455555566655
Q ss_pred cccccc-----cCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCC---------CCCc
Q 038671 84 NNQLRG-----PIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRC---------PKLG 149 (707)
Q Consensus 84 ~n~i~~-----~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~---------~~L~ 149 (707)
+|.++. ++..+..+++|++|+|++|.++......+.. .+..+ ++|+
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~--------------------~l~~l~~~~~~~~~~~L~ 162 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--------------------ALQELAVNKKAKNAPPLR 162 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--------------------HHHHHHHHHHHHTCCCCC
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHH--------------------HHHHHhhhhhcccCCCCc
Confidence 555543 2222344445555555555444322222211 11112 5666
Q ss_pred EEEcCCCccCCC-Cc---hhhhCCCCCCEEeCCCCCCCC-----CCChhhhCCCCCcEEEecCCccc----cCCccccCC
Q 038671 150 TLDFSSNNITGS-MP---AEIIHSSQLKVLDLSSNHIVG-----EMPSKLGKLSSLIKLILNSNQLC----GQLSLELGS 216 (707)
Q Consensus 150 ~L~L~~n~i~~~-~~---~~~~~~~~L~~L~l~~n~l~~-----~~~~~~~~l~~L~~L~l~~n~l~----~~~~~~~~~ 216 (707)
+|+|++|.++.. .+ ..+..+++|+.|+|++|.++. ..+..+..+++|++|+|++|.++ ...+..+..
T Consensus 163 ~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~ 242 (386)
T 2ca6_A 163 SIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242 (386)
T ss_dssp EEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGG
T ss_pred EEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHcc
Confidence 666666666522 22 345566677777777777652 22335667777777777777775 345566777
Q ss_pred CCcccEEEccCCccCCC----CCcccc--CcccCceEeeecccccc----cCchhh-hhcccCCeeeecCccCCCCCC--
Q 038671 217 LTQLERLDLSSNRLSNS----IPKSLG--NLVKLHYLNLSNNQFIK----KIPVEL-EKLIHLSELDLSHNFLGEEMP-- 283 (707)
Q Consensus 217 l~~L~~L~l~~n~i~~~----~~~~l~--~l~~L~~L~l~~n~l~~----~~~~~~-~~l~~L~~L~l~~n~l~~~~~-- 283 (707)
+++|++|+|++|.+++. ++..+. .+++|+.|+|++|.+++ ..+..+ ..+++|+.|++++|.+++..+
T Consensus 243 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~ 322 (386)
T 2ca6_A 243 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVV 322 (386)
T ss_dssp CTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHH
T ss_pred CCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHH
Confidence 77788888888877654 344453 37788888888888776 245555 557888888888888866542
Q ss_pred cccc-cccccceEecccc
Q 038671 284 SQIC-NMQSLEKLNLSHN 300 (707)
Q Consensus 284 ~~~~-~~~~L~~L~l~~n 300 (707)
..+. .++.++.+.+..+
T Consensus 323 ~~l~~~l~~~~~~~l~~~ 340 (386)
T 2ca6_A 323 DEIREVFSTRGRGELDEL 340 (386)
T ss_dssp HHHHHHHHHHTCCEECCC
T ss_pred HHHHHHhhhcCcchhhhc
Confidence 2222 2455555555443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=9.6e-25 Score=226.18 Aligned_cols=223 Identities=19% Similarity=0.199 Sum_probs=134.5
Q ss_pred CCCcEEEcccCcCcccCCccccCC--CCCCeeecccccccccCCCCCCCCCccEEEeccCccccc-cCccccCCCCCcEE
Q 038671 51 TQITFLTLFDNALSGAIPKEYGNL--VKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGN-ISESFGIHPNLAFI 127 (707)
Q Consensus 51 ~~L~~L~L~~n~i~~~~~~~~~~l--~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~-~~~~~~~~~~L~~L 127 (707)
..++.|++++|.+. +..+..+ ++++.|++++|.+....+.+..+++|++|++++|.++.. .+..+..+++|++|
T Consensus 47 ~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 47 SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 34777888877766 4566666 778888888888877666667777888888887777644 44556677777777
Q ss_pred EcccccccccCCCCCCCCCCCcEEEcCCC-ccCCC-CchhhhCCCCCCEEeCCCC-CCCCC-CChhhhCCC-CCcEEEec
Q 038671 128 DLSHNYFYGEISSDWGRCPKLGTLDFSSN-NITGS-MPAEIIHSSQLKVLDLSSN-HIVGE-MPSKLGKLS-SLIKLILN 202 (707)
Q Consensus 128 ~L~~n~i~~~~~~~~~~~~~L~~L~L~~n-~i~~~-~~~~~~~~~~L~~L~l~~n-~l~~~-~~~~~~~l~-~L~~L~l~ 202 (707)
+|++|.+++..+..+..+++|++|+|++| .+++. .+..+..+++|+.|++++| .+++. .+..+..++ +|++|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 77777776555556666777777777777 45532 3444556667777777776 66532 344555666 66666666
Q ss_pred CCc--cc-cCCccccCCCCcccEEEccCCc-cCCCCCccccCcccCceEeeeccc-ccccCchhhhhcccCCeeeecCc
Q 038671 203 SNQ--LC-GQLSLELGSLTQLERLDLSSNR-LSNSIPKSLGNLVKLHYLNLSNNQ-FIKKIPVELEKLIHLSELDLSHN 276 (707)
Q Consensus 203 ~n~--l~-~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~l~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n 276 (707)
+|. ++ ...+..+..+++|++|++++|. +++..+..+..+++|+.|++++|. +.......+..+++|+.|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 663 33 2233344455555555555555 444444455555555555555552 22222223444444555555444
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=4.5e-24 Score=217.35 Aligned_cols=195 Identities=25% Similarity=0.353 Sum_probs=123.3
Q ss_pred cCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEE
Q 038671 48 GNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFI 127 (707)
Q Consensus 48 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L 127 (707)
.++++|++|++++|.++.. + .+..+++|++|++++|.+..+++ +..+++|++|++++|+++.+. .+..+++|++|
T Consensus 38 ~~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L 112 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS--AIAGLQSIKTL 112 (308)
T ss_dssp HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEE
T ss_pred HHcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCch--hhcCCCCCCEE
Confidence 3455555555555555532 2 35555555555555555554444 555555555555555555442 45566666666
Q ss_pred EcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccc
Q 038671 128 DLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLC 207 (707)
Q Consensus 128 ~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 207 (707)
++++|.++.+. .+..+++|++|++++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|.++
T Consensus 113 ~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 113 DLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS 186 (308)
T ss_dssp ECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred ECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCccC
Confidence 66666666542 26666777777777777664333 6667777777777777764322 677777777777777777
Q ss_pred cCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeeccccccc
Q 038671 208 GQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKK 257 (707)
Q Consensus 208 ~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~ 257 (707)
+..+ +..+++|++|++++|.+++..+ +..+++|+.|++++|++++.
T Consensus 187 ~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp CCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred cChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence 4433 6777888888888888875543 77788888888888887653
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.7e-25 Score=249.23 Aligned_cols=321 Identities=12% Similarity=0.048 Sum_probs=245.3
Q ss_pred CCCCceeeccCCeee----ecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCc---ccCCccccCC
Q 038671 2 LSNLAFLYLYNNSFS----GSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALS---GAIPKEYGNL 74 (707)
Q Consensus 2 l~~l~~L~l~~n~i~----~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~---~~~~~~~~~l 74 (707)
+++|++|++++|.++ +.++..+..+++|++|+|++|.+.+ ++..+.++++|++|+++..... ...+..+..+
T Consensus 191 ~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~ 269 (592)
T 3ogk_B 191 NTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFP 269 (592)
T ss_dssp CCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCC
T ss_pred CCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhcc
Confidence 689999999999997 3455566788999999999999984 6688999999999999864332 2334567888
Q ss_pred CCCCeeecccccccccCCCCCCCCCccEEEeccCccccccC-ccccCCCCCcEEEccccccc-ccCCCCCCCCCCCcEEE
Q 038671 75 VKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNIS-ESFGIHPNLAFIDLSHNYFY-GEISSDWGRCPKLGTLD 152 (707)
Q Consensus 75 ~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~L~~n~i~-~~~~~~~~~~~~L~~L~ 152 (707)
++|+.|+++++....++..+..+++|++|++++|.++.... ..+..+++|++|+++ +.+. ...+..+..+++|++|+
T Consensus 270 ~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~ 348 (592)
T 3ogk_B 270 RKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLR 348 (592)
T ss_dssp TTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEE
T ss_pred ccccccCccccchhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEE
Confidence 99999999987666666667889999999999999765443 346889999999999 4444 22333345789999999
Q ss_pred cCC-----------CccCCCCchh-hhCCCCCCEEeCCCCCCCCCCChhhhC-CCCCcEEEec----CCccccC-----C
Q 038671 153 FSS-----------NNITGSMPAE-IIHSSQLKVLDLSSNHIVGEMPSKLGK-LSSLIKLILN----SNQLCGQ-----L 210 (707)
Q Consensus 153 L~~-----------n~i~~~~~~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~----~n~l~~~-----~ 210 (707)
|++ |.+++..... +..+++|+.|+++.|.+++..+..+.. +++|++|+++ .|.+++. .
T Consensus 349 L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~ 428 (592)
T 3ogk_B 349 IERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGV 428 (592)
T ss_dssp EECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHH
T ss_pred eecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHH
Confidence 993 5666433333 445899999999999998766666665 8999999996 6777743 2
Q ss_pred ccccCCCCcccEEEccCCc--cCCCCCccccC-cccCceEeeecccccccC-chhhhhcccCCeeeecCccCCCCC-Ccc
Q 038671 211 SLELGSLTQLERLDLSSNR--LSNSIPKSLGN-LVKLHYLNLSNNQFIKKI-PVELEKLIHLSELDLSHNFLGEEM-PSQ 285 (707)
Q Consensus 211 ~~~~~~l~~L~~L~l~~n~--i~~~~~~~l~~-l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~-~~~ 285 (707)
+..+..+++|++|+++.|. +++..+..++. +++|++|++++|++++.. +..+.++++|+.|+|++|.+++.. +..
T Consensus 429 ~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~ 508 (592)
T 3ogk_B 429 RSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAA 508 (592)
T ss_dssp HHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHH
T ss_pred HHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHH
Confidence 2336679999999998643 66555555543 789999999999987644 444578899999999999986543 333
Q ss_pred cccccccceEeccccccCCchhHhhc-cCCCceeEeeccC
Q 038671 286 ICNMQSLEKLNLSHNNLSGFIPSCFE-ELHGLSYIDISYN 324 (707)
Q Consensus 286 ~~~~~~L~~L~l~~n~i~~~~~~~~~-~~~~L~~l~l~~n 324 (707)
...+++|+.|++++|++++.....+. .++.+....+..+
T Consensus 509 ~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~~ 548 (592)
T 3ogk_B 509 VTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSR 548 (592)
T ss_dssp HHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEECCC
T ss_pred HHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEecCc
Confidence 45789999999999999876444443 5677777666654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-23 Score=210.79 Aligned_cols=208 Identities=23% Similarity=0.285 Sum_probs=133.4
Q ss_pred EEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEccccccc
Q 038671 56 LTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFY 135 (707)
Q Consensus 56 L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~ 135 (707)
+.+..+.+.+.. .+..+++|++|++++|.+..++ ++..+++|++|++++|+++.+.+ +..+++|++|+|++|.++
T Consensus 24 ~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~ 98 (308)
T 1h6u_A 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK 98 (308)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS
T ss_pred HHhCCCCcCcee--cHHHcCCcCEEEeeCCCccCch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCC
Confidence 344455554322 2445667777777777776543 56667777777777777766554 666777777777777776
Q ss_pred ccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccC
Q 038671 136 GEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG 215 (707)
Q Consensus 136 ~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 215 (707)
.+ ..+..+++|++|+|++|.+++.. .+..+++|+.|++++|.+++..+ +..+++|++|++++|.+++..+ +.
T Consensus 99 ~~--~~~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~ 170 (308)
T 1h6u_A 99 NV--SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LA 170 (308)
T ss_dssp CC--GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GT
T ss_pred Cc--hhhcCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hc
Confidence 54 25666777777777777776432 26667777777777777764322 6666777777777777764333 66
Q ss_pred CCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCC
Q 038671 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGE 280 (707)
Q Consensus 216 ~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 280 (707)
.+++|+.|++++|.+++..+ +..+++|+.|++++|++.+.. .+..+++|+.|++++|.+++
T Consensus 171 ~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 171 NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp TCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred CCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 67777777777777765443 666677777777777765544 26666777777777777643
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-25 Score=252.54 Aligned_cols=322 Identities=15% Similarity=0.136 Sum_probs=145.5
Q ss_pred CCCCceeeccCCeeeecCCcccc-CCCCCCeEECCCC-ccccc-cCcCccCCCCCcEEEcccCcCcccCCcccc----CC
Q 038671 2 LSNLAFLYLYNNSFSGSIPSEIG-RLKSLSDLELSGN-KLCGS-IPHSLGNLTQITFLTLFDNALSGAIPKEYG----NL 74 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~~~~~~~~-~l~~L~~L~l~~n-~i~~~-~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~----~l 74 (707)
+++|++|+|++|.+++..+..+. .+++|++|+|++| .+++. ++..+.++++|++|+|++|.+++..+..+. .+
T Consensus 104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 35666777777666665555554 4667777777766 44432 223334566777777777666654444443 44
Q ss_pred CCCCeeeccccc--ccc--cCCCCCCCCCccEEEeccC-ccccccCccccCCCCCcEEEccccc----------------
Q 038671 75 VKLTLLTLENNQ--LRG--PIPNLRNLTSLVRVRLNQN-HLTGNISESFGIHPNLAFIDLSHNY---------------- 133 (707)
Q Consensus 75 ~~L~~L~l~~n~--i~~--~~~~l~~l~~L~~L~l~~n-~l~~~~~~~~~~~~~L~~L~L~~n~---------------- 133 (707)
++|++|++++|. +.. +..-+..+++|++|++++| .+++ .+..+..+++|++|+++.+.
T Consensus 184 ~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~ 262 (594)
T 2p1m_B 184 TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262 (594)
T ss_dssp CCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHH
T ss_pred CcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHh
Confidence 467777776665 110 0000233466666666665 2222 22233334444444433221
Q ss_pred ----------cccc----CCCCCCCCCCCcEEEcCCCccCCCCch-hhhCCCCCCEEeCCCCCCCCC-CChhhhCCCCCc
Q 038671 134 ----------FYGE----ISSDWGRCPKLGTLDFSSNNITGSMPA-EIIHSSQLKVLDLSSNHIVGE-MPSKLGKLSSLI 197 (707)
Q Consensus 134 ----------i~~~----~~~~~~~~~~L~~L~L~~n~i~~~~~~-~~~~~~~L~~L~l~~n~l~~~-~~~~~~~l~~L~ 197 (707)
+... .+..+..+++|++|+|++|.+++.... .+..+++|+.|++++| +.+. .+.....+++|+
T Consensus 263 ~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~ 341 (594)
T 2p1m_B 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLR 341 (594)
T ss_dssp TCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCC
T ss_pred cCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCC
Confidence 0000 011111346666666666665432211 2335566666666655 3211 111122355555
Q ss_pred EEEecC---------CccccCCccccC-CCCcccEEEccCCccCCCCCcccc-CcccCceEeee--c----ccccccC--
Q 038671 198 KLILNS---------NQLCGQLSLELG-SLTQLERLDLSSNRLSNSIPKSLG-NLVKLHYLNLS--N----NQFIKKI-- 258 (707)
Q Consensus 198 ~L~l~~---------n~l~~~~~~~~~-~l~~L~~L~l~~n~i~~~~~~~l~-~l~~L~~L~l~--~----n~l~~~~-- 258 (707)
+|++.+ +.++......+. .+++|+.|.++.|.+++.....+. .+++|+.|+++ + |.+++..
T Consensus 342 ~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~ 421 (594)
T 2p1m_B 342 ELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLD 421 (594)
T ss_dssp EEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTH
T ss_pred EEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchh
Confidence 555522 233322111221 245555555555555433333332 24555555555 2 2332111
Q ss_pred ---chhhhhcccCCeeeecCccCCCCCCccccc-ccccceEeccccccCCchhHhh-ccCCCceeEeeccCcc
Q 038671 259 ---PVELEKLIHLSELDLSHNFLGEEMPSQICN-MQSLEKLNLSHNNLSGFIPSCF-EELHGLSYIDISYNEL 326 (707)
Q Consensus 259 ---~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-~~~L~~L~l~~n~i~~~~~~~~-~~~~~L~~l~l~~n~~ 326 (707)
+..+..+++|+.|++++ .+++.....+.. +++|+.|++++|.+++.....+ ..+++|+.|++++|++
T Consensus 422 ~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 422 IGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp HHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred hHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 11133444455555544 333322222322 4445555555554443333322 3344555555555544
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.8e-25 Score=233.66 Aligned_cols=188 Identities=21% Similarity=0.318 Sum_probs=116.5
Q ss_pred CCCCCCcEEEcCCCccCCC----CchhhhCCCCCCEEeCCCCCCCCCCChhhh----CC---------CCCcEEEecCCc
Q 038671 143 GRCPKLGTLDFSSNNITGS----MPAEIIHSSQLKVLDLSSNHIVGEMPSKLG----KL---------SSLIKLILNSNQ 205 (707)
Q Consensus 143 ~~~~~L~~L~L~~n~i~~~----~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~----~l---------~~L~~L~l~~n~ 205 (707)
..+++|++|+|++|.++.. .+..+..+++|++|+|++|.++...+..+. .+ ++|++|++++|+
T Consensus 91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~ 170 (386)
T 2ca6_A 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170 (386)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSC
T ss_pred hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCC
Confidence 4556666666666666642 344555666666666666666533222222 22 667777777777
Q ss_pred ccc-CCc---cccCCCCcccEEEccCCccCC-----CCCccccCcccCceEeeeccccc----ccCchhhhhcccCCeee
Q 038671 206 LCG-QLS---LELGSLTQLERLDLSSNRLSN-----SIPKSLGNLVKLHYLNLSNNQFI----KKIPVELEKLIHLSELD 272 (707)
Q Consensus 206 l~~-~~~---~~~~~l~~L~~L~l~~n~i~~-----~~~~~l~~l~~L~~L~l~~n~l~----~~~~~~~~~l~~L~~L~ 272 (707)
++. ..+ ..+..+++|++|+|++|.++. ..+..+..+++|+.|+|++|.++ ...+..+..+++|+.|+
T Consensus 171 l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~ 250 (386)
T 2ca6_A 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 250 (386)
T ss_dssp CTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEE
T ss_pred CCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEE
Confidence 652 222 245566677777777776652 23335666777777777777765 33455666777777777
Q ss_pred ecCccCCCC----CCcccc--cccccceEeccccccCC----chhHhh-ccCCCceeEeeccCcccccC
Q 038671 273 LSHNFLGEE----MPSQIC--NMQSLEKLNLSHNNLSG----FIPSCF-EELHGLSYIDISYNELHGSI 330 (707)
Q Consensus 273 l~~n~l~~~----~~~~~~--~~~~L~~L~l~~n~i~~----~~~~~~-~~~~~L~~l~l~~n~~~~~~ 330 (707)
|++|.+++. ++..+. .+++|+.|++++|++++ .++..+ ..+++|+.|++++|++++..
T Consensus 251 L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp CTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred CCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 777777554 233442 26777888888887776 355555 45778888888888777554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.2e-23 Score=211.72 Aligned_cols=223 Identities=21% Similarity=0.185 Sum_probs=138.0
Q ss_pred CCcEEEcccCcCcccCCc---cccCCCCCCeeecccccccccCC-CC--CCCCCccEEEeccCccccccC----ccccCC
Q 038671 52 QITFLTLFDNALSGAIPK---EYGNLVKLTLLTLENNQLRGPIP-NL--RNLTSLVRVRLNQNHLTGNIS----ESFGIH 121 (707)
Q Consensus 52 ~L~~L~L~~n~i~~~~~~---~~~~l~~L~~L~l~~n~i~~~~~-~l--~~l~~L~~L~l~~n~l~~~~~----~~~~~~ 121 (707)
.++.|.+.++.++..... .+..+++|++|++++|.+....+ .+ ..+++|++|++++|.++...+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 355666666555421110 11123456666666666654333 33 566666666666666664322 233456
Q ss_pred CCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCC----CchhhhCCCCCCEEeCCCCCCCCCCCh----hhhCC
Q 038671 122 PNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGS----MPAEIIHSSQLKVLDLSSNHIVGEMPS----KLGKL 193 (707)
Q Consensus 122 ~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~----~~~~~~~~~~L~~L~l~~n~l~~~~~~----~~~~l 193 (707)
++|++|+|++|.++.+.+..|..+++|++|+|++|.+.+. ....+..+++|++|+|++|+++ ..+. .+..+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence 6777777777777666666677777777777777765421 1122345677777777777775 2222 24566
Q ss_pred CCCcEEEecCCccccCCccccCCC---CcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCe
Q 038671 194 SSLIKLILNSNQLCGQLSLELGSL---TQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSE 270 (707)
Q Consensus 194 ~~L~~L~l~~n~l~~~~~~~~~~l---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 270 (707)
++|++|++++|.+++..|..+..+ ++|++|+|++|+++ .+|..+. ++|+.|+|++|++++.. . +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~-~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAP-Q-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCC-C-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCc-h-hhhCCCccE
Confidence 777777777777776656555555 57888888888887 4455553 67888888888876542 2 566778888
Q ss_pred eeecCccCCC
Q 038671 271 LDLSHNFLGE 280 (707)
Q Consensus 271 L~l~~n~l~~ 280 (707)
|++++|++++
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 8888888754
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.4e-24 Score=223.17 Aligned_cols=253 Identities=19% Similarity=0.243 Sum_probs=189.0
Q ss_pred CCCeEECCCCccccccCcCccCC--CCCcEEEcccCcCcccCCccccCCCCCCeeecccccccc--cCCCCCCCCCccEE
Q 038671 28 SLSDLELSGNKLCGSIPHSLGNL--TQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRG--PIPNLRNLTSLVRV 103 (707)
Q Consensus 28 ~L~~L~l~~n~i~~~~~~~~~~l--~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~--~~~~l~~l~~L~~L 103 (707)
.++.|+++++.+. +..+..+ ++++.|++++|.+.+..+. +..+++|++|++++|.+.. ++..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 4677777777766 3445555 7778888888877765544 4567788888888887764 33346777888888
Q ss_pred EeccCccccccCccccCCCCCcEEEcccc-ccccc-CCCCCCCCCCCcEEEcCCC-ccCCC-CchhhhCCC-CCCEEeCC
Q 038671 104 RLNQNHLTGNISESFGIHPNLAFIDLSHN-YFYGE-ISSDWGRCPKLGTLDFSSN-NITGS-MPAEIIHSS-QLKVLDLS 178 (707)
Q Consensus 104 ~l~~n~l~~~~~~~~~~~~~L~~L~L~~n-~i~~~-~~~~~~~~~~L~~L~L~~n-~i~~~-~~~~~~~~~-~L~~L~l~ 178 (707)
++++|+++...+..++.+++|++|+|++| .+++. .+..+..+++|++|++++| .+++. .+..+..++ +|++|+++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 88888877666677778888888888888 56642 3445677888999999998 88754 456677788 99999999
Q ss_pred CC--CCC-CCCChhhhCCCCCcEEEecCCc-cccCCccccCCCCcccEEEccCCc-cCCCCCccccCcccCceEeeeccc
Q 038671 179 SN--HIV-GEMPSKLGKLSSLIKLILNSNQ-LCGQLSLELGSLTQLERLDLSSNR-LSNSIPKSLGNLVKLHYLNLSNNQ 253 (707)
Q Consensus 179 ~n--~l~-~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~l~~l~~L~~L~l~~n~ 253 (707)
+| .++ ..++..+..+++|++|++++|. +++..+..+..+++|++|++++|. +.......++++++|+.|++++|
T Consensus 204 ~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~- 282 (336)
T 2ast_B 204 GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI- 282 (336)
T ss_dssp SCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-
T ss_pred CCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-
Confidence 99 454 3456677889999999999999 776777788899999999999995 33333336888999999999999
Q ss_pred ccccCchhhhhc-ccCCeeeecCccCCCCCCccccc
Q 038671 254 FIKKIPVELEKL-IHLSELDLSHNFLGEEMPSQICN 288 (707)
Q Consensus 254 l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~ 288 (707)
+.... +..+ .++..|++++|.+++..|..++.
T Consensus 283 i~~~~---~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 283 VPDGT---LQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp SCTTC---HHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred cCHHH---HHHHHhhCcceEEecccCccccCCcccc
Confidence 54433 3344 35888889999998888877654
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=3.4e-22 Score=197.32 Aligned_cols=177 Identities=24% Similarity=0.255 Sum_probs=93.9
Q ss_pred CceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeeccc
Q 038671 5 LAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLEN 84 (707)
Q Consensus 5 l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~ 84 (707)
.++++++++.++ .+|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 345555555555 4444443 3555555555555555555555555555555555555555555555555555555555
Q ss_pred ccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCch
Q 038671 85 NQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPA 164 (707)
Q Consensus 85 n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~ 164 (707)
|.++. +.+..|..+++|++|+|++|.++.+.+..|..+++|++|+|++|.+++..+.
T Consensus 93 n~l~~-----------------------~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 149 (251)
T 3m19_A 93 NQLAS-----------------------LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAG 149 (251)
T ss_dssp SCCCC-----------------------CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred Ccccc-----------------------cChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHH
Confidence 55554 4444444445555555555555544444445555555555555555544444
Q ss_pred hhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccc
Q 038671 165 EIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLC 207 (707)
Q Consensus 165 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 207 (707)
.|..+++|+.|+|++|++++..+..|..+++|++|++++|.+.
T Consensus 150 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred HcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCcee
Confidence 4555555555555555555444445555555555555555554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.4e-23 Score=211.45 Aligned_cols=224 Identities=17% Similarity=0.161 Sum_probs=176.4
Q ss_pred CCceeeccCCeeeecCCc---cccCCCCCCeEECCCCccccccCcCc--cCCCCCcEEEcccCcCcccCC----ccccCC
Q 038671 4 NLAFLYLYNNSFSGSIPS---EIGRLKSLSDLELSGNKLCGSIPHSL--GNLTQITFLTLFDNALSGAIP----KEYGNL 74 (707)
Q Consensus 4 ~l~~L~l~~n~i~~~~~~---~~~~l~~L~~L~l~~n~i~~~~~~~~--~~l~~L~~L~L~~n~i~~~~~----~~~~~l 74 (707)
.++.|.+.++.++...-. .+..+++|++|+|++|++++..|..+ .++++|++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 467788888777632111 12234679999999999998888887 889999999999999986554 445678
Q ss_pred CCCCeeecccccccccCC-CCCCCCCccEEEeccCcccc---cc-CccccCCCCCcEEEcccccccccCCC---CCCCCC
Q 038671 75 VKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLNQNHLTG---NI-SESFGIHPNLAFIDLSHNYFYGEISS---DWGRCP 146 (707)
Q Consensus 75 ~~L~~L~l~~n~i~~~~~-~l~~l~~L~~L~l~~n~l~~---~~-~~~~~~~~~L~~L~L~~n~i~~~~~~---~~~~~~ 146 (707)
++|++|+|++|.+...++ .+..+++|++|+|++|++.+ +. ...+..+++|++|+|++|.++.+... .+..++
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~ 224 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGV 224 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTC
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCC
Confidence 899999999999987765 58899999999999998764 22 23346789999999999999743221 246789
Q ss_pred CCcEEEcCCCccCCCCchhhhCC---CCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEE
Q 038671 147 KLGTLDFSSNNITGSMPAEIIHS---SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERL 223 (707)
Q Consensus 147 ~L~~L~L~~n~i~~~~~~~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 223 (707)
+|++|+|++|.+++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|++|++++|++++. +. +..+++|+.|
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L 299 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNL 299 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCE
T ss_pred CCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEE
Confidence 99999999999997767666665 69999999999998 5666664 7999999999999954 33 6788999999
Q ss_pred EccCCccCC
Q 038671 224 DLSSNRLSN 232 (707)
Q Consensus 224 ~l~~n~i~~ 232 (707)
+|++|++++
T Consensus 300 ~L~~N~l~~ 308 (310)
T 4glp_A 300 TLDGNPFLV 308 (310)
T ss_dssp ECSSTTTSC
T ss_pred ECcCCCCCC
Confidence 999999874
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=4.8e-22 Score=196.27 Aligned_cols=177 Identities=22% Similarity=0.253 Sum_probs=86.6
Q ss_pred CCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCC
Q 038671 77 LTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSN 156 (707)
Q Consensus 77 L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n 156 (707)
.++++++++.++.++..+. ++|+.|++++|+++.+.+..|..+++|++|+|++|.++.+.+..|..+++|++|+|++|
T Consensus 16 ~~~l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 93 (251)
T 3m19_A 16 KKEVDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANN 93 (251)
T ss_dssp GTEEECTTCCCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CeEEecCCCCccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCC
Confidence 3444555555444444332 34445555555554444444444444555555544444444444444444444444444
Q ss_pred ccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCc
Q 038671 157 NITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPK 236 (707)
Q Consensus 157 ~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~ 236 (707)
.++...+ ..|..+++|++|++++|++++..+..|..+++|++|+|++|.+++..+.
T Consensus 94 ~l~~~~~------------------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 149 (251)
T 3m19_A 94 QLASLPL------------------------GVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAG 149 (251)
T ss_dssp CCCCCCT------------------------TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred cccccCh------------------------hHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHH
Confidence 4443333 4444444444444444444433344444455555555555555544444
Q ss_pred cccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCC
Q 038671 237 SLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLG 279 (707)
Q Consensus 237 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 279 (707)
.|.++++|+.|+|++|++++..+..+..+++|+.|++++|.++
T Consensus 150 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 192 (251)
T 3m19_A 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFD 192 (251)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred HcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCcee
Confidence 4555555555555555555444445555555555555555553
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.9e-23 Score=205.43 Aligned_cols=155 Identities=16% Similarity=0.144 Sum_probs=122.1
Q ss_pred HHHHHHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchh---------------hhHHHHHHHHHHHhcCC
Q 038671 429 EEIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEM---------------ASQQEFLNEVKTLTGIR 493 (707)
Q Consensus 429 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~ 493 (707)
.........|++.+.||+|+||.||+|...+|+.||+|++........ .....+.+|++++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 334445566778899999999999999778899999999864321110 23567899999999998
Q ss_pred CCceeeeeeeeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCee
Q 038671 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVL 573 (707)
Q Consensus 494 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 573 (707)
| +++.+++.. +..++||||++|++|.+ +.. .....++.|++.||+|||+. ||+||||||+||+
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NIL 225 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 225 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEE
Confidence 4 666665543 56799999999999987 421 23457999999999999999 9999999999999
Q ss_pred ecCCCCeEEeccccceecCCCCCCccccccccCCCCccccc
Q 038671 574 LDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614 (707)
Q Consensus 574 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 614 (707)
++ ++.+||+|||+++. +..+.|||.+.
T Consensus 226 l~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence 99 99999999999964 33467888765
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.4e-22 Score=208.73 Aligned_cols=200 Identities=15% Similarity=0.113 Sum_probs=111.5
Q ss_pred ceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcc-cCCccccCCCCCCe-eecc
Q 038671 6 AFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSG-AIPKEYGNLVKLTL-LTLE 83 (707)
Q Consensus 6 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~-L~l~ 83 (707)
+.++.++++++ .+|..+. +++++|+|++|+|+.+.+++|.++++|++|+|++|+|.+ ..+.+|.++++|++ +.+.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 34566666666 5565552 466777777777764444566667777777777766643 33345666666554 3444
Q ss_pred cccccccCC-CCCCCCCccEEEeccCccccccCccccCCCCCcEEEccc-ccccccCCCCCCCCC-CCcEEEcCCCccCC
Q 038671 84 NNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSH-NYFYGEISSDWGRCP-KLGTLDFSSNNITG 160 (707)
Q Consensus 84 ~n~i~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~-n~i~~~~~~~~~~~~-~L~~L~L~~n~i~~ 160 (707)
.|++..+++ .|..+++|++|++++|+++.+.+..+....++..|++.+ +.+..+....|..++ .++.|+|++|.|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 566665544 356666666666666666655555555555566666643 455555555555543 35556666666553
Q ss_pred CCchhhhCCCCCCEEeCCC-CCCCCCCChhhhCCCCCcEEEecCCccccC
Q 038671 161 SMPAEIIHSSQLKVLDLSS-NHIVGEMPSKLGKLSSLIKLILNSNQLCGQ 209 (707)
Q Consensus 161 ~~~~~~~~~~~L~~L~l~~-n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 209 (707)
+.+..| ...+|+.|++.+ |.++...++.|..+++|++|++++|+|+..
T Consensus 169 i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~l 217 (350)
T 4ay9_X 169 IHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 217 (350)
T ss_dssp ECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCC
T ss_pred CChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCcc
Confidence 333322 234555555543 444433334455555555555555555533
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.4e-22 Score=206.78 Aligned_cols=240 Identities=23% Similarity=0.147 Sum_probs=194.6
Q ss_pred CeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccc-cCC-CCCCCCCccE-EEec
Q 038671 30 SDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRG-PIP-NLRNLTSLVR-VRLN 106 (707)
Q Consensus 30 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~-~~~-~l~~l~~L~~-L~l~ 106 (707)
+.++.++++++ .+|..+ .+++++|+|++|+|+.+.+++|+++++|++|+|++|++.+ +++ .|.++++|.+ +.+.
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 56788899999 777766 4689999999999998877899999999999999999865 443 4788988775 6667
Q ss_pred cCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCC-CccCCCCchhhhCCC-CCCEEeCCCCCCCC
Q 038671 107 QNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS-NNITGSMPAEIIHSS-QLKVLDLSSNHIVG 184 (707)
Q Consensus 107 ~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~-n~i~~~~~~~~~~~~-~L~~L~l~~n~l~~ 184 (707)
.|+++.+.++.|..+++|++|++++|.++.+.+..+....++..|++.+ +.+.......|..+. .++.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 7999999999999999999999999999988888888888899999965 667766667777764 68999999999984
Q ss_pred CCChhhhCCCCCcEEEec-CCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhh
Q 038671 185 EMPSKLGKLSSLIKLILN-SNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELE 263 (707)
Q Consensus 185 ~~~~~~~~l~~L~~L~l~-~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~ 263 (707)
..+. ....++|++|.+. +|.++...+..|..+++|++|+|++|+|+.+.+..|.++++|+.+++.+ + +..| .+.
T Consensus 169 i~~~-~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~~~--l-~~lP-~l~ 243 (350)
T 4ay9_X 169 IHNS-AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN--L-KKLP-TLE 243 (350)
T ss_dssp ECTT-SSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTCTT--C-CCCC-CTT
T ss_pred CChh-hccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccCCC--c-CcCC-Cch
Confidence 4444 4456789999997 4788866667889999999999999999977777776666655555432 3 3344 478
Q ss_pred hcccCCeeeecCcc
Q 038671 264 KLIHLSELDLSHNF 277 (707)
Q Consensus 264 ~l~~L~~L~l~~n~ 277 (707)
.+++|+.++++++.
T Consensus 244 ~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 244 KLVALMEASLTYPS 257 (350)
T ss_dssp TCCSCCEEECSCHH
T ss_pred hCcChhhCcCCCCc
Confidence 88999999998754
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-23 Score=233.91 Aligned_cols=323 Identities=15% Similarity=0.123 Sum_probs=225.6
Q ss_pred CCCCceeeccCC-eeeec-CCccccCCCCCCeEECCCCccccccCcCc----cCCCCCcEEEcccCcCcccCCcc----c
Q 038671 2 LSNLAFLYLYNN-SFSGS-IPSEIGRLKSLSDLELSGNKLCGSIPHSL----GNLTQITFLTLFDNALSGAIPKE----Y 71 (707)
Q Consensus 2 l~~l~~L~l~~n-~i~~~-~~~~~~~l~~L~~L~l~~n~i~~~~~~~~----~~l~~L~~L~L~~n~i~~~~~~~----~ 71 (707)
+++|++|+|++| .+++. ++..+..+++|++|+|++|.+++..+..+ ..+++|++|++++|. ....... +
T Consensus 129 ~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~ 207 (594)
T 2p1m_B 129 FKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLV 207 (594)
T ss_dssp CTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHH
T ss_pred CCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHH
Confidence 678999999998 66643 34444578999999999998876544433 366789999999887 2122222 3
Q ss_pred cCCCCCCeeecccc-cccccCCCCCCCCCccEEEeccCc--------------------------cccc----cCccccC
Q 038671 72 GNLVKLTLLTLENN-QLRGPIPNLRNLTSLVRVRLNQNH--------------------------LTGN----ISESFGI 120 (707)
Q Consensus 72 ~~l~~L~~L~l~~n-~i~~~~~~l~~l~~L~~L~l~~n~--------------------------l~~~----~~~~~~~ 120 (707)
..+++|++|++++| .+..++..+..+++|++|++..+. +... .+..+..
T Consensus 208 ~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~ 287 (594)
T 2p1m_B 208 TRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSV 287 (594)
T ss_dssp HHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHH
T ss_pred HhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHh
Confidence 45689999999887 444433335556667777654431 1111 1222336
Q ss_pred CCCCcEEEcccccccccC-CCCCCCCCCCcEEEcCCCccCCCCchhh-hCCCCCCEEeCC---------CCCCCCCCChh
Q 038671 121 HPNLAFIDLSHNYFYGEI-SSDWGRCPKLGTLDFSSNNITGSMPAEI-IHSSQLKVLDLS---------SNHIVGEMPSK 189 (707)
Q Consensus 121 ~~~L~~L~L~~n~i~~~~-~~~~~~~~~L~~L~L~~n~i~~~~~~~~-~~~~~L~~L~l~---------~n~l~~~~~~~ 189 (707)
+++|++|+|++|.++... ...+..+++|++|++++| +++.....+ ..+++|+.|++. .+.+++.....
T Consensus 288 ~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~ 366 (594)
T 2p1m_B 288 CSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVS 366 (594)
T ss_dssp HTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHH
T ss_pred hCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHH
Confidence 799999999999976432 223568899999999988 543322223 348999999983 34555333333
Q ss_pred hh-CCCCCcEEEecCCccccCCccccC-CCCcccEEEcc--C----CccCCCCC-----ccccCcccCceEeeecccccc
Q 038671 190 LG-KLSSLIKLILNSNQLCGQLSLELG-SLTQLERLDLS--S----NRLSNSIP-----KSLGNLVKLHYLNLSNNQFIK 256 (707)
Q Consensus 190 ~~-~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~--~----n~i~~~~~-----~~l~~l~~L~~L~l~~n~l~~ 256 (707)
+. .+++|++|.++.|.+++.....+. .+++|+.|+++ + |.+++... ..+..+++|+.|+|++ .+++
T Consensus 367 l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~ 445 (594)
T 2p1m_B 367 VSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTD 445 (594)
T ss_dssp HHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCH
T ss_pred HHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccH
Confidence 33 489999999999999866555554 58999999999 4 56663221 1256788999999987 6666
Q ss_pred cCchhhhh-cccCCeeeecCccCCCCCCccc-ccccccceEeccccccCCchhH-hhccCCCceeEeeccCccc
Q 038671 257 KIPVELEK-LIHLSELDLSHNFLGEEMPSQI-CNMQSLEKLNLSHNNLSGFIPS-CFEELHGLSYIDISYNELH 327 (707)
Q Consensus 257 ~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~-~~~~~L~~L~l~~n~i~~~~~~-~~~~~~~L~~l~l~~n~~~ 327 (707)
.....+.. +++|+.|++++|.+++.....+ ..+++|+.|++++|++++.... ....+++|+.|++++|+++
T Consensus 446 ~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~ 519 (594)
T 2p1m_B 446 KVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519 (594)
T ss_dssp HHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred HHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence 66666665 8899999999999976555444 5689999999999999655444 4456899999999999884
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.1e-20 Score=178.77 Aligned_cols=114 Identities=25% Similarity=0.236 Sum_probs=45.5
Q ss_pred CCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceE
Q 038671 168 HSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYL 247 (707)
Q Consensus 168 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L 247 (707)
.+++|++|+|++|.+++..+..|..+++|++|++++|++++..+..+..+++|++|+|++|.+++..+..|..+++|+.|
T Consensus 74 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 153 (208)
T 2o6s_A 74 KLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYI 153 (208)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEE
T ss_pred CCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEE
Confidence 33333333333333332223333333344444444444433333333344444444444444443333334444444444
Q ss_pred eeecccccccCchhhhhcccCCeeeecCccCCCCCCccccc
Q 038671 248 NLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICN 288 (707)
Q Consensus 248 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 288 (707)
++++|.+.. .+++|+.|+++.|.+++.+|..++.
T Consensus 154 ~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~ 187 (208)
T 2o6s_A 154 WLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGS 187 (208)
T ss_dssp ECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSS
T ss_pred EecCCCeec-------CCCCHHHHHHHHHhCCceeeccCcc
Confidence 444443321 2234444444444444444444443
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=5e-21 Score=184.42 Aligned_cols=155 Identities=21% Similarity=0.295 Sum_probs=88.9
Q ss_pred EEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeeccc
Q 038671 174 VLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQ 253 (707)
Q Consensus 174 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~ 253 (707)
.++++++.++ .+|..+. ++|++|++++|.++...+..|..+++|++|+|++|.|++..|..|.++++|++|+|++|.
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 3444444444 3333222 355555555555554444455555555555555555555555555556666666666666
Q ss_pred ccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCC
Q 038671 254 FIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIP 331 (707)
Q Consensus 254 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~ 331 (707)
|+...+..|.++++|+.|+|++|.+++..+..|..+++|+.|++++|+|++..+..+..+++|+.|++++|+|.|.+.
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCCCc
Confidence 555555555556666666666666655555566666666666666666665555556666666666666666666554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.3e-20 Score=178.52 Aligned_cols=177 Identities=19% Similarity=0.132 Sum_probs=85.6
Q ss_pred eeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCcc
Q 038671 79 LLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNI 158 (707)
Q Consensus 79 ~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i 158 (707)
.++.+++.+..++..+ .++|++|++++|+++.+.+..|..+++|++|++++|.++.+.+..|..+++|++|+|++|.+
T Consensus 11 ~v~c~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 88 (208)
T 2o6s_A 11 TVECYSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL 88 (208)
T ss_dssp EEECCSSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEEecCCCccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcC
Confidence 3444444444443332 23455555555555544444445555555555555555544444445555555555555555
Q ss_pred CCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccc
Q 038671 159 TGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSL 238 (707)
Q Consensus 159 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l 238 (707)
++..+..|..+++|++|++++|.+++..+..|..+++|++|++++|.+++..+..+..+++|++|++++|.+..
T Consensus 89 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~------ 162 (208)
T 2o6s_A 89 QSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC------ 162 (208)
T ss_dssp CCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC------
T ss_pred CccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec------
Confidence 54444444445555555555555544444444455555555555555554444444455555555555554431
Q ss_pred cCcccCceEeeecccccccCchhhhh
Q 038671 239 GNLVKLHYLNLSNNQFIKKIPVELEK 264 (707)
Q Consensus 239 ~~l~~L~~L~l~~n~l~~~~~~~~~~ 264 (707)
.+++|++|+++.|++++..|..++.
T Consensus 163 -~~~~l~~L~~~~n~~~g~ip~~~~~ 187 (208)
T 2o6s_A 163 -TCPGIRYLSEWINKHSGVVRNSAGS 187 (208)
T ss_dssp -CTTTTHHHHHHHHHCTTTBBCTTSS
T ss_pred -CCCCHHHHHHHHHhCCceeeccCcc
Confidence 2334455555555555444444433
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.8e-21 Score=196.22 Aligned_cols=172 Identities=26% Similarity=0.320 Sum_probs=95.1
Q ss_pred CCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEE
Q 038671 49 NLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFID 128 (707)
Q Consensus 49 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~ 128 (707)
.+++|++|++++|.+++. + .++.+++|++|++++|.++.+++ +..+++|+.|++++|+++.+. .+..+++|++|+
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~ 118 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP-LANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLS 118 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc-cccCCCCCEEECCCCcCCCCh--hhccCCCCCEEE
Confidence 444444444444444422 1 24444445555555554444333 444555555555555554432 255555555555
Q ss_pred cccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCcccc
Q 038671 129 LSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCG 208 (707)
Q Consensus 129 L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 208 (707)
+++|.++.+ ..+..+++|+.|++++|.+++. ..+..+++|+.|++++|.+++..+ +..+++|++|++++|.+++
T Consensus 119 L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~ 192 (291)
T 1h6t_A 119 LEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD 192 (291)
T ss_dssp CTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB
T ss_pred CCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCC
Confidence 555555543 3455566666666666666643 455666666666666666664333 6666677777777776664
Q ss_pred CCccccCCCCcccEEEccCCccCCC
Q 038671 209 QLSLELGSLTQLERLDLSSNRLSNS 233 (707)
Q Consensus 209 ~~~~~~~~l~~L~~L~l~~n~i~~~ 233 (707)
. + .+..+++|+.|++++|+++..
T Consensus 193 l-~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 193 L-R-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp C-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred C-h-hhccCCCCCEEECcCCcccCC
Confidence 3 2 366677777777777777643
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=8.3e-21 Score=182.88 Aligned_cols=156 Identities=19% Similarity=0.256 Sum_probs=102.7
Q ss_pred EEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCc-cccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecc
Q 038671 174 VLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLS-LELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNN 252 (707)
Q Consensus 174 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n 252 (707)
.+++++|.++ .+|..+. +.+++|++++|.+++..+ ..|..+++|++|+|++|.|+++.+..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 5555555555 3343332 244566666666664432 34566666666777666666666666667777777777777
Q ss_pred cccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCC
Q 038671 253 QFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332 (707)
Q Consensus 253 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~ 332 (707)
++++..+..|.++++|++|+|++|.+++..+..|..+++|+.|++++|+|++..|..+..+++|+.|++++|+|+|.++.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGGG
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCch
Confidence 77666666677777777777777777666666777777777777777777766677777777777777777777776653
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.83 E-value=2.9e-20 Score=187.46 Aligned_cols=188 Identities=26% Similarity=0.338 Sum_probs=99.5
Q ss_pred CcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccc
Q 038671 53 ITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHN 132 (707)
Q Consensus 53 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n 132 (707)
+..+.+..+.+++.. .+..+++|++|++++|.+..+ +++..+++|++|++++|+++.+.+ +..+++|++|++++|
T Consensus 26 ~~~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n 100 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN 100 (291)
T ss_dssp HHHHHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred HHHHHhcCCCccccc--chhhcCcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCC
Confidence 333445555554322 234566666666666666644 345666666666666666665543 556666666666666
Q ss_pred cccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCcc
Q 038671 133 YFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSL 212 (707)
Q Consensus 133 ~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 212 (707)
.++.+ ..+..+++|++|+|++|.+++. ..+..+++|+.|++++|++++. ..+..+++|++|++++|.+++..+
T Consensus 101 ~l~~~--~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~- 173 (291)
T 1h6t_A 101 KVKDL--SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP- 173 (291)
T ss_dssp CCCCG--GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-
T ss_pred cCCCC--hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-
Confidence 66543 2255555666666666655532 3345555555555555555432 344555555555555555553322
Q ss_pred ccCCCCcccEEEccCCccCCCCCccccCcccCceEeeeccccc
Q 038671 213 ELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFI 255 (707)
Q Consensus 213 ~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~ 255 (707)
+..+++|++|++++|.+++. + .+..+++|+.|++++|++.
T Consensus 174 -l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~ 213 (291)
T 1h6t_A 174 -LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL 213 (291)
T ss_dssp -GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred -hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCccc
Confidence 44555555555555555432 1 2444455555555555443
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.83 E-value=6.8e-21 Score=210.29 Aligned_cols=189 Identities=25% Similarity=0.306 Sum_probs=121.0
Q ss_pred CceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeeccc
Q 038671 5 LAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLEN 84 (707)
Q Consensus 5 l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~ 84 (707)
+..+.+..+.+++..+ +..+++|+.|++++|.++. ++ .+..+++|+.|+|++|.+++..+ |..+++|++|+|++
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 3445566666664433 4567777777887777773 33 47777777888887777775543 77777777777777
Q ss_pred ccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCch
Q 038671 85 NQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPA 164 (707)
Q Consensus 85 n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~ 164 (707)
|.+..+ +.+..+++|+.|+|++|++..+ ..+..+++|+.|+|++|.++.+ ..+..+++|+.|+|++|.+++..+
T Consensus 97 N~l~~l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~- 170 (605)
T 1m9s_A 97 NKIKDL-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP- 170 (605)
T ss_dssp SCCCCC-TTSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-
T ss_pred CCCCCC-hhhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-
Confidence 777753 3567777777777777777654 3466666666666666666654 455666666666666666664433
Q ss_pred hhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCcccc
Q 038671 165 EIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCG 208 (707)
Q Consensus 165 ~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 208 (707)
+..+++|+.|+|++|.|++. ..+..+++|+.|+|++|.+..
T Consensus 171 -l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 171 -LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp -GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred -hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 55566666666666666532 235555566666666665553
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.2e-20 Score=201.53 Aligned_cols=189 Identities=26% Similarity=0.311 Sum_probs=138.4
Q ss_pred CCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEecc
Q 038671 28 SLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQ 107 (707)
Q Consensus 28 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~ 107 (707)
+|+.|+|++|++++ +|..+ +++|++|+|++|.|+ .+| ..+++|++|++++|.|+.++. +.+ +|+.|+|++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~ip~-l~~--~L~~L~Ls~ 129 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLSTLPE-LPA--SLKHLDVDN 129 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCCCC-CCT--TCCEEECCS
T ss_pred CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCCcch-hhc--CCCEEECCC
Confidence 77788888887774 55544 367888888888777 445 446778888888888777555 544 788888888
Q ss_pred CccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCC
Q 038671 108 NHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMP 187 (707)
Q Consensus 108 n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 187 (707)
|++++++. .+++|+.|+|++|.++.+.. .+++|++|+|++|.+++ .+. |. ++|+.|+|++|.|+ .+|
T Consensus 130 N~l~~lp~----~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp 196 (571)
T 3cvr_A 130 NQLTMLPE----LPALLEYINADNNQLTMLPE----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLP 196 (571)
T ss_dssp SCCSCCCC----CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCC
T ss_pred CcCCCCCC----cCccccEEeCCCCccCcCCC----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chh
Confidence 88877554 56788888888888876433 56788888888888875 443 44 78888888888887 555
Q ss_pred hhhhCCCCC-------cEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCccc
Q 038671 188 SKLGKLSSL-------IKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVK 243 (707)
Q Consensus 188 ~~~~~l~~L-------~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~ 243 (707)
. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|.+++..|..|..+..
T Consensus 197 ~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 197 A-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp C-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred h-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 5 543 66 99999999998 56777777999999999999998888877776543
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.82 E-value=2.5e-20 Score=194.32 Aligned_cols=160 Identities=26% Similarity=0.239 Sum_probs=90.1
Q ss_pred CCEEeCCCCCCCCCCChhhh-CCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeee
Q 038671 172 LKVLDLSSNHIVGEMPSKLG-KLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLS 250 (707)
Q Consensus 172 L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~ 250 (707)
++.|+|++|.|++..+..|. .+++|++|+|++|+|++..+..|..+++|++|+|++|+|+...+..|.++++|+.|+|+
T Consensus 41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 120 (361)
T 2xot_A 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLY 120 (361)
T ss_dssp CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECC
Confidence 44444444444444444444 45555555555555554444455555555555555555554445555555556666666
Q ss_pred cccccccCchhhhhcccCCeeeecCccCCCCCCccc---ccccccceEeccccccCCchhHhhccCCCc--eeEeeccCc
Q 038671 251 NNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQI---CNMQSLEKLNLSHNNLSGFIPSCFEELHGL--SYIDISYNE 325 (707)
Q Consensus 251 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~---~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L--~~l~l~~n~ 325 (707)
+|+|....+..|.++++|+.|+|++|.|+...+..| ..+++|+.|+|++|+|+...+..+..++.+ +.|++++|+
T Consensus 121 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~ 200 (361)
T 2xot_A 121 NNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP 200 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred CCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence 665555555555666666666666666644333333 446667777777777766655666666653 667777777
Q ss_pred ccccCC
Q 038671 326 LHGSIP 331 (707)
Q Consensus 326 ~~~~~~ 331 (707)
|.|.+.
T Consensus 201 ~~C~C~ 206 (361)
T 2xot_A 201 LECDCK 206 (361)
T ss_dssp EECCHH
T ss_pred ccCCcC
Confidence 777654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-19 Score=198.29 Aligned_cols=186 Identities=23% Similarity=0.249 Sum_probs=90.7
Q ss_pred CCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEccc
Q 038671 52 QITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSH 131 (707)
Q Consensus 52 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~ 131 (707)
+|+.|+|++|.+++ +|..+. ++|++|+|++|.|+.++ ..+++|+.|++++|++++++. +.. +|++|+|++
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~ip---~~l~~L~~L~Ls~N~l~~ip~--l~~--~L~~L~Ls~ 129 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALISLP---ELPASLEYLDACDNRLSTLPE--LPA--SLKHLDVDN 129 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCSCCCC--CCT--TCCEEECCS
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcccc---cccCCCCEEEccCCCCCCcch--hhc--CCCEEECCC
Confidence 56666666666664 343332 45666666666666444 334566666666666655433 332 555666666
Q ss_pred ccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCc
Q 038671 132 NYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLS 211 (707)
Q Consensus 132 n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 211 (707)
|.++++.. .+++|+.|+|++|.+++ .+. .+++|+.|+|++|+|++ +|. |. ++|+.|+|++|+|+ .+|
T Consensus 130 N~l~~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp 196 (571)
T 3cvr_A 130 NQLTMLPE----LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLP 196 (571)
T ss_dssp SCCSCCCC----CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCC
T ss_pred CcCCCCCC----cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chh
Confidence 55554322 34555555555555553 222 34455555555555553 333 33 45555555555555 222
Q ss_pred cccCCCCcc-------cEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhh
Q 038671 212 LELGSLTQL-------ERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEK 264 (707)
Q Consensus 212 ~~~~~l~~L-------~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 264 (707)
. +.. +| +.|+|++|.|+ .+|..+..+++|+.|+|++|++++..|..+..
T Consensus 197 ~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~ 252 (571)
T 3cvr_A 197 A-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252 (571)
T ss_dssp C-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHH
T ss_pred h-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHH
Confidence 2 222 33 44444444444 23333333444444444444444444444433
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=8.6e-20 Score=201.51 Aligned_cols=172 Identities=27% Similarity=0.369 Sum_probs=84.4
Q ss_pred cCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEE
Q 038671 72 GNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTL 151 (707)
Q Consensus 72 ~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L 151 (707)
..+++|+.|++++|.+..++ .+..+++|+.|+|++|+++.+.+ +..+++|+.|+|++|.++.+ ..+..+++|+.|
T Consensus 40 ~~L~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L 114 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIKSVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSL 114 (605)
T ss_dssp HHHTTCCCCBCTTCCCCCCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC--TTSTTCTTCCEE
T ss_pred hcCCCCCEEECcCCCCCCCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC--hhhccCCCCCEE
Confidence 34444444444444444332 34444445555555554444433 44555555555555555432 134555555555
Q ss_pred EcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccC
Q 038671 152 DFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLS 231 (707)
Q Consensus 152 ~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~ 231 (707)
+|++|.+++. ..+..+++|+.|+|++|.+++. ..+..+++|+.|+|++|.+++..+ +..+++|+.|+|++|.|+
T Consensus 115 ~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 115 SLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp ECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred EecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCC
Confidence 5555555532 2344555555555555555432 344555555555555555553333 455555555555555555
Q ss_pred CCCCccccCcccCceEeeecccccc
Q 038671 232 NSIPKSLGNLVKLHYLNLSNNQFIK 256 (707)
Q Consensus 232 ~~~~~~l~~l~~L~~L~l~~n~l~~ 256 (707)
+. ..+..+++|+.|+|++|++.+
T Consensus 189 ~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 189 DL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp BC--GGGTTCTTCSEEECCSEEEEC
T ss_pred CC--hHHccCCCCCEEEccCCcCcC
Confidence 33 234555555555555555543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=2.5e-19 Score=172.54 Aligned_cols=149 Identities=18% Similarity=0.273 Sum_probs=80.3
Q ss_pred eeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeeccccc
Q 038671 7 FLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQ 86 (707)
Q Consensus 7 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~ 86 (707)
.+++++++++ .+|..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|.
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 4556666666 4454443 456666666666665555556666666666666666665555556666666666666655
Q ss_pred ccccCCC-CCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCcc
Q 038671 87 LRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNI 158 (707)
Q Consensus 87 i~~~~~~-l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i 158 (707)
|+.+++. |.++++|+.|+|++|+++.+.+..|..+++|++|+|++|.++.+.+..|..+++|+.|+|++|.+
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 5554443 34455555555555555554444444455555555555554444444444444444444444443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.81 E-value=7.2e-21 Score=195.90 Aligned_cols=284 Identities=11% Similarity=0.078 Sum_probs=182.2
Q ss_pred CCCCCeEECCCCccccccCcCccC-CCCCcEEEcccCcCc--ccCCccccCCCCCCeeecccccccccCCCCCC------
Q 038671 26 LKSLSDLELSGNKLCGSIPHSLGN-LTQITFLTLFDNALS--GAIPKEYGNLVKLTLLTLENNQLRGPIPNLRN------ 96 (707)
Q Consensus 26 l~~L~~L~l~~n~i~~~~~~~~~~-l~~L~~L~L~~n~i~--~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~------ 96 (707)
+.+|+.|.++++- .......+.. +++|++|+|++|+|. ...... ++.++.+.+..|.|. ...|.+
T Consensus 24 ~~~l~~L~l~g~i-~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~I~--~~aF~~~~~~~~ 97 (329)
T 3sb4_A 24 ANSITHLTLTGKL-NAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANFVP--AYAFSNVVNGVT 97 (329)
T ss_dssp HHHCSEEEEEEEE-CHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTEEC--TTTTEEEETTEE
T ss_pred hCceeEEEEeccc-cHHHHHHHHHhhccCeEEecCcceeEEecCcccc---ccccccccccccccC--HHHhcccccccc
Confidence 4567777777642 2111123333 677888888888777 222222 223555566666443 234666
Q ss_pred --CCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCc----cCCCCchhhhCCC
Q 038671 97 --LTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNN----ITGSMPAEIIHSS 170 (707)
Q Consensus 97 --l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~----i~~~~~~~~~~~~ 170 (707)
+++|+.|+|.+ +++.+...+|..+++|+.|++++|.+..+.+.+|..+.++..+.+..+. ........|..+.
T Consensus 98 ~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~ 176 (329)
T 3sb4_A 98 KGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGE 176 (329)
T ss_dssp EECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESC
T ss_pred cccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccc
Confidence 78888888877 7777878888888888888888888877777888887777777666532 2223444555566
Q ss_pred CCC-EEeCCCCCCCCCCChhhh----CCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCc
Q 038671 171 QLK-VLDLSSNHIVGEMPSKLG----KLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLH 245 (707)
Q Consensus 171 ~L~-~L~l~~n~l~~~~~~~~~----~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~ 245 (707)
.|+ .+.+.... .++..+. ...++..+.+.++-...........+++|+.|+|++|.++.+.+.+|.++.+|+
T Consensus 177 ~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~ 253 (329)
T 3sb4_A 177 PLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLL 253 (329)
T ss_dssp CCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCC
T ss_pred ccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCC
Confidence 666 44443321 1111111 234555666655432211111112367788888888778777777788888888
Q ss_pred eEeeecccccccCchhhhhcccCC-eeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEee
Q 038671 246 YLNLSNNQFIKKIPVELEKLIHLS-ELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDI 321 (707)
Q Consensus 246 ~L~l~~n~l~~~~~~~~~~l~~L~-~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l 321 (707)
.|+|.+| +..+...+|.++.+|+ .+++.+ .++.+.+.+|.++++|+.+++++|.++.+.+..|..+++|+.++.
T Consensus 254 ~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 254 KIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 8888777 6677777788888888 888877 666677778888888888888888887777777888888877763
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.81 E-value=9.1e-21 Score=195.13 Aligned_cols=281 Identities=12% Similarity=0.088 Sum_probs=213.8
Q ss_pred CCCceeeccCCeeeecCCccccC-CCCCCeEECCCCccc--cccCcCccCCCCCcEEEcccCcCcccCCccccC------
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGR-LKSLSDLELSGNKLC--GSIPHSLGNLTQITFLTLFDNALSGAIPKEYGN------ 73 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~-l~~L~~L~l~~n~i~--~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~------ 73 (707)
.+++.|.++++ +.......+.. +++|+.|+|++|+|. ......+ +.+..+.+..|. +.+.+|.+
T Consensus 25 ~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~---I~~~aF~~~~~~~~ 97 (329)
T 3sb4_A 25 NSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANF---VPAYAFSNVVNGVT 97 (329)
T ss_dssp HHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTE---ECTTTTEEEETTEE
T ss_pred CceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---cccccccccccc---cCHHHhcccccccc
Confidence 45788888875 33222234445 889999999999998 3333333 335667777774 44678888
Q ss_pred --CCCCCeeecccccccccCC-CCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccc----cccCCCCCCCCC
Q 038671 74 --LVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYF----YGEISSDWGRCP 146 (707)
Q Consensus 74 --l~~L~~L~l~~n~i~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i----~~~~~~~~~~~~ 146 (707)
+++|+.|+|++ .++.+.+ +|.+|++|+.|++.+|.+..+...+|..+.++..+.+..+.. ..+...+|.++.
T Consensus 98 ~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~ 176 (329)
T 3sb4_A 98 KGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGE 176 (329)
T ss_dssp EECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESC
T ss_pred cccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccc
Confidence 99999999999 8887766 599999999999999999999999999999898888877433 345567788888
Q ss_pred CCc-EEEcCCCccCCCCchhhh----CCCCCCEEeCCCCCCCCCCChhh-hCCCCCcEEEecCCccccCCccccCCCCcc
Q 038671 147 KLG-TLDFSSNNITGSMPAEII----HSSQLKVLDLSSNHIVGEMPSKL-GKLSSLIKLILNSNQLCGQLSLELGSLTQL 220 (707)
Q Consensus 147 ~L~-~L~L~~n~i~~~~~~~~~----~~~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 220 (707)
.|+ .+.+.... ..+..+. ...++..+.+.++-.. .....+ ..+++|++|++++|+++.+...+|.++++|
T Consensus 177 ~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L 252 (329)
T 3sb4_A 177 PLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYL 252 (329)
T ss_dssp CCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTC
T ss_pred ccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCC
Confidence 888 66665432 1222221 2456777777765322 212222 237899999999999998888889999999
Q ss_pred cEEEccCCccCCCCCccccCcccCc-eEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEec
Q 038671 221 ERLDLSSNRLSNSIPKSLGNLVKLH-YLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNL 297 (707)
Q Consensus 221 ~~L~l~~n~i~~~~~~~l~~l~~L~-~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l 297 (707)
+.|+|++| ++.+.+.+|.++++|+ .|++.+ .++.+.+.+|.++++|+.|++++|.++...+.+|.++++|+.++.
T Consensus 253 ~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 253 LKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred CEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 99999988 7778888999999999 999988 777888889999999999999999998888889999999998864
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.5e-19 Score=188.43 Aligned_cols=136 Identities=29% Similarity=0.303 Sum_probs=63.7
Q ss_pred CCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEE
Q 038671 144 RCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERL 223 (707)
Q Consensus 144 ~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 223 (707)
.+++|++|+|++|.|+...+..|.++++|+.|+|++|+|+...+..|..+++|++|+|++|+|+...+..|..+++|+.|
T Consensus 62 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L 141 (361)
T 2xot_A 62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL 141 (361)
T ss_dssp CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred cccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence 33333333333333333333333344444444444444443333334444444444444444444444444455555555
Q ss_pred EccCCccCCCCCccc---cCcccCceEeeecccccccCchhhhhccc--CCeeeecCccCC
Q 038671 224 DLSSNRLSNSIPKSL---GNLVKLHYLNLSNNQFIKKIPVELEKLIH--LSELDLSHNFLG 279 (707)
Q Consensus 224 ~l~~n~i~~~~~~~l---~~l~~L~~L~l~~n~l~~~~~~~~~~l~~--L~~L~l~~n~l~ 279 (707)
+|++|.|+.+.+..| ..+++|+.|+|++|+|+...+..+..++. |+.|+|++|.+.
T Consensus 142 ~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 142 YLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp ECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred ECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 555555544333333 34555666666666665555555555554 356666666663
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=4.1e-19 Score=172.22 Aligned_cols=157 Identities=25% Similarity=0.305 Sum_probs=96.4
Q ss_pred CCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeec
Q 038671 172 LKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSN 251 (707)
Q Consensus 172 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~ 251 (707)
.+.++.+++.++ .+|..+. ++|++|++++|.+++..+..|..+++|++|+|++|.|+.+.+..|..+++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 344555555554 3333222 5566666666666655555566666666666666666555555566666666666666
Q ss_pred ccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCC
Q 038671 252 NQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIP 331 (707)
Q Consensus 252 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~ 331 (707)
|++++..+..|..+++|+.|+|++|.++ .+|..+..+++|+.|++++|+|++..+..+..+++|+.|++++|+|+|.++
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 6666555555666666666666666664 455566666677777777777666655666666777777777777777665
Q ss_pred C
Q 038671 332 N 332 (707)
Q Consensus 332 ~ 332 (707)
.
T Consensus 177 ~ 177 (229)
T 3e6j_A 177 D 177 (229)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.2e-18 Score=178.73 Aligned_cols=261 Identities=12% Similarity=0.104 Sum_probs=126.9
Q ss_pred CCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCC-CCCCCCCccEEEe
Q 038671 27 KSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRL 105 (707)
Q Consensus 27 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~l~~l~~L~~L~l 105 (707)
..++.+.+.++ ++.+...+|.+. +|+.+.+.++ ++.+...+|.+. +|+.+.+.+ .+..+.. +|.+|++|+.+++
T Consensus 113 ~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 45555555442 333445555553 4666665544 444555555553 456665554 3433332 3555555666665
Q ss_pred ccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCC
Q 038671 106 NQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGE 185 (707)
Q Consensus 106 ~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~ 185 (707)
.+|+++.++..+|. +.+|+.+.|..+ ++.+...+|.+|++|+.+.+..| ++.+...+|.+ .+|+.+.+. +.++.+
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I 262 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNI 262 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEE
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEE
Confidence 55555555555555 355555555533 44455555555555555555543 33344444444 455555552 233334
Q ss_pred CChhhhCCCCCcEEEecCCccc-----cCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCch
Q 038671 186 MPSKLGKLSSLIKLILNSNQLC-----GQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPV 260 (707)
Q Consensus 186 ~~~~~~~l~~L~~L~l~~n~l~-----~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~ 260 (707)
...+|..+++|+++.+.+|.+. ......|.++++|+.++|. +.++.+...+|.++.+|+.|.|.+| ++.+...
T Consensus 263 ~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~ 340 (401)
T 4fdw_A 263 ASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFS 340 (401)
T ss_dssp CTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTT
T ss_pred ChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHH
Confidence 4455555555555555554443 2333444444445544444 2244344444444444444444332 3334444
Q ss_pred hhhhcccCCeeeecCccCCCCCCccccccc-ccceEecccc
Q 038671 261 ELEKLIHLSELDLSHNFLGEEMPSQICNMQ-SLEKLNLSHN 300 (707)
Q Consensus 261 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~-~L~~L~l~~n 300 (707)
+|.++ +|+.+++++|.+.......|.+++ .+..|++..+
T Consensus 341 aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~ 380 (401)
T 4fdw_A 341 AFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAE 380 (401)
T ss_dssp SSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGG
T ss_pred hCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHH
Confidence 44444 444444444444333333444332 3344444433
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.4e-18 Score=178.55 Aligned_cols=264 Identities=11% Similarity=0.051 Sum_probs=226.7
Q ss_pred CCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeec
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTL 82 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 82 (707)
..++.+.+.++ ++.+...+|.+. +|+.+.+..+ ++.+...+|.+. +|+.+.+.+ .++.+...+|.++.+|+.+++
T Consensus 113 ~~l~~i~ip~~-i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPNS-VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCTT-CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECCc-cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 45677777664 555778889885 8999999877 776888899985 699999986 777788899999999999999
Q ss_pred ccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCC
Q 038671 83 ENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSM 162 (707)
Q Consensus 83 ~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~ 162 (707)
++|.++.++.....+.+|+.+.+.. .++.+...+|..+++|+.+++..| ++.+...+|.+ .+|+.+.|. +.++.+.
T Consensus 188 ~~n~l~~I~~~aF~~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~ 263 (401)
T 4fdw_A 188 SKTKITKLPASTFVYAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIA 263 (401)
T ss_dssp TTSCCSEECTTTTTTCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEEC
T ss_pred CCCcceEechhhEeecccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEC
Confidence 9999998887644479999999984 588899999999999999999986 67788899998 789999994 5577788
Q ss_pred chhhhCCCCCCEEeCCCCCCC-----CCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCcc
Q 038671 163 PAEIIHSSQLKVLDLSSNHIV-----GEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKS 237 (707)
Q Consensus 163 ~~~~~~~~~L~~L~l~~n~l~-----~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~ 237 (707)
..+|.++++|+.+++.+|.+. ......|..+++|+.+.+. +.++.....+|.++++|+.+.|..| ++.+...+
T Consensus 264 ~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~a 341 (401)
T 4fdw_A 264 SRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSA 341 (401)
T ss_dssp TTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTS
T ss_pred hhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHh
Confidence 999999999999999988765 4677899999999999999 5588788899999999999999665 77788899
Q ss_pred ccCcccCceEeeecccccccCchhhhhcc-cCCeeeecCccC
Q 038671 238 LGNLVKLHYLNLSNNQFIKKIPVELEKLI-HLSELDLSHNFL 278 (707)
Q Consensus 238 l~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l 278 (707)
|.++ +|+.|++++|.+.......|.+++ +++.|.+..+.+
T Consensus 342 F~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 342 FNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp SSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred CCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 9999 999999999998877778888884 788999888765
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=5.6e-20 Score=182.27 Aligned_cols=80 Identities=25% Similarity=0.363 Sum_probs=34.9
Q ss_pred CCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEc
Q 038671 146 PKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDL 225 (707)
Q Consensus 146 ~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 225 (707)
++|++|+|++|.+++. ..+..+++|+.|++++|++++. + .+..+++|++|++++|++++. ..+..+++|+.|++
T Consensus 106 ~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l 179 (263)
T 1xeu_A 106 ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL 179 (263)
T ss_dssp SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEE
T ss_pred CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeC
Confidence 4444444444444422 1244444444444444444422 1 344444444444444444432 33444444444444
Q ss_pred cCCccC
Q 038671 226 SSNRLS 231 (707)
Q Consensus 226 ~~n~i~ 231 (707)
++|.++
T Consensus 180 ~~N~~~ 185 (263)
T 1xeu_A 180 TGQKCV 185 (263)
T ss_dssp EEEEEE
T ss_pred CCCccc
Confidence 444444
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-18 Score=167.19 Aligned_cols=113 Identities=27% Similarity=0.326 Sum_probs=56.2
Q ss_pred CCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccE
Q 038671 143 GRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLER 222 (707)
Q Consensus 143 ~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 222 (707)
..+++|++|+|++|.+++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..+..|..+++|++
T Consensus 54 ~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 133 (220)
T 2v70_A 54 KKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRL 133 (220)
T ss_dssp GGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSE
T ss_pred ccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCE
Confidence 33344444444444444333333444444444444444444333444444445555555555555444455555555555
Q ss_pred EEccCCccCCCCCccccCcccCceEeeeccccc
Q 038671 223 LDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFI 255 (707)
Q Consensus 223 L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~ 255 (707)
|+|++|.+++..|..|..+++|+.|+|++|++.
T Consensus 134 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 134 LSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp EECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred EECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 555555555555555666666666666666654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-19 Score=179.39 Aligned_cols=171 Identities=22% Similarity=0.295 Sum_probs=111.3
Q ss_pred CCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEE
Q 038671 73 NLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLD 152 (707)
Q Consensus 73 ~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~ 152 (707)
++.++..+++++|.+++++ .+..+++|+.|++++|+++.+. .+..+++|++|+|++|.++++.+ +..+++|++|+
T Consensus 17 ~l~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 3445555666666665444 4555666666666666666543 45666666677777666665543 66677777777
Q ss_pred cCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCC
Q 038671 153 FSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSN 232 (707)
Q Consensus 153 L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~ 232 (707)
|++|.+++... +.. ++|+.|++++|++++. ..+..+++|++|++++|++++. + .+..+++|++|++++|.+++
T Consensus 92 L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 92 VNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred CCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence 77777764322 222 7788888888877643 3477777777777777777743 2 56677777777777777775
Q ss_pred CCCccccCcccCceEeeeccccccc
Q 038671 233 SIPKSLGNLVKLHYLNLSNNQFIKK 257 (707)
Q Consensus 233 ~~~~~l~~l~~L~~L~l~~n~l~~~ 257 (707)
. ..+..+++|+.|++++|++...
T Consensus 165 ~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEEEEECC
T ss_pred h--HHhccCCCCCEEeCCCCcccCC
Confidence 5 5567777777777777777554
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=6e-19 Score=174.27 Aligned_cols=139 Identities=18% Similarity=0.221 Sum_probs=108.1
Q ss_pred CCCCceeeecCCeeEEEEEc-CCCcE--EEEEecCCCCCc---------------------hhhhHHHHHHHHHHHhcCC
Q 038671 438 FDDEHCIGKGGQGSVYKAEL-PSGEI--VAVKKFHSPLPS---------------------EMASQQEFLNEVKTLTGIR 493 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~-~~~~~--vavK~~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~ 493 (707)
|++.+.||+|+||.||+|.. .+|+. ||||++...... .......+.+|++.+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999999976 78988 999987543211 0112246788999999998
Q ss_pred CCce--eeeeeeeecCCceeEEEeeecc-C----cHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHH-hCCCCCeEec
Q 038671 494 HRNI--VKFYGFCSHARHSFIVYEYLEM-G----SLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH-NDCFPPIVHR 565 (707)
Q Consensus 494 h~ni--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~ 565 (707)
|+++ +.++++ +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +. ||+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence 8754 444432 467899999943 3 77766421 235567889999999999999 88 99999
Q ss_pred CCCCCCeeecCCCCeEEeccccceec
Q 038671 566 DISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 566 dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
||||+|||++. .++|+|||+|...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999997 9999999999764
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=5.8e-18 Score=164.09 Aligned_cols=151 Identities=21% Similarity=0.197 Sum_probs=85.1
Q ss_pred cEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCC
Q 038671 101 VRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180 (707)
Q Consensus 101 ~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n 180 (707)
+.+++++++++.++... .++|++|+|++|.++.+.+..|..+++|++|+|++|.++...+..|..+++|+.|+|++|
T Consensus 22 ~~v~c~~~~l~~ip~~~---~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHASVPAGI---PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCSSCCSCC---CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcCccCCCC---CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 34444444444443321 145555555555555554555555555555555555555444444555555555555555
Q ss_pred CCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeeccccc
Q 038671 181 HIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFI 255 (707)
Q Consensus 181 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~ 255 (707)
+|++..+..|..+++|++|++++|+++ .+|..+..+++|++|+|++|.+++..+..|..+++|+.|+|++|++.
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 555444455555666666666666665 44555566666666666666666555556666666677777766664
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=2e-18 Score=163.25 Aligned_cols=152 Identities=18% Similarity=0.214 Sum_probs=75.5
Q ss_pred cCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEE
Q 038671 72 GNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTL 151 (707)
Q Consensus 72 ~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L 151 (707)
+.+++|++|++++|.+..++ ++..+++|++|++++|.++.+ ..+..+++|++|++++|.++...+..+..+++|++|
T Consensus 41 ~~l~~L~~L~l~~n~i~~l~-~l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 117 (197)
T 4ezg_A 41 AQMNSLTYITLANINVTDLT-GIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117 (197)
T ss_dssp HHHHTCCEEEEESSCCSCCT-TGGGCTTCSEEEEESCCCSCC--GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred hhcCCccEEeccCCCccChH-HHhcCCCCCEEEccCCCCCcc--hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence 34455555555555555433 455555555555555544432 245555555555555555555444555555555555
Q ss_pred EcCCCccCCCCchhhhCCCCCCEEeCCCCC-CCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCcc
Q 038671 152 DFSSNNITGSMPAEIIHSSQLKVLDLSSNH-IVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRL 230 (707)
Q Consensus 152 ~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i 230 (707)
++++|.+++..+..+..+++|+.|++++|. ++ .++ .+..+++|++|++++|.+++. + .+..+++|++|++++|+|
T Consensus 118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC--
T ss_pred EecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCccc
Confidence 555555554445555555555555555554 33 222 344444444444444444421 1 333444444444444443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=4.4e-21 Score=210.60 Aligned_cols=203 Identities=22% Similarity=0.195 Sum_probs=128.3
Q ss_pred cCCCCCcEEEcccCcCcccCCccccCCCCCCeeeccccc-------------ccc-cCCCCCCCCCccEEE-eccCcccc
Q 038671 48 GNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQ-------------LRG-PIPNLRNLTSLVRVR-LNQNHLTG 112 (707)
Q Consensus 48 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~-------------i~~-~~~~l~~l~~L~~L~-l~~n~l~~ 112 (707)
..+++|+.|+|++|.++ .+|..++++++|+.|++++|. ... .+..+..+++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 34556666666666665 446666666666666665543 111 111233444444444 3333322
Q ss_pred ccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhC
Q 038671 113 NISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGK 192 (707)
Q Consensus 113 ~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 192 (707)
+|+.+.+++|.++.+.+ ..|+.|+|++|.+++ .+. +..+++|+.|+|++|.|+ .+|..++.
T Consensus 424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhc
Confidence 23334444555543322 237777777777774 344 777777888888888777 66777778
Q ss_pred CCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCC-CccccCcccCceEeeecccccccCch---hhhhcccC
Q 038671 193 LSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSI-PKSLGNLVKLHYLNLSNNQFIKKIPV---ELEKLIHL 268 (707)
Q Consensus 193 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~-~~~l~~l~~L~~L~l~~n~l~~~~~~---~~~~l~~L 268 (707)
+++|+.|+|++|.+++ +| .+..+++|++|+|++|.|++.. |..|+.+++|+.|+|++|++++..+. .+..+++|
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L 562 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 562 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTC
T ss_pred CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCccc
Confidence 8888888888888875 45 6778888888888888888766 77888888888888888888766442 24457778
Q ss_pred Ceeee
Q 038671 269 SELDL 273 (707)
Q Consensus 269 ~~L~l 273 (707)
+.|++
T Consensus 563 ~~L~l 567 (567)
T 1dce_A 563 SSILT 567 (567)
T ss_dssp SEEEC
T ss_pred CccCC
Confidence 87764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=3.9e-18 Score=161.33 Aligned_cols=153 Identities=16% Similarity=0.275 Sum_probs=95.0
Q ss_pred hCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCce
Q 038671 167 IHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHY 246 (707)
Q Consensus 167 ~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~ 246 (707)
..+++|+.|++++|.++ .++ .+..+++|++|++++|.++ .+..+..+++|++|++++|.+++..+..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 34455666666666665 333 4556666666666666554 2235566666666666666666555666666677777
Q ss_pred EeeecccccccCchhhhhcccCCeeeecCcc-CCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCc
Q 038671 247 LNLSNNQFIKKIPVELEKLIHLSELDLSHNF-LGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNE 325 (707)
Q Consensus 247 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~ 325 (707)
|++++|++++..+..+..+++|++|++++|. ++. .+ .+..+++|+.|++++|++++.. .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~-~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-IM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCC-CG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCccc-cH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcc
Confidence 7777777666566666667777777777776 533 33 4666777777777777776542 56667777777777776
Q ss_pred cc
Q 038671 326 LH 327 (707)
Q Consensus 326 ~~ 327 (707)
+.
T Consensus 193 i~ 194 (197)
T 4ezg_A 193 IG 194 (197)
T ss_dssp --
T ss_pred cC
Confidence 64
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=8.5e-21 Score=208.32 Aligned_cols=188 Identities=23% Similarity=0.216 Sum_probs=113.9
Q ss_pred cCCCCCCeeecccccccccCCCCCCCCCccEEEeccCc-------------cccccCccccCCCCCcEEE-ccccccccc
Q 038671 72 GNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNH-------------LTGNISESFGIHPNLAFID-LSHNYFYGE 137 (707)
Q Consensus 72 ~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~-------------l~~~~~~~~~~~~~L~~L~-L~~n~i~~~ 137 (707)
..+++|+.|+|++|.++.++..+..+++|+.|++++|. ..+..+..++.+++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH--
T ss_pred ccCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc--
Confidence 45678888888888888777777888888888876654 2333344455555555555 4544432
Q ss_pred CCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCC
Q 038671 138 ISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSL 217 (707)
Q Consensus 138 ~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 217 (707)
+|+.+.+++|.++...+ ..|+.|+|++|.|++ +|. +..+++|+.|+|++|.|+ .+|..+..+
T Consensus 424 ---------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 485 (567)
T 1dce_A 424 ---------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAAL 485 (567)
T ss_dssp ---------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGC
T ss_pred ---------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcC
Confidence 23344445554442111 246667777777663 444 666666666666666666 455566666
Q ss_pred CcccEEEccCCccCCCCCccccCcccCceEeeecccccccC-chhhhhcccCCeeeecCccCCCC
Q 038671 218 TQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKI-PVELEKLIHLSELDLSHNFLGEE 281 (707)
Q Consensus 218 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~ 281 (707)
++|+.|+|++|.|++ +| .++++++|+.|+|++|+|++.. |..+..+++|+.|+|++|.+++.
T Consensus 486 ~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 486 RCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp TTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred CCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence 666666666666664 33 5666666666666666665554 55566666666666666666443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=3.4e-18 Score=160.84 Aligned_cols=173 Identities=23% Similarity=0.294 Sum_probs=109.5
Q ss_pred CEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCcc-ccCCCCcccEEEccCCccCCCCCccccCcccCceEeeec
Q 038671 173 KVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSL-ELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSN 251 (707)
Q Consensus 173 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~ 251 (707)
+.+++++|.++ .+|..+.. +|++|++++|.+++..+. .+..+++|++|+|++|.|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 67788888776 55554432 777777777777755543 367777777777777777777777777777777777777
Q ss_pred ccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCC
Q 038671 252 NQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIP 331 (707)
Q Consensus 252 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~ 331 (707)
|+|++..+..|.++++|+.|+|++|.+++..|..+..+++|+.|++++|++.+..+-.+- ...++...+.++...|.-|
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~-~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWF-AEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHH-HHHHHHHCCSGGGCBBCSS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHH-HHHHHHcCCCCCCCCCCCC
Confidence 777777666677777777777777777766677777777777777777777655432110 1122333344444444433
Q ss_pred CccccccCchhhcccCcCcC
Q 038671 332 NSTAFRDAPMEALQGNKGLC 351 (707)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~c 351 (707)
. .+++.....+..+...|
T Consensus 167 ~--~l~~~~l~~l~~~~~~C 184 (192)
T 1w8a_A 167 S--KVRDVQIKDLPHSEFKC 184 (192)
T ss_dssp T--TTTTSBGGGSCTTTCCC
T ss_pred h--HHcCCChhhCcHhhcCc
Confidence 2 23334444444444444
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.72 E-value=2.5e-17 Score=154.83 Aligned_cols=133 Identities=24% Similarity=0.326 Sum_probs=84.5
Q ss_pred cEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCc-cccCcccCceEeeecccccccCchhhhhcccCCeeeecC
Q 038671 197 IKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPK-SLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSH 275 (707)
Q Consensus 197 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 275 (707)
+.|++++|.++ .+|..+. .+|++|++++|.+++..+. .|..+++|++|+|++|++++..+..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56666666665 3343332 2666666666666655443 366666666666666666666666666666666666666
Q ss_pred ccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCC
Q 038671 276 NFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332 (707)
Q Consensus 276 n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~ 332 (707)
|.|++..+..|..+++|+.|++++|+|++..|..+..+++|+.|++++|+|+|.++.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 666666666666666666666666666666666666666666666666666666553
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=155.55 Aligned_cols=130 Identities=26% Similarity=0.294 Sum_probs=77.1
Q ss_pred EEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCcc
Q 038671 198 KLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNF 277 (707)
Q Consensus 198 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 277 (707)
.+++++|.++ .+|..+ .++|++|+|++|.|+ .+|..|.++++|+.|+|++|.|++..+..|.++++|++|+|++|.
T Consensus 14 ~l~~~~~~l~-~ip~~~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGI--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCS-SCCSCC--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCC-cCCCCC--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 4444444444 222222 135555555555555 334555566666666666666655555556666666666666666
Q ss_pred CCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCC
Q 038671 278 LGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIP 331 (707)
Q Consensus 278 l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~ 331 (707)
|++..+..|..+++|+.|++++|+|+...+..|..+++|+.|++++|+|.|.+.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~ 143 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence 665555566666666666666666665555556667777777777777777664
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.4e-16 Score=164.34 Aligned_cols=297 Identities=12% Similarity=0.081 Sum_probs=187.7
Q ss_pred eeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCC
Q 038671 14 SFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN 93 (707)
Q Consensus 14 ~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~ 93 (707)
.++.+...+|.++.+|+.+.|.. .++.+...+|.++++|+.++|.++ ++.+...+|.++.+|+.+.+..+-..-...+
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~a 135 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEA 135 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTT
T ss_pred eEeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeeccee
Confidence 57778888899999999999974 477677788999999999999755 6667788899998888887765422211122
Q ss_pred ----------------------CCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEE
Q 038671 94 ----------------------LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTL 151 (707)
Q Consensus 94 ----------------------l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L 151 (707)
|.++++|+.+.+.++ +..+...+|..+.+|+.+++..+ ++.+...+|.+++.|+.+
T Consensus 136 F~~~~~~~~~~~~~~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i 213 (394)
T 4fs7_A 136 FKGCDFKEITIPEGVTVIGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENM 213 (394)
T ss_dssp TTTCCCSEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBC
T ss_pred eecccccccccCccccccchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhcccccccee
Confidence 444555555555432 23344445555555555555444 333444455555555555
Q ss_pred EcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccC
Q 038671 152 DFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLS 231 (707)
Q Consensus 152 ~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~ 231 (707)
.+..+... .........+|+.+.+..+. +......|..+..|+.+.+..+... .....|..+..++.+....+.+.
T Consensus 214 ~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~ 289 (394)
T 4fs7_A 214 EFPNSLYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP 289 (394)
T ss_dssp CCCTTCCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC
T ss_pred ecCCCceE--eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec
Confidence 54443322 11122223455555554332 2234455666666666666665443 55556666667776666555432
Q ss_pred CCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhc
Q 038671 232 NSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFE 311 (707)
Q Consensus 232 ~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~ 311 (707)
...|..+.+|+.+.+.++ +..+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+.+..| ++.+...+|.
T Consensus 290 ---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~ 363 (394)
T 4fs7_A 290 ---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQ 363 (394)
T ss_dssp ---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBT
T ss_pred ---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhh
Confidence 345677778888887655 55666777888888888888654 65666777888888888888766 6656667788
Q ss_pred cCCCceeEeeccC
Q 038671 312 ELHGLSYIDISYN 324 (707)
Q Consensus 312 ~~~~L~~l~l~~n 324 (707)
.+.+|+.+++..+
T Consensus 364 ~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 364 GCINLKKVELPKR 376 (394)
T ss_dssp TCTTCCEEEEEGG
T ss_pred CCCCCCEEEECCC
Confidence 8888888877644
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.2e-17 Score=189.19 Aligned_cols=189 Identities=25% Similarity=0.277 Sum_probs=111.8
Q ss_pred EcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccc
Q 038671 128 DLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLC 207 (707)
Q Consensus 128 ~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 207 (707)
+++.|.+. +.+..|..+++|+.|+|++|.+. .++..+..+++|+.|+|++|.|+ .+|..|..+++|+.|+|++|.|+
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 33444444 55667788888888888888887 45555668888888888888888 77888888888888888888888
Q ss_pred cCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhccc-CCeeeecCccCCCCCCccc
Q 038671 208 GQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIH-LSELDLSHNFLGEEMPSQI 286 (707)
Q Consensus 208 ~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~-L~~L~l~~n~l~~~~~~~~ 286 (707)
.+|..|..+++|++|+|++|.|+ .+|..|+++++|+.|+|++|++++..+..+..+.. +..|+|++|.+++..|..
T Consensus 284 -~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~- 360 (727)
T 4b8c_D 284 -SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE- 360 (727)
T ss_dssp -SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred -ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc-
Confidence 66888888888888888888887 55667888888999999999888877777755432 234788888887766654
Q ss_pred ccccccceEecccc--------ccCCchhHhhccCCCceeEeeccCccc
Q 038671 287 CNMQSLEKLNLSHN--------NLSGFIPSCFEELHGLSYIDISYNELH 327 (707)
Q Consensus 287 ~~~~~L~~L~l~~n--------~i~~~~~~~~~~~~~L~~l~l~~n~~~ 327 (707)
|..|++++| .+.+..+..+..+..+....+++|-+.
T Consensus 361 -----l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 361 -----RRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp ----------------------------------------------CCC
T ss_pred -----cceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 445566666 333333334445555566666666654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=4e-17 Score=150.13 Aligned_cols=131 Identities=23% Similarity=0.246 Sum_probs=65.9
Q ss_pred CCCCeEECCCCccc-cccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCC-CCCCCCccEEE
Q 038671 27 KSLSDLELSGNKLC-GSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVR 104 (707)
Q Consensus 27 ~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~-l~~l~~L~~L~ 104 (707)
++|++|++++|+++ +.+|..+.++++|++|+|++|.+++. ..|..+++|++|++++|.+....+. +..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 44555555555554 33444445555555555555555433 4455555555555555555542222 23355555555
Q ss_pred eccCccccccC-ccccCCCCCcEEEcccccccccCC---CCCCCCCCCcEEEcCCCccC
Q 038671 105 LNQNHLTGNIS-ESFGIHPNLAFIDLSHNYFYGEIS---SDWGRCPKLGTLDFSSNNIT 159 (707)
Q Consensus 105 l~~n~l~~~~~-~~~~~~~~L~~L~L~~n~i~~~~~---~~~~~~~~L~~L~L~~n~i~ 159 (707)
+++|+++.+.. ..+..+++|++|++++|.++...+ ..+..+++|++|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 55555554432 445555555555555555554433 34555555555555555554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.5e-17 Score=169.70 Aligned_cols=143 Identities=12% Similarity=0.140 Sum_probs=101.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCc------h-----hhhHH--------HHHHHHHHHhcCCCCc
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPS------E-----MASQQ--------EFLNEVKTLTGIRHRN 496 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~------~-----~~~~~--------~~~~e~~~l~~l~h~n 496 (707)
.=|++.++||+|++|.||+|..++|+.||||+++..... . ..... ...+|...+.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 348999999999999999999889999999987532110 0 00001 1234566666664443
Q ss_pred eeeeeeeeecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC
Q 038671 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL 576 (707)
Q Consensus 497 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~ 576 (707)
+....-+.. ...++||||++|+++..+.. ......++.|++.+|.+||+. |||||||||.|||+++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 322111111 23479999999998865431 223457889999999999999 9999999999999987
Q ss_pred CCC----------eEEeccccceecC
Q 038671 577 ENE----------AHVSDFGTAKFLK 592 (707)
Q Consensus 577 ~~~----------~kl~Dfg~~~~~~ 592 (707)
+|. +.|+||+.+....
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCcccccccccceEEEEeCCcccCC
Confidence 763 8999999987644
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.68 E-value=7e-18 Score=191.17 Aligned_cols=181 Identities=23% Similarity=0.243 Sum_probs=83.5
Q ss_pred cCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCC
Q 038671 66 AIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRC 145 (707)
Q Consensus 66 ~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~ 145 (707)
..+..|..+++|+.|+|++|.+..++..+..+++|++|+|++|.|+.+ +..|+.+++|++|+|++|.|+ ..+..|..+
T Consensus 215 ~~~~~~~~l~~L~~L~Ls~n~l~~l~~~~~~l~~L~~L~Ls~N~l~~l-p~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 292 (727)
T 4b8c_D 215 MPKDSKYDDQLWHALDLSNLQIFNISANIFKYDFLTRLYLNGNSLTEL-PAEIKNLSNLRVLDLSHNRLT-SLPAELGSC 292 (727)
T ss_dssp -------CCCCCCEEECTTSCCSCCCGGGGGCCSCSCCBCTTSCCSCC-CGGGGGGTTCCEEECTTSCCS-SCCSSGGGG
T ss_pred cChhhhccCCCCcEEECCCCCCCCCChhhcCCCCCCEEEeeCCcCccc-ChhhhCCCCCCEEeCcCCcCC-ccChhhcCC
Confidence 345555666666666666666665555555566666666666666633 345566666666666666666 335556666
Q ss_pred CCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCC-CCcEEEecCCccccCCccccCCCCcccEEE
Q 038671 146 PKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLS-SLIKLILNSNQLCGQLSLELGSLTQLERLD 224 (707)
Q Consensus 146 ~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 224 (707)
++|++|+|++|.++ .++..|..+++|+.|+|++|.|++.+|..+..+. .+..|+|++|.+++..|. .|+.|+
T Consensus 293 ~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~ 365 (727)
T 4b8c_D 293 FQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIE 365 (727)
T ss_dssp TTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C-----
T ss_pred CCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeE
Confidence 66666666666665 4455566666666666666666666665554432 122356667776654443 344555
Q ss_pred ccCC--------ccCCCCCccccCcccCceEeeeccccc
Q 038671 225 LSSN--------RLSNSIPKSLGNLVKLHYLNLSNNQFI 255 (707)
Q Consensus 225 l~~n--------~i~~~~~~~l~~l~~L~~L~l~~n~l~ 255 (707)
++.| .+.+..+..+.++.++....+++|-+.
T Consensus 366 l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 366 INTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp ------------------------------------CCC
T ss_pred eecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 5555 333333444455556666677777654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.66 E-value=2.9e-16 Score=144.26 Aligned_cols=134 Identities=23% Similarity=0.218 Sum_probs=90.6
Q ss_pred CCCCCcEEEcccCcCc-ccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEE
Q 038671 49 NLTQITFLTLFDNALS-GAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFI 127 (707)
Q Consensus 49 ~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L 127 (707)
..++|++|++++|.++ +.+|..+..+++|++|++++|.++.+ ..+..+++|++|++++|+++...+..+..+++|++|
T Consensus 22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 3467888888888877 45666777778888888888877766 667777777777777777776555556667777777
Q ss_pred EcccccccccCC-CCCCCCCCCcEEEcCCCccCCCCc---hhhhCCCCCCEEeCCCCCCC
Q 038671 128 DLSHNYFYGEIS-SDWGRCPKLGTLDFSSNNITGSMP---AEIIHSSQLKVLDLSSNHIV 183 (707)
Q Consensus 128 ~L~~n~i~~~~~-~~~~~~~~L~~L~L~~n~i~~~~~---~~~~~~~~L~~L~l~~n~l~ 183 (707)
+|++|.++.+.. ..+..+++|+.|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 777777765432 456666666666666666664443 35555666666666666554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.1e-16 Score=143.84 Aligned_cols=126 Identities=24% Similarity=0.280 Sum_probs=68.2
Q ss_pred CCCceeeccCCeee-ecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeee
Q 038671 3 SNLAFLYLYNNSFS-GSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLT 81 (707)
Q Consensus 3 ~~l~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 81 (707)
++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+.++++|++|+|++|.+++.+|..++.+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 34556666666665 45555555566666666666665533 4455556666666666666544555555555555555
Q ss_pred cccccccccC--CCCCCCCCccEEEeccCccccccC---ccccCCCCCcEEEcc
Q 038671 82 LENNQLRGPI--PNLRNLTSLVRVRLNQNHLTGNIS---ESFGIHPNLAFIDLS 130 (707)
Q Consensus 82 l~~n~i~~~~--~~l~~l~~L~~L~l~~n~l~~~~~---~~~~~~~~L~~L~L~ 130 (707)
+++|.++.++ ..+..+++|++|++++|++++.++ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 5555555432 334555555555555555554443 344444555554443
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-15 Score=143.41 Aligned_cols=126 Identities=24% Similarity=0.299 Sum_probs=81.4
Q ss_pred CeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCC-CCCCCCCccEEEeccC
Q 038671 30 SDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLVRVRLNQN 108 (707)
Q Consensus 30 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~l~~l~~L~~L~l~~n 108 (707)
+.+++++|+++ .+|..+. ++|++|+|++|.|+ .+|..|.++++|++|+|++|.|+.+++ .|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45566666665 4444332 45666666666665 444566666666666666666665554 3666666666666666
Q ss_pred ccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccC
Q 038671 109 HLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNIT 159 (707)
Q Consensus 109 ~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~ 159 (707)
+++.+.+..|..+++|++|+|++|.++.+.+..|..+++|+.|+|++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 666666666777777777777777777666666777777777777777765
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.64 E-value=9.3e-15 Score=154.13 Aligned_cols=304 Identities=11% Similarity=0.042 Sum_probs=242.5
Q ss_pred CCCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccC-------------------
Q 038671 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDN------------------- 61 (707)
Q Consensus 1 nl~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n------------------- 61 (707)
++++|+.+.|..+ ++.+...+|.++++|+.++|..+ ++.+...+|.++++|+.+.+..+
T Consensus 69 ~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~~~~~~ 146 (394)
T 4fs7_A 69 GCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDFKEITI 146 (394)
T ss_dssp TCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCCSEEEC
T ss_pred CCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeeccccccccc
Confidence 4678999999854 77788889999999999999865 66567778888888887766432
Q ss_pred --cCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCC
Q 038671 62 --ALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEIS 139 (707)
Q Consensus 62 --~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~ 139 (707)
.+......+|.++.+|+.+.+.++...-....|.++.+|+.+.+..+ ++.+...+|..+..|+.+.+..+... +.
T Consensus 147 ~~~~~~i~~~aF~~c~~L~~i~l~~~~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~-i~- 223 (394)
T 4fs7_A 147 PEGVTVIGDEAFATCESLEYVSLPDSMETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY-LG- 223 (394)
T ss_dssp CTTCCEECTTTTTTCTTCCEEECCTTCCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE-EC-
T ss_pred CccccccchhhhcccCCCcEEecCCccceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE-ee-
Confidence 22223456788899999999987654423346999999999999876 77788999999999999999887654 33
Q ss_pred CCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCc
Q 038671 140 SDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQ 219 (707)
Q Consensus 140 ~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 219 (707)
..+....+|+.+.+..+ ++.+....+..+..|+.+.+..+... .....|..+..++.+....+.+. ...|..+.+
T Consensus 224 ~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~ 298 (394)
T 4fs7_A 224 DFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSS 298 (394)
T ss_dssp TTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTT
T ss_pred hhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---ccccccccc
Confidence 34455678999999755 44467788899999999999988655 77788999999999998877654 456889999
Q ss_pred ccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccc
Q 038671 220 LERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSH 299 (707)
Q Consensus 220 L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~ 299 (707)
|+.+.+..+ ++.+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+++..| ++.+...+|.++.+|+.+++..
T Consensus 299 L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~ 375 (394)
T 4fs7_A 299 LTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPK 375 (394)
T ss_dssp CCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEG
T ss_pred ccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECC
Confidence 999999765 66677889999999999999755 77788899999999999999877 7677888999999999999976
Q ss_pred cccCCchhHhhccCCCceeE
Q 038671 300 NNLSGFIPSCFEELHGLSYI 319 (707)
Q Consensus 300 n~i~~~~~~~~~~~~~L~~l 319 (707)
+ +. .....|..+.+|+.+
T Consensus 376 ~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 376 R-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp G-GG-GGGGGBCTTCEEEEE
T ss_pred C-CE-EhhheecCCCCCcEE
Confidence 6 33 234567777877765
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.9e-14 Score=151.69 Aligned_cols=301 Identities=12% Similarity=0.115 Sum_probs=199.2
Q ss_pred eeeecCCccccCCC-CCCeEECCCCccccccCcCccCCCCCcEEEcccCc---CcccCCccccCCCCCCeeecccccccc
Q 038671 14 SFSGSIPSEIGRLK-SLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA---LSGAIPKEYGNLVKLTLLTLENNQLRG 89 (707)
Q Consensus 14 ~i~~~~~~~~~~l~-~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~---i~~~~~~~~~~l~~L~~L~l~~n~i~~ 89 (707)
.++.+...+|.+++ .|+.+.|..+ ++.+...+|.++++|+.+.+..|. ++.+...+|.++.+|+.+.+.++ +..
T Consensus 50 ~Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~ 127 (394)
T 4gt6_A 50 PVSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE 127 (394)
T ss_dssp EEEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE
T ss_pred eeeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce
Confidence 35666677888774 5999999764 666788899999999999998764 77677888999999999888766 333
Q ss_pred cC-CCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhC
Q 038671 90 PI-PNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIH 168 (707)
Q Consensus 90 ~~-~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~ 168 (707)
+. ..|..+.+|+.+.+.. .+..+...+|..+.+|+.+.+..+ ++.+...+|.. .+|+.+.+..+-.. ....+|..
T Consensus 128 I~~~aF~~c~~L~~i~lp~-~~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~ 203 (394)
T 4gt6_A 128 IDSEAFHHCEELDTVTIPE-GVTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSE 203 (394)
T ss_dssp ECTTTTTTCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTT
T ss_pred ehhhhhhhhcccccccccc-eeeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhh
Confidence 33 3588899999999964 456688888999999999998765 55577777764 57888888765433 66677777
Q ss_pred CCCCCEEeCCCCCCCCCCChhh--------------hCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCC
Q 038671 169 SSQLKVLDLSSNHIVGEMPSKL--------------GKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSI 234 (707)
Q Consensus 169 ~~~L~~L~l~~n~l~~~~~~~~--------------~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~ 234 (707)
+..++......+.... ....+ .....+..+.+. +.++.....+|..+.+|+.+.+..+... +.
T Consensus 204 c~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~ 280 (394)
T 4gt6_A 204 CFALSTITSDSESYPA-IDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IG 280 (394)
T ss_dssp CTTCCEEEECCSSSCB-SSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-EC
T ss_pred ccccceeccccccccc-ccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ec
Confidence 7777777666554331 11111 111223333332 2233344556666677777766544332 55
Q ss_pred CccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCC
Q 038671 235 PKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELH 314 (707)
Q Consensus 235 ~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~ 314 (707)
..+|.++++|+.+.+. +.++.+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+.+..+ ++.+....|..+.
T Consensus 281 ~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~ 357 (394)
T 4gt6_A 281 TGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCT 357 (394)
T ss_dssp TTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCT
T ss_pred CcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCC
Confidence 5666666677777664 3345555666666777777776543 44555566666777777776543 5545556666677
Q ss_pred CceeEeeccCcc
Q 038671 315 GLSYIDISYNEL 326 (707)
Q Consensus 315 ~L~~l~l~~n~~ 326 (707)
+|+.+++.+|..
T Consensus 358 ~L~~i~~~~~~~ 369 (394)
T 4gt6_A 358 ALNNIEYSGSRS 369 (394)
T ss_dssp TCCEEEESSCHH
T ss_pred CCCEEEECCcee
Confidence 777777666543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-15 Score=141.99 Aligned_cols=113 Identities=28% Similarity=0.298 Sum_probs=55.9
Q ss_pred cccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEecc
Q 038671 219 QLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLS 298 (707)
Q Consensus 219 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~ 298 (707)
+|+.|++++|.+++..+..|.++++|++|++++|.+++..+..|..+++|+.|++++|.+++..+..+..+++|+.|+++
T Consensus 29 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 108 (177)
T 2o6r_A 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALD 108 (177)
T ss_dssp TCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECc
Confidence 44444444444444433444444444444444444444444444445555555555555544444444555555555555
Q ss_pred ccccCCchhHhhccCCCceeEeeccCcccccCC
Q 038671 299 HNNLSGFIPSCFEELHGLSYIDISYNELHGSIP 331 (707)
Q Consensus 299 ~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~ 331 (707)
+|++++..+..+..+++|+.|++++|+|.|.++
T Consensus 109 ~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 109 TNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 555554444444555555555555555555544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1e-15 Score=137.49 Aligned_cols=127 Identities=26% Similarity=0.325 Sum_probs=78.0
Q ss_pred CCCcEEEecCCccc-cCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeee
Q 038671 194 SSLIKLILNSNQLC-GQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELD 272 (707)
Q Consensus 194 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 272 (707)
++|++|++++|.++ +..+..+..+++|++|++++|.+++. ..++.+++|++|++++|.+++..+..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45555555555555 34444555566666666666666544 4556666666666666666555555566666666666
Q ss_pred ecCccCCCC-CCcccccccccceEeccccccCCchh---HhhccCCCceeEeec
Q 038671 273 LSHNFLGEE-MPSQICNMQSLEKLNLSHNNLSGFIP---SCFEELHGLSYIDIS 322 (707)
Q Consensus 273 l~~n~l~~~-~~~~~~~~~~L~~L~l~~n~i~~~~~---~~~~~~~~L~~l~l~ 322 (707)
+++|.+++. .+..+..+++|+.|++++|++++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 666666542 23556666777777777777765544 456667777777665
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.61 E-value=7.5e-16 Score=142.63 Aligned_cols=133 Identities=20% Similarity=0.252 Sum_probs=80.5
Q ss_pred ccCCCCCCeEECCCCccccccCcCccCCC-CCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCC-CCCCCc
Q 038671 23 IGRLKSLSDLELSGNKLCGSIPHSLGNLT-QITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNL-RNLTSL 100 (707)
Q Consensus 23 ~~~l~~L~~L~l~~n~i~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l-~~l~~L 100 (707)
+..+.+|++|++++|+++ .++. +..+. +|++|+|++|.|++. ..|+.+++|++|++++|.++.+++.+ ..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 445566666666666666 3333 33333 666666666666644 45666666666666666666655443 566666
Q ss_pred cEEEeccCccccccC-ccccCCCCCcEEEcccccccccCCC---CCCCCCCCcEEEcCCCccC
Q 038671 101 VRVRLNQNHLTGNIS-ESFGIHPNLAFIDLSHNYFYGEISS---DWGRCPKLGTLDFSSNNIT 159 (707)
Q Consensus 101 ~~L~l~~n~l~~~~~-~~~~~~~~L~~L~L~~n~i~~~~~~---~~~~~~~L~~L~L~~n~i~ 159 (707)
++|++++|+++.++. ..+..+++|+.|++++|.++.+... .+..+++|+.|++++|.+.
T Consensus 91 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 666666666655443 3566666777777777766644322 3566677777777766654
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=5.4e-15 Score=137.03 Aligned_cols=133 Identities=28% Similarity=0.282 Sum_probs=97.5
Q ss_pred CCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeec
Q 038671 172 LKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSN 251 (707)
Q Consensus 172 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~ 251 (707)
.+.+++++|.++ .+|..+ .++|++|++++|++++..+..+..+++|++|++++|.+++..+..|.++++|++|++++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 355666666665 333322 25677777777777766666677777788888888887766666777788888888888
Q ss_pred ccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchh
Q 038671 252 NQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIP 307 (707)
Q Consensus 252 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~ 307 (707)
|.+++..+..+..+++|+.|++++|.+++..+..+..+++|+.|++++|++.+..+
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 88877766677788888888888888876666667778888888888888887654
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.59 E-value=5.3e-14 Score=148.35 Aligned_cols=311 Identities=11% Similarity=0.108 Sum_probs=236.6
Q ss_pred CCceeeccCCeeeecCCccccCCCCCCeEECCCCc---cccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCee
Q 038671 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNK---LCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLL 80 (707)
Q Consensus 4 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~---i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L 80 (707)
.|+.+.|..+ ++.+...+|.++.+|+.+.+..|. ++.+...+|.++.+|+.+.+.++ ++.+...+|..+.+|+.+
T Consensus 65 ~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i 142 (394)
T 4gt6_A 65 VLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTV 142 (394)
T ss_dssp CCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEE
T ss_pred cCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccc
Confidence 4899999875 777889999999999999998763 77677889999999999988765 555778899999999999
Q ss_pred ecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCC
Q 038671 81 TLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITG 160 (707)
Q Consensus 81 ~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~ 160 (707)
.+..+...-....+..+.+|+.+.+..+ ++.+...+|.. .+|+.+.+..+... +...+|..+.++.......+....
T Consensus 143 ~lp~~~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~ 219 (394)
T 4gt6_A 143 TIPEGVTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPA 219 (394)
T ss_dssp ECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCB
T ss_pred cccceeeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceeccccccccc
Confidence 9986544423346899999999999764 77788888865 67999999876544 778899999999999887766542
Q ss_pred CCchhhh-------------CCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccC
Q 038671 161 SMPAEII-------------HSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSS 227 (707)
Q Consensus 161 ~~~~~~~-------------~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 227 (707)
.....+. ....+..+.+.. .+......+|..+..|+.+.+..+... ....+|.++++|+.+.+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~- 296 (394)
T 4gt6_A 220 IDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS- 296 (394)
T ss_dssp SSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-
T ss_pred ccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-
Confidence 2221111 223445555543 334456678899999999999876654 777889999999999996
Q ss_pred CccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchh
Q 038671 228 NRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIP 307 (707)
Q Consensus 228 n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~ 307 (707)
+.++.+...+|.++.+|+.+.|.++ ++.+...+|.++.+|+++.|.++ ++.+...+|.++.+|+.+++.+|... -
T Consensus 297 ~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~---~ 371 (394)
T 4gt6_A 297 SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ---W 371 (394)
T ss_dssp TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH---H
T ss_pred CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee---h
Confidence 5666677889999999999999865 66778889999999999999765 66777889999999999999998653 2
Q ss_pred HhhccCCCceeEeeccCccc
Q 038671 308 SCFEELHGLSYIDISYNELH 327 (707)
Q Consensus 308 ~~~~~~~~L~~l~l~~n~~~ 327 (707)
..+....+|+.+.+..|.++
T Consensus 372 ~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 372 NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp HTCBCCCCC-----------
T ss_pred hhhhccCCCCEEEeCCCCEE
Confidence 56677788999888776543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=3.7e-15 Score=137.91 Aligned_cols=106 Identities=25% Similarity=0.268 Sum_probs=52.0
Q ss_pred CCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCcc--ccCCCCcccEEE
Q 038671 147 KLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSL--ELGSLTQLERLD 224 (707)
Q Consensus 147 ~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~--~~~~l~~L~~L~ 224 (707)
+|++|+|++|.+++. ..+..+++|++|++++|.|++..+..|..+++|++|++++|.++. .+. .+..+++|+.|+
T Consensus 43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~ 119 (176)
T 1a9n_A 43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLC 119 (176)
T ss_dssp CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEE
T ss_pred CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCc-chhhHhhhcCCCCCEEE
Confidence 344444444443322 233344444444444444443333333445555555555555542 222 455566666666
Q ss_pred ccCCccCCCCCc---cccCcccCceEeeeccccc
Q 038671 225 LSSNRLSNSIPK---SLGNLVKLHYLNLSNNQFI 255 (707)
Q Consensus 225 l~~n~i~~~~~~---~l~~l~~L~~L~l~~n~l~ 255 (707)
+++|.++..... .+..+++|+.|++++|.+.
T Consensus 120 l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 120 ILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred ecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 666666533221 3666677777777777654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=4.1e-17 Score=154.42 Aligned_cols=151 Identities=21% Similarity=0.199 Sum_probs=81.5
Q ss_pred CCCCeEECCCCccccccCc------CccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCc
Q 038671 27 KSLSDLELSGNKLCGSIPH------SLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSL 100 (707)
Q Consensus 27 ~~L~~L~l~~n~i~~~~~~------~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L 100 (707)
..++.++++.+.+.+..|. .|.++++|++|+|++|.+++ +| .+..+++|++|++++|.++.++..+..+++|
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L 95 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTL 95 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHC
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcC
Confidence 3444444444444433333 45555555555555555553 33 5555555555555555555444434444556
Q ss_pred cEEEeccCccccccCccccCCCCCcEEEcccccccccCC-CCCCCCCCCcEEEcCCCccCCCCch----------hhhCC
Q 038671 101 VRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEIS-SDWGRCPKLGTLDFSSNNITGSMPA----------EIIHS 169 (707)
Q Consensus 101 ~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~-~~~~~~~~L~~L~L~~n~i~~~~~~----------~~~~~ 169 (707)
++|++++|++++++ .+..+++|++|++++|.++.+.. ..+..+++|++|++++|.+++..+. .+..+
T Consensus 96 ~~L~L~~N~l~~l~--~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l 173 (198)
T 1ds9_A 96 EELWISYNQIASLS--GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRL 173 (198)
T ss_dssp SEEEEEEEECCCHH--HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHC
T ss_pred CEEECcCCcCCcCC--ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhC
Confidence 66666666555543 35555666666666666654322 3455666666666666666533222 35667
Q ss_pred CCCCEEeCCCCCCC
Q 038671 170 SQLKVLDLSSNHIV 183 (707)
Q Consensus 170 ~~L~~L~l~~n~l~ 183 (707)
++|+.|+ +|.++
T Consensus 174 ~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 174 PNLKKLD--GMPVD 185 (198)
T ss_dssp SSCSEEC--CGGGT
T ss_pred CCcEEEC--CcccC
Confidence 7777775 55554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.55 E-value=1.8e-16 Score=149.91 Aligned_cols=152 Identities=23% Similarity=0.263 Sum_probs=104.0
Q ss_pred CCCCCEEeCCCCCCCCCCCh------hhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcc
Q 038671 169 SSQLKVLDLSSNHIVGEMPS------KLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLV 242 (707)
Q Consensus 169 ~~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~ 242 (707)
...++.++++.+.+.+..|. .+..+++|++|++++|.+++ .+ .+..+++|++|++++|.++ .+|..+..++
T Consensus 17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~ 93 (198)
T 1ds9_A 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD 93 (198)
T ss_dssp TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence 34445555555555444443 67777777777777777774 44 6677777778888777777 4555666677
Q ss_pred cCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCC-cccccccccceEeccccccCCchhH----------hhc
Q 038671 243 KLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMP-SQICNMQSLEKLNLSHNNLSGFIPS----------CFE 311 (707)
Q Consensus 243 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~l~~n~i~~~~~~----------~~~ 311 (707)
+|++|++++|++++. + .+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|++.+..|. .+.
T Consensus 94 ~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~ 171 (198)
T 1ds9_A 94 TLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171 (198)
T ss_dssp HCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHH
T ss_pred cCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHH
Confidence 888888888887653 2 57777888888888888855322 3567778888888888888655443 367
Q ss_pred cCCCceeEeeccCccc
Q 038671 312 ELHGLSYIDISYNELH 327 (707)
Q Consensus 312 ~~~~L~~l~l~~n~~~ 327 (707)
.+++|+.|+ +|+++
T Consensus 172 ~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 172 RLPNLKKLD--GMPVD 185 (198)
T ss_dssp HCSSCSEEC--CGGGT
T ss_pred hCCCcEEEC--CcccC
Confidence 788888776 66654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=6.9e-14 Score=128.25 Aligned_cols=109 Identities=25% Similarity=0.348 Sum_probs=64.4
Q ss_pred cEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEecccc
Q 038671 221 ERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHN 300 (707)
Q Consensus 221 ~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n 300 (707)
+.|++++|.++. +|..+. ++|++|+|++|.|++..+..|..+++|+.|+|++|.|++..+..|..+++|+.|++++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 455555555553 333332 45566666666665555555666666666666666665555555566666666666666
Q ss_pred ccCCchhHhhccCCCceeEeeccCcccccCCC
Q 038671 301 NLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332 (707)
Q Consensus 301 ~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~ 332 (707)
+|++..+..|..+++|+.|++++|+|+|.++.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 66655555566666666666666666666653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.3e-13 Score=126.85 Aligned_cols=90 Identities=24% Similarity=0.300 Sum_probs=45.1
Q ss_pred ccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEee
Q 038671 242 VKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDI 321 (707)
Q Consensus 242 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l 321 (707)
++|+.|+|++|+|.+..+..|.++++|+.|+|++|.|++..+..|..+++|+.|++++|+|++..+..+..+++|+.|++
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L 112 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL 112 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence 34444444444444444444444555555555555554443334445555555555555555444444555555555555
Q ss_pred ccCcccccCC
Q 038671 322 SYNELHGSIP 331 (707)
Q Consensus 322 ~~n~~~~~~~ 331 (707)
++|+|.|.++
T Consensus 113 ~~N~~~c~~~ 122 (174)
T 2r9u_A 113 YNNPWDCECR 122 (174)
T ss_dssp CSSCBCTTBG
T ss_pred CCCCcccccc
Confidence 5555555544
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.45 E-value=9.3e-12 Score=130.50 Aligned_cols=288 Identities=13% Similarity=0.061 Sum_probs=172.1
Q ss_pred ccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCC-CCCCCCCcc
Q 038671 23 IGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-NLRNLTSLV 101 (707)
Q Consensus 23 ~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~-~l~~l~~L~ 101 (707)
+....+|+.+.+.. .++.+...+|.++.+|+.+.|..+ ++.+...+|.+. +|+.+.+..+ +..+.. +|.. .+|+
T Consensus 42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~ 116 (379)
T 4h09_A 42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLD 116 (379)
T ss_dssp GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCS
T ss_pred cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcc
Confidence 44455777777764 355566677777788888877543 565667777776 5777766544 333333 3444 3677
Q ss_pred EEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCC------------CCchhhhCC
Q 038671 102 RVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITG------------SMPAEIIHS 169 (707)
Q Consensus 102 ~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~------------~~~~~~~~~ 169 (707)
.+.+..+ ++.+...+|..+ +|+.+.+..+ ++.+...+|..+.+++.+.+..+.... .....+...
T Consensus 117 ~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (379)
T 4h09_A 117 DFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAA 193 (379)
T ss_dssp EEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTT
T ss_pred cccCCCc-cccccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceecccccc
Confidence 7777654 444556666554 5666655543 344666677777777777766544321 112223334
Q ss_pred CCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEee
Q 038671 170 SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNL 249 (707)
Q Consensus 170 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l 249 (707)
..+..+.+..+... .....+....+|+.+.+..+ ++......+..+..|+.+.+..+ ++.+...+|.++.+|+.+.+
T Consensus 194 ~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l 270 (379)
T 4h09_A 194 KTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNF 270 (379)
T ss_dssp CCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEE
T ss_pred ccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccc
Confidence 45555555443322 44455566666766666544 33355556666677777777654 44455566666677777776
Q ss_pred ecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeecc
Q 038671 250 SNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISY 323 (707)
Q Consensus 250 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~ 323 (707)
..+ +..+....|.++.+|+.+.+.++.++.+...+|.++.+|+.+.+..+ ++.+...+|..+.+|+.+.+..
T Consensus 271 ~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 271 YAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp CCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred ccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 543 44555566677777777777666665566666777777777777543 4444456666667777666644
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=4.8e-13 Score=122.62 Aligned_cols=103 Identities=29% Similarity=0.331 Sum_probs=56.0
Q ss_pred ceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccc
Q 038671 6 AFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENN 85 (707)
Q Consensus 6 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n 85 (707)
+.|++++|.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 45555666555 3444442 45555555555555555555555555555555555555554555555555555555555
Q ss_pred cccccCCC-CCCCCCccEEEeccCccc
Q 038671 86 QLRGPIPN-LRNLTSLVRVRLNQNHLT 111 (707)
Q Consensus 86 ~i~~~~~~-l~~l~~L~~L~l~~n~l~ 111 (707)
+|+.+++. +..+++|+.|+|++|.+.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 55554442 445555555555555544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.42 E-value=6e-13 Score=122.36 Aligned_cols=103 Identities=26% Similarity=0.330 Sum_probs=51.1
Q ss_pred CeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCC-CCCCCCccEEEeccC
Q 038671 30 SDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQN 108 (707)
Q Consensus 30 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~-l~~l~~L~~L~l~~n 108 (707)
+.+++++|+++ .+|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|+|+.+++. |..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 34455555444 3333332 4455555555555544444455555555555555555544443 344555555555555
Q ss_pred ccccccCccccCCCCCcEEEccccccc
Q 038671 109 HLTGNISESFGIHPNLAFIDLSHNYFY 135 (707)
Q Consensus 109 ~l~~~~~~~~~~~~~L~~L~L~~n~i~ 135 (707)
+++.+++..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 555554444555555555555555544
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.41 E-value=8.3e-15 Score=152.13 Aligned_cols=96 Identities=24% Similarity=0.262 Sum_probs=50.3
Q ss_pred CCcccEEEccCCccCCC----CCccccCcccCceEeeecccccccC----chhhhhcccCCeeeecCccCCCCCC----c
Q 038671 217 LTQLERLDLSSNRLSNS----IPKSLGNLVKLHYLNLSNNQFIKKI----PVELEKLIHLSELDLSHNFLGEEMP----S 284 (707)
Q Consensus 217 l~~L~~L~l~~n~i~~~----~~~~l~~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~l~~~~~----~ 284 (707)
.++|++|+|++|.|++. .+..+..+++|++|+|++|.|++.. ...+...++|++|+|++|.|++... .
T Consensus 154 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~ 233 (372)
T 3un9_A 154 QCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALAR 233 (372)
T ss_dssp TCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHH
T ss_pred CCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHH
Confidence 34555555555555432 2223344555666666666655432 2334455566666666666644222 2
Q ss_pred ccccccccceEeccccccCCchhHhhcc
Q 038671 285 QICNMQSLEKLNLSHNNLSGFIPSCFEE 312 (707)
Q Consensus 285 ~~~~~~~L~~L~l~~n~i~~~~~~~~~~ 312 (707)
.+...++|+.|+|++|+|++.....+..
T Consensus 234 ~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 234 AAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred HHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 2334466777777777766554444443
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.38 E-value=1e-14 Score=151.45 Aligned_cols=110 Identities=20% Similarity=0.159 Sum_probs=54.1
Q ss_pred CCCcEEEecCCccccC----CccccCCCCcccEEEccCCccCCCC----CccccCcccCceEeeecccccccCch----h
Q 038671 194 SSLIKLILNSNQLCGQ----LSLELGSLTQLERLDLSSNRLSNSI----PKSLGNLVKLHYLNLSNNQFIKKIPV----E 261 (707)
Q Consensus 194 ~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~i~~~~----~~~l~~l~~L~~L~l~~n~l~~~~~~----~ 261 (707)
++|++|+|++|.++.. ++..+..+++|++|+|++|.|++.. +..+...++|+.|+|++|.|++.... .
T Consensus 155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 4455555555555422 1222344555666666666554322 33444555666666666666543322 2
Q ss_pred hhhcccCCeeeecCccCCCCCCccccccc-----ccceEe--ccccccC
Q 038671 262 LEKLIHLSELDLSHNFLGEEMPSQICNMQ-----SLEKLN--LSHNNLS 303 (707)
Q Consensus 262 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~-----~L~~L~--l~~n~i~ 303 (707)
+..+++|++|+|++|.|++.....+..+. .|+.+. +..|.+.
T Consensus 235 L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 235 AREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp HHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred HHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 34456677777777776554333333321 155555 5555554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.37 E-value=3.8e-11 Score=125.81 Aligned_cols=298 Identities=12% Similarity=0.063 Sum_probs=223.2
Q ss_pred CCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeec
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTL 82 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 82 (707)
.+|+.+.+.. .++.+...+|.++.+|+.+.|..+ ++.+...+|.++ +|+.+.+..+ ++.+...+|... +|+.+.+
T Consensus 46 ~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L~~i~l 120 (379)
T 4h09_A 46 DRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DLDDFEF 120 (379)
T ss_dssp GGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CCSEEEC
T ss_pred cCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-CcccccC
Confidence 4577777764 467688889999999999999754 666777889887 6888887654 555667778764 8999999
Q ss_pred ccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEccccccccc------------CCCCCCCCCCCcE
Q 038671 83 ENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGE------------ISSDWGRCPKLGT 150 (707)
Q Consensus 83 ~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~------------~~~~~~~~~~L~~ 150 (707)
..+...-....|.++ +|+.+.+.. .++.+...+|..+.+++.+.+..+..... ....+..+..+..
T Consensus 121 p~~~~~i~~~~F~~~-~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (379)
T 4h09_A 121 PGATTEIGNYIFYNS-SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTE 198 (379)
T ss_dssp CTTCCEECTTTTTTC-CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSE
T ss_pred CCccccccccccccc-eeeeeeccc-eeeccccchhcccccccccccccccceeecccceecccccceeccccccccccc
Confidence 876443222345544 677777654 46668888899999999988876544311 1234556667777
Q ss_pred EEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCcc
Q 038671 151 LDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRL 230 (707)
Q Consensus 151 L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i 230 (707)
+.+...... .....+....+|+.+.+..+ +.......|..+..|+.+.+..+ ++.....+|..+.+|+.+.+..+ +
T Consensus 199 ~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i 274 (379)
T 4h09_A 199 FTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-V 274 (379)
T ss_dssp EECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-C
T ss_pred cccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-c
Confidence 777655433 56667778889999998766 44466778888999999999876 66677788899999999999754 6
Q ss_pred CCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhh
Q 038671 231 SNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCF 310 (707)
Q Consensus 231 ~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~ 310 (707)
+.+....|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|.++ ++.+...+|.++.+|+.+.+..+ ++.+...+|
T Consensus 275 ~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF 352 (379)
T 4h09_A 275 KTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAF 352 (379)
T ss_dssp SEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTT
T ss_pred eeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHh
Confidence 5577788999999999999988888888889999999999999765 66677788999999999988665 554445566
Q ss_pred ccC
Q 038671 311 EEL 313 (707)
Q Consensus 311 ~~~ 313 (707)
..+
T Consensus 353 ~~c 355 (379)
T 4h09_A 353 EGS 355 (379)
T ss_dssp TTS
T ss_pred hCC
Confidence 554
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=8.8e-12 Score=123.48 Aligned_cols=147 Identities=12% Similarity=0.065 Sum_probs=114.0
Q ss_pred HHHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCce
Q 038671 432 IRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHS 510 (707)
Q Consensus 432 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 510 (707)
....+.|++....+.|+.+.||+++.. ++.+++|+....... ....+.+|+++++.+. +..++++++++...+..
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 345567888888999999999999764 678999997542111 1234778999998884 67888999999988899
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC-------------------------------- 558 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-------------------------------- 558 (707)
|+||||++|.++.+.+. +......++.+++++++.||+..
T Consensus 86 ~lv~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred EEEEEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 99999999999987631 12234578899999999999810
Q ss_pred ------------------------CCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 559 ------------------------FPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 559 ------------------------~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
.+.++|||++|.||+++.++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 02589999999999998655667999987753
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.26 E-value=8.8e-12 Score=129.01 Aligned_cols=131 Identities=20% Similarity=0.153 Sum_probs=63.8
Q ss_pred EEecCC-ccccCCccccCCCCcccEEEccC-CccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCc
Q 038671 199 LILNSN-QLCGQLSLELGSLTQLERLDLSS-NRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHN 276 (707)
Q Consensus 199 L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 276 (707)
++++++ .++. +|. +..+++|+.|+|++ |.|+++.+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 344444 4442 333 55555555555553 5555444455555555555555555555555555555555555555555
Q ss_pred cCCCCCCcccccccccceEeccccccCCchh-HhhccCCCceeEeeccCcccccCCC
Q 038671 277 FLGEEMPSQICNMQSLEKLNLSHNNLSGFIP-SCFEELHGLSYIDISYNELHGSIPN 332 (707)
Q Consensus 277 ~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~-~~~~~~~~L~~l~l~~n~~~~~~~~ 332 (707)
.|++..+..|..++ |+.|+|.+|++..... ..+..+.......+..++++|..|.
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 55444444444333 5555565555553322 2222222222333444555555444
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.20 E-value=3.3e-11 Score=124.67 Aligned_cols=103 Identities=20% Similarity=0.176 Sum_probs=68.0
Q ss_pred eeeccCC-eeeecCCccccCCCCCCeEECCC-CccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeeccc
Q 038671 7 FLYLYNN-SFSGSIPSEIGRLKSLSDLELSG-NKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLEN 84 (707)
Q Consensus 7 ~L~l~~n-~i~~~~~~~~~~l~~L~~L~l~~-n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~ 84 (707)
.++++++ +++ .+|. |..+++|++|+|++ |+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4566666 666 4566 77777777777774 777766556677777777777777777766666777777777777777
Q ss_pred ccccccCCCCCCCCCccEEEeccCccc
Q 038671 85 NQLRGPIPNLRNLTSLVRVRLNQNHLT 111 (707)
Q Consensus 85 n~i~~~~~~l~~l~~L~~L~l~~n~l~ 111 (707)
|+|+.+++......+|+.|+|.+|.+.
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred CccceeCHHHcccCCceEEEeeCCCcc
Confidence 777666554332223666666666655
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.12 E-value=7.6e-11 Score=116.67 Aligned_cols=137 Identities=15% Similarity=0.136 Sum_probs=99.8
Q ss_pred CCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCc--eeeeeeeeecCCceeEEE
Q 038671 437 DFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN--IVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~ 514 (707)
.+.+....+.|..+.||++...+|+.+++|+..... ...+..|+.+++.+++.+ ++++++++..++..++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 444433334566799999988778889999975431 134677888888885433 567888888888899999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC------------------------------------ 558 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 558 (707)
||++|.++. ... . ....++.++++.++.||+..
T Consensus 95 e~i~G~~l~--~~~------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 95 GEVPGQDLL--SSH------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp ECCSSEETT--TSC------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EecCCcccC--cCc------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999998884 211 1 12356777888888888752
Q ss_pred -------------------CCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 559 -------------------FPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 559 -------------------~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
.+.++|||++|.||+++.++.+.|+|||.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01399999999999998766677999998753
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.09 E-value=9.4e-11 Score=120.44 Aligned_cols=157 Identities=17% Similarity=0.183 Sum_probs=95.8
Q ss_pred hhhhCCCCCCEEeCCCCC-CCCCCChhhhCCCCCcEEEecCCccccCCccccC--CCCcccEEEccC--CccCCC-----
Q 038671 164 AEIIHSSQLKVLDLSSNH-IVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG--SLTQLERLDLSS--NRLSNS----- 233 (707)
Q Consensus 164 ~~~~~~~~L~~L~l~~n~-l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--~l~~L~~L~l~~--n~i~~~----- 233 (707)
..+..+++|+.|+|++|. + ..+. + .+++|++|.+..|.+.......+. .+|+|+.|+|+. |...+.
T Consensus 166 ~ll~~~P~L~~L~L~g~~~l--~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~ 241 (362)
T 2ra8_A 166 PVLDAMPLLNNLKIKGTNNL--SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNV 241 (362)
T ss_dssp HHHHTCTTCCEEEEECCBTC--BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGG
T ss_pred HHHhcCCCCcEEEEeCCCCc--eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHH
Confidence 445566777777776662 2 1222 2 267777777777777644333333 577788777753 221111
Q ss_pred CCccc--cCcccCceEeeecccccccCchhhh---hcccCCeeeecCccCCCCC----CcccccccccceEeccccccCC
Q 038671 234 IPKSL--GNLVKLHYLNLSNNQFIKKIPVELE---KLIHLSELDLSHNFLGEEM----PSQICNMQSLEKLNLSHNNLSG 304 (707)
Q Consensus 234 ~~~~l--~~l~~L~~L~l~~n~l~~~~~~~~~---~l~~L~~L~l~~n~l~~~~----~~~~~~~~~L~~L~l~~n~i~~ 304 (707)
+...+ ..+++|+.|+|++|.+.+.....+. .+++|+.|+|+.|.+++.. +..+..+++|+.|++++|.|++
T Consensus 242 l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 242 FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp TGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred HHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 01122 2468888888888887654433333 4678888888888886632 3334567888888998888876
Q ss_pred chhHhhccCCCceeEeeccCc
Q 038671 305 FIPSCFEELHGLSYIDISYNE 325 (707)
Q Consensus 305 ~~~~~~~~~~~L~~l~l~~n~ 325 (707)
.....+...- ...+++++++
T Consensus 322 ~~~~~l~~al-g~~~~~~~~~ 341 (362)
T 2ra8_A 322 EMKKELQKSL-PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHHHC-CSEEECCSBC
T ss_pred HHHHHHHHHc-CCEEEecCCc
Confidence 5555555411 3457777765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.05 E-value=6e-10 Score=115.64 Aligned_cols=145 Identities=15% Similarity=0.262 Sum_probs=106.9
Q ss_pred CCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC--CCceeeeeeeeecC---CceeEEE
Q 038671 440 DEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR--HRNIVKFYGFCSHA---RHSFIVY 514 (707)
Q Consensus 440 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~ 514 (707)
..+.++.|.++.+|+++..+ ..+++|+...+..........+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 45678999999999998764 578888875111111112346788999999886 45678889888766 5589999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC------------------------------------ 558 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 558 (707)
||++|..+.+.. ...++..++..++.+++++|+.||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998774311 123677888899999999999999831
Q ss_pred -------------------CCCeEecCCCCCCeeecCCCC--eEEecccccee
Q 038671 559 -------------------FPPIVHRDISSKNVLLDLENE--AHVSDFGTAKF 590 (707)
Q Consensus 559 -------------------~~~ivH~dlk~~Nil~~~~~~--~kl~Dfg~~~~ 590 (707)
.+.++|||+++.||+++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 137999999999999997753 68999999875
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.04 E-value=6.7e-11 Score=121.53 Aligned_cols=184 Identities=15% Similarity=0.095 Sum_probs=87.2
Q ss_pred ccCCCCCcEEEcccCcCc---------ccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCcc
Q 038671 47 LGNLTQITFLTLFDNALS---------GAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISES 117 (707)
Q Consensus 47 ~~~l~~L~~L~L~~n~i~---------~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 117 (707)
..++++|+.|.+.++... ..+...+..+++|+.|+|++|.-..+++ + .+++|+.|+|..|.++......
T Consensus 135 ~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~l~~-~-~~~~L~~L~L~~~~l~~~~l~~ 212 (362)
T 2ra8_A 135 KEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGK-K-PRPNLKSLEIISGGLPDSVVED 212 (362)
T ss_dssp HHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCBCCS-C-BCTTCSEEEEECSBCCHHHHHH
T ss_pred hhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCceecc-c-cCCCCcEEEEecCCCChHHHHH
Confidence 445566666666543221 0122344556666777666652111222 2 2566666666666655333333
Q ss_pred cc--CCCCCcEEEccc--ccccccCCCCCCCCCCCcEEEcCCCccCCCCchhh--hCCCCCCEEeCCCCCCCCCCChhhh
Q 038671 118 FG--IHPNLAFIDLSH--NYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEI--IHSSQLKVLDLSSNHIVGEMPSKLG 191 (707)
Q Consensus 118 ~~--~~~~L~~L~L~~--n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~ 191 (707)
+. .+|+|++|+|+. |...+. .. +.. ....+ ..+++|+.|+|.+|.+.+..+..+.
T Consensus 213 l~~~~lp~L~~L~L~~~~~~~~~~--~~----------------~~~-l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la 273 (362)
T 2ra8_A 213 ILGSDLPNLEKLVLYVGVEDYGFD--GD----------------MNV-FRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273 (362)
T ss_dssp HHHSBCTTCCEEEEECBCGGGTCC--SC----------------GGG-TGGGSCTTTCTTCCEEEEESCTTHHHHHHHHH
T ss_pred HHHccCCCCcEEEEeccccccccc--hh----------------HHH-HHHHHhcCCCCCcCEEeCCCCCCchHHHHHHH
Confidence 32 456666666642 111000 00 000 00011 1245555555555555422222222
Q ss_pred ---CCCCCcEEEecCCccccCC----ccccCCCCcccEEEccCCccCCCCCccccC-cccCceEeeeccc
Q 038671 192 ---KLSSLIKLILNSNQLCGQL----SLELGSLTQLERLDLSSNRLSNSIPKSLGN-LVKLHYLNLSNNQ 253 (707)
Q Consensus 192 ---~l~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~-l~~L~~L~l~~n~ 253 (707)
.+++|++|+|+.|.++... +..+..+++|+.|+|++|.|++.....+.. + ...+++++++
T Consensus 274 ~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 274 ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred hCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 3556666666666665432 222234567777777777766443333432 2 2456777765
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.94 E-value=1.3e-09 Score=110.17 Aligned_cols=185 Identities=21% Similarity=0.234 Sum_probs=123.3
Q ss_pred CceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCc--eeeeeeeeecCC---ceeEEE
Q 038671 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRN--IVKFYGFCSHAR---HSFIVY 514 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~ 514 (707)
.+.++.|....||++. +.+++|+.... .....+.+|++.++.+. +.. +++++......+ ..|+||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4668999999999873 45889985421 24567889999998873 322 455555544333 458999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC------------------------------------ 558 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 558 (707)
|+++|.++.+... ..++..++..++.++++.++.||+..
T Consensus 96 ~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (304)
T 3sg8_A 96 TKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM 170 (304)
T ss_dssp ECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred cccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence 9999998875432 23667777888888888888888621
Q ss_pred -------------------CCCeEecCCCCCCeeecC--CCCeEEeccccceecCCCCCCccc--------------ccc
Q 038671 559 -------------------FPPIVHRDISSKNVLLDL--ENEAHVSDFGTAKFLKPDSSNWAE--------------LAG 603 (707)
Q Consensus 559 -------------------~~~ivH~dlk~~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~--------------~~g 603 (707)
.+.++|||++|.||+++. ++.+.++||+.+....+..+.... ...
T Consensus 171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence 135899999999999998 456789999998764322110000 000
Q ss_pred ccCCCC-ccccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 038671 604 TYGYVA-PELAYTMKVTEKCDVYSFGVLALEVIKGKHPR 641 (707)
Q Consensus 604 ~~~y~a-PE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~ 641 (707)
.++... |+.... .....+.|++|.++|.+.+|+.+|
T Consensus 251 ~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 251 HYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111111 221111 122368999999999999999886
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.62 E-value=8.2e-09 Score=95.55 Aligned_cols=13 Identities=15% Similarity=0.342 Sum_probs=5.6
Q ss_pred CCCCCcEEEcCCC
Q 038671 144 RCPKLGTLDFSSN 156 (707)
Q Consensus 144 ~~~~L~~L~L~~n 156 (707)
..++|++|+|++|
T Consensus 34 ~~~~L~~L~L~~n 46 (185)
T 1io0_A 34 NDPDLEEVNLNNI 46 (185)
T ss_dssp TCTTCCEEECTTC
T ss_pred cCCCCCEEEecCC
Confidence 3444444444444
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.61 E-value=1e-08 Score=94.95 Aligned_cols=62 Identities=16% Similarity=0.250 Sum_probs=29.6
Q ss_pred ccCCeeeecCccCCCC----CCcccccccccceEec--cccccCCch----hHhhccCCCceeEeeccCccc
Q 038671 266 IHLSELDLSHNFLGEE----MPSQICNMQSLEKLNL--SHNNLSGFI----PSCFEELHGLSYIDISYNELH 327 (707)
Q Consensus 266 ~~L~~L~l~~n~l~~~----~~~~~~~~~~L~~L~l--~~n~i~~~~----~~~~~~~~~L~~l~l~~n~~~ 327 (707)
++|++|+|++|.|++. +...+...+.|+.|++ ++|.|.+.. ...+...+.|++|++++|.+.
T Consensus 93 ~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 93 NTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp SSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred CCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4455555555544332 1223334445555555 555555332 233334456666666666553
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=6.6e-07 Score=88.56 Aligned_cols=135 Identities=13% Similarity=0.145 Sum_probs=98.4
Q ss_pred eeeecCCe-eEEEEEcC-CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCceeEEEeeecc
Q 038671 443 CIGKGGQG-SVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 443 ~lg~G~~g-~vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
.+..|..+ .||+.... +++.+++|+... .....+.+|...++.+. +-.++++++++.+.+..++|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 45556655 58988654 466789998532 23456788999988874 44478889999999999999999999
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC----------------------------------------- 558 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------------- 558 (707)
.++.+..... ......++.++++.|+.||+..
T Consensus 105 ~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (272)
T 4gkh_A 105 KTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVE 177 (272)
T ss_dssp EEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHH
T ss_pred ccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHH
Confidence 9988765321 1233456667777777777531
Q ss_pred --------------CCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 559 --------------FPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 559 --------------~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
.+.++|||+.+.||+++.++.+-|+||+.+..
T Consensus 178 ~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 178 QVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 02379999999999999777778999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.5e-06 Score=87.48 Aligned_cols=137 Identities=16% Similarity=0.159 Sum_probs=95.2
Q ss_pred CceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCC---ceeeeeeeee-cCCceeEEEee
Q 038671 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR---NIVKFYGFCS-HARHSFIVYEY 516 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~ 516 (707)
.+.++.|....||+. |+.+++|+... ......+.+|++++..+.+. .+++.+.++. ..+..+++|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 456888999999998 56688888421 12346788999999998642 3667777774 45678899999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHND--------------------------------------- 557 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------------------------------------- 557 (707)
++|.++.+... ..++..+...++.++++.|+.||+.
T Consensus 95 i~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 95 VQGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred cCCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 99998876321 1133444444555555555555542
Q ss_pred ------------------CCCCeEecCCCCCCeeecC---CCCe-EEeccccceec
Q 038671 558 ------------------CFPPIVHRDISSKNVLLDL---ENEA-HVSDFGTAKFL 591 (707)
Q Consensus 558 ------------------~~~~ivH~dlk~~Nil~~~---~~~~-kl~Dfg~~~~~ 591 (707)
..+.++|||++|.||+++. ++.+ .|+||+.+...
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235799999999999987 4554 89999988753
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.32 E-value=6.6e-08 Score=93.90 Aligned_cols=78 Identities=31% Similarity=0.329 Sum_probs=37.9
Q ss_pred cccCceEeeecccccccC--chhhhhcccCCeeeecCccCCCCCCccccccc--ccceEeccccccCCchh-------Hh
Q 038671 241 LVKLHYLNLSNNQFIKKI--PVELEKLIHLSELDLSHNFLGEEMPSQICNMQ--SLEKLNLSHNNLSGFIP-------SC 309 (707)
Q Consensus 241 l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~--~L~~L~l~~n~i~~~~~-------~~ 309 (707)
+++|+.|+|++|+|++.. +..+..+++|+.|+|++|.|++. ..+..+. +|+.|+|++|++.+..| ..
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~i 246 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAI 246 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHH
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHH
Confidence 344444555554444421 23344555555555555555432 2223333 56666666666553222 23
Q ss_pred hccCCCceeEe
Q 038671 310 FEELHGLSYID 320 (707)
Q Consensus 310 ~~~~~~L~~l~ 320 (707)
+..+|+|+.||
T Consensus 247 l~~~P~L~~LD 257 (267)
T 3rw6_A 247 RERFPKLLRLD 257 (267)
T ss_dssp HHHCTTCCEES
T ss_pred HHHCcccCeEC
Confidence 55667776665
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.32 E-value=9.3e-08 Score=92.83 Aligned_cols=62 Identities=35% Similarity=0.439 Sum_probs=26.6
Q ss_pred CCcccEEEccCCccCCC--CCccccCcccCceEeeecccccccCchhhhhcc--cCCeeeecCccCCC
Q 038671 217 LTQLERLDLSSNRLSNS--IPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLI--HLSELDLSHNFLGE 280 (707)
Q Consensus 217 l~~L~~L~l~~n~i~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~--~L~~L~l~~n~l~~ 280 (707)
+++|+.|+|++|+|+++ ++..+..+++|+.|+|++|+|.+. ..+..+. +|++|+|++|.+.+
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~ 234 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD 234 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc
Confidence 44455555555544432 123333444455555555544433 1122222 44455555554443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.28 E-value=3.1e-07 Score=82.45 Aligned_cols=83 Identities=12% Similarity=0.118 Sum_probs=45.0
Q ss_pred cccEEEccCCccCCCCCccccCcccCceEeeeccc-ccccCchhhhhc----ccCCeeeecCcc-CCCCCCccccccccc
Q 038671 219 QLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQ-FIKKIPVELEKL----IHLSELDLSHNF-LGEEMPSQICNMQSL 292 (707)
Q Consensus 219 ~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~-l~~~~~~~~~~l----~~L~~L~l~~n~-l~~~~~~~~~~~~~L 292 (707)
+|+.||++++.|++.....+.++++|+.|+|++|. |++.....+..+ ++|++|+|++|. ||+.....+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 45555555555555444455555666666666653 544444444442 356666666653 555444445555666
Q ss_pred ceEeccccc
Q 038671 293 EKLNLSHNN 301 (707)
Q Consensus 293 ~~L~l~~n~ 301 (707)
+.|++++++
T Consensus 142 ~~L~L~~c~ 150 (176)
T 3e4g_A 142 KYLFLSDLP 150 (176)
T ss_dssp CEEEEESCT
T ss_pred CEEECCCCC
Confidence 666666653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=98.25 E-value=4.7e-07 Score=81.28 Aligned_cols=87 Identities=14% Similarity=0.100 Sum_probs=61.4
Q ss_pred CCCcEEEecCCccccCCccccCCCCcccEEEccCCc-cCCCCCccccCc----ccCceEeeeccc-ccccCchhhhhccc
Q 038671 194 SSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNR-LSNSIPKSLGNL----VKLHYLNLSNNQ-FIKKIPVELEKLIH 267 (707)
Q Consensus 194 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~-i~~~~~~~l~~l----~~L~~L~l~~n~-l~~~~~~~~~~l~~ 267 (707)
..|++|++++|.++......+..+++|+.|+|++|. |++..-..++.+ ++|++|+|++|. |++.....+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 467777777777776666666777788888888774 665544555553 468888888874 77766677777888
Q ss_pred CCeeeecCcc-CCC
Q 038671 268 LSELDLSHNF-LGE 280 (707)
Q Consensus 268 L~~L~l~~n~-l~~ 280 (707)
|++|++++|. +++
T Consensus 141 L~~L~L~~c~~Itd 154 (176)
T 3e4g_A 141 LKYLFLSDLPGVKE 154 (176)
T ss_dssp CCEEEEESCTTCCC
T ss_pred CCEEECCCCCCCCc
Confidence 8888888875 543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=1.9e-06 Score=89.08 Aligned_cols=82 Identities=5% Similarity=0.006 Sum_probs=53.5
Q ss_pred cee-eecCCeeEEEEEcC-------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-C--CceeeeeeeeecC---
Q 038671 442 HCI-GKGGQGSVYKAELP-------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-H--RNIVKFYGFCSHA--- 507 (707)
Q Consensus 442 ~~l-g~G~~g~vy~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~--- 507 (707)
+.| +.|....+|+.+.. +++.+++|+..............+.+|+.+++.+. + -.+++++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 556 78888999998654 26778999864321000001134567778777774 2 3577788877655
Q ss_pred CceeEEEeeeccCcHH
Q 038671 508 RHSFIVYEYLEMGSLA 523 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~ 523 (707)
+..++||||++|.++.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 4578999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=2e-05 Score=82.55 Aligned_cols=78 Identities=14% Similarity=0.045 Sum_probs=49.0
Q ss_pred CceeeecCCeeEEEEEcC-CCcEEEEEecCCCCC--ch--hhhHHHHHHHHHHHhcCCC--C-ceeeeeeeeecCCceeE
Q 038671 441 EHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLP--SE--MASQQEFLNEVKTLTGIRH--R-NIVKFYGFCSHARHSFI 512 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~-~~~~vavK~~~~~~~--~~--~~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~l 512 (707)
.+.+|.|..+.||+++.. +++.+++|....... .. .....++..|.+.++.+.. | .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999654 468899998653211 00 0122346678888877632 3 45566654 3445689
Q ss_pred EEeeeccC
Q 038671 513 VYEYLEMG 520 (707)
Q Consensus 513 v~e~~~~~ 520 (707)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.99 E-value=3.1e-05 Score=79.34 Aligned_cols=148 Identities=20% Similarity=0.316 Sum_probs=82.0
Q ss_pred hcCCCC----CceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC--CCceeeeee------
Q 038671 435 TNDFDD----EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR--HRNIVKFYG------ 502 (707)
Q Consensus 435 ~~~~~~----~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~------ 502 (707)
...|.+ .+.++.|..+.+|++...+| .+++|+.... ...+..|..++..+. .-.+++++.
T Consensus 27 ~~~~~~~~~~~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~ 98 (346)
T 2q83_A 27 LQGWDVQAEKIDVIQGNQMALVWKVHTDSG-AVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSL 98 (346)
T ss_dssp GGGSCCCCCEEEECC----CEEEEEEETTE-EEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCS
T ss_pred HHHcCCceEEeeeccccccCcEEEEEeCCC-CEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCE
Confidence 355553 23455677899999977655 4899988642 122334444444442 113344443
Q ss_pred eeecCCceeEEEeeeccCcHH--------------HHHhcccc----c-------CCCChHHH-----------------
Q 038671 503 FCSHARHSFIVYEYLEMGSLA--------------MILSNDAA----A-------KDLGWTKR----------------- 540 (707)
Q Consensus 503 ~~~~~~~~~lv~e~~~~~~L~--------------~~l~~~~~----~-------~~l~~~~~----------------- 540 (707)
+....+..+++|||++|.++. ..+|.... . ....|...
T Consensus 99 ~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 178 (346)
T 2q83_A 99 YSKHGSFLFVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEA 178 (346)
T ss_dssp CEEETTEEEEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEECCEEEEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHh
Confidence 123456789999999986542 01121110 0 00122211
Q ss_pred --------------HHHHHHHHHHHHHHHh----------CCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 541 --------------MNVIKGVVDALSYMHN----------DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 541 --------------~~i~~~i~~~l~~LH~----------~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
..+..++.+++++|+. ...+.++|||+++.||+++.++.+.++||+.+..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 179 EKEDPFSQLYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred ccCCcHHHHHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111234445666653 0123899999999999998888999999998854
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.85 E-value=7.4e-05 Score=74.69 Aligned_cols=76 Identities=20% Similarity=0.225 Sum_probs=60.1
Q ss_pred CCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC---CCceeeeeeeeecCCceeEEEee
Q 038671 440 DEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR---HRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 440 ~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
..+.++.|....+|+.+. +++.+++|+... .....+..|+..++.+. ...++++++++...+..++||||
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~------~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~ 112 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINER------SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEA 112 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEG------GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCc------ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEe
Confidence 346789999999999986 467788998642 13466888988888883 36788899988888889999999
Q ss_pred eccCcH
Q 038671 517 LEMGSL 522 (707)
Q Consensus 517 ~~~~~L 522 (707)
++|..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.85 E-value=3e-06 Score=77.62 Aligned_cols=86 Identities=14% Similarity=0.133 Sum_probs=37.2
Q ss_pred CCCCCCeeecccccccc-----cCCCCCCCCCccEEEeccCccccccC----ccccCCCCCcEEEcccc---cccc----
Q 038671 73 NLVKLTLLTLENNQLRG-----PIPNLRNLTSLVRVRLNQNHLTGNIS----ESFGIHPNLAFIDLSHN---YFYG---- 136 (707)
Q Consensus 73 ~l~~L~~L~l~~n~i~~-----~~~~l~~l~~L~~L~l~~n~l~~~~~----~~~~~~~~L~~L~L~~n---~i~~---- 136 (707)
....|+.|+|++|+|.+ +...+...+.|++|+|+.|.|+.... +++...+.|++|+|++| .+..
T Consensus 68 ~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~ 147 (197)
T 1pgv_A 68 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEM 147 (197)
T ss_dssp TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHH
T ss_pred hCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHH
Confidence 33444444444444442 11123334445555555555543222 22333444555555543 2221
Q ss_pred cCCCCCCCCCCCcEEEcCCCcc
Q 038671 137 EISSDWGRCPKLGTLDFSSNNI 158 (707)
Q Consensus 137 ~~~~~~~~~~~L~~L~L~~n~i 158 (707)
....++...++|+.|+++.|.+
T Consensus 148 ~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 148 DMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHhCCCcCeEeccCCCc
Confidence 1122344455666666655543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.80 E-value=7.6e-06 Score=74.90 Aligned_cols=10 Identities=10% Similarity=0.341 Sum_probs=4.2
Q ss_pred CCCcEEEcCC
Q 038671 146 PKLGTLDFSS 155 (707)
Q Consensus 146 ~~L~~L~L~~ 155 (707)
+.|++|+|++
T Consensus 41 ~~L~~L~L~~ 50 (197)
T 1pgv_A 41 TDLKEVNINN 50 (197)
T ss_dssp SSCCEEECTT
T ss_pred CCccEEECCC
Confidence 3444444443
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.0002 Score=75.44 Aligned_cols=75 Identities=12% Similarity=0.097 Sum_probs=46.3
Q ss_pred CeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCcccccc--ccCCCCccccccC---CCCccchhHHHHHHHHHHH
Q 038671 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAG--TYGYVAPELAYTM---KVTEKCDVYSFGVLALEVI 635 (707)
Q Consensus 561 ~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~---~~~~~~Dv~slG~~l~el~ 635 (707)
.++|||++|.||+++.++ ++++||+.+....+..+. ..... ...|++|+..... ......++......+|+.+
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 899999999999998776 999999998763322111 11111 1235555544311 1122345567777777777
Q ss_pred hC
Q 038671 636 KG 637 (707)
Q Consensus 636 tg 637 (707)
++
T Consensus 311 ~~ 312 (420)
T 2pyw_A 311 NK 312 (420)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00046 Score=68.46 Aligned_cols=80 Identities=16% Similarity=0.221 Sum_probs=56.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-C--CceeeeeeeeecCCceeE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-H--RNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~l 512 (707)
.+....+.+|.|..+.||+.+..+|+.|++|+....... ....+..|+..|+.+. . -.+++++++. ..++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 345556789999999999999999999999986543221 2245778888888774 2 2345555542 3478
Q ss_pred EEeeeccCcH
Q 038671 513 VYEYLEMGSL 522 (707)
Q Consensus 513 v~e~~~~~~L 522 (707)
||||++++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999986643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.54 E-value=7.9e-05 Score=63.74 Aligned_cols=62 Identities=19% Similarity=0.238 Sum_probs=45.8
Q ss_pred CeeeecCccCC-CCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCC
Q 038671 269 SELDLSHNFLG-EEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332 (707)
Q Consensus 269 ~~L~l~~n~l~-~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~ 332 (707)
..++.+++.++ ..+|..+. ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|+|.|.+..
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l 73 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRL 73 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGG
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCcc
Confidence 36777777774 14554332 3688888888888877777888888888899999999887753
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00049 Score=69.97 Aligned_cols=143 Identities=17% Similarity=0.140 Sum_probs=73.2
Q ss_pred ceeeecCCee-EEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-C-CceeeeeeeeecCCceeEEEeeec
Q 038671 442 HCIGKGGQGS-VYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-H-RNIVKFYGFCSHARHSFIVYEYLE 518 (707)
Q Consensus 442 ~~lg~G~~g~-vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~niv~~~~~~~~~~~~~lv~e~~~ 518 (707)
+.++.|.... +|+....+|+.+++|....... ..+..|+.++..+. + -.+++++.+....+ +++||++.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~ 95 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG 95 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence 3465555444 6787765467788886543211 12334555555553 2 23566776644333 68999998
Q ss_pred cCcHHHHHhcccc---------------------c--CCCChHHHH-------H-H------------HHHHHHHHHHHH
Q 038671 519 MGSLAMILSNDAA---------------------A--KDLGWTKRM-------N-V------------IKGVVDALSYMH 555 (707)
Q Consensus 519 ~~~L~~~l~~~~~---------------------~--~~l~~~~~~-------~-i------------~~~i~~~l~~LH 555 (707)
+..+.+++..... . ..++..... . + ...+.+.++.+.
T Consensus 96 ~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~ 175 (333)
T 3csv_A 96 DALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQIL 175 (333)
T ss_dssp SCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHH
T ss_pred CcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHH
Confidence 7776544421110 0 011111100 0 0 011112222221
Q ss_pred h---CCCCCeEecCCCCCCeeecCC----CCeEEeccccceecC
Q 038671 556 N---DCFPPIVHRDISSKNVLLDLE----NEAHVSDFGTAKFLK 592 (707)
Q Consensus 556 ~---~~~~~ivH~dlk~~Nil~~~~----~~~kl~Dfg~~~~~~ 592 (707)
. ...+.++|||+.+.||+++.+ +.+.|+||+.+....
T Consensus 176 ~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 176 SAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp HHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred HhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 1 112379999999999999875 679999999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0015 Score=65.90 Aligned_cols=159 Identities=13% Similarity=0.148 Sum_probs=87.4
Q ss_pred chHHHHHHHhcCCCCC-----ceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCC--cee
Q 038671 426 IVYEEIIRVTNDFDDE-----HCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR--NIV 498 (707)
Q Consensus 426 ~~~~~~~~~~~~~~~~-----~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv 498 (707)
++.+++..+..+|.+. +.++.|....+|++...+| .+++|+..... ..+.+..|+.++..+... .++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP 80 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCP 80 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCC
Confidence 3456666666677763 3466688889999977656 58899876521 112344566666655311 134
Q ss_pred eeeee------eecCCceeEEEeeeccCcHHH--------------HHhcccc--cCC----C---ChHHHHH-------
Q 038671 499 KFYGF------CSHARHSFIVYEYLEMGSLAM--------------ILSNDAA--AKD----L---GWTKRMN------- 542 (707)
Q Consensus 499 ~~~~~------~~~~~~~~lv~e~~~~~~L~~--------------~l~~~~~--~~~----l---~~~~~~~------- 542 (707)
+++.. ....+..+++++|++|..+.. .+|.... ..+ . .|.....
T Consensus 81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~ 160 (322)
T 2ppq_A 81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 160 (322)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence 44422 123456789999999865311 0111100 000 0 1211100
Q ss_pred -----HHHHHHHHHHHHHhC----CCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 543 -----VIKGVVDALSYMHND----CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 543 -----i~~~i~~~l~~LH~~----~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
+...+.+.+++++.. ..++++|+|+.+.||+++.++.+.++||+.+..
T Consensus 161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234445555532 123799999999999998776668999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0026 Score=64.37 Aligned_cols=142 Identities=13% Similarity=0.156 Sum_probs=80.6
Q ss_pred ceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCC--Cceeeeeee-----eecCCceeEEE
Q 038671 442 HCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH--RNIVKFYGF-----CSHARHSFIVY 514 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~-----~~~~~~~~lv~ 514 (707)
..++ |....+|++...+|+.+++|+...... ....+..|..++..+.. -.+++++.. ....+..+++|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 3466 888899999777787899999864321 23455667777776632 124445443 12245668899
Q ss_pred eeeccCcHH-----H------H---Hhcccc----c--CCCChHHH----HH---------------HHHHHHHHHHHHH
Q 038671 515 EYLEMGSLA-----M------I---LSNDAA----A--KDLGWTKR----MN---------------VIKGVVDALSYMH 555 (707)
Q Consensus 515 e~~~~~~L~-----~------~---l~~~~~----~--~~l~~~~~----~~---------------i~~~i~~~l~~LH 555 (707)
|+++|..+. . . +|.... . ...++... .. +...+.+.++.+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999886532 1 0 111100 0 01111110 00 0111112223332
Q ss_pred hC----CCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 556 ND----CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 556 ~~----~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
.. ..+.++|||+++.||+++ + .+.++||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 21 123689999999999998 4 899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.18 E-value=0.00081 Score=70.71 Aligned_cols=73 Identities=19% Similarity=0.240 Sum_probs=49.1
Q ss_pred CceeeecCCeeEEEEEcCC--------CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCcee
Q 038671 441 EHCIGKGGQGSVYKAELPS--------GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 511 (707)
.+.|+.|....+|++..++ ++.+++|+..... . .+.+..|..+++.+. +.-.+++++.+.+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~----~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T----ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----C
Confidence 4568888899999997653 5789999974321 1 133457888888774 3333667766543 2
Q ss_pred EEEeeeccCcH
Q 038671 512 IVYEYLEMGSL 522 (707)
Q Consensus 512 lv~e~~~~~~L 522 (707)
+|+||++|.++
T Consensus 149 ~v~e~l~G~~l 159 (429)
T 1nw1_A 149 RLEEYIPSRPL 159 (429)
T ss_dssp EEECCCCEEEC
T ss_pred EEEEEeCCccc
Confidence 89999987544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00081 Score=67.18 Aligned_cols=142 Identities=13% Similarity=0.049 Sum_probs=76.3
Q ss_pred CCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCceeEEEee
Q 038671 438 FDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 438 ~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
+.-.+.++.|....+|++ +.+++|+........ ....+|+..++.+. +.-.++++++. .+.-++++||
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~----~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~ 88 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY----INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRY 88 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC----C----CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEEC
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCCccce----eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEee
Confidence 444788999999999999 458889875421111 11234666666553 22125666554 3334689999
Q ss_pred e-ccCcHHHH------------------Hhccccc--CCCCh-HHHHHHHH--------------HHHHHH----HHHHh
Q 038671 517 L-EMGSLAMI------------------LSNDAAA--KDLGW-TKRMNVIK--------------GVVDAL----SYMHN 556 (707)
Q Consensus 517 ~-~~~~L~~~------------------l~~~~~~--~~l~~-~~~~~i~~--------------~i~~~l----~~LH~ 556 (707)
+ +|.++... +|..... ...+. .....+.. .+.+.+ +.+..
T Consensus 89 i~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~ 168 (301)
T 3dxq_A 89 IAGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAA 168 (301)
T ss_dssp CTTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHS
T ss_pred cCCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHh
Confidence 9 66555321 1111110 00111 11111110 011111 11111
Q ss_pred -CCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 557 -DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 557 -~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
...+.++|+|+.+.||+ ..++.+.++||..+...
T Consensus 169 ~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 169 HPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp SCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred cCCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 11235899999999999 56778899999988753
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0022 Score=65.79 Aligned_cols=142 Identities=15% Similarity=0.211 Sum_probs=83.8
Q ss_pred CceeeecCCeeEEEEEcC--------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCcee
Q 038671 441 EHCIGKGGQGSVYKAELP--------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 511 (707)
.+.+..|-...+|++..+ +++.+++|+..... .....+.+|.++++.+. +.-.+++++++.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 356777888999999765 35789999864321 12344568888888774 3334677776654 2
Q ss_pred EEEeeeccCcHHHH-----------------Hhccc--ccCCCC--hHHHHHHHHHHHH-------------------HH
Q 038671 512 IVYEYLEMGSLAMI-----------------LSNDA--AAKDLG--WTKRMNVIKGVVD-------------------AL 551 (707)
Q Consensus 512 lv~e~~~~~~L~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~i~~-------------------~l 551 (707)
+||||++|.++..- +|... ..++.. +.++.++..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 89999998765310 12111 112222 3445555544322 12
Q ss_pred HHH----HhC-CCCCeEecCCCCCCeeecCC----CCeEEecccccee
Q 038671 552 SYM----HND-CFPPIVHRDISSKNVLLDLE----NEAHVSDFGTAKF 590 (707)
Q Consensus 552 ~~L----H~~-~~~~ivH~dlk~~Nil~~~~----~~~kl~Dfg~~~~ 590 (707)
++| ... ....++|+|+.+.||+++.+ +.+.++||.++..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 333 221 12368999999999999876 7899999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0026 Score=58.31 Aligned_cols=104 Identities=18% Similarity=0.135 Sum_probs=68.3
Q ss_pred cCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCCc
Q 038671 519 MGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW 598 (707)
Q Consensus 519 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 598 (707)
.-+|.+.+... ..++++.++|.++.|.+.+|.-.-.... . ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 32 ~vSL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 32 ALSLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cccHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc---------
Confidence 35888998643 5689999999999999999888732111 1 1333457899999999998764 1110
Q ss_pred cccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 038671 599 AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP 640 (707)
Q Consensus 599 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p 640 (707)
.....+.|||... ...+.+.=|||||+++|..+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123466888753 3456778899999999999975555
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0023 Score=67.60 Aligned_cols=74 Identities=16% Similarity=0.081 Sum_probs=46.8
Q ss_pred CceeeecCCeeEEEEEcCC-CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCc-eeeeeeeeecCCceeEEEeeec
Q 038671 441 EHCIGKGGQGSVYKAELPS-GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN-IVKFYGFCSHARHSFIVYEYLE 518 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~ 518 (707)
.+.|+.|....+|++...+ ++.+++|+........ . ...+|..++..+...+ .+++++++. . .+|+||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-i---dR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-I---NREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-S---CHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-c---CHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeC
Confidence 3568888899999997765 5788999875422111 0 1146788888775333 366777763 2 25999998
Q ss_pred cCcH
Q 038671 519 MGSL 522 (707)
Q Consensus 519 ~~~L 522 (707)
|.++
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7655
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0024 Score=54.46 Aligned_cols=37 Identities=30% Similarity=0.248 Sum_probs=20.5
Q ss_pred CCcEEEcccCcCcccCCccccCCCCCCeeeccccccc
Q 038671 52 QITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLR 88 (707)
Q Consensus 52 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~ 88 (707)
+|++|+|++|+|+.+.++.|..+++|++|+|++|.+.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4555555555555555555555555555555555543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0034 Score=64.65 Aligned_cols=74 Identities=12% Similarity=0.096 Sum_probs=42.9
Q ss_pred CceeeecCCeeEEEEEcCC---------CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCce
Q 038671 441 EHCIGKGGQGSVYKAELPS---------GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHS 510 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~ 510 (707)
.+.++.|....+|++...+ ++.+++|+...... . ......|.++++.+. +.-++++++.. . -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~---~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-E---LYNTISEFEVYKTMSKYKIAPQLLNTF--N--G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-G---TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-c---eecHHHHHHHHHHHHhcCCCCceEEec--C--C
Confidence 3567788888999997653 26889998754211 1 112346777777664 22245666544 2 3
Q ss_pred eEEEeeeccCcH
Q 038671 511 FIVYEYLEMGSL 522 (707)
Q Consensus 511 ~lv~e~~~~~~L 522 (707)
++||||++|.++
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999987643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.37 E-value=0.016 Score=58.76 Aligned_cols=32 Identities=25% Similarity=0.348 Sum_probs=28.3
Q ss_pred CCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 560 PPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 560 ~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
..++|+|+.+.||+++.++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 37999999999999998889999999888653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.12 E-value=0.073 Score=55.28 Aligned_cols=141 Identities=9% Similarity=0.092 Sum_probs=82.4
Q ss_pred CceeeecCCeeEEEEEcCC--------CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCcee
Q 038671 441 EHCIGKGGQGSVYKAELPS--------GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 511 (707)
.+.+..|-...+|++...+ ++.+++|+.......- -...+|.++++.+. +.-.+++++.+. -+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~----idR~~E~~~l~~L~~~gi~P~l~~~~~----~~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF----YDSKVELDVFRYLSNINIAPNIIADFP----EG 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC----CCHHHHHHHHHHHHHTTSSCCEEEEET----TE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh----cCHHHHHHHHHHHHhcCCCCCEEEEcC----CC
Confidence 3567778889999997653 5789999865432111 11245677776663 333456665432 26
Q ss_pred EEEeeeccCcHHH-----------H------Hhcccc----------cCCCChHHHHHHHHHH-----------------
Q 038671 512 IVYEYLEMGSLAM-----------I------LSNDAA----------AKDLGWTKRMNVIKGV----------------- 547 (707)
Q Consensus 512 lv~e~~~~~~L~~-----------~------l~~~~~----------~~~l~~~~~~~i~~~i----------------- 547 (707)
+|+||++|.++.. . +|.... ..+.-+.++.++..++
T Consensus 147 ~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~ 226 (424)
T 3mes_A 147 RIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYS 226 (424)
T ss_dssp EEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHH
T ss_pred EEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHH
Confidence 8999999876421 0 111111 1111234444443322
Q ss_pred --HHHHHHHHh---------------------CCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 548 --VDALSYMHN---------------------DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 548 --~~~l~~LH~---------------------~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
...+++|.+ .....++|+|+.+.||+ +.++.+.++||.++..
T Consensus 227 ~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 227 KILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 122333321 11136899999999999 7788999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.41 E-value=0.11 Score=53.99 Aligned_cols=30 Identities=23% Similarity=0.411 Sum_probs=25.4
Q ss_pred CeEecCCCCCCeee------cCCCCeEEecccccee
Q 038671 561 PIVHRDISSKNVLL------DLENEAHVSDFGTAKF 590 (707)
Q Consensus 561 ~ivH~dlk~~Nil~------~~~~~~kl~Dfg~~~~ 590 (707)
.++|+|+.+.||++ ++++.++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4466799999999865
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.19 E-value=0.18 Score=46.24 Aligned_cols=115 Identities=9% Similarity=0.096 Sum_probs=80.9
Q ss_pred CCCceeeeeeeeecCCceeEEEeeec-cCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCC
Q 038671 493 RHRNIVKFYGFCSHARHSFIVYEYLE-MGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKN 571 (707)
Q Consensus 493 ~h~niv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~N 571 (707)
.||+++.. .+-.+.+.+.+.++.-+ +-++.. -+..+...+++++.+|+....++++. +|--+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-------ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-------IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-------GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-------HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 58888766 45555566655565433 223322 23478899999999999999888777 899999999
Q ss_pred eeecCCCCeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 038671 572 VLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 642 (707)
Q Consensus 572 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 642 (707)
++++.++.+++.-.|....+. |. ..+...=.-.+=+++..+++|+..|+
T Consensus 110 L~f~~~~~p~i~~RGik~~l~-----------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVVD-----------------PL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTTBS-----------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccCCC-----------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999998877654322 22 12222233456788899999999986
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.75 E-value=0.64 Score=42.78 Aligned_cols=114 Identities=12% Similarity=0.099 Sum_probs=78.6
Q ss_pred CCCceeeeeeeeecCCceeEEEeeec-cCcHHHHHhcccccCCCChHHHHHHHHHHHHHHH-HHHhCCCCCeEecCCCCC
Q 038671 493 RHRNIVKFYGFCSHARHSFIVYEYLE-MGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALS-YMHNDCFPPIVHRDISSK 570 (707)
Q Consensus 493 ~h~niv~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~ivH~dlk~~ 570 (707)
.||++ --.+-.+++.+.+.++.-+ +-+.... +.++...+++++.+|+.... ++++. +|--+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCc
Confidence 57888 3333356666666666543 3344433 23788999999999999888 77766 89999999
Q ss_pred CeeecCCCCeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 038671 571 NVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRD 642 (707)
Q Consensus 571 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 642 (707)
|++++.++.+++.-.|.-..+ +|.. .+...=.-.+=+++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l-----------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL-----------------PPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB-----------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcccC-----------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999887765432 3322 1111123356678888888988875
|
| >2lz0_A Uncharacterized protein; hypothetical leucine rich repeat protein, structural genomic unknown function; NMR {Bacteroides capillosus} | Back alignment and structure |
|---|
Probab=84.73 E-value=1.5 Score=34.71 Aligned_cols=47 Identities=15% Similarity=0.130 Sum_probs=28.0
Q ss_pred CccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCC
Q 038671 108 NHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS 155 (707)
Q Consensus 108 n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~ 155 (707)
..++.+...+|.++.+|+.+.|-.+ ++.+...+|.+|.+|+.+.+..
T Consensus 6 ~~vt~I~~~aF~~c~~L~~i~iP~~-v~~Ig~~aF~~C~~L~~i~~~~ 52 (100)
T 2lz0_A 6 EPVVGMDKSLFAGNTVIREITVQPN-IGLLYDGMFSGCTALEKLILTG 52 (100)
T ss_dssp CCCCSSCSCTTTTCTTCCCEEECTT-SSCCCTTSSTTCTTCCCEEECC
T ss_pred CccCEecHHHhcCCCCCcEEEcCCc-hheEcHHHHhccCCccEEEEcC
Confidence 3455556666666666666666654 3345556666666666666654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 707 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-55 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-53 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-50 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-50 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-48 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-47 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-39 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-39 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-37 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-35 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-29 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-26 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-09 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-19 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.001 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-14 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-12 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-11 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 5e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-10 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-09 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 7e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-08 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-08 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-07 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-07 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-07 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 1e-60
Identities = 71/282 (25%), Positives = 120/282 (42%), Gaps = 22/282 (7%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTL 489
EI IG G G+VYK + VAVK + P+ Q F NEV L
Sbjct: 4 EIPD--GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVL 58
Query: 490 TGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD 549
RH NI+ F G+ + IV ++ E SL L K +++ +
Sbjct: 59 RKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQ 115
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGY 607
+ Y+H I+HRD+ S N+ L + + DFG A S + + +L+G+ +
Sbjct: 116 GMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 608 VAPELAYTMK---VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP 664
+APE+ + + DVY+FG++ E++ G+ P S+I++ + + L P
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSP 229
Query: 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
L N + +M CL + + RP ++ ++
Sbjct: 230 DLSKVRSNCPKAMKRLMA---ECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 1e-58
Identities = 65/272 (23%), Positives = 112/272 (41%), Gaps = 20/272 (7%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+G G G V+ VAVK L S FL E + ++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS----LKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
+V+ Y + +I+ EY+E GSL L + K L K +++ + + ++++
Sbjct: 69 RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIE 126
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE-LAGTYGYVAPELAY 614
+HRD+ + N+L+ ++DFG A+ ++ + E + APE
Sbjct: 127 ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674
T K DV+SFG+L E++ +N E+ N R+ P N
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPY------PGMTNPEVIQNLERGYRMVRPD-NCP 236
Query: 675 DKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
++L +M C E PE RPT + +L+
Sbjct: 237 EELYQLMR---LCWKERPEDRPTFDYLRSVLE 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-57
Identities = 68/271 (25%), Positives = 121/271 (44%), Gaps = 18/271 (6%)
Query: 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
D++ + IG G G K G+I+ K+ +E A +Q ++EV L ++H
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHP 63
Query: 496 NIVKFYGFCSHARHS--FIVYEYLEMGSLAMILSNDAAAKD-LGWTKRMNVIKGVVDALS 552
NIV++Y ++ +IV EY E G LA +++ + L + V+ + AL
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 553 YMH--NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAP 610
H +D ++HRD+ NV LD + + DFG A+ L D+S GT Y++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670
E M EK D++S G L E+ P + + + ++ + +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFT--------AFSQKELAGKIREGKFRRIP 235
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQKV 701
+ D+L I+ L+ RP+++++
Sbjct: 236 YRYSDELNEIIT---RMLNLKDYHRPSVEEI 263
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 6e-56
Identities = 61/272 (22%), Positives = 113/272 (41%), Gaps = 20/272 (7%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
++ IG G G V+ + + VA+K + S+++F+ E + + + H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT----IREGAMSEEDFIEEAEVMMKLSHP 60
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
+V+ YG C +V+E++E G L+ L + + V + ++Y+
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLE 118
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE-LAGTYGYVAPELAY 614
++HRD++++N L+ VSDFG +F+ D + + +PE+
Sbjct: 119 E---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674
+ + K DV+SFGVL EV + SN E+ + RL P
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKI------PYENRSNSEVVEDISTGFRLYKPRLAST 229
Query: 675 DKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ ++ C E PE RP ++ + L
Sbjct: 230 H----VYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-55
Identities = 72/275 (26%), Positives = 122/275 (44%), Gaps = 23/275 (8%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
D +G G G V + VA+K + S+ EF+ E K + + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM----IKEGSMSEDEFIEEAKVMMNLSHE 59
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
+V+ YG C+ R FI+ EY+ G L L + + + K V +A+ Y+
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE-LAGTYGYVAPELAY 614
+HRD++++N L++ + VSDFG ++++ D + + PE+
Sbjct: 118 ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174
Query: 615 TMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673
K + K D+++FGVL E+ GK P + +N E A + RL P H
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYE-------RFTNSETAEHIAQGLRLYRP-HLA 226
Query: 674 QDKLISIMEVAISCLDESPESRPTIQKV-SQLLKI 707
+K+ +IM SC E + RPT + + S +L +
Sbjct: 227 SEKVYTIMY---SCWHEKADERPTFKILLSNILDV 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 9e-55
Identities = 68/300 (22%), Positives = 120/300 (40%), Gaps = 42/300 (14%)
Query: 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR 493
+DF+ +G G G V+K PSG ++A K H L + A + + + E++ L
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECN 62
Query: 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
IV FYG I E+++ GSL +L A + V V+ L+Y
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTY 119
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELA 613
+ I+HRD+ N+L++ E + DFG + L +N GT Y++PE
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERL 175
Query: 614 YTMKVTEKCDVYSFGVLALEVIKGKHP------------------------------RDF 643
+ + D++S G+ +E+ G++P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 644 ISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAI--SCLDESPESRPTIQKV 701
S S +A+ E+LD + P + + S+ CL ++P R ++++
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 3e-54
Identities = 69/267 (25%), Positives = 117/267 (43%), Gaps = 21/267 (7%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
DF+ +GKG G+VY A S I+A+K + + + EV+ + +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
NI++ YG+ A +++ EY +G++ L + I + +ALSY
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYC 122
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
H+ ++HRDI +N+LL E ++DFG + SS L GT Y+ PE+
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMIE 177
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674
EK D++S GVL E + GK P + ++ + + P V
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFE--------ANTYQETYKRISRVEFTFPDF-VT 228
Query: 675 DKLISIMEVAISCLDESPESRPTIQKV 701
+ ++ L +P RP +++V
Sbjct: 229 EGARDLIS---RLLKHNPSQRPMLREV 252
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 2e-53
Identities = 70/278 (25%), Positives = 114/278 (41%), Gaps = 22/278 (7%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTL 489
EI R E +G+G G V+ VA+K L S + FL E + +
Sbjct: 13 EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKT----LKPGTMSPEAFLQEAQVM 66
Query: 490 TGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD 549
+RH +V+ Y S +IV EY+ GSL L + K L + +++ +
Sbjct: 67 KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIAS 124
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE-LAGTYGYV 608
++Y+ VHRD+ + N+L+ V+DFG A+ ++ + + +
Sbjct: 125 GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668
APE A + T K DV+SFG+L E+ N E+ R+P
Sbjct: 182 APEAALYGRFTIKSDVWSFGILLTELTTKGRV------PYPGMVNREVLDQVERGYRMPC 235
Query: 669 PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
P + L +M C + PE RPT + + L+
Sbjct: 236 PP-ECPESLHDLMC---QCWRKEPEERPTFEYLQAFLE 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 183 bits (465), Expect = 5e-53
Identities = 66/270 (24%), Positives = 123/270 (45%), Gaps = 24/270 (8%)
Query: 438 FDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
F D IG G G+VY A + + E+VA+KK Q+ + EV+ L +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
+++ G +++V EY + ++ + K L + V G + L+Y+H+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS 133
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTM 616
++HRD+ + N+LL + DFG+A + P +S GT ++APE+ M
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAM 186
Query: 617 ---KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673
+ K DV+S G+ +E+ + K P + + + + + S +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLF-------NMNAMSALYHIAQNESPALQSGHW 239
Query: 674 QDKLISIMEVAISCLDESPESRPTIQKVSQ 703
+ + ++ SCL + P+ RPT + + +
Sbjct: 240 SEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (460), Expect = 2e-52
Identities = 66/298 (22%), Positives = 123/298 (41%), Gaps = 37/298 (12%)
Query: 428 YEEIIRVTNDFDDE---------HCIGKGGQGSVYKAELPS----GEIVAVKKFHSPLPS 474
+E+ +F E IG G G V L VA+K S
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 475 EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKD 534
+ +++FL+E + H N++ G + + I+ E++E GSL L +
Sbjct: 69 KQ--RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 535 LGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594
+ + +++G+ + Y+ + VHRD++++N+L++ VSDFG ++FL+ D
Sbjct: 127 --VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 595 SSNWAELA-----GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSIS 648
+S+ + + APE K T DV+S+G++ EV+ G+ P
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW------ 235
Query: 649 SSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+N ++ D RLP P + ++ + C + RP ++ L
Sbjct: 236 -DMTNQDVINAIEQDYRLPPPMDCPSA----LHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-52
Identities = 70/272 (25%), Positives = 109/272 (40%), Gaps = 24/272 (8%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+ IGKG G V + G VAVK + A+ Q FL E +T +RH
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60
Query: 496 NIVKFYGFCSHARHS-FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
N+V+ G + +IV EY+ GSL L LG + V +A+ Y+
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
VHRD++++NVL+ +N A VSDFG K SS + APE
Sbjct: 120 EG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALR 173
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674
K + K DV+SFG+L E+ ++ ++ P
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRV------PYPRIPLKDVVPRVEKGYKMDAPDG-CP 226
Query: 675 DKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ +M+ +C RP+ ++ + L+
Sbjct: 227 PAVYEVMK---NCWHLDAAMRPSFLQLREQLE 255
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 9e-52
Identities = 62/283 (21%), Positives = 124/283 (43%), Gaps = 26/283 (9%)
Query: 428 YEEIIRVTN---DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFL 483
YE + R N ++ +G G G VYKA+ + + A K + E+ ++++
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYM 57
Query: 484 NEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNV 543
E+ L H NIVK + + +I+ E+ G++ ++ + L ++ V
Sbjct: 58 VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVV 115
Query: 544 IKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAG 603
K +DAL+Y+H+ I+HRD+ + N+L L+ + ++DFG + G
Sbjct: 116 CKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 172
Query: 604 TYGYVAPELAYTM-----KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIAL 658
T ++APE+ K DV+S G+ +E+ + + P + + + +
Sbjct: 173 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-----ELNPMRVLLKI 227
Query: 659 NEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
+ P L PS ++ CL+++ ++R T ++
Sbjct: 228 AKSEPPTLAQPSR-WSSNFKDFLK---KCLEKNVDARWTTSQL 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-51
Identities = 63/270 (23%), Positives = 116/270 (42%), Gaps = 25/270 (9%)
Query: 438 FDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
FD E IG+G +VYK + VA + ++ + +Q F E + L G++H N
Sbjct: 13 FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 69
Query: 497 IVKFYGFCSHA----RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALS 552
IV+FY + +V E + G+L L K + + + ++ L
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQ 126
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE 611
++H PPI+HRD+ N+ + + D G A + + + GT ++APE
Sbjct: 127 FLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPE 183
Query: 612 LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671
+ Y K E DVY+FG+ LE+ ++P S + +I + +
Sbjct: 184 M-YEEKYDESVDVYAFGMCMLEMATSEYP------YSECQNAAQIYRRVTSGVKPASFDK 236
Query: 672 NVQDKLISIMEVAISCLDESPESRPTIQKV 701
++ I+E C+ ++ + R +I+ +
Sbjct: 237 VAIPEVKEIIE---GCIRQNKDERYSIKDL 263
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 177 bits (449), Expect = 4e-51
Identities = 60/273 (21%), Positives = 112/273 (41%), Gaps = 20/273 (7%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
D +H +G G G VY+ VAVK L + +EFL E + I+H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT----LKEDTMEVEEFLKEAAVMKEIKH 72
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
N+V+ G C+ +I+ E++ G+L L + +++ + + + A+ Y+
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN-WAELAGTYGYVAPELA 613
+HRD++++N L+ + V+DFG ++ + D+ A + APE
Sbjct: 132 EK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 614 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673
K + K DV++FGVL E+ +L +
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPY-------PGIDLSQVYELLEKDYRMERPEGC 241
Query: 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+K+ +M +C +P RP+ ++ Q +
Sbjct: 242 PEKVYELMR---ACWQWNPSDRPSFAEIHQAFE 271
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 6e-51
Identities = 66/274 (24%), Positives = 112/274 (40%), Gaps = 26/274 (9%)
Query: 440 DEHCIGKGGQGSVYKAELP---SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN 496
++ +G G G+V K + VAVK + ++ A + E L E + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPY 69
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
IV+ G C +V E E+G L L + + + + ++ V + Y+
Sbjct: 70 IVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLE- 124
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA---ELAGTYGYVAPELA 613
VHRD++++NVLL ++ A +SDFG +K L+ D + + + APE
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 614 YTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672
K + K DV+SFGVL E G+ P E+ R+ P+
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYR-------GMKGSEVTAMLEKGERMGCPA-G 234
Query: 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
++ +M C E+RP V L+
Sbjct: 235 CPREMYDLMN---LCWTYDVENRPGFAAVELRLR 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (448), Expect = 9e-51
Identities = 59/300 (19%), Positives = 119/300 (39%), Gaps = 44/300 (14%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTL 489
N+ + IG+G G V++A P +VAVK ++M Q +F E +
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALM 70
Query: 490 TGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSN--------------------- 528
+ NIVK G C+ + +++EY+ G L L +
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 529 DAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588
L +++ + + V ++Y+ VHRD++++N L+ ++DFG +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLS 187
Query: 589 KFLKPDSSNWAE--LAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 646
+ + A+ A ++ PE + + T + DV+++GV+ E+ +
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY--- 244
Query: 647 ISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
E + + D + N +L ++M C + P RP+ + ++L+
Sbjct: 245 ----GMAHEEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSFCSIHRILQ 297
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 1e-50
Identities = 61/269 (22%), Positives = 125/269 (46%), Gaps = 20/269 (7%)
Query: 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI 492
+ IG+G G+VY A ++ +G+ VA+++ + + ++ +NE+ +
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMREN 74
Query: 493 RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALS 552
++ NIV + ++V EYL GSL +++ + + V + + AL
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALE 130
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPEL 612
++H++ ++HRDI S N+LL ++ ++DFG + P+ S + + GT ++APE+
Sbjct: 131 FLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 613 AYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672
K D++S G++A+E+I+G+ P + + + P L P
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-----NENPLRALYLIATNGTPELQNPEK- 241
Query: 673 VQDKLISIMEVAISCLDESPESRPTIQKV 701
+ + CLD E R + +++
Sbjct: 242 LSAIFRDFLN---RCLDMDVEKRGSAKEL 267
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 2e-50
Identities = 64/270 (23%), Positives = 106/270 (39%), Gaps = 26/270 (9%)
Query: 444 IGKGGQGSVYKAEL---PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
+G G GSV + VA+K +E A +E + E + + + + IV+
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK--QGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
G C A +V E G L L +++ + ++ V + Y+
Sbjct: 75 IGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLE---EK 128
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE---LAGTYGYVAPELAYTMK 617
VHRD++++NVLL + A +SDFG +K L D S + + APE K
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 188
Query: 618 VTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDK 676
+ + DV+S+GV E + G+ P E+ R+ P +
Sbjct: 189 FSSRSDVWSYGVTMWEALSYGQKPYK-------KMKGPEVMAFIEQGKRMECPP-ECPPE 240
Query: 677 LISIMEVAISCLDESPESRPTIQKVSQLLK 706
L ++M C E RP V Q ++
Sbjct: 241 LYALMS---DCWIYKWEDRPDFLTVEQRMR 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-50
Identities = 65/270 (24%), Positives = 110/270 (40%), Gaps = 21/270 (7%)
Query: 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
D+D +G+G G V A + E VAVK + + + E+ + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNH 62
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
N+VKFYG ++ EY G L + D + ++ + Y+
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYL 119
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPEL 612
H I HRDI +N+LLD + +SDFG A + ++ ++ GT YVAPEL
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 613 AYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671
+ E DV+S G++ ++ G+ P D S + + + P
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWD------QPSDSCQEYSDWKEKKTYLNPWK 230
Query: 672 NVQDKLISIMEVAISCLDESPESRPTIQKV 701
+ ++++ L E+P +R TI +
Sbjct: 231 KIDSAPLALLH---KILVENPSARITIPDI 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 8e-50
Identities = 62/296 (20%), Positives = 114/296 (38%), Gaps = 40/296 (13%)
Query: 441 EHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKF 500
+ IGKG G V++ + GE VAVK F S E+ +RH NI+ F
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENILGF 62
Query: 501 YGFCSHARHS----FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
+ + ++V +Y E GSL L+ + + + L+++H
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHM 118
Query: 557 DCF-----PPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW----AELAGTYGY 607
+ P I HRD+ SKN+L+ ++D G A + GT Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 608 VAPELAYTM------KVTEKCDVYSFGVLALEVIKGKHP-----------RDFISSISSS 650
+APE+ + ++ D+Y+ G++ E+ + D + S S
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238
Query: 651 SSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
++ + L P +P + + L + ++ C + +R T ++ + L
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-48
Identities = 67/279 (24%), Positives = 115/279 (41%), Gaps = 25/279 (8%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGE-----IVAVKKFHSPLPSEMASQQEFLNEVKTLT 490
+ + IG G G VYK L + VA+K + + + +FL E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMG 64
Query: 491 GIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDA 550
H NI++ G S + I+ EY+E G+L L + + + +++G+
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAG 122
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW---AELAGTYGY 607
+ Y+ N VHRD++++N+L++ VSDFG ++ L+ D + +
Sbjct: 123 MKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 608 VAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667
APE K T DV+SFG++ EV+ + SN E+ RLP
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW------ELSNHEVMKAINDGFRLP 233
Query: 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
TP I ++ + C + RP + +L
Sbjct: 234 TPMDCPSA----IYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-48
Identities = 61/272 (22%), Positives = 104/272 (38%), Gaps = 26/272 (9%)
Query: 444 IGKGGQGSVYKAELP----SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK 499
IG+G G VY L AVK + +++ +FL E + H N++
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 500 FYGFCSHARHS-FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC 558
G C + S +V Y++ G L + N+ + + M
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA-----KGMKFLA 147
Query: 559 FPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE----LAGTYGYVAPELAY 614
VHRD++++N +LD + V+DFG A+ + + ++A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674
T K T K DV+SFGVL E++ P + +I + + RL P +
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP------PYPDVNTFDITVYLLQGRRLLQPEYCPD 261
Query: 675 DKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ EV + C E RP+ ++ +
Sbjct: 262 P----LYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-48
Identities = 57/274 (20%), Positives = 100/274 (36%), Gaps = 21/274 (7%)
Query: 437 DFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
DF +G+G +V A EL + A+K + E ++ + H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
VK Y + Y + G L + T +V AL Y+H
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLH 125
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA--ELAGTYGYVAPELA 613
I+HRD+ +N+LL+ + ++DFGTAK L P+S GT YV+PEL
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
Query: 614 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673
+ D+++ G + +++ G P + N + +++ P
Sbjct: 183 TEKSACKSSDLWALGCIIYQLVAGLPPFR--------AGNEYLIFQKIIKLEYDFPEK-F 233
Query: 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLKI 707
K ++E L R +++ +
Sbjct: 234 FPKARDLVE---KLLVLDATKRLGCEEMEGYGPL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-47
Identities = 60/279 (21%), Positives = 105/279 (37%), Gaps = 24/279 (8%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPS----GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG 491
D +G G G V + E + VAVK + S+ + +F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 492 IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDAL 551
+ HRN+++ YG +V E +GSL L LG R V + +
Sbjct: 68 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY--AVQVAEGM 124
Query: 552 SYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA---ELAGTYGYV 608
Y+ + +HRD++++N+LL + + DFG + L + ++ + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667
APE T + D + FGV E+ G+ P + +I +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-------GLNGSQILHKIDKEGERL 234
Query: 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ + ++M C PE RPT + L
Sbjct: 235 PRPEDCPQDIYNVMV---QCWAHKPEDRPTFVALRDFLL 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-47
Identities = 61/307 (19%), Positives = 110/307 (35%), Gaps = 47/307 (15%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELPS------GEIVAVKKFHSPLPSEMASQQEFL 483
E R + + +G G G V A VAVK S ++ +
Sbjct: 33 EFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE--REALM 88
Query: 484 NEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSN-------------- 528
+E+K +T + H NIV G C+ + ++++EY G L L +
Sbjct: 89 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 529 ------DAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHV 582
+ L + + V + ++ VHRD++++NVL+ +
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKI 205
Query: 583 SDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKH 639
DFG A+ + DS+ ++APE + T K DV+S+G+L E+ G +
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 640 PRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQ 699
P + + +++ IM+ SC RP+
Sbjct: 266 PYP-------GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFP 315
Query: 700 KVSQLLK 706
++ L
Sbjct: 316 NLTSFLG 322
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 169 bits (430), Expect = 1e-47
Identities = 56/271 (20%), Positives = 108/271 (39%), Gaps = 20/271 (7%)
Query: 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI 492
V + +D +G G G V++ E +G A K +P S+ ++ E++T++ +
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVL 80
Query: 493 RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALS 552
RH +V + ++YE++ G L +++ + + + ++ V L
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLC 138
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAKFLKPDSSNWAELAGTYGYVAP 610
+MH + VH D+ +N++ + + DFG L P S GT + AP
Sbjct: 139 HMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK-VTTGTAEFAAP 194
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670
E+A V D++S GVL+ ++ G P + L + + S
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG----GENDDETLRNVKSCDWNMDDSAFS 250
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQKV 701
+ + + L P +R TI +
Sbjct: 251 -GISEDGKDFIR---KLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 168 bits (427), Expect = 3e-47
Identities = 54/271 (19%), Positives = 107/271 (39%), Gaps = 20/271 (7%)
Query: 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI 492
V + +D +G G G V++ E +G + K ++P P + + NE+ + +
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQL 83
Query: 493 RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALS 552
H ++ + ++ E+L G L ++ + + + +N ++ + L
Sbjct: 84 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLK 141
Query: 553 YMHNDCFPPIVHRDISSKNVLLDLENEAHV--SDFGTAKFLKPDSSNWAELAGTYGYVAP 610
+MH IVH DI +N++ + + + V DFG A L PD T + AP
Sbjct: 142 HMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAP 197
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670
E+ V D+++ GVL ++ G P + + L+ + S
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET----LQNVKRCDWEFDEDAFS 253
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQKV 701
V + ++ + L + P R T+
Sbjct: 254 S-VSPEAKDFIK---NLLQKEPRKRLTVHDA 280
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-47
Identities = 62/303 (20%), Positives = 120/303 (39%), Gaps = 44/303 (14%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFL 483
E R N +G G G V +A + VAVK + + ++ +
Sbjct: 19 EFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTEREALM 74
Query: 484 NEVKTLTGI-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSN-------------- 528
+E+K L+ + H NIV G C+ + ++ EY G L L
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 529 -DAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGT 587
+ L ++ V ++++ + +HRD++++N+LL + DFG
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGL 191
Query: 588 AKFLKPDSSNWA--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFIS 645
A+ +K DS+ ++APE + T + DV+S+G+ E+
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-- 249
Query: 646 SISSSSSNLEIALNEMLD--PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703
++ +M+ R+ +P H + + ++ +C D P RPT +++ Q
Sbjct: 250 -----GMPVDSKFYKMIKEGFRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQ 300
Query: 704 LLK 706
L++
Sbjct: 301 LIE 303
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 8e-47
Identities = 61/288 (21%), Positives = 110/288 (38%), Gaps = 33/288 (11%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSG---EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI 492
ND + IG+G G V KA + A+K+ + ++F E++ L +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKL 67
Query: 493 -RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSN-------------DAAAKDLGWT 538
H NI+ G C H + ++ EY G+L L ++ A L
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 539 KRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW 598
+ ++ V + Y+ +HRD++++N+L+ A ++DFG ++ +
Sbjct: 128 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
Query: 599 AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIAL 658
++A E T DV+S+GVL E++ + E+
Sbjct: 185 M-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP------YCGMTCAELYE 237
Query: 659 NEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
RL P N D++ +M C E P RP+ ++ L
Sbjct: 238 KLPQGYRLEKPL-NCDDEVYDLMR---QCWREKPYERPSFAQILVSLN 281
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 4e-46
Identities = 69/283 (24%), Positives = 114/283 (40%), Gaps = 27/283 (9%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELPS----GEIVAVKKFHSPLPSEMASQQEFLNE 485
EI R + CIG+G G V++ S VA+K + + +++FL E
Sbjct: 3 EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQE 58
Query: 486 VKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIK 545
T+ H +IVK G + +I+ E +G L L L +
Sbjct: 59 ALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAY 115
Query: 546 GVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA-ELAGT 604
+ AL+Y+ + VHRDI+++NVL+ + + DFG +++++ + A +
Sbjct: 116 QLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 605 YGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEMLD 663
++APE + T DV+ FGV E++ G P N ++
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ-------GVKNNDVIGRIENG 225
Query: 664 PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
RLP P N L S+M C P RP ++ L
Sbjct: 226 ERLPMPP-NCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLS 264
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (409), Expect = 1e-45
Identities = 63/275 (22%), Positives = 117/275 (42%), Gaps = 26/275 (9%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG 491
+++ ++ +G GG V+ A L VAVK + L + + F E +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 492 IRHRNIVKFYGFCSHARHS----FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGV 547
+ H IV Y + +IV EY++ +L I+ + + + + VI
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADA 120
Query: 548 VDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE---LAGT 604
AL++ H I+HRD+ N+++ N V DFG A+ + ++ + + GT
Sbjct: 121 CQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 605 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP 664
Y++PE A V + DVYS G + EV+ G+ P S + +A + +
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-------GDSPVSVAYQHVRED 230
Query: 665 RLPTPSH--NVQDKLISIMEVAISCLDESPESRPT 697
+P + + L +++ L ++PE+R
Sbjct: 231 PIPPSARHEGLSADLDAVVL---KALAKNPENRYQ 262
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (407), Expect = 6e-45
Identities = 65/278 (23%), Positives = 115/278 (41%), Gaps = 21/278 (7%)
Query: 428 YEEIIRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEV 486
+++ + + +D +G G V AE + ++VA+K + + NE+
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA--KKALEGKEGSMENEI 58
Query: 487 KTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG 546
L I+H NIV H +++ + + G L + +I
Sbjct: 59 AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQ 115
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLENE---AHVSDFGTAKFLKPDSSNWAELAG 603
V+DA+ Y+H+ IVHRD+ +N+L +E +SDFG +K P S G
Sbjct: 116 VLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS-TACG 171
Query: 604 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD 663
T GYVAPE+ ++ D +S GV+A ++ G P F + + E L +
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYD--ENDAKLFEQILKAEYE 227
Query: 664 PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
P ++ D + +++ PE R T ++
Sbjct: 228 FDSPYWD-DISDSAKDFIR---HLMEKDPEKRFTCEQA 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 9e-45
Identities = 56/273 (20%), Positives = 103/273 (37%), Gaps = 22/273 (8%)
Query: 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLT-GIR 493
DF +GKG G V+ AE + + A+K + + + E + L+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 494 HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSY 553
H + + + F V EYL G L + + ++ ++ L +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQF 118
Query: 554 MHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELA 613
+H+ IV+RD+ N+LLD + ++DFG K + GT Y+APE+
Sbjct: 119 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175
Query: 614 YTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673
K D +SFGVL E++ G+ P + E + + P +
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFH--------GQDEEELFHSIRMDNPFYPRW-L 226
Query: 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ + ++ PE R ++ + +
Sbjct: 227 EKEAKDLLV---KLFVREPEKRLGVR--GDIRQ 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-44
Identities = 61/285 (21%), Positives = 116/285 (40%), Gaps = 28/285 (9%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAE-LPSGE----IVAVKKFHSPLPSEMASQQEFLN 484
I++ T +F +G G G+VYK +P GE VA+K+ + +E L+
Sbjct: 4 RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILD 60
Query: 485 EVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVI 544
E + + + ++ + G C + ++ + + G L + ++G +N
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWC 117
Query: 545 KGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA--ELA 602
+ ++Y+ +VHRD++++NVL+ ++DFG AK L + +
Sbjct: 118 VQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 603 GTYGYVAPELAYTMKVTEKCDVYSFGVLALEVI-KGKHPRDFISSISSSSSNLEIALNEM 661
++A E T + DV+S+GV E++ G P D EI+
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-------GIPASEISSILE 227
Query: 662 LDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
RLP P D + + + C +SRP +++
Sbjct: 228 KGERLPQPPICTID----VYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 9e-44
Identities = 57/292 (19%), Positives = 112/292 (38%), Gaps = 32/292 (10%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFL 483
E+ R +G+G G VY+ VA+K + + M + EFL
Sbjct: 16 EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFL 71
Query: 484 NEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL-------SNDAAAKDLG 536
NE + ++V+ G S + + ++ E + G L L +N+
Sbjct: 72 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 537 WTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596
+K + + + D ++Y++ VHRD++++N ++ + + DFG + +
Sbjct: 132 LSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188
Query: 597 --NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL 654
+ +++PE T DV+SFGV+ E+ +
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-------PYQGLSN 241
Query: 655 EIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
E L +++ L N D L +M C +P+ RP+ ++ +K
Sbjct: 242 EQVLRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIK 290
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 4e-43
Identities = 51/261 (19%), Positives = 105/261 (40%), Gaps = 21/261 (8%)
Query: 444 IGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYG 502
+G+G G V++ E S + K + + Q E+ L RHRNI+ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKF----VKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 503 FCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562
+++E++ + ++ A +L + ++ + V +AL ++H+ I
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HNI 123
Query: 563 VHRDISSKNVLLDLENEAHV--SDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTE 620
H DI +N++ + + +FG A+ LKP + L Y APE+ V+
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEVHQHDVVST 182
Query: 621 KCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISI 680
D++S G L ++ G +P ++ +E +N + + +
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLA----ETNQQIIENIMNAEYTFDEEAFKE-ISIEAMDF 237
Query: 681 MEVAISCLDESPESRPTIQKV 701
++ L + +SR T +
Sbjct: 238 VD---RLLVKERKSRMTASEA 255
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (389), Expect = 1e-42
Identities = 46/287 (16%), Positives = 99/287 (34%), Gaps = 27/287 (9%)
Query: 432 IRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLT 490
+RV N + IG G G +Y + +GE VA+K + E K
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYK 57
Query: 491 GIRHRNIVKFYGFC-SHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD 549
++ + +C + ++ +V E L + + + + ++
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMIS 114
Query: 550 ALSYMHNDCFPPIVHRDISSKNVL---LDLENEAHVSDFGTAKFLKPDSSN-------WA 599
+ Y+H+ +HRD+ N L N ++ DFG AK + ++
Sbjct: 115 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALN 659
L GT Y + ++ + + D+ S G + + G P + + ++ E
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA-ATKRQKYERISE 230
Query: 660 EMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ + + + + + C + +P + QL +
Sbjct: 231 KKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 57/276 (20%), Positives = 105/276 (38%), Gaps = 23/276 (8%)
Query: 434 VTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVK---KFHSPLPSEMASQQEFLNEVKTL 489
V + +D +G G V K E +G A K K + S+++ EV L
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 490 TGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD 549
I+H N++ + + ++ E + G L L+ + L + +K +++
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILN 124
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEA----HVSDFGTAKFLKPDSSNWAELAGTY 605
+ Y+H+ I H D+ +N++L N + DFG A + + + GT
Sbjct: 125 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-NIFGTP 180
Query: 606 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPR 665
+VAPE+ + + D++S GV+ ++ G P + L +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG----DTKQETLANVSAVNYEFE 236
Query: 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
S N + L + P+ R TIQ
Sbjct: 237 DEYFS-NTSALAKDFIR---RLLVKDPKKRMTIQDS 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-42
Identities = 62/295 (21%), Positives = 113/295 (38%), Gaps = 39/295 (13%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPS--------GEIVAVKKFHSPLPSEMASQQEFLNEVK 487
+ +G+G G V AE VAVK S + + ++E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 70
Query: 488 TLTGI-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL-------------SNDAAAK 533
+ I +H+NI+ G C+ +++ EY G+L L + +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 534 DLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593
L ++ V + Y+ + +HRD++++NVL+ +N ++DFG A+ +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 187
Query: 594 DSSNWA--ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSS 651
++APE + T + DV+SFGVL E+
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------PYPGV 241
Query: 652 SNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
E+ R+ PS N ++L +M C P RPT +++ + L
Sbjct: 242 PVEELFKLLKEGHRMDKPS-NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLD 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 153 bits (388), Expect = 3e-42
Identities = 55/274 (20%), Positives = 103/274 (37%), Gaps = 24/274 (8%)
Query: 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
DF +G G G V+ +G A+K + + + +E L+ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
I++ +G A+ F++ +Y+E G L +L + + +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
I++RD+ +N+LLD ++DFG AK++ L GT Y+APE+
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVVS 174
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674
T + D +SFG+L E++ G P SN ++L+ L P
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTPFY--------DSNTMKTYEKILNAELRFPPF-FN 225
Query: 675 DKLISIMEVAISCLDESPESRPTIQKVS--QLLK 706
+ + ++ + R + +
Sbjct: 226 EDVKDLLS---RLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 154 bits (389), Expect = 6e-42
Identities = 57/272 (20%), Positives = 93/272 (34%), Gaps = 22/272 (8%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELP-SGEIVAVKKFHSPLPSEMASQQEFLNEV---KTLTG 491
NDF IG+GG G VY +G++ A+K + LNE ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 492 IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDAL 551
IV + + + G L LS ++ L
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGL 120
Query: 552 SYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE 611
+MHN +V+RD+ N+LLD +SD G A + + GT+GY+APE
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPE 175
Query: 612 -LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670
L + D +S G + ++++G P + + L + P
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR-----QHKTKDKHEIDRMTLTMAVELPD 230
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVS 702
+L S++E L R
Sbjct: 231 S-FSPELRSLLE---GLLQRDVNRRLGCLGRG 258
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 147 bits (373), Expect = 1e-40
Identities = 55/279 (19%), Positives = 112/279 (40%), Gaps = 29/279 (10%)
Query: 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQ------QEFLNEVKTL 489
+++ + +G+G V + P+ + AVK +++ + L EV L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 490 TGIR-HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVV 548
+ H NI++ F+V++ ++ G L L+ L + +++ ++
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALL 120
Query: 549 DALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYV 608
+ + +H IVHRD+ +N+LLD + ++DFG + L P E+ GT Y+
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR-EVCGTPSYL 176
Query: 609 APELAYTM------KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML 662
APE+ ++ D++S GV+ ++ G P L + ++
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH----RKQMLMLRMIMSGNY 232
Query: 663 DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
P D + ++ L P+ R T ++
Sbjct: 233 QFGSPEWDD-YSDTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (373), Expect = 2e-40
Identities = 59/291 (20%), Positives = 111/291 (38%), Gaps = 39/291 (13%)
Query: 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+ IG+G G VYKA+ GE A+KK E + E+ L ++H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
NIVK Y + +V+E+L+ ++ + L + + +++ ++Y H
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCH 117
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE-LAY 614
+ ++HRD+ +N+L++ E E ++DFG A+ + T Y AP+ L
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHP------------------------RDFISSISSS 650
+ K + D++S G + E++ G ++ +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 651 SSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
N + + L + D L+S L P R T ++
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGID-LLS------KMLKLDPNQRITAKQA 278
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-39
Identities = 61/278 (21%), Positives = 105/278 (37%), Gaps = 22/278 (7%)
Query: 433 RVT-NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLT 490
+VT NDFD +GKG G V +G A+K + + E + L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 491 GIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDA 550
RH + V EY G L LS + + + +V A
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERARFYGAEIVSA 117
Query: 551 LSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAP 610
L Y+H+ +V+RDI +N++LD + ++DFG K D + GT Y+AP
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670
E+ D + GV+ E++ G+ P + + E +L + P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY--------NQDHERLFELILMEEIRFPR 226
Query: 671 HNVQDKLISIMEVAISCLDESPESRPTIQK--VSQLLK 706
+ + S++ L + P+ R ++++
Sbjct: 227 T-LSPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVME 260
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (367), Expect = 1e-39
Identities = 44/277 (15%), Positives = 97/277 (35%), Gaps = 29/277 (10%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN-IVKFY 501
IG+G G +++ L + + VA+K + + +E +T + I Y
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 502 GFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP 561
F H+ +V + L ++ + K ++ + +H
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KS 121
Query: 562 IVHRDISSKNVLLDLENEAH-----VSDFGTAKFLKPDSSN-------WAELAGTYGYVA 609
+V+RDI N L+ N + V DFG KF + + L+GT Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 610 PELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669
+ + + D+ + G + + ++G P + + ++ I + P
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
+ ++ M + + ++ P + L
Sbjct: 242 A-GFPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-39
Identities = 59/281 (20%), Positives = 105/281 (37%), Gaps = 32/281 (11%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQ--QEFLNEVKTLTGIRHRNIVKF 500
+G+G +VYKA + +IVA+KK SE + L E+K L + H NI+
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 501 YGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFP 560
H + +V++++E +I N L + + + L Y+H
Sbjct: 66 LDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 561 PIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKV-T 619
I+HRD+ N+LLD ++DFG AK + + T Y APEL + ++
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 620 EKCDVYSFGVLALEVIKGKHPRDFISSI-------------------SSSSSNLEIALNE 660
D+++ G + E++ S + S +
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
L D L+ +++ +P +R T +
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQA 277
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 1e-38
Identities = 55/287 (19%), Positives = 108/287 (37%), Gaps = 31/287 (10%)
Query: 437 DFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+F IG+G G VYKA +GE+VA+KK +E + E+ L + H
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 496 NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMH 555
NIVK ++V+E+L + ++ + + + ++ L++ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCH 119
Query: 556 NDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPE-LAY 614
+ ++HRD+ +N+L++ E ++DFG A+ + T Y APE L
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIS--------------------SSSSNL 654
+ D++S G + E++ + S I +S +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 655 EIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
+ + + + + S++ L P R + +
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAA 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-38
Identities = 59/300 (19%), Positives = 107/300 (35%), Gaps = 39/300 (13%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKA------ELPSGEIVAVKKFHSPLPSEMASQQEFL 483
E R + +G+G G V +A + + VAVK + +
Sbjct: 9 EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALM 64
Query: 484 NEVKTLTGIRHR-NIVKFYGFCSHARHS-FIVYEYLEMGSLAMILSN------------- 528
+E+K L I H N+V G C+ ++ E+ + G+L+ L +
Sbjct: 65 SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 529 DAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588
D L + V + ++ + +HRD++++N+LL +N + DFG A
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA 181
Query: 589 KFLKPDSSNW--AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISS 646
+ + D + ++APE + T + DV+SFGVL E+
Sbjct: 182 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---- 237
Query: 647 ISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706
E + + ++ M C P RPT ++ + L
Sbjct: 238 --PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML---DCWHGEPSQRPTFSELVEHLG 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 5e-38
Identities = 55/274 (20%), Positives = 102/274 (37%), Gaps = 33/274 (12%)
Query: 436 NDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPL---PSEMASQQEFLNEVKTLTG 491
+ + +G GG GSVY + VA+K E+ + EV L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 492 IR--HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD 549
+ +++ + ++ E E + L + V++
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLE 121
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTAKFLKPDSSNWAELAGTYGYV 608
A+ + HN ++HRDI +N+L+DL E + DFG+ LK + + + GT Y
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYS 176
Query: 609 APE-LAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLP 667
PE + Y V+S G+L +++ G P + E++ ++
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--------------HDEEIIRGQVF 222
Query: 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
V + ++ CL P RPT +++
Sbjct: 223 FRQR-VSSECQHLIR---WCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 7e-38
Identities = 58/278 (20%), Positives = 107/278 (38%), Gaps = 27/278 (9%)
Query: 434 VTNDFD-DEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTG 491
+ +D+ +G G G V + + E A+K + EV+
Sbjct: 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWR 60
Query: 492 I-RHRNIVKFYGFCSHA----RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG 546
+ +IV+ + + IV E L+ G L + D + + ++K
Sbjct: 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKS 119
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLENE---AHVSDFGTAKFLKPDSSNWAELAG 603
+ +A+ Y+H+ I HRD+ +N+L + ++DFG AK +S
Sbjct: 120 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT-TPCY 175
Query: 604 TYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD 663
T YVAPE+ K + CD++S GV+ ++ G P ++ S +
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235
Query: 664 PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
P S V +++ ++ + L P R TI +
Sbjct: 236 FPNPEWSE-VSEEVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-37
Identities = 59/299 (19%), Positives = 106/299 (35%), Gaps = 35/299 (11%)
Query: 430 EIIRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKT 488
++ V + + IG+G G V A + + VA+KK Q L E+K
Sbjct: 2 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKI 59
Query: 489 LTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVV 548
L RH NI+ + YL + L + L + ++
Sbjct: 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQIL 119
Query: 549 DALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA---ELAGTY 605
L Y+H+ ++HRD+ N+LL+ + + DFG A+ PD + E T
Sbjct: 120 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 606 GYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHP----------------------RD 642
Y APE+ T+ D++S G + E++ + D
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236
Query: 643 FISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
I+ + N ++L N K + +++ L +P R +++
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQA 292
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 7e-37
Identities = 47/294 (15%), Positives = 99/294 (33%), Gaps = 32/294 (10%)
Query: 433 RVTNDFDDEHCIGKGGQGSVYKAE--LPSGEIVAVKKFHSPLPSEMASQQEF--LNEVKT 488
R ++ IG+G G V+KA G VA+K+ E + ++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 489 LTGIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLA---MILSNDAAAKDLGWTKRMNVIK 545
L H N+V+ + C+ +R L + + + +++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 546 GVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTY 605
++ L ++H+ +VHRD+ +N+L+ + ++DFG A+ + + T
Sbjct: 124 QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVVTL 179
Query: 606 GYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP------------------RDFISSI 647
Y APE+ D++S G + E+ + K
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 648 SSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKV 701
+ A + + ++ + ++ CL +P R +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSA 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-36
Identities = 60/290 (20%), Positives = 110/290 (37%), Gaps = 35/290 (12%)
Query: 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHR 495
+ D IG G G VY+A+L SGE+VA+KK ++ E++ + + H
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-------DKRFKNRELQIMRKLDHC 73
Query: 496 NIVKFYGFCSHA------RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD 549
NIV+ F + + +V +Y+ + A + L + +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAH-VSDFGTAKFLKPDSSNWAELAGTYGYV 608
+L+Y+H+ I HRDI +N+LLD + + DFG+AK L N + + Y
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190
Query: 609 APELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPT 668
+ T DV+S G + E++ G+ S + +++ +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 669 PSHNVQDKLISIMEVAIS-----------------CLDESPESRPTIQKV 701
+ + K I + L+ +P +R T +
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 6e-35
Identities = 51/286 (17%), Positives = 108/286 (37%), Gaps = 27/286 (9%)
Query: 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
++ IG+G G+V+KA+ + EIVA+K+ E L E+ L ++H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKH 60
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
+NIV+ + + +V+E+ + S + G V + L +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGL 114
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
++HRD+ +N+L++ E +++FG A+ ++ T Y P++ +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 615 TMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673
K+ + D++S G + E+ P + + + L + + P+ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 674 QDKLISIMEVAIS------------------CLDESPESRPTIQKV 701
K + S L +P R + ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (335), Expect = 8e-35
Identities = 55/274 (20%), Positives = 99/274 (36%), Gaps = 24/274 (8%)
Query: 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+ FD +G G G V + SG A+K ++ + LNE + L +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 495 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYM 554
+VK + ++V EY+ G + L +V Y+
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYL 157
Query: 555 HNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAY 614
H+ +++RD+ +N+L+D + V+DFG AK L GT +APE+
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR---VKGRTWTLCGTPEALAPEIIL 211
Query: 615 TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674
+ + D ++ GVL E+ G P ++ I + E + +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFF---------ADQPIQIYEKIVSGKVRFPSHFS 262
Query: 675 DKLISIMEVAISCLDESPESRPTIQK--VSQLLK 706
L ++ + L R K V+ +
Sbjct: 263 SDLKDLLR---NLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 6e-34
Identities = 56/282 (19%), Positives = 112/282 (39%), Gaps = 25/282 (8%)
Query: 436 NDFDDEHCIGKGGQGSVYKAEL----PSGEIVAVKKFH-SPLPSEMASQQEFLNEVKTLT 490
+F+ +G G G V+ +G++ A+K + + + + + E + L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 491 GIRHR-NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVD 549
IR +V + ++ +Y+ G L LS + + + +V
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVL 140
Query: 550 ALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA-ELAGTYGYV 608
AL ++H I++RDI +N+LLD ++DFG +K D + A + GT Y+
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 609 APELAYTMK--VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666
AP++ + D +S GVL E++ G P F ++ ++ +L
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--F--TVDGEKNSQAEISRRILKSEP 253
Query: 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQK--VSQLLK 706
P P + +++ L + P+ R ++ +
Sbjct: 254 PYPQE-MSALAKDLIQ---RLLMKDPKKRLGCGPRDADEIKE 291
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-33
Identities = 48/303 (15%), Positives = 103/303 (33%), Gaps = 47/303 (15%)
Query: 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH 494
+ ++ IG+G G V+KA +G+ VA+KK E L E+K L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKH 68
Query: 495 RNIVKFYGFCSHA--------RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKG 546
N+V C ++V+++ E ++ L + +
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------NVLVKFTLSEIKRV 122
Query: 547 VVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAE----LA 602
+ L+ ++ I+HRD+ + NVL+ + ++DFG A+ ++
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 603 GTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHP--------------------- 640
T Y PEL + D++ G + E+
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 641 RDFISSISSSSSNLEIALNEMLDPRLPT--PSHNVQDKLISIMEVAISCLDESPESRPTI 698
+ ++ + ++ L + ++ ++ + +++ L P R
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQRIDS 299
Query: 699 QKV 701
Sbjct: 300 DDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-33
Identities = 65/303 (21%), Positives = 120/303 (39%), Gaps = 39/303 (12%)
Query: 424 GKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEF 482
K +E V + D +G G G+V A + +G VA+KK + P SE+ +++
Sbjct: 10 TKTAWE----VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR-A 64
Query: 483 LNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE-YLEMGSLAMILSNDAAAKDLGWTKRM 541
E++ L +RH N++ + + YL M + L + LG +
Sbjct: 65 YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 124
Query: 542 NVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWAEL 601
++ ++ L Y+H HRD+ N+ ++ + E + DFG A+ + + +
Sbjct: 125 FLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY--- 178
Query: 602 AGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHP-------------------- 640
T Y APE+ M+ T+ D++S G + E+I GK
Sbjct: 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238
Query: 641 -RDFISSISSSSS-NLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTI 698
+F+ + S + N L E+ + N ++++E L E R T
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTA 295
Query: 699 QKV 701
+
Sbjct: 296 GEA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (304), Expect = 7e-31
Identities = 56/297 (18%), Positives = 102/297 (34%), Gaps = 46/297 (15%)
Query: 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR- 493
+D+ +G+G V++A + + E V VK +++ E+K L +R
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRG 88
Query: 494 HRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDAL 551
NI+ R +V+E++ + + L + ++ AL
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKAL 142
Query: 552 SYMHNDCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAP 610
Y H+ I+HRD+ NV++D E+ + + D+G A+F P +A Y
Sbjct: 143 DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 199
Query: 611 ELAYTMKVTEKCDVYSFGVLALEVIKGKHP-----------------------RDFISSI 647
L D++S G + +I K P D+I
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 648 SSS-SSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAI--SCLDESPESRPTIQKV 701
+ L R H+ L+S + L +SR T ++
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-30
Identities = 58/307 (18%), Positives = 111/307 (36%), Gaps = 30/307 (9%)
Query: 421 SFEGKIVYEEIIRVTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQ 479
+F + + + I V + + +G G GSV A +G VAVKK P S + ++
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 480 QEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF-IVYEYLEMGSLAMILSNDAAAKDLGWT 538
+ E++ L ++H N++ + AR YL + L+N + L
Sbjct: 63 R-TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 539 KRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNW 598
+I ++ L Y+H+ HRD+ N+ ++ + E + DFG A+ + + +
Sbjct: 122 HVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178
Query: 599 AELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEI-- 656
+ + M + D++S G + E++ G+ I L +
Sbjct: 179 VA--TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 657 -------------ALNEMLDPRLPTPSHNVQDKLISIMEVAI----SCLDESPESRPTIQ 699
+ + P N + I +A+ L + R T
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 700 KVSQLLK 706
Q L
Sbjct: 297 ---QALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 4e-29
Identities = 50/312 (16%), Positives = 106/312 (33%), Gaps = 48/312 (15%)
Query: 427 VYEEIIRVTNDFDDEHCIGKGGQGSVYKA-ELPSGEIVAVKKFHSPLPSEMASQQEFLNE 485
V + V + + IG G QG V A + VA+KK P ++ +++ E
Sbjct: 8 VGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR-AYRE 66
Query: 486 VKTLTGIRHRNIVKFYGFCSHARHS------FIVYEYLEMGSLAMILSNDAAAKDLGWTK 539
+ + + H+NI+ + + ++V E ++ +I +L +
Sbjct: 67 LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHER 120
Query: 540 RMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSNWA 599
++ ++ + ++H+ +HRD+ N+++ + + DFG A+
Sbjct: 121 MSYLLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT- 176
Query: 600 ELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHP------------------- 640
T Y APE+ M E D++S G + E+++ K
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236
Query: 641 --RDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAIS---------CLD 689
+F+ + + N + P + S + L
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296
Query: 690 ESPESRPTIQKV 701
P R ++
Sbjct: 297 IDPAKRISVDDA 308
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 108 bits (270), Expect = 1e-26
Identities = 62/279 (22%), Positives = 103/279 (36%), Gaps = 12/279 (4%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA 62
+ A L L NN + + LK+L L L NK+ P + L ++ L L N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 63 LSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHP 122
L K L +L + E ++R + N N +V + N +G + +F
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 123 NLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHI 182
L++I ++ + G P L L N IT A + + L L LS N I
Sbjct: 151 KLSYIRIADTNI---TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 207
Query: 183 VGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSN------SIPK 236
L L +L LN+N+L L ++ + L +N +S P
Sbjct: 208 SAVDNGSLANTPHLRELHLNNNKLVKVPG-GLADHKYIQVVYLHNNNISAIGSNDFCPPG 266
Query: 237 SLGNLVKLHYLNLSNN--QFIKKIPVELEKLIHLSELDL 273
++L +N Q+ + P + + + L
Sbjct: 267 YNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 100 bits (248), Expect = 1e-23
Identities = 55/270 (20%), Positives = 98/270 (36%), Gaps = 16/270 (5%)
Query: 77 LTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFY 135
LL L+NN++ +NL +L + L N ++ +F L + LS N
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 136 GEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS--NHIVGEMPSKLGKL 193
L N IT + +Q+ V++L + G +
Sbjct: 93 ELPEKMPKTLQ---ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 194 SSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQ 253
L + + + ++ G L L L N+++ SL L L L LS N
Sbjct: 150 KKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 254 FIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCF--- 310
L HL EL L++N L ++P + + + ++ + L +NN+S + F
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265
Query: 311 ---EELHGLSYIDISYNELHGSIPNSTAFR 337
+ S + + N + + FR
Sbjct: 266 GYNTKKASYSGVSLFSNPVQYWEIQPSTFR 295
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.8 bits (216), Expect = 2e-19
Identities = 47/257 (18%), Positives = 89/257 (34%), Gaps = 12/257 (4%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
NL NL L L NN S P L L L LS N+L L ++
Sbjct: 53 NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEI 112
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
+ ++ ++ + L T + + L +R+ ++T + G+
Sbjct: 113 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGL 169
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
P+L + L N ++ L L S N+I+ + ++ L+ L L++N
Sbjct: 170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 229
Query: 181 HIVGEMPSKLGKLSSLIKLILNSNQLCG------QLSLELGSLTQLERLDLSSNRLSNS- 233
+V ++P L + + L++N + + L SN +
Sbjct: 230 KLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288
Query: 234 -IPKSLGNLVKLHYLNL 249
P + + + L
Sbjct: 289 IQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.2 bits (204), Expect = 5e-18
Identities = 45/209 (21%), Positives = 81/209 (38%), Gaps = 4/209 (1%)
Query: 119 GIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS 178
+ P+ A +DL +N D+ L TL +N I+ P +L+ L LS
Sbjct: 28 DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87
Query: 179 SNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSL 238
N + L L ++ + L + +E L + + S +
Sbjct: 88 KNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAF 146
Query: 239 GNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLS 298
+ KL Y+ +++ I IP L L+EL L N + + + + + +L KL LS
Sbjct: 147 QGMKKLSYIRIADTN-ITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLS 203
Query: 299 HNNLSGFIPSCFEELHGLSYIDISYNELH 327
N++S L + ++ N+L
Sbjct: 204 FNSISAVDNGSLANTPHLRELHLNNNKLV 232
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 83.2 bits (204), Expect = 5e-18
Identities = 43/217 (19%), Positives = 77/217 (35%), Gaps = 8/217 (3%)
Query: 146 PKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQ 205
P LD +N IT + + L L L +N I P L L +L L+ NQ
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 206 LCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSN--NQFIKKIPVELE 263
L L L+ L + N ++ L ++ + L + +
Sbjct: 91 L---KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ 147
Query: 264 KLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISY 323
+ LS + ++ + +P + SL +L+L N ++ + + L+ L+ + +S+
Sbjct: 148 GMKKLSYIRIADTNI-TTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 204
Query: 324 NELHGSIPNSTAFRDAPMEALQGNKGLCGDIKGFPSC 360
N + S A E N L G
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH 241
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 106 bits (265), Expect = 2e-25
Identities = 71/358 (19%), Positives = 128/358 (35%), Gaps = 50/358 (13%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+L + L SI + L +L+ + S N+L P L NLT++ + + +
Sbjct: 42 DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNN 97
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLR----------NLTSLVRVRLNQNHL 110
N ++ P + L P+ NL ++ + + +
Sbjct: 98 NQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQ 157
Query: 111 TGNISESFGIHPNLA----FIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEI 166
+ LA L + S + L +L ++N I+ P I
Sbjct: 158 QLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI 217
Query: 167 IHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLS 226
+ + L L L+ N + L L++L L L +NQ+ L LT+L L L
Sbjct: 218 LTN--LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLG 271
Query: 227 SNRLSNSIP--------------------KSLGNLVKLHYLNLSNNQFIKKIPVELEKLI 266
+N++SN P + NL L YL L N P + L
Sbjct: 272 ANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLT 329
Query: 267 HLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYN 324
L L ++N + + S + N+ ++ L+ HN +S P L ++ + ++
Sbjct: 330 KLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 80.4 bits (197), Expect = 9e-17
Identities = 79/342 (23%), Positives = 130/342 (38%), Gaps = 32/342 (9%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L+ L + + ++ L ++ L+ + SI + L +T + +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 75
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIP-----NLRNLTSLVRVRLNQNHLTGNIS 115
N L+ P NL KL + + NNQ+ P NL LT + + L +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 116 ESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHS------ 169
+ + D+S + ++ +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 170 ---SQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLS 226
+ L+ L ++N I P + ++L +L LN NQL +L SLT L LDL+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDIGTL--ASLTNLTDLDLA 249
Query: 227 SNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQI 286
+N++SN P L L KL L L NQ P L L L+ L+L+ N E S I
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ--LEDISPI 303
Query: 287 CNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHG 328
N+++L L L NN+S P L L + + N++
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.4 bits (184), Expect = 4e-15
Identities = 73/359 (20%), Positives = 123/359 (34%), Gaps = 64/359 (17%)
Query: 26 LKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENN 85
L L + ++ + +L Q+T L + L LT + NN
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 76
Query: 86 QLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRC 145
QL P L+NLT LV + +N N + + + + + + +
Sbjct: 77 QLTDITP-LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 146 P------KLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIV-------GEMPSKLGK 192
+ + S + + + LK L + S L K
Sbjct: 136 RLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195
Query: 193 LSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNN 252
L++L LI +NQ+ L + T L+ L L+ N+L + +L +L L L+L+NN
Sbjct: 196 LTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 253 QFIKKIPVELEKLIHLSELDLSHNFLGEEMP--------------------SQICNMQSL 292
Q P L L L+EL L N + P S I N+++L
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 293 EKLNLSHNNLSGFIP--------------------SCFEELHGLSYIDISYNELHGSIP 331
L L NN+S P S L ++++ +N++ P
Sbjct: 310 TYLTLYFNNISDISPVSSLTKLQRLFFANNKVSDVSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 56.2 bits (134), Expect = 5e-09
Identities = 21/62 (33%), Positives = 31/62 (50%), Gaps = 4/62 (6%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+L+ L L+ NN S S + L +++ L N++ P L NLT+IT L L D
Sbjct: 327 SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382
Query: 61 NA 62
A
Sbjct: 383 QA 384
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 100 bits (249), Expect = 2e-23
Identities = 51/245 (20%), Positives = 94/245 (38%), Gaps = 27/245 (11%)
Query: 444 IGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVK--- 499
+G G +V+ A+ + + VA+K + + + +E+K L + + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKI----VRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 500 ------------FYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGV 547
F + H +V+E L LA+I + L + K++ K +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI--SKQL 134
Query: 548 VDALSYMHNDCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTAKFLKPDSS--NWAELAGT 604
+ L YMH C I+H DI +NVL+++ + ++ A ++ T
Sbjct: 135 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 605 YGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP 664
Y +PE+ D++S L E+I G + S + + IA L
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 665 RLPTP 669
LP+
Sbjct: 253 ELPSY 257
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 92.5 bits (228), Expect = 4e-21
Identities = 63/293 (21%), Positives = 105/293 (35%), Gaps = 31/293 (10%)
Query: 72 GNLVKLTLLTLENNQLRGPIP---NLRNLTSLVRVRLNQNH-LTGNISESFGIHPNLAFI 127
++ L L L P P +L NL L + + + L G I + L ++
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 128 DLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMP 187
++H G I + L TLDFS N ++G++P I L + N I G +P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 188 SKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYL 247
G S L + S NRL+ IP +
Sbjct: 167 DSYGSFSKLFTSMTISR-----------------------NRLTGKIPPT--FANLNLAF 201
Query: 248 NLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIP 307
+ ++ L ++ ++ ++L L+L +N + G +P
Sbjct: 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLP 261
Query: 308 SCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLCGDIKGFPSC 360
+L L +++S+N L G IP + + A NK LCG P+C
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG--SPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 87.5 bits (215), Expect = 2e-19
Identities = 67/269 (24%), Positives = 104/269 (38%), Gaps = 6/269 (2%)
Query: 12 NNSFSGSIPSEIGRLKSLSDLELSGNKLCG--SIPHSLGNLTQITFLTLFDNA-LSGAIP 68
N ++ G + + +++L+LSG L IP SL NL + FL + L G IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 69 KEYGNLVKLTLLTL-ENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFI 127
L +L L + N L + +LV + + N L+G + S PNL I
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 128 DLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMP 187
N G I +G KL T S N + S +++
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDA 213
Query: 188 SKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYL 247
S L + I + ++G L LDL +NR+ ++P+ L L LH L
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273
Query: 248 NLSNNQFIKKIPVELEKLIHLSELDLSHN 276
N+S N +IP + L ++N
Sbjct: 274 NVSFNNLCGEIP-QGGNLQRFDVSAYANN 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 86.7 bits (213), Expect = 4e-19
Identities = 65/263 (24%), Positives = 103/263 (39%), Gaps = 6/263 (2%)
Query: 1 NLSNLAFLYLYNNSFSG--SIPSEIGRLKSLSDLELSGN-KLCGSIPHSLGNLTQITFLT 57
+ L L + IPS + L L+ L + G L G IP ++ LTQ+ +L
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 58 LFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISE 116
+ +SGAIP + L L N L G +P + +L +LV + + N ++G I +
Sbjct: 108 ITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
Query: 117 SFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLD 176
S+G L L +D S N + G
Sbjct: 168 SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN-TQKI 226
Query: 177 LSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPK 236
+ + + K+G +L L L +N++ G L L L L L++S N L IP
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP- 285
Query: 237 SLGNLVKLHYLNLSNNQFIKKIP 259
GNL + +NN+ + P
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 39.3 bits (90), Expect = 0.001
Identities = 39/198 (19%), Positives = 67/198 (33%), Gaps = 23/198 (11%)
Query: 128 DLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMP 187
D + + G + + ++ LD S N+ P +P
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP----------------------IP 69
Query: 188 SKLGKLSSLIKLILNSN-QLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHY 246
S L L L L + L G + + LTQL L ++ +S +IP L + L
Sbjct: 70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129
Query: 247 LNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFI 306
L+ S N +P + L +L + N + +P + L N
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189
Query: 307 PSCFEELHGLSYIDISYN 324
L+++D+S N
Sbjct: 190 IPPTFANLNLAFVDLSRN 207
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.8 bits (209), Expect = 2e-19
Identities = 30/183 (16%), Positives = 57/183 (31%), Gaps = 27/183 (14%)
Query: 444 IGKGGQGSVYKAELPSGEIVAVKKFHSPLPS-------EMASQQEFLNEVKTLTGIRHRN 496
+G+G + +V+ VK S F R
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 497 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN 556
+ K G +++ E ++ M L + + V+ +++ ++ ++
Sbjct: 68 LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK---------FLKPDSSNWAE-LAGTYG 606
IVH D+S NVL+ E + DF + L+ D N + TY
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYR 177
Query: 607 YVA 609
Sbjct: 178 TEK 180
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.6 bits (210), Expect = 6e-19
Identities = 52/253 (20%), Positives = 84/253 (33%), Gaps = 5/253 (1%)
Query: 98 TSLVRVRLNQNHLTGNISESFGIHPNL-AFIDLSHNYFYGEISSDWGRCPKLGTLDFSSN 156
+ R+ L+ N ++ + SF NL S+ + ++ G +
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 157 NITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGS 216
+ PA +L L L + P L++L L L N L
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 217 LTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHN 276
L L L L NR+S+ ++ L L L L N+ P L L L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 277 FLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNS--- 333
L + +++L+ L L+ N + L S +E+ S+P
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAG 270
Query: 334 TAFRDAPMEALQG 346
+ LQG
Sbjct: 271 RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (203), Expect = 4e-18
Identities = 54/254 (21%), Positives = 89/254 (35%), Gaps = 6/254 (2%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA 62
+ ++L+ N S + ++L+ L L N L + L + L L DNA
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 63 LSGAI-PKEYGNLVKLTLLTLENNQLRG-PIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
++ P + L +L L L+ L+ R L +L + L N L ++F
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
NL + L N + L L N + P +L L L +N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 181 HIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGN 240
++ L L +L L LN N L++ SS+ + S+P+ L
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAG 270
Query: 241 LVKLHYLNLSNNQF 254
L+ N
Sbjct: 271 ---RDLKRLAANDL 281
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (194), Expect = 7e-17
Identities = 53/261 (20%), Positives = 83/261 (31%), Gaps = 7/261 (2%)
Query: 18 SIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKL 77
++P I + + L GN++ S +T L L N L+ + L L
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 78 TLLTLENNQLRGPIP--NLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFY 135
L L +N + L L + L++ L F L ++ L N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 136 GEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSS 195
+ L L N I+ L L L N + P L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 196 LIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFI 255
L+ L L +N L + L L L+ L L+ N + L S+++
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVP 261
Query: 256 KKIPVELE--KLIHLSELDLS 274
+P L L L+ DL
Sbjct: 262 CSLPQRLAGRDLKRLAANDLQ 282
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (172), Expect = 5e-14
Identities = 41/185 (22%), Positives = 74/185 (40%), Gaps = 5/185 (2%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L L L+L P L +L L L N L + +L +T L L
Sbjct: 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHG 162
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFG 119
N +S + + L L L L N++ P+ R+L L+ + L N+L+ +E+
Sbjct: 163 NRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALA 222
Query: 120 IHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS 179
L ++ L+ N + + + L SS+ + S+P + + + L++
Sbjct: 223 PLRALQYLRLNDNPWVCDCRARPLW-AWLQKFRGSSSEVPCSLPQRL---AGRDLKRLAA 278
Query: 180 NHIVG 184
N + G
Sbjct: 279 NDLQG 283
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 65.4 bits (158), Expect = 2e-12
Identities = 33/217 (15%), Positives = 69/217 (31%), Gaps = 21/217 (9%)
Query: 49 NLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQN 108
L + + ++ + + +L +T L+ + I ++ L +L+ + L N
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDN 73
Query: 109 HLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIH 168
+T + + I+ T ++ + + +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 169 SSQLKVL--------------DLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLEL 214
LS + + L LS L L + N++ L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD--ISPL 191
Query: 215 GSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSN 251
SL L + L +N++S+ P L N L + L+N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.7 bits (130), Expect = 7e-09
Identities = 36/227 (15%), Positives = 66/227 (29%), Gaps = 17/227 (7%)
Query: 73 NLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHN 132
L + + + + +L + + +T E NL ++L N
Sbjct: 17 ALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDN 73
Query: 133 YFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGK 192
L + ++ + ++ S L
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 193 LSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNN 252
L + I N + L LS S L NL KL L +N
Sbjct: 134 LYLDLNQITNISPLA----------GLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 253 QFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSH 299
+ P L L +L E+ L +N + + P + N +L + L++
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 7e-06
Identities = 47/205 (22%), Positives = 68/205 (33%), Gaps = 16/205 (7%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+L + L + + + L +L LEL N++ P NLT+IT L L
Sbjct: 39 DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAPL--KNLTKITELELSG 94
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
N L +K LT P+ L NL L I+ +
Sbjct: 95 NPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL-------YLDLNQITNISPL 147
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
LS + KL TL N I+ P + L + L +N
Sbjct: 148 AGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNN 205
Query: 181 HIVGEMPSKLGKLSSLIKLILNSNQ 205
I P L S+L + L +NQ
Sbjct: 206 QISDVSP--LANTSNLFIVTL-TNQ 227
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.8 bits (151), Expect = 2e-11
Identities = 43/213 (20%), Positives = 69/213 (32%), Gaps = 7/213 (3%)
Query: 90 PIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLG 149
PI + + S + V ++ +LT + + + + LS N Y + +L
Sbjct: 2 PICEVSKVASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLT 58
Query: 150 TLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ 209
L+ +T + L + + + L L+ L L
Sbjct: 59 QLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 210 LSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLS 269
L L +L+ L L N L P L KL L+L+NN + L L +L
Sbjct: 119 ---ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLD 175
Query: 270 ELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNL 302
L L N +P L L N
Sbjct: 176 TLLLQEN-SLYTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 3e-09
Identities = 35/178 (19%), Positives = 52/178 (29%), Gaps = 3/178 (1%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA 62
+ L+L N + + L+ L L +L L + L L N
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPVLGTLDLSHNQ 88
Query: 63 LSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHP 122
L L N P+ LR L L + L N L P
Sbjct: 89 LQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP 148
Query: 123 NLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSN 180
L + L++N + L TL N++ ++P S L L N
Sbjct: 149 KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 5e-09
Identities = 49/209 (23%), Positives = 78/209 (37%), Gaps = 6/209 (2%)
Query: 143 GRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILN 202
+ ++ N+T ++P ++ +L LS N + + L + L +L L+
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 203 SNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVEL 262
+L +L L LDLS N+L + ++S N+ L
Sbjct: 64 RAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGAL 120
Query: 263 EKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDIS 322
L L EL L N L P + LEKL+L++NNL+ L L + +
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 323 YNELHGSIPNSTAFRDAPMEALQGNKGLC 351
N L+ P L GN LC
Sbjct: 181 ENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 14/67 (20%), Positives = 27/67 (40%), Gaps = 3/67 (4%)
Query: 261 ELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYID 320
E+ K+ E++ L +P + + L+LS N L F + L+ ++
Sbjct: 5 EVSKVASHLEVNCDKRNL-TALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 321 ISYNELH 327
+ EL
Sbjct: 62 LDRAELT 68
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 61.6 bits (148), Expect = 2e-11
Identities = 41/203 (20%), Positives = 80/203 (39%), Gaps = 15/203 (7%)
Query: 49 NLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQN 108
+ L +++ A+ + L + + N+ ++ + ++ L ++ ++ LN N
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGN 78
Query: 109 HLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIH 168
LT + + F+D + + S + S ++H
Sbjct: 79 KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS------LSLEHNGISDINGLVH 132
Query: 169 SSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSN 228
QL+ L L +N I +L+ L L L NQ+ + L LT+L+ L LS N
Sbjct: 133 LPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKN 188
Query: 229 RLSNSIPKSLGNLVKLHYLNLSN 251
+S+ ++L L L L L +
Sbjct: 189 HISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 2e-05
Identities = 28/205 (13%), Positives = 64/205 (31%), Gaps = 20/205 (9%)
Query: 96 NLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWG--RCPKLGTLDF 153
++ L + +T ++++ ++ I +++ +I S G P + L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQNEL--NSIDQIIANNS----DIKSVQGIQYLPNVTKLFL 75
Query: 154 SSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLE 213
+ N +T + LK L K +K + + ++
Sbjct: 76 NGNKLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGL 130
Query: 214 LGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDL 273
+ ++ ++ L + I I L L L L L
Sbjct: 131 VHLPQLESLYLGNNKITDITVLSRLTK----LDTLSLEDNQISDIV-PLAGLTKLQNLYL 185
Query: 274 SHNFLGEEMPSQICNMQSLEKLNLS 298
S N + + + +++L+ L L
Sbjct: 186 SKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 5e-05
Identities = 27/179 (15%), Positives = 52/179 (29%), Gaps = 13/179 (7%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L+++ + N+ I L +++ L L+GNKL + L
Sbjct: 44 ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIK--------PLANLKNLG 93
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGI 120
+ + +K + I ++ L L ++ +
Sbjct: 94 WLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLS 153
Query: 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSS 179
+ +I KL L S N+I+ + L VL+L S
Sbjct: 154 RLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 1e-04
Identities = 26/187 (13%), Positives = 62/187 (33%), Gaps = 22/187 (11%)
Query: 151 LDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQL 210
+ ++T ++ ++S + + +++ I + L ++ KL LN N+L
Sbjct: 29 DNLKKKSVTDAVTQNELNS--IDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIK 84
Query: 211 SLELGSLTQLERLDLSSNRLS---------------NSIPKSLGNLVKLHYLNLSNNQFI 255
L LD + + ++ + LV L L
Sbjct: 85 PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNN 144
Query: 256 KKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHG 315
K + + + + + ++ + + L+ L LS N++S L
Sbjct: 145 KITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL--RALAGLKN 201
Query: 316 LSYIDIS 322
L +++
Sbjct: 202 LDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 36.9 bits (84), Expect = 0.004
Identities = 11/71 (15%), Positives = 25/71 (35%), Gaps = 4/71 (5%)
Query: 240 NLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSH 299
+ NL V +L + ++ +++ + I + ++ KL L+
Sbjct: 22 AFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 300 NNLSGFIPSCF 310
N L+ P
Sbjct: 78 NKLTDIKPLAN 88
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.9 bits (148), Expect = 1e-10
Identities = 22/118 (18%), Positives = 41/118 (34%), Gaps = 10/118 (8%)
Query: 220 LERLDLSSNRLSNS-IPKSLGNLVKLHYLNLSNNQF----IKKIPVELEKLIHLSELDLS 274
++ LD+ LS++ + L L + + L + K I L L+EL+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 275 HNFLGEEMPSQIC-----NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELH 327
N LG+ + ++KL+L + L+G +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 121
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.8 bits (140), Expect = 1e-09
Identities = 20/96 (20%), Positives = 34/96 (35%), Gaps = 10/96 (10%)
Query: 169 SSQLKVLDLSSNHIVGEMPSKL-GKLSSLIKLILNSNQL----CGQLSLELGSLTQLERL 223
S ++ LD+ + ++L L + L+ L C +S L L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 224 DLSSNRLSNSIPKSLG-----NLVKLHYLNLSNNQF 254
+L SN L + + K+ L+L N
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 3e-08
Identities = 20/80 (25%), Positives = 29/80 (36%), Gaps = 9/80 (11%)
Query: 243 KLHYLNLSNNQF----IKKIPVELEKLIHLSELDLSHNFLGEEMPSQIC-----NMQSLE 293
L L L++ + L L ELDLS+N LG+ Q+ LE
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 294 KLNLSHNNLSGFIPSCFEEL 313
+L L S + + L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.2 bits (128), Expect = 3e-08
Identities = 22/109 (20%), Positives = 36/109 (33%), Gaps = 25/109 (22%)
Query: 162 MPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLE 221
S L+VL L+ + S L L + L
Sbjct: 361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT--------------------LLANHSLR 400
Query: 222 RLDLSSNRLSNSIPKSLGNLVK-----LHYLNLSNNQFIKKIPVELEKL 265
LDLS+N L ++ L V+ L L L + + +++ L+ L
Sbjct: 401 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 6e-08
Identities = 22/95 (23%), Positives = 37/95 (38%), Gaps = 15/95 (15%)
Query: 218 TQLERLDLSSNRLSN----SIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLI-----HL 268
+ L L L+ +S+ S+ +L L L+LSNN ++L + + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 269 SELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLS 303
+L L + EEM L+ L +L
Sbjct: 429 EQLVLYDIYWSEEME------DRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (116), Expect = 1e-06
Identities = 12/73 (16%), Positives = 28/73 (38%), Gaps = 5/73 (6%)
Query: 266 IHLSELDLSHNFLGEEMPSQIC-NMQSLEKLNLSHNNLSG----FIPSCFEELHGLSYID 320
+ + LD+ L + +++ +Q + + L L+ I S L+ ++
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 321 ISYNELHGSIPNS 333
+ NEL +
Sbjct: 62 LRSNELGDVGVHC 74
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 1e-06
Identities = 15/77 (19%), Positives = 24/77 (31%), Gaps = 5/77 (6%)
Query: 242 VKLHYLNLSNNQFIKKIPVEL-EKLIHLSELDLSHNFLGEEMPSQIC----NMQSLEKLN 296
+ + L++ + EL L + L L E I +L +LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 297 LSHNNLSGFIPSCFEEL 313
L N L C +
Sbjct: 62 LRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 3e-06
Identities = 19/111 (17%), Positives = 35/111 (31%), Gaps = 23/111 (20%)
Query: 139 SSDWGRCPKLGTLDFSSNNITG----SMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLS 194
L L + +++ S+ A ++ + L+ LDLS+N + +L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES- 420
Query: 195 SLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLH 245
+ LE+L L S + L L K
Sbjct: 421 ------VRQPG------------CLLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 5e-06
Identities = 14/82 (17%), Positives = 28/82 (34%), Gaps = 9/82 (10%)
Query: 121 HPNLAFIDLSHNYFYGE----ISSDWGRCPKLGTLDFSSNNITGSMPAEII-----HSSQ 171
L + L+ +++ L LD S+N + + +++
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 172 LKVLDLSSNHIVGEMPSKLGKL 193
L+ L L + EM +L L
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 6e-06
Identities = 14/91 (15%), Positives = 29/91 (31%), Gaps = 5/91 (5%)
Query: 4 NLAFLYLYNNSFSGSIPSEI-GRLKSLSDLELSGNKL----CGSIPHSLGNLTQITFLTL 58
++ L + S + +E+ L+ + L L C I +L + L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 59 FDNALSGAIPKEYGNLVKLTLLTLENNQLRG 89
N L ++ ++ L+
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 4e-05
Identities = 11/95 (11%), Positives = 29/95 (30%), Gaps = 10/95 (10%)
Query: 123 NLAFIDLSHNYFYGE-ISSDWGRCPKLGTLDFSSNNITG----SMPAEIIHSSQLKVLDL 177
++ +D+ + + + +T + + + + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 178 SSNHIVGEMPSKLGKL-----SSLIKLILNSNQLC 207
SN + + + + KL L + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 4e-05
Identities = 22/97 (22%), Positives = 34/97 (35%), Gaps = 15/97 (15%)
Query: 1 NLSNLAFLYLYNNSFSG----SIPSEIGRLKSLSDLELSGNKLCGSIPHSLG-----NLT 51
S L L+L + S S+ + + SL +L+LS N L + L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 52 QITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLR 88
+ L L+D S + L L + LR
Sbjct: 427 LLEQLVLYDIYWSEEMEDR------LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 17/97 (17%), Positives = 35/97 (36%), Gaps = 17/97 (17%)
Query: 75 VKLTLLTLENNQLRGP-----IPNLRNLTSLVRVRLNQNHLTG----NISESFGIHPNLA 125
+ + L ++ +L +P L+ + RL+ LT +IS + ++P LA
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVV---RLDDCGLTEARCKDISSALRVNPALA 58
Query: 126 FIDLSHNYFYGEISSDWGR-----CPKLGTLDFSSNN 157
++L N + K+ L +
Sbjct: 59 ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 17/94 (18%), Positives = 31/94 (32%), Gaps = 14/94 (14%)
Query: 27 KSLSDLELSGNKL----CGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVK-----L 77
L L L+ + C S+ +L + L L +N L A + V+ L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 78 TLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLT 111
L L + + + L + ++ L
Sbjct: 429 EQLVLYDIYWSEEMEDR-----LQALEKDKPSLR 457
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.2 bits (139), Expect = 8e-10
Identities = 43/271 (15%), Positives = 95/271 (35%), Gaps = 15/271 (5%)
Query: 78 TLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGE 137
L L L + ++ R ++ + ++E F + +DLS++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVS 61
Query: 138 -ISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPS-------- 188
+ +C KL L ++ + + +S L L+LS E
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 189 KLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLN 248
+L +L+ + ++ ++TQL N + + + L +L+
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 249 LSNNQFIK-KIPVELEKLIHLSELDLSH-NFLGEEMPSQICNMQSLEKLNLSHNNLSGFI 306
LS++ +K E +L +L L LS + E ++ + +L+ L + G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 307 PSCFEELHGLSYIDISYNELHGSIPNSTAFR 337
E L ++ I+ + + +
Sbjct: 242 QLLKE---ALPHLQINCSHFTTIARPTIGNK 269
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 1e-07
Identities = 43/250 (17%), Positives = 85/250 (34%), Gaps = 16/250 (6%)
Query: 32 LELSGNKLCGSIPHSLGNLTQITFLTL-FDNALSGAIPKEYGNLVKLTLLTLENNQLRGP 90
L+L+G L P G L + + E+ + ++ + L N+ +
Sbjct: 5 LDLTGKNL---HPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 91 IPN--LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSH--NYFYGEISSDWGRCP 146
+ L + L + L L+ I + + NL ++LS + + + C
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 147 KLGTLDFSSNNITGSM------PAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLI 200
+L L+ S +QL + N ++ + + + +L+ L
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 201 LNSNQLC-GQLSLELGSLTQLERLDLSS-NRLSNSIPKSLGNLVKLHYLNLSNNQFIKKI 258
L+ + + E L L+ L LS + LG + L L + +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 259 PVELEKLIHL 268
+ E L HL
Sbjct: 242 QLLKEALPHL 251
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.1 bits (118), Expect = 4e-07
Identities = 39/262 (14%), Positives = 74/262 (28%), Gaps = 38/262 (14%)
Query: 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCG-SIPHSLGNLTQITFLTLFDNA 62
+ + + E + ++LS + + ++ L +++ L+L
Sbjct: 24 GVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 63 LSGAIPKEYGNLVKLTLLTLENNQLRGPIP---------NLRNLTSLVRVRLNQNHLTGN 113
LS I L L L L L + H+
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 142
Query: 114 ISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSN-NITGSMPAEIIHSSQL 172
++ L N ++S+ RCP L LD S + + E + L
Sbjct: 143 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202
Query: 173 KVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSN 232
+ L LS + + LELG + L+ L +
Sbjct: 203 QHLSLS-----------------------RCYDIIPETLLELGEIPTLKTLQVFGIVPDG 239
Query: 233 SIPKSLGNLVKLHYLNLSNNQF 254
++ L L ++ + F
Sbjct: 240 TLQLLKEALPH---LQINCSHF 258
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 54.7 bits (131), Expect = 9e-10
Identities = 27/120 (22%), Positives = 51/120 (42%), Gaps = 7/120 (5%)
Query: 150 TLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQ 209
L + ++T + + LDLS N + P+ L L L +L ++ +
Sbjct: 2 VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLE--VLQASDNALE 56
Query: 210 LSLELGSLTQLERLDLSSNRLSN-SIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHL 268
+ +L +L+ L L +NRL + + L + +L LNL N + + E+L +
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS-LCQEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.6 bits (123), Expect = 1e-08
Identities = 35/125 (28%), Positives = 47/125 (37%), Gaps = 9/125 (7%)
Query: 199 LILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKI 258
L L L + L L + LDLS NRL P +L L L L + +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALEN 57
Query: 259 PVELEKLIHLSELDLSHNFLGE-EMPSQICNMQSLEKLNLSHNNLS---GFIPSCFEELH 314
+ L L EL L +N L + + + L LNL N+L G E L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 315 GLSYI 319
+S I
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 3e-07
Identities = 23/106 (21%), Positives = 38/106 (35%), Gaps = 5/106 (4%)
Query: 56 LTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNIS 115
L L L+ + L+ +T L L +N+LR P L L L + +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVL--QASDNALENV 58
Query: 116 ESFGIHPNLAFIDLSHNYF-YGEISSDWGRCPKLGTLDFSSNNITG 160
+ P L + L +N CP+L L+ N++
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.6 bits (102), Expect = 8e-06
Identities = 24/119 (20%), Positives = 47/119 (39%), Gaps = 7/119 (5%)
Query: 127 IDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEM 186
+ L+H + + + LD S N + PA ++ + L ++ E
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA---LAALRCLEVLQASDNALEN 57
Query: 187 PSKLGKLSSLIKLILNSNQLCGQLSLE-LGSLTQLERLDLSSNRLSNSIPKSLGNLVKL 244
+ L L +L+L +N+L +++ L S +L L+L N L L ++
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 1e-05
Identities = 29/107 (27%), Positives = 47/107 (43%), Gaps = 7/107 (6%)
Query: 8 LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAI 67
L+L + + + + +L ++ L+LS N+L P +L L + L DN +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALEN 57
Query: 68 PKEYGNLVKLTLLTLENNQLRG--PIPNLRNLTSLVRVRLNQNHLTG 112
NL +L L L NN+L+ I L + LV + L N L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.3 bits (91), Expect = 2e-04
Identities = 26/107 (24%), Positives = 40/107 (37%), Gaps = 5/107 (4%)
Query: 32 LELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPI 91
L L+ L ++ L L +T L L N L P L L +L +N +
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA-LENV 58
Query: 92 PNLRNLTSLVRVRLNQNHLTGNIS-ESFGIHPNLAFIDLSHNYFYGE 137
+ NL L + L N L + + + P L ++L N E
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 35.8 bits (82), Expect = 0.004
Identities = 22/102 (21%), Positives = 38/102 (37%), Gaps = 4/102 (3%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
L + L L +N P+ + L+ L L + + NL ++ L L +
Sbjct: 18 QLLLVTHLDLSHNRLRALPPA-LAALRCLEV--LQASDNALENVDGVANLPRLQELLLCN 74
Query: 61 NAL-SGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLV 101
N L A + + +L LL L+ N L L ++
Sbjct: 75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.8 bits (131), Expect = 2e-09
Identities = 31/146 (21%), Positives = 54/146 (36%), Gaps = 6/146 (4%)
Query: 201 LNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPV 260
L Q+ QL L + + L L + L LN ++ + +
Sbjct: 4 LKPEQV-EQLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSS-MAATLRI 59
Query: 261 ELEKLIHLSELDLSHNFL--GEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSY 318
E + L L+LS+N L ++M S + +L+ LNLS N L + L
Sbjct: 60 IEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE 119
Query: 319 IDISYNELHGSIPNSTAFRDAPMEAL 344
+ + N L + + + + A E
Sbjct: 120 LWLDGNSLSDTFRDQSTYISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (104), Expect = 7e-06
Identities = 27/145 (18%), Positives = 54/145 (37%), Gaps = 4/145 (2%)
Query: 67 IPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAF 126
+ + L+ LR P+L V + ++ + + P L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLRS-DPDLVAQNIDVVLNR-RSSMAATLRIIEENIPELLS 69
Query: 127 IDLSHN--YFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVG 184
++LS+N Y ++SS + P L L+ S N + + I +L+ L L N +
Sbjct: 70 LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129
Query: 185 EMPSKLGKLSSLIKLILNSNQLCGQ 209
+ +S++ + +L G
Sbjct: 130 TFRDQSTYISAIRERFPKLLRLDGH 154
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 8e-04
Identities = 27/130 (20%), Positives = 52/130 (40%), Gaps = 14/130 (10%)
Query: 128 DLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVG--E 185
DL ++ + L+ +++ ++ + +L L+LS+N + +
Sbjct: 28 DLKGLRSDPDLVA----QNIDVVLN-RRSSMAATLRIIEENIPELLSLNLSNNRLYRLDD 82
Query: 186 MPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKS-------L 238
M S + K +L L L+ N+L + L+ +LE L L N LS++
Sbjct: 83 MSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIR 142
Query: 239 GNLVKLHYLN 248
KL L+
Sbjct: 143 ERFPKLLRLD 152
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.4 bits (134), Expect = 5e-09
Identities = 26/92 (28%), Positives = 40/92 (43%), Gaps = 9/92 (9%)
Query: 225 LSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPS 284
N SN I L LN+SNN+ + ++P +L L S N L E+P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNK-LIELPALPPRL---ERLIASFNHL-AEVPE 321
Query: 285 QICNMQSLEKLNLSHNNLSGFIPSCFEELHGL 316
Q+L++L++ +N L P E + L
Sbjct: 322 LP---QNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 2e-08
Identities = 24/92 (26%), Positives = 40/92 (43%), Gaps = 9/92 (9%)
Query: 177 LSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPK 236
N E+ S SL +L +++N+L L +LERL S N L+ +P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI---ELP-ALPPRLERLIASFNHLA-EVPE 321
Query: 237 SLGNLVKLHYLNLSNNQFIKKIPVELEKLIHL 268
N L L++ N +++ P E + L
Sbjct: 322 LPQN---LKQLHVEYNP-LREFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 53.3 bits (126), Expect = 5e-08
Identities = 64/331 (19%), Positives = 109/331 (32%), Gaps = 26/331 (7%)
Query: 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNA 62
L L N S S+P L+SL S N L +P +L + A
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLESLV---ASCNSL-TELPELPQSLKSLLVDNNNLKA 92
Query: 63 LSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHP 122
LS +L L +N +P L+N + L + ++ N L +
Sbjct: 93 LS--------DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEF 144
Query: 123 NLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHI 182
A + + ++ S+ + + ++ L+ L N
Sbjct: 145 IAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLP 204
Query: 183 VGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLV 242
L + + S + L L +L + + N
Sbjct: 205 FLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP 264
Query: 243 KLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNL 302
L+YLN S+N+ L EL++S+N L E+P+ LE+L S N+L
Sbjct: 265 NLYYLNASSNEIRSLCD----LPPSLEELNVSNNKL-IELPALPPR---LERLIASFNHL 316
Query: 303 SGFIPSCFEELHGLSYIDISYNELHGSIPNS 333
+ +P E L + + YN L P+
Sbjct: 317 AE-VP---ELPQNLKQLHVEYNPLR-EFPDI 342
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 1e-07
Identities = 21/119 (17%), Positives = 46/119 (38%), Gaps = 10/119 (8%)
Query: 130 SHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSK 189
F + + +L + N + + + L+ L++S+N ++ E+P+
Sbjct: 244 QSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL 302
Query: 190 LGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLN 248
+L +LI + N L + L++L + N L P ++ L +N
Sbjct: 303 PPRLE---RLIASFNHLA---EVP-ELPQNLKQLHVEYNPLR-EFPDIPESVEDL-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.1 bits (110), Expect = 4e-06
Identities = 20/79 (25%), Positives = 30/79 (37%), Gaps = 9/79 (11%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
+L L + NN +P+ RL+ L S N L +P NL Q L +
Sbjct: 282 LPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHL-AEVPELPQNLKQ---LHVEY 333
Query: 61 NALSGAIPKEYGNLVKLTL 79
N L P ++ L +
Sbjct: 334 NPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 7e-06
Identities = 19/92 (20%), Positives = 35/92 (38%), Gaps = 9/92 (9%)
Query: 105 LNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPA 164
N + I + P+L +++S+N ++ P+L L S N++ +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNN----KLIELPALPPRLERLIASFNHLA-EVPE 321
Query: 165 EIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSL 196
LK L + N + E P + L
Sbjct: 322 LP---QNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.1 bits (128), Expect = 1e-08
Identities = 36/242 (14%), Positives = 72/242 (29%), Gaps = 24/242 (9%)
Query: 18 SIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKL 77
IPS++ ++ +L KL + + + + N + I +
Sbjct: 22 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV------ 73
Query: 78 TLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGE 137
NL L + + N + + I + +
Sbjct: 74 -------------FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD 120
Query: 138 ISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLI 197
+ L + + N T + + S + +L L+ N I
Sbjct: 121 VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDE 180
Query: 198 KLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKK 257
+ ++N L + + LD+S R+ + L NL KL + N +KK
Sbjct: 181 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN---LKK 237
Query: 258 IP 259
+P
Sbjct: 238 LP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (98), Expect = 8e-05
Identities = 12/88 (13%), Positives = 20/88 (22%), Gaps = 3/88 (3%)
Query: 245 HYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSG 304
L L+ N + +N L E L++S +
Sbjct: 156 VILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 215
Query: 305 FIPSCFEELHGLSYIDISYNELHGSIPN 332
E L L + +P
Sbjct: 216 LPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 7e-04
Identities = 31/227 (13%), Positives = 70/227 (30%), Gaps = 6/227 (2%)
Query: 78 TLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGE 137
+ + +++ +L + + +R L +F +L I++S N
Sbjct: 11 RVFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 138 ISSDWGRCPKLGT--LDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVG--EMPSKLGKL 193
I +D +NN+ P + L+ L +S+ I ++
Sbjct: 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128
Query: 194 SSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQ 253
L+ + N N + + +G + L L+ N + + NN
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188
Query: 254 FIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHN 300
+ LD+S + + N++ L + +
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 26/205 (12%), Positives = 47/205 (22%), Gaps = 5/205 (2%)
Query: 77 LTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFY 135
L +LR L ++ ++QN + I +
Sbjct: 31 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 90
Query: 136 GEISSDWGRCPKLGTLDFSSNNIT----GSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLG 191
+ +N + L + + N E S +G
Sbjct: 91 LLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 150
Query: 192 KLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSN 251
+ L LN N + + E +N L L++S
Sbjct: 151 LSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISR 210
Query: 252 NQFIKKIPVELEKLIHLSELDLSHN 276
+ LE L L +
Sbjct: 211 TRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 52.5 bits (124), Expect = 2e-08
Identities = 45/196 (22%), Positives = 74/196 (37%), Gaps = 13/196 (6%)
Query: 145 CPK-----LGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGE-MPSKLGKLSSLIK 198
CP T+D + + +P +I L L+ N + G+L L+K
Sbjct: 2 CPAMCHCEGTTVDCTGRGLK-EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVK 58
Query: 199 LILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKI 258
L L NQL G + ++ L L N++ K L +L LNL +NQ +
Sbjct: 59 LELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVM 118
Query: 259 PVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSY 318
P E L L+ L+ + + L K +L+ PS ++ +
Sbjct: 119 PGSFEHLNSLTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQI 174
Query: 319 IDISYNELHGSIPNST 334
D+ ++E S NS
Sbjct: 175 KDLPHSEFKCSSENSE 190
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 45.2 bits (105), Expect = 6e-06
Identities = 34/176 (19%), Positives = 63/176 (35%), Gaps = 9/176 (5%)
Query: 8 LYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSL-GNLTQITFLTLFDNALSGA 66
+ IP +I ++L L+ N+L L G L + L L N L+G
Sbjct: 13 VDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69
Query: 67 IPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLNQNHLTGNISESFGIHPNLA 125
P + + L L N+++ L L + L N ++ + SF +L
Sbjct: 70 EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129
Query: 126 FIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNH 181
++L+ N F W L + P+++ +++ DL +
Sbjct: 130 SLNLASNPFNCNCHLAWFAE-WLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSE 181
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 1e-07
Identities = 37/199 (18%), Positives = 72/199 (36%), Gaps = 15/199 (7%)
Query: 49 NLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQN 108
L + L ++ + + +L ++T L + ++ I + L +L ++ + N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNN 72
Query: 109 HLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIH 168
LT ++ + +++ +
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGL--------TLFNNQITDIDPL 124
Query: 169 SSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSN 228
+ + L + S L L+SL +L +SNQ+ L +LT LERLD+SSN
Sbjct: 125 KNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD--LKPLANLTTLERLDISSN 182
Query: 229 RLSNSIPKSLGNLVKLHYL 247
++S+ L L L L
Sbjct: 183 KVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.9 bits (102), Expect = 2e-05
Identities = 34/199 (17%), Positives = 74/199 (37%), Gaps = 15/199 (7%)
Query: 73 NLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHN 132
L + L + + +L + ++ ++ + +I + NL I+ S+N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNN 72
Query: 133 YFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGK 192
++ + + + + ++ + + L +
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 193 LSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNN 252
L I + + L G T L++L+ SSN++++ P L NL L L++S+N
Sbjct: 133 LELSSNTISDISALSGL--------TSLQQLNFSSNQVTDLKP--LANLTTLERLDISSN 182
Query: 253 QFIKKIPVELEKLIHLSEL 271
+ + I L KL +L L
Sbjct: 183 K-VSDIS-VLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 27/183 (14%), Positives = 59/183 (32%), Gaps = 20/183 (10%)
Query: 151 LDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQL 210
N+T ++ + Q+ L I + + L++L ++ ++NQL
Sbjct: 23 TVLGKTNVTDTVSQTDL--DQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDIT 78
Query: 211 SLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSE 270
L+ + ++ + + + N + K L +L S
Sbjct: 79 PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 138
Query: 271 LDLSHNFLGEEM--------------PSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGL 316
+ L + N+ +LE+L++S N +S S +L L
Sbjct: 139 TISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNL 196
Query: 317 SYI 319
+
Sbjct: 197 ESL 199
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 3e-07
Identities = 23/113 (20%), Positives = 37/113 (32%), Gaps = 3/113 (2%)
Query: 216 SLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEK-LIHLSELDLS 274
L + + L L L + N Q ++ + + + L L L +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 275 HNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELH 327
+ L P L +LNLS N L + L + +S N LH
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTV-QGLSLQELVLSGNPLH 116
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.8 bits (91), Expect = 3e-04
Identities = 21/132 (15%), Positives = 43/132 (32%), Gaps = 3/132 (2%)
Query: 77 LTLLTLENNQLRGPIPNLRNLTSLVRVRL-NQNHLTGNISESFGIHPNLAFIDLSHNYFY 135
+ L + + +L +L + + NQ HL L + + +
Sbjct: 10 SSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69
Query: 136 GEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIV-GEMPSKLGKLS 194
+ P+L L+ S N + S+ + + L+ L LS N + L +
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128
Query: 195 SLIKLILNSNQL 206
+ +L
Sbjct: 129 EEGLGGVPEQKL 140
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 49.9 bits (117), Expect = 6e-07
Identities = 36/312 (11%), Positives = 79/312 (25%), Gaps = 19/312 (6%)
Query: 18 SIPSEIGRLKSLSDLELSGNKL----CGSIPHSLGNLTQITFLTLFDN---ALSGAIPKE 70
S+ + + S+ ++ LSGN + + ++ + + D + IP+
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 71 YGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLS 130
L++ L + + +R + H
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 131 HNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKL 190
+ + N + + + L + +V
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 191 GKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLS 250
G L++ + +L SS + L+ LS
Sbjct: 202 GIEHLLLEGLAYCQELKVL-----DLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256
Query: 251 NNQFIKKI-PVELEKLIHLSELDLSHNFLGEEMPSQIC-----NMQSLEKLNLSHNNLSG 304
+ + I L L L +N + + + M L L L+ N S
Sbjct: 257 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316
Query: 305 FIPSCFEELHGL 316
+E+ +
Sbjct: 317 -EDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.9 bits (104), Expect = 2e-05
Identities = 17/89 (19%), Positives = 29/89 (32%), Gaps = 5/89 (5%)
Query: 243 KLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQIC----NMQSLEKLNLS 298
L ++ K + L + + E+ LS N +G E + + + LE S
Sbjct: 9 SLKLDAITTED-EKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 299 HNNLSGFIPSCFEELHGLSYIDISYNELH 327
E L L + +LH
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLH 96
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.5 bits (103), Expect = 3e-05
Identities = 46/312 (14%), Positives = 87/312 (27%), Gaps = 40/312 (12%)
Query: 1 NLSNLAFLYLYNNSFSG----SIPSEIGRLKSLSDLELSGN---KLCGSIPHSLGNLTQI 53
++ + L N+ + I K L E S ++ IP +L L Q
Sbjct: 29 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA 88
Query: 54 TF-LTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTG 112
L ++ L + L ++ +
Sbjct: 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 148
Query: 113 NISESFGIHPNLAFIDLSHNYF----YGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIH 168
+++ P L I N E + + L T+ N I ++
Sbjct: 149 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 208
Query: 169 SSQLKVLDLSSNHIV---------GEMPSKLGKLSSLIKLILNSNQLCGQ------LSLE 213
+L + + L +L +L LN L + +
Sbjct: 209 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 268
Query: 214 LGSLTQLERLDLSSNRLSNSIPKSL-----GNLVKLHYLNLSNNQF--IKKIPVELEKLI 266
L+ L L N + ++L + L +L L+ N+F + E+ ++
Sbjct: 269 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVF 328
Query: 267 ------HLSELD 272
L ELD
Sbjct: 329 STRGRGELDELD 340
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.9 bits (99), Expect = 8e-05
Identities = 34/340 (10%), Positives = 90/340 (26%), Gaps = 31/340 (9%)
Query: 27 KSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSG----AIPKEYGNLVKLTLLTL 82
KSL ++ S+ L + + L N + + + + L +
Sbjct: 8 KSLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 83 ENNQLRGPIPNL----RNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEI 138
+ + R L + + + + + LS + +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 139 SSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIK 198
+ ++ + ++ L+ + N + + K +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 199 LILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKI 258
L+ + R + + L + V N + +
Sbjct: 187 LLHTVKMVQNG-----------IRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235
Query: 259 PVELEKLIHLSELDLSHNFLGEEMPSQICNM------QSLEKLNLSHNNLSGFIPSCFEE 312
+ L+ +L EL L+ L + + + L+ L L +N + +
Sbjct: 236 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 295
Query: 313 -----LHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGN 347
+ L +++++ N R+ +G
Sbjct: 296 VIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGE 335
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.6 bits (112), Expect = 6e-07
Identities = 18/128 (14%), Positives = 44/128 (34%), Gaps = 3/128 (2%)
Query: 209 QLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHL 268
+ + + + + LDL ++ I L + ++ S+N+ I+K+ L L
Sbjct: 9 EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNE-IRKLDGF-PLLRRL 65
Query: 269 SELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHG 328
L +++N + + L +L L++N+L
Sbjct: 66 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125
Query: 329 SIPNSTAF 336
+ + +
Sbjct: 126 NKKHYRLY 133
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 1e-04
Identities = 12/84 (14%), Positives = 29/84 (34%), Gaps = 5/84 (5%)
Query: 249 LSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPS 308
L+ I++ + + ELDL + + + + + ++ S N +
Sbjct: 3 LTAE-LIEQAA-QYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKL--D 57
Query: 309 CFEELHGLSYIDISYNELHGSIPN 332
F L L + ++ N +
Sbjct: 58 GFPLLRRLKTLLVNNNRICRIGEG 81
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (88), Expect = 9e-04
Identities = 25/135 (18%), Positives = 42/135 (31%), Gaps = 8/135 (5%)
Query: 1 NLSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFD 60
N L L I + L ++ S N++ L ++ L + +
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNN 72
Query: 61 NALSGAIPKEYGNLVKLTLLTLENNQLR--GPIPNLRNLTSLVRVRL---NQNHLTGNIS 115
N + L LT L L NN L G + L +L SL + + +
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 116 ESFGIHPNLAFIDLS 130
P + +D
Sbjct: 133 YVIYKVPQVRVLDFQ 147
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 37.0 bits (84), Expect = 0.004
Identities = 17/80 (21%), Positives = 26/80 (32%), Gaps = 8/80 (10%)
Query: 217 LTQLERLDLSSNRLSNSIPK------SLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSE 270
+ + L IP +L L +L LS N I+KI L + +L
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNN-IEKIS-SLSGMENLRI 74
Query: 271 LDLSHNFLGEEMPSQICNMQ 290
L L N + +
Sbjct: 75 LSLGRNLIKKIENLDAVADT 94
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 707 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.83 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.82 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.8 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.8 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.79 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.74 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.72 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.64 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.63 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.62 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.61 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.6 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.59 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.55 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.44 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.39 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.37 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.36 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.6 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.53 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.52 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.19 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.04 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.0 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.58 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.51 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.43 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.16 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.11 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.66 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=404.47 Aligned_cols=248 Identities=27% Similarity=0.453 Sum_probs=209.5
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||+||+|+. .+|+.||+|++...........+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999965 578999999986433233334567899999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++|+|.+++... ..+++..++.++.||++||+|||++ ||+||||||+||+++.++.+||+|||+|......
T Consensus 86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 999999999999643 4589999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
......||+.|+|||++.+..++.++|||||||++|||++|+.||+... .......+.......+..
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~~p~~--- 226 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISRVEFTFPDF--- 226 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTTCCCCCTT---
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCCCcc---
Confidence 3355689999999999999999999999999999999999999996322 222333333333333322
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+.++.+++.+||+.||++|||++|+++
T Consensus 227 -~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 227 -VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 2345889999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-51 Score=403.15 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=197.0
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec--CCceeE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH--ARHSFI 512 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l 512 (707)
++|++.+.||+|+||+||+|+ ..+|+.||+|++......+ ...+.+.+|++++++++||||+++++++.+ .+..|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 679999999999999999995 4679999999987654433 346779999999999999999999999864 456899
Q ss_pred EEeeeccCcHHHHHhccc-ccCCCChHHHHHHHHHHHHHHHHHHhCCC--CCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 513 VYEYLEMGSLAMILSNDA-AAKDLGWTKRMNVIKGVVDALSYMHNDCF--PPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~--~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
||||+++|+|.+++.... ....+++..++.++.||+.||+|||++.. .+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 999999999999986432 34569999999999999999999999710 139999999999999999999999999998
Q ss_pred ecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
.............||+.|+|||++.+..++.++|||||||++|||+||+.||...+. ......+.....+..
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~~~i~~~~~~~~ 234 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREGKFRRI 234 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCCCC
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCCCC
Confidence 876655555667899999999999999999999999999999999999999964221 122222222222221
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
+. ..+.++.+++.+||+.||++|||++|+++
T Consensus 235 ~~---~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 PY---RYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cc---ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11 23346899999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=401.74 Aligned_cols=249 Identities=25% Similarity=0.454 Sum_probs=209.1
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 4799999999999999999964 6799999999864322 23467899999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++||+|.+++.. +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.....
T Consensus 97 Ey~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp ECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence 99999999998753 3589999999999999999999999 9999999999999999999999999999987766
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.......+||+.|+|||++.+..++.++||||+||++|+|+||+.||...... ..... ......+....+ .
T Consensus 170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~~-~~~~~~~~~~~~----~ 240 (293)
T d1yhwa1 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL----RALYL-IATNGTPELQNP----E 240 (293)
T ss_dssp TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH----HHHHH-HHHHCSCCCSSG----G
T ss_pred cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH----HHHHH-HHhCCCCCCCCc----c
Confidence 55566778999999999999999999999999999999999999999632211 11111 111111222221 2
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..+.++.+++.+||+.||++|||++|+++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33456899999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=401.07 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=202.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|+||+||+|+.+ ..||||++...... ....+.|.+|++++++++|||||++++++.+ +..++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEE
Confidence 468999999999999999999865 35999998754333 3356789999999999999999999998754 5689999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++|+|.+++.... ..+++..+.+++.||++||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 83 Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp ECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred ecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999996432 4589999999999999999999999 9999999999999999999999999999876543
Q ss_pred C--CCccccccccCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 595 S--SNWAELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 595 ~--~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
. .......||+.|||||++.+ ..++.++|||||||++|||+||+.||...... .............+....
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~p~~~~- 233 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIFMVGRGYLSPDLSK- 233 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHHHHHTSCCCCGGG-
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH---HHHHHHHhcCCCCCcchh-
Confidence 2 23345689999999999864 34789999999999999999999999743221 111111112222222221
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.....+.++.+++.+||+.||++|||++|+++.|+
T Consensus 234 --~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le 268 (276)
T d1uwha_ 234 --VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268 (276)
T ss_dssp --SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 12233456899999999999999999999999885
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=401.39 Aligned_cols=251 Identities=26% Similarity=0.375 Sum_probs=203.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||+||+|+. .+|+.||||++...... ...+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 46799999999999999999965 57999999998754322 2345689999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++|+|.+++... ..+++..++.++.||++||+|||++ ||+||||||+|||+++++.+||+|||+|+....
T Consensus 82 mEy~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp EECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EeccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 9999999999998543 4599999999999999999999999 999999999999999999999999999987653
Q ss_pred CC--CCccccccccCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC-CCCCC
Q 038671 594 DS--SNWAELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP-RLPTP 669 (707)
Q Consensus 594 ~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 669 (707)
.. ......+||+.|||||++.+..+ +.++||||+||++|||+||+.||...... .......... ....+
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~-------~~~~~~~~~~~~~~~~ 228 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-------CQEYSDWKEKKTYLNP 228 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT-------SHHHHHHHTTCTTSTT
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcCCCCCCc
Confidence 32 23445689999999999988776 57899999999999999999999643211 1111111111 11111
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
....+.++.+++.+||+.||++|||++|+++
T Consensus 229 ---~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 ---WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1223456889999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-50 Score=395.10 Aligned_cols=251 Identities=25% Similarity=0.415 Sum_probs=197.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
++|++.+.||+|+||+||+|++++++.||||++..... ..+++.+|++++++++||||+++++++..++..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 57888999999999999999988899999999875322 34679999999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++|+|.+++... ...+++..+++++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred ecCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCC
Confidence 99999999998643 34689999999999999999999999 99999999999999999999999999998765443
Q ss_pred C-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 596 S-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 596 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
. ......||+.|+|||++.+..++.++||||||+++|||+|| ++||..... .......... .+...+..
T Consensus 156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-----~~~~~~i~~~--~~~~~p~~-- 226 (263)
T d1sm2a_ 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDISTG--FRLYKPRL-- 226 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-----HHHHHHHHHT--CCCCCCTT--
T ss_pred ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHhc--CCCCCccc--
Confidence 2 22345789999999999999999999999999999999995 555542211 1111112221 12222222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.++.+++.+||+.||++|||++|+++.|+
T Consensus 227 --~~~~l~~li~~cl~~~p~~Rps~~~il~~L~ 257 (263)
T d1sm2a_ 227 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257 (263)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --cCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 2345889999999999999999999999885
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=403.19 Aligned_cols=250 Identities=21% Similarity=0.306 Sum_probs=206.0
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||+||+|+. .+|+.||||++...........+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5799999999999999999964 679999999986432223334567999999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++||+|.+++... +.+++..++.++.|++.||+|||+. ||+||||||+||++++++.+||+|||+|+.....
T Consensus 88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccC
Confidence 999999999988643 4599999999999999999999999 9999999999999999999999999999887543
Q ss_pred C--CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 595 S--SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 595 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||...+ .......+.......+..
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~~~~p~~- 232 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQKIIKLEYDFPEK- 232 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTTCCCCCTT-
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHHHHHcCCCCCCcc-
Confidence 2 23345689999999999999999999999999999999999999996322 222233333333333322
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.+.++.+++.+||+.||++|||++|+++
T Consensus 233 ---~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 233 ---FFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 2345889999999999999999998643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=399.43 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=205.1
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
+.|++.+.||+|+||.||+|+ ..+|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 568999999999999999996 45799999999875432 23457889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++|+|.+++... .+.+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 Ey~~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp ECCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred ecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 999999999987532 34699999999999999999999999 9999999999999999999999999999765433
Q ss_pred CCCccccccccCCCCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 595 SSNWAELAGTYGYVAPELAY-----TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
........||+.|+|||++. +..|+.++||||+||++|||+||+.||...... ..... ......+....+
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~----~~~~~-i~~~~~~~~~~~ 238 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM----RVLLK-IAKSEPPTLAQP 238 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG----GHHHH-HHHSCCCCCSSG
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH----HHHHH-HHcCCCCCCCcc
Confidence 33334568999999999874 456889999999999999999999999643221 11111 111111122221
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+.++.+++.+||+.||++|||++|+++
T Consensus 239 ----~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 239 ----SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 234456899999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=386.87 Aligned_cols=250 Identities=26% Similarity=0.433 Sum_probs=209.9
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
++|++.+.||+|+||+||+|+.++++.||||++..... ..+++.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 68999999999999999999988899999999875432 34678999999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+.+|++.+++... ...+++..+++++.||++||+|||+. ||+||||||+||+++.++.+||+|||+++......
T Consensus 80 y~~~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 80 YMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CCTTEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred ccCCCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 99999999997543 34689999999999999999999999 99999999999999999999999999998765443
Q ss_pred C-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 596 S-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 596 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
. ......||+.|+|||.+.+..++.++||||||+++|||+| |+.||+.... ......+... .+.+.+.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-----~~~~~~i~~~--~~~~~p~--- 224 (258)
T d1k2pa_ 155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-----SETAEHIAQG--LRLYRPH--- 224 (258)
T ss_dssp CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-----HHHHHHHHTT--CCCCCCT---
T ss_pred ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-----HHHHHHHHhC--CCCCCcc---
Confidence 2 2334678999999999999999999999999999999998 8999974332 1111122221 2222222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHh
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLL 705 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L 705 (707)
..+.++.+++.+||+.||++|||++++++.|
T Consensus 225 -~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 225 -LASEKVYTIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp -TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred -cccHHHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence 2234689999999999999999999999876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-49 Score=397.91 Aligned_cols=252 Identities=26% Similarity=0.472 Sum_probs=195.8
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CC---cEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SG---EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
++|++.+.||+|+||+||+|+.+ ++ ..||||++..... ....++|.+|++++++++|||||++++++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccC--HHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 45777899999999999999654 33 3588998865432 234567999999999999999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||+++|+|.+++... ...+++.++++++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 104 iv~Ey~~~g~L~~~~~~~--~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEEECCTTEEHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEecCCCcceeeeccc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999999988643 34589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCC-----ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhc-CC
Q 038671 592 KPDSSN-----WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEML-DP 664 (707)
Q Consensus 592 ~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~ 664 (707)
...... .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||..... ......+. ..
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--------~~~~~~i~~~~ 250 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--------QDVINAIEQDY 250 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCC
Confidence 543221 122457899999999999999999999999999999998 8999864321 11112222 22
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.+.+. +.+.++.+++.+||+.||++|||++||++.|+
T Consensus 251 ~~~~~~----~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~ 288 (299)
T d1jpaa_ 251 RLPPPM----DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288 (299)
T ss_dssp CCCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCCCCc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 333332 23456899999999999999999999999874
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=393.22 Aligned_cols=252 Identities=22% Similarity=0.371 Sum_probs=205.1
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
.++|++.+.||+|+||.||+|++++++.||||++..... ..+.+.+|++++++++|||||++++++.+ +..++||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEE
Confidence 467889999999999999999988889999999875432 34679999999999999999999998854 5679999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++|+|.+++.... ..++++..+++++.||++||+|||++ +|+||||||+||++++++.+||+|||+|+.....
T Consensus 87 Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp ECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCC
Confidence 9999999999886433 34589999999999999999999999 9999999999999999999999999999887543
Q ss_pred CC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcC-CCCCCCCcc
Q 038671 595 SS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD-PRLPTPSHN 672 (707)
Q Consensus 595 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 672 (707)
.. ......||+.|+|||++.+..++.++||||||+++|||+||..|+.... ........+.. .+.+.+.
T Consensus 163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-------~~~~~~~~i~~~~~~~~p~-- 233 (272)
T d1qpca_ 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-------TNPEVIQNLERGYRMVRPD-- 233 (272)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHHHHTTCCCCCCT--
T ss_pred ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-------CHHHHHHHHHhcCCCCCcc--
Confidence 32 2334578999999999998899999999999999999999655543111 11112222222 1222222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.||++|||+++|++.|+
T Consensus 234 --~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~ 265 (272)
T d1qpca_ 234 --NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265 (272)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 23345899999999999999999999999874
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.5e-50 Score=402.12 Aligned_cols=253 Identities=25% Similarity=0.333 Sum_probs=193.7
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeE
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l 512 (707)
+.+.|++.+.||+|+||+||+|+. .+|+.||||++....... ....+.+|++++++++||||+++++++.+++..|+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 356799999999999999999965 578999999987643322 34568899999999999999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec---CCCCeEEeccccce
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD---LENEAHVSDFGTAK 589 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~---~~~~~kl~Dfg~~~ 589 (707)
||||++||+|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+||++. +++.+||+|||+|+
T Consensus 85 vmE~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp EECCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EEeccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence 99999999999999653 4599999999999999999999999 999999999999994 57899999999998
Q ss_pred ecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 590 FLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 590 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
..... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+.......+
T Consensus 159 ~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~~~~~ 229 (307)
T d1a06a_ 159 MEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAKLFEQILKAEYEFD 229 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHTTCCCCC
T ss_pred EccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHhccCCCCC
Confidence 65533 23345689999999999999999999999999999999999999996322 1222223333333222
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.......+.++.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 2222344566899999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-50 Score=398.90 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=207.2
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||+||+|.+ .+|+.||||++..... ..+++.+|++++++++|||||++++++.+++..++|
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 46788999999999999999965 4689999999875432 346789999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++|+|.+++.... ...+++..++.++.||++||+|||++ ||+||||||+|||+++++.+||+|||+|+....
T Consensus 92 ~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp EECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999986433 35689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCC-ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcc
Q 038671 594 DSSN-WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHN 672 (707)
Q Consensus 594 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 672 (707)
.... .....|++.|+|||++.+..++.++||||||+++|||++|..||..... ............ +.+.+.
T Consensus 168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~----~~~~~~~i~~~~--~~~~~~-- 239 (287)
T d1opja_ 168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELLEKDY--RMERPE-- 239 (287)
T ss_dssp SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHHHHHHHHTTC--CCCCCT--
T ss_pred CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch----HHHHHHHHhcCC--CCCCCc--
Confidence 3322 2334588999999999999999999999999999999997776532111 111111222211 222222
Q ss_pred hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 673 VQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 673 ~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.||++|||++|+++.|+
T Consensus 240 --~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~ 271 (287)
T d1opja_ 240 --GCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271 (287)
T ss_dssp --TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 23346899999999999999999999998774
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-49 Score=398.36 Aligned_cols=248 Identities=27% Similarity=0.438 Sum_probs=204.5
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
+.|+..+.||+|+||+||+|+ ..+|+.||||++...........+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 348999999999999999995 5678999999997765555556678999999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+|++..+.... +++++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+|......
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999998766432 4699999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCccccccccCCCCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 595 SSNWAELAGTYGYVAPELAYT---MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||..... .. ..........+....
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~-~~~~i~~~~~~~~~~ 236 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MS-ALYHIAQNESPALQS 236 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HH-HHHHHHHSCCCCCSC
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HH-HHHHHHhCCCCCCCC
Confidence 34579999999999864 4589999999999999999999999863221 11 111111111111111
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+.++.+++.+||+.||++|||++|+++
T Consensus 237 --~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 --GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 123456899999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.4e-49 Score=401.29 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=211.0
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|+ ..+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3689999999999999999996 4679999999987542 23456789999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC--CCCeEEeccccceec
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL--ENEAHVSDFGTAKFL 591 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~--~~~~kl~Dfg~~~~~ 591 (707)
|||++||+|.+++... ...+++..++.++.||+.||+|||++ |||||||||+|||++. ++.+||+|||+++..
T Consensus 102 mE~~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 102 YEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp ECCCCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEcCCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 9999999999998543 34589999999999999999999999 9999999999999964 678999999999876
Q ss_pred CCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
... .......||+.|||||++.+..++.++||||+||++|+|++|+.||.... .......+.......+..
T Consensus 177 ~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~~ 247 (350)
T d1koaa2 177 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCDWNMDDS 247 (350)
T ss_dssp CTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCCCSCCG
T ss_pred ccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCCcc
Confidence 543 33455789999999999999999999999999999999999999996322 122233333333333333
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.....+.++.+++.+||+.||++|||++|+++
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33344567899999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=388.66 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=203.6
Q ss_pred cCCCCCce-eeecCCeeEEEEEcC---CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHC-IGKGGQGSVYKAELP---SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~-lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
++|.+.+. ||+|+||.||+|..+ ++..||||++.... .....++|.+|++++++++|||||++++++.. +..|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence 45666664 999999999999543 45679999987543 23456789999999999999999999999865 4689
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||+++|+|.+++... ...+++..+++++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 85 lvmE~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEECCTTEEHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999999998543 34689999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCC---ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 592 KPDSSN---WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 592 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
...... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ......+.... +.+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-----~~~~~~i~~~~--~~~ 232 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-----PEVMAFIEQGK--RME 232 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-----HHHHHHHHTTC--CCC
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCC--CCC
Confidence 644321 233468899999999999999999999999999999998 9999974322 11111222212 222
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+. ..+.++.+++.+||+.||++|||+.++.+.|+
T Consensus 233 ~p~----~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~ 267 (285)
T d1u59a_ 233 CPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267 (285)
T ss_dssp CCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCC----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 222 23356889999999999999999999998875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=385.82 Aligned_cols=246 Identities=23% Similarity=0.360 Sum_probs=197.9
Q ss_pred CCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec----CCceeEE
Q 038671 439 DDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH----ARHSFIV 513 (707)
Q Consensus 439 ~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv 513 (707)
+..+.||+|+||+||+|.. .+++.||+|++...... ....+.+.+|++++++++|||||++++++.. +..+++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 5667899999999999954 57899999998654332 2345679999999999999999999999864 3468999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCC--eEecCCCCCCeeec-CCCCeEEecccccee
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPP--IVHRDISSKNVLLD-LENEAHVSDFGTAKF 590 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~dlk~~Nil~~-~~~~~kl~Dfg~~~~ 590 (707)
|||+++|+|.+++.+. ..+++..++.++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+|+.
T Consensus 91 mE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 9999999999999643 4589999999999999999999998 6 99999999999996 578999999999976
Q ss_pred cCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCC
Q 038671 591 LKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670 (707)
Q Consensus 591 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (707)
... ......+||+.|+|||++.+ +++.++||||+||++|||++|+.||.... ........+.....+.
T Consensus 165 ~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-------~~~~~~~~i~~~~~~~-- 232 (270)
T d1t4ha_ 165 KRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-------NAAQIYRRVTSGVKPA-- 232 (270)
T ss_dssp CCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-------SHHHHHHHHTTTCCCG--
T ss_pred ccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-------cHHHHHHHHHcCCCCc--
Confidence 432 33456789999999998876 59999999999999999999999996322 1122222222222111
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
......+.++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111123345889999999999999999999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=397.60 Aligned_cols=250 Identities=24% Similarity=0.305 Sum_probs=211.2
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|+ ..+|+.||+|++...........+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 579999999999999999995 4689999999986533223334567889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||++||+|.+++... +.+++..++.++.||+.||+|||++ ||+||||||+||+++.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 999999999998653 4589999999999999999999999 9999999999999999999999999999877665
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.......+||+.|+|||++.+..|+.++||||+||++|||++|++||...+ .......+.......+..
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--------~~~~~~~i~~~~~~~p~~--- 227 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEEIRFPRT--- 227 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCTT---
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--------HHHHHHHHhcCCCCCCcc---
Confidence 556667899999999999999999999999999999999999999996422 122223333333333322
Q ss_pred HHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRPT-----IQKVSQ 703 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps-----~~~l~~ 703 (707)
.+.++.++|.+||+.||++||+ ++|+++
T Consensus 228 -~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 228 -LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 2345889999999999999995 778765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=393.30 Aligned_cols=255 Identities=21% Similarity=0.294 Sum_probs=210.8
Q ss_pred HhcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCc---hhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCc
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPS---EMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARH 509 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 509 (707)
+.++|++.+.||+|+||+||+|+. .+|+.||||++...... .....+.+.+|++++++++|||||++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 346799999999999999999965 67999999998643222 22245789999999999999999999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC----CeEEecc
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN----EAHVSDF 585 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~----~~kl~Df 585 (707)
.|+||||++||+|.+++... +.+++..++.++.||+.||+|||+. +|+||||||+||+++.++ .+|++||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecch
Confidence 99999999999999999643 4599999999999999999999999 999999999999998876 4999999
Q ss_pred ccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCC
Q 038671 586 GTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPR 665 (707)
Q Consensus 586 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (707)
|++...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+....
T Consensus 162 G~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~ 232 (293)
T d1jksa_ 162 GLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANVSAVN 232 (293)
T ss_dssp TTCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHTTC
T ss_pred hhhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcC
Confidence 999886543 23345689999999999999999999999999999999999999996322 122223333333
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+.......+..+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 32222222234456889999999999999999999986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-48 Score=399.78 Aligned_cols=252 Identities=19% Similarity=0.288 Sum_probs=210.0
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||.||+|+ ..+|+.||||++.... ......+.+|++++++++|||||++++++.+++..|+|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3579999999999999999995 4679999999987643 22456788999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeec--CCCCeEEeccccceec
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLD--LENEAHVSDFGTAKFL 591 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~--~~~~~kl~Dfg~~~~~ 591 (707)
|||++||+|.+++... ..++++..++.++.||+.||+|||++ ||+||||||+|||++ .++.+||+|||+|...
T Consensus 105 mE~~~gg~L~~~~~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 105 LEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EECCCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEcCCCChHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence 9999999999887543 34589999999999999999999999 999999999999997 5789999999999887
Q ss_pred CCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
... .......||+.|+|||++.+..++.++||||+||++|+|+||+.||..... ......+.......+..
T Consensus 180 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~~ 250 (352)
T d1koba_ 180 NPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--------LETLQNVKRCDWEFDED 250 (352)
T ss_dssp CTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHCCCCCCSS
T ss_pred CCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCcc
Confidence 644 334556899999999999999999999999999999999999999963221 22222222222222222
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.....+.++.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22334556899999999999999999999986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=399.83 Aligned_cols=257 Identities=23% Similarity=0.363 Sum_probs=204.0
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||+||+|+ ..+|+.||+|++...... ...+.+.+|+.++++++|||||++++++.+++..++|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 5789999999999999999996 467999999998764322 3456789999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeecCCCCeEEeccccceecC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN-DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLK 592 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~ 592 (707)
|||++||+|.+++.+. ..+++..++.++.|++.||+|||+ + ||+||||||+|||++.+|.+||+|||+|+...
T Consensus 83 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999999643 358999999999999999999997 5 89999999999999999999999999998754
Q ss_pred CCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccc----------------------
Q 038671 593 PDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS---------------------- 650 (707)
Q Consensus 593 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~---------------------- 650 (707)
.. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.........
T Consensus 157 ~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 157 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp HH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred CC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 32 224568999999999999999999999999999999999999999642210000
Q ss_pred ------------cchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 651 ------------SSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 651 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
................+... ....+.++.+++.+||..||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000000001111111000 0112346889999999999999999999986
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-49 Score=400.07 Aligned_cols=256 Identities=23% Similarity=0.391 Sum_probs=205.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcCC------CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCC
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPS------GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHAR 508 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 508 (707)
++|++.+.||+|+||+||+|+... ...||+|++..... ......+.+|+.++.++ +|||||++++++.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 678999999999999999996532 23699999865432 22446788999999998 8999999999999999
Q ss_pred ceeEEEeeeccCcHHHHHhcccc--------------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCC
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAA--------------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDIS 568 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk 568 (707)
..++||||+++|+|.++++.... ...+++..++.++.||++||+|||++ +|||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCc
Confidence 99999999999999999975431 23489999999999999999999999 99999999
Q ss_pred CCCeeecCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccc
Q 038671 569 SKNVLLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFIS 645 (707)
Q Consensus 569 ~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~ 645 (707)
|+||+++.++.+||+|||+|+........ .....||+.|||||++.+..++.++|||||||++|||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544332 234568999999999999999999999999999999998 899996432
Q ss_pred ccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 646 SISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 646 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
. ............. ++.+.. .+.++.+++.+||+.||++|||++||++.|.
T Consensus 272 ~----~~~~~~~~~~~~~--~~~p~~----~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 V----DANFYKLIQNGFK--MDQPFY----ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp C----SHHHHHHHHTTCC--CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H----HHHHHHHHhcCCC--CCCCCc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2 1122222222222 222222 2346899999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-48 Score=384.13 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=196.5
Q ss_pred ceeeecCCeeEEEEEcC---CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEeeec
Q 038671 442 HCIGKGGQGSVYKAELP---SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEYLE 518 (707)
Q Consensus 442 ~~lg~G~~g~vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 518 (707)
+.||+|+||+||+|.++ .++.||||++..... .....+++.+|++++++++|||||++++++.. +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence 56999999999999643 357899999865432 23345789999999999999999999999865 45789999999
Q ss_pred cCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCCC-
Q 038671 519 MGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSSN- 597 (707)
Q Consensus 519 ~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 597 (707)
+|+|.++++.. ..+++..+++++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 91 ~g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 91 LGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp TEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999998643 4589999999999999999999999 9999999999999999999999999999876544322
Q ss_pred --ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 598 --WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 598 --~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.....||+.|+|||.+.+..++.++||||||+++|||+| |+.||..... ......+.. ..+.+.+.
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-----~~~~~~i~~--~~~~~~p~---- 233 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEK--GERMGCPA---- 233 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHT--TCCCCCCT----
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-----HHHHHHHHc--CCCCCCCc----
Confidence 233568999999999999999999999999999999998 8999974322 111111211 12222222
Q ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 675 DKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.||++|||+++|.+.|+
T Consensus 234 ~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~ 265 (277)
T d1xbba_ 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265 (277)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence 23456889999999999999999999988764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=385.68 Aligned_cols=253 Identities=26% Similarity=0.444 Sum_probs=197.8
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCC-----cEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSG-----EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
++|+..+.||+|+||.||+|.++.. ..||||++...... ....+|.+|++++++++|||||++++++.+.+..
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccCh--HHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence 4688899999999999999965432 47999998654332 3456789999999999999999999999999999
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++||||+.++++.+.+... ...+++.++++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999887543 34689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC---ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC-CC
Q 038671 591 LKPDSSN---WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP-RL 666 (707)
Q Consensus 591 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 666 (707)
....... .....||+.|+|||++.+..++.++||||||+++|||++|..|+.... ........+.+. +.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-------~~~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-------SNHEVMKAINDGFRL 232 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHHHHTTCCC
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-------CHHHHHHHHhccCCC
Confidence 6543221 233468999999999999999999999999999999999766643211 111222222222 22
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
+.+. +.+.++.+++.+||+.||++|||+.||++.|+
T Consensus 233 ~~~~----~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~ 268 (283)
T d1mqba_ 233 PTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSILD 268 (283)
T ss_dssp CCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred CCch----hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHH
Confidence 2222 23456899999999999999999999998874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-48 Score=389.70 Aligned_cols=247 Identities=24% Similarity=0.362 Sum_probs=206.7
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||+||+|+. .+|+.||||++...........+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5699999999999999999965 679999999986433233334577899999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.||++..++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999999988643 3478899999999999999999999 9999999999999999999999999999886533
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
....+||+.|+|||++.+..++.++||||+||++|||+||+.||...+ .......+.......+..
T Consensus 158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~~~~~p~~--- 223 (316)
T d1fota_ 158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAELRFPPF--- 223 (316)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCCCCCCTT---
T ss_pred ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--------HHHHHHHHHcCCCCCCCC---
Confidence 345689999999999999999999999999999999999999996322 122222333333332222
Q ss_pred HHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
.+.++.+++.+||..||.+|| |++++++
T Consensus 224 -~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 224 -FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 234588999999999999996 8898875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.1e-48 Score=386.33 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=202.6
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC----c
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR----H 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 509 (707)
.++|++.+.||+|+||.||+|+ ..+|+.||||++...........+.+.+|++++++++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4679999999999999999995 5689999999998765555556678999999999999999999999987643 4
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.|+||||++|++|.+++... +.+++.+++.++.||+.||+|||++ ||+||||||+||+++.++..+++|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 78999999999999988543 4589999999999999999999999 99999999999999999999999999987
Q ss_pred ecCCCC---CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 590 FLKPDS---SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 590 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
...... ......+||+.|+|||++.+..++.++||||+||++|||+||++||..... .+........ ..
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~~~~~-~~ 231 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAYQHVRE-DP 231 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHC-CC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-------HHHHHHHHhc-CC
Confidence 654332 233456799999999999999999999999999999999999999964221 1111111111 11
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCC-CHHHHHHHh
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRP-TIQKVSQLL 705 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-s~~~l~~~L 705 (707)
..+.......+.++.+++.+||+.||.+|| |++++++.|
T Consensus 232 ~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l 271 (277)
T d1o6ya_ 232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271 (277)
T ss_dssp CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence 111111223445689999999999999999 899988776
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=383.50 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=199.7
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
++|++.+.||+|+||.||+|+.++++.||||++..... ..+.|.+|+.++++++|||||++++++.+ +..++|||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 57999999999999999999988888999999865432 34679999999999999999999999854 56899999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+.+|++.+++.... .+.+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 92 y~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 92 YMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred ecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 999999999886432 34599999999999999999999999 99999999999999999999999999998764332
Q ss_pred -CCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcC-CCCCCCCcch
Q 038671 596 -SNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLD-PRLPTPSHNV 673 (707)
Q Consensus 596 -~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 673 (707)
.......||+.|+|||++.++.++.++||||||+++|||+||..|+.... ........+.. .+.+.+.
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-------~~~~~~~~i~~~~~~~~~~--- 237 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVLDQVERGYRMPCPP--- 237 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHHHHTTCCCCCCT---
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-------CHHHHHHHHHhcCCCCCCc---
Confidence 22334578999999999999999999999999999999999766653211 11112222221 2222222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.||++||++++|+++|+
T Consensus 238 -~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 269 (285)
T d1fmka3 238 -ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269 (285)
T ss_dssp -TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHh
Confidence 23456899999999999999999999998774
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.3e-47 Score=380.05 Aligned_cols=255 Identities=22% Similarity=0.339 Sum_probs=208.7
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCch------hhhHHHHHHHHHHHhcCC-CCceeeeeeeeec
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSE------MASQQEFLNEVKTLTGIR-HRNIVKFYGFCSH 506 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 506 (707)
.++|++.+.||+|+||+||+|+. .+|+.||||++....... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 46899999999999999999964 679999999987543222 122346889999999997 9999999999999
Q ss_pred CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 507 ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 507 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
++..|+||||+++|+|.++++.. ..+++..++.++.||++||+|||++ ||+||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 99999999999999999999643 4699999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCccccccccCCCCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYT------MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
+++...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ......
T Consensus 156 ~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~~~ 226 (277)
T d1phka_ 156 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLRM 226 (277)
T ss_dssp TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred heeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHHHH
Confidence 998876543 3455689999999998763 3468899999999999999999999974221 112222
Q ss_pred hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
+.......+.......+.++.+++.+||+.||++|||++|+++.
T Consensus 227 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 227 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 22222222222223455679999999999999999999999863
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-47 Score=390.15 Aligned_cols=247 Identities=22% Similarity=0.282 Sum_probs=207.3
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|+. .+|+.||||++...........+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999964 579999999986432223334567899999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.+|+|.+++... +.+++..++.++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 999999999998643 3589999999999999999999999 9999999999999999999999999999886533
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcchH
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQ 674 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 674 (707)
.....||+.|||||++.+..++.++|||||||++|||+||+.||.... .......+.......+..
T Consensus 195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~~~~~p~~--- 260 (350)
T d1rdqe_ 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSGKVRFPSH--- 260 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCCCCTT---
T ss_pred ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--------HHHHHHHHhcCCCCCCcc---
Confidence 345689999999999999999999999999999999999999996322 122222233333333222
Q ss_pred HHHHHHHHHHHhccCCCCCCCC-----CHHHHHH
Q 038671 675 DKLISIMEVAISCLDESPESRP-----TIQKVSQ 703 (707)
Q Consensus 675 ~~~~~l~~li~~cl~~~P~~Rp-----s~~~l~~ 703 (707)
.+.++.+++.+||+.||.+|+ +++++++
T Consensus 261 -~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 261 -FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 234588999999999999994 8999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=386.26 Aligned_cols=251 Identities=21% Similarity=0.284 Sum_probs=209.0
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv 513 (707)
.++|++.+.||+|+||+||+|.. .+|+.||+|++.... .....+.+|+++++.++||||+++++++.+++..|+|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999954 578999999997542 2345688999999999999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC--CCeEEeccccceec
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE--NEAHVSDFGTAKFL 591 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~--~~~kl~Dfg~~~~~ 591 (707)
|||++||+|.+++... ...+++.+++.++.||+.||+|||++ ||+||||||+||+++.+ ..+||+|||++...
T Consensus 80 mE~~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 80 FEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp ECCCCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 9999999999999643 23589999999999999999999999 99999999999999854 48999999999876
Q ss_pred CCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
... .......+++.|+|||...+..++.++||||+||++|+|++|+.||.... .......+.......+..
T Consensus 155 ~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--------~~~~~~~i~~~~~~~~~~ 225 (321)
T d1tkia_ 155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEYTFDEE 225 (321)
T ss_dssp CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCCCCHH
T ss_pred ccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCCCCChh
Confidence 543 33455688999999999999999999999999999999999999996322 222333333333333222
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.....+.++.+++.+|+..||++|||++|+++
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22234556899999999999999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=387.66 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=204.9
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHh-cCCCCceeeeeeeeecCCceeEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLT-GIRHRNIVKFYGFCSHARHSFIV 513 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv 513 (707)
++|++.+.||+|+||+||+|.. .+|+.||||++...........+.+..|...+. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999954 579999999986432222233455666766655 68999999999999999999999
Q ss_pred EeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCC
Q 038671 514 YEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKP 593 (707)
Q Consensus 514 ~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~ 593 (707)
|||+++|+|.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999999643 4589999999999999999999999 999999999999999999999999999987765
Q ss_pred CCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 594 DSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 594 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......+.......+.
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~~~~p~--- 224 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDNPFYPR--- 224 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCT---
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCc---
Confidence 55556667899999999999999999999999999999999999999964221 1222222222222222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHH-HHHH
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQ-KVSQ 703 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~-~l~~ 703 (707)
..+.++.+++.+||+.||++||++. ++++
T Consensus 225 -~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 225 -WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2234588999999999999999985 6653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-47 Score=384.51 Aligned_cols=261 Identities=21% Similarity=0.389 Sum_probs=210.0
Q ss_pred HHHHHhcCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeee
Q 038671 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGF 503 (707)
Q Consensus 430 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 503 (707)
+++...++|++.+.||+|+||+||+|+.+ +++.||||++..... ....+++.+|++++++++||||++++++
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcC--hHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 34444578999999999999999999653 457899999875432 3346789999999999999999999999
Q ss_pred eecCCceeEEEeeeccCcHHHHHhccc---------------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCe
Q 038671 504 CSHARHSFIVYEYLEMGSLAMILSNDA---------------------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPI 562 (707)
Q Consensus 504 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 562 (707)
+...+..+++|||+.+|+|.+++.... ....+++..+++++.|++.||+|||+. ++
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 999999999999999999999985322 123489999999999999999999999 99
Q ss_pred EecCCCCCCeeecCCCCeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCC-C
Q 038671 563 VHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-H 639 (707)
Q Consensus 563 vH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~-~ 639 (707)
|||||||+||+++.++.+||+|||+|+....... ......+++.|+|||.+.+..++.++||||||+++|||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999986644322 233467889999999999999999999999999999999985 5
Q ss_pred CCCcccccccccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 640 PRDFISSISSSSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 640 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
||.... .......+.....+..+. ..+.++.+++.+||+.||++||||.||+++|+
T Consensus 242 p~~~~~--------~~e~~~~v~~~~~~~~p~---~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 242 PYYGMA--------HEEVIYYVRDGNILACPE---NCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp TTTTSC--------HHHHHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCC--------HHHHHHHHHcCCCCCCCc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 665322 122222333333322111 23345899999999999999999999999885
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=373.65 Aligned_cols=247 Identities=29% Similarity=0.421 Sum_probs=195.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec-CCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH-ARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 514 (707)
++|++.+.||+|+||.||+|+.+ |+.||||+++... ..+.+.+|++++++++||||+++++++.+ .+..++||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEE
Confidence 46888999999999999999884 7889999996532 34678999999999999999999999854 46789999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+++|+|.+++.... ...+++..+++++.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred eccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence 9999999999996432 23589999999999999999999999 9999999999999999999999999999865432
Q ss_pred CCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCCCcch
Q 038671 595 SSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSHNV 673 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 673 (707)
.....+++.|+|||++.+..++.++||||||+++|||+| |++||+.... ......+.....+..+.
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----~~~~~~i~~~~~~~~~~----- 223 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEKGYKMDAPD----- 223 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHHHHHTTTCCCCCCT-----
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcCCCCCCCc-----
Confidence 234567899999999999999999999999999999998 7888764322 11122222222222222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 674 QDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 674 ~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
..+.++.+++.+||+.||++|||+.++++.|+
T Consensus 224 -~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~ 255 (262)
T d1byga_ 224 -GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255 (262)
T ss_dssp -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 22346889999999999999999999999885
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=377.04 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=195.5
Q ss_pred cCCCCCceeeecCCeeEEEEEc--CCC--cEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL--PSG--EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~--~~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
++|++.+.||+|+||.||+|+. .++ ..||||++...........++|.+|++++++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5699999999999999999954 233 4689999876655555556789999999999999999999999966 4678
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||+++|++.+.+... ...+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999999887643 34599999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCCC---ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCC--C
Q 038671 592 KPDSSN---WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDP--R 665 (707)
Q Consensus 592 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~ 665 (707)
...... .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||..... ......+... +
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~--------~~~~~~i~~~~~~ 233 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG--------SQILHKIDKEGER 233 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTSCCC
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH--------HHHHHHHHhCCCC
Confidence 554332 233467889999999999999999999999999999998 8999964322 1122222221 2
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.+. ..+.++.+++.+||+.||++|||++||.+.|+
T Consensus 234 ~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~ 270 (273)
T d1u46a_ 234 LPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270 (273)
T ss_dssp CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 22222 23346899999999999999999999998874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-46 Score=388.44 Aligned_cols=251 Identities=21% Similarity=0.248 Sum_probs=201.1
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHH---HHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFL---NEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
++|++.+.||+|+||.||+|+. .+|+.||||++.............+. .++++++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999964 57999999998543222212222333 4577788889999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||++||+|.+++... ..+++..++.++.||+.||+|||++ |||||||||+|||++.+|.+||+|||+|+..
T Consensus 84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 999999999999999653 4588999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCC
Q 038671 592 KPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPS 670 (707)
Q Consensus 592 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (707)
.... .....||+.|+|||++.+ ..|+.++|||||||++|||+||+.||..... .................+.
T Consensus 158 ~~~~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~~~~~~~~~ 230 (364)
T d1omwa3 158 SKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMTLTMAVELPD 230 (364)
T ss_dssp SSSC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-----SCHHHHHHHSSSCCCCCCS
T ss_pred CCCc--ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhcccCCCCCCC
Confidence 5432 345689999999999864 5689999999999999999999999964321 1122222233333332222
Q ss_pred cchHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 038671 671 HNVQDKLISIMEVAISCLDESPESRPT-----IQKVSQ 703 (707)
Q Consensus 671 ~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~l~~ 703 (707)
. .+.++.++|.+||+.||++||| ++|+++
T Consensus 231 ~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 231 S----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp S----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred C----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 2 2345899999999999999999 688765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=384.46 Aligned_cols=252 Identities=21% Similarity=0.266 Sum_probs=202.6
Q ss_pred hcCCCCCc-eeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeec----C
Q 038671 435 TNDFDDEH-CIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSH----A 507 (707)
Q Consensus 435 ~~~~~~~~-~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~ 507 (707)
.++|++.. .||+|+||+||+|+ ..+|+.||||++... ..+.+|++++.++ +|||||+++++|.+ .
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 46788875 59999999999995 467999999998532 3567889887655 89999999999865 4
Q ss_pred CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC---CCCeEEec
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL---ENEAHVSD 584 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~---~~~~kl~D 584 (707)
..+|+||||++||+|.+++.... ...+++.+++.++.||+.||+|||+. ||+||||||+||+++. ++.+||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred CEEEEEEECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccc
Confidence 67899999999999999997543 35699999999999999999999999 9999999999999985 45799999
Q ss_pred cccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCC
Q 038671 585 FGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDP 664 (707)
Q Consensus 585 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 664 (707)
||+|+...... ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||...... .........+...
T Consensus 158 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~----~~~~~~~~~i~~~ 232 (335)
T d2ozaa1 158 FGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL----AISPGMKTRIRMG 232 (335)
T ss_dssp CTTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSC
T ss_pred cceeeeccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH----HHHHHHHHHHhcC
Confidence 99998766543 335568999999999999999999999999999999999999999643221 1111222233333
Q ss_pred CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 665 RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 665 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
....+.......+.++.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 333333344456678999999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-47 Score=375.40 Aligned_cols=252 Identities=24% Similarity=0.399 Sum_probs=194.0
Q ss_pred cCCCCCceeeecCCeeEEEEEcCC----CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPS----GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 511 (707)
++|++.+.||+|+||.||+|.+.. +..||||++.... .....+.+.+|++++++++||||+++++++. ++..+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 578999999999999999996532 4568999886532 3345677999999999999999999999996 46789
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceec
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFL 591 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~ 591 (707)
+||||+++|++.+++... ...+++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+|+..
T Consensus 84 iv~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheec
Confidence 999999999999987533 34689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC-CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCCCC
Q 038671 592 KPDSS-NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLPTP 669 (707)
Q Consensus 592 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 669 (707)
..... ......||+.|+|||.+.+..++.++||||||+++|||+| |.+||..... .. ....... ..+.+.+
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~----~~-~~~~i~~--~~~~~~~ 231 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN----ND-VIGRIEN--GERLPMP 231 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG----GG-HHHHHHT--TCCCCCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH----HH-HHHHHHc--CCCCCCC
Confidence 54322 2334568899999999999999999999999999999998 8999864332 11 1111111 1122222
Q ss_pred CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 670 SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 670 ~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
. ..+.++.+++.+||+.||++|||++||++.|+
T Consensus 232 ~----~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~ 264 (273)
T d1mp8a_ 232 P----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264 (273)
T ss_dssp T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred C----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 2 23456899999999999999999999998874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=380.89 Aligned_cols=252 Identities=24% Similarity=0.453 Sum_probs=199.1
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCc----EEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCce
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGE----IVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHS 510 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 510 (707)
.+|++.+.||+|+||+||+|.+ .+|+ +||+|++..... ....+++.+|++++++++|||||++++++.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 4699999999999999999964 4454 688998865322 23457799999999999999999999999864 56
Q ss_pred eEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 511 FIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 511 ~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
++++||+.+++|.+++... ...+++..+++++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEEEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred eEEEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeecccccee
Confidence 7889999999999887643 35689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCcccccccccchhhhhhhhhcCCCCC
Q 038671 591 LKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISSSSSNLEIALNEMLDPRLP 667 (707)
Q Consensus 591 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (707)
....... .....||+.|+|||.+.+..++.++||||||+++|||+| |+.||+.... .......... .+.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-----~~~~~~i~~~--~~~~ 233 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEKG--ERLP 233 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-----GGHHHHHHHT--CCCC
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHcC--CCCC
Confidence 7544332 233468999999999999999999999999999999998 8999874322 1122222221 2233
Q ss_pred CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 668 TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 668 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.. .+.++.+++.+||+.||++|||+.|+++.|+
T Consensus 234 ~p~~----~~~~~~~li~~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 234 QPPI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp CCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcc----cCHHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence 3322 2345889999999999999999999998763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=378.02 Aligned_cols=257 Identities=23% Similarity=0.380 Sum_probs=196.4
Q ss_pred hcCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHA 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 507 (707)
.++|++.+.||+|+||.||+|+.. +++.||||++..... ....+.+.+|...+.++ +|+||+.+++++...
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 467999999999999999999642 357899999875432 23456678888888777 689999999987654
Q ss_pred -CceeEEEeeeccCcHHHHHhcccc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCee
Q 038671 508 -RHSFIVYEYLEMGSLAMILSNDAA-------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVL 573 (707)
Q Consensus 508 -~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil 573 (707)
+..++||||+++|+|.++++.... ...+++..++.++.||++||+|||++ +|+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcccee
Confidence 568999999999999999965432 23488999999999999999999999 9999999999999
Q ss_pred ecCCCCeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCcccccccc
Q 038671 574 LDLENEAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKG-KHPRDFISSISSS 650 (707)
Q Consensus 574 ~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~ 650 (707)
++.++.+||+|||+|+....... ......||+.|+|||.+.+..++.++|||||||++|||+|| .+||.....
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~---- 242 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI---- 242 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC----
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999999987654432 23456799999999999999999999999999999999996 557753221
Q ss_pred cchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 651 SSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 651 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.............+..+. . .+.++.+++.+||+.||++|||++|+++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~~~--~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 243 DEEFCRRLKEGTRMRAPD--Y----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp SHHHHHHHHHTCCCCCCT--T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCc--c----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 122222233322232222 2 2345889999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=372.24 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=203.3
Q ss_pred hcCCCCCceeeecCCeeEEEEEcCC--------CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeee
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAELPS--------GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCS 505 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 505 (707)
.++|++.+.||+|+||.||+|+... +..||||++..... .....++.+|...+.++ +|||||++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 3578899999999999999996422 34799999976533 23456788899999888 7999999999999
Q ss_pred cCCceeEEEeeeccCcHHHHHhcccc-------------cCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 038671 506 HARHSFIVYEYLEMGSLAMILSNDAA-------------AKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572 (707)
Q Consensus 506 ~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 572 (707)
+++..++||||+.+|+|.+++..... .+.+++.++++++.||+.||+|||+. +||||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999965432 24589999999999999999999999 999999999999
Q ss_pred eecCCCCeEEeccccceecCCCCC--CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccc
Q 038671 573 LLDLENEAHVSDFGTAKFLKPDSS--NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISS 649 (707)
Q Consensus 573 l~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 649 (707)
|++.++.+||+|||.++....... ......+++.|+|||.+.+..|+.++||||||+++|||++ |++||.....
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--- 243 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 243 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH---
Confidence 999999999999999987654432 2344678999999999999999999999999999999998 7888863221
Q ss_pred ccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 650 SSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
......+.... +.+.+.. .+.++.+++.+||+.||.+|||+.||++.|+
T Consensus 244 --~~~~~~i~~~~--~~~~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~ 292 (299)
T d1fgka_ 244 --EELFKLLKEGH--RMDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292 (299)
T ss_dssp --HHHHHHHHTTC--CCCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --HHHHHHHHcCC--CCCCCcc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence 11112222222 2222222 2345899999999999999999999999885
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-46 Score=374.84 Aligned_cols=254 Identities=23% Similarity=0.292 Sum_probs=196.1
Q ss_pred CCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhh--hHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEee
Q 038671 440 DEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMA--SQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYEY 516 (707)
Q Consensus 440 ~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 516 (707)
..+.||+|+||+||+|+. .+|+.||||++......... ..+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999975 56999999998654322211 134688999999999999999999999999999999999
Q ss_pred eccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCCC
Q 038671 517 LEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDSS 596 (707)
Q Consensus 517 ~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 596 (707)
+.++++...... ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||.++.......
T Consensus 82 ~~~~~~~~~~~~---~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred hcchHHhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 999888776543 34589999999999999999999999 999999999999999999999999999987766555
Q ss_pred CccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhh--------------
Q 038671 597 NWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM-------------- 661 (707)
Q Consensus 597 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-------------- 661 (707)
.....+||+.|+|||++.+. .++.++||||+||++|||+||+.||....... .........
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~----~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCTTTSSSTTSS
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH----HHHHHHHhcCCCChhhccchhcc
Confidence 55567899999999988654 57999999999999999999999996432211 000000000
Q ss_pred ----cCCCCCCCC--cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 662 ----LDPRLPTPS--HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 662 ----~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.....+... ......+.++.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000000 000122356899999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=369.94 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=197.8
Q ss_pred CceeeecCCeeEEEEEcCCC----cEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec-CCceeEEEe
Q 038671 441 EHCIGKGGQGSVYKAELPSG----EIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH-ARHSFIVYE 515 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e 515 (707)
.++||+|+||+||+|+..++ ..||||++.... .....++|.+|++++++++||||+++++++.+ ++..++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 46899999999999975432 358999986532 33456789999999999999999999999865 568899999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
|+++|+|.++++.. ....++..+++++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999998643 34577889999999999999999999 99999999999999999999999999998765432
Q ss_pred C----CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCCCCCCc
Q 038671 596 S----NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRLPTPSH 671 (707)
Q Consensus 596 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 671 (707)
. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... ......... ..+...+..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~----~~~~~~i~~--g~~~~~p~~ 258 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FDITVYLLQ--GRRLLQPEY 258 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHHHT--TCCCCCCTT
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH----HHHHHHHHc--CCCCCCccc
Confidence 2 123356899999999999999999999999999999999988886532211 111111111 122222222
Q ss_pred chHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 672 NVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 672 ~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+.++.+++.+||+.||++||++.||++.|+
T Consensus 259 ----~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~ 289 (311)
T d1r0pa_ 259 ----CPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289 (311)
T ss_dssp ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ----CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 2345889999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-46 Score=375.06 Aligned_cols=257 Identities=24% Similarity=0.413 Sum_probs=208.8
Q ss_pred hcCCCCCceeeecCCeeEEEEEc------CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL------PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHA 507 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 507 (707)
.++|++.++||+|+||.||+|+. .+++.||||++..... .....++.+|+.+++++ +|||||++++++.++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 36788999999999999999964 3567899999976432 33556799999999999 699999999999999
Q ss_pred CceeEEEeeeccCcHHHHHhccc---------------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCe
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDA---------------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNV 572 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Ni 572 (707)
+..++||||+++|+|.++++... ....+++..+.+++.||++||+|||++ ++|||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 99999999999999999996543 223589999999999999999999999 999999999999
Q ss_pred eecCCCCeEEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCccccccc
Q 038671 573 LLDLENEAHVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIK-GKHPRDFISSISS 649 (707)
Q Consensus 573 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t-g~~p~~~~~~~~~ 649 (707)
+++.++.+|++|||.++........ .....||+.|+|||.+.+..++.++||||||+++|||+| |++||+....
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~--- 253 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--- 253 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH---
Confidence 9999999999999999877644332 234578999999999999999999999999999999999 5555543221
Q ss_pred ccchhhhhhhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 650 SSSNLEIALNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 650 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.............+..+. ..+..+.+++.+||+.||++|||++|++++|+
T Consensus 254 -~~~~~~~i~~~~~~~~~~------~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~ 303 (311)
T d1t46a_ 254 -DSKFYKMIKEGFRMLSPE------HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (311)
T ss_dssp -SHHHHHHHHHTCCCCCCT------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHHHHHhcCCCCCCcc------cccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 122223333322222221 12345899999999999999999999999885
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=374.13 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=200.3
Q ss_pred cCCCCCceeeecCCeeEEEEEcC-CCc--EEEEEecCCCCCchhhhHHHHHHHHHHHhcC-CCCceeeeeeeeecCCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELP-SGE--IVAVKKFHSPLPSEMASQQEFLNEVKTLTGI-RHRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 511 (707)
++|++.++||+|+||.||+|+++ +|. .||||++...... ...+.+.+|+++++++ +||||+++++++.+++..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh--HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeE
Confidence 57889999999999999999654 444 4778887543222 2456799999999999 7999999999999999999
Q ss_pred EEEeeeccCcHHHHHhcc-------------cccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC
Q 038671 512 IVYEYLEMGSLAMILSND-------------AAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN 578 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~ 578 (707)
+||||+++|+|.++++.. .....+++..+++++.||++||+|+|+. +|+||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence 999999999999999754 2235699999999999999999999999 999999999999999999
Q ss_pred CeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCcccccccccchhhhh
Q 038671 579 EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HPRDFISSISSSSSNLEIA 657 (707)
Q Consensus 579 ~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~ 657 (707)
.+||+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|. +||.... ....
T Consensus 165 ~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--------~~~~ 235 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAEL 235 (309)
T ss_dssp CEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHH
T ss_pred ceEEcccccccccccccc-ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--------HHHH
Confidence 999999999976543322 23457899999999999999999999999999999999975 4665321 1111
Q ss_pred hhhhcC-CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 658 LNEMLD-PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 658 ~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+.. .+.+.+. ..+.++.+++.+||+.||++|||++||++.|+
T Consensus 236 ~~~i~~~~~~~~~~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 281 (309)
T d1fvra_ 236 YEKLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281 (309)
T ss_dssp HHHGGGTCCCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHhcCCCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 222222 2222222 23346899999999999999999999998874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-46 Score=373.64 Aligned_cols=263 Identities=22% Similarity=0.319 Sum_probs=201.6
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||+||+|. ..+|+.||||++...... ....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 579999999999999999995 567999999999654322 223467889999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
||+.++.+...... ....+++..++.++.||+.||+|||++ |||||||||+||+++.++.+||+|||.|+.....
T Consensus 81 e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 81 EFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp ECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred eecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 99987655544332 234699999999999999999999999 9999999999999999999999999999887666
Q ss_pred CCCccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccc----------hhhhhhhhhc-
Q 038671 595 SSNWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSS----------NLEIALNEML- 662 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~----------~~~~~~~~~~- 662 (707)
........||+.|+|||.+.... ++.++||||+||++|+|++|+.||...+....... ..........
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccc
Confidence 55566678999999999877665 47899999999999999999999964322110000 0000000000
Q ss_pred -CCCCCCCC-cc----hHHHHHHHHHHHHhccCCCCCCCCCHHHHHHH
Q 038671 663 -DPRLPTPS-HN----VQDKLISIMEVAISCLDESPESRPTIQKVSQL 704 (707)
Q Consensus 663 -~~~~~~~~-~~----~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~ 704 (707)
....+... .. ....+.++.+++.+||..||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00011000 00 11223568899999999999999999999873
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-46 Score=375.44 Aligned_cols=257 Identities=21% Similarity=0.340 Sum_probs=209.5
Q ss_pred HhcCCCCCceeeecCCeeEEEEEcC------CCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAELP------SGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA 507 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 507 (707)
..++|++.+.||+|+||+||+|.++ +++.||||++.... .......+.+|++++++++||||+++++++..+
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 95 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence 3478899999999999999999653 35789999997543 233556799999999999999999999999999
Q ss_pred CceeEEEeeeccCcHHHHHhccc-------ccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCe
Q 038671 508 RHSFIVYEYLEMGSLAMILSNDA-------AAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEA 580 (707)
Q Consensus 508 ~~~~lv~e~~~~~~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~ 580 (707)
+..++||||+.+|+|.+++.... ....+++..+.+++.|+++||+|||++ +|+||||||+|||++.++.+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 99999999999999999886432 123478999999999999999999999 99999999999999999999
Q ss_pred EEeccccceecCCCCCC--ccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCcccccccccchhhhh
Q 038671 581 HVSDFGTAKFLKPDSSN--WAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGK-HPRDFISSISSSSSNLEIA 657 (707)
Q Consensus 581 kl~Dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~ 657 (707)
||+|||+++........ .....||+.|+|||.+.+..++.++||||||+++|||+||. .||.... ....
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--------~~~~ 244 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------NEQV 244 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--------HHHH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--------HHHH
Confidence 99999999876543322 23346899999999999999999999999999999999984 6765322 2223
Q ss_pred hhhhcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 658 LNEMLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 658 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
...+.+...+.... ..+..+.+++.+||+.||.+|||+++|++.|+
T Consensus 245 ~~~i~~~~~~~~p~---~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~ 290 (308)
T d1p4oa_ 245 LRFVMEGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290 (308)
T ss_dssp HHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred HHHHHhCCCCCCcc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 33333333332221 22346999999999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-45 Score=368.76 Aligned_cols=261 Identities=23% Similarity=0.321 Sum_probs=197.6
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC----cee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR----HSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~ 511 (707)
++|.+.+.||+|+||.||+|+. +|+.||||++... .........|+..+.+++||||+++++++.+.+ ..+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 5677889999999999999986 5889999998532 112222334666667889999999999997644 578
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCC-----CCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC-----FPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
+||||+++|+|.+++++. .++|..+++++.|++.||+|+|+.. .+||+||||||+|||++.++.+||+|||
T Consensus 78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 999999999999999643 4899999999999999999999731 1399999999999999999999999999
Q ss_pred cceecCCCCC----CccccccccCCCCccccccCC------CCccchhHHHHHHHHHHHhCCCCCCcccccc-------c
Q 038671 587 TAKFLKPDSS----NWAELAGTYGYVAPELAYTMK------VTEKCDVYSFGVLALEVIKGKHPRDFISSIS-------S 649 (707)
Q Consensus 587 ~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~-------~ 649 (707)
+++....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||....... .
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 9987754432 234467999999999987542 5778999999999999999998875322111 1
Q ss_pred ccchhhhhhhhhcC----CCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 650 SSSNLEIALNEMLD----PRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 650 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.............. +.++... ...+.+..+.+++.+||+.||++|||+.||++.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGG-GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCccc-CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 11111222222222 2222211 12345567999999999999999999999998875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-45 Score=369.13 Aligned_cols=257 Identities=23% Similarity=0.358 Sum_probs=200.8
Q ss_pred cCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEEe
Q 038671 436 NDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVYE 515 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 515 (707)
++|++.+.||+|+||+||+|+.++|+.||||++...... ....+.+.+|+.++++++||||+++++++..++..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 579999999999999999998889999999999765332 2335678999999999999999999999999999999999
Q ss_pred eeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCCC
Q 038671 516 YLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPDS 595 (707)
Q Consensus 516 ~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~~ 595 (707)
++.++.+..+.... +.+++..++.++.||+.||+|||+. +||||||||+||+++.++.+|++|||.+.......
T Consensus 81 ~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred eehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 99988887776433 4699999999999999999999999 99999999999999999999999999998876655
Q ss_pred CCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhh-------------
Q 038671 596 SNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM------------- 661 (707)
Q Consensus 596 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------------- 661 (707)
.......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||....... .........
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD----QLMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTGGG
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH----HHHHHHHhhCCCChhhccchhh
Confidence 555566799999999998754 46899999999999999999999996432110 000000000
Q ss_pred ---cCCCCC----CC-CcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 662 ---LDPRLP----TP-SHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 662 ---~~~~~~----~~-~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...... .+ .......+..+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00 0011122346889999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=369.38 Aligned_cols=243 Identities=22% Similarity=0.360 Sum_probs=197.0
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCch---hhhHHHHHHHHHHHhcCC--CCceeeeeeeeecCC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSE---MASQQEFLNEVKTLTGIR--HRNIVKFYGFCSHAR 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~ 508 (707)
.++|++.+.||+|+||+||+|+ ..+|+.||||++....... .....++.+|+.++++++ ||||+++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 4689999999999999999995 5679999999986432211 112234668999999886 899999999999999
Q ss_pred ceeEEEeeecc-CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCC-CCeEEeccc
Q 038671 509 HSFIVYEYLEM-GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLE-NEAHVSDFG 586 (707)
Q Consensus 509 ~~~lv~e~~~~-~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~-~~~kl~Dfg 586 (707)
..++||||+.+ +++.+++... ..+++..++.++.||+.||+|||+. ||+||||||+||+++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 99999999975 6788887543 4589999999999999999999999 99999999999999855 799999999
Q ss_pred cceecCCCCCCccccccccCCCCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCC
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYTMKV-TEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPR 665 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 665 (707)
+|+.... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||..... +....
T Consensus 157 ~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i~~~~ 220 (273)
T d1xwsa_ 157 SGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIRGQ 220 (273)
T ss_dssp TCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHHCC
T ss_pred cceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------------Hhhcc
Confidence 9987543 23455789999999999987765 5778999999999999999999963211 11111
Q ss_pred CCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 666 LPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 666 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...+.. .+.++.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 VFFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCCCC----CCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 111111 2345889999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=366.92 Aligned_cols=262 Identities=19% Similarity=0.308 Sum_probs=194.5
Q ss_pred hcCCCCCceeeecCCeeEEEEEc-CC-CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcC---CCCceeeeeeeeec---
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAEL-PS-GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGI---RHRNIVKFYGFCSH--- 506 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~--- 506 (707)
.++|++.+.||+|+||+||+|+. ++ ++.||||++......+. ....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-HHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 47899999999999999999965 44 67799999864322211 122345666666555 79999999999853
Q ss_pred --CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEec
Q 038671 507 --ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSD 584 (707)
Q Consensus 507 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~D 584 (707)
....+++|||+.++++...... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred ccCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 3578999999999888765543 234689999999999999999999999 999999999999999999999999
Q ss_pred cccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhh--------
Q 038671 585 FGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEI-------- 656 (707)
Q Consensus 585 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~-------- 656 (707)
||.+...... .......||+.|+|||++.+.+|+.++||||+||++|||++|+.||...............
T Consensus 160 fg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 160 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 9998764432 3345568999999999999999999999999999999999999999743221100000000
Q ss_pred ------hhhhhcCCCCCC-CCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 657 ------ALNEMLDPRLPT-PSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 657 ------~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
............ ........+..+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000 00111123345889999999999999999999976
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-43 Score=351.99 Aligned_cols=261 Identities=20% Similarity=0.280 Sum_probs=206.2
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCCceeEEE
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHARHSFIVY 514 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 514 (707)
++|++.+.||+|+||+||+|+ ..+|+.||||++..... ......++.+|+.+++.++||||+++++++.+....++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 579999999999999999995 46889999999865433 2335678899999999999999999999999999999999
Q ss_pred eeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccceecCCC
Q 038671 515 EYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKFLKPD 594 (707)
Q Consensus 515 e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~~~~~ 594 (707)
|++.++++..+.... +.+++..++.++.|++.||+|||++ ||+||||||+||+++.++.+|++|||.++.....
T Consensus 81 ~~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 81 EFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp ECCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eeccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999998887543 4588999999999999999999999 9999999999999999999999999999987766
Q ss_pred CCCccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhh---------------
Q 038671 595 SSNWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIAL--------------- 658 (707)
Q Consensus 595 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------------- 658 (707)
........+++.|+|||.+.+.. ++.++||||+||++|||++|+.||.................
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 55555667889999999887665 68999999999999999999999742221110000000000
Q ss_pred hhhcCC---CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 659 NEMLDP---RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 659 ~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.....+ ...............+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 000111112233456889999999999999999999986
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-43 Score=360.37 Aligned_cols=256 Identities=24% Similarity=0.291 Sum_probs=194.0
Q ss_pred CCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecC------Cc
Q 038671 437 DFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHA------RH 509 (707)
Q Consensus 437 ~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~ 509 (707)
+|+..++||+|+||+||+|+. .+|+.||||++..... ...+|++++++++||||+++++++... .+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 588899999999999999965 5799999999865422 224699999999999999999998532 34
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC-CeEEeccccc
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTA 588 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~-~~kl~Dfg~~ 588 (707)
.++||||++++.+..+.........+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 789999998776555544334455799999999999999999999999 999999999999999875 8999999999
Q ss_pred eecCCCCCCccccccccCCCCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCcccccccc-----------cchhhh
Q 038671 589 KFLKPDSSNWAELAGTYGYVAPELAYT-MKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS-----------SSNLEI 656 (707)
Q Consensus 589 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~-----------~~~~~~ 656 (707)
....... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||......... ......
T Consensus 171 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 171 KQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp EECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhccCCc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 8775443 3345689999999998765 56899999999999999999999999643221100 000000
Q ss_pred hhhhhcCCCCCCCC------cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 657 ALNEMLDPRLPTPS------HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 657 ~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..........+... ......+.++.+++.+||..||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111111110 001123456889999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-43 Score=359.38 Aligned_cols=258 Identities=21% Similarity=0.302 Sum_probs=194.0
Q ss_pred HhcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC----
Q 038671 434 VTNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR---- 508 (707)
Q Consensus 434 ~~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 508 (707)
+.++|++.+.||+|+||+||+|. ..+|+.||||++...... ....+.+.+|++++++++|||||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 35689999999999999999995 567999999999765433 334567899999999999999999999997654
Q ss_pred --ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 509 --HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 509 --~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
..|+||||+ +.++..+.+. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence 569999999 6678777643 3599999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCCCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccc---------------
Q 038671 587 TAKFLKPDSSNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSS--------------- 650 (707)
Q Consensus 587 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~--------------- 650 (707)
.|+..... .....||+.|+|||.+.+. .++.++||||+||++|+|++|+.||.........
T Consensus 167 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 167 LARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp TCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ceeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 99876533 3456899999999998764 4689999999999999999999999643211100
Q ss_pred ---cchhhhhhhhhcCC-CCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 651 ---SSNLEIALNEMLDP-RLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 651 ---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.............. ...............+.+++.+||..||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000000000 000000111122345789999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-43 Score=358.60 Aligned_cols=260 Identities=21% Similarity=0.266 Sum_probs=194.8
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeecCC----c
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSHAR----H 509 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 509 (707)
..+|++.+.||+|+||+||+|. ..+|+.||||++.... .....+.+.+|++++++++|||++++++++.... .
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 4679999999999999999995 5689999999987543 2334567899999999999999999999986543 2
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.+++++|+.+|+|.+++.. +.+++..++.++.||+.||+|||++ |||||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 3555667779999999863 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC---CccccccccCCCCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccch------------
Q 038671 590 FLKPDSS---NWAELAGTYGYVAPELAY-TMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSN------------ 653 (707)
Q Consensus 590 ~~~~~~~---~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~------------ 653 (707)
....... .....+||+.|+|||.+. +..++.++||||+|+++|+|++|+.||............
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 7643322 234567999999999875 455789999999999999999999999643211000000
Q ss_pred -----hhhhhhhhcCCCCCCCC--cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 654 -----LEIALNEMLDPRLPTPS--HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 654 -----~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
..........+...... ...+....++.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000011110000 001112245889999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-42 Score=351.79 Aligned_cols=256 Identities=20% Similarity=0.323 Sum_probs=194.3
Q ss_pred cCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec--------
Q 038671 436 NDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH-------- 506 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------- 506 (707)
++|++.+.||+|+||+||+|+ ..+|+.||||++......+ ....++.+|+++++.++|||++++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 689999999999999999996 4689999999986543332 234668899999999999999999998754
Q ss_pred CCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccc
Q 038671 507 ARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFG 586 (707)
Q Consensus 507 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg 586 (707)
++..++||||+.++.+..... ....+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+|++|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 346899999999887775543 234689999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCC----CCccccccccCCCCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhh
Q 038671 587 TAKFLKPDS----SNWAELAGTYGYVAPELAYTM-KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEM 661 (707)
Q Consensus 587 ~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 661 (707)
++....... ......+||+.|+|||.+.+. .+++++||||+||++|||++|+.||+...... ... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~----~~~-~i~~~ 237 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QLA-LISQL 237 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHH-HHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH----HHH-HHHHh
Confidence 998765432 122345799999999998765 58999999999999999999999996422111 000 00000
Q ss_pred cCC-------------------CCCCCCcchHH------HHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 662 LDP-------------------RLPTPSHNVQD------KLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 662 ~~~-------------------~~~~~~~~~~~------~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
... ........... ....+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000 00000111111 1235678999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.9e-43 Score=350.10 Aligned_cols=257 Identities=18% Similarity=0.227 Sum_probs=200.6
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCC-CceeeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRH-RNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~l 512 (707)
.++|++.+.||+|+||+||+|+ ..+|+.||||++..... ...+.+|++.++.++| +|++.+++++..+...++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 4689999999999999999996 45789999998754322 2346678888888864 999999999999999999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC-----CCCeEEecccc
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL-----ENEAHVSDFGT 587 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~-----~~~~kl~Dfg~ 587 (707)
||||+ +++|.+++... ...+++.++..++.|++.||+|||+. ||+||||||+||+++. ++.+||+|||+
T Consensus 79 vme~~-~~~l~~~~~~~--~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~ 152 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152 (293)
T ss_dssp EEECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHhh--ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccce
Confidence 99998 68998888543 34689999999999999999999999 9999999999999974 56899999999
Q ss_pred ceecCCCCC-------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhh
Q 038671 588 AKFLKPDSS-------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNE 660 (707)
Q Consensus 588 ~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 660 (707)
|+....... ......||+.|||||.+.+..++.++||||||+++|||+||+.||......... .........
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~-~~~~~i~~~ 231 (293)
T d1csna_ 153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-QKYERIGEK 231 (293)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-HHHHHHHHH
T ss_pred eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH-HHHHHHHhc
Confidence 987654321 233467999999999999999999999999999999999999999743321111 011111111
Q ss_pred hcCCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 661 MLDPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 661 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.... .........+.++.+++..|++.+|++||+++.+.+.|+
T Consensus 232 ~~~~---~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~ 274 (293)
T d1csna_ 232 KQST---PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274 (293)
T ss_dssp HHHS---CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred cCCC---ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence 0000 000011123456899999999999999999998877653
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-42 Score=349.11 Aligned_cols=257 Identities=19% Similarity=0.258 Sum_probs=193.6
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCce-eeeeeeeecCCceeE
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNI-VKFYGFCSHARHSFI 512 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~l 512 (707)
.++|++.+.||+|+||.||+|+ ..+|+.||||++..... .+++..|+++++.++|+++ +.+.+++.+.+..++
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 4679999999999999999995 46789999998765322 2347789999999986664 555566677888999
Q ss_pred EEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecC---CCCeEEeccccce
Q 038671 513 VYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDL---ENEAHVSDFGTAK 589 (707)
Q Consensus 513 v~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~---~~~~kl~Dfg~~~ 589 (707)
||||+. +++.+.+.. ..+.+++..+..++.|++.||+|||++ ||+||||||+||+++. +..+|++|||+|+
T Consensus 81 vme~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp EEECCC-CBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEEEcC-Cchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 999995 555555432 234689999999999999999999999 9999999999999864 4579999999999
Q ss_pred ecCCCCC-------CccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhc
Q 038671 590 FLKPDSS-------NWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEML 662 (707)
Q Consensus 590 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 662 (707)
....... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence 8754322 123457999999999999999999999999999999999999999754332211111111111111
Q ss_pred CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHHHhc
Q 038671 663 DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQLLK 706 (707)
Q Consensus 663 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~~L~ 706 (707)
.+ .+ ......+.++.+++..||+.+|++||+++++.+.|+
T Consensus 235 ~~-~~---~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 274 (299)
T d1ckia_ 235 TP-IE---VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274 (299)
T ss_dssp SC-HH---HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred CC-hh---HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence 00 00 011123456899999999999999999998887664
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=354.71 Aligned_cols=254 Identities=21% Similarity=0.315 Sum_probs=202.1
Q ss_pred cCCCCCceeeecCCeeEEEEEc----CCCcEEEEEecCCCCC-chhhhHHHHHHHHHHHhcCCC-CceeeeeeeeecCCc
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL----PSGEIVAVKKFHSPLP-SEMASQQEFLNEVKTLTGIRH-RNIVKFYGFCSHARH 509 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~ 509 (707)
++|++.+.||+|+||+||+|+. .+|+.||||++..... .+....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999953 3588999999865321 122234567889999999966 899999999999999
Q ss_pred eeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccce
Q 038671 510 SFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTAK 589 (707)
Q Consensus 510 ~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~ 589 (707)
.+++|||+.+|+|.+++... +.+++..++.++.||+.||+|+|+. +|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999998644 3478899999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCC-CCccccccccCCCCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCcccccccccchhhhhhhhhcCCCC
Q 038671 590 FLKPDS-SNWAELAGTYGYVAPELAYTM--KVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLEIALNEMLDPRL 666 (707)
Q Consensus 590 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 666 (707)
.+.... .......|++.|+|||.+.+. .++.++||||+||++|+|++|+.||...... ...............
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~----~~~~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSEP 253 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcccCCC
Confidence 764332 234456799999999998754 3678999999999999999999999754321 222222222222233
Q ss_pred CCCCcchHHHHHHHHHHHHhccCCCCCCCCC-----HHHHHH
Q 038671 667 PTPSHNVQDKLISIMEVAISCLDESPESRPT-----IQKVSQ 703 (707)
Q Consensus 667 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps-----~~~l~~ 703 (707)
+.+. ..+.++.+++.+||+.||++||| ++|+++
T Consensus 254 ~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 PYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 3222 23455889999999999999994 788875
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=351.92 Aligned_cols=257 Identities=20% Similarity=0.281 Sum_probs=190.9
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec------CC
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH------AR 508 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~~ 508 (707)
++|++.+.||+|+||+||+|.+ .+|+.||||++...... .....++.+|+.++++++||||+++++++.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 5799999999999999999964 57999999999765433 3345678999999999999999999999853 35
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
..|+||||+.++.+..+. +.+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+|++|||.+
T Consensus 96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 789999999877665442 3489999999999999999999999 9999999999999999999999999998
Q ss_pred eecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccc------------------cc
Q 038671 589 KFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSIS------------------SS 650 (707)
Q Consensus 589 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~------------------~~ 650 (707)
+..... .......+|+.|+|||++.+..+++++||||+||++|+|++|+.||...+... ..
T Consensus 167 ~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 167 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred hccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 765543 23345679999999999999999999999999999999999999995322110 00
Q ss_pred cchhhhhhhhhc------------CCCCCCCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 651 SSNLEIALNEML------------DPRLPTPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 651 ~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
............ ....+.........+.++.+++.+|+..||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000 00011111122345677899999999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.4e-42 Score=350.10 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=195.0
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeec--CCcee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSH--ARHSF 511 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~ 511 (707)
++|++.+.||+|+||+||+|+. .+|+.||||++... ..+++.+|+++++.++ ||||+++++++.. ....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 5799999999999999999965 67999999998643 2356889999999995 9999999999874 45689
Q ss_pred EEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCC-CeEEecccccee
Q 038671 512 IVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLEN-EAHVSDFGTAKF 590 (707)
Q Consensus 512 lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~-~~kl~Dfg~~~~ 590 (707)
+||||+.+++|..+. +.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+.
T Consensus 109 ~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccccee
Confidence 999999999987653 3589999999999999999999999 999999999999998765 699999999987
Q ss_pred cCCCCCCccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccchh---------hhh---
Q 038671 591 LKPDSSNWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNL---------EIA--- 657 (707)
Q Consensus 591 ~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~---------~~~--- 657 (707)
..... ......+|+.|+|||.+.+.. ++.++||||+||++|+|++|+.||............. ...
T Consensus 180 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 180 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred ccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 66443 335567899999999987654 7999999999999999999999986422111000000 000
Q ss_pred --------hhhhcCCCCC------CCCcchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 658 --------LNEMLDPRLP------TPSHNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 658 --------~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
.......... .........+.++.+++.+|+..||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 000111223456889999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-41 Score=349.38 Aligned_cols=258 Identities=20% Similarity=0.282 Sum_probs=195.0
Q ss_pred hcCCCCCceeeecCCeeEEEEE-cCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCceeeeeeeeec-----CC
Q 038671 435 TNDFDDEHCIGKGGQGSVYKAE-LPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNIVKFYGFCSH-----AR 508 (707)
Q Consensus 435 ~~~~~~~~~lg~G~~g~vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~ 508 (707)
.++|++.+.||+|+||+||+|+ ..+|+.||||++...... ....+.+.+|++++++++|||+|++++++.. ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcC-hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 5689999999999999999995 568999999999765433 3345678899999999999999999999853 33
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEeccccc
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVSDFGTA 588 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~ 588 (707)
..+++++|+.+|+|.+++.. +.+++..++.++.||+.||+|||++ ||+||||||+||+++.++.+|++|||.+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ceEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 45677788899999999853 3589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCCccccccccCCCCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCcccccccccchhh------------
Q 038671 589 KFLKPDSSNWAELAGTYGYVAPELAYTMK-VTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSSNLE------------ 655 (707)
Q Consensus 589 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~~~~------------ 655 (707)
.... .......|++.|+|||...+.. ++.++||||+||++|+|++|+.||...+..........
T Consensus 169 ~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 169 RHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp -CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 7543 2334567899999999877654 58899999999999999999999964321110000000
Q ss_pred ---hhhhhh--cCCCCCCCC--cchHHHHHHHHHHHHhccCCCCCCCCCHHHHHH
Q 038671 656 ---IALNEM--LDPRLPTPS--HNVQDKLISIMEVAISCLDESPESRPTIQKVSQ 703 (707)
Q Consensus 656 ---~~~~~~--~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rps~~~l~~ 703 (707)
...... .....+... ......+.++.+++.+|+..||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000 001111100 000122356889999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1e-36 Score=316.94 Aligned_cols=258 Identities=18% Similarity=0.261 Sum_probs=188.5
Q ss_pred cCCCCCceeeecCCeeEEEEEc-CCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-----------CCceeeeeee
Q 038671 436 NDFDDEHCIGKGGQGSVYKAEL-PSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-----------HRNIVKFYGF 503 (707)
Q Consensus 436 ~~~~~~~~lg~G~~g~vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~ 503 (707)
++|++.+.||+|+||+||+|+. .+|+.||||++... ....+.+.+|+++++.++ |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 3599999999999999999964 67999999998753 123456778888887774 5789999988
Q ss_pred eecC--CceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHh-CCCCCeEecCCCCCCeeecCCC--
Q 038671 504 CSHA--RHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN-DCFPPIVHRDISSKNVLLDLEN-- 578 (707)
Q Consensus 504 ~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~dlk~~Nil~~~~~-- 578 (707)
+... ...+++++++..+..............+++..+..++.||+.||+|||+ . ||+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETT
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcc
Confidence 8543 4566677766554433333333444568999999999999999999998 6 999999999999998665
Q ss_pred ----CeEEeccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHHHHHHhCCCCCCcccccccccc--
Q 038671 579 ----EAHVSDFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVIKGKHPRDFISSISSSSS-- 652 (707)
Q Consensus 579 ----~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~-- 652 (707)
.++++|||.+...... ....+||+.|+|||++.+..++.++||||+|+++++|++|+.||...........
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cccceeeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 3999999999865432 2446799999999999999999999999999999999999999964322110000
Q ss_pred hhhhhh-----------------hhhcC-----CCCCC------------CCcchHHHHHHHHHHHHhccCCCCCCCCCH
Q 038671 653 NLEIAL-----------------NEMLD-----PRLPT------------PSHNVQDKLISIMEVAISCLDESPESRPTI 698 (707)
Q Consensus 653 ~~~~~~-----------------~~~~~-----~~~~~------------~~~~~~~~~~~l~~li~~cl~~~P~~Rps~ 698 (707)
...... ....+ ..... ........+.++.+++.+|+..||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 000000 00000 00000 111234566789999999999999999999
Q ss_pred HHHHH
Q 038671 699 QKVSQ 703 (707)
Q Consensus 699 ~~l~~ 703 (707)
+|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99986
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.96 E-value=1.9e-28 Score=256.74 Aligned_cols=300 Identities=26% Similarity=0.357 Sum_probs=180.5
Q ss_pred CCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeee
Q 038671 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLT 81 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 81 (707)
+.+|++|++++++|++. +.+..+++|++|+|++|+|++.. .|+++++|++|++++|.|.+.. .++++++|+.|+
T Consensus 43 l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~ 116 (384)
T d2omza2 43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLT 116 (384)
T ss_dssp HTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEE
T ss_pred hCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc--cccccccccccc
Confidence 45788999999999843 45788899999999999988543 3888999999999999988543 488889999999
Q ss_pred cccccccccCCCCCCCCCccEEEeccCccccc-----------------------------------------cCccccC
Q 038671 82 LENNQLRGPIPNLRNLTSLVRVRLNQNHLTGN-----------------------------------------ISESFGI 120 (707)
Q Consensus 82 l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~-----------------------------------------~~~~~~~ 120 (707)
+++|.++.... ......+..+....|.+... ....+..
T Consensus 117 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (384)
T d2omza2 117 LFNNQITDIDP-LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195 (384)
T ss_dssp CCSSCCCCCGG-GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGG
T ss_pred ccccccccccc-ccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccccccccccccc
Confidence 98888775433 23334445555544443221 1123344
Q ss_pred CCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEE
Q 038671 121 HPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLI 200 (707)
Q Consensus 121 ~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 200 (707)
+++++.+++++|.++.+.+ +..+++|++|++++|.+++. ..+..+++|+.|++++|.+++.. .+..+++|++|+
T Consensus 196 l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~ 269 (384)
T d2omza2 196 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELK 269 (384)
T ss_dssp CTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred ccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCC--cccccccCCEee
Confidence 4556666666665554422 34445566666666655532 24555566666666666655322 255555666666
Q ss_pred ecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCC
Q 038671 201 LNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGE 280 (707)
Q Consensus 201 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 280 (707)
+++|++++.. .+..++.++.++++.|.+++. ..+..+++++.|++++|++++.. .+..+++|++|++++|++++
T Consensus 270 l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~ 343 (384)
T d2omza2 270 LGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD 343 (384)
T ss_dssp CCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC
T ss_pred ccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC
Confidence 6666655322 244555666666666655532 23555556666666666655432 25555666666666666643
Q ss_pred CCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccC
Q 038671 281 EMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYN 324 (707)
Q Consensus 281 ~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n 324 (707)
. ..+.++++|+.|++++|+|++..| +..+++|+.|++++|
T Consensus 344 l--~~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 344 V--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp C--GGGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred C--hhHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 2 235556666666666666655433 555566666666555
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=3.8e-27 Score=238.07 Aligned_cols=244 Identities=24% Similarity=0.319 Sum_probs=170.4
Q ss_pred CceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeeccc
Q 038671 5 LAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLEN 84 (707)
Q Consensus 5 l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~ 84 (707)
.+.++-++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 467788888888 6777764 5899999999999855556889999999999999999988888899999999999999
Q ss_pred ccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEccccccc--ccCCCCCCCCCCCcEEEcCCCccCCCC
Q 038671 85 NQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFY--GEISSDWGRCPKLGTLDFSSNNITGSM 162 (707)
Q Consensus 85 n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~--~~~~~~~~~~~~L~~L~L~~n~i~~~~ 162 (707)
|+++.++..+ ...|+.|++..|.+..+....+.....+..++...|... ......|..+++|+.+++++|.++..
T Consensus 89 n~l~~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l- 165 (305)
T d1xkua_ 89 NQLKELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI- 165 (305)
T ss_dssp SCCSBCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC-
T ss_pred CccCcCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcccc-
Confidence 9988776543 357888888888888877777777777788887777544 23344566666777777777766532
Q ss_pred chhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcc
Q 038671 163 PAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLV 242 (707)
Q Consensus 163 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~ 242 (707)
+.. -+++|+.|++++|.+....+..|..++.++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|.+|.+++
T Consensus 166 ~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~ 242 (305)
T d1xkua_ 166 PQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 242 (305)
T ss_dssp CSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCS
T ss_pred Ccc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-cccccccccc
Confidence 221 1356666666666666555556666666666666666666555555556666666666666665 3344555556
Q ss_pred cCceEeeeccccccc
Q 038671 243 KLHYLNLSNNQFIKK 257 (707)
Q Consensus 243 ~L~~L~l~~n~l~~~ 257 (707)
+|++|+|++|+|+.+
T Consensus 243 ~L~~L~Ls~N~i~~i 257 (305)
T d1xkua_ 243 YIQVVYLHNNNISAI 257 (305)
T ss_dssp SCCEEECCSSCCCCC
T ss_pred CCCEEECCCCccCcc
Confidence 666666666655543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=2.5e-28 Score=247.74 Aligned_cols=258 Identities=26% Similarity=0.467 Sum_probs=175.4
Q ss_pred CccEEEeccCccccc--cCccccCCCCCcEEEccc-ccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEE
Q 038671 99 SLVRVRLNQNHLTGN--ISESFGIHPNLAFIDLSH-NYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVL 175 (707)
Q Consensus 99 ~L~~L~l~~n~l~~~--~~~~~~~~~~L~~L~L~~-n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L 175 (707)
+++.|+|++|.+++. .+..++.+++|++|+|++ |.+++..|..|.++++|++|+|++|.+.+..+..+..+.+|+.+
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence 456666666666542 345566666666666664 56665556666666666666666666666666666666677777
Q ss_pred eCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcc-cEEEccCCccCCCCCccccCcccCceEeeecccc
Q 038671 176 DLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQL-ERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQF 254 (707)
Q Consensus 176 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l 254 (707)
++++|.+...+|..+..++.|+.+++++|.+.+..|..+..+..+ +.+++++|++++..+..+..+.. ..+++++|..
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEE
T ss_pred ccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence 777776666666667777777777777777766666666666554 66777777777666666666543 3577777777
Q ss_pred cccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCCcc
Q 038671 255 IKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNST 334 (707)
Q Consensus 255 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~ 334 (707)
.+..+..+..+++|+.+++++|.+++.. ..+..+++|+.|++++|++++.+|..+..+++|++|+|++|+++|.+|...
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~-~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBG-GGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred cccccccccccccccccccccccccccc-cccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 6667777777777777777777775543 346667777777777777777777777777777777777777777777666
Q ss_pred ccccCchhhcccCcCcCCCCCCCCCc
Q 038671 335 AFRDAPMEALQGNKGLCGDIKGFPSC 360 (707)
Q Consensus 335 ~~~~~~~~~~~~~~~~c~~~~~~~~c 360 (707)
.+.......+.+|+.+|+.| +|+|
T Consensus 289 ~L~~L~~l~l~~N~~l~g~p--lp~c 312 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSP--LPAC 312 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTT--SSCC
T ss_pred cCCCCCHHHhCCCccccCCC--CCCC
Confidence 66666667777777777754 5566
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=2.7e-27 Score=247.90 Aligned_cols=300 Identities=25% Similarity=0.331 Sum_probs=243.0
Q ss_pred eccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeeccccccc
Q 038671 9 YLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLR 88 (707)
Q Consensus 9 ~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~ 88 (707)
.+..+++++.++ ...+.+|++|+++++.|+. + +.+..+++|++|+|++|+|++.. .|+++++|++|++++|++.
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccc
Confidence 455666665554 3567899999999999994 3 56899999999999999999653 4999999999999999998
Q ss_pred ccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEccccccccc-------------------------------
Q 038671 89 GPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGE------------------------------- 137 (707)
Q Consensus 89 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~------------------------------- 137 (707)
.+. .+.++++|+.|++.+|.++.... ......+..+....|.+...
T Consensus 102 ~i~-~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (384)
T d2omza2 102 DIT-PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLE 178 (384)
T ss_dssp CCG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCC
T ss_pred ccc-ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhccccccc
Confidence 754 48899999999999999886644 33445555555555443211
Q ss_pred ----------CCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccc
Q 038671 138 ----------ISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLC 207 (707)
Q Consensus 138 ----------~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 207 (707)
....+..+++++.+++++|.+++..+ +...++|+.|++++|.++. + ..+..+++|+.|++++|.++
T Consensus 179 ~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~ 254 (384)
T d2omza2 179 RLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQIS 254 (384)
T ss_dssp EEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCC
T ss_pred cccccccccccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccC
Confidence 12345567899999999999986544 4567899999999999974 3 46888999999999999998
Q ss_pred cCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccc
Q 038671 208 GQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQIC 287 (707)
Q Consensus 208 ~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 287 (707)
+.. .+..+++|++|++++|.+++.. .+..++.++.+.+++|.+.+. ..+..+++++.|++++|++++.. .+.
T Consensus 255 ~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~ 326 (384)
T d2omza2 255 NLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVS 326 (384)
T ss_dssp CCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGG
T ss_pred CCC--cccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccc
Confidence 543 4788999999999999998654 377889999999999998653 45888999999999999997653 488
Q ss_pred cccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCC
Q 038671 288 NMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIP 331 (707)
Q Consensus 288 ~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~ 331 (707)
.+++|+.|++++|+|++. ..+..+++|++|++++|++++.+|
T Consensus 327 ~l~~L~~L~L~~n~l~~l--~~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 327 SLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp GCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCBCGG
T ss_pred cCCCCCEEECCCCCCCCC--hhHcCCCCCCEEECCCCcCCCChh
Confidence 999999999999999864 368899999999999999997654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=8.2e-28 Score=243.93 Aligned_cols=248 Identities=26% Similarity=0.386 Sum_probs=153.6
Q ss_pred CCCcEEEcccCcCcc--cCCccccCCCCCCeeeccc-cccc-ccCCCCCCCCCccEEEeccCccccccCccccCCCCCcE
Q 038671 51 TQITFLTLFDNALSG--AIPKEYGNLVKLTLLTLEN-NQLR-GPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAF 126 (707)
Q Consensus 51 ~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~l~~-n~i~-~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~ 126 (707)
.+++.|+|++|.+++ .+|..++++++|++|+|++ |++. .+|+.+.++++|++|+|++|++.++.+..+..+.+|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 357777777777665 3566777777777777765 5565 34445666667777777777666666666666777777
Q ss_pred EEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCC-CEEeCCCCCCCCCCChhhhCCCCCcEEEecCCc
Q 038671 127 IDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQL-KVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQ 205 (707)
Q Consensus 127 L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 205 (707)
+++++|.+....+..+..+++|+.+++++|.+++..+..+..+.++ +.+++++|++++..+..+..+.. ..++++.|.
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~ 208 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSE
T ss_pred cccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccccc-ccccccccc
Confidence 7777776666666666666666666666666665566666665554 66666666666555655555433 356666666
Q ss_pred cccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcc
Q 038671 206 LCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQ 285 (707)
Q Consensus 206 l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 285 (707)
..+..+..+..+++|+.|++++|.+.+.++ .+..+++|+.|+|++|++++..|..+.++++|++|+|++|++++.+|.
T Consensus 209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~- 286 (313)
T d1ogqa_ 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ- 286 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-
T ss_pred cccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-
Confidence 666666666666666666666666654333 455556666666666666555555566666666666666666554442
Q ss_pred cccccccceEeccccc
Q 038671 286 ICNMQSLEKLNLSHNN 301 (707)
Q Consensus 286 ~~~~~~L~~L~l~~n~ 301 (707)
++++++|+.+++++|+
T Consensus 287 ~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 287 GGNLQRFDVSAYANNK 302 (313)
T ss_dssp STTGGGSCGGGTCSSS
T ss_pred cccCCCCCHHHhCCCc
Confidence 3445555555555554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=9.8e-26 Score=227.60 Aligned_cols=247 Identities=22% Similarity=0.228 Sum_probs=142.4
Q ss_pred CCCeeecccccccccCC-CCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcC
Q 038671 76 KLTLLTLENNQLRGPIP-NLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFS 154 (707)
Q Consensus 76 ~L~~L~l~~n~i~~~~~-~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~ 154 (707)
++++|+|++|+|+.+++ .|.++++|++|++++|.+..+.+..|..+++|++|++++|+++.+... ..+.++.|.+.
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~---~~~~l~~L~~~ 108 (305)
T d1xkua_ 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEK---MPKTLQELRVH 108 (305)
T ss_dssp TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSS---CCTTCCEEECC
T ss_pred CCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccCcCccc---hhhhhhhhhcc
Confidence 34444444444444443 244444444444444444444444455555555555555555433221 22345555555
Q ss_pred CCccCCCCchhhhCCCCCCEEeCCCCCCC--CCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCC
Q 038671 155 SNNITGSMPAEIIHSSQLKVLDLSSNHIV--GEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSN 232 (707)
Q Consensus 155 ~n~i~~~~~~~~~~~~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~ 232 (707)
+|.+.......+.....+..++...|... ...+..+..+++|+.+.+++|.++. .+.. .+++|+.|++++|.++.
T Consensus 109 ~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~-l~~~--~~~~L~~L~l~~n~~~~ 185 (305)
T d1xkua_ 109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQG--LPPSLTELHLDGNKITK 185 (305)
T ss_dssp SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSS--CCTTCSEEECTTSCCCE
T ss_pred ccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc-cCcc--cCCccCEEECCCCcCCC
Confidence 55555555555555555566665555432 2234455566666666666666653 2222 24566677777776666
Q ss_pred CCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhh--
Q 038671 233 SIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCF-- 310 (707)
Q Consensus 233 ~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~-- 310 (707)
..+..|.+++.++.|++++|.+.+..+..+.++++|++|+|++|.|+ .+|..+..+++|+.|++++|+|+.+....|
T Consensus 186 ~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~ 264 (305)
T d1xkua_ 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264 (305)
T ss_dssp ECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSC
T ss_pred CChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccC
Confidence 66666666777777777777776666666777777777777777774 345566677777777777777765433332
Q ss_pred ----ccCCCceeEeeccCccccc
Q 038671 311 ----EELHGLSYIDISYNELHGS 329 (707)
Q Consensus 311 ----~~~~~L~~l~l~~n~~~~~ 329 (707)
..+.+|+.|++++|+|+..
T Consensus 265 ~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 265 PGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp SSCCTTSCCCSEEECCSSSSCGG
T ss_pred cchhcccCCCCEEECCCCcCccC
Confidence 3456778888888887643
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.7e-26 Score=230.50 Aligned_cols=209 Identities=23% Similarity=0.201 Sum_probs=112.9
Q ss_pred CcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCC-CCCCCCCCChhhhCCCCCcEEEec
Q 038671 124 LAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLS-SNHIVGEMPSKLGKLSSLIKLILN 202 (707)
Q Consensus 124 L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~-~n~l~~~~~~~~~~l~~L~~L~l~ 202 (707)
+++|+|++|.|+.+.+..|.++++|++|++++|.+..+....+..+..++.+... .|.++...+..|.++++|++|+++
T Consensus 34 ~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~ 113 (284)
T d1ozna_ 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLD 113 (284)
T ss_dssp CSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECT
T ss_pred CCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecC
Confidence 4444444444444444444444444444444444444444444444444444332 333433444445555555555555
Q ss_pred CCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCC
Q 038671 203 SNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEM 282 (707)
Q Consensus 203 ~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 282 (707)
+|.+....+..+...++|+.+++++|.++++.+..|..+++|+.|++++|.+....+..|.++++|+.+++++|.+++..
T Consensus 114 ~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~ 193 (284)
T d1ozna_ 114 RCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193 (284)
T ss_dssp TSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccC
Confidence 55555444444555555555555555555555555555556666666666665555555666666666666666665555
Q ss_pred CcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCC
Q 038671 283 PSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPN 332 (707)
Q Consensus 283 ~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~ 332 (707)
|..|..+++|+.|++++|++.+..++.+..+++|+.|++++|+|.|.++.
T Consensus 194 ~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred hhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc
Confidence 56666666666666666666665556666666666666666666665543
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=9.6e-26 Score=224.90 Aligned_cols=250 Identities=20% Similarity=0.179 Sum_probs=143.2
Q ss_pred ECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCC-CCCCCCccEEEec-cCcc
Q 038671 33 ELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLVRVRLN-QNHL 110 (707)
Q Consensus 33 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~-l~~l~~L~~L~l~-~n~l 110 (707)
+.++++++ .+|..+. +.+++|+|++|+|+.+.+.+|.++++|++|++++|++..+... +..+..++.+... .|.+
T Consensus 17 ~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~ 93 (284)
T d1ozna_ 17 SCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93 (284)
T ss_dssp ECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTC
T ss_pred EcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccccc
Confidence 34444444 3343322 3445555555555544444555555555555555555544332 3444555554432 3445
Q ss_pred ccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhh
Q 038671 111 TGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKL 190 (707)
Q Consensus 111 ~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~ 190 (707)
+.+.+..|..+++|++|++++|.+..+....+...++|+.+++++|.++.+.+..|..+++|+.|++++|.++...+..|
T Consensus 94 ~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f 173 (284)
T d1ozna_ 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAF 173 (284)
T ss_dssp CCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTT
T ss_pred ccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhh
Confidence 55555556666666666666666665555566666666666666666665555666666666666666666665556666
Q ss_pred hCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCe
Q 038671 191 GKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSE 270 (707)
Q Consensus 191 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 270 (707)
.++++|+++++++|++++..+..|..+++|++|++++|.+.+..+..|+++++|++|+|++|++...-. ...-...++.
T Consensus 174 ~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~-~~~l~~~l~~ 252 (284)
T d1ozna_ 174 RGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQK 252 (284)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG-GHHHHHHHHH
T ss_pred ccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCcc-chHHHHHHHh
Confidence 666777777777777766666667777777777777777776666667777777777777776642211 1111123444
Q ss_pred eeecCccCCCCCCccc
Q 038671 271 LDLSHNFLGEEMPSQI 286 (707)
Q Consensus 271 L~l~~n~l~~~~~~~~ 286 (707)
+....+.+....|..+
T Consensus 253 ~~~~~~~~~C~~p~~l 268 (284)
T d1ozna_ 253 FRGSSSEVPCSLPQRL 268 (284)
T ss_dssp CCSEECCCBEEESGGG
T ss_pred CcCCCCceEeCCchHH
Confidence 4545555544444443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.1e-23 Score=207.27 Aligned_cols=198 Identities=22% Similarity=0.154 Sum_probs=124.6
Q ss_pred CCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeec
Q 038671 3 SNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTL 82 (707)
Q Consensus 3 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 82 (707)
..+..++.++++++ .+|..+. ++|++|+|++|+|++..+.+|.++++|++|+|++|+|+.. + .++.+++|++|+|
T Consensus 10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~L 84 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDL 84 (266)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEEC
T ss_pred CCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccccc
Confidence 44556677777777 5566554 3677777777777755556677777777777777777643 2 3556777777777
Q ss_pred ccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCC
Q 038671 83 ENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSM 162 (707)
Q Consensus 83 ~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~ 162 (707)
++|+++..+..+.++++|+.|++++|.+..+....+..+.++++|++++|.++.+.+..+..+++|+.|++++|++++..
T Consensus 85 s~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~ 164 (266)
T d1p9ag_ 85 SHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELP 164 (266)
T ss_dssp CSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCC
T ss_pred ccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccC
Confidence 77777666666666666666666666666666666666666666666666666555555555666666666666665555
Q ss_pred chhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCcc
Q 038671 163 PAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQL 206 (707)
Q Consensus 163 ~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 206 (707)
+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+
T Consensus 165 ~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 165 AGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp TTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred ccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCC
Confidence 555555555555555555555 4444444455555555555544
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=9.8e-24 Score=207.73 Aligned_cols=205 Identities=23% Similarity=0.227 Sum_probs=112.1
Q ss_pred CCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEE
Q 038671 96 NLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVL 175 (707)
Q Consensus 96 ~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L 175 (707)
+...+.+++.++++++.++.+ + .++|++|+|++|.|+.+.+.+|.++++|++|+|++|.|+... .+..+++|+.|
T Consensus 8 ~~~~~~~v~C~~~~L~~iP~~-l--p~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLTALPPD-L--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCSSCCSC-C--CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCCeeCcC-c--CcCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccccc
Confidence 445556667777777765432 2 145677777777776666666666666666666666665321 23445556666
Q ss_pred eCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeeccccc
Q 038671 176 DLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFI 255 (707)
Q Consensus 176 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~ 255 (707)
+|++|+++ ..+..+..+++|+.|++++|.+....+ ..+..+.+++.|++++|.+.
T Consensus 83 ~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~------------------------~~~~~l~~l~~L~l~~n~l~ 137 (266)
T d1p9ag_ 83 DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPL------------------------GALRGLGELQELYLKGNELK 137 (266)
T ss_dssp ECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCS------------------------STTTTCTTCCEEECTTSCCC
T ss_pred cccccccc-ccccccccccccccccccccccceeec------------------------cccccccccccccccccccc
Confidence 66666555 333344445555555555555544444 44444444555555555544
Q ss_pred ccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCC
Q 038671 256 KKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIP 331 (707)
Q Consensus 256 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~ 331 (707)
...+..+..+++|+.|++++|++++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|.|.|.
T Consensus 138 ~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred eeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCcc
Confidence 444444444555555555555554444444555555555555555555 334444455556666666666666553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=3.8e-23 Score=192.27 Aligned_cols=172 Identities=16% Similarity=0.150 Sum_probs=122.6
Q ss_pred CCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCc---------------hhhhHHHHHHHHHHHhcCCCCceeeeeee
Q 038671 439 DDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPS---------------EMASQQEFLNEVKTLTGIRHRNIVKFYGF 503 (707)
Q Consensus 439 ~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~niv~~~~~ 503 (707)
.++++||+|+||+||+|...+|+.||||+++..... ..........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999998888999999987532110 11122345678889999999999988766
Q ss_pred eecCCceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCCCCCeEecCCCCCCeeecCCCCeEEe
Q 038671 504 CSHARHSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDCFPPIVHRDISSKNVLLDLENEAHVS 583 (707)
Q Consensus 504 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~dlk~~Nil~~~~~~~kl~ 583 (707)
. ..+++|||+++..+. .++......++.|++++++|||++ ||+||||||+|||++++ .++++
T Consensus 83 ~----~~~lvme~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELY----------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGG----------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeecccccc----------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 3 237999999876543 245566778999999999999999 99999999999999854 58999
Q ss_pred ccccceecCCCCCCccccccccCCCCccccccCCCCccchhHHHHHHH
Q 038671 584 DFGTAKFLKPDSSNWAELAGTYGYVAPELAYTMKVTEKCDVYSFGVLA 631 (707)
Q Consensus 584 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l 631 (707)
|||.|.....+.... ....+... -.+ +....|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~~-~l~rd~~~-~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWRE-ILERDVRN-IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHH-HHHHHHHH-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHH-HHHHHHHH-HHH-HHcCCCCCcccHHHHHHHH
Confidence 999998754332110 00000000 011 1235588899999976543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.83 E-value=8.2e-19 Score=180.22 Aligned_cols=285 Identities=27% Similarity=0.294 Sum_probs=195.0
Q ss_pred CCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecc
Q 038671 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLE 83 (707)
Q Consensus 4 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~ 83 (707)
++++|||++++++ .+|+. .++|++|+|++|+|+ .+|+. +.+|+.|++++|.++.. +.. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l-~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccchh-hhh---cccccccccc
Confidence 6899999999999 67853 568999999999999 66765 46799999999999843 321 2469999999
Q ss_pred cccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCc
Q 038671 84 NNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMP 163 (707)
Q Consensus 84 ~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~ 163 (707)
+|.+..++ .+..+++|+.|++++|.+..... ....+..+.+..+.... ...+..++.++.|.+++|.......
T Consensus 107 ~n~l~~lp-~~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~~~~ 179 (353)
T d1jl5a_ 107 NNQLEKLP-ELQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKLPD 179 (353)
T ss_dssp SSCCSSCC-CCTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSSCCC
T ss_pred cccccccc-chhhhccceeecccccccccccc----ccccccchhhccccccc--cccccccccceeccccccccccccc
Confidence 99999765 46889999999999998875432 35677788887776643 3557788889999999888763221
Q ss_pred hhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCcccc----
Q 038671 164 AEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLG---- 239 (707)
Q Consensus 164 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~---- 239 (707)
.....+.+...++.+. ..+ .+..++.|+.+++++|.... .+ ....++..+.+..|.+... +....
T Consensus 180 ----~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~---~~~~~l~~~~~~~~~~~~~-~~~~~~l~~ 248 (353)
T d1jl5a_ 180 ----LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LP---DLPPSLEALNVRDNYLTDL-PELPQSLTF 248 (353)
T ss_dssp ----CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CC---SCCTTCCEEECCSSCCSCC-CCCCTTCCE
T ss_pred ----cccccccccccccccc-ccc-cccccccccccccccccccc-cc---ccccccccccccccccccc-ccccccccc
Confidence 1233455666655554 222 24566777777777776652 22 2344566666666665422 11111
Q ss_pred ------------Cc-ccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCch
Q 038671 240 ------------NL-VKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFI 306 (707)
Q Consensus 240 ------------~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~ 306 (707)
.+ ......++..+.+.+. ...+++|++|+|++|+++. +|. .+++|+.|++++|+|+..
T Consensus 249 ~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~~l- 319 (353)
T d1jl5a_ 249 LDVSENIFSGLSELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLAEV- 319 (353)
T ss_dssp EECCSSCCSEESCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCC-
T ss_pred cccccccccccccccchhcccccccCccccc----cccCCCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCCcc-
Confidence 01 1223334444443322 2335789999999999964 553 357899999999999854
Q ss_pred hHhhccCCCceeEeeccCcccccC
Q 038671 307 PSCFEELHGLSYIDISYNELHGSI 330 (707)
Q Consensus 307 ~~~~~~~~~L~~l~l~~n~~~~~~ 330 (707)
|. .+++|++|++++|+++..+
T Consensus 320 ~~---~~~~L~~L~L~~N~L~~lp 340 (353)
T d1jl5a_ 320 PE---LPQNLKQLHVEYNPLREFP 340 (353)
T ss_dssp CC---CCTTCCEEECCSSCCSSCC
T ss_pred cc---ccCCCCEEECcCCcCCCCC
Confidence 43 3568999999999998644
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.82 E-value=7.7e-20 Score=175.03 Aligned_cols=61 Identities=30% Similarity=0.395 Sum_probs=25.5
Q ss_pred cCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccc
Q 038671 48 GNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLT 111 (707)
Q Consensus 48 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~ 111 (707)
+.+++|++|++.+|.|++. ..+..+++|++|++++|.+..+. .+..+++|+.+++++|.++
T Consensus 38 ~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~-~l~~l~~l~~l~~~~n~~~ 98 (227)
T d1h6ua2 38 ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA-PLKNLTKITELELSGNPLK 98 (227)
T ss_dssp HHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG-GGTTCCSCCEEECCSCCCS
T ss_pred HHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc-ccccccccccccccccccc
Confidence 3444444444444444422 12444444444444444444322 1333444444444444333
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=1e-19 Score=174.12 Aligned_cols=203 Identities=23% Similarity=0.267 Sum_probs=107.4
Q ss_pred EEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccc
Q 038671 55 FLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYF 134 (707)
Q Consensus 55 ~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i 134 (707)
.++++.+.+++.. .++.+.+|++|++.+|.|+.+ +++..+++|++|++++|+++.+. .+..+++|+.+++++|.+
T Consensus 23 ~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNPL 97 (227)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCCC
T ss_pred HHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc-hhHhcCCCCcEeecCCceeeccc--cccccccccccccccccc
Confidence 3444445544332 334455555555555555544 34555555555555555555442 255555555555555555
Q ss_pred cccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCcccc
Q 038671 135 YGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLEL 214 (707)
Q Consensus 135 ~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 214 (707)
+.+ ..+..+++|+.+.++++...+ ...+...+.+..+.++++.+.. ...+..+++|++|++++|.+... ..+
T Consensus 98 ~~i--~~l~~l~~L~~l~l~~~~~~~--~~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~~L~~L~l~~n~~~~~--~~l 169 (227)
T d1h6ua2 98 KNV--SAIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDL--TPL 169 (227)
T ss_dssp SCC--GGGTTCTTCCEEECTTSCCCC--CGGGTTCTTCCEEECCSSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGG
T ss_pred ccc--ccccccccccccccccccccc--cchhccccchhhhhchhhhhch--hhhhccccccccccccccccccc--hhh
Confidence 533 234555555555555555442 2234445555556665555532 22345555666666666655422 225
Q ss_pred CCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeec
Q 038671 215 GSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLS 274 (707)
Q Consensus 215 ~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 274 (707)
.++++|+.|+|++|+++++. .++++++|++|+|++|++++.. .+..+++|+.|+++
T Consensus 170 ~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 170 ANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp TTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred cccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 55666666666666665432 2555666666666666665443 25566666666664
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=1.9e-19 Score=174.39 Aligned_cols=198 Identities=19% Similarity=0.107 Sum_probs=89.2
Q ss_pred CCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCC--CCCCCCCccEEEecc-CccccccCccccCCCCCcEEE
Q 038671 52 QITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIP--NLRNLTSLVRVRLNQ-NHLTGNISESFGIHPNLAFID 128 (707)
Q Consensus 52 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~--~l~~l~~L~~L~l~~-n~l~~~~~~~~~~~~~L~~L~ 128 (707)
++++|+|++|+|+...+.+|.++++|++|++++|.+...++ .|.+++++++|.+.. |.+....+..|..+++|++|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 34444444444443333444444444444444444433211 234444444444432 344444444455555555555
Q ss_pred cccccccccCCC-CCCCCCCCcEEEcCCCccCCCCchhhhCCC-CCCEEeCCCCCCCCCCChhhhCCCCCcEE-EecCCc
Q 038671 129 LSHNYFYGEISS-DWGRCPKLGTLDFSSNNITGSMPAEIIHSS-QLKVLDLSSNHIVGEMPSKLGKLSSLIKL-ILNSNQ 205 (707)
Q Consensus 129 L~~n~i~~~~~~-~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L-~l~~n~ 205 (707)
+++|.+....+. .+..+..+..+...++.+.......|.+++ .++.|++++|+++...+.. ...+++.++ .+++|+
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~-~~~~~l~~~~~l~~n~ 188 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA-FNGTQLDELNLSDNNN 188 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTT-TTTCCEEEEECTTCTT
T ss_pred cchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccccccccc-ccchhhhccccccccc
Confidence 555555432221 122233344444444444433334444332 4555555555554222222 223333333 344455
Q ss_pred cccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeee
Q 038671 206 LCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLS 250 (707)
Q Consensus 206 l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~ 250 (707)
++...+..|.++++|++|+|++|+|+.+.+..|.++++|+.+++.
T Consensus 189 l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp CCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred cccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 554434445555555555555555554444555555555555543
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=2e-19 Score=174.13 Aligned_cols=197 Identities=16% Similarity=0.081 Sum_probs=75.9
Q ss_pred CccEEEeccCccccccCccccCCCCCcEEEcccccccc-cCCCCCCCCCCCcEEEcCC-CccCCCCchhhhCCCCCCEEe
Q 038671 99 SLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYG-EISSDWGRCPKLGTLDFSS-NNITGSMPAEIIHSSQLKVLD 176 (707)
Q Consensus 99 ~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~-~~~~~~~~~~~L~~L~L~~-n~i~~~~~~~~~~~~~L~~L~ 176 (707)
++++|++++|+|+.++..+|.++++|++|++++|.+.. +.+..|..++++++|.+.. |.+....+..|.++++|+.|+
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~ 109 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 109 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence 34444444444444444444444444444444444432 2233344444444444332 333333334444444444444
Q ss_pred CCCCCCCCCCC-hhhhCCCCCcEEEecCCccccCCccccCCCC-cccEEEccCCccCCCCCccccCcccCceEeeecccc
Q 038671 177 LSSNHIVGEMP-SKLGKLSSLIKLILNSNQLCGQLSLELGSLT-QLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQF 254 (707)
Q Consensus 177 l~~n~l~~~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l 254 (707)
+++|.+....+ ..+..+..+..+..+++.+....+..+..++ .++.|++++|+++.+.+..+....-++.+++++|++
T Consensus 110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l 189 (242)
T d1xwdc1 110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189 (242)
T ss_dssp EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTC
T ss_pred cchhhhcccccccccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhcccccccccc
Confidence 44444432111 1112223333333333344333333333332 344444444444433222222211112223333444
Q ss_pred cccCchhhhhcccCCeeeecCccCCCCCCcccccccccceE
Q 038671 255 IKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKL 295 (707)
Q Consensus 255 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L 295 (707)
+...+..|.++++|+.|+|++|+++...+..|.++++|+.+
T Consensus 190 ~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l 230 (242)
T d1xwdc1 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR 230 (242)
T ss_dssp CCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESS
T ss_pred ccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccC
Confidence 33333334444444444444444433333333333333333
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=5.2e-22 Score=212.35 Aligned_cols=325 Identities=21% Similarity=0.139 Sum_probs=177.8
Q ss_pred CCceeeccCCeeeecC-CccccCCCCCCeEECCCCccccc----cCcCccCCCCCcEEEcccCcCcccCCccc----cC-
Q 038671 4 NLAFLYLYNNSFSGSI-PSEIGRLKSLSDLELSGNKLCGS----IPHSLGNLTQITFLTLFDNALSGAIPKEY----GN- 73 (707)
Q Consensus 4 ~l~~L~l~~n~i~~~~-~~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~~~----~~- 73 (707)
+|+.|||++|+|++.. .+.+..+++++.|+|++|.+++. +...+..+++|++|+|++|.|++.....+ ..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6888999999998632 34456778899999999988743 34556788899999999998874332222 22
Q ss_pred CCCCCeeeccccccccc-----CCCCCCCCCccEEEeccCccccccCc--------------------------------
Q 038671 74 LVKLTLLTLENNQLRGP-----IPNLRNLTSLVRVRLNQNHLTGNISE-------------------------------- 116 (707)
Q Consensus 74 l~~L~~L~l~~n~i~~~-----~~~l~~l~~L~~L~l~~n~l~~~~~~-------------------------------- 116 (707)
..+|++|+|++|++++. ...+..+++|++|++++|.++.....
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 24799999999988652 23477888999999998887532111
Q ss_pred -cccCCCCCcEEEcccccccccCC---------------------------------CCCCCCCCCcEEEcCCCccCCC-
Q 038671 117 -SFGIHPNLAFIDLSHNYFYGEIS---------------------------------SDWGRCPKLGTLDFSSNNITGS- 161 (707)
Q Consensus 117 -~~~~~~~L~~L~L~~n~i~~~~~---------------------------------~~~~~~~~L~~L~L~~n~i~~~- 161 (707)
.+.....++.++++++.+..... ..+...+.++.+.+++|.+...
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 11223566777776665431100 0011234455555555543211
Q ss_pred ----CchhhhCCCCCCEEeCCCCCCCCC----CChhhhCCCCCcEEEecCCccccCCcccc-----CCCCcccEEEccCC
Q 038671 162 ----MPAEIIHSSQLKVLDLSSNHIVGE----MPSKLGKLSSLIKLILNSNQLCGQLSLEL-----GSLTQLERLDLSSN 228 (707)
Q Consensus 162 ----~~~~~~~~~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~l~~n 228 (707)
..........++.|++++|.+... ....+...+.++.+++++|.++......+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 111222244566666666655411 12223345556666666666542221111 12345666666666
Q ss_pred ccCCCCCccc----cCcccCceEeeecccccccCchhh----h-hcccCCeeeecCccCCCC----CCcccccccccceE
Q 038671 229 RLSNSIPKSL----GNLVKLHYLNLSNNQFIKKIPVEL----E-KLIHLSELDLSHNFLGEE----MPSQICNMQSLEKL 295 (707)
Q Consensus 229 ~i~~~~~~~l----~~l~~L~~L~l~~n~l~~~~~~~~----~-~l~~L~~L~l~~n~l~~~----~~~~~~~~~~L~~L 295 (707)
.++......+ ...++|++|+|++|++++.....+ . ..+.|+.|+|++|.|++. +...+..+++|++|
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence 6554332222 233456666666666544322222 1 234466666666666432 12233444666666
Q ss_pred eccccccCCchhHhh----c-cCCCceeEeeccCcccc
Q 038671 296 NLSHNNLSGFIPSCF----E-ELHGLSYIDISYNELHG 328 (707)
Q Consensus 296 ~l~~n~i~~~~~~~~----~-~~~~L~~l~l~~n~~~~ 328 (707)
++++|+|++.....+ . ....|+.|++.+|.+..
T Consensus 403 ~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp ECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred ECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 666666654333222 1 12246666666666553
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=4.2e-19 Score=165.75 Aligned_cols=162 Identities=29% Similarity=0.356 Sum_probs=86.8
Q ss_pred CCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEE
Q 038671 49 NLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFID 128 (707)
Q Consensus 49 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~ 128 (707)
.+.+|++|++++|.|+.. ..++.+++|++|++++|+++.+.+ +.++++|+.|++++|.+..+. .+..+++|+.|+
T Consensus 38 ~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~ 112 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADIT--PLANLTNLTGLT 112 (199)
T ss_dssp HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEE
T ss_pred HhcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc-ccCCccccccccccccccccc--cccccccccccc
Confidence 344555555555555432 234455555555555555554332 555555555555555554432 255555566666
Q ss_pred cccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCcccc
Q 038671 129 LSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCG 208 (707)
Q Consensus 129 L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 208 (707)
+++|.+... ..+..+++|+.|++++|.+.. ...+..+++|+.|++.+|++++. ..++++++|++|++++|++++
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~--~~~l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCC--CGGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhcc--cccccccccccccccccccccCC--ccccCCCCCCEEECCCCCCCC
Confidence 655555432 235556666666666666552 22355566666666666666532 235666666666666666653
Q ss_pred CCccccCCCCcccEE
Q 038671 209 QLSLELGSLTQLERL 223 (707)
Q Consensus 209 ~~~~~~~~l~~L~~L 223 (707)
. ..++.+++|+.|
T Consensus 187 i--~~l~~L~~L~~L 199 (199)
T d2omxa2 187 I--SVLAKLTNLESL 199 (199)
T ss_dssp C--GGGGGCTTCSEE
T ss_pred C--ccccCCCCCCcC
Confidence 2 235566666654
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.76 E-value=5.5e-17 Score=166.34 Aligned_cols=279 Identities=24% Similarity=0.247 Sum_probs=184.4
Q ss_pred CCCCceeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeee
Q 038671 2 LSNLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLT 81 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~ 81 (707)
+++|++|+|++|+|+ .+|+. +.+|+.|++++|+++ .+++ + .+.|++|++++|.+.. +|. ++.+++|++|+
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~~-lp~-~~~l~~L~~L~ 126 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLEK-LPE-LQNSSFLKIID 126 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCSS-CCC-CTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh-h--cccccccccccccccc-ccc-hhhhccceeec
Confidence 468999999999999 77865 458999999999998 4443 1 2469999999999994 453 68899999999
Q ss_pred cccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCC
Q 038671 82 LENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGS 161 (707)
Q Consensus 82 l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~ 161 (707)
+++|.+...+.. ...+..+.+..+.... ...+..++.++.|++++|.+..... .....+.+...++.+..
T Consensus 127 l~~~~~~~~~~~---~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~~~~----~~~~~~~l~~~~~~~~~- 196 (353)
T d1jl5a_ 127 VDNNSLKKLPDL---PPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKLPD----LPLSLESIVAGNNILEE- 196 (353)
T ss_dssp CCSSCCSCCCCC---CTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCSS-
T ss_pred cccccccccccc---cccccchhhccccccc--cccccccccceeccccccccccccc----ccccccccccccccccc-
Confidence 999998765443 3456667776655543 3456778888999998888764321 22234555555555442
Q ss_pred CchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccC----------------CC-CcccEEE
Q 038671 162 MPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELG----------------SL-TQLERLD 224 (707)
Q Consensus 162 ~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~----------------~l-~~L~~L~ 224 (707)
. ..+..++.|+.+++++|... ..+. ...++..+.+..|.+... +.... .+ ......+
T Consensus 197 ~-~~~~~l~~L~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~ 270 (353)
T d1jl5a_ 197 L-PELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTDL-PELPQSLTFLDVSENIFSGLSELPPNLYYLN 270 (353)
T ss_dssp C-CCCTTCTTCCEEECCSSCCS-SCCS---CCTTCCEEECCSSCCSCC-CCCCTTCCEEECCSSCCSEESCCCTTCCEEE
T ss_pred c-cccccccccccccccccccc-cccc---cccccccccccccccccc-ccccccccccccccccccccccccchhcccc
Confidence 2 22455667777777777655 2222 234566666666665521 11111 11 2233444
Q ss_pred ccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCC
Q 038671 225 LSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSG 304 (707)
Q Consensus 225 l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~ 304 (707)
+..|.+.+ ....+++|++|+|++|+++.. |. .+++|+.|+|++|.|+. +|.. +++|+.|++++|+|+.
T Consensus 271 ~~~~~~~~----~~~~~~~L~~L~Ls~N~l~~l-p~---~~~~L~~L~L~~N~L~~-l~~~---~~~L~~L~L~~N~L~~ 338 (353)
T d1jl5a_ 271 ASSNEIRS----LCDLPPSLEELNVSNNKLIEL-PA---LPPRLERLIASFNHLAE-VPEL---PQNLKQLHVEYNPLRE 338 (353)
T ss_dssp CCSSCCSE----ECCCCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSS
T ss_pred cccCcccc----ccccCCCCCEEECCCCccCcc-cc---ccCCCCEEECCCCcCCc-cccc---cCCCCEEECcCCcCCC
Confidence 44444432 223457899999999998754 33 36789999999999964 4543 4689999999999985
Q ss_pred chhHhhccCCCceeEeec
Q 038671 305 FIPSCFEELHGLSYIDIS 322 (707)
Q Consensus 305 ~~~~~~~~~~~L~~l~l~ 322 (707)
+|+. ...|+.|.+.
T Consensus 339 -lp~~---~~~L~~L~~~ 352 (353)
T d1jl5a_ 339 -FPDI---PESVEDLRMN 352 (353)
T ss_dssp -CCCC---CTTCCEEECC
T ss_pred -CCcc---ccccCeeECc
Confidence 3543 2356666553
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=3.9e-18 Score=160.43 Aligned_cols=162 Identities=27% Similarity=0.359 Sum_probs=67.9
Q ss_pred CCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCC
Q 038671 76 KLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS 155 (707)
Q Consensus 76 ~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~ 155 (707)
+|++|++++|.++.+ .++..+++|++|++++|+++++. .++.+++|+.|++++|+++.+. .+..+++|+.|++++
T Consensus 47 ~L~~L~l~~~~i~~l-~~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 47 SIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLSLEH 121 (210)
T ss_dssp TCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEECTT
T ss_pred CccEEECcCCCCCCc-hhHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccccc--ccccccccccccccc
Confidence 344444444444322 12333444444444444444332 1334444444444444444321 244444444444444
Q ss_pred CccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCC
Q 038671 156 NNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIP 235 (707)
Q Consensus 156 n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~ 235 (707)
|.+.. ...+..+++++.+++++|.+++ +..+..+++|+++++++|++++.. .+.++++|+.|+|++|.|+++ +
T Consensus 122 ~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~l-~ 194 (210)
T d1h6ta2 122 NGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISDL-R 194 (210)
T ss_dssp SCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCBC-G
T ss_pred ccccc--cccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCCC-h
Confidence 44431 1234444444555554444431 122344444444444444444221 244444444444444444422 1
Q ss_pred ccccCcccCceEeee
Q 038671 236 KSLGNLVKLHYLNLS 250 (707)
Q Consensus 236 ~~l~~l~~L~~L~l~ 250 (707)
.|.++++|++|+|+
T Consensus 195 -~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 195 -ALAGLKNLDVLELF 208 (210)
T ss_dssp -GGTTCTTCSEEEEE
T ss_pred -hhcCCCCCCEEEcc
Confidence 34444444444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=3.1e-18 Score=161.14 Aligned_cols=180 Identities=24% Similarity=0.295 Sum_probs=115.6
Q ss_pred ECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCcccc
Q 038671 33 ELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTG 112 (707)
Q Consensus 33 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~ 112 (707)
++..+++++..+. ..+.+|++|++++|.|++.. .+..+++|++|++++|.|++++ .+..+++|+.|++++|+++.
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~~ 104 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKD 104 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc-ccccCccccccccccccccc
Confidence 4555555533321 24556666666666666332 3566666666666666666543 35566667777776666665
Q ss_pred ccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhC
Q 038671 113 NISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGK 192 (707)
Q Consensus 113 ~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~ 192 (707)
+. .+..+++|+.|++++|.+..+ ..+..+++++.+++++|.+++ ...+..+++|+.+++++|++++. + .+.+
T Consensus 105 l~--~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~ 176 (210)
T d1h6ta2 105 LS--SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAG 176 (210)
T ss_dssp GG--GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTT
T ss_pred cc--ccccccccccccccccccccc--ccccccccccccccccccccc--ccccccccccccccccccccccc-c-cccC
Confidence 43 466677777777777766543 346677777777777777763 33456677788888888877643 2 3777
Q ss_pred CCCCcEEEecCCccccCCccccCCCCcccEEEccC
Q 038671 193 LSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSS 227 (707)
Q Consensus 193 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 227 (707)
+++|++|++++|+++. ++ .+..+++|++|+|++
T Consensus 177 l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 177 LTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred CCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 7888888888888774 33 477788888888763
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=1.3e-18 Score=161.24 Aligned_cols=106 Identities=26% Similarity=0.309 Sum_probs=39.2
Q ss_pred CCcEEEcCCCccCC-CCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEc
Q 038671 147 KLGTLDFSSNNITG-SMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDL 225 (707)
Q Consensus 147 ~L~~L~L~~n~i~~-~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 225 (707)
++++|+|++|.|+. .....|.++++|+.|+|++|.+....+..|..+++|++|++++|+|+...+.+|.++++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence 34444444444432 22233333333444444333333333333333333333333333333333333333333333333
Q ss_pred cCCccCCCCCccccCcccCceEeeecc
Q 038671 226 SSNRLSNSIPKSLGNLVKLHYLNLSNN 252 (707)
Q Consensus 226 ~~n~i~~~~~~~l~~l~~L~~L~l~~n 252 (707)
++|.|+.+.+..|..+++|++|+|++|
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N 136 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASN 136 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTC
T ss_pred CCccccccCHHHhcCCccccccccccc
Confidence 333333333333333333333333333
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=8.9e-18 Score=156.59 Aligned_cols=178 Identities=25% Similarity=0.313 Sum_probs=85.3
Q ss_pred EEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcEEEcccccc
Q 038671 55 FLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAFIDLSHNYF 134 (707)
Q Consensus 55 ~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~i 134 (707)
.+.++.+.+++..+ ...+++|++|++++|.++.+ +++..+++|++|++++|+++++.+ ++.+++|++|++++|.+
T Consensus 22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCCc-cccccCCCcCcCccccccccCccc--ccCCccccccccccccc
Confidence 33444555543322 23455566666666655542 334455555555555555554322 44455555555555544
Q ss_pred cccCCCCCCCCCCCcEEEcCCCccCCCCchhhhCCCCCCEEeCCCCCCCCCCChhhhCCCCCcEEEecCCccccCCcccc
Q 038671 135 YGEISSDWGRCPKLGTLDFSSNNITGSMPAEIIHSSQLKVLDLSSNHIVGEMPSKLGKLSSLIKLILNSNQLCGQLSLEL 214 (707)
Q Consensus 135 ~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 214 (707)
..+. .+.. +++|+.|++++|.+.. ...+..+++|+.|++++|++.. . ..+
T Consensus 97 ~~~~--~l~~------------------------l~~L~~L~l~~~~~~~--~~~~~~l~~L~~L~l~~n~l~~-~-~~l 146 (199)
T d2omxa2 97 ADIT--PLAN------------------------LTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD-I-SAL 146 (199)
T ss_dssp CCCG--GGTT------------------------CTTCSEEECCSSCCCC--CGGGTTCTTCSEEECCSSCCCC-C-GGG
T ss_pred cccc--cccc------------------------cccccccccccccccc--ccccchhhhhHHhhhhhhhhcc-c-ccc
Confidence 4321 2444 4445555554444432 1224444555555555555542 1 234
Q ss_pred CCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCee
Q 038671 215 GSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSEL 271 (707)
Q Consensus 215 ~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 271 (707)
..+++|+.|++++|++++.. .++++++|+.|++++|++++. ..+.++++|++|
T Consensus 147 ~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 147 SGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp TTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cccccccccccccccccCCc--cccCCCCCCEEECCCCCCCCC--ccccCCCCCCcC
Confidence 45555555555555555332 255555555555555555442 234555555543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.74 E-value=3.3e-18 Score=158.55 Aligned_cols=154 Identities=23% Similarity=0.286 Sum_probs=70.5
Q ss_pred CCcEEEecCCcccc-CCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeee
Q 038671 195 SLIKLILNSNQLCG-QLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDL 273 (707)
Q Consensus 195 ~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 273 (707)
++++|+|++|+|+. .....|..+++|+.|+|++|.+....+..|..+++|++|+|++|+|....+..|.++++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence 44444444444432 22333444455555555555554444444544555555555555554444444555555555555
Q ss_pred cCccCCCCCCcccccccccceEeccccccCCchhHhhccCCCceeEeeccCcccccCCCccccccCchhhcccCcCcC
Q 038671 274 SHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIPSCFEELHGLSYIDISYNELHGSIPNSTAFRDAPMEALQGNKGLC 351 (707)
Q Consensus 274 ~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~~~~~~~~~L~~l~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~c 351 (707)
++|.|++..++.|..+++|++|+|++|++.......+ -...++.+.+..|.+.|..|. .+++.....+..+...|
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~p~--~l~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPS--KVRDVQIKDLPHSEFKC 184 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCSST--TTTTSBGGGSCTTTCCC
T ss_pred CCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCCCh--hhcCCEeeecCHhhCcC
Confidence 5555544444455555555555555555543322111 112344444555555554332 22333334444444444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=5.8e-20 Score=196.21 Aligned_cols=318 Identities=23% Similarity=0.189 Sum_probs=221.5
Q ss_pred CCCCceeeccCCeeee----cCCccccCCCCCCeEECCCCccccc----cCcCccC-CCCCcEEEcccCcCcccC----C
Q 038671 2 LSNLAFLYLYNNSFSG----SIPSEIGRLKSLSDLELSGNKLCGS----IPHSLGN-LTQITFLTLFDNALSGAI----P 68 (707)
Q Consensus 2 l~~l~~L~l~~n~i~~----~~~~~~~~l~~L~~L~l~~n~i~~~----~~~~~~~-l~~L~~L~L~~n~i~~~~----~ 68 (707)
+++++.|+|++|+|+. .++..++.+++|++|+|++|.|++. +.+.+.. ..+|++|+|++|.|++.. +
T Consensus 26 l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~ 105 (460)
T d1z7xw1 26 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 105 (460)
T ss_dssp HTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCcccccccccc
Confidence 5789999999999985 3345567899999999999999743 2333332 357999999999998543 4
Q ss_pred ccccCCCCCCeeecccccccccC----------------------CC------------CCCCCCccEEEeccCcccc--
Q 038671 69 KEYGNLVKLTLLTLENNQLRGPI----------------------PN------------LRNLTSLVRVRLNQNHLTG-- 112 (707)
Q Consensus 69 ~~~~~l~~L~~L~l~~n~i~~~~----------------------~~------------l~~l~~L~~L~l~~n~l~~-- 112 (707)
..+..+++|++|++++|.++... .. +.....++.++++.+.+..
T Consensus 106 ~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~ 185 (460)
T d1z7xw1 106 STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAG 185 (460)
T ss_dssp HHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred chhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccccccccccccccccccccccccc
Confidence 56778999999999999875310 00 1123456666666554321
Q ss_pred ---------------------------c----cCccccCCCCCcEEEcccccccc-----cCCCCCCCCCCCcEEEcCCC
Q 038671 113 ---------------------------N----ISESFGIHPNLAFIDLSHNYFYG-----EISSDWGRCPKLGTLDFSSN 156 (707)
Q Consensus 113 ---------------------------~----~~~~~~~~~~L~~L~L~~n~i~~-----~~~~~~~~~~~L~~L~L~~n 156 (707)
. ....+...+.++.+++++|.+.. .....+.....++.|++++|
T Consensus 186 ~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n 265 (460)
T d1z7xw1 186 VRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWEC 265 (460)
T ss_dssp HHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred ccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhcccccccccccccccccc
Confidence 0 00112345778899999888742 22334556789999999999
Q ss_pred ccCCCC----chhhhCCCCCCEEeCCCCCCCCCCChhh-----hCCCCCcEEEecCCccccCCcccc----CCCCcccEE
Q 038671 157 NITGSM----PAEIIHSSQLKVLDLSSNHIVGEMPSKL-----GKLSSLIKLILNSNQLCGQLSLEL----GSLTQLERL 223 (707)
Q Consensus 157 ~i~~~~----~~~~~~~~~L~~L~l~~n~l~~~~~~~~-----~~l~~L~~L~l~~n~l~~~~~~~~----~~l~~L~~L 223 (707)
.+.... ...+...+.++.+++++|.+.......+ .....|+.+++++|.++......+ ...++|++|
T Consensus 266 ~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L 345 (460)
T d1z7xw1 266 GITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLEL 345 (460)
T ss_dssp CCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEE
T ss_pred cccccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhh
Confidence 987432 2335568899999999999864322222 234689999999999986544433 456799999
Q ss_pred EccCCccCCCC----Ccccc-CcccCceEeeecccccccCc----hhhhhcccCCeeeecCccCCCCCCcccc-----cc
Q 038671 224 DLSSNRLSNSI----PKSLG-NLVKLHYLNLSNNQFIKKIP----VELEKLIHLSELDLSHNFLGEEMPSQIC-----NM 289 (707)
Q Consensus 224 ~l~~n~i~~~~----~~~l~-~l~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~l~~n~l~~~~~~~~~-----~~ 289 (707)
+|++|.+++.. +..+. ..+.|++|+|++|.|++... ..+..+++|++|+|++|.|++.....+. +.
T Consensus 346 ~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~ 425 (460)
T d1z7xw1 346 QISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425 (460)
T ss_dssp ECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTT
T ss_pred heeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCC
Confidence 99999997532 22333 45679999999999976533 3466779999999999999764333332 23
Q ss_pred cccceEeccccccCCchhHhh----ccCCCceeE
Q 038671 290 QSLEKLNLSHNNLSGFIPSCF----EELHGLSYI 319 (707)
Q Consensus 290 ~~L~~L~l~~n~i~~~~~~~~----~~~~~L~~l 319 (707)
..|+.|++++|.+.......+ ...|+|+.|
T Consensus 426 ~~L~~l~l~~~~~~~~~~~~l~~l~~~~~~l~~~ 459 (460)
T d1z7xw1 426 CLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459 (460)
T ss_dssp CCCCEEECTTCCCCHHHHHHHHHHHHHCTTSEEE
T ss_pred CccCEEECCCCCCCHHHHHHHHHHHHhCCCCEEe
Confidence 479999999999985544433 345666554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=3.8e-17 Score=161.35 Aligned_cols=61 Identities=23% Similarity=0.234 Sum_probs=29.0
Q ss_pred CCCCCcEEEecCC-ccccCCccccCCCCcccEEEccCC-ccCCCCCccccCcccCceEeeecc
Q 038671 192 KLSSLIKLILNSN-QLCGQLSLELGSLTQLERLDLSSN-RLSNSIPKSLGNLVKLHYLNLSNN 252 (707)
Q Consensus 192 ~l~~L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~n-~i~~~~~~~l~~l~~L~~L~l~~n 252 (707)
.+++|++|++++| .+++.....+..+++|++|+|++| .+++.....++++++|+.|+++++
T Consensus 173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 3445555555443 244334444445555555555553 344333344445555555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=5e-17 Score=160.49 Aligned_cols=200 Identities=16% Similarity=0.132 Sum_probs=92.8
Q ss_pred CeeecccccccccCCCCCCCCCccEEEeccCcccccc-CccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCCC
Q 038671 78 TLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNI-SESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSSN 156 (707)
Q Consensus 78 ~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~n 156 (707)
..+.++...+...........+|++|++++|.++... ...+..+++|++|+|++|.+++.....+..+++|++|+++++
T Consensus 26 ~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c 105 (284)
T d2astb2 26 IAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGC 105 (284)
T ss_dssp SEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred eEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccccc
Confidence 3344444433332223334445666666666554322 233455666666666666665444445556666666666663
Q ss_pred -ccCCCCch-hhhCCCCCCEEeCCCC-CCCCC-CChhhhC-CCCCcEEEecCCc--cccC-CccccCCCCcccEEEccCC
Q 038671 157 -NITGSMPA-EIIHSSQLKVLDLSSN-HIVGE-MPSKLGK-LSSLIKLILNSNQ--LCGQ-LSLELGSLTQLERLDLSSN 228 (707)
Q Consensus 157 -~i~~~~~~-~~~~~~~L~~L~l~~n-~l~~~-~~~~~~~-l~~L~~L~l~~n~--l~~~-~~~~~~~l~~L~~L~l~~n 228 (707)
.+++.... .+.++++|++|+++++ .+++. ....+.. .++|++|+++++. ++.. ....+..+++|++|++++|
T Consensus 106 ~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~ 185 (284)
T d2astb2 106 SGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDS 185 (284)
T ss_dssp BSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTC
T ss_pred ccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccc
Confidence 34422211 2234566666666664 23211 1111222 2455555555432 2211 1111223444444444443
Q ss_pred ccCCCCCccccCcccCceEeeecccccccCchhhhhcccCCeeeecCc-cCCCCCCcccccccccceEecccc
Q 038671 229 RLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHN-FLGEEMPSQICNMQSLEKLNLSHN 300 (707)
Q Consensus 229 ~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n-~l~~~~~~~~~~~~~L~~L~l~~n 300 (707)
. .+++.....+..+++|++|++++| .+++.....++++++|+.|+++++
T Consensus 186 ~-----------------------~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 186 V-----------------------MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp T-----------------------TCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred c-----------------------CCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 1 233333444444555555555553 344443444455555555555555
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=3.1e-16 Score=139.86 Aligned_cols=128 Identities=19% Similarity=0.124 Sum_probs=85.2
Q ss_pred ccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCccccccCccccCCCCCcE
Q 038671 47 LGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNHLTGNISESFGIHPNLAF 126 (707)
Q Consensus 47 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~ 126 (707)
|.++.+|++|+|++|+|+. ++..+..+++|++|+|++|+|+.+ +++..+++|++|++++|+++.+++..+..+++|++
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE 91 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCcccccccccccc
Confidence 5566677777777777773 355566677777777777777755 45677777777777777777776666667777777
Q ss_pred EEcccccccccCC-CCCCCCCCCcEEEcCCCccCCCC---chhhhCCCCCCEEe
Q 038671 127 IDLSHNYFYGEIS-SDWGRCPKLGTLDFSSNNITGSM---PAEIIHSSQLKVLD 176 (707)
Q Consensus 127 L~L~~n~i~~~~~-~~~~~~~~L~~L~L~~n~i~~~~---~~~~~~~~~L~~L~ 176 (707)
|++++|.++.+.. ..+..+++|++|++++|+++... ...+..+++|++||
T Consensus 92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 7777777765432 34666677777777777765322 12355566666665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.61 E-value=2.3e-17 Score=168.48 Aligned_cols=38 Identities=16% Similarity=0.303 Sum_probs=18.7
Q ss_pred cccceEeccccccCCch----hHhhc-cCCCceeEeeccCccc
Q 038671 290 QSLEKLNLSHNNLSGFI----PSCFE-ELHGLSYIDISYNELH 327 (707)
Q Consensus 290 ~~L~~L~l~~n~i~~~~----~~~~~-~~~~L~~l~l~~n~~~ 327 (707)
+.|+.|++++|.|.... ...+. +.++|+.|++++|++.
T Consensus 273 ~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 273 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp CCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred CCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 34555555555554321 12221 3455666666666654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.60 E-value=6.4e-17 Score=165.06 Aligned_cols=239 Identities=18% Similarity=0.132 Sum_probs=179.2
Q ss_pred CCccccCCCCCCeeecccccccc-----cCCCCCCCCCccEEEeccCcccccc----------CccccCCCCCcEEEccc
Q 038671 67 IPKEYGNLVKLTLLTLENNQLRG-----PIPNLRNLTSLVRVRLNQNHLTGNI----------SESFGIHPNLAFIDLSH 131 (707)
Q Consensus 67 ~~~~~~~l~~L~~L~l~~n~i~~-----~~~~l~~l~~L~~L~l~~n~l~~~~----------~~~~~~~~~L~~L~L~~ 131 (707)
+...+....+|+.|+|++|.|.. +...+...++|+.|+++++...... ...+..+++|++|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 34567778999999999999864 3345888999999999987654321 23456689999999999
Q ss_pred ccccccCC----CCCCCCCCCcEEEcCCCccCCCCchh-------------hhCCCCCCEEeCCCCCCCCCC----Chhh
Q 038671 132 NYFYGEIS----SDWGRCPKLGTLDFSSNNITGSMPAE-------------IIHSSQLKVLDLSSNHIVGEM----PSKL 190 (707)
Q Consensus 132 n~i~~~~~----~~~~~~~~L~~L~L~~n~i~~~~~~~-------------~~~~~~L~~L~l~~n~l~~~~----~~~~ 190 (707)
|.++.... ..+..+++|+.|++++|.++...... ....+.|+.+.+++|.++... ...+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l 182 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence 99875422 33456799999999999876321111 134678999999999987432 3345
Q ss_pred hCCCCCcEEEecCCccccC-----CccccCCCCcccEEEccCCccCCC----CCccccCcccCceEeeecccccccCchh
Q 038671 191 GKLSSLIKLILNSNQLCGQ-----LSLELGSLTQLERLDLSSNRLSNS----IPKSLGNLVKLHYLNLSNNQFIKKIPVE 261 (707)
Q Consensus 191 ~~l~~L~~L~l~~n~l~~~-----~~~~~~~l~~L~~L~l~~n~i~~~----~~~~l~~l~~L~~L~l~~n~l~~~~~~~ 261 (707)
..++.|++|++++|.++.. ....+..+++|+.|+|++|.++.. +...+..+++|++|+|++|.|++.....
T Consensus 183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~ 262 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262 (344)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHH
T ss_pred hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHH
Confidence 6789999999999999742 334567889999999999998643 3456678899999999999998765444
Q ss_pred h----hh--cccCCeeeecCccCCCCCC----cccc-cccccceEeccccccCCc
Q 038671 262 L----EK--LIHLSELDLSHNFLGEEMP----SQIC-NMQSLEKLNLSHNNLSGF 305 (707)
Q Consensus 262 ~----~~--l~~L~~L~l~~n~l~~~~~----~~~~-~~~~L~~L~l~~n~i~~~ 305 (707)
+ .. ...|++|++++|.|+.... ..+. +.++|+.|++++|++...
T Consensus 263 l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp HHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred HHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence 4 22 3679999999999965322 2232 467899999999999753
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=7.5e-16 Score=137.29 Aligned_cols=127 Identities=19% Similarity=0.196 Sum_probs=91.6
Q ss_pred ccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCC-CCCCCCcc
Q 038671 23 IGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPN-LRNLTSLV 101 (707)
Q Consensus 23 ~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~-l~~l~~L~ 101 (707)
|.+..+|++|+|++|+|+ .++..+..+++|++|+|++|.|+.. +.|..+++|++|++++|+++.+++. +..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccc
Confidence 456667788888888887 4455567777888888888887754 3477778888888888888776665 45677888
Q ss_pred EEEeccCccccccC-ccccCCCCCcEEEcccccccccCC---CCCCCCCCCcEEE
Q 038671 102 RVRLNQNHLTGNIS-ESFGIHPNLAFIDLSHNYFYGEIS---SDWGRCPKLGTLD 152 (707)
Q Consensus 102 ~L~l~~n~l~~~~~-~~~~~~~~L~~L~L~~n~i~~~~~---~~~~~~~~L~~L~ 152 (707)
.|++++|+++.+.. ..+..+++|++|++++|.++.... ..+..+|+|+.|+
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 88888888776543 567778888888888888765432 2456778888776
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.55 E-value=5.2e-15 Score=125.12 Aligned_cols=100 Identities=30% Similarity=0.383 Sum_probs=46.6
Q ss_pred eeeccCCeeeecCCccccCCCCCCeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeeccccc
Q 038671 7 FLYLYNNSFSGSIPSEIGRLKSLSDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQ 86 (707)
Q Consensus 7 ~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~ 86 (707)
+|+|++|+|+ .++ .+..+++|++|++++|+|+ .+|..|..+++|++|++++|.|++. | .++.+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCc
Confidence 4555555555 222 2455555555555555555 3344455555555555555555422 2 24445555555555555
Q ss_pred ccccCC--CCCCCCCccEEEeccCccc
Q 038671 87 LRGPIP--NLRNLTSLVRVRLNQNHLT 111 (707)
Q Consensus 87 i~~~~~--~l~~l~~L~~L~l~~n~l~ 111 (707)
|+.++. .+..+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 443322 2334444444444444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.55 E-value=5.9e-15 Score=124.77 Aligned_cols=118 Identities=25% Similarity=0.308 Sum_probs=101.0
Q ss_pred CeEECCCCccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEeccCc
Q 038671 30 SDLELSGNKLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRLNQNH 109 (707)
Q Consensus 30 ~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n~ 109 (707)
|.|+|++|+++ .++ .+.++++|++|++++|.|+ .+|..|+.+++|+.|++++|.|+.+ +++..+++|++|++++|+
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCCc
Confidence 68999999999 444 4899999999999999999 5677899999999999999999976 469999999999999999
Q ss_pred cccccC-ccccCCCCCcEEEcccccccccC---CCCCCCCCCCcEE
Q 038671 110 LTGNIS-ESFGIHPNLAFIDLSHNYFYGEI---SSDWGRCPKLGTL 151 (707)
Q Consensus 110 l~~~~~-~~~~~~~~L~~L~L~~n~i~~~~---~~~~~~~~~L~~L 151 (707)
++.+.. ..+..+++|++|++++|.++... ......+|+|+.|
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 998764 67899999999999999998543 2223457888766
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.44 E-value=6.6e-16 Score=142.83 Aligned_cols=149 Identities=17% Similarity=0.173 Sum_probs=89.9
Q ss_pred CCCeEECCCC--ccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeecccccccccCCCCCCCCCccEEEe
Q 038671 28 SLSDLELSGN--KLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTLENNQLRGPIPNLRNLTSLVRVRL 105 (707)
Q Consensus 28 ~L~~L~l~~n--~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~l~~l~~L~~L~l 105 (707)
.++.+++++. .++ .++.++..+++|++|+|++|.|+.. + .|.++++|++|+|++|.|+.++.....+++|+.|++
T Consensus 24 ~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 24 EAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWI 100 (198)
T ss_dssp TCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEEC
T ss_pred ccceeeeecccCchh-hhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccccccccccccccccccc
Confidence 3445555543 233 3445566667777777777776643 2 466667777777777776655433334456777777
Q ss_pred ccCccccccCccccCCCCCcEEEcccccccccCC-CCCCCCCCCcEEEcCCCccCCCCch----------hhhCCCCCCE
Q 038671 106 NQNHLTGNISESFGIHPNLAFIDLSHNYFYGEIS-SDWGRCPKLGTLDFSSNNITGSMPA----------EIIHSSQLKV 174 (707)
Q Consensus 106 ~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~-~~~~~~~~L~~L~L~~n~i~~~~~~----------~~~~~~~L~~ 174 (707)
++|+++.+ ..+..+++|+.|++++|+|+.+.. ..+..+++|+.|+|++|++....+. .+..+++|+.
T Consensus 101 ~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~ 178 (198)
T d1m9la_ 101 SYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKK 178 (198)
T ss_dssp SEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCE
T ss_pred cccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCE
Confidence 77777654 246666777777777777765432 3466777777777777776422111 2566788888
Q ss_pred EeCCCCCCC
Q 038671 175 LDLSSNHIV 183 (707)
Q Consensus 175 L~l~~n~l~ 183 (707)
|| +..++
T Consensus 179 LD--~~~I~ 185 (198)
T d1m9la_ 179 LD--GMPVD 185 (198)
T ss_dssp ES--SGGGT
T ss_pred eC--CccCC
Confidence 76 44443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.39 E-value=1.3e-14 Score=134.08 Aligned_cols=128 Identities=26% Similarity=0.273 Sum_probs=66.0
Q ss_pred hhhhCCCCCcEEEecCCccccCCccccCCCCcccEEEccCCccCCCCCccccCcccCceEeeecccccccCchhhhhccc
Q 038671 188 SKLGKLSSLIKLILNSNQLCGQLSLELGSLTQLERLDLSSNRLSNSIPKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIH 267 (707)
Q Consensus 188 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 267 (707)
..++.+++|++|+|++|+|+.. + .+..+++|++|+|++|.|+. ++..+..+++|+.|++++|+++.. ..+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHHHH
T ss_pred hHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccc-cccccccccccccccccccccccc--cccccccc
Confidence 4455555555555555555522 1 24455555555555555552 233333344566666666665432 23555566
Q ss_pred CCeeeecCccCCCCCC-cccccccccceEeccccccCCchhH----------hhccCCCceeEe
Q 038671 268 LSELDLSHNFLGEEMP-SQICNMQSLEKLNLSHNNLSGFIPS----------CFEELHGLSYID 320 (707)
Q Consensus 268 L~~L~l~~n~l~~~~~-~~~~~~~~L~~L~l~~n~i~~~~~~----------~~~~~~~L~~l~ 320 (707)
|+.|++++|.|++... ..+..+++|+.|++++|++....+. .+..+|+|+.||
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 6666666666643211 2355556666666666665432211 245667777765
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=7.1e-13 Score=116.82 Aligned_cols=107 Identities=19% Similarity=0.122 Sum_probs=83.9
Q ss_pred CCceeeccCCeeeecCCccccCCCCCCeEECCCC-ccccccCcCccCCCCCcEEEcccCcCcccCCccccCCCCCCeeec
Q 038671 4 NLAFLYLYNNSFSGSIPSEIGRLKSLSDLELSGN-KLCGSIPHSLGNLTQITFLTLFDNALSGAIPKEYGNLVKLTLLTL 82 (707)
Q Consensus 4 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n-~i~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~l 82 (707)
..+.++.++++++ ..|..+..+++|++|++++| .++.+.+++|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 4566788888888 66777888888888888765 477666677888888888888888888777888888888888888
Q ss_pred ccccccccCCCCCCCCCccEEEeccCccc
Q 038671 83 ENNQLRGPIPNLRNLTSLVRVRLNQNHLT 111 (707)
Q Consensus 83 ~~n~i~~~~~~l~~l~~L~~L~l~~n~l~ 111 (707)
++|+|+.++.......+|+.|+|++|.+.
T Consensus 88 s~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 88 SFNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred cCCCCcccChhhhccccccccccCCCccc
Confidence 88888877776555557888888888764
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=1.2e-12 Score=115.43 Aligned_cols=106 Identities=15% Similarity=0.106 Sum_probs=65.9
Q ss_pred CCeeecccccccccCCCCCCCCCccEEEeccC-ccccccCccccCCCCCcEEEcccccccccCCCCCCCCCCCcEEEcCC
Q 038671 77 LTLLTLENNQLRGPIPNLRNLTSLVRVRLNQN-HLTGNISESFGIHPNLAFIDLSHNYFYGEISSDWGRCPKLGTLDFSS 155 (707)
Q Consensus 77 L~~L~l~~n~i~~~~~~l~~l~~L~~L~l~~n-~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~L~~ 155 (707)
.+.++.+++.+.+.+..+..+++|++|++++| .++.+...+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++
T Consensus 10 ~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 10 SSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34555666666555555666666666666544 36666666666666677777777766666666666666666666666
Q ss_pred CccCCCCchhhhCCCCCCEEeCCCCCCC
Q 038671 156 NNITGSMPAEIIHSSQLKVLDLSSNHIV 183 (707)
Q Consensus 156 n~i~~~~~~~~~~~~~L~~L~l~~n~l~ 183 (707)
|+++......|.. .+|+.|+|++|.+.
T Consensus 90 N~l~~l~~~~~~~-~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALESLSWKTVQG-LSLQELVLSGNPLH 116 (156)
T ss_dssp SCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred CCCcccChhhhcc-ccccccccCCCccc
Confidence 6666444444433 35666666666653
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.60 E-value=2.4e-09 Score=94.51 Aligned_cols=80 Identities=31% Similarity=0.260 Sum_probs=34.6
Q ss_pred cccCceEeeecccccccC--chhhhhcccCCeeeecCccCCCCCCcccccccccceEeccccccCCchh-------Hhhc
Q 038671 241 LVKLHYLNLSNNQFIKKI--PVELEKLIHLSELDLSHNFLGEEMPSQICNMQSLEKLNLSHNNLSGFIP-------SCFE 311 (707)
Q Consensus 241 l~~L~~L~l~~n~l~~~~--~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~l~~n~i~~~~~-------~~~~ 311 (707)
+++|++|+|++|+|+... +..+..+++|+.|++++|.|++..+-.+.....|+.|++++|++.+... ..+.
T Consensus 64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~ 143 (162)
T d1koha1 64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRE 143 (162)
T ss_dssp CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHT
T ss_pred CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHH
Confidence 344444444444443332 1223444445555555555433222222223344555555555543221 2244
Q ss_pred cCCCceeEe
Q 038671 312 ELHGLSYID 320 (707)
Q Consensus 312 ~~~~L~~l~ 320 (707)
.+|+|+.||
T Consensus 144 ~~P~L~~LD 152 (162)
T d1koha1 144 RFPKLLRLD 152 (162)
T ss_dssp TSTTCCEET
T ss_pred HCCCCCEEC
Confidence 566666654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.53 E-value=1.6e-07 Score=90.21 Aligned_cols=149 Identities=13% Similarity=0.085 Sum_probs=101.7
Q ss_pred HHHHHhcCCCCCceeeecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCC
Q 038671 430 EIIRVTNDFDDEHCIGKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHAR 508 (707)
Q Consensus 430 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 508 (707)
++......|+..+..+.++.+.||+... +++.+++|+....... ....+.+|...+..+. +--+++++++...++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 4556667787776655555678999875 4556788876543211 1224567777777664 444678888888888
Q ss_pred ceeEEEeeeccCcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 038671 509 HSFIVYEYLEMGSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHNDC------------------------------ 558 (707)
Q Consensus 509 ~~~lv~e~~~~~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------ 558 (707)
..++||++++|.++.+.... ......++.++++.++.||+..
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred ceEEEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 99999999999988765421 1122334556666666666431
Q ss_pred --------------------------CCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 559 --------------------------FPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 559 --------------------------~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
.+.++|+|+.|.||++++++.+.|.||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 02379999999999999776677999998853
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.52 E-value=4.2e-09 Score=92.87 Aligned_cols=66 Identities=30% Similarity=0.324 Sum_probs=35.2
Q ss_pred CCCCcccEEEccCCccCCCC--CccccCcccCceEeeecccccccCchhhhhcccCCeeeecCccCCC
Q 038671 215 GSLTQLERLDLSSNRLSNSI--PKSLGNLVKLHYLNLSNNQFIKKIPVELEKLIHLSELDLSHNFLGE 280 (707)
Q Consensus 215 ~~l~~L~~L~l~~n~i~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 280 (707)
..+++|++|+|++|+|+... +..+..+++|+.|+|++|.|+......+.+..+|++|++++|+++.
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~ 129 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCc
Confidence 44556666666666665432 2334455566666666666555444333334455666666666544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.19 E-value=2.9e-06 Score=80.62 Aligned_cols=131 Identities=15% Similarity=0.132 Sum_probs=85.2
Q ss_pred eeeecCC-eeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC--CCceeeeeeeeecCCceeEEEeeecc
Q 038671 443 CIGKGGQ-GSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR--HRNIVKFYGFCSHARHSFIVYEYLEM 519 (707)
Q Consensus 443 ~lg~G~~-g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~ 519 (707)
.+..|.. +.||+....++..+++|....... ..+..|+..++.+. .-.+++++++..+++..++||++++|
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 4455554 678999888888899998654322 23556677666663 33467788888888899999999998
Q ss_pred CcHHHHHhcccccCCCChHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 038671 520 GSLAMILSNDAAAKDLGWTKRMNVIKGVVDALSYMHN------------------------------------------- 556 (707)
Q Consensus 520 ~~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~------------------------------------------- 556 (707)
.++.+.. .. ....+.++.+.++-||+
T Consensus 91 ~~~~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (255)
T d1nd4a_ 91 QDLLSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 159 (255)
T ss_dssp EETTTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred ccccccc--------cc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHH
Confidence 7663210 00 01112222333333332
Q ss_pred --------CC----CCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 557 --------DC----FPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 557 --------~~----~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
.. .+.++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 11 12479999999999999776678999998753
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.04 E-value=1.2e-06 Score=77.02 Aligned_cols=86 Identities=14% Similarity=0.142 Sum_probs=38.5
Q ss_pred CCCCcEEEcCCC-ccCCC----CchhhhCCCCCCEEeCCCCCCCC----CCChhhhCCCCCcEEEecCCccccCC----c
Q 038671 145 CPKLGTLDFSSN-NITGS----MPAEIIHSSQLKVLDLSSNHIVG----EMPSKLGKLSSLIKLILNSNQLCGQL----S 211 (707)
Q Consensus 145 ~~~L~~L~L~~n-~i~~~----~~~~~~~~~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~l~~n~l~~~~----~ 211 (707)
.++|++|+|+++ .++.. ....+...++|+.|+|++|.+.. .+...+...+.|++|++++|.++... .
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 345555555542 24321 12233344555555555555542 12223334455555555555555321 1
Q ss_pred cccCCCCcccEEEccCCcc
Q 038671 212 LELGSLTQLERLDLSSNRL 230 (707)
Q Consensus 212 ~~~~~l~~L~~L~l~~n~i 230 (707)
..+...++|++|+|++|.+
T Consensus 94 ~aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HHTTTTCCCSEEECCCCSS
T ss_pred HHHHhCCcCCEEECCCCcC
Confidence 2233444555555555443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.00 E-value=8e-07 Score=78.21 Aligned_cols=87 Identities=15% Similarity=0.195 Sum_probs=47.0
Q ss_pred CCCCCCeEECCCC-ccccc----cCcCccCCCCCcEEEcccCcCcccCCc----cccCCCCCCeeecccccccc-----c
Q 038671 25 RLKSLSDLELSGN-KLCGS----IPHSLGNLTQITFLTLFDNALSGAIPK----EYGNLVKLTLLTLENNQLRG-----P 90 (707)
Q Consensus 25 ~l~~L~~L~l~~n-~i~~~----~~~~~~~l~~L~~L~L~~n~i~~~~~~----~~~~l~~L~~L~l~~n~i~~-----~ 90 (707)
+.++|++|+|+++ .++.. +..++...+.|++|+|++|.+...... .+...+.|++|+|++|.|+. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 3466777777653 35432 233455566677777777766533222 23344566666666666653 2
Q ss_pred CCCCCCCCCccEEEeccCccc
Q 038671 91 IPNLRNLTSLVRVRLNQNHLT 111 (707)
Q Consensus 91 ~~~l~~l~~L~~L~l~~n~l~ 111 (707)
..++...++|++|++++|.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHhCCcCCEEECCCCcCC
Confidence 223555555666666555443
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.58 E-value=0.00012 Score=73.66 Aligned_cols=79 Identities=15% Similarity=0.036 Sum_probs=48.2
Q ss_pred CceeeecCCeeEEEEEcCC-CcEEEEEecCCCC----CchhhhHHHHHHHHHHHhcCC-C--CceeeeeeeeecCCceeE
Q 038671 441 EHCIGKGGQGSVYKAELPS-GEIVAVKKFHSPL----PSEMASQQEFLNEVKTLTGIR-H--RNIVKFYGFCSHARHSFI 512 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~l 512 (707)
.+.||.|....||+++..+ ++.++||...... ..-.....+...|++.++.+. + ..+++++.+. +...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 3568999999999997654 6789999653211 000112234456777776652 2 3466666553 445679
Q ss_pred EEeeeccCc
Q 038671 513 VYEYLEMGS 521 (707)
Q Consensus 513 v~e~~~~~~ 521 (707)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.51 E-value=1.8e-05 Score=69.31 Aligned_cols=87 Identities=14% Similarity=0.160 Sum_probs=41.4
Q ss_pred CcccCceEeeecccccccCch----hhhhcccCCeeeecCccCCCCC----CcccccccccceEec--cccccCCc----
Q 038671 240 NLVKLHYLNLSNNQFIKKIPV----ELEKLIHLSELDLSHNFLGEEM----PSQICNMQSLEKLNL--SHNNLSGF---- 305 (707)
Q Consensus 240 ~l~~L~~L~l~~n~l~~~~~~----~~~~l~~L~~L~l~~n~l~~~~----~~~~~~~~~L~~L~l--~~n~i~~~---- 305 (707)
..++|++|++++|.++..... .+...++++.+++++|.++... ...+...++|+.++| ++|++.+.
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~ 123 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME 123 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence 344455555555544333221 2333455555555555553321 123344455554333 34555432
Q ss_pred hhHhhccCCCceeEeeccCcc
Q 038671 306 IPSCFEELHGLSYIDISYNEL 326 (707)
Q Consensus 306 ~~~~~~~~~~L~~l~l~~n~~ 326 (707)
+.+.+...++|+.|++++++.
T Consensus 124 La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 124 IANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHhCCCcCEEeCcCCCC
Confidence 234455666777777766654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.43 E-value=1.9e-05 Score=69.05 Aligned_cols=11 Identities=18% Similarity=0.480 Sum_probs=5.3
Q ss_pred CCCCcEEEcCC
Q 038671 145 CPKLGTLDFSS 155 (707)
Q Consensus 145 ~~~L~~L~L~~ 155 (707)
.++|++|+|++
T Consensus 16 ~~~L~~L~L~~ 26 (166)
T d1io0a_ 16 DPDLEEVNLNN 26 (166)
T ss_dssp CTTCCEEECTT
T ss_pred CCCCcEEEcCC
Confidence 34455555544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.16 E-value=0.00047 Score=67.24 Aligned_cols=138 Identities=13% Similarity=0.132 Sum_probs=78.0
Q ss_pred cCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCce--eeeee-----eeecCCceeEEEeeecc
Q 038671 447 GGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRNI--VKFYG-----FCSHARHSFIVYEYLEM 519 (707)
Q Consensus 447 G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~-----~~~~~~~~~lv~e~~~~ 519 (707)
|..-.||+++..+|+.|++|+.+.... ..+++..|...+..|....+ +..+. .....+..+.+++++.|
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 334579999999999999999765322 24557778888777742222 11111 22445677889999886
Q ss_pred CcHH-----HH------H---hc----ccc-c-CC-------------------CChHHHHHHHHHHHHHHHHHHh----
Q 038671 520 GSLA-----MI------L---SN----DAA-A-KD-------------------LGWTKRMNVIKGVVDALSYMHN---- 556 (707)
Q Consensus 520 ~~L~-----~~------l---~~----~~~-~-~~-------------------l~~~~~~~i~~~i~~~l~~LH~---- 556 (707)
..+. .+ + |. ... . .. ++......+...+.+.++.+..
T Consensus 109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 188 (325)
T d1zyla1 109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 188 (325)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred cCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccc
Confidence 5431 11 0 10 000 0 00 1111111122222223333322
Q ss_pred CCCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 557 DCFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 557 ~~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
....++||+|+.+.||+++. + ..+.||+-+..
T Consensus 189 ~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 189 DFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp CSCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred cCCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 12247899999999999974 3 45899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.11 E-value=0.0028 Score=61.29 Aligned_cols=159 Identities=12% Similarity=0.075 Sum_probs=84.7
Q ss_pred chHHHHHHHhcCCCCCcee-----eecCCeeEEEEEcCCCcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCCCCc--ee
Q 038671 426 IVYEEIIRVTNDFDDEHCI-----GKGGQGSVYKAELPSGEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIRHRN--IV 498 (707)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~l-----g~G~~g~vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv 498 (707)
.+.++++.+..+|.+++.. ..|---+.|+.+..+|+ +++|++..... .+++..|++.+..+...+ ++
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pvp 76 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSCP 76 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC--------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC-----HHHHHHHHHHHHhhhhcccccc
Confidence 4567888888999886654 35656778999876665 89998764321 133455666666663222 22
Q ss_pred eeee------eeecCCceeEEEeeeccCcHHH-----------H---Hhcc----cccC--------------------C
Q 038671 499 KFYG------FCSHARHSFIVYEYLEMGSLAM-----------I---LSND----AAAK--------------------D 534 (707)
Q Consensus 499 ~~~~------~~~~~~~~~lv~e~~~~~~L~~-----------~---l~~~----~~~~--------------------~ 534 (707)
..+. +....+..+.++.+..+..... . ++.. .... .
T Consensus 77 ~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (316)
T d2ppqa1 77 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD 156 (316)
T ss_dssp CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred ccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhh
Confidence 2211 1223344556666655432210 0 0000 0000 0
Q ss_pred CChHHHHHHHHHHHHHHHHHHhC-CCCCeEecCCCCCCeeecCCCCeEEecccccee
Q 038671 535 LGWTKRMNVIKGVVDALSYMHND-CFPPIVHRDISSKNVLLDLENEAHVSDFGTAKF 590 (707)
Q Consensus 535 l~~~~~~~i~~~i~~~l~~LH~~-~~~~ivH~dlk~~Nil~~~~~~~kl~Dfg~~~~ 590 (707)
.........+..+...+...+.. ...|+||+|+.+.||+++.+...-|.||+.+..
T Consensus 157 ~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 157 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 01111122222333333333321 123899999999999999887778999998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.66 E-value=0.0022 Score=64.16 Aligned_cols=73 Identities=19% Similarity=0.250 Sum_probs=49.2
Q ss_pred CceeeecCCeeEEEEEcCC--------CcEEEEEecCCCCCchhhhHHHHHHHHHHHhcCC-CCceeeeeeeeecCCcee
Q 038671 441 EHCIGKGGQGSVYKAELPS--------GEIVAVKKFHSPLPSEMASQQEFLNEVKTLTGIR-HRNIVKFYGFCSHARHSF 511 (707)
Q Consensus 441 ~~~lg~G~~g~vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~ 511 (707)
.++|+.|-.-.+|+++.++ .+.|++++.... .. .....+|..+++.+. +.-.+++++++.+ .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~----~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET----ESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch----hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 3568889999999997543 356777776532 11 123456888887774 4445678887753 4
Q ss_pred EEEeeeccCcH
Q 038671 512 IVYEYLEMGSL 522 (707)
Q Consensus 512 lv~e~~~~~~L 522 (707)
+|+||++|.++
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 78999987655
|